Citrus Sinensis ID: 040925
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 833 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.979 | 0.807 | 0.426 | 0.0 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.969 | 0.788 | 0.442 | 1e-180 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.973 | 0.786 | 0.421 | 1e-177 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.967 | 0.822 | 0.360 | 1e-127 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.956 | 0.679 | 0.319 | 1e-109 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.945 | 0.690 | 0.296 | 1e-100 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.939 | 0.625 | 0.316 | 1e-99 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.954 | 0.636 | 0.314 | 4e-98 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.942 | 0.774 | 0.299 | 1e-97 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.942 | 0.658 | 0.313 | 3e-97 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 662 bits (1707), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/852 (42%), Positives = 540/852 (63%), Gaps = 36/852 (4%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L + N + G+LP +GNL+ LE + + N+L G+IP+ + L + SL + N FS
Sbjct: 164 LVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFS 223
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G+FP ++ N+SSL+L+ + N FSG L D+ + LPNL + +GGN F GSIP +LSN S
Sbjct: 224 GVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNIS 283
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
LE L ++ N G++ F ++ NL L L N+LG+ ++ DL+F+T LTNC+ L+ L
Sbjct: 284 TLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLG 342
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ N+ GG+LP SIANLS+ ++ +G ISG+IP I NL+NL ++N L G +P
Sbjct: 343 IGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLP 402
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
++G+L NL+ L LF N L G IP+ +GN+T L L+LS+N +G +P+SLGNC +L+
Sbjct: 403 TSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLEL 462
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
NKL G +P +++ I L L LD+S N L GSLP +G L+NL L + N+ SG +
Sbjct: 463 WIGDNKLNGTIPLEIMKIQQL-LRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKL 521
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P TL C+ +E L + N F+G IP L L +KE+++S+N+LSG IPE+ + S LE+
Sbjct: 522 PQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEY 580
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHL-------PSCPSKGSRKPK 473
L+LS+N+ EG+VP KG+F N T +S+ GN LCGGI L PS K S + K
Sbjct: 581 LNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLK 640
Query: 474 IILLKVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSP--MEKQFPMVSYAELSKATG 531
+++ V + + + L+ + +T+++ RKR+ ++ + +P +E +SY +L AT
Sbjct: 641 KVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATN 700
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
FSSSNM+G GSFG VYK L ++ +VAVKV+N++ +GA +SF+AECE+L++IRHRNL+
Sbjct: 701 GFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLV 760
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK----LSLIQRVNIAID 647
K++T CSS DF+G +F+A ++E+M NGSL WLH + + E+ + L+L++R+NIAID
Sbjct: 761 KLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVE-EIHRPSRTLTLLERLNIAID 819
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
VAS ++YLH HC P+ H DLKPSNVLLD D+ AHV DFGLA+ L ++ SS+
Sbjct: 820 VASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSA 879
Query: 708 IGLKGTVGYVAPEYGMGSEASMTGDI----------FTGRRPIDAVFNEGHSLHEFAKTA 757
G++GT+GY APEYG+G + S+ GD+ FTG+RP + +F +L+ + K+A
Sbjct: 880 -GVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSA 938
Query: 758 LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDV 817
LPE++++IVD S+L I ECL + G+ C ESP R+ V
Sbjct: 939 LPERILDIVDESIL--------HIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIV 990
Query: 818 VAKLCHTRETFL 829
V +L RE F
Sbjct: 991 VKELISIRERFF 1002
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 631 bits (1628), Expect = e-180, Method: Compositional matrix adjust.
Identities = 375/847 (44%), Positives = 530/847 (62%), Gaps = 39/847 (4%)
Query: 9 NYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSIC 68
N LTG+ P +GNL+ L+++ + N + G+IP + L+ ++ +A NKF+G+FP I
Sbjct: 187 NNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFPPPIY 246
Query: 69 NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLS 128
N+SSL + + N FSG L D LPNL+ L +G N+F G+IP +LSN S+L LD+
Sbjct: 247 NLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSLRQLDIP 306
Query: 129 VNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGG 188
N G + + F L+NLL L L N+LG ++ DLDF+ LTNCS L+ L++ N+ GG
Sbjct: 307 SNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVGFNKLGG 366
Query: 189 ELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKN 248
+LP IANLS+ + +G N ISG+IP GI NLV+L EN L G +P ++GEL
Sbjct: 367 QLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLPPSLGELSE 426
Query: 249 LQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT 308
L+K+ L+ N L G IPS LGN++ L L L +NS +G+IPSSLG+C L+ NKL
Sbjct: 427 LRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDLNLGTNKLN 486
Query: 309 GALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCV 368
G++PH+L+ + +L + L++S NLL G L +G LK L+ LD+S N+ SG IP TL+ C+
Sbjct: 487 GSIPHELMELPSL-VVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIPQTLANCL 545
Query: 369 CLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHF 428
LE+L + NSF G IP + L ++ L++S NNLSG IPE++ N S L+ L+LS N+F
Sbjct: 546 SLEFLLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNLNLSLNNF 604
Query: 429 EGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSC----PSKGSRKPKIILLKVLIPVA 484
+G VPT+GVF N + +S+ GN+ LCGGI L L C P + S KII + V +A
Sbjct: 605 DGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITICVSAVMA 664
Query: 485 VSSLILSSCLTIVYARKRRSAQKFVDT------SPMEKQFPMVSYAELSKATGEFSSSNM 538
L+ + + + + R + + + SP++ + +SY EL K TG FSSSN+
Sbjct: 665 ALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTGGFSSSNL 724
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG G+FG V+KG LG VA+KV+NL +GA++SF+AECEAL IRHRNL+K++TICS
Sbjct: 725 IGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLVKLVTICS 784
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVC-----KLSLIQRVNIAIDVASAME 653
S+DF+G DF+A V+E+M NG+L WLH D++E L L R+NIAIDVASA+
Sbjct: 785 SSDFEGNDFRALVYEFMPNGNLDMWLHP--DEIEETGNPSRTLGLFARLNIAIDVASALV 842
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YLH +C P+ H D+KPSN+LLD D+ AHV DFGLA+ L DT SS G++GT
Sbjct: 843 YLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDT-FHIQFSSAGVRGT 901
Query: 714 VGYVAPEYGMGSEASMTGD----------IFTGRRPIDAVFNEGHSLHEFAKTALPEK-V 762
+GY APEYGMG S+ GD IFTG+RP + +F +G +LH F K+AL ++
Sbjct: 902 IGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTKSALQKRQA 961
Query: 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822
++I D ++L + ECL + R GV CS ESP R+ M + ++KL
Sbjct: 962 LDITDETILRGAYA--------QHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKLV 1013
Query: 823 HTRETFL 829
RE+F
Sbjct: 1014 SIRESFF 1020
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 622 bits (1603), Expect = e-177, Method: Compositional matrix adjust.
Identities = 361/857 (42%), Positives = 516/857 (60%), Gaps = 46/857 (5%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L ++ N LTG P +GNL+ L+ + N + G+IP + L +V +A N FS
Sbjct: 171 LAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFS 230
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G FP ++ NISSLE + LA N FSGNL D LPNL+ L +G N F G+IP +L+N S
Sbjct: 231 GGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANIS 290
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
+LE D+S N G++ + F L+NL WL + N+LG +++ L+F+ + NC+ L+ L
Sbjct: 291 SLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLD 350
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ N+ GGELP SIANLS+T+ + +G+N ISGTIP I NLV+L E N L G +P
Sbjct: 351 VGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELP 410
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ G+L NLQ + L+ N + G IPS GN+T+L L L+SNS G IP SLG C+ L+
Sbjct: 411 VSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDL 470
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
N+L G +P ++L I +L+ Y+DLSNN L G P +VG L+ LV L S N+ SG +
Sbjct: 471 WMDTNRLNGTIPQEILQIPSLA-YIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSGKM 529
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P + C+ +E+L + NSF G IP +S L S+K ++ S+NNLSG+IP +L +L L
Sbjct: 530 PQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRN 588
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGS---RKPKIILL 477
L+LS N FEG VPT GVF N T +S+ GN +CGG+ E+ L C + S RKP +
Sbjct: 589 LNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRK 648
Query: 478 KVL--IPVAVSSLILSSCL-TIVYARKRRSAQKFVDTSPMEKQ-----FPMVSYAELSKA 529
KV+ I + ++SL+L + ++ + KR+ D +P + VSY EL A
Sbjct: 649 KVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSA 708
Query: 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRN 589
T FSS+N+IG G+FG V+KG LG + +VAVKV+NL GA++SF+AECE + IRHRN
Sbjct: 709 TSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRN 768
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD-DQVEVCKLSLI--QRVNIAI 646
L+K+IT+CSS D +G DF+A V+E+M GSL WL D ++V SL +++NIAI
Sbjct: 769 LVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAI 828
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
DVASA+EYLH HC P+ H D+KPSN+LLD D+ AHV DFGLA+ L + ++ + SS
Sbjct: 829 DVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSS 888
Query: 707 SIGLKGTVGYVAPEYGMGSEASMTGDI----------FTGRRPIDAVFNEGHSLHEFAKT 756
+ G++GT+GY APEYGMG + S+ GD+ F+G++P D F ++LH + K+
Sbjct: 889 A-GVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKS 947
Query: 757 ALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRD 816
L + +E L +++ G+ CS E P +RM +
Sbjct: 948 IL-------------------SGCTSSGGSNAIDEGLRLVLQVGIKCSEEYPRDRMRTDE 988
Query: 817 VVAKLCHTRETFLGRRV 833
V +L R F +
Sbjct: 989 AVRELISIRSKFFSSKT 1005
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 456 bits (1172), Expect = e-127, Method: Compositional matrix adjust.
Identities = 320/887 (36%), Positives = 467/887 (52%), Gaps = 81/887 (9%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSD-LEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKF 59
L L ++ N+ G++P +G+L + L+ + + N L G IP LGLL LV L++ N+
Sbjct: 92 LTVLDLSRNFFVGKIPPEIGSLHETLKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRL 151
Query: 60 SGMFPRSI-CN--ISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL 116
+G P + CN SSL+ I L+ N +G +P + +L L+ L + N G++P SL
Sbjct: 152 NGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSL 211
Query: 117 SNASNLELLDLSVNQFKGNV-SIDFSSLKNLLWLNLEQNN-LGTGTATDLD-FVTFLTNC 173
SN++NL+ +DL N G + S S + L +L L N+ + T+L+ F L N
Sbjct: 212 SNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANS 271
Query: 174 SSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-------------- 219
S L+ L LA N GGE+ S+ +LS ++ + +N+I G+IPP I
Sbjct: 272 SDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLNLSSN 331
Query: 220 -------RNLVNLIGFGA---EENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGN 269
R L L N L G IP +G++ L L + RN L G IP GN
Sbjct: 332 LLSGPIPRELCKLSKLERVYLSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGN 391
Query: 270 LTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLS-ITTLSLYLDLS 328
L++L L L N L G +P SLG C NL S N LTG +P +++S + L LYL+LS
Sbjct: 392 LSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLS 451
Query: 329 NNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSL 388
+N L+G +PL++ + ++ +D+SSN+ SG IP L +C+ LE+L++S N F +P SL
Sbjct: 452 SNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSL 511
Query: 389 SFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQG 448
L +KEL+VS N L+G IP + S L+ L+ S+N G V KG FS T S G
Sbjct: 512 GQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLG 571
Query: 449 NMKLCGGIDELHLPSCPSKGS---RKPKIILLKVLIPV-------AVSSLILSSCLTIVY 498
+ LCG I + +C K ++L + PV V LT+
Sbjct: 572 DSLLCGSIKGMQ--ACKKKHKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYA 629
Query: 499 ARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMI 558
+ +K P ++P +SY +L ATG F++S++IG G FG+VYKG L +
Sbjct: 630 KEEVEDEEKQNQNDP---KYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVL-RNNTK 685
Query: 559 VAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMEN 617
VAVKV++ K S SF EC+ L+ RHRNLI+IIT CS F A V M N
Sbjct: 686 VAVKVLDPKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK-----PGFNALVLPLMPN 740
Query: 618 GSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH 677
GSL+ L+ + + L LIQ VNI DVA + YLHH+ +VH DLKPSN+LLD
Sbjct: 741 GSLERHLYPGEYSSK--NLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDD 798
Query: 678 DMVAHVCDFGLAKFLSDHQ----LDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDI 733
+M A V DFG+++ + + D +V S+ L G+VGY+APEYGMG AS GD+
Sbjct: 799 EMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDV 858
Query: 734 F----------TGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQE 783
+ +GRRP D + NEG SLHEF K+ P+ + I++ +L + +
Sbjct: 859 YSFGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQAL-------SRWKPQ 911
Query: 784 DKRVKTE----ECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826
K K E E + +I G++C+ +P R DM DV ++ +E
Sbjct: 912 GKPEKCEKLWREVILEMIELGLVCTQYNPSTRPDMLDVAHEMGRLKE 958
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 397 bits (1021), Expect = e-109, Method: Compositional matrix adjust.
Identities = 294/920 (31%), Positives = 463/920 (50%), Gaps = 123/920 (13%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTL----------------- 43
L L + DN LTG++P +GNL L+ +RI N L IP++L
Sbjct: 266 LVQLELYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLV 325
Query: 44 -------GLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLP 96
G L +L L + N F+G FP+SI N+ +L ++ + N SG LP D+ + L
Sbjct: 326 GPISEEIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL-LT 384
Query: 97 NLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156
NL+ L+ N G IP S+SN + L+LLDLS NQ G + F + NL ++++ +N+
Sbjct: 385 NLRNLSAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHF 443
Query: 157 GTGTATDLDFVTFLTNCSSLKALSLADNQFGGEL------------------------PH 192
TG D F NCS+L+ LS+ADN G L P
Sbjct: 444 -TGEIPDDIF-----NCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPR 497
Query: 193 SIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKL 252
I NL I + + N +G IP + NL L G N L G IP+ + ++K L L
Sbjct: 498 EIGNLKDLNILY-LHSNGFTGRIPREMSNLTLLQGLRMYSNDLEGPIPEEMFDMKLLSVL 556
Query: 253 CLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALP 312
L N G+IP+ L L L L N G+IP+SL + L +F S N LTG +P
Sbjct: 557 DLSNNKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIP 616
Query: 313 HQLL-SITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTC---V 368
+LL S+ + LYL+ SNNLL G++P ++G L+ + +D+S+N FSG IP +L C
Sbjct: 617 GELLASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVF 676
Query: 369 CLEY----------------------LDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG 406
L++ L++S NSF G IP S + + L++SSNNL+G
Sbjct: 677 TLDFSQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTG 736
Query: 407 QIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPS 466
+IPE L NLS L+ L L+ N+ +G VP GVF N L GN LCG L +
Sbjct: 737 EIPESLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQ 796
Query: 467 KG---SRKPKIILL----KVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFP 519
K S++ ++IL+ + + + +++ +C + S++ + +
Sbjct: 797 KSSHFSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLK 856
Query: 520 MVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVA 577
EL +AT F+S+N+IG S VYKG L ED ++AVKV+NLK A + F
Sbjct: 857 RFEPKELEQATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWFYT 915
Query: 578 ECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLS 637
E + L ++HRNL+KI+ ++ KA V +MENG+L+D +H S + S
Sbjct: 916 EAKTLSQLKHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAPIG----S 967
Query: 638 LIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL 697
L++++++ + +AS ++YLH P+VH DLKP+N+LLD D VAHV DFG A+ L +
Sbjct: 968 LLEKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFRED 1027
Query: 698 DTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRP--IDAVFN 745
+ T +S+ +GT+GY+APE+ + + D+F T +RP ++ +
Sbjct: 1028 GS---TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDS 1084
Query: 746 EGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSM 805
+ +L + + ++ +V ++++ +S++ +K EE + ++ + C+
Sbjct: 1085 QDMTLRQLVEKSIGNGRKGMVR---VLDMELGDSIVS----LKQEEAIEDFLKLCLFCTS 1137
Query: 806 ESPFERMDMRDVVAKLCHTR 825
P +R DM +++ L R
Sbjct: 1138 SRPEDRPDMNEILTHLMKLR 1157
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 366 bits (939), Expect = e-100, Method: Compositional matrix adjust.
Identities = 275/928 (29%), Positives = 423/928 (45%), Gaps = 140/928 (15%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGN-SLGGKIPTTLGLLRNLVSLNVAENKF 59
L++L + DN LTG +P +G LS LEVIRI GN + G+IP+ +G NL L +AE
Sbjct: 179 LKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSV 238
Query: 60 SGMFPRSICNISSLELIQLALNRFSGNLPFDI-----------------------VVNLP 96
SG P S+ + LE + + SG +P D+ + L
Sbjct: 239 SGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIGQLT 298
Query: 97 NLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156
L+ L + N+ G IP + N SNL+++DLS+N G++ L L + N
Sbjct: 299 KLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKF 358
Query: 157 GTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIP 216
T + +NCSSL L L NQ G +P + L+ + F NQ+ G+IP
Sbjct: 359 SGSIPTTI------SNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWS-NQLEGSIP 411
Query: 217 PGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANL 276
PG+ + +L N L GTIP + L+NL KL L N L G IP +GN + L L
Sbjct: 412 PGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRL 471
Query: 277 ELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSL 336
L N + G IPS +G+ + + S N+L G +P ++ S + L + +DLSNN L GSL
Sbjct: 472 RLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQM-IDLSNNSLEGSL 530
Query: 337 PLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKE 396
P V L L +LD+S+NQFSG IP +L V L L +S N F G IP SL ++
Sbjct: 531 PNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQL 590
Query: 397 LNVSSNNLSGQIPEFLKNLSVLEF------------------------------------ 420
L++ SN LSG+IP L ++ LE
Sbjct: 591 LDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGD 650
Query: 421 ------------LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGI-DELHLPSCPSK 467
L++SYN F G +P +F + L+GN KLC D L
Sbjct: 651 LAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSCFLTYRKGN 710
Query: 468 G-------SRKPKIILLKVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPM 520
G SR K+ L L+ L++ + ++ AR+ ++ + K +
Sbjct: 711 GLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYK-WQF 769
Query: 521 VSYAELSKATGE----FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVI--------NLKY 568
+ +L+ + + N+IG+G G VY+ + E+I K+ + K
Sbjct: 770 TPFQKLNFSVDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGHDEKT 829
Query: 569 KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD 628
K SF AE + L IRH+N+++ + C + + + +++YM NGSL LH+
Sbjct: 830 KNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTR-----LLMYDYMPNGSLGSLLHERR 884
Query: 629 DQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688
L R I + A + YLHH C PP+VH D+K +N+L+ D ++ DFGL
Sbjct: 885 GS----SLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGL 940
Query: 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRR 738
AK + + + T + G+ GY+APEYG + + D++ TG++
Sbjct: 941 AKLVDEGDIGRCSNT------VAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQ 994
Query: 739 PIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIR 798
PID EG L ++ + +E++D S ++ + +E + ++
Sbjct: 995 PIDPTVPEGIHLVDWVRQN--RGSLEVLD-----------STLRSRTEAEADEMMQ-VLG 1040
Query: 799 TGVLCSMESPFERMDMRDVVAKLCHTRE 826
T +LC SP ER M+DV A L ++
Sbjct: 1041 TALLCVNSSPDERPTMKDVAAMLKEIKQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 364 bits (935), Expect = 1e-99, Method: Compositional matrix adjust.
Identities = 280/884 (31%), Positives = 433/884 (48%), Gaps = 101/884 (11%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L +N+N L G L + NL++L+ + N+L GK+P +G L L + + EN+FS
Sbjct: 387 LTNLYLNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFS 446
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G P I N + L+ I NR SG +P I L +L L + N G+IP SL N
Sbjct: 447 GEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIG-RLKDLTRLHLRENELVGNIPASLGNCH 505
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
+ ++DL+ NQ G++ F L L + N+L G D L N +L ++
Sbjct: 506 QMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSL-QGNLPD-----SLINLKNLTRIN 559
Query: 181 LADNQFGGELPHSIANL--SSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGT 238
+ N+F G SI+ L SS+ ++F + N G IP + NL +NQ G
Sbjct: 560 FSSNKFNG----SISPLCGSSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGR 615
Query: 239 IPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLM 298
IP G++ L L + RN L G IP LG KL +++L++N L G IP+ LG L
Sbjct: 616 IPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLG 675
Query: 299 SFTASQNKLTGALPHQLLSITT-LSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFS 357
S NK G+LP ++ S+T L+L+LD N LNGS+P ++G+L+ L L++ NQ S
Sbjct: 676 ELKLSSNKFVGSLPTEIFSLTNILTLFLD--GNSLNGSIPQEIGNLQALNALNLEENQLS 733
Query: 358 GVIPGTLSTCVCL-------------------------EYLDISSNSFHGVIPLSLSFLK 392
G +P T+ L LD+S N+F G IP ++S L
Sbjct: 734 GPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLP 793
Query: 393 SIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKL 452
++ L++S N L G++P + ++ L +L+LSYN+ EG++ K FS + GN L
Sbjct: 794 KLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGL 851
Query: 453 CGGIDELHLPSCPSKGSRKPKIILLK-VLIPVAVSSLILSSCLTIVYA----------RK 501
CG L C GS+ + + K V+I A+SSL + + +V +K
Sbjct: 852 CGS----PLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKK 907
Query: 502 RRSAQKFVDTSPMEKQFPMVS---------YAELSKATGEFSSSNMIGQGSFGYVYKGTL 552
R ++ Q P+ S + ++ +AT + MIG G G VYK L
Sbjct: 908 VRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAEL 967
Query: 553 GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612
E I K++ +++SF E + L IRHR+L+K++ CSS K ++
Sbjct: 968 KNGETIAVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSS---KADGLNLLIY 1024
Query: 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSN 672
EYM NGS+ DWLH +++ + L R+ IA+ +A +EYLH+ C PP+VH D+K SN
Sbjct: 1025 EYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSN 1084
Query: 673 VLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGD 732
VLLD ++ AH+ DFGLAK L+ + DT + S+ G+ GY+APEY +A+ D
Sbjct: 1085 VLLDSNIEAHLGDFGLAKILTGN-YDTNTE---SNTMFAGSYGYIAPEYAYSLKATEKSD 1140
Query: 733 IF----------TGRRPIDAVFNEGHSLHEFAKTAL-----PEKVMEIVDPSLLMEVMTN 777
++ TG+ P +A+F+E + + +T L E +++D L
Sbjct: 1141 VYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSEL------- 1193
Query: 778 NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
S++ + EE ++ + C+ P ER R L
Sbjct: 1194 KSLLPCE-----EEAAYQVLEIALQCTKSYPQERPSSRQASEYL 1232
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 359 bits (922), Expect = 4e-98, Method: Compositional matrix adjust.
Identities = 277/880 (31%), Positives = 430/880 (48%), Gaps = 85/880 (9%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L +++N L G L + NL++L+ + + N+L GK+P + LR L L + EN+FS
Sbjct: 386 LTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFS 445
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G P+ I N +SL++I + N F G +P I L L L + N G +P SL N
Sbjct: 446 GEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIG-RLKELNLLHLRQNELVGGLPASLGNCH 504
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTN-------- 172
L +LDL+ NQ G++ F LK L L L N+L L + LT
Sbjct: 505 QLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRL 564
Query: 173 -------CSSLKALS--LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLV 223
C S LS + +N F E+P + N S + +G+NQ++G IP + +
Sbjct: 565 NGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGN-SQNLDRLRLGKNQLTGKIPWTLGKIR 623
Query: 224 NLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSL 283
L N L GTIP + K L + L NFL G IP LG L++L L+LSSN
Sbjct: 624 ELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQF 683
Query: 284 QGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHL 343
++P+ L NC L+ + N L G++P ++ ++ L++ L+L N +GSLP +G L
Sbjct: 684 VESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNV-LNLDKNQFSGSLPQAMGKL 742
Query: 344 KNLVILDISSNQFSGVIPGTLSTCVCLE-YLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402
L L +S N +G IP + L+ LD+S N+F G IP ++ L ++ L++S N
Sbjct: 743 SKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHN 802
Query: 403 NLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLP 462
L+G++P + ++ L +L++S+N+ G++ K FS S GN LCG L
Sbjct: 803 QLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFSRWPADSFLGNTGLCGS----PLS 856
Query: 463 SCPSKGS--RKPKIILLKVLIPVAVSSLILSSCLTIVYA---RKRR----------SAQK 507
C S ++ + V+I A+S+L + +V A ++R +A
Sbjct: 857 RCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQRHDFFKKVGHGSTAYT 916
Query: 508 FVDTSPMEKQFPM---------VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMI 558
+S P+ + + ++ +AT S MIG G G VYK L E +
Sbjct: 917 SSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETV 976
Query: 559 VAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENG 618
K++ +++SF E + L IRHR+L+K++ CSS K ++EYM+NG
Sbjct: 977 AVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNG 1033
Query: 619 SLKDWLHQSDDQVEVCK--LSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676
S+ DWLH+ +E K L R+ IA+ +A +EYLHH C PP+VH D+K SNVLLD
Sbjct: 1034 SIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLD 1093
Query: 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIF-- 734
+M AH+ DFGLAK L+++ DT S+ + GY+APEY +A+ D++
Sbjct: 1094 SNMEAHLGDFGLAKVLTEN-CDTNT---DSNTWFACSYGYIAPEYAYSLKATEKSDVYSM 1149
Query: 735 --------TGRRPIDAVFNEGHSLHEFAKTALP---EKVMEIVDPSLLMEVMTNNSMIQE 783
TG+ P D+VF + + +T L +++DP L + +E
Sbjct: 1150 GIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKLKPLL-----PFEE 1204
Query: 784 DKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823
D + ++ + C+ SP ER R L H
Sbjct: 1205 DAACQ-------VLEIALQCTKTSPQERPSSRQACDSLLH 1237
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 358 bits (919), Expect = 1e-97, Method: Compositional matrix adjust.
Identities = 256/855 (29%), Positives = 432/855 (50%), Gaps = 70/855 (8%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+ L + N+ G LP NL L + + GN+L G++P+ LG L +L + + N+F
Sbjct: 166 LEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNNLTGELPSVLGQLPSLETAILGYNEFK 225
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G P NI+SL+ + LA+ + SG +P ++ L +L+ L + NNF G+IP + + +
Sbjct: 226 GPIPPEFGNINSLKYLDLAIGKLSGEIPSELG-KLKSLETLLLYENNFTGTIPREIGSIT 284
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L++LD S N G + ++ + LKNL LNL +N L + ++ + L+ L
Sbjct: 285 TLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNKLSGSIPPAI------SSLAQLQVLE 338
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
L +N GELP + +S + + N SG IP + N NL N G IP
Sbjct: 339 LWNNTLSGELPSDLGK-NSPLQWLDVSSNSFSGEIPSTLCNKGNLTKLILFNNTFTGQIP 397
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ ++L ++ + N L G IP G G L KL LEL+ N L G IP + + +L
Sbjct: 398 ATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNRLSGGIPGDISDSVSLSFI 457
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
S+N++ +LP +LSI L +L +++N ++G +P Q +L LD+SSN +G I
Sbjct: 458 DFSRNQIRSSLPSTILSIHNLQAFL-VADNFISGEVPDQFQDCPSLSNLDLSSNTLTGTI 516
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P ++++C L L++ +N+ G IP ++ + ++ L++S+N+L+G +PE + LE
Sbjct: 517 PSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNSLTGVLPESIGTSPALEL 576
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSC-------PSKGSRKPK 473
L++SYN G VP G L+GN LCGG+ LP C S S K
Sbjct: 577 LNVSYNKLTGPVPINGFLKTINPDDLRGNSGLCGGV----LPPCSKFQRATSSHSSLHGK 632
Query: 474 IILLKVLIPVA-VSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFP--MVSYAELSKAT 530
I+ LI +A V +L + + +T +K S D + + ++P ++++ L
Sbjct: 633 RIVAGWLIGIASVLALGILTIVTRTLYKKWYSNGFCGDETASKGEWPWRLMAFHRLGFTA 692
Query: 531 GE----FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY----KGASRSFVAECEAL 582
+ SNMIG G+ G VYK + ++AVK + G + FV E L
Sbjct: 693 SDILACIKESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLL 752
Query: 583 RNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRV 642
+RHRN+++++ V+E+M NG+L D +H + + + + R
Sbjct: 753 GKLRHRNIVRLLGF-----LYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLL-VDWVSRY 806
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVK 702
NIA+ VA + YLHH C PP++H D+K +N+LLD ++ A + DFGLA+ ++ + ++
Sbjct: 807 NIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETVSM- 865
Query: 703 TPSSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHE 752
+ G+ GY+APEYG + DI+ TGRRP++ F E + E
Sbjct: 866 -------VAGSYGYIAPEYGYTLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGESVDIVE 918
Query: 753 FAKTALPEKVM--EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFE 810
+ + + + + E +DP+ + N +QE+ + +++ +LC+ + P +
Sbjct: 919 WVRRKIRDNISLEEALDPN-----VGNCRYVQEEMLL--------VLQIALLCTTKLPKD 965
Query: 811 RMDMRDVVAKLCHTR 825
R MRDV++ L +
Sbjct: 966 RPSMRDVISMLGEAK 980
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 357 bits (915), Expect = 3e-97, Method: Compositional matrix adjust.
Identities = 288/919 (31%), Positives = 435/919 (47%), Gaps = 134/919 (14%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L T + N L+G LP ++G L+ + + N G+IP + L L++A N S
Sbjct: 307 LLTFSAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLS 366
Query: 61 GMFPRSICNISSLELIQLALNRFSG------------------------NLPFDIVVNLP 96
G PR +C SLE I L+ N SG ++P D+ LP
Sbjct: 367 GSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLW-KLP 425
Query: 97 NLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156
L AL + NNF G IP SL ++NL S N+ +G + + + +L L L N L
Sbjct: 426 -LMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQL 484
Query: 157 G------TGTATDLDFVTF------------LTNCSSLKALSLADNQFGGELPHSI---A 195
G T L + L +C+SL L L N G++P I A
Sbjct: 485 TGEIPREIGKLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALA 544
Query: 196 NLSSTVINFGIGRNQISGTIP------------PGIRNLVNLIGFGAEENQLHGTIPDAI 243
L V+++ N +SG+IP P + L + F N+L G IP+ +
Sbjct: 545 QLQCLVLSY----NNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEEL 600
Query: 244 GELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTAS 303
GE L ++ L N L G IP+ L LT L L+LS N+L G+IP +GN L +
Sbjct: 601 GECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLA 660
Query: 304 QNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGT 363
N+L G +P + +L + L+L+ N L+G +P +G+LK L +D+S N SG +
Sbjct: 661 NNQLNGHIPESFGLLGSL-VKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSE 719
Query: 364 LSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSL 423
LST L L I N F G IP L L ++ L+VS N LSG+IP + L LEFL+L
Sbjct: 720 LSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNL 779
Query: 424 SYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGI--DELHLPSCPSKGSRKPKIILLKVLI 481
+ N+ GEVP+ GV + +K L GN +LCG + + + + + ++L I
Sbjct: 780 AKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDCKIEGTKLRSAWGIAGLMLGFTI 839
Query: 482 PVAVSSLILSSCLTIVYARKRRSAQK--------FVDTS-----------PM-------E 515
V V L ++R ++ FVD + P+ E
Sbjct: 840 IVFVFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFE 899
Query: 516 KQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSF 575
+ V ++ +AT FS N+IG G FG VYK L E VAVK ++ +R F
Sbjct: 900 QPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACL-PGEKTVAVKKLSEAKTQGNREF 958
Query: 576 VAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK 635
+AE E L ++H NL+ ++ CS ++ K V+EYM NGSL WL +EV
Sbjct: 959 MAEMETLGKVKHPNLVSLLGYCSF-----SEEKLLVYEYMVNGSLDHWLRNQTGMLEVLD 1013
Query: 636 LSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695
S +R+ IA+ A + +LHH P ++H D+K SN+LLD D V DFGLA+ +S
Sbjct: 1014 WS--KRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLIS-- 1069
Query: 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDAVF- 744
A ++ S++ + GT GY+ PEYG + A+ GD++ TG+ P F
Sbjct: 1070 ----ACESHVSTV-IAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFK 1124
Query: 745 -NEGHSLHEFAKTALPE-KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVL 802
+EG +L +A + + K ++++DP LL+ V NS ++ +++ +L
Sbjct: 1125 ESEGGNLVGWAIQKINQGKAVDVIDP-LLVSVALKNSQLR-------------LLQIAML 1170
Query: 803 CSMESPFERMDMRDVVAKL 821
C E+P +R +M DV+ L
Sbjct: 1171 CLAETPAKRPNMLDVLKAL 1189
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 833 | ||||||
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.985 | 0.789 | 0.491 | 0.0 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.980 | 0.800 | 0.494 | 0.0 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.985 | 0.431 | 0.488 | 0.0 | |
| 224081190 | 1011 | predicted protein [Populus trichocarpa] | 0.987 | 0.814 | 0.485 | 0.0 | |
| 224113117 | 1006 | predicted protein [Populus trichocarpa] | 0.995 | 0.824 | 0.484 | 0.0 | |
| 449441592 | 1023 | PREDICTED: probable LRR receptor-like se | 0.987 | 0.804 | 0.472 | 0.0 | |
| 357484501 | 1006 | Kinase-like protein [Medicago truncatula | 0.979 | 0.811 | 0.479 | 0.0 | |
| 255577438 | 1028 | receptor-kinase, putative [Ricinus commu | 0.987 | 0.800 | 0.473 | 0.0 | |
| 224127492 | 1022 | predicted protein [Populus trichocarpa] | 0.991 | 0.808 | 0.469 | 0.0 | |
| 449499190 | 1023 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.987 | 0.804 | 0.470 | 0.0 |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/851 (49%), Positives = 557/851 (65%), Gaps = 30/851 (3%)
Query: 9 NYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSIC 68
N LTG +PD +GNL+ ++ + N L G IP LG L+ L + + N FSG+ P S+
Sbjct: 187 NNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVY 246
Query: 69 NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLS 128
N+SSLE+ L N+ G+LP+D+ LPNL+ L IG N+F GS+P SLSNASNL D++
Sbjct: 247 NMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGSLPSSLSNASNLLEFDIT 306
Query: 129 VNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGG 188
++ F G VSIDF + NL L L N LG G A DL F+ L C +LK L L+ +QFGG
Sbjct: 307 MSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGG 366
Query: 189 ELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKN 248
LP+SIANLS+ ++ + NQ+SGTIPPGI NLVNL N G+IP IG L+
Sbjct: 367 VLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQM 426
Query: 249 LQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT 308
L ++ L RN L G IPS LGN+T+L +L L +N L G IPSS GN L S N L
Sbjct: 427 LGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLN 486
Query: 309 GALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCV 368
G +P +++ + +L++ L+L+ N L G LP +V LKNL LD+S N+ SG IP L +C+
Sbjct: 487 GTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCL 546
Query: 369 CLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHF 428
LE+L + N F G IP S L+ + +L++S NNLSGQIPEFL+ LS L L+LS+N+F
Sbjct: 547 TLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNF 605
Query: 429 EGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSC----PSKGSRKPKIILLKVLIPVA 484
EG++PTKGVF+N T S+ GN KLCGGI ELHLP+C P G K + L+ L+
Sbjct: 606 EGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGF 665
Query: 485 VSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPM-VSYAELSKATGEFSSSNMIGQGS 543
+ +++ S L I R RR ++ TS K + VSY L KATG FSS+N+IG G
Sbjct: 666 LGLVLIMSLLVI--NRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGG 723
Query: 544 FGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603
FG VYKG LG+DE +VAVKVI L +GA +SF AECEALRNIRHRNL+K++T CSS D++
Sbjct: 724 FGSVYKGILGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQ 783
Query: 604 GTDFKAFVFEYMENGSLKDWLH---QSDDQVEVCK-LSLIQRVNIAIDVASAMEYLHHHC 659
G DFKA V+E+M NGSL++WLH D+ +V + LSL QR+NIAIDVASA++YLHHHC
Sbjct: 784 GNDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHC 843
Query: 660 QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAP 719
P+VH DLKPSN+LLD+DM AHV DFGLA+F+ + + + SSSIGLKGT+GY AP
Sbjct: 844 HKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAA-GRSHPSQSSSIGLKGTIGYAAP 902
Query: 720 EYGMGSEASMTGD----------IFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769
EYGMG++ S GD +FTG+RP +++F++ +LH F K ALPE++ +I+DP
Sbjct: 903 EYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPF 962
Query: 770 LLME-------VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822
L ++S + KR K ECL +I+R GV CS+ESP ERM + + + +L
Sbjct: 963 FLSSEAKEEETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQ 1022
Query: 823 HTRETFLGRRV 833
R+ LG V
Sbjct: 1023 LIRKILLGNGV 1033
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 759 bits (1960), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/844 (49%), Positives = 554/844 (65%), Gaps = 27/844 (3%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNS-LGGKIPTTLGLLRNLVSLNVAENKF 59
L+ L + N LTG +P +GNLS LE++R+ N L G +P+TLG L+NL LN+ +N+
Sbjct: 169 LKNLTLEVNGLTGTIPPSLGNLSSLEILRLEKNKILFGNVPSTLGKLKNLRILNLMDNRL 228
Query: 60 SGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA 119
SG+ P SI N+SSL + + N F GNLP DI ++LPNL+ +I N F GSIP S+SNA
Sbjct: 229 SGVIPPSIFNLSSLTALDIGFNLFHGNLPSDIGISLPNLEFFSIASNQFTGSIPVSISNA 288
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL 179
SN+ELL +S+N G V L L + L N+LG+G A DL F++ LTN ++L+ L
Sbjct: 289 SNIELLQVSLNNLTGEVPT-LEKLHRLNFFTLFSNHLGSGQANDLSFLSSLTNATTLEYL 347
Query: 180 SLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239
S+ N FGGELP I+NLS+ + + N I G+IP GI LVNL F N++ G I
Sbjct: 348 SIKRNNFGGELPKQISNLSTMLGVISLPENNILGSIPAGIEKLVNLKVFDVGNNKISGII 407
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMS 299
P +IGEL+NL+ L L N L GRIPS +GNLTKL L L NSL+G+IPSSLGNC+ L+
Sbjct: 408 PSSIGELQNLEGLVLDYNNLSGRIPSSVGNLTKLMALYLGDNSLEGSIPSSLGNCKKLLV 467
Query: 300 FTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGV 359
T N L+G +P L I +L LY+ S N +GSLP+++G L NL LD+S N SG
Sbjct: 468 LTLCGNNLSGDIPPGLFGIFSL-LYICFSKNHFSGSLPIEIGKLINLEFLDVSGNMLSGE 526
Query: 360 IPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLE 419
IP +L C+ LE L ++SN FHG IP +LS L+ + + N S NNLSG+IPEF + + LE
Sbjct: 527 IPSSLGGCISLEDLYMNSNFFHGSIPSALSSLRGVLQFNFSHNNLSGKIPEFFQGFNSLE 586
Query: 420 FLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSC----PSKGSRKPKII 475
L LSYN+FEG +P +G+F N T +S+ GN +LCGG EL LP C P + K KI
Sbjct: 587 MLDLSYNNFEGMIPDEGIFKNSTAVSVIGNSQLCGGNTELGLPRCKVHQPKRLKLKLKIA 646
Query: 476 LLKVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSS 535
+ + + +A++ ++ +CL + +R++R K S M + VSY L KAT FSS
Sbjct: 647 IFAITVLLALALVV--TCLFLCSSRRKRREIKL---SSMRNELLEVSYQILLKATNGFSS 701
Query: 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIIT 595
SN++G GSFG VYKG L ++ M++AVKV+NL +GASRSF+AECEALRNIRHRNL+K++T
Sbjct: 702 SNLVGIGSFGSVYKGMLDQNGMVIAVKVLNLMRQGASRSFIAECEALRNIRHRNLVKVLT 761
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLH-QSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
CSS D+ G DFKA V+E+M NGSL+DWLH L+L+QR+NIAIDVA A+EY
Sbjct: 762 ACSSIDYHGNDFKAIVYEFMANGSLEDWLHPTGTGGGTTLTLNLLQRLNIAIDVACALEY 821
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LHHHC+ P+ H DLKPSNVLLD ++ HV DFGLAKFLS LD S+SIG++GT+
Sbjct: 822 LHHHCEMPIAHCDLKPSNVLLDDELTGHVGDFGLAKFLSGASLDYPTNE-STSIGVRGTI 880
Query: 715 GYVAPEYGMGSEASMTGD----------IFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764
GY PEYG+G E S GD +FTG+RP D +F EG +LH F K A+PE+V +
Sbjct: 881 GYAPPEYGVGGEVSAYGDTYSYGILLLEMFTGKRPTDEMFREGSNLHNFVKRAVPEQVKQ 940
Query: 765 IVDPSLLMEVMTNNSMIQEDKRVKTE---ECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
I DP+LL E T + E ++ ECLN+I+R G+ CS+E P ERM + D VA+L
Sbjct: 941 ITDPTLLQEEPTGDDDKHEISSMRNSRPLECLNSILRIGISCSVEFPRERMKISDAVAQL 1000
Query: 822 CHTR 825
R
Sbjct: 1001 HSVR 1004
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 756 bits (1953), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 416/851 (48%), Positives = 556/851 (65%), Gaps = 30/851 (3%)
Query: 9 NYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSIC 68
N LTG +PD +GNL+ ++ + N L G IP LG L+ L + + N FSG+ P S+
Sbjct: 218 NNLTGPVPDSLGNLTSIKSLSFAVNHLEGSIPQALGQLQTLEFMGLGMNGFSGIIPSSVY 277
Query: 69 NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLS 128
N+SSLE+ L N+ G+LP+D+ LPNL+ L IG N+F G +P SLSNASNL D++
Sbjct: 278 NMSSLEVFSLPYNKLYGSLPWDLAFTLPNLQVLNIGNNDFTGPLPSSLSNASNLLEFDIT 337
Query: 129 VNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGG 188
++ F G VSIDF + NL L L N LG G A DL F+ L C +LK L L+ +QFGG
Sbjct: 338 MSNFTGKVSIDFGGMPNLWGLFLASNPLGKGEADDLSFLNSLMKCRALKVLDLSGSQFGG 397
Query: 189 ELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKN 248
LP+SIANLS+ ++ + NQ+SGTIPPGI NLVNL N G+IP IG L+
Sbjct: 398 VLPNSIANLSTQLMKLKLDNNQLSGTIPPGIGNLVNLTDLILANNDFTGSIPVLIGNLQM 457
Query: 249 LQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT 308
L ++ L RN L G IPS LGN+T+L +L L +N L G IPSS GN L S N L
Sbjct: 458 LGRIDLSRNQLSGHIPSSLGNITRLYSLHLQNNHLSGKIPSSFGNLLYLQELDLSYNSLN 517
Query: 309 GALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCV 368
G +P +++ + +L++ L+L+ N L G LP +V LKNL LD+S N+ SG IP L +C+
Sbjct: 518 GTIPEKVMDLVSLTISLNLARNQLTGLLPSEVRKLKNLGHLDVSENKLSGEIPDGLGSCL 577
Query: 369 CLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHF 428
LE+L + N F G IP S L+ + +L++S NNLSGQIPEFL+ LS L L+LS+N+F
Sbjct: 578 TLEHLHMEGNFFKGSIPPSFISLRGLLDLDLSRNNLSGQIPEFLQQLS-LSNLNLSFNNF 636
Query: 429 EGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSC----PSKGSRKPKIILLKVLIPVA 484
EG++PTKGVF+N T S+ GN KLCGGI ELHLP+C P G K + L+ L+
Sbjct: 637 EGQLPTKGVFNNATSTSVAGNNKLCGGIPELHLPACPVTKPKTGESKRGLKLMIGLLTGF 696
Query: 485 VSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPM-VSYAELSKATGEFSSSNMIGQGS 543
+ +++ S L I R RR ++ TS K + VSY L KATG FSS+N+IG G
Sbjct: 697 LGLVLIMSLLVI--NRLRRVKREPSQTSASSKDLILNVSYDGLFKATGGFSSANLIGTGG 754
Query: 544 FGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603
FG VYKG LG+DE +VAVKVI L +GA +SF AECEALRNIRHRNL+K++T CSS D++
Sbjct: 755 FGSVYKGXLGQDETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQ 814
Query: 604 GTDFKAFVFEYMENGSLKDWLH---QSDDQVEVCK-LSLIQRVNIAIDVASAMEYLHHHC 659
G DFKA V+E+M NGSL++WLH D+ +V + LSL QR+NIAIDVASA++YLHHHC
Sbjct: 815 GNDFKALVYEFMPNGSLENWLHPVPTPDEINDVLRILSLPQRLNIAIDVASALDYLHHHC 874
Query: 660 QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAP 719
P+VH DLKPSN+LLD+DM AHV DFGLA+F+ + + + SSSIGLKGT+GY AP
Sbjct: 875 HKPIVHCDLKPSNILLDNDMTAHVGDFGLARFIPEAA-GRSHPSQSSSIGLKGTIGYAAP 933
Query: 720 EYGMGSEASMTGD----------IFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769
EYGMG++ S GD +FTG+RP +++F++ +LH F K ALPE++ +I+DP
Sbjct: 934 EYGMGTKVSALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPF 993
Query: 770 LLME-------VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822
L ++S + KR K ECL +I+R GV CS+ESP ERM + + + +L
Sbjct: 994 FLSSEAKEEETTAADSSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQ 1053
Query: 823 HTRETFLGRRV 833
R+ LG +
Sbjct: 1054 LIRKILLGNGI 1064
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224081190|ref|XP_002306327.1| predicted protein [Populus trichocarpa] gi|222855776|gb|EEE93323.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/848 (48%), Positives = 540/848 (63%), Gaps = 25/848 (2%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L + N L G +P GNLS ++ N L G IP +LG L+ L VAEN S
Sbjct: 172 LGAFVLQGNNLVGDIPSSFGNLSSVQNFFWTKNYLRGGIPESLGNLKRLKYFAVAENDLS 231
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G P SICNISSL + L N+ G+LP D+ +NLPNL L I N+ G IP +LSNAS
Sbjct: 232 GTIPSSICNISSLAYVSLGQNQLHGSLPPDLGLNLPNLAYLVINFNHLNGPIPATLSNAS 291
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
+ L+DLS N G + D +SL +L L + N+LG G DL F+ L N ++L++L
Sbjct: 292 KIFLVDLSYNNLTGKIP-DLASLPDLQKLLVHHNDLGNGEEDDLSFLYTLANSTNLESLG 350
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ DN FGG LP ++N S+ + GRNQI G+IP I NL++L E NQLHG IP
Sbjct: 351 INDNNFGGVLPEIVSNFSTNLKGITFGRNQIHGSIPTEIGNLISLDTLSLETNQLHGIIP 410
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+IG+L+NL L L N + G IPS LGN+T L + + N+LQG IP+SLGN L+
Sbjct: 411 SSIGKLQNLAALYLNENKISGSIPSSLGNITSLVEVSFAQNNLQGTIPASLGNWHKLLIL 470
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
SQN L+G +P ++L I++LS+ L L +N L GSLP +VG L NL L +S N+ SG I
Sbjct: 471 DLSQNNLSGPIPKEVLGISSLSVLLYLHDNQLTGSLPSEVGQLVNLGFLRVSKNRLSGEI 530
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P +L +C LE LD+ N F G +P LS L++++ L +S NNLSGQIP+FLK+ +LE
Sbjct: 531 PKSLDSCKSLEGLDLGGNFFEGPVP-DLSSLRALQMLLLSYNNLSGQIPQFLKDFKLLET 589
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGSRKPK---IILL 477
L LSYN FEGEVP +GVF N ++IS+QGN KLCGGI +L LP C S +PK ++L
Sbjct: 590 LDLSYNDFEGEVPEQGVFENTSRISVQGNKKLCGGIPQLDLPKCTSNEPARPKSHTKLIL 649
Query: 478 KVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSSN 537
+ IP ++L + + Y+RK + E F ++Y +L +AT FSSSN
Sbjct: 650 IIAIPCGFLGIVLMTSFLLFYSRKTKDEP--ASGPSWESSFQRLTYQDLLQATDGFSSSN 707
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITIC 597
++G G+FG VY+GTL D +VAVKV+NL KGAS+SF+AEC AL NIRHRNL+K+IT C
Sbjct: 708 LVGAGAFGSVYRGTLTSDGAVVAVKVLNLLRKGASKSFMAECAALINIRHRNLVKVITAC 767
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQ---SDDQVEVCKLSLIQRVNIAIDVASAMEY 654
SS DF+G DFKA V+E+M NGSL++WLH SD E L L+QR+NIAIDVASA++Y
Sbjct: 768 SSNDFQGNDFKALVYEFMVNGSLEEWLHPVHISDVTPETRNLDLVQRLNIAIDVASALDY 827
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH+HCQ P+VH DLKPSNVLL DM A V DFGLA+FL + + SSS+GLKGT+
Sbjct: 828 LHNHCQVPVVHCDLKPSNVLLGDDMTACVGDFGLARFLPEAS-NQLPADESSSVGLKGTI 886
Query: 715 GYVAPEYGMGSEASMTGDI----------FTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764
GY APEYGMGSE S GD+ FTGRRP D +F +GH+LH +AK LP+ V+E
Sbjct: 887 GYAAPEYGMGSEVSTYGDVYSYGILLLEMFTGRRPTDGMFKDGHNLHNYAKMVLPDNVLE 946
Query: 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824
VDP+L + M D K EC+ +II+ G+ CS E P ERM + +VV +L
Sbjct: 947 FVDPTL----REHEEMNHNDDSHKVMECMVSIIKVGLACSAELPGERMGIANVVVELHRI 1002
Query: 825 RETFLGRR 832
RE GR+
Sbjct: 1003 REMLDGRK 1010
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 750 bits (1936), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/852 (48%), Positives = 552/852 (64%), Gaps = 23/852 (2%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
LQ + N+L G++P NLS +E+I + N L G IP +G L+ L L+V N S
Sbjct: 155 LQACLLVTNHLVGEIPLSFENLSSVEIIGVGDNHLQGSIPYGIGKLKRLRKLSVPLNNLS 214
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G P SI N+SSL L +A+N+F G+LP D+ LP+L+ L N F G IP ++SNAS
Sbjct: 215 GTIPPSIYNLSSLTLFSVAINQFHGSLPSDLGQKLPSLEVLVFYANRFNGPIPVTISNAS 274
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L ++D N F G V F++L NL +L ++ N LG G DL F+ L N ++L+ L
Sbjct: 275 TLSVIDFGNNSFTGKVP-PFANLPNLQYLGIDSNELGNGEEGDLSFLQSLANYTNLEELG 333
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
++DN GG P I+N SS +GRNQ+ G+IP I NL++L E NQL G IP
Sbjct: 334 MSDNNLGGMFPEIISNFSSQFTTLSMGRNQVRGSIPVDIGNLISLDTLMLETNQLTGVIP 393
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+IG+LKNL L L N + G IPS LGN+T L L LS+N+LQG IPSSL NCQNLMS
Sbjct: 394 TSIGKLKNLHGLTLVENKISGNIPSSLGNVTSLVELYLSANNLQGGIPSSLANCQNLMSL 453
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
+QN L+G L Q++ + +LS+ LDLS+N L G LP +VG L NL LD+S N+ SG I
Sbjct: 454 KLAQNNLSGPLTKQVIGMASLSVSLDLSHNQLIGPLPSEVGRLVNLGYLDVSHNRLSGEI 513
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
PG+L +C+ LEYL + N G IP LS L++++ LN+S NNL+GQIP FL + +L+
Sbjct: 514 PGSLGSCIMLEYLHLEGNFLQGSIPELLSSLRALQYLNLSYNNLTGQIPRFLADFQLLQR 573
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGSRKPKI---ILL 477
L LS+NH EGE+PT+ VF N + +S+ GN KLCGGI +L+L C S RKPK + L
Sbjct: 574 LDLSFNHLEGEMPTQRVFGNVSAVSVLGNDKLCGGISQLNLSRCTSNELRKPKFSTKLKL 633
Query: 478 KVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSSN 537
+ IP +L ++++ R++ + + E F V+Y EL +ATG FSSSN
Sbjct: 634 VISIPCGFIIALLLISSLLIHSW-RKTKNEPASGASWEVSFRRVTYEELYQATGGFSSSN 692
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITIC 597
IG GSFG VYK L D MIVAVKV NL KGAS+S++AEC AL NIRHRNL+KI+T C
Sbjct: 693 FIGGGSFGSVYKAILAPDGMIVAVKVFNLLRKGASKSYMAECAALINIRHRNLVKILTAC 752
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWL---HQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
SS DF+G DFKA V+E+M NGSL++WL H SD++ E L+LIQR+N+AIDVASA++Y
Sbjct: 753 SSLDFRGNDFKALVYEFMVNGSLEEWLHPVHTSDEEREQGNLNLIQRLNVAIDVASALDY 812
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH+HCQ +VH DLKPSNVLLD DM AHV DFGLA+F + + + +SSIGLKGTV
Sbjct: 813 LHYHCQMAVVHCDLKPSNVLLDGDMTAHVGDFGLARFRPEASVQLS-SNQNSSIGLKGTV 871
Query: 715 GYVAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHEFAKTALPEKVME 764
GY APEYG+G+E S GD++ TG+ P D F EG +LH++ K ALP++V+E
Sbjct: 872 GYAAPEYGIGNEVSTYGDVYSYGILLLEILTGKTPTDGSFKEGLNLHKYVKMALPDRVVE 931
Query: 765 IVDPSLLMEVMTNNSMIQED-KRV---KTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820
+VDP LL E+ ++ + KR+ K ECL +I+ GV CS++ P ER ++ +VVA+
Sbjct: 932 VVDPILLREIEQTSANASDGMKRIGNDKVLECLVSIMEVGVSCSVDLPRERTNISNVVAE 991
Query: 821 LCHTRETFLGRR 832
L R LG R
Sbjct: 992 LHRIRGILLGTR 1003
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449441592|ref|XP_004138566.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1913), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/850 (47%), Positives = 550/850 (64%), Gaps = 27/850 (3%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+ + N L G++P+ GNLS L N+ G IP++ G LRNL +L + NK S
Sbjct: 178 LEVFQCSSNELFGEIPETFGNLSSLRGFWGTLNNFHGNIPSSFGQLRNLTALVIGANKLS 237
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G P SI NISS+ + L +N+ G LP ++ PNL+ L I N F G IP++LSNAS
Sbjct: 238 GTIPSSIYNISSMRIFSLPVNQLEGGLPTNLGFIFPNLQILKIHTNQFSGPIPFTLSNAS 297
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
LE +S N F G V +S ++L +++NNLG G DL+F+ L NC++L ++
Sbjct: 298 KLEEFVISNNMFSGKVP-SLASTRHLEVFGIDRNNLGYGNVDDLNFLFPLVNCTNLSSVV 356
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
++DN FGG LP I+N S+ + G GRNQI GTIP I NL L G E NQL G+IP
Sbjct: 357 ISDNNFGGALPEYISNFSTKLRIIGFGRNQIHGTIPTEIGNLFQLEALGLETNQLTGSIP 416
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ G+L L L L N L G IP LGNL+ L L N+L G IP SLG Q+L+
Sbjct: 417 SSFGKLYKLNDLFLNMNKLSGTIPKSLGNLSALGRCNLRLNNLTGAIPPSLGESQSLLML 476
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
SQN+L+GA+P +LLSI++LS+ LDLS N L GS+PL+VG L NL L IS N +GVI
Sbjct: 477 ALSQNQLSGAIPKELLSISSLSIALDLSENYLTGSIPLEVGKLVNLGYLHISDNMLTGVI 536
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P TLS C LE L + N G IP SLS L+ I+EL++S NNLSG+IP +L+ VL +
Sbjct: 537 PSTLSACTSLEDLYLDGNFLEGPIPESLSSLRGIEELDLSRNNLSGKIPTYLQEFEVLSY 596
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGSRKPKIIL-LKV 479
L+LS+N+ EGEVPT+GVF N T S+ GN KLC GI+EL+LP C RK K+ LK+
Sbjct: 597 LNLSFNNLEGEVPTQGVFKNTTAFSILGNKKLCNGINELNLPRCRLDYPRKQKLTTKLKI 656
Query: 480 LIPVA---VSSLILSSCLTIVYARKRRSAQKFVDTSP-MEKQFPMVSYAELSKATGEFSS 535
+I V V +L++ CL ++RK+++ D SP ++ + VSY +L KAT EFS
Sbjct: 657 IISVVSGLVGALLIICCLLFFWSRKKKNKS---DLSPSLKASYFAVSYNDLLKATNEFSP 713
Query: 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIIT 595
N+IG G +G VYKG L +D+ +VAVKV NL+++GAS+SF+AECEAL+NIRHRNL++I++
Sbjct: 714 DNLIGVGGYGSVYKGILSQDKSVVAVKVFNLQHRGASKSFLAECEALKNIRHRNLVRILS 773
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD---QVEVCKLSLIQRVNIAIDVASAM 652
CS DF+G DF A VF++M NGSL+ WLH D+ + E L+++QR++IAIDVASA+
Sbjct: 774 ACSGVDFQGNDFMALVFDFMVNGSLEKWLHPVDNLNQEGEKMYLNIMQRLDIAIDVASAL 833
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
+YLH+ P+ H DLKPSNVLLD DM AHV DFGLAKF+++ T S SIG++G
Sbjct: 834 DYLHNGSPMPIAHCDLKPSNVLLDADMTAHVGDFGLAKFMAETSFQNR-STESESIGIRG 892
Query: 713 TVGYVAPEYGMGSEASMTGDI----------FTGRRPIDAVFNEGHSLHEFAKTALPEKV 762
TVGY PEY MGS+ S GD+ FTG+ P D +F +G +L+ + TALPE+V
Sbjct: 893 TVGYAPPEYAMGSKISTYGDVYSYGILLLEMFTGKSPTDNMFKDGLTLNNYVLTALPERV 952
Query: 763 MEIVDPSLLMEVM----TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVV 818
EI DP++ ++ + NN M + ++ ++ ++CL +I GV CS + P +RM++ DVV
Sbjct: 953 QEIADPTMGIQELNGMGNNNLMFEANQSLRIKDCLFSIFSIGVACSTQMPNQRMNISDVV 1012
Query: 819 AKLCHTRETF 828
++LC RE F
Sbjct: 1013 SQLCLAREIF 1022
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357484501|ref|XP_003612538.1| Kinase-like protein [Medicago truncatula] gi|355513873|gb|AES95496.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 740 bits (1910), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/848 (47%), Positives = 538/848 (63%), Gaps = 32/848 (3%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
LQ + V N LTG P F+GNLS L I + N+L G+IP + L+N+ L+V EN S
Sbjct: 158 LQLINVWGNNLTGGFPSFIGNLSSLIGIAVTYNNLKGEIPQEICNLKNIRRLHVGENNLS 217
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
GMFP + NISSL + L N+F G+LP ++ LPNL IG N FFGS+P S+ NAS
Sbjct: 218 GMFPSCLYNISSLTQLSLTENKFIGSLPSNLFNTLPNLNMFQIGKNQFFGSMPISIVNAS 277
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
+L+LLDL+ N G V L++L WLNLE N G + DL+F+ +LTNCS L+ +S
Sbjct: 278 SLQLLDLAQNYLVGQVP-SLEKLQDLYWLNLEDNYFGNNSTIDLEFLKYLTNCSKLEVVS 336
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ +N+FGG LP+SI +LS+ + +G N ISG IP I NLV LI + N G IP
Sbjct: 337 ICNNKFGGSLPNSIGSLSTQLTELCLGGNLISGKIPVEIGNLVELILLAIDFNHFEGIIP 396
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ G+ + +Q L L N L G IP +GNL++L L+L N QGNIP S+ NCQ L
Sbjct: 397 TSFGKFQKMQYLALSGNKLSGYIPPFIGNLSQLFKLDLYRNMFQGNIPPSIENCQKLQYL 456
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
S NKL+G +P ++ I +LS L+LS+N L+GSLP +VG LKN+ LD+S N SG I
Sbjct: 457 DLSHNKLSGTIPSEIFHIFSLSNLLNLSHNFLSGSLPREVGLLKNIDWLDVSENHLSGDI 516
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P T+ C LEYL + NSF+G IP SL+ L+ ++ L++S N LSG IP+ ++N+SVLE+
Sbjct: 517 PTTIGDCTALEYLHLQGNSFNGTIPSSLASLEGLQHLDLSRNRLSGSIPDVMQNISVLEY 576
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKG---SRKPKIILL 477
L++S+N EGEVP GVF N TK+ L GN KLCGGI LHLP CP KG ++ K +L+
Sbjct: 577 LNVSFNMLEGEVPKNGVFGNVTKVELIGNNKLCGGILLLHLPPCPIKGRKDTKHHKFMLV 636
Query: 478 KVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSSN 537
V++ V LILS +TI + RKR + + SP Q VSY +L T FSS N
Sbjct: 637 AVIVSVVFFLLILSFIITIYWVRKRNNKRSI--DSPTIDQLATVSYQDLHHGTNGFSSRN 694
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITIC 597
+IG GSFG VYKG L + VAVKV+NL+ KGA +SF+ EC L+NIRHRNL+KI+T C
Sbjct: 695 LIGSGSFGSVYKGNLVSENNAVAVKVLNLQKKGAHKSFIVECNVLKNIRHRNLVKILTCC 754
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK-LSLIQRVNIAIDVASAMEYLH 656
SS D+K +FKA VF Y++NGSL+ WLH E K L L R+NI IDVAS + YLH
Sbjct: 755 SSIDYKVQEFKALVFYYIKNGSLEQWLHPEFLNEEHPKTLDLGHRLNIIIDVASTLHYLH 814
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
C+ ++H DLKPSNVLLD DMVAHV DFG+AK +S A +S+IG+KGTVGY
Sbjct: 815 QECEQLVIHCDLKPSNVLLDDDMVAHVTDFGIAKLVS------ATSGNTSTIGIKGTVGY 868
Query: 717 VAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766
PEYGMGSE S GD++ TGRRP D VF +G +LH F + P+ ++ I+
Sbjct: 869 APPEYGMGSEVSTYGDMYSFGILMLEMLTGRRPTDEVFEDGQNLHNFVAISFPDNLINIL 928
Query: 767 DPSLL----MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822
DP LL +E N ++I K ECL ++ R G++C++ESP ERM+ DV +L
Sbjct: 929 DPHLLSRDAVEDGNNENLIPTVK-----ECLVSLFRIGLICTIESPKERMNTVDVTRELN 983
Query: 823 HTRETFLG 830
R+ FL
Sbjct: 984 IIRKAFLA 991
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255577438|ref|XP_002529598.1| receptor-kinase, putative [Ricinus communis] gi|223530931|gb|EEF32790.1| receptor-kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 739 bits (1907), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/855 (47%), Positives = 557/855 (65%), Gaps = 32/855 (3%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
LQ NYLTG++ NLS LE+I N+ G+IP ++G L++L + ++ + FS
Sbjct: 174 LQMFEFEINYLTGEISPSFSNLSSLEIIYGTRNNFHGEIPNSIGQLKSLQTFSLGGSNFS 233
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G+ P SI N+SSL ++ + +N+ GNLP D+ +LP L+ L + N F GSIP ++SNAS
Sbjct: 234 GVIPPSIFNLSSLTILSVPINQLHGNLPPDLGQSLPKLEVLRLYANKFSGSIPPTISNAS 293
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
NL LD+S N F G V + L NL ++ + +NNLG G DL F+ L N ++L+ L+
Sbjct: 294 NLVALDVSQNNFTGKVP-SLARLHNLSYIGIHKNNLGNGEDDDLSFLYTLANNTNLEILA 352
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ +N GG LP ++N S+ +++ GRN+I G IP I NL+ L G E N+L G+IP
Sbjct: 353 ITENNLGGVLPEMLSNFSTKLVHMAFGRNKIRGRIPSEIDNLIRLEALGFERNELTGSIP 412
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
++G+LKNL KL L N + G IPS LGN+T L+ + L N+L+G+IPSSLGNCQ ++
Sbjct: 413 SSLGKLKNLIKLYLNDNNISGSIPSSLGNITSLSTISLKVNNLEGSIPSSLGNCQQMLLM 472
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
S+N L+G +P +L+SI +LS+ LDLS N GSLP++VG L NL LD+S N+ SG I
Sbjct: 473 DLSRNNLSGTIPKELISIPSLSISLDLSENQFTGSLPMEVGGLVNLGYLDVSKNKLSGEI 532
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P +L +C LE L + N+F G IP+SLS L+ I +LN+S NNL+GQIP F LE
Sbjct: 533 PKSLGSCTRLETLYLQGNAFQGTIPVSLSSLRGINDLNLSHNNLTGQIPNFFAEFKSLEK 592
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGSRKPKI-----I 475
L LSYN FEGEVP +GVF N + S+ GN LCGGI E++LP C S KPK +
Sbjct: 593 LDLSYNDFEGEVPAEGVFKNASAFSISGNKNLCGGIPEINLPRCTLNKSMKPKTSHKLRL 652
Query: 476 LLKVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSS 535
++ V V L+L+S L + R++ K S ++ F VSY L KAT FSS
Sbjct: 653 IIVVACCGVVGVLLLTSALLFCCLKMRKN--KEASGSSLDIFFQKVSYQNLLKATDGFSS 710
Query: 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIIT 595
+N+IG GSFG VYKG L DE I+AVKV+NL++KGASRSF+ EC+AL N+RHRNL+K++T
Sbjct: 711 ANLIGAGSFGSVYKGILAPDETIIAVKVLNLQHKGASRSFMTECQALANVRHRNLVKVLT 770
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLH--QSDDQVEVCK-LSLIQRVNIAIDVASAM 652
CSS+DF+ DFKA V+EYM NGSL++WLH Q+ DQ + + LSLI+R++I+IDVASA+
Sbjct: 771 ACSSSDFEENDFKALVYEYMVNGSLEEWLHPTQNPDQDQPPRILSLIERLSISIDVASAL 830
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
+YLH+ CQ P+VH DLKPSN+LLD DM AHV DFGLA+FL ++ + SIG++G
Sbjct: 831 DYLHNQCQVPVVHCDLKPSNILLDSDMTAHVGDFGLARFLIAAPHHSSPSS---SIGIRG 887
Query: 713 TVGYVAPEYGMGSEASMTGDI----------FTGRRPIDAVFNEGHSLHEFAKTALPEKV 762
TVGY APEYGMGS+ S GD+ FTG++P DA+F +G +LH AK A+P+++
Sbjct: 888 TVGYAAPEYGMGSDVSTYGDVYTYGILLLELFTGKKPTDAMFKDGLNLHILAKMAMPDRL 947
Query: 763 MEIVDPSLLM--EVMTNNSMIQEDKRV------KTEECLNAIIRTGVLCSMESPFERMDM 814
DP LL+ + T+ S R+ K CLN+I++ GV CS ESP +RMD+
Sbjct: 948 ALAADPFLLITEDEGTSASATSASHRITCIARDKVLGCLNSILKIGVDCSAESPRDRMDI 1007
Query: 815 RDVVAKLCHTRETFL 829
DV +L R L
Sbjct: 1008 SDVANELVRIRNILL 1022
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224127492|ref|XP_002329291.1| predicted protein [Populus trichocarpa] gi|222870745|gb|EEF07876.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 737 bits (1903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 401/854 (46%), Positives = 550/854 (64%), Gaps = 28/854 (3%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
LQ L + N G++P GNLS + I N+L G IP G L+ L L++ N S
Sbjct: 174 LQVLTIELNNFVGEIPYSFGNLSAINAIYGSINNLEGSIPNVFGQLKRLKILSLGANNLS 233
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
GM P SI N+SSL L+ +N+ G+LP + + LPNL+ I N F G IP + SNAS
Sbjct: 234 GMIPPSIFNLSSLTLLSFPVNQLYGSLPHTLGLTLPNLQVFNIHTNQFGGLIPATFSNAS 293
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTN-CSSLKAL 179
NL + N F G V SS +L L + NNLG G DL+FV L N +SL+AL
Sbjct: 294 NLLSFQIGSNNFNGKVP-PLSSSHDLQVLGVGDNNLGKGENNDLNFVYPLANNMTSLEAL 352
Query: 180 SLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239
+DN FGG LP ++N S+ ++ RNQI G+IP I NL+NL G E NQL G I
Sbjct: 353 DTSDNNFGGVLPEIVSNFSTKLMKMTFARNQIRGSIPTQIGNLINLEALGLETNQLTGMI 412
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMS 299
P ++G+L+ L L L N + G IPS +GN+T L + + N+L+G+IP SLGN Q L+S
Sbjct: 413 PSSMGKLQKLSDLFLNGNKISGMIPSSMGNMTSLGRVNMRLNNLEGSIPPSLGNWQKLLS 472
Query: 300 FTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGV 359
SQN L+G +P +L+SI +LS+YL LS N L GSLP+++ L NL LD+S N+FSG
Sbjct: 473 LALSQNNLSGPIPKELVSIPSLSMYLVLSENELTGSLPIEMEKLVNLGYLDVSKNRFSGE 532
Query: 360 IPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLE 419
IP +L +CV LE L + N G IP++LS L++I+ELN+S NNL+GQIPEFL++ +LE
Sbjct: 533 IPKSLGSCVSLESLHLEENFLQGPIPITLSSLRAIQELNLSYNNLTGQIPEFLEDFKLLE 592
Query: 420 FLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSK---GSRKPKIIL 476
L+LS+N FEGEVP +G F N + IS+ GN KLCGGI +L+L CPS S+ P ++
Sbjct: 593 SLNLSFNDFEGEVPVQGAFQNTSAISIFGNKKLCGGIPQLNLTRCPSSEPTNSKSPTKLI 652
Query: 477 LKVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSS 536
+ +IL + Y +++ + +E FP V+Y +L AT FSS+
Sbjct: 653 WIIGSVCGFLGVILIISFLLFYCFRKKKDKPAASQPSLETSFPRVAYEDLLGATDGFSSA 712
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITI 596
N+IG+GSFG V+KG LG D+++VAVKV+NL KGAS+SF+AECEAL++IRHRNL+K++T
Sbjct: 713 NLIGEGSFGSVFKGILGPDKIVVAVKVLNLLRKGASKSFMAECEALKSIRHRNLVKLLTT 772
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLH--QSDDQVEVCK-LSLIQRVNIAIDVASAME 653
CSS DF+G DFKA V+E+M NG+L++WLH Q+ D+ K L L+ R+NIAI +ASA+
Sbjct: 773 CSSIDFQGNDFKALVYEFMVNGNLEEWLHPVQTSDEANGPKALDLMHRLNIAIHMASALN 832
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YLHH CQ P++H DLKPSN+LLD +M AHV DFGLA+F S+ T SS+GLKGT
Sbjct: 833 YLHHDCQMPIIHCDLKPSNILLDTNMTAHVGDFGLARFHSEASNQT------SSVGLKGT 886
Query: 714 VGYVAPEYGMGSEASMTGDI----------FTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763
+GY APEYG+G + S GD+ FTG+RP+D +F +G +LH +AK ALP++++
Sbjct: 887 IGYAAPEYGIGGKVSTYGDVYSYGILLLEMFTGKRPVDGMFKDGLNLHSYAKMALPDRIV 946
Query: 764 EIVDPSLLMEVMTNNSM----IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819
E+VDP L+ E+ + NS + + CL II+ GV CS+E P ERMD+ DVV
Sbjct: 947 EVVDPLLVREIRSVNSSDEMGMYHIGPHEISACLMTIIKMGVACSVELPRERMDIGDVVT 1006
Query: 820 KLCHTRETFLGRRV 833
+L ++T LG R+
Sbjct: 1007 ELNRIKDTLLGTRM 1020
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449499190|ref|XP_004160745.1| PREDICTED: LOW QUALITY PROTEIN: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 735 bits (1897), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/850 (47%), Positives = 547/850 (64%), Gaps = 27/850 (3%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+ + N L G++P+ GNLS L N+ G IP++ G LRNL +L + NK S
Sbjct: 178 LEVFQCSSNELFGEIPETFGNLSSLRGFWGTLNNFHGNIPSSFGQLRNLTALVIGANKLS 237
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G P SI NISS+ + L +N+ G LP ++ PNL+ L I N F G IP++LSNAS
Sbjct: 238 GTIPSSIYNISSMRIFSLPVNQLEGGLPTNLGFIFPNLQILKIHTNQFSGPIPFTLSNAS 297
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
LE +S N F G V +S ++L +++NNLG G DL+F+ L NC++L ++
Sbjct: 298 KLEEFVISNNMFSGKVP-SLASTRHLEVFGIDRNNLGYGNVDDLNFLFPLVNCTNLSSVV 356
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
++DN FGG LP I+N S+ + G GRNQI GTIP I NL L G E NQL G+IP
Sbjct: 357 ISDNNFGGALPEYISNFSTKLRIIGFGRNQIHGTIPTEIGNLFQLEALGLETNQLTGSIP 416
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ G+L L L L N L G IP LGNL+ L L N+L G IP SLG Q+L+
Sbjct: 417 SSFGKLYKLNDLFLNMNKLSGTIPKSLGNLSALGRCNLRLNNLTGAIPPSLGESQSLLML 476
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
SQN+L+GA+P +LLSI++LS+ LDLS N L GS+PL+VG L NL L IS N +GVI
Sbjct: 477 ALSQNQLSGAIPKELLSISSLSIALDLSENYLTGSIPLEVGKLVNLGYLHISDNMLTGVI 536
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P TLS C LE L + N G IP SLS L+ I+EL++S NNLSG+IP +L+ VL +
Sbjct: 537 PSTLSACTSLEDLYLDGNFLEGPIPESLSSLRGIEELDLSRNNLSGKIPTYLQEFEVLSY 596
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGSRKPKIIL-LKV 479
L+LS+N+ EGEVPT+GVF N T S+ GN KLC GI+EL+LP C RK K+ LK+
Sbjct: 597 LNLSFNNLEGEVPTQGVFKNTTAFSILGNKKLCNGINELNLPRCRLDYPRKQKLTTKLKI 656
Query: 480 LIPVA---VSSLILSSCLTIVYARKRRSAQKFVDTSP-MEKQFPMVSYAELSKATGEFSS 535
+I V V +L++ CL ++ ++ D SP ++ + VSY +L KAT EFS
Sbjct: 657 IISVVSGLVGALLIICCLLFXLVKEEKNKS---DLSPSLKASYFAVSYNDLLKATNEFSP 713
Query: 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIIT 595
N+IG G +G VYKG L +D+ +VAVKV NL+++GAS+SF+AECEAL+NIRHRNL++I++
Sbjct: 714 DNLIGVGGYGSVYKGILSQDKSVVAVKVFNLQHRGASKSFLAECEALKNIRHRNLVRILS 773
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD---QVEVCKLSLIQRVNIAIDVASAM 652
CS DF+G DF A VF++M NGSL+ WLH D+ + E L+++QR++IAIDVASA+
Sbjct: 774 ACSGVDFQGNDFMALVFDFMVNGSLEKWLHPVDNLNQEGEKMYLNIMQRLDIAIDVASAL 833
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
+YLH+ P+ H DLKPSNVLLD DM AHV DFGLAKF+++ T S SIG++G
Sbjct: 834 DYLHNGSPMPIAHCDLKPSNVLLDADMTAHVGDFGLAKFMAETSFQNR-STESESIGIRG 892
Query: 713 TVGYVAPEYGMGSEASMTGDI----------FTGRRPIDAVFNEGHSLHEFAKTALPEKV 762
TVGY PEY MGS+ S GD+ FTG+ P D +F +G +L+ + TALPE+V
Sbjct: 893 TVGYAPPEYAMGSKISTYGDVYSYGILLLEMFTGKSPTDNMFKDGLTLNNYVLTALPERV 952
Query: 763 MEIVDPSLLMEVM----TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVV 818
EI DP++ ++ + NN M + ++ ++ ++CL +I GV CS + P +RM++ DVV
Sbjct: 953 QEIADPTMGIQELNGMGNNNLMFEANQSLRIKDCLFSIFSIGVACSTQMPNQRMNISDVV 1012
Query: 819 AKLCHTRETF 828
++LC RE F
Sbjct: 1013 SQLCLAREIF 1022
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 833 | ||||||
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.986 | 0.801 | 0.414 | 9e-164 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.986 | 0.813 | 0.398 | 4.5e-162 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.986 | 0.801 | 0.409 | 1.9e-161 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.985 | 0.813 | 0.396 | 8.9e-157 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.983 | 0.794 | 0.403 | 4.9e-156 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.992 | 0.818 | 0.383 | 1.3e-153 | |
| UNIPROTKB|O24435 | 813 | O24435 "Receptor kinase-like p | 0.770 | 0.789 | 0.412 | 7.6e-128 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.967 | 0.822 | 0.334 | 4.4e-107 | |
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.951 | 0.676 | 0.312 | 1.4e-94 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.368 | 0.263 | 0.370 | 1.2e-89 |
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1594 (566.2 bits), Expect = 9.0e-164, P = 9.0e-164
Identities = 351/847 (41%), Positives = 505/847 (59%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L++ N LTG+ P +GNL+ L+++ + N + G+IP + L+ ++ +A NKF+
Sbjct: 179 LVLLSLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFN 238
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G+FP I N+SSL + + N FSG L D LPNL+ L +G N+F G+IP +LSN S
Sbjct: 239 GVFPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNIS 298
Query: 121 NLELLDLSVNQFKGNVSIDFSSXXXXXXXXXXXXXXGTGTATDLDFVTFLTNCSSLKALS 180
+L LD+ N G + + F G ++ DLDF+ LTNCS L+ L+
Sbjct: 299 SLRQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLN 358
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ N+ GG+LP IANLS+ + +G N ISG+IP GI NLV+L EN L G +P
Sbjct: 359 VGFNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSLQTLDLGENLLTGKLP 418
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
++GEL L+K+ L+ N L G IPS LGN++ L L L +NS +G+IPSSLG+C L+
Sbjct: 419 PSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDL 478
Query: 301 TASQNKLTGALPHQLLSITTXXXXXXXXXXXXXXXXXXQVGHLKNLVILDISSNQFSGVI 360
NKL G++PH+L+ + + +G LK L+ LD+S N+ SG I
Sbjct: 479 NLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQ-DIGKLKFLLALDVSYNKLSGQI 537
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P TL+ C+ LE+L + NSF G IP + L ++ L++S NNLSG IPE++ N S L+
Sbjct: 538 PQTLANCLSLEFLLLQGNSFVGPIP-DIRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQN 596
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGSRKPKIILLKVL 480
L+LS N+F+G VPT+GVF N + +S+ GN+ LCGGI L L C + R+ + +
Sbjct: 597 LNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIIT 656
Query: 481 IPV-AVSSLILSSCLTIVY-------ARKRRSAQKFVDTS--PMEKQFPMVSYAELSKAT 530
I V AV + +L CL +VY + R+ D S P++ + +SY EL K T
Sbjct: 657 ICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTT 716
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNL 590
G FSSSN+IG G+FG V+KG LG VA+KV+NL +GA++SF+AECEAL IRHRNL
Sbjct: 717 GGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNL 776
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVC-----KLSLIQRVNIA 645
+K++TICSS+DF+G DF+A V+E+M NG+L WLH D++E L L R+NIA
Sbjct: 777 VKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHP--DEIEETGNPSRTLGLFARLNIA 834
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
IDVASA+ YLH +C P+ H D+KPSN+LLD D+ AHV DFGLA+ L DT
Sbjct: 835 IDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDT-FHIQF 893
Query: 706 SSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHE-FAK-TALPEKVM 763
SS G++GT+GY APEYGMG S+ GD+++ + +F ++ F L
Sbjct: 894 SSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHSFTK 953
Query: 764 EIVDPSLLMEVMTNNSMIQED--KRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
+ +++ T+ ++++ + ECL + R GV CS ESP R+ M + ++KL
Sbjct: 954 SALQKRQALDI-TDETILRGAYAQHFNMVECLTLVFRVGVSCSEESPVNRISMAEAISKL 1012
Query: 822 CHTRETF 828
RE+F
Sbjct: 1013 VSIRESF 1019
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1578 (560.5 bits), Expect = 4.5e-162, P = 4.5e-162
Identities = 336/844 (39%), Positives = 512/844 (60%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L + N + G+LP +GNL+ LE + + N+L G+IP+ + L + SL + N FS
Sbjct: 164 LVQLNLYGNNMRGKLPTSLGNLTLLEQLALSHNNLEGEIPSDVAQLTQIWSLQLVANNFS 223
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G+FP ++ N+SSL+L+ + N FSG L D+ + LPNL + +GGN F GSIP +LSN S
Sbjct: 224 GVFPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNIS 283
Query: 121 NLELLDLSVNQFKGNVSIDFSSXXXXXXXXXXXXXXGTGTATDLDFVTFLTNCSSLKALS 180
LE L ++ N G++ F + G+ ++ DL+F+T LTNC+ L+ L
Sbjct: 284 TLERLGMNENNLTGSIPT-FGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLG 342
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ N+ GG+LP SIANLS+ ++ +G ISG+IP I NL+NL ++N L G +P
Sbjct: 343 IGRNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINLQKLILDQNMLSGPLP 402
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
++G+L NL+ L LF N L G IP+ +GN+T L L+LS+N +G +P+SLGNC +L+
Sbjct: 403 TSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLEL 462
Query: 301 TASQNKLTGALPHQLLSITTXXXXXXXXXXXXXXXXXXQVGHLKNLVILDISSNQFSGVI 360
NKL G +P +++ I +G L+NL L + N+ SG +
Sbjct: 463 WIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQ-DIGALQNLGTLSLGDNKLSGKL 521
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P TL C+ +E L + N F+G IP L L +KE+++S+N+LSG IPE+ + S LE+
Sbjct: 522 PQTLGNCLTMESLFLEGNLFYGDIP-DLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEY 580
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSC----PS---KGSRKPK 473
L+LS+N+ EG+VP KG+F N T +S+ GN LCGGI L C PS K S + K
Sbjct: 581 LNLSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLK 640
Query: 474 IILLKVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSP--MEKQFPMVSYAELSKATG 531
+++ V + + + L+ + +T+++ RKR+ ++ + +P +E +SY +L AT
Sbjct: 641 KVVIGVSVGITLLLLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATN 700
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
FSSSNM+G GSFG VYK L ++ +VAVKV+N++ +GA +SF+AECE+L++IRHRNL+
Sbjct: 701 GFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLV 760
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK----LSLIQRVNIAID 647
K++T CSS DF+G +F+A ++E+M NGSL WLH + + E+ + L+L++R+NIAID
Sbjct: 761 KLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVE-EIHRPSRTLTLLERLNIAID 819
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
VAS ++YLH HC P+ H DLKPSNVLLD D+ AHV DFGLA+ L ++ SS+
Sbjct: 820 VASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSA 879
Query: 708 IGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHE-FAKTALPEKVMEIV 766
G++GT+GY APEYG+G + S+ GD+++ + +F +E F +
Sbjct: 880 -GVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSA 938
Query: 767 DPSLLMEVMTNNSMIQEDKRV--KTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824
P +++++ + S++ RV ECL + G+ C ESP R+ VV +L
Sbjct: 939 LPERILDIV-DESILHIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVKELISI 997
Query: 825 RETF 828
RE F
Sbjct: 998 RERF 1001
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1572 (558.4 bits), Expect = 1.9e-161, P = 1.9e-161
Identities = 346/844 (40%), Positives = 500/844 (59%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L + N L+G++P +GNL+ L+ + N L G IP++LG L +L+++N+ +N S
Sbjct: 178 LSNLYLYKNGLSGEIPSALGNLTSLQEFDLSFNRLSGAIPSSLGQLSSLLTMNLGQNNLS 237
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
GM P SI N+SSL + N+ G +P + L L+ + +G N F G IP S++NAS
Sbjct: 238 GMIPNSIWNLSSLRAFSVRENKLGGMIPTNAFKTLHLLEVIDMGTNRFHGKIPASVANAS 297
Query: 121 NLELLDLSVNQFKGNVSIDFSSXXXXXXXXXXXXXXGTGTATDLDFVTFLTNCSSLKALS 180
+L ++ + N F G ++ F T D F++ LTNCS L+ L+
Sbjct: 298 HLTVIQIYGNLFSGIITSGFGRLRNLTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLN 357
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
L +N GG LP+S +NLS+++ + N+I+G+IP I NL+ L N G++P
Sbjct: 358 LGENNLGGVLPNSFSNLSTSLSFLALELNKITGSIPKDIGNLIGLQHLYLCNNNFRGSLP 417
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
++G LKNL L + N L G IP +GNLT+L L L +N G IP +L N NL+S
Sbjct: 418 SSLGRLKNLGILLAYENNLSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSL 477
Query: 301 TASQNKLTGALPHQLLSITTXXXXXXXXXXXXXXXXXXQVGHLKNLVILDISSNQFSGVI 360
S N L+G +P +L +I T ++GHLKNLV SN+ SG I
Sbjct: 478 GLSTNNLSGPIPSELFNIQTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKI 537
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P TL C L YL + +N G IP +L LK ++ L++SSNNLSGQIP L ++++L
Sbjct: 538 PNTLGDCQLLRYLYLQNNLLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHS 597
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSC-PSKGSRKPKIILLKV 479
L+LS+N F GEVPT G F+ + IS+QGN KLCGGI +LHLP C P +RK +L +
Sbjct: 598 LNLSFNSFVGEVPTIGAFAAASGISIQGNAKLCGGIPDLHLPRCCPLLENRK-HFPVLPI 656
Query: 480 LIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSSNMI 539
+ +A + ILSS ++ KR +K + K P+VSY++L KAT F+ +N++
Sbjct: 657 SVSLAAALAILSSLYLLITWHKR--TKKGAPSRTSMKGHPLVSYSQLVKATDGFAPTNLL 714
Query: 540 GQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSS 599
G GSFG VYKG L + VAVKV+ L+ A +SF AECEALRN+RHRNL+KI+TICSS
Sbjct: 715 GSGSFGSVYKGKLNIQDH-VAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSS 773
Query: 600 TDFKGTDFKAFVFEYMENGSLKDWLH-QSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
D +G DFKA V+++M NGSL+DW+H +++DQ + L+L +RV I +DVA A++YLH H
Sbjct: 774 IDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRH 833
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
P+VH D+K SNVLLD DMVAHV DFGLA+ L D + ++ +SS+G GT+GY A
Sbjct: 834 GPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGT--SLIQQSTSSMGFIGTIGYAA 891
Query: 719 PEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768
PEYG+G AS GDI+ TG+RP D+ F L ++ + L +V ++VD
Sbjct: 892 PEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDT 951
Query: 769 SLLM--EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826
L++ E N++ +R+ EC+ ++R G+ CS E P R D++ +L ++
Sbjct: 952 KLILDSENWLNSTNNSPCRRIT--ECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQ 1009
Query: 827 TFLG 830
G
Sbjct: 1010 NLSG 1013
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1528 (542.9 bits), Expect = 8.9e-157, P = 8.9e-157
Identities = 335/844 (39%), Positives = 498/844 (59%)
Query: 4 LAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMF 63
L +ND L G+ P F+ NL+ L V+ + N L G+IP + +L +VSL + N FSG+F
Sbjct: 169 LGLND--LKGKFPVFIRNLTSLIVLNLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVF 226
Query: 64 PRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLE 123
P + N+SSLE + L N FSGNL D LPN+ L++ GN G+IP +L+N S LE
Sbjct: 227 PPAFYNLSSLENLYLLGNGFSGNLKPDFGNLLPNIHELSLHGNFLTGAIPTTLANISTLE 286
Query: 124 LLDLSVNQFKGNVSIDFSSXXXXXXXXXXXXXXGTGTATDLDFVTFLTNCSSLKALSLAD 183
+ + N+ G++S +F G+ + DL F+ LTNCS L LS++
Sbjct: 287 MFGIGKNRMTGSISPNFGKLENLHYLELANNSLGSYSFGDLAFLDALTNCSHLHGLSVSY 346
Query: 184 NQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAI 243
N+ GG LP SI N+S+ + + N I G+IP I NL+ L +N L G +P ++
Sbjct: 347 NRLGGALPTSIVNMSTELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNLLTGPLPTSL 406
Query: 244 GELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTAS 303
G L L +L LF N G IPS +GNLT+L L LS+NS +G +P SLG+C +++
Sbjct: 407 GNLVGLGELILFSNRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIG 466
Query: 304 QNKLTGALPHQLLSITTXXXXXXXXXXXXXXXXXXQVGHLKNLVILDISSNQFSGVIPGT 363
NKL G +P +++ I T +G L+NLV L + +N SG +P T
Sbjct: 467 YNKLNGTIPKEIMQIPTLVHLNMESNSLSGSLPN-DIGRLQNLVELLLGNNNLSGHLPQT 525
Query: 364 LSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSL 423
L C+ +E + + N F G IP + L +K +++S+NNLSG I E+ +N S LE+L+L
Sbjct: 526 LGKCLSMEVIYLQENHFDGTIP-DIKGLMGVKNVDLSNNNLSGSISEYFENFSKLEYLNL 584
Query: 424 SYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSC----PSKGSRKPKIILLKV 479
S N+FEG VPT+G+F N T +S+ GN LCG I EL L C P +R P + L KV
Sbjct: 585 SDNNFEGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSL-LKKV 643
Query: 480 LIPVAV--SSLILSSCLTIVYARKRRSAQKFVDTSP--MEKQFPMVSYAELSKATGEFSS 535
I V+V + L+L +++ + +KR++ QK +++P +E +SY +L AT FSS
Sbjct: 644 AIGVSVGIALLLLLFIVSLSWFKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSS 703
Query: 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIIT 595
SN++G GSFG V+K L + IVAVKV+N++ +GA +SF+AECE+L++IRHRNL+K++T
Sbjct: 704 SNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLT 763
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK----LSLIQRVNIAIDVASA 651
C+S DF+G +F+A ++E+M NGSL WLH + + E+ + L+L++R+NIAIDVAS
Sbjct: 764 ACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVE-EIHRPSRTLTLLERLNIAIDVASV 822
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
++YLH HC P+ H DLKPSN+LLD D+ AHV DFGLA+ L ++ SS+ G++
Sbjct: 823 LDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFFNQLSSA-GVR 881
Query: 712 GTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHE-FAKTALPEKVMEIVDPSL 770
GT+GY APEYGMG + S+ GD+++ + +F +E F + P
Sbjct: 882 GTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNSYTKAALPER 941
Query: 771 LMEVMTNNSMIQEDKRV--KTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828
++++ + S++ RV ECL I+ G+ C ESP R+ + +L RE F
Sbjct: 942 VLDI-ADKSILHSGLRVGFPVLECLKGILDVGLRCCEESPLNRLATSEAAKELISIRERF 1000
Query: 829 LGRR 832
R
Sbjct: 1001 FKTR 1004
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1521 (540.5 bits), Expect = 4.9e-156, P = 4.9e-156
Identities = 342/847 (40%), Positives = 494/847 (58%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L ++ N LTG P +GNL+ L+ + N + G+IP + L +V +A N FS
Sbjct: 171 LAILDLSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFS 230
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G FP ++ NISSLE + LA N FSGNL D LPNL+ L +G N F G+IP +L+N S
Sbjct: 231 GGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLANIS 290
Query: 121 NLELLDLSVNQFKGNVSIDFSSXXXXXXXXXXXXXXGTGTATDLDFVTFLTNCSSLKALS 180
+LE D+S N G++ + F G +++ L+F+ + NC+ L+ L
Sbjct: 291 SLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLD 350
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ N+ GGELP SIANLS+T+ + +G+N ISGTIP I NLV+L E N L G +P
Sbjct: 351 VGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVSLQELSLETNMLSGELP 410
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ G+L NLQ + L+ N + G IPS GN+T+L L L+SNS G IP SLG C+ L+
Sbjct: 411 VSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYLLDL 470
Query: 301 TASQNKLTGALPHQLLSITTXXXXXXXXXXXXXXXXXXQVGHLKNLVILDISSNQFSGVI 360
N+L G +P ++L I + +VG L+ LV L S N+ SG +
Sbjct: 471 WMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPE-EVGKLELLVGLGASYNKLSGKM 529
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P + C+ +E+L + NSF G IP +S L S+K ++ S+NNLSG+IP +L +L L
Sbjct: 530 PQAIGGCLSMEFLFMQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRN 588
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGS---RKPKIILL 477
L+LS N FEG VPT GVF N T +S+ GN +CGG+ E+ L C + S RKP +
Sbjct: 589 LNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRK 648
Query: 478 KVL--IPVAVSSLILSSCL-TIVYARKRRSAQKFVDTSPMEK----QF-PMVSYAELSKA 529
KV+ I + ++SL+L + ++ + KR+ D +P + F VSY EL A
Sbjct: 649 KVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELHSA 708
Query: 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRN 589
T FSS+N+IG G+FG V+KG LG + +VAVKV+NL GA++SF+AECE + IRHRN
Sbjct: 709 TSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRN 768
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD-DQVEVCKLSLI--QRVNIAI 646
L+K+IT+CSS D +G DF+A V+E+M GSL WL D ++V SL +++NIAI
Sbjct: 769 LVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAI 828
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
DVASA+EYLH HC P+ H D+KPSN+LLD D+ AHV DFGLA+ L + ++ + SS
Sbjct: 829 DVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSS 888
Query: 707 SIGLKGTVGYVAPEYGMGSEASMTGDIFT-GRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765
+ G++GT+GY APEYGMG + S+ GD+++ G ++ + + FA + +
Sbjct: 889 A-GVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAG----DYNLHS 943
Query: 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825
S+L ++ D E L +++ G+ CS E P +RM + V +L R
Sbjct: 944 YTKSILSGCTSSGGSNAID------EGLRLVLQVGIKCSEEYPRDRMRTDEAVRELISIR 997
Query: 826 ETFLGRR 832
F +
Sbjct: 998 SKFFSSK 1004
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1498 (532.4 bits), Expect = 1.3e-153, P = 1.3e-153
Identities = 325/848 (38%), Positives = 499/848 (58%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L + N L G+LP +GNL+ L+ + N++ G++P L L +V L ++ NKF
Sbjct: 164 LVILDLGRNNLKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFF 223
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G+FP +I N+S+LE + L + FSG+L D LPN++ L +G N+ G+IP +LSN S
Sbjct: 224 GVFPPAIYNLSALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLSNIS 283
Query: 121 NLELLDLSVNQFKGNVSIDFSSXXXXXXXXXXXXXXGTGTATDLDFVTFLTNCSSLKALS 180
L+ ++ N G + +F G+ T DL+F+ LTNC+ L+ LS
Sbjct: 284 TLQKFGINKNMMTGGIYPNFGKVPSLQYLDLSENPLGSYTFGDLEFIDSLTNCTHLQLLS 343
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ + GG LP SIAN+S+ +I+ + N G+IP I NL+ L +N L G +P
Sbjct: 344 VGYTRLGGALPTSIANMSTELISLNLIGNHFFGSIPQDIGNLIGLQRLQLGKNMLTGPLP 403
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
++G+L L L L+ N + G IPS +GNLT+L L LS+NS +G +P SLG C +++
Sbjct: 404 TSLGKLLRLGLLSLYSNRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDL 463
Query: 301 TASQNKLTGALPHQLLSITTXXXXXXXXXXXXXXXXXXQVGHLKNLVILDISSNQFSGVI 360
NKL G +P +++ I T +G L+NLV L + +N+FSG +
Sbjct: 464 RIGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPN-DIGSLQNLVKLSLENNKFSGHL 522
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P TL C+ +E L + NSF G IP ++ L ++ +++S+N+LSG IPE+ N S LE+
Sbjct: 523 PQTLGNCLAMEQLFLQGNSFDGAIP-NIRGLMGVRRVDLSNNDLSGSIPEYFANFSKLEY 581
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSC-----P--SKGSRKPK 473
L+LS N+F G+VP+KG F N T + + GN LCGGI +L L C P +K S K
Sbjct: 582 LNLSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLK 641
Query: 474 IILLKVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQF--PMVSYAELSKATG 531
+ + V I +A+ L++ + + + + RKRR Q+ + P + + +SY +L AT
Sbjct: 642 KVAILVSIGIALLLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATN 701
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
FSSSNM+G GSFG V+K L + IVAVKV+N++ +GA +SF+AECE+L++ RHRNL+
Sbjct: 702 GFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLV 761
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK----LSLIQRVNIAID 647
K++T C+STDF+G +F+A ++EY+ NGS+ WLH + + E+ + L+L++R+NI ID
Sbjct: 762 KLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVE-EIRRPPRTLTLLERLNIVID 820
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
VAS ++YLH HC P+ H DLKPSNVLL+ D+ AHV DFGLA+ L ++ + SS+
Sbjct: 821 VASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLNQLSSA 880
Query: 708 IGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHE-FAKTALPEKVMEIV 766
G++GT+GY APEYGMG + S+ GD+++ + +F E F ++
Sbjct: 881 -GVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSYTKLA 939
Query: 767 DPSLLMEVMTNNSMIQEDKRV--KTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824
P + E+ + +++ RV +T ECL ++ G+ C E P R+ +V +L
Sbjct: 940 LPEKVFEI-ADKAILHIGLRVGFRTAECLTLVLEVGLRCCEEYPTNRLATSEVAKELISI 998
Query: 825 RETFLGRR 832
RE F R
Sbjct: 999 RERFFKTR 1006
|
|
| UNIPROTKB|O24435 O24435 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 1255 (446.8 bits), Expect = 7.6e-128, P = 7.6e-128
Identities = 268/649 (41%), Positives = 389/649 (59%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L + +N L+G +P +G L+ L + + N+L G IP++ G LR L L++A N S
Sbjct: 152 LSVLELTNNTLSGAIPSSLGKLTGLTDLALAENTLSGSIPSSFGQLRRLSFLSLAFNNLS 211
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G P I NISSL + ++ N+ SG LP + NLP+L+ + + N F G IP S+ NAS
Sbjct: 212 GAIPDPIWNISSLTIFEVISNKLSGTLPTNAFSNLPSLQEVYMYYNQFHGRIPASIGNAS 271
Query: 121 NLELLDLSVNQFKGNVSIDFSSXXXXXXXXXXXXXXGTGTATDLDFVTFLTNCSSLKALS 180
N+ + + +N F G V + D F+T LTNCS+L+ +
Sbjct: 272 NISIFTIGLNSFSGVVPPEIGRMRNLQRLELPETLSEAEETNDWKFMTALTNCSNLQEVE 331
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
L +FGG LP S++NLSS++++ I N+ISG++P I NLVNL N L G++P
Sbjct: 332 LGGCKFGGVLPDSVSNLSSSLVSLSIRDNKISGSLPRDIGNLVNLQYLSLANNSLTGSLP 391
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ +LKNL++L + N L G +P +GNLT+L N+E+ N+ G IPS+LGN L
Sbjct: 392 SSFSKLKNLRRLTVDNNKLIGSLPLTIGNLTQLTNMEVQFNAFGGTIPSTLGNLTKLFQI 451
Query: 301 TASQNKLTGALPHQLLSITTXXXXXXXXXXXXXXXXXXQVGHLKNLVILDISSNQFSGVI 360
N G +P ++ SI ++G LKN+V SN+ SG
Sbjct: 452 NLGHNNFIGQIPIEIFSIPALSEILDVSHNNLEGSIPKEIGKLKNIVEFHADSNKLSGEN 511
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
P T+ C L++L + +N +G IP++L+ LK + L++S NNLSGQIP L ++ +L
Sbjct: 512 PSTIGECQLLQHLFLQNNFLNGSIPIALTQLKGLDTLDLSGNNLSGQIPMSLGDMPLLHS 571
Query: 421 LSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGSRKPKI-ILLKV 479
L+LS+N F GEVPT GVF+N ++I +QGN +CGGI ELHLP+C K +K K ILL V
Sbjct: 572 LNLSFNSFHGEVPTNGVFANASEIYIQGNAHICGGIPELHLPTCSLKSRKKKKHQILLLV 631
Query: 480 LIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSSNMI 539
++ VS+L + S L ++ +R ++ T+ M+ PM++Y +L KAT FSSS+++
Sbjct: 632 VVICLVSTLAVFSLLYMLLTCHKRRKKEVPATTSMQGH-PMITYKQLVKATDGFSSSHLL 690
Query: 540 GQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIIT 595
G GSFG VYKG GE +VAV+V+ L+ A +SF AECE LRN RHRNL+KI+T
Sbjct: 691 GSGSFGSVYKGEFDSQDGEITSLVAVRVLKLETPKALKSFTAECETLRNTRHRNLVKIVT 750
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLH-QSDDQVEVCKLSLIQRVN 643
ICSS D +G DFKA V+++M NGSL+DWLH +++DQ E L+L QRV+
Sbjct: 751 ICSSIDNRGNDFKAIVYDFMPNGSLEDWLHPETNDQAEQRHLTLHQRVS 799
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1059 (377.8 bits), Expect = 4.4e-107, P = 4.4e-107
Identities = 288/862 (33%), Positives = 439/862 (50%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTL---GLLRNLVSLNVAEN 57
L+ L++++N L G +P +G L+ L + + N L G IP L G +L ++++ N
Sbjct: 117 LKQLSLSENLLHGNIPQELGLLNRLVYLDLGSNRLNGSIPVQLFCNGSSSSLQYIDLSNN 176
Query: 58 KFSGMFPRSI-CNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYS- 115
+G P + C++ L + L N+ +G +P + N NLK + + N G +P
Sbjct: 177 SLTGEIPLNYHCHLKELRFLLLWSNKLTGTVPSSLS-NSTNLKWMDLESNMLSGELPSQV 235
Query: 116 LSNASNLELLDLSVNQF---KGNVSID-FSSXXXXXXXXXXXXXXGTGTATDLDFVTFLT 171
+S L+ L LS N F N +++ F + G ++ + +
Sbjct: 236 ISKMPQLQFLYLSYNHFVSHNNNTNLEPFFASLANSSDLQELELAGNSLGGEI--TSSVR 293
Query: 172 NCS-SLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFG 229
+ S +L + L N+ G +P I+NL + T++N + N +SG IP + L L
Sbjct: 294 HLSVNLVQIHLDQNRIHGSIPPEISNLLNLTLLN--LSSNLLSGPIPRELCKLSKLERVY 351
Query: 230 AEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPS 289
N L G IP +G++ L L + RN L G IP GNL++L L L N L G +P
Sbjct: 352 LSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQ 411
Query: 290 SLGNCQNLMSFTASQNKLTGALPHQLLS-ITTXXXXXXXXXXXXXXXXXXQVGHLKNLVI 348
SLG C NL S N LTG +P +++S + ++ + ++
Sbjct: 412 SLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLS 471
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
+D+SSN+ SG IP L +C+ LE+L++S N F +P SL L +KEL+VS N L+G I
Sbjct: 472 VDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAI 531
Query: 409 PEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKG 468
P + S L+ L+ S+N G V KG FS T S G+ LCG I + +C K
Sbjct: 532 PPSFQQSSTLKHLNFSFNLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKK- 588
Query: 469 SRKPKIILLKVLIPVAVSSLILSSCLTIVYARKRRSAQKFV--DTSPMEKQ------FPM 520
+ P ++L +L +A L + + +R ++ + + EKQ +P
Sbjct: 589 HKYPSVLLPVLLSLIATPVLCVFGYPLVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPR 648
Query: 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAEC 579
+SY +L ATG F++S++IG G FG+VYKG L + VAVKV++ K S SF EC
Sbjct: 649 ISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTK-VAVKVLDPKTALEFSGSFKREC 707
Query: 580 EALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLI 639
+ L+ RHRNLI+IIT CS F A V M NGSL+ L+ + + L LI
Sbjct: 708 QILKRTRHRNLIRIITTCSKPGFN-----ALVLPLMPNGSLERHLYPGEYSSK--NLDLI 760
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT 699
Q VNI DVA + YLHH+ +VH DLKPSN+LLD +M A V DFG+++ + + +T
Sbjct: 761 QLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVE-ET 819
Query: 700 AVKTPSSSIG-----LKGTVGYVAPEYGMGSEASMTGDIFT----------GRRPIDAVF 744
S S G L G+VGY+APEYGMG AS GD+++ GRRP D +
Sbjct: 820 VSTDDSVSFGSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLV 879
Query: 745 NEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCS 804
NEG SLHEF K+ P+ + I++ +L ++ +++ E L +I G++C+
Sbjct: 880 NEGSSLHEFMKSHYPDSLEGIIEQALSR--WKPQGKPEKCEKLWREVILE-MIELGLVCT 936
Query: 805 MESPFERMDMRDVVAKLCHTRE 826
+P R DM DV ++ +E
Sbjct: 937 QYNPSTRPDMLDVAHEMGRLKE 958
|
|
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 941 (336.3 bits), Expect = 1.4e-94, P = 1.4e-94
Identities = 266/852 (31%), Positives = 424/852 (49%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+ L ++ N TG+ P + NL +L V+ + N++ G++P LGLL NL +L+ +N +
Sbjct: 338 LEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGLLTNLRNLSAHDNLLT 397
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G P SI N + L+L+ L+ N+ +G +P NL ++IG N+F G IP + N S
Sbjct: 398 GPIPSSISNCTGLKLLDLSHNQMTGEIPRGF--GRMNLTFISIGRNHFTGEIPDDIFNCS 455
Query: 121 NLELLDLSVNQFKGNVSIDFSSXXXXXXXXXXXXXXGTGTATDLDFVTFLTNCSSLKALS 180
NLE L ++ N G + TG + N L L
Sbjct: 456 NLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSL-TGPIP-----REIGNLKDLNILY 509
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
L N F G +P ++NL+ + + N + G IP + ++ L N+ G IP
Sbjct: 510 LHSNGFTGRIPREMSNLT-LLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSNNKFSGQIP 568
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIP----SSLGNCQN 296
+L++L L L N G IP+ L +L+ L ++S N L G IP +SL N Q
Sbjct: 569 ALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELLASLKNMQL 628
Query: 297 LMSFTASQNKLTGALPHQLLSITTXXXXXXXXXXXXXXXXXXQVGHLKNLVILDISSNQF 356
++F S N LTG +P +L + + KN+ LD S N
Sbjct: 629 YLNF--SNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRS-LQACKNVFTLDFSQNNL 685
Query: 357 SGVIPGTLSTCV-CLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNL 415
SG IP + + + L++S NSF G IP S + + L++SSNNL+G+IPE L NL
Sbjct: 686 SGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPESLANL 745
Query: 416 SVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGS---RKP 472
S L+ L L+ N+ +G VP GVF N L GN LCG L + K S ++
Sbjct: 746 STLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSHFSKRT 805
Query: 473 KIILLKVLIPVAVSSLILSSCLTIVYARKR-RSAQKFVDTS-P-MEKQFPMVSYA--ELS 527
++IL+ +L A L+L L + +K+ + + ++S P ++ + + EL
Sbjct: 806 RVILI-ILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLDSALKLKRFEPKELE 864
Query: 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS--FVAECEALRNI 585
+AT F+S+N+IG S VYKG L ED ++AVKV+NLK A F E + L +
Sbjct: 865 QATDSFNSANIIGSSSLSTVYKGQL-EDGTVIAVKVLNLKEFSAESDKWFYTEAKTLSQL 923
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
+HRNL+KI+ ++ KA V +MENG+L+D +H S + SL++++++
Sbjct: 924 KHRNLVKILGFA----WESGKTKALVLPFMENGNLEDTIHGSAAPIG----SLLEKIDLC 975
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
+ +AS ++YLH P+VH DLKP+N+LLD D VAHV DFG A+ L + D + T +
Sbjct: 976 VHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFRE-DGS--TTA 1032
Query: 706 SSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHEFAK 755
S+ +GT+GY+APE+ + + D+F T +RP N+ S +
Sbjct: 1033 STSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTS--LNDEDS-QDMTL 1089
Query: 756 TALPEKVMEIVDPSLL--MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD 813
L EK + ++ +++ +S++ +K EE + ++ + C+ P +R D
Sbjct: 1090 RQLVEKSIGNGRKGMVRVLDMELGDSIVS----LKQEEAIEDFLKLCLFCTSSRPEDRPD 1145
Query: 814 MRDVVAKLCHTR 825
M +++ L R
Sbjct: 1146 MNEILTHLMKLR 1157
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 461 (167.3 bits), Expect = 1.2e-89, Sum P(3) = 1.2e-89
Identities = 121/327 (37%), Positives = 173/327 (52%)
Query: 1 LQTLAVNDNYLTGQLP--DFVGNLSDLEVIRIMGNSLGGKIPTTLGLL-RNLVSLNVAEN 57
L+TL ++ N L G++P ++ G+ +L+ + + N L G+IP L LL + LV L+++ N
Sbjct: 253 LETLNISRNNLAGKIPNGEYWGSFQNLKQLSLAHNRLSGEIPPELSLLCKTLVILDLSGN 312
Query: 58 KFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLS 117
FSG P L+ + L N SG+ +V + + L + NN GS+P SL+
Sbjct: 313 TFSGELPSQFTACVWLQNLNLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLT 372
Query: 118 NASNLELLDLSVNQFKGNVSIDFSSXXXXXXXXXXXXXXGTGTATDLDFVTFLTNCSSLK 177
N SNL +LDLS N F GNV F S + T L C SLK
Sbjct: 373 NCSNLRVLDLSSNGFTGNVPSGFCSLQSSPVLEKILIANNYLSGT---VPMELGKCKSLK 429
Query: 178 ALSLADNQFGGELPHSI---ANLSSTVINFGIGRNQISGTIPPGI----RNLVNLIGFGA 230
+ L+ N+ G +P I NLS V+ N ++GTIP G+ NL LI
Sbjct: 430 TIDLSFNELTGPIPKEIWMLPNLSDLVM----WANNLTGTIPEGVCVKGGNLETLI---L 482
Query: 231 EENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSS 290
N L G+IP++I N+ + L N L G+IPSG+GNL+KLA L+L +NSL GN+P
Sbjct: 483 NNNLLTGSIPESISRCTNMIWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQ 542
Query: 291 LGNCQNLMSFTASQNKLTGALPHQLLS 317
LGNC++L+ + N LTG LP +L S
Sbjct: 543 LGNCKSLIWLDLNSNNLTGDLPGELAS 569
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGP4 | Y3475_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4260 | 0.9795 | 0.8079 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 833 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-88 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-63 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-57 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-51 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-42 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-40 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-36 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-35 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-22 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-15 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-13 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-13 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-12 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-11 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-11 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 6e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-11 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-11 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-10 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 5e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-09 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-08 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-08 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-07 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-06 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-06 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-06 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-05 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-05 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-04 | |
| COG3173 | 321 | COG3173, COG3173, Predicted aminoglycoside phospho | 3e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 7e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.001 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.001 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.001 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.001 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.002 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.002 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 0.002 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.002 | |
| cd05155 | 235 | cd05155, APH_ChoK_like_1, Uncharacterized bacteria | 0.002 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.003 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.003 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.003 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.004 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.004 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.004 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 298 bits (765), Expect = 9e-88
Identities = 251/805 (31%), Positives = 390/805 (48%), Gaps = 70/805 (8%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+ L + N L G++P+ + NL+ LE + + N L G+IP LG +++L + + N S
Sbjct: 166 LKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
G P I ++SL + L N +G +P + NL NL+ L + N G IP S+ +
Sbjct: 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLG-NLKNLQYLFLYQNKLSGPIPPSIFSLQ 284
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L LDLS N G + L+NL L+L NN TG LT+ L+ L
Sbjct: 285 KLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF-TGKIP-----VALTSLPRLQVLQ 338
Query: 181 LADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGI---RNLVNLIGFGAEENQLH 236
L N+F GE+P ++ ++ TV++ + N ++G IP G+ NL LI F N L
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLD--LSTNNLTGEIPEGLCSSGNLFKLILF---SNSLE 393
Query: 237 GTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQN 296
G IP ++G ++L+++ L N G +PS L + L++S+N+LQG I S + +
Sbjct: 394 GEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPS 453
Query: 297 LMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQF 356
L + ++NK G LP S +L DLS N +G++P ++G L L+ L +S N+
Sbjct: 454 LQMLSLARNKFFGGLPDSFGSKRLENL--DLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511
Query: 357 SGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLS 416
SG IP LS+C L LD+S N G IP S S + + +L++S N LSG+IP+ L N+
Sbjct: 512 SGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVE 571
Query: 417 VLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGSRKPKIIL 476
L +++S+NH G +P+ G F ++ GN+ LCGG LP C K RK
Sbjct: 572 SLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC--KRVRKTPSWW 629
Query: 477 LKVLIPVAVSSLILSSCLTIVYARKRRSAQ-KFVDTSP--MEKQFPMVSYAELSKATGEF 533
+ + ++ V+ R R + + K V+ E QF S S +
Sbjct: 630 FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQF-FDSKVSKSITINDI 688
Query: 534 SSS----NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRN 589
SS N+I +G G YKG ++ M VK IN S +A+ + ++H N
Sbjct: 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHPN 744
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
++K+I +C S KG + EY+E +L + L LS +R IAI +A
Sbjct: 745 IVKLIGLCRSE--KGA---YLIHEYIEGKNLSEVLRN---------LSWERRRKIAIGIA 790
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
A+ +LH C P +V G+L P +++D H+ L L T K SS
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-----TDTKCFISS-- 842
Query: 710 LKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHEFAKTALP 759
YVAPE + + DI+ TG+ P DA F S+ E+A+
Sbjct: 843 -----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS 897
Query: 760 EKVMEI-VDPSLLMEVMTNNSMIQE 783
+ +++ +DPS+ +V N + I E
Sbjct: 898 DCHLDMWIDPSIRGDVSVNQNEIVE 922
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 2e-63
Identities = 159/456 (34%), Positives = 236/456 (51%), Gaps = 16/456 (3%)
Query: 11 LTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTL-GLLRNLVSLNVAENKFSGMFPRSICN 69
++G++ + L ++ I + N L G IP + +L LN++ N F+G PR +
Sbjct: 81 ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG--S 138
Query: 70 ISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSV 129
I +LE + L+ N SG +P DI +LK L +GGN G IP SL+N ++LE L L+
Sbjct: 139 IPNLETLDLSNNMLSGEIPNDIGS-FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS 197
Query: 130 NQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGE 189
NQ G + + +K+L W+ L NNL ++ +T SL L L N G
Sbjct: 198 NQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT------SLNHLDLVYNNLTGP 251
Query: 190 LPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNL 249
+P S+ NL + F + +N++SG IPP I +L LI +N L G IP+ + +L+NL
Sbjct: 252 IPSSLGNLKNLQYLF-LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNL 310
Query: 250 QKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTG 309
+ L LF N G+IP L +L +L L+L SN G IP +LG NL S N LTG
Sbjct: 311 EILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG 370
Query: 310 ALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVC 369
+P L S L L L +N L G +P +G ++L + + N FSG +P +
Sbjct: 371 EIPEGLCSSGNL-FKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429
Query: 370 LEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE 429
+ +LDIS+N+ G I + S++ L+++ N G +P+ + LE L LS N F
Sbjct: 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFS 488
Query: 430 GEVPTK-GVFSNKTKISLQGNMKLCGGIDELHLPSC 464
G VP K G S ++ L N KL G I + L SC
Sbjct: 489 GAVPRKLGSLSELMQLKLSEN-KLSGEIPD-ELSSC 522
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 1e-57
Identities = 138/387 (35%), Positives = 206/387 (53%), Gaps = 10/387 (2%)
Query: 49 LVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNF 108
+VS++++ SG +I + ++ I L+ N+ SG +P DI +L+ L + NNF
Sbjct: 71 VVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNF 130
Query: 109 FGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVT 168
GSIP + NLE LDLS N G + D S +L L+L N L G
Sbjct: 131 TGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL-VGKIP-----N 182
Query: 169 FLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGF 228
LTN +SL+ L+LA NQ G++P + + S + +G N +SG IP I L +L
Sbjct: 183 SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY-LGYNNLSGEIPYEIGGLTSLNHL 241
Query: 229 GAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIP 288
N L G IP ++G LKNLQ L L++N L G IP + +L KL +L+LS NSL G IP
Sbjct: 242 DLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
Query: 289 SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVI 348
+ QNL N TG +P L S+ L + L L +N +G +P +G NL +
Sbjct: 302 ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV-LQLWSNKFSGEIPKNLGKHNNLTV 360
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
LD+S+N +G IP L + L L + SNS G IP SL +S++ + + N+ SG++
Sbjct: 361 LDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL 420
Query: 409 PEFLKNLSVLEFLSLSYNHFEGEVPTK 435
P L ++ FL +S N+ +G + ++
Sbjct: 421 PSEFTKLPLVYFLDISNNNLQGRINSR 447
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 7e-51
Identities = 131/358 (36%), Positives = 199/358 (55%), Gaps = 12/358 (3%)
Query: 94 NLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLE 152
N + ++ + G N G I ++ ++ ++LS NQ G + D F++ +L +LNL
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 153 QNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQIS 212
NN TG+ + +L+ L L++N GE+P+ I + SS + +G N +
Sbjct: 127 NNNF-TGSIPR-------GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKV-LDLGGNVLV 177
Query: 213 GTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTK 272
G IP + NL +L NQL G IP +G++K+L+ + L N L G IP +G LT
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS 237
Query: 273 LANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLL 332
L +L+L N+L G IPSSLGN +NL QNKL+G +P + S+ L + LDLS+N L
Sbjct: 238 LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKL-ISLDLSDNSL 296
Query: 333 NGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLK 392
+G +P V L+NL IL + SN F+G IP L++ L+ L + SN F G IP +L
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN 356
Query: 393 SIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK-GVFSNKTKISLQGN 449
++ L++S+NNL+G+IPE L + L L L N EGE+P G + ++ LQ N
Sbjct: 357 NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 6e-42
Identities = 128/366 (34%), Positives = 191/366 (52%), Gaps = 23/366 (6%)
Query: 108 FFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKN-------LLWLNLEQNNLGTGT 160
FF + +S+ +A LELL LS FK +++ L N LW + NN
Sbjct: 17 FFLFLNFSMLHAEELELL-LS---FKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVV 72
Query: 161 ATDLDFVTFLTNCSS-------LKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISG 213
+ DL SS ++ ++L++NQ G +P I SS++ + N +G
Sbjct: 73 SIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132
Query: 214 TIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKL 273
+IP G ++ NL N L G IP+ IG +L+ L L N L G+IP+ L NLT L
Sbjct: 133 SIPRG--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSL 190
Query: 274 ANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLN 333
L L+SN L G IP LG ++L N L+G +P+++ +T+L+ +LDL N L
Sbjct: 191 EFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN-HLDLVYNNLT 249
Query: 334 GSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKS 393
G +P +G+LKNL L + N+ SG IP ++ + L LD+S NS G IP + L++
Sbjct: 250 GPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN 309
Query: 394 IKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK-GVFSNKTKISLQGNMKL 452
++ L++ SNN +G+IP L +L L+ L L N F GE+P G +N T + L N L
Sbjct: 310 LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN-NL 368
Query: 453 CGGIDE 458
G I E
Sbjct: 369 TGEIPE 374
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 7e-40
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 24/199 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASR-SFVAECEALRNIRHRNLIKIITIC 597
+G+G FG VY + VA+K+I + + + E E L+ + H N++K+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+ V EY E GSLKD L +++ KLS + + I + + +EYLH
Sbjct: 61 EDENHLY-----LVMEYCEGGSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHS 110
Query: 658 HCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
+ ++H DLKP N+LLD D + DFGL+K L+ S + GT Y
Sbjct: 111 N---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD--------KSLLKTIVGTPAY 159
Query: 717 VAPEYGMG-SEASMTGDIF 734
+APE +G S DI+
Sbjct: 160 MAPEVLLGKGYYSEKSDIW 178
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 62/184 (33%), Positives = 89/184 (48%), Gaps = 26/184 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL-KYKGASRSFVAECEALRNIRHRNLIKIITIC 597
+G+GSFG VY + +VA+KVI K K + E + L+ ++H N++++ +
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV- 65
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
F+ D V EY E G L D L + +LS + + SA+EYLH
Sbjct: 66 ----FEDEDKLYLVMEYCEGGDLFDLLKKRG------RLSEDEARFYLRQILSALEYLHS 115
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ-LDTAVKTPSSSIGLKGTVGY 716
+VH DLKP N+LLD D + DFGLA+ L + L T V GT Y
Sbjct: 116 KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV----------GTPEY 162
Query: 717 VAPE 720
+APE
Sbjct: 163 MAPE 166
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 27/198 (13%)
Query: 539 IGQGSFGYVYKGTL----GEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKI 593
+G+G+FG VYKGTL E VAVK + + F+ E ++ + H N++++
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
+ +C+ +G V EYM G L D+L + + KL+L + +A+ +A ME
Sbjct: 67 LGVCT----QGEPLY-IVTEYMPGGDLLDFLRKHGE-----KLTLKDLLQMALQIAKGME 116
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YL VH DL N L+ ++V + DFGL++ + + D K G K
Sbjct: 117 YLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED--DYYRKRG----GGKLP 167
Query: 714 VGYVAPE---YGMGSEAS 728
+ ++APE G + S
Sbjct: 168 IKWMAPESLKDGKFTSKS 185
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 29/200 (14%)
Query: 538 MIGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIK 592
+G+G+FG VYKGTL E+ VAVK + F+ E +R + H N++K
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 593 IITICSSTD-FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
++ +C+ + V EYM G L D+L ++ + LSL ++ A+ +A
Sbjct: 66 LLGVCTEEEPLM------IVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARG 115
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
MEYL +H DL N L+ ++V + DFGL++ L D G K
Sbjct: 116 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK-------GGK 165
Query: 712 GTVGYVAPE---YGMGSEAS 728
+ ++APE G + S
Sbjct: 166 LPIRWMAPESLKEGKFTSKS 185
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 36/203 (17%)
Query: 538 MIGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRN 589
+G+G+FG VYKG L G+ ++ VAVK + + AS F+ E +R + H N
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLK---EDASEQQIEEFLREARIMRKLDHPN 62
Query: 590 LIKIITICSSTD-FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
++K++ +C+ + V EYME G L +L ++ KLSL ++ A+ +
Sbjct: 63 VVKLLGVCTEEEPLY------IVMEYMEGGDLLSYLRKNRP-----KLSLSDLLSFALQI 111
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
A MEYL +H DL N L+ ++V + DFGL++ L D
Sbjct: 112 ARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR------- 161
Query: 709 GLKGTVGYVAPE---YGMGSEAS 728
G K + ++APE G + S
Sbjct: 162 GGKLPIRWMAPESLKEGKFTSKS 184
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 64/186 (34%), Positives = 89/186 (47%), Gaps = 28/186 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITI 596
+G GSFG VYK IVAVK++ + ++ E LR + H N++++I
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
F+ D V EY E G L D+L + LS + IA+ + +EYLH
Sbjct: 67 -----FEDKDHLYLVMEYCEGGDLFDYLSRG------GPLSEDEAKKIALQILRGLEYLH 115
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL--SDHQLDTAVKTPSSSIGLKGTV 714
+ ++H DLKP N+LLD + V + DFGLAK L S L T V GT
Sbjct: 116 SN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV----------GTP 162
Query: 715 GYVAPE 720
Y+APE
Sbjct: 163 WYMAPE 168
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 15/167 (8%)
Query: 537 NMIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIK 592
+G+G+FG VYKG L VAVK + R F+ E ++ + H N+++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK---LSLIQRVNIAIDVA 649
++ +C+ + + V EYME G L D+L +S + LSL ++ AI +A
Sbjct: 61 LLGVCTE---EEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
MEYL VH DL N L+ D+V + DFGL++ + D
Sbjct: 116 KGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA--SRSFVAECEALRNIRHRN 589
E++ ++G+GSFG VY + ++AVK + L + E L +++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 590 LIKIITICSSTDFKGTDFKAF-----VF-EYMENGSLKDWLHQSDDQVEVCKLSLIQRVN 643
+++ + G++ +F EY+ GSL L + +I++
Sbjct: 61 IVR---------YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKY- 106
Query: 644 IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKT 703
+ + YLH + +VH D+K +N+L+D D V + DFG AK L D ++T
Sbjct: 107 -TRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD------IET 156
Query: 704 PSSSIGLKGTVGYVAPEYGMGSEASMTGDI----------FTGRRP 739
+ ++GT ++APE G E DI TG+ P
Sbjct: 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 26/199 (13%)
Query: 537 NMIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIK 592
+IG G FG V +G L G+ E+ VA+K + R F+ E + H N+I+
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + + K + EYMENGSL +L ++D + ++ Q V + +AS M
Sbjct: 70 LEGVVT----KSRPV-MIITEYMENGSLDKFLRENDGK-----FTVGQLVGMLRGIASGM 119
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
+YL VH DL N+L++ ++V V DFGL++ L D + T I ++
Sbjct: 120 KYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED--SEATYTTKGGKIPIRW 174
Query: 713 TVGYVAPE---YGMGSEAS 728
T APE Y + AS
Sbjct: 175 T----APEAIAYRKFTSAS 189
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 9e-23
Identities = 56/152 (36%), Positives = 80/152 (52%), Gaps = 15/152 (9%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG+G FG V G + VAVK + A+++F+AE + +RH NL++++ +
Sbjct: 14 IGKGEFGDVMLGDYRGQK--VAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVV- 69
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+G V EYM GSL D+L V ++L Q++ A+DV MEYL
Sbjct: 70 ---LQGNPL-YIVTEYMAKGSLVDYLRSRGRAV----ITLAQQLGFALDVCEGMEYLE-- 119
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+ VH DL NVL+ D+VA V DFGLAK
Sbjct: 120 -EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 9e-23
Identities = 57/189 (30%), Positives = 88/189 (46%), Gaps = 22/189 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
F IG+G FG VYK VA+KVI L+ K + E + L+ +H N++
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
K S K + V E+ GSLKD L ++ L+ Q + ++
Sbjct: 61 KYYG---SYLKKDELW--IVMEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKG 110
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+EYLH + ++H D+K +N+LL D + DFGL+ LSD K ++ +
Sbjct: 111 LEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD------TKARNTMV--- 158
Query: 712 GTVGYVAPE 720
GT ++APE
Sbjct: 159 GTPYWMAPE 167
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 57/189 (30%), Positives = 91/189 (48%), Gaps = 21/189 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
EF+ +G G FG V++G L ++ + VA+K++ + F E +AL+ +RH++LI
Sbjct: 7 EFTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ +CS + + E ME GSL +L + QV L + +++A VA
Sbjct: 66 SLFAVCS-----VGEPVYIITELMEKGSLLAFLRSPEGQV----LPVASLIDMACQVAEG 116
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
M YL +H DL N+L+ D+V V DFGLA+ + + V S K
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE-----DVYLSSDK---K 165
Query: 712 GTVGYVAPE 720
+ APE
Sbjct: 166 IPYKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 98.7 bits (244), Expect = 6e-22
Identities = 69/204 (33%), Positives = 104/204 (50%), Gaps = 24/204 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRH-RNLIKII 594
+G+GSFG VY L D +VA+KV+ K F+ E + L ++ H N++K+
Sbjct: 8 LGEGSFGEVY---LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
F+ V EY++ GSL+D L + + LS + + I + SA+EY
Sbjct: 65 DF-----FQDEGSLYLVMEYVDGGSLEDLLKKIGRKG---PLSESEALFILAQILSALEY 116
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
LH ++H D+KP N+LLD D V + DFGLAK L D +++ S+ GT
Sbjct: 117 LHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS--VGT 171
Query: 714 VGYVAPEYGMGSE---ASMTGDIF 734
GY+APE +G AS + DI+
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIW 195
|
Length = 384 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 64/190 (33%), Positives = 99/190 (52%), Gaps = 26/190 (13%)
Query: 538 MIGQGSFGYVYKGTL---GEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIK- 592
+IG G FG V +G L G+ E+ VA+K + Y + R F++E + H N+I
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 593 --IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
++T + E+MENG+L +L Q+D Q V IQ V + +A+
Sbjct: 71 EGVVTKSRPV--------MIITEFMENGALDSFLRQNDGQFTV-----IQLVGMLRGIAA 117
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
M+YL + VH DL N+L++ ++V V DFGL++FL D DT+ T +SS+G
Sbjct: 118 GMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED---DTSDPTYTSSLGG 171
Query: 711 KGTVGYVAPE 720
K + + APE
Sbjct: 172 KIPIRWTAPE 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 56/170 (32%), Positives = 81/170 (47%), Gaps = 30/170 (17%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNL 590
+G+G+FG V+ G D+ +VAVK LK A + F E E L N +H N+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKT--LKETASNDARKDFEREAELLTNFQHENI 70
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK--------LSLIQRV 642
+K +C+ D VFEYME+G L +L K L+L Q +
Sbjct: 71 VKFYGVCTEGDPP-----IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 643 NIAIDVASAMEYL--HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
IA+ +AS M YL H VH DL N L+ +D+V + DFG+++
Sbjct: 126 QIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 536 SNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRN 589
+G+G FG V E VAVK +N + RS F E E LR + H N
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQ-VAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
++K +C + + EY+ +GSL+D+L + DQ ++L + + + +
Sbjct: 68 IVKYKGVCEKPGGRSL---RLIMEYLPSGSLRDYLQRHRDQ-----INLKRLLLFSSQIC 119
Query: 650 SAMEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
M+YL +H DL N+L++ + + + DFGLAK L + + VK P S
Sbjct: 120 KGMDYLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES- 174
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDIFT 735
+ + APE S+ S D+++
Sbjct: 175 ----PIFWYAPECLRTSKFSSASDVWS 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 56/185 (30%), Positives = 89/185 (48%), Gaps = 27/185 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS---FVAECEALRNIRHRNLIKIIT 595
+G G FG V+ GT VAVK + K + S F+ E + ++ +RH L+++
Sbjct: 14 LGAGQFGEVWMGTW-NGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+CS + V EYM GSL D+L + + KL L Q V++A +A M YL
Sbjct: 69 VCS-----EEEPIYIVTEYMSKGSLLDFLKSGEGK----KLRLPQLVDMAAQIAEGMAYL 119
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
+H DL N+L+ ++V + DFGLA+ + D + ++ G K +
Sbjct: 120 E---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-------TAREGAKFPIK 169
Query: 716 YVAPE 720
+ APE
Sbjct: 170 WTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 56/199 (28%), Positives = 82/199 (41%), Gaps = 29/199 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN----LKYKGASRSFVAECEALRNIRHRNLIKII 594
+G+GSFG V + + A+KV+ +K K + E L I H ++K
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVK-- 57
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD-QVEVCKLSLIQRVNIAIDVASAME 653
+ F+ + V EY G L L + E + A ++ A+E
Sbjct: 58 LHYA---FQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF-------YAAEIVLALE 107
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YLH +++ DLKP N+LLD D + DFGLAK LS + T GT
Sbjct: 108 YLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE--GSRTNTFC------GT 156
Query: 714 VGYVAPEYGMGSEASMTGD 732
Y+APE +G D
Sbjct: 157 PEYLAPEVLLGKGYGKAVD 175
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 6e-20
Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 34/202 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKIITIC 597
+GQGS G VYK I A+K I++ R + E + LR+ ++K C
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVK----C 64
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV--EVCKLSLIQRVNIAIDVASAMEYL 655
+K + + V EYM+ GSL D L + ++ V IA + ++YL
Sbjct: 65 YGAFYKEGEI-SIVLEYMDGGSLAD-LLKKVGKIPEPVLAY-------IARQILKGLDYL 115
Query: 656 H--HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL--DTAVKTPSSSIGLK 711
H H ++H D+KPSN+L++ + DFG++K L + +T V
Sbjct: 116 HTKRH----IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---------- 161
Query: 712 GTVGYVAPEYGMGSEASMTGDI 733
GTV Y++PE G S DI
Sbjct: 162 GTVTYMSPERIQGESYSYAADI 183
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 8e-20
Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 42/197 (21%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKII 594
IG+GSFG VY D + +K I+L + E + L+ + H N+IK
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ--------SDDQVEVCKLSLIQRVNIAI 646
F+ V EY + G L + + ++Q+ ++ +
Sbjct: 66 E-----SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI----------LDWFV 110
Query: 647 DVASAMEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ--LDTAVKT 703
+ A++YLH ++H D+KP N+ L + + + DFG++K LS T V T
Sbjct: 111 QLCLALKYLHSRK----ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGT 166
Query: 704 PSSSIGLKGTVGYVAPE 720
P Y++PE
Sbjct: 167 PY----------YLSPE 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 26/205 (12%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINL--KYKGASRSFVAECEALRNIRHRN 589
+ ++IG+G+FG VYKG E VA+K I+L + A +S + E + L+N++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVE-VCKLSLIQRVNIAIDV 648
++K I + +D + EY ENGSL+ + + E + + + Q V
Sbjct: 61 IVKYIGS-----IETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ-------V 108
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
+ YLH + ++H D+K +N+L D V + DFG+A +L+ K +S +
Sbjct: 109 LQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVAT-----KLNDVSKDDASVV 160
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDI 733
GT ++APE S AS DI
Sbjct: 161 ---GTPYWMAPEVIEMSGASTASDI 182
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 46/160 (28%), Positives = 85/160 (53%), Gaps = 14/160 (8%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITI 596
IG+G++G VYK + +VA+K I ++ +G + + E + L+ +RH N++++ I
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
+S KG+ + VFEYM++ L L + K + Q + ++YLH
Sbjct: 67 VTS-KGKGSIY--MVFEYMDH-DLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLH 117
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
+ ++H D+K SN+L+++D V + DFGLA+ +
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 7e-19
Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 44/232 (18%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEAL-RNIRHRNLIKII 594
IG+GSF V E A+K+++ + + + E E L R H +IK+
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
T F+ + FV EY NG L ++ + L A ++ A+EY
Sbjct: 69 ----YT-FQDEENLYFVLEYAPNGELLQYIRK------YGSLDEKCTRFYAAEILLALEY 117
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVC--DFGLAKFLSDHQLDTAVKTPSSSIGLK- 711
LH ++H DLKP N+LLD DM H+ DFG AK L + + K +++I +
Sbjct: 118 LHSK---GIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172
Query: 712 -----------GTVGYVAPEYGMGSEASMTGDI----------FTGRRPIDA 742
GT YV+PE A + D+ TG+ P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 18/158 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITI 596
+G+G++G VYK + IVA+K I L + G + + E L+ ++H N++K++
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLL-- 64
Query: 597 CSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
D T+ K + VFEY + LK +L + + +LI+ I + + Y
Sbjct: 65 ----DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLS---PNLIKS--IMYQLLRGLAYC 114
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
H H ++H DLKP N+L++ D V + DFGLA+
Sbjct: 115 HSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 28/207 (13%)
Query: 532 EFSSSNMIGQGSFGYVYKGT-LGEDEMIVAVKVINLKYKGA--SRSFVAECEALRNIRHR 588
E + +G G FG V+ G G+ + VA+K+I +GA F+ E + + + H
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKID--VAIKMIR---EGAMSEDDFIEEAKVMMKLSHP 59
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
NL+++ +C+ + F V EYM NG L ++L + KL +++ DV
Sbjct: 60 NLVQLYGVCTK---QRPIF--IVTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDV 109
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
AMEYL + +H DL N L+ D V V DFGLA+++ D Q +SS
Sbjct: 110 CEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-------TSSQ 159
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDIFT 735
G K V + PE S S D+++
Sbjct: 160 GTKFPVKWAPPEVFDYSRFSSKSDVWS 186
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 26/223 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA--SRSFVAECEALRNIRHRN 589
E + IG G FG V+ G E VA+K I +GA F+ E + + + H
Sbjct: 5 ELTLVQEIGSGQFGLVWLGYWLEKRK-VAIKTIR---EGAMSEEDFIEEAQVMMKLSHPK 60
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
L+++ +C + + VFE+ME+G L D+L + + K S + + +DV
Sbjct: 61 LVQLYGVC----TERSPI-CLVFEFMEHGCLSDYL-----RAQRGKFSQETLLGMCLDVC 110
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
M YL ++H DL N L+ + V V DFG+ +F+ D Q +SS G
Sbjct: 111 EGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-------TSSTG 160
Query: 710 LKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHE 752
K V + +PE S+ S D+++ + VF+EG + +E
Sbjct: 161 TKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 57/198 (28%), Positives = 96/198 (48%), Gaps = 23/198 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS-RSFVAECEALRNIRHRNLIKIITIC 597
+G G FG V++G L + VAVK LK + F+AE + ++ +RH LI++ +C
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+ + V E M+ GSL ++L + L L Q +++A VAS M YL
Sbjct: 71 TLEEPI-----YIVTELMKYGSLLEYLQGGAGR----ALKLPQLIDMAAQVASGMAYLEA 121
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYV 717
+H DL NVL+ + + V DFGLA+ + + + + G K + +
Sbjct: 122 Q---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-------AREGAKFPIKWT 171
Query: 718 APEYGMGSEASMTGDIFT 735
APE + + S+ D+++
Sbjct: 172 APEAALYNRFSIKSDVWS 189
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 35/220 (15%)
Query: 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKI 593
N IG G+FG VY + ++AVK I ++ + E + L ++H NL+K
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 594 ITICSSTDFKGTDFKAFVF-EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + K ++F EY G+L++ L E I+ + + +
Sbjct: 65 YGVEVHRE------KVYIFMEYCSGGTLEELLEHGRILDEHV----IRV--YTLQLLEGL 112
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
YLH H +VH D+KP+N+ LDH+ V + DFG A L ++ L G
Sbjct: 113 AYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN----TTTMGEEVQSLAG 165
Query: 713 TVGYVAPEYGMGSEASMTG---DIF----------TGRRP 739
T Y+APE G + G DI+ TG+RP
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 67/186 (36%), Positives = 89/186 (47%), Gaps = 34/186 (18%)
Query: 539 IGQGSFGYV----YKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKII 594
IG+G FG V Y+G VAVK I K +++F+AE + +RH NL++++
Sbjct: 14 IGKGEFGDVMLGDYRGNK------VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLL 65
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ + KG + V EYM GSL D+L V L + ++DV AMEY
Sbjct: 66 GVI--VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEY 117
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
L + VH DL NVL+ D VA V DFGL K S Q DT K P V
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTG-KLP---------V 163
Query: 715 GYVAPE 720
+ APE
Sbjct: 164 KWTAPE 169
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 6e-18
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 9/164 (5%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDE-MIVAVKVINLKYKGASRS----FVAECEALRNIRH 587
++G+G FG V +G L +D+ + V V +K + S F++E +++ H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 588 RNLIKIITIC-SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
N++K+I +C ++ + + +M++G L +L S KL L + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
D+A MEYL + +H DL N +L DM V DFGL+K
Sbjct: 121 DIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 58/194 (29%), Positives = 90/194 (46%), Gaps = 22/194 (11%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIR 586
+ +IG G FG V++G L G E+ VA+K + Y R F++E +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H N+I++ + T FK + EYMENG+L +L D + S Q V +
Sbjct: 65 HHNIIRLEGVV--TKFKPA---MIITEYMENGALDKYLRDHDGE-----FSSYQLVGMLR 114
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
+A+ M+YL VH DL N+L++ ++ V DFGL++ L D T +
Sbjct: 115 GIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS--- 168
Query: 707 SIGLKGTVGYVAPE 720
G K + + APE
Sbjct: 169 --GGKIPIRWTAPE 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 54/192 (28%), Positives = 94/192 (48%), Gaps = 26/192 (13%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNL 590
+ + + +G G +G VY+G + + VAVK LK F+ E ++ I+H NL
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVEEFLKEAAVMKEIKHPNL 64
Query: 591 IKIITICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
++++ +C T F + E+M G+L D+L + + Q EV + L+ +A +
Sbjct: 65 VQLLGVC-------TREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLY---MATQI 113
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
+SAMEYL +H DL N L+ + + V DFGL++ ++ T ++
Sbjct: 114 SSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTYTAHA 163
Query: 709 GLKGTVGYVAPE 720
G K + + APE
Sbjct: 164 GAKFPIKWTAPE 175
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 63/190 (33%), Positives = 90/190 (47%), Gaps = 28/190 (14%)
Query: 538 MIGQGSFGYVYKGTL---GEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIK- 592
+IG G FG V G L G+ E+ VA+K + Y + R F++E + H N+I
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 593 --IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
++T V EYMENGSL +L + D Q V IQ V + +AS
Sbjct: 71 EGVVTKSKPV--------MIVTEYMENGSLDAFLRKHDGQFTV-----IQLVGMLRGIAS 117
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
M+YL VH DL N+L++ ++V V DFGL++ L D + A T I +
Sbjct: 118 GMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTRGGKIPI 173
Query: 711 KGTVGYVAPE 720
+ T APE
Sbjct: 174 RWT----APE 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 4e-17
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 36/200 (18%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVK------VINLKYKGASRSFVAECEALRNIRHRNLIK 592
IG+G+FG VYKG L + VAVK +LK K F+ E E L+ H N++K
Sbjct: 3 IGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRK-----FLQEAEILKQYDHPNIVK 56
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+I +C V E + GSL +L + +++ V KL + +++D A+ M
Sbjct: 57 LIGVCVQ-----KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGM 106
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
EYL +H DL N L+ + V + DFG+++ + + + T S GLK
Sbjct: 107 EYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSD--GLKQ 156
Query: 713 T-VGYVAPE---YGMGSEAS 728
+ + APE YG + S
Sbjct: 157 IPIKWTAPEALNYGRYTSES 176
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 22/197 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+GQG FG V+ GT VA+K + + +F+ E + ++ +RH L+++ + S
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
V EYM GSL D+L + L L Q V++A +AS M Y+
Sbjct: 72 EEPI------YIVTEYMSKGSLLDFLKGEMGKY----LRLPQLVDMAAQIASGMAYVE-- 119
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
+ VH DL+ +N+L+ ++V V DFGLA+ + D++ ++ G K + + A
Sbjct: 120 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAKFPIKWTA 171
Query: 719 PEYGMGSEASMTGDIFT 735
PE + ++ D+++
Sbjct: 172 PEAALYGRFTIKSDVWS 188
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-16
Identities = 70/236 (29%), Positives = 113/236 (47%), Gaps = 33/236 (13%)
Query: 539 IGQGSFGYVYKGT-LGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITIC 597
IG+G FG V +G G+ VAVK N+K +++F+ E + + H+NL++++ +
Sbjct: 14 IGEGEFGAVLQGEYTGQK---VAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVI 68
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
V E M G+L ++L + +S+IQ + ++DVA MEYL
Sbjct: 69 LHNGLY------IVMELMSKGNLVNFLRTRGRAL----VSVIQLLQFSLDVAEGMEYLE- 117
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYV 717
+VH DL N+L+ D VA V DFGLA+ + +D + K P V +
Sbjct: 118 --SKKLVHRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNS-KLP---------VKWT 164
Query: 718 APEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLME 773
APE + S D+++ + VF+ G + + K +L E V E V+ ME
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGRA--PYPKMSLKE-VKECVEKGYRME 217
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 56/198 (28%), Positives = 97/198 (48%), Gaps = 24/198 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS-RSFVAECEALRNIRHRNLIKIITIC 597
+G G FG V+ GT + VAVK LK S SF+ E + ++ +RH L+++ +
Sbjct: 14 LGNGQFGEVWMGTWNGNTK-VAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
S V EYM GSL D+L + + L L V++A VA+ M Y+
Sbjct: 71 SEEPI------YIVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIE- 119
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYV 717
+ +H DL+ +N+L+ +V + DFGLA+ + D++ ++ G K + +
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-------TARQGAKFPIKWT 170
Query: 718 APEYGMGSEASMTGDIFT 735
APE + ++ D+++
Sbjct: 171 APEAALYGRFTIKSDVWS 188
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 5e-16
Identities = 52/197 (26%), Positives = 96/197 (48%), Gaps = 22/197 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+GQG FG V+ GT VA+K + +F+ E + ++ +RH L+ + + S
Sbjct: 14 LGQGCFGEVWMGTW-NGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
V E+M GSL D+L + D + L L Q V++A +A M Y+
Sbjct: 72 EEPI------YIVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYIE-- 119
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
+ +H DL+ +N+L+ ++V + DFGLA+ + D++ ++ G K + + A
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-------TARQGAKFPIKWTA 171
Query: 719 PEYGMGSEASMTGDIFT 735
PE + ++ D+++
Sbjct: 172 PEAALYGRFTIKSDVWS 188
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 7e-16
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 30/200 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS---FVAECEALRNIRHRNLIKIIT 595
+G G FG V G + VA+K+I K S S F+ E + + + H L+++
Sbjct: 12 LGTGQFGVVKYGKW-RGQYDVAIKMI----KEGSMSEDEFIEEAKVMMKLSHEKLVQLYG 66
Query: 596 ICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+C+ + V EYM NG L ++L + + + +L + + DV M Y
Sbjct: 67 VCT------KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAY 115
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
L +H DL N L+D V DFGL++++ D + +SS+G K V
Sbjct: 116 LESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-------TSSVGSKFPV 165
Query: 715 GYVAPEYGMGSEASMTGDIF 734
+ PE + S+ S D++
Sbjct: 166 RWSPPEVLLYSKFSSKSDVW 185
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (194), Expect = 7e-16
Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 25/159 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-------HRNLI 591
+G G+FG VY E +VA+K + K+ EC LR ++ H N++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYS-----WEECMNLREVKSLRKLNEHPNIV 61
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
K+ + F+ D FVFEYME L+Q + S +I +
Sbjct: 62 KLKEV-----FRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+ ++H H H DLKP N+L+ V + DFGLA+
Sbjct: 112 LAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 1e-15
Identities = 51/195 (26%), Positives = 79/195 (40%), Gaps = 39/195 (20%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIIT 595
IG G++G V VA+K I+ + A R E + LR++RH N+I ++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRIL-REIKLLRHLRHENIIGLLD 66
Query: 596 ICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDD-QVEVCKLSLIQRVNIAIDVASAM 652
I DF V E ME L + + + L Q + +
Sbjct: 67 I--LRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQ-------ILRGL 116
Query: 653 EYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+YLH + +H DLKPSN+L++ + +CDFGLA+ + + + T
Sbjct: 117 KYLHSANV----IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT-------- 164
Query: 712 GTVGYV------APE 720
YV APE
Sbjct: 165 ---EYVVTRWYRAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 28/164 (17%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS------RSFVAECEALRNIRHRNLI 591
++G+G++G V K IVA+K K+K + ++ + E + LR +RH N++
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK----KFKESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV--EVCKLSLIQRVNIAIDVA 649
+ KG + VFEY+E +L + L S + + + + Q +
Sbjct: 64 NLKEAFRR---KGRLY--LVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQ------ 111
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
A+ Y H H ++H D+KP N+L+ V +CDFG A+ L
Sbjct: 112 -AIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALR 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 22/182 (12%)
Query: 531 GEFSSSNMIGQGSFGYVYKGT---LGEDEMI-VAVKVINLKY-KGASRSFVAECEALRNI 585
E ++G G+FG VYKG GE I VA+KV+ + A++ + E + ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
H ++++++ IC S+ + + M G L D++ D + +N
Sbjct: 67 DHPHVVRLLGICLSSQV------QLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWC 115
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL---SDHQLDTAVK 702
+ +A M YL +VH DL NVL+ + DFGLAK L K
Sbjct: 116 VQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 703 TP 704
P
Sbjct: 173 VP 174
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 25/168 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR------HRNLIK 592
IG+G++G VYK IVA+K I L++ S ALR I+ H N+IK
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRF----ESEGIPKTALREIKLLKELNHPNIIK 62
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
++ + F+ VFE+M+ D D+ SLI+ + + +
Sbjct: 63 LLDV-----FRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIK--SYLYQLLQGL 111
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK-FLSDHQLDT 699
+ H H ++H DLKP N+L++ + V + DFGLA+ F S + T
Sbjct: 112 AFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT 156
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 49/166 (29%), Positives = 81/166 (48%), Gaps = 22/166 (13%)
Query: 539 IGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKI 593
+G+G+FG V+ +D+M+VAVK + + A + F E E L ++H+++++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWL--HQSD-------DQVEVCKLSLIQRVNI 644
+C+ VFEYM +G L +L H D + V +L+L Q + I
Sbjct: 73 YGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
A +AS M YL VH DL N L+ +V + DFG+++
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 22/164 (13%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASR-SFVAECEALRNIRHRNLIK 592
+GQGSFG VY+G GE E VA+K +N R F+ E ++ ++++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 593 IITICSSTDFKGTDFKAFV-FEYMENGSLKDWL--HQSDDQVEVCKL---SLIQRVNIAI 646
++ + S T V E M G LK +L + + + L +L + + +A
Sbjct: 74 LLGVVS------TGQPTLVVMELMAKGDLKSYLRSRRPEAE-NNPGLGPPTLQKFIQMAA 126
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++A M YL VH DL N ++ D+ + DFG+ +
Sbjct: 127 EIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 28/183 (15%)
Query: 525 ELSKATGEFSSSNMIGQGSFGYVYKG---TLGEDEMIVAVKVINLKYKGASR---SFVAE 578
E+ + F +G+G+FG VYKG E +V + LK + F E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 579 CEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL----------HQSD 628
E + +++H N++ ++ +C+ +FEY+ +G L ++L +S
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPT-----CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 629 DQVEVCKLSLIQRVNIAIDVASAMEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687
D+ L ++IAI +A+ MEYL HH VH DL N L+ + + DFG
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH----FVHRDLAARNCLVGEGLTVKISDFG 169
Query: 688 LAK 690
L++
Sbjct: 170 LSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 52/188 (27%), Positives = 84/188 (44%), Gaps = 25/188 (13%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITI 596
IG+G+ G V+K E VA+K + L+ G + E +AL+ +H ++K++ +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
G+ F V EYM L + L + L Q + + + Y+H
Sbjct: 68 FP----HGSGF-VLVMEYMP-SDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMH 116
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
++H DLKP+N+L+ D V + DFGLA+ S+ + S + T Y
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE----EPRLYSHQV---ATRWY 166
Query: 717 VAPE--YG 722
APE YG
Sbjct: 167 RAPELLYG 174
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 22/201 (10%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK 592
+ + IG+G+ G VYK T VA+K + L+ K + E +++ +H N++
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPNIVD 79
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
S + V EYM+ GSL D + Q+ ++ +++ + R +V +
Sbjct: 80 YY---DSYLVGDELW--VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR-----EVLQGL 129
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
EYLH ++H D+K N+LL D + DFG A QL +S + G
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAA-----QLTKEKSKRNS---VVG 178
Query: 713 TVGYVAPEYGMGSEASMTGDI 733
T ++APE + DI
Sbjct: 179 TPYWMAPEVIKRKDYGPKVDI 199
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRN 589
EF N IG+G++G VY+ IVA+K + + + G S + E L N+RH N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMEN--GSLKDWLHQ--SDDQVEVCKLSLIQRVNIA 645
++++ + K D V EY E SL D + S+ QV+ C +
Sbjct: 68 IVELKEVVVG---KHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVK-C---------LM 114
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
+ + ++YLH + ++H DLK SN+LL + DFGLA+ TP
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP---MTPK 168
Query: 706 SSIGLKGTVGYVAPEYGMGSE 726
T+ Y APE +G
Sbjct: 169 VV-----TLWYRAPELLLGCT 184
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 69/297 (23%), Positives = 135/297 (45%), Gaps = 52/297 (17%)
Query: 539 IGQGSFGYV-----YKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKI 593
+G+G+FG V Y + +D+M+VAVK + A + F E E L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEV--------CKLSLIQRVN 643
+C D VFEYM++G L +L H D + V +L L Q ++
Sbjct: 73 YGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 644 IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK--FLSD-HQLDTA 700
IA +AS M YL VH DL N L+ +++ + DFG+++ + +D +++
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 701 VKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760
P + ++ PE M + + D+++ + +F G +
Sbjct: 185 TMLP---------IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYG------------K 223
Query: 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDV 817
+ + + ++E +T ++ E RV +E + ++ C P +R++++++
Sbjct: 224 QPWFQLSNTEVIECITQGRVL-ERPRVCPKEVYDIMLG----CWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 538 MIGQGSFGYVYKGT--LGEDEMI-VAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKI 593
IG+G FG VY+G E+E I VAVK + R F+ E +R H +++K+
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
I + + + V E G L+ +L + +++ L L + +++A+
Sbjct: 73 IGVITE------NPVWIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQLSTALA 121
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YL VH D+ NVL+ + DFGL+++L D A K K
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG-------KLP 171
Query: 714 VGYVAPE------YGMGSEASMTG----DIFT-GRRPIDAVFNE 746
+ ++APE + S+ M G +I G +P V N
Sbjct: 172 IKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN 215
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 50/183 (27%), Positives = 92/183 (50%), Gaps = 24/183 (13%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS-RSFVAECEALRNIRHRNLIKIITIC 597
+G G FG V+ G VA+K +LK S +F+AE ++ ++H L+++ +
Sbjct: 14 LGAGQFGEVWMG-YYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+ + EYMENGSL D+L + KL++ + +++A +A M ++
Sbjct: 71 TQEPI------YIITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIE- 119
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYV 717
+ +H DL+ +N+L+ + + DFGLA+ + D++ TA + G K + +
Sbjct: 120 --RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-TARE------GAKFPIKWT 170
Query: 718 APE 720
APE
Sbjct: 171 APE 173
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 8/157 (5%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRNLIKII 594
+G+G FG V +G L +D+ I+ V V +K +RS F++E ++ H N++++I
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 595 TIC-SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
+C + + +G + +M++G L +L S L V D+AS ME
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
YL +H DL N +L+ +M V DFGL+K
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 7e-14
Identities = 52/159 (32%), Positives = 76/159 (47%), Gaps = 22/159 (13%)
Query: 539 IGQGSFG----YVYKGTLGEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKI 593
+G+G FG Y Y +VAVK + + + S + E L+ + H N++K
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
CS KG + EY+ GSL+D+L + KL+L Q + A + M
Sbjct: 72 KGCCSEQGGKGL---QLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMA 121
Query: 654 YLH--HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
YLH H+ +H DL NVLLD+D + + DFGLAK
Sbjct: 122 YLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 7e-14
Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 35/202 (17%)
Query: 538 MIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS---FVAECEALRNI-RHR 588
+G+G+FG V K + VAVK+ LK + V+E E ++ I +H+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK----------LSL 638
N+I ++ +C+ +G + V EY +G+L+D+L E L+
Sbjct: 77 NIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 639 IQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLD 698
V+ A VA ME+L +H DL NVL+ D V + DFGLA+ + H +D
Sbjct: 132 KDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI--HHID 186
Query: 699 TAVKTPSSSIGLKGTVGYVAPE 720
KT + + +K ++APE
Sbjct: 187 YYRKTTNGRLPVK----WMAPE 204
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 8e-14
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 46/212 (21%)
Query: 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI 585
L TG F +IG+G++G VYK + +VA+K++++ + E LR
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKY 59
Query: 586 -RHRNLIKIITICSSTDFKGTDFKA----------FVFEYMENGSLKDW---LHQSDDQV 631
H N+ F G K V E GS+ D L + ++
Sbjct: 60 SNHPNIA---------TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL 110
Query: 632 EVCKLSLIQRVNIAIDVASAMEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGL 688
+ ++ I R + + YLH + +H D+K N+LL + A V DFG+
Sbjct: 111 KEEWIAYILR-----ETLRGLAYLHENKV----IHRDIKGQNILLTKN--AEVKLVDFGV 159
Query: 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
+ QLD+ + ++ I GT ++APE
Sbjct: 160 SA-----QLDSTLGRRNTFI---GTPYWMAPE 183
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 18/173 (10%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIV--AVKVINLKYKGASRS----FVAECEALRNIR 586
+ S+++ +G+FG ++ G L +++ V V +K AS + E L +
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK-DHASEIQVTLLLQESCLLYGLS 66
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK--LSLIQRVNI 644
H+N++ I+ +C + ++ YM G+LK +L Q LS Q V++
Sbjct: 67 HQNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK--FLSDH 695
AI +A M YLH ++H D+ N ++D ++ + D L++ F D+
Sbjct: 123 AIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY 172
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 27/170 (15%)
Query: 537 NMIGQGSFGYVYKGTL------GEDEMIVAVKVINLKYKGASRS----FVAECEALRNIR 586
N +G G+FG VY+GT G + VAVK + KGA+ F+ E + N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KGATDQEKKEFLKEAHLMSNFN 57
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ-VEVCKLSLIQRVNIA 645
H N++K++ +C + + + E ME G L +L + + L+L + ++I
Sbjct: 58 HPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDIC 112
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLL-----DHDMVAHVCDFGLAK 690
+DVA YL Q +H DL N L+ D D V + DFGLA+
Sbjct: 113 LDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-13
Identities = 86/314 (27%), Positives = 136/314 (43%), Gaps = 24/314 (7%)
Query: 112 IPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLT 171
+P SLS +L+LL S +L L L+L N L ++ L
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSEN-LLNLLPLPSLDLNLNRL-------RSNISELL 113
Query: 172 NCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAE 231
++L +L L +N ++P I L S + + N+I ++P +RNL NL
Sbjct: 114 ELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLS 171
Query: 232 ENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSL 291
N L +P + L NL L L N + +P + L+ L L+LS+NS+ + SSL
Sbjct: 172 FNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSL 228
Query: 292 GNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDI 351
N +NL S NKL + + + LDLSNN ++ S+ G L NL LD+
Sbjct: 229 SNLKNLSGLELSNNKLE--DLPESIGNLSNLETLDLSNNQIS-SISSL-GSLTNLRELDL 284
Query: 352 SSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEF 411
S N S +P + LE L + + + + +++N LS
Sbjct: 285 SGNSLSNALPLIALLLLLLELLLNLLLT-------LKALELKLNSILLNNNILSNGETSS 337
Query: 412 LKNLSVLEFLSLSY 425
+ LS+LE L+ +
Sbjct: 338 PEALSILESLNNLW 351
|
Length = 394 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 51/223 (22%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKI---- 593
+G G+ G V K I+AVK I L+ A + + E + L ++
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 594 -----ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
I+IC EYM+ GSL L + ++ L IA+ V
Sbjct: 69 YNNGDISIC--------------MEYMDGGSLDKILKEVQGRIPERILG-----KIAVAV 109
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
+ YLH + ++H D+KPSN+L++ +CDFG++ L + T V
Sbjct: 110 LKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV------- 160
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPID 741
GT Y+APE G++ S+ DI+ TGR P
Sbjct: 161 ---GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 53/195 (27%), Positives = 89/195 (45%), Gaps = 34/195 (17%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRN 589
F +IG+G+FG V + + + A+K +N + KG+ R+ + E L+ + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ----SDDQVEVCKLSLIQRVNIA 645
L+ + S F+ + V + + G L+ L Q S++QV+
Sbjct: 62 LVNL---WYS--FQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF----------WI 106
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
++ A+EYLH ++H D+KP N+LLD H+ DF +A ++ L T
Sbjct: 107 CEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT------ 157
Query: 706 SSIGLKGTVGYVAPE 720
GT GY+APE
Sbjct: 158 ---STSGTPGYMAPE 169
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 39/202 (19%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVI------NLKYKGASRSFVAECEALRNIRHRNLI 591
++G+G+FG V+KGTL +D+ VAVK LK K F++E L+ H N++
Sbjct: 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIV 55
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
K+I +C+ V E + G +L + D+ L Q V A+D A+
Sbjct: 56 KLIGVCTQ-----RQPIYIVMELVPGGDFLSFLRKKKDE-----LKTKQLVKFALDAAAG 105
Query: 652 MEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
M YL +C +H DL N L+ + V + DFG+++ Q D + SS GL
Sbjct: 106 MAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGI---YSSSGL 153
Query: 711 KGT-VGYVAPE---YGMGSEAS 728
K + + APE YG S S
Sbjct: 154 KQIPIKWTAPEALNYGRYSSES 175
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 46/158 (29%), Positives = 70/158 (44%), Gaps = 17/158 (10%)
Query: 539 IGQGSFGYVYKG---TLGEDEMIVAVKVI-NLKYKGASRSFVAECEALRNIRHRNLIKII 594
+G GSFG V +G T G + VAVK + + K F+ E + ++ H NLI++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ + V E GSL D L D + +S + + A+ +A+ M Y
Sbjct: 63 GVVLTHPLM------MVTELAPLGSLLDRLR--KDALGHFLISTL--CDYAVQIANGMRY 112
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692
L +H DL N+LL D + DFGL + L
Sbjct: 113 LE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRAL 147
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 30/213 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA--SRSFVAECEALRNIRHRNLIKIITI 596
+G G FG V+ G ++ VA+K IN +GA F+ E + + + H L+++ +
Sbjct: 12 LGSGQFGVVHLGKW-RAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGV 67
Query: 597 CSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
C T K V E+MENG L ++L Q KLS +++ DV MEY
Sbjct: 68 C-------TQQKPLYIVTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEY 115
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
L + +H DL N L+ V V DFG+ +++ D + +SS G K V
Sbjct: 116 LE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKFPV 165
Query: 715 GYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEG 747
+ PE S+ S D+++ + VF EG
Sbjct: 166 KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEG 198
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 4e-13
Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 39/168 (23%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL-KYKGAS----RSFVAECEALRNIRHRNLIKI 593
+G+G++ VYK E IVA+K I L + K A + + E + L+ ++H N+I +
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI---DVAS 650
+ + F VFE+ME +D + +I+ +I + D+ S
Sbjct: 68 LDV-----FGHKSNINLVFEFME----------TDLEK------VIKDKSIVLTPADIKS 106
Query: 651 AM-------EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691
M EYLH + ++H DLKP+N+L+ D V + DFGLA+
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARS 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 27/190 (14%)
Query: 539 IGQGSFGYVY---KGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRHRNLIK 592
I +G++G V+ K + G+ I A+KVI + K + E + L + ++K
Sbjct: 1 ISKGAYGRVFLAKKKSTGD---IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ--SDDQVEVCKLSLIQRVNIAIDVAS 650
+ S F+G V EY+ G L L S D+ +V ++ + + V
Sbjct: 58 LY--YS---FQGKKNLYLVMEYLPGGDLASLLENVGSLDE-DVARIYIAEIVL------- 104
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
A+EYLH + ++H DLKP N+L+D + + DFGL+K + +
Sbjct: 105 ALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 711 KGTVGYVAPE 720
GT Y+APE
Sbjct: 162 VGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 72/293 (24%), Positives = 130/293 (44%), Gaps = 38/293 (12%)
Query: 539 IGQGSFGYV----YKGTLGEDEMIVAVKVINLKYKGA-SRSFVAECEALRNIRHRNLIKI 593
+G+G FG V Y VAVK + + G E E LRN+ H N++K
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
IC T+ G K + E++ +GSLK++L ++ K++L Q++ A+ + M+
Sbjct: 72 KGIC--TEDGGNGIK-LIMEFLPSGSLKEYLPRN-----KNKINLKQQLKYAVQICKGMD 123
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YL VH DL NVL++ + + DFGL K + + VK L
Sbjct: 124 YLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD-----DLDSP 175
Query: 714 VGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEF-----AKTALPEKVMEIVDP 768
V + APE + S+ + D V++ G +L+E ++++ ++++ P
Sbjct: 176 VFWYAPECLIQSKFYIASD----------VWSFGVTLYELLTYCDSESSPMTLFLKMIGP 225
Query: 769 SL-LMEVMTNNSMIQEDKRV-KTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819
+ M V +++E KR+ + C + + C P +R ++++
Sbjct: 226 THGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 50/185 (27%), Positives = 85/185 (45%), Gaps = 26/185 (14%)
Query: 530 TGEFSSSNMIGQGSFGYVYKGT-LGEDEMI---VAVKVINLKYKGASRSFVAECE---AL 582
E ++G G FG V+KG + E + I VA+K I + + ++F + A+
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAM 63
Query: 583 RNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRV 642
++ H +++++ IC + V + GSL D + Q D ++ +L +
Sbjct: 64 GSLDHAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLDPQRL-----L 112
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL--SDHQ-LDT 699
N + +A M YL H MVH +L N+LL D + + DFG+A L D + +
Sbjct: 113 NWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS 169
Query: 700 AVKTP 704
KTP
Sbjct: 170 EHKTP 174
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 32/239 (13%)
Query: 536 SNMIGQGSFGYVYKGTLGEDEMIVAVK--VINLKYKGASRSFVAECEALRNIR---HRNL 590
IG+G++G VYK VA+K + L +G S + E L+ + H N+
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
++++ +C VFE+++ +D L + L ++ +
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVD----QD-LATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
+++LH H +VH DLKP N+L+ D + DFGLA+ S T+V
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV------- 168
Query: 711 KGTVGYVAPEYGMGSEASMTGDIFT---------GRRPIDAVFNEGHSLHE-FAKTALP 759
T+ Y APE + S + D+++ RRP+ +E L + F LP
Sbjct: 169 --TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLP 225
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 5e-13
Identities = 52/188 (27%), Positives = 78/188 (41%), Gaps = 42/188 (22%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
F+ IG+GSFG VYK +VA+KVI+L+ EA I ++
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE------------EAEDEIE--DIQ 47
Query: 592 KIITICSS------TDFKGTDFKAF----VFEYMENGSLKDWLHQSDDQVEVCKLSLIQR 641
+ I S T + G+ K + EY GS D L K +
Sbjct: 48 QEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL----------KPGKLDE 97
Query: 642 VNIAI---DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL- 697
IA +V +EYLH + +H D+K +N+LL + + DFG++ L+
Sbjct: 98 TYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154
Query: 698 -DTAVKTP 704
+T V TP
Sbjct: 155 RNTFVGTP 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-13
Identities = 55/198 (27%), Positives = 83/198 (41%), Gaps = 43/198 (21%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSF---VAECEALRNIRHRN 589
F+ IG GSFG VY +VA+K ++ K ++ + + E L+ +RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 590 LIKIITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
I ++KG + V EY L + D +EV K L Q V IA
Sbjct: 77 TI---------EYKGCYLREHTAWLVMEYC--------LGSASDILEVHKKPL-QEVEIA 118
Query: 646 I---DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVK 702
+ YLH H +H D+K N+LL + DFG A ++
Sbjct: 119 AICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA----------SLV 165
Query: 703 TPSSSIGLKGTVGYVAPE 720
+P++S GT ++APE
Sbjct: 166 SPANS--FVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-13
Identities = 36/85 (42%), Positives = 54/85 (63%)
Query: 325 LDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI 384
L L N L G +P + L++L +++S N G IP +L + LE LD+S NSF+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 385 PLSLSFLKSIKELNVSSNNLSGQIP 409
P SL L S++ LN++ N+LSG++P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 53/177 (29%), Positives = 80/177 (45%), Gaps = 36/177 (20%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGAS----RSFVAECEALRNIRHRN 589
IGQG+FG V++ E +VAVK+ LK + AS F E + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LK-EEASADMQADFQREAALMAEFDHPN 69
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL-HQSDDQVEV--------------- 633
++K++ +C+ G +FEYM G L ++L H+S
Sbjct: 70 IVKLLGVCA----VGKPM-CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 634 CKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
LS +++ IA VA+ M YL + VH DL N L+ +MV + DFGL++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 53/191 (27%), Positives = 75/191 (39%), Gaps = 49/191 (25%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRNLIK-- 592
IG+GSFG V K D I+ K I+ Y + V+E LR ++H N+++
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 593 --IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQR--------- 641
II + T + V EY E G L LIQ+
Sbjct: 66 DRIIDRSNQTLY-------IVMEYCEGGDLA---------------QLIQKCKKERKYIE 103
Query: 642 ----VNIAIDVASAMEYLHH--HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695
I + A+ H+ ++H DLKP+N+ LD + + DFGLAK L
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD 163
Query: 696 QLD--TAVKTP 704
T V TP
Sbjct: 164 SSFAKTYVGTP 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-12
Identities = 36/89 (40%), Positives = 52/89 (58%)
Query: 227 GFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN 286
G G + L G IP+ I +L++LQ + L N ++G IP LG++T L L+LS NS G+
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 287 IPSSLGNCQNLMSFTASQNKLTGALPHQL 315
IP SLG +L + N L+G +P L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 63/233 (27%), Positives = 105/233 (45%), Gaps = 29/233 (12%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIIT 595
++G+G+FG V+ D+ +V +K I ++ K + EC+ L+ + H N+I+
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+F V EY G+L +++ + + SL+ I + L
Sbjct: 67 -----NFLEDKALMIVMEYAPGGTLAEYIQKRCN-------SLLDEDTILHFFVQILLAL 114
Query: 656 HHHCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
HH ++H DLK N+LLD H MV + DFG++K LS + S + + GT
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS---------SKSKAYTVVGTP 165
Query: 715 GYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHE-FAKTALPEKVMEIV 766
Y++PE G + DI+ + V E SL F LP V++I+
Sbjct: 166 CYISPELCEGKPYNQKSDIWA----LGCVLYELASLKRAFEAANLPALVLKIM 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 1e-12
Identities = 54/186 (29%), Positives = 76/186 (40%), Gaps = 30/186 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN----LKYKGASRSFVAECEALRNIRHRNLIKII 594
+G GSFG V A+K+++ +K K + E L++IRH L+ +
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHV-LNEKRILQSIRHPFLVNLY 67
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
F+ V EY+ G L L +S + A V A+EY
Sbjct: 68 G-----SFQDDSNLYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEY 116
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH +V+ DLKP N+LLD D + DFG AK + T L GT
Sbjct: 117 LHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYT------LCGTP 162
Query: 715 GYVAPE 720
Y+APE
Sbjct: 163 EYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 31/175 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G+GS+G VYK E +VA+KV+ + + + + E L+ ++K
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK------ 62
Query: 599 STDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI---DVASA 651
+ G+ FK V EY GS+ D +++ +L + IA
Sbjct: 63 ---YYGSYFKNTDLWIVMEYCGAGSVS-------DIMKITNKTLTEE-EIAAILYQTLKG 111
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD--HQLDTAVKTP 704
+EYLH + +H D+K N+LL+ + A + DFG++ L+D + +T + TP
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTP 163
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 60/186 (32%), Positives = 82/186 (44%), Gaps = 26/186 (13%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN----LKYKGASRSFVAECEALRNIRHRNLIKII 594
IG+GSFG V D AVKV+ LK K L+N++H L+ +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
F+ D FV +Y+ G L + H Q E R A ++ASA+ Y
Sbjct: 62 ----HYSFQTADKLYFVLDYVNGGEL--FFHL---QRERSFPEPRARF-YAAEIASALGY 111
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH +++ DLKP N+LLD + DFGL K +H KT S+ GT
Sbjct: 112 LH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-----KTTST---FCGTP 160
Query: 715 GYVAPE 720
Y+APE
Sbjct: 161 EYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 48/164 (29%), Positives = 81/164 (49%), Gaps = 20/164 (12%)
Query: 539 IGQGSFGYV-----YKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKI 593
+G+G+FG V Y +D+++VAVK + A + F E E L N++H +++K
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLH-QSDDQVEVC------KLSLIQRVNIAI 646
+C D VFEYM++G L +L D V + +L+ Q ++IA
Sbjct: 73 YGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+A+ M YL VH DL N L+ +++ + DFG+++
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDE---MIVAVKVINLKYKGAS--RSFVAECEALRNIRH 587
F+ M+G+G FG V + L ++ VAVK++ +S F+ E ++ H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 588 RNLIKIITICSSTDFKGT-DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
N+IK+I + + KG + +M++G L +L S E L L V I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
D+AS MEYL +H DL N +L+ +M V DFGL+K
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 40/212 (18%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK 592
F+ IG+GSFG VYKG + +VA+K+I+L+ AE E + +I+ I
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54
Query: 593 IITICSS---TDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
+++ C S T + G+ K + EY+ GS D L +E ++ I R
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG--PLEETYIATILR---- 108
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL--DTAVKT 703
++ ++YLH + +H D+K +NVLL + DFG+A L+D Q+ +T V T
Sbjct: 109 -EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 704 PSSSIGLKGTVGYVAPEYGMGSEASMTGDIFT 735
P ++APE S DI++
Sbjct: 165 PF----------WMAPEVIKQSAYDFKADIWS 186
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 9e-12
Identities = 55/201 (27%), Positives = 83/201 (41%), Gaps = 35/201 (17%)
Query: 539 IGQGSFGYVYKGTL---GEDEMIVAVKVI-NLKYKGASRSFVAECEALRNIRHRNLIKII 594
+G G+FG V KG E+ VAVK + + F+ E + + H ++++I
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+C V E G L +L + ++ V L +A VA M Y
Sbjct: 63 GVCKGEPL------MLVMELAPLGPLLKYL-KKRREIPVSDL-----KELAHQVAMGMAY 110
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL---SD-HQLDTAVKTPSSSIGL 710
L VH DL NVLL + A + DFG+++ L SD ++ TA + P
Sbjct: 111 LE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWP------ 161
Query: 711 KGTVGYVAPE---YGMGSEAS 728
+ + APE YG S S
Sbjct: 162 ---LKWYAPECINYGKFSSKS 179
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 50/183 (27%), Positives = 92/183 (50%), Gaps = 23/183 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS-RSFVAECEALRNIRHRNLIKIITIC 597
+G G FG V+ G + VAVK LK S ++F+ E ++ ++H L+++ +
Sbjct: 14 LGAGQFGEVWMGYY-NNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+ + + EYM GSL D+L +SD E K+ L + ++ + +A M Y+
Sbjct: 71 TKEEPI-----YIITEYMAKGSLLDFL-KSD---EGGKVLLPKLIDFSAQIAEGMAYIE- 120
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYV 717
+ +H DL+ +NVL+ ++ + DFGLA+ + D++ ++ G K + +
Sbjct: 121 --RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-------TAREGAKFPIKWT 171
Query: 718 APE 720
APE
Sbjct: 172 APE 174
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
L + + G IP +S L+ +++S NS G IP SL + S++ L++S N+ +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 409 PEFLKNLSVLEFLSLSYNHFEGEVPTK--GVFSNKTKISLQGNMKLCGGIDELHLPSCPS 466
PE L L+ L L+L+ N G VP G ++ + N LCG +P +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG------IPGLRA 536
Query: 467 KGSRKPKIILLKVLIPVAVSSLILSSCLTIVYARK 501
G + + V+V+ L L C + R+
Sbjct: 537 CGPHLSVGAKIGIAFGVSVAFLFLVICAMCWWKRR 571
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 39/106 (36%), Positives = 56/106 (52%), Gaps = 25/106 (23%)
Query: 259 LQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSI 318
L+G IP+ + L L ++ LS NS++GNIP SLG+ I
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGS------------------------I 465
Query: 319 TTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTL 364
T+L + LDLS N NGS+P +G L +L IL+++ N SG +P L
Sbjct: 466 TSLEV-LDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 49/164 (29%), Positives = 87/164 (53%), Gaps = 16/164 (9%)
Query: 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVI---NLKYKGASRSFVAECEALRNIRHRNLIK 592
IGQG+FG V+K + + IVA+K + N K +G + + E + L+ ++H N++
Sbjct: 17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVN 75
Query: 593 IITICSSTDFKGTDFKA---FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+I IC + +K VFE+ E+ L L S+ V+ LS I++V +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL--SNKNVKF-TLSEIKKV--MKMLL 129
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
+ + Y+H + ++H D+K +N+L+ D + + DFGLA+ S
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFS 170
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 47/168 (27%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 537 NMIGQGSFGYVYKGTLGED--EMIVAVKVIN-LKYKGASRSFVAECEALRNI-RHRNLIK 592
++IG+G+FG V + + +D +M A+K++ + R F E E L + H N+I
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQS----------DDQVEVCKLSLIQRV 642
++ C + +G + A EY G+L D+L +S + L+ Q +
Sbjct: 68 LLGACEN---RGYLYIAI--EYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
A DVA+ M+YL + +H DL NVL+ ++ + + DFGL++
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 64/232 (27%), Positives = 116/232 (50%), Gaps = 45/232 (19%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINL--KYKGASRSFVAECEALRNIRHRN 589
+F IG+G++G VYK + +VA+K + L + +G + + E + LR + HRN
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 590 LIKIITICS----STDFKGTDFKAF--VFEYMEN---GSLKDWL-HQSDDQVEVCKLSLI 639
++ + I + + DFK D AF VFEYM++ G L+ L H S+D ++ S +
Sbjct: 68 IVNLKEIVTDKQDALDFK-KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK----SFM 122
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT 699
+++ +E L++ + +H D+K SN+LL++ + DFGLA+ + +
Sbjct: 123 KQL---------LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE--- 170
Query: 700 AVKTPSSSIGLKGTVGYVAPEYGMGSE-----------ASMTGDIFTGRRPI 740
P ++ + T+ Y PE +G E + G++FT ++PI
Sbjct: 171 --SRPYTNKVI--TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 24/200 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITIC 597
+G+G++ VYKG IVA+K I+L +G + + E ++ ++H N++++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL---- 63
Query: 598 SSTDFKGTDFK-AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
D T+ K VFEYM+ LK ++ D L + + + + H
Sbjct: 64 --HDVIHTENKLMLVFEYMDK-DLKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
+ ++H DLKP N+L++ + DFGLA+ V T S+ + T+ Y
Sbjct: 118 EN---RVLHRDLKPQNLLINKRGELKLADFGLAR-----AFGIPVNTFSNEV---VTLWY 166
Query: 717 VAPEYGMGSEASMTG-DIFT 735
AP+ +GS T DI++
Sbjct: 167 RAPDVLLGSRTYSTSIDIWS 186
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 50/199 (25%), Positives = 77/199 (38%), Gaps = 24/199 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRHRNLIKIIT 595
+G+G FG V + + A K ++ LK + + + E + L + R
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSR-----FI 55
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ + F+ D V M G LK ++ + + + A + +E+L
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG----FPEARAIFYAAQIICGLEHL 111
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
H Q +V+ DLKP NVLLD + D GLA L K GT G
Sbjct: 112 H---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------KKIKGRA---GTPG 159
Query: 716 YVAPEYGMGSEASMTGDIF 734
Y+APE G + D F
Sbjct: 160 YMAPEVLQGEVYDFSVDWF 178
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 37/203 (18%)
Query: 539 IGQGSFGYVYKG-TLGED----EMIVAVKVINLKYKGASRSF---VAECEALRNI-RHRN 589
+G+G FG V + G D + V V V LK + ++E E ++ I +H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 590 LIKIITICSSTDFKGTDFKAFVF-EYMENGSLKDWLHQS-----DDQVEVCK-----LSL 638
+I ++ +C+ + +V EY G+L+++L D ++ K LS
Sbjct: 80 IINLLGVCTQ------EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 639 IQRVNIAIDVASAMEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL 697
V+ A VA MEYL C +H DL NVL+ D V + DFGLA+ + H +
Sbjct: 134 KDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGV--HDI 187
Query: 698 DTAVKTPSSSIGLKGTVGYVAPE 720
D KT + + +K ++APE
Sbjct: 188 DYYKKTSNGRLPVK----WMAPE 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 53/192 (27%), Positives = 81/192 (42%), Gaps = 41/192 (21%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG G++G VYK +VA+KVI L+ E L+ RH N++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA------ 64
Query: 599 STDFKGTDFKA----FVFEYMENGSLKDWLHQ-----SDDQVE-VCKLSLIQRVNIAIDV 648
+ G+ + V EY GSL+D S+ Q+ VC+ +L
Sbjct: 65 ---YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL---------- 111
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
+ YLH + +H D+K +N+LL D + DFG++ QL + S I
Sbjct: 112 -KGLAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSA-----QLTATIAKRKSFI 162
Query: 709 GLKGTVGYVAPE 720
GT ++APE
Sbjct: 163 ---GTPYWMAPE 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 51/189 (26%), Positives = 84/189 (44%), Gaps = 30/189 (15%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINL-----KYKGASRSFVAECEALRNIRHRNLIK 592
++G GSFG VY+G +D AVK ++L + A + E L ++H N+++
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 593 IITICSSTDFKGTDFKAFVF-EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ D ++F E + GSL L + E +I+ +
Sbjct: 67 YLGTEREED------NLYIFLELVPGGSLAKLLKKYGSFPE----PVIR--LYTRQILLG 114
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+EYLH VH D+K +N+L+D + V + DFG+AK V S + K
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK---------QVVEFSFAKSFK 162
Query: 712 GTVGYVAPE 720
G+ ++APE
Sbjct: 163 GSPYWMAPE 171
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 538 MIGQGSFGYVYK---GTLGEDE-MIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKI 593
+G+G+FG V L ++ +VAVK + R F E E L++++H N++K
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
+C S G V EY+ GSL+D+L + ++++ KL L A + ME
Sbjct: 71 KGVCYS---AGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY-----ASQICKGME 122
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YL VH DL N+L++ + + DFGL K L + V+ P S
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGES-----P 174
Query: 714 VGYVAPEYGMGSEASMTGDIFT 735
+ + APE S+ S+ D+++
Sbjct: 175 IFWYAPESLTESKFSVASDVWS 196
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 37/201 (18%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVI------NLKYKGASRSFVAECEALRNIRHRNLIK 592
IG+G+FG V+ G L D VAVK +LK K F+ E L+ H N+++
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-----FLQEARILKQYSHPNIVR 57
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+I +C+ K + V E ++ G +L + E +L + + + + + A+ M
Sbjct: 58 LIGVCTQ---KQPIY--IVMELVQGGDFLTFL-----RTEGPRLKVKELIQMVENAAAGM 107
Query: 653 EYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
EYL HC +H DL N L+ V + DFG+++ D +S+ G+K
Sbjct: 108 EYLESKHC----IHRDLAARNCLVTEKNVLKISDFGMSREEED-------GVYASTGGMK 156
Query: 712 GT-VGYVAPE---YGMGSEAS 728
V + APE YG S S
Sbjct: 157 QIPVKWTAPEALNYGRYSSES 177
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 72/283 (25%), Positives = 123/283 (43%), Gaps = 44/283 (15%)
Query: 537 NMIGQGSFGYVYKGTLGED--EMIVAVKVI-NLKYKGASRSFVAECEALRNI-RHRNLIK 592
++IG+G+FG V K + +D M A+K + K R F E E L + H N+I
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQS-----DDQVEVCK-----LSLIQRV 642
++ C + +G + A EY +G+L D+L +S D + LS Q +
Sbjct: 73 LLGAC---EHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA------------- 689
+ A DVA M+YL Q +H DL N+L+ + VA + DFGL+
Sbjct: 128 HFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 184
Query: 690 ---KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRP----IDA 742
++++ L+ +V T +S + G + + G MT + P ++
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 244
Query: 743 VFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDK 785
N +++ + EK E PS +++ N M++E K
Sbjct: 245 PLNCDDEVYDLMRQCWREKPYE--RPSFAQILVSLNRMLEERK 285
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 3e-11
Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 43/174 (24%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVI-----NLKYKGASRSFVAECEALRNIR-HRNLIK 592
+G+G++G V+K + +VA+K I N A R+F E L+ + H N++K
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNAT--DAQRTF-REIMFLQELGDHPNIVK 71
Query: 593 IITICSSTDFKGTDFKAF-------VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVN-- 643
++ + KA VFEYME D LH V + ++++ V+
Sbjct: 72 LLNV----------IKAENDKDIYLVFEYMET----D-LHA------VIRANILEDVHKR 110
Query: 644 -IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
I + A++Y+H ++H DLKPSN+LL+ D + DFGLA+ LS+ +
Sbjct: 111 YIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 21/177 (11%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMI---VAVKVIN-LKYKGASRSFVAECEALRNIRHRNLIK 592
+IG+G FG VY GTL + + AVK +N + F+ E +++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
++ IC ++ G+ V YM++G L++++ V L + + VA M
Sbjct: 61 LLGICLPSE--GSPL--VVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGM 111
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLD-----TAVKTP 704
EYL VH DL N +LD V DFGLA+ + D + T K P
Sbjct: 112 EYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP 165
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 67/252 (26%), Positives = 110/252 (43%), Gaps = 45/252 (17%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS-----RSFVA----ECEALRNIRHR 588
+IG GSFG VY G ++AVK + L AS RS + E L+ ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
N+++ + SS D D EY+ GS+ L+ E +L++ N +
Sbjct: 67 NIVQYLG--SSLD---ADHLNIFLEYVPGGSVAALLNNYGAFEE----TLVR--NFVRQI 115
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
+ YLH+ ++H D+K +N+L+D+ + DFG++K L + L T S
Sbjct: 116 LKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS- 171
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDI----------FTGRRP------IDAVFNEGHSLHE 752
L+G+V ++APE + + DI TG+ P + A+F G E
Sbjct: 172 -LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG----E 226
Query: 753 FAKTALPEKVME 764
A +P +
Sbjct: 227 NASPEIPSNISS 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 24/166 (14%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSF----VAECEALRNIRH 587
E+ N I +G++G VY+ + IVA+K LK + F + E L ++H
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREINILLKLQH 63
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL---HQSDDQVEVCKLSLIQRVNI 644
N++ + + ++ D V EY+E+ LK + Q Q EV K ++Q
Sbjct: 64 PNIVTVKEVVVGSNL---DKIYMVMEYVEH-DLKSLMETMKQPFLQSEV-KCLMLQ---- 114
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+ S + +LH + ++H DLK SN+LL++ + +CDFGLA+
Sbjct: 115 ---LLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 48/182 (26%), Positives = 88/182 (48%), Gaps = 22/182 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G FG V+ T + VAVK + +F+AE ++ ++H L+K+ + +
Sbjct: 14 LGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+ E+M GSL D+L +SD E K L + ++ + +A M ++
Sbjct: 72 KEPI------YIITEFMAKGSLLDFL-KSD---EGSKQPLPKLIDFSAQIAEGMAFIE-- 119
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
Q +H DL+ +N+L+ +V + DFGLA+ + D++ ++ G K + + A
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-------TAREGAKFPIKWTA 171
Query: 719 PE 720
PE
Sbjct: 172 PE 173
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 5e-11
Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 40/212 (18%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK 592
F+ IG+GSFG V+KG + +VA+K+I+L+ AE E + +I+ I
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54
Query: 593 IITICSS---TDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
+++ C S T + G+ K + EY+ GS D L Q +
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG-------PFDEFQIATML 107
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL--DTAVKT 703
++ ++YLH + +H D+K +NVLL + DFG+A L+D Q+ +T V T
Sbjct: 108 KEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGT 164
Query: 704 PSSSIGLKGTVGYVAPEYGMGSEASMTGDIFT 735
P ++APE S DI++
Sbjct: 165 PF----------WMAPEVIQQSAYDSKADIWS 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 63/227 (27%), Positives = 91/227 (40%), Gaps = 40/227 (17%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAEC--EA--LRNIRH 587
+F N IG+GSFG V+K D+ + A+K I+L +R E EA L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL--SKMNRREREEAIDEARVLAKLDS 58
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAID 647
+I+ F V EY ENG L L + L Q I
Sbjct: 59 SYIIRYY-----ESFLDKGKLNIVMEYAENGDLHKLLKMQRGR----PLPEDQVWRFFIQ 109
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL--DTAVKTPS 705
+ + +LH ++H D+K N+ LD + D G+AK LSD+ +T V TP
Sbjct: 110 ILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPY 166
Query: 706 SSIGLKGTVGYVAPE------YGMGSEASMTGDIF----TGRRPIDA 742
Y++PE Y S+ G + TG+ P DA
Sbjct: 167 ----------YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 55/200 (27%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-ECEALRNIRHRNLIKIITI 596
+IG+G++G VY+G +VA+K+INL S + E L +R I
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
S KG + EY E GS++ L ++ E +S+I R +V A++Y+H
Sbjct: 68 YGSY-LKGPRL-WIIMEYAEGGSVRT-LMKAGPIAEKY-ISVIIR-----EVLVALKYIH 118
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
++H D+K +N+L+ + +CDFG+A L + S GT +
Sbjct: 119 KV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL--------NQNSSKRSTFVGTPYW 167
Query: 717 VAPEYGM-GSEASMTGDIFT 735
+APE G DI++
Sbjct: 168 MAPEVITEGKYYDTKADIWS 187
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 30/218 (13%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINL--KYKGASRSFVAECEALRNIRHRNL 590
F IG+G++G VYK +VA+K I L + +G + + E L+ + H N+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 591 IKIITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+K++ D T+ K + VFE++ + LK ++ S + L LI+ + +
Sbjct: 62 VKLL------DVIHTENKLYLVFEFL-HQDLKKFMDAS--PLSGIPLPLIK--SYLFQLL 110
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
+ + H H ++H DLKP N+L++ + + DFGLA+ V+T + +
Sbjct: 111 QGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR-----AFGVPVRTYTHEV- 161
Query: 710 LKGTVGYVAPEYGMGSEASMTG-DIFTGRRPIDAVFNE 746
T+ Y APE +G + T DI++ + +F E
Sbjct: 162 --VTLWYRAPEILLGCKYYSTAVDIWS----LGCIFAE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 32/165 (19%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVK---------VINLKYKGASRSFVAECEALRNIRHRN 589
IG+GS+G V+K E IVA+K VI K A R E L+ ++H N
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK---KIALR----EIRMLKQLKHPN 61
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
L+ +I + F+ VFEY ++ ++ L++ + LI++ I
Sbjct: 62 LVNLIEV-----FRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKK--IIWQTL 110
Query: 650 SAMEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
A+ + H H+C +H D+KP N+L+ +CDFG A+ L+
Sbjct: 111 QAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILT 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-11
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 36/210 (17%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK 592
F+ IG+GSFG V+KG + +VA+K+I+L+ AE E + +I+ I
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--------AEDE-IEDIQQE--IT 54
Query: 593 IITICSS---TDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
+++ C S T + G+ K + EY+ GS D L E L Q I
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-------EPGPLDETQIATIL 107
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
++ ++YLH + +H D+K +NVLL + DFG+A L+D Q+
Sbjct: 108 REILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN----- 159
Query: 706 SSIGLKGTVGYVAPEYGMGSEASMTGDIFT 735
GT ++APE S DI++
Sbjct: 160 ---TFVGTPFWMAPEVIKQSAYDSKADIWS 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 19/166 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGT-LGEDEMI---VAVKVIN-LKYKGASRSFVAECEALRNIR 586
E ++G G+FG VYKG + E E + VA+K++N A+ F+ E + ++
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 67
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H +L++++ +C S + V + M +G L D++H+ D + L +N +
Sbjct: 68 HPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCV 116
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692
+A M YL + +VH DL NVL+ + DFGLA+ L
Sbjct: 117 QIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 61/187 (32%), Positives = 83/187 (44%), Gaps = 26/187 (13%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVIN----LKYKGASRSFVAECEALRNIRHRNLIKI 593
+IG+GSFG V +E AVKV+ LK K L+N++H L+ +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
F+ D FV +Y+ G L L Q E C L R A ++ASA+
Sbjct: 62 -----HFSFQTADKLYFVLDYINGGELFYHL-----QRERCFLEPRARF-YAAEIASALG 110
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YLH +V+ DLKP N+LLD + DFGL K +H T+ GT
Sbjct: 111 YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST--------FCGT 159
Query: 714 VGYVAPE 720
Y+APE
Sbjct: 160 PEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 54/188 (28%), Positives = 79/188 (42%), Gaps = 26/188 (13%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-ECEALRNIRHRNLIKIITIC 597
IG G+ VY + VA+K I+L+ S + E +A+ H N++K
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK----- 63
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI---DVASAMEY 654
T F D V Y+ GSL D + S + IA +V +EY
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSS------YPRGGLDEAIIATVLKEVLKGLEY 117
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT--AVKTPSSSIGLKG 712
LH + Q +H D+K N+LL D + DFG++ L+D T KT G
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT------FVG 168
Query: 713 TVGYVAPE 720
T ++APE
Sbjct: 169 TPCWMAPE 176
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 57/191 (29%), Positives = 85/191 (44%), Gaps = 34/191 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG+G+FG VY+ + I A+KV++ K VA+ E I RN++ +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKK------EIVAKKEVAHTIGERNILVRTLLDE 54
Query: 599 STDFKGTDFK-------AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI-DVAS 650
S G F V +YM G L W Q + + R I ++
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELF-WHLQKEGRFSE------DRAKFYIAELVL 107
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF-LSDHQLDTAVKTPSSSIG 709
A+E+LH + +V+ DLKP N+LLD +CDFGL+K L+D++
Sbjct: 108 ALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--------- 155
Query: 710 LKGTVGYVAPE 720
GT Y+APE
Sbjct: 156 FCGTTEYLAPE 166
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 35/202 (17%)
Query: 539 IGQGSFGYVYKG-TLGEDE----MIVAVKVINLKYKGASRSF---VAECEALRNI-RHRN 589
+G+G FG V +G D+ + V V LK + ++E E ++ I +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 590 LIKIITICSSTDFKGTDFKAFVF-EYMENGSLKDWLHQ----------SDDQVEVCKLSL 638
+I ++ C+ D +V EY G+L+++L + QV +LS
Sbjct: 86 IINLLGACTQ------DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 639 IQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLD 698
V+ A VA MEYL +H DL NVL+ D V + DFGLA+ + H +D
Sbjct: 140 KDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHID 194
Query: 699 TAVKTPSSSIGLKGTVGYVAPE 720
KT + + +K ++APE
Sbjct: 195 YYKKTTNGRLPVK----WMAPE 212
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-10
Identities = 34/85 (40%), Positives = 46/85 (54%), Gaps = 1/85 (1%)
Query: 209 NQ-ISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGL 267
NQ + G IP I L +L N + G IP ++G + +L+ L L N G IP L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 268 GNLTKLANLELSSNSLQGNIPSSLG 292
G LT L L L+ NSL G +P++LG
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 44/216 (20%)
Query: 532 EFSSSNM-----IGQGSFGYVYKG-TLGEDE------MIVAVKVINLKYKGASRSF---V 576
E S + + +G+G FG V +G D+ + VAVK+ LK + V
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKM--LKDDATDKDLSDLV 65
Query: 577 AECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF-EYMENGSLKDWLHQS-----DD 629
+E E ++ I +H+N+I ++ C+ D +V EY G+L+++L D
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACTQ------DGPLYVLVEYASKGNLREYLRARRPPGMDY 119
Query: 630 QVEVCK-----LSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684
+ CK L+ V+ A VA MEYL +H DL NVL+ D V +
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIA 176
Query: 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
DFGLA+ + H +D KT + + +K ++APE
Sbjct: 177 DFGLARDV--HNIDYYKKTTNGRLPVK----WMAPE 206
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 22/161 (13%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-----ECEALRNIRHRNLIK 592
++G+GS+G V K E IVA+K + V E L+ +RH NL+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF---LESEDDKMVKKIAMREIRMLKQLRHENLVN 64
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+I + F+ VFE++++ L D L + + ++ S +++ + +
Sbjct: 65 LIEV-----FRRKKRLYLVFEFVDHTVLDD-LEKYPNGLD---ESRVRK--YLFQILRGI 113
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
E+ H H ++H D+KP N+L+ V +CDFG A+ L+
Sbjct: 114 EFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 49/189 (25%), Positives = 72/189 (38%), Gaps = 34/189 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIIT 595
+G G FG V + A+K + ++ G +E E L H ++K+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ----SDDQVEVCKLSLIQRVNIAIDVASA 651
FK + + EY G L L + ++ A
Sbjct: 61 -----TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVV----------LA 105
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
EYLH+ +++ DLKP N+LLD + + DFG AK L Q KT +
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTWT----FC 153
Query: 712 GTVGYVAPE 720
GT YVAPE
Sbjct: 154 GTPEYVAPE 162
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 85/288 (29%), Positives = 122/288 (42%), Gaps = 44/288 (15%)
Query: 69 NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLS 128
N+ L + L LNR N+ ++ L NL +L + NN P SNL+ LDLS
Sbjct: 91 NLLPLPSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLS 148
Query: 129 VNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGG 188
N+ + ++ +L NL L+L N+L D L+N S+L L L+ N+
Sbjct: 149 DNKIE-SLPSPLRNLPNLKNLDLSFNDL-------SDLPKLLSNLSNLNNLDLSGNKIS- 199
Query: 189 ELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKN 248
+LP I LS+ + N I + + NL NL G N+L
Sbjct: 200 DLPPEIELLSALE-ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL------------- 244
Query: 249 LQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT 308
+P +GNL+ L L+LS+N Q + SSLG+ NL S N L+
Sbjct: 245 ------------EDLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLRELDLSGNSLS 290
Query: 309 GALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQF 356
ALP L + L L L+L L L L L+ +I SN
Sbjct: 291 NALPLIALLLLLLELLLNLLLTLKALELKL----NSILLNNNILSNGE 334
|
Length = 394 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/194 (30%), Positives = 83/194 (42%), Gaps = 47/194 (24%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS-----RSFVAECEALRNIRHRNLIKI 593
IG GSFG VY T +VAVK + Y G + + E + L+ ++H N I
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVK--KMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI-- 84
Query: 594 ITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
++KG K V EY L + D +EV K L Q V IA
Sbjct: 85 -------EYKGCYLKEHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIAAITH 128
Query: 650 SAME---YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
A++ YLH H M+H D+K N+LL + DFG A + +P++
Sbjct: 129 GALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSA----------SKSSPAN 175
Query: 707 SIGLKGTVGYVAPE 720
S GT ++APE
Sbjct: 176 S--FVGTPYWMAPE 187
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 27/212 (12%)
Query: 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVI---NLKYKGASRSFVAECEALRNIR 586
G F IG+G F VYK D +VA+K + + A + + E + L+ +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI-- 644
H N+IK + F + V E + G L + Q LI I
Sbjct: 61 HPNVIKYLA-----SFIENNELNIVLELADAGDLSRMIKHFKKQKR-----LIPERTIWK 110
Query: 645 -AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKT 703
+ + SA+E++H ++H D+KP+NV + V + D GL +F S KT
Sbjct: 111 YFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KT 160
Query: 704 PSSSIGLKGTVGYVAPEYGMGSEASMTGDIFT 735
+++ L GT Y++PE + + DI++
Sbjct: 161 -TAAHSLVGTPYYMSPERIHENGYNFKSDIWS 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 59/234 (25%), Positives = 96/234 (41%), Gaps = 37/234 (15%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA-SRSFVAECEALRNIRHRN 589
+ + +G+G+ G V K L MI A+K I + + E E ++ +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLI--QRV--NIA 645
++K + + EY E GSL D +++ +V K ++V IA
Sbjct: 61 IVKYYGAFLD---ESSSSIGIAMEYCEGGSL-DSIYK-----KVKKRGGRIGEKVLGKIA 111
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
V + YLH ++H D+KPSN+LL +CDFG++ L + T
Sbjct: 112 ESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---- 164
Query: 706 SSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759
GT Y+APE G S+T D+++ G +L E A+ P
Sbjct: 165 ------GTSFYMAPERIQGKPYSITSDVWS----------LGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 55/190 (28%), Positives = 93/190 (48%), Gaps = 27/190 (14%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-ECEALRNIRHRNL 590
E N IG G+ G VYK + A+KVI ++ R + E E LR++ H N+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
+K C + + + E+M+ GSL + H +D+Q ++A + S
Sbjct: 135 VK----CHDMFDHNGEIQ-VLLEFMDGGSL-EGTHIADEQ---------FLADVARQILS 179
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
+ YLH +VH D+KPSN+L++ + DFG+++ L+ +D +SS+
Sbjct: 180 GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILA-QTMDPC----NSSV-- 229
Query: 711 KGTVGYVAPE 720
GT+ Y++PE
Sbjct: 230 -GTIAYMSPE 238
|
Length = 353 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 66/292 (22%)
Query: 538 MIGQGSFGYVYKG---TLGEDEMIVAVKVINL------KYKGASRSFV----AECEALRN 584
+IG+G++G VY T GE ++AVK + L ++ + V +E E L++
Sbjct: 8 LIGKGTYGRVYLALNVTTGE---MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 585 IRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI 644
+ H N+++ + F+ EY+ GS+ L E ++V
Sbjct: 65 LDHLNIVQ----YLGFETTEEYLSIFL-EYVPGGSIGSCLRTYGRFEEQLVRFFTEQV-- 117
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
+ YLH ++H DLK N+L+D D + + DFG++K D +
Sbjct: 118 ----LEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD------IYDN 164
Query: 705 SSSIGLKGTVGYVAPE----YGMGSEASMTGDI----------FTGRRP------IDAVF 744
++ ++G+V ++APE Y G A + DI F GRRP I A+F
Sbjct: 165 DQNMSMQGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRPWSDEEAIAAMF 222
Query: 745 NEGHSLHEFAKTA--LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLN 794
G+ ++A +P V + P L + + I D R E L
Sbjct: 223 KLGNK-----RSAPPIPPDVSMNLSPVAL-DFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 43/172 (25%), Positives = 74/172 (43%), Gaps = 22/172 (12%)
Query: 533 FSSSNM-----IGQGSFGYVYKGTL-----GEDEMIVAVKVIN-LKYKGASRSFVAECEA 581
F SN+ +G+G FG V+ E +V VK + K + F E +
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 582 LRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK---LSL 638
R + H+N+++++ +C + + + EY + G LK +L + + E K LS
Sbjct: 62 FRKLSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 639 IQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
Q+V + +A M++L + VH DL N L+ V L+K
Sbjct: 117 KQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 26/187 (13%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVIN----LKYKGASRSFVAECEALRNIRHRNLIKI 593
+IG+GSFG V D AVKV+ LK K + L+N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
F+ + FV +Y+ G L + H Q E C L R A +VASA+
Sbjct: 62 -----HYSFQTAEKLYFVLDYVNGGEL--FFHL---QRERCFLEPRARF-YAAEVASAIG 110
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YLH +++ DLKP N+LLD + DFGL K V+ ++ GT
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGVEPEETTSTFCGT 159
Query: 714 VGYVAPE 720
Y+APE
Sbjct: 160 PEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 18/164 (10%)
Query: 537 NMIGQGSFGYVYKGT-LGED----EMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNL 590
+G G+FG VY+G G D E+ VAVK + S F+ E + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQS-DDQVEVCKLSLIQRVNIAIDVA 649
+++I + F+ + + E M G LK +L ++ L++ + A DVA
Sbjct: 72 VRLIGVS----FERLP-RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVCDFGLAK 690
+YL + +H D+ N LL VA + DFG+A+
Sbjct: 127 KGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 55/195 (28%), Positives = 84/195 (43%), Gaps = 34/195 (17%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVK------VINLKYKGASRSFVAECEALRNI 585
+ +G G+FG V+ E A+K VI LK + + E L+ +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN---EKRVLKEV 58
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
H +I++ + D F + EY+ G L +L S + S + A
Sbjct: 59 SHPFIIRLF--WTEHD---QRFLYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYA 107
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
++ A+EYLH +V+ DLKP N+LLD + + DFG AK L D +T +
Sbjct: 108 SEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-------RTWT 157
Query: 706 SSIGLKGTVGYVAPE 720
L GT Y+APE
Sbjct: 158 ----LCGTPEYLAPE 168
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 14/155 (9%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA---SRSFVAECEALRNIRHRNLIKIIT 595
IG G FG V G + V V L+ + F+ E + R+++H NL++ +
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLH-QSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
C+ T + V E+ G LK +L ++ + +QR +A ++A + +
Sbjct: 63 QCTEV----TPY-LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLH 115
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
LH + +H DL N LL D+ + D+GL+
Sbjct: 116 LHKN---NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 5e-10
Identities = 29/85 (34%), Positives = 51/85 (60%)
Query: 4 LAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMF 63
L +++ L G +P+ + L L+ I + GNS+ G IP +LG + +L L+++ N F+G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 64 PRSICNISSLELIQLALNRFSGNLP 88
P S+ ++SL ++ L N SG +P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITIC 597
+G+GS+ VYKG + +VA+KVI++K + G + + E L+ ++H N++ + I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+ + FVFEYM L ++ Q + + L + + Y+H
Sbjct: 73 HTKETL-----TFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFM-----FQLLRGLAYIHG 121
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++H DLKP N+L+ + + DFGLA+
Sbjct: 122 Q---HILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 52/202 (25%), Positives = 92/202 (45%), Gaps = 22/202 (10%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIR---HRNLIKI 593
IG G++G VYK VA+K + ++ G S V E L+ + H N++++
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
+ +C+++ VFE+++ L+ +L D+V L ++ ++
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL----DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
+LH +C +VH DLKP N+L+ + DFGLA+ S T V T
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV---------T 170
Query: 714 VGYVAPEYGMGSEASMTGDIFT 735
+ Y APE + S + D+++
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWS 192
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 30/218 (13%)
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTK---LANLELSSNSLQGN----IPSSLG 292
+ + LQ+L L N L L +L + L L+L++N L + L
Sbjct: 74 LQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLK 133
Query: 293 NCQ-NLMSFTASQNKLTGALPHQLL----SITTLSLYLDLSNNLLNG----SLPLQVGHL 343
+ L +N+L GA L + L L+L+NN + +L +
Sbjct: 134 DLPPALEKLVLGRNRLEGASCEALAKALRANRDLKE-LNLANNGIGDAGIRALAEGLKAN 192
Query: 344 KNLVILDISSNQF----SGVIPGTLSTCVCLEYLDISSNSF--HGVIPLSLSFLK---SI 394
NL +LD+++N + + TL++ LE L++ N+ G L+ + L S+
Sbjct: 193 CNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISL 252
Query: 395 KELNVSSNNL----SGQIPEFLKNLSVLEFLSLSYNHF 428
L++S N++ + + E L L L L N F
Sbjct: 253 LTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGTL---GEDEMI-VAVKVI-NLKYKGASRSFVAECEALRNIR 586
EF ++G G+FG VYKG GE I VA+K + A++ + E + ++
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 67
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
+ ++ +++ IC ++ + + + M G L D++ + D + L+ N +
Sbjct: 68 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNI--GSQYLL---NWCV 116
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
+A M YL +VH DL NVL+ + DFGLAK L
Sbjct: 117 QIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 24/169 (14%)
Query: 537 NMIGQGSFGYVYKGTLGED--EMIVAVKVINLKYKGAS--RSFVAECEALRNI-RHRNLI 591
++IG+G+FG V K + +D M A+K + +Y R F E E L + H N+I
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD----------DQVEVCKLSLIQR 641
++ C +G + A EY +G+L D+L +S LS Q
Sbjct: 60 NLLGACEH---RGYLYLAI--EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 642 VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++ A DVA M+YL Q +H DL N+L+ + VA + DFGL++
Sbjct: 115 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 49/211 (23%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVK-VINLKYKG---ASRSFVAEC----------EAL 582
+G+G++G V K IVA+K V ++ R V C + +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 583 RNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRV 642
I+H N++ ++ + + DF V + M LK + D ++ +L+ Q
Sbjct: 75 NEIKHENIMGLVDV-----YVEGDFINLVMDIMA-SDLKKVV---DRKI---RLTESQVK 122
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA-KFLSDHQLDTAV 701
I + + + + LH +H DL P+N+ ++ + + DFGLA ++ DT
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 702 KTPSSSIGLKG-----TVGYVAPEYGMGSEA 727
K + + T+ Y APE MG+E
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEK 210
|
Length = 335 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 67/189 (35%), Positives = 96/189 (50%), Gaps = 7/189 (3%)
Query: 264 PSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL 323
S L LT L +L+L +N++ P NL S NK+ +LP L ++ L
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLK- 166
Query: 324 YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV 383
LDLS N L+ LP + +L NL LD+S N+ S +P + LE LD+S+NS
Sbjct: 167 NLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-E 223
Query: 384 IPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK 443
+ SLS LK++ L +S NN +PE + NLS LE L LS N + + G +N +
Sbjct: 224 LLSSLSNLKNLSGLELS-NNKLEDLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRE 281
Query: 444 ISLQGNMKL 452
+ L GN
Sbjct: 282 LDLSGNSLS 290
|
Length = 394 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 47/193 (24%), Positives = 90/193 (46%), Gaps = 23/193 (11%)
Query: 532 EFSSSN---MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHR 588
E+ + ++G+G++G VY ++ +A+K I + + E ++HR
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
N+++ + S F FK F+ E + GSL L ++ + ++I +
Sbjct: 66 NIVQYLGSDSENGF----FKIFM-EQVPGGSLSALLRSKWGPLKDNEQTIIFYTK---QI 117
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
++YLH + +VH D+K NVL++ + V + DFG +K L+ ++ +T
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTET---- 168
Query: 708 IGLKGTVGYVAPE 720
GT+ Y+APE
Sbjct: 169 --FTGTLQYMAPE 179
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/189 (28%), Positives = 94/189 (49%), Gaps = 25/189 (13%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITIC 597
+G+G++ V+KG E +VA+K I L++ +GA + + E L+N++H N++ + I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI-DVASAMEYLH 656
T+ T VFEY+++ LK +L + L + V I + + + Y H
Sbjct: 73 H-TERCLT----LVFEYLDS-DLKQYLDNCGN------LMSMHNVKIFMFQLLRGLSYCH 120
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
++H DLKP N+L++ + DFGLA+ S KT S+ + T+ Y
Sbjct: 121 KR---KILHRDLKPQNLLINEKGELKLADFGLARAKS-----VPTKTYSNEV---VTLWY 169
Query: 717 VAPEYGMGS 725
P+ +GS
Sbjct: 170 RPPDVLLGS 178
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 49/175 (28%), Positives = 82/175 (46%), Gaps = 29/175 (16%)
Query: 539 IGQGSFGYVY-------KGTLGEDE-------MIVAVKVINLKY-KGASRSFVAECEALR 583
+G+G FG V+ LGE ++VAVK++ K A F+ E + +
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 584 NIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVN 643
+++ N+I+++ +C S D + EYMENG L +L Q + + + I V+
Sbjct: 73 RLKNPNIIRLLGVCVSDDPL-----CMITEYMENGDLNQFLSQREIESTFTHANNIPSVS 127
Query: 644 I------AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692
I A+ +AS M+YL VH DL N L+ + + DFG+++ L
Sbjct: 128 IANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 46/176 (26%), Positives = 84/176 (47%), Gaps = 30/176 (17%)
Query: 539 IGQGSFGYVY----KGTL------------GEDEMIVAVKVINLKY-KGASRSFVAECEA 581
+G+G FG V+ +G G ++VAVK++ K A F+ E +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 582 LRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL--HQ---SDDQVEVCKL 636
+ ++ N+I+++ +C + +D + EYMENG L +L H+ + ++ +V +
Sbjct: 73 MSRLKDPNIIRLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 637 SLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692
S + +A +AS M+YL VH DL N L+ + + DFG+++ L
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASR---SFVAECEALRNIRHRNLIKIIT 595
IG G FG V + D + V V LK +S+ F+ + + R ++H N+++ +
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
C + + VFEY E G LK +L Q +L L+QR +A ++A+ + ++
Sbjct: 63 QC----VEAIPY-LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHM 115
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688
H H +H DL N L D+ V D+G+
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 50/209 (23%), Positives = 88/209 (42%), Gaps = 48/209 (22%)
Query: 539 IGQGSFGYVYKGTL--GEDEMIVAVKVI---NLKYKGASRSFVAECEALRNIRHRNLIKI 593
IG+G++G VYK G+D A+K +Y G S+S E LR ++H N++ +
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 594 ITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + + D + +F+Y E+ D + K R + + +M
Sbjct: 68 VEVF----LEHADKSVYLLFDYAEH----DLWQ-------IIKF---HRQAKRVSIPPSM 109
Query: 653 ------------EYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCDFGLAKFLSDHQ 696
YLH + ++H DLKP+N+L+ V + D GLA+
Sbjct: 110 VKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL----- 161
Query: 697 LDTAVKTPSSSIGLKGTVGYVAPEYGMGS 725
+ +K + + T+ Y APE +G+
Sbjct: 162 FNAPLKPLADLDPVVVTIWYRAPELLLGA 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 33/88 (37%), Positives = 44/88 (50%), Gaps = 11/88 (12%)
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
+ S +E+LH +++ DLKP NVLLD+D + D GLA L D Q T
Sbjct: 106 IISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK------- 155
Query: 708 IGLKGTVGYVAPEYGMGSEASMTGDIFT 735
G GT G++APE G E + D F
Sbjct: 156 -GYAGTPGFMAPELLQGEEYDFSVDYFA 182
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 43/171 (25%), Positives = 67/171 (39%), Gaps = 30/171 (17%)
Query: 539 IGQGSFGYVY----KGTLGEDEMI------------VAVKVINLKY-KGASRSFVAECEA 581
+G+G FG V+ G E VAVKV+ A F+ E +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 582 LRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEVCKLSLI 639
L + N+ +++ +C+ + EYMENG L +L H ++ C +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPL-----CMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 640 QR---VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687
+ +A +AS M YL VH DL N L+ + + DFG
Sbjct: 128 SFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 42/173 (24%), Positives = 79/173 (45%), Gaps = 38/173 (21%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRN 589
+++ IG+G++G VYKG + IVA+K I L+ + G + + E L+ ++H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 590 LIKIITICSST-------DFKGTDFKAFV-----FEYMENGSLKDWLHQSDDQVEVCKLS 637
++ + + +F D K ++ +YM+ +K +L+Q
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQ----------- 109
Query: 638 LIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+ + + H ++H DLKP N+L+D+ V + DFGLA+
Sbjct: 110 ----------ILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-09
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 34/219 (15%)
Query: 538 MIGQGSFGYVYKGTLGEDEMI---VAVKVIN---LKYKGASRSFVAECEALRNIRHRNLI 591
+IG+G G VY L D + VA+K I + + F+ E + ++ H ++
Sbjct: 9 LIGKGGMGEVY---LAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIV 65
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA------ 645
+ +ICS D + Y+E +LK L +S Q E L ++ ++
Sbjct: 66 PVYSICSDGDPV-----YYTMPYIEGYTLKSLL-KSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS---DHQLDTAVK 702
+ + +EY+H ++H DLKP N+LL + D+G A F + LD V
Sbjct: 120 HKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 703 TPSS-----SIGLK--GTVGYVAPEYGMGSEASMTGDIF 734
+ +I K GT Y+APE +G AS + DI+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIY 215
|
Length = 932 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 20/156 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITI 596
IG+G++G V+K E IVA+K + L +G S + E L+ ++H+N++++ +
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVE--VCKLSLIQRVNIAIDVASAMEY 654
S D K T VFEY + LK + + ++ + K + Q + + +
Sbjct: 68 LHS-DKKLT----LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQ-------LLKGLAF 114
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
H H ++H DLKP N+L++ + + DFGLA+
Sbjct: 115 CHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 61/226 (26%), Positives = 105/226 (46%), Gaps = 46/226 (20%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+F + +G G+ G V K +I+A K+I+L+ K A R+ + IR +
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI--------IRE---L 54
Query: 592 KIITICSS---TDFKGTDFK----AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI 644
+++ C+S F G + + E+M+ GSL L ++ E ++ +V+I
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE----EILGKVSI 110
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
A V + YL Q ++H D+KPSN+L++ +CDFG++ L D ++ V
Sbjct: 111 A--VLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 163
Query: 705 SSSIGLKGTVGYVAPEYGMGSEASMTGDIFT----------GRRPI 740
GT Y++PE G+ S+ DI++ GR PI
Sbjct: 164 -------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 21/191 (10%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVK---VINLKYKGASRSFVAECEALRNIRHRN 589
F IG+G F VY+ T D + VA+K + +L A + E + L+ + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+IK F + V E + G L + Q + + + + +
Sbjct: 64 VIKY-----YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY--FVQLC 116
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
SA+E++H ++H D+KP+NV + V + D GL +F S KT +++
Sbjct: 117 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KT-TAAHS 165
Query: 710 LKGTVGYVAPE 720
L GT Y++PE
Sbjct: 166 LVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 52/209 (24%), Positives = 91/209 (43%), Gaps = 44/209 (21%)
Query: 539 IGQGSFGYVYKGTLGEDE-----MIVAVKVINLKYKGAS----RSFVAECEALRNIRHRN 589
+G+G FG V K T + VAVK++ + AS R ++E L+ + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK---ENASSSELRDLLSEFNLLKQVNHPH 64
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQS------------------DDQV 631
+IK+ CS + EY + GSL+ +L +S D
Sbjct: 65 VIKLYGACSQDGPL-----LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 632 EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691
+ L++ ++ A ++ M+YL + +VH DL NVL+ + DFGL++
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD 176
Query: 692 LSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
+ ++ D+ VK I +K ++A E
Sbjct: 177 V--YEEDSYVKRSKGRIPVK----WMAIE 199
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 52/206 (25%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 539 IGQGSFGYVYKG-TLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIR---HRNLIK 592
IG+G++G V+K L VA+K + ++ +G S + E LR++ H N+++
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ---VEVCKLSLIQRVNIAIDVA 649
+ +C+ + VFE+++ L +L + + E K + Q +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ-------LL 120
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
+++LH H +VH DLKP N+L+ + DFGLA+ S T+V
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV------ 171
Query: 710 LKGTVGYVAPEYGMGSEASMTGDIFT 735
T+ Y APE + S + D+++
Sbjct: 172 ---TLWYRAPEVLLQSSYATPVDLWS 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 26/211 (12%)
Query: 510 DTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK 569
D +EK +VS + K F IGQG+ G VY VA+K +NL+ +
Sbjct: 1 DEEILEKLRTIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDVATGQEVAIKQMNLQQQ 57
Query: 570 GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD 629
+ E +R +H N++ + + D V EY+ GSL D
Sbjct: 58 PKKELIINEILVMRENKHPNIVNYL-----DSYLVGDELWVVMEYLAGGSLT-------D 105
Query: 630 QVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
V + Q + + A+E+LH + ++H D+K N+LL D + DFG
Sbjct: 106 VVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162
Query: 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
++ Q S + GT ++APE
Sbjct: 163 AQITPEQ--------SKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASR-SFVAECEALRNIRHRNLIK 592
+GQGSFG VY+G GE E VAVK +N R F+ E ++ ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLH--QSDDQVEVCKL--SLIQRVNIAIDV 648
++ + S KG V E M +G LK +L + + + + +L + + +A ++
Sbjct: 74 LLGVVS----KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
A M YL+ VH DL N ++ HD + DFG+ +
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 39/204 (19%)
Query: 538 MIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGAS----RSFVAECEALRNIRHRNL 590
++G G FG + +G L + E+ VA+ + G S R F+AE L H N+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLR---AGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 591 IK---IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAID 647
++ +IT ++ V EYM NG+L +L + + Q L Q + +
Sbjct: 69 VRLEGVITRGNTM--------MIVTEYMSNGALDSFLRKHEGQ-----LVAGQLMGMLPG 115
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
+AS M+YL + VH L VL++ D+V + F + + + ++
Sbjct: 116 LASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ-------EDKSEAIYTT 165
Query: 708 IGLKGTVGYVAPE---YGMGSEAS 728
+ K V + APE Y S AS
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSAS 189
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 54/194 (27%), Positives = 91/194 (46%), Gaps = 32/194 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITI 596
IG+G++G VYK +A+K I L+ + G + + E L+ ++H N++++ +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 597 CSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDD---QVEVCKLSLIQRVNIAIDVASAM 652
S + + + VFEY++ LK + S D + K L Q + +
Sbjct: 70 VHS------EKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQ-------ILRGI 115
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVA-HVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
Y H H ++H DLKP N+L+D A + DFGLA+ V+T + +
Sbjct: 116 AYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR-----AFGIPVRTFTHEV--- 164
Query: 712 GTVGYVAPEYGMGS 725
T+ Y APE +GS
Sbjct: 165 VTLWYRAPEILLGS 178
|
Length = 294 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 26/172 (15%)
Query: 532 EFSSSNM-----IGQGSFGYVYKGT---LGEDE--MIVAVKVINLKYKGASR-SFVAECE 580
EF +N+ +G G+FG V + T L + + M VAVK++ + R + ++E +
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 581 ALRNI-RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLI 639
+ ++ H N++ ++ C+ G + EY G L ++L + + L+L
Sbjct: 91 IMSHLGNHENIVNLLGACTIG---GPIL--VITEYCCYGDLLNFLRRKRESF----LTLE 141
Query: 640 QRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++ + VA M +L +C +H DL NVLL H + +CDFGLA+
Sbjct: 142 DLLSFSYQVAKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 23/193 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITIC 597
+G+G++ V+KG E +VA+K I L+++ GA + + E L++++H N++ + I
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
TD T VFEY++ KD DD C +++ N+ I + + L +
Sbjct: 74 H-TDKSLT----LVFEYLD----KDLKQYMDD----CG-NIMSMHNVKIFLYQILRGLAY 119
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYV 717
+ ++H DLKP N+L++ + DFGLA+ S KT S+ + T+ Y
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS-----VPTKTYSNEV---VTLWYR 171
Query: 718 APEYGMGSEASMT 730
P+ +GS T
Sbjct: 172 PPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 1e-08
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 44/209 (21%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN----LKYKGASRSFVAECEALRNIRHRNLIKII 594
IG+G+FG V+ + + A+KV+ +K + AE + L + ++K+
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIK-RNQIAHVRAERDILADADSPWIVKLY 67
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
S F+ + V EYM G L + L + D E R IA ++ A++
Sbjct: 68 --YS---FQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE-----TARFYIA-ELVLALDS 116
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAK----------FLSDHQLDTAVK 702
+H + +H D+KP N+L+D D H+ DFGL K +L+D
Sbjct: 117 VH---KLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 703 TPSSSIGLK-----------GTVGYVAPE 720
GT Y+APE
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPE 200
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-08
Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 46/226 (20%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+F + +G G+ G V+K + +I+A K+I+L+ K A R+ + IR +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI--------IRE---L 54
Query: 592 KIITICSS---TDFKGTDFK----AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI 644
+++ C+S F G + + E+M+ GSL L ++ E ++ +V+I
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSI 110
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
A V + YL + ++H D+KPSN+L++ +CDFG++ L D ++ V
Sbjct: 111 A--VIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 163
Query: 705 SSSIGLKGTVGYVAPEYGMGSEASMTGDIFT----------GRRPI 740
GT Y++PE G+ S+ DI++ GR PI
Sbjct: 164 -------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 52/190 (27%), Positives = 92/190 (48%), Gaps = 27/190 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITIC 597
+G+G++ VYKG + +VA+K I L+++ GA + + E L++++H N++ + I
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEV--CKLSLIQRVNIAIDVASAMEYL 655
+ VFEY++ LK +L + + + KL L Q + + Y
Sbjct: 74 HTEKSL-----TLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ-------LLRGLNYC 120
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
H ++H DLKP N+L++ + DFGLA+ S KT S+ + T+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS-----IPTKTYSNEV---VTLW 169
Query: 716 YVAPEYGMGS 725
Y P+ +GS
Sbjct: 170 YRPPDILLGS 179
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 34/184 (18%)
Query: 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA--SRSFVAECEALRNIRH 587
T + +G G+FG V VA+K I + ++ E + L+++RH
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 588 RNLIKIITICSS--------TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLI 639
N+I + I S T+ GTD + + L+ Q
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRL----LTSRPLEKQFIQY------------ 112
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT 699
+ ++Y+H +VH DLKPSN+L++ + +CDFGLA+ + D Q+
Sbjct: 113 ----FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR-IQDPQMTG 164
Query: 700 AVKT 703
V T
Sbjct: 165 YVST 168
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 41/238 (17%)
Query: 539 IGQGSFG--YVYKGTLGEDEMIVAVKVINLKYKGASRSFVA--ECEALRNIRHRNLIKII 594
+G+G+FG +Y+ T ED+ +V K +NL A E L ++H N II
Sbjct: 8 LGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN---II 62
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV---EVCKLSLIQRVNIAIDVASA 651
+ T EY G+L D + + Q+ E+ L Q + SA
Sbjct: 63 AYYNHFMDDNTLL--IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-------IVSA 113
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL--DTAVKTPSSSIG 709
+ Y+H + ++H D+K N+ L + + DFG++K L +T V TP
Sbjct: 114 VSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY---- 166
Query: 710 LKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHE-FAKTALPEKVMEIV 766
Y++PE G + + DI+ + V E +L F T V++IV
Sbjct: 167 ------YMSPELCQGVKYNFKSDIWA----LGCVLYELLTLKRTFDATNPLNLVVKIV 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 56/214 (26%), Positives = 94/214 (43%), Gaps = 32/214 (14%)
Query: 510 DTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGT---LGEDEMIVAVKVINL 566
D MEK +VS + K +++ IGQG+ G V+ G++ VA+K INL
Sbjct: 1 DEEIMEKLRTIVSIGDPKK---KYTRYEKIGQGASGTVFTAIDVATGQE---VAIKQINL 54
Query: 567 KYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ 626
+ + + E ++ +++ N++ + F D V EY+ GSL D +
Sbjct: 55 QKQPKKELIINEILVMKELKNPNIVNFLD-----SFLVGDELFVVMEYLAGGSLTDVV-- 107
Query: 627 SDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686
E C + Q + + A+E+LH + ++H D+K NVLL D + DF
Sbjct: 108 ----TETC-MDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDF 159
Query: 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
G ++ Q S + GT ++APE
Sbjct: 160 GFCAQITPEQ--------SKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 39/159 (24%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVK-VINLKYK-GASRSFVAECEALRNIRHRNLIKII-T 595
+G+G+FG VYK + +VA+K ++ K G + + E + L+ ++H N++ +I
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM 75
Query: 596 ICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVC--KLSLIQRVNIAIDVASA 651
D + V YM++ L L ++ K ++Q +
Sbjct: 76 AVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQ-------LLEG 127
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+ YLH + ++H D+K +N+L+D+ + + DFGLA+
Sbjct: 128 INYLH---ENHILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 51/168 (30%), Positives = 77/168 (45%), Gaps = 40/168 (23%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIIT 595
IG+G++G V E VA+K I + A R+ + E + LR++ H N+I I
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIKD 71
Query: 596 ICSSTDFKGTDFKAF-----VFEYMENGSLKDWLHQ--------SDDQVEVCKLSLIQRV 642
I +AF V+E M+ LHQ SDD C+ L Q
Sbjct: 72 I-----MPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDH---CQYFLYQ-- 116
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+ ++Y+H ++H DLKPSN+LL+ + +CDFGLA+
Sbjct: 117 -----LLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITIC 597
+G+GS+ VYKG +VA+K I L++ +GA + + E L++++H N++ + I
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
T T VFEY++ LK ++ + +L L Q + + Y
Sbjct: 73 -HTKKTLT----LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ-------LLRGLAYC 119
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
H ++H DLKP N+L+ + DFGLA+
Sbjct: 120 HQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 52/163 (31%), Positives = 79/163 (48%), Gaps = 28/163 (17%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS--FVAECEALRNIRHRNLIKIIT 595
+IG+GS+G V VA+K IN ++ S + + E + LR +RH ++++I
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 596 IC---SSTDFKGTDFKAFVFEYMENGSLKDWLHQ----SDDQV-EVCKLSLIQRVNIAID 647
I S +FK VFE ME+ LHQ +DD E + L Q
Sbjct: 67 IMLPPSRREFKDI---YVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQ------- 111
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+ A++Y+H + H DLKP N+L + D +CDFGLA+
Sbjct: 112 LLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 23/158 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITI 596
IG+G++G VYK IVA+K I L+ +G + + E L+ + H N+++++ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 597 CSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQV---EVCKLSLIQRVNIAIDVASAM 652
S + K + VFE++ + LK ++ S + K L Q + +
Sbjct: 67 VHS------ENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL-------QGI 112
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
Y H H ++H DLKP N+L+D + + DFGLA+
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 42/215 (19%)
Query: 532 EFSSSNM-----IGQGSFGYVYKG-TLGEDE------MIVAVKVI--NLKYKGASRSFVA 577
EFS + +G+G FG V LG D+ + VAVK++ + K S V+
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVS 69
Query: 578 ECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ--------SD 628
E E ++ I +H+N+I ++ C+ G + + EY G+L+++L S
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQ---DGPLY--VIVEYASKGNLREYLRARRPPGMEYSY 124
Query: 629 DQVEVC--KLSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685
D V +++ V+ VA MEYL C +H DL NVL+ + V + D
Sbjct: 125 DIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIAD 180
Query: 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
FGLA+ + + +D KT + + +K ++APE
Sbjct: 181 FGLARDV--NNIDYYKKTTNGRLPVK----WMAPE 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 58/198 (29%), Positives = 85/198 (42%), Gaps = 43/198 (21%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSF---VAECEALRNIRHRN 589
F+ IG GSFG VY +VA+K ++ K ++ + + E + L+ I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 590 LIKIITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
S ++KG + V EY L + D +EV K L Q V IA
Sbjct: 87 ---------SIEYKGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVEIA 128
Query: 646 IDVASAME---YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVK 702
A++ YLH H M+H D+K N+LL + DFG A S
Sbjct: 129 AITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS--------- 176
Query: 703 TPSSSIGLKGTVGYVAPE 720
P++S GT ++APE
Sbjct: 177 -PANS--FVGTPYWMAPE 191
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 53/190 (27%), Positives = 88/190 (46%), Gaps = 32/190 (16%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIIT-- 595
+IG+G FG VY + + A+K ++ K R + + E L + R ++ +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54
Query: 596 -----ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
+C S F D +F+ + M G L H S V S + A ++
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV----FSEAEMRFYAAEIIL 108
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
+E++H+ +V+ DLKP+N+LLD + D GLA D + K P +S+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV-- 156
Query: 711 KGTVGYVAPE 720
GT GY+APE
Sbjct: 157 -GTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 52/190 (27%), Positives = 87/190 (45%), Gaps = 32/190 (16%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIIT-- 595
+IG+G FG VY + + A+K ++ K R + + E L + R ++ +++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKK-----RIKMKQGETLA-LNERIMLSLVSTG 54
Query: 596 -----ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
+C + F D F+ + M G L H S V S + A ++
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLH--YHLSQHGV----FSEKEMRFYATEIIL 108
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
+E++H+ +V+ DLKP+N+LLD + D GLA D + K P +S+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASV-- 156
Query: 711 KGTVGYVAPE 720
GT GY+APE
Sbjct: 157 -GTHGYMAPE 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 63/228 (27%), Positives = 98/228 (42%), Gaps = 60/228 (26%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G+ G V K +I+A K+I+L+ K A+RN R L K++ C+
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIK----------PAIRNQIIREL-KVLHECN 57
Query: 599 STDFKGTDFKAFV--------FEYMENGSLKDWLHQSDDQVEVCKLSLIQRV------NI 644
S G + AF E+M+ GSL DQV L R+ I
Sbjct: 58 SPYIVGF-YGAFYSDGEISICMEHMDGGSL--------DQV----LKKAGRIPENILGKI 104
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
+I V + YL + ++H D+KPSN+L++ +CDFG++ L D ++ V
Sbjct: 105 SIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 159
Query: 705 SSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDA 742
GT Y++PE G+ ++ DI+ GR PI
Sbjct: 160 -------GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 50/186 (26%), Positives = 81/186 (43%), Gaps = 31/186 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG+GS G V T VAVK ++L+ + E +R+ +H N I+ + S
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPN---IVEMYS 83
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQ---SDDQVE-VCKLSLIQRVNIAIDVASAMEY 654
S + D V E++E G+L D + +++Q+ VC L A+ +
Sbjct: 84 S--YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVL-----------KALSF 130
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH ++H D+K ++LL D + DFG +S + P L GT
Sbjct: 131 LHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-------EVPRRK-SLVGTP 179
Query: 715 GYVAPE 720
++APE
Sbjct: 180 YWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 56/187 (29%), Positives = 84/187 (44%), Gaps = 26/187 (13%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEAL-RNIRHRNLIKI 593
+IG+GSFG V D AVKV+ K + + +AE L +N++H L+ +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
F+ T+ FV +++ G L + H Q E R A ++ASA+
Sbjct: 62 -----HYSFQTTEKLYFVLDFVNGGEL--FFHL---QRERSFPEPRARFYAA-EIASALG 110
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YLH +V+ DLKP N+LLD + DFGL K + ++ GT
Sbjct: 111 YLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK--------EGIAQSDTTTTFCGT 159
Query: 714 VGYVAPE 720
Y+APE
Sbjct: 160 PEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 51/199 (25%), Positives = 84/199 (42%), Gaps = 22/199 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITI 596
+G+GS+G VYK D A+K ++L + V E L ++ H N+I
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII----- 62
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
F + V EY G L + + + ++ I R I I + ++ LH
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--IFIQLLRGLQALH 120
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
++H DLK +N+LL + + + D G++K L + T + TP Y
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPH----------Y 167
Query: 717 VAPEYGMGSEASMTGDIFT 735
+APE G S DI++
Sbjct: 168 MAPEVWKGRPYSYKSDIWS 186
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 57/200 (28%), Positives = 83/200 (41%), Gaps = 47/200 (23%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS-----RSFVAECEALRNIRH 587
FS IG GSFG VY + +VA+K + Y G + + E L+ +RH
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 588 RNLIKIITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVN 643
N I ++G + V EY L + D +EV K L Q V
Sbjct: 75 PNTI---------QYRGCYLREHTAWLVMEYC--------LGSASDLLEVHKKPL-QEVE 116
Query: 644 IAIDVASAME---YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTA 700
IA A++ YLH H M+H D+K N+LL + + DFG A ++
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166
Query: 701 VKTPSSSIGLKGTVGYVAPE 720
P++ GT ++APE
Sbjct: 167 ---PANX--FVGTPYWMAPE 181
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 15/217 (6%)
Query: 238 TIPDAIGELKNL--QKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN--IPSSLGN 293
PD+ E + L L N L +L++L +L+L S S + +L N
Sbjct: 36 NFPDSNLESVAVNRLALNLSSNTLLLL----PSSLSRLLSLDLLSPSGISSLDGSENLLN 91
Query: 294 CQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLK-NLVILDIS 352
L S + N+L + L T LDL NN + +P +G LK NL LD+S
Sbjct: 92 LLPLPSLDLNLNRLRSNISE--LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLS 148
Query: 353 SNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFL 412
N+ +P L L+ LD+S N +P LS L ++ L++S N +S +P +
Sbjct: 149 DNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEI 205
Query: 413 KNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
+ LS LE L LS N + + N + + L N
Sbjct: 206 ELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNN 242
|
Length = 394 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 70/311 (22%), Positives = 123/311 (39%), Gaps = 77/311 (24%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS------RSFVAECEALRNI 585
+F ++G+G++G V K E + IVA+K K+K + + + E + LR +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIK----KFKDSEENEEVKETTLRELKMLRTL 57
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD----DQVEVCKLSLIQR 641
+ N++++ F+ VFEY+E L+ + ++V LI+
Sbjct: 58 KQENIVEL-----KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK- 111
Query: 642 VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701
A+ + H + +VH D+KP N+L+ H+ V +CDFG A+ LS+
Sbjct: 112 ---------AIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE------- 152
Query: 702 KTPSSSIGLKGTVGYVAPEYGMGS----------------EASMTGDIFTGRRPIDAVFN 745
+ ++ T Y +PE +G+ E S +F G ID +F
Sbjct: 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
Query: 746 EGHSLH--------------EFAKTALP--------EKVMEIVDPSLLMEVMTNNSMIQE 783
L F P E+ + +L+++M N +
Sbjct: 213 IQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNP 272
Query: 784 DKRVKTEECLN 794
R TE+CLN
Sbjct: 273 TDRYLTEQCLN 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 25/186 (13%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G+G++G V K I+AVK I R+ V E R + ++ C
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI--------RATVNSQEQKRLLMDLDISMRSVDCP 60
Query: 599 ST-DFKGTDFK-AFVFEYME--NGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
T F G F+ V+ ME + SL + + D+ ++ + IA+ + A+EY
Sbjct: 61 YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEY 118
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH + ++H D+KPSNVL++ + +CDFG +S + +D+ KT + G
Sbjct: 119 LHS--KLSVIHRDVKPSNVLINRNGQVKLCDFG----ISGYLVDSVAKTIDA-----GCK 167
Query: 715 GYVAPE 720
Y+APE
Sbjct: 168 PYMAPE 173
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 32/227 (14%)
Query: 525 ELSKATGEFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS-FVAE 578
E++ +T F +G+ FG VYKG L GE VA+K + K +G R F E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 579 CEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL----------HQSD 628
++H N++ ++ + + + +F Y + L ++L D
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPL-----SMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113
Query: 629 DQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688
D+ L V+I +A+ ME+L H +VH DL NVL+ + + D GL
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGL 170
Query: 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFT 735
F + D +S + ++ +++PE M + S+ DI++
Sbjct: 171 --FREVYAADYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWS 211
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 532 EFSSSNMIGQGSFGYVYKGTL---GEDEMI-VAVKVI--NLKYKGASRSFVAECEALRNI 585
E ++G G+FG VYKG GE+ I VA+KV+ N K A++ + E + +
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPK-ANKEILDEAYVMAGV 66
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
+ +++ IC ++ + V + M G L D++ ++ D++ L +N
Sbjct: 67 GSPYVCRLLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL-----LNWC 115
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692
+ +A M YL + +VH DL NVL+ + DFGLA+ L
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-07
Identities = 23/64 (35%), Positives = 40/64 (62%)
Query: 325 LDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI 384
++LS N + G++P +G + +L +LD+S N F+G IP +L L L+++ NS G +
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 385 PLSL 388
P +L
Sbjct: 507 PAAL 510
|
Length = 623 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 23/185 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEA--LRNIRHRNLIKIITI 596
+G+GS+G V D +K +NL+ AE EA L ++H N++
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY--- 64
Query: 597 CSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
++G D + V + E G L L + ++ L Q V + +A A++YL
Sbjct: 65 --RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL----LPENQVVEWFVQIAMALQYL 118
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
H + ++H DLK NV L + V D G+A+ L ++Q D A L GT
Sbjct: 119 H---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMAST-------LIGTPY 167
Query: 716 YVAPE 720
Y++PE
Sbjct: 168 YMSPE 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 539 IGQGSFGYVYKGT--LGEDEMIVAVKVINLKYKGASR-SFVAECEALRNIRHRNLIKIIT 595
+G G+FG V KG + + ++ VA+KV+ + + + R + E E + + + ++++I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+C + V E G L +L D++ V + V + V+ M+YL
Sbjct: 63 VCEAEAL------MLVMEMASGGPLNKFLSGKKDEITVSNV-----VELMHQVSMGMKYL 111
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692
VH DL NVLL + A + DFGL+K L
Sbjct: 112 E---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 26/169 (15%)
Query: 539 IGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASR--SFVAECEALRNIRHRNLIK 592
+G+ +FG +YKG L + +VA+K + + F E + + H N++
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWL-----HQ----SDDQVEVCKLSLIQR-- 641
++ + + +FEY+ G L ++L H S D+ K SL
Sbjct: 72 LLGVVTQEQPV-----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDF 126
Query: 642 VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++IAI +A+ MEYL H VH DL N+L+ + + D GL++
Sbjct: 127 LHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 66/253 (26%), Positives = 103/253 (40%), Gaps = 57/253 (22%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNL 590
G F ++ + + G Y + + E+IVA K + E L+N RH L
Sbjct: 6 GTFGKVILVKEKATGRYYAMKILKKEVIVA--------KDEVAHTLTENRVLQNSRHPFL 57
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
+ F+ D FV EY G L + H S ++V S + ++ S
Sbjct: 58 TAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGAEIVS 106
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
A++YLH + +V+ DLK N++LD D + DFGL K +K ++
Sbjct: 107 ALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--------EGIKDGATMKTF 156
Query: 711 KGTVGYVAPE------YGMGSEASMTG----DIFTGRRPIDAVFNEGHSLHEFAKTALPE 760
GT Y+APE YG + G ++ GR P +N+ H E
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDH-----------E 202
Query: 761 KVMEIVDPSLLME 773
K+ E++ LME
Sbjct: 203 KLFELI----LME 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 21/192 (10%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVK---VINLKYKGASRSFVAECEALRNIRHR 588
F IG+G F VY+ T D VA+K + + A + V E + L+ + H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
N+IK + F + V E + G L + Q + + + + +
Sbjct: 63 NVIKYLD-----SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY--FVQL 115
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
SA+E++H ++H D+KP+NV + V + D GL +F S KT +++
Sbjct: 116 CSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-------KT-TAAH 164
Query: 709 GLKGTVGYVAPE 720
L GT Y++PE
Sbjct: 165 SLVGTPYYMSPE 176
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 53/201 (26%), Positives = 89/201 (44%), Gaps = 23/201 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+F +IG+G+FG V + E I A+K++N K++ R+ A RN+
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN-KWEMLKRAETACFREERNVLVNGDC 60
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV--EVCKLSLIQRVNIAIDVA 649
+ IT F+ ++ V +Y G L L + +D++ ++ + + + V +AI
Sbjct: 61 QWITTLHYA-FQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV-LAIHSI 118
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG-LAKFLSDHQLDTAVKTPSSSI 708
+ Y VH D+KP NVLLD + + DFG K D + ++V
Sbjct: 119 HQLHY---------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV----- 164
Query: 709 GLKGTVGYVAPEYGMGSEASM 729
GT Y++PE E M
Sbjct: 165 ---GTPDYISPEILQAMEDGM 182
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 46/173 (26%), Positives = 75/173 (43%), Gaps = 35/173 (20%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIIT 595
IG G++G V VA+K I + A R+ E + LR+ +H N+I I
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDNIIAIRD 71
Query: 596 ICSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ--------SDDQVEVCKLSLIQRVNIA 645
I G DFK V + ME+ LH +++ + L++
Sbjct: 72 ILRP---PGADFKDVYVVMDLMESD-----LHHIIHSDQPLTEEHIRYFLYQLLR----- 118
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLD 698
++Y+H ++H DLKPSN+L++ D + DFG+A+ LS +
Sbjct: 119 -----GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 43/162 (26%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASR-SFVAECEALRNIRHRNLIK 592
+GQGSFG VY+G E E VA+K +N R F+ E ++ ++++
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVE----VCKLSLIQRVNIAIDV 648
++ + S +G + E M G LK +L ++E SL + + +A ++
Sbjct: 74 LLGVVS----QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
A M YL+ + VH DL N ++ D + DFG+ +
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 47/182 (25%), Positives = 82/182 (45%), Gaps = 23/182 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG+GS G V T+ +VAVK ++L+ + E +R+ +H N++++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMY---- 83
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+ D V E++E G+L D + + +++ Q + + V A+ LH
Sbjct: 84 -NSYLVGDELWVVMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
++H D+K ++LL HD + DFG Q+ V S L GT ++A
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA-----QVSKEVPRRKS---LVGTPYWMA 184
Query: 719 PE 720
PE
Sbjct: 185 PE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 19/159 (11%)
Query: 539 IGQGSFGYVYKGTLG--EDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKII 594
+G G+FG V KG + E VAVK++ + + E ++ + + ++++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
IC + + V E E G L +L ++ E L+ +V++ M+Y
Sbjct: 63 GICEAESW------MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMG------MKY 110
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
L VH DL NVLL A + DFGL+K L
Sbjct: 111 LEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 40/194 (20%)
Query: 538 MIGQGSFGYV----YKGTLGEDEMIVAVKVINLKYKGASRSFVAECE-------ALRNIR 586
++G+GSFG V KGT DE+ AVKV LK + EC AL +
Sbjct: 2 VLGKGSFGKVLLAELKGT---DELY-AVKV--LKKDVILQDDDVECTMTEKRVLALAG-K 54
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H L ++ + C F+ D FV EY+ G L + +S + + A
Sbjct: 55 HPFLTQLHS-C----FQTKDRLFFVMEYVNGGDLMFHIQRSG------RFDEPRARFYAA 103
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
++ +++LH +++ DLK NVLLD + + DFG+ K + V T +
Sbjct: 104 EIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK----EGILGGVTTST- 155
Query: 707 SIGLKGTVGYVAPE 720
GT Y+APE
Sbjct: 156 ---FCGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 22/150 (14%)
Query: 557 MIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615
++VAVK++ K A F+ E + L ++ N+I+++ +C D + EYM
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL-----CMITEYM 101
Query: 616 ENGSLKDWL--HQSDDQVE-----------VCKLSLIQRVNIAIDVASAMEYLHHHCQPP 662
ENG L +L H DD+ E + +S +++A+ +AS M+YL
Sbjct: 102 ENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLN 158
Query: 663 MVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692
VH DL N L+ ++ + DFG+++ L
Sbjct: 159 FVHRDLATRNCLVGENLTIKIADFGMSRNL 188
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 24/188 (12%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINL-----KYKGASRSFVAECEALRNIRHRNLIK 592
++GQG+FG VY + +AVK + + K + E + L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
C D + F EYM GS+KD L E ++ ++ I +
Sbjct: 69 YYG-CLRDDETLSIF----MEYMPGGSVKDQLKAYGALTE----TVTRKYTRQI--LEGV 117
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
EYLH + +VH D+K +N+L D + DFG +K L Q + T S+ G
Sbjct: 118 EYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICSSGTGMKSV--TG 169
Query: 713 TVGYVAPE 720
T +++PE
Sbjct: 170 TPYWMSPE 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITIC 597
+G+GS+ VYKG + +VA+KVI L+ + G + + E L+ ++H N++ + I
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ + VFEY+ L ++ H E KL L Q + + Y+
Sbjct: 73 HTKETL-----TLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQ-------LLRGLSYI 119
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
H Q ++H DLKP N+L+ + DFGLA+
Sbjct: 120 H---QRYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 27/174 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G+FG VYK E + A K+I ++ + F+ E + L +H N++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY---- 68
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQ-----SDDQVE-VCKLSLIQRVNIAIDVASAM 652
F + E+ + G+L + + ++ Q+ VC+ + A+
Sbjct: 69 EAYFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCR-----------QMLEAL 116
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL-AKFLSDHQ-LDTAVKTP 704
+LH H ++H DLK N+LL D + DFG+ AK S Q DT + TP
Sbjct: 117 NFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTP 167
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 53/194 (27%), Positives = 79/194 (40%), Gaps = 32/194 (16%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN----LKYKGASRSFVAECEALRNIRH 587
+F +G GSFG V A+K + LK K E L + H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQH-VAQEKSILMELSH 77
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD-QVEVCKLSLIQRVNIAI 646
++ ++ CS F+ + F+ E++ G L L ++ +V K
Sbjct: 78 PFIVNMM--CS---FQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF-------YHA 125
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
++ A EYLH +++ DLKP N+LLD+ V DFG AK K P
Sbjct: 126 ELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----------KVPDR 171
Query: 707 SIGLKGTVGYVAPE 720
+ L GT Y+APE
Sbjct: 172 TFTLCGTPEYLAPE 185
|
Length = 329 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 49/185 (26%), Positives = 79/185 (42%), Gaps = 21/185 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G+FG VYK E + A KVI K + ++ E E L H ++K++
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGA-- 77
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
F + E+ G++ + + D + ++ +I R + A++YLH
Sbjct: 78 ---FYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICR-----QMLEALQYLH-- 127
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
++H DLK NVLL D + DFG++ VKT GT ++A
Sbjct: 128 -SMKIIHRDLKAGNVLLTLDGDIKLADFGVSA--------KNVKTLQRRDSFIGTPYWMA 178
Query: 719 PEYGM 723
PE M
Sbjct: 179 PEVVM 183
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 60/232 (25%), Positives = 95/232 (40%), Gaps = 54/232 (23%)
Query: 538 MIGQGSFGYV-----------YKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR 586
++G+G+FG V Y + + E+I+A K + E L+N R
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIA--------KDEVAHTLTESRVLKNTR 53
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H L + F+ D FV EY+ G L + H S ++V S +
Sbjct: 54 HPFLTSL-----KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERV----FSEDRTRFYGA 102
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
++ SA++YLH +V+ DLK N++LD D + DFGL K + ++
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK--------EGITDAAT 151
Query: 707 SIGLKGTVGYVAPE------YGMGSEASMTG----DIFTGRRPIDAVFNEGH 748
GT Y+APE YG + G ++ GR P +N+ H
Sbjct: 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDH 200
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 25/186 (13%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKII 594
++G+G+FG V A+K++ + K V E L+N RH L +
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
F+ D FV EY G L + H S ++V + + ++ SA+EY
Sbjct: 61 ----KYAFQTHDRLCFVMEYANGGEL--FFHLSRERV----FTEERARFYGAEIVSALEY 110
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH +V+ D+K N++LD D + DFGL K + ++ GT
Sbjct: 111 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--------EGISDGATMKTFCGTP 159
Query: 715 GYVAPE 720
Y+APE
Sbjct: 160 EYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 24/67 (35%), Positives = 41/67 (61%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
LQ++ ++ N + G +P +G+++ LEV+ + NS G IP +LG L +L LN+ N S
Sbjct: 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLS 503
Query: 61 GMFPRSI 67
G P ++
Sbjct: 504 GRVPAAL 510
|
Length = 623 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 50/192 (26%), Positives = 88/192 (45%), Gaps = 23/192 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+F +IG+G+FG V L + + A+K++N K++ R+ A R++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN-KWEMLKRAETACFREERDVLVNGDN 60
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV--EVCKLSLIQRVNIAIDVA 649
+ IT F+ + V +Y G L L + +D++ ++ + L + V IAID
Sbjct: 61 QWITTLHYA-FQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAIDSV 118
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG-LAKFLSDHQLDTAVKTPSSSI 708
+ Y VH D+KP N+L+D + + DFG K + D + ++V
Sbjct: 119 HQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV----- 164
Query: 709 GLKGTVGYVAPE 720
GT Y++PE
Sbjct: 165 ---GTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 47/209 (22%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKI-- 593
++G G+ G VYK I+AVKVI L + ++E E L +I
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 594 -------ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
I+IC+ E+M+ GSL D + + V + R IA+
Sbjct: 67 AFFVENRISICT--------------EFMDGGSL-DVYRKIPEHV-------LGR--IAV 102
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
V + YL ++H D+KPSN+L++ +CDFG++ L + T V
Sbjct: 103 AVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV----- 154
Query: 707 SIGLKGTVGYVAPEYGMGSEASMTGDIFT 735
GT Y+APE G + + D+++
Sbjct: 155 -----GTNAYMAPERISGEQYGIHSDVWS 178
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 60/231 (25%), Positives = 97/231 (41%), Gaps = 46/231 (19%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G+FG VYK E ++ A KVI+ K + ++ E + L + H N++K++
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA-- 70
Query: 599 STDFKGTDFKAFVFEYMENGS-------LKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
F + + E+ G+ L+ L + +V VCK +L A
Sbjct: 71 ---FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTL-----------EA 115
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+ YLH + ++H DLK N+L D + DFG++ +T
Sbjct: 116 LNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSA--------KNTRTIQRRDSFI 164
Query: 712 GTVGYVAPEYGMGSEASMTGDIFTGRRPID---AVFNEGHSLHEFAKTALP 759
GT ++APE M E S RP D V++ G +L E A+ P
Sbjct: 165 GTPYWMAPEVVM-CETSKD-------RPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 6e-07
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 510 DTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK 569
D +EK +VS + K F IGQG+ G VY VA++ +NL+ +
Sbjct: 2 DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 570 GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD 629
+ E +R ++ N++ + + D V EY+ GSL D +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV----- 108
Query: 630 QVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
E C + Q + + A+E+LH + ++H D+K N+LL D + DFG
Sbjct: 109 -TETC-MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
++ Q S + GT ++APE
Sbjct: 164 AQITPEQ--------SKRSTMVGTPYWMAPE 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 51/204 (25%), Positives = 89/204 (43%), Gaps = 22/204 (10%)
Query: 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECE 580
+ + L G F ++G G++G VYKG + + A+KV+++ + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEIN 64
Query: 581 ALRNI-RHRNLIKIITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQV--EVCKL 636
L+ HRN+ G D + + V E+ GS+ D + + E +
Sbjct: 65 MLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-I 123
Query: 637 SLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
+ I R ++ + +LH H ++H D+K NVLL + + DFG++ Q
Sbjct: 124 AYICR-----EILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-----Q 170
Query: 697 LDTAVKTPSSSIGLKGTVGYVAPE 720
LD V ++ I GT ++APE
Sbjct: 171 LDRTVGRRNTFI---GTPYWMAPE 191
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 32/102 (31%), Positives = 49/102 (48%), Gaps = 25/102 (24%)
Query: 35 LGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVN 94
L G IP + LR+L S+N++ N G P S+ +I+SLE++ L+ N F+G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG--------- 480
Query: 95 LPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNV 136
SIP SL ++L +L+L+ N G V
Sbjct: 481 ----------------SIPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 32/195 (16%)
Query: 539 IGQGSFGYVYK-GTLGEDEMIVAVKVINLKY----KGAS------RSFVAECEALR-NIR 586
+G G+FG VYK + ++A+K IN+ K V+E ++ +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H N+++ F D V + +E L + H + + + + + + NI +
Sbjct: 68 HPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGE--HFNSLKEKKQRFTEERIWNIFV 120
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
+ A+ YLH + +VH DL P+N++L D + DFGLAK K P S
Sbjct: 121 QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK----------QKQPES 168
Query: 707 SIGLK-GTVGYVAPE 720
+ GT+ Y PE
Sbjct: 169 KLTSVVGTILYSCPE 183
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITIC- 597
+G GS G V+ + + VAVK I L + + + E + +R + H N++K+ +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 598 -SSTDFKG-----TDFKA--FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
S +D T+ + V EYME L + L Q E +L + Q +
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQ-------LL 124
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGLAKFLSDH 695
++Y+H ++H DLKP+NV ++ D+V + DFGLA+ + H
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPH 168
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 56/231 (24%), Positives = 106/231 (45%), Gaps = 39/231 (16%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS------RSFVAECEALRNI 585
E++ ++G+G++G VY G + ++I AVK + L E + L+++
Sbjct: 1 EWTKGEVLGKGAYGTVYCGLTNQGQLI-AVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL 59
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVF-EYMENGSLKDWLHQSDDQVEV--CKLSLIQRV 642
+H N+++ + C D +F E++ GS+ L++ E CK +
Sbjct: 60 KHVNIVQYLGTCLD------DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK---- 109
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVK 702
+ + YLH++C +VH D+K +NV+L + + + DFG A+ L+ L
Sbjct: 110 ----QILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162
Query: 703 TPSSSIGLKGTVGYVAPE------YGMGSEASMTG----DIFTGRRPIDAV 743
S + GT ++APE YG S+ G ++ TG+ P+ ++
Sbjct: 163 NMLKS--MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 26/211 (12%)
Query: 510 DTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK 569
D +EK +VS + K F IGQG+ G VY VA+K +NL+ +
Sbjct: 1 DEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQMNLQQQ 57
Query: 570 GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD 629
+ E +R ++ N++ + + D V EY+ GSL D +
Sbjct: 58 PKKELIINEILVMRENKNPNIVNYLD-----SYLVGDELWVVMEYLAGGSLTDVV----- 107
Query: 630 QVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
E C + Q + + A+++LH + ++H D+K N+LL D + DFG
Sbjct: 108 -TETC-MDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162
Query: 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
++ Q S + GT ++APE
Sbjct: 163 AQITPEQ--------SKRSTMVGTPYWMAPE 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 26/161 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS------FVAECEALRNIRHRNLIK 592
IG G FG V LGE ++ + +K AS + F+ E + R + H N+++
Sbjct: 3 IGNGWFGKVL---LGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 593 IITIC-SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLS---LIQRVNIAIDV 648
+ C S + V E+ G LK++L ++ V +++ ++QR +A +V
Sbjct: 60 CLGQCIESIPY------LLVLEFCPLGDLKNYLRS--NRGMVAQMAQKDVLQR--MACEV 109
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
AS + +LH Q +H DL N L D+ + D+GLA
Sbjct: 110 ASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 46/204 (22%), Positives = 79/204 (38%), Gaps = 50/204 (24%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+ + IG G+ G VYK + ++AVK + R+ E E R + +
Sbjct: 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQM-------RRTGNKE-ENKRILMD---L 64
Query: 592 KIITICSSTDFKGTDFKAFVFEY-----MENGSLKDWLHQSDDQVEVCKLSLIQRVN--- 643
++ + + F+ + ME + C L++R+
Sbjct: 65 DVVLKSHDCPYIVKCYGYFITDSDVFICME-------------LMSTCLDKLLKRIQGPI 111
Query: 644 -------IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
+ + + A+ YL ++H D+KPSN+LLD +CDFG++ L D +
Sbjct: 112 PEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169
Query: 697 LDTAVKTPSSSIGLKGTVGYVAPE 720
KT S G Y+APE
Sbjct: 170 ----AKTRS-----AGCAAYMAPE 184
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 28/168 (16%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-----ECEALRNIR 586
+ + + IG+G++G V T + VA+K K E + LR +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIK----KISPFEHQTFCQRTLREIKILRRFK 61
Query: 587 HRNLIKIITICSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ--SDDQVEVCKLSLIQRV 642
H N+I I+ I F+ F V E ME K Q S+D + L Q
Sbjct: 62 HENIIGILDIIRPPSFE--SFNDVYIVQELMETDLYKLIKTQHLSNDH---IQYFLYQ-- 114
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+ ++Y+H ++H DLKPSN+LL+ + +CDFGLA+
Sbjct: 115 -----ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 21/60 (35%), Positives = 35/60 (58%)
Query: 345 NLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNL 404
NL LD+S+N+ + + G L+ LD+S N+ + P + S L S++ L++S NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 43/201 (21%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHR 588
+ + + +G G++G V + VA+K ++ ++ A R++ E L+++ H
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHE 74
Query: 589 NLIKIITI----CSSTDFKGTDFKAFVFEYME---NGSLKDWLHQ--SDDQVEVCKLSLI 639
N+I ++ + S DF D V M N +K Q SDD ++
Sbjct: 75 NVIGLLDVFTPASSLEDF--QDV-YLVTHLMGADLNNIVK---CQKLSDDHIQF------ 122
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT 699
+ + ++Y+H ++H DLKPSN+ ++ D + DFGLA+ +D ++
Sbjct: 123 ----LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEMTG 174
Query: 700 AVKTPSSSIGLKGTVGYVAPE 720
V T Y APE
Sbjct: 175 YV----------ATRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 18/197 (9%)
Query: 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI 585
L G F ++G G++G VYKG + + A+KV+++ E L+
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKY 59
Query: 586 -RHRNLIKIITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVN 643
HRN+ + G D + + V E+ GS+ D + + L
Sbjct: 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT----LKEEWIAY 115
Query: 644 IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKT 703
I ++ + +LH H ++H D+K NVLL + + DFG++ QLD V
Sbjct: 116 ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA-----QLDRTVGR 167
Query: 704 PSSSIGLKGTVGYVAPE 720
++ I GT ++APE
Sbjct: 168 RNTFI---GTPYWMAPE 181
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 52/190 (27%), Positives = 80/190 (42%), Gaps = 32/190 (16%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAEC-----EALRNIRHRNLIK 592
++G+GSFG V L E + AVKV LK + EC L R+ +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD--DQVEVCKLSLIQRVNIAIDVAS 650
+ C F+ D FV E++ G L + +S D+ A ++ S
Sbjct: 60 QLYCC----FQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--------AAEITS 107
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
A+ +LH +++ DLK NVLLDH+ + DFG+ K + ++
Sbjct: 108 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--------EGIFNGKTTSTF 156
Query: 711 KGTVGYVAPE 720
GT Y+APE
Sbjct: 157 CGTPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 34/144 (23%), Positives = 70/144 (48%), Gaps = 20/144 (13%)
Query: 539 IGQGSFGYVYKGT---LGED----EMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+GQG+F ++KG +G+ + V +KV++ ++ S SF + + H++L+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+C D V EY++ GSL +L ++ + +++ ++ +A +A A
Sbjct: 63 LNYGVCV-----CGDESIMVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWA 112
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLL 675
+ +L + HG++ NVLL
Sbjct: 113 LHFLE---DKGLTHGNVCAKNVLL 133
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 29/72 (40%), Positives = 45/72 (62%), Gaps = 1/72 (1%)
Query: 85 GNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLK 144
G +P DI L +L+++ + GN+ G+IP SL + ++LE+LDLS N F G++ L
Sbjct: 432 GFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLT 490
Query: 145 NLLWLNLEQNNL 156
+L LNL N+L
Sbjct: 491 SLRILNLNGNSL 502
|
Length = 623 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 23/182 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG+GS G V T VAVK ++L+ + E +R+ H N++ +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMY---- 85
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+ D V E++E G+L D + + +++ Q + + V A+ YLH+
Sbjct: 86 -NSYLVGDELWVVMEFLEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ 137
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
++H D+K ++LL D + DFG +S K L GT ++A
Sbjct: 138 ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS--------KEVPKRKSLVGTPYWMA 186
Query: 719 PE 720
PE
Sbjct: 187 PE 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 54/182 (29%), Positives = 90/182 (49%), Gaps = 25/182 (13%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
EF I +G+FG VY G + + AVKV+ K +++ V + +A R+ L
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVK-KADMINKNMVHQVQAERDAL--ALS 61
Query: 592 K---IITICSSTDFKGTDFKAFVFEYMENGSLKDWLH---QSDDQVEVCKLSLIQRVNIA 645
K I+ + S + + V EY+ G +K LH D+++ V +S
Sbjct: 62 KSPFIVHLYYS--LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-------- 111
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTA--VKT 703
+VA A++YLH H ++H DLKP N+L+ ++ + DFGL+K + +L+ + T
Sbjct: 112 -EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTT 167
Query: 704 PS 705
PS
Sbjct: 168 PS 169
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 4e-06
Identities = 20/59 (33%), Positives = 31/59 (52%)
Query: 370 LEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHF 428
L+ LD+S+N + + L ++K L++S NNL+ PE L L L LS N+
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 52/198 (26%), Positives = 87/198 (43%), Gaps = 35/198 (17%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN----LKYKGASRSFVAECEALRNIRH 587
+F +IG+G+FG V + + A+K++N LK + + F E + L N
Sbjct: 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK-RAETACFREERDVLVNGDR 60
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV--EVCKLSLIQRVNIA 645
R + + F+ + V +Y G L L + +D++ ++ + L + V +A
Sbjct: 61 RWITNL-----HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-LA 114
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFG-LAKFLSDHQLDTAVK 702
ID + Y VH D+KP NVLL D H+ DFG + L+D + + V
Sbjct: 115 IDSVHQLGY---------VHRDIKPDNVLL--DKNGHIRLADFGSCLRLLADGTVQSNVA 163
Query: 703 TPSSSIGLKGTVGYVAPE 720
GT Y++PE
Sbjct: 164 V--------GTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 51/192 (26%), Positives = 82/192 (42%), Gaps = 26/192 (13%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY----KGASRSFVAECEALRNIRHR 588
F ++G+G FG V + + A K + K KG S + + E + L + R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA-LNEKQILEKVNSR 60
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
++ + + ++ D V M G LK ++ + + V A ++
Sbjct: 61 FVVSL-----AYAYETKDALCLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEI 111
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
+E LH Q +V+ DLKP N+LLD + D GLA + + Q +K
Sbjct: 112 CCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIK------ 159
Query: 709 GLKGTVGYVAPE 720
G GTVGY+APE
Sbjct: 160 GRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 22/191 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEAL--RNIRHRN 589
+F+ ++G+GSFG V + + A+K+ LK + EC + R + ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+T S F+ D FV EY+ G L + Q V K Q V A +++
Sbjct: 59 KPPFLTQLHSC-FQTVDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPQAVFYAAEIS 111
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
+ +LH + +++ DLK NV+LD + + DFG+ K +H +D V T +
Sbjct: 112 VGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVD-GVTTRT---- 160
Query: 710 LKGTVGYVAPE 720
GT Y+APE
Sbjct: 161 FCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 54/194 (27%), Positives = 80/194 (41%), Gaps = 41/194 (21%)
Query: 538 MIGQGSFGYV-----------YKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR 586
++G+G+FG V Y + + E+I+A K + E L+N R
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIA--------KDEVAHTLTESRVLQNTR 53
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H L + F+ D FV EY G L + H S ++V S +
Sbjct: 54 HPFLTAL-----KYSFQTHDRLCFVMEYANGGEL--FFHLSRERV----FSEDRARFYGA 102
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
++ SA+ YLH +V+ DLK N++LD D + DFGL K +KT
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT--- 154
Query: 707 SIGLKGTVGYVAPE 720
GT Y+APE
Sbjct: 155 ---FCGTPEYLAPE 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 5e-06
Identities = 49/182 (26%), Positives = 78/182 (42%), Gaps = 35/182 (19%)
Query: 542 GSFG--YVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSS 599
G FG V K ++ V K+I K A V + +++ + N IK+ ++
Sbjct: 27 GKFGKVSVLKHK-PTQKLFV-QKIIKAKNFNAIEPMVHQL--MKD--NPNFIKLYYSVTT 80
Query: 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC 659
KG + +Y+++G L D L + KLS + I + A+ LH H
Sbjct: 81 --LKGH---VLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH- 128
Query: 660 QPPMVHGDLKPSNVLLDHDMV-AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
++H D+K NVL D ++CD+GL K + TPS GT+ Y +
Sbjct: 129 --NIIHNDIKLENVLYDRAKDRIYLCDYGLCK---------IIGTPSC---YDGTLDYFS 174
Query: 719 PE 720
PE
Sbjct: 175 PE 176
|
Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-06
Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 25/189 (13%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHR-NLIKIITIC 597
IG+GSFG V + + + I A+K I + SRS V A R + + N I+ +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLK 59
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
S F+ + V ++ G L L Q E R A ++ A+E LH
Sbjct: 60 FS--FQSPEKLYLVLAFINGGELFHHL-----QREGRFDLSRARFYTA-ELLCALENLH- 110
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF--LSDHQLDTAVKTPSSSIGLKGTVG 715
+ +++ DLKP N+LLD+ +CDFGL K D + +T TP
Sbjct: 111 --KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE---------- 158
Query: 716 YVAPEYGMG 724
Y+APE +G
Sbjct: 159 YLAPELLLG 167
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 41/195 (21%)
Query: 538 MIGQGSFGYVY--KGTLGEDE-MIVAVKVI---NLKYKGASRSFVAECEALRNIRHRNLI 591
++GQGSFG V+ + G D + A+KV+ LK + R+ + E + L + H ++
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61
Query: 592 KIITICSSTDFKGTDFKAF-VFEYMENGSL-----KDWLHQSDDQVEVCKLSLIQRVNIA 645
K+ F+ T+ K + + +++ G L K+ + +D K L +
Sbjct: 62 KL-----HYAFQ-TEGKLYLILDFLRGGDLFTRLSKEVMFTEED----VKFYLAE----- 106
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
+A A+++LH +++ DLKP N+LLD + + DFGL+K DH+
Sbjct: 107 --LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--------K 153
Query: 706 SSIGLKGTVGYVAPE 720
+ GTV Y+APE
Sbjct: 154 KAYSFCGTVEYMAPE 168
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 19/193 (9%)
Query: 520 MVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAEC 579
M+ L T + IG+G++G VYK T +D + AVK+++ AE
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILD-PISDVDEEIEAEY 69
Query: 580 EALRNI-RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSL 638
L+++ H N++K + D V E GS+ E+ K L
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV----------TELVKGLL 119
Query: 639 I--QRVN---IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
I QR++ I+ + A+ L H ++H D+K +N+LL + + DFG++ L+
Sbjct: 120 ICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179
Query: 694 DHQL--DTAVKTP 704
+L +T+V TP
Sbjct: 180 STRLRRNTSVGTP 192
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 29/78 (37%), Positives = 37/78 (47%), Gaps = 16/78 (20%)
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
A ++ +E LH + V+ DLKP N+LLD + D GL AVK P
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGL-----------AVKIP 153
Query: 705 SSSI--GLKGTVGYVAPE 720
G GTVGY+APE
Sbjct: 154 EGESIRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 9e-06
Identities = 41/150 (27%), Positives = 66/150 (44%), Gaps = 34/150 (22%)
Query: 613 EYMENGSLKDWLHQSDD-QVEVCKLSLIQRVNIAIDVASAMEYLH--HHCQPPMVHGDLK 669
E+M+ GSL + VE+ IA+ V + YL+ H ++H D+K
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEILG-------KIAVAVVEGLTYLYNVHR----IMHRDIK 131
Query: 670 PSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASM 729
PSN+L++ +CDFG++ L + DT V GT Y++PE G + ++
Sbjct: 132 PSNILVNSRGQIKLCDFGVSGELINSIADTFV----------GTSTYMSPERIQGGKYTV 181
Query: 730 TGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759
D V++ G S+ E A P
Sbjct: 182 KSD----------VWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 22/203 (10%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS---FVAECEA--LRNIRHRNLIK 592
++GQG+FG VY + +A K + + S ECE L+N++H +++
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ EYM GS+KD L E +++ M
Sbjct: 69 YYGCLRD---RAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGM 119
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
YLH + +VH D+K +N+L D + DFG +K +L T + + + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK-----RLQTICMSGTGIRSVTG 171
Query: 713 TVGYVAPEYGMGSEASMTGDIFT 735
T +++PE G D+++
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWS 194
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 63/271 (23%), Positives = 98/271 (36%), Gaps = 75/271 (27%)
Query: 539 IGQGSFGYVY---KGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIIT 595
I +G+FG VY K + G+ A+KV+ K +++ V +A R I
Sbjct: 4 ISKGAFGSVYLAKKRSTGD---YFAIKVLK-KSDMIAKNQVTNVKAERAIMMIQGESPYV 59
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRV---------NIAI 646
F+ D+ V EY+ G SLI+ +
Sbjct: 60 AKLYYSFQSKDYLYLVMEYLNGGDCA---------------SLIKTLGGLPEDWAKQYIA 104
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
+V +E LH Q ++H D+KP N+L+D + DFGL S
Sbjct: 105 EVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGL-----------------S 144
Query: 707 SIGLK-----GTVGYVAPEYGMGSEASMTGDIF----------TGRRPI-----DAVFNE 746
GL+ GT Y+APE +G D + G P DAVF+
Sbjct: 145 RNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204
Query: 747 GHS----LHEFAKTALPEKVMEIVDPSLLME 773
S E K + +++++ L M+
Sbjct: 205 ILSRRINWPEEVKEFCSPEAVDLINRLLCMD 235
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 41/171 (23%), Positives = 68/171 (39%), Gaps = 26/171 (15%)
Query: 559 VAVKVINLKYKGASRSF------VAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612
VA+K++ A C L H N++ ++ + VF
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLY---HPNIVALLDSGEAPP----GLLFAVF 58
Query: 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSN 672
EY+ +L++ L +D L + + + V A+ H+ +VH DLKP N
Sbjct: 59 EYVPGRTLREVL-AADG-----ALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQN 109
Query: 673 VLL---DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
+++ A V DFG+ L + D V T + + + GT Y APE
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVR-DADVATLTRTTEVLGTPTYCAPE 159
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 55/204 (26%), Positives = 84/204 (41%), Gaps = 36/204 (17%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRN------IRHRNLI 591
M+G+GSFG V+ L A+K LK EC + H L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVC-KLSLIQRVNIAIDVAS 650
+ C+ F+ + FV EY+ G L H ++ C K L + A ++
Sbjct: 60 HLY--CT---FQTKENLFFVMEYLNGGDLM--FH-----IQSCHKFDLPRATFYAAEIIC 107
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK--FLSDHQLDTAVKTPSSSI 708
+++LH +V+ DLK N+LLD D + DFG+ K L D + T TP
Sbjct: 108 GLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPD--- 161
Query: 709 GLKGTVGYVAPEYGMGSEASMTGD 732
Y+APE +G + + + D
Sbjct: 162 -------YIAPEILLGQKYNTSVD 178
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 30/122 (24%), Positives = 57/122 (46%), Gaps = 16/122 (13%)
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVK 702
NI D+ + +EY+H H + HGD+KP N+++D + ++ D+G+A H ++
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIH--GKHIE 184
Query: 703 TPSSSIGL-KGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761
L +GT+ Y + G+ + GD+ + G+ + ++A LP K
Sbjct: 185 YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLES----------LGYCMLKWAGIKLPWK 234
Query: 762 VM 763
Sbjct: 235 GF 236
|
Length = 294 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 47/206 (22%)
Query: 533 FSSSNM-----IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS-RSFVAECEALRNIR 586
F++ ++ IG+G+FG V K I+AVK I + + + + + +R
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVV--MR 58
Query: 587 HRNLIKIITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRV 642
+ I+ F G F+ E M+ SL D ++ + + +
Sbjct: 59 SSDCPYIVK------FYGALFREGDCWICMELMDI-SL-DKFYK--------YVYEVLKS 102
Query: 643 NI--------AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
I A+ A+ YL + ++H D+KPSN+LLD + +CDFG +S
Sbjct: 103 VIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFG----ISG 156
Query: 695 HQLDTAVKTPSSSIGLKGTVGYVAPE 720
+D+ KT + G Y+APE
Sbjct: 157 QLVDSIAKTRDA-----GCRPYMAPE 177
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 54/180 (30%), Positives = 84/180 (46%), Gaps = 35/180 (19%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL-----KYKGASRSFVAECEALRNIRHRNLIKI 593
IG+GSFG +Y D +K I+L K K AS+ E L ++H N I
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK---EVILLAKMKHPN---I 61
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ------SDDQVEVCKLSLIQRVNIAID 647
+T +S G F V EY + G L +++ S+DQ+ L V I++
Sbjct: 62 VTFFASFQENGRLF--IVMEYCDGGDLMKRINRQRGVLFSEDQI------LSWFVQISL- 112
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAKFLSDHQ--LDTAVKTP 704
++++H ++H D+K N+ L + MVA + DFG+A+ L+D T V TP
Sbjct: 113 ---GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 22/189 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+F IG G++G VYK + A+KVI L+ E +++ +H N++
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ D E+ GSL+D H + LS Q ++ +
Sbjct: 70 AYF-----GSYLRRDKLWICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQG 118
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+ YLH + +H D+K +N+LL + + DFG++ Q+ + S I
Sbjct: 119 LYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSA-----QITATIAKRKSFI--- 167
Query: 712 GTVGYVAPE 720
GT ++APE
Sbjct: 168 GTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 54/189 (28%), Positives = 81/189 (42%), Gaps = 17/189 (8%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+F +++G+G FG V I A+KV+ A + V+ E R+I +
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQET-VSFFEEERDILSISNS 60
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
I F+ D V EY G L L++ +DQ + + Q +A
Sbjct: 61 PWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE---DMAQ-----FYLAEL 111
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+ +H Q VH D+KP NVL+D + DFG A L TA K +S + +
Sbjct: 112 VLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL------TANKMVNSKLPV- 164
Query: 712 GTVGYVAPE 720
GT Y+APE
Sbjct: 165 GTPDYIAPE 173
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 31/147 (21%), Positives = 63/147 (42%), Gaps = 24/147 (16%)
Query: 547 VYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI--KIITICSSTDFKG 604
VY +++ ++ K+ + KGA R E L+ + + L K++ + G
Sbjct: 14 VYLLGTKDEDYVL--KINPSREKGADR--EREVAILQLLARKGLPVPKVLASG---ESDG 66
Query: 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMV 664
+ + E++E +L ++S ++ +IA +A + LH +
Sbjct: 67 WSY--LLMEWIEGETLD-------------EVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111
Query: 665 HGDLKPSNVLLDHDMVAHVCDFGLAKF 691
HGDL P N+L+D + + D+ A +
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 45/182 (24%), Positives = 81/182 (44%), Gaps = 23/182 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG+GS G V VAVK+++L+ + E +R+ +H+N++++
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMY---- 84
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+ G + + E+++ G+L D + Q+ +L+ Q + V A+ YLH
Sbjct: 85 KSYLVGEELWV-LMEFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ 136
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
++H D+K ++LL D + DFG +S K L GT ++A
Sbjct: 137 ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS--------KDVPKRKSLVGTPYWMA 185
Query: 719 PE 720
PE
Sbjct: 186 PE 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 51/188 (27%), Positives = 80/188 (42%), Gaps = 28/188 (14%)
Query: 538 MIGQGSFGYVYKGTL-GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK---- 592
++G+GSFG V L G DE + A+KV LK + +C + R L
Sbjct: 2 VLGKGSFGKVMLAELKGTDE-VYAIKV--LKKDVILQDDDVDC-TMTEKRILALAAKHPF 57
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + F+ D FV EY+ G L + +S K + A +V A+
Sbjct: 58 LTALHCC--FQTKDRLFFVMEYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLAL 109
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
+LH H +++ DLK N+LLD + + DFG+ K + ++ G
Sbjct: 110 MFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK--------EGILNGVTTTTFCG 158
Query: 713 TVGYVAPE 720
T Y+APE
Sbjct: 159 TPDYIAPE 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 10/212 (4%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L N + + NL +L++ N + +P+ L L NL +L+++ N S
Sbjct: 121 LDLDNNNITDIPPLIGLLKSNLKELDLSD---NKIE-SLPSPLRNLPNLKNLDLSFNDLS 176
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
P+ + N+S+L + L+ N+ S +LP + L L+ L + N+ + SLSN
Sbjct: 177 -DLPKLLSNLSNLNNLDLSGNKIS-DLP-PEIELLSALEELDLSNNSII-ELLSSLSNLK 232
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTA-TDLDFVTFLTNCSSLKAL 179
NL L+LS N+ + +L NL L+L N + + ++ L + L + +
Sbjct: 233 NLSGLELSNNKLEDLPES-IGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSN 291
Query: 180 SLADNQFGGELPHSIANLSSTVINFGIGRNQI 211
+L L + NL T+ + N I
Sbjct: 292 ALPLIALLLLLLELLLNLLLTLKALELKLNSI 323
|
Length = 394 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 49/204 (24%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI------RHRNLIK 592
IG G+FG V+ T D VA+K K ++ V+ R + +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALK----KMPNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 593 IITICSSTDFKGTDFKAFVF---EYMENGSLKDWLHQ--------SDDQVEVCKLSLIQR 641
+ I D ++ E M++ LH+ S D V K+ L Q
Sbjct: 64 ALDILQPPHI---DPFEEIYVVTELMQSD-----LHKIIVSPQPLSSDHV---KVFLYQ- 111
Query: 642 VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701
+ ++YLH ++H D+KP N+L++ + V +CDFGLA+ + D +
Sbjct: 112 ------ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV---EEPDESK 159
Query: 702 KTPSSSIGLKGTVGYVAPEYGMGS 725
+ T Y APE MGS
Sbjct: 160 HMTQEVV----TQYYRAPEILMGS 179
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 52/187 (27%), Positives = 90/187 (48%), Gaps = 29/187 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS-RSFVAECEALRNIRHRNLIKIITIC 597
+G+G++G VYK + +A+K I L+ + + E + L H+ + I
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL----HKAVSPYIV-- 62
Query: 598 SSTDFKGTDF-KAFVF---EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
DF G F + V+ EYM+ GSL D L+ E +++R I V ++
Sbjct: 63 ---DFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRR--ITYAVVKGLK 116
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
+L ++H D+KP+NVL++ + +CDFG +S + + + KT +IG +
Sbjct: 117 FLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFG----VSGNLVASLAKT---NIGCQ-- 165
Query: 714 VGYVAPE 720
Y+APE
Sbjct: 166 -SYMAPE 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 43/216 (19%)
Query: 519 PMVSYAELSKATGE----FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---A 571
P EL+K E + + + +G G++G V + + VAVK ++ ++ A
Sbjct: 1 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 60
Query: 572 SRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ----- 626
R++ E L++++H N+I ++ + + + F Y+ + L+
Sbjct: 61 KRTY-RELRLLKHMKHENVIGLLDVFTP----ARSLEEFNDVYLVTHLMGADLNNIVKCQ 115
Query: 627 --SDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684
+DD V+ +++ ++Y+H ++H DLKPSN+ ++ D +
Sbjct: 116 KLTDDHVQFLIYQILR----------GLKYIH---SADIIHRDLKPSNLAVNEDCELKIL 162
Query: 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
DFGLA+ D G T Y APE
Sbjct: 163 DFGLARHTDDEM-----------TGYVATRWYRAPE 187
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 22/203 (10%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS---FVAECEA--LRNIRHRNLIK 592
++GQG+FG VY + +AVK + + S ECE L+N+ H +++
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + E+M GS+KD L E +++ +
Sbjct: 69 YYGCLRDPMERTL---SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGV 119
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
YLH + +VH D+K +N+L D + DFG +K +L T + + + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK-----RLQTICLSGTGMKSVTG 171
Query: 713 TVGYVAPEYGMGSEASMTGDIFT 735
T +++PE G DI++
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWS 194
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 46/177 (25%), Positives = 76/177 (42%), Gaps = 25/177 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-----RHRNLIKI 593
IG+G++G V+K ++ AVK+++ E EA NI H N++K
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILD-----PIHDIDEEIEAEYNILKALSDHPNVVKF 80
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKD----WLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+ D K D V E GS+ D +L + + E IA +
Sbjct: 81 YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI---------IAYILH 131
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD--HQLDTAVKTP 704
A+ L H +H D+K +N+LL + + DFG++ L+ + +T+V TP
Sbjct: 132 EALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 188
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 52/212 (24%), Positives = 86/212 (40%), Gaps = 42/212 (19%)
Query: 531 GEFSSSNMIGQGSFGYVY---KGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRN 584
+F +GQG +G V+ K GE IVA+K + L R + E + L
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGE---IVALKRMKKSLLFKLNEVRHVLTERDILTT 57
Query: 585 IRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ----SDDQVEVCKLSLIQ 640
+ L+K++ F+ ++ EY+ G + L+ S+D + + +
Sbjct: 58 TKSEWLVKLLY-----AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA---RFYMAE 109
Query: 641 RVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTA 700
A+D + Y +H DLKP N L+D + DFGL+K
Sbjct: 110 MF-EAVDALHELGY---------IHRDLKPENFLIDASGHIKLTDFGLSK---------G 150
Query: 701 VKTPSSSIGLKGTVGYVAPEYGMGSEASMTGD 732
+ T ++S+ G+ Y+APE G T D
Sbjct: 151 IVTYANSV--VGSPDYMAPEVLRGKGYDFTVD 180
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 8e-05
Identities = 36/152 (23%), Positives = 71/152 (46%), Gaps = 25/152 (16%)
Query: 539 IGQGSFGYVYKGTLG------------EDEMIVAVKVINLKYKGASRSFVAECEALRNIR 586
+G+G+ +Y G L E E+ V +KV++ ++ S +F +R +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H++++ + +C D + V E++E G L ++H+ D L+ + +A
Sbjct: 63 HKHIVLLYGVCVR-DVENI----MVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAK 112
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678
+ASA+ YL +VHG++ N+LL +
Sbjct: 113 QLASALSYLE---DKDLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 53/195 (27%), Positives = 86/195 (44%), Gaps = 27/195 (13%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVI--NLKYKGASRSFVAECEALRNIRHRNLIKII 594
N+IG GSFG VY+ + VA+K + + +YK E ++N+ H N+I +
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINIIFLK 125
Query: 595 TICSSTDFKGTDFKAF---VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ FK + F V E++ K H + + L L++ + + A
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNN-HALPLFLVKLY--SYQLCRA 182
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
+ Y+H + H DLKP N+L+D + +CDFG AK L Q S+
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---------RSVSY 230
Query: 711 KGTVGYVAPEYGMGS 725
+ Y APE +G+
Sbjct: 231 ICSRFYRAPELMLGA 245
|
Length = 440 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 27/80 (33%), Positives = 42/80 (52%), Gaps = 7/80 (8%)
Query: 614 YMENGSLKDWLHQSDDQVEVCK--LSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKP 670
++E SL D + +Q ++ K L+L + + VA ME+L C +H DL
Sbjct: 152 FVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKC----IHRDLAA 207
Query: 671 SNVLLDHDMVAHVCDFGLAK 690
N+LL + V +CDFGLA+
Sbjct: 208 RNILLSENNVVKICDFGLAR 227
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 40/164 (24%), Positives = 79/164 (48%), Gaps = 21/164 (12%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRN 589
++S +G G++G V VA+K ++ ++ A R++ E L++++H N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHEN 75
Query: 590 LIKIITICSSTDFKGTDFKAF--VFEYMENGSLKDW-LHQSDDQVEVCKLSLIQRVNIAI 646
+I ++ + +S G +F+ F V YM+ K S+D+V+ ++
Sbjct: 76 VIGLLDVFTSAV-SGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC------ 128
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++Y+H ++H DLKP N+ ++ D + DFGLA+
Sbjct: 129 ----GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 45/189 (23%), Positives = 83/189 (43%), Gaps = 33/189 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIIT 595
+G G++G V VA+K + ++ A R++ E L++++H N+I ++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLD 81
Query: 596 ICSSTDFKGTDFKAF--VFEYM--ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ + D F F V +M + G L S+D+++ +++
Sbjct: 82 VFTP-DLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK----------G 130
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
++Y+H ++H DLKP N+ ++ D + DFGLA+ +T S G
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------QTDSEMTGYV 176
Query: 712 GTVGYVAPE 720
T Y APE
Sbjct: 177 VTRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 49/193 (25%), Positives = 88/193 (45%), Gaps = 21/193 (10%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLI-KIIT 595
IG+G++G VYK +VA+K L+ +G + + E L+ + I +++
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKL--SLIQRVNIAIDVASAME 653
+ + G VFEY+++ LK ++ S+ + L I+ + + +
Sbjct: 69 VEHVEEKNGKPSLYLVFEYLDS-DLKKFM-DSNGRGPGRPLPAKTIK--SFMYQLLKGVA 124
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
+ H H ++H DLKP N+L+D + + D GL + S VK+ + I
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS-----IPVKSYTHEI---V 173
Query: 713 TVGYVAPEYGMGS 725
T+ Y APE +GS
Sbjct: 174 TLWYRAPEVLLGS 186
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 42/188 (22%), Positives = 80/188 (42%), Gaps = 31/188 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA--SRSFVAECEALRNIRHRNLIKIITI 596
+G G++G V VAVK ++ ++ +R E L++++H N+I ++ +
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 597 CSSTDFKGTDF-KAFVFEYMENGSLKDWLH---QSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ +F + ++ + L + + SD+ V+ L++ +
Sbjct: 83 FTPAT-SIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR----------GL 131
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
+Y+H ++H DLKPSNV ++ D + DFGLA+ + G
Sbjct: 132 KYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----------QADDEMTGYVA 177
Query: 713 TVGYVAPE 720
T Y APE
Sbjct: 178 TRWYRAPE 185
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 32/114 (28%), Positives = 47/114 (41%), Gaps = 21/114 (18%)
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
+HH M+H D+K +N+LL + + + DFG +K + D +T GT
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT------FCGTP 209
Query: 715 GYVAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHEFAKTAL 758
YVAPE S D+F T +RP D G ++ E L
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD-----GENMEEVMHKTL 258
|
Length = 496 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 53/193 (27%), Positives = 86/193 (44%), Gaps = 27/193 (13%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNL 590
+F +IG+G+FG V + + A+K+++ K++ RS A R+I H N
Sbjct: 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS-KFEMIKRSDSAFFWEERDIMAHANS 102
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
I+ + + F+ + V EYM G L + L + D E V +A+D
Sbjct: 103 EWIVQLHYA--FQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA-KFLSDHQL--DTAVKTPSSS 707
+M + +H D+KP N+LLD + DFG K ++ + DTAV TP
Sbjct: 160 SMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD-- 208
Query: 708 IGLKGTVGYVAPE 720
Y++PE
Sbjct: 209 --------YISPE 213
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 27/76 (35%), Positives = 39/76 (51%), Gaps = 12/76 (15%)
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
A ++ +E LH +V+ DLKP N+LLD D+G + +SD L +
Sbjct: 108 AAEITCGLEDLHRE---RIVYRDLKPENILLD--------DYGHIR-ISDLGLAVEIPEG 155
Query: 705 SSSIGLKGTVGYVAPE 720
+ G GTVGY+APE
Sbjct: 156 ETIRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|225714 COG3173, COG3173, Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 22/81 (27%), Positives = 33/81 (40%), Gaps = 14/81 (17%)
Query: 617 NGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME-YLHHHC-----QPPMVHGDLKP 670
L W DD+ K L R I +A + +L + P +VHGD +P
Sbjct: 156 GRQLARW----DDEYRRAKKELGGR----IPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207
Query: 671 SNVLLDHDMVAHVCDFGLAKF 691
N+++D V D+ LA
Sbjct: 208 GNLIIDPGRPTGVLDWELATL 228
|
Length = 321 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 26/184 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFV-AECEALRNIRHRNLIKIITIC 597
+G G++G VYK + AVK+I L+ G S + E ++ +H N++
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE-PGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 598 SSTDFKGTDFKAFV-FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
S + K ++ EY GSL+D H + E +++ + R + + YLH
Sbjct: 76 LSRE------KLWICMEYCGGGSLQDIYHVTGPLSE-LQIAYVCR-----ETLQGLAYLH 123
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
+ +H D+K +N+LL + + DFG+A ++ + S I GT +
Sbjct: 124 SKGK---MHRDIKGANILLTDNGDVKLADFGVAA-----KITATIAKRKSFI---GTPYW 172
Query: 717 VAPE 720
+APE
Sbjct: 173 MAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 49/196 (25%), Positives = 90/196 (45%), Gaps = 23/196 (11%)
Query: 539 IGQGSFGYVYKGTL--GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITI 596
+G+G++G+VYK G+DE A+K I + G S S E LR ++H N+I + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 597 CSSTDFKGTDFKAFV-FEYMENG--SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
S +D K ++ F+Y E+ + + S + +L ++ + +
Sbjct: 67 FLSH----SDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 654 YLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
YLH + ++H DLKP+N+L+ + D G A+ ++ +K +
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL-----FNSPLKPLADLDP 174
Query: 710 LKGTVGYVAPEYGMGS 725
+ T Y APE +G+
Sbjct: 175 VVVTFWYRAPELLLGA 190
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 33/112 (29%), Positives = 56/112 (50%), Gaps = 20/112 (17%)
Query: 611 VFEYMENGSLKDWLHQSD--DQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDL 668
+ +Y+ G L L+Q + + EV RV IA ++ A+++LH Q +++ D+
Sbjct: 83 ILDYVNGGELFTHLYQREHFTESEV-------RVYIA-EIVLALDHLH---QLGIIYRDI 131
Query: 669 KPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
K N+LLD + + DFGL+K + + A GT+ Y+APE
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-------FCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 53/212 (25%), Positives = 80/212 (37%), Gaps = 48/212 (22%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL-------KYKGASRSFVAECEALRNIRHRNLI 591
+G+G G V+ L + A+KV++ K K E E L + H
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL----TEQEILATLDHP--- 61
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ T+ +S F+ + V +Y G L L Q C + R A +V A
Sbjct: 62 FLPTLYAS--FQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEVARFYAA-EVLLA 115
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLS--DHQLDTAVKTPSSS 707
+EYLH +V+ DLKP N+LL H+ DF L+K + A++ S
Sbjct: 116 LEYLH--LLG-IVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170
Query: 708 IGLK-------------------GTVGYVAPE 720
+ GT Y+APE
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE 202
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 33/205 (16%)
Query: 533 FSSSNMIGQGSFGYVY--KGTLGEDE-MIVAVKV-----INLKYKGASRSFVAECEALRN 584
F ++G G++G V+ + G D + A+KV I K K + E + L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEH 60
Query: 585 IRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI 644
IR + + TD K + +Y+ G L L Q + E Q V I
Sbjct: 61 IRQSPFLVTLHYAFQTDTK----LHLILDYINGGELFTHLSQRERFKE-------QEVQI 109
Query: 645 AI-DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK-FLSDHQLDTAVK 702
++ A+E+LH + +++ D+K N+LLD + + DFGL+K F D
Sbjct: 110 YSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV------ 160
Query: 703 TPSSSIGLKGTVGYVAPEYGMGSEA 727
+ GT+ Y+AP+ G +
Sbjct: 161 --ERAYSFCGTIEYMAPDIVRGGDG 183
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVA-ECEA--LRNIRHRNLIK 592
++G+G+FG VY + +AVK + + S+ A ECE L+N+RH +++
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
D + FV EYM GS+KD L E ++ +R I +
Sbjct: 69 YYGCLR--DPEEKKLSIFV-EYMPGGSIKDQLKAYGALTE----NVTRRYTRQI--LQGV 119
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
YLH + +VH D+K +N+L D + DFG +K ++ T + + + G
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK-----RIQTICMSGTGIKSVTG 171
Query: 713 TVGYVAPEYGMGSEASMTGDIFT 735
T +++PE G D+++
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWS 194
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 5e-04
Identities = 25/65 (38%), Positives = 34/65 (52%), Gaps = 7/65 (10%)
Query: 627 SDDQVEVCKLSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685
SDD E L+ + ++ VA ME+L +C VH DL NVLL + +CD
Sbjct: 227 SDDGSE--GLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICD 280
Query: 686 FGLAK 690
FGLA+
Sbjct: 281 FGLAR 285
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 51/218 (23%), Positives = 89/218 (40%), Gaps = 32/218 (14%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVIN--LKYKGASRSFVAECEALRNIRHRNLIKIIT 595
+IG+GS+ V L +++ I A+KV+ L + +V + +++ +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWV---QTEKHVFEQASSNPFL 58
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ + F+ T V EY+ G L H + KL A ++ A+ +L
Sbjct: 59 VGLHSCFQTTSRLFLVIEYVNGGDLM--FHMQRQR----KLPEEHARFYAAEICIALNFL 112
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
H + +++ DLK NVLLD D + D+G+ K + ++ GT
Sbjct: 113 H---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK--------EGLGPGDTTSTFCGTPN 161
Query: 716 YVAPEYGMGSEASMTGD----------IFTGRRPIDAV 743
Y+APE G E + D + GR P D +
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 31/121 (25%), Positives = 50/121 (41%), Gaps = 21/121 (17%)
Query: 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQP 661
F+ + FV EY+ G L + S + + A ++ +++LH
Sbjct: 65 FQTKEHLFFVMEYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK--- 115
Query: 662 PMVHGDLKPSNVLLDHDMVAHVCDFGLAK--FLSDHQLDTAVKTPSSSIGLKGTVGYVAP 719
+++ DLK NVLLD D + DFG+ K + + T TP Y+AP
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPD----------YIAP 165
Query: 720 E 720
E
Sbjct: 166 E 166
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNL 590
++ +IG+G+FG V + + A+K+++ K++ RS A R+I N
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANS 102
Query: 591 IKIITI-CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
++ + C+ F+ + V EYM G L + + D + K + V +A+D
Sbjct: 103 PWVVQLFCA---FQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV-LALDAI 158
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL---DTAVKTPSS 706
+M ++H D+KP N+LLD + DFG + + + DTAV TP
Sbjct: 159 HSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD- 208
Query: 707 SIGLKGTVGYVAPEYGMGSEASMTGDIFTGR 737
Y++PE S GD + GR
Sbjct: 209 ---------YISPEV----LKSQGGDGYYGR 226
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 7e-04
Identities = 21/57 (36%), Positives = 27/57 (47%)
Query: 324 YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSF 380
LDLSNN L L NL +LD+S N + + P S L LD+S N+
Sbjct: 4 SLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 49/164 (29%), Positives = 71/164 (43%), Gaps = 33/164 (20%)
Query: 539 IGQGSFGYV----YKGT--------LGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR 586
+G+G FG V YK T L + ++I +V +L + R F E + R
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCE--KRIF----ETANSER 60
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H L+ + C F+ D FV EY G L +H D S + V A
Sbjct: 61 HPFLVNLFA-C----FQTEDHVCFVMEYAAGGDLM--MHIHTDV-----FSEPRAVFYAA 108
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
V ++YLH + +V+ DLK N+LLD + + DFGL K
Sbjct: 109 CVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 7e-04
Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 40/193 (20%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL-----KYKGASRSFVAECEALRNIRHRNLIKI 593
IG+GSFG ED +K IN+ K + SR E L N++H N I
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNMKHPN---I 61
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ------SDDQVEVCKLSLIQRVNIAID 647
+ S + G + V +Y E G L ++ +DQ+ ++ +
Sbjct: 62 VQYQESFEENGNLY--IVMDYCEGGDLYKKINAQRGVLFPEDQI----------LDWFVQ 109
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
+ A++++H ++H D+K N+ L D + DFG+A+ L++ V+ +
Sbjct: 110 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV-----LNSTVELARTC 161
Query: 708 IGLKGTVGYVAPE 720
I GT Y++PE
Sbjct: 162 I---GTPYYLSPE 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 24/185 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRHRNLIKIIT 595
+G+G FG V + + A K ++ LK K + + E E L + N I+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV---NSPFIVN 57
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ + + K V M G LK ++ V L + + ++ + + + +L
Sbjct: 58 LAYAFESK--THLCLVMSLMNGGDLKYHIYN----VGERGLEMERVIHYSAQITCGILHL 111
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
H +V+ D+KP NVLLD + D GLA +K + GT G
Sbjct: 112 H---SMDIVYRDMKPENVLLDDQGNCRLSDLGLA---------VELKDGKTITQRAGTNG 159
Query: 716 YVAPE 720
Y+APE
Sbjct: 160 YMAPE 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 97 NLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156
NLK+L + N + NL++LDLS N FS L +L L+L NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.001
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 58/231 (25%)
Query: 539 IGQGSFGYV----YKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-------H 587
+GQG++G V T +E VA+K I + S+ +A+ ALR ++ H
Sbjct: 8 LGQGAYGIVCSARNAET--SEEETVAIKKITNVF---SKKILAK-RALRELKLLRHFRGH 61
Query: 588 RNLIKII--TICSSTDFKGTDFKAFVFEYMENGSLKDW-LHQ---SDDQVEVCKL-SLIQ 640
+N+ + I +F ++ Y E L + LHQ S + S I
Sbjct: 62 KNITCLYDMDIVFPGNFNE------LYLYEE---LMEADLHQIIRSGQPLTDAHFQSFIY 112
Query: 641 RVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTA 700
++ ++Y+H ++H DLKP N+L++ D +CDFGLA+ S++
Sbjct: 113 QI------LCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP---- 159
Query: 701 VKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDI-----------FTGRRPI 740
+ T Y APE M S S T I GR+P+
Sbjct: 160 GENAGFMTEYVATRWYRAPEI-MLSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 54/200 (27%), Positives = 87/200 (43%), Gaps = 49/200 (24%)
Query: 538 MIGQGSFGYVY--KGTLGED-EMIVAVKVINLKYKGASRSFVAECEALRNI----RHRNL 590
++G+G +G V+ + G D I A+KV+ ++ A +A RNI +H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 591 IKIITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI-DV 648
+ +I F+ T K + + EY+ G L ++H ++R I + D
Sbjct: 63 VDLIYA-----FQ-TGGKLYLILEYLSGGEL--FMH-------------LEREGIFMEDT 101
Query: 649 AS--------AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTA 700
A A+E+LH +++ DLKP N+LLD + DFGL K T
Sbjct: 102 ACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTV 156
Query: 701 VKTPSSSIGLKGTVGYVAPE 720
T GT+ Y+APE
Sbjct: 157 THT------FCGTIEYMAPE 170
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 50/201 (24%), Positives = 79/201 (39%), Gaps = 30/201 (14%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRN----IRHRNLIKI 593
++G+GSFG V L AVK LK EC + + N
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
C+ F+ + FV E++ G L H D + L + A ++ ++
Sbjct: 60 HLYCT---FQTKEHLFFVMEFLNGGDLM--FHIQDKG----RFDLYRATFYAAEIVCGLQ 110
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK--FLSDHQLDTAVKTPSSSIGLK 711
+LH +++ DLK NV+LD D + DFG+ K D++ T TP
Sbjct: 111 FLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPD------ 161
Query: 712 GTVGYVAPEYGMGSEASMTGD 732
Y+APE G + + + D
Sbjct: 162 ----YIAPEILQGLKYTFSVD 178
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 525 ELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRN 584
+L ++ +IG+G+FG V + A+K+++ K++ RS A R+
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS-KFEMIKRSDSAFFWEERD 95
Query: 585 IR-HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVN 643
I N ++ + + F+ + V EYM G L + + D + + + V
Sbjct: 96 IMAFANSPWVVQLFYA--FQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVV- 152
Query: 644 IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL---DTA 700
+A+D +M ++H D+KP N+LLD + DFG ++ + DTA
Sbjct: 153 LALDAIHSMGFIHR---------DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA 203
Query: 701 VKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGR 737
V TP Y++PE S GD + GR
Sbjct: 204 VGTPD----------YISPEV----LKSQGGDGYYGR 226
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 48/196 (24%), Positives = 89/196 (45%), Gaps = 23/196 (11%)
Query: 539 IGQGSFGYVYKGTL--GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITI 596
+G+G++G+VYK G+D+ A+K I + G S S E LR ++H N+I + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 597 CSSTDFKGTDFKAFV-FEYMENG--SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
S D K ++ F+Y E+ + + S + +L ++ + +
Sbjct: 67 FLSH----ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 654 YLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
YLH + ++H DLKP+N+L+ + D G A+ ++ +K +
Sbjct: 123 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL-----FNSPLKPLADLDP 174
Query: 710 LKGTVGYVAPEYGMGS 725
+ T Y APE +G+
Sbjct: 175 VVVTFWYRAPELLLGA 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 20/58 (34%), Positives = 34/58 (58%), Gaps = 1/58 (1%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLG-LLRNLVSLNVAEN 57
L+ L ++ N G +P+ +G L+ L ++ + GNSL G++P LG L + S N +N
Sbjct: 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.002
Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 26/201 (12%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRH--R 588
+F + +I G++G VY E A+K IN K R+ + + R+I
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKIN-KQNLILRNQIQQVFVERDILTFAE 59
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL-HQSDDQVEVCKLSLIQRVNIAID 647
N + CS F+ V EY+E G L + V++ ++ + V
Sbjct: 60 NPFVVSMFCS---FETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETV----- 111
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF--------LSDHQLDT 699
A+EYLH++ +VH DLKP N+L+ + DFGL+K L + ++
Sbjct: 112 --LALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 700 AVKTPSSSIGLKGTVGYVAPE 720
+ + GT Y+APE
Sbjct: 167 DTREFLDK-QVCGTPEYIAPE 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 10/81 (12%)
Query: 614 YMENGSLKDWLHQSDDQVE---VCKLSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLK 669
++E+ SL D + D++ + L+L ++ + VA ME+L C +H DL
Sbjct: 147 FIEDKSLSD--VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC----IHRDLA 200
Query: 670 PSNVLLDHDMVAHVCDFGLAK 690
N+LL + V +CDFGLA+
Sbjct: 201 ARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 18/50 (36%), Positives = 28/50 (56%), Gaps = 5/50 (10%)
Query: 642 VNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++ + VA M +L +C +H DL N+LL H + +CDFGLA+
Sbjct: 217 LSFSYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLAR 262
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 35/157 (22%), Positives = 54/157 (34%), Gaps = 32/157 (20%)
Query: 540 GQGSFGYVYK----GTLGEDEMIVAVKVINLKYKGASRSFV---AECEALRNIRHRNLIK 592
++ K TL VAVK INL + E R ++H N++
Sbjct: 11 EDLMIVHLAKHKPTNTL------VAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILP 63
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRV--NIAIDVAS 650
+T F V M GS +D L L + I DV +
Sbjct: 64 YVTS-----FIVDSELYVVSPLMAYGSCEDLLK------THFPEGLPELAIAFILKDVLN 112
Query: 651 AMEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686
A++Y+H +H +K S++LL D +
Sbjct: 113 ALDYIHSKGF----IHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 35/233 (15%)
Query: 512 SPMEKQFPMVSYAELS-KATGEFSSSNMIGQGSFGYV---YKGTLGEDEMIVAVKVINLK 567
S + QF V A+ + + IG G+ G V + LG + VAVK ++
Sbjct: 1 SEEDSQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLG---INVAVKKLSRP 57
Query: 568 YKG---ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYME--NGSLKD 622
++ A R++ E L+ + H+N+I ++ + T K + V+ ME + +L
Sbjct: 58 FQNQTHAKRAY-RELVLLKCVNHKNIISLLNV--FTPQKSLEEFQDVYLVMELMDANLCQ 114
Query: 623 WLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682
+H D + L L Q + +++LH ++H DLKPSN+++ D
Sbjct: 115 VIHMELDHERMSYL-LYQ-------MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 163
Query: 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFT 735
+ DFGLA+ + + T T Y APE +G DI++
Sbjct: 164 ILDFGLARTACTNFMMTPYVV---------TRYYRAPEVILGMGYKENVDIWS 207
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 36/129 (27%), Positives = 51/129 (39%), Gaps = 25/129 (19%)
Query: 580 EALRNIRHRNLIKIITICSSTD-------FKGTDFKAFVFEYMENGSLKDWLHQSDDQVE 632
E LR R R +I+ D V EY+E LKD L ++ +
Sbjct: 39 EKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEAR--PD 96
Query: 633 VCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692
+ + + V LH +VHGDL SN++L + + DFGL +F
Sbjct: 97 LLR-------EVGRLVGK----LHKA---GIVHGDLTTSNIILSGGRI-YFIDFGLGEF- 140
Query: 693 SDHQLDTAV 701
SD D AV
Sbjct: 141 SDEVEDKAV 149
|
Length = 204 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 51/219 (23%), Positives = 86/219 (39%), Gaps = 34/219 (15%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSF---VAECEALRNIRHRNLIKII 594
+IG+GS+ V L + E I A+KV+ + E + + +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
C T+ + FV EY+ G L H + KL + +++ A+ Y
Sbjct: 62 HSCFQTESR----LFFVIEYVNGGDLM--FHMQRQR----KLPEEHARFYSAEISLALNY 111
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH + +++ DLK NVLLD + + D+G+ K ++ ++ GT
Sbjct: 112 LH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--------EGLRPGDTTSTFCGTP 160
Query: 715 GYVAPEYGMGSEASMTGD----------IFTGRRPIDAV 743
Y+APE G + + D + GR P D V
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 532 EFSSSNMIGQGSFGYVY---KGTLGEDEMIVAVKVIN----LKYKGASRSFVAECEALRN 584
F ++G G++G V+ K T + + A+KV+ ++ E L +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 585 IRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ----SDDQVEVCKLSLIQ 640
+R + + T+ K + +Y+ G + L+Q S+D+V
Sbjct: 61 VRQSPFLVTLHYAFQTEAK----LHLILDYVSGGEMFTHLYQRDNFSEDEVRF------- 109
Query: 641 RVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK-FLSDHQLDT 699
+ ++ A+E+LH + +V+ D+K N+LLD + + DFGL+K FLS+ + T
Sbjct: 110 ---YSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 700 AVKTPSSSIGLKGTVGYVAPE 720
GT+ Y+APE
Sbjct: 164 --------YSFCGTIEYMAPE 176
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 56/195 (28%), Positives = 87/195 (44%), Gaps = 30/195 (15%)
Query: 532 EFSSSNMIGQGSFGYVY----KGTLGEDEMIVAVKVINLKYKGASRSFVAECEAL--RNI 585
+F+ ++G+GSFG V KGT DE+ A+K+ LK + EC + R +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGT---DELY-AIKI--LKKDVVIQDDDVECTMVEKRVL 54
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
+T S F+ D FV EY+ G L + Q V + V A
Sbjct: 55 ALSGKPPFLTQLHSC-FQTMDRLYFVMEYVNGGDLMYQIQQ------VGRFKEPHAVFYA 107
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
++A + +LH +++ DLK NV+LD + + DFG+ K ++ D V T +
Sbjct: 108 AEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWD-GVTTKT 160
Query: 706 SSIGLKGTVGYVAPE 720
GT Y+APE
Sbjct: 161 ----FCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|240176 cd05155, APH_ChoK_like_1, Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 17/49 (34%), Positives = 22/49 (44%), Gaps = 6/49 (12%)
Query: 646 IDVASAMEY----LHHHCQPP--MVHGDLKPSNVLLDHDMVAHVCDFGL 688
IDV +A L P HGDL P N+L+ ++ V DFG
Sbjct: 143 IDVDAARALWEAALRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGC 191
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 235 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 0.002
Identities = 30/91 (32%), Positives = 41/91 (45%), Gaps = 19/91 (20%)
Query: 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670
V EY+ LKD L + + V + VA LH +VHGDL
Sbjct: 414 VMEYIGGKDLKDVLEGNPELVR----------KVGEIVAK----LHKA---GIVHGDLTT 456
Query: 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701
SN ++ D + ++ DFGL K+ SD D AV
Sbjct: 457 SNFIVRDDRL-YLIDFGLGKY-SDLIEDKAV 485
|
Length = 535 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 54/210 (25%), Positives = 82/210 (39%), Gaps = 45/210 (21%)
Query: 525 ELSKATGEFSSSNM-------IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA 577
E + ++ S M + GS G V+ T DE KVI +K ++
Sbjct: 79 ETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQ--RKKVI-VKAVTGGKTPGR 135
Query: 578 ECEALRNIRHRNLIKII-------TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ 630
E + L+ I HR +I +I T+C +K +F Y++
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVM----PKYKCDLFTYVDRSG----------- 180
Query: 631 VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
L L Q + I + A+ YLH ++H D+K N+ LD A + DFG A
Sbjct: 181 ----PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA- 232
Query: 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
+LD TP G GT+ +PE
Sbjct: 233 ----CKLDAHPDTP-QCYGWSGTLETNSPE 257
|
Length = 392 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 50/194 (25%), Positives = 81/194 (41%), Gaps = 28/194 (14%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+F+ ++G+GSFG V + + A+K+ LK + EC + R L
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTM---VEKRVLA 55
Query: 592 -----KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
+T S F+ D FV EY+ G L + Q V K V A
Sbjct: 56 LPGKPPFLTQLHSC-FQTMDRLYFVMEYVNGGDLMYHIQQ------VGKFKEPHAVFYAA 108
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
++A + +LH +++ DLK NV+LD + + DFG+ K ++ +
Sbjct: 109 EIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFG-----GKT 157
Query: 707 SIGLKGTVGYVAPE 720
+ GT Y+APE
Sbjct: 158 TRTFCGTPDYIAPE 171
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 55/194 (28%), Positives = 78/194 (40%), Gaps = 31/194 (15%)
Query: 532 EFSSSNMIGQGSFGYVYKGTL-GEDEMIVAVKVIN----LKYKGASRSFVAECEALRNIR 586
+F+ +G GSFG V T ED VA+K +K K F +E + L I
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYIN 89
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H + + FK + V E++ G +L ++ + A
Sbjct: 90 HPFCVNL-----YGSFKDESYLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAA 138
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
+ EYL +V+ DLKP N+LLD D + DFG AK +DT T
Sbjct: 139 QIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYT--- 187
Query: 707 SIGLKGTVGYVAPE 720
L GT Y+APE
Sbjct: 188 ---LCGTPEYIAPE 198
|
Length = 340 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 49/199 (24%), Positives = 80/199 (40%), Gaps = 40/199 (20%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY----KGASRSFVAECEALRNIRHR 588
F ++G+G FG V + + A K + K KG + + + E L + R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKRILEKVNSR 60
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQS-----DDQVEVCKLSLIQRVN 643
++ + + ++ D V M G LK ++ D+Q + +
Sbjct: 61 FVVSL-----AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ---------RAIF 106
Query: 644 IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKT 703
A ++ +E L + +V+ DLKP N+LLD + D GL AV+
Sbjct: 107 YAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGL-----------AVQI 152
Query: 704 PSSSI--GLKGTVGYVAPE 720
P G GTVGY+APE
Sbjct: 153 PEGETVRGRVGTVGYMAPE 171
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 51/193 (26%), Positives = 71/193 (36%), Gaps = 22/193 (11%)
Query: 12 TGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNV---AENKFSGMFPRSIC 68
L + L+ + + N+LG L L SL N R +
Sbjct: 70 LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA 129
Query: 69 -----NISSLELIQLALNRFSGNLPFDIVVNLP---NLKALAIGGNNFFGS-IPY---SL 116
+LE + L NR G + L +LK L + N + I L
Sbjct: 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGL 189
Query: 117 SNASNLELLDLSVNQF--KGNV--SIDFSSLKNLLWLNLEQNNLG-TGTATDLDFVTFLT 171
NLE+LDL+ N +G + +SLK+L LNL NNL G A L+
Sbjct: 190 KANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALAS--ALLS 247
Query: 172 NCSSLKALSLADN 184
SL LSL+ N
Sbjct: 248 PNISLLTLSLSCN 260
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 37/165 (22%), Positives = 77/165 (46%), Gaps = 25/165 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASR-SFVAECEALRNIR-HRNLIKIITI 596
IG+G+F V K + A+K + +K + + + E +ALR + H N++++I +
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWL-----HQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ T A VFE M+ +L + + + +V K + Q + +
Sbjct: 67 LFD---RKTGRLALVFELMD-MNLYELIKGRKRPLPEKRV---KSYMYQLL-------KS 112
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
++++H + + H D+KP N+L+ D++ + DFG + +
Sbjct: 113 LDHMHRN---GIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKP 153
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 48/193 (24%), Positives = 77/193 (39%), Gaps = 46/193 (23%)
Query: 543 SFGYVYKGTL---GEDEMIVAVK-------VINLKYKGASRSFVAECEALRNIRHRNLIK 592
S GY TL E + VA K V+ + KG + + E L+N+ H ++I+
Sbjct: 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT---LIEAMLLQNVNHPSVIR 121
Query: 593 IITICSS---TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+ S T + + ++ Y+ S L + Q + I +
Sbjct: 122 MKDTLVSGAITCMVLPHYSSDLYTYLTKRSRP--------------LPIDQALIIEKQIL 167
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC--DFGLAKFLSDHQLDTAVKTPSSS 707
+ YLH ++H D+K N+ ++ V VC D G A+F V P +
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFIND--VDQVCIGDLGAAQF--------PVVAP-AF 213
Query: 708 IGLKGTVGYVAPE 720
+GL GTV APE
Sbjct: 214 LGLAGTVETNAPE 226
|
Length = 357 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 18/91 (19%)
Query: 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670
V EY+E LKD + + E+ + I V LH +VHGDL
Sbjct: 75 VMEYIEGKPLKDVI--EEGNDELLR-------EIGRLVGK----LHKA---GIVHGDLTT 118
Query: 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701
SN+++ D + ++ DFGL K+ SD D AV
Sbjct: 119 SNIIVRDDKL-YLIDFGLGKY-SDEIEDKAV 147
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 833 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.72 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.48 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.46 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.29 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.29 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.29 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.28 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.27 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.24 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.23 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.22 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.17 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.17 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.04 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.03 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.01 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.92 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.8 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.79 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.68 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.65 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.61 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-93 Score=875.45 Aligned_cols=777 Identities=30% Similarity=0.471 Sum_probs=558.0
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..|+.+++|++|+|++|.+++..|..|.++++|+.|+|++
T Consensus 142 L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~ 221 (968)
T PLN00113 142 LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGY 221 (968)
T ss_pred CCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcC
Confidence 56778888877777777777777888888877777777777777777777777777777777777777777777777777
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
|++++.+|. .|.++++|++|+|++|.+++..|..|+++++|++|+|++|++.+..+..|.++++|++|+|++|.+....
T Consensus 222 n~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~ 300 (968)
T PLN00113 222 NNLSGEIPY-EIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEI 300 (968)
T ss_pred CccCCcCCh-hHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCC
Confidence 777655554 3467777777777777777667777777777777777777776666666667777777777777665321
Q ss_pred CCCc------------------ccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcC
Q 040925 161 ATDL------------------DFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNL 222 (833)
Q Consensus 161 ~~~~------------------~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l 222 (833)
+..+ ..+..+..+++|+.|+|++|++++.+|..+..+. .++.|++++|++++..|..+..+
T Consensus 301 p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~~~ 379 (968)
T PLN00113 301 PELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLCSS 379 (968)
T ss_pred ChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChhHhCc
Confidence 1100 0112234445555555555555555555544442 25555555555555555555555
Q ss_pred CCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeec
Q 040925 223 VNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTA 302 (833)
Q Consensus 223 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 302 (833)
.+|+.|++++|++.+..|..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++.+.+|..+..+++|+.|++
T Consensus 380 ~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 459 (968)
T PLN00113 380 GNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSL 459 (968)
T ss_pred CCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEEC
Confidence 66666666666666666666666777777777777777777777777777777777777777777777777778888888
Q ss_pred CCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCcccc
Q 040925 303 SQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHG 382 (833)
Q Consensus 303 ~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 382 (833)
++|++.+.+|..+ ....+ +.|++++|++++..|..|.++++|+.|+|++|++++.+|..+..+++|++|+|++|.+++
T Consensus 460 ~~n~~~~~~p~~~-~~~~L-~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 537 (968)
T PLN00113 460 ARNKFFGGLPDSF-GSKRL-ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSG 537 (968)
T ss_pred cCceeeeecCccc-ccccc-eEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccc
Confidence 8888776666644 33444 789999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCCCcccCCCC
Q 040925 383 VIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLP 462 (833)
Q Consensus 383 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~~~~~~~~ 462 (833)
..|..|..+++|+.|+|++|++++.+|..+.++++|+.|++++|++++.+|..+.+.......+.||+..||+.+....+
T Consensus 538 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~ 617 (968)
T PLN00113 538 QIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLP 617 (968)
T ss_pred cCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCC
Confidence 99999999999999999999999999999999999999999999999999998888888888999999999987665667
Q ss_pred CCCCCCCCCcceeEEEEeehhhhhHHHHHHHHHHHHHhhhccc-ccccCC-Cc-ccC------CCCccchHHHHHHhcCC
Q 040925 463 SCPSKGSRKPKIILLKVLIPVAVSSLILSSCLTIVYARKRRSA-QKFVDT-SP-MEK------QFPMVSYAELSKATGEF 533 (833)
Q Consensus 463 ~~~~~~~~~~~~~~~~~~i~~~~~~~~l~~~~~~~~~~rrr~~-~~~~~~-~~-~~~------~~~~~~~~~~~~~~~~y 533 (833)
.|..... ....++.+++++++.+++++++++++++++|+.. .+..+. .. .+. ....+++++ ....|
T Consensus 618 ~c~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 692 (968)
T PLN00113 618 PCKRVRK--TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND---ILSSL 692 (968)
T ss_pred CCccccc--cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHH---HHhhC
Confidence 7743211 1122222222221112222222222222222211 111111 10 000 001122333 34567
Q ss_pred ccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 534 SSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 534 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
...+.||+|+||.||+|++..++..||||+++.... ....|++++++++|||||+++|+|...+ ..++|||
T Consensus 693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~-----~~~lv~E 763 (968)
T PLN00113 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEK-----GAYLIHE 763 (968)
T ss_pred CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCC-----CCEEEEe
Confidence 888999999999999999988999999999863322 2245688999999999999999987654 7899999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
|+++|+|.++++ .++|.++.+++.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||.+....
T Consensus 764 y~~~g~L~~~l~---------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 764 YIEGKNLSEVLR---------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred CCCCCcHHHHHh---------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 999999999995 47899999999999999999996666699999999999999999988875 66554321
Q ss_pred cccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccch--
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL-- 771 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~-- 771 (833)
.. ....||+.|||||++.+..++.++|||| +|+++||++++..|+...........
T Consensus 834 ~~------------~~~~~t~~y~aPE~~~~~~~~~~sDv~S----------~Gvvl~el~tg~~p~~~~~~~~~~~~~~ 891 (968)
T PLN00113 834 TD------------TKCFISSAYVAPETRETKDITEKSDIYG----------FGLILIELLTGKSPADAEFGVHGSIVEW 891 (968)
T ss_pred cC------------CCccccccccCcccccCCCCCcccchhh----------HHHHHHHHHhCCCCCCcccCCCCcHHHH
Confidence 11 1125899999999999999999999999 88888888888887642111111110
Q ss_pred -hhhccccc---hhhh---hhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 772 -MEVMTNNS---MIQE---DKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 772 -~~~~~~~~---~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
........ ..++ .......+...++.+++.+||+.||++||||+||+++|+++.+.
T Consensus 892 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 892 ARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 00000000 0000 01112234566788999999999999999999999999998763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-54 Score=528.03 Aligned_cols=445 Identities=34% Similarity=0.532 Sum_probs=359.3
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|..|+.+++|++|+|++|.+.+..|.+|+++++|++|+|++
T Consensus 120 L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 197 (968)
T PLN00113 120 LRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS 197 (968)
T ss_pred CCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccC
Confidence 78999999999988886 5689999999999999989999999999999999999999999999999999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
|++++.+|. .|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|.++++|++|+|++|++....
T Consensus 198 n~l~~~~p~-~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 276 (968)
T PLN00113 198 NQLVGQIPR-ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276 (968)
T ss_pred CCCcCcCCh-HHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccC
Confidence 999866664 5689999999999999999999999999999999999999999889999999999999999999986532
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (833)
+..+.++++|++|+|++|++.+.+|..+.++.. ++.|++++|.+.+..|..+..+++|+.|++++|.+.+.+|
T Consensus 277 ------p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~-L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p 349 (968)
T PLN00113 277 ------PPSIFSLQKLISLDLSDNSLSGEIPELVIQLQN-LEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349 (968)
T ss_pred ------chhHhhccCcCEEECcCCeeccCCChhHcCCCC-CcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCC
Confidence 344667788888888888887777777766643 6777777777777777777777777777777777777777
Q ss_pred ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccc
Q 040925 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITT 320 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ 320 (833)
..++.+++|+.|+|++|.+++.+|..+..+++|+.|++++|++.+..|..+..+++|+.|++++|++++.+|..+..++.
T Consensus 350 ~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~ 429 (968)
T PLN00113 350 KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPL 429 (968)
T ss_pred hHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCC
Confidence 77777777777777777776666666665555555555555555555555555555555555555555545544444433
Q ss_pred c-----------------------ceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecC
Q 040925 321 L-----------------------SLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISS 377 (833)
Q Consensus 321 l-----------------------l~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 377 (833)
+ ++.|++++|.+.+..|..+ ..++|+.|++++|++++..|..|..+++|+.|+|++
T Consensus 430 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 508 (968)
T PLN00113 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSE 508 (968)
T ss_pred CCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcC
Confidence 3 1445555555554445443 346777888888888888888899999999999999
Q ss_pred CccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCC-CccCCCccccccCCcCCCCCc
Q 040925 378 NSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK-GVFSNKTKISLQGNMKLCGGI 456 (833)
Q Consensus 378 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~l~l~~N~~~c~~~ 456 (833)
|++.+..|..+..+++|+.|+|++|.+++.+|..+..+++|+.|||++|++++..|.. ..+..+..+++++|+..+.-|
T Consensus 509 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 509 NKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred CcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 9999999999999999999999999999999999999999999999999999877764 567889999999998765433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=375.48 Aligned_cols=251 Identities=26% Similarity=0.376 Sum_probs=209.1
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
+.+..+.||+|..|+||+|.++.+++.+|+|++....+ ...+++.+|++++++.+||+||++||.|+... . .+++
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~---~-~isI 155 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG---E-EISI 155 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC---c-eEEe
Confidence 34556899999999999999999999999999964433 34578999999999999999999999987654 1 5999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++|||+++++..+ ++++...-+++.++++||.|||+ + +||||||||+|||++..|+|||||||.+
T Consensus 156 ~mEYMDgGSLd~~~k~~g------~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS 226 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVG------RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVS 226 (364)
T ss_pred ehhhcCCCCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEecccccc
Confidence 999999999999998765 79999999999999999999996 6 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc--cccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM--EIVD 767 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~--~~~~ 767 (833)
+.+... ...+++||..|||||.+.+..|+.++|||| +|.++.|++.|++|+... ...+
T Consensus 227 ~~lvnS----------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWS----------LGLsllE~a~GrfP~~~~~~~~~~ 286 (364)
T KOG0581|consen 227 GILVNS----------IANTFVGTSAYMSPERISGESYSVKSDIWS----------LGLSLLELAIGRFPYPPPNPPYLD 286 (364)
T ss_pred HHhhhh----------hcccccccccccChhhhcCCcCCcccceec----------ccHHHHHHhhCCCCCCCcCCCCCC
Confidence 876543 233578999999999999999999999999 899999999999987643 1122
Q ss_pred ccchhhhccccchhhhhhhhchH-HHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTE-ECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......+-.. .....++ .+++++.+++..|+++||.+|||++|++++
T Consensus 287 ~~~Ll~~Iv~~-----ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 287 IFELLCAIVDE-----PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHHHHHHhcC-----CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22112211111 1111222 478899999999999999999999999876
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=389.70 Aligned_cols=408 Identities=22% Similarity=0.215 Sum_probs=327.9
Q ss_pred CCccccCCCCCCEEEccCCcccccCCccCCCC--CCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhh
Q 040925 15 LPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLL--RNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIV 92 (833)
Q Consensus 15 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 92 (833)
.|....+ .-..|+.++++|..+.-..+..+ ..-+.||+++|+++.+.+..|.++++|+.++|.+|.++ .||...
T Consensus 46 cpa~c~c--~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~- 121 (873)
T KOG4194|consen 46 CPATCPC--NTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFG- 121 (873)
T ss_pred CCCcCCC--CceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccc-
Confidence 3444444 33456777777744332333222 23455888888887777777788888888888888877 777522
Q ss_pred cCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCC
Q 040925 93 VNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTN 172 (833)
Q Consensus 93 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~ 172 (833)
....+|+.|+|.+|.|+.+....++.++.|+.||||.|.|+.++...|..-.++++|+|++|.|+++.... |.+
T Consensus 122 ~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~------F~~ 195 (873)
T KOG4194|consen 122 HESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGH------FDS 195 (873)
T ss_pred ccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccccc------ccc
Confidence 33455888888888887777777777788888888888888777777777777888888888887776643 566
Q ss_pred CCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEE
Q 040925 173 CSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKL 252 (833)
Q Consensus 173 l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 252 (833)
+.+|..|.|+.|+++ .+|...+.-...++.|+|..|+|.-..--+|.+|++|+.|.|..|.+.....++|.++.++++|
T Consensus 196 lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l 274 (873)
T KOG4194|consen 196 LNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHL 274 (873)
T ss_pred cchheeeecccCccc-ccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeeccccee
Confidence 777778888888887 5555444433447778888888876667889999999999999999998889999999999999
Q ss_pred EcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCcc
Q 040925 253 CLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLL 332 (833)
Q Consensus 253 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l 332 (833)
+|+.|+++..-..++.++++|+.|+||+|.|..+.++++.-.++|++|+|+.|+|+ .+++.-+.....++.|+|++|++
T Consensus 275 ~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~-~l~~~sf~~L~~Le~LnLs~Nsi 353 (873)
T KOG4194|consen 275 NLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRIT-RLDEGSFRVLSQLEELNLSHNSI 353 (873)
T ss_pred ecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccc-cCChhHHHHHHHhhhhcccccch
Confidence 99999999888899999999999999999999999999999999999999999999 55554444444448899999999
Q ss_pred CCCCCcccccCCCcCEEeccCCcCCCCCC---ccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCch
Q 040925 333 NGSLPLQVGHLKNLVILDISSNQFSGVIP---GTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIP 409 (833)
Q Consensus 333 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~---~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 409 (833)
+.+-..+|..+++|++|||++|.|+..+. ..|.+++.|+.|+|.+|+|..+...+|.++..|+.|||.+|.|.++.|
T Consensus 354 ~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~ 433 (873)
T KOG4194|consen 354 DHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQP 433 (873)
T ss_pred HHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecc
Confidence 98888899999999999999999987655 358999999999999999998888999999999999999999999999
Q ss_pred hhhcCCCCCceEECccCcCccccCCC
Q 040925 410 EFLKNLSVLEFLSLSYNHFEGEVPTK 435 (833)
Q Consensus 410 ~~l~~l~~L~~L~l~~N~l~~~~~~~ 435 (833)
++|..+ .|+.|-+..-.|-|+|...
T Consensus 434 nAFe~m-~Lk~Lv~nSssflCDCql~ 458 (873)
T KOG4194|consen 434 NAFEPM-ELKELVMNSSSFLCDCQLK 458 (873)
T ss_pred cccccc-hhhhhhhcccceEEeccHH
Confidence 999999 8999999998899988754
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=365.26 Aligned_cols=200 Identities=31% Similarity=0.529 Sum_probs=180.8
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
..++|...+.||+|+||+||+|+++.++..||||.+... .....+.+..|+.+|+.++|||||++++++...+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~----- 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD----- 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC-----
Confidence 457899999999999999999999999999999999755 3445677899999999999999999999987766
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC------Cc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD------MV 680 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~------~~ 680 (833)
++|+|||||.||||.+|++.++ .+++..++.++.|+|.||++||++ +||||||||+|||++.. -.
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~ 153 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRG------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPV 153 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCce
Confidence 9999999999999999999876 799999999999999999999999 99999999999999764 46
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
+||+|||+|+.+...... ...+|+|.|||||+++.+.|+.|+|+|| .|.++|++++|..|+
T Consensus 154 LKIADFGfAR~L~~~~~a---------~tlcGSplYMAPEV~~~~~YdAKADLWS----------iG~Ilyq~l~g~~Pf 214 (429)
T KOG0595|consen 154 LKIADFGFARFLQPGSMA---------ETLCGSPLYMAPEVIMSQQYDAKADLWS----------IGTILYQCLTGKPPF 214 (429)
T ss_pred EEecccchhhhCCchhHH---------HHhhCCccccCHHHHHhccccchhhHHH----------HHHHHHHHHhCCCCc
Confidence 899999999988764432 3468999999999999999999999999 888999999999887
Q ss_pred c
Q 040925 761 K 761 (833)
Q Consensus 761 ~ 761 (833)
.
T Consensus 215 ~ 215 (429)
T KOG0595|consen 215 D 215 (429)
T ss_pred c
Confidence 6
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=388.79 Aligned_cols=366 Identities=24% Similarity=0.264 Sum_probs=222.8
Q ss_pred EEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCC
Q 040925 27 VIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGN 106 (833)
Q Consensus 27 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N 106 (833)
+|++++|+|..+.+..|-+++||+.++|..|.++ .+|.-.....+|+.|+|.+|.|+ .+..+.++.++.|+.|||+.|
T Consensus 82 ~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN 159 (873)
T KOG4194|consen 82 TLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRN 159 (873)
T ss_pred eeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhc
Confidence 3555555555555555555555555555555554 44443333334555555555554 444444445555555555555
Q ss_pred cceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcC
Q 040925 107 NFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186 (833)
Q Consensus 107 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 186 (833)
.|+.+.-..|..-.++++|+|++|+|+.+..+.|.++.+|..|.|++|+|++++. ..|.+|++|+.|+|..|+|
T Consensus 160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~------r~Fk~L~~L~~LdLnrN~i 233 (873)
T KOG4194|consen 160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQ------RSFKRLPKLESLDLNRNRI 233 (873)
T ss_pred hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCH------HHhhhcchhhhhhccccce
Confidence 5554433444444455555555555555555555555555555555555555443 2244455555555555555
Q ss_pred cccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCcc
Q 040925 187 GGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG 266 (833)
Q Consensus 187 ~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 266 (833)
.-.---.|..+ ..+++|.|.+|.|.....+.|..+.++++|+|+.|++...-.+++.+|+.|+.|+||+|.|..+.+++
T Consensus 234 rive~ltFqgL-~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~ 312 (873)
T KOG4194|consen 234 RIVEGLTFQGL-PSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDS 312 (873)
T ss_pred eeehhhhhcCc-hhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecch
Confidence 41112222222 22455555555555556666666666666666666666666666666666666666666666666666
Q ss_pred ccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCc-ccccccccceeeecCCCccCCCC---Cccccc
Q 040925 267 LGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPH-QLLSITTLSLYLDLSNNLLNGSL---PLQVGH 342 (833)
Q Consensus 267 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~~~~ll~~L~ls~N~l~~~~---~~~~~~ 342 (833)
....++|++|+|++|+|+...+.+|..+..|++|+|++|+++ .+-+ .+..+.++ +.|||++|.|+..+ ...|.+
T Consensus 313 WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~l~e~af~~lssL-~~LdLr~N~ls~~IEDaa~~f~g 390 (873)
T KOG4194|consen 313 WSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-HLAEGAFVGLSSL-HKLDLRSNELSWCIEDAAVAFNG 390 (873)
T ss_pred hhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-HHHhhHHHHhhhh-hhhcCcCCeEEEEEecchhhhcc
Confidence 666666666666666666666666666666666666666666 3333 33333333 56677777666443 346888
Q ss_pred CCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCccc
Q 040925 343 LKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNL 404 (833)
Q Consensus 343 l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 404 (833)
|++|+.|+|.+|+|..+...+|.+++.|++|||.+|.|.++.|.+|..+ .|++|-+..-.+
T Consensus 391 l~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 391 LPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred chhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence 9999999999999998888999999999999999999999999999999 999998765443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=375.90 Aligned_cols=269 Identities=38% Similarity=0.618 Sum_probs=218.9
Q ss_pred CCCccchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeE
Q 040925 517 QFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITI 596 (833)
Q Consensus 517 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 596 (833)
....|++.++..+|++|.....||+|+||.||+|... +++.||||++........++|.+|++++.+++|||+|+++||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 4667999999999999999999999999999999997 458999998865433214569999999999999999999999
Q ss_pred eecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 597 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
|.+.+ ...++|+|||++|+|.+++...... .++|.++++|+.++|+||+|||+.+.|+||||||||+|||+|
T Consensus 140 C~e~~----~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 140 CLEGG----EHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred EecCC----ceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 97665 1589999999999999999986542 689999999999999999999999888999999999999999
Q ss_pred CCCcEEEcccccccccCc-ccccccccCCCccccc-cccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 677 HDMVAHVCDFGLAKFLSD-HQLDTAVKTPSSSIGL-KGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~-~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
+++++||+|||+|+.... ... . ... .||.+|+|||+...+..+.|+|||| +|+++.|++
T Consensus 212 ~~~~aKlsDFGLa~~~~~~~~~---~------~~~~~gt~gY~~PEy~~~g~lt~KsDVyS----------FGVvllEli 272 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEGDTS---V------STTVMGTFGYLAPEYASTGKLTEKSDVYS----------FGVVLLELI 272 (361)
T ss_pred CCCCEEccCccCcccCCccccc---e------eeecCCCCccCChhhhccCCcCccccccc----------chHHHHHHH
Confidence 999999999999975543 111 0 011 5999999999999999999999999 444555555
Q ss_pred HHhCCCc----------------------ccccccccchhhhccccchhhhhhhhch-HHHHHHHHHHhhccCCCCCCCC
Q 040925 755 KTALPEK----------------------VMEIVDPSLLMEVMTNNSMIQEDKRVKT-EECLNAIIRTGVLCSMESPFER 811 (833)
Q Consensus 755 ~~~~p~~----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~R 811 (833)
++..+.. ..+++|+.+.. .... .+....+..++.+|++.+|.+|
T Consensus 273 tgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~-------------~~~~~~~~~~~~~~~a~~C~~~~~~~R 339 (361)
T KOG1187|consen 273 TGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKE-------------GEYPDEKEVKKLAELALRCLRPDPKER 339 (361)
T ss_pred hCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccC-------------CCCChHHHHHHHHHHHHHHcCcCCCcC
Confidence 5443222 33344443321 1111 1467779999999999999999
Q ss_pred CCHHHHHHHHHHhhh
Q 040925 812 MDMRDVVAKLCHTRE 826 (833)
Q Consensus 812 Pt~~eil~~L~~i~~ 826 (833)
|+|.||+++|+.+..
T Consensus 340 P~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 340 PTMSQVVKELEGILS 354 (361)
T ss_pred cCHHHHHHHHHhhcc
Confidence 999999999976653
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=358.64 Aligned_cols=254 Identities=26% Similarity=0.349 Sum_probs=202.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-------cchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-------GASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
.+.|.+.+.||+|+||.|-+|..+.+|+.||||++..... .......+|+++|++++|||||++++++..++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d- 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD- 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-
Confidence 4568889999999999999999999999999999964311 12234679999999999999999999976655
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC---C
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD---M 679 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~ 679 (833)
..||||||++||+|.+.+-.++ .+.+...+.+++|++.|+.|||+. ||+||||||+|||+..+ .
T Consensus 250 ----s~YmVlE~v~GGeLfd~vv~nk------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~ 316 (475)
T KOG0615|consen 250 ----SSYMVLEYVEGGELFDKVVANK------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDC 316 (475)
T ss_pred ----ceEEEEEEecCccHHHHHHhcc------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcce
Confidence 8899999999999999998876 577788899999999999999999 99999999999999766 6
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCC---CcccccccCCcCCCccccCCccHHHHHHH
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA---SMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
.+||+|||+|+..+.. ......+|||.|.|||++.+..+ ..++|||| .|+++|-+++|
T Consensus 317 llKItDFGlAK~~g~~---------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWS----------lGcvLfvcLsG 377 (475)
T KOG0615|consen 317 LLKITDFGLAKVSGEG---------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWS----------LGCVLFVCLSG 377 (475)
T ss_pred EEEecccchhhccccc---------eehhhhcCCccccChhheecCCeecccchheeee----------ccceEEEEecc
Confidence 8999999999976543 33445799999999999887653 34779999 55555555666
Q ss_pred hCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 757 ALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..|+.. +.-++.+..+..+..+... .....++.++..++|.+||..||++|||++|+++.
T Consensus 378 ~pPFS~-~~~~~sl~eQI~~G~y~f~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 378 YPPFSE-EYTDPSLKEQILKGRYAFG---PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred CCCccc-ccCCccHHHHHhcCccccc---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 666642 2223334333333333222 22334567788999999999999999999999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=374.42 Aligned_cols=249 Identities=22% Similarity=0.302 Sum_probs=211.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.+|...+.||+|+|+.||++++.++|+.||+|++... .....+++.+|+++.++|+|||||+++++|.+ ..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-----s~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-----SNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-----CCc
Confidence 4699999999999999999999889999999999753 34456789999999999999999999999554 459
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
+|+|.|+|+.|+|.++++.++ ++++.+++.+++||+.||.|||+. +|+|||||..|++++++.+|||+|||
T Consensus 93 VYivLELC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFG 163 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFG 163 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccc
Confidence 999999999999999999654 799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|..+..+. .+....+|||.|.|||++.....+..+|||| .|+++|-++.|..|++....-+
T Consensus 164 LAt~le~~~--------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWS----------lGcvmYtLL~G~PPFetk~vke 225 (592)
T KOG0575|consen 164 LATQLEYDG--------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWS----------LGCVMYTLLVGRPPFETKTVKE 225 (592)
T ss_pred eeeeecCcc--------cccceecCCCcccChhHhccCCCCCchhhhh----------hhhHHHhhhhCCCCcccchHHH
Confidence 999876432 3445689999999999999999999999999 8888999999999987443222
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.--......+ ..++..+.+..++|..+|.+||.+|||+++|+..
T Consensus 226 ty~~Ik~~~Y---------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 226 TYNKIKLNEY---------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred HHHHHHhcCc---------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2111111111 1233456677899999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=372.83 Aligned_cols=260 Identities=29% Similarity=0.436 Sum_probs=210.4
Q ss_pred CccCceeccCcceEEEEEEECCCceE-EEEEEeeccCCcc--hhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMI-VAVKVINLKYKGA--SRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
..+.+.+|+|+||+||+|.++ |.. ||||++....... .+.|.+|+.+|++++|||||+++|+|.... ...+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~~~ 116 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GSLC 116 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----CceE
Confidence 444566999999999999996 444 9999997553322 458999999999999999999999987654 2589
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC-ceeeCCCCCCeeecCCC-cEEEcccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP-MVHGDLKPSNVLLDHDM-VAHVCDFG 687 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kL~DfG 687 (833)
+||||+++|+|.+++..... ..+++..+.+|+.|||+||.|||+. + ||||||||+|||++.++ ++||+|||
T Consensus 117 iVtEy~~~GsL~~~l~~~~~----~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRK----RKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred EEEEeCCCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCc
Confidence 99999999999999987421 2799999999999999999999999 7 99999999999999998 99999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccC--CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM--GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
+++...... .......||+.|||||++. ...|+.|+|||| +|+++||+.++..|+.....
T Consensus 190 lsr~~~~~~--------~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvyS----------FgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 190 LSREKVISK--------TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYS----------FGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cceeecccc--------ccccCCCCCccccChhhhcCCCCcCCccchhhh----------HHHHHHHHHHCCCCCCCCCH
Confidence 998655421 1112256999999999999 568999999999 89999999999999874432
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
.. .......... ....+.++++.+..++.+||..||++||++.+|+..|+.+...+..
T Consensus 252 ~~--~~~~v~~~~~-----Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 252 VQ--VASAVVVGGL-----RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred HH--HHHHHHhcCC-----CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 21 1111111111 1122334788999999999999999999999999999999876553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=348.33 Aligned_cols=264 Identities=24% Similarity=0.322 Sum_probs=208.8
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
...+|++.++||+|+||+||+|....+|..||.|.++.. +....+....|+.+|++++|||||+++++.... +..
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~---~~e 93 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE---DNE 93 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc---cch
Confidence 345689999999999999999999999999999999744 234457889999999999999999999853222 223
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceeeCCCCCCeeecCCCcEEEc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP--MVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
-.++|||||++|+|.++|+..+.+ ...+++..+|+++.|++.||.++|+.. +. |+||||||.||+++.+|.|||+
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeec
Confidence 489999999999999999865543 237999999999999999999999942 24 8999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+++.+.... ....+.+|||.||+||.+.+.+|+.+||||| .|+.+|||..-..|+.-..
T Consensus 171 DfGL~r~l~s~~--------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWs----------lGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 171 DFGLGRFLSSKT--------TFAHSLVGTPYYMSPERIHESGYNFKSDIWS----------LGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred cchhHhHhcchh--------HHHHhhcCCCcccCHHHHhcCCCCcchhHHH----------HHHHHHHHHhcCCCccccc
Confidence 999999876543 2344578999999999999999999999999 7777888888877765332
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
.. .+......... .+...+.++..+.+++..|+..||+.||+.-.++..+..
T Consensus 233 ~~--~L~~KI~qgd~-----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 233 LL--SLCKKIEQGDY-----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HH--HHHHHHHcCCC-----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 11111111111 112235678889999999999999999986666555544
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=372.90 Aligned_cols=427 Identities=32% Similarity=0.447 Sum_probs=333.1
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|+.|++++|.++ .+.+.+.++..|++|++++|++ ...|++++.+..++.|+.++|+++ .+|+++..+.+|..|++++
T Consensus 47 l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l-~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~ 123 (565)
T KOG0472|consen 47 LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKL-SQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSS 123 (565)
T ss_pred hhhhhhccCchh-hccHhhhcccceeEEEeccchh-hhCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhccc
Confidence 467888999998 5667788899999999999999 567888888999999999999998 7888889999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
|++. .+|++++ .+..|..|+..+|+++ ..|..+..+.+|..|++.+|+++..+++.+. |+.|++|++..|.++++|
T Consensus 124 n~~~-el~~~i~-~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tlP 199 (565)
T KOG0472|consen 124 NELK-ELPDSIG-RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETLP 199 (565)
T ss_pred ccee-ecCchHH-HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcCC
Confidence 9988 7887774 6778888888888887 6777788888888888888888877776666 888888888888888776
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChh-hhcCCCCCeEeccCCcccccC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPG-IRNLVNLIGFGAEENQLHGTI 239 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~-~~~l~~L~~L~L~~N~l~~~~ 239 (833)
++ ++.+.+|+-|||..|+|. .+| +|.... .+.+|+++.|+|+ .+|.+ ..+++++..|||.+|+++ ..
T Consensus 200 ~~-------lg~l~~L~~LyL~~Nki~-~lP-ef~gcs-~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~ 267 (565)
T KOG0472|consen 200 PE-------LGGLESLELLYLRRNKIR-FLP-EFPGCS-LLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EV 267 (565)
T ss_pred hh-------hcchhhhHHHHhhhcccc-cCC-CCCccH-HHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cC
Confidence 54 667777777777777776 566 454443 3666777777777 34433 347777777777777777 56
Q ss_pred CccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccC----------------------------------
Q 040925 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQG---------------------------------- 285 (833)
Q Consensus 240 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~---------------------------------- 285 (833)
|+.+.-+.+|..||+|+|.|+ ..|..++++ .|+.|-+.+|.+..
T Consensus 268 Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e 345 (565)
T KOG0472|consen 268 PDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTE 345 (565)
T ss_pred chHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccc
Confidence 677777777777777777777 456667776 67777777766531
Q ss_pred ------------------------------CCCCCCCCCC---ccceeecCCceecccCCcccccccccceeeecCCCcc
Q 040925 286 ------------------------------NIPSSLGNCQ---NLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLL 332 (833)
Q Consensus 286 ------------------------------~~~~~~~~l~---~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l 332 (833)
.+|+...... -....++++|++. .+|..+..+..+...+.+++|.+
T Consensus 346 ~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~i 424 (565)
T KOG0472|consen 346 TAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKI 424 (565)
T ss_pred ccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCcc
Confidence 1111111111 1345566667766 67776666666666677777777
Q ss_pred CCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhh
Q 040925 333 NGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFL 412 (833)
Q Consensus 333 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l 412 (833)
. .+|..++.+++|+.|+|++|.+. .+|..+..+..|+.|++|+|++. ..|.....+..|+.+-.++|++....|..+
T Consensus 425 s-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l 501 (565)
T KOG0472|consen 425 S-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGL 501 (565)
T ss_pred c-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHh
Confidence 6 77888889999999999999997 67888899999999999999998 678888888888888888899998888889
Q ss_pred cCCCCCceEECccCcCccccCCCCccCCCccccccCCcCC
Q 040925 413 KNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKL 452 (833)
Q Consensus 413 ~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~ 452 (833)
.++.+|.+|||.+|.+...||..|...+++.+.+.|||+-
T Consensus 502 ~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 502 KNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhhhcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence 9999999999999999999999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.06 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=206.2
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
.+...+.||+|.||+||.|.+. ....||+|.++.. ....+.|.+|+.+|++++|++||+++|+|...+ .+|||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIV 279 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIV 279 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEE
Confidence 3556689999999999999997 4557999999855 334578899999999999999999999997654 68999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
||||+.|+|.+++....+. .+...+.+.++.|||+|++||+++ ++|||||..+|||++++..+||+|||+|+.
T Consensus 280 tE~m~~GsLl~yLr~~~~~----~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTREGG----LLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEecccCcHHHHhhhcCCC----ccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence 9999999999999974332 789999999999999999999999 999999999999999999999999999996
Q ss_pred cCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccch
Q 040925 692 LSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771 (833)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~ 771 (833)
+.++...... +-.-...|.|||.+....++.||||||+|+.++++++.|...|.-++. .++.+.++...
T Consensus 353 ~~d~~Y~~~~-------~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---~ev~~~le~Gy- 421 (468)
T KOG0197|consen 353 IGDDEYTASE-------GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---EEVLELLERGY- 421 (468)
T ss_pred cCCCceeecC-------CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---HHHHHHHhccC-
Confidence 6654432211 112456899999999999999999999777777666664432210000 00111111111
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
.-+.++.|++.+.++|..||+.+|++|||++.+...++.+....
T Consensus 422 -------------Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 422 -------------RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred -------------cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 12345668999999999999999999999999999999887643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=329.27 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=195.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
+.|+...++|+|+||+||+++++++|+.||||++....+ ...+...+|+++|++++|||+|.++.+|. .....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-----rkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-----RKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-----hccee
Confidence 468888999999999999999999999999999964322 23466899999999999999999999954 44589
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++|+|||+. ++.+-+..... .++...+.++++|+++|+.|+|++ ++|||||||+|||++.+|.+||||||+
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~-----G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGF 147 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPN-----GVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGF 147 (396)
T ss_pred EEEeeecch-HHHHHHHhccC-----CCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchh
Confidence 999999986 77666766553 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCc---------cHHHHHH--H
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGH---------SLHEFAK--T 756 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~---------~l~~~~~--~ 756 (833)
|+.+..+. ...+.++.|.+|+|||.+.| ..|...+|||+-||.|.++..+.. .+|.+.. |
T Consensus 148 AR~L~~pg--------d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG 219 (396)
T KOG0593|consen 148 ARTLSAPG--------DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG 219 (396)
T ss_pred hHhhcCCc--------chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence 99876422 12234678999999999887 679999999996666655443210 1111111 1
Q ss_pred hCCCcccccccccchhhhccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 757 ALPEKVMEIVDPSLLMEVMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+......++...-....+.-.. .-...-+...+....-+.+++..|++.||++|++.+|++..
T Consensus 220 ~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 220 NLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11111111111000000000000 00001112233455678999999999999999999999754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=353.71 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=215.5
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCC
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDF 602 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 602 (833)
.+...+|...+.||+|+|++||+|+.+.+++.||||++.+. .+...+.+..|-.+|.+| .||.|+++|..|.+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~- 147 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE- 147 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-
Confidence 34456899999999999999999999999999999999644 233456788999999999 7999999998865544
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
..|+|+||+++|+|.++|++.+ .+++..++.++.+|+.||+|||+. |||||||||+|||+|+||.+|
T Consensus 148 ----sLYFvLe~A~nGdll~~i~K~G------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhik 214 (604)
T KOG0592|consen 148 ----SLYFVLEYAPNGDLLDLIKKYG------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIK 214 (604)
T ss_pred ----ceEEEEEecCCCcHHHHHHHhC------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEE
Confidence 8999999999999999999876 799999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccc-----cccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHh
Q 040925 683 VCDFGLAKFLSDHQLDT-----AVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTA 757 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~-----~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~ 757 (833)
|+|||.|+.+.+..... .........+++||..|.+||++.+...++.+|||+ +|+++|.|+.|.
T Consensus 215 ITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWA----------lGCilyQmlaG~ 284 (604)
T KOG0592|consen 215 ITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWA----------LGCILYQMLAGQ 284 (604)
T ss_pred EeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHH----------HHHHHHHHhcCC
Confidence 99999999887654431 111122235689999999999999999999999999 888999999999
Q ss_pred CCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 758 LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 758 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.|+...... -....++.-.. ..++.+++.+.+|+.+.|..||.+|+|++||.++
T Consensus 285 PPFra~Ney--liFqkI~~l~y-------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 285 PPFRAANEY--LIFQKIQALDY-------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCccccHH--HHHHHHHHhcc-------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 998732211 11111111111 2244556788899999999999999999888765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=339.99 Aligned_cols=244 Identities=24% Similarity=0.307 Sum_probs=200.5
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
..++|++.+.||+|+||+||.++.+++++.||+|++++. .....+...+|..+|.+++||.||+++..+ ++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence 356899999999999999999999999999999999754 233457789999999999999999999874 455
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...|+|+||+.||.|..++.+.+ .+++..++-++..|+.||.|||++ |||||||||+|||+|.+|.++|+|
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtD 168 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREG------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTD 168 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcC------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEec
Confidence 59999999999999999999776 799999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+|+..-.. ...+.+++||+.|||||++.+..|+.++|+|| .|+.+|+|.+|..|+...+.
T Consensus 169 FgL~k~~~~~--------~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWs----------LGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 169 FGLCKEDLKD--------GDATRTFCGTPEYMAPEILLGKGYDKAVDWWS----------LGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred cccchhcccC--------CCccccccCCccccChHHHhcCCCCcccchHh----------HHHHHHHHhhCCCCCcCccH
Confidence 9999854332 12233478999999999999999999999999 89999999999999763321
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM 812 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 812 (833)
. ...+.+.... ....+.-......+++.+.+.+||++|.
T Consensus 231 ~---~~~~~I~~~k-----~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 231 K---KMYDKILKGK-----LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred H---HHHHHHhcCc-----CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1 1111111110 0111112345677899999999999995
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=342.59 Aligned_cols=263 Identities=25% Similarity=0.343 Sum_probs=200.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
..+|...+.||+|+||.||++.+..+|+.+|||.+........+.+.+|+++|++++|||||+++|...... + ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence 345788899999999999999999889999999997553333667899999999999999999999743332 1 3689
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-CCcEEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~ 688 (833)
+.|||+++|+|.+++...+. ++++..++.+.+||++||+|||++ |||||||||+|||++. ++.+||+|||+
T Consensus 93 i~mEy~~~GsL~~~~~~~g~-----~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~ 164 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG-----KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGL 164 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcc
Confidence 99999999999999998753 489999999999999999999999 9999999999999999 69999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++...... ..........||+.|||||++.++ ....++||||.| +++.||+++..||.......
T Consensus 165 a~~~~~~~-----~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlG----------CtVvEM~Tg~~PW~~~~~~~ 229 (313)
T KOG0198|consen 165 AKKLESKG-----TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLG----------CTVVEMLTGKPPWSEFFEEA 229 (313)
T ss_pred cccccccc-----ccccccccccCCccccCchhhcCCCcCCccchhhhcC----------CEEEeccCCCCcchhhcchH
Confidence 98765311 111223346799999999999853 344599999954 45555555555544310001
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
........... . ...+...+....+++.+|+.+||++||||+++++.-.-.
T Consensus 230 ~~~~~ig~~~~--~----P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 230 EALLLIGREDS--L----PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred HHHHHHhccCC--C----CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 11111111110 0 022334566788999999999999999999999875443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=318.52 Aligned_cols=268 Identities=22% Similarity=0.303 Sum_probs=202.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.+|...+++|+|.||.||+|++..+|+.||||+++.... +......+|+..|+.++||||+.+++++.+. ...
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-----~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-----SNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-----Cce
Confidence 468889999999999999999999999999999986532 2346789999999999999999999996544 489
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
.+|+||++. +|+..|+.... .++..++..|+.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+
T Consensus 77 ~lVfEfm~t-dLe~vIkd~~i-----~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGL 147 (318)
T KOG0659|consen 77 SLVFEFMPT-DLEVVIKDKNI-----ILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGL 147 (318)
T ss_pred EEEEEeccc-cHHHHhccccc-----ccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccc
Confidence 999999986 99999998653 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCcccc-----CCc-cHHHHHH--HhC-
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFN-----EGH-SLHEFAK--TAL- 758 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~-----~g~-~l~~~~~--~~~- 758 (833)
|+.+..+.... ...+-|.+|+|||.+.|. .|+...|+||.||.+.|+.- .|. .+-++.. +.+
T Consensus 148 Ar~f~~p~~~~--------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG 219 (318)
T KOG0659|consen 148 ARFFGSPNRIQ--------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG 219 (318)
T ss_pred hhccCCCCccc--------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence 99887654322 123689999999998875 59999999998888776532 122 1222111 111
Q ss_pred CCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 759 PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 759 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.....+..+-....++..-.....+........+.....+++..++..||.+|+|+.|++++
T Consensus 220 TP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 220 TPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00000111111111222211111222222334456677999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=350.51 Aligned_cols=269 Identities=20% Similarity=0.252 Sum_probs=200.6
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcch-hHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS-RSFVAECEALRNIR-HRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 606 (833)
..++|.+.++||.|.||.||+|+...++..||||+++....... -.-.+|+..|++++ |||||++.+++.+.+ .
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~ 83 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----R 83 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence 45689999999999999999999999999999999986544322 23468999999998 999999999975543 3
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++|||||+. +|+++++.+++ .+++.+++.|++||++||+|+|.+ |+.|||+||+|||+.....+||+||
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~R~r-----~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDF 154 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKDRNR-----LFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADF 154 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhhcCC-----cCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccc
Confidence 89999999974 99999998743 799999999999999999999999 9999999999999998999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccC-CCCCCcccccccCCcCCCccccCC-----c----cHHHHHHH
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-GSEASMTGDIFTGRRPIDAVFNEG-----H----SLHEFAKT 756 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~~~~~~~~~~~g-----~----~l~~~~~~ 756 (833)
|+|+.+..... .+.++.|.+|+|||++. ..-|+.+.|+|+.||.+.+++++- . .+|.+..-
T Consensus 155 GLARev~SkpP---------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V 225 (538)
T KOG0661|consen 155 GLAREVRSKPP---------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV 225 (538)
T ss_pred ccccccccCCC---------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH
Confidence 99997755332 23467899999999865 566999999999777777665431 1 11221111
Q ss_pred hCCCcccccccccchhhhccccch---hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 757 ALPEKVMEIVDPSLLMEVMTNNSM---IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.-.....+..........+..... ..+.....+ .++.+..+++.+|+.+||++||||.|.+++
T Consensus 226 LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 226 LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 100000000000001111111111 111111222 267788999999999999999999999876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=337.02 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=212.1
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
..++|++.+.||.|..++||+|+...+++.||||++..+.-. ..+.+.+|+..|+.++||||++++..|.... .
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-----~ 98 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-----E 98 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-----e
Confidence 456899999999999999999999999999999999755333 3588999999999999999999999876665 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||.||.+||+.++++..-.. .+++..+..|.+++++||.|||.+ |.||||||+.||||+.+|.|||+|||
T Consensus 99 LWvVmpfMa~GS~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 99 LWVVMPFMAGGSLLDIIKTYYPD----GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred eEEeehhhcCCcHHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence 99999999999999999876543 699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC--CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
.+..+.+.... ...+...++||+.|||||++.. ..|+.|+|||| +|++..|++.|..|+.....
T Consensus 172 vsa~l~~~G~R----~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwS----------fGITA~ELA~G~aPf~k~pP 237 (516)
T KOG0582|consen 172 VSASLFDSGDR----QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWS----------FGITACELAHGHAPFSKYPP 237 (516)
T ss_pred eeeeecccCce----eeEeeccccCcccccChHHhhhcccCccchhhhhh----------hhHHHHHHhcCCCCcccCCh
Confidence 88766554311 1112256789999999999543 45999999999 88999999999999874332
Q ss_pred ccccchhhhccccch---hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSM---IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. +.....++... ....+......+...+.+++..|+.+||++|||++++++.
T Consensus 238 mk--vLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 238 MK--VLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HH--HHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11 11111111111 0011112233456689999999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=351.99 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=212.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
..|...++||+|+.|.||.|+...+++.||||++........+-+.+|+.+|+..+|+|||.+++.|... +..|+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLWV 347 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELWV 347 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeEE
Confidence 4678889999999999999999999999999999877776777899999999999999999999876444 48999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||++||+|.|++... .+++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+|||+|.
T Consensus 348 VMEym~ggsLTDvVt~~-------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT-------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred EEeecCCCchhhhhhcc-------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence 99999999999999865 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
.+..... +....+|||+|||||+.....|++|+|||| +|.+..||+.|+.|+-....+..-+
T Consensus 418 qi~~~~~--------KR~TmVGTPYWMAPEVvtrk~YG~KVDIWS----------LGIMaIEMveGEPPYlnE~PlrAly 479 (550)
T KOG0578|consen 418 QISEEQS--------KRSTMVGTPYWMAPEVVTRKPYGPKVDIWS----------LGIMAIEMVEGEPPYLNENPLRALY 479 (550)
T ss_pred ccccccC--------ccccccCCCCccchhhhhhcccCccccchh----------hhhHHHHHhcCCCCccCCChHHHHH
Confidence 7765432 334568999999999999999999999999 8999999999999876433222222
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..... ....-..++..+..+.+++.+||+.||++||++.|+++.
T Consensus 480 LIa~n------g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 480 LIATN------GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHhhc------CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 11110 011112344567789999999999999999999999876
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=343.91 Aligned_cols=269 Identities=23% Similarity=0.311 Sum_probs=205.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
+.|+.+++||+|.||.||+|++..+|+.||+|+++... .+...-+.+|+.||++++||||+++.+...+.. ...+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~---~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL---SGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC---CceE
Confidence 35778899999999999999999999999999998664 445677899999999999999999999987652 4589
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
|+|+|||+. ||..++....- .+++.++..++.|++.||+|+|++ ||+|||||.+|||||.+|.+||+|||+
T Consensus 194 YlVFeYMdh-DL~GLl~~p~v-----kft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPGV-----KFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred EEEEecccc-hhhhhhcCCCc-----ccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccc
Confidence 999999987 99999887542 799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccH---------HHHHH--H
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSL---------HEFAK--T 756 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l---------~~~~~--~ 756 (833)
|+++..... ...+..+-|.+|+|||.+.|. .|+++.|+||.||++.++|.+..++ ..+.. |
T Consensus 265 Ar~y~~~~~-------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcG 337 (560)
T KOG0600|consen 265 ARFYTPSGS-------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCG 337 (560)
T ss_pred eeeccCCCC-------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhC
Confidence 998765432 123446789999999998875 5999999999888888877543221 11111 1
Q ss_pred hCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 757 ALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
...+..+...+-.. ....+.........+......+....+++..+|..||++|.||.++++
T Consensus 338 SP~e~~W~~~kLP~-~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 338 SPTEDYWPVSKLPH-ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCChhccccccCCc-ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111111111000 000111111111222334556778889999999999999999999875
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=358.02 Aligned_cols=409 Identities=30% Similarity=0.468 Sum_probs=343.5
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|++++|++. .+|.+++.+..+..|+.+.|++ ..+|+.++.+.+|+.|+.++|.+. ..|+.++.+..|+.|+..+
T Consensus 70 l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~l-s~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 70 LTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKL-SELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred eeEEEeccchhh-hCCHHHHHHHHHHHhhcccchH-hhccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 578999999999 7999999999999999999999 678889999999999999999998 7888899999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
|+++ .+|++++ .+.+|..|++.+|.++...|..+. ++.|++||...|-++.+ |..+++|.+|..|+|.+|+|...|
T Consensus 147 N~i~-slp~~~~-~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~tl-P~~lg~l~~L~~LyL~~Nki~~lP 222 (565)
T KOG0472|consen 147 NQIS-SLPEDMV-NLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLETL-PPELGGLESLELLYLRRNKIRFLP 222 (565)
T ss_pred cccc-cCchHHH-HHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhcC-ChhhcchhhhHHHHhhhcccccCC
Confidence 9998 8887764 788899999999999865555554 88999999999988854 457888999999999999987655
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (833)
. |.+++.|++|+++.|+|. .+|.+.+.-.+.+..||+++|+++ ..|+.+.-+.+|+.||+++|.|+ ..|
T Consensus 223 e--------f~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp 291 (565)
T KOG0472|consen 223 E--------FPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLP 291 (565)
T ss_pred C--------CCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCC
Confidence 3 778888888999888888 788877755566778888899888 77888888888889999988888 466
Q ss_pred ccccCCCCCCEEEcccccCcc-----------------------------------------------------------
Q 040925 241 DAIGELKNLQKLCLFRNFLQG----------------------------------------------------------- 261 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~----------------------------------------------------------- 261 (833)
..++++ +|+.|-+.+|.+..
T Consensus 292 ~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s 370 (565)
T KOG0472|consen 292 YSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVS 370 (565)
T ss_pred cccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccc
Confidence 678888 88888888887651
Q ss_pred -----cCCccccCCC---CCCeEEeecccccCCCCCCCCCCCccc-eeecCCceecccCCcccccccccceeeecCCCcc
Q 040925 262 -----RIPSGLGNLT---KLANLELSSNSLQGNIPSSLGNCQNLM-SFTASQNKLTGALPHQLLSITTLSLYLDLSNNLL 332 (833)
Q Consensus 262 -----~~~~~~~~l~---~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l 332 (833)
.+|+....-. -.+..+++.|++. .+|..+..+..+. .+.+++|.+. .+|..++.++++ ..|+|++|-+
T Consensus 371 ~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kL-t~L~L~NN~L 447 (565)
T KOG0472|consen 371 DKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKL-TFLDLSNNLL 447 (565)
T ss_pred ccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcc-eeeecccchh
Confidence 1111111111 1456789999998 7888888777654 4566777776 888899999998 7899999999
Q ss_pred CCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhh
Q 040925 333 NGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFL 412 (833)
Q Consensus 333 ~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l 412 (833)
. .+|..++.+..|+.||+|.|++. ..|..+..+..|+.+-.++|++..+.+..+.++.+|..|||.+|.+. .+|..+
T Consensus 448 n-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~L 524 (565)
T KOG0472|consen 448 N-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPIL 524 (565)
T ss_pred h-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhh
Confidence 8 78999999999999999999998 88998888888999989999999888888999999999999999998 788899
Q ss_pred cCCCCCceEECccCcCccccCCC
Q 040925 413 KNLSVLEFLSLSYNHFEGEVPTK 435 (833)
Q Consensus 413 ~~l~~L~~L~l~~N~l~~~~~~~ 435 (833)
+++++|++|++.+|+|. .|+..
T Consensus 525 gnmtnL~hLeL~gNpfr-~Pr~~ 546 (565)
T KOG0472|consen 525 GNMTNLRHLELDGNPFR-QPRHQ 546 (565)
T ss_pred ccccceeEEEecCCccC-CCHHH
Confidence 99999999999999999 44443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=347.19 Aligned_cols=269 Identities=27% Similarity=0.383 Sum_probs=216.2
Q ss_pred chHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeec
Q 040925 522 SYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSS 599 (833)
Q Consensus 522 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 599 (833)
+..++....+...+.++||+|+||+||+|.|.++ ||||++..... +..+.|++|+.++++-+|.||+-+.|||..
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3456666667788889999999999999999754 99999976543 345789999999999999999999999876
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
+. ..||+.+|+|-+|+.+++..+. +++..+.+.|+.||++|+.|||.+ +|||||||..||++.+++
T Consensus 460 p~------~AIiTqwCeGsSLY~hlHv~et-----kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~ 525 (678)
T KOG0193|consen 460 PP------LAIITQWCEGSSLYTHLHVQET-----KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDL 525 (678)
T ss_pred Cc------eeeeehhccCchhhhhccchhh-----hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCC
Confidence 65 3899999999999999997653 799999999999999999999999 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCC---CCCcccccccCCcCCCccccCCccHHHHHHH
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS---EASMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
+|||+|||++..-........ .....|...|||||+++.+ +|+..+|||+ +|.++||++++
T Consensus 526 kVkIgDFGLatvk~~w~g~~q------~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYa----------FGiV~YELltg 589 (678)
T KOG0193|consen 526 KVKIGDFGLATVKTRWSGEQQ------LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYA----------FGIVWYELLTG 589 (678)
T ss_pred cEEEecccceeeeeeeccccc------cCCCccchhhhcHHHHhhcccCCCCcccchhh----------hhHHHHHHHhC
Confidence 999999999975433211111 1223588899999998743 5899999888 89999999999
Q ss_pred hCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 757 ALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.+|+. .+..|.-+.+-...+ .-+..-.....+++++.+|+..||..+|++||.+.+|+..|+.+..+
T Consensus 590 ~lPys-i~~~dqIifmVGrG~---l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 590 ELPYS-IQNRDQIIFMVGRGY---LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCCcC-CCChhheEEEecccc---cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 99987 333333222111110 00111123456888999999999999999999999999999988775
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=339.67 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=209.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
..|+..+.||+|+||.||+|.+..+++.||+|++..... ...+++.+|+.++.+++++||.++||.+.... ..+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~-----~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT-----KLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----cHH
Confidence 357888999999999999999999999999999986643 44678999999999999999999999876554 889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
++||||.||++.+.++... .+++..+.-++++++.|+.|+|++ +.+|||||+.||++..+|.+|++|||.+
T Consensus 88 iiMey~~gGsv~~lL~~~~------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred HHHHHhcCcchhhhhccCC------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence 9999999999999998765 458888888999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
..+.... .+...++|||.|||||++.+..|+.|+|||| .|++.+|+++|..|+...... +
T Consensus 159 ~ql~~~~--------~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWS----------LGITaiEla~GePP~s~~hPm--r 218 (467)
T KOG0201|consen 159 GQLTNTV--------KRRKTFVGTPFWMAPEVIKQSGYDTKADIWS----------LGITAIELAKGEPPHSKLHPM--R 218 (467)
T ss_pred eeeechh--------hccccccccccccchhhhccccccchhhhhh----------hhHHHHHHhcCCCCCcccCcc--e
Confidence 8765532 2234678999999999999999999999999 899999999999998633321 1
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+.- +.+ ...+... .++.+.+.+++..|+.+||+.||||.+++++
T Consensus 219 vlfl-Ipk----~~PP~L~-~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 219 VLFL-IPK----SAPPRLD-GDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred EEEe-ccC----CCCCccc-cccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1111 111 1111222 2577889999999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=306.34 Aligned_cols=279 Identities=19% Similarity=0.216 Sum_probs=220.2
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
...++|++.+.+|+|||+.||.++.-.+++.||+|++.....+..+...+|++..++++||||+++++++....-+++..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 34468999999999999999999999999999999998887777889999999999999999999999887665556778
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|++++|+..|||.+.+......+. .+++.+++.|+.++++||++||+. .|+++||||||.||++++++.++|.|||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~--~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGN--FVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCC--ccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 9999999999999999987654332 699999999999999999999998 4569999999999999999999999999
Q ss_pred cccccCccccccc-ccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 688 LAKFLSDHQLDTA-VKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 688 ~a~~~~~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
.++...-.-.... ............|..|+|||.+. +...++++|||| +|+++|.++.+..|++..
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWS----------LGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWS----------LGCTLYAMMFGESPFERI 244 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhh----------hhHHHHHHHHcCCcchHH
Confidence 9976543211000 00011112245799999999754 556789999999 788888888888887733
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
..-...+...+.......+.. ..++..+.+++.+|++.||.+||++.+++..+..+
T Consensus 245 ~~~GgSlaLAv~n~q~s~P~~-----~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 245 YQQGGSLALAVQNAQISIPNS-----SRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred hhcCCeEEEeeeccccccCCC-----CCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 222223322222222222211 12677899999999999999999999999988764
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=342.16 Aligned_cols=251 Identities=24% Similarity=0.318 Sum_probs=206.9
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc----CC-cchhHHHHHHHHHhhcC-CCccceEeeEeecCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK----YK-GASRSFVAECEALRNIR-HRNLIKIITICSSTD 601 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 601 (833)
...++|.+.+.||+|+||+|+.|.+..+++.||+|+++.. .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567899999999999999999999999999999987643 11 23456778999999999 999999999976655
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-Cc
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MV 680 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 680 (833)
.+++||||+.||+|.+++...+ ++.+..++++++|++.|++|+|++ ||+||||||+||+++.+ ++
T Consensus 94 -----~~~ivmEy~~gGdL~~~i~~~g------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~ 159 (370)
T KOG0583|consen 94 -----KIYIVMEYCSGGDLFDYIVNKG------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGN 159 (370)
T ss_pred -----eEEEEEEecCCccHHHHHHHcC------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCC
Confidence 7999999999999999999854 789999999999999999999999 99999999999999999 99
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCCC-CC-cccccccCCcCCCccccCCccHHHHHHHhC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-AS-MTGDIFTGRRPIDAVFNEGHSLHEFAKTAL 758 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~ 758 (833)
+||+|||++..... ........+||+.|+|||++.+.. |+ .++|||| .|+++|.++.|..
T Consensus 160 ~Kl~DFG~s~~~~~--------~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS----------~GViLy~ml~G~~ 221 (370)
T KOG0583|consen 160 LKLSDFGLSAISPG--------EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWS----------LGVILYVLLCGRL 221 (370)
T ss_pred EEEeccccccccCC--------CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhh----------hHHHHHHHHhCCC
Confidence 99999999987631 112233468999999999999987 86 8899999 8999999999999
Q ss_pred CCcccccccccchhhhccccchhhhhhhhchHHH-HHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 759 PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEEC-LNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 759 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
|+.... .+.+......... ..+..+ ...+..++.+|+..||.+|+|+.+|++
T Consensus 222 PF~d~~--~~~l~~ki~~~~~-------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 222 PFDDSN--VPNLYRKIRKGEF-------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred CCCCcc--HHHHHHHHhcCCc-------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 987522 1122111111111 112222 567789999999999999999999984
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.12 Aligned_cols=266 Identities=24% Similarity=0.405 Sum_probs=214.8
Q ss_pred cCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
.+.+..+.||+|+||+||+|+.. +....||||.++..... ...+|++|++.++.++|||||+++|+|...+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~--- 562 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD--- 562 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC---
Confidence 45566789999999999999874 24568999999876655 6789999999999999999999999998776
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccc--------cccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVE--------VCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
-.|+|+|||..|||.+++........ ..+++..+.+.||.|||.|+.||-++ .+|||||..+|+||+
T Consensus 563 --P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 563 --PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred --eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 78999999999999999986553211 23488999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHH
Q 040925 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
+...|||+|||+++.+-...+..... ...-..+|||||.+..++++++|||||.|+.+|++|+.|...|+-++
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~------~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS- 710 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRG------NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS- 710 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccC------CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-
Confidence 99999999999999765544332210 12346799999999999999999999999999999998865443111
Q ss_pred hCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 757 ALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
+.+. .+.++... .-..++.||.++..||..||+.+|++||+++||...|+...+.
T Consensus 711 ----------n~EV-Ie~i~~g~-----lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 711 ----------NQEV-IECIRAGQ-----LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ----------hHHH-HHHHHcCC-----cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 1111 11111111 1234677899999999999999999999999999999987654
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=337.10 Aligned_cols=248 Identities=28% Similarity=0.410 Sum_probs=206.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+ .+.+.+.+|++|+++++|||||.++++| +...+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 579999999999999999999999999999999965432 3456799999999999999999999984 555599
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
|+|+||+.| +|..++...+ .++++++..++.|++.||.|||+. +|+|||+||.||++++.|.+|+||||+
T Consensus 77 ~vVte~a~g-~L~~il~~d~------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~ 146 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDG------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGL 146 (808)
T ss_pred EEEehhhhh-hHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhh
Confidence 999999986 9999998876 799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
|+.+..... ....+.|||.|||||+..+++|+..+|+|| .|+++||++.|..|+-...+..
T Consensus 147 Ar~m~~~t~--------vltsikGtPlYmAPElv~e~pyd~~sDlWs----------lGcilYE~~~G~PPF~a~si~~- 207 (808)
T KOG0597|consen 147 ARAMSTNTS--------VLTSIKGTPLYMAPELVEEQPYDHTSDLWS----------LGCILYELYVGQPPFYARSITQ- 207 (808)
T ss_pred hhhcccCce--------eeeeccCcccccCHHHHcCCCccchhhHHH----------HHHHHHHHhcCCCCchHHHHHH-
Confidence 998765322 233467999999999999999999999999 7888889888888875333211
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+....... +...+......+..++...+.+||.+|.|..+++.+
T Consensus 208 -Lv~~I~~d-------~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 208 -LVKSILKD-------PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -HHHHHhcC-------CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 11111111 111223456678899999999999999999998764
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=309.94 Aligned_cols=238 Identities=24% Similarity=0.245 Sum_probs=200.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||.|+||.|.+++.+.+|..||+|+++.+. ....+...+|.++|+.+.||+++++++.+.+.+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~----- 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS----- 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC-----
Confidence 347889999999999999999999999999999997542 223456788999999999999999999876655
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
+.++||||++||.|..++.+.+ ++++..++.++.||+.|++|||+. +|++||+||+|||+|.+|.+||+||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDF 188 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDF 188 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEec
Confidence 9999999999999999999876 799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+|+.+... +...+|||.|+|||++...+|..++|+|+ +|+.+|||+.|..|+......
T Consensus 189 GFAK~v~~r-----------T~TlCGTPeYLAPEii~sk~ynkavDWWa----------lGVLIYEMlaG~pPF~~~~~~ 247 (355)
T KOG0616|consen 189 GFAKRVSGR-----------TWTLCGTPEYLAPEIIQSKGYNKAVDWWA----------LGVLIYEMLAGYPPFYDDNPI 247 (355)
T ss_pred cceEEecCc-----------EEEecCCccccChHHhhcCCCCcchhHHH----------HHHHHHHHHcCCCCCcCCChH
Confidence 999977653 22468999999999999999999999999 899999999999998643321
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCC
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFER 811 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 811 (833)
.-. ..... .+-..+..+...+.+++...++.|-.+|
T Consensus 248 ~iY--~KI~~-------~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 248 QIY--EKILE-------GKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHH--HHHHh-------CcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 100 00111 1112344556678889999999999888
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=337.82 Aligned_cols=249 Identities=22% Similarity=0.312 Sum_probs=210.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.+-|+..+.||.|+.|.|-.|++..||+.+|||++.... ......+.+|+.+|+-+.||||+++|+++....
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~----- 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQ----- 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCc-----
Confidence 467999999999999999999999999999999996542 223467899999999999999999999965544
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
+.|+|.||+++|-|.+++-.++ ++++.++.++++||+.|+.|+|.. +|+|||+||+|+|+|+.+.+||+||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADF 156 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKG------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADF 156 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhC------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeecc
Confidence 9999999999999999999877 799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|+|..-.++.. ....||+|.|.|||++.|.+| ..++|||| .|+++|.+++|.+|++...
T Consensus 157 GMAsLe~~gkl---------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWS----------CGVILfALLtG~LPFdDdN- 216 (786)
T KOG0588|consen 157 GMASLEVPGKL---------LETSCGSPHYAAPEIVSGRPYDGRPSDVWS----------CGVILFALLTGKLPFDDDN- 216 (786)
T ss_pred ceeecccCCcc---------ccccCCCcccCCchhhcCCCCCCCccccch----------hHHHHHHHHhCCCCCCCcc-
Confidence 99986544332 234589999999999999998 48899999 8999999999999987222
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++ .+...+.... -..+..++.+..+|+.+|+..||++|.|++||+++
T Consensus 217 ir-~LLlKV~~G~-------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 217 IR-VLLLKVQRGV-------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HH-HHHHHHHcCc-------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 11 1111222222 12345567788999999999999999999999986
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=333.27 Aligned_cols=244 Identities=27% Similarity=0.417 Sum_probs=204.4
Q ss_pred cCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEe
Q 040925 535 SSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEY 614 (833)
Q Consensus 535 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 614 (833)
..+-||+|+.|.||+|+.+ ++.||||+++.- -..++.-|++|+||||+.+.|+|.... .+||||||
T Consensus 128 ELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsP-----cyCIiMEf 193 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSP-----CYCIIMEF 193 (904)
T ss_pred hhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCc-----eeEEeeec
Confidence 3568999999999999995 788999998522 234788899999999999999998776 89999999
Q ss_pred cCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCc
Q 040925 615 MENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 615 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
|+.|-|+++++..+ .++......|..+||.|+.|||.+ .|||||||.-||||+.+..|||+|||-++...+
T Consensus 194 Ca~GqL~~VLka~~------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 194 CAQGQLYEVLKAGR------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred cccccHHHHHhccC------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 99999999999876 788999999999999999999999 999999999999999999999999999986544
Q ss_pred ccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhh
Q 040925 695 HQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEV 774 (833)
Q Consensus 695 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~ 774 (833)
. .-...++||..|||||++...+.+.|+|||| +|+++||++++..|+...+ ...+...+
T Consensus 265 ~---------STkMSFaGTVaWMAPEvIrnePcsEKVDIwS----------fGVVLWEmLT~EiPYkdVd--ssAIIwGV 323 (904)
T KOG4721|consen 265 K---------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWS----------FGVVLWEMLTGEIPYKDVD--SSAIIWGV 323 (904)
T ss_pred h---------hhhhhhhhhHhhhCHHHhhcCCcccccceeh----------hHHHHHHHHhcCCCccccc--hheeEEec
Confidence 2 1234578999999999999999999999999 8999999999999976322 11221111
Q ss_pred ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 775 MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
-.+.. .-+.++.|++-+.=++.+||+-.|..||++++|+..|.-....
T Consensus 324 GsNsL-----~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 324 GSNSL-----HLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred cCCcc-----cccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 11111 1234567888899999999999999999999999998765544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=329.01 Aligned_cols=263 Identities=19% Similarity=0.232 Sum_probs=205.8
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
....++|++.+.||+|+||.||+|+.+.+|..||+|++++.. ....+.++.|-.+|....+|.||++|..|.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD---- 212 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD---- 212 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC----
Confidence 345678999999999999999999999999999999997542 3445678899999999999999999988554
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
..+.|+||||++||++..++...+ .+++..++.++.+++.|+.-+|.. |+|||||||+|+|||..|.+||
T Consensus 213 -~~~LYLiMEylPGGD~mTLL~~~~------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKL 282 (550)
T KOG0605|consen 213 -KEYLYLIMEYLPGGDMMTLLMRKD------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKL 282 (550)
T ss_pred -CCeeEEEEEecCCccHHHHHHhcC------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEee
Confidence 459999999999999999999876 799999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccc-------------------cccc-----c---------------CCCccccccccccccCccccCC
Q 040925 684 CDFGLAKFLSDHQL-------------------DTAV-----K---------------TPSSSIGLKGTVGYVAPEYGMG 724 (833)
Q Consensus 684 ~DfG~a~~~~~~~~-------------------~~~~-----~---------------~~~~~~~~~gt~~y~aPE~~~~ 724 (833)
+|||+|.-...... .... . ......+.+|||-|||||++.+
T Consensus 283 SDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~ 362 (550)
T KOG0605|consen 283 SDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG 362 (550)
T ss_pred ccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc
Confidence 99999854321000 0000 0 0011235789999999999999
Q ss_pred CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccC
Q 040925 725 SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCS 804 (833)
Q Consensus 725 ~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 804 (833)
..|+..+|+|| .|+++||++.|..|+.........-........+.. +...++.++..++|.+|+
T Consensus 363 kgY~~~cDwWS----------LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-----P~~~~~s~eA~DLI~rll 427 (550)
T KOG0605|consen 363 KGYGKECDWWS----------LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-----PEEVDLSDEAKDLITRLL 427 (550)
T ss_pred CCCCccccHHH----------HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-----CCcCcccHHHHHHHHHHh
Confidence 99999999999 889999999999998743322111111111111111 111223467789999999
Q ss_pred CCCCCCCCC---HHHHHH
Q 040925 805 MESPFERMD---MRDVVA 819 (833)
Q Consensus 805 ~~dP~~RPt---~~eil~ 819 (833)
. ||++|-. ++||-+
T Consensus 428 ~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 428 C-DPENRLGSKGAEEIKK 444 (550)
T ss_pred c-CHHHhcCcccHHHHhc
Confidence 9 9999975 555543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=319.12 Aligned_cols=276 Identities=22% Similarity=0.295 Sum_probs=208.3
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEee--ccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN--LKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
....|...+.||+|+||.|+.|+++.+|+.||+|++. .......++..+|++++++++|+||+.+++++..+....-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777899999999999999999999999999997 33445568899999999999999999999998774444455
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
.+|+|+|+|+ -+|.+.++.++ .++...+..+++|+++||+|+|+. +|+|||+||+|++++.+..+||+||
T Consensus 100 DvYiV~elMe-tDL~~iik~~~------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQ------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCc------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccc
Confidence 7999999995 59999999875 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCcccc-CCCCCCcccccccCCcCCCccccC-----Cc-cHHH--HHHHh
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYG-MGSEASMTGDIFTGRRPIDAVFNE-----GH-SLHE--FAKTA 757 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~s~~~~~~~~~~~-----g~-~l~~--~~~~~ 757 (833)
|+|+..... ......+..+.|.+|+|||++ ....|+.+.||||.||.+.++..+ |. .+.+ +....
T Consensus 170 GLAR~~~~~------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~ 243 (359)
T KOG0660|consen 170 GLARYLDKF------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILEL 243 (359)
T ss_pred cceeecccc------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHh
Confidence 999987543 112234557899999999975 456799999999988887776542 21 1111 11221
Q ss_pred C---CCcccccccccchhhhccccchhhhhh-hhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 758 L---PEKVMEIVDPSLLMEVMTNNSMIQEDK-RVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 758 ~---p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. +......+.......++......++.. ....+...+...+++.+||..||.+|+|++|.++.
T Consensus 244 lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 244 LGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred cCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1 112222222222222333222111111 11122455678899999999999999999999875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=309.58 Aligned_cols=268 Identities=21% Similarity=0.287 Sum_probs=198.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|+...+|++|+||.||+|+++.+++.||+|+++.... +..-...+|+.++.+++|||||.+..+....+ -+.+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~---~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN---MDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc---ccee
Confidence 458888999999999999999999999999999975432 22345689999999999999999999876554 3469
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
|+|||||+. +|..+++..+. ++...++..++.|+++|++|||.. .|+||||||+|+|++..|.+||+|||+
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q-----~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGL 223 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQ-----PFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGL 223 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccch
Confidence 999999987 99999987653 799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccC-----C-ccHHH---HHH--H
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNE-----G-HSLHE---FAK--T 756 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~-----g-~~l~~---~~~--~ 756 (833)
|+.++.+.. ..+..+-|.+|+|||.+.+.+ |+++.|+||.||.+.++... | .-+.+ ++. |
T Consensus 224 AR~ygsp~k--------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG 295 (419)
T KOG0663|consen 224 AREYGSPLK--------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG 295 (419)
T ss_pred hhhhcCCcc--------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence 998876521 233467899999999988765 99999999988877664321 1 11111 111 1
Q ss_pred hCCCccccccc-ccch--hhhccccchhhhhhhhchH-HHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 757 ALPEKVMEIVD-PSLL--MEVMTNNSMIQEDKRVKTE-ECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 757 ~~p~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
...+.++..++ ...+ ........ ......... ...+.-.+++...+..||.+|.|++|.++.
T Consensus 296 tPte~iwpg~~~lp~~k~~~f~~~py--n~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 296 TPSEAIWPGYSELPAVKKMTFSEHPY--NNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccCCCccccchhhccccCCCCc--hhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11111222111 1111 01111111 000111111 133566789999999999999999998764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.72 Aligned_cols=263 Identities=23% Similarity=0.298 Sum_probs=201.9
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---------C-----cchhHHHHHHHHHhhcCCCccce
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---------K-----GASRSFVAECEALRNIRHRNLIK 592 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~-----~~~~~~~~E~~~l~~l~h~niv~ 592 (833)
.+..+.|++.+.||+|.||.|-+|++..+++.||||++.... . ...+...+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 355678999999999999999999999999999999996331 0 11257899999999999999999
Q ss_pred EeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCC
Q 040925 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSN 672 (833)
Q Consensus 593 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~N 672 (833)
++.+..+.. .+.+|||+|||..|.+...=.... .+++.++++|+++++.||+|||.+ |||||||||+|
T Consensus 173 LiEvLDDP~---s~~~YlVley~s~G~v~w~p~d~~------els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsN 240 (576)
T KOG0585|consen 173 LIEVLDDPE---SDKLYLVLEYCSKGEVKWCPPDKP------ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSN 240 (576)
T ss_pred EEEeecCcc---cCceEEEEEeccCCccccCCCCcc------cccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchhh
Confidence 999976654 568999999999887754322221 389999999999999999999999 99999999999
Q ss_pred eeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCC----CCcccccccCCcCCCccccCCc
Q 040925 673 VLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE----ASMTGDIFTGRRPIDAVFNEGH 748 (833)
Q Consensus 673 Ill~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~s~~~~~~~~~~~g~ 748 (833)
+|++++|+|||+|||.+.......... ........+|||.|||||...++. .+.+.|||+ .|+
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~---~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWa----------lGV 307 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEG---SDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWA----------LGV 307 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccc---cHHHHhhcCCCccccchHhhcCCCCccccchhhhhhh----------hhh
Confidence 999999999999999998664321111 111122367999999999876632 356778888 899
Q ss_pred cHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 749 SLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 749 ~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
++|.++.|..|+......+ +....+.... .-+..++....+.++|.++|.+||++|.+..+|..+.
T Consensus 308 TLYCllfG~~PF~~~~~~~--l~~KIvn~pL-----~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDFELE--LFDKIVNDPL-----EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred hHHHhhhccCCcccchHHH--HHHHHhcCcc-----cCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 9999999999986222111 1111111111 1122334567889999999999999999999987653
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=317.85 Aligned_cols=268 Identities=24% Similarity=0.360 Sum_probs=195.4
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
.|...+.+|+|+||.||+|...++++.||||++....+ .--+|+.+|+.++|||||++..++......+.-+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 57778999999999999999999999999999864432 33469999999999999999998877653323466789
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-CcEEEccccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAK 690 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~ 690 (833)
|||+|. ||.++++..... ...++...++-+.+||.+||+|||+. +|+||||||+|+|+|.+ |.+||||||.|+
T Consensus 101 leymP~-tL~~~~r~~~~~--~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRA--NQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHhchH-HHHHHHHHHhhc--CCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 999996 999999853111 11688889999999999999999998 99999999999999977 899999999999
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCc---------cHHHHHHHhCCC
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGH---------SLHEFAKTALPE 760 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~---------~l~~~~~~~~p~ 760 (833)
....... ..+...|..|+|||.+.|. .|+.+.||||.||.+.|+..++. .+.++..---.+
T Consensus 175 ~L~~~ep---------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~P 245 (364)
T KOG0658|consen 175 VLVKGEP---------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTP 245 (364)
T ss_pred eeccCCC---------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCC
Confidence 8765432 2345689999999998875 49999999998888777654322 122222211111
Q ss_pred --cccccccccchhhhccccchhhhh-hhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 761 --KVMEIVDPSLLMEVMTNNSMIQED-KRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 761 --~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+......+... + .......... .+......+++..+++.+++.++|.+|.++.|++..
T Consensus 246 t~e~I~~mn~~y~-~-~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 246 TREDIKSMNPNYT-E-FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CHHHHhhcCcccc-c-ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 11111111110 0 0000000000 112334456778999999999999999999999865
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=338.59 Aligned_cols=268 Identities=21% Similarity=0.331 Sum_probs=203.1
Q ss_pred HhcCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSSTD 601 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 601 (833)
..++|++.+.||+|+||.||+|.+. .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++....
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3468999999999999999999752 3457899999974422 2345789999999999 8999999999875432
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCcc--------------------------------------------------
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQV-------------------------------------------------- 631 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-------------------------------------------------- 631 (833)
...++||||+++|+|.+++.......
T Consensus 85 ----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 85 ----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 46899999999999999997532100
Q ss_pred ------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCC
Q 040925 632 ------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705 (833)
Q Consensus 632 ------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~ 705 (833)
....+++.++..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++.........
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~------ 231 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------ 231 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchh------
Confidence 012478889999999999999999999 99999999999999999999999999998653321110
Q ss_pred ccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchhhhccccchhhhh
Q 040925 706 SSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQED 784 (833)
Q Consensus 706 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (833)
......+++.|+|||++.+..++.++|||| +|++++++++ +..|+..... +............
T Consensus 232 ~~~~~~~~~~y~aPE~~~~~~~~~~sDiws----------lG~il~el~~~g~~pf~~~~~-~~~~~~~~~~~~~----- 295 (338)
T cd05102 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWS----------FGVLLWEIFSLGASPYPGVQI-NEEFCQRLKDGTR----- 295 (338)
T ss_pred cccCCCCCccccCcHHhhcCCCCcccCHHH----------HHHHHHHHHhCCCCCCCCCCc-cHHHHHHHhcCCC-----
Confidence 111234678899999999999999999999 7888888876 6666542211 1111111111100
Q ss_pred hhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 785 KRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 785 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
...+..+++.+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 296 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 296 -MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 01122345678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=328.58 Aligned_cols=254 Identities=21% Similarity=0.306 Sum_probs=213.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|..++.+|+|+||.++.++++.++..||+|.+.... ....+...+|+.++++++|||||.+.+.+...+ ..
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~----~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDG----QL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCC----ce
Confidence 357999999999999999999999999999999997543 334567899999999999999999999865444 34
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.+|||+||+||++.+.+++.++. .++++++..|+.|++.|+.|||+. +|+|||||++||++++++.|||+|||
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~----~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfG 151 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGV----LFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFG 151 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchh
Confidence 99999999999999999987633 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+.+..+. ....+++|||.||+||++.+.+|..|+|||| .|+.+||+.+-..++...+..
T Consensus 152 laK~l~~~~--------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWs----------LGC~~yEm~~lk~aF~a~~m~- 212 (426)
T KOG0589|consen 152 LAKILNPED--------SLASTVVGTPYYMCPEILSDIPYNEKSDIWS----------LGCCLYEMCTLKPAFKASNMS- 212 (426)
T ss_pred hhhhcCCch--------hhhheecCCCcccCHHHhCCCCCCccCcchh----------hcchHHHHHhcccccCccchH-
Confidence 999887643 1233468999999999999999999999999 788888988888777643321
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+........ ..+.+..+..++..++..|+..+|+.||++.+++.+
T Consensus 213 -~Li~ki~~~~------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 213 -ELILKINRGL------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -HHHHHHhhcc------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1111111111 123455677889999999999999999999999987
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=295.50 Aligned_cols=250 Identities=21% Similarity=0.304 Sum_probs=208.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|.||.||.|+.+.++-.||+|++... ..+....+.+|++|-+.++||||+++|+++.+..
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~----- 95 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK----- 95 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-----
Confidence 45799999999999999999999999999999998533 2344578999999999999999999999976655
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
.+|+++||.++|+++..+...+.. ++++.....++.|+|.|+.|+|.. +||||||||+|+|++..+..||+||
T Consensus 96 riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdf 168 (281)
T KOG0580|consen 96 RIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADF 168 (281)
T ss_pred eeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCC
Confidence 999999999999999999965543 789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|.+...+. .+....+||.-|.|||...+..++..+|+|+ .|+..||++.+..|+....
T Consensus 169 GwsV~~p~----------~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~----------lgvl~yeflvg~ppFes~~-- 226 (281)
T KOG0580|consen 169 GWSVHAPS----------NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWS----------LGVLCYEFLVGLPPFESQS-- 226 (281)
T ss_pred CceeecCC----------CCceeeecccccCCHhhcCCCCccchhhHHH----------HHHHHHHHHhcCCchhhhh--
Confidence 99875432 2233578999999999999999999999999 8888999999999987333
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..+.-....+.+. ..++.++....++|.+|+.++|.+|.+..|+++.
T Consensus 227 ~~etYkrI~k~~~-------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 227 HSETYKRIRKVDL-------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hHHHHHHHHHccc-------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1111111111111 1224456678899999999999999999999875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=314.59 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=205.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
-+|++.+.||+|.||.|-+|+....|+.||||.++... +++.-.+++|++||+.++||||+.+|.+ |+..+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV-----FENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV-----FENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh-----hcCCce
Confidence 47999999999999999999998899999999997543 3334568999999999999999999999 555569
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
+.+||||..+|.|++|+.+.+ .+++.+++.+++||+.|+.|+|.. +++|||||.+|||+|+++.+||+|||
T Consensus 128 IvivMEYaS~GeLYDYiSer~------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFG 198 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERG------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFG 198 (668)
T ss_pred EEEEEEecCCccHHHHHHHhc------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccc
Confidence 999999999999999999876 799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
++-.+.+..+ .+.++|+|-|.+||++.|.+| .+.+|-|| .|+.+|.++.|..|+.-.+.
T Consensus 199 LSNly~~~kf---------LqTFCGSPLYASPEIvNG~PY~GPEVDsWs----------LGvLLYtLVyGtMPFDG~Dh- 258 (668)
T KOG0611|consen 199 LSNLYADKKF---------LQTFCGSPLYASPEIVNGTPYKGPEVDSWS----------LGVLLYTLVYGTMPFDGRDH- 258 (668)
T ss_pred hhhhhccccH---------HHHhcCCcccCCccccCCCCCCCCccchhh----------HHHHHHHHhhcccccCCchH-
Confidence 9987765432 345789999999999999887 47789888 88899999999999763321
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
..+..+.....+ . ... -+....-+|++|+..+|++|.|+++|....
T Consensus 259 -k~lvrQIs~GaY-r---EP~----~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 259 -KRLVRQISRGAY-R---EPE----TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -HHHHHHhhcccc-c---CCC----CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 112222211111 0 011 123345789999999999999999998764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=303.54 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=203.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.+.|++.+.||+|.|+.||++.+..+|+.+|+|.+... .....+++.+|++|.+.++||||+++.+.+.+. .+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~-----~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc-----ce
Confidence 45788999999999999999999999999999998643 233567899999999999999999999885544 48
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CCcEEEc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVC 684 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~ 684 (833)
.|+|+|+|+|++|..-|-.+. .+++..+-.+++||++||.|+|.. +|||||+||+|+++.. ...+||+
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~ 155 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLA 155 (355)
T ss_pred eEEEEecccchHHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeec
Confidence 999999999999987665543 689999999999999999999999 9999999999999953 3479999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+|..+.+.. ...+.+|||+|||||++...+|+..+|||+ -|+++|-++.|..|+.-.+
T Consensus 156 ~FGvAi~l~~g~---------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~----------cGViLfiLL~G~~PF~~~~ 216 (355)
T KOG0033|consen 156 DFGLAIEVNDGE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWA----------CGVILYILLVGYPPFWDED 216 (355)
T ss_pred ccceEEEeCCcc---------ccccccCCCcccCHHHhhcCCCCCcchhhh----------hhHHHHHHHhCCCCCCCcc
Confidence 999998776322 234578999999999999999999999999 7888999999999976322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. .++....+......+. ...+.+.++..+++.+|+..||++|.|+.|.++.
T Consensus 217 ~--~rlye~I~~g~yd~~~---~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 217 Q--HRLYEQIKAGAYDYPS---PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred H--HHHHHHHhccccCCCC---cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1 1121222222221111 1223345677899999999999999999998764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=315.19 Aligned_cols=269 Identities=26% Similarity=0.340 Sum_probs=194.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhh--cCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRN--IRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
......+.+|+|+||.||+|... ++.||||++.. ...+.+..|-+|++. ++|+||++++++-....- ....+
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~ey 283 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEY 283 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccce
Confidence 44566789999999999999994 68999999963 345678888887766 479999999987443321 24478
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC------CCCceeeCCCCCCeeecCCCcEE
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC------QPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
++|+||.+.|+|.+|++.+ .++|....+++.-+++||+|||+.. .|+|+|||||.+|||+..|+++.
T Consensus 284 wLVt~fh~kGsL~dyL~~n-------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc 356 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC 356 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence 9999999999999999986 6999999999999999999999764 57899999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCC------CCcccccccCCcCCCccccCCccHHHHHHH
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE------ASMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
|+|||+|..+..... .....+.+||.+|||||++.+.. .-.+.||||.|. ++||++.+
T Consensus 357 IaDFGLAl~~~p~~~------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgL----------VLWEi~SR 420 (534)
T KOG3653|consen 357 IADFGLALRLEPGKP------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGL----------VLWEIASR 420 (534)
T ss_pred eeccceeEEecCCCC------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHH----------HHHHHHhh
Confidence 999999998764332 22334578999999999987643 224578888444 44454443
Q ss_pred hCCCc---ccc---------cccccc--hhh-hccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 757 ALPEK---VME---------IVDPSL--LME-VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 757 ~~p~~---~~~---------~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
.--.. ..+ ..+|.+ +.+ ++.++....-...+.-......+.+.+..||.+||+.|.|+.=+.+++
T Consensus 421 C~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~ 500 (534)
T KOG3653|consen 421 CTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERM 500 (534)
T ss_pred cccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence 21110 000 001110 011 111110000001111123567789999999999999999999999998
Q ss_pred HHhhhhh
Q 040925 822 CHTRETF 828 (833)
Q Consensus 822 ~~i~~~~ 828 (833)
.++....
T Consensus 501 ~~l~~~~ 507 (534)
T KOG3653|consen 501 AELMMLW 507 (534)
T ss_pred HHHhccC
Confidence 8876544
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=344.66 Aligned_cols=268 Identities=21% Similarity=0.258 Sum_probs=213.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeE-eecCCCCC-Cce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITI-CSSTDFKG-TDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~-~~~~~~~~-~~~ 607 (833)
-++++.+.|.+|||+.||.|.+...+..||+|++-..++...+.+.+|+++|++|+ |||||.+++. .....-.+ .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 35778899999999999999999777999999997777777889999999999997 9999999993 22221122 346
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
+++.||||+||.|-|++..+... .+++.++++|++|+++|+++||.. +|+|||||||-|||||+.+|..||||||
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 88999999999999999876543 699999999999999999999998 7789999999999999999999999999
Q ss_pred cccccCcccc-cccccCCCccccccccccccCccc---cCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 688 LAKFLSDHQL-DTAVKTPSSSIGLKGTVGYVAPEY---GMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 688 ~a~~~~~~~~-~~~~~~~~~~~~~~gt~~y~aPE~---~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
.|........ ......-........|+.|+|||+ ..+.+.++|+|||+ .|+.+|.+.....|++..
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWA----------LGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWA----------LGCLLYKLCYFTTPFEES 261 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHH----------HHHHHHHHHHhCCCcCcC
Confidence 9874432211 000000001112357999999996 46778999999999 888899999888888632
Q ss_pred ---ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 764 ---EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 764 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.+++..+ .+ +..+.++..+.+||..||+.||++||++-||+..+.++...
T Consensus 262 g~laIlng~Y---------~~-----P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 262 GKLAILNGNY---------SF-----PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cceeEEeccc---------cC-----CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 2222222 11 12245788899999999999999999999999999998754
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=309.06 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=208.2
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
|.++.+||+|+||.||+|.++++|..||+|.+.. ..+.+++.+|+.+|+++++|+||++||.+.... ..|+||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-----DLWIVM 107 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-----DLWIVM 107 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCC-----ceEeeh
Confidence 6778899999999999999999999999999864 345678999999999999999999999864443 789999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
|||..|++.+++..+.. ++++.++..+++..++||+|||.. .-||||||..|||++.+|.+||+|||.|..+
T Consensus 108 EYCGAGSiSDI~R~R~K-----~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRK-----PLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQL 179 (502)
T ss_pred hhcCCCcHHHHHHHhcC-----CccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchh
Confidence 99999999999987653 799999999999999999999999 8999999999999999999999999999876
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.+.. .+...+.|||.|||||++..-.|+.++|||| .|.+..|++.|..|+........-++.
T Consensus 180 TDTM--------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWS----------LGITaIEMAEG~PPYsDIHPMRAIFMI 241 (502)
T KOG0574|consen 180 TDTM--------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWS----------LGITAIEMAEGRPPYSDIHPMRAIFMI 241 (502)
T ss_pred hhhH--------HhhCccccCcccccHHHHHHhccchhhhHhh----------hcchhhhhhcCCCCcccccccceeEec
Confidence 6533 2334578999999999999999999999999 788888999999887632222111110
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ..++.--..++..+..+.+++..|+.+.|++|-|+-++++.
T Consensus 242 ---P---T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 242 ---P---TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ---c---CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 0 01111223456778889999999999999999999998875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.54 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=201.3
Q ss_pred CCccCceeccCcceEEEEEEECCCc----eEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDE----MIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
+-...++||+|+||.||+|+.+..+ ..||||..+.. ......++.+|+++|++++|||||++||++....
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~--- 234 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE--- 234 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC---
Confidence 3445589999999999999986432 23899998752 2445678999999999999999999999987665
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
-+++|||+|+||+|.++++..+. .++..+...++.++|.||+|||++ ++|||||-.+|+|++.++.+||+
T Consensus 235 --Pl~ivmEl~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 235 --PLMLVMELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred --ccEEEEEecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence 78999999999999999998763 489999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+++.-......... ..-...|+|||.+....|++++||||+|+..|++|..|...|.-....
T Consensus 305 DFGLs~~~~~~~~~~~~--------~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------- 369 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKFL--------KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------- 369 (474)
T ss_pred ccccccCCcceeecccc--------ccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------
Confidence 99998754321111100 124578999999999999999999999999888888665322111000
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.....+..... ....+...+..+..++.+||..||++||||.++.+.++.+...
T Consensus 370 ----~v~~kI~~~~~-----r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 370 ----EVKAKIVKNGY-----RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred ----HHHHHHHhcCc-----cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 11111101111 0111223466788889999999999999999999999988754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=329.88 Aligned_cols=243 Identities=23% Similarity=0.273 Sum_probs=201.5
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCC
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIR-HRNLIKIITICSSTDF 602 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 602 (833)
....++|...++||+|+||+|++|..+.+++.||||++++. ..++.+....|.+|+.... ||.++.+++.+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f----- 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF----- 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----
Confidence 34456899999999999999999999999999999999865 3455677888999988885 99999999985
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
++..+.|+||||+.||++..+++.. .+++.+++.|+..|+.||.|||++ ||||||||.+|||+|.+|.+|
T Consensus 439 QT~~~l~fvmey~~Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~k 508 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVK 508 (694)
T ss_pred ccCCeEEEEEEecCCCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEE
Confidence 4455999999999999955544433 699999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc-
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK- 761 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~- 761 (833)
|+|||+++.-- .....+.+++|||.|||||++.+..|+.++|+|+ +|+.+|+|+.|..|+.
T Consensus 509 iADFGlcKe~m--------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~----------lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 509 IADFGLCKEGM--------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWG----------LGVLLYEMLVGESPFPG 570 (694)
T ss_pred ecccccccccC--------CCCCccccccCChhhcChhhhccCcccchhhHHH----------HHHHHHHHHcCCCCCCC
Confidence 99999998532 1233455689999999999999999999999999 8999999999999976
Q ss_pred --ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 762 --VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 762 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
..+..|.-...+. ..+..++.+...++.+++.++|++|-.+
T Consensus 571 ddEee~FdsI~~d~~------------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 571 DDEEEVFDSIVNDEV------------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCHHHHHHHHhcCCC------------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2222222221111 1233356778899999999999999855
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.57 Aligned_cols=251 Identities=19% Similarity=0.258 Sum_probs=200.2
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCCcc---hhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA---SRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
..||+|++|.||+|.+ +|+.||||+++...... .+.+.+|++++++++||||++++|++.+.. ++....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 6799999999999998 68899999997543322 467789999999999999999999986521 22346899999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
|+++|+|.+++...+ .+++..+..++.|++.|+.|||+.. +++||||||+||++++++.+||+|||+++...
T Consensus 103 y~~~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~ 174 (283)
T PHA02988 103 YCTRGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILS 174 (283)
T ss_pred eCCCCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence 999999999998654 6889999999999999999999742 78899999999999999999999999998654
Q ss_pred cccccccccCCCccccccccccccCccccCC--CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccch
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~ 771 (833)
.... ...||+.|+|||++.+ ..++.++|||| +|+++|+++++..|+..... ....
T Consensus 175 ~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~k~Di~S----------lGvil~el~~g~~Pf~~~~~--~~~~ 231 (283)
T PHA02988 175 SPPF-----------KNVNFMVYFSYKMLNDIFSEYTIKDDIYS----------LGVVLWEIFTGKIPFENLTT--KEIY 231 (283)
T ss_pred cccc-----------cccCcccccCHHHhhhccccccchhhhhH----------HHHHHHHHHHCCCCCCCCCH--HHHH
Confidence 3211 2358999999999876 67999999999 88899999999988763221 1111
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
........ ....+..+++.+.+++.+||+.||++|||++|+++.|+..+.
T Consensus 232 ~~i~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 232 DLIINKNN-----SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHHhcCC-----CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 11111111 011122457789999999999999999999999999998764
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=328.09 Aligned_cols=243 Identities=23% Similarity=0.258 Sum_probs=194.0
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++...+ ..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHD-----RLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCC-----EEEEEEe
Confidence 47999999999999999999999999997432 223456788999999999999999999876554 8999999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
|+++|+|.+++.... .+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~ 146 (323)
T cd05571 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccc
Confidence 999999999997654 689999999999999999999999 99999999999999999999999999987532
Q ss_pred cccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhh
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLME 773 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~ 773 (833)
... .......||+.|+|||++.+..++.++|||| .|+++++++++..|+...+.. .....
T Consensus 147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lG~il~elltg~~Pf~~~~~~--~~~~~ 206 (323)
T cd05571 147 SDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG----------LGVVMYEMMCGRLPFYNQDHE--KLFEL 206 (323)
T ss_pred cCC--------CcccceecCccccChhhhcCCCCCccccCcc----------cchhhhhhhcCCCCCCCCCHH--HHHHH
Confidence 211 1122356999999999999999999999999 778888888888886422110 00000
Q ss_pred hccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 774 VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
..... ...+...+..+.+++.+||+.||++|| ++.++++.
T Consensus 207 ~~~~~-------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 207 ILMEE-------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHcCC-------CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11110 011223456788999999999999999 79988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=312.02 Aligned_cols=271 Identities=25% Similarity=0.348 Sum_probs=206.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc--CCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI--RHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~ 607 (833)
..+....+.||+|.||+||+|.++ |+.||||+|. ..+.+.+.+|.+|++.. +|+||+.+++.-..+. ..-..
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~---srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQ 283 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFS---SRDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQ 283 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEec---ccchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEE
Confidence 346778899999999999999996 7889999995 34567889999999885 9999999988643332 22346
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCceeeCCCCCCeeecCCCcEE
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC-----QPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
.|+|++|.+.|||+||+... .++....++++..+|.||++||... .|.|+|||||+.|||+.+++++.
T Consensus 284 LwLvTdYHe~GSL~DyL~r~-------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~ 356 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN-------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC 356 (513)
T ss_pred EEEeeecccCCcHHHHHhhc-------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE
Confidence 89999999999999999975 6899999999999999999999653 68999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCC------CCcccccccCCcCCCccccCCccHHHHHHH
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE------ASMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
|+|+|+|.........- .......+||.+|||||++.... .-..+|||| +|.++||++.+
T Consensus 357 IADLGLAv~h~~~t~~i----di~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa----------fgLVlWEiarR 422 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTI----DIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA----------FGLVLWEIARR 422 (513)
T ss_pred EeeceeeEEecccCCcc----cCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH----------HHHHHHHHHHH
Confidence 99999998765543211 12233468999999999875432 124578888 55555555554
Q ss_pred hC----------CCcccccccccc---hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 757 AL----------PEKVMEIVDPSL---LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 757 ~~----------p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
.. |+...-..||.+ ..-+...........++...++...+.++|..||..+|+.|-|+-.|-+.+.+
T Consensus 423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 32 222111122222 11112222333445567778899999999999999999999999999999999
Q ss_pred hhhh
Q 040925 824 TRET 827 (833)
Q Consensus 824 i~~~ 827 (833)
+.+.
T Consensus 503 l~~~ 506 (513)
T KOG2052|consen 503 LSNS 506 (513)
T ss_pred HhcC
Confidence 8854
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=329.45 Aligned_cols=254 Identities=20% Similarity=0.233 Sum_probs=201.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+++++.++||||+++++++...+ .
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE-----Y 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC-----E
Confidence 47999999999999999999999899999999997432 223456889999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg 146 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFG 146 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCc
Confidence 999999999999999997654 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++..... ......||+.|+|||++.+..++.++|||| .|+++++++++..|+......+
T Consensus 147 ~a~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws----------lG~il~ell~g~~pf~~~~~~~ 205 (333)
T cd05600 147 LSKGIVT-----------YANSVVGSPDYMAPEVLRGKGYDFTVDYWS----------LGCMLYEFLCGFPPFSGSTPNE 205 (333)
T ss_pred CCccccc-----------ccCCcccCccccChhHhcCCCCCCccceec----------chHHHhhhhhCCCCCCCCCHHH
Confidence 9975533 112346999999999999999999999999 7888888888888875322111
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
............ ..+........++..+.+++.+||..+|++||+++|+++.
T Consensus 206 ~~~~i~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 206 TWENLKYWKETL-QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHhccccc-cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000000000 0000000011345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=338.84 Aligned_cols=366 Identities=25% Similarity=0.403 Sum_probs=268.6
Q ss_pred cEEEcCCCcCc-ccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 2 QTLAVNDNYLT-GQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 2 ~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
+-.|+++|..+ +-+|.....++.++-|.|...++ ..+|+.++.+.+|+.|.+++|++. .+-+.+..|+.|+.+++..
T Consensus 10 rGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L-~~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~ 87 (1255)
T KOG0444|consen 10 RGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKL-EQVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRD 87 (1255)
T ss_pred ecccccCCcCCCCcCchhHHHhhheeEEEechhhh-hhChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhc
Confidence 34678888887 57788888888888888888888 678888888888888888888887 5566788888888888888
Q ss_pred cccc-cccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCC
Q 040925 81 NRFS-GNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTG 159 (833)
Q Consensus 81 N~l~-~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 159 (833)
|++. +.||.++| .+..|++|+||+|+++ ..|..+..-+++-+|+||+|+|..|+...|-+|+.|-.|+||+|++..+
T Consensus 88 N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~L 165 (1255)
T KOG0444|consen 88 NNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEML 165 (1255)
T ss_pred cccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhc
Confidence 8875 34788887 6888888888888887 6788888888888888888888888888888888888888888888765
Q ss_pred CCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCccc-cc
Q 040925 160 TATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLH-GT 238 (833)
Q Consensus 160 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~ 238 (833)
|+ .+..|..|++|+|++|.+. .+++ ..+-.+++|+.|.+++.+=+ .-
T Consensus 166 PP-------Q~RRL~~LqtL~Ls~NPL~------hfQL-------------------rQLPsmtsL~vLhms~TqRTl~N 213 (1255)
T KOG0444|consen 166 PP-------QIRRLSMLQTLKLSNNPLN------HFQL-------------------RQLPSMTSLSVLHMSNTQRTLDN 213 (1255)
T ss_pred CH-------HHHHHhhhhhhhcCCChhh------HHHH-------------------hcCccchhhhhhhcccccchhhc
Confidence 54 3667778888888888764 1111 12334556667777765532 34
Q ss_pred CCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccc
Q 040925 239 IPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSI 318 (833)
Q Consensus 239 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 318 (833)
+|.++.++.+|..+|||.|.+. +.|+.+.++.+|+.|+||+|+|+ .+........+|++|+||.|+++ .+|..++.+
T Consensus 214 ~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL 290 (1255)
T KOG0444|consen 214 IPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKL 290 (1255)
T ss_pred CCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhh
Confidence 6777777777777788777777 67777777777777777777777 44444555667777777777777 677777777
Q ss_pred cccceeeecCCCccCC-CCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeE
Q 040925 319 TTLSLYLDLSNNLLNG-SLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKEL 397 (833)
Q Consensus 319 ~~ll~~L~ls~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 397 (833)
+.+ +.|++.+|+++- -+|..++.|.+|+++..++|.+. ..|..++.|..|+.|.|++|++- ..|+++.-++.|+.|
T Consensus 291 ~kL-~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vL 367 (1255)
T KOG0444|consen 291 TKL-TKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVL 367 (1255)
T ss_pred HHH-HHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCccee
Confidence 666 456666666652 25677777777777777777776 67777777777777777777776 566677777777777
Q ss_pred EccCcccCCCch
Q 040925 398 NVSSNNLSGQIP 409 (833)
Q Consensus 398 ~l~~N~l~~~~p 409 (833)
|+.+|.-.-.+|
T Consensus 368 DlreNpnLVMPP 379 (1255)
T KOG0444|consen 368 DLRENPNLVMPP 379 (1255)
T ss_pred eccCCcCccCCC
Confidence 777776543343
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=328.18 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=201.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||.||+|++..++..||+|.++.... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----EE
Confidence 3689999999999999999999999999999999975432 23467899999999999999999999976554 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 150 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGV 150 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcc
Confidence 99999999999999997654 6889999999999999999999862 699999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc--
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV-- 766 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~-- 766 (833)
+....... .....||+.|+|||++.+..++.++|||| +|+++++++++..|+...+..
T Consensus 151 ~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~tg~~p~~~~~~~~~ 210 (331)
T cd06649 151 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWS----------MGLSLVELAIGRYPIPPPDAKEL 210 (331)
T ss_pred cccccccc----------cccCCCCcCcCCHhHhcCCCCCchHhHHH----------HHHHHHHHHhCCCCCCCCCHHHH
Confidence 87653321 12246999999999999999999999999 778888888888876421110
Q ss_pred ----cccch-------hhhcc----------------cc----------chhhhhhhhchHHHHHHHHHHhhccCCCCCC
Q 040925 767 ----DPSLL-------MEVMT----------------NN----------SMIQEDKRVKTEECLNAIIRTGVLCSMESPF 809 (833)
Q Consensus 767 ----~~~~~-------~~~~~----------------~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 809 (833)
..... ..... .. .............++..+.+++.+||+.||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~ 290 (331)
T cd06649 211 EAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPA 290 (331)
T ss_pred HHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcc
Confidence 00000 00000 00 0000000000112456789999999999999
Q ss_pred CCCCHHHHHHH
Q 040925 810 ERMDMRDVVAK 820 (833)
Q Consensus 810 ~RPt~~eil~~ 820 (833)
+|||++|+++.
T Consensus 291 ~Rpt~~ell~h 301 (331)
T cd06649 291 ERADLKMLMNH 301 (331)
T ss_pred cCCCHHHHhcC
Confidence 99999999876
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=325.48 Aligned_cols=268 Identities=22% Similarity=0.327 Sum_probs=196.8
Q ss_pred hcCCccCceeccCcceEEEEEEECC----------------CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGE----------------DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIK 592 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 592 (833)
.++|++.+.||+|+||.||+|.+.. ++..||+|.++.... .....+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3579999999999999999998632 345799999875432 23457899999999999999999
Q ss_pred EeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCc-------------cccccCCHHHHHHHHHHHHHHHHHHhhcC
Q 040925 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ-------------VEVCKLSLIQRVNIAIDVASAMEYLHHHC 659 (833)
Q Consensus 593 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~ 659 (833)
+++++...+ ..++||||+++|+|.+++...... .....+++..+++++.|++.||+|||+.
T Consensus 84 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~- 157 (304)
T cd05096 84 LLGVCVDED-----PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL- 157 (304)
T ss_pred EEEEEecCC-----ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-
Confidence 999976554 789999999999999998653211 0112478889999999999999999999
Q ss_pred CCCceeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcC
Q 040925 660 QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRP 739 (833)
Q Consensus 660 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~ 739 (833)
+|+||||||+||+++.++.+||+|||+++......... ......++..|||||++.+..++.++||||
T Consensus 158 --~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s---- 225 (304)
T cd05096 158 --NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR------IQGRAVLPIRWMAWECILMGKFTTASDVWA---- 225 (304)
T ss_pred --CccccCcchhheEEcCCccEEECCCccceecccCceeE------ecCcCCCCccccCHHHHhcCCCCchhhhHH----
Confidence 99999999999999999999999999998654322111 111234688999999998888999999999
Q ss_pred CCccccCCccHHHHHHH--hCCCcccccccccchhhhccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHH
Q 040925 740 IDAVFNEGHSLHEFAKT--ALPEKVMEIVDPSLLMEVMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRD 816 (833)
Q Consensus 740 ~~~~~~~g~~l~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 816 (833)
+|+++++++++ ..|+.... +............ .........+..++..+.+++.+||..||++|||++|
T Consensus 226 ------lG~~l~el~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~ 297 (304)
T cd05096 226 ------FGVTLWEILMLCKEQPYGELT--DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD 297 (304)
T ss_pred ------HHHHHHHHHHccCCCCCCcCC--HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 77777777653 33332111 1111100000000 0000000112235678899999999999999999999
Q ss_pred HHHHHHH
Q 040925 817 VVAKLCH 823 (833)
Q Consensus 817 il~~L~~ 823 (833)
|.+.|++
T Consensus 298 i~~~l~~ 304 (304)
T cd05096 298 IHAFLTE 304 (304)
T ss_pred HHHHHhC
Confidence 9988763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=307.97 Aligned_cols=276 Identities=22% Similarity=0.311 Sum_probs=202.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCc-cceEeeEeecCC-CCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRN-LIKIITICSSTD-FKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-~~~~ 605 (833)
...|..+++||+|+||+||+|+.+.+|+.||+|+++...+ +......+|+.++++++|+| |+.+++++.... +...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4467788899999999999999999999999999986644 35677899999999999999 999999987654 2334
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||++. +|.+++....... ..++...++.+++|++.||+|||++ +|+||||||+||+++++|.+||+|
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaD 163 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLAD 163 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeec
Confidence 478899999975 9999999866321 2577789999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccC-----CccHHHHHHH---
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNE-----GHSLHEFAKT--- 756 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~-----g~~l~~~~~~--- 756 (833)
||+|+...-+.. ..+..++|.+|+|||++.+. .|++..||||.||.|.+|+.. |..-.+....
T Consensus 164 FGlAra~~ip~~--------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~ 235 (323)
T KOG0594|consen 164 FGLARAFSIPMR--------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFR 235 (323)
T ss_pred cchHHHhcCCcc--------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHH
Confidence 999996553321 12345799999999999887 699999999988887776542 2111111111
Q ss_pred --hCC-Ccccccc--cccchhhhccccchhhhhhhhchHH---HHHHHHHHhhccCCCCCCCCCCHHHHHHH--HHHh
Q 040925 757 --ALP-EKVMEIV--DPSLLMEVMTNNSMIQEDKRVKTEE---CLNAIIRTGVLCSMESPFERMDMRDVVAK--LCHT 824 (833)
Q Consensus 757 --~~p-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~i 824 (833)
..| ...++.+ -+.+...+ ... ...+..... ......+++.+|++.+|++|.|++.++++ +..+
T Consensus 236 ~lGtP~e~~Wp~v~~~~~~k~~f--~~~---~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 236 LLGTPNEKDWPGVSSLPDYKAPF--PKW---PGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred HcCCCCccCCCCccccccccccC--cCC---CCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 011 1111100 01110000 000 001111111 11367899999999999999999999886 4444
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=321.44 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=199.4
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.|+..+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|++++++++|++|+++++++...+ ..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~-----~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKD-----AL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCC-----eE
Confidence 3778899999999999999999899999999986432 122345788999999999999999999875544 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++...... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~ 148 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNP----GFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999888654321 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc-
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD- 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~- 767 (833)
+........ .....||+.|+|||++.+..++.++|||| .|+++++++++..|+.......
T Consensus 149 ~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~Dvws----------lGvil~el~~g~~pf~~~~~~~~ 209 (285)
T cd05631 149 AVQIPEGET---------VRGRVGTVGYMAPEVINNEKYTFSPDWWG----------LGCLIYEMIQGQSPFRKRKERVK 209 (285)
T ss_pred cEEcCCCCe---------ecCCCCCCCccCHhhhcCCCCCcccCchh----------HHHHHHHHHhCCCCCCCCCcchh
Confidence 976533211 12346999999999999999999999999 8889999999999876322110
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
......... ......+..++..+.+++.+||+.||++||+ ++++++.
T Consensus 210 ~~~~~~~~~------~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 210 REEVDRRVK------EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred HHHHHHHhh------cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 000000000 0011122335667889999999999999997 7888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=294.36 Aligned_cols=254 Identities=24% Similarity=0.308 Sum_probs=207.0
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--------chhHHHHHHHHHhhc-CCCccceEeeEee
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--------ASRSFVAECEALRNI-RHRNLIKIITICS 598 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 598 (833)
...+.|...+.+|.|..+.|-++.++.+|..+|+|++...... ..+...+|+.|++++ .||+|+++.+++.
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4456788899999999999999999999999999999643221 124567899999998 5999999999976
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
++. +.++|+|.|+.|.|.|++...- .+++.+.++|++|+.+|++|||.. .||||||||+|||++++
T Consensus 94 s~s-----F~FlVFdl~prGELFDyLts~V------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn 159 (411)
T KOG0599|consen 94 SDA-----FVFLVFDLMPRGELFDYLTSKV------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDN 159 (411)
T ss_pred Ccc-----hhhhhhhhcccchHHHHhhhhe------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccc
Confidence 655 8999999999999999998754 799999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccC------CCCCCcccccccCCcCCCccccCCccHHH
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM------GSEASMTGDIFTGRRPIDAVFNEGHSLHE 752 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~s~~~~~~~~~~~g~~l~~ 752 (833)
.++||+|||+|+.+.... +....+|||+|.|||.+. ...|+..+|+|+ .|+++|.
T Consensus 160 ~~i~isDFGFa~~l~~Ge---------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa----------~GVImyT 220 (411)
T KOG0599|consen 160 MNIKISDFGFACQLEPGE---------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWA----------CGVIMYT 220 (411)
T ss_pred cceEEeccceeeccCCch---------hHHHhcCCCcccChhheeeecccCCCCccchhhHHH----------HHHHHHH
Confidence 999999999999776533 233568999999999754 345888899998 7888888
Q ss_pred HHHHhCCCccc-ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 753 FAKTALPEKVM-EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 753 ~~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++.|..|++-. +.+--++ .+..... ...+..++......++|.+|++.||.+|.|++|.++.
T Consensus 221 LLaGcpPFwHRkQmlMLR~---ImeGkyq---F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 221 LLAGCPPFWHRKQMLMLRM---IMEGKYQ---FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHcCCCchhHHHHHHHHHH---HHhcccc---cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 88898887622 2221111 1222221 1223446678889999999999999999999999876
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=323.27 Aligned_cols=245 Identities=26% Similarity=0.357 Sum_probs=200.6
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
|.-.+.||.|+||.||-|++..+.+.||||++.-..+. ...++.+|++.|++++|||+|.+.|+|.-.. ..|
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~-----TaW 102 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH-----TAW 102 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc-----hHH
Confidence 55668999999999999999999999999999644332 3468999999999999999999999865443 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+|||||- |+-.|++.-.+. ++.+.++..|+.+.+.||+|||+. +.||||||..|||+++.|.|||+|||.|
T Consensus 103 LVMEYCl-GSAsDlleVhkK-----plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSA 173 (948)
T KOG0577|consen 103 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSA 173 (948)
T ss_pred HHHHHHh-ccHHHHHHHHhc-----cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccch
Confidence 9999996 588888876653 688999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
..+.+.. +++|||+|||||++. .+.|+-++|||| .|++..+++....|..-+...
T Consensus 174 si~~PAn------------sFvGTPywMAPEVILAMDEGqYdgkvDvWS----------LGITCIELAERkPPlFnMNAM 231 (948)
T KOG0577|consen 174 SIMAPAN------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWS----------LGITCIELAERKPPLFNMNAM 231 (948)
T ss_pred hhcCchh------------cccCCccccchhHheeccccccCCccceee----------ccchhhhhhhcCCCccCchHH
Confidence 8765432 478999999999865 467999999999 888888888888775533322
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. ...+..+ ..+.....+.+..+..++..|+.+-|.+|||.+++++.
T Consensus 232 SA--LYHIAQN-----esPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 232 SA--LYHIAQN-----ESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HH--HHHHHhc-----CCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11 1122222 12233355677889999999999999999999998875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=325.39 Aligned_cols=246 Identities=23% Similarity=0.263 Sum_probs=199.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++.+. ..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-----RF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-----Ce
Confidence 47899999999999999999999899999999996432 12345688999999999999999999885443 48
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++...+ .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg 146 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFG 146 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecC
Confidence 999999999999999997654 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+++...... ....||+.|+|||++.+..++.++|||| +|+++++++++..|+.....
T Consensus 147 ~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lG~il~~l~~g~~pf~~~~~-- 203 (291)
T cd05612 147 FAKKLRDRT-----------WTLCGTPEYLAPEVIQSKGHNKAVDWWA----------LGILIYEMLVGYPPFFDDNP-- 203 (291)
T ss_pred cchhccCCc-----------ccccCChhhcCHHHHcCCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCH--
Confidence 998653311 1246999999999999989999999999 88889999999888753211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
............ ..+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 204 ~~~~~~i~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 204 FGIYEKILAGKL-------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred HHHHHHHHhCCc-------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111111111111 111223557889999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=328.93 Aligned_cols=247 Identities=22% Similarity=0.252 Sum_probs=199.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++...+
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN----- 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC-----
Confidence 357999999999999999999999999999999996432 223457889999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Df 162 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDF 162 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeec
Confidence 8999999999999999998654 688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++...... ....||+.|+|||++.+..++.++|||| +|+++|+++++..|+......
T Consensus 163 g~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~elltg~~pf~~~~~~ 221 (329)
T PTZ00263 163 GFAKKVPDRT-----------FTLCGTPEYLAPEVIQSKGHGKAVDWWT----------MGVLLYEFIAGYPPFFDDTPF 221 (329)
T ss_pred cCceEcCCCc-----------ceecCChhhcCHHHHcCCCCCCcceeec----------hHHHHHHHHcCCCCCCCCCHH
Confidence 9998654321 1246999999999999999999999999 888899999998887522111
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
........... ..+..+...+.+++.+||+.||++||+ ++++++.
T Consensus 222 --~~~~~i~~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 222 --RIYEKILAGRL-------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --HHHHHHhcCCc-------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00011111100 011123456789999999999999997 6777654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=332.60 Aligned_cols=258 Identities=26% Similarity=0.421 Sum_probs=210.9
Q ss_pred CccCceeccCcceEEEEEEECCCc---eEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDE---MIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
..+.++||.|.||+||+|+.+..+ ..||||.++....+ ...+|..|+.||.++.||||+++.|+..... -.
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~-----Pv 705 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK-----PV 705 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc-----ee
Confidence 457799999999999999987555 57999999877543 4578999999999999999999999976554 78
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
+||+|||++|+|+.++..+.+ .+++.+...++++|+.|++||-+. ++|||||..+|||++.+..+|++|||+
T Consensus 706 MIiTEyMENGsLDsFLR~~DG-----qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 706 MIITEYMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred EEEhhhhhCCcHHHHHhhcCC-----ceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999998775 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCcc-HHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHS-LHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~-l~~~~~~~~p~~~~~~~~ 767 (833)
++.+.++.. ....+. +-.-..+|.|||.+...+++.++||||.|+.+|++.+.|.- +|+|..+++-..+ .
T Consensus 778 SRvledd~~-~~ytt~----GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI----e 848 (996)
T KOG0196|consen 778 SRVLEDDPE-AAYTTL----GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI----E 848 (996)
T ss_pred eeecccCCC-cccccc----CCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH----H
Confidence 998765441 111111 11124689999999999999999999999999999888753 3333322221111 0
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
..+ .-+.+-+|+..+.+||..||++|-.+||.+.||+..|.++.+
T Consensus 849 ~gy--------------RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 849 QGY--------------RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred hcc--------------CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 000 123456789999999999999999999999999999998865
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=326.47 Aligned_cols=253 Identities=21% Similarity=0.319 Sum_probs=209.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
+.|.++..||.|+||.||+|..++++...|-|++........+++.-|++||+.++||+||++++.|+..+ ..|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-----kLwi 106 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-----KLWI 106 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-----ceEE
Confidence 34677789999999999999999999899999998777778889999999999999999999999865444 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
+.|||.||....++-.-+. .+++.++..+++|++.||.|||+. .|||||||..|||++-+|.++|+|||.+.
T Consensus 107 liEFC~GGAVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSA 178 (1187)
T KOG0579|consen 107 LIEFCGGGAVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSA 178 (1187)
T ss_pred EEeecCCchHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccc
Confidence 9999999999998887653 799999999999999999999999 99999999999999999999999999886
Q ss_pred ccCcccccccccCCCccccccccccccCcccc-----CCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYG-----MGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
.... +..+..++.|||+|||||+. .+.+|++++|||| +|+++.+|+....|......
T Consensus 179 Kn~~--------t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWS----------lGITLIEMAqiEPPHhelnp 240 (1187)
T KOG0579|consen 179 KNKS--------TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWS----------LGITLIEMAQIEPPHHELNP 240 (1187)
T ss_pred cchh--------HHhhhccccCCcccccchheeeccccCCCchhhhhHHh----------hhhHHHHHhccCCCccccch
Confidence 4332 23344568899999999974 4678999999999 89999999999988763322
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
...-+ .+.+. .+.--..+......+.+++.+|+.+||..||++.++++.
T Consensus 241 MRVll--KiaKS----ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 241 MRVLL--KIAKS----EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred HHHHH--HHhhc----CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 21111 11111 111223455567789999999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=350.80 Aligned_cols=268 Identities=25% Similarity=0.392 Sum_probs=209.1
Q ss_pred CCccCceeccCcceEEEEEEECCCc-----eEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDE-----MIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.-+..+.||+|+||.||+|...+.. ..||||.++... .+...+|.+|..+|++++|||||+++|+|.+..
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~---- 768 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG---- 768 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC----
Confidence 4456689999999999999986432 348999997553 345678999999999999999999999996644
Q ss_pred ceEeEEEEecCCCChhhhhccCCCc-cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQ-VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..++++|||++|+|..+|.+.+.. .....++..+.+.++.|||+|+.||+++ ++|||||..+|+|++....|||+
T Consensus 769 -~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIa 844 (1025)
T KOG1095|consen 769 -PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIA 844 (1025)
T ss_pred -CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEc
Confidence 789999999999999999986322 1123688999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+|+.+-...+...... -.-...|||||.+..+.++.|+||||+|+..||++++|.+.|. ...
T Consensus 845 DFGlArDiy~~~yyr~~~~------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~---------~~~ 909 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGE------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYP---------SRS 909 (1025)
T ss_pred ccchhHhhhhchheeccCc------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCC---------Ccc
Confidence 9999995544332221100 1234689999999999999999999977777777776654332 111
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
..+....+... ..-..+..|+..+.++|..||+.+|++||++..|++++..+.....+
T Consensus 910 --n~~v~~~~~~g------gRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 910 --NFEVLLDVLEG------GRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred --hHHHHHHHHhC------CccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 01111111111 12234667899999999999999999999999999999998876654
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.16 Aligned_cols=258 Identities=21% Similarity=0.285 Sum_probs=196.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.++++++||||+++++++...+ ..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRG-----KL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCC-----EE
Confidence 47999999999999999999999999999999997542 223467889999999999999999999875544 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++++.+..+..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~ 146 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPN------GVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGF 146 (287)
T ss_pred EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccC
Confidence 99999999877765543322 588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+........ .......||+.|+|||++.+..++.++|||| .|++++++.++..|+......+.
T Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws----------lGvil~el~~g~~pf~~~~~~~~ 209 (287)
T cd07848 147 ARNLSEGSN-------ANYTEYVATRWYRSPELLLGAPYGKAVDMWS----------VGCILGELSDGQPLFPGESEIDQ 209 (287)
T ss_pred ccccccccc-------ccccccccccccCCcHHHcCCCCCCchhHHh----------HHHHHHHHHhCCCCCCCCCHHHH
Confidence 986543211 1112346899999999999989999999999 77778888888776642211110
Q ss_pred cchhh-------------hccc------cch----hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 769 SLLME-------------VMTN------NSM----IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 769 ~~~~~-------------~~~~------~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
..... .... ... ............+..+.+++.+||++||++|||++|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 210 LFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0000 000 000000111224567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.06 Aligned_cols=257 Identities=22% Similarity=0.323 Sum_probs=199.8
Q ss_pred hcCCccCceeccCcceEEEEEEEC---CCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
..+|++.+.||+|+||.||+|.+. ..+..||+|.++.... ...+.+.+|+..+++++||||+++++++...+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 79 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN---- 79 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC----
Confidence 357899999999999999999874 3567899999975432 23457889999999999999999999976544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+|++|
T Consensus 80 -~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~d 150 (266)
T cd05064 80 -TMMIVTEYMSNGALDSFLRKHEG-----QLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISG 150 (266)
T ss_pred -CcEEEEEeCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECC
Confidence 78999999999999999976432 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||.+......... ......++..|+|||++.+..++.++|||| +|++++++++ +..|+....
T Consensus 151 fg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 151 FRRLQEDKSEAIY-------TTMSGKSPVLWAAPEAIQYHHFSSASDVWS----------FGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred Ccccccccccchh-------cccCCCCceeecCHHHHhhCCccchhHHHH----------HHHHHHHHhcCCCCCcCcCC
Confidence 9987653222110 011223567899999999999999999999 7777777654 666654221
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
. ...... +.... ....+..++..+.+++.+||+.+|++|||++||.+.|.++
T Consensus 214 ~--~~~~~~-~~~~~-----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 214 G--QDVIKA-VEDGF-----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred H--HHHHHH-HHCCC-----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 111111 11110 0112334677889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=322.55 Aligned_cols=243 Identities=23% Similarity=0.278 Sum_probs=194.9
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|+++++.++||||+++++++...+ ..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKD-----RLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----EEEEEEe
Confidence 46999999999999999999999999997432 233457788999999999999999999865554 8999999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
|+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 y~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 76 YVNGGELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred CCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 999999999987654 689999999999999999999999 99999999999999999999999999987532
Q ss_pred cccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhh
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLME 773 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~ 773 (833)
... .......||+.|+|||++.+..++.++|||| .|+++++++++..|+...... .....
T Consensus 147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lGvil~elltG~~Pf~~~~~~--~~~~~ 206 (328)
T cd05593 147 TDA--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG----------LGVVMYEMMCGRLPFYNQDHE--KLFEL 206 (328)
T ss_pred Ccc--------cccccccCCcCccChhhhcCCCCCccCCccc----------cchHHHHHhhCCCCCCCCCHH--HHHHH
Confidence 211 1112356999999999999989999999999 888899999999887532110 11111
Q ss_pred hccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 774 VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
...... ..+...+..+.+++.+||..||++|| ++.|+++.
T Consensus 207 ~~~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 207 ILMEDI-------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred hccCCc-------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 111100 11223456788999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=326.15 Aligned_cols=264 Identities=23% Similarity=0.266 Sum_probs=197.5
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|++++++++||||+++++++...........|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5889999999999999999999999999999986432 22345688999999999999999999988655434445689
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~ 150 (338)
T cd07859 81 VVFELME-SDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLA 150 (338)
T ss_pred EEEecCC-CCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccc
Confidence 9999995 69999987654 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCC--CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+......... .......||+.|+|||++.+ ..++.++|||| +|+++++++++..|+.......
T Consensus 151 ~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwS----------lGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 151 RVAFNDTPTA-----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS----------IGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred cccccccCcc-----ccccCCCCCCCcCCHHHHhccccccCchhHHHH----------HHHHHHHHHcCCCCCCCCChHH
Confidence 8643321111 11123569999999998765 67899999999 7777888888877664221100
Q ss_pred c-------------cchh--------hhccccchhhh-hhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 P-------------SLLM--------EVMTNNSMIQE-DKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~-------------~~~~--------~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. .... ..........+ .........+..+.+++.+||..||++|||++|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 0000 00000000000 0000011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=322.83 Aligned_cols=243 Identities=23% Similarity=0.269 Sum_probs=194.3
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++...+ ..|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD-----RLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----EEEEEEe
Confidence 47999999999999999899999999997432 223456778999999999999999999876544 8999999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
|+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 146 (323)
T cd05595 76 YANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 146 (323)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhcccc
Confidence 999999999887654 689999999999999999999999 99999999999999999999999999987532
Q ss_pred cccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhh
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLME 773 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~ 773 (833)
... .......||+.|+|||++.+..++.++|||| +|+++|+++++..|+...+.. .....
T Consensus 147 ~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lGvil~ell~g~~Pf~~~~~~--~~~~~ 206 (323)
T cd05595 147 SDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG----------LGVVMYEMMCGRLPFYNQDHE--RLFEL 206 (323)
T ss_pred CCC--------CccccccCCcCcCCcccccCCCCCchhchhh----------hHHHHHHHHhCCCCCCCCCHH--HHHHH
Confidence 211 1112356999999999999999999999999 888999999999887522110 11111
Q ss_pred hccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 774 VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
...... ..+..+++.+.+++.+||..||++|| ++.++++.
T Consensus 207 ~~~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 207 ILMEEI-------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HhcCCC-------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 111110 01223456788999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.79 Aligned_cols=248 Identities=22% Similarity=0.261 Sum_probs=199.0
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCc-eEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDE-MIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+++++.++||||+++++++....
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~--- 104 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES--- 104 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC---
Confidence 3457999999999999999999876554 789999986432 233457889999999999999999999976554
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+
T Consensus 105 --~~~lv~Ey~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~ 173 (340)
T PTZ00426 105 --YLYLVLEFVIGGEFFTFLRRNK------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMT 173 (340)
T ss_pred --EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEe
Confidence 8999999999999999998654 689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+++...... ....||+.|||||++.+..++.++|||| .|+++|++++|..|+...+
T Consensus 174 DFG~a~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lGvil~ell~G~~Pf~~~~ 232 (340)
T PTZ00426 174 DFGFAKVVDTRT-----------YTLCGTPEYIAPEILLNVGHGKAADWWT----------LGIFIYEILVGCPPFYANE 232 (340)
T ss_pred cCCCCeecCCCc-----------ceecCChhhcCHHHHhCCCCCccccccc----------hhhHHHHHhcCCCCCCCCC
Confidence 999998653311 1346999999999999888999999999 8889999999998876322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
.. ........... ..+...++.+.+++.+|++.||++|+ |++++++.
T Consensus 233 ~~--~~~~~i~~~~~-------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 233 PL--LIYQKILEGII-------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred HH--HHHHHHhcCCC-------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 10 01111111110 01122345678999999999999995 88888765
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=323.13 Aligned_cols=258 Identities=23% Similarity=0.351 Sum_probs=198.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||.||+|++..++..||+|.++.... .....+.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC-----EE
Confidence 3689999999999999999999998999999999875432 23457899999999999999999999986654 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~ 150 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 150 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCc
Confidence 99999999999999997654 5889999999999999999999752 799999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+....... .....||+.|+|||++.+..++.++|||| +|++++++.++..|+......+-
T Consensus 151 ~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws----------lG~il~~l~~g~~p~~~~~~~~~ 210 (333)
T cd06650 151 SGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWS----------MGLSLVEMAIGRYPIPPPDAKEL 210 (333)
T ss_pred chhhhhhc----------cccCCCCccccCHHHhcCCCCCcHHHHHH----------HHHHHHHHHHCCCCCCCcchhHH
Confidence 87553321 11245899999999999988999999999 77778888887777542110000
Q ss_pred cc------hhhh-----------cc--------ccc------------hhhhhhhhchHHHHHHHHHHhhccCCCCCCCC
Q 040925 769 SL------LMEV-----------MT--------NNS------------MIQEDKRVKTEECLNAIIRTGVLCSMESPFER 811 (833)
Q Consensus 769 ~~------~~~~-----------~~--------~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 811 (833)
.. .... .. ... ............++.++.+++.+||+.||++|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R 290 (333)
T cd06650 211 ELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAER 290 (333)
T ss_pred HHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccC
Confidence 00 0000 00 000 00000000001134568899999999999999
Q ss_pred CCHHHHHHH
Q 040925 812 MDMRDVVAK 820 (833)
Q Consensus 812 Pt~~eil~~ 820 (833)
||++|+++.
T Consensus 291 pt~~ell~h 299 (333)
T cd06650 291 ADLKQLMVH 299 (333)
T ss_pred cCHHHHhhC
Confidence 999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.04 Aligned_cols=241 Identities=22% Similarity=0.295 Sum_probs=192.6
Q ss_pred eccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 539 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
||+|+||.||+|++..+++.||+|+++.. .......+.+|++++++++||||+++++++...+ ..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPE-----KLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCC-----eEEEEEcCC
Confidence 69999999999999999999999999643 2233456788999999999999999999875544 899999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 146 (312)
T cd05585 76 NGGELFHHLQREG------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD 146 (312)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC
Confidence 9999999997654 689999999999999999999999 9999999999999999999999999998753221
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhc
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVM 775 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~ 775 (833)
. .......||+.|+|||++.+..++.++|||| .|+++++++++..|+..... ........
T Consensus 147 ~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws----------lGvil~el~tg~~pf~~~~~--~~~~~~~~ 206 (312)
T cd05585 147 D--------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWT----------LGVLLYEMLTGLPPFYDENV--NEMYRKIL 206 (312)
T ss_pred C--------CccccccCCcccCCHHHHcCCCCCCccceec----------hhHHHHHHHhCCCCcCCCCH--HHHHHHHH
Confidence 1 1122356999999999999999999999999 88899999999988752211 11111111
Q ss_pred cccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC---HHHHHHH
Q 040925 776 TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD---MRDVVAK 820 (833)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~ 820 (833)
... ...+...++.+.+++.+||..||++||+ +.|++..
T Consensus 207 ~~~-------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 207 QEP-------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred cCC-------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 111 1112335567889999999999999985 5666543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=301.30 Aligned_cols=260 Identities=23% Similarity=0.263 Sum_probs=208.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|+..+.||.|.-|+||+|..++++..+|+|++.... .....++..|.+||+.++||.++.+|+.+..+. +
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~-----~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK-----Y 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc-----e
Confidence 45777899999999999999999999999999997543 233457788999999999999999999965554 9
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+|||||+||+|..+.+++... .+++..++.++..++-||+|||-. |||+|||||+||||.++|.+.|+||.
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~----~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFD 224 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGK----RFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFD 224 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCC----ccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecc
Confidence 99999999999999999887754 799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcc-c------------------------------ccc-----------------cccCCCccccccccccccCc
Q 040925 688 LAKFLSDH-Q------------------------------LDT-----------------AVKTPSSSIGLKGTVGYVAP 719 (833)
Q Consensus 688 ~a~~~~~~-~------------------------------~~~-----------------~~~~~~~~~~~~gt~~y~aP 719 (833)
++...... . ... ...+..+..+++||-.|.||
T Consensus 225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP 304 (459)
T KOG0610|consen 225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP 304 (459)
T ss_pred ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence 88644210 0 000 01122345678999999999
Q ss_pred cccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHH
Q 040925 720 EYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRT 799 (833)
Q Consensus 720 E~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 799 (833)
|++.|...+.++|+|+ +|+.+||++.|.-|+.-.. ..+-...++......+ .....+....+|
T Consensus 305 EvI~G~GHgsAVDWWt----------fGIflYEmLyG~TPFKG~~--~~~Tl~NIv~~~l~Fp-----~~~~vs~~akDL 367 (459)
T KOG0610|consen 305 EVIRGEGHGSAVDWWT----------FGIFLYEMLYGTTPFKGSN--NKETLRNIVGQPLKFP-----EEPEVSSAAKDL 367 (459)
T ss_pred eeeecCCCCchhhHHH----------HHHHHHHHHhCCCCcCCCC--chhhHHHHhcCCCcCC-----CCCcchhHHHHH
Confidence 9999999999999999 8999999999999976222 1122222222222111 112456778999
Q ss_pred hhccCCCCCCCCCC----HHHHHH
Q 040925 800 GVLCSMESPFERMD----MRDVVA 819 (833)
Q Consensus 800 i~~cl~~dP~~RPt----~~eil~ 819 (833)
|++.|.+||.+|.. +.||-+
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred HHHHhccChhhhhccccchHHhhc
Confidence 99999999999997 666644
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=325.68 Aligned_cols=252 Identities=20% Similarity=0.239 Sum_probs=192.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
++|++.+.||+|+||.||+|.+..+++.||+|... .+.+.+|++++++++||||+++++++.... ..++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~l 160 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNK-----FTCL 160 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECC-----eeEE
Confidence 57999999999999999999999999999999753 245688999999999999999999976544 7899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
|||++. ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+|+
T Consensus 161 v~e~~~-~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~ 230 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKR------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAAC 230 (391)
T ss_pred EEecCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccc
Confidence 999995 69998887654 688999999999999999999999 99999999999999999999999999997
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc-
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS- 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~- 769 (833)
...... ........||+.|+|||++.+..++.++|||| +|+++|+++++..|+...+..+..
T Consensus 231 ~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lGvil~elltg~~p~~~~~~~~~~~ 293 (391)
T PHA03212 231 FPVDIN-------ANKYYGWAGTIATNAPELLARDPYGPAVDIWS----------AGIVLFEMATCHDSLFEKDGLDGDC 293 (391)
T ss_pred cccccc-------ccccccccCccCCCChhhhcCCCCCcHHHHHH----------HHHHHHHHHHCCCCcCCcccccccC
Confidence 543211 11122357999999999999999999999999 666677777665543211100000
Q ss_pred ----ch----------------------hhhc---cccchhhhhhh---hchHHHHHHHHHHhhccCCCCCCCCCCHHHH
Q 040925 770 ----LL----------------------MEVM---TNNSMIQEDKR---VKTEECLNAIIRTGVLCSMESPFERMDMRDV 817 (833)
Q Consensus 770 ----~~----------------------~~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 817 (833)
.. .... .......+..+ ....+.+..+.+++.+||+.||++|||++|+
T Consensus 294 ~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~el 373 (391)
T PHA03212 294 DSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEAL 373 (391)
T ss_pred chhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHH
Confidence 00 0000 00000000001 1112346678999999999999999999999
Q ss_pred HHH
Q 040925 818 VAK 820 (833)
Q Consensus 818 l~~ 820 (833)
++.
T Consensus 374 L~h 376 (391)
T PHA03212 374 LDF 376 (391)
T ss_pred hcC
Confidence 864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=327.07 Aligned_cols=264 Identities=22% Similarity=0.368 Sum_probs=198.9
Q ss_pred hcCCccCceeccCcceEEEEEEE-----CCCceEEEEEEeeccC-CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKY-KGASRSFVAECEALRNI-RHRNLIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 602 (833)
.++|++.+.||+|+||.||+|++ .+++..||||+++... ....+.+.+|+++++.+ +||||++++++|...+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~- 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG- 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence 45799999999999999999974 3457789999997432 22345788999999999 8999999999976554
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCc----------------------------------------------------
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQ---------------------------------------------------- 630 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 630 (833)
..++||||+++|+|.+++......
T Consensus 113 ----~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 113 ----PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ----cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 789999999999999998653210
Q ss_pred -----------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 631 -----------------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 631 -----------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
.....+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0012478899999999999999999999 99999999999999999999999999998654
Q ss_pred cccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchh
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLM 772 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~ 772 (833)
...... ......++..|+|||++.+..++.++|||| +|++++++++ +..|+..... +... .
T Consensus 266 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~s----------lG~~l~ellt~g~~p~~~~~~-~~~~-~ 327 (375)
T cd05104 266 NDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWS----------YGILLWEIFSLGSSPYPGMPV-DSKF-Y 327 (375)
T ss_pred Cccccc------ccCCCCCCcceeChhHhcCCCCCCCCCHHH----------HHHHHHHHHhcCCCCCCCCCc-hHHH-H
Confidence 322110 011123567899999999999999999999 7777888776 5555432110 1111 1
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
....... ....+...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus 328 ~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 328 KMIKEGY-----RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHhCc-----cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111110 0001122356788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=315.01 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=192.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... .....+.+|++++++++||||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTER-----CL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCC-----eE
Confidence 3579999999999999999999999999999999974432 23456789999999999999999999965443 88
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++ |+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~ 149 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGL 149 (288)
T ss_pred EEEEeCCC-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcc
Confidence 99999997 499998875432 478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++....... ......||+.|+|||++.+ ..++.++|||| .|+++++++++..|+......+
T Consensus 150 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws----------lG~~l~~l~~g~~pf~~~~~~~ 211 (288)
T cd07871 150 ARAKSVPTK--------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWG----------VGCILYEMATGRPMFPGSTVKE 211 (288)
T ss_pred eeeccCCCc--------cccCceecccccChHHhcCCcccCcHHHHHH----------HHHHHHHHHhCCCCCCCCCHHH
Confidence 975432211 1122458999999998765 56899999999 6777777777776653211100
Q ss_pred -------------ccchhhhccc----cchhhh----hhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 -------------PSLLMEVMTN----NSMIQE----DKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 -------------~~~~~~~~~~----~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
+......... ....+. ..............+++.+|+..||.+|||++|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 212 ELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 000000 000001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=327.74 Aligned_cols=260 Identities=18% Similarity=0.223 Sum_probs=199.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|++..+++.||||+++... ......+.+|+++++.++||||+++++++...+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN-----Y 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC-----e
Confidence 47999999999999999999999999999999997432 223456788999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 146 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFG 146 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecc
Confidence 999999999999999997654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCccccccccc------------------------------CCCccccccccccccCccccCCCCCCcccccccCC
Q 040925 688 LAKFLSDHQLDTAVK------------------------------TPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGR 737 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~ 737 (833)
+++.+.......... ........+||+.|+|||++.+..++.++||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS-- 224 (364)
T cd05599 147 LCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS-- 224 (364)
T ss_pred cceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeec--
Confidence 987543221100000 000112346999999999999999999999999
Q ss_pred cCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC---H
Q 040925 738 RPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD---M 814 (833)
Q Consensus 738 ~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~ 814 (833)
+|++++++++|..|+....... ............. .......++.+.+++.+|+. +|.+|++ +
T Consensus 225 --------lG~il~el~~G~~Pf~~~~~~~--~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~ 290 (364)
T cd05599 225 --------LGVIMYEMLVGYPPFCSDNPQE--TYRKIINWKETLQ---FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV 290 (364)
T ss_pred --------chhHHHHhhcCCCCCCCCCHHH--HHHHHHcCCCccC---CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH
Confidence 8888999999988875322111 0011111000000 00011234567788888986 9999998 8
Q ss_pred HHHHHH
Q 040925 815 RDVVAK 820 (833)
Q Consensus 815 ~eil~~ 820 (833)
+|+++.
T Consensus 291 ~~ll~h 296 (364)
T cd05599 291 NEIKSH 296 (364)
T ss_pred HHHhcC
Confidence 888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=327.37 Aligned_cols=266 Identities=20% Similarity=0.333 Sum_probs=200.5
Q ss_pred HhcCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSSTD 601 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 601 (833)
..++|++.+.||+|+||.||+|++.. ++..||||+++.... .....+.+|+++++.+ +||||++++++|....
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 34579999999999999999998643 335799999975432 2345688999999999 8999999999976554
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCc---------------------------------------------------
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQ--------------------------------------------------- 630 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------- 630 (833)
..++||||+++|+|.+++......
T Consensus 116 -----~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 116 -----PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred -----CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 789999999999999998643210
Q ss_pred -------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcccc
Q 040925 631 -------------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL 697 (833)
Q Consensus 631 -------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 697 (833)
....++++.++++++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 0112478899999999999999999999 999999999999999999999999999976543221
Q ss_pred cccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchhhhcc
Q 040925 698 DTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLMEVMT 776 (833)
Q Consensus 698 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~ 776 (833)
.. ......+++.|||||++.+..++.++|||| +|++++++++ +..|+..... +... .....
T Consensus 268 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS----------lGvil~ellt~G~~Pf~~~~~-~~~~-~~~~~ 329 (374)
T cd05106 268 YV------VKGNARLPVKWMAPESIFDCVYTVQSDVWS----------YGILLWEIFSLGKSPYPGILV-NSKF-YKMVK 329 (374)
T ss_pred ee------eccCCCCccceeCHHHhcCCCCCccccHHH----------HHHHHHHHHhCCCCCCccccc-cHHH-HHHHH
Confidence 10 111123567899999999889999999999 7778888876 7777642211 1111 11111
Q ss_pred ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 777 NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 777 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
... ....+...++.+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 330 ~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 330 RGY-----QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccc-----CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 100 00011123567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=326.58 Aligned_cols=260 Identities=20% Similarity=0.261 Sum_probs=197.5
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.|++.+.||+|+||+||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++.+.+ ..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~-----~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKD-----NL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCC-----EE
Confidence 5889999999999999999999999999999997432 223456889999999999999999999976554 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 99999999999999997654 688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCccccccc---------------------------------------ccCCCccccccccccccCccccCCCCCCc
Q 040925 689 AKFLSDHQLDTA---------------------------------------VKTPSSSIGLKGTVGYVAPEYGMGSEASM 729 (833)
Q Consensus 689 a~~~~~~~~~~~---------------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 729 (833)
++.......... ..........+||+.|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 864321100000 00000112457999999999999889999
Q ss_pred ccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhc--cCCCC
Q 040925 730 TGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVL--CSMES 807 (833)
Q Consensus 730 ~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~d 807 (833)
++|||| +|++++++++|..|+......... .......... ..+....+++++.+++.+ |+..+
T Consensus 228 ~~DiwS----------lG~il~elltG~~Pf~~~~~~~~~--~~i~~~~~~~---~~~~~~~~s~~~~dli~~ll~~~~~ 292 (381)
T cd05626 228 LCDWWS----------VGVILFEMLVGQPPFLAPTPTETQ--LKVINWENTL---HIPPQVKLSPEAVDLITKLCCSAEE 292 (381)
T ss_pred ccceee----------hhhHHHHHHhCCCCCcCCCHHHHH--HHHHcccccc---CCCCCCCCCHHHHHHHHHHccCccc
Confidence 999999 888999999999987632211110 1111000000 000111234556677766 66667
Q ss_pred CCCCCCHHHHHHH
Q 040925 808 PFERMDMRDVVAK 820 (833)
Q Consensus 808 P~~RPt~~eil~~ 820 (833)
|..||+++|+++.
T Consensus 293 ~~~R~~~~~~l~h 305 (381)
T cd05626 293 RLGRNGADDIKAH 305 (381)
T ss_pred ccCCCCHHHHhcC
Confidence 7779999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=310.09 Aligned_cols=256 Identities=23% Similarity=0.432 Sum_probs=202.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.+|++.+.||+|++|.||+|.+..+++.||+|.++.. ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 79 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFYI 79 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCC-----CcEE
Confidence 4688899999999999999999988999999998643 334567899999999999999999999976554 7899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++++|.+++...... .+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||.+.
T Consensus 80 v~e~~~~~~L~~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 80 ITEFMTYGNLLDYLRECNRQ----EVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred EEEeCCCCcHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 99999999999999764322 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPS 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~ 769 (833)
......... .....+++.|+|||++.+..++.++|||| +|++++++++ +..|+...... .
T Consensus 153 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~il~el~t~g~~p~~~~~~~--~ 213 (263)
T cd05052 153 LMTGDTYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWA----------FGVLLWEIATYGMSPYPGIDLS--Q 213 (263)
T ss_pred ccccceeec-------cCCCCCccccCCHHHhccCCCCchhHHHH----------HHHHHHHHHcCCCCCCCCCCHH--H
Confidence 765432111 11123467899999999889999999999 7777888876 65554321110 0
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
. ........ ....+..++..+.+++.+||..||++|||+.++++.|+.+
T Consensus 214 ~-~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 214 V-YELLEKGY-----RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred H-HHHHHCCC-----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0 01111100 0111233567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=321.32 Aligned_cols=243 Identities=23% Similarity=0.259 Sum_probs=190.0
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
+.||+|+||.||+|++..+++.||+|+++... ......+.+|+++++.++||||+++++++...+ ..|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~-----~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD-----RLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCC-----EEEEEEe
Confidence 47999999999999999999999999997432 223456788999999999999999999866554 8999999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
|+++|+|.+++.... .+++.+++.++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 76 YANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred CCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 999999999887654 68999999999999999999997 7 9999999999999999999999999998753
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
..... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+..... .....
T Consensus 147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~tG~~Pf~~~~~--~~~~~ 206 (325)
T cd05594 147 IKDGA--------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWG----------LGVVMYEMMCGRLPFYNQDH--EKLFE 206 (325)
T ss_pred CCCCc--------ccccccCCcccCCHHHHccCCCCCcccccc----------ccceeeeeccCCCCCCCCCH--HHHHH
Confidence 22111 112346999999999999999999999999 66666677777777642111 00000
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
....... ..+...++.+.+++.+||+.||++|+ ++.++++.
T Consensus 207 ~i~~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 207 LILMEEI-------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHhcCCC-------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0000000 01122456788999999999999996 89998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=325.64 Aligned_cols=258 Identities=20% Similarity=0.270 Sum_probs=202.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+++++.++||||+++++++.+.+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE-----H 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC-----e
Confidence 47999999999999999999999899999999997432 234567889999999999999999998865544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg 146 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFG 146 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCC
Confidence 999999999999999998753 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccc---------------------cccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccC
Q 040925 688 LAKFLSDHQLDT---------------------AVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNE 746 (833)
Q Consensus 688 ~a~~~~~~~~~~---------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~ 746 (833)
++.......... ............||+.|+|||++.+..++.++|||| +
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------l 216 (350)
T cd05573 147 LCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS----------L 216 (350)
T ss_pred CCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEe----------c
Confidence 998665432000 000011123356999999999999999999999999 7
Q ss_pred CccHHHHHHHhCCCcccccccccchhhhcc--ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-HHHHHHH
Q 040925 747 GHSLHEFAKTALPEKVMEIVDPSLLMEVMT--NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-MRDVVAK 820 (833)
Q Consensus 747 g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~~ 820 (833)
|+++++++++..|+....... ....... .... .+....+++.+.+++.+|+. ||++||+ ++|+++.
T Consensus 217 G~il~ell~g~~Pf~~~~~~~--~~~~i~~~~~~~~-----~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 217 GVILYEMLYGFPPFYSDTLQE--TYNKIINWKESLR-----FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred chhhhhhccCCCCCCCCCHHH--HHHHHhccCCccc-----CCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 888888888888875332111 1111111 0000 00111145678899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=320.13 Aligned_cols=246 Identities=22% Similarity=0.287 Sum_probs=192.3
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|+.++.++ +||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES-----RLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC-----EEEEEE
Confidence 47999999999999999999999999997542 22345678899988877 7999999999976554 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 76 EYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 9999999999887654 689999999999999999999999 9999999999999999999999999998753
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc-c--
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP-S-- 769 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~-~-- 769 (833)
.... .......||+.|+|||++.+..++.++|||| +|+++++++++..|+......+. .
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~~g~~Pf~~~~~~~~~~~~ 208 (329)
T cd05618 147 LRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWA----------LGVLMFEMMAGRSPFDIVGSSDNPDQN 208 (329)
T ss_pred cCCC--------CccccccCCccccCHHHHcCCCCCCccceec----------ccHHHHHHhhCCCCCccCCCcCCcccc
Confidence 2211 1112356999999999999999999999999 88899999999988752211110 0
Q ss_pred ---chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH------HHHHHH
Q 040925 770 ---LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM------RDVVAK 820 (833)
Q Consensus 770 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~eil~~ 820 (833)
.....+... ....+......+.+++.+||+.||++|||+ .++++.
T Consensus 209 ~~~~~~~~i~~~------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 209 TEDYLFQVILEK------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred cHHHHHHHHhcC------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 000000000 001122345677899999999999999984 566543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.96 Aligned_cols=262 Identities=24% Similarity=0.298 Sum_probs=205.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|+...+++.||||.++... ......+.+|++++++++||||+++++++...+ .
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-----E 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-----e
Confidence 57999999999999999999999899999999886422 223356889999999999999999999876544 7
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g 151 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccc
Confidence 89999999999999988643221 11578999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++......... .....|++.|+|||++.+..++.++|+|| +|+++++++++..|+.......
T Consensus 152 ~~~~~~~~~~~--------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s----------lG~~l~el~~g~~p~~~~~~~~ 213 (267)
T cd08228 152 LGRFFSSKTTA--------AHSLVGTPYYMSPERIHENGYNFKSDIWS----------LGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred cceeccchhHH--------HhcCCCCccccChhhhccCCCCchhhHHH----------HHHHHHHHhcCCCCCccccccH
Confidence 98866442211 11245889999999998888999999999 7888888888887764221110
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
.... ....... ........++..+.+++.+||..+|++|||+.++++.++.++
T Consensus 214 ~~~~-~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 214 FSLC-QKIEQCD----YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHH-HHHhcCC----CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1111 1111000 011122345677899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=320.45 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=193.5
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|..+++++ +||||+++++++.... ..|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~-----~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES-----RLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC-----EEEEEE
Confidence 47999999999999999999999999997532 22345678899999998 6999999999976554 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++...+ .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 146 (329)
T cd05588 76 EFVSGGDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 146 (329)
T ss_pred eCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccc
Confidence 9999999999887654 689999999999999999999999 9999999999999999999999999998743
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc-cc--
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD-PS-- 769 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~-~~-- 769 (833)
.... .......||+.|+|||++.+..++.++|||| +|+++|+++++..|+......+ +.
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~~l~el~~g~~Pf~~~~~~~~~~~~ 208 (329)
T cd05588 147 IRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWA----------LGVLMFEMMAGRSPFDIVGMSDNPDQN 208 (329)
T ss_pred ccCC--------CccccccCCccccCHHHHcCCCCCCccceec----------hHHHHHHHHHCCCCccccccccccccc
Confidence 2111 1122356999999999999999999999999 8889999999999886322111 00
Q ss_pred ---chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC------HHHHHHH
Q 040925 770 ---LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD------MRDVVAK 820 (833)
Q Consensus 770 ---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~eil~~ 820 (833)
...+.+.... ...+..++..+.+++.+||+.||++||| ++++++.
T Consensus 209 ~~~~~~~~~~~~~------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 209 TEDYLFQVILEKQ------IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred chHHHHHHHHcCC------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 0111111100 0112234567889999999999999997 5676543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=313.57 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=193.6
Q ss_pred cCCccCceeccCcceEEEEEEECC-CceEEEEEEeeccCC--cchhHHHHHHHHHhhc---CCCccceEeeEeecCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGE-DEMIVAVKVINLKYK--GASRSFVAECEALRNI---RHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 604 (833)
++|++.+.||+|+||.||+|++.. +++.||+|+++.... .....+.+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 379999999999999999999853 578899999875432 2234566788877776 6999999999986544444
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
....++||||++ ++|.+++...... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~ 152 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 152 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEc
Confidence 557899999997 6999998765432 589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+++...... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+....
T Consensus 153 Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 153 DFGLARIYSFQM---------ALTSVVVTLWYRAPEVLLQSSYATPVDLWS----------VGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred cccceEeccCCc---------ccccccccccccChHHHhCCCCCCccchHH----------HHHHHHHHHcCCCCcCCCC
Confidence 999997654321 112346899999999998889999999999 6667777777666654211
Q ss_pred cccc--------------cchhhh--ccccch--hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 765 IVDP--------------SLLMEV--MTNNSM--IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 765 ~~~~--------------~~~~~~--~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
..+. .+.... ...... ..........+.+..+.+++.+|++.||++|||+.|+++
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 214 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 1000 000000 000000 000000111234567789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.28 Aligned_cols=259 Identities=21% Similarity=0.302 Sum_probs=194.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.+++.++||||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKE-----TL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCC-----eE
Confidence 3689999999999999999999998999999999974432 23346788999999999999999999976544 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++ +++.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 149 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDKHPG-----GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGL 149 (303)
T ss_pred EEEEECCC-cCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCc
Confidence 99999996 688888865432 588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++....... ......||+.|+|||++.+ ..++.++|||| .|++++++++|..|+.......
T Consensus 150 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws----------lG~il~~l~~g~~pf~~~~~~~ 211 (303)
T cd07869 150 ARAKSVPSH--------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWG----------VGCIFVEMIQGVAAFPGMKDIQ 211 (303)
T ss_pred ceeccCCCc--------cCCCCcccCCCCChHHHcCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCccHH
Confidence 875432211 1122458999999998765 45888999999 7788888888887764211100
Q ss_pred ccchhh--------------hcc------ccch--hhh--hhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLME--------------VMT------NNSM--IQE--DKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~--------------~~~------~~~~--~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.....- ... .... ... .........++.+.+++.+|++.||++|||++|+++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 212 DQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred HHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000000 000 0000 000 0000001123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=317.55 Aligned_cols=259 Identities=21% Similarity=0.367 Sum_probs=200.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCce----EEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEM----IVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|++.+.||+|+||.||+|++..+++ .||+|+++... ....+.+.+|+.+++.++||||++++|+|...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~----- 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence 469999999999999999999865554 48999986443 23456788999999999999999999998543
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++|+||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~D 152 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITD 152 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcc
Confidence 36799999999999999986542 578899999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||+++.......... .....++..|+|||++.+..++.++|||| +|+++|++++ +..|+....
T Consensus 153 fG~a~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~s----------lGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 153 FGLAKLLGADEKEYH------AEGGKVPIKWMALESILHRIYTHQSDVWS----------YGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred ccccccccCCCccee------ccCCccceeecChHHhccCCCCchhhhHH----------HHHHHHHHHcCCCCCCCCCC
Confidence 999987654321110 11123567899999999999999999999 7777888776 666654211
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
. ... ........ ....+..++..+.+++.+||..||++|||+.+++..+..+...
T Consensus 217 ~--~~~-~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 217 A--SEI-SSILEKGE-----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred H--HHH-HHHHhCCC-----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 1 011 11111110 0011122445688999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.64 Aligned_cols=261 Identities=24% Similarity=0.404 Sum_probs=201.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCc-----eEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDE-----MIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
++|++.+.||+|+||.||+|.....+ ..||+|.++.... .....+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~--- 81 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ--- 81 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC---
Confidence 47899999999999999999886544 6899999864432 23456889999999999999999999975544
Q ss_pred CceEeEEEEecCCCChhhhhccCCCcc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCee
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQV----------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVL 674 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIl 674 (833)
..+++|||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. +++||||||+||+
T Consensus 82 --~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil 156 (283)
T cd05048 82 --PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCL 156 (283)
T ss_pred --ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEE
Confidence 7899999999999999997643211 013688999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 675 LDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 675 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
+++++.+||+|||+++........ .......+++.|+|||++.+..++.++|||| +|+++++++
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s----------lG~il~el~ 220 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYY------RVQSKSLLPVRWMPPEAILYGKFTTESDIWS----------FGVVLWEIF 220 (283)
T ss_pred EcCCCcEEECCCcceeeccccccc------cccCCCcccccccCHHHhccCcCchhhhHHH----------HHHHHHHHH
Confidence 999999999999999765332211 0111234788999999998889999999999 777777777
Q ss_pred H-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 755 K-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 755 ~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
+ +..|+..... ... ...+... .....+..++..+.+++.+||..||++|||+.||+++|++
T Consensus 221 ~~g~~p~~~~~~--~~~-~~~i~~~-----~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 221 SYGLQPYYGFSN--QEV-IEMIRSR-----QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCCCCCCCCCCH--HHH-HHHHHcC-----CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 6 5555432111 111 1111111 0112234567889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.68 Aligned_cols=246 Identities=23% Similarity=0.284 Sum_probs=193.1
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHH---hhcCCCccceEeeEeecCCCCCCc
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEAL---RNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++ ++++||||+++++++...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~----- 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED----- 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC-----
Confidence 678899999999999999999999999999997432 22345667777665 4567999999999976544
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||+++|+|..++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 899999999999999888643 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++...... .......||+.|+|||++.+..++.++|||| +|+++|++++|..|+...+..
T Consensus 146 g~~~~~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~~G~~pf~~~~~~ 207 (324)
T cd05589 146 GLCKEGMGFG--------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWG----------LGVLIYEMLVGESPFPGDDEE 207 (324)
T ss_pred cCCccCCCCC--------CcccccccCccccCHhHhcCCCCCcccchhh----------HHHHHHHHHhCCCCCCCCCHH
Confidence 9987432211 1122356999999999999999999999999 888999999999887532211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
.......... ...+..++..+.+++.+||+.||++|| ++.++++.
T Consensus 208 --~~~~~i~~~~-------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 208 --EVFDSIVNDE-------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred --HHHHHHHhCC-------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 1111111110 011223456788999999999999999 46666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=322.47 Aligned_cols=249 Identities=25% Similarity=0.341 Sum_probs=192.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|+..+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG-----EIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC-----eEE
Confidence 457778999999999999999998999999999964432 23467899999999999999999999965444 889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+.. ..++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 149 lv~e~~~~~~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~ 215 (353)
T PLN00034 149 VLLEFMDGGSLEGTH----------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVS 215 (353)
T ss_pred EEEecCCCCcccccc----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccc
Confidence 999999999986532 356778889999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCC-----CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-----SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
+....... ......||..|+|||++.. ...+.++|||| +|+++++++++..|+....
T Consensus 216 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvws----------lGvil~el~~g~~pf~~~~ 277 (353)
T PLN00034 216 RILAQTMD--------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWS----------LGVSILEFYLGRFPFGVGR 277 (353)
T ss_pred eecccccc--------cccccccCccccCccccccccccCcCCCcchhHHH----------HHHHHHHHHhCCCCCCCCC
Confidence 86543211 1123469999999998743 23456899999 8888999999998876222
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..+........... ........++..+.+++.+||..||++|||+.|+++.
T Consensus 278 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 278 QGDWASLMCAICMS-----QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CccHHHHHHHHhcc-----CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111100000000 0011123456778999999999999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.17 Aligned_cols=251 Identities=25% Similarity=0.376 Sum_probs=196.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
++|++.+.||+|+||.||+|+++ .+..+|+|.++.. ....+.+.+|++++++++||||+++++++...+ ..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~i 76 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQK-----PLYI 76 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCC-----CEEE
Confidence 46889999999999999999986 4567999988633 233567889999999999999999999976544 7899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~ 148 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcc
Confidence 9999999999999875432 588999999999999999999999 99999999999999999999999999988
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPS 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~ 769 (833)
......... .....++..|+|||++.+..++.++|||| +|+.++++.+ +..|+..... ..
T Consensus 149 ~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------~G~~l~el~~~g~~p~~~~~~--~~ 209 (256)
T cd05114 149 YVLDDEYTS-------SSGAKFPVKWSPPEVFNFSKYSSKSDVWS----------FGVLMWEVFTEGKMPFEKKSN--YE 209 (256)
T ss_pred ccCCCceec-------cCCCCCchhhCChhhcccCccchhhhhHH----------HHHHHHHHHcCCCCCCCCCCH--HH
Confidence 654322111 11223567899999998888999999999 7788888887 6666542211 11
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
.......... ...+...+..+.+++.+||..||++|||++++++.|
T Consensus 210 ~~~~i~~~~~------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 210 VVEMISRGFR------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HHHHHHCCCC------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1111111110 001122345789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=334.19 Aligned_cols=255 Identities=19% Similarity=0.204 Sum_probs=201.8
Q ss_pred CCccCceeccCcceEEEEEEECCC-ceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGED-EMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.|.+.+.||+|++|.||+|....+ ++.||+|.+..........+.+|+++++.++||||+++++++...+ ..|+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~-----~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDD-----KLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECC-----EEEE
Confidence 499999999999999999998777 7889999876554444567888999999999999999999976654 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++|+|.+++...... ..++++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 143 v~E~~~gg~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKE--HLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred EEECCCCCCHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 99999999999988653211 12688999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
....... .......+||+.|+|||++.+..++.++|||| +|+++++++++..|+..... ...
T Consensus 218 ~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s----------lG~~l~el~tg~~Pf~~~~~--~~~ 279 (478)
T PTZ00267 218 QYSDSVS------LDVASSFCGTPYYLAPELWERKRYSKKADMWS----------LGVILYELLTLHRPFKGPSQ--REI 279 (478)
T ss_pred ecCCccc------cccccccCCCccccCHhHhCCCCCCcHHhHHH----------HHHHHHHHHhCCCCCCCCCH--HHH
Confidence 6543211 11122356999999999999999999999999 88889999999888752211 111
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......... ...+..++..+.+++.+||..||++|||+++++..
T Consensus 280 ~~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 280 MQQVLYGKY------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred HHHHHhCCC------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 111111110 01122345678999999999999999999999753
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=310.62 Aligned_cols=257 Identities=26% Similarity=0.427 Sum_probs=205.8
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
...+|++.+.||+|++|.||+|.+.. +..||+|.++.........+.+|+.+++.++||||+++++++.... ..
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 77 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-----PV 77 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-----Ce
Confidence 45679999999999999999999986 8899999997665545678899999999999999999999976554 78
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++...... .+++.+++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~ 150 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQ----VLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGL 150 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccc
Confidence 9999999999999999865432 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~ 767 (833)
+.......... ....++..|+|||+..+..++.++|||| +|+.++++.+ +..|+.... .
T Consensus 151 ~~~~~~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~Diws----------lG~~l~~l~~~g~~p~~~~~--~ 210 (261)
T cd05148 151 ARLIKEDVYLS--------SDKKIPYKWTAPEAASHGTFSTKSDVWS----------FGILLYEMFTYGQVPYPGMN--N 210 (261)
T ss_pred hhhcCCccccc--------cCCCCceEecCHHHHccCCCCchhhHHH----------HHHHHHHHHcCCCCCCCcCC--H
Confidence 98664432111 1234678899999998888999999999 7788888887 666664221 1
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
........ ... ....+..+++.+.+++.+||..||++|||++++++.|+.+
T Consensus 211 ~~~~~~~~-~~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 211 HEVYDQIT-AGY-----RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HHHHHHHH-hCC-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11111111 000 1111234567789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=308.03 Aligned_cols=256 Identities=22% Similarity=0.292 Sum_probs=200.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++..+++.||+|+++.........+.+|+.++++++||||+++++++...+ ..+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~-----~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSRE-----KLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCC-----EEE
Confidence 357999999999999999999998899999999997654445567889999999999999999999976544 889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++.... .+++.++..++.|++.|+.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 iv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~ 153 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVA 153 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccc
Confidence 9999999999999987543 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
........ ......|++.|+|||.+. ...++.++|||| +|+++++++++..|+......
T Consensus 154 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws----------~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 154 AKITATIA--------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWA----------VGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred eeeccccc--------ccCccccCccccCHhHcccccCCCCcchhhHHH----------HHHHHHHHHhCCCCccccchh
Confidence 86543211 112245899999999874 345788999999 788888888888776422111
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
+..... ..... .+........++..+.+++.+||..||++|||++++++.+
T Consensus 216 ~~~~~~--~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 216 RALFLM--SKSNF--QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred hhheee--ecCCC--CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 110000 00000 0000111123456788999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=315.13 Aligned_cols=257 Identities=24% Similarity=0.376 Sum_probs=208.4
Q ss_pred CCccCceeccCcceEEEEEEECCC----ceEEEEEEeecc-CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGED----EMIVAVKVINLK-YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
..+..++||.|.||.||+|.+... .--||||..+.. ..+..+.|..|..+|+.++|||||+++|+|.+..
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P----- 464 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP----- 464 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-----
Confidence 344568999999999999988432 346899998864 3445678999999999999999999999997664
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
.|+|||.++.|.|+.|++.... .++......+++||+.||+|||+. ..|||||..+|||+.....|||+||
T Consensus 465 -~WivmEL~~~GELr~yLq~nk~-----sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 465 -MWIVMELAPLGELREYLQQNKD-----SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred -eeEEEecccchhHHHHHHhccc-----cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence 8999999999999999998764 688999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++.+.+........ ..-...|||||.+.-..+++++|||-+|+-+|++++.|+..+.+++. .
T Consensus 536 GLSR~~ed~~yYkaS~-------~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN---------s 599 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASR-------GKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN---------S 599 (974)
T ss_pred chhhhccccchhhccc-------cccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc---------c
Confidence 9999988876544331 12456899999999999999999999666666666665544432221 1
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
|. .+..- .....+.++.|++.+..++.+||.+||.+||.+.|+...|+.+.+
T Consensus 600 DV--I~~iE------nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 600 DV--IGHIE------NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ce--EEEec------CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11 11111 112234567789999999999999999999999999999999876
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.36 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=197.7
Q ss_pred cCCccCceeccCcceEEEEEEE----CCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.+|++.+.||+|+||.||+|.. ..+++.||+|.++.......+.+.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---RR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC---CC
Confidence 4789999999999999999984 3468899999987555445568899999999999999999999875432 34
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~df 152 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDF 152 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCC
Confidence 68999999999999999975432 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc---
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM--- 763 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~--- 763 (833)
|+++........... .....++..|+|||+..+..++.++|||| +|+++++++++..+....
T Consensus 153 g~~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~el~~~~~~~~~~~~~ 217 (284)
T cd05081 153 GLTKVLPQDKEYYKV-----REPGESPIFWYAPESLTESKFSVASDVWS----------FGVVLYELFTYSDKSCSPPAE 217 (284)
T ss_pred cccccccCCCcceee-----cCCCCCceEeeCHHHhccCCcChHHHHHH----------HHHHHHHHhhcCCcCCCcchh
Confidence 999876432211000 01112455699999998888999999999 566666666543332110
Q ss_pred --ccccccch--------hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 764 --EIVDPSLL--------MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 764 --~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
........ .+..... ........++..+.+++.+||..+|++|||++||++.|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 218 FMRMMGNDKQGQMIVYHLIELLKNN-----GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hhhhcccccccccchHHHHHHHhcC-----CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000 0000000 00011223456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.48 Aligned_cols=260 Identities=19% Similarity=0.212 Sum_probs=195.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++...+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKD-----N 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----E
Confidence 37999999999999999999999999999999986431 223456889999999999999999999976544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG 146 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 146 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999997654 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccc-----------------------------------cccCCCccccccccccccCccccCCCCCCcccc
Q 040925 688 LAKFLSDHQLDT-----------------------------------AVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGD 732 (833)
Q Consensus 688 ~a~~~~~~~~~~-----------------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 732 (833)
+|..+....... ...........+||+.|||||++.+..++.++|
T Consensus 147 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 226 (376)
T cd05598 147 LCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226 (376)
T ss_pred CCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCccee
Confidence 985332100000 000001112357999999999999999999999
Q ss_pred cccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC
Q 040925 733 IFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM 812 (833)
Q Consensus 733 i~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 812 (833)
||| +|+++|++++|..|+......+.............. .....+++.+.+++.+|+ .+|.+|+
T Consensus 227 iwS----------lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~-----~~~~~~s~~~~~li~~l~-~~p~~R~ 290 (376)
T cd05598 227 WWS----------VGVILYEMLVGQPPFLADTPAETQLKVINWETTLHI-----PSQAKLSREASDLILRLC-CGAEDRL 290 (376)
T ss_pred eee----------ccceeeehhhCCCCCCCCCHHHHHHHHhccCccccC-----CCCCCCCHHHHHHHHHHh-cCHhhcC
Confidence 999 677777888888876532211110000000000000 011123455677777766 5999999
Q ss_pred ---CHHHHHHH
Q 040925 813 ---DMRDVVAK 820 (833)
Q Consensus 813 ---t~~eil~~ 820 (833)
|+.|+++.
T Consensus 291 ~~~t~~ell~h 301 (376)
T cd05598 291 GKNGADEIKAH 301 (376)
T ss_pred CCCCHHHHhCC
Confidence 88998865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=321.06 Aligned_cols=259 Identities=19% Similarity=0.217 Sum_probs=195.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||+||+|++..+++.||+|+++... ......+.+|+.++.+++||+|+++++++.+.. .
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~-----~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL-----N 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-----e
Confidence 47999999999999999999999899999999997432 223356788999999999999999999876544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFG 146 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFG 146 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeecc
Confidence 999999999999999998654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccc---------------------------cCCCccccccccccccCccccCCCCCCcccccccCCcCC
Q 040925 688 LAKFLSDHQLDTAV---------------------------KTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPI 740 (833)
Q Consensus 688 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~ 740 (833)
+++........... .........+||+.|+|||++.+..++.++||||
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwS----- 221 (363)
T cd05628 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWS----- 221 (363)
T ss_pred CcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhh-----
Confidence 99765332110000 0000112457999999999999999999999999
Q ss_pred CccccCCccHHHHHHHhCCCcccccccccchhhhcc--ccchhhhhhhhchHHHHHHHHHHhhccCC--CCCCCCCCHHH
Q 040925 741 DAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMT--NNSMIQEDKRVKTEECLNAIIRTGVLCSM--ESPFERMDMRD 816 (833)
Q Consensus 741 ~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPt~~e 816 (833)
+|+++|++++|..|+...... ........ .....++ .. ...+...+++.+++. .++..||+++|
T Consensus 222 -----lGvil~ell~G~~Pf~~~~~~--~~~~~i~~~~~~~~~p~-~~----~~s~~~~~li~~l~~~~~~r~~r~~~~e 289 (363)
T cd05628 222 -----LGVIMYEMLIGYPPFCSETPQ--ETYKKVMNWKETLIFPP-EV----PISEKAKDLILRFCCEWEHRIGAPGVEE 289 (363)
T ss_pred -----hHHHHHHHHhCCCCCCCCCHH--HHHHHHHcCcCcccCCC-cC----CCCHHHHHHHHHHcCChhhcCCCCCHHH
Confidence 888999999999997532211 11111111 0010110 00 123345566655332 34445789999
Q ss_pred HHHH
Q 040925 817 VVAK 820 (833)
Q Consensus 817 il~~ 820 (833)
|++.
T Consensus 290 i~~h 293 (363)
T cd05628 290 IKTN 293 (363)
T ss_pred HhCC
Confidence 9876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=328.27 Aligned_cols=373 Identities=26% Similarity=0.377 Sum_probs=321.3
Q ss_pred cCCCCCCEEEccCCccc-ccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCc
Q 040925 20 GNLSDLEVIRIMGNSLG-GKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL 98 (833)
Q Consensus 20 ~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L 98 (833)
+-|+..+-+|+++|..+ +..|.....+++++-|.|...++. .+|+.++.|.+|+.|.+++|++. .+..+ ++.|+.|
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGE-Ls~Lp~L 80 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGE-LSDLPRL 80 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhh-hccchhh
Confidence 45667777899999997 678999999999999999999998 78999999999999999999987 55433 4688999
Q ss_pred cEEEccCCcce-eeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCC
Q 040925 99 KALAIGGNNFF-GSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLK 177 (833)
Q Consensus 99 ~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~ 177 (833)
+.+.+..|++. +-+|..+..|..|+.||||+|+++.. |..+..-+++-.|+||+|+|.+||. ..|.+|+.|-
T Consensus 81 Rsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~Ev-P~~LE~AKn~iVLNLS~N~IetIPn------~lfinLtDLL 153 (1255)
T KOG0444|consen 81 RSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREV-PTNLEYAKNSIVLNLSYNNIETIPN------SLFINLTDLL 153 (1255)
T ss_pred HHHhhhccccccCCCCchhcccccceeeecchhhhhhc-chhhhhhcCcEEEEcccCccccCCc------hHHHhhHhHh
Confidence 99999999986 33666777899999999999999854 5567888889999999999988876 3467888888
Q ss_pred EEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccc
Q 040925 178 ALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRN 257 (833)
Q Consensus 178 ~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 257 (833)
.||||+|++. ..|+.++.+..|++|.|++|.+....-.-+..+++|+.|.+++.
T Consensus 154 fLDLS~NrLe--------------------------~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~T 207 (1255)
T KOG0444|consen 154 FLDLSNNRLE--------------------------MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNT 207 (1255)
T ss_pred hhccccchhh--------------------------hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccc
Confidence 8888888887 56677788889999999999887554455667788999999987
Q ss_pred cCc-ccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCC
Q 040925 258 FLQ-GRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSL 336 (833)
Q Consensus 258 ~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~ 336 (833)
+=+ .-+|.++..+.+|..+|||.|.+. ..|+.+-++++|+.|+||+|+|+ .+.........+ +.|+||.|+++ .+
T Consensus 208 qRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~l-EtLNlSrNQLt-~L 283 (1255)
T KOG0444|consen 208 QRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENL-ETLNLSRNQLT-VL 283 (1255)
T ss_pred cchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhh-hhhccccchhc-cc
Confidence 643 358889999999999999999998 89999999999999999999999 666666666666 78999999999 89
Q ss_pred CcccccCCCcCEEeccCCcCCC-CCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCC
Q 040925 337 PLQVGHLKNLVILDISSNQFSG-VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNL 415 (833)
Q Consensus 337 ~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 415 (833)
|.++..|+.|+.|.+.+|+++- -+|..++.+.+|+.+..++|++. ..|+.+..+..|+.|.|+.|++- .+|+.+.-|
T Consensus 284 P~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL 361 (1255)
T KOG0444|consen 284 PDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLL 361 (1255)
T ss_pred hHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhc
Confidence 9999999999999999999863 46888999999999999999998 88999999999999999999998 789999999
Q ss_pred CCCceEECccCcCccccCC
Q 040925 416 SVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 416 ~~L~~L~l~~N~l~~~~~~ 434 (833)
+.|+.||+.+|+=---||.
T Consensus 362 ~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 362 PDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred CCcceeeccCCcCccCCCC
Confidence 9999999999986666664
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.24 Aligned_cols=260 Identities=18% Similarity=0.185 Sum_probs=195.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++.+.. +
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ-----Y 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC-----e
Confidence 47999999999999999999999999999999986431 223456888999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfG 146 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFG 146 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999997654 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccc---------ccc------------------------------CCCccccccccccccCccccCCCCCC
Q 040925 688 LAKFLSDHQLDT---------AVK------------------------------TPSSSIGLKGTVGYVAPEYGMGSEAS 728 (833)
Q Consensus 688 ~a~~~~~~~~~~---------~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 728 (833)
+++......... ... ........+||+.|+|||++.+..++
T Consensus 147 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 226 (377)
T cd05629 147 LSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG 226 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC
Confidence 996432110000 000 00001124699999999999999999
Q ss_pred cccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCC
Q 040925 729 MTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESP 808 (833)
Q Consensus 729 ~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 808 (833)
.++|||| +|++++++++|..|+......+ ............ ..+........+.+++.+|+. +|
T Consensus 227 ~~~DiwS----------lGvil~elltG~~Pf~~~~~~~--~~~~i~~~~~~~---~~p~~~~~s~~~~dli~~lL~-~~ 290 (377)
T cd05629 227 QECDWWS----------LGAIMFECLIGWPPFCSENSHE--TYRKIINWRETL---YFPDDIHLSVEAEDLIRRLIT-NA 290 (377)
T ss_pred CceeeEe----------cchhhhhhhcCCCCCCCCCHHH--HHHHHHccCCcc---CCCCCCCCCHHHHHHHHHHhc-CH
Confidence 9999999 7888888888888875322111 000110000000 000111234567889999997 77
Q ss_pred CCC---CCHHHHHHH
Q 040925 809 FER---MDMRDVVAK 820 (833)
Q Consensus 809 ~~R---Pt~~eil~~ 820 (833)
.+| +|+.|+++.
T Consensus 291 ~~r~~r~~~~~~l~h 305 (377)
T cd05629 291 ENRLGRGGAHEIKSH 305 (377)
T ss_pred hhcCCCCCHHHHhcC
Confidence 765 599998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=322.36 Aligned_cols=269 Identities=23% Similarity=0.334 Sum_probs=203.0
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCC-cchhHHHHHHHHHhhcC-CCccceEeeEeec
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYK-GASRSFVAECEALRNIR-HRNLIKIITICSS 599 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~ 599 (833)
....++|++.+.||+|+||.||+|++.. .+..||||+++.... ...+.+.+|+++++++. ||||+++++++..
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3445689999999999999999998743 245799999975432 23457899999999996 9999999999765
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCc-------------------------------------------------
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ------------------------------------------------- 630 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------- 630 (833)
.. ..++|||||++|+|.+++......
T Consensus 113 ~~-----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 113 SG-----PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred CC-----ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 44 799999999999999998653210
Q ss_pred -----------------------------------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCC
Q 040925 631 -----------------------------------------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLK 669 (833)
Q Consensus 631 -----------------------------------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlk 669 (833)
.....+++.++..++.|++.||+|||+. +|+|||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dik 264 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLA 264 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCC
Confidence 0012478888999999999999999999 99999999
Q ss_pred CCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCcc
Q 040925 670 PSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHS 749 (833)
Q Consensus 670 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~ 749 (833)
|+||+++.++.+||+|||+++........ .......+++.|+|||++.+..++.++|||| +|++
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS----------lGvi 328 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSNY------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWS----------YGIL 328 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccccc------cccCCcCCCcceEChhhhcCCCCCchhhHHH----------HHHH
Confidence 99999999999999999999865432211 1112235788999999999888999999999 6777
Q ss_pred HHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 750 LHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 750 l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
++++++ +..|+.... .+.... ....... ....+..++..+.+++.+||+.||++|||+.+|.+.|+++.+
T Consensus 329 l~ellt~g~~P~~~~~-~~~~~~-~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 329 LWEIFSLGGTPYPGMI-VDSTFY-NKIKSGY-----RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHCCCCCCcccc-hhHHHH-HHHhcCC-----CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 777765 555553211 111111 1111100 011123456788999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=306.48 Aligned_cols=255 Identities=23% Similarity=0.398 Sum_probs=200.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.++||+|++|.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+ ..+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 77 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEE-----PIY 77 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-----CcE
Confidence 457999999999999999999976 56779999986432 23567899999999999999999999865443 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
++|||+++|+|.+++...... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 150 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGG----KVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLA 150 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccc
Confidence 999999999999999764322 678899999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
.......... .....++..|+|||+..+..++.++|||| +|++++++++ +..|+......
T Consensus 151 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~~l~t~g~~p~~~~~~~-- 211 (261)
T cd05072 151 RVIEDNEYTA-------REGAKFPIKWTAPEAINFGSFTIKSDVWS----------FGILLYEIVTYGKIPYPGMSNS-- 211 (261)
T ss_pred eecCCCceec-------cCCCccceecCCHHHhccCCCChhhhhhh----------hHHHHHHHHccCCCCCCCCCHH--
Confidence 8764422111 11234677899999998888999999999 7888888887 77776421110
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
.. ...+..... ......++.++.+++.+||..+|++|||++++.+.|+.
T Consensus 212 ~~-~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 212 DV-MSALQRGYR-----MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HH-HHHHHcCCC-----CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11 111111110 01112345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=317.49 Aligned_cols=242 Identities=22% Similarity=0.251 Sum_probs=191.9
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCC-CccceEeeEeecCCCCCCce
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRH-RNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~ 607 (833)
+|++.+.||+|+||.||+|++..+++.||||+++... ....+.+..|.++++.++| ++|+++++++...+ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD-----R 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC-----E
Confidence 5889999999999999999999899999999997432 2344567889999999976 56888888865544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg 146 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFG 146 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecC
Confidence 999999999999999997654 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+++...... .......||+.|+|||++.+..++.++|||| .|++++++++|..|+......
T Consensus 147 ~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lGvil~elltG~~pf~~~~~~- 207 (324)
T cd05587 147 MCKENIFGG--------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA----------FGVLLYEMLAGQPPFDGEDED- 207 (324)
T ss_pred cceecCCCC--------CceeeecCCccccChhhhcCCCCCcccchhh----------hHHHHHHHHhCCCCCCCCCHH-
Confidence 987432111 1112356999999999999999999999999 888999999999887532211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
........... ..+...+..+.+++.+||..||++||++
T Consensus 208 -~~~~~i~~~~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 208 -ELFQSIMEHNV-------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -HHHHHHHcCCC-------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11111111110 1112345678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=336.66 Aligned_cols=272 Identities=22% Similarity=0.281 Sum_probs=206.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.++||+|+||.||+|++..+++.||+|+++.... ...+++.+|++++++++||||+++++++...+ .
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~-----~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD-----P 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC-----E
Confidence 689999999999999999999998999999999974322 22457899999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCc-----cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQ-----VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
.++||||++||+|.+++...... ......++..++.++.|+++||+|||+. ||+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEE
Confidence 89999999999999998742110 0112467788899999999999999999 999999999999999999999
Q ss_pred EcccccccccCccccccc----------ccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHH
Q 040925 683 VCDFGLAKFLSDHQLDTA----------VKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHE 752 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~----------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~ 752 (833)
|+|||+++.......... ..........+||+.|||||++.+..++.++|||| .|+++++
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWS----------LGVILyE 223 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYA----------LGVILYQ 223 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHH----------HHHHHHH
Confidence 999999986622110000 00011112357999999999999999999999999 8889999
Q ss_pred HHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-CHHHHHHHHHHhhh
Q 040925 753 FAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-DMRDVVAKLCHTRE 826 (833)
Q Consensus 753 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~i~~ 826 (833)
++++..|+.......... ......+.......++++.+.+++.+|+..||++|| +++++.+.|+...+
T Consensus 224 LLTG~~PF~~~~~~ki~~------~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 224 MLTLSFPYRRKKGRKISY------RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred HHHCCCCCCCcchhhhhh------hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 999998875322110000 000001111111234567788999999999999996 57777777777654
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=310.25 Aligned_cols=265 Identities=22% Similarity=0.384 Sum_probs=204.9
Q ss_pred cCCccCceeccCcceEEEEEEE-----CCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|.+.+.||+|+||.||+|.. ..++..||+|.++.......+.+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 80 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence 4789999999999999999985 2356679999987554445667999999999999999999999976544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCc-------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQ-------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
..++||||+++++|.+++...... .....+++.+++.++.|++.||+|||+. |++||||||+||+++++
T Consensus 81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~ 156 (288)
T cd05093 81 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 156 (288)
T ss_pred -ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccC
Confidence 789999999999999999754310 1112589999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-Hh
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TA 757 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~ 757 (833)
+.+||+|||+++........ .......+++.|+|||++.+..++.++|||| +|+.++++++ +.
T Consensus 157 ~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiws----------lG~il~~l~t~g~ 220 (288)
T cd05093 157 LLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWS----------LGVVLWEIFTYGK 220 (288)
T ss_pred CcEEeccCCccccccCCcee------ecCCCCCccccccCHHHhccCCCCchhhHHH----------HHHHHHHHHhCCC
Confidence 99999999999865432110 0111234678899999999888999999999 7788888887 66
Q ss_pred CCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 758 LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 758 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.|+..... ............. .....++..+.+++.+||+.||.+|||++|+.+.|+.+...
T Consensus 221 ~p~~~~~~--~~~~~~i~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 221 QPWYQLSN--NEVIECITQGRVL------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred CCCCCCCH--HHHHHHHHcCCcC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 66542211 1111111111100 01112456789999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.29 Aligned_cols=237 Identities=24% Similarity=0.284 Sum_probs=189.2
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|+++.+++.||+|+++.. .....+.+..|.+++..+ +||||+++++++...+ ..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~-----~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD-----RLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC-----EEEEEE
Confidence 4799999999999999989999999999743 223345677888888877 6999999999875544 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 Ey~~~g~L~~~i~~~~------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 76 EFVNGGDLMFHIQKSR------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred cCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 9999999999987654 689999999999999999999999 9999999999999999999999999998753
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.... .......||+.|+|||++.+..++.++|||| .|+++++++++..|+..... .....
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~~g~~Pf~~~~~--~~~~~ 206 (320)
T cd05590 147 IFNG--------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWA----------MGVLLYEMLCGHAPFEAENE--DDLFE 206 (320)
T ss_pred CcCC--------CcccccccCccccCHHHHcCCCCCCccchhh----------hHHHHHHHhhCCCCCCCCCH--HHHHH
Confidence 2211 1112346999999999999989999999999 88899999999988753221 11111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
....... ..+...+..+.+++.+||+.||++||++
T Consensus 207 ~i~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 207 AILNDEV-------VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHhcCCC-------CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1111110 1112245678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.77 Aligned_cols=242 Identities=22% Similarity=0.292 Sum_probs=189.2
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|++..+++.||+|+++... ....+....|..++... +||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~-----~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE-----HLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence 47999999999999999999999999997432 22334556677777654 7999999999865544 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~gg~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 76 EYLNGGDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred cCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999999999997654 689999999999999999999999 9999999999999999999999999999754
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.... .......||+.|+|||++.+..++.++|||| .|+++++++++..|+..... .....
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws----------lG~il~ell~G~~Pf~~~~~--~~~~~ 206 (316)
T cd05592 147 MNGE--------GKASTFCGTPDYIAPEILKGQKYNESVDWWS----------FGVLLYEMLIGQSPFHGEDE--DELFD 206 (316)
T ss_pred CCCC--------CccccccCCccccCHHHHcCCCCCCcccchh----------HHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 3211 1122356999999999999989999999999 88899999999888753221 11111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHH-HHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMR-DVVA 819 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~ 819 (833)
... ... ...+..++..+.+++.+||..||++||++. ++++
T Consensus 207 ~i~-~~~------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 207 SIL-NDR------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHH-cCC------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 111 100 011122455678999999999999999875 4543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=324.08 Aligned_cols=259 Identities=19% Similarity=0.250 Sum_probs=195.5
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
+|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|++++++++||||+++++++...+ ..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~-----~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-----NL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCC-----EE
Confidence 5889999999999999999999999999999996432 223457889999999999999999999976554 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 99999999999999997654 688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccc---------------------------------------cccCCCccccccccccccCccccCCCCCCc
Q 040925 689 AKFLSDHQLDT---------------------------------------AVKTPSSSIGLKGTVGYVAPEYGMGSEASM 729 (833)
Q Consensus 689 a~~~~~~~~~~---------------------------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 729 (833)
|.......... ...........+||+.|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 85432100000 000001112357999999999999999999
Q ss_pred ccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCC
Q 040925 730 TGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPF 809 (833)
Q Consensus 730 ~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 809 (833)
++|||| .|+++++++++..|+......... .......... ..+.....++...+++.+|+ .+|+
T Consensus 228 ~~DiwS----------lGvil~elltG~~Pf~~~~~~~~~--~~i~~~~~~~---~~p~~~~~s~~~~~li~~l~-~~p~ 291 (382)
T cd05625 228 LCDWWS----------VGVILYEMLVGQPPFLAQTPLETQ--MKVINWQTSL---HIPPQAKLSPEASDLIIKLC-RGPE 291 (382)
T ss_pred eeeEEe----------chHHHHHHHhCCCCCCCCCHHHHH--HHHHccCCCc---CCCCcccCCHHHHHHHHHHc-cCHh
Confidence 999999 888999999999987633211111 1111100000 00111123445667776665 5999
Q ss_pred CCCC---HHHHHHH
Q 040925 810 ERMD---MRDVVAK 820 (833)
Q Consensus 810 ~RPt---~~eil~~ 820 (833)
+|++ ++|++++
T Consensus 292 ~R~~~~~~~ei~~h 305 (382)
T cd05625 292 DRLGKNGADEIKAH 305 (382)
T ss_pred HcCCCCCHHHHhcC
Confidence 9997 8887654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=312.94 Aligned_cols=247 Identities=23% Similarity=0.317 Sum_probs=202.8
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEecC
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYME 616 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 616 (833)
-+||+|.||+||-|++..++..+|||.+........+-+.+|+...++++|.|||+++|.+...+ +.-+.||-++
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-----f~kIFMEqVP 655 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-----FFKIFMEQVP 655 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-----eEEEEeecCC
Confidence 37999999999999999999999999998777667778999999999999999999999965544 8889999999
Q ss_pred CCChhhhhccCCCccccccC--CHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec-CCCcEEEcccccccccC
Q 040925 617 NGSLKDWLHQSDDQVEVCKL--SLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 617 ~gsL~~~l~~~~~~~~~~~l--~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~ 693 (833)
||+|.+++...=+ ++ .+.+.-.+.+||++||.|||+. .|||||||-+|+|++ -.|.+||+|||-++...
T Consensus 656 GGSLSsLLrskWG-----PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 656 GGSLSSLLRSKWG-----PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred CCcHHHHHHhccC-----CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 9999999976432 44 6788889999999999999999 999999999999996 57899999999988654
Q ss_pred cccccccccCCCccccccccccccCccccCCC--CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccch
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS--EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~ 771 (833)
.-. ..+..+.||..|||||++-.+ .|..++|||| +|+++.||++|..|+.........+.
T Consensus 728 gin--------P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS----------~GCT~vEMATGrPPF~ElgspqAAMF 789 (1226)
T KOG4279|consen 728 GIN--------PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWS----------FGCTMVEMATGRPPFVELGSPQAAMF 789 (1226)
T ss_pred cCC--------ccccccccchhhhChHhhccCCcCCCchhhhhh----------ccceeEeeccCCCCeeecCChhHhhh
Confidence 321 122346799999999998654 4899999999 78888899999998764333333333
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.-.+.+.. .+.+++...+...+|.+|+.+||.+||++.+++..
T Consensus 790 kVGmyKvH------P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 790 KVGMYKVH------PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred hhcceecC------CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 33333222 23456677888999999999999999999999764
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=312.21 Aligned_cols=253 Identities=23% Similarity=0.269 Sum_probs=207.7
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcC-CCccceEeeEeecCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIR-HRNLIKIITICSSTDFKG 604 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 604 (833)
....|++.+.||+|.||.||+|+.+.+|+.+|+|++...... ....+.+|+.+|+++. |||||.+++++.+..
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~--- 109 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD--- 109 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC---
Confidence 345789999999999999999999999999999999755332 3468999999999998 999999999966555
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC----Cc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD----MV 680 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~ 680 (833)
..++|||++.||.|.+.+... .+++..+..++.|++.|++|||+. ||+|||+||+|+|+... +.
T Consensus 110 --~~~lvmEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ 177 (382)
T KOG0032|consen 110 --SVYLVMELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGR 177 (382)
T ss_pred --eEEEEEEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCc
Confidence 999999999999999999864 289999999999999999999999 99999999999999643 58
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
+|++|||+|...... ......+||+.|+|||++.+..|+..+|||| .|++.|.++.|..|+
T Consensus 178 ik~~DFGla~~~~~~---------~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS----------~Gvi~yiLL~G~~PF 238 (382)
T KOG0032|consen 178 IKLIDFGLAKFIKPG---------ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWS----------IGVILYILLSGVPPF 238 (382)
T ss_pred EEEeeCCCceEccCC---------ceEeeecCCccccCchhhcCCCCCcccchhH----------HHHHHHHHhhCCCCC
Confidence 999999999876552 2233578999999999999999999999999 888888888888887
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
........ ......... .......+.......+++..|+..||.+|+|+.+++++
T Consensus 239 ~~~~~~~~--~~~i~~~~~---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 239 WGETEFEI--FLAILRGDF---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred cCCChhHH--HHHHHcCCC---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 63331111 111111211 11223345567788999999999999999999999985
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=316.73 Aligned_cols=251 Identities=19% Similarity=0.229 Sum_probs=194.1
Q ss_pred CCccCceeccCcceEEEEEEEC---CCceEEEEEEeeccC----CcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKY----KGASRSFVAECEALRNIR-HRNLIKIITICSSTDFK 603 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 603 (833)
+|++.+.||+|+||.||+|+.. .+++.||+|+++... ....+.+.+|+.++++++ ||+|+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~-- 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA-- 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC--
Confidence 5889999999999999999874 468899999996421 223456788999999994 999999998865444
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 79 ---~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl 146 (332)
T cd05614 79 ---KLHLILDYVSGGEMFTHLYQRD------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVL 146 (332)
T ss_pred ---EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEE
Confidence 8899999999999999997654 689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
+|||+++....... .......||+.|+|||++.+. .++.++|||| +|+++++++++..|+..
T Consensus 147 ~DfG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws----------lG~il~elltg~~pf~~ 209 (332)
T cd05614 147 TDFGLSKEFLSEEK-------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWS----------LGILIFELLTGASPFTL 209 (332)
T ss_pred eeCcCCccccccCC-------CccccccCCccccCHHHhcCCCCCCCcccccc----------chhhhhhhhcCCCCCCC
Confidence 99999976533211 112235699999999998765 4788999999 78888888888888752
Q ss_pred ccccc-c-cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 763 MEIVD-P-SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 763 ~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
..... . .......... ...+...+..+.+++.+||+.||++|| +++++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 210 EGERNTQSEVSRRILKCD-------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCHHHHHHHHhcCC-------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 21111 0 1101111100 111223456788999999999999999 67787754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=315.14 Aligned_cols=244 Identities=21% Similarity=0.262 Sum_probs=192.3
Q ss_pred CceeccCcceEEEEEEEC---CCceEEEEEEeeccC----CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 536 SNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKY----KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.+.||+|+||.||+|+.. .+++.||+|+++... ......+.+|+++++.++||||+++++++...+ ..
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~-----~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG-----KL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC-----eE
Confidence 368999999999999873 468899999997431 122346788999999999999999999875544 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 146 (323)
T cd05584 76 YLILEYLSGGELFMHLEREG------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGL 146 (323)
T ss_pred EEEEeCCCCchHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcC
Confidence 99999999999999997654 578889999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
++...... .......||+.|+|||++.+..++.++|||| +|+++++++++..|+...+..
T Consensus 147 ~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~G~~pf~~~~~~-- 206 (323)
T cd05584 147 CKESIHEG--------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWS----------LGALMYDMLTGAPPFTAENRK-- 206 (323)
T ss_pred CeecccCC--------CcccccCCCccccChhhccCCCCCCcceecc----------cHHHHHHHhcCCCCCCCCCHH--
Confidence 87432211 1112346999999999999888999999999 888899999998887532211
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
........... ..+...++.+.+++.+||+.||++|| +++++++.
T Consensus 207 ~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 207 KTIDKILKGKL-------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred HHHHHHHcCCC-------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11111111111 11223456788999999999999999 78888764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=309.01 Aligned_cols=265 Identities=20% Similarity=0.304 Sum_probs=204.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcc-hhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA-SRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
....+.++||+|.||+|.++... .+.+||||.++...... ..+|.+|+++|.+++|||||+++|+|..++ .++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Pic 611 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLC 611 (807)
T ss_pred hheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chH
Confidence 34567899999999999999986 47999999998765544 478999999999999999999999998776 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+|||||++|+|.+++.++... ........+|+.||+.|++||.+. ++||||+.+.|+|+|.++++||+|||++
T Consensus 612 mI~EYmEnGDLnqFl~aheap----t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgms 684 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELP----TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMS 684 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCc----ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccc
Confidence 999999999999999987532 345566778999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
+-.-........ ...+-..+|||||.+.-+++++++|+|+ +|+++||++.........+.-|..
T Consensus 685 R~lysg~yy~vq------gr~vlpiRwmawEsillgkFttaSDvWa----------fgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 685 RNLYSGDYYRVQ------GRAVLPIRWMAWESILLGKFTTASDVWA----------FGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred cccccCCceeee------cceeeeeeehhHHHHHhccccchhhhhh----------hHHHHHHHHHHHhhCchhhhhHHH
Confidence 855433221111 1134567999999999999999999999 666777766654433322322222
Q ss_pred chhhhccc-cchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 770 LLMEVMTN-NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 770 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
...+...- .......-...+.-|+..+.++|.+||.+|-++|||++++...|.+.
T Consensus 749 vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 749 VVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22111000 00000011123445788999999999999999999999999988764
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.03 Aligned_cols=255 Identities=18% Similarity=0.240 Sum_probs=199.5
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
..++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~---- 116 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK---- 116 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence 456899999999999999999999999999999999642 1223345788999999999999999999865544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 117 -~~~lv~Ey~~gg~L~~~l~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~D 185 (370)
T cd05596 117 -YLYMVMEYMPGGDLVNLMSNY-------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLAD 185 (370)
T ss_pred -EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEe
Confidence 899999999999999998653 478889999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCC----CCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS----EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
||++........ .......||+.|+|||++.+. .++.++|||| +|+++|+++++..|+.
T Consensus 186 fG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwS----------lGvilyelltG~~Pf~ 248 (370)
T cd05596 186 FGTCMKMDANGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS----------VGVFLYEMLVGDTPFY 248 (370)
T ss_pred ccceeeccCCCc-------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeee----------hhHHHHHHHhCCCCcC
Confidence 999976543211 011234699999999987653 4789999999 8889999999998876
Q ss_pred ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCC--CCCHHHHHHH
Q 040925 762 VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFE--RMDMRDVVAK 820 (833)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 820 (833)
..... ............. ..+....++..+.+++.+|+..+|++ |||++|+++.
T Consensus 249 ~~~~~--~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 249 ADSLV--GTYSKIMDHKNSL---TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHH--HHHHHHHcCCCcC---CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 32211 1111111110000 00111124567889999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.15 Aligned_cols=252 Identities=23% Similarity=0.275 Sum_probs=199.0
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|++++++++||||+++++++...+ ..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-----AL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCC-----eE
Confidence 48889999999999999999988999999999864321 22345778999999999999999999865443 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++...... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNP----GFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 9999999999999888654321 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+........ .....||+.|+|||++.+..++.++|||| .|+++|+++++..|+........
T Consensus 149 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Diws----------~G~~l~el~~g~~pf~~~~~~~~ 209 (285)
T cd05605 149 AVEIPEGET---------IRGRVGTVGYMAPEVVKNERYTFSPDWWG----------LGCLIYEMIEGKSPFRQRKEKVK 209 (285)
T ss_pred ceecCCCCc---------cccccCCCCccCcHHhcCCCCCccccchh----------HHHHHHHHHHCCCCCCCCchhhH
Confidence 976533211 11246899999999999889999999999 78889999999888753221100
Q ss_pred -cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 769 -SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 769 -~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
......+. ......+..++..+.+++.+||..||++|| +++++++.
T Consensus 210 ~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 210 REEVERRVK------EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred HHHHHHHhh------hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00000000 001112234567789999999999999999 88888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.69 Aligned_cols=243 Identities=22% Similarity=0.277 Sum_probs=192.4
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|++..+++.||+|+++... ....+.+..|.++++.+ +||||+++++++...+ ..|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~-----~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD-----RLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----eEEEEE
Confidence 46999999999999999899999999997432 23345677889998876 7999999999976554 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 76 EYVNGGDLMFQIQRSR------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 9999999999987654 688999999999999999999999 9999999999999999999999999998753
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
..... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+..... .....
T Consensus 147 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws----------lG~il~el~tg~~Pf~~~~~--~~~~~ 206 (321)
T cd05591 147 ILNGV--------TTTTFCGTPDYIAPEILQELEYGPSVDWWA----------LGVLMYEMMAGQPPFEADNE--DDLFE 206 (321)
T ss_pred ccCCc--------cccccccCccccCHHHHcCCCCCCccceec----------hhHHHHHHhcCCCCCCCCCH--HHHHH
Confidence 32111 112356999999999999989999999999 88889999999888753221 11111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-------CHHHHHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-------DMRDVVAK 820 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-------t~~eil~~ 820 (833)
....... ..+..++..+.+++.+||+.||++|| +++++++.
T Consensus 207 ~i~~~~~-------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 207 SILHDDV-------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHcCCC-------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1111110 11122356788999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.77 Aligned_cols=254 Identities=20% Similarity=0.219 Sum_probs=194.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~-----~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD-----N 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC-----e
Confidence 47999999999999999999999999999999997542 223456889999999999999999999865544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg 147 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFG 147 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCC
Confidence 9999999999999999987532 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccC------CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM------GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
++......... ......||+.|+|||++. +..++.++|||| +|+++++++++..|+.
T Consensus 148 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diws----------lG~il~el~~g~~Pf~ 210 (330)
T cd05601 148 SAARLTANKMV-------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWS----------LGVIAYEMIYGRSPFH 210 (330)
T ss_pred CCeECCCCCce-------eeecccCCccccCHHHhccccccccCCCCCcceeec----------ccceeeeeccCCCCCC
Confidence 99866432211 111246899999999876 456789999999 5666666666766664
Q ss_pred ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 762 VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..... .............. .+.....+..+.+++..|+. +|++|||++++++.
T Consensus 211 ~~~~~--~~~~~i~~~~~~~~---~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 211 EGTSA--KTYNNIMNFQRFLK---FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCHH--HHHHHHHcCCCccC---CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 22110 00011111000000 00111235567889999997 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.07 Aligned_cols=265 Identities=20% Similarity=0.222 Sum_probs=205.8
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCC--
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDF-- 602 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 602 (833)
....++|++.+.||+|+||+||+|++..+++.||||+++... ......+.+|+.++..++|+||+++++.+...+.
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 344579999999999999999999999899999999997542 2234568889999999999999999877644321
Q ss_pred -CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcE
Q 040925 603 -KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681 (833)
Q Consensus 603 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 681 (833)
......++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~--~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKT--NRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCE
Confidence 1112468999999999999999754321 12689999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
||+|||+++........ .......||+.|+|||++.+..++.++|||| +|+++|+++++..|+.
T Consensus 183 kL~DFGls~~~~~~~~~------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwS----------lGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSD------DVGRTFCGTPYYVAPEIWRRKPYSKKADMFS----------LGVLLYELLTLKRPFD 246 (496)
T ss_pred EEEecccCeeccccccc------cccccccCCcceeCHHHhCCCCCCcHHHHHH----------HHHHHHHHHHCCCCCC
Confidence 99999999865432111 1122356999999999999999999999999 8888999999988875
Q ss_pred ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 762 VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..... .......... ....+..+++.+.+++.+||+.||++||++.++++.
T Consensus 247 ~~~~~--~~~~~~~~~~------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 247 GENME--EVMHKTLAGR------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCHH--HHHHHHhcCC------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 32110 1111111110 011223456778999999999999999999999864
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.37 Aligned_cols=258 Identities=18% Similarity=0.246 Sum_probs=198.7
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
+....++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~- 116 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK- 116 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-
Confidence 334457899999999999999999999999999999998642 1223456789999999999999999999976544
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
..|+||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+|
T Consensus 117 ----~~~lv~Ey~~gg~L~~~l~~~-------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~k 182 (370)
T cd05621 117 ----YLYMVMEYMPGGDLVNLMSNY-------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLK 182 (370)
T ss_pred ----EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEE
Confidence 899999999999999999653 478899999999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCC----CCcccccccCCcCCCccccCCccHHHHHHHhC
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE----ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTAL 758 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~ 758 (833)
|+|||+|........ .......||+.|||||++.+.. ++.++|||| .|+++|++++|..
T Consensus 183 L~DFG~a~~~~~~~~-------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwS----------lG~ilyell~G~~ 245 (370)
T cd05621 183 LADFGTCMKMDETGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS----------VGVFLFEMLVGDT 245 (370)
T ss_pred EEecccceecccCCc-------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEe----------ehHHHHHHHhCCC
Confidence 999999986543211 1112356999999999986543 788999999 8899999999999
Q ss_pred CCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCC--CCCHHHHHHH
Q 040925 759 PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFE--RMDMRDVVAK 820 (833)
Q Consensus 759 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 820 (833)
|+...... ............. ..+.....++.+.+++..|+..+|.+ |||++|+++.
T Consensus 246 Pf~~~~~~--~~~~~i~~~~~~~---~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 246 PFYADSLV--GTYSKIMDHKNSL---NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCCCHH--HHHHHHHhCCccc---CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 87632211 1111111110000 00111234566788888899755543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=311.12 Aligned_cols=264 Identities=23% Similarity=0.399 Sum_probs=212.7
Q ss_pred HHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 525 ELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 525 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
+++-...+....++||-|.||.||.|.|+...-.||||.++.. ....++|.+|+.+|+.++|||+|+++|+|....
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep--- 336 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP--- 336 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC---
Confidence 3333444566778999999999999999999999999999743 445789999999999999999999999998766
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
-+|||+|||..|+|.+|+.+..+. .++.-..+.++.||+.|+.||..+ ++|||||..+|.|++++..||++
T Consensus 337 --PFYIiTEfM~yGNLLdYLRecnr~----ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvA 407 (1157)
T KOG4278|consen 337 --PFYIITEFMCYGNLLDYLRECNRS----EVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVA 407 (1157)
T ss_pred --CeEEEEecccCccHHHHHHHhchh----hcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEee
Confidence 789999999999999999887643 577788899999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhC-CCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTAL-PEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~-p~~~~ 763 (833)
|||+++.+..+.+.... +..-...|.|||-+....++.|+|||+ +|+.+||+++-.. |+.
T Consensus 408 DFGLsRlMtgDTYTAHA-------GAKFPIKWTAPEsLAyNtFSiKSDVWA----------FGVLLWEIATYGMsPYP-- 468 (1157)
T KOG4278|consen 408 DFGLSRLMTGDTYTAHA-------GAKFPIKWTAPESLAYNTFSIKSDVWA----------FGVLLWEIATYGMSPYP-- 468 (1157)
T ss_pred ccchhhhhcCCceeccc-------CccCcccccCcccccccccccchhhHH----------HHHHHHHHHhcCCCCCC--
Confidence 99999999876554322 122456899999999999999999999 5556666655322 221
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
.+|.....+...+.+ ....++.|++.+.++|..||+++|.+||++.||.+.++.+..
T Consensus 469 -GidlSqVY~LLEkgy-----RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 469 -GIDLSQVYGLLEKGY-----RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -CccHHHHHHHHhccc-----cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 122222222222211 122356789999999999999999999999999999998864
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=309.02 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=201.9
Q ss_pred hcCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|.+.+.||+|+||.||+|+... +++.||||.++..... ..+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD-- 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC--
Confidence 3568899999999999999998743 3678999999755443 4568999999999999999999999976554
Q ss_pred CCceEeEEEEecCCCChhhhhccCCC--------ccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDD--------QVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL 675 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll 675 (833)
..++||||+++|+|.+++...+. ......+++.++..++.|++.|++|||+. +++||||||+||++
T Consensus 82 ---~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili 155 (280)
T cd05049 82 ---PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLV 155 (280)
T ss_pred ---CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEE
Confidence 79999999999999999976532 11123578999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH
Q 040925 676 DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK 755 (833)
Q Consensus 676 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~ 755 (833)
+.++.+||+|||.++........ .......+++.|+|||++.+..++.++|||| +|++++++++
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~e~~~ 219 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWS----------FGVVLWEIFT 219 (280)
T ss_pred cCCCeEEECCcccceecccCcce------ecCCCCcccceecChhhhccCCcchhhhHHH----------HHHHHHHHHh
Confidence 99999999999999754332110 0111234678999999999999999999999 7777888887
Q ss_pred -HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 756 -TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 756 -~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
+..|+..... .... +...... ....+..++..+.+++.+||..||++|||++||++.|+
T Consensus 220 ~g~~p~~~~~~--~~~~-~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 220 YGKQPWYGLSN--EEVI-ECITQGR-----LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred cCCCCCCCCCH--HHHH-HHHHcCC-----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 7766542111 1111 1111100 01112235677899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.22 Aligned_cols=267 Identities=21% Similarity=0.330 Sum_probs=201.9
Q ss_pred hcCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 602 (833)
.++|++.+.||+|+||.||+|...+ +++.||+|+++.... ...+.+.+|+.+++++ +||||++++++|...+
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~- 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG- 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC-
Confidence 3579999999999999999997533 457899999874322 2235678899999999 7999999999875433
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCc----------------------------------------------------
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQ---------------------------------------------------- 630 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------- 630 (833)
...+++|||+++|+|.+++......
T Consensus 85 ---~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 85 ---GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred ---CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4788999999999999998643210
Q ss_pred ---cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCcc
Q 040925 631 ---VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707 (833)
Q Consensus 631 ---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~ 707 (833)
.....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.+....... ..
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~------~~ 232 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV------RK 232 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh------hc
Confidence 0012688999999999999999999999 99999999999999999999999999998764322111 01
Q ss_pred ccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchhhhccccchhhhhhh
Q 040925 708 IGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKR 786 (833)
Q Consensus 708 ~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 786 (833)
....++..|+|||++.+..++.++|||| +|++++++++ +..|+.... .+.... ....... ..
T Consensus 233 ~~~~~~~~y~aPE~~~~~~~~~~~Di~S----------lGv~l~el~t~g~~p~~~~~-~~~~~~-~~~~~~~-----~~ 295 (337)
T cd05054 233 GDARLPLKWMAPESIFDKVYTTQSDVWS----------FGVLLWEIFSLGASPYPGVQ-IDEEFC-RRLKEGT-----RM 295 (337)
T ss_pred cCCCCCccccCcHHhcCCCCCccccHHH----------HHHHHHHHHHcCCCCCCCCC-ccHHHH-HHHhccC-----CC
Confidence 1234677899999999999999999999 7788888876 766654211 111111 1111100 00
Q ss_pred hchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 787 VKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 787 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
..+..+...+.+++.+||+.+|++||++.|+++.|+.+.+
T Consensus 296 ~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122345678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.56 Aligned_cols=241 Identities=21% Similarity=0.267 Sum_probs=190.0
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|++..+++.||+|.++... .........|.+++... +||+|+++++++...+ ..|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE-----HLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC-----EEEEEE
Confidence 47999999999999999999999999997532 23345667788888765 8999999999976544 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 E~~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 76 EFLNGGDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 9999999999987654 688999999999999999999999 9999999999999999999999999998743
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.... .......||+.|+|||++.+..++.++|||| .|+++++++++..|+...+. ... .
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lGvil~el~~g~~Pf~~~~~--~~~-~ 205 (316)
T cd05620 147 VFGD--------NRASTFCGTPDYIAPEILQGLKYTFSVDWWS----------FGVLLYEMLIGQSPFHGDDE--DEL-F 205 (316)
T ss_pred ccCC--------CceeccCCCcCccCHHHHcCCCCCcccchhh----------hHHHHHHHHhCCCCCCCCCH--HHH-H
Confidence 2111 1122356999999999999999999999999 88899999999988753221 111 1
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHH-HHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMR-DVV 818 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil 818 (833)
+.+.... ...+..+...+.+++.+||+.||++||++. ++.
T Consensus 206 ~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 206 ESIRVDT------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHhCC------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111100 001112355678999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=303.32 Aligned_cols=255 Identities=26% Similarity=0.421 Sum_probs=200.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|++|.||+|.+. +++.||+|.++... ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 77 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEE-----PIY 77 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCC-----Cee
Confidence 457999999999999999999986 56789999987443 33567899999999999999999999875544 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++...... .+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||++
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~ 150 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGR----ALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLA 150 (261)
T ss_pred eeeecccCCcHHHHHhccCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceE
Confidence 999999999999999765421 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
+......... ..+..++..|+|||+..+..++.++|||| +|++++++++ +..|+.... ..
T Consensus 151 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~el~t~g~~p~~~~~--~~ 211 (261)
T cd05068 151 RVIKEDIYEA-------REGAKFPIKWTAPEAALYNRFSIKSDVWS----------FGILLTEIVTYGRMPYPGMT--NA 211 (261)
T ss_pred EEccCCcccc-------cCCCcCceeccCccccccCCCCchhhHHH----------HHHHHHHHHhcCCCCCCCCC--HH
Confidence 8765322111 11122356899999999889999999999 7888888887 776654211 11
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
.... .+..... ...+..++..+.+++.+||+.+|++||+++++.+.|++
T Consensus 212 ~~~~-~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 212 EVLQ-QVDQGYR-----MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHH-HHHcCCC-----CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1111 1111100 01122346778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=309.40 Aligned_cols=251 Identities=28% Similarity=0.497 Sum_probs=189.2
Q ss_pred cCceeccCcceEEEEEEEC----CCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 535 SSNMIGQGSFGYVYKGTLG----EDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 535 ~~~~lg~G~~g~Vy~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+.+.||.|+||.||+|.+. ..+..|+||.++..... ..+.+.+|++.+++++||||++++|++...+ ..+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~-----~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE-----PLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS-----SEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccc-----ccc
Confidence 4578999999999999997 45788999999654332 3678999999999999999999999987444 589
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++...... .+++.++..|+.||++||+|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~----~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~ 150 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKE----PLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLS 150 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTT----TSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTG
T ss_pred ccccccccccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 999999999999999987222 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
.......... ......+...|+|||++.+..++.++|||| +|+.++|+++ +..|+.... ..
T Consensus 151 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~ksDVys----------fG~~l~ei~~~~~~p~~~~~--~~ 212 (259)
T PF07714_consen 151 RPISEKSKYK------NDSSQQLPLRYLAPEVLKDGEYTKKSDVYS----------FGMLLYEILTLGKFPFSDYD--NE 212 (259)
T ss_dssp EETTTSSSEE------ESTTSESGGGGS-HHHHHHSEESHHHHHHH----------HHHHHHHHHTTSSGTTTTSC--HH
T ss_pred cccccccccc------cccccccccccccccccccccccccccccc----------cccccccccccccccccccc--cc
Confidence 8763221110 111234778999999998888999999999 7778888887 455543211 11
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
...... .... ....+..++..+.+++.+||..||++|||++++++.|
T Consensus 213 ~~~~~~-~~~~-----~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 213 EIIEKL-KQGQ-----RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHHHHH-HTTE-----ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccc-cccc-----cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111111 1111 1112233567788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=304.76 Aligned_cols=265 Identities=25% Similarity=0.390 Sum_probs=201.1
Q ss_pred CccCceeccCcceEEEEEEECCC---ceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCC-CCCc
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDF-KGTD 606 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 606 (833)
|.+.+.||+|+||.||+|....+ +..||+|.++.... .....+.+|++.++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56789999999999999987543 47899999875422 234578999999999999999999998765442 2334
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..+++|||+++|+|.+++...........+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 5799999999999999986543222223689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
|+++.......... .....++..|+|||++.+..++.++|||| +|++++++++ +..|+....
T Consensus 158 g~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~S----------lG~il~el~~~g~~p~~~~~- 220 (273)
T cd05035 158 GLSKKIYSGDYYRQ------GRIAKMPVKWIAIESLADRVYTSKSDVWA----------FGVTMWEIATRGQTPYPGVE- 220 (273)
T ss_pred cceeeccccccccc------cccccCCccccCHhhcccCCCCcccchHH----------HHHHHHHHHhCCCCCCCCCC-
Confidence 99986644321110 11123567899999998888999999999 7778888877 666653211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
............ ....+..++..+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 221 -~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 221 -NHEIYDYLRHGN------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -HHHHHHHHHcCC------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111111111 0111234567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.54 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=206.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|++|.||+|....+++.||+|.++... ....+.+.+|++++++++|++|+++++++...+ .
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~-----~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN-----E 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC-----e
Confidence 57999999999999999999999899999999986422 223567899999999999999999999976544 7
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~ 151 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhccc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccc
Confidence 89999999999999998653221 12589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++........ ......|++.|+|||++.+..++.++|||| +|++++++.++..|+......-
T Consensus 152 ~~~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~~~ 213 (267)
T cd08224 152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWS----------LGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred eeeeccCCCc--------ccceecCCccccCHHHhccCCCCchhcHHH----------HHHHHHHHHHCCCCcccCCccH
Confidence 9876543211 111245889999999998888999999999 7888889988888764222100
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
............ .......++..+.+++.+||..+|++|||+.+|++.++++.
T Consensus 214 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 214 YSLCKKIEKCDY-----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred HHHHhhhhcCCC-----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 001000000000 00111245667899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=305.71 Aligned_cols=259 Identities=22% Similarity=0.341 Sum_probs=197.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCce----EEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEM----IVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
++|++.+.||+|+||.||+|.+..+++ .||+|.+..... ....++..|+..+++++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 478899999999999999999876665 477787753322 233567888889999999999999998642
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...+++|||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~D 152 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIAD 152 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcC
Confidence 246789999999999999976432 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||.++........ .......++..|+|||++.+..++.++|||| +|++++++++ +..|+....
T Consensus 153 fg~~~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s----------lG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 153 FGVADLLYPDDKK------YFYSEHKTPIKWMALESILFGRYTHQSDVWS----------YGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred CccceeccCCCcc------cccCCCCCcccccCHHHhccCCcCchhhHHH----------HHHHHHHHHcCCCCCCCCCC
Confidence 9999865432211 1112234778899999998888999999999 7777888876 666654211
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
+....+........ ..+..++..+.+++.+||..||++|||+.|+++.+..+.++
T Consensus 217 ---~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 217 ---PHEVPDLLEKGERL-----AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred ---HHHHHHHHHCCCcC-----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11111111111100 01112345678899999999999999999999999887764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=312.77 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=190.5
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|++..+++.||||+++... .........|..++... +||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~-----~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE-----NLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC-----EEEEEE
Confidence 47999999999999999899999999997542 23345567788888765 8999999999976554 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 ey~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 76 EYLNGGDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999999999997643 688999999999999999999999 9999999999999999999999999998743
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.... .......||+.|+|||++.+..++.++|||| .|+++++++++..|+..... ....
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws----------lG~il~el~~G~~pf~~~~~---~~~~ 205 (316)
T cd05619 147 MLGD--------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWS----------FGVLLYEMLIGQSPFHGHDE---EELF 205 (316)
T ss_pred CCCC--------CceeeecCCccccCHHHHcCCCCCchhhhhh----------HHHHHHHHHhCCCCCCCCCH---HHHH
Confidence 2211 1112356999999999999999999999999 88899999999888753221 1111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHH-HHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMR-DVVA 819 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~ 819 (833)
..+.... ...+......+.+++.+||..||++||++. ++.+
T Consensus 206 ~~i~~~~------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 206 QSIRMDN------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHhCC------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1111000 011122455678999999999999999997 5643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.68 Aligned_cols=190 Identities=27% Similarity=0.368 Sum_probs=166.3
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-C-----CccceEeeEeecCCCCCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-H-----RNLIKIITICSSTDFKGT 605 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 605 (833)
+|.+.+.||+|+||+|.+|.+..+++.||||+++.. ....++...|+.+|..++ | -|+|++++++...+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~---- 261 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN---- 261 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc----
Confidence 899999999999999999999999999999999743 334567788999999996 4 48999999966554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC--CcEEE
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD--MVAHV 683 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL 683 (833)
+.|||+|.++. +|+++++.+... .++...++.++.||+.||.+||+. +|||+||||||||+.+- ..+||
T Consensus 262 -HlciVfELL~~-NLYellK~n~f~----Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 262 -HLCIVFELLST-NLYELLKNNKFR----GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred -ceeeeehhhhh-hHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 99999999964 999999988754 799999999999999999999999 99999999999999754 37999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccC
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNE 746 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~ 746 (833)
+|||.|+.....-. .++.+..|+|||++.|.+|+.+.||||.||+..|++.+
T Consensus 333 IDFGSSc~~~q~vy-----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG 384 (586)
T KOG0667|consen 333 IDFGSSCFESQRVY-----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG 384 (586)
T ss_pred EecccccccCCcce-----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcC
Confidence 99999987654321 35688999999999999999999999999988887643
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=306.43 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=195.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|++|.||+|++..+++.||+|.+.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVEN-----RIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECC-----EEE
Confidence 36888999999999999999998899999999986542 223457889999999999999999999976654 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|..+. .+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++
T Consensus 76 lv~e~~~~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~ 142 (279)
T cd06619 76 ICTEFMDGGSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVS 142 (279)
T ss_pred EEEecCCCCChHHhh----------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 999999999997542 467888999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
....... .....||+.|+|||++.+..++.++|+|| +|++++++.++..|+.........
T Consensus 143 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws----------lG~~l~~l~~g~~pf~~~~~~~~~ 202 (279)
T cd06619 143 TQLVNSI----------AKTYVGTNAYMAPERISGEQYGIHSDVWS----------LGISFMELALGRFPYPQIQKNQGS 202 (279)
T ss_pred eeccccc----------ccCCCCChhhcCceeecCCCCCCcchHHH----------HHHHHHHHHhCCCCchhhcccccc
Confidence 7653321 11246899999999999989999999999 788888888888886532111110
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......................+..+.+++.+||..||++||+++|+++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 203 LMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred cchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000000000000000011112244568899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=306.77 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=200.5
Q ss_pred CC-ccCceeccCcceEEEEEEE----CCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 532 EF-SSSNMIGQGSFGYVYKGTL----GEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 532 ~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
+| ++.+.||+|+||+||++.. ..++..||+|.++.... .....+.+|++++++++||||+++++++.... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQG---G 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence 45 8899999999999988653 34678899999975432 23567889999999999999999999875432 3
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++|+|.+++... .+++.+++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~d 150 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGD 150 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEee
Confidence 4689999999999999999753 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc-
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME- 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~- 764 (833)
||+++........... .....++..|+|||+..+..++.++|||| +|+++++++++..|+....
T Consensus 151 fg~~~~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Di~s----------lG~~l~el~tg~~p~~~~~~ 215 (283)
T cd05080 151 FGLAKAVPEGHEYYRV-----REDGDSPVFWYAVECLKENKFSYASDVWS----------FGVTLYELLTHCDSKQSPPK 215 (283)
T ss_pred cccccccCCcchhhcc-----CCCCCCCceeeCHhHhcccCCCcccccHH----------HHHHHHHHHhCCCCCCCCcc
Confidence 9999866442211100 11123567799999998888999999999 7888888888877754211
Q ss_pred ----cccccchhhhccc--cchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 765 ----IVDPSLLMEVMTN--NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 765 ----~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
..+.......... ...........+..++..+.+++.+||+.||++|||++++++.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 216 KFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 1111000000000 000000000112335678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=303.25 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=199.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|.+..+ ...||||.++.... .....+.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 78 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR---- 78 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC----
Confidence 35799999999999999999998643 46799999875433 23457889999999999999999999875544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++++|.+++..... .+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+||+|
T Consensus 79 -~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~d 149 (266)
T cd05033 79 -PVMIITEYMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSD 149 (266)
T ss_pred -ceEEEEEcCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECc
Confidence 78999999999999999976432 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||+++......... ......+++.|+|||.+.+..++.++|||| +|+.++++++ +..|+....
T Consensus 150 fg~~~~~~~~~~~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~s----------lG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 150 FGLSRRLEDSEATY------TTKGGKIPIRWTAPEAIAYRKFTSASDVWS----------FGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cchhhcccccccce------eccCCCCCccccChhhhccCCCccccchHH----------HHHHHHHHHccCCCCCCCCC
Confidence 99998764211100 011123567899999999889999999999 6667777665 655553211
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
+...... +.... ....+.+++..+.+++.+||+.+|++||+++||++.|+++
T Consensus 214 --~~~~~~~-~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 214 --NQDVIKA-VEDGY-----RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --HHHHHHH-HHcCC-----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111111 11110 0011233466789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=303.51 Aligned_cols=252 Identities=23% Similarity=0.384 Sum_probs=195.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
++|++.+.||+|++|.||+|.+. .+..||+|.++... ...+.+.+|+.++++++||||+++++++...+ ..++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 76 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-----PIYI 76 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-----CcEE
Confidence 46889999999999999999886 35569999987432 33467899999999999999999999976544 6799
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~ 148 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccce
Confidence 9999999999999976432 589999999999999999999999 99999999999999999999999999987
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPS 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~ 769 (833)
......... .....++..|+|||+..+..++.++|||| +|++++++++ +..|+..... +.
T Consensus 149 ~~~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Di~s----------lG~~l~~l~~~g~~p~~~~~~--~~ 209 (256)
T cd05113 149 YVLDDEYTS-------SVGSKFPVRWSPPEVLLYSKFSSKSDVWA----------FGVLMWEVYSLGKMPYERFNN--SE 209 (256)
T ss_pred ecCCCceee-------cCCCccChhhCCHHHHhcCcccchhHHHH----------HHHHHHHHhcCCCCCcCcCCH--HH
Confidence 654432111 11223667899999998888999999999 6777777776 6666542211 11
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
........... ..+...+..+.+++.+||+.||++|||+.++++.++
T Consensus 210 ~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 210 TVEKVSQGLRL------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHhcCCCC------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11111111110 011123567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=301.37 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=191.5
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
+.||+|+||.||+|++..+++.||+|.+..... .....+.+|++++++++||||+++++++.... ..++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----PIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-----CeEEEEeec
Confidence 479999999999999988999999998864322 23467899999999999999999999976544 789999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+......
T Consensus 76 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 76 QGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred cCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence 99999999975431 588999999999999999999999 9999999999999999999999999998754432
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchhhh
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLMEV 774 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~ 774 (833)
..... .....++..|+|||.+.+..++.++|||| +|++++++++ +..|+......+ . ...
T Consensus 148 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~il~e~~~~~~~p~~~~~~~~--~-~~~ 208 (252)
T cd05084 148 VYAST------GGMKQIPVKWTAPEALNYGRYSSESDVWS----------FGILLWEAFSLGAVPYANLSNQQ--T-REA 208 (252)
T ss_pred ccccc------CCCCCCceeecCchhhcCCCCChHHHHHH----------HHHHHHHHHhCCCCCccccCHHH--H-HHH
Confidence 11000 00112356799999998888999999999 6777777775 555543211100 0 011
Q ss_pred ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 775 MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
..... ....+..++..+.+++.+||..||++|||+.|+.+.|+
T Consensus 209 ~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 209 IEQGV-----RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHcCC-----CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 10000 01112234667899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=314.31 Aligned_cols=238 Identities=26% Similarity=0.299 Sum_probs=185.7
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHH-HHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||+||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~-----~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD-----KLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC-----EEEEEE
Confidence 47999999999999999999999999996432 122334455554 567889999999999875544 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 76 DYVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred cCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 9999999999987654 688999999999999999999999 9999999999999999999999999998753
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.... .......||+.|+|||++.+..++.++|||| +|+++++++++..|+...+.. ....
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws----------lG~il~ell~g~~pf~~~~~~--~~~~ 206 (323)
T cd05575 147 IEHS--------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC----------LGAVLYEMLYGLPPFYSRDTA--EMYD 206 (323)
T ss_pred ccCC--------CccccccCChhhcChhhhcCCCCCccccccc----------cchhhhhhhcCCCCCCCCCHH--HHHH
Confidence 2211 1122356999999999999999999999999 788888888888887532211 1111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMR 815 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 815 (833)
....... ......+..+.+++.+|++.||++||++.
T Consensus 207 ~i~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 207 NILNKPL-------RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHcCCC-------CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1111111 01122356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=313.63 Aligned_cols=242 Identities=21% Similarity=0.261 Sum_probs=192.8
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCce
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 607 (833)
+|++.+.||+|+||.||+|++..+++.||+|+++... ....+....|.+++..+ +|++|+++++++...+ .
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD-----R 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC-----E
Confidence 5888999999999999999999999999999997432 22234567788888877 5899999999865544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG 146 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCC
Confidence 999999999999999987654 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+++....... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+.....
T Consensus 147 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lGvil~elltg~~Pf~~~~~-- 206 (323)
T cd05616 147 MCKENMWDGV--------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWA----------FGVLLYEMLAGQAPFEGEDE-- 206 (323)
T ss_pred CceecCCCCC--------ccccCCCChhhcCHHHhcCCCCCCccchhc----------hhHHHHHHHhCCCCCCCCCH--
Confidence 9875432111 112356999999999999999999999999 88899999999988753221
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
............ ..+...+..+.+++.+|++.||++|++.
T Consensus 207 ~~~~~~i~~~~~-------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 207 DELFQSIMEHNV-------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHHHHHHHhCCC-------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111111111111 1122345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=306.11 Aligned_cols=246 Identities=23% Similarity=0.300 Sum_probs=191.7
Q ss_pred eccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 539 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
||+|+||.||+|+...+++.||+|.+.... ....+.+..|++++++++||||+++++++.... ..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~-----~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKT-----HLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCC-----eEEEEEecC
Confidence 699999999999999899999999986321 122345667999999999999999999865544 899999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++|+|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 76 ~g~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~ 148 (277)
T cd05607 76 NGGDLKYHIYNVGER----GLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG 148 (277)
T ss_pred CCCCHHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC
Confidence 999999888654422 588999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc-cccccch-hh
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME-IVDPSLL-ME 773 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~-~~~~~~~-~~ 773 (833)
.. .....||+.|+|||++.+..++.++|||| .|+++++++++..|+.... ....... ..
T Consensus 149 ~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws----------lGv~l~el~~g~~p~~~~~~~~~~~~~~~~ 209 (277)
T cd05607 149 KT---------ITQRAGTNGYMAPEILKEEPYSYPVDWFA----------MGCSIYEMVAGRTPFKDHKEKVAKEELKRR 209 (277)
T ss_pred ce---------eeccCCCCCccCHHHHccCCCCCchhHHH----------HHHHHHHHHhCCCCCCCCcchhhHHHHHHH
Confidence 11 11235899999999999888999999999 8889999999998875211 1111110 00
Q ss_pred hccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 774 VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
..... .......++..+.+++.+||+.||++||+++|+++.+
T Consensus 210 ~~~~~------~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 210 TLEDE------VKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred hhccc------cccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 00000 0011123466789999999999999999997766443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=304.60 Aligned_cols=262 Identities=23% Similarity=0.295 Sum_probs=205.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|++|.||+|++..+++.||||.+..... .....+.+|+++++.++||||+++++++...+ .
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-----E 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-----e
Confidence 478899999999999999999988999999998864322 23357889999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.+++|||+++++|.+++...... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg 151 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLG 151 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcch
Confidence 89999999999999998743211 12689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++........ ......|++.|+|||+..+..++.++|+|| +|+++++++++..|+.....-.
T Consensus 152 ~~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~p~~~~~~~~ 213 (267)
T cd08229 152 LGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWS----------LGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred hhhccccCCc--------ccccccCCcCccCHHHhcCCCccchhhHHH----------HHHHHHHHHhCCCCcccccchH
Confidence 9876543221 112345899999999998888999999999 7888888888888764211100
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
.......... .........++..+.+++.+||..||++|||+.+|++.++++.
T Consensus 214 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 214 YSLCKKIEQC-----DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred HHHhhhhhcC-----CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0110000000 0011112345678999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=305.04 Aligned_cols=265 Identities=23% Similarity=0.393 Sum_probs=198.1
Q ss_pred CccCceeccCcceEEEEEEECCCce--EEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCC-CCCce
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEM--IVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDF-KGTDF 607 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 607 (833)
|.+.+.||+|+||.||+|++..++. .||+|.++... ....+.+.+|+++++.++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999999876664 68999986432 2335678899999999999999999998754321 12235
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.+++|||+++|+|.+++...........+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 789999999999999875332111122589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~ 766 (833)
+++.+........ .....+++.|+|||+..+..++.++|||| +|++++++++ +..|+....
T Consensus 158 ~~~~~~~~~~~~~------~~~~~~~~~~~~pe~~~~~~~~~~~Di~s----------lG~il~el~~~g~~p~~~~~-- 219 (272)
T cd05075 158 LSKKIYNGDYYRQ------GRIAKMPVKWIAIESLADRVYTTKSDVWS----------FGVTMWEIATRGQTPYPGVE-- 219 (272)
T ss_pred cccccCcccceec------CCcccCCcccCCHHHccCCCcChHHHHHH----------HHHHHHHHHcCCCCCCCCCC--
Confidence 9987644321100 01123677899999999989999999999 7777888877 555553211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
.... .+...... .......++..+.+++.+||+.||++|||++++++.|+++
T Consensus 220 ~~~~-~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 220 NSEI-YDYLRQGN-----RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHH-HHHHHcCC-----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 11111110 0011223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.61 Aligned_cols=422 Identities=28% Similarity=0.364 Sum_probs=338.2
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|+.||+++|++. ..|..+..+.+|+.|+++.|-| ...|.+..++.+|++|+|.+|++. ..|..+..+.+|++|++|.
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i-~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI-RSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhH-hhCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 678999999998 7999999999999999999999 678888999999999999999998 7899999999999999999
Q ss_pred cccccccCchhhcCCCC-------------------ccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCcc
Q 040925 81 NRFSGNLPFDIVVNLPN-------------------LKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFS 141 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~-------------------L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~ 141 (833)
|.+. .+|.-++ .+.. ++.++|..|.+.+.++..+..+++ .|||++|.+. .....
T Consensus 124 N~f~-~~Pl~i~-~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls 196 (1081)
T KOG0618|consen 124 NHFG-PIPLVIE-VLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLS 196 (1081)
T ss_pred hccC-CCchhHH-hhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhh
Confidence 9986 6775442 3333 444555555555555555544444 4788888776 33566
Q ss_pred CCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhc
Q 040925 142 SLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRN 221 (833)
Q Consensus 142 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~ 221 (833)
.+.+|+.|.++.|++..+.. ..++|+.|+.++|.++...+ .-.+..++.++++.|++++ .|+.++.
T Consensus 197 ~~~~l~~l~c~rn~ls~l~~----------~g~~l~~L~a~~n~l~~~~~---~p~p~nl~~~dis~n~l~~-lp~wi~~ 262 (1081)
T KOG0618|consen 197 NLANLEVLHCERNQLSELEI----------SGPSLTALYADHNPLTTLDV---HPVPLNLQYLDISHNNLSN-LPEWIGA 262 (1081)
T ss_pred hccchhhhhhhhcccceEEe----------cCcchheeeeccCcceeecc---ccccccceeeecchhhhhc-chHHHHh
Confidence 77778888888887765432 34788888999998872222 1234568889999999994 4599999
Q ss_pred CCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCC-cccee
Q 040925 222 LVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQ-NLMSF 300 (833)
Q Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L 300 (833)
+.+|+.+...+|++. ..|..+....+|+.|.+.+|.+. -+|....+++.|++|+|..|+|....+..|.-+. +|..|
T Consensus 263 ~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~l 340 (1081)
T KOG0618|consen 263 CANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTL 340 (1081)
T ss_pred cccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHH
Confidence 999999999999996 77888888999999999999998 6777888899999999999999854444444444 38888
Q ss_pred ecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCcc
Q 040925 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSF 380 (833)
Q Consensus 301 ~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 380 (833)
+.+.|++. ..|..-......++.|++.+|.++...-..+.+.+.|+.|+|++|++...+...+.++..|++|+||+|+|
T Consensus 341 n~s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL 419 (1081)
T KOG0618|consen 341 NVSSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKL 419 (1081)
T ss_pred hhhhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchh
Confidence 88999988 66644444444557899999999988777888999999999999999877777899999999999999999
Q ss_pred ccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCcccc-CCCCccCCCccccccCCcCC
Q 040925 381 HGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEV-PTKGVFSNKTKISLQGNMKL 452 (833)
Q Consensus 381 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~-~~~~~~~~~~~l~l~~N~~~ 452 (833)
+ .+|.....+..|++|...+|+|. ..| .+..++.|+.+|++.|+++... |....+++++.+++.||.|.
T Consensus 420 ~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l 489 (1081)
T KOG0618|consen 420 T-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL 489 (1081)
T ss_pred h-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence 9 56788999999999999999998 677 7889999999999999998644 33334588999999999873
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.47 Aligned_cols=243 Identities=22% Similarity=0.263 Sum_probs=193.5
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|++..+++.||+|+++... ......+..|.++++.+ +||||+++++++...+ ..|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~-----~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD-----RLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC-----EEEEEE
Confidence 47999999999999999899999999997432 23345677899999888 6999999999875544 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 76 EYVNGGDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 9999999999987654 689999999999999999999999 9999999999999999999999999998743
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.... .......||+.|+|||++.+..++.++|||| +|++++++++|..|+...+. .....
T Consensus 147 ~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws----------lGvil~~l~~G~~pf~~~~~--~~~~~ 206 (318)
T cd05570 147 ILGG--------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWA----------LGVLLYEMLAGQSPFEGDDE--DELFQ 206 (318)
T ss_pred CcCC--------CcccceecCccccCHHHhcCCCCCcchhhhh----------HHHHHHHHhhCCCCCCCCCH--HHHHH
Confidence 2211 1112346999999999999999999999999 88889999999888753221 11111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH-----HHHHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM-----RDVVAK 820 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~~ 820 (833)
....... ..+...+..+.+++.+||..||++|||+ .++++.
T Consensus 207 ~i~~~~~-------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 207 SILEDEV-------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHcCCC-------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1111111 1112345678899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=306.22 Aligned_cols=261 Identities=22% Similarity=0.356 Sum_probs=201.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCce----EEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEM----IVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
..+|++.+.||+|+||.||+|++..+++ .||+|+++.... ...+.+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence 3578999999999999999999866665 489999864432 2346788999999999999999999997543
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..+++|||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 82 --~~~l~~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~ 151 (279)
T cd05109 82 --TVQLVTQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKIT 151 (279)
T ss_pred --CcEEEEEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEEC
Confidence 46799999999999999976432 589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~ 763 (833)
|||+++.......... .....+++.|+|||+..+..++.++|||| +|++++++++ +..|+...
T Consensus 152 dfG~~~~~~~~~~~~~------~~~~~~~~~y~~PE~~~~~~~~~~~Di~s----------lG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 152 DFGLARLLDIDETEYH------ADGGKVPIKWMALESILHRRFTHQSDVWS----------YGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred CCCceeecccccceee------cCCCccchhhCCHHHhccCCCCchhHHHH----------HHHHHHHHHcCCCCCCCCC
Confidence 9999987643221110 11123577899999998889999999999 7777888776 66665421
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
.. ........... ....+..++..+.+++.+||..||++||++.++++.++.+..+.
T Consensus 216 ~~---~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 216 PA---REIPDLLEKGE-----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CH---HHHHHHHHCCC-----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 11 10011111110 00112234667889999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=306.75 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=192.9
Q ss_pred eccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 539 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
||+|+||+||+|.+..+++.||+|.+..... ...+.+..|+++++.++||||+++.+++.... ..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKT-----DLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCC-----eEEEEEeCC
Confidence 6999999999999999999999999864321 12356778999999999999999998865443 799999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 76 ~~g~L~~~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 150 (280)
T cd05608 76 NGGDLRYHIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150 (280)
T ss_pred CCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC
Confidence 999999887543211 12689999999999999999999999 9999999999999999999999999999765432
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc-ccc-cchhh
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI-VDP-SLLME 773 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~-~~~-~~~~~ 773 (833)
.. ......||+.|+|||++.+..++.++|||| +|+++++++++..|+..... ... .....
T Consensus 151 ~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws----------lG~il~el~~g~~pf~~~~~~~~~~~~~~~ 212 (280)
T cd05608 151 QS--------KTKGYAGTPGFMAPELLQGEEYDFSVDYFA----------LGVTLYEMIAARGPFRARGEKVENKELKQR 212 (280)
T ss_pred Cc--------cccccCCCcCccCHHHhcCCCCCccccHHH----------HHHHHHHHHhCCCCCCCCCcchhHHHHHHh
Confidence 21 112346999999999999999999999999 88899999999988753211 111 11111
Q ss_pred hccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 774 VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
.... ....+..++..+.+++.+||+.||++|| +++++++.
T Consensus 213 ~~~~-------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 213 ILND-------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred hccc-------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 0000 0111234567788999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.44 Aligned_cols=261 Identities=21% Similarity=0.280 Sum_probs=194.2
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhc---CCCccceEeeEeecCCCCCCc
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNI---RHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 606 (833)
+|++.+.||+|+||.||+|++..+++.||+|.++.... .....+.+|+++++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 58899999999999999999999999999999875422 2234566788877766 699999999998665444455
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||++ ++|.+++...... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~df 152 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPP----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADF 152 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcc
Confidence 7899999997 4899988765422 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++....... .....||+.|+|||++.+..++.++|||| .|+++++++++..++......
T Consensus 153 g~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Diws----------lG~~l~~l~~g~~~f~~~~~~ 213 (288)
T cd07863 153 GLARIYSCQMA---------LTPVVVTLWYRAPEVLLQSTYATPVDMWS----------VGCIFAEMFRRKPLFCGNSEA 213 (288)
T ss_pred CccccccCccc---------CCCccccccccCchHhhCCCCCCcchhhh----------HHHHHHHHHhCCcCcCCCCHH
Confidence 99986543211 11245899999999999889999999999 667777777666554311100
Q ss_pred cc--------------cchhhh--ccccch--hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 767 DP--------------SLLMEV--MTNNSM--IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 767 ~~--------------~~~~~~--~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
+. .+.... ...... .........++++..+.+++.+|++.||++|||+.|++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 214 DQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000 000000 000001111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=307.44 Aligned_cols=263 Identities=23% Similarity=0.364 Sum_probs=198.1
Q ss_pred HhcCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
..++|++.+.||+|+||.||+|.+. .++..||+|+++.... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~- 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ- 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence 4678999999999999999999864 2457899999864322 23456889999999999999999999975443
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCcc----ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQV----EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
..++||||+++|+|.+++....... ....+++..+..++.|++.||+|||+. +++||||||+||+++++
T Consensus 83 ----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 83 ----PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred ----CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 7899999999999999997543211 112467889999999999999999999 99999999999999999
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-Hh
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TA 757 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~ 757 (833)
+.+||+|||+++.......... .....+++.|||||++.+..++.++|||| +|++++++++ +.
T Consensus 156 ~~~~l~dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~el~~~~~ 219 (277)
T cd05062 156 FTVKIGDFGMTRDIYETDYYRK------GGKGLLPVRWMSPESLKDGVFTTYSDVWS----------FGVVLWEIATLAE 219 (277)
T ss_pred CCEEECCCCCccccCCcceeec------CCCCccCHhhcChhHhhcCCcCchhHHHH----------HHHHHHHHHcCCC
Confidence 9999999999876543221110 01124678899999999888999999999 7777788877 45
Q ss_pred CCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 758 LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 758 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
.|+.... ............. ...+..++..+.+++.+||+.||++|||+.|+++.+++
T Consensus 220 ~p~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 220 QPYQGMS--NEQVLRFVMEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CCCCCCC--HHHHHHHHHcCCc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 5543111 0111111111100 01122345678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=307.55 Aligned_cols=266 Identities=24% Similarity=0.362 Sum_probs=199.0
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCC-----ceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGED-----EMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSST 600 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 600 (833)
...++|++.+.||+|+||.||+|..... ...||+|.++.... .....+.+|+++++++ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 4456799999999999999999988643 37899999874322 2335688999999999 799999999997654
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
+ ..+++|||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +|+||||||
T Consensus 89 ~-----~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp 160 (293)
T cd05053 89 G-----PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA 160 (293)
T ss_pred C-----CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence 4 789999999999999999753210 1122689999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+||++++++.+||+|||.++.+........ .....++..|+|||++.+..++.++|||| +|+++
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il 224 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRK------TTNGRLPVKWMAPEALFDRVYTHQSDVWS----------FGVLL 224 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceec------cCCCCCCccccCHHHhccCCcCcccceee----------hhhHH
Confidence 999999999999999999987654321111 11123567899999998888999999999 55666
Q ss_pred HHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 751 HEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 751 ~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
+++++ +..|+..... .... ....... ....+..++..+.+++.+||..||++|||+.|+++.|+.+.
T Consensus 225 ~el~~~g~~p~~~~~~--~~~~-~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 225 WEIFTLGGSPYPGIPV--EELF-KLLKEGY-----RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHhcCCCCCCCCCCH--HHHH-HHHHcCC-----cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 66554 4444331110 0000 0000000 00112234567889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=299.75 Aligned_cols=251 Identities=18% Similarity=0.249 Sum_probs=199.1
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
+|++.+.||+|+||.||++.+..+++.||+|.++... ....+.+.+|+.++++++||||+++++++.... ..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADG-----HLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECC-----EEEE
Confidence 5888999999999999999999999999999986432 234567889999999999999999999975544 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++|+|.+++...... .+++..++.++.|++.||.|||+. +|+|+||||+||++++++.++++|||.+.
T Consensus 76 v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~ 148 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGK----LFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSAR 148 (255)
T ss_pred EEeeCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcce
Confidence 99999999999988754322 578999999999999999999999 99999999999999999999999999987
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
....... ......|++.|+|||++.+..++.++|+|| +|+++++++++..|+...... ..
T Consensus 149 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~s----------lG~i~~~l~~g~~p~~~~~~~--~~ 208 (255)
T cd08219 149 LLTSPGA--------YACTYVGTPYYVPPEIWENMPYNNKSDIWS----------LGCILYELCTLKHPFQANSWK--NL 208 (255)
T ss_pred eeccccc--------ccccccCCccccCHHHHccCCcCchhhhhh----------hchhheehhhccCCCCCCCHH--HH
Confidence 6543211 112346899999999998888999999999 677777777877776532211 00
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......... ...+..++..+.+++.+||+.||++|||+.+++.+
T Consensus 209 ~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 209 ILKVCQGSY------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHhcCCC------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 011111100 11122345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=306.85 Aligned_cols=265 Identities=24% Similarity=0.388 Sum_probs=204.6
Q ss_pred cCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
++|.+.+.||+|+||.||+|++. .++..+|+|.++.......+.+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD---- 80 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC----
Confidence 46888999999999999999863 245679999987554444567899999999999999999999976544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL 675 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll 675 (833)
..++||||+++++|.+++...... .....+++..++.++.|++.|++|||++ +|+||||||+||++
T Consensus 81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~ 156 (291)
T cd05094 81 -PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLV 156 (291)
T ss_pred -ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEE
Confidence 789999999999999999764321 0112488999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH
Q 040925 676 DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK 755 (833)
Q Consensus 676 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~ 755 (833)
+.++.+||+|||++......... .......+++.|+|||++.+..++.++|||| +|++++++++
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~t 220 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYY------RVGGHTMLPIRWMPPESIMYRKFTTESDVWS----------FGVILWEIFT 220 (291)
T ss_pred ccCCcEEECCCCcccccCCCcee------ecCCCCCcceeecChHHhccCCCCchhhHHH----------HHHHHHHHHh
Confidence 99999999999999765432211 0111234788999999999989999999999 7778888887
Q ss_pred -HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 756 -TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 756 -~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
+..|+..... ... .+...... .......++..+.+++.+||+.||++|||+++|++.|+++...
T Consensus 221 ~g~~p~~~~~~--~~~-~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 221 YGKQPWFQLSN--TEV-IECITQGR-----VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCCCCCCCCCH--HHH-HHHHhCCC-----CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 7776532111 111 11111110 0011122456789999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.44 Aligned_cols=251 Identities=21% Similarity=0.264 Sum_probs=203.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.+|++.+.||+|++|.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~-----~~~l 94 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV 94 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC-----EEEE
Confidence 47999999999999999999998899999999997655555677899999999999999999999876544 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+.
T Consensus 95 v~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred eecccCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence 99999999999998643 478899999999999999999999 99999999999999999999999999987
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
....... ......|++.|+|||.+.+..++.++|||| +|+++++++++..|+......+...
T Consensus 165 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------~Gvil~~l~~g~~pf~~~~~~~~~~ 226 (296)
T cd06654 165 QITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS----------LGIMAIEMIEGEPPYLNENPLRALY 226 (296)
T ss_pred hcccccc--------ccCcccCCccccCHHHHcCCCCCccchHHH----------HHHHHHHHHhCCCCCCCCCHHHhHH
Confidence 6533211 111245899999999998888999999999 8888999999998875332211110
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....... .....+...+..+.+++.+||..||++|||++++++.
T Consensus 227 --~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 227 --LIATNGT----PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --HHhcCCC----CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0000000 0001123456678899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=324.86 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=192.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCC---CCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFK---GTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---~~~ 606 (833)
.++|++.+.||+|+||.||+|.+..+++.||||++... .....+|+.+++.++||||+++++++....+. ...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 45799999999999999999999989999999988532 23345799999999999999999887543321 223
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-cEEEcc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCD 685 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~D 685 (833)
..++||||+++ ++.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARN--NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 57799999974 787777542211 12689999999999999999999999 999999999999998665 799999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
||+|+...... ......||+.|+|||++.+. .++.++|||| +|++++++++|..|+....
T Consensus 215 FGla~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS----------lGvil~elltG~~pf~~~~ 275 (440)
T PTZ00036 215 FGSAKNLLAGQ---------RSVSYICSRFYRAPELMLGATNYTTHIDLWS----------LGCIIAEMILGYPIFSGQS 275 (440)
T ss_pred cccchhccCCC---------CcccCCCCcCccCHHHhcCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCC
Confidence 99998654321 11234689999999987664 6899999999 7888888888887764221
Q ss_pred cccccch-hhhccc--------------c-----chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPSLL-MEVMTN--------------N-----SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~-~~~~~~--------------~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..+.-.. ...... . ..........+...+.++.+++.+||.+||.+|||+.|+++.
T Consensus 276 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 276 SVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 1100000 000000 0 000000011112235678899999999999999999999865
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=313.51 Aligned_cols=242 Identities=26% Similarity=0.303 Sum_probs=187.5
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHH-HHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~-----~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD-----KLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC-----eEEEEE
Confidence 47999999999999999999999999996432 122234444444 567789999999999876554 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 76 DYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred eCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999999999997654 578889999999999999999999 9999999999999999999999999998754
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.... .......||+.|+|||++.+..++.++|||| .|+++++++++..|+...... ....
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~~~~~--~~~~ 206 (325)
T cd05602 147 IEHN--------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC----------LGAVLYEMLYGLPPFYSRNTA--EMYD 206 (325)
T ss_pred ccCC--------CCcccccCCccccCHHHHcCCCCCCcccccc----------ccHHHHHHhcCCCCCCCCCHH--HHHH
Confidence 2211 1122356999999999999999999999999 788889999998887522211 1111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
....... ......+..+.+++.+|++.||.+||++.+.+.
T Consensus 207 ~i~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 207 NILNKPL-------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred HHHhCCc-------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1111111 111234567889999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=316.80 Aligned_cols=261 Identities=17% Similarity=0.226 Sum_probs=200.9
Q ss_pred hHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeec
Q 040925 523 YAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSS 599 (833)
Q Consensus 523 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 599 (833)
..++....++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455566789999999999999999999999999999999986421 2233567889999999999999999998755
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
.. ..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 115 ~~-----~~~lv~Ey~~gg~L~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~ 179 (371)
T cd05622 115 DR-----YLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 179 (371)
T ss_pred CC-----EEEEEEcCCCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCC
Confidence 44 899999999999999998753 478889999999999999999999 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCC----CCcccccccCCcCCCccccCCccHHHHHH
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE----ASMTGDIFTGRRPIDAVFNEGHSLHEFAK 755 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~s~~~~~~~~~~~g~~l~~~~~ 755 (833)
.+||+|||+++....... .......||+.|||||++.+.. ++.++|||| .|+++|++++
T Consensus 180 ~ikL~DfG~a~~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwS----------lGvilyell~ 242 (371)
T cd05622 180 HLKLADFGTCMKMNKEGM-------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS----------VGVFLYEMLV 242 (371)
T ss_pred CEEEEeCCceeEcCcCCc-------ccccCcccCccccCHHHHhccCCCccCCCccceee----------hhHHHHHHHh
Confidence 999999999986543211 1112356999999999986543 788999999 8899999999
Q ss_pred HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCC--CCCHHHHHHH
Q 040925 756 TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFE--RMDMRDVVAK 820 (833)
Q Consensus 756 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 820 (833)
+..|+....... ........... ...+.....+..+.+++..|+..+|.+ ||+++|+++.
T Consensus 243 G~~Pf~~~~~~~--~~~~i~~~~~~---~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 243 GDTPFYADSLVG--TYSKIMNHKNS---LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCCCCCCCHHH--HHHHHHcCCCc---ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 999976322110 11111111000 001111234567788999999844433 7799998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=313.29 Aligned_cols=239 Identities=21% Similarity=0.259 Sum_probs=185.8
Q ss_pred ceeccCcceEEEEEEE---CCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 537 NMIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
+.||+|+||.||+++. ..+++.||+|+++.... .....+.+|++++++++||||+++++++...+ ..|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEG-----KLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----EEEEE
Confidence 6799999999999876 35789999999974321 22345778999999999999999999976554 89999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
|||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 77 ~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 147 (318)
T ss_pred EcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcc
Confidence 99999999999997643 689999999999999999999999 999999999999999999999999999875
Q ss_pred cCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccch
Q 040925 692 LSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771 (833)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~ 771 (833)
..... .......||+.|+|||++.+..++.++|||| +|+++++++++..|+...+.. ...
T Consensus 148 ~~~~~--------~~~~~~~g~~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~tg~~p~~~~~~~--~~~ 207 (318)
T cd05582 148 SIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWS----------FGVLMFEMLTGSLPFQGKDRK--ETM 207 (318)
T ss_pred cCCCC--------CceecccCChhhcCHHHHcCCCCCCccceec----------cceEeeeeccCCCCCCCCCHH--HHH
Confidence 43321 1122356999999999999888999999999 566666666676665422110 111
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHH
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRD 816 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 816 (833)
........ ..+...++.+.+++.+||+.||++|||+.+
T Consensus 208 ~~i~~~~~-------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 208 TMILKAKL-------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHcCCC-------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 11111110 112234567889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.15 Aligned_cols=263 Identities=26% Similarity=0.384 Sum_probs=198.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCce--EEEEEEeeccC-CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEM--IVAVKVINLKY-KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|.+..++. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~---- 81 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG---- 81 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC----
Confidence 4578999999999999999999876665 45777765332 22345788999999999 8999999999975544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCcc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQV----------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL 675 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll 675 (833)
..++||||+++|+|.+++....... ....+++.+++.++.|++.|++|||+. ||+||||||+||++
T Consensus 82 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili 157 (303)
T cd05088 82 -YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV 157 (303)
T ss_pred -CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEe
Confidence 7899999999999999997543110 112578999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH
Q 040925 676 DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK 755 (833)
Q Consensus 676 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~ 755 (833)
+.++.+||+|||++....... ......++..|+|||++.+..++.++|||| +|++++++++
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ellt 218 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVYV---------KKTMGRLPVRWMAIESLNYSVYTTNSDVWS----------YGVLLWEIVS 218 (303)
T ss_pred cCCCcEEeCccccCcccchhh---------hcccCCCcccccCHHHHhccCCcccccchh----------hhhHHHHHHh
Confidence 999999999999986322110 001112467899999998888999999999 7888888887
Q ss_pred -HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 756 -TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 756 -~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
+..|+......+ . ........ ....+..++..+.+++.+||+.+|++||+++++++.+..+.+.
T Consensus 219 ~g~~p~~~~~~~~--~-~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 219 LGGTPYCGMTCAE--L-YEKLPQGY-----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred cCCCCcccCChHH--H-HHHHhcCC-----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 776654221111 0 00010000 0001122455788999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=283.00 Aligned_cols=257 Identities=23% Similarity=0.254 Sum_probs=211.9
Q ss_pred HhcCCccC-ceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSS-NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 606 (833)
.+++|++. ++||-|-.|.|-.+.++.+|+.+|+|++. +....++|++..-.. .|||||.+++++... +.+..
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs-~~~rk 132 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENS-YQGRK 132 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhh-ccCce
Confidence 45677765 57999999999999999999999999985 345678899886666 599999999997654 67788
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CCcEEE
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHV 683 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL 683 (833)
...+|||.++||.|...+.+++.. .+++.++..|+.||+.|+.|||+. +|.||||||+|+|... +..+||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~----afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQ----AFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccc----cchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEe
Confidence 899999999999999999988755 799999999999999999999999 9999999999999964 458999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc--
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK-- 761 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~-- 761 (833)
+|||+|+..... ......+-||+|.|||++...+|+...|+|| .|+++|-++-|..|+-
T Consensus 206 tDfGFAK~t~~~---------~~L~TPc~TPyYvaPevlg~eKydkscdmwS----------lgVimYIlLCGyPPFYS~ 266 (400)
T KOG0604|consen 206 TDFGFAKETQEP---------GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWS----------LGVIMYILLCGYPPFYSN 266 (400)
T ss_pred cccccccccCCC---------ccccCCcccccccCHHHhCchhcCCCCCccc----------hhHHHHHhhcCCCccccc
Confidence 999999865432 1223356899999999999999999999999 7788888888888864
Q ss_pred ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 762 VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
-...+.|.+........+.+ +.+..+.+++...++|+..|..+|.+|.|+.|+++.
T Consensus 267 hg~aispgMk~rI~~gqy~F---P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 267 HGLAISPGMKRRIRTGQYEF---PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CCccCChhHHhHhhccCccC---CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 33455666655555544432 233455678889999999999999999999998764
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=304.49 Aligned_cols=259 Identities=22% Similarity=0.336 Sum_probs=201.8
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCC-C
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKG-T 605 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~ 605 (833)
.+.+.|++.+.||+|+||.||+|....+++.||+|.+.... .....+..|+.+++++ +||||+++++++......+ .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678999999999999999999999899999999987443 3446788999999999 6999999999986543221 3
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++|+|.+++...... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 4689999999999999999864322 688999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
||++........ ......|++.|+|||++. +..++.++|||| .|+++++++++..|+
T Consensus 155 fg~~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s----------lGv~l~el~~g~~p~ 216 (272)
T cd06637 155 FGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS----------LGITAIEMAEGAPPL 216 (272)
T ss_pred CCCceecccccc--------cCCcccccccccCHhHhccccCcCCCCCchhhHHH----------HHHHHHHHHhCCCCc
Confidence 999876533211 112346899999999875 345888999999 788888988888876
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
........... .... .........++..+.+++.+||..||.+|||++|+++
T Consensus 217 ~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 217 CDMHPMRALFL--IPRN-----PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cccCHHHHHHH--HhcC-----CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 42221111110 0000 0011111234567889999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=299.43 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=202.6
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|++..+++.||+|.+... .....+.+.+|++++++++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKG-----KLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCC-----EEE
Confidence 478889999999999999999999999999998643 2334567889999999999999999999975544 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++...... .+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~ 148 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGR----PLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVA 148 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccc
Confidence 999999999999999865322 689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
+....... ......|++.|+|||+..+..++.++|+|| +|+++++++++..|+.... ...
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~--~~~ 208 (256)
T cd08529 149 KLLSDNTN--------FANTIVGTPYYLSPELCEDKPYNEKSDVWA----------LGVVLYECCTGKHPFDANN--QGA 208 (256)
T ss_pred eeccCccc--------hhhccccCccccCHHHhcCCCCCCccchHH----------HHHHHHHHHhCCCCCCCCC--HHH
Confidence 86654221 112245889999999999888999999999 8888999999988875322 111
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... ......++..+.+++.+||+.+|++||++.++++.
T Consensus 209 ~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 209 LILKIIRGVF------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HHHHHHcCCC------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1111111110 11122456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=299.93 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=198.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.++||+|++|.||+|++.++ ..||+|.++... ...+.+.+|++++++++||||+++++++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY 76 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcE
Confidence 45799999999999999999998755 469999987432 234678999999999999999999987532 2578
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++...... .+++..+..++.|+++||+|+|+. +++||||||+||++++++.+||+|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~ 149 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGK----YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 149 (262)
T ss_pred EEEEcCCCCcHHHHHhhcccc----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCce
Confidence 999999999999999764321 578999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
+......... .....++..|+|||+..+..++.++|||| +|++++++++ +..|+.... +.
T Consensus 150 ~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Dvws----------lG~~l~ellt~g~~p~~~~~--~~ 210 (262)
T cd05071 150 RLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWS----------FGILLTELTTKGRVPYPGMV--NR 210 (262)
T ss_pred eecccccccc-------ccCCcccceecCHhHhccCCCCchhhHHH----------HHHHHHHHHcCCCCCCCCCC--hH
Confidence 8664332111 11234678899999998888999999999 7778888887 555553211 11
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
... ....... ......+++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 211 ~~~-~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 211 EVL-DQVERGY-----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHH-HHHhcCC-----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 111 1110000 0111234667889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=300.70 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=194.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.+|++.+.||+|++|.||+|.++ ++..+|+|.+.... ...+.+.+|++++++++||||+++++++...+ ..++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l 76 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR-----PIFI 76 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-----ceEE
Confidence 35889999999999999999986 56789999986432 23457888999999999999999999875444 7899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++++|.+++..... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.++
T Consensus 77 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~ 148 (256)
T cd05059 77 VTEYMANGCLLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLAR 148 (256)
T ss_pred EEecCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccce
Confidence 9999999999999976432 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPS 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~ 769 (833)
......... .....++..|+|||++.+..++.++|||| +|++++++++ +..|+..... ..
T Consensus 149 ~~~~~~~~~-------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s----------lG~il~~l~~~g~~p~~~~~~--~~ 209 (256)
T cd05059 149 YVLDDQYTS-------SQGTKFPVKWAPPEVFDYSRFSSKSDVWS----------FGVLMWEVFSEGKMPYERFSN--SE 209 (256)
T ss_pred ecccccccc-------cCCCCCCccccCHHHhccCCCCchhhHHH----------HHHHHHHHhccCCCCCCCCCH--HH
Confidence 654322111 11122456899999999889999999999 6777778776 5666542211 11
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
.... ...... ...+..++.++.+++.+||..+|++|||+.|+++.|
T Consensus 210 ~~~~-~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 210 VVES-VSAGYR-----LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHH-HHcCCc-----CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1111 111000 011122466899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=316.49 Aligned_cols=258 Identities=20% Similarity=0.228 Sum_probs=193.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|+...+++.||+|+++... ......+.+|+.++..++||+|+++++.+.... .
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~-----~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR-----N 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence 46899999999999999999999999999999997432 233457888999999999999999999865544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG 146 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFG 146 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeecc
Confidence 999999999999999997654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccc---------------------------cCCCccccccccccccCccccCCCCCCcccccccCCcCC
Q 040925 688 LAKFLSDHQLDTAV---------------------------KTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPI 740 (833)
Q Consensus 688 ~a~~~~~~~~~~~~---------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~ 740 (833)
+++........... .........+||+.|+|||++.+..++.++||||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS----- 221 (360)
T cd05627 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWS----- 221 (360)
T ss_pred CCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecc-----
Confidence 98755321110000 0001112457999999999999999999999999
Q ss_pred CccccCCccHHHHHHHhCCCcccccccccchhhhcc--ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC---HH
Q 040925 741 DAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMT--NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD---MR 815 (833)
Q Consensus 741 ~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~ 815 (833)
.|+++|++++|..|+...... ........ .....+ .. ....+.+.+++.+|+ .||.+|++ ++
T Consensus 222 -----lGvilyel~tG~~Pf~~~~~~--~~~~~i~~~~~~~~~p-~~----~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 288 (360)
T cd05627 222 -----LGVIMYEMLIGYPPFCSETPQ--ETYRKVMNWKETLVFP-PE----VPISEKAKDLILRFC-TDSENRIGSNGVE 288 (360)
T ss_pred -----ccceeeecccCCCCCCCCCHH--HHHHHHHcCCCceecC-CC----CCCCHHHHHHHHHhc-cChhhcCCCCCHH
Confidence 677777777877776422111 00011110 000000 00 012445677777766 49999995 56
Q ss_pred HHHHH
Q 040925 816 DVVAK 820 (833)
Q Consensus 816 eil~~ 820 (833)
|+++.
T Consensus 289 ei~~h 293 (360)
T cd05627 289 EIKSH 293 (360)
T ss_pred HHhcC
Confidence 66554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=312.88 Aligned_cols=242 Identities=24% Similarity=0.281 Sum_probs=186.4
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHH-HHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||+||+|++..+++.||+|+++... ......+..|.. +++.++||||+++++++...+ ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~-----~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE-----KLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC-----EEEEEE
Confidence 46999999999999999999999999996432 223344555555 467789999999999875544 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++.++..++.||+.||+|||+. ||+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 76 DFVNGGELFFHLQRER------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 9999999999887654 689999999999999999999999 9999999999999999999999999998743
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.... .......||+.|+|||++.+..++.++|||| +|++++++++|..|+...+.. ....
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws----------lG~il~el~~G~~pf~~~~~~--~~~~ 206 (325)
T cd05604 147 IAQS--------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWC----------LGAVLYEMLYGLPPFYCRDVA--EMYD 206 (325)
T ss_pred CCCC--------CCcccccCChhhCCHHHHcCCCCCCcCcccc----------ccceehhhhcCCCCCCCCCHH--HHHH
Confidence 2211 1122356999999999999999999999999 777788888888876532211 1111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
........ .....+..+.+++.+|+..||.+||++++.++
T Consensus 207 ~~~~~~~~-------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 207 NILHKPLV-------LRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred HHHcCCcc-------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 11111110 11123456788999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=313.20 Aligned_cols=262 Identities=19% Similarity=0.246 Sum_probs=196.9
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTD-FKG 604 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 604 (833)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.... ...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34578999999999999999999999899999999996432 233467889999999999999999999875443 122
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
....|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~ 165 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 165 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEe
Confidence 2457999999975 67776642 478889999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+++...... ......||+.|+|||++.+..++.++|||| .|+++++++++..|+...+
T Consensus 166 Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS----------lG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 166 DFGLARTACTNF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWS----------VGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred cCCCccccccCc---------cCCCCcccCCCCCchhccCCCCCcchhhHH----------HHHHHHHHHhCCCCCCCCC
Confidence 999997543221 112346899999999999999999999999 7788888888888775322
Q ss_pred ccccc-------------c-------hhhhccccchhh-------------hhhhhchHHHHHHHHHHhhccCCCCCCCC
Q 040925 765 IVDPS-------------L-------LMEVMTNNSMIQ-------------EDKRVKTEECLNAIIRTGVLCSMESPFER 811 (833)
Q Consensus 765 ~~~~~-------------~-------~~~~~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~cl~~dP~~R 811 (833)
..+.- . ............ +............+.+++.+||..||++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 227 HIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 11100 0 000000000000 00000001123567899999999999999
Q ss_pred CCHHHHHHH
Q 040925 812 MDMRDVVAK 820 (833)
Q Consensus 812 Pt~~eil~~ 820 (833)
||+.|+++.
T Consensus 307 ~t~~e~l~h 315 (359)
T cd07876 307 ISVDEALRH 315 (359)
T ss_pred CCHHHHhcC
Confidence 999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=311.27 Aligned_cols=240 Identities=23% Similarity=0.266 Sum_probs=189.1
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|+...+++.||+|+++... ....+.+.+|+.++.++ +||+|+++++++.... ..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS-----RLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC-----EEEEEE
Confidence 47999999999999999999999999997542 22345688899999998 5999999999865544 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 76 EYVNGGDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred eCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 9999999999887654 689999999999999999999999 9999999999999999999999999998743
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc-c--c-
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV-D--P- 768 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~-~--~- 768 (833)
.... .......||+.|+|||++.+..++.++|||| +|+++++++++..|+...... + .
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lGvil~ell~g~~pf~~~~~~~~~~~~ 208 (327)
T cd05617 147 LGPG--------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWA----------LGVLMFEMMAGRSPFDIITDNPDMNTE 208 (327)
T ss_pred cCCC--------CceecccCCcccCCHHHHCCCCCCchheeeh----------hHHHHHHHHhCCCCCCccCCCcccccH
Confidence 2211 1112356999999999999999999999999 888999999999987522110 0 0
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
.......... ....+...+..+.+++.+||+.||++||++
T Consensus 209 ~~~~~~~~~~------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 209 DYLFQVILEK------PIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHHHHHhC------CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 0001110000 001122345567899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.80 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=198.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|+||.||+|.+..++..||+|.++..... ....+.+|++++++++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDG-----EIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----EEE
Confidence 3699999999999999999999999999999998754322 3356889999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++.... .+++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||++
T Consensus 76 lv~ey~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 147 (308)
T ss_pred EEeeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCc
Confidence 9999999999999997654 6889999999999999999999732 8999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
....... .....|++.|+|||++.+..++.++|||| +|+++++++++..|+...+..+..
T Consensus 148 ~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Diws----------lG~~l~~l~~g~~p~~~~~~~~~~ 207 (308)
T cd06615 148 GQLIDSM----------ANSFVGTRSYMSPERLQGTHYTVQSDIWS----------LGLSLVEMAIGRYPIPPPDAKELE 207 (308)
T ss_pred ccccccc----------cccCCCCcCccChhHhcCCCCCccchHHH----------HHHHHHHHHhCCCCCCCcchhhHH
Confidence 7543321 12246899999999998888999999999 777788888887775321100000
Q ss_pred chhhhccccc-----------------------------hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNS-----------------------------MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... ............++..+.+++.+||..||++|||++|+++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 208 AMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred HhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000 00000000011245678999999999999999999999877
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=303.20 Aligned_cols=254 Identities=21% Similarity=0.273 Sum_probs=197.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++..+++.||+|.++.........+.+|+.+++.++||||+++++++...+ ..+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~-----~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD-----KLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC-----EEE
Confidence 347888999999999999999999899999999997654445567889999999999999999999876554 889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++...+ .+++.+++.++.|++.|+.|||+. +++|+||||+||+++.++.+||+|||.+
T Consensus 83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~ 153 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTG------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVS 153 (267)
T ss_pred EEEeccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceee
Confidence 9999999999999987654 689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
........ ......|++.|+|||++. ...++.++|+|| .|++++++.++..|+......
T Consensus 154 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwS----------lG~il~~l~~~~~p~~~~~~~ 215 (267)
T cd06645 154 AQITATIA--------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWA----------VGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred eEccCccc--------ccccccCcccccChhhhccccCCCCCchhhhHH----------HHHHHHHHhcCCCCcccccch
Confidence 75533211 112346899999999874 456889999999 778888888887775421110
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.... ........ +........++..+.+++.+||..||++|||++++++
T Consensus 216 ~~~~--~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 216 RALF--LMTKSNFQ--PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hhHH--hhhccCCC--CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0000 00000000 0000011123456789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=306.49 Aligned_cols=266 Identities=21% Similarity=0.317 Sum_probs=194.5
Q ss_pred cCCccCceeccCcceEEEEEEECCC--------------ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEee
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGED--------------EMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIIT 595 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~ 595 (833)
++|++.+.||+|+||.||+|+..++ ...||+|.++.... .....+.+|++++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5799999999999999999987543 23589999875422 23457899999999999999999999
Q ss_pred EeecCCCCCCceEeEEEEecCCCChhhhhccCCCc------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCC
Q 040925 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLK 669 (833)
Q Consensus 596 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlk 669 (833)
++.... ..++||||+++++|.+++...... .....+++..++.++.|++.||+|||+. +++|||||
T Consensus 85 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlk 156 (295)
T cd05097 85 VCVSDD-----PLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLA 156 (295)
T ss_pred EEcCCC-----ccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccC
Confidence 976544 789999999999999998653211 0112468899999999999999999999 99999999
Q ss_pred CCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCcc
Q 040925 670 PSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHS 749 (833)
Q Consensus 670 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~ 749 (833)
|+||++++++.+||+|||++.......... ......+++.|+|||+..+..++.++|||| +|++
T Consensus 157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS----------lG~~ 220 (295)
T cd05097 157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYR------IQGRAVLPIRWMAWESILLGKFTTASDVWA----------FGVT 220 (295)
T ss_pred hhhEEEcCCCcEEecccccccccccCccee------ccCcCcCceeecChhhhccCCcCchhhHHH----------HHHH
Confidence 999999999999999999997653321110 111234578899999998888999999999 6777
Q ss_pred HHHHHHH--hCCCcccccccccchhhhccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 750 LHEFAKT--ALPEKVMEIVDPSLLMEVMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 750 l~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
++++.+. ..|+.... ............. ............++..+.+++.+||..||++|||+++|++.|+
T Consensus 221 l~el~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 221 LWEMFTLCKEQPYSLLS--DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHcCCCCCCcccC--hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 7777663 33432111 0111000000000 0000000011224568999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=301.78 Aligned_cols=262 Identities=24% Similarity=0.391 Sum_probs=196.2
Q ss_pred CCccCceeccCcceEEEEEEE----CCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 532 EFSSSNMIGQGSFGYVYKGTL----GEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
-|++.+.||+|+||.||+|++ ..++..||+|.++... ....+.+.+|++++++++||||+++++++...+ ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---GN 81 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---CC
Confidence 478899999999999999985 3468899999987443 233467899999999999999999999876542 34
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++++|.+++..... .+++.++..++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~df 153 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDF 153 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCC
Confidence 68999999999999999865431 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc----
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV---- 762 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~---- 762 (833)
|+++......... .......|+..|+|||+..+..++.++|||| +|++++++.++..+...
T Consensus 154 g~~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s----------lG~il~ellt~~~~~~~~~~~ 218 (284)
T cd05079 154 GLTKAIETDKEYY-----TVKDDLDSPVFWYAPECLIQSKFYIASDVWS----------FGVTLYELLTYCDSESSPMTL 218 (284)
T ss_pred ccccccccCccce-----eecCCCCCCccccCHHHhccCCCCccccchh----------hhhhhhhhhcCCCCCccccch
Confidence 9998664322110 0111245778899999998888999999999 55555555553332210
Q ss_pred -cccccc---c----chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 763 -MEIVDP---S----LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 763 -~~~~~~---~----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
.....+ . ......... ........++..+.+++.+||+.||++|||++++++.++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 219 FLKMIGPTHGQMTVTRLVRVLEEG-----KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhhhcccccccccHHHHHHHHHcC-----ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000000 0 000000000 00111223567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.09 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=197.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|++|.||+|... ++..||+|.++.... ..+.+.+|+.++++++||+++++++++.. ...+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIY 76 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcE
Confidence 357999999999999999999886 566799999875432 34678999999999999999999998632 2478
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
++|||+++++|.+++...... .+++.+++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~ 149 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGR----ALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLA 149 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceee
Confidence 999999999999999764322 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
.......... .....++..|+|||+..+..++.++|||| +|++++++++ +..|+......
T Consensus 150 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~~l~~~g~~p~~~~~~~-- 210 (260)
T cd05070 150 RLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWS----------FGILLTELVTKGRVPYPGMNNR-- 210 (260)
T ss_pred eeccCccccc-------ccCCCCCccccChHHHhcCCCcchhhhHH----------HHHHHHHHHhcCCCCCCCCCHH--
Confidence 7654322111 11223567899999998888999999999 7788888887 66665422111
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
... +.+.... ....+.+.+..+.+++.+||..||++|||++++.+.|+.
T Consensus 211 ~~~-~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 211 EVL-EQVERGY-----RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHH-HHHHcCC-----CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111 1111100 011123456678999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.47 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=201.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-----cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-----GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
++|++.+.||+|++|.||+|....+++.||+|.++.... ...+.+.+|++++++++||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 77 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE---- 77 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC----
Confidence 479999999999999999999988999999999864321 12356888999999999999999999975544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|
T Consensus 78 -~~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~d 147 (263)
T cd06625 78 -TLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGD 147 (263)
T ss_pred -eEEEEEEECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence 8999999999999999997654 688999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++......... .......|+..|+|||++.+..++.++|||| .|+++++++++..|+...+.
T Consensus 148 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~~g~~p~~~~~~ 212 (263)
T cd06625 148 FGASKRLQTICSSG-----TGMKSVTGTPYWMSPEVISGEGYGRKADVWS----------VGCTVVEMLTEKPPWAEFEA 212 (263)
T ss_pred cccceecccccccc-----ccccCCCcCccccCcceeccCCCCchhhhHH----------HHHHHHHHHhCCCCccccch
Confidence 99987654321111 0112245889999999999988999999999 78889999998888643221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..... ..... ......+..++..+.+++.+||..+|++|||+.|+++.
T Consensus 213 ~~~~~--~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 213 MAAIF--KIATQ-----PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HHHHH--HHhcc-----CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11100 00000 00111223456678899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.44 Aligned_cols=270 Identities=20% Similarity=0.258 Sum_probs=206.0
Q ss_pred cchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeec
Q 040925 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSS 599 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 599 (833)
+.++.+..+.++|++.+.||+|+||.||+|.+..+++.||+|+++.. ......+.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 45566777888999999999999999999999989999999988642 22345688899999999 69999999998865
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
.........++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~ 161 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEG 161 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCC
Confidence 4444556799999999999999987643211 12588999999999999999999999 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
.+||+|||+++....... ......|++.|+|||++. +..++.++|||| .|++++++.
T Consensus 162 ~~kl~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s----------lGvi~~el~ 223 (286)
T cd06638 162 GVKLVDFGVSAQLTSTRL--------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS----------LGITAIELG 223 (286)
T ss_pred CEEEccCCceeecccCCC--------ccccccCCCcccChhhhchhhhccccccchhhhhh----------HHHHHHHHh
Confidence 999999999876543211 112245899999999875 345788999999 778888888
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++..|+....... ......... ......+..++..+.+++.+||+.||++|||+.|+++.
T Consensus 224 ~g~~p~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 224 DGDPPLADLHPMR--ALFKIPRNP----PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cCCCCCCCCchhH--HHhhccccC----CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 8887764221111 000000000 00001112234578899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=304.83 Aligned_cols=264 Identities=24% Similarity=0.356 Sum_probs=200.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCce--EEEEEEeeccC-CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEM--IVAVKVINLKY-KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 606 (833)
++|++.+.||+|+||.||+|....++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRG----- 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCC-----
Confidence 579999999999999999999876654 46888886322 22346788999999999 7999999999975544
Q ss_pred eEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEEC
Confidence 789999999999999999764311 0112588999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-
Q 040925 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK- 755 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~- 755 (833)
+++.+||+|||++........ ......+..|+|||+..+..++.++|||| +|++++++++
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS----------lG~il~el~t~ 214 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYVK---------KTMGRLPVRWMAIESLNYSVYTTKSDVWS----------FGVLLWEIVSL 214 (297)
T ss_pred CCCeEEECCcCCCccccceec---------cCCCCcCccccCchhhccCCCCchhhHHH----------HHHHHHHHHcC
Confidence 999999999999864321100 00112356799999998888999999999 7778888876
Q ss_pred HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 756 TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 756 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
+..|+...... ......... . ....+..++..+.+++.+||..+|.+|||++++++.|+.+.+...
T Consensus 215 g~~pf~~~~~~--~~~~~~~~~-~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 215 GGTPYCGMTCA--ELYEKLPQG-Y-----RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred CCCCCCCCCHH--HHHHHHhcC-C-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 66665422110 011111000 0 001122345678899999999999999999999999998887554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.02 Aligned_cols=242 Identities=22% Similarity=0.268 Sum_probs=191.8
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCce
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 607 (833)
+|+..+.||+|+||.||+|++..+++.||+|+++... ....+.+..|.++++.+. |++|+++++++...+ .
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~-----~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD-----R 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC-----E
Confidence 4778899999999999999999999999999997432 233456778999998886 577888888865544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg 146 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFG 146 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccc
Confidence 999999999999999997654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+++....... ......||+.|+|||++.+..++.++|||| .|+++++++++..|+.....
T Consensus 147 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lGvil~elltG~~pf~~~~~-- 206 (323)
T cd05615 147 MCKEHMVDGV--------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWA----------YGVLLYEMLAGQPPFDGEDE-- 206 (323)
T ss_pred cccccCCCCc--------cccCccCCccccCHHHHcCCCCCCccchhh----------hHHHHHHHHhCCCCCCCCCH--
Confidence 9875432211 112346999999999999989999999999 88899999999988753221
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
............ ..+...+..+.+++.+||+.||++|++.
T Consensus 207 ~~~~~~i~~~~~-------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 207 DELFQSIMEHNV-------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHHHHHhCCC-------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111111111 1122345677899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.23 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=198.8
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.++++++|++|+++++.+...+ ..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKD-----AL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCC-----EE
Confidence 37788999999999999999999999999999864322 12345778999999999999999999876544 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++...... .+++.++..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEA----GFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGL 148 (285)
T ss_pred EEEEEecCCCcHHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999998654322 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc-cc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI-VD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~-~~ 767 (833)
+........ .....||+.|+|||++.+..++.++|||| .|+++++++++..|+..... ..
T Consensus 149 ~~~~~~~~~---------~~~~~g~~~y~aPE~~~~~~~~~~~Diws----------lG~~l~~l~~g~~Pf~~~~~~~~ 209 (285)
T cd05630 149 AVHVPEGQT---------IKGRVGTVGYMAPEVVKNERYTFSPDWWA----------LGCLLYEMIAGQSPFQQRKKKIK 209 (285)
T ss_pred eeecCCCcc---------ccCCCCCccccChHHHcCCCCCCccccHH----------HHHHHHHHHhCCCCCCCCCccch
Confidence 875432211 11246999999999999989999999999 78889999999988763211 00
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
.......... .....+..+++.+.+++.+||+.||++||| ++|++++
T Consensus 210 ~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 210 REEVERLVKE------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred HHHHHhhhhh------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0000000000 001112335567889999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.93 Aligned_cols=269 Identities=22% Similarity=0.316 Sum_probs=202.5
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCCc-chhHHHHHHHHHhhcC-CCccceEeeEee
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYKG-ASRSFVAECEALRNIR-HRNLIKIITICS 598 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 598 (833)
+....++|.+.+.||+|+||.||+|++. ..++.||+|+++..... ..+.+.+|++++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344557889999999999999999964 34568999999754322 2356889999999997 999999999986
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCc------------------------------------------------
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ------------------------------------------------ 630 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------ 630 (833)
... ..++||||+++|+|.++++..+..
T Consensus 112 ~~~-----~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 112 KGG-----PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred cCC-----CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 654 789999999999999999754210
Q ss_pred --------------------------------------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceee
Q 040925 631 --------------------------------------------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHG 666 (833)
Q Consensus 631 --------------------------------------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~ 666 (833)
.....+++.+++.++.|++.||+|||+. +|+||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHr 263 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHR 263 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcc
Confidence 0112467888999999999999999999 99999
Q ss_pred CCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccC
Q 040925 667 DLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNE 746 (833)
Q Consensus 667 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~ 746 (833)
||||+||++++++.+||+|||+++........ .......+++.|+|||++.+..++.++|||| +
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws----------l 327 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNY------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWS----------F 327 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceeccccccc------ccCCCcCCCCceeChHHhcCCCCCcHhHHHH----------H
Confidence 99999999999999999999999865332110 0111235788999999998888999999999 7
Q ss_pred CccHHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 747 GHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 747 g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
|++++++++ +..|+...... ............ ...+..++..+.+++.+||..+|++||+++||++.|+.+.
T Consensus 328 Gvil~e~l~~g~~P~~~~~~~--~~~~~~~~~~~~-----~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 328 GILLWEIFTLGGTPYPELPMN--EQFYNAIKRGYR-----MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHHcCCCCCCCCCch--HHHHHHHHcCCC-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 778888776 55565322111 111111111100 0112234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=311.30 Aligned_cols=268 Identities=21% Similarity=0.324 Sum_probs=198.5
Q ss_pred hcCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 602 (833)
.++|++.+.||+|+||.||+|.+. .+++.||||+++.... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence 357999999999999999999852 4578999999975432 2345688999999999 6899999999875432
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCcc---------------------------------------------------
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQV--------------------------------------------------- 631 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------------- 631 (833)
...++||||+++|+|.+++.......
T Consensus 85 ---~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 85 ---GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred ---CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 46789999999999999986532100
Q ss_pred ----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcccccccc
Q 040925 632 ----------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701 (833)
Q Consensus 632 ----------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 701 (833)
....+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-- 236 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-- 236 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchh--
Confidence 012468889999999999999999999 99999999999999999999999999997653321100
Q ss_pred cCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchhhhccccch
Q 040925 702 KTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSM 780 (833)
Q Consensus 702 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~ 780 (833)
......+++.|+|||++.+..++.++|||| +|++++++++ +..|+..... +............
T Consensus 237 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~- 300 (343)
T cd05103 237 ----RKGDARLPLKWMAPETIFDRVYTIQSDVWS----------FGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEGTR- 300 (343)
T ss_pred ----hcCCCCCCcceECcHHhcCCCCCchhhHHH----------HHHHHHHHHHCCCCCCCCccc-cHHHHHHHhccCC-
Confidence 011123567899999998888999999999 6667777765 5555432111 1111110000000
Q ss_pred hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 781 IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 781 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
...+...++.+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 301 -----~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 301 -----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred -----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 001112345688999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=309.78 Aligned_cols=248 Identities=21% Similarity=0.360 Sum_probs=197.9
Q ss_pred cCceeccCcceEEEEEEECCCceEEEEEEeec----cCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 535 SSNMIGQGSFGYVYKGTLGEDEMIVAVKVINL----KYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 535 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
....||+|+|-+||+|.+..+|..||--.++. ......++|..|+++|+.|+|||||++|.++.+.. ...+.+
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in~ 120 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTINF 120 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceeee
Confidence 44789999999999999999998887433321 12334578999999999999999999999987765 356889
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-CCcEEEcccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVCDFGLA 689 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a 689 (833)
|+|.+..|+|+.|.++.+ .+....++.|++||++||.|||++ .|+|||||||.+||+|+. -|.|||+|.|+|
T Consensus 121 iTEL~TSGtLr~Y~kk~~------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 121 ITELFTSGTLREYRKKHR------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred eeecccCCcHHHHHHHhc------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHH
Confidence 999999999999999887 788999999999999999999998 789999999999999975 589999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
....... ..++.|||.|||||++. ..|+..+|||| +|+.+.||++..+|+..- -.+.
T Consensus 194 tl~r~s~----------aksvIGTPEFMAPEmYE-E~YnE~VDVYa----------FGMCmLEMvT~eYPYsEC--~n~A 250 (632)
T KOG0584|consen 194 TLLRKSH----------AKSVIGTPEFMAPEMYE-ENYNELVDVYA----------FGMCMLEMVTSEYPYSEC--TNPA 250 (632)
T ss_pred HHhhccc----------cceeccCccccChHHHh-hhcchhhhhhh----------hhHHHHHHHhccCChhhh--CCHH
Confidence 8765422 22367999999999876 68999999998 999999999999997621 1222
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
-....+............. .+++.++|.+|+.. .++|||+.|+++.
T Consensus 251 QIYKKV~SGiKP~sl~kV~----dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 251 QIYKKVTSGIKPAALSKVK----DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHcCCCHHHhhccC----CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2222222111111111112 34688999999999 9999999999874
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.20 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=198.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCce---EEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEM---IVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
++|++.+.||+|+||.||+|....+++ .||||.++... ......+..|+.++++++||||+++++++....
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~----- 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR----- 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC-----
Confidence 468899999999999999999876554 69999987542 233467999999999999999999999965443
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++..... .+++.+++.++.|++.|++|||+. |++||||||+||+++.++.+||+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~df 150 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDF 150 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCC
Confidence 78999999999999999976432 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
|++............ ....+..++..|+|||++.+..++.++|||| +|+.++++++ +..|+.....
T Consensus 151 g~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dvws----------lG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 151 GLSRFLEDDTSDPTY---TSSLGGKIPIRWTAPEAIAYRKFTSASDVWS----------YGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred ccccccccCcccccc---ccccCCCcceeecCHhHhccCcccchhhhhh----------hHHHHHHHhcCCCCCCCCCCH
Confidence 998765432211100 0001111246799999999889999999999 6777777664 6666542211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
. .. ...+.... ....+.+++..+.+++.+||..+|++||++++|++.|+++
T Consensus 218 ~--~~-~~~i~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 218 Q--DV-INAIEQDY-----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred H--HH-HHHHHcCC-----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 11 11111110 1112234566788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=302.99 Aligned_cols=260 Identities=24% Similarity=0.375 Sum_probs=199.5
Q ss_pred cCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|+..++||+|+||.||+|... .++..||+|.++.........+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 80 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR---- 80 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC----
Confidence 46888999999999999999753 356789999987555555678999999999999999999999976554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCc---------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQ---------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
..++||||+++|+|.+++...... .....+++.+++.++.|++.|++|||+. +++||||||+||+++
T Consensus 81 -~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~ 156 (280)
T cd05092 81 -PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVG 156 (280)
T ss_pred -ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEc
Confidence 789999999999999999765321 0112578999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-
Q 040925 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK- 755 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~- 755 (833)
+++.+||+|||++.......... ......+++.|+|||++.+..++.++|||| +|+.++++++
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~~~ 220 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYR------VGGRTMLPIRWMPPESILYRKFTTESDIWS----------FGVVLWEIFTY 220 (280)
T ss_pred CCCCEEECCCCceeEcCCCceee------cCCCccccccccCHHHhccCCcCchhhHHH----------HHHHHHHHHcC
Confidence 99999999999987553321100 011234678899999999889999999999 7777888876
Q ss_pred HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 756 TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 756 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
+..|+..... ........... ....+..++..+.+++.+||+.||++||+++||++.|+
T Consensus 221 g~~p~~~~~~--~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 221 GKQPWYQLSN--TEAIECITQGR------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CCCCCccCCH--HHHHHHHHcCc------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 6666532111 11111111100 00112234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=295.96 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=206.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.+=|...+.||+|.|+.|-+|++.-+|+.||||++.+..- .....+.+|++.|+-++|||||++|.+.... ..
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ-----TK 91 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ-----TK 91 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc-----ce
Confidence 4568888999999999999999999999999999975432 2345788999999999999999999995444 48
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee-cCCCcEEEccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL-DHDMVAHVCDF 686 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kL~Df 686 (833)
.|+|+|.-++|+|++||-++.. .+.+.-+.+++.||+.|+.|+|.. .+|||||||+|+.+ .+-|-|||.||
T Consensus 92 lyLiLELGD~GDl~DyImKHe~-----Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDF 163 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEE-----GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDF 163 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhc-----cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeec
Confidence 9999999999999999988764 689999999999999999999999 99999999999876 56789999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCC-cccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEAS-MTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|++-.+.+.. .....+|+..|-|||++.|..|+ +++|||| .|+++|.++-|..|+...
T Consensus 164 GFSNkf~PG~---------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWS----------LGVILyMLVCGq~PFqeA-- 222 (864)
T KOG4717|consen 164 GFSNKFQPGK---------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWS----------LGVILYMLVCGQPPFQEA-- 222 (864)
T ss_pred cccccCCCcc---------hhhcccchhhccCchhhhcCccCCcchhhhH----------HHHHHHHHHhCCCccccc--
Confidence 9997765532 23346899999999999999987 5679999 899999999999998633
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.|.+-....+.-++ ..+.....+..++|..|+.+||.+|.|.+||+..
T Consensus 223 NDSETLTmImDCKY-------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 223 NDSETLTMIMDCKY-------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cchhhhhhhhcccc-------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 23333222222111 1245567788999999999999999999999754
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=306.01 Aligned_cols=258 Identities=21% Similarity=0.298 Sum_probs=194.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|.+.+.||+|+||.||+|++..+++.||+|.++.... .....+.+|++++++++||||+++++++...+ ..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDK-----SLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCC-----eEE
Confidence 579999999999999999999998999999999975432 23356788999999999999999999976554 799
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++ +|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 151 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLA 151 (309)
T ss_pred EEEeCCCC-CHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccc
Confidence 99999975 89888865432 578999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+....... ......+|+.|+|||++.+ ..++.++|||| .|+++++++++..|+......+.
T Consensus 152 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws----------lG~il~el~tg~~pf~~~~~~~~ 213 (309)
T cd07872 152 RAKSVPTK--------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWG----------VGCIFFEMASGRPLFPGSTVEDE 213 (309)
T ss_pred eecCCCcc--------ccccccccccccCCHHHhCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCChHHH
Confidence 75433211 1112358999999998765 45889999999 77778888888776642211110
Q ss_pred cc-------------hhhhcccc----chhh----hhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 SL-------------LMEVMTNN----SMIQ----EDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~~-------------~~~~~~~~----~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. ........ .... ..........+.++.+++.+|+..||++|||++|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 00 00000000 0000 00000112245677899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=300.08 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=200.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCce---EEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEM---IVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|+..+.||+|++|.||+|+...++. .||+|.++... ....+.+..|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 79 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK---- 79 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC----
Confidence 3478889999999999999999865543 79999986542 223467889999999999999999999976554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++++|.+++..... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 80 -~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 150 (268)
T cd05063 80 -PAMIITEYMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSD 150 (268)
T ss_pred -CcEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECC
Confidence 78999999999999999976432 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||++............ ......++.|+|||++.+..++.++|||| +|++++++++ +..|+....
T Consensus 151 fg~~~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s----------lG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 151 FGLSRVLEDDPEGTYT-----TSGGKIPIRWTAPEAIAYRKFTSASDVWS----------FGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred Cccceeccccccccee-----ccCCCcCceecCHHHhhcCCcChHhHHHH----------HHHHHHHHHhCCCCCCCcCC
Confidence 9998765432211100 01122356799999998888999999999 7778888776 777764221
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
. ....... .... ......+++..+.+++.+||..+|++||++.+|++.|.++
T Consensus 216 ~--~~~~~~i-~~~~-----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 216 N--HEVMKAI-NDGF-----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred H--HHHHHHH-hcCC-----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 1111111 1100 1112234567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=309.44 Aligned_cols=238 Identities=26% Similarity=0.286 Sum_probs=184.8
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHH-HHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|++..+++.||+|++.... ......+..|.. +++.++||||+++++++...+ ..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~-----~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE-----KLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----EEEEEE
Confidence 47999999999999999999999999996432 122334555554 578889999999999875554 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 76 DYVNGGELFFHLQRER------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred cCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 9999999998887543 688999999999999999999999 9999999999999999999999999998753
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.... .......||+.|+|||++.+..++.++|||| +|+++|+++++..|+...+.. ....
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~~~~~--~~~~ 206 (321)
T cd05603 147 VEPE--------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWC----------LGAVLYEMLYGLPPFYSRDVS--QMYD 206 (321)
T ss_pred CCCC--------CccccccCCcccCCHHHhcCCCCCCcCcccc----------cchhhhhhhcCCCCCCCCCHH--HHHH
Confidence 2211 1112356999999999999889999999999 788888888888887532210 1111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMR 815 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 815 (833)
....... ..+......+.+++.+|++.||++||++.
T Consensus 207 ~i~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 207 NILHKPL-------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHhcCCC-------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111111 11122355688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=301.43 Aligned_cols=253 Identities=27% Similarity=0.403 Sum_probs=197.6
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcch--hHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
|++.+.||+|+||+||+|+...+++.||+|++........ ....+|+.++++++||||+++++++.... ..++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDN-----YLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESS-----EEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccc-----cccc
Confidence 6788999999999999999999999999999975543222 23456999999999999999999976654 8899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++++|.+++.... .+++..++.++.|+++||++||+. +|+|+||||+||+++.++.++|+|||.+.
T Consensus 76 v~~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp EEEEETTEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred cccccccccccccccccc------cccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 999999999999998333 689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCcccccccccCCCccccccccccccCccccC-CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
...... .......+|+.|+|||++. +..++.++|||| .|.++++++++..|+......+..
T Consensus 147 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~~l~~~~~p~~~~~~~~~~ 208 (260)
T PF00069_consen 147 KLSENN--------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWS----------LGIILYELLTGKLPFEESNSDDQL 208 (260)
T ss_dssp ESTSTT--------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHH----------HHHHHHHHHHSSSSSTTSSHHHHH
T ss_pred cccccc--------cccccccccccccccccccccccccccccccc----------cccccccccccccccccccchhhh
Confidence 541111 1122346899999999988 888999999999 888899999998887643111111
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
......... ...............+.+++.+||+.||++|||+.++++
T Consensus 209 ~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 209 EIIEKILKR--PLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHHHHHT--HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhhhhcccc--cccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111000000 000001111111378999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=302.76 Aligned_cols=262 Identities=21% Similarity=0.337 Sum_probs=199.0
Q ss_pred HhcCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
..++|.+.+.||+|++|.||+|.+.. ++..||+|.+..... .....+.+|+.++++++|+||+++++++....
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL- 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence 34679999999999999999999976 678899999864432 23456899999999999999999999875544
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCc-cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC--
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQ-VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-- 679 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 679 (833)
..++||||+++|+|.+++...... .....+++.+++.++.||+.|++|||+. +++||||||+||+++.++
T Consensus 83 ----~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 83 ----PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred ----CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCC
Confidence 678999999999999999765421 1122589999999999999999999999 999999999999998755
Q ss_pred -cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-Hh
Q 040925 680 -VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TA 757 (833)
Q Consensus 680 -~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~ 757 (833)
.+||+|||+++......... ......++..|+|||++.+..++.++|||| +|++++++++ +.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~~~g~ 219 (277)
T cd05036 156 RVAKIADFGMARDIYRASYYR------KGGRAMLPIKWMPPEAFLDGIFTSKTDVWS----------FGVLLWEIFSLGY 219 (277)
T ss_pred cceEeccCccccccCCcccee------cCCCCCccHhhCCHHHHhcCCcCchhHHHH----------HHHHHHHHHcCCC
Confidence 69999999998663321110 011123457899999999889999999999 7777777775 66
Q ss_pred CCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 758 LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 758 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
.|+..... ... ........ ....+..++..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 220 ~pf~~~~~--~~~-~~~~~~~~-----~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 220 MPYPGRTN--QEV-MEFVTGGG-----RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCH--HHH-HHHHHcCC-----cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 66542111 111 11111100 00112334567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.53 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=198.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|++..+ +..||+|.++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 78 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK---- 78 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC----
Confidence 35789999999999999999987533 34799999865432 23467899999999999999999999975544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++..... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+||+|
T Consensus 79 -~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~d 149 (267)
T cd05066 79 -PVMIVTEYMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSD 149 (267)
T ss_pred -ccEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCC
Confidence 78999999999999999976532 579999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||.+..+........ ......++..|+|||++.+..++.++|+|| +|+.++++++ +..|+....
T Consensus 150 fg~~~~~~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s----------lG~~l~ell~~g~~p~~~~~ 214 (267)
T cd05066 150 FGLSRVLEDDPEAAY-----TTRGGKIPIRWTAPEAIAYRKFTSASDVWS----------YGIVMWEVMSYGERPYWEMS 214 (267)
T ss_pred CCcccccccccceee-----ecCCCccceeecCHhHhccCccCchhhhHH----------HHHHHHHHhcCCCCCcccCC
Confidence 999987654221110 011123467899999999888999999999 6777777664 666654221
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
.. .... .+.... .......++..+.+++.+||+.+|++||++.++++.|.++
T Consensus 215 ~~--~~~~-~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 215 NQ--DVIK-AIEEGY-----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HH--HHHH-HHhCCC-----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11 1111 111110 0011223466788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.92 Aligned_cols=262 Identities=21% Similarity=0.279 Sum_probs=195.3
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++...........|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999999988999999999864322 2346788999999999999999999997655433334689
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+. ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a 150 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLA 150 (372)
T ss_pred EEeeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccce
Confidence 9999996 58888886543 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+....... .......+|+.|+|||++.+. .++.++|||| .|+++++++++..|+......+.
T Consensus 151 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~~~~~~~ 213 (372)
T cd07853 151 RVEEPDES-------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWS----------VGCIFAELLGRRILFQAQSPIQQ 213 (372)
T ss_pred eecccCcc-------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHh----------HHHHHHHHHcCCCCCCCCCHHHH
Confidence 76433211 111224589999999998774 4789999999 77777888887777642211100
Q ss_pred c-chh--------------------hhccccchhhhhh--hhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 S-LLM--------------------EVMTNNSMIQEDK--RVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~-~~~--------------------~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
- ... ............. .....+..+.+.+++.+||+.||++|||++|+++.
T Consensus 214 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 214 LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 000 0000000000000 00111235678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=303.05 Aligned_cols=261 Identities=22% Similarity=0.350 Sum_probs=197.4
Q ss_pred cCCccCceeccCcceEEEEEEE----CCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTL----GEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|++.+.||+|+||.||+|.. ..++..||+|.++.... .....+.+|++++++++||||+++++++....
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 80 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ---- 80 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC----
Confidence 4688899999999999999985 34567899999974332 23357889999999999999999999975544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCc-----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCee
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQ-----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVL 674 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIl 674 (833)
..|+||||+++|+|.+++...... .....+++.++..++.|++.||+|||+. +|+||||||+||+
T Consensus 81 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nil 156 (283)
T cd05090 81 -PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNIL 156 (283)
T ss_pred -ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEE
Confidence 789999999999999998643210 0112578899999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 675 LDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 675 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
++.++.+||+|||+++......... ......++..|+|||++.+..++.++|||| +|+++++++
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~il~el~ 220 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYR------VQPKSLLPIRWMPPEAIMYGKFSSDSDIWS----------FGVVLWEIF 220 (283)
T ss_pred EcCCCcEEeccccccccccCCccee------cccCCCccceecChHHhccCCCCchhhhHH----------HHHHHHHHH
Confidence 9999999999999998654322111 111234677899999998888999999999 777778877
Q ss_pred H-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 755 K-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 755 ~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
+ +..|+.... +....+...... ....+..++..+.+++.+||+.||++||++.+|.+++..
T Consensus 221 ~~g~~p~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 221 SFGLQPYYGFS---NQEVIEMVRKRQ-----LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCCCCCCCCC---HHHHHHHHHcCC-----cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 6 555543111 101011111100 011122345678899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=323.97 Aligned_cols=261 Identities=19% Similarity=0.255 Sum_probs=191.8
Q ss_pred HHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCC------CccceEeeEe
Q 040925 524 AELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRH------RNLIKIITIC 597 (833)
Q Consensus 524 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~ 597 (833)
.++....++|++.+.||+|+||.||+|.+..+++.||||+++... ...+....|+.+++.++| ++++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456789999999999999999999999899999999996432 233456678888877754 4588888887
Q ss_pred ecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeCCCCCCeeec
Q 040925 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 598 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~Dlkp~NIll~ 676 (833)
... ..+.|+|||++ +++|.+++...+ .+++..+..|+.||+.||+|||+ . |||||||||+|||++
T Consensus 201 ~~~----~~~~~iv~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~ 266 (467)
T PTZ00284 201 QNE----TGHMCIVMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILME 266 (467)
T ss_pred EcC----CceEEEEEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEe
Confidence 543 34789999998 679999887654 68999999999999999999997 5 999999999999998
Q ss_pred CCC----------------cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCC
Q 040925 677 HDM----------------VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPI 740 (833)
Q Consensus 677 ~~~----------------~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~ 740 (833)
.++ .+||+|||.+..... .....+||+.|||||++.+..++.++||||
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS----- 330 (467)
T PTZ00284 267 TSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWS----- 330 (467)
T ss_pred cCCcccccccccccCCCCceEEECCCCccccCcc-----------ccccccCCccccCcHHhhcCCCCcHHHHHH-----
Confidence 765 499999998764221 112357999999999999999999999999
Q ss_pred CccccCCccHHHHHHHhCCCcccccccc-------------cchh--------hhccccch------hhhhhh------h
Q 040925 741 DAVFNEGHSLHEFAKTALPEKVMEIVDP-------------SLLM--------EVMTNNSM------IQEDKR------V 787 (833)
Q Consensus 741 ~~~~~~g~~l~~~~~~~~p~~~~~~~~~-------------~~~~--------~~~~~~~~------~~~~~~------~ 787 (833)
+|+++|++++|..|+......+. .+.. +....... .....+ .
T Consensus 331 -----lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (467)
T PTZ00284 331 -----MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPV 405 (467)
T ss_pred -----HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccch
Confidence 77788888888877642211100 0000 00000000 000000 0
Q ss_pred chHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 788 KTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 788 ~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
........+.+++.+||++||++|||++|++++
T Consensus 406 ~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred hhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence 000013457899999999999999999999874
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=296.59 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=190.8
Q ss_pred eeccCcceEEEEEEEC--CCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEe
Q 040925 538 MIGQGSFGYVYKGTLG--EDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEY 614 (833)
Q Consensus 538 ~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 614 (833)
.||+|+||.||+|.+. .++..||+|++..... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 4899999999999774 4566799999875432 234568999999999999999999998642 257899999
Q ss_pred cCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCc
Q 040925 615 MENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 615 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
+++|+|.+++..... .+++..+++++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 76 ASGGPLNKFLSGKKD-----EITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred CCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccC
Confidence 999999999875432 689999999999999999999999 999999999999999999999999999975543
Q ss_pred ccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchhh
Q 040925 695 HQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLME 773 (833)
Q Consensus 695 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~ 773 (833)
...... ......+++.|+|||++.+..++.++|||| +|++++++++ +..|+..... .... .
T Consensus 148 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~el~~~g~~p~~~~~~--~~~~-~ 209 (257)
T cd05115 148 DDSYYK-----ARSAGKWPLKWYAPECINFRKFSSRSDVWS----------YGITMWEAFSYGQKPYKKMKG--PEVM-S 209 (257)
T ss_pred Ccccee-----ccCCCCCCcccCCHHHHccCCCCchhhHHH----------HHHHHHHHhcCCCCCcCcCCH--HHHH-H
Confidence 221100 011122467899999988888999999999 7777777775 6666542211 1111 1
Q ss_pred hccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 774 VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 774 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
...... ....+..++.++.+++.+||..||++||++.+|.+.|+.+
T Consensus 210 ~~~~~~-----~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 210 FIEQGK-----RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHCCC-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 111100 0111233467888999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=305.18 Aligned_cols=267 Identities=22% Similarity=0.347 Sum_probs=200.7
Q ss_pred HhcCCccCceeccCcceEEEEEEEC-------CCceEEEEEEeeccC-CcchhHHHHHHHHHhhc-CCCccceEeeEeec
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLG-------EDEMIVAVKVINLKY-KGASRSFVAECEALRNI-RHRNLIKIITICSS 599 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 599 (833)
..++|.+.+.||+|+||.||+|+.. .++..||+|.++... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3567899999999999999999752 235579999986432 23346789999999999 79999999999765
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCcc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCC
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV----------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLK 669 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlk 669 (833)
.. ..++||||+++|+|.+++....... ....+++.++..++.|++.||+|||+. ||+|||||
T Consensus 93 ~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlk 164 (304)
T cd05101 93 DG-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLA 164 (304)
T ss_pred CC-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecccc
Confidence 54 7899999999999999997643210 112578899999999999999999999 99999999
Q ss_pred CCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCcc
Q 040925 670 PSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHS 749 (833)
Q Consensus 670 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~ 749 (833)
|+||+++.++.+||+|||.++......... ......+++.|+|||++.+..++.++|||| +|++
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~ 228 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWS----------FGVL 228 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccc------cccCCCCCceeeCchhhccCCCCchhhHHH----------HHHH
Confidence 999999999999999999998664422111 111223678899999998888999999999 6666
Q ss_pred HHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 750 LHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 750 l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
++++++ +..|+.... ............ ....+..++..+.+++.+||..+|++|||+.|+++.|.++...
T Consensus 229 l~el~~~g~~p~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 229 MWEIFTLGGSPYPGIP---VEELFKLLKEGH-----RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHcCCCCCcccCC---HHHHHHHHHcCC-----cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 666665 344432111 000011111100 0011234567789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=303.82 Aligned_cols=265 Identities=22% Similarity=0.372 Sum_probs=197.2
Q ss_pred cCCccCceeccCcceEEEEEEECC----------------CceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGE----------------DEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKI 593 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~ 593 (833)
++|++.+.||+|+||.||+|.+.. ++..||+|+++... ......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 479999999999999999986532 34579999997542 2234678999999999999999999
Q ss_pred eeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCcc-----ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCC
Q 040925 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV-----EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDL 668 (833)
Q Consensus 594 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dl 668 (833)
++++...+ ..++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. +++||||
T Consensus 85 ~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl 156 (296)
T cd05095 85 LAVCITSD-----PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDL 156 (296)
T ss_pred EEEEecCC-----ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccC
Confidence 99976654 7899999999999999997643211 112478889999999999999999999 9999999
Q ss_pred CCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCc
Q 040925 669 KPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGH 748 (833)
Q Consensus 669 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~ 748 (833)
||+||+++.++.+||+|||+++.+....... ......+++.|+|||+..+..++.++|||| +|+
T Consensus 157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~DiwS----------lG~ 220 (296)
T cd05095 157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYR------IQGRAVLPIRWMSWESILLGKFTTASDVWA----------FGV 220 (296)
T ss_pred ChheEEEcCCCCEEeccCcccccccCCccee------ccCcCcCccccCCHHHHhcCCccchhhhhH----------HHH
Confidence 9999999999999999999998654322110 011123567899999988888999999999 777
Q ss_pred cHHHHHH--HhCCCcccccccccchhhh---ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 749 SLHEFAK--TALPEKVMEIVDPSLLMEV---MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 749 ~l~~~~~--~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
+++++++ +..|+.... +....... ..... .......+..++..+.+++.+||+.||++|||+.||.+.|++
T Consensus 221 ~l~el~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 221 TLWEILTLCKEQPYSQLS--DEQVIENTGEFFRDQG--RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHHHHhCCCCCccccC--hHHHHHHHHHHHhhcc--ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 8888876 445543211 11110000 00000 000011122345788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=303.26 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=202.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.+|++.+.||+|++|.||+|....+++.||+|.+........+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l 93 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV 93 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----EEEE
Confidence 57999999999999999999998899999999997655555677889999999999999999999976544 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++++|.+++... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 94 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 94 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred eecccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccce
Confidence 99999999999998653 578899999999999999999999 99999999999999999999999999987
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
....... ......|++.|+|||...+..++.++|+|| +|+++++++++..|+...+......
T Consensus 164 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lGvil~~l~tg~~pf~~~~~~~~~~ 225 (297)
T cd06656 164 QITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS----------LGIMAIEMVEGEPPYLNENPLRALY 225 (297)
T ss_pred EccCCcc--------CcCcccCCccccCHHHHcCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCcchhee
Confidence 6543221 111235889999999998888999999999 7888899999988875322111100
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ...... .....+...+..+.+++.+||..||++||+++++++.
T Consensus 226 ~--~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 226 L--IATNGT----PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred e--eccCCC----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000000 0001123345678899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=301.89 Aligned_cols=261 Identities=22% Similarity=0.353 Sum_probs=198.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCC-----ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGED-----EMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||.||+|..... +..||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-- 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ-- 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC--
Confidence 45799999999999999999988643 47899999864422 23456889999999999999999999975543
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCcc----ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQV----EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
..++||||+++|+|.+++....... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++
T Consensus 83 ---~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 83 ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred ---CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 7899999999999999997643211 112478899999999999999999999 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhC
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TAL 758 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~ 758 (833)
.+||+|||+++......... ......++..|+|||.+.+..++.++|||| +|++++++++ +..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~t~g~~ 220 (277)
T cd05032 157 TVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMAPESLKDGVFTTKSDVWS----------FGVVLWEMATLAEQ 220 (277)
T ss_pred CEEECCcccchhhccCcccc------cCCCCCccccccCHHHHhcCCCCcccchHH----------HHHHHHHhhccCCC
Confidence 99999999998654432111 111234688999999998888999999999 6777777776 555
Q ss_pred CCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 759 PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 759 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
|+..... ........... ....+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 221 p~~~~~~--~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 221 PYQGLSN--EEVLKFVIDGG------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCccCCH--HHHHHHHhcCC------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 5431110 01111111110 01112234678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=305.60 Aligned_cols=267 Identities=23% Similarity=0.335 Sum_probs=202.4
Q ss_pred hcCCccCceeccCcceEEEEEEECC-------CceEEEEEEeeccC-CcchhHHHHHHHHHhhc-CCCccceEeeEeecC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGE-------DEMIVAVKVINLKY-KGASRSFVAECEALRNI-RHRNLIKIITICSST 600 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 600 (833)
.++|.+.+.||+|+||.||+|++.. +...||+|.++... ......+.+|+++++.+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 4679999999999999999998643 23579999997542 22345688899999999 799999999997655
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCcc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQV----------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
+ ..++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. |++||||||
T Consensus 97 ~-----~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 168 (307)
T cd05098 97 G-----PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAA 168 (307)
T ss_pred C-----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccH
Confidence 4 7899999999999999997653210 112588999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+||+++.++.+||+|||.++......... ......+++.|+|||++.+..++.++|||| +|+++
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws----------lG~~l 232 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYK------KTTNGRLPVKWMAPEALFDRIYTHQSDVWS----------FGVLL 232 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhh------ccccCCCccceeChHHhccCCCCcHHHHHH----------HHHHH
Confidence 99999999999999999987654321110 011122457899999999888999999999 67777
Q ss_pred HHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 751 HEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 751 ~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
+++++ +..|+.... ............ ....+..++..+.+++.+||..+|++|||+.++++.|.++.+..
T Consensus 233 ~el~~~g~~p~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 233 WEIFTLGGSPYPGVP---VEELFKLLKEGH-----RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHcCCCCCCCcCC---HHHHHHHHHcCC-----CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 77776 555543211 111111111110 01112335668889999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=333.25 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=200.3
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
....++|++.+.||+|+||.||+|++..++..||+|.+.... ......+..|+.++++++|||||++++++....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~--- 85 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA--- 85 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC---
Confidence 345578999999999999999999999999999999987432 223467889999999999999999999875432
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCC----CCceeeCCCCCCeeecC---
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQ----PPMVHGDLKPSNVLLDH--- 677 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~----~~ivH~Dlkp~NIll~~--- 677 (833)
...+|+||||+++|+|.+++...... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 34789999999999999999753211 1168999999999999999999998510 25999999999999964
Q ss_pred --------------CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCC--CCCCcccccccCCcCCC
Q 040925 678 --------------DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFTGRRPID 741 (833)
Q Consensus 678 --------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~~~~~~ 741 (833)
.+.+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWS------ 228 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIESM---------AHSCVGTPYYWSPELLLHETKSYDDKSDMWA------ 228 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccccc---------ccccCCCccccCHHHHhccCCCCCchhHHHH------
Confidence 23589999999986543221 123469999999998854 45889999999
Q ss_pred ccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 742 AVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 742 ~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
+|+++|+++++..|+....... .+... +... ........+..+.++|..||..+|++|||+.|++.
T Consensus 229 ----LG~ILYELLTGk~PF~~~~~~~-qli~~-lk~~------p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 229 ----LGCIIYELCSGKTPFHKANNFS-QLISE-LKRG------PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred ----HHHHHHHHHHCCCCCCcCCcHH-HHHHH-HhcC------CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 8889999999999875322111 11111 1110 01111223567889999999999999999999985
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=312.16 Aligned_cols=262 Identities=18% Similarity=0.242 Sum_probs=196.7
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTD-FKG 604 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 604 (833)
...++|++.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.... ...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 355789999999999999999999988999999999974422 23457788999999999999999999875443 123
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
....++||||+++ ++.+.+.. .+++..+..++.|+++||+|||+. ||+||||||+||+++.++.+||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~ 161 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKIL 161 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEe
Confidence 3467999999975 77777643 478889999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+++...... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+...+
T Consensus 162 Dfg~~~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 162 DFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWS----------VGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred eCcccccCCCcc---------ccCCccccCCccCHHHHcCCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCC
Confidence 999998653321 112346899999999999999999999999 6777777777777654221
Q ss_pred cccc-------------cc-------hhhhccccc-----h--------hhhhhhhchHHHHHHHHHHhhccCCCCCCCC
Q 040925 765 IVDP-------------SL-------LMEVMTNNS-----M--------IQEDKRVKTEECLNAIIRTGVLCSMESPFER 811 (833)
Q Consensus 765 ~~~~-------------~~-------~~~~~~~~~-----~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 811 (833)
..+. .. ......... . ..+............+.+++.+|+..||++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 302 (355)
T cd07874 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhc
Confidence 1100 00 000000000 0 0000000111224567899999999999999
Q ss_pred CCHHHHHHH
Q 040925 812 MDMRDVVAK 820 (833)
Q Consensus 812 Pt~~eil~~ 820 (833)
||+.|+++.
T Consensus 303 ps~~ell~h 311 (355)
T cd07874 303 ISVDEALQH 311 (355)
T ss_pred CCHHHHhcC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=302.65 Aligned_cols=267 Identities=21% Similarity=0.306 Sum_probs=197.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCc----------------eEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDE----------------MIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIK 592 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 592 (833)
.++|++.+.||+|+||.||+|++...+ ..||+|.+..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 457999999999999999999876433 5689999875432 23567889999999999999999
Q ss_pred EeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCcc-----ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeC
Q 040925 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV-----EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGD 667 (833)
Q Consensus 593 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~D 667 (833)
+++++...+ ..++||||+++++|.+++....... ....+++..++.++.|++.||+|||+. +|+|||
T Consensus 84 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~d 155 (296)
T cd05051 84 LLGVCTVDP-----PLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRD 155 (296)
T ss_pred EEEEEecCC-----CcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccc
Confidence 999976544 7899999999999999997654110 112589999999999999999999999 999999
Q ss_pred CCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCC
Q 040925 668 LKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEG 747 (833)
Q Consensus 668 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g 747 (833)
|||+||+++.++.++|+|||.++......... ......+++.|+|||++.+..++.++|||| +|
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG 219 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYR------VQGRAPLPIRWMAWESVLLGKFTTKSDVWA----------FG 219 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCccee------ecCcCCCCceecCHHHhhcCCCCccchhhh----------hH
Confidence 99999999999999999999987654322111 111234678999999998888999999999 67
Q ss_pred ccHHHHHH--HhCCCcccccccccchhhhccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 748 HSLHEFAK--TALPEKVMEIVDPSLLMEVMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 748 ~~l~~~~~--~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
++++++.+ +..|+.... +............ .........+..++.++.+++.+||+.||++|||+.||++.|+
T Consensus 220 ~~l~el~~~~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 220 VTLWEILTLCREQPYEHLT--DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhcCCCCCCCCcC--hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 77777766 334433111 1111110000000 0000001112234567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=296.69 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=194.5
Q ss_pred ceeccCcceEEEEEEECCCc---eEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDE---MIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
++||+|+||.||+|++...+ ..||+|.++.... ...+.+.+|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence 47999999999999875544 7899999875433 244678999999999999999999998642 2578999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++..
T Consensus 75 e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~ 145 (257)
T cd05060 75 ELAPLGPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRAL 145 (257)
T ss_pred EeCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccccee
Confidence 9999999999998654 589999999999999999999999 9999999999999999999999999999866
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccch
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLL 771 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~ 771 (833)
....... .......++..|+|||...+..++.++|||| +|+.++++++ +..|+..... ....
T Consensus 146 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~~~~~~g~~p~~~~~~--~~~~ 208 (257)
T cd05060 146 GAGSDYY-----RATTAGRWPLKWYAPECINYGKFSSKSDVWS----------YGVTLWEAFSYGAKPYGEMKG--AEVI 208 (257)
T ss_pred ecCCccc-----ccccCccccccccCHHHhcCCCCCccchHHH----------HHHHHHHHHcCCCCCcccCCH--HHHH
Confidence 4322110 0011122456899999998888999999999 7777888876 6666542211 1111
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
.. ..... ....+..++..+.+++.+||..+|++|||+.++++.|+++.
T Consensus 209 ~~-~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 209 AM-LESGE-----RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HH-HHcCC-----cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11 11110 01122335678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=305.21 Aligned_cols=268 Identities=23% Similarity=0.360 Sum_probs=201.0
Q ss_pred hcCCccCceeccCcceEEEEEEEC-------CCceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLG-------EDEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSST 600 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 600 (833)
.++|.+.+.||+|+||.||+|+.. .....||+|.++.... .....+.+|+++++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457899999999999999999863 2356799999874322 2345688999999999 699999999997554
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
. ..++||||+++|+|.+++...... .....+++.++..++.|++.||.|||+. ||+||||||
T Consensus 91 ~-----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp 162 (314)
T cd05099 91 G-----PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAA 162 (314)
T ss_pred C-----ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccccc
Confidence 4 789999999999999999764321 0112588999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+||+++.++.+||+|||.++........... ....+++.|||||++.+..++.++|||| +|+++
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~Diws----------lG~~l 226 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKT------SNGRLPVKWMAPEALFDRVYTHQSDVWS----------FGILM 226 (314)
T ss_pred eeEEEcCCCcEEEcccccccccccccccccc------ccCCCCccccCHHHHccCCcCccchhhH----------HHHHH
Confidence 9999999999999999999866432211100 0112456899999998888999999999 67777
Q ss_pred HHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 751 HEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 751 ~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
+++++ +..|+.... ............ ....+..++.++.+++.+||..||++|||+.|+++.|.++.....
T Consensus 227 ~el~~~g~~p~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~ 298 (314)
T cd05099 227 WEIFTLGGSPYPGIP---VEELFKLLREGH-----RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS 298 (314)
T ss_pred HHHHhCCCCCCCCCC---HHHHHHHHHcCC-----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence 77776 555543211 111111111100 001122345678899999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=303.67 Aligned_cols=261 Identities=21% Similarity=0.308 Sum_probs=197.7
Q ss_pred cCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
.+|++.+.||+|+||.||+|.+.. .+..||+|+++..... ..+.+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~--- 81 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ--- 81 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC---
Confidence 357888999999999999998753 3578999999744332 2356889999999999999999999976554
Q ss_pred CceEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCee
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVL 674 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIl 674 (833)
..++++||+++++|.+++...... .....+++..++.++.|++.||+|+|+. +|+||||||+||+
T Consensus 82 --~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil 156 (283)
T cd05091 82 --PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVL 156 (283)
T ss_pred --ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheE
Confidence 789999999999999998632110 1122578899999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 675 LDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 675 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
+++++.+||+|||+++......... ......+++.|+|||++.+..++.++|||| +|+++++++
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~~l~el~ 220 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYK------LMGNSLLPIRWMSPEAIMYGKFSIDSDIWS----------YGVVLWEVF 220 (283)
T ss_pred ecCCCceEecccccccccccchhee------eccCccCCccccCHHHHhcCCCCcchhHHH----------HHHHHHHHH
Confidence 9999999999999988654322111 111234678999999998888999999999 677777777
Q ss_pred H-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 755 K-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 755 ~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
+ +..|+.... ............ ....+.+++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 221 ~~g~~p~~~~~--~~~~~~~i~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 221 SYGLQPYCGYS--NQDVIEMIRNRQ------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred cCCCCCCCCCC--HHHHHHHHHcCC------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 6 444543111 011111111111 111234567788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=296.29 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=192.9
Q ss_pred eeccCcceEEEEEEE--CCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 538 MIGQGSFGYVYKGTL--GEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 538 ~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
.||+|+||.||+|.+ ..++..||+|+++.... ...+.+.+|+.+++.++||||+++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 689999999999965 45678999999864432 234678999999999999999999998642 25689999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~ 146 (257)
T cd05116 76 LAELGPLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALG 146 (257)
T ss_pred cCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccC
Confidence 999999999997643 689999999999999999999999 99999999999999999999999999998664
Q ss_pred cccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchh
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLM 772 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~ 772 (833)
...... .......+++.|+|||.+....++.++|||| +|+.++++++ +..|+..... ....
T Consensus 147 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~el~t~g~~p~~~~~~---~~~~ 208 (257)
T cd05116 147 ADENYY-----KAKTHGKWPVKWYAPECMNYYKFSSKSDVWS----------FGVLMWEAFSYGQKPYKGMKG---NEVT 208 (257)
T ss_pred CCCCee-----eecCCCCCCccccCHhHhccCCcCchhHHHH----------HHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence 332110 0011123568999999998888999999999 7888888887 7777652211 1111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
+.+..... ...+..++..+.+++.+||+.||++||++++|.+.|++.
T Consensus 209 ~~i~~~~~-----~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 209 QMIESGER-----MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHCCCC-----CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11111110 011223567789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=302.08 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=199.4
Q ss_pred CCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
+|++.+.||+|+||.||+|+... ....+|+|.+..... ...+.+.+|+.+++.++||||+++++.+...+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 76 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG---- 76 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC----
Confidence 47888999999999999998743 235789998864432 23457889999999999999999999876554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCc------------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeC
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQ------------------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGD 667 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~D 667 (833)
..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +|+|||
T Consensus 77 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~d 152 (290)
T cd05045 77 -PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRD 152 (290)
T ss_pred -CcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhh
Confidence 689999999999999998653211 0112578999999999999999999999 999999
Q ss_pred CCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCC
Q 040925 668 LKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEG 747 (833)
Q Consensus 668 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g 747 (833)
|||+||++++++.+||+|||+++......... ......++..|+|||+..+..++.++|||| +|
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~s----------lG 216 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYV------KRSKGRIPVKWMAIESLFDHIYTTQSDVWS----------FG 216 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchh------cccCCCCCccccCHHHHccCCcchHhHHHH----------HH
Confidence 99999999999999999999997653322110 111234677899999998888999999999 77
Q ss_pred ccHHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 748 HSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 748 ~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
+.++++++ +..|+.... +....+...... ....+..++..+.+++.+||+.+|++||+++|+++.|+++..
T Consensus 217 ~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 217 VLLWEIVTLGGNPYPGIA---PERLFNLLKTGY-----RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhcCCCCCCCCC---HHHHHHHHhCCC-----CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 77888887 666653211 111111111110 011122345678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=295.80 Aligned_cols=251 Identities=29% Similarity=0.419 Sum_probs=198.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|++|.||+|... ++.||+|.++.... ..+.+.+|+.++++++|+||+++++++... ...+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 76 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQG-----NPLY 76 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCC-----CCeE
Confidence 457899999999999999999884 78899999975533 457889999999999999999999997553 3789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++...... .+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~ 149 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRA----VITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLA 149 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccc
Confidence 999999999999999765422 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
+....... ...++..|+|||++.+..++.++|||| +|++++++++ +..|+.....
T Consensus 150 ~~~~~~~~-----------~~~~~~~~~ape~~~~~~~~~~~Di~s----------lG~il~~l~~~g~~p~~~~~~--- 205 (256)
T cd05039 150 KEASQGQD-----------SGKLPVKWTAPEALREKKFSTKSDVWS----------FGILLWEIYSFGRVPYPRIPL--- 205 (256)
T ss_pred cccccccc-----------cCCCcccccCchhhcCCcCCcHHHHHH----------HHHHHHHHHhcCCCCCCCCCH---
Confidence 86633211 122466799999998888999999999 6777777776 6666542211
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
........... ....+..+++.+.+++.+||..+|++|||++|++++|+.+
T Consensus 206 ~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 206 KDVVPHVEKGY-----RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred HHHHHHHhcCC-----CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11111111110 0011223467789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=309.01 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=195.2
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCC-CC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDF-KG 604 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 604 (833)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++..... ..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345789999999999999999999998999999999864322 233567789999999999999999998754321 22
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
....+++||++ +++|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~ 160 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL 160 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence 24578999998 67999888643 589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
|||+++..... .....||+.|+|||++.+ ..++.++|||| .|+++++++++..|+...
T Consensus 161 Dfg~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~~ 219 (343)
T cd07878 161 DFGLARQADDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS----------VGCIMAELLKGKALFPGN 219 (343)
T ss_pred CCccceecCCC-----------cCCccccccccCchHhcCCccCCchhhhHh----------HHHHHHHHHHCCCCCCCC
Confidence 99999865331 123468999999999876 56899999999 777888888887765422
Q ss_pred ccccc-------------cchhh--------hccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDP-------------SLLME--------VMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~-------------~~~~~--------~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+..+. ..... ...... ..............+.+.+++.+|++.||++|||+.|+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 220 DYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11100 00000 000000 00000000001123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=296.10 Aligned_cols=251 Identities=29% Similarity=0.367 Sum_probs=195.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
..+|++.+.||+|++|.||+|... +..||+|.++.. ...+.+.+|+.++++++|++++++++++... ....+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 76 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceE
Confidence 347899999999999999999874 678999998633 2356789999999999999999999976432 24689
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++...... .+++..++.++.|++.||+|||+. |++||||||+||++++++.+||+|||++
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~ 149 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 149 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccc
Confidence 999999999999999765432 578999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
....... ....++..|+|||++.+..++.++|||| +|++++++++ +..|+......
T Consensus 150 ~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~i~~~l~~~g~~p~~~~~~~-- 206 (256)
T cd05082 150 KEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWS----------FGILLWEIYSFGRVPYPRIPLK-- 206 (256)
T ss_pred eeccccC-----------CCCccceeecCHHHHccCCCCchhhhHH----------HHHHHHHHHhCCCCCCCCCCHH--
Confidence 7543311 1123567899999998888999999999 6777777776 66665321110
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
.... ...... .......++..+.+++.+||..+|++|||+.++++.|+++
T Consensus 207 ~~~~-~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 207 DVVP-RVEKGY-----KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred HHHH-HHhcCC-----CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0000 000000 0011233567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=296.01 Aligned_cols=254 Identities=24% Similarity=0.294 Sum_probs=203.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
++|++.+.||.|++|.||+|.+..+++.+|+|.+........+.+.+|++++++++||||+++++++.... ..++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-----KLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC-----EEEE
Confidence 57999999999999999999998889999999998665556678999999999999999999999875544 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
+|||+++++|.+++..... .+++.++..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||.+.
T Consensus 78 ~~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTRG-----PLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred EEeCCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 9999999999999876521 689999999999999999999999 99999999999999999999999999987
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCC---CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS---EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
....... ......|+..|+|||.+.+. .++.++|+|| +|+.+++++++..|+.......
T Consensus 150 ~~~~~~~--------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~s----------lG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 150 QLTATIA--------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWA----------LGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred hhhhhhh--------ccccccCCccccCchhhcccccCCcCchhhhHH----------HHHHHHHHHhCCCCCCCCCHHH
Confidence 6543211 11224588999999998776 7899999999 8888999999988865222111
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
... ....... ...........+..+.+++.+||..||++|||+.+|+.
T Consensus 212 ~~~--~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 212 ALF--LISKSNF--PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHH--HHHhccC--CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 100 0000000 00011122345667899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=295.49 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=198.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|.+.+.||+|++|.||+|.+..+ ..||+|.+.... ...+.+.+|++++++++|||++++++++.. ...+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~ 76 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIY 76 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcE
Confidence 35689999999999999999998744 469999886432 334678899999999999999999988632 2578
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++...... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~ 149 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGK----YLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLA 149 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccc
Confidence 999999999999999764321 578999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
.......... .....++..|+|||+..+..++.++|||| +|++++++++ +..|+.... +.
T Consensus 150 ~~~~~~~~~~-------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s----------lG~~l~el~t~g~~p~~~~~--~~ 210 (260)
T cd05069 150 RLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWS----------FGILLTELVTKGRVPYPGMV--NR 210 (260)
T ss_pred eEccCCcccc-------cCCCccchhhCCHHHhccCCcChHHHHHH----------HHHHHHHHHhCCCCCCCCCC--HH
Confidence 7654322111 11223678899999998888999999999 7888888888 676654211 11
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
..... ..... ....+.+.+..+.+++.+||..||++||++++|++.|++
T Consensus 211 ~~~~~-~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 211 EVLEQ-VERGY-----RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHH-HHcCC-----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11111 11110 011123456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=299.91 Aligned_cols=251 Identities=20% Similarity=0.314 Sum_probs=196.7
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
|++.+.||+|+||.||+|.+..++..+|+|.+........+.+.+|+++++.++||||+++++++.... ..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC-----EEEEEE
Confidence 678899999999999999999899999999997554445567889999999999999999999976544 889999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++..... ++++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 82 e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 153 (282)
T cd06643 82 EFCAGGAVDAVMLELER-----PLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKN 153 (282)
T ss_pred EecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccc
Confidence 99999999998765321 689999999999999999999999 9999999999999999999999999998754
Q ss_pred CcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
.... .......||+.|+|||++. +..++.++|||| +|+++++++++..|+.....
T Consensus 154 ~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s----------lGvil~el~~g~~p~~~~~~-- 213 (282)
T cd06643 154 TRTI--------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS----------LGITLIEMAQIEPPHHELNP-- 213 (282)
T ss_pred cccc--------cccccccccccccCHhhccccCCCCCCCCccchhhh----------HHHHHHHHccCCCCccccCH--
Confidence 3221 1112346899999999873 455788999999 77888888888777642211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
............ .....+..++..+.+++.+||+.||++|||+.++++.
T Consensus 214 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 214 MRVLLKIAKSEP----PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred HHHHHHHhhcCC----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111111100 0011122345678999999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=302.08 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=202.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.+|++.+.||.|++|.||+|.+..+++.||+|.+........+.+.+|+.+++.++||||+++++++...+ ..++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGD-----ELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCc-----eEEE
Confidence 46999999999999999999998899999999997655555677899999999999999999999976544 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 94 v~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 94 VMEYLAGGSLTDVVTET-------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred EEEecCCCcHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence 99999999999998643 588999999999999999999999 99999999999999999999999999987
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
....... ......|++.|+|||.+.+..++.++|||| +|+++++++++..|+...+..+...
T Consensus 164 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lGvil~~lltg~~pf~~~~~~~~~~ 225 (296)
T cd06655 164 QITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS----------LGIMAIEMVEGEPPYLNENPLRALY 225 (296)
T ss_pred hcccccc--------cCCCcCCCccccCcchhcCCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 6543211 111245899999999998888999999999 7888899999888875332211100
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ..... ......+..++..+.+++.+||..||++|||+.+++..
T Consensus 226 ~--~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 226 L--IATNG----TPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred H--HHhcC----CcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0 00000 00011123356678899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.96 Aligned_cols=253 Identities=21% Similarity=0.277 Sum_probs=197.3
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.|+..+.||+|+||+||+|.+..+++.||+|.++... ......+.+|++++++++|++|+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~-----~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKD-----AL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCC-----EE
Confidence 3677889999999999999999999999999986432 122345788999999999999999998865544 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++...... .+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||+
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~ 148 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNP----GFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCc
Confidence 9999999999999988654322 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+........ .....|++.|+|||++.+..++.++|+|| +|+++++++++..|+......
T Consensus 149 ~~~~~~~~~---------~~~~~g~~~~~aPE~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~P~~~~~~~-- 207 (285)
T cd05632 149 AVKIPEGES---------IRGRVGTVGYMAPEVLNNQRYTLSPDYWG----------LGCLIYEMIEGQSPFRGRKEK-- 207 (285)
T ss_pred ceecCCCCc---------ccCCCCCcCccChHHhcCCCCCcccchHH----------HHHHHHHHHhCCCCCCCCCHH--
Confidence 875432211 12246899999999999889999999999 788899999999887532110
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
...+.+.... ..........++..+.+++..||+.||++||+ ++++++.
T Consensus 208 -~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 208 -VKREEVDRRV--LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -HHHHHHHHhh--hccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0000000000 00011112334567889999999999999999 6677664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=303.25 Aligned_cols=260 Identities=22% Similarity=0.384 Sum_probs=199.4
Q ss_pred hcCCccCceeccCcceEEEEEEE-----CCCceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 602 (833)
.++|.+.+.||+|+||.||+|+. ..++..||+|.++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG- 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC-
Confidence 35799999999999999999975 33566899999874432 2345788999999999 7999999999976554
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
..++||||+++|+|.+++...... .+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.+|
T Consensus 113 ----~~~lv~e~~~~~~L~~~i~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 113 ----PILVITEYCCYGDLLNFLRRKRES----FLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred ----ceEEEEEcCCCCcHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence 789999999999999999764321 489999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCc
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEK 761 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~ 761 (833)
++|||+++......... ......+++.|+|||++.+..++.++|||| +|++++++++ +..|+.
T Consensus 182 l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws----------lGvil~el~t~g~~p~~ 245 (302)
T cd05055 182 ICDFGLARDIMNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWS----------YGILLWEIFSLGSNPYP 245 (302)
T ss_pred ECCCcccccccCCCcee------ecCCCCcccccCCHhhhccCCCCcHhHHHH----------HHHHHHHHHhCCCCCcC
Confidence 99999998654322100 011234678899999999888999999999 7777888876 666653
Q ss_pred ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 762 VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
.... +... ........ ........+..+.+++.+||..+|++|||+.|+++.|+++
T Consensus 246 ~~~~-~~~~-~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 246 GMPV-DSKF-YKLIKEGY-----RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCc-hHHH-HHHHHcCC-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 2111 1111 00000000 0001112346788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=302.71 Aligned_cols=266 Identities=22% Similarity=0.339 Sum_probs=198.9
Q ss_pred HHhcCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTD 601 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 601 (833)
...++|++.+.||+|+||.||+|..++ .+..||+|.++.... .....+.+|+.++++++||||+++++++....
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 346789999999999999999997642 356899999864322 22346788999999999999999999975544
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCcc----ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQV----EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH 677 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 677 (833)
..++||||+++|+|.+++....... .....++..+..++.|++.||+|||+. +|+||||||+||+++.
T Consensus 83 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~ 154 (288)
T cd05061 83 -----PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAH 154 (288)
T ss_pred -----CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcC
Confidence 7899999999999999997543211 112456788899999999999999999 9999999999999999
Q ss_pred CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-H
Q 040925 678 DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-T 756 (833)
Q Consensus 678 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~ 756 (833)
++.+||+|||+++.......... .....++..|+|||.+.+..++.++|||| +|++++++.+ +
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~------~~~~~~~~~y~~pE~~~~~~~~~~~Dvws----------lG~~l~el~~~~ 218 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRK------GGKGLLPVRWMAPESLKDGVFTTSSDMWS----------FGVVLWEITSLA 218 (288)
T ss_pred CCcEEECcCCccccccccccccc------cCCCcccccccCHHHhccCCCChHhHHHH----------HHHHHHHHHhCC
Confidence 99999999999986543221110 11123577899999998888999999999 6777777776 4
Q ss_pred hCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 757 ALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
..|+..... ........... ....+..++..+.+++.+||+.||++|||+.++++.+++..
T Consensus 219 ~~p~~~~~~--~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 219 EQPYQGLSN--EQVLKFVMDGG------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCCCCCCH--HHHHHHHHcCC------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 555432111 11111000000 00112234568999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=296.87 Aligned_cols=240 Identities=21% Similarity=0.377 Sum_probs=182.8
Q ss_pred ceeccCcceEEEEEEECC------------CceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 537 NMIGQGSFGYVYKGTLGE------------DEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
+.||+|+||.||+|+... ....||+|.+..........+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~--- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV--- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence 468999999999998642 23468999886554445567889999999999999999999976554
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc----
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV---- 680 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---- 680 (833)
..++||||+++|+|..++..... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.
T Consensus 78 --~~~lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~ 147 (262)
T cd05077 78 --ENIMVEEFVEFGPLDLFMHRKSD-----VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGEC 147 (262)
T ss_pred --CCEEEEecccCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCC
Confidence 67899999999999998875432 589999999999999999999999 9999999999999987664
Q ss_pred ---EEEcccccccccCcccccccccCCCccccccccccccCccccC-CCCCCcccccccCCcCCCccccCCccHHHHH-H
Q 040925 681 ---AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-GSEASMTGDIFTGRRPIDAVFNEGHSLHEFA-K 755 (833)
Q Consensus 681 ---~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~-~ 755 (833)
+|++|||.+....... ...|+..|+|||++. +..++.++|||| +|+++|+++ .
T Consensus 148 ~~~~~l~d~g~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~Diws----------lG~~l~el~~~ 205 (262)
T cd05077 148 GPFIKLSDPGIPITVLSRQ------------ECVERIPWIAPECVEDSKNLSIAADKWS----------FGTTLWEICYN 205 (262)
T ss_pred CceeEeCCCCCCccccCcc------------cccccccccChhhhcCCCCCCchhHHHH----------HHHHHHHHHhC
Confidence 8999999987543211 234788999999876 466899999999 677777776 3
Q ss_pred HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 756 TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 756 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
+..|+......+. ........ .......+.+.+++.+||+.||++||++.+|++.+
T Consensus 206 ~~~p~~~~~~~~~---~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 206 GEIPLKDKTLAEK---ERFYEGQC-------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred CCCCCCCcchhHH---HHHHhcCc-------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 5555432111110 00000000 00111245688999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=296.50 Aligned_cols=254 Identities=24% Similarity=0.450 Sum_probs=199.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.++||+|+||.||+|... +++.||+|.+.... ...+.+.+|+.++++++||||+++++++.. ...+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~ 76 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIY 76 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcE
Confidence 457999999999999999999876 67789999987433 345678999999999999999999987532 2579
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
++|||+++|+|.+++...... .+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 149 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGI----KLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLA 149 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcce
Confidence 999999999999998764422 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
.......... .....++..|+|||++.+..++.++|||| +|++++++++ +..|+.... ++
T Consensus 150 ~~~~~~~~~~-------~~~~~~~~~y~~pe~~~~~~~~~~~Di~s----------lG~~l~el~~~g~~p~~~~~--~~ 210 (260)
T cd05067 150 RLIEDNEYTA-------REGAKFPIKWTAPEAINYGTFTIKSDVWS----------FGILLTEIVTYGRIPYPGMT--NP 210 (260)
T ss_pred eecCCCCccc-------ccCCcccccccCHHHhccCCcCcccchHH----------HHHHHHHHHhCCCCCCCCCC--hH
Confidence 7654322111 11234678899999998888999999999 7888888887 777764221 11
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
...... .... ....+...+.++.+++.+||..+|++|||++++++.|+.
T Consensus 211 ~~~~~~-~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 211 EVIQNL-ERGY-----RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHHH-HcCC-----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111111 1110 001122345679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=301.15 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=199.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
+.|++.+.||+|+||.||+|++..+++.||+|.+........+.+.+|+.+++.++||||+++++++.... ..++
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 86 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-----KLWI 86 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-----eEEE
Confidence 57999999999999999999999899999999997665555677889999999999999999999876544 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++++|..++.+... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 87 v~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred EEecCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 9999999999988765432 589999999999999999999999 99999999999999999999999999987
Q ss_pred ccCcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
...... .......+++.|+|||++. ...++.++|||| +|+++|+++++..|+.....
T Consensus 159 ~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s----------lG~il~el~~g~~p~~~~~~ 220 (292)
T cd06644 159 KNVKTL--------QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS----------LGITLIEMAQIEPPHHELNP 220 (292)
T ss_pred eccccc--------cccceecCCccccCceeeccccccCCCCCchhhhHh----------HHHHHHHHhcCCCCCccccH
Confidence 543211 1112345889999999874 345788899999 88888899998888653221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ........... .....+..++..+.+++.+||..||++||+++|+++.
T Consensus 221 ~--~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 221 M--RVLLKIAKSEP----PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred H--HHHHHHhcCCC----ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1 01111110000 0011123345678899999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=296.13 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=199.9
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcc---------hhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA---------SRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
+|.+.+.||+|++|.||+|.+..+++.||+|.+....... .+.+.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDAD- 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCC-
Confidence 4788899999999999999998889999999986443221 246788999999999999999999976544
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.+|
T Consensus 80 ----~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~ 146 (267)
T cd06628 80 ----HLNIFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIK 146 (267)
T ss_pred ----ccEEEEEecCCCCHHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEE
Confidence 8899999999999999997654 688999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
|+|||.++........... ........|++.|+|||++.+..++.++|+|| .|+++++++++..|+..
T Consensus 147 l~dfg~~~~~~~~~~~~~~--~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~p~~~ 214 (267)
T cd06628 147 ISDFGISKKLEANSLSTKT--NGARPSLQGSVFWMAPEVVKQTSYTRKADIWS----------LGCLVVEMLTGKHPFPD 214 (267)
T ss_pred ecccCCCcccccccccCCc--cccccccCCCcCccChhHhccCCCCchhhhHH----------HHHHHHHHhhCCCCCCC
Confidence 9999999876532211111 11112345889999999998888999999999 88889999998888753
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
...... ....... .....+..++..+.+++.+||+.||++||++.|+++
T Consensus 215 ~~~~~~--~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 215 CTQLQA--IFKIGEN------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ccHHHH--HHHHhcc------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 221110 0000000 001112335677889999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=297.21 Aligned_cols=257 Identities=21% Similarity=0.280 Sum_probs=198.4
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
+.+++.+.....||+|+||.||+|++..++..||+|.+........+.+.+|+.++++++|+||+++++++...+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 78 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG----- 78 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC-----
Confidence 345556666789999999999999998899999999987655555678999999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccC--CHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-CCcEEE
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKL--SLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHV 683 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l--~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL 683 (833)
..++||||+++++|.+++..... .+ ++..+..++.|++.||+|||+. +|+||||||+||+++. ++.+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l 150 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWG-----PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKI 150 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcc-----cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEE
Confidence 89999999999999999976421 34 7888899999999999999999 9999999999999976 679999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCC--CCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE--ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
+|||.+........ ......|++.|+|||++.+.. ++.++|||| +|+++++++++..|+.
T Consensus 151 ~dfg~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~s----------lGvvl~~l~~g~~p~~ 212 (268)
T cd06624 151 SDFGTSKRLAGINP--------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWS----------LGCTIVEMATGKPPFI 212 (268)
T ss_pred ecchhheecccCCC--------ccccCCCCccccChhhhccccccCCchhhhHH----------HHHHHHHHHhCCCCCc
Confidence 99999876533211 111235899999999876543 788999999 7888888888887764
Q ss_pred ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 762 VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
................ .....+..+.+.+.+++.+||..+|++|||+.|+++.
T Consensus 213 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 213 ELGEPQAAMFKVGMFK------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred cccChhhhHhhhhhhc------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 2211111110000000 0011123356678899999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=302.38 Aligned_cols=270 Identities=21% Similarity=0.256 Sum_probs=206.9
Q ss_pred cchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeec
Q 040925 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSS 599 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 599 (833)
+.+.++..+.++|++.+.||+|+||.||+|....+++.||+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 455667777899999999999999999999999899999999986432 2345678899999999 79999999999876
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
.+.......++||||+++|+|.++++..... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC--GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG 165 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence 5433345789999999999999988643211 11689999999999999999999999 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCC-----CCCcccccccCCcCCCccccCCccHHHHH
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-----EASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
.+||+|||++......... .....|+..|+|||++... .++.++|||| +|++++++.
T Consensus 166 ~~kl~dfg~~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s----------lGvi~~el~ 227 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLR--------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWS----------LGITAIELG 227 (291)
T ss_pred CEEEeecccchhccccccc--------ccCccCCccccChhhhcCCCCcccccCCccchHH----------HHHHHHHHh
Confidence 9999999998865432211 1124589999999987543 3688999999 788888999
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++..|+........ ......... ......++....+.+++.+||..||++||++.|+++.
T Consensus 228 ~g~~p~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 228 DGDPPLFDMHPVKT--LFKIPRNPP----PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hCCCCCCCCcHHHH--HHHHhcCCC----CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 88887653221111 011100000 0001122345678999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=297.13 Aligned_cols=258 Identities=21% Similarity=0.323 Sum_probs=199.9
Q ss_pred cCCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.+|.+.+.||+|+||.||+|.+... ...||+|...... ....+.+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN------ 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC------
Confidence 4688899999999999999987543 4568999886543 23456789999999999999999999987532
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~ 151 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDF 151 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccC
Confidence 46899999999999999976432 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
|+++.......... ....+++.|+|||.+....++.++|||| +|+.++++++ +..|+.....
T Consensus 152 g~~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~~~g~~pf~~~~~ 214 (270)
T cd05056 152 GLSRYLEDESYYKA-------SKGKLPIKWMAPESINFRRFTSASDVWM----------FGVCMWEILMLGVKPFQGVKN 214 (270)
T ss_pred ceeeecccccceec-------CCCCccccccChhhhccCCCCchhhhHH----------HHHHHHHHHHcCCCCCCCCCH
Confidence 99986644321110 1123567899999988888999999999 7777788765 6666542211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
. ........... ...+..++..+.+++.+||..+|++|||+.++++.|.++...
T Consensus 215 ~--~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 215 N--DVIGRIENGER------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred H--HHHHHHHcCCc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1 11111111100 011234567889999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.12 Aligned_cols=246 Identities=22% Similarity=0.272 Sum_probs=191.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 606 (833)
...|++.++||+||.+.||++... +.+.||+|++... +....+.+.+|+..|.+++ |.+||++++|-.. .+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----Cc
Confidence 346999999999999999999886 4556677766432 3344578999999999996 9999999999544 44
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
+.||||||-+ .+|..++++... ..+...++.+..|++.|+.++|.+ ||||.||||+|+++ ..|.+||+||
T Consensus 434 ~lYmvmE~Gd-~DL~kiL~k~~~-----~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDF 503 (677)
T KOG0596|consen 434 YLYMVMECGD-IDLNKILKKKKS-----IDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDF 503 (677)
T ss_pred eEEEEeeccc-ccHHHHHHhccC-----CCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeee
Confidence 9999999985 599999988653 233338889999999999999999 99999999999998 5789999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCC-----------CCcccccccCCcCCCccccCCccHHHHHH
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-----------ASMTGDIFTGRRPIDAVFNEGHSLHEFAK 755 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~Di~s~~~~~~~~~~~g~~l~~~~~ 755 (833)
|+|..+..+... ......+||+.|||||.+.... .+.++|||| .|+++|+|+.
T Consensus 504 GIA~aI~~DTTs------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWS----------LGCILYqMvY 567 (677)
T KOG0596|consen 504 GIANAIQPDTTS------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWS----------LGCILYQMVY 567 (677)
T ss_pred chhcccCccccc------eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhh----------hhhHHHHHHh
Confidence 999988775432 2334578999999999765432 568889998 8888999999
Q ss_pred HhCCCcccc--------cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 756 TALPEKVME--------IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 756 ~~~p~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+..|+.... +.+|....++... .. ..++.++|..||.+||++|||+.|+++.
T Consensus 568 gktPf~~~~n~~aKl~aI~~P~~~Iefp~~---------~~----~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 568 GKTPFGQIINQIAKLHAITDPNHEIEFPDI---------PE----NDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred cCCchHHHHHHHHHHHhhcCCCccccccCC---------CC----chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 988876222 2233221111110 01 1238899999999999999999999875
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=295.76 Aligned_cols=256 Identities=24% Similarity=0.428 Sum_probs=191.4
Q ss_pred ceeccCcceEEEEEEECC---CceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGE---DEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|.+.. .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++...+ ...++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSE----GSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCC----CCcEEEE
Confidence 468999999999998643 35679999985332 233567889999999999999999999875332 3578999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++..... ..++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 77 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~ 148 (262)
T cd05058 77 PYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDI 148 (262)
T ss_pred ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccc
Confidence 99999999999976432 467788899999999999999999 9999999999999999999999999999765
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCC-Ccccccccccch
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP-EKVMEIVDPSLL 771 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p-~~~~~~~~~~~~ 771 (833)
....... ........+++.|+|||++.+..++.++|||| +|+++++++++..| +...... ...
T Consensus 149 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~el~~~~~~~~~~~~~~--~~~ 212 (262)
T cd05058 149 YDKEYYS----VHNHTGAKLPVKWMALESLQTQKFTTKSDVWS----------FGVLLWELMTRGAPPYPDVDSF--DIT 212 (262)
T ss_pred cCCccee----ecccccCcCCccccChhHhccCccchHHHHHH----------HHHHHHHHHcCCCCCCCCCCHH--HHH
Confidence 4322110 01111234678899999998888999999999 77777777775433 3211111 111
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
....... ....+..+++.+.+++.+||..+|++||++.|+++.++++..
T Consensus 213 ~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 213 VYLLQGR------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred HHHhcCC------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 1111100 011112345678899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=301.04 Aligned_cols=254 Identities=20% Similarity=0.339 Sum_probs=201.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||.|++|.||+|.+..++..||+|.++.......+.+.+|++++++++||||+++++++.... ..+
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYEN-----KLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCC-----eEE
Confidence 457999999999999999999998889999999997655555567889999999999999999999976544 889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~ 150 (280)
T cd06611 79 ILIEFCDGGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150 (280)
T ss_pred EEeeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccc
Confidence 99999999999999876432 589999999999999999999999 9999999999999999999999999988
Q ss_pred cccCcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
........ ......||+.|+|||++. +..++.++|||| +|++++++.++..|+...+
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~s----------lG~il~~l~~g~~p~~~~~ 212 (280)
T cd06611 151 AKNKSTLQ--------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWS----------LGITLIELAQMEPPHHELN 212 (280)
T ss_pred hhhccccc--------ccceeecchhhcCHHHHhhcccCCCCCCccccHHH----------HHHHHHHHHhCCCCcccCC
Confidence 75433211 112346899999999864 345778999999 7888889999988875322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... .......... .....+..++..+.+++.+||+.||++||+++++++.
T Consensus 213 ~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 213 PMR--VLLKILKSEP----PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHH--HHHHHhcCCC----CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111 1111111000 0001122345678899999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=300.67 Aligned_cols=257 Identities=21% Similarity=0.339 Sum_probs=202.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|++|+||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++.... ..+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNEN-----NIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCC-----EEE
Confidence 578899999999999999999998899999999865432 33567899999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.. +++||||||+||+++.++.++|+|||++
T Consensus 80 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~ 151 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVS 151 (284)
T ss_pred EEEecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcc
Confidence 9999999999999987644 6899999999999999999999732 8999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc-c-
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV-D- 767 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~-~- 767 (833)
....... .....|+..|+|||++.+..++.++|||| +|+++++++++..|+...... +
T Consensus 152 ~~~~~~~----------~~~~~~~~~~~aPE~~~~~~~~~~~Di~s----------lG~~l~~l~tg~~p~~~~~~~~~~ 211 (284)
T cd06620 152 GELINSI----------ADTFVGTSTYMSPERIQGGKYTVKSDVWS----------LGISIIELALGKFPFAFSNIDDDG 211 (284)
T ss_pred cchhhhc----------cCccccCcccCCHHHHccCCCCccchHHH----------HHHHHHHHHhCCCCCcccchhhhh
Confidence 6543211 11246899999999998888999999999 788899999988887532210 0
Q ss_pred ---ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 768 ---PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 768 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
+....+.... ............+++..+.+++.+||..||++|||++|+++..
T Consensus 212 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 212 QDDPMGILDLLQQ-IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhhhhHHHHHHHH-HhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000000000 0000011112233667889999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=299.31 Aligned_cols=268 Identities=22% Similarity=0.316 Sum_probs=204.8
Q ss_pred HhcCCccCceeccCcceEEEEEEECC----CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGE----DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
..++|++.+.||+|+||.||+|.+.. ++..||+|+++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 34679999999999999999999875 368899999864322 2346688999999999999999999987543
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCc--cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQ--VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 681 (833)
....++++||+++|+|.+++...... .....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~ 156 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQV 156 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcE
Confidence 24678999999999999998764321 0112689999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCC
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPE 760 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~ 760 (833)
||+|||+++.+........ .....++..|+|||++.+..++.++|||| +|++++++++ +..|+
T Consensus 157 kl~d~g~~~~~~~~~~~~~------~~~~~~~~~y~apE~~~~~~~~~~~Di~s----------lG~~l~el~~~g~~p~ 220 (280)
T cd05043 157 KITDNALSRDLFPMDYHCL------GDNENRPVKWMALESLVNKEYSSASDVWS----------FGVLLWELMTLGQTPY 220 (280)
T ss_pred EECCCCCcccccCCceEEe------CCCCCcchhccCHHHHhcCCCCchhhHHH----------hHHHHHHHhcCCCCCc
Confidence 9999999986543221100 01124677899999998888999999999 7777888877 66665
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
...... ........... ......+++.+.+++.+||..||++|||+.++++.|+.+.+.
T Consensus 221 ~~~~~~---~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 221 VEIDPF---EMAAYLKDGYR-----LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CcCCHH---HHHHHHHcCCC-----CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 422111 11111111110 001123456789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.67 Aligned_cols=256 Identities=21% Similarity=0.242 Sum_probs=192.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|+...+++.||+|+++.. .....+.+.+|+.+++.++|+||+++++++...+ .
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN-----N 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC-----e
Confidence 4799999999999999999999999999999999642 1223456888999999999999999999876554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg 147 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFG 147 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECC
Confidence 9999999999999999975332 588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC-----CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-----SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
++......... ......||+.|||||++.+ ..++.++|||| .|+++++++++..|+..
T Consensus 148 ~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws----------lG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 148 SCLRLLADGTV-------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWS----------LGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeecCCCCCc-------cccceeccccccCHHHHhhccccccCCCCcceeeh----------hhhHHHHHhhCCCCCCC
Confidence 98765432210 1112359999999999863 45788999999 78888999998888753
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCC--CCCCCHHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESP--FERMDMRDVVAK 820 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP--~~RPt~~eil~~ 820 (833)
....+. ............ .......++..+.+++.+|+..++ ..||+++++++.
T Consensus 211 ~~~~~~--~~~i~~~~~~~~--~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 211 ESLVET--YGKIMNHKEHFQ--FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCHHHH--HHHHHcCCCccc--CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 221110 000110000000 000111245567778887775433 348899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=314.43 Aligned_cols=187 Identities=25% Similarity=0.305 Sum_probs=157.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
..+|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|++++++++|||||++++++...+ ..+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-----~~~ 236 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGG-----LTC 236 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECC-----EEE
Confidence 457999999999999999999999999999999642 234678999999999999999999976554 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+|||++. ++|.+++..... .+++.+++.|+.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 237 lv~e~~~-~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla 307 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLR-----PLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAA 307 (461)
T ss_pred EEEEccC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCc
Confidence 9999995 699998865432 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDA 742 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~ 742 (833)
+....... ........||+.|+|||++.+..++.++||||.|+.+++
T Consensus 308 ~~~~~~~~------~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~E 354 (461)
T PHA03211 308 CFARGSWS------TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354 (461)
T ss_pred eecccccc------cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHH
Confidence 86543211 111123569999999999999999999999994444443
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=298.80 Aligned_cols=266 Identities=21% Similarity=0.311 Sum_probs=206.1
Q ss_pred cchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeec
Q 040925 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSS 599 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 599 (833)
.+..++....+.|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 355666677889999999999999999999999899999999986432 2345688899999999 69999999998754
Q ss_pred CCC-CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 600 TDF-KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 600 ~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
... ......+++|||+++|+|.+++...... .+++..++.++.|++.|++|||+. +|+||||||+||+++++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~ 157 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN----ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTEN 157 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence 321 2245789999999999999999764422 578888999999999999999999 99999999999999999
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHHH
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHEF 753 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~ 753 (833)
+.++|+|||++........ ......|++.|+|||++. +..++.++|||| +|++++++
T Consensus 158 ~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvws----------lG~~l~el 219 (282)
T cd06636 158 AEVKLVDFGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWS----------LGITAIEM 219 (282)
T ss_pred CCEEEeeCcchhhhhcccc--------CCCcccccccccCHhhcCcccCcCcCCCcccchhH----------HHHHHHHH
Confidence 9999999999875532111 112346899999999875 356888999999 88889999
Q ss_pred HHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 754 AKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 754 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
+++..|+.......... . ... ..........++..+.+++.+||..||.+|||+.|+++
T Consensus 220 ~~g~~p~~~~~~~~~~~--~-~~~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 220 AEGAPPLCDMHPMRALF--L-IPR----NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HhCCCCccccCHHhhhh--h-Hhh----CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 99988874221110000 0 000 00111122345678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=308.90 Aligned_cols=261 Identities=18% Similarity=0.229 Sum_probs=196.1
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTD-FKGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 605 (833)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.... +...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999999899999999996432 233467889999999999999999999875432 2233
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...|+||||+++ ++.+++.. .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~D 169 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 169 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEe
Confidence 468999999975 78877743 478889999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++...... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+...+.
T Consensus 170 fG~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwS----------lG~il~ell~g~~pf~~~~~ 230 (364)
T cd07875 170 FGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWS----------VGCIMGEMIKGGVLFPGTDH 230 (364)
T ss_pred CCCccccCCCC---------cccCCcccCCcCCHHHHhCCCCCchhhHHh----------HHHHHHHHHhCCCCCCCCCH
Confidence 99998653321 112346899999999999999999999999 67777788777776642211
Q ss_pred ccc-------------cchhh-------hccccch-------------hhhhhhhchHHHHHHHHHHhhccCCCCCCCCC
Q 040925 766 VDP-------------SLLME-------VMTNNSM-------------IQEDKRVKTEECLNAIIRTGVLCSMESPFERM 812 (833)
Q Consensus 766 ~~~-------------~~~~~-------~~~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 812 (833)
.+. ..... ....... ..+............+.+++.+|++.||++||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~ 310 (364)
T cd07875 231 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310 (364)
T ss_pred HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC
Confidence 100 00000 0000000 00000000111234678999999999999999
Q ss_pred CHHHHHHH
Q 040925 813 DMRDVVAK 820 (833)
Q Consensus 813 t~~eil~~ 820 (833)
|++|+++.
T Consensus 311 t~~e~L~h 318 (364)
T cd07875 311 SVDEALQH 318 (364)
T ss_pred CHHHHhcC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.53 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=201.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
++|++.+.||+|++|.||+|....+++.||+|.++.... .+.+.+|++++++++||||+++++++.... ..|+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l 75 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNT-----DLWI 75 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----cEEE
Confidence 579999999999999999999998899999999864422 678999999999999999999999976554 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
+|||+++++|.+++..... .+++..++.++.|++.|+.|||+. +++||||+|+||+++.++.+||+|||++.
T Consensus 76 ~~e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~ 147 (256)
T cd06612 76 VMEYCGAGSVSDIMKITNK-----TLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG 147 (256)
T ss_pred EEecCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccch
Confidence 9999999999999875432 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
....... ......|+..|+|||++.+..++.++|||| +|+++++++++..|+..........
T Consensus 148 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s----------~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 148 QLTDTMA--------KRNTVIGTPFWMAPEVIQEIGYNNKADIWS----------LGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred hcccCcc--------ccccccCCccccCHHHHhcCCCCchhhHHH----------HHHHHHHHHhCCCCCCCcchhhhhh
Confidence 7654321 111235889999999999889999999999 7888899998888765322111110
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
...... ......+..+...+.+++.+||+.||++|||+.|+++
T Consensus 210 ---~~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 210 ---MIPNKP---PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ---hhccCC---CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000000 0001112335567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.40 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=200.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCce----EEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEM----IVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
++|++.+.||+|+||.||+|.+..+++ .||+|.++.... .....+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 578899999999999999999865554 689998864432 234678899999999999999999999864
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~d 152 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD 152 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECC
Confidence 368999999999999999976542 589999999999999999999998 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||.++......... ......++..|+|||......++.++|||| +|+.++++++ +..|+....
T Consensus 153 fg~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s----------lG~~l~el~~~g~~p~~~~~ 216 (279)
T cd05057 153 FGLAKLLDVDEKEY------HAEGGKVPIKWMALESILHRIYTHKSDVWS----------YGVTVWELMTFGAKPYEGIP 216 (279)
T ss_pred CcccccccCcccce------ecCCCcccccccCHHHhhcCCcCchhhHHH----------HHHHHHHHhcCCCCCCCCCC
Confidence 99998765322111 011122467899999998888999999999 7777888776 666654221
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
. ............ ...+..+...+.+++.+||..||++|||+.++++.+.++..+
T Consensus 217 ~--~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 217 A--VEIPDLLEKGER------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred H--HHHHHHHhCCCC------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 1 111111111100 011112345678999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=298.42 Aligned_cols=240 Identities=22% Similarity=0.349 Sum_probs=180.7
Q ss_pred eeccCcceEEEEEEECC------------------------CceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceE
Q 040925 538 MIGQGSFGYVYKGTLGE------------------------DEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKI 593 (833)
Q Consensus 538 ~lg~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 593 (833)
.||+|+||.||+|.... ....||+|+++.........+.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 68999999999997531 124689999865444445678899999999999999999
Q ss_pred eeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCe
Q 040925 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNV 673 (833)
Q Consensus 594 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NI 673 (833)
++++.... ..++||||+++|+|.+++..... .+++..+..++.|+++||+|||+. +|+||||||+||
T Consensus 82 ~~~~~~~~-----~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Ni 148 (274)
T cd05076 82 HGVCVRGS-----ENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNI 148 (274)
T ss_pred EEEEEeCC-----ceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccE
Confidence 99987655 78999999999999999865332 588999999999999999999999 999999999999
Q ss_pred eecCCC-------cEEEcccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCcccc
Q 040925 674 LLDHDM-------VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFN 745 (833)
Q Consensus 674 ll~~~~-------~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~ 745 (833)
++++++ .+|++|||.+....... ...++..|+|||++.+ ..++.++||||
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~~------------~~~~~~~~~aPe~~~~~~~~~~~~Dv~s---------- 206 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALSRE------------ERVERIPWIAPECVPGGNSLSTAADKWS---------- 206 (274)
T ss_pred EEeccCcccCccceeeecCCcccccccccc------------ccccCCcccCchhhcCCCCCCcHHHHHH----------
Confidence 997644 48999999886432211 1247888999998865 56899999999
Q ss_pred CCccHHHHH-HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 746 EGHSLHEFA-KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 746 ~g~~l~~~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
+|++++++. .+..|+.... +........... ..+......+.+++.+||+.+|++|||+++|++.|+
T Consensus 207 lG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 207 FGTTLLEICFDGEVPLKERT---PSEKERFYEKKH-------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HHHHHHHHHhCCCCCccccC---hHHHHHHHHhcc-------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 666777763 4555543211 111011111100 001112346889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=292.92 Aligned_cols=252 Identities=21% Similarity=0.307 Sum_probs=199.2
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|.+..+++.||+|.+.... ....+.+.+|++++++++|||++++++.+... ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGE----DGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCC----CCEEE
Confidence 5889999999999999999999889999999986432 23345788999999999999999999875322 23689
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++...... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||++
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~----~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~ 149 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGK----LLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIA 149 (257)
T ss_pred EEecccCCCcHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccce
Confidence 999999999999999764322 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
........ ......|++.|+|||+..+..++.++|||| .|+++++++++..|+...+.. .
T Consensus 150 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~~~~~~~~~--~ 209 (257)
T cd08223 150 RVLENQCD--------MASTLIGTPYYMSPELFSNKPYNYKSDVWA----------LGCCVYEMATLKHAFNAKDMN--S 209 (257)
T ss_pred EEecccCC--------ccccccCCcCccChhHhcCCCCCchhhhHH----------HHHHHHHHHcCCCCCCCCCHH--H
Confidence 76543211 112345899999999999989999999999 788888888887776422211 1
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... ...+...++.+.+++.+||+.||++|||+.+++++
T Consensus 210 ~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 210 LVYRIIEGKL------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred HHHHHHhcCC------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111110 01123456778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.62 Aligned_cols=263 Identities=22% Similarity=0.357 Sum_probs=197.6
Q ss_pred cCCccCceeccCcceEEEEEEECC----CceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGE----DEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|++.+.||+|+||.||+|++.. +++.||||+++..... ..+.+.+|++++++++||||+++++++.... .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~---~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPG---G 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCC---C
Confidence 468888999999999999998643 4789999999755443 4568999999999999999999999875432 4
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 152 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISD 152 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcc
Confidence 478999999999999999976542 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||.+............ .....++..|+|||...+..++.++||||.|+.++ +++++..|+.....
T Consensus 153 fg~~~~~~~~~~~~~~-----~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~----------el~tg~~p~~~~~~ 217 (284)
T cd05038 153 FGLAKVLPEDKDYYYV-----KEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLY----------ELFTYGDPSQSPPA 217 (284)
T ss_pred cccccccccCCcceec-----cCCCCCcccccCcHHHccCCCCcccchHHHhhhhh----------eeeccCCCcccccc
Confidence 9999876532211100 11123566799999998888999999999555544 44444444321100
Q ss_pred cccc---------ch---hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 766 VDPS---------LL---MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 766 ~~~~---------~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
.... .. .+..... .....+..++.++.+++.+||..+|++|||+.||+++|+.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 218 EFLRMIGIAQGQMIVTRLLELLKEG-----ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred hhccccccccccccHHHHHHHHHcC-----CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 0000 00 0000000 01111233557899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=294.65 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=201.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
..|+..+.||+|+||.||+|.+..++..||+|.++... ......+.+|+.++++++||||+++++++.... ..+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGT-----KLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----EEE
Confidence 45888899999999999999998889999999987443 234567889999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++... ++++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++|+|||++
T Consensus 79 lv~e~~~~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred EEEecCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 999999999999998653 578899999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
........ ......++..|+|||++.+..++.++|+|| +|++++++.++..|+........
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~s----------lG~il~el~tg~~p~~~~~~~~~- 209 (277)
T cd06640 149 GQLTDTQI--------KRNTFVGTPFWMAPEVIQQSAYDSKADIWS----------LGITAIELAKGEPPNSDMHPMRV- 209 (277)
T ss_pred eeccCCcc--------ccccccCcccccCHhHhccCCCccHHHHHH----------HHHHHHHHHHCCCCCCCcChHhH-
Confidence 76543221 111245888999999998888999999999 88889999999888653221110
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....... ........++..+.+++.+||+.+|++||+++++++.
T Consensus 210 --~~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 210 --LFLIPKN-----NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred --hhhhhcC-----CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0000000 0112234567789999999999999999999999776
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=308.62 Aligned_cols=188 Identities=22% Similarity=0.304 Sum_probs=157.5
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
....+|++.+.||+|+||.||+|++..+++.||+|+... .....|+.++++++||||+++++++.... .
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~ 131 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGA-----I 131 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCC-----e
Confidence 344579999999999999999999998999999998532 22356999999999999999999976554 7
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+. |+|.+++..... .+++..++.|+.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG 202 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKRSR-----PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG 202 (357)
T ss_pred eEEEEEccC-CcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCc
Confidence 899999995 689988865432 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVF 744 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~ 744 (833)
+++...... ......||+.|+|||++.+..++.++||||.|+.++++.
T Consensus 203 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell 250 (357)
T PHA03209 203 AAQFPVVAP---------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250 (357)
T ss_pred cccccccCc---------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHH
Confidence 997532211 112346999999999999999999999999555544443
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=306.94 Aligned_cols=241 Identities=23% Similarity=0.259 Sum_probs=179.5
Q ss_pred eccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc---CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI---RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 539 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
||+|+||+||+|++..+++.||||++.... .........|..++... +||+|+++++++.... ..|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~-----~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS-----DLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC-----eEEEEE
Confidence 699999999999999999999999986432 11223455677777665 6999999999866554 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 76 e~~~~g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 76 DYMSGGELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred cCCCCChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 9999999999987654 689999999999999999999999 9999999999999999999999999998753
Q ss_pred CcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccch
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~ 771 (833)
.... .......||+.|+|||++.+. .++.++|||| .|+++|+++++..|+...+.. ...
T Consensus 147 ~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvws----------lGvil~elltG~~Pf~~~~~~--~~~ 206 (330)
T cd05586 147 LTDN--------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWS----------LGVLVFEMCCGWSPFYAEDTQ--QMY 206 (330)
T ss_pred CCCC--------CCccCccCCccccCHHHHcCCCCCCCccceec----------cccEEEEeccCCCCCCCCCHH--HHH
Confidence 2211 111235699999999998764 4899999999 555566666666665422110 010
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC----CHHHHHH
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM----DMRDVVA 819 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----t~~eil~ 819 (833)
........ +......++.+.+++.+||..||++|| ++.++++
T Consensus 207 ~~i~~~~~------~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 207 RNIAFGKV------RFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHcCCC------CCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11100000 000112355678999999999999998 4666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=293.86 Aligned_cols=256 Identities=26% Similarity=0.455 Sum_probs=200.1
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
..++|++.+.||+|++|.||+|... +++.||||.++... ...+++.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 76 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEE-----PI 76 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCC-----ce
Confidence 3468999999999999999999986 56789999987432 34567899999999999999999999865443 78
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++++|.+++...... .+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~----~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~ 149 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGK----KLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGL 149 (261)
T ss_pred EEEEeccCCCCHHHHHhccccC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccc
Confidence 9999999999999999765422 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~ 767 (833)
+.......... .....++..|+|||.+.+..++.++|||| .|++++++++ +..|+.... +
T Consensus 150 ~~~~~~~~~~~-------~~~~~~~~~y~~PE~~~~~~~~~~~Di~s----------lG~il~~l~t~g~~p~~~~~--~ 210 (261)
T cd05034 150 ARLIEDDEYTA-------REGAKFPIKWTAPEAANYGRFTIKSDVWS----------FGILLTEIVTYGRVPYPGMT--N 210 (261)
T ss_pred ceeccchhhhh-------hhccCCCccccCHHHhccCCcCchhHHHH----------HHHHHHHHHhCCCCCCCCCC--H
Confidence 98665321111 11123567899999999888999999999 7777888877 666653211 1
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
...... +.... ....+.+++..+.+++.+||..+|++||+++++.+.|+.
T Consensus 211 ~~~~~~-~~~~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 211 REVLEQ-VERGY-----RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHHH-HHcCC-----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 111111 11110 001122335678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.37 Aligned_cols=256 Identities=20% Similarity=0.238 Sum_probs=194.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|++..+++.||+|++... .......+.+|..++..++|++|+++++++...+ .
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~-----~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN-----Y 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC-----E
Confidence 4799999999999999999999999999999998642 1223345788999999999999999999976544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG 147 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFG 147 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEecc
Confidence 9999999999999999976432 588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC-----CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-----SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
+++........ ......||+.|+|||++.+ ..++.++|||| .|+++|+++++..|+..
T Consensus 148 ~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwS----------lGvil~ell~g~~Pf~~ 210 (331)
T cd05624 148 SCLKMNQDGTV-------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWS----------LGVCMYEMLYGETPFYA 210 (331)
T ss_pred ceeeccCCCce-------eeccccCCcccCCHHHHhccccCCCCCCCcccEEe----------eehhhhhhhhCCCCccC
Confidence 99765432211 1112469999999998865 46788999999 78888999999888753
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCC--CCCHHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFE--RMDMRDVVAK 820 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 820 (833)
....+ ............. ......+.+..+.+++.+|+..+|++ |++++++++.
T Consensus 211 ~~~~~--~~~~i~~~~~~~~--~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 211 ESLVE--TYGKIMNHEERFQ--FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCHHH--HHHHHHcCCCccc--CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 22111 0011111000000 00111234567888999998866544 4688888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=301.27 Aligned_cols=261 Identities=23% Similarity=0.374 Sum_probs=198.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCce----EEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEM----IVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
.++|+..+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.++++++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 3568889999999999999999876665 578888864332 2234688999999999999999999987543
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..++++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~ 151 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 151 (303)
T ss_pred --CceeeehhcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEc
Confidence 35789999999999999876532 578999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~ 763 (833)
|||+++......... ......++..|+|||++.+..++.++|||| +|++++++++ +..|+...
T Consensus 152 Dfg~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Diws----------lG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 152 DFGLARLLEGDEKEY------NADGGKMPIKWMALECIHYRKFTHQSDVWS----------YGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred cccccccccCccccc------ccCCCccccccCCHHHhccCCCChHHHHHH----------HHHHHHHHHhCCCCCCCCC
Confidence 999998654322110 111234678899999999889999999999 6777778776 55554311
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
. .....+....... ...+..++..+.+++.+||..+|++||+++++++.+..+.+..
T Consensus 216 ~---~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 216 P---TREIPDLLEKGER-----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred C---HHHHHHHHHCCCC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 1 0000111111100 0011223456889999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.27 Aligned_cols=240 Identities=21% Similarity=0.335 Sum_probs=184.7
Q ss_pred ceeccCcceEEEEEEECCCce-------EEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 537 NMIGQGSFGYVYKGTLGEDEM-------IVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+.||+|+||.||+|.+...+. .||+|.+........+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-----~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-----ESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-----CcE
Confidence 469999999999998865443 48888886544444567889999999999999999999976544 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc--------E
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV--------A 681 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~ 681 (833)
+||||+++|+|.+++...+. .+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +
T Consensus 76 lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~ 147 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFI 147 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceE
Confidence 99999999999999986542 588999999999999999999999 9999999999999987765 6
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHh-CC
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTA-LP 759 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~-~p 759 (833)
+++|||.+....... ...+++.|+|||++.+ ..++.++|||| +|+++++++++. .|
T Consensus 148 ~l~d~g~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~Diws----------lG~~l~~l~~g~~~~ 205 (258)
T cd05078 148 KLSDPGISITVLPKE------------ILLERIPWVPPECIENPQNLSLAADKWS----------FGTTLWEIFSGGDKP 205 (258)
T ss_pred EecccccccccCCch------------hccccCCccCchhccCCCCCCchhhHHH----------HHHHHHHHHcCCCCC
Confidence 999999886543211 2358889999999876 45789999999 677777777763 33
Q ss_pred CcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
+...+ +........... ..+.....++.+++.+||+.||++|||++++++.|
T Consensus 206 ~~~~~---~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 206 LSALD---SQKKLQFYEDRH-------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred hhhcc---HHHHHHHHHccc-------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 32111 111111111100 01112235688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.00 Aligned_cols=261 Identities=18% Similarity=0.184 Sum_probs=191.1
Q ss_pred cCceeccC--cceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 535 SSNMIGQG--SFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 535 ~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
+.++||+| ++++||+++.+.+++.||+|+++.... ...+.+.+|+++++.++||||+++++++...+ ..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~-----~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-----ELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECC-----EEEE
Confidence 45789999 678999999999999999999975422 23456788999999999999999999986655 8899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++|+|.+++...... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.
T Consensus 77 v~e~~~~~~l~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMD----GMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred EEeccCCCcHHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 99999999999999764322 589999999999999999999999 99999999999999999999999998765
Q ss_pred ccCcccccccccCCCccccccccccccCccccCC--CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
........... .........++..|+|||++.+ ..++.++|||| +|+++++++++..|+..... .
T Consensus 150 ~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~~~~--~ 216 (327)
T cd08227 150 SMINHGQRLRV-VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS----------VGITACELANGHVPFKDMPA--T 216 (327)
T ss_pred ccccccccccc-cccccccccceecccChHHhhcccCCCCchhhHHH----------HHHHHHHHHHCCCCCCCcch--h
Confidence 43221110000 0011122357888999999876 45899999999 67777777777776541110 0
Q ss_pred cchhhhcccc-------------------------------c--------hhhhhhhhchHHHHHHHHHHhhccCCCCCC
Q 040925 769 SLLMEVMTNN-------------------------------S--------MIQEDKRVKTEECLNAIIRTGVLCSMESPF 809 (833)
Q Consensus 769 ~~~~~~~~~~-------------------------------~--------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 809 (833)
.......... . ............+.+.+.+++.+||+.||+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 296 (327)
T cd08227 217 QMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPD 296 (327)
T ss_pred HHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCch
Confidence 0000000000 0 000000011223456789999999999999
Q ss_pred CCCCHHHHHHH
Q 040925 810 ERMDMRDVVAK 820 (833)
Q Consensus 810 ~RPt~~eil~~ 820 (833)
+|||++|+++.
T Consensus 297 ~Rpt~~ell~~ 307 (327)
T cd08227 297 ARPSASTLLNH 307 (327)
T ss_pred hcCCHHHHhcC
Confidence 99999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=299.40 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=197.0
Q ss_pred hcCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||.||+|.+.. ++..||+|.++.... ...+.+.+|+.++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-- 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-- 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC--
Confidence 4679999999999999999998743 578899999875432 23456889999999999999999999976544
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCc----------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeC
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQ----------------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGD 667 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~D 667 (833)
..++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||+. +++|||
T Consensus 82 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~d 155 (288)
T cd05050 82 ---PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRD 155 (288)
T ss_pred ---ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence 789999999999999999753211 1112578899999999999999999999 999999
Q ss_pred CCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCC
Q 040925 668 LKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEG 747 (833)
Q Consensus 668 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g 747 (833)
|||+||++++++.+||+|||.+.......... ......+++.|+|||++.+..++.++|||| +|
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG 219 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYK------ASENDAIPIRWMPPESIFYNRYTTESDVWA----------YG 219 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCcccc------ccCCCccChhhcCHHHHhcCCCCchhHHHH----------HH
Confidence 99999999999999999999987553321100 011123567899999998889999999999 66
Q ss_pred ccHHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 748 HSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 748 ~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
++++++++ +..|+.... ............. ...+..++..+.+++.+||+.||++|||+.|+++.|++
T Consensus 220 ~il~el~~~~~~p~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 220 VVLWEIFSYGMQPYYGMA--HEEVIYYVRDGNV------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHhCCCCCCCCCC--HHHHHHHHhcCCC------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 66777665 444432111 0111111100100 01122346778999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.46 Aligned_cols=264 Identities=23% Similarity=0.363 Sum_probs=199.3
Q ss_pred cCCccCceeccCcceEEEEEEECC-------CceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGE-------DEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSSTD 601 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 601 (833)
.+|++.+.||+|+||.||+|++.. .+..||+|.++.... ...+.+.+|+++++++ +||||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 469999999999999999998642 234789998874322 2346789999999999 7999999999976544
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCC
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPS 671 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~ 671 (833)
..+++|||+++|+|.+++...... .....+++.++..++.|++.||+|||+. +|+||||||+
T Consensus 92 -----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~ 163 (334)
T cd05100 92 -----PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163 (334)
T ss_pred -----ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccc
Confidence 789999999999999999764311 1122588899999999999999999999 9999999999
Q ss_pred CeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHH
Q 040925 672 NVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLH 751 (833)
Q Consensus 672 NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~ 751 (833)
||+++.++.+||+|||+++......... ......++..|+|||++.+..++.++|||| +|++++
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ 227 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWS----------FGVLLW 227 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccc------cccCCCcCceEcCHHHhccCCcCchhhhHH----------HHHHHH
Confidence 9999999999999999998654322111 011123467899999999999999999999 677777
Q ss_pred HHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 752 EFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 752 ~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
++++ +..|+...... .. ........ ....+..++..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 228 el~~~g~~p~~~~~~~--~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 228 EIFTLGGSPYPGIPVE--EL-FKLLKEGH-----RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHhcCCCCCCCCCHH--HH-HHHHHcCC-----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 7776 55554321110 01 11111100 001122345678899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=297.99 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=193.2
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|++..++..||+|+++.... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQES-----RLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCC-----eEE
Confidence 58899999999999999999998999999999864422 23467889999999999999999999976544 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++ ++|.+++...... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 148 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKG---QYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLA 148 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCC---CcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccce
Confidence 9999997 6899888654321 1689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
........ ......+++.|+|||++.+. .++.++|||| +|++++++.++..|+......+.
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lG~il~~l~tg~~~~~~~~~~~~ 210 (285)
T cd07861 149 RAFGIPVR--------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWS----------IGTIFAEMATKKPLFHGDSEIDQ 210 (285)
T ss_pred eecCCCcc--------cccCCcccccccChHHhcCCCCcCcHHHHHH----------HHHHHHHHHHCCCCCCCCCHHHH
Confidence 75533211 11123578999999987654 4788999999 77778888887766542211110
Q ss_pred cchh---------h-------hccccch----hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 769 SLLM---------E-------VMTNNSM----IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 769 ~~~~---------~-------~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.... . ....... ...........+++++.+++.+||..||++|||++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 211 LFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0 0000000 000000011224567789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=294.12 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=190.5
Q ss_pred ceeccCcceEEEEEEECCCce--EEEEEEeeccC-CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEM--IVAVKVINLKY-KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|+..+++. .+|+|.++... ....+.+.+|+++++++ +||||+++++++...+ ..++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-----~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-----YLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-----CceEEE
Confidence 368999999999999977765 46888886332 23446788999999999 7999999999976554 789999
Q ss_pred EecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 613 EYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
||+++|+|.+++...... .....+++.+++.++.|++.|++|||+. +++||||||+||++++++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEE
Confidence 999999999999764311 1112578999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCc
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEK 761 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~ 761 (833)
|+|||++........ ......++.|+|||++.+..++.++|||| +|++++++++ +..|+.
T Consensus 153 l~dfgl~~~~~~~~~---------~~~~~~~~~y~apE~~~~~~~~~~~Di~s----------lG~il~el~~~g~~pf~ 213 (270)
T cd05047 153 IADFGLSRGQEVYVK---------KTMGRLPVRWMAIESLNYSVYTTNSDVWS----------YGVLLWEIVSLGGTPYC 213 (270)
T ss_pred ECCCCCccccchhhh---------ccCCCCccccCChHHHccCCCCchhhHHH----------HHHHHHHHHcCCCCCcc
Confidence 999999863221100 00112466799999998888999999999 6677777775 666653
Q ss_pred ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 762 VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
.... ........ ... ....+..++..+.+++.+||..||.+|||+.++++.|..+.
T Consensus 214 ~~~~--~~~~~~~~-~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 214 GMTC--AELYEKLP-QGY-----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ccCH--HHHHHHHh-CCC-----CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 2111 01111100 000 00011224567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.48 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=198.4
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC------cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK------GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
+|++.+.||+|+||.||+|... +++.+|+|.++.... ...+.+.+|++++++++|+||+++++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDN---- 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCC----
Confidence 5888999999999999999875 788999999864321 12246889999999999999999999976554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|
T Consensus 76 -~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~d 145 (265)
T cd06631 76 -TISIFMEFVPGGSISSILNRFG------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLID 145 (265)
T ss_pred -eEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEecc
Confidence 8999999999999999997654 578999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||++........... .........|+..|+|||++.+..++.++|+|| +|+.+++++++..|+...+.
T Consensus 146 fg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s----------lG~~~~~l~~g~~p~~~~~~ 213 (265)
T cd06631 146 FGCARRLAWVGLHGT--HSNMLKSMHGTPYWMAPEVINESGYGRKSDIWS----------IGCTVFEMATGKPPLASMDR 213 (265)
T ss_pred chhhHhhhhcccccc--ccccccccCCCccccChhhhcCCCCcchhhHHH----------HHHHHHHHHhCCCccccCCh
Confidence 999876532111100 011122346899999999999888999999999 88889999999988753221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
....... ..... .....+..++..+.+++.+||..+|++|||+.|+++
T Consensus 214 ~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 214 LAAMFYI--GAHRG----LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHHHHHh--hhccC----CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111000 00000 001112235667889999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=290.69 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=189.5
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
+.||+|+||.||+|... ++..||+|.++..... ....+.+|++++++++||||+++++++.... ..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-----PIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-----ccEEEEECC
Confidence 47899999999999875 6888999998654322 2346889999999999999999999976554 789999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++|+|.+++..... .+++..++.++.|++.||.|+|+. +++||||||+||+++.++.+||+|||++......
T Consensus 75 ~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (250)
T cd05085 75 PGGDFLSFLRKKKD-----ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG 146 (250)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceecccc
Confidence 99999999875432 578999999999999999999999 9999999999999999999999999998754332
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchhhh
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLMEV 774 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~ 774 (833)
.... .....+++.|+|||++.+..++.++|||| +|+.++++.+ +..|+...... .....
T Consensus 147 ~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~ll~~~~~~g~~p~~~~~~~--~~~~~- 206 (250)
T cd05085 147 IYSS-------SGLKQIPIKWTAPEALNYGRYSSESDVWS----------YGILLWETFSLGVCPYPGMTNQ--QAREQ- 206 (250)
T ss_pred cccc-------CCCCCCcccccCHHHhccCCCCchhHHHH----------HHHHHHHHhcCCCCCCCCCCHH--HHHHH-
Confidence 1110 01123467899999998888999999999 6777777766 55565321111 11000
Q ss_pred ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 775 MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
..... ....+..++..+.+++.+||..+|++|||+.|+.+.|.
T Consensus 207 ~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 207 VEKGY-----RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHcCC-----CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 00000 00112234567899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=295.90 Aligned_cols=262 Identities=24% Similarity=0.311 Sum_probs=201.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|++++++++||||+++++++.... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence 468889999999999999999988999999999875432 34567899999999999999999999875432 34689
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKR--GGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence 999999999999987643211 12588999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc--cc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI--VD 767 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~--~~ 767 (833)
........ ....++..|+|||.+.+..++.++|||+ .|+++++++++..|+..... ..
T Consensus 153 ~~~~~~~~----------~~~~~~~~y~~pE~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~p~~~~~~~~~~ 212 (287)
T cd06621 153 GELVNSLA----------GTFTGTSFYMAPERIQGKPYSITSDVWS----------LGLTLLEVAQNRFPFPPEGEPPLG 212 (287)
T ss_pred cccccccc----------ccccCCccccCHHHhcCCCCCchhhHHH----------HHHHHHHHHhCCCCCCcccCCCCC
Confidence 75533211 1234788999999999889999999999 88889999999888763321 11
Q ss_pred ccchhhhccc-cchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTN-NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+......... ...............++.+.+++.+||..||++|||+.|+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 213 PIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1111111111 0000000111011245678999999999999999999999884
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=291.33 Aligned_cols=251 Identities=21% Similarity=0.291 Sum_probs=201.6
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||.|+||.||.++...+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDN-----TLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCC-----eEE
Confidence 5889999999999999999999999999999986442 334567889999999999999999999976544 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
++|||+++|+|.+++...... .+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+|||.+
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQ----LFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred EEEEecCCCcHHHHHHhcccc----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 999999999999999865322 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
........ ......|++.|+|||+..+..++.++|+|| +|++++++.++..|+..... ..
T Consensus 149 ~~~~~~~~--------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~s----------lG~i~~~l~~g~~~~~~~~~--~~ 208 (256)
T cd08221 149 KILGSEYS--------MAETVVGTPYYMSPELCQGVKYNFKSDIWA----------LGCVLYELLTLKRTFDATNP--LN 208 (256)
T ss_pred EEcccccc--------cccccCCCccccCHhhcCCCCCCCcchhHH----------HHHHHHHHHHCCCCCCCCCH--HH
Confidence 86544321 112346899999999998888899999999 78888888888777542211 11
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... ......++..+.+++.+||..+|++||+++++++.
T Consensus 209 ~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 209 LVVKIVQGNY------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred HHHHHHcCCC------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1111111111 11123356678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=299.68 Aligned_cols=268 Identities=19% Similarity=0.277 Sum_probs=199.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||.||+|++..+++.||+|.++... ......+.+|+.++++++||||+++++++.... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~-----~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCC-----eE
Confidence 357999999999999999999999899999999987443 223456788999999999999999999976544 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++ ++|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 150 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGL 150 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcc
Confidence 99999997 599998876432 578999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+........ ......+++.|+|||++.+ ..++.++|||| .|+++++++++..|+...+..+
T Consensus 151 ~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~s----------lG~~l~el~tg~~~f~~~~~~~ 212 (301)
T cd07873 151 ARAKSIPTK--------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWG----------VGCIFYEMSTGRPLFPGSTVEE 212 (301)
T ss_pred hhccCCCCC--------cccccceeecccCcHHHhCCCCCccHHHHHH----------HHHHHHHHHhCCCCCCCCCHHH
Confidence 975432211 1112357899999998765 45788999999 7778888888877654221100
Q ss_pred -------------ccchhhhccccc----hhh----hhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH--HHHh
Q 040925 768 -------------PSLLMEVMTNNS----MIQ----EDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK--LCHT 824 (833)
Q Consensus 768 -------------~~~~~~~~~~~~----~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~i 824 (833)
............ ... ..........++.+.+++.+|++.||.+|||++|+++. +..+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 213 QLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred HHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 000000000000 000 00001112345577899999999999999999999873 5444
Q ss_pred hhhhh
Q 040925 825 RETFL 829 (833)
Q Consensus 825 ~~~~~ 829 (833)
.+.+.
T Consensus 293 ~~~~~ 297 (301)
T cd07873 293 GERIH 297 (301)
T ss_pred cchhh
Confidence 44443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=299.25 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=203.9
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
...+.|.+.+.||+|.|++|.+|++..++..||+|.+++..-. ....+.+|+++|..++|||||+++.+.....
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~---- 128 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA---- 128 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc----
Confidence 3457899999999999999999999999999999999755332 2356899999999999999999999966555
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..|+||||+.+|.+++|+..++ ...+..+..++.|+..|++|||++ .|||||||.+||+++.+..+||+|
T Consensus 129 -~lylV~eya~~ge~~~yl~~~g------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaD 198 (596)
T KOG0586|consen 129 -TLYLVMEYASGGELFDYLVKHG------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIAD 198 (596)
T ss_pred -eeEEEEEeccCchhHHHHHhcc------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeec
Confidence 8999999999999999999887 566789999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCCCcc--
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV-- 762 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~-- 762 (833)
||++..+..... ....+|++.|.|||++.+.+| .+.+|+|| .|+++|-++.+.+|++-
T Consensus 199 fgfS~~~~~~~~---------lqt~cgsppyAaPEl~~g~~y~gpe~D~Ws----------lgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 199 FGFSTFFDYGLM---------LQTFCGSPPYAAPELFNGKKYDGPEVDIWS----------LGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred cccceeeccccc---------ccccCCCCCccChHhhcCcccCCcceehhh----------hhhhheeeeecccccCCcc
Confidence 999988765332 334689999999999998876 57899999 77778888888888762
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.....++.. .....+ +-....+..+++.+++..+|.+|+++++|.+.
T Consensus 260 lk~Lr~rvl----~gk~rI-------p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 260 LKELRPRVL----RGKYRI-------PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cccccchhe----eeeecc-------cceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 222222221 111111 11123345688889999999999999999765
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=297.66 Aligned_cols=248 Identities=25% Similarity=0.343 Sum_probs=198.3
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.|+..+.||+|+||.||+|.+..+++.||+|.++... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-----TKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-----CceEE
Confidence 4777889999999999999998889999999987443 23346789999999999999999999986544 48999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++++|.+++... .+++..++.++.|+++|+.|||+. +++|+||+|+||++++++.+||+|||++.
T Consensus 80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06642 80 IMEYLGGGSALDLLKPG-------PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAG 149 (277)
T ss_pred EEEccCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccc
Confidence 99999999999998643 588999999999999999999999 99999999999999999999999999997
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
....... ......|+..|+|||++.+..++.++|+|| +|+++++++++..|+.......
T Consensus 150 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~il~el~tg~~p~~~~~~~~--- 208 (277)
T cd06642 150 QLTDTQI--------KRNTFVGTPFWMAPEVIKQSAYDFKADIWS----------LGITAIELAKGEPPNSDLHPMR--- 208 (277)
T ss_pred cccCcch--------hhhcccCcccccCHHHhCcCCCchhhhHHH----------HHHHHHHHHhCCCCCcccchhh---
Confidence 6543221 111235889999999999888999999999 7888899999888764221111
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......... .......++..+.+++.+||..+|++|||+.++++.
T Consensus 209 ~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 209 VLFLIPKNS-----PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHhhhhcCC-----CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000000000 011122346678899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=291.62 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=195.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-----cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-----GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|+..+.||+|+||.||+|.+..++..||+|.++.... ...+.+.+|+.++++++||||+++++++.... .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRA---E 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCC---C
Confidence 368999999999999999999998999999999864321 12356888999999999999999999875432 3
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...+++|||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~d 149 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 46889999999999999997654 578999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++......... .......++..|+|||++.+..++.++|||| .|+++++++++..|+...+.
T Consensus 150 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~i~~el~~g~~pf~~~~~ 214 (266)
T cd06651 150 FGASKRLQTICMSG-----TGIRSVTGTPYWMSPEVISGEGYGRKADVWS----------LGCTVVEMLTEKPPWAEYEA 214 (266)
T ss_pred CCCccccccccccC-----CccccCCccccccCHHHhCCCCCCchhhhHH----------HHHHHHHHHHCCCCccccch
Confidence 99987653321100 1112245899999999999888999999999 78888999998888652211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
. ......... ......+....+.+.+++ +||..+|++||+++||++
T Consensus 215 ~--~~~~~~~~~-----~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 215 M--AAIFKIATQ-----PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred H--HHHHHHhcC-----CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 000000000 000111223445566776 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=292.09 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=198.2
Q ss_pred ceeccCcceEEEEEEECCC---ceEEEEEEeeccCCcc-hhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGED---EMIVAVKVINLKYKGA-SRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|..... +..||+|.++...... .+.+.+|++.++.++|+||+++++++... ...++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE-----EPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC-----CceEEEE
Confidence 4799999999999999865 8899999997554333 57889999999999999999999997653 4899999
Q ss_pred EecCCCChhhhhccCCCc---cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 613 EYMENGSLKDWLHQSDDQ---VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
||+++++|.+++...... .....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccc
Confidence 999999999999875210 0012689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHH-hCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKT-ALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~-~~p~~~~~~~~~ 768 (833)
........ ........+++.|+|||.+.+..++.++|||| .|++++++.++ ..|+.... ..
T Consensus 153 ~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~~g~~p~~~~~--~~ 214 (262)
T cd00192 153 RDVYDDDY------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWS----------FGVLLWEIFTLGATPYPGLS--NE 214 (262)
T ss_pred cccccccc------cccccCCCcCccccCHHHhccCCcchhhccHH----------HHHHHHHHHhcCCCCCCCCC--HH
Confidence 87654321 01122345789999999988888999999999 77788888773 66654321 11
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
.... ..... .....+..++..+.+++.+||..||++|||+.|+++.|+
T Consensus 215 ~~~~-~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 215 EVLE-YLRKG-----YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HHHH-HHHcC-----CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111 11110 011123344678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=329.60 Aligned_cols=258 Identities=25% Similarity=0.342 Sum_probs=206.0
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
+...+-+|....+||.|.||.||-|.+.++|+..|+|.++.... ...+.+.+|..++..++|||+|++||+-.+.+
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH--
Confidence 34455678889999999999999999999999999999875432 33467889999999999999999999965554
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
..+|.||||++|+|.+.+...+ ..++.....+..|++.|++|||++ |||||||||+||+++.+|.+|+
T Consensus 1308 ---kv~IFMEyC~~GsLa~ll~~gr------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~ 1375 (1509)
T KOG4645|consen 1308 ---KVYIFMEYCEGGSLASLLEHGR------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKY 1375 (1509)
T ss_pred ---HHHHHHHHhccCcHHHHHHhcc------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEe
Confidence 7899999999999999998765 567888888999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCC---CCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE---ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
+|||.|..+..... ..+....+.+||+.|||||++.+.. -.-++|||| .|++..||++|..||
T Consensus 1376 ~DFGsa~ki~~~~~----~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWs----------lGCVVlEM~tGkrPW 1441 (1509)
T KOG4645|consen 1376 GDFGSAVKIKNNAQ----TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWS----------LGCVVLEMATGKRPW 1441 (1509)
T ss_pred ecccceeEecCchh----cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhc----------ccceEEEeecCCCch
Confidence 99999998876521 1223445678999999999987643 456789999 666777888888887
Q ss_pred cccccccccch--hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 761 KVMEIVDPSLL--MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 761 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... |..+. ..+..... ...++....+-.+++..|++.||++|+++.|+++.
T Consensus 1442 ~~~---dne~aIMy~V~~gh~------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1442 AEL---DNEWAIMYHVAAGHK------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred hhc---cchhHHHhHHhccCC------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 632 22222 22211111 11223355667789999999999999999988765
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.09 Aligned_cols=256 Identities=20% Similarity=0.242 Sum_probs=194.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|+...+++.||+|++... .......+.+|+.++..++|++|+++++++...+ .
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN-----N 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-----E
Confidence 4799999999999999999999999999999998632 1223345788999999999999999999876554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG 147 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFG 147 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecc
Confidence 9999999999999999976432 588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
++........ .......||+.|+|||++. ...++.++|||| +|+++++++++..|+..
T Consensus 148 ~a~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwS----------lGvil~ell~g~~Pf~~ 210 (332)
T cd05623 148 SCLKLMEDGT-------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWS----------LGVCMYEMLYGETPFYA 210 (332)
T ss_pred hheecccCCc-------ceecccccCccccCHHHHhccccCCCCCCCcCCEEe----------eHHHHHHHhcCCCCCCC
Confidence 9875432211 0111246999999999875 346889999999 88899999999988753
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCC--CCCHHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFE--RMDMRDVVAK 820 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 820 (833)
.+.... ............ .......+++.+.+++.+|+..+|++ |++++|+++.
T Consensus 211 ~~~~~~--~~~i~~~~~~~~--~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 211 ESLVET--YGKIMNHKERFQ--FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCHHHH--HHHHhCCCcccc--CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 321111 011111100000 00111234567788888888654444 7899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=271.83 Aligned_cols=252 Identities=19% Similarity=0.273 Sum_probs=194.8
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+.+.+..||+|+.|+||+++.+.+|...|||.++... .+..+++...++++..-+ +|+||+.+|||..+. .++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----dV~ 167 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----DVF 167 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----hHH
Confidence 4455678999999999999999999999999997543 344567778888776664 899999999987665 788
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+.||.|.. -.+.+++.... ++++..+-++..-+++||.||.+++ +|+|||+||+|||+|+.|.+|+||||++
T Consensus 168 IcMelMs~-C~ekLlkrik~-----piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 168 ICMELMST-CAEKLLKRIKG-----PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHHHH-HHHHHHHHhcC-----CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 99999853 45555554432 6899999999999999999999987 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCC---CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG---SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
..+.+... ....+|.+.|||||.+.- ..|+.++|||| +|++++|++++.+|+..-+ .
T Consensus 240 GrlvdSkA---------htrsAGC~~YMaPERidp~~~~kYDiRaDVWS----------lGITlveLaTg~yPy~~c~-t 299 (391)
T KOG0983|consen 240 GRLVDSKA---------HTRSAGCAAYMAPERIDPPDKPKYDIRADVWS----------LGITLVELATGQYPYKGCK-T 299 (391)
T ss_pred ceeecccc---------cccccCCccccCccccCCCCCCccchhhhhhh----------hccchhhhhcccCCCCCCC-c
Confidence 87655332 122469999999997653 46899999999 8999999999999986321 1
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
|-+....+.... +..-.....+++.+.+++..|+.+|+.+||...+++++
T Consensus 300 dFe~ltkvln~e----PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 300 DFEVLTKVLNEE----PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred cHHHHHHHHhcC----CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 111111111111 11111112267789999999999999999999999875
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=291.55 Aligned_cols=255 Identities=23% Similarity=0.425 Sum_probs=198.5
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
..++|++.+.||+|+||.||+|... .+..||+|.++.. ....+.+.+|++++++++|+||+++++++.. ...
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~ 75 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPI 75 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCe
Confidence 3468999999999999999999876 5567999988643 2234678899999999999999999998654 267
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
+++|||+++|+|.+++...... .+++.+++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||.
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~ 148 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL 148 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCcc----ccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcc
Confidence 9999999999999999764322 578899999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~ 767 (833)
+......... ......++..|+|||++.+..++.++|+|| +|+.++++++ +..|+.... +
T Consensus 149 ~~~~~~~~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s----------lG~~l~~l~t~g~~p~~~~~--~ 209 (260)
T cd05073 149 ARVIEDNEYT-------AREGAKFPIKWTAPEAINFGSFTIKSDVWS----------FGILLMEIVTYGRIPYPGMS--N 209 (260)
T ss_pred eeeccCCCcc-------cccCCcccccccCHhHhccCCcCccccchH----------HHHHHHHHHhcCCCCCCCCC--H
Confidence 9765432111 111223667899999998888999999999 7888888887 676654221 1
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
+... ........ .......+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 210 ~~~~-~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 210 PEVI-RALERGYR-----MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHH-HHHhCCCC-----CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1111 11111110 01122345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=294.09 Aligned_cols=250 Identities=25% Similarity=0.318 Sum_probs=201.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGS-----KLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECC-----eEE
Confidence 46889999999999999999999899999999987543 333467889999999999999999999876544 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+|+||+++++|.+++... .+++..++.++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~ 145 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVS 145 (274)
T ss_pred EEEEeeCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 999999999999998754 588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
+....... ......|++.|+|||++.+..++.++|||| +|++++++.++..|+...+. .
T Consensus 146 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~s----------lG~il~~l~tg~~p~~~~~~---~ 204 (274)
T cd06609 146 GQLTSTMS--------KRNTFVGTPFWMAPEVIKQSGYDEKADIWS----------LGITAIELAKGEPPLSDLHP---M 204 (274)
T ss_pred eeeccccc--------ccccccCCccccChhhhccCCCCchhhHHH----------HHHHHHHHHhCCCCcccCch---H
Confidence 87654321 112245889999999999888999999999 88889999998888753221 1
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... ........++..+.+++.+||..||++|||++++++.
T Consensus 205 ~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 205 RVLFLIPKNN----PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred HHHHHhhhcC----CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1100011100 0000111146678899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.75 Aligned_cols=255 Identities=19% Similarity=0.282 Sum_probs=197.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEG-----AVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCC-----eEE
Confidence 368899999999999999999998999999999875422 23467889999999999999999999866544 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++..... ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~ 150 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVS 150 (286)
T ss_pred EEEeecCCCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCc
Confidence 99999999999999876421 125899999999999999999999632 8999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCC------CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS------EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
........ ....|++.|+|||++.+. .++.++|||| .|+++++++++..|+...
T Consensus 151 ~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Diws----------lG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 151 GNLVASLA----------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWS----------LGLSILEMALGRYPYPPE 210 (286)
T ss_pred ccccCCcc----------ccCCCccCccCcchhcCCCCCccCCCCcccchHh----------HHHHHHHHHhCCCCCCCc
Confidence 76533211 123488899999987554 3578899999 888899999998887532
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... ..... .... ........+.+++..+.+++.+||..+|++||+++++++.
T Consensus 211 ~~~--~~~~~-~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 211 TYA--NIFAQ-LSAI--VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred chh--hHHHH-HHHH--hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111 10000 0000 0000111223467788999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=298.70 Aligned_cols=202 Identities=24% Similarity=0.318 Sum_probs=158.4
Q ss_pred CceeccCcceEEEEEEEC--CCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 536 SNMIGQGSFGYVYKGTLG--EDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
.++||+|+||.||+|++. .+++.||+|.++.. .....+.+|++++++++||||+++++++.... ....++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHA---DRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCC---CcEEEEEEe
Confidence 368999999999999975 36788999998633 23456788999999999999999999875432 347899999
Q ss_pred ecCCCChhhhhccCCCc---cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee----cCCCcEEEccc
Q 040925 614 YMENGSLKDWLHQSDDQ---VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCDF 686 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~Df 686 (833)
|++ ++|.+++...... .....+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 996 5898887643211 1112588999999999999999999999 99999999999999 45679999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
|+|+........ ........||+.|+|||++.+ ..++.++|||| .|+++++++++..|+.
T Consensus 157 G~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~el~~g~~~f~ 217 (317)
T cd07868 157 GFARLFNSPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWA----------IGCIFAELLTSEPIFH 217 (317)
T ss_pred CceeccCCCCcc-----ccccCCccccccccCCHHHcCCCCcCchhhHHH----------HHHHHHHHHhCCCCcc
Confidence 999866432211 111223568999999999876 45899999999 6777777777776654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.64 Aligned_cols=257 Identities=22% Similarity=0.317 Sum_probs=195.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|+.++++++||||+++++++.... ..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKR-----KL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCC-----EE
Confidence 468999999999999999999998899999999864322 23356789999999999999999999976544 88
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++++++..++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 146 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGF 146 (286)
T ss_pred EEEEeccCccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECcccc
Confidence 99999999988888776543 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+........ ......++..|+|||++.+ ..++.++|||| +|+++++++++..|+......+
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s----------lG~i~~~l~~g~~p~~~~~~~~ 208 (286)
T cd07847 147 ARILTGPGD--------DYTDYVATRWYRAPELLVGDTQYGPPVDVWA----------IGCVFAELLTGQPLWPGKSDVD 208 (286)
T ss_pred ceecCCCcc--------cccCcccccccCCHHHHhCCCCcCchhhhHH----------HHHHHHHHHhCCCCCCCCChHH
Confidence 986644221 1112357899999998776 45788999999 7777888888877654211111
Q ss_pred ccchhh------------------hccccchhhhh----hhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 PSLLME------------------VMTNNSMIQED----KRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 ~~~~~~------------------~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
...... .........+. .....+..+..+.+++.+||..||++|||+.|++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 209 QLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000 00000000000 00111234567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=290.84 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=194.3
Q ss_pred ceeccCcceEEEEEEECC-C--ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGE-D--EMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~-~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|++|.||+|.+.. . ...||+|.++.... ...+.+.+|++++++++||||+++++++.. ...++||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999999854 2 33699999976544 456789999999999999999999998654 3789999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 75 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~ 147 (257)
T cd05040 75 ELAPLGSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRAL 147 (257)
T ss_pred EecCCCcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccc
Confidence 99999999999987542 1689999999999999999999999 9999999999999999999999999999876
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccch
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLL 771 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~ 771 (833)
........ ......++..|+|||++.+..++.++|||| +|++++++++ +..|+......+ ..
T Consensus 148 ~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Di~s----------lG~~l~el~t~g~~p~~~~~~~~--~~ 210 (257)
T cd05040 148 PQNEDHYV-----MEEHLKVPFAWCAPESLRTRTFSHASDVWM----------FGVTLWEMFTYGEEPWAGLSGSQ--IL 210 (257)
T ss_pred ccccccee-----cccCCCCCceecCHHHhcccCcCchhhhHH----------HHHHHHHHHhCCCCCCCCCCHHH--HH
Confidence 44221100 011235788999999998889999999999 6777778776 666653211111 10
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
...... ......+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus 211 ~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 211 KKIDKE-----GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred HHHHhc-----CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 000000 0011112335678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=292.51 Aligned_cols=256 Identities=19% Similarity=0.305 Sum_probs=200.6
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC------cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK------GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
+|+..+.||+|++|.||+|....+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---- 76 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS---- 76 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC----
Confidence 48888999999999999999988999999999974321 12467889999999999999999999975544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-cEEEc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVC 684 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~ 684 (833)
..++||||+++++|.+++.... ++++..+..++.|++.||+|||+. +++|+||||+||+++.++ .+||+
T Consensus 77 -~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~ 146 (268)
T cd06630 77 -HFNLFVEWMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIA 146 (268)
T ss_pred -eEEEEEeccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEc
Confidence 8899999999999999997654 688999999999999999999999 999999999999998776 69999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||.+.......... ........||..|+|||++.+..++.++|+|+ .|+++++++++..|+...+
T Consensus 147 dfg~~~~~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s----------lG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 147 DFGAAARLAAKGTGA----GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWS----------VGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ccccccccccccccC----CccccccccccceeCHhHhccCCCCcccchHH----------HHHHHHHHHhCCCCCCCCC
Confidence 999998765432111 11122346899999999998888999999999 7888888888888865322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
............. .......+....+.+.+++.+||..+|++|||+.|+++
T Consensus 213 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 213 HSNHLALIFKIAS----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CcchHHHHHHHhc----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 2111111000000 00011223345678899999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=310.76 Aligned_cols=255 Identities=21% Similarity=0.227 Sum_probs=191.8
Q ss_pred hcCCccCceeccCcceEEEEEEECC--CceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGE--DEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
..+|++.+.||+|+||.||+|...+ +++.||+|.+... +...+|++++++++||||+++++++.... .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~-----~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKS-----T 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCC-----E
Confidence 3579999999999999999997643 4678999988532 34568999999999999999999865444 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+. ++|.+++.... .+++.+++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG 230 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFG 230 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCc
Confidence 999999996 68999885433 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+++........ .......||+.|+|||++.+..++.++|||| +|+++|+++++..|+.......
T Consensus 231 ~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dvws----------lGvil~el~~g~~pf~~~~~~~ 294 (392)
T PHA03207 231 AACKLDAHPDT------PQCYGWSGTLETNSPELLALDPYCAKTDIWS----------AGLVLFEMSVKNVTLFGKQVKS 294 (392)
T ss_pred cccccCccccc------ccccccccccCccCHhHhcCCCCCchhhHHH----------HHHHHHHHHHCCCCCCCCCCCC
Confidence 99765442211 1122356999999999999999999999999 7777888888777764211100
Q ss_pred c-cchhhhc-----------------------cccchhhh----hhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 P-SLLMEVM-----------------------TNNSMIQE----DKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 ~-~~~~~~~-----------------------~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
. ....... .......+ ............+.+++.+||..||++|||+.|++.
T Consensus 295 ~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 295 SSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred cHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 0000000 00000000 000000122456788999999999999999999987
Q ss_pred H
Q 040925 820 K 820 (833)
Q Consensus 820 ~ 820 (833)
.
T Consensus 375 ~ 375 (392)
T PHA03207 375 L 375 (392)
T ss_pred C
Confidence 6
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=292.76 Aligned_cols=257 Identities=20% Similarity=0.300 Sum_probs=185.2
Q ss_pred ceeccCcceEEEEEEEC--CCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 537 NMIGQGSFGYVYKGTLG--EDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
+.||+|+||.||+|... .++..+|+|.++.... .....+.+|+.++++++||||+++++++.+.. ..++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-----PYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-----CcEEEEE
Confidence 36899999999999864 3456799999875432 23357888999999999999999999876544 6899999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
|+++|+|.+++...... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||+++...
T Consensus 76 ~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 76 FCPLGDLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred CCCCCcHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999999754321 112456778889999999999999999 99999999999999999999999999987543
Q ss_pred cccccccccCCCccccccccccccCccccCCC-------CCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-------EASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
...... ......|++.|+|||++.+. .++.++|||| +|++++++++ +..|+.....
T Consensus 152 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws----------lG~~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 152 KEDYYV------TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWS----------LGVTIWELFELGSQPYRHLSD 215 (269)
T ss_pred Ccceee------cCCCcCCcccccCHhHhccccccccccCCCccchhHH----------HHHHHHHHHhCCCCCCCCCCh
Confidence 322110 11224578899999987542 3578999999 7777888775 7767642211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
.+ .............+ ........++.+.+++..|| .+|++|||++||+..|+
T Consensus 216 ~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 216 EQ--VLTYTVREQQLKLP-KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HH--HHHHHhhcccCCCC-CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 00000000000000 00001123456788999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=290.50 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=203.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.+.|+.-++||+|+||.||-++.+.+|+.||.|.+..+ .........+|-.++++++.+.||.+-.. |+..+
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA-----feTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA-----FETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee-----ecCCC
Confidence 35688889999999999999999999999999988533 23344567899999999999999988766 44555
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||..|.||+|.-+|...+.. .+++.+++.++.+|+.||++||.. +||.||+||+|||+|+.|.++|+|.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~----gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNP----GFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCC----CCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeecc
Confidence 999999999999999999988754 799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc-cc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM-EI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~-~~ 765 (833)
|+|..+..... ..+.+||.+|||||++.++.|+...|+|+ .|+.+|+++.|..|+... +-
T Consensus 332 GLAvei~~g~~---------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~----------lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 332 GLAVEIPEGKP---------IRGRVGTVGYMAPEVLQNEVYDFSPDWFS----------LGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred ceEEecCCCCc---------cccccCcccccCHHHHcCCcccCCccHHH----------HHhHHHHHHcccCchhhhhhh
Confidence 99998766432 22347999999999999999999999999 888999999999997632 22
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
+..+...... .......++.++++..+++...|.+||++|-..
T Consensus 393 vk~eEvdrr~------~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 393 VKREEVDRRT------LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhHHHHHHHH------hcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 2111111111 111223345677788899999999999999754
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=290.16 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=197.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-----cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-----GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|++.+.||+|+||.||+|.+..+++.||+|.++.... ...+.+.+|++++++++||||+++++++.+.. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 478999999999999999999998999999999864321 12357888999999999999999999865432 2
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~D 149 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGD 149 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECc
Confidence 46789999999999999997654 578899999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||.++........ ........|+..|+|||++.+..++.++|||| +|+++++++++..|+...+.
T Consensus 150 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~il~el~~g~~p~~~~~~ 214 (265)
T cd06652 150 FGASKRLQTICLS-----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWS----------VGCTVVEMLTEKPPWAEFEA 214 (265)
T ss_pred Ccccccccccccc-----ccccccCCCCccccChhhhcCCCCCcchhHHH----------HHHHHHHHhhCCCCCCccch
Confidence 9998865432111 01112345899999999998888999999999 78888999988888652211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. ....... .+.....+......+.+++.+|+. +|++||+++|+++.
T Consensus 215 ~~--~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 215 MA--AIFKIAT-----QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred HH--HHHHHhc-----CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 10 0000000 001111233455678889999994 99999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=290.52 Aligned_cols=238 Identities=23% Similarity=0.379 Sum_probs=184.3
Q ss_pred ceeccCcceEEEEEEECCCc----------eEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 537 NMIGQGSFGYVYKGTLGEDE----------MIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
+.||+|+||.||+|.+..++ ..|++|.++..... ...+.+|+.++++++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~----- 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D----- 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C-----
Confidence 46899999999999997666 45888887644332 6788999999999999999999999765 3
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-------
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM------- 679 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~------- 679 (833)
..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~ 145 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVP 145 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCce
Confidence 56899999999999999986542 588999999999999999999999 999999999999999888
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCC--CCCcccccccCCcCCCccccCCccHHHHHHH-
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS--EASMTGDIFTGRRPIDAVFNEGHSLHEFAKT- 756 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~- 756 (833)
.+||+|||++....... ...++..|+|||++.+. .++.++|||| +|+++++++++
T Consensus 146 ~~kl~Dfg~a~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~~Di~s----------lG~~~~~l~~~~ 203 (259)
T cd05037 146 FIKLSDPGIPITVLSRE------------ERVERIPWIAPECIRNGQASLTIAADKWS----------FGTTLLEICSNG 203 (259)
T ss_pred eEEeCCCCccccccccc------------ccccCCCccChhhhcCCCCCcchhhHHHH----------HHHHHHHHHhCC
Confidence 79999999998654311 13467889999998776 7899999999 66777777663
Q ss_pred hCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 757 ALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
..|+.... +............ .... ....+.+++.+||..+|++|||+.++++.|
T Consensus 204 ~~p~~~~~---~~~~~~~~~~~~~---~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 204 EEPLSTLS---SSEKERFYQDQHR---LPMP----DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCCcccCC---chhHHHHHhcCCC---CCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 44443221 1110010000000 0000 126788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=293.18 Aligned_cols=262 Identities=21% Similarity=0.282 Sum_probs=202.8
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCC-CCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDF-KGT 605 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 605 (833)
.++++|++.+.||+|++|.||+|.+..+++.||+|++..... ..+.+.+|+++++++ +||||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 456899999999999999999999988899999999875432 346789999999999 69999999999876542 234
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++++|.+++...... ...+++..++.++.|++.||.|||+. +++|+||+|+||++++++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 5789999999999999998753311 12689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCC-----CCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-----SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
||++........ ......|++.|+|||++.. ..++.++|||| .|+++++++++..|+
T Consensus 157 ~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~p~ 218 (275)
T cd06608 157 FGVSAQLDSTLG--------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWS----------LGITAIELADGKPPL 218 (275)
T ss_pred Cccceecccchh--------hhcCccccccccCHhHhcccccccCCccccccHHH----------hHHHHHHHHhCCCCc
Confidence 999876543211 1122458999999998653 34678899999 888889999988887
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
...... .......... .........+++.+.+++.+||..||++|||++|+++
T Consensus 219 ~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 219 CDMHPM--RALFKIPRNP----PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cccchH--HHHHHhhccC----CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 522111 1111111110 0011112335678899999999999999999999976
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=289.76 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=193.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.+|++.+.||+|+||.||+|.+. .+..+|+|.++... .....+.+|++++++++||+++++++++.... ..++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~ 76 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERS-----PICL 76 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCC-----ceEE
Confidence 47888999999999999999886 46789999986432 23467899999999999999999999865544 7899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++|+|.+++..... .+++..++.++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+.
T Consensus 77 v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 148 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTR 148 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCccee
Confidence 9999999999999875432 578999999999999999999999 99999999999999999999999999987
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPS 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~ 769 (833)
......... .....++..|+|||++.+..++.++|||| +|++++++.+ +..|+..... ..
T Consensus 149 ~~~~~~~~~-------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~s----------lG~~l~el~~~g~~p~~~~~~--~~ 209 (256)
T cd05112 149 FVLDDQYTS-------STGTKFPVKWSSPEVFSFSKYSSKSDVWS----------FGVLMWEVFSEGKTPYENRSN--SE 209 (256)
T ss_pred ecccCcccc-------cCCCccchhhcCHhHhccCCcChHHHHHH----------HHHHHHHHHcCCCCCCCcCCH--HH
Confidence 654322110 11223567899999998888999999999 6777777776 5666532110 01
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
.......... ...+...+..+.+++.+||+.+|++|||+.|++++|
T Consensus 210 ~~~~~~~~~~------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 210 VVETINAGFR------LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred HHHHHhCCCC------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1111000000 000111356789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=293.61 Aligned_cols=260 Identities=21% Similarity=0.342 Sum_probs=197.1
Q ss_pred cCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
.+|++.+.||+|+||.||+|+.+. +.+.||+|.+...... ..+.+.+|++++++++||||+++++++...+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--- 81 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE--- 81 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC---
Confidence 578999999999999999999753 3567999988654333 3467999999999999999999999975544
Q ss_pred CceEeEEEEecCCCChhhhhccCCCcc---ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcE
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQV---EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 681 (833)
..++||||+++|+|.+++....... ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 --~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 82 --PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred --cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcE
Confidence 7899999999999999997654211 011589999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCC
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPE 760 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~ 760 (833)
+++|||++........ .......+++.|+|||.+.+..++.++|||| +|++++++++ +..|+
T Consensus 157 ~l~~~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s----------lG~~l~~l~~~~~~p~ 219 (275)
T cd05046 157 KVSLLSLSKDVYNSEY-------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWS----------FGVLMWEVFTQGELPF 219 (275)
T ss_pred EEcccccccccCcccc-------cccCCceeEEeecChhhhccCCCCchhhHHH----------HHHHHHHHHhCCCCCc
Confidence 9999999875432211 1112235678899999988888999999999 6666777665 44454
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
... .+............ .......++..+.+++.+||+.||++|||+.|+++.|.
T Consensus 220 ~~~--~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 220 YGL--SDEEVLNRLQAGKL-----ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ccc--chHHHHHHHHcCCc-----CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 311 11111111110000 00112235668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=290.33 Aligned_cols=251 Identities=20% Similarity=0.267 Sum_probs=199.8
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|+||.||+++...+++.||+|.+.... ....+.+.+|++++++++||||+++++++... +..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-----GNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-----CeEE
Confidence 5889999999999999999999899999999986432 23346789999999999999999999986544 4899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++...... .+++.+++.++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~ 148 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGV----LFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIA 148 (256)
T ss_pred EEEecCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccce
Confidence 999999999999998764322 578999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
......... .....|++.|+|||+..+..++.++|+|| +|+.++++.++..|+...+.. .
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s----------lG~i~~~l~~g~~~~~~~~~~--~ 208 (256)
T cd08218 149 RVLNSTVEL--------ARTCIGTPYYLSPEICENRPYNNKSDIWA----------LGCVLYEMCTLKHAFEAGNMK--N 208 (256)
T ss_pred eecCcchhh--------hhhccCCccccCHHHhCCCCCCCccchhH----------HHHHHHHHHcCCCCccCCCHH--H
Confidence 765432211 11235889999999998888999999999 788888888887776432211 1
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... ...+..++..+.+++.+||+.+|++||++++|++.
T Consensus 209 ~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 209 LVLKIIRGSY------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred HHHHHhcCCC------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111111110 11123346678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=293.15 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=193.8
Q ss_pred ceeccCcceEEEEEEECCCc------eEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 537 NMIGQGSFGYVYKGTLGEDE------MIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+.||+|+||.||+|+..+.. +.||+|.+.... ......+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-----PQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-----CeE
Confidence 46899999999999986433 689999886443 234567889999999999999999999975544 789
Q ss_pred EEEEecCCCChhhhhccCCCcc-ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-----cEEE
Q 040925 610 FVFEYMENGSLKDWLHQSDDQV-EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-----VAHV 683 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kL 683 (833)
+||||+++|+|.+++....... ....+++.+++.++.|++.|++|||+. +++|+||||+||+++.++ .+|+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l 152 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKI 152 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEE
Confidence 9999999999999997543211 122578999999999999999999999 999999999999999877 8999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKV 762 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~ 762 (833)
+|||+++......... ......++..|+|||++.+..++.++|||| +|++++++++ +..|+..
T Consensus 153 ~dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~il~ellt~g~~p~~~ 216 (269)
T cd05044 153 GDFGLARDIYKSDYYR------KEGEGLLPVRWMAPESLLDGKFTTQSDVWS----------FGVLMWEILTLGQQPYPA 216 (269)
T ss_pred CCcccccccccccccc------cCcccCCCccccCHHHHccCCcccchhHHH----------HHHHHHHHHHcCCCCCcc
Confidence 9999997654322111 011224678899999999999999999999 7888888887 6666542
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
... ...... ..... ....+..++..+.+++.+||..+|++||+++++++.|++
T Consensus 217 ~~~--~~~~~~-~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 217 LNN--QEVLQH-VTAGG-----RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cCH--HHHHHH-HhcCC-----ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 211 111111 00000 011123456788999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=289.20 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=198.2
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|....+++.||+|.+.... ....+.+.+|++++++++||||+++++.+... ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-----KALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-----CEEE
Confidence 5889999999999999999999899999999986442 23356788999999999999999999986544 4899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-CcEEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~ 688 (833)
+||||+++++|.+++...... .+++..++.++.|+++|++|||+. +++||||||+||+++.+ +.+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNS----LLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred EEEecCCCCCHHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 999999999999999765422 589999999999999999999999 99999999999999865 4689999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+........ .....|++.|+|||.+.+..++.++|||| +|+.++++.++..|+...+. +
T Consensus 149 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~~l~~l~~~~~~~~~~~~--~ 207 (256)
T cd08220 149 SKILSSKSK---------AYTVVGTPCYISPELCEGKPYNQKSDIWA----------LGCVLYELASLKRAFEAANL--P 207 (256)
T ss_pred ceecCCCcc---------ccccccCCcccCchhccCCCCCcccchHH----------HHHHHHHHHhCCCCcccCch--H
Confidence 986643221 11245899999999999888999999999 78888888888777643221 1
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... ....+..++..+.+++.+||..||++|||++|+++.
T Consensus 208 ~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 208 ALVLKIMSGT------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred HHHHHHHhcC------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1111111110 011122356678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=288.19 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=192.6
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
++||+|++|.||+|.+.. ++.||+|.++..... ....+.+|++++++++||||+++++++.... ..++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-----PIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-----CeEEEEEcC
Confidence 479999999999999986 999999998754333 4567899999999999999999999976554 789999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 75 ~~~~l~~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 75 PGGSLLTFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred CCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 99999999965432 578999999999999999999999 9999999999999999999999999999765422
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchhhh
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLMEV 774 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~ 774 (833)
..... .....++..|+|||++.+..++.++|||| +|++++++++ +..|+......+ . ...
T Consensus 147 ~~~~~------~~~~~~~~~y~~PE~~~~~~~~~~~Di~s----------lG~i~~~l~t~~~~p~~~~~~~~--~-~~~ 207 (251)
T cd05041 147 IYTVS------DGLKQIPIKWTAPEALNYGRYTSESDVWS----------YGILLWETFSLGDTPYPGMSNQQ--T-RER 207 (251)
T ss_pred cceec------cccCcceeccCChHhhccCCCCcchhHHH----------HHHHHHHHHhccCCCCccCCHHH--H-HHH
Confidence 11100 01122466799999998888999999999 7777888887 555553221111 0 111
Q ss_pred ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 775 MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
..... ....+..++..+.+++.+||..+|++|||++|+++.|.
T Consensus 208 ~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 208 IESGY-----RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HhcCC-----CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11000 00112335668999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=291.26 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=201.6
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||.|++|.||+|.+..+++.||+|.++... ....+.+..|++++++++||||+++++++.... ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRS---NQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCC---CCEEE
Confidence 5888999999999999999999899999999986432 223456888999999999999999999765432 34689
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHh-----hcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH-----HHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
++|||+++++|.+++...... ...+++..++.++.|++.||+||| +. +++|+||||+||+++.++.+||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred EEehhccCCCHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEe
Confidence 999999999999999764211 126899999999999999999999 77 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||++........ ......|++.|+|||++.+..++.++|+|| +|+++++++++..|+...+
T Consensus 153 d~g~~~~~~~~~~--------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 153 DFGLAKILGHDSS--------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWS----------LGCLIYELCALSPPFTARN 214 (265)
T ss_pred cccccccccCCcc--------cccccccCCCccChhhhcCCCCCchhHHHH----------HHHHHHHHHHCCCcccCcC
Confidence 9999987644221 011245899999999998888999999999 7888889999888876332
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.... .+...... ....+...+..+.+++.+|+..+|++|||+++|++.
T Consensus 215 --~~~~-~~~~~~~~-----~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 215 --QLQL-ASKIKEGK-----FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --HHHH-HHHHhcCC-----CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111 11111110 111223456788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.80 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=196.5
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
|.....||+|+||.||+|....++..||||.++.......+.+.+|+.+++.++||||+++++.+...+ ..++||
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~-----~~~lv~ 98 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGD-----ELWVVM 98 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCC-----eEEEEE
Confidence 444567999999999999998889999999987554455667899999999999999999999875544 889999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++++|.+++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 99 e~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (292)
T cd06658 99 EFLEGGALTDIVTHT-------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168 (292)
T ss_pred eCCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhc
Confidence 999999999988543 578999999999999999999999 9999999999999999999999999998754
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
..... ......|++.|+|||+..+..++.++|||| +|+++++++++..|+...+.... .
T Consensus 169 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lGvil~el~~g~~p~~~~~~~~~---~ 227 (292)
T cd06658 169 SKEVP--------KRKSLVGTPYWMAPEVISRLPYGTEVDIWS----------LGIMVIEMIDGEPPYFNEPPLQA---M 227 (292)
T ss_pred ccccc--------cCceeecCccccCHHHHccCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCHHHH---H
Confidence 33211 112245899999999998888999999999 78889999998888653221110 0
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....... . .........+..+.+++.+||..||++|||++|+++.
T Consensus 228 ~~~~~~~--~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 228 RRIRDNL--P-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHhcC--C-CccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0000000 0 0000111245568889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=294.42 Aligned_cols=252 Identities=22% Similarity=0.272 Sum_probs=202.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|.+.+.||+|+||.||+|....++..||+|.+........+.+.+|+.++++++||||+++++++.... ..+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-----ELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-----cEE
Confidence 368999999999999999999998889999999987554455577899999999999999999999876544 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++.+. .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++
T Consensus 93 lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~ 162 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 162 (293)
T ss_pred EEEecCCCCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcce
Confidence 999999999999998753 478889999999999999999999 9999999999999999999999999988
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
........ ......|++.|+|||.+.+..++.++|+|| +|+.++++.++..|+......+..
T Consensus 163 ~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s----------lG~ll~~ll~g~~pf~~~~~~~~~ 224 (293)
T cd06647 163 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS----------LGIMAIEMVEGEPPYLNENPLRAL 224 (293)
T ss_pred eccccccc--------ccccccCChhhcCchhhccCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCChhhhe
Confidence 75543221 112245889999999998888999999999 888899999998887532211110
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ....... .........+..+.+++.+||..+|++||++++++.+
T Consensus 225 ~--~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 225 Y--LIATNGT----PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred e--ehhcCCC----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000000 0011122345678899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=289.03 Aligned_cols=247 Identities=28% Similarity=0.405 Sum_probs=193.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
++|++.+.||+|+||.||+|.. +++.||+|.++.. ...+.+.+|+.++++++||||+++++++... ..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~ 75 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYI 75 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEE
Confidence 5699999999999999999975 6778999998643 2346788999999999999999999987432 3689
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++|+|.+++...... .+++..++.++.|++.|+.|||+. |++||||||+||+++.++.+||+|||++.
T Consensus 76 v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~ 148 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRA----LVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR 148 (254)
T ss_pred EEECCCCCCHHHHHHhcCcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccce
Confidence 99999999999999765422 588999999999999999999999 99999999999999999999999999987
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPS 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~ 769 (833)
...... .....+..|+|||++.+..++.++|+|| +|+.++++++ +..|+.......
T Consensus 149 ~~~~~~-----------~~~~~~~~y~~pe~~~~~~~~~~~Dv~s----------lG~~l~el~~~g~~p~~~~~~~~-- 205 (254)
T cd05083 149 VGSMGV-----------DNSKLPVKWTAPEALKHKKFSSKSDVWS----------YGVLLWEVFSYGRAPYPKMSLKE-- 205 (254)
T ss_pred eccccC-----------CCCCCCceecCHHHhccCCcCchhhHHH----------HHHHHHHHHhCCCCCCccCCHHH--
Confidence 543211 0123467899999998888999999999 7778888776 666654222111
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
. .......... .....++..+.+++.+||+.+|++||+++++++.+++
T Consensus 206 ~-~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 206 V-KECVEKGYRM-----EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred H-HHHHhCCCCC-----CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1 1111111100 1122346778899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=301.81 Aligned_cols=255 Identities=24% Similarity=0.371 Sum_probs=200.8
Q ss_pred CCccCceeccCcceEEEEEEECC---CceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGE---DEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
+....+.||+|.||.|++|.|.. +...||||.++..... ..++|.+|+.+|.+|+|||++++||+..+. -
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------p 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------P 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------h
Confidence 34456899999999999999953 3456899999866444 568999999999999999999999997553 4
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
..||||.++.|+|.+.+.+.... .+.......++.|||.|+.||.++ +.|||||..+|+++...-.|||+|||
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~----~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG 257 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKA----ILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG 257 (1039)
T ss_pred hhHHhhhcccchHHHHHhhcccc----ceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence 78999999999999999873322 688889999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+.+.++...-...+. + ...-...|.|||.+....++.++|||++|+.+|+||+.|...|. |..+..+.+.+|
T Consensus 258 LmRaLg~ned~Yvm~-p----~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~---G~~g~qIL~~iD 329 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMA-P----QRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV---GCRGIQILKNID 329 (1039)
T ss_pred ceeccCCCCcceEec-C----CCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC---CCCHHHHHHhcc
Confidence 999876543221111 1 12245679999999999999999999988888888877654332 111111222233
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
... .-..++.|++.+.+++..||.++|++|||+..|.+.+
T Consensus 330 ~~e--------------rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGE--------------RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccc--------------cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 111 1233567899999999999999999999999998553
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=297.55 Aligned_cols=260 Identities=22% Similarity=0.249 Sum_probs=200.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|++|.||+|....+++.||+|.+...... ..+.+..|+++++.++||||+++++++.... .
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET-----Y 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC-----E
Confidence 3688999999999999999999988999999999754322 3457889999999999999999999865544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++++|.+++...... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 148 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGK----CLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFD 148 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCC----ccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecc
Confidence 99999999999999998764322 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccc---------------------cCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccC
Q 040925 688 LAKFLSDHQLDTAV---------------------KTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNE 746 (833)
Q Consensus 688 ~a~~~~~~~~~~~~---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~ 746 (833)
++............ ..........||..|+|||++.+..++.++|||| +
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s----------l 218 (316)
T cd05574 149 LSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT----------L 218 (316)
T ss_pred hhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHH----------H
Confidence 98765332110000 0001112356899999999999888999999999 8
Q ss_pred CccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC----HHHHHH
Q 040925 747 GHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD----MRDVVA 819 (833)
Q Consensus 747 g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~eil~ 819 (833)
|+++++++++..|+...+.. ............ .......+..+.+++.+||..||++||| ++|+++
T Consensus 219 G~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 219 GILLYEMLYGTTPFKGSNRD--ETFSNILKKEVT-----FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHHHHhhCCCCCCCCchH--HHHHHHhcCCcc-----CCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 88899999998887522211 111111111110 0111124678899999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=288.50 Aligned_cols=252 Identities=29% Similarity=0.470 Sum_probs=196.4
Q ss_pred CccCceeccCcceEEEEEEECCCc----eEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDE----MIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
+++.+.||.|+||.||+|++...+ ..||+|+++..... ..+.+..|++.+++++|+||+++++++...+ .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEE-----P 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-----e
Confidence 456789999999999999998766 89999999755433 4678999999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.+++|||+++++|.+++...... .+++.+++.++.|++.|++|||+. +++||||||+||+++.++.++|+|||
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg 148 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFG 148 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccC
Confidence 99999999999999999865421 289999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~ 766 (833)
.+........... ....+++.|+|||...+..++.++|||| .|++++++.+ +..|+.....
T Consensus 149 ~~~~~~~~~~~~~-------~~~~~~~~y~~Pe~~~~~~~~~~~Di~s----------lG~i~~~l~~~g~~p~~~~~~- 210 (258)
T smart00219 149 LSRDLYDDDYYKK-------KGGKLPIRWMAPESLKDGKFTSKSDVWS----------FGVLLWEIFTLGESPYPGMSN- 210 (258)
T ss_pred Cceeccccccccc-------ccCCCcccccChHHhccCCCCcchhHHH----------HHHHHHHHHhCCCCCCCCCCH-
Confidence 9987654321110 0123788999999998888999999999 6777777776 4455432110
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
............ ...+..++..+.+++.+||..||++|||+.|+++.|
T Consensus 211 -~~~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 211 -EEVLEYLKKGYR------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -HHHHHHHhcCCC------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111111111110 111222567789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=291.23 Aligned_cols=257 Identities=21% Similarity=0.279 Sum_probs=183.8
Q ss_pred ceeccCcceEEEEEEECC--CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 537 NMIGQGSFGYVYKGTLGE--DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
+.||+|+||.||+|+... ....+|+|.+..... .....+.+|+++++.++||||+++++++.... ..++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-----~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-----PYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-----ceEEEEE
Confidence 368999999999997532 345788988764322 23456889999999999999999999976544 7899999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
|+++|+|.+++....... ....++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred eCCCCcHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 999999999997654211 11356788899999999999999999 99999999999999999999999999987543
Q ss_pred cccccccccCCCccccccccccccCccccC-------CCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-------GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
...... ......+++.|+|||+.. ...++.++|||| +|++++++++ +..|+.....
T Consensus 152 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws----------lG~~l~el~~~~~~p~~~~~~ 215 (269)
T cd05042 152 PEDYYI------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS----------LGVTMWELFTAADQPYPDLSD 215 (269)
T ss_pred cchhee------ccCCCCCcccccCHHHHhhccccccccccchhhHHHH----------HHHHHHHHHhCCCCCCCcCCH
Confidence 321100 011234678899999864 345688999999 7777888777 5555432111
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
............. ..........+++.+.+++..|| .||++|||++||++.+.
T Consensus 216 --~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 216 --EQVLKQVVREQDI-KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred --HHHHHHHhhccCc-cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111111111000 00011112235567778889999 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=290.29 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=196.6
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc----------chhHHHHHHHHHhhcCCCccceEeeEeecCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG----------ASRSFVAECEALRNIRHRNLIKIITICSSTD 601 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 601 (833)
+|.+.+.||.|++|.||+|....+++.||+|.++..... ..+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 578889999999999999999888999999998642111 1245788999999999999999999875544
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcE
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 681 (833)
..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+
T Consensus 82 -----~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~ 147 (272)
T cd06629 82 -----YLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGIC 147 (272)
T ss_pred -----ceEEEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeE
Confidence 8899999999999999997653 688999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCCCC--CCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE--ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
+|+|||+++....... ........|+..|+|||++.... ++.++|+|| +|++++++.++..|
T Consensus 148 ~l~d~~~~~~~~~~~~------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~s----------lG~~l~~l~~g~~p 211 (272)
T cd06629 148 KISDFGISKKSDDIYD------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWS----------LGCVVLEMFAGRRP 211 (272)
T ss_pred EEeecccccccccccc------ccccccccCCccccCHHHhccccCCCCccchhHH----------HHHHHHHHHhCCCC
Confidence 9999999976433211 11112345899999999877654 789999999 78888888888877
Q ss_pred CcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+...+..... .+...... ..........+++..+.+++.+||..||++|||+++|++.
T Consensus 212 ~~~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 212 WSDEEAIAAM--FKLGNKRS-APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred CcCcchHHHH--HHhhcccc-CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 6422211100 00000000 0000111112356788999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=296.66 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=196.8
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
|.....||+|+||.||+|.+..+++.||+|.++.......+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-----~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGE-----ELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCC-----eEEEEE
Confidence 334458999999999999998889999999997655455667889999999999999999999875544 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++++|.+++... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 98 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~ 167 (297)
T cd06659 98 EFLQGGALTDIVSQT-------RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167 (297)
T ss_pred ecCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhc
Confidence 999999999987643 588999999999999999999999 9999999999999999999999999998754
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
..... ......|++.|+|||++.+..++.++|||| +|+++++++++..|+........ .
T Consensus 168 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~il~el~~g~~p~~~~~~~~~---~ 226 (297)
T cd06659 168 SKDVP--------KRKSLVGTPYWMAPEVISRTPYGTEVDIWS----------LGIMVIEMVDGEPPYFSDSPVQA---M 226 (297)
T ss_pred ccccc--------cccceecCccccCHHHHccCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCHHHH---H
Confidence 43211 112246899999999998888999999999 78888899998888653221110 0
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....... ..........+..+.+++.+||+.+|++||+++++++.
T Consensus 227 ~~~~~~~---~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 227 KRLRDSP---PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHhccC---CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 00001112235568899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=289.95 Aligned_cols=265 Identities=25% Similarity=0.374 Sum_probs=196.0
Q ss_pred CccCceeccCcceEEEEEEEC---CCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC-Cc
Q 040925 533 FSSSNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKG-TD 606 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-~~ 606 (833)
|++.+.||+|+||.||+|.+. .+++.||||+++... ....+.+.+|++++++++||||+++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 677889999999999999864 357899999986542 223457889999999999999999999876543111 12
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++++||+++|+|.+++...........+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3578999999999998875432211122578899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
|+++......... ......+++.|++||...+..++.++|||| +|++++++++ +..|+...+.
T Consensus 158 g~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~s----------lG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05074 158 GLSKKIYSGDYYR------QGCASKLPVKWLALESLADNVYTTHSDVWA----------FGVTMWEIMTRGQTPYAGVEN 221 (273)
T ss_pred cccccccCCccee------cCCCccCchhhcCHhHHhcCccchhhhhHH----------HHHHHHHHhhCCCCCCCCCCH
Confidence 9998654322110 011224567899999998888999999999 6777777776 4455432111
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
. .......... ......+++..+.+++.+||..+|++|||+.|+++.|+++
T Consensus 222 ~--~~~~~~~~~~------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 222 S--EIYNYLIKGN------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred H--HHHHHHHcCC------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 1100011000 0011123456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=291.37 Aligned_cols=255 Identities=24% Similarity=0.373 Sum_probs=200.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|+..+.||+|++|.||+|.+..+++.||+|.+..... ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNG-----DIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCC-----EEE
Confidence 468889999999999999999998999999999875432 34467889999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
+||||+++++|.+++.... ..+++..+..++.|++.|++|+|+ . +++|+||||+||+++.++.+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~ 147 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGV 147 (265)
T ss_pred EEEEecCCCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 9999999999999998653 168999999999999999999999 8 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+......... ...|+..|+|||++.+..++.++|||| +|++++++.++..|+........
T Consensus 148 ~~~~~~~~~~----------~~~~~~~y~~PE~~~~~~~~~~~Dv~s----------lG~~l~~l~~g~~p~~~~~~~~~ 207 (265)
T cd06605 148 SGQLVNSLAK----------TFVGTSSYMAPERIQGNDYSVKSDIWS----------LGLSLIELATGRFPYPPENDPPD 207 (265)
T ss_pred chhhHHHHhh----------cccCChhccCHHHHcCCCCCchhhHHH----------HHHHHHHHHhCCCCCCccccccc
Confidence 8765432111 145889999999999889999999999 78888888888887653211001
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. .+....... ..........++..+.+++.+||..||++|||+.|+++.
T Consensus 208 ~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 208 GI-FELLQYIVN-EPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cH-HHHHHHHhc-CCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00 011100000 000111111256778999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=294.32 Aligned_cols=256 Identities=21% Similarity=0.312 Sum_probs=190.2
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|++..+|+.||+|.++.... .....+.+|++++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-----KKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-----CceE
Confidence 58889999999999999999999999999999974422 2335678899999999999999999986544 4899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++ ++|.+++..... .+++..++.++.||++||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 76 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 146 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNG-----DIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLA 146 (284)
T ss_pred EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchh
Confidence 9999997 588888765332 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+....... ......+++.|+|||++.+. .++.++|||| +|+++++++++..|+........
T Consensus 147 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws----------lG~il~~l~tg~~p~~~~~~~~~ 208 (284)
T cd07839 147 RAFGIPVR--------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS----------AGCIFAELANAGRPLFPGNDVDD 208 (284)
T ss_pred hccCCCCC--------CcCCCccccCCcChHHHhCCcccCcHHHHHH----------HHHHHHHHHhcCCCCcCCCCHHH
Confidence 75533211 11123578999999987764 4789999999 67777777776666321110000
Q ss_pred cch-----------------hhhccccc----hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 769 SLL-----------------MEVMTNNS----MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 769 ~~~-----------------~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
... ........ .............++.+.+++.+||..||++|||++|+++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 209 QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00000000 0000000111234567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=248.58 Aligned_cols=195 Identities=24% Similarity=0.410 Sum_probs=166.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.+|...++||+|.||+||+|+.+++++.||+|+++... ++......+|+-+++.++|+|||+++++..++. ..
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdk-----kl 76 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL 76 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCc-----ee
Confidence 35777899999999999999999999999999998653 345678999999999999999999999865444 78
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
.+|+|||. .+|..+.....+ .++.+.++.++.|+++||.|+|++ ++.|||+||.|.+|+.+|+.|++|||+
T Consensus 77 tlvfe~cd-qdlkkyfdslng-----~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfgl 147 (292)
T KOG0662|consen 77 TLVFEFCD-QDLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGL 147 (292)
T ss_pred EEeHHHhh-HHHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccch
Confidence 99999996 499999887654 588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccCC
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNEG 747 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~g 747 (833)
|+.++-+... ....+-|.+|++|.++.+.+ |++..|+||.||.|.++-..|
T Consensus 148 arafgipvrc--------ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanag 199 (292)
T KOG0662|consen 148 ARAFGIPVRC--------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_pred hhhcCCceEe--------eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcC
Confidence 9977654311 11235799999999999876 899999999888887665444
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=295.22 Aligned_cols=263 Identities=22% Similarity=0.230 Sum_probs=199.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+++++.++||||+++++.+...+ .
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR-----H 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC-----E
Confidence 368999999999999999999999999999999875432 23456789999999999999999999875544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg 146 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFG 146 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCC
Confidence 999999999999999997654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCccccccc-------ccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 688 LAKFLSDHQLDTA-------VKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 688 ~a~~~~~~~~~~~-------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
+++.......... ...........|+..|+|||++.+..++.++|||| +|+++++++++..|+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~vl~el~~g~~pf 216 (305)
T cd05609 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWA----------MGIILYEFLVGCVPF 216 (305)
T ss_pred CccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHH----------HHHHHHHHHhCCCCC
Confidence 9874211100000 00001111245889999999998888999999999 788899999998886
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
..... .............. ......++..+.+++.+||+.||++||++.++.+.++.
T Consensus 217 ~~~~~--~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 217 FGDTP--EELFGQVISDDIEW----PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCH--HHHHHHHHhcccCC----CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 42111 11111111110000 00111346678999999999999999996555555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=293.48 Aligned_cols=258 Identities=22% Similarity=0.299 Sum_probs=195.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|++|.||+|.+..+++.||+|+++... ....+.+.+|++++++++|+||+++++++...+ ..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-----RL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECC-----EE
Confidence 46899999999999999999999899999999986432 233467899999999999999999999976544 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++++.+..+..... .+++.+++.++.|++.|++|||+. +++||||+|+||++++++.+||+|||+
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~ 146 (288)
T cd07833 76 YLVFEYVERTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGF 146 (288)
T ss_pred EEEEecCCCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeec
Confidence 99999999877766554432 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+........ .......++..|+|||++.+. .++.++|||| +|++++++.++..|+......+
T Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~s----------lG~~l~~l~~g~~~~~~~~~~~ 209 (288)
T cd07833 147 ARALRARPA-------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWA----------IGCIMAELLDGEPLFPGDSDID 209 (288)
T ss_pred ccccCCCcc-------ccccCcccccCCcCCchhcCCCCcCchhhHHH----------HHHHHHHHHhCCCCCCCCCHHH
Confidence 986654321 011234688999999998887 7899999999 6777777777766554211110
Q ss_pred cc-----------------------chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 PS-----------------------LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 ~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.. ...................+..++..+.+++.+||..+|++|||++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 210 QLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00000000000000001112224678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=293.23 Aligned_cols=245 Identities=23% Similarity=0.244 Sum_probs=198.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|++|.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++.... .
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS-----N 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC-----e
Confidence 36899999999999999999999899999999986432 223467889999999999999999999975544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg 146 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFG 146 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCC
Confidence 999999999999999997654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++...... .....|++.|+|||.+.+..++.++|||| +|+++++++++..|+...+.
T Consensus 147 ~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~-- 203 (290)
T cd05580 147 FAKRVKGR-----------TYTLCGTPEYLAPEIILSKGYGKAVDWWA----------LGILIYEMLAGYPPFFDDNP-- 203 (290)
T ss_pred CccccCCC-----------CCCCCCCccccChhhhcCCCCCccccHHH----------HHHHHHHHHhCCCCCCCCCH--
Confidence 99865432 11245899999999998888899999999 88899999999888653221
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVA 819 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 819 (833)
............ ..+...+..+.+++.+||..||++|| +++|+++
T Consensus 204 ~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 204 IQIYEKILEGKV-------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHHHHHHhcCCc-------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111111111111 11222356788999999999999999 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=317.39 Aligned_cols=268 Identities=21% Similarity=0.266 Sum_probs=189.2
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCC---
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDF--- 602 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--- 602 (833)
.....+|+..+.||+||||.||+|+++-+|+.||||++.... ......+.+|+..+++++|||||++|..+.+...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 456678999999999999999999999999999999997553 2334678999999999999999999876532110
Q ss_pred --------------------------------------------------------------------------------
Q 040925 603 -------------------------------------------------------------------------------- 602 (833)
Q Consensus 603 -------------------------------------------------------------------------------- 602 (833)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred --CC---------------------C--------ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHH
Q 040925 603 --KG---------------------T--------DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651 (833)
Q Consensus 603 --~~---------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~g 651 (833)
++ + ...||=||||+.-++++++.+.... -.....++++++|++|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEG 709 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHH
Confidence 00 0 2467889999998888888765421 1467889999999999
Q ss_pred HHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC----------cccccccccCCCccccccccccccCccc
Q 040925 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS----------DHQLDTAVKTPSSSIGLKGTVGYVAPEY 721 (833)
Q Consensus 652 L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~----------~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 721 (833)
|+|+|++ |||||||||.||+++++..|||+|||+|+... ..............++.+||.-|+|||+
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999999 99999999999999999999999999998721 0000011111113356789999999999
Q ss_pred cCCCC---CCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHH
Q 040925 722 GMGSE---ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIR 798 (833)
Q Consensus 722 ~~~~~---~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 798 (833)
+.+.. |+.|+|+|| .|++++|+... ++..+..+ ......-.... +.. .....+..+.-..
T Consensus 787 l~~~~~~~Yn~KiDmYS----------LGIVlFEM~yP-F~TsMERa---~iL~~LR~g~i--P~~-~~f~~~~~~~e~s 849 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYS----------LGIVLFEMLYP-FGTSMERA---SILTNLRKGSI--PEP-ADFFDPEHPEEAS 849 (1351)
T ss_pred hcccccccccchhhhHH----------HHHHHHHHhcc-CCchHHHH---HHHHhcccCCC--CCC-cccccccchHHHH
Confidence 87655 999999999 55555555443 22111110 00000000000 000 0001112233467
Q ss_pred HhhccCCCCCCCCCCHHHHHH
Q 040925 799 TGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 799 li~~cl~~dP~~RPt~~eil~ 819 (833)
+|.+++++||++||||.|++.
T Consensus 850 lI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 850 LIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHhcCCCccCCCHHHHhh
Confidence 899999999999999999986
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=287.38 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=204.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|++|.||+|++..+++.||+|++..... ...+.+.+|++.+++++||||+++++++.... ..+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEG-----EIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCC-----eEE
Confidence 368899999999999999999998999999999875543 34578999999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
+||||+++++|.+++.... .+++..++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.
T Consensus 76 lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~ 146 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVG------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGI 146 (264)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCcc
Confidence 9999999999999998653 68999999999999999999999 8 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc-
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD- 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~- 767 (833)
+......... .....++..|+|||.+.+..++.++|+|| +|+++++++++..|+......+
T Consensus 147 ~~~~~~~~~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s----------lG~il~~l~tg~~p~~~~~~~~~ 208 (264)
T cd06623 147 SKVLENTLDQ--------CNTFVGTVTYMSPERIQGESYSYAADIWS----------LGLTLLECALGKFPFLPPGQPSF 208 (264)
T ss_pred ceecccCCCc--------ccceeecccccCHhhhCCCCCCchhhHHH----------HHHHHHHHHhCCCCCccccccCH
Confidence 9866442211 11245889999999998888999999999 8888999999888875332101
Q ss_pred ccchhhhccccchhhhhhhhchHH-HHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEE-CLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
........... ....... ++..+.+++.+||..+|++|||+.|+++.
T Consensus 209 ~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 209 FELMQAICDGP------PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHHHHHhcCC------CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111111100 0111222 56788999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=287.25 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=197.9
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-----cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-----GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
+|+..+.||+|++|.||+|....+++.||+|.+..... ...+.+.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----- 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREED----- 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCC-----
Confidence 47888999999999999999988899999999865431 23467899999999999999999999875544
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+|+||+|+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~ 146 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADF 146 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccC
Confidence 8899999999999999997653 588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|.+....... ......|++.|+|||.+.... ++.++|+|| +|+.+++++++..|+.....
T Consensus 147 ~~~~~~~~~~---------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~s----------lG~~l~~l~~g~~pf~~~~~ 207 (258)
T cd06632 147 GMAKQVVEFS---------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWS----------LGCTVLEMATGKPPWSQLEG 207 (258)
T ss_pred ccceeccccc---------cccccCCCcceeCHHHhcCCCCCCchhhhHH----------HHHHHHHHHhCCCCcccCcH
Confidence 9987654322 112345899999999887766 899999999 78888999998888653221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.+... ...... .....+..+...+.+++.+||..+|++|||++++++
T Consensus 208 ~~~~~--~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 208 VAAVF--KIGRSK-----ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHHH--HHHhcc-----cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11111 000000 001112234567889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=295.24 Aligned_cols=257 Identities=22% Similarity=0.317 Sum_probs=193.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ...+.+.+|+++++.++||||+++++++... ...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-----KRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-----CeE
Confidence 468999999999999999999988899999999864322 2345688999999999999999999996544 489
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++++++.++..... .+++.+++.++.|++.||+|||+. +++||||+|+||++++++.+||+|||+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~ 146 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGF 146 (286)
T ss_pred EEEEecCCccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeee
Confidence 99999999999988776543 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+........ ......++..|+|||+..+ ..++.++|||| +|+.+++++++..++......+
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lG~~l~el~~g~~~~~~~~~~~ 208 (286)
T cd07846 147 ARTLAAPGE--------VYTDYVATRWYRAPELLVGDTKYGRAVDIWA----------VGCLVTEMLTGEPLFPGDSDID 208 (286)
T ss_pred eeeccCCcc--------ccCcccceeeccCcHHhccccccCchHhHHH----------HHHHHHHHHcCCCCCCCCchHH
Confidence 876543221 1122458899999998765 44788999999 6777777777765543111100
Q ss_pred c---------------------cchhhhcccc-chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 P---------------------SLLMEVMTNN-SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 ~---------------------~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
. ......+... ...........+.++..+.+++.+||..+|++|||+.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 209 QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 0000000000 00000000112234677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=291.03 Aligned_cols=255 Identities=21% Similarity=0.299 Sum_probs=192.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHH-HhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEA-LRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||.||+|++..+|+.||+|+++.... .....+..|+.+ ++..+||||+++++++...+ ..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-----~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-----DV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-----cE
Confidence 478999999999999999999999999999999875432 223455666665 55568999999999976544 78
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++ |+|.+++...... ...+++..++.++.|++.||+|||+++ +++||||||+||+++.++.+||+|||.
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~ 150 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI 150 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999997 6898887653221 126899999999999999999999853 899999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC----CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG----SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
+........ .....|+..|+|||++.+ ..++.++|+|| +|+++++++++..|+....
T Consensus 151 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~p~~~~~ 211 (283)
T cd06617 151 SGYLVDSVA---------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWS----------LGITMIELATGRFPYDSWK 211 (283)
T ss_pred ccccccccc---------cccccCCccccChhhcCCcccccccCccccchh----------hHHHHHHHHhCCCCCCccc
Confidence 986543211 112358899999998765 44688999999 7888999999988865211
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..-... ....... ........++..+.+++.+||..+|++|||++++++.
T Consensus 212 ~~~~~~-~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 212 TPFQQL-KQVVEEP-----SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred cCHHHH-HHHHhcC-----CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100000 0111100 0111112356778999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=289.10 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=199.8
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-----EENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-----CCeE
Confidence 58899999999999999999998899999999974422 345688999999999999999999988544 3489
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~ 146 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeeccc
Confidence 99999999999999997653 688999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+....... ......|+..|+|||++.+..++.++|+|| .|+++++++++..|+........
T Consensus 147 ~~~~~~~~---------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~p~~~~~~~~~ 207 (258)
T cd05578 147 ATKVTPDT---------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWS----------LGVTAYECLRGKRPYRGHSRTIR 207 (258)
T ss_pred ccccCCCc---------cccccCCChhhcCHHHHcccCCCCcccchh----------hHHHHHHHHhCCCCCCCCCccHH
Confidence 87654322 111245889999999998888999999999 88889999999888763321111
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH--HHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM--RDVV 818 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~eil 818 (833)
......... .....+...+..+.+++.+||..||++||++ +|++
T Consensus 208 ~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 208 DQIRAKQET------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred HHHHHHhcc------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 111111110 1112233456788999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=298.77 Aligned_cols=265 Identities=22% Similarity=0.268 Sum_probs=199.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|++|.||+|++..+++.||+|+++... ......+.+|+.++++++||||+++++++....+......
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999899999999986432 2334568889999999999999999998876665555678
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++ +++.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred EEEehhcc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 99999997 4888887643 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+.......... .......||+.|+|||++.+ ..++.++|||| .|++++++++|..|+...+...
T Consensus 153 ~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws----------lGvil~el~~G~~~f~~~~~~~ 217 (336)
T cd07849 153 ARIADPEHDHT-----GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWS----------VGCILAEMLSNRPLFPGKDYLH 217 (336)
T ss_pred eeecccccccc-----CCcCCcCcCCCccChHHhhCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCHHH
Confidence 97654322111 11223568999999998654 56889999999 7778888888877664221100
Q ss_pred -------------ccchhhhccc-------cchhhhh--hhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 -------------PSLLMEVMTN-------NSMIQED--KRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 -------------~~~~~~~~~~-------~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+......... ....... .....+..+..+.+++.+||+.||++|||+.|+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 218 QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 0000000 000012235678899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=298.13 Aligned_cols=270 Identities=24% Similarity=0.334 Sum_probs=203.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTD-FKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~ 608 (833)
..|...+.||+|+||.||+++++.+|+.||||.++... ....+..-+|+++|++++|||||+++++-.... .--....
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 34666789999999999999999999999999997543 345677889999999999999999998732221 0113457
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee--cCCC--cEEEc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL--DHDM--VAHVC 684 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kL~ 684 (833)
.+|||||+||||+.++.+-.. .+.+++.+.+.++.+++.||.|||+. |||||||||.||++ +.+| ..||+
T Consensus 93 vlvmEyC~gGsL~~~L~~PEN---~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLt 166 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPEN---AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLT 166 (732)
T ss_pred eEEEeecCCCcHHHHhcCccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeee
Confidence 899999999999999987543 34799999999999999999999999 99999999999998 3445 58999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
|||.|+..++.. ...+++||+.|.+||.+.. +.|+..+|.|| +|+++|+.++|.+|+...
T Consensus 167 DfG~Arel~d~s---------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS----------~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 167 DFGAARELDDNS---------LFTSLVGTEEYLHPELYERQKKYTATVDLWS----------FGVTLYECATGELPFIPF 227 (732)
T ss_pred cccccccCCCCC---------eeeeecCchhhcChHHHhhccCcCceeehhh----------hhhHHHHHhccCCCCCcC
Confidence 999999877643 3446789999999999884 88999999999 888999999999987632
Q ss_pred cccc--ccchhhhccccc-------------------hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC--CHHHHHHH
Q 040925 764 EIVD--PSLLMEVMTNNS-------------------MIQEDKRVKTEECLNAIIRTGVLCSMESPFERM--DMRDVVAK 820 (833)
Q Consensus 764 ~~~~--~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~eil~~ 820 (833)
.... .........+.. ..+. ...........+...+..++..+|++|. ...+....
T Consensus 228 ~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~ 306 (732)
T KOG4250|consen 228 GGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAE 306 (732)
T ss_pred CCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHH
Confidence 2211 011111111000 0000 0111122334455667778999999999 77777776
Q ss_pred HHHhhh
Q 040925 821 LCHTRE 826 (833)
Q Consensus 821 L~~i~~ 826 (833)
+..|..
T Consensus 307 ~~dIL~ 312 (732)
T KOG4250|consen 307 VDDILN 312 (732)
T ss_pred HHHHHh
Confidence 666643
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.92 Aligned_cols=257 Identities=22% Similarity=0.292 Sum_probs=190.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|++|.||+|+...+++.||+|.++.... .....+.+|++++++++||||+++++++...+ ..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKK-----TLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCC-----eEE
Confidence 579999999999999999999988899999999875432 22345778999999999999999999976544 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++ ++|.+++..... .+++..++.++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 80 lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 150 (291)
T cd07844 80 LVFEYLD-TDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLA 150 (291)
T ss_pred EEEecCC-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccc
Confidence 9999997 499998876532 578999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+....... ......++..|+|||++.+ ..++.++|||| .|+++++++++..|+........
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~~~~~~~~~~~ 212 (291)
T cd07844 151 RAKSVPSK--------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWG----------VGCIFYEMATGRPLFPGSTDVED 212 (291)
T ss_pred cccCCCCc--------cccccccccccCCcHHhhcCcccCcHHHHHH----------HHHHHHHHHhCCCCCCCCccHHH
Confidence 75432111 0111246889999998765 45889999999 67777777777766532110000
Q ss_pred --------------cchhhhcc--------ccchhhhhhhhchHHH--HHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 769 --------------SLLMEVMT--------NNSMIQEDKRVKTEEC--LNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 769 --------------~~~~~~~~--------~~~~~~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
........ ................ ...+.+++.+|++.||++|||+.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 213 QLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 0000000000000011 256789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=285.73 Aligned_cols=261 Identities=24% Similarity=0.320 Sum_probs=202.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||.|++|+||+|....++..||+|++.... ....+.+.+|+++++.++|+||+++++.+.... ..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGD-----ELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCC-----EEE
Confidence 47999999999999999999998889999999986432 224577899999999999999999999875544 889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++...... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||++
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~ 149 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPR---GGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVS 149 (267)
T ss_pred EEEeccCCCcHHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchH
Confidence 999999999999999764320 1589999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
.......... ........|+..|+|||++... .++.++|+|| +|+.+++++++..|+......
T Consensus 150 ~~~~~~~~~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~s----------lG~i~~~l~~g~~p~~~~~~~-- 213 (267)
T cd06610 150 ASLADGGDRT----RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWS----------FGITAIELATGAAPYSKYPPM-- 213 (267)
T ss_pred HHhccCcccc----ccccccccCChhhcChHHHccccCcCcccchHh----------HhHHHHHHHhCCCCccccChh--
Confidence 7665432211 0112234689999999998776 7899999999 888889999998887532211
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
............. .........++..+.+++.+||..||++|||++|+++
T Consensus 214 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 214 KVLMLTLQNDPPS-LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred hhHHHHhcCCCCC-cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111111110000 0000111245678899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.00 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=191.9
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-----chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-----ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
+|++.+.||+|++|.||+|.+..+++.||+|.++..... ....+..|++++++++|+||+++++++....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----- 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS----- 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC-----
Confidence 478889999999999999999888999999999754322 2345778999999999999999999976543
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+ +|+|.+++..... .+++..++.++.|+++||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~df 146 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSI-----VLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADF 146 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccc
Confidence 899999999 8899999976431 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|+++....... ......+++.|+|||.+.+ ..++.++|||| +|++++++.++..++.....
T Consensus 147 g~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 147 GLARSFGSPNR--------KMTHQVVTRWYRAPELLFGARHYGVGVDMWS----------VGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred eeeeeccCCCc--------cccccccceeeeCHHHHhCCCCCCcHHHHHH----------HHHHHHHHHcCCccccCCcc
Confidence 99986644221 1112347889999998754 45789999999 66667777666433321110
Q ss_pred cc-------------ccc------hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VD-------------PSL------LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~-------------~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+ ... ......................+..+.+++.+||+.||++|||+.|+++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 209 IDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 000 00000000000000011122345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.47 Aligned_cols=201 Identities=24% Similarity=0.328 Sum_probs=157.8
Q ss_pred ceeccCcceEEEEEEECC--CceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEe
Q 040925 537 NMIGQGSFGYVYKGTLGE--DEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEY 614 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 614 (833)
.+||+|+||.||+|+... ++..||+|.++.. .....+.+|++++++++||||+++++++.... ....++||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSHS---DRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccC---CCeEEEEEee
Confidence 589999999999999753 5678999998633 23356789999999999999999999875432 3478999999
Q ss_pred cCCCChhhhhccCCCc---cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee----cCCCcEEEcccc
Q 040925 615 MENGSLKDWLHQSDDQ---VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCDFG 687 (833)
Q Consensus 615 ~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DfG 687 (833)
++ ++|.+++...... .....+++..++.++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 97 4888887543211 1122588999999999999999999999 99999999999999 566799999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
+++........ ........||+.|+|||++.+ ..++.++|||| .|+++++++++..|+.
T Consensus 158 ~a~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS----------lG~il~el~tg~~~f~ 217 (317)
T cd07867 158 FARLFNSPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWA----------IGCIFAELLTSEPIFH 217 (317)
T ss_pred ceeccCCCccc-----ccccCcceecccccCcHHhcCCCccCcHHHHHh----------HHHHHHHHHhCCCCcc
Confidence 99876443211 111223568999999999876 45889999999 7777888888777654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=285.01 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=199.7
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|....+++.||+|.++..... ..+.+.+|+.++++++|+||+++++++...+ ..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHRE-----KVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCC-----EEE
Confidence 588899999999999999999888999999999755443 5578999999999999999999999865443 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+|+||+++++|.+++.... .+++..++.++.|++.|++|||+. +|+|+||+|+||+++.++.+||+|||.+
T Consensus 76 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~ 146 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCA 146 (264)
T ss_pred EEEecCCCCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccc
Confidence 9999999999999998653 578899999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCC---CCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE---ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
........... .......+++.|+|||++.+.. ++.++|||| +|++++++.++..|+...+
T Consensus 147 ~~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s----------~G~il~~l~~g~~pf~~~~-- 210 (264)
T cd06626 147 VKLKNNTTTMG----EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWS----------LGCVVLEMATGKRPWSELD-- 210 (264)
T ss_pred cccCCCCCccc----ccccCCcCCcCccChhhccCCCCCCCCcccchHH----------HHHHHHHHHhCCCCccCCc--
Confidence 87654322110 0012345889999999987766 889999999 7888889999888865221
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
............ .....+....+...+.+++.+||+.+|++|||++|++.
T Consensus 211 -~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 211 -NEFQIMFHVGAG--HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -chHHHHHHHhcC--CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111000000000 00001111223567789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=288.86 Aligned_cols=249 Identities=22% Similarity=0.368 Sum_probs=197.5
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcC---CCccceEeeEeecCCCCCCce
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIR---HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 607 (833)
.|++.+.||+|+||.||+|.+..+++.||+|.++... ......+.+|+.++++++ |||++++++++.... .
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~-----~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP-----R 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC-----E
Confidence 4788899999999999999998899999999987542 234467889999999996 999999999875543 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++++|.+++... .+++..++.++.|++.||.|||+. +|+||||+|+||+++.++.++|+|||
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 89999999999999998653 588999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
.+........ ......|+..|+|||++.+ ..++.++|+|| +|+++++++++..|+...+..
T Consensus 147 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lG~~l~~ll~g~~p~~~~~~~ 208 (277)
T cd06917 147 VAALLNQNSS--------KRSTFVGTPYWMAPEVITEGKYYDTKADIWS----------LGITIYEMATGNPPYSDVDAF 208 (277)
T ss_pred ceeecCCCcc--------ccccccCCcceeCHHHhccCCccccchhHHH----------HHHHHHHHHhCCCCCCCCChh
Confidence 9986654321 1122458999999998765 44688999999 888899999998887532211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.... ...... ........++..+.+++.+||..||++||++.|+++.
T Consensus 209 ~~~~---~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 209 RAMM---LIPKSK----PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred hhhh---ccccCC----CCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1110 000100 0011111246678999999999999999999999774
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=290.36 Aligned_cols=259 Identities=24% Similarity=0.285 Sum_probs=190.9
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++++|.+.+.||+|+||.||+|....+++.||+|+++.... .....+.+|+.+++.++|+||+++++++.... .
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~-----~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKE-----T 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC-----e
Confidence 35689999999999999999999988899999999965432 22346788999999999999999999976543 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||++ +++.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg 148 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFG 148 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccc
Confidence 899999996 688777654321 578888999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
+++....... ......+++.|+|||++.+. .++.++|||| +|+++++++++..|+......
T Consensus 149 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lG~~l~~l~~g~~~f~~~~~~ 210 (291)
T cd07870 149 LARAKSIPSQ--------TYSSEVVTLWYRPPDVLLGATDYSSALDIWG----------AGCIFIEMLQGQPAFPGVSDV 210 (291)
T ss_pred cccccCCCCC--------CCCCccccccccCCceeecCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCchhH
Confidence 9875433211 11123578999999988654 4788999999 777788888887776421100
Q ss_pred ccc------------------------chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 767 DPS------------------------LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 767 ~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
... ....................-.....+.+++.+|+..||++|||++|++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 211 FEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 00000000000000000000011456789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=285.79 Aligned_cols=256 Identities=23% Similarity=0.310 Sum_probs=180.8
Q ss_pred ceeccCcceEEEEEEECCC--ceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 537 NMIGQGSFGYVYKGTLGED--EMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
+.||+|+||.||+|..... ...+++|.++... ....+.+.+|+.+++.++||||+++++++.... ..++|||
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-----~~~lv~e 75 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-----PYLLVFE 75 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-----ccEEEEe
Confidence 3699999999999975422 3456677765432 234568999999999999999999999976544 7899999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
|+++|+|.+++...... ....++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 76 YCELGDLKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred cCCCCcHHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence 99999999999764321 11467778889999999999999999 99999999999999999999999999986432
Q ss_pred cccccccccCCCccccccccccccCccccCC-------CCCCcccccccCCcCCCccccCCccHHHHHHH-hCCCccccc
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-------SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKT-ALPEKVMEI 765 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~-~~p~~~~~~ 765 (833)
.... ........|+..|+|||++.. ..++.++|||| +|+++++++++ ..|+....
T Consensus 151 ~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws----------lG~~l~el~~~~~~p~~~~~- 213 (268)
T cd05086 151 KEDY------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA----------LGVTLWELFENAAQPYSHLS- 213 (268)
T ss_pred cchh------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHH----------HHHHHHHHHhCCCCCCCCCC-
Confidence 2111 011123458899999998743 34578899999 67777777654 33432111
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
+............... ........+.+.+.+++..|| .+|++|||++||++.|.
T Consensus 214 -~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 214 -DREVLNHVIKDQQVKL-FKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -HHHHHHHHHhhccccc-CCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1111111111100000 000111124556788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=287.62 Aligned_cols=248 Identities=25% Similarity=0.353 Sum_probs=197.7
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
-|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.... ..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCC-----eEEE
Confidence 3778899999999999999998889999999986432 223467889999999999999999999976554 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 80 v~e~~~~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~ 149 (277)
T cd06641 80 IMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAG 149 (277)
T ss_pred EEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccce
Confidence 99999999999998643 588999999999999999999999 99999999999999999999999999987
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
........ .....|+..|+|||.+.+..++.++|+|| +|++++++.++..|+.... +..
T Consensus 150 ~~~~~~~~--------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s----------lG~~l~~l~~g~~p~~~~~---~~~ 208 (277)
T cd06641 150 QLTDTQIK--------RNTFVGTPFWMAPEVIKQSAYDSKADIWS----------LGITAIELAKGEPPHSELH---PMK 208 (277)
T ss_pred ecccchhh--------hccccCCccccChhhhccCCCCchhhHHH----------HHHHHHHHHcCCCCCCccc---hHH
Confidence 65432211 11245889999999998888899999999 7788888888888765221 111
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......... .......++..+.+++.+||..+|++||++.++++.
T Consensus 209 ~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 209 VLFLIPKNN-----PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHhcCC-----CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 111110000 011122346678899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=289.04 Aligned_cols=258 Identities=21% Similarity=0.259 Sum_probs=193.4
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-----~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGS-----GFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCC-----eeE
Confidence 5889999999999999999998899999999997543 233467899999999999999999999976544 889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+ +++|.+++..... .+++.+++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||.+
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~ 146 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEER-----PLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLA 146 (286)
T ss_pred EEeccc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeec
Confidence 999999 9999999875432 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc-
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD- 767 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~- 767 (833)
........ .......|+..|+|||++.+. .++.++|||| .|+++++++++..++.......
T Consensus 147 ~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~~l~~l~tg~~~~~~~~~~~~ 209 (286)
T cd07832 147 RLFSEEEP-------RLYSHQVATRWYRAPELLYGARKYDPGVDLWA----------VGCIFAELLNGSPLFPGENDIEQ 209 (286)
T ss_pred ccccCCCC-------CccccccCcccccCceeeeccccCCchhHHHH----------HHHHHHHHHcCCcCcCCCCHHHH
Confidence 86644321 011124589999999987654 4689999999 6666667766644332110000
Q ss_pred ------------ccchh------hhccccchhhh--hhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 ------------PSLLM------EVMTNNSMIQE--DKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ------------~~~~~------~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+.... ........... ......++....+.+++.+|+..||++|||++++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 210 LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000000000 0001112345788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=291.37 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=195.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
..|++.+.||+|++|.||+|+...+++.||+|.+..... ...+.+.+|+++++.++||||+++++++...+ .
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-----~ 89 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-----T 89 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-----e
Confidence 458899999999999999999988899999999864322 22356889999999999999999999986654 7
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||++ |++.+++..... .+++..+..++.|++.||.|||+. +|+||||+|+||++++++.+||+|||
T Consensus 90 ~~lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg 160 (307)
T cd06607 90 AWLVMEYCL-GSASDILEVHKK-----PLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFG 160 (307)
T ss_pred EEEEHHhhC-CCHHHHHHHccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecC
Confidence 899999997 588777764332 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
++....... ...|++.|+|||++. ...++.++|||| +|++++++.++..|+...+
T Consensus 161 ~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s----------~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 161 SASLVSPAN------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWS----------LGITCIELAERKPPLFNMN 218 (307)
T ss_pred cceecCCCC------------CccCCccccCceeeeccCCCCCCcccchHH----------HHHHHHHHHcCCCCCCCcc
Confidence 987543221 235888999999874 456888999999 8888899999888764322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..... ...... .........++..+.+++.+||..||++||++.+++..
T Consensus 219 ~~~~~--~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 219 AMSAL--YHIAQN-----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHHHH--HHHhcC-----CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 11110 000000 00111123456778999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.60 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=189.2
Q ss_pred cCCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccCCcch-----------hHHHHHHHHHhhcCCCccceEeeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKYKGAS-----------RSFVAECEALRNIRHRNLIKIITI 596 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~~~~~ 596 (833)
++|.+.+.||+|+||.||+|.+..+ +..+|+|+......... .....+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999999876 66777776543322111 112233344556789999999987
Q ss_pred eecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 597 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
+.... ......+++||++. .++.+.+.... ..++..+..++.|++.||+|||+. +|+||||||+||+++
T Consensus 92 ~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 92 GSFKR-CRMYYRFILLEKLV-ENTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred eeEec-CCceEEEEEEehhc-cCHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 65432 11224578888875 47777766532 357888999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHH
Q 040925 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
.++.+||+|||+|+........... .........||+.|+|||+..+..++.++|||| +|+++++++++
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~-~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwS----------lG~~l~el~~g 229 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEY-SKEQKDLHRGTLYYAGLDAHNGACVTRRGDLES----------LGYCMLKWAGI 229 (294)
T ss_pred CCCcEEEEEcCCceeeccCCccccc-ccccccccCCCccccCHHHhCCCCCCcHHHHHH----------HHHHHHHHHhC
Confidence 9999999999999876432211100 011112346999999999999999999999999 88899999999
Q ss_pred hCCCcccccccccc---hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 757 ALPEKVMEIVDPSL---LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 757 ~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
..|+.......... ..+..... .........+++.+.+++..||..+|++||+++++.+.+
T Consensus 230 ~~P~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 230 KLPWKGFGHNGNLIHAAKCDFIKRL----HEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCCccccchHHHHHhHHHHHHHh----hhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99986332111000 00010000 001112234567889999999999999999999999875
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=287.45 Aligned_cols=243 Identities=22% Similarity=0.249 Sum_probs=185.8
Q ss_pred eeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhh---cCCCccceEeeEeecCCCCCCceEeEE
Q 040925 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRN---IRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 538 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
.||+|+||.||+|.+..+++.||+|.++..... ....+.+|..+++. .+||+|+.+++++...+ ..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPD-----KLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCC-----eEEEE
Confidence 489999999999999989999999998643221 12234445444433 36999999999875544 78999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 76 ~e~~~~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~ 146 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (279)
T ss_pred EecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCccee
Confidence 99999999999987654 689999999999999999999999 999999999999999999999999999875
Q ss_pred cCcccccccccCCCccccccccccccCccccC-CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 692 LSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
..... .....||+.|+|||... +..++.++|||| .|+++++++++..|+......+...
T Consensus 147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~pf~~~~~~~~~~ 206 (279)
T cd05633 147 FSKKK----------PHASVGTHGYMAPEVLQKGTAYDSSADWFS----------LGCMLFKLLRGHSPFRQHKTKDKHE 206 (279)
T ss_pred ccccC----------ccCcCCCcCccCHHHhcCCCCCCchhhhHH----------HHHHHHHHHhCCCCcCCCCCcCHHH
Confidence 43221 11235899999999876 456899999999 7888999999998875332211111
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
....... .....++.++..+.+++.+||..||++|| |++|++++
T Consensus 207 ~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 207 IDRMTLT------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred HHHHhhc------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1110000 01112234567888999999999999999 59988775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=288.00 Aligned_cols=250 Identities=22% Similarity=0.269 Sum_probs=197.0
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
.|...+.||+|++|.||+|....+++.||+|+++.......+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~-----~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGD-----ELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCC-----eEEEE
Confidence 3555679999999999999998889999999987554445567889999999999999999999876544 88999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
+||+++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||.+..
T Consensus 95 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~ 164 (285)
T cd06648 95 MEFLEGGALTDIVTHT-------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ 164 (285)
T ss_pred EeccCCCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchh
Confidence 9999999999998762 588999999999999999999999 999999999999999999999999998875
Q ss_pred cCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccch
Q 040925 692 LSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771 (833)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~ 771 (833)
...... ......|++.|+|||+..+..++.++|||| +|+++++++++..|+...+.. ..
T Consensus 165 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lGv~l~ell~g~~p~~~~~~~---~~ 223 (285)
T cd06648 165 VSKEVP--------RRKSLVGTPYWMAPEVISRLPYGTEVDIWS----------LGIMVIEMVDGEPPYFNEPPL---QA 223 (285)
T ss_pred hccCCc--------ccccccCCccccCHHHhcCCCCCCcccHHH----------HHHHHHHHHhCCCCCcCCCHH---HH
Confidence 433211 111245899999999998888999999999 788888888888776422110 00
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
........ +........++..+.+++.+||..+|++|||+.++++.
T Consensus 224 ~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 224 MKRIRDNL---PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred HHHHHhcC---CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 00000000 00000111245678999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=286.45 Aligned_cols=255 Identities=22% Similarity=0.345 Sum_probs=196.5
Q ss_pred CCccCceeccCcceEEEEEEECC-CceEEEEEEeeccC----------CcchhHHHHHHHHHhh-cCCCccceEeeEeec
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGE-DEMIVAVKVINLKY----------KGASRSFVAECEALRN-IRHRNLIKIITICSS 599 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 599 (833)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .....++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 67899999885321 1123457778888865 799999999999765
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeCCCCCCeeecCC
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~ 678 (833)
.+ ..++||||+++++|.+++...... ...+++..++.++.|++.||.|||+ . +++|+||||+||+++.+
T Consensus 81 ~~-----~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~ 150 (269)
T cd08528 81 ND-----RLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGED 150 (269)
T ss_pred CC-----eEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCC
Confidence 44 899999999999999988542211 1268899999999999999999996 5 89999999999999999
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhC
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTAL 758 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~ 758 (833)
+.+||+|||.+....... ......|+..|+|||++.+..++.++|+|| +|+.+++++++..
T Consensus 151 ~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~s----------lG~ll~~l~~g~~ 211 (269)
T cd08528 151 DKVTITDFGLAKQKQPES---------KLTSVVGTILYSCPEIVKNEPYGEKADVWA----------FGCILYQMCTLQP 211 (269)
T ss_pred CcEEEecccceeeccccc---------ccccccCcccCcChhhhcCCCCchHHHHHH----------HHHHHHHHHhCCC
Confidence 999999999998654422 112345899999999999888999999999 7888889888887
Q ss_pred CCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 759 PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 759 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
|+...+... ........... ......++..+.+++.+||+.||++||++.|+.++++
T Consensus 212 p~~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 212 PFYSTNMLS--LATKIVEAVYE-----PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cccccCHHH--HHHHHhhccCC-----cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 765322111 11111111000 0011124567889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=286.14 Aligned_cols=246 Identities=22% Similarity=0.313 Sum_probs=192.7
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
.+.||+|.||+||-|+++.+|+.||||++.+. .......+++|+.||+++.||.||.+...|... +.+++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-----ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-----ERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-----ceEEEEeh
Confidence 37899999999999999999999999999643 223457899999999999999999999885544 49999999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC---CcEEEccccccc
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHVCDFGLAK 690 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfG~a~ 690 (833)
-+. |+..++|-....+ ++++.....++.||+.||.|||.+ +|+|+||||+|||+... .++||||||+|+
T Consensus 644 Kl~-GDMLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR 715 (888)
T KOG4236|consen 644 KLH-GDMLEMILSSEKG----RLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFAR 715 (888)
T ss_pred hhc-chHHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccccee
Confidence 995 6887777665433 799999999999999999999999 99999999999999643 489999999999
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
.+++..+ ..+++|||.|.|||+++...|...-|+||. |+++|--+.|.+|+...+.+...+
T Consensus 716 iIgEksF---------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSV----------GVIiYVsLSGTFPFNEdEdIndQI 776 (888)
T KOG4236|consen 716 IIGEKSF---------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSV----------GVIIYVSLSGTFPFNEDEDINDQI 776 (888)
T ss_pred ecchhhh---------hhhhcCCccccCHHHHhhccccccccceee----------eEEEEEEecccccCCCccchhHHh
Confidence 9877543 234689999999999999999999999994 444455556777776444333322
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. ...+.++. ...++....+++|...++..=.+|-|.++-+.+
T Consensus 777 QN----AaFMyPp~---PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 777 QN----AAFMYPPN---PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred hc----cccccCCC---chhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 11 11111111 123455667888888888888889888776544
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=289.11 Aligned_cols=257 Identities=22% Similarity=0.310 Sum_probs=192.4
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|++..+++.||||.++.... ...+.+.+|++++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-----CcEE
Confidence 48889999999999999999998999999999864432 2335788999999999999999999996544 4889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++ ++|.+++...... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~ 147 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLS----GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLA 147 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccch
Confidence 9999996 6899988764422 689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
........ ......+++.|+|||++.+.. ++.++|||| +|+++++++++..|+...+..+.
T Consensus 148 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lG~il~~l~tg~~p~~~~~~~~~ 209 (284)
T cd07860 148 RAFGVPVR--------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWS----------LGCIFAEMVTRRALFPGDSEIDQ 209 (284)
T ss_pred hhcccCcc--------ccccccccccccCCeEEecCCCCCcHHHHHH----------HHHHHHHHHHCCCCCCCCCHHHH
Confidence 76543211 011234788999999876644 588899999 78888888888877542211100
Q ss_pred cch-hhhccc---------------cchhhh----hhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 769 SLL-MEVMTN---------------NSMIQE----DKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 769 ~~~-~~~~~~---------------~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
... ...... ...... ............+.+++.+||+.||++|||++|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 210 LFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 000000 000000 000001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=270.45 Aligned_cols=204 Identities=24% Similarity=0.326 Sum_probs=168.8
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCc----eEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDE----MIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
....|+.+..||+|.||.||+|....+. +.+|+|+++... .+......+|+..++.++||||+.+..++...
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-- 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-- 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc--
Confidence 3457999999999999999999665443 378999997542 23456788999999999999999999887543
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC----
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD---- 678 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---- 678 (833)
...+++++||.+. +|.++|+-++.... ..++...+..|++||+.|+.|||+. =|+||||||+|||+..+
T Consensus 100 --d~~v~l~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgper 172 (438)
T KOG0666|consen 100 --DKKVWLLFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPER 172 (438)
T ss_pred --CceEEEEehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCcc
Confidence 3589999999987 99999987765433 4789999999999999999999999 89999999999999877
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccC
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNE 746 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~ 746 (833)
|.|||+|||+|+.+..+-. .......++-|.+|+|||.+.|.. |+.+.|||+-||.|.++.+.
T Consensus 173 G~VKIaDlGlaR~~~~plk-----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl 236 (438)
T KOG0666|consen 173 GRVKIADLGLARLFNNPLK-----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL 236 (438)
T ss_pred CeeEeecccHHHHhhcccc-----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc
Confidence 8999999999998765432 222334567899999999988764 99999999988888776543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=297.53 Aligned_cols=268 Identities=20% Similarity=0.288 Sum_probs=215.2
Q ss_pred cchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeec
Q 040925 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSS 599 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 599 (833)
..++.+...++.|++.+.||.|.+|.||+++.+.+++.+|+|+.... .+..+++..|.++++.. .|||++.+||++.-
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 44555566678899999999999999999999999999999998744 33456788899999998 59999999999987
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
.+....+..|+|||||.+||..|+++...+. .+.|..+..|++.++.|+.+||.. .++|||||-.|||++.++
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~----rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~ 160 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGN----RLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENA 160 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhccc----chhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccC
Confidence 7766778999999999999999999987643 799999999999999999999999 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCC-----CCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-----SEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
.|||+|||.+...+.. ..+.....|||.|||||++.- ..|+..+|+|| .|++..|+.
T Consensus 161 ~VKLvDFGvSaQldsT--------~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~Ws----------LGITaIEla 222 (953)
T KOG0587|consen 161 EVKLVDFGVSAQLDST--------VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWS----------LGITAIEMA 222 (953)
T ss_pred cEEEeeeeeeeeeecc--------cccccCcCCCcccccceeeecccCCCCCcccccchhh----------ccceeehhc
Confidence 9999999999866542 333445679999999998642 34778889999 777777877
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.|..|...+.... .+..... .++..-..++...+++.++|..|+.+|-++||++.++++.
T Consensus 223 dG~PPl~DmHPmr--aLF~IpR----NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 223 EGAPPLCDMHPMR--ALFLIPR----NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCCccCcchhh--hhccCCC----CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 7777754221111 1001111 1112223356678899999999999999999999998754
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=271.55 Aligned_cols=250 Identities=24% Similarity=0.281 Sum_probs=199.3
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
..++|...+.||+|.||+|.+++.+.+++.||+|++++.- +........|-++|+..+||.+..+... |+..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-----FQt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-----FQTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-----hccC
Confidence 4568999999999999999999999999999999997542 2334456779999999999999888765 4455
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
+..|+||||..||.|.-++...+ .+++...+.+...|+.||.|||++ +||.||+|.+|.++|+||.+||+|
T Consensus 241 drlCFVMeyanGGeLf~HLsrer------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitD 311 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRER------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITD 311 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhh------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeee
Confidence 59999999999999999998755 789999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++.--. .......++|||.|.|||++....|..++|+|- .|+++||++-|.+|+-..+.
T Consensus 312 FGLCKE~I~--------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG----------~GVVMYEMmCGRLPFyn~dh 373 (516)
T KOG0690|consen 312 FGLCKEEIK--------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWG----------VGVVMYEMMCGRLPFYNKDH 373 (516)
T ss_pred cccchhccc--------ccceeccccCChhhcCchhhccccccceeehhh----------hhHHHHHHHhccCcccccch
Confidence 999974221 223345689999999999999999999999888 88999999999999753221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVA 819 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 819 (833)
....+.+-- ..-..+....++...++...+.+||.+|. .+.||.+
T Consensus 374 ---~kLFeLIl~------ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 374 ---EKLFELILM------EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ---hHHHHHHHh------hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 111111000 00111223345667888899999999995 3555544
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=295.73 Aligned_cols=267 Identities=22% Similarity=0.260 Sum_probs=199.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
..+|.+.+.||+|+||.||+|++..+++.||||.++.. .......+.+|+.+++.++||||+++++++.....+....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35799999999999999999999999999999998643 2223456788999999999999999999876544333346
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg 153 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFG 153 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCc
Confidence 899999996 69999987654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
+++...... .......++..|+|||++.+ ..++.++|||| +|+++++++++..|+...+..
T Consensus 154 ~~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diws----------lG~il~~l~~g~~pf~~~~~~ 215 (337)
T cd07858 154 LARTTSEKG--------DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWS----------VGCIFAELLGRKPLFPGKDYV 215 (337)
T ss_pred cccccCCCc--------ccccccccccCccChHHHhcCCCCCCcccHHH----------HHHHHHHHHcCCCCCCCCChH
Confidence 998654321 11122458899999998764 46889999999 666777777776665321100
Q ss_pred ---------------------cccchhhhcccc-chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH--HH
Q 040925 767 ---------------------DPSLLMEVMTNN-SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK--LC 822 (833)
Q Consensus 767 ---------------------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~ 822 (833)
............ ...........+++++.+.+++.+||+.||++|||++|+++. ++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~ 295 (337)
T cd07858 216 HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLA 295 (337)
T ss_pred HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchh
Confidence 000000000000 000000011123456778999999999999999999999887 54
Q ss_pred Hh
Q 040925 823 HT 824 (833)
Q Consensus 823 ~i 824 (833)
.+
T Consensus 296 ~~ 297 (337)
T cd07858 296 SL 297 (337)
T ss_pred hh
Confidence 44
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=294.80 Aligned_cols=261 Identities=18% Similarity=0.252 Sum_probs=196.1
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTD-FKGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 605 (833)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+.+|+.++++++||||+++++++.... +.+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999999999999999986432 223456788999999999999999999875433 2233
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...|+||||++ ++|.+.+.. .+++.++..++.|++.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~--------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEcc
Confidence 46799999996 588888753 378889999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++....... .....||+.|+|||++.+..++.++|||| +|+++++++++..|+...+.
T Consensus 162 fg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws----------lG~~l~~l~~g~~pf~~~~~ 222 (353)
T cd07850 162 FGLARTAGTSFM---------MTPYVVTRYYRAPEVILGMGYKENVDIWS----------VGCIMGEMIRGTVLFPGTDH 222 (353)
T ss_pred CccceeCCCCCC---------CCCCcccccccCHHHHhCCCCCCchhhHh----------HHHHHHHHHHCCCCCCCCCH
Confidence 999986543211 12245889999999999999999999999 67777777777766542211
Q ss_pred ccc-------------cch-------hhhccccc--------------hhhhhhhhchHHHHHHHHHHhhccCCCCCCCC
Q 040925 766 VDP-------------SLL-------MEVMTNNS--------------MIQEDKRVKTEECLNAIIRTGVLCSMESPFER 811 (833)
Q Consensus 766 ~~~-------------~~~-------~~~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 811 (833)
.+. .+. ........ .............+..+.+++.+||+.||++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 302 (353)
T cd07850 223 IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302 (353)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhC
Confidence 000 000 00000000 00000000011235667899999999999999
Q ss_pred CCHHHHHHH
Q 040925 812 MDMRDVVAK 820 (833)
Q Consensus 812 Pt~~eil~~ 820 (833)
||+.|+++.
T Consensus 303 ~t~~eiL~~ 311 (353)
T cd07850 303 ISVDDALQH 311 (353)
T ss_pred cCHHHHhcC
Confidence 999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=281.85 Aligned_cols=250 Identities=22% Similarity=0.266 Sum_probs=194.5
Q ss_pred chHHHHHHhcCCccCcee--ccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEee
Q 040925 522 SYAELSKATGEFSSSNMI--GQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICS 598 (833)
Q Consensus 522 ~~~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 598 (833)
+..+.....++|++.+.+ |+|+||.||++..+.++..+|+|.++...... . |+.....+ +||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEe
Confidence 345556667788888887 99999999999999999999999986432111 1 22222222 6999999999976
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
..+ ..++||||+++|+|.+++.... .+++.+++.++.|+++||.|||+. +++||||||+||+++.+
T Consensus 80 ~~~-----~~~iv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~ 145 (267)
T PHA03390 80 TLK-----GHVLIMDYIKDGDLFDLLKKEG------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRA 145 (267)
T ss_pred cCC-----eeEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCC
Confidence 654 8999999999999999998654 689999999999999999999999 99999999999999999
Q ss_pred C-cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHh
Q 040925 679 M-VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTA 757 (833)
Q Consensus 679 ~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~ 757 (833)
+ .++|+|||.+....... ...|+..|+|||++.+..++.++|||| .|+++++++++.
T Consensus 146 ~~~~~l~dfg~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~Dvws----------lG~il~~l~~g~ 203 (267)
T PHA03390 146 KDRIYLCDYGLCKIIGTPS------------CYDGTLDYFSPEKIKGHNYDVSFDWWA----------VGVLTYELLTGK 203 (267)
T ss_pred CCeEEEecCccceecCCCc------------cCCCCCcccChhhhcCCCCCchhhHHH----------HHHHHHHHHHCC
Confidence 8 99999999987654321 135899999999999888999999999 888999999999
Q ss_pred CCCccccc--ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-HHHHHH
Q 040925 758 LPEKVMEI--VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-MRDVVA 819 (833)
Q Consensus 758 ~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~ 819 (833)
.|+..... .+......... .........+..+.+++.+||+.||.+||+ ++|+++
T Consensus 204 ~p~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 204 HPFKEDEDEELDLESLLKRQQ-------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCCCCCCcchhhHHHHHHhhc-------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 88762211 11111111110 011122245678899999999999999996 588874
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=295.01 Aligned_cols=265 Identities=20% Similarity=0.249 Sum_probs=198.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|++|.||+|....+++.||+|++..... ...+.+.+|+.++++++||||+++++++.... ......
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence 689999999999999999999999999999999875422 23466788999999999999999999875543 334578
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+. |+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~ 153 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGM 153 (334)
T ss_pred EEEEehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccc
Confidence 99999996 69999987654 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+......... .........|+..|+|||++.+ ..++.++|||| +|+++++++++..|+...+...
T Consensus 154 ~~~~~~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s----------lG~~l~el~~g~~pf~~~~~~~ 219 (334)
T cd07855 154 ARGLSSSPTE----HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWS----------VGCIFAEMLGRRQLFPGKNYVH 219 (334)
T ss_pred ceeecccCcC----CCcccccccccccccChHHhcCCcccccccchHH----------HHHHHHHHHcCCCccCCCChHH
Confidence 9765432211 1111223468999999998765 45889999999 6777777777776653221100
Q ss_pred c-------------cc--------hhhhcccc-chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 P-------------SL--------LMEVMTNN-SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~-------------~~--------~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. .. ........ ..............+..+.+++.+||+.||++|||+++++..
T Consensus 220 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0 00 00000000 000000000112346788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=287.90 Aligned_cols=267 Identities=20% Similarity=0.254 Sum_probs=195.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|.+..+++.||+|.++.... .....+.+|+.+++.++ ||||+++++++...+..+...
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 468999999999999999999998999999999864432 23457888999999995 699999999887655333445
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-CCcEEEccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVCDF 686 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~Df 686 (833)
.++||||+++ ++.+++...... ....+++..++.++.||+.||.|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df 155 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL 155 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence 8999999985 899888754321 012589999999999999999999999 9999999999999998 889999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|.++....... ......+++.|+|||++.+ ..++.++|||| +|+++++++++..|+...+.
T Consensus 156 g~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~~~~~~~~ 217 (295)
T cd07837 156 GLGRAFSIPVK--------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWS----------VGCIFAEMSRKQPLFPGDSE 217 (295)
T ss_pred ccceecCCCcc--------ccCCcccccCCCChHHhhCCCCCCchHHHHH----------HHHHHHHHHcCCCCCCCCCH
Confidence 99876533211 1112347889999998765 45789999999 77778888877766542111
Q ss_pred ccccc-------------hhhh------ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSL-------------LMEV------MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~-------------~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..... .... ...............+..+..+.+++.+||.+||++|||++|++..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 218 LQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred HHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000 0000000000011112356778999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=288.18 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=193.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||.|++|.||+|.+..+++.||+|.++..... ....+.+|+.++++++||||+++++++.... ...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCc
Confidence 35799999999999999999999989999999999754322 2345678999999999999999999876542 248
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||++ ++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~-~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 81 IYMVMEYVE-HDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred EEEEehhcC-cCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence 999999997 599998876442 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
.+........ ......+++.|+|||++.+. .++.++|||| .|++++++.++..|+......
T Consensus 152 ~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 152 LAREYGSPLK--------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWS----------VGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred ceeeccCCcc--------ccccccccccccCchhhcCCccccchhhHHH----------HHHHHHHHHhCCCCCCCCChH
Confidence 9986654321 11123578999999987654 4688999999 666677777766655321110
Q ss_pred cccc-------------hh---h--hcc-c---cchhhhhhhhchHH-HHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSL-------------LM---E--VMT-N---NSMIQEDKRVKTEE-CLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~-------------~~---~--~~~-~---~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+... .. . ... . ...........+.. ..+.+.+++.+||+.||++|||+.|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 214 DQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000 00 0 000 0 00000000001111 35678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=283.65 Aligned_cols=251 Identities=20% Similarity=0.294 Sum_probs=197.9
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|....++..||+|.+.... ....+.+.+|+.++++++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~-----~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENG-----RLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCC-----eEE
Confidence 5888999999999999999999899999999986532 223457889999999999999999999875544 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-cEEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~ 688 (833)
+||||+++++|.+++...... .+++..+..++.|++.||+|||+. +++|+||||+||++++++ .+||+|||.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~ 148 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGV----LFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGI 148 (257)
T ss_pred EEEecCCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEeccccc
Confidence 999999999999999764422 578999999999999999999999 999999999999999886 579999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+........ ......|++.|+|||+..+..++.++|+|| +|+++++++++..|+..... .
T Consensus 149 ~~~~~~~~~--------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~p~~~~~~--~ 208 (257)
T cd08225 149 ARQLNDSME--------LAYTCVGTPYYLSPEICQNRPYNNKTDIWS----------LGCVLYELCTLKHPFEGNNL--H 208 (257)
T ss_pred chhccCCcc--------cccccCCCccccCHHHHcCCCCCchhhHHH----------HHHHHHHHHhCCCCCCCccH--H
Confidence 876543211 111235899999999988888999999999 78888888888888652211 1
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
........... .......+..+.+++.+||..+|++|||+.|+++.
T Consensus 209 ~~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 209 QLVLKICQGYF------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred HHHHHHhcccC------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111111100 01112345678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=285.68 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=204.0
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
...+.|++.+.||+|++|.||+|.+..++..||+|+++.... ..+.+.+|++.+++++|+||+++++++.... .
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD-----E 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC-----E
Confidence 345678899999999999999999988899999999975543 4567889999999999999999999976654 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. |++|+||+|+||+++.++.++|+|||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~ 161 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFG 161 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccc
Confidence 999999999999999998754 1589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
.+........ ......+++.|+|||++.+..++.++|+|| +|+++++++++..|+.......
T Consensus 162 ~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~s----------lGvil~~l~~g~~p~~~~~~~~ 223 (286)
T cd06614 162 FAAQLTKEKS--------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWS----------LGIMCIEMAEGEPPYLREPPLR 223 (286)
T ss_pred hhhhhccchh--------hhccccCCcccCCHhHhcCCCCCCccccHH----------HHHHHHHHHhCCCCCCCCCHHH
Confidence 8875543211 112245889999999998888999999999 8888999999888865222111
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ......... ........++..+.+++.+||+.+|.+|||+.++++.
T Consensus 224 ~--~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 224 A--LFLITTKGI----PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred H--HHHHHhcCC----CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 000000000 0111122356788999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-34 Score=266.99 Aligned_cols=276 Identities=21% Similarity=0.323 Sum_probs=202.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeec--cCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCC---CC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINL--KYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFK---GT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~---~~ 605 (833)
+.|+...+||+|.||+||+|+.+.+++.||+|++-. +..+......+|++++..++|+|++.++.+|....-. ..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 457778899999999999999999999999987632 2233456678999999999999999999988664322 23
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...|+||.+|+. +|..++..... +++..++.+++.+++.||.|+|+. .|+|||+||+|++|+.+|.+||+|
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v-----r~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV-----RFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc-----cccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 358999999986 99999987542 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccH-----------HHH
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSL-----------HEF 753 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l-----------~~~ 753 (833)
||+|+.+....... ..+.+..+-|.+|++||.+.| ..|+++.|||..+|.+.++|....++ ...
T Consensus 168 FGlar~fs~~~n~~----kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 168 FGLARAFSTSKNVV----KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred cccccceecccccC----CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 99998765443221 122344567999999998776 46999999999999998888754322 112
Q ss_pred HHHhCCCcccccccccchhhhccccchhhhhhhhchHHHH------HHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 754 AKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECL------NAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 754 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+-|....+.+..+|.--..+.+..... ........++.. +...+++..++..||.+||++++++..
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl-~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPL-PKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCC-CcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 223333333333333222222211100 000001111111 256788999999999999999999765
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=280.93 Aligned_cols=243 Identities=24% Similarity=0.291 Sum_probs=193.3
Q ss_pred eccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 539 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
||.|++|.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.... ..++||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKK-----YIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCC-----ccEEEEecC
Confidence 699999999999999889999999996432 233467899999999999999999999875544 789999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~ 146 (262)
T cd05572 76 LGGELWTILRDRG------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146 (262)
T ss_pred CCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc
Confidence 9999999997654 588999999999999999999999 9999999999999999999999999999866443
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhc
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVM 775 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~ 775 (833)
. ......|++.|+|||.+.+..++.++|+|+ .|+++++++++..|+...+...........
T Consensus 147 ~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 207 (262)
T cd05572 147 Q---------KTWTFCGTPEYVAPEIILNKGYDFSVDYWS----------LGILLYELLTGRPPFGEDDEDPMEIYNDIL 207 (262)
T ss_pred c---------ccccccCCcCccChhHhcCCCCCChhhhhh----------hHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence 2 111235889999999988888999999999 888899999998887633311111111111
Q ss_pred cccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHH
Q 040925 776 TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVA 819 (833)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~ 819 (833)
.... ....+...++.+.+++.+||..||++||+ ++|+++
T Consensus 208 ~~~~-----~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 208 KGNG-----KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCC-----CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0000 01112223567899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=289.64 Aligned_cols=266 Identities=20% Similarity=0.243 Sum_probs=194.5
Q ss_pred CCccCceeccCcceEEEEEEECC--CceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGE--DEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
+|++.+.||+|++|.||+|.+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHA---DK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC---Cc
Confidence 48889999999999999999987 78999999997532 334467888999999999999999999986542 24
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC----CCcEE
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH----DMVAH 682 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~k 682 (833)
..++||||+++ ++.+++....... ...+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+|
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~k 152 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVK 152 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEE
Confidence 79999999975 7877775433211 12588999999999999999999999 9999999999999999 89999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
|+|||++......... ........+|+.|+|||++.+. .++.++|||| +|+++++++++..|+.
T Consensus 153 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lG~~l~~l~~~~~~~~ 217 (316)
T cd07842 153 IGDLGLARLFNAPLKP-----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWA----------IGCIFAELLTLEPIFK 217 (316)
T ss_pred ECCCccccccCCCccc-----ccccCCccccccccCHHHHhCCCCCCcHHHHHH----------HHHHHHHHHhcCCCCc
Confidence 9999999866443211 1112235689999999987664 5789999999 7777888888777654
Q ss_pred cccccc----c----------------------------cchh---hhccccchhhhhhhhchH--HHHHHHHHHhhccC
Q 040925 762 VMEIVD----P----------------------------SLLM---EVMTNNSMIQEDKRVKTE--ECLNAIIRTGVLCS 804 (833)
Q Consensus 762 ~~~~~~----~----------------------------~~~~---~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl 804 (833)
...... + .... .................. .....+.+++.+|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 297 (316)
T cd07842 218 GREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLL 297 (316)
T ss_pred CCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHh
Confidence 221111 0 0000 000000000000000000 23456889999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 040925 805 MESPFERMDMRDVVAK 820 (833)
Q Consensus 805 ~~dP~~RPt~~eil~~ 820 (833)
+.||++|||+.|+++.
T Consensus 298 ~~~P~~Rps~~eil~~ 313 (316)
T cd07842 298 EYDPTKRITAEEALEH 313 (316)
T ss_pred cCCcccCcCHHHHhcC
Confidence 9999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=286.03 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=192.8
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
|++.+.||.|++|.||+|.+..+|..||+|++.... ....+.+.+|++++++++|||++++++++... ...++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-----~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-----NKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-----CeEEE
Confidence 678899999999999999998899999999987543 22335688899999999999999999997654 48999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
+|||++ ++|.+++...... .+++..++.++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.+.
T Consensus 76 v~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSPLT----GLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred EEeccC-cCHHHHHhhCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 999995 6999998765421 589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
....... ......+++.|+|||++.+. .++.++|||| +|+++++++++..|+...+..+..
T Consensus 148 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~pf~~~~~~~~~ 209 (283)
T cd07835 148 AFGVPVR--------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWS----------IGCIFAEMVNRRPLFPGDSEIDQL 209 (283)
T ss_pred ccCCCcc--------ccCccccccCCCCCceeecCcccCcHHHHHH----------HHHHHHHHHhCCCCCCCCCHHHHH
Confidence 5533211 01123478899999987654 5788999999 788888888887775422111000
Q ss_pred ch--h-----------------hhccc-cchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 770 LL--M-----------------EVMTN-NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 770 ~~--~-----------------~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.. . +.... ...............+..+.+++.+||+.||++|||++|+++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 210 FRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0 00000 000000001111223467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=289.00 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=191.4
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|...+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.++.++. ||||+++++++.... ..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-----~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-----DCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-----cEE
Confidence 56677899999999999999999999999999874432 33457889999999996 999999999875543 788
Q ss_pred EEEEecCCCChhhhhc---cCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 610 FVFEYMENGSLKDWLH---QSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~---~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
++|||++ +++.++.. .... ..+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+||
T Consensus 80 ~~~e~~~-~~l~~l~~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~df 152 (288)
T cd06616 80 ICMELMD-ISLDKFYKYVYEVLK----SVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDF 152 (288)
T ss_pred EEEeccc-CCHHHHHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeec
Confidence 9999986 46655432 2111 16899999999999999999999742 8999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCC---CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS---EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
|+++....... .....|++.|+|||++.+. .++.++|||| +|+++++++++..|+...
T Consensus 153 g~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~s----------lG~il~el~~g~~p~~~~ 213 (288)
T cd06616 153 GISGQLVDSIA---------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWS----------LGITLYEVATGKFPYPKW 213 (288)
T ss_pred chhHHhccCCc---------cccccCccCccCHHHhccccccCCcchhhhhH----------HHHHHHHHHhCCCCchhc
Confidence 99976543211 1123589999999998766 6899999999 788888888888886532
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..... .......... ..........++..+.+++.+||+.||++|||+++|++.
T Consensus 214 ~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 214 NSVFD-QLTQVVKGDP--PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred chHHH-HHhhhcCCCC--CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 21000 0011111000 000011112356788999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=280.84 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=199.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-----CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-----KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|++.+.||+|++|.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++++.+.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 47899999999999999999999899999999875321 223457889999999999999999999875432 3
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~d 149 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGD 149 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECc
Confidence 46889999999999999987643 578999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++........ ........|+..|+|||++.+..++.++|+|| +|+++++++++..|+.....
T Consensus 150 fg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~ 214 (264)
T cd06653 150 FGASKRIQTICMS-----GTGIKSVTGTPYWMSPEVISGEGYGRKADVWS----------VACTVVEMLTEKPPWAEYEA 214 (264)
T ss_pred ccccccccccccc-----CccccccCCcccccCHhhhcCCCCCccccHHH----------HHHHHHHHHhCCCCCCccCH
Confidence 9999865332110 01112346899999999998888999999999 88889999999888753211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.. ...... ..+.....+....+.+.+++.+||. +|..|||+.+++.
T Consensus 215 ~~--~~~~~~-----~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 215 MA--AIFKIA-----TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HH--HHHHHH-----cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11 000000 0111112234456778999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=287.15 Aligned_cols=261 Identities=24% Similarity=0.290 Sum_probs=193.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|.+..+++.||+|+++..... ....+.+|++++++++|+||+++++++.... ...
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~~ 82 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LDS 82 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CCe
Confidence 46799999999999999999999989999999999754322 2335678999999999999999999875432 236
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||++ ++|.+++.... ..+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||
T Consensus 83 ~~lv~e~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 83 IFLVMEYCE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred EEEEEecCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 899999997 48988887543 1689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
.+........ ......+++.|+|||++.+ ..++.++|||| .|+++++++++..|+......
T Consensus 154 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws----------lG~il~el~~g~~~f~~~~~~ 215 (309)
T cd07845 154 LARTYGLPAK--------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWA----------VGCILAELLAHKPLLPGKSEI 215 (309)
T ss_pred eeeecCCccC--------CCCcccccccccChhhhcCCCCcCchHHHHH----------HHHHHHHHHhCCCCCCCCCHH
Confidence 9986643211 1112246888999998765 45789999999 677777777777665311110
Q ss_pred cc-------------cchhhhc---c-ccchhh----hhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DP-------------SLLMEVM---T-NNSMIQ----EDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~-------------~~~~~~~---~-~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+. ....... . ...... ..........++.+.+++.+|+..||++|||++|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 216 EQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0000000 0 000000 00000011235677899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=286.71 Aligned_cols=268 Identities=22% Similarity=0.319 Sum_probs=192.3
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCC---
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFK--- 603 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 603 (833)
..++|++.+.||+|+||.||+|....+++.||||.+..... .....+.+|++++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 45689999999999999999999999999999999864322 2234567899999999999999999998665321
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
.....++||||++ +++.+++..... .+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 160 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNV-----KFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKL 160 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEE
Confidence 2345799999996 588888865431 589999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
+|||++.......... ........++..|+|||++.+. .++.++|||| +|++++++.++..++..
T Consensus 161 ~dfg~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~~l~el~t~~~~~~~ 226 (310)
T cd07865 161 ADFGLARAFSLSKNSK----PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWG----------AGCIMAEMWTRSPIMQG 226 (310)
T ss_pred CcCCCcccccCCcccC----CCCccCcccCccccCcHHhcCCcccCchhhhHH----------HHHHHHHHHhCCCCCCC
Confidence 9999998664432111 1111234578999999987664 4788999999 66666676666555431
Q ss_pred cccc-------------cccchhhh----ccccchhhh------hhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 763 MEIV-------------DPSLLMEV----MTNNSMIQE------DKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 763 ~~~~-------------~~~~~~~~----~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.+.. .+...... ......... ..+....-....+.+++.+||..||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 227 NTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred CCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 1100 00000000 000000000 000000011345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=286.05 Aligned_cols=246 Identities=22% Similarity=0.295 Sum_probs=194.3
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
...||+|++|.||+|....+++.||+|++..........+.+|+.+++.++|+||+++++++...+ ..++||||+
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~ 99 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWVVMEFL 99 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCC-----EEEEEEecC
Confidence 468999999999999999899999999986544445567899999999999999999999976554 899999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++++|.+++... .+++..+..++.|++.|++|||+. |++||||||+||+++.++.++|+|||.+......
T Consensus 100 ~~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~ 169 (292)
T cd06657 100 EGGALTDIVTHT-------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169 (292)
T ss_pred CCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccc
Confidence 999999987543 578999999999999999999999 9999999999999999999999999998755432
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhc
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVM 775 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~ 775 (833)
.. ......|++.|+|||+..+..++.++|+|| .|+++++++++..|+........ ....
T Consensus 170 ~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s----------lGvil~el~tg~~p~~~~~~~~~---~~~~ 228 (292)
T cd06657 170 VP--------RRKSLVGTPYWMAPELISRLPYGPEVDIWS----------LGIMVIEMVDGEPPYFNEPPLKA---MKMI 228 (292)
T ss_pred cc--------cccccccCccccCHHHhcCCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCHHHH---HHHH
Confidence 11 112245899999999988888899999999 78888899988887642211100 0000
Q ss_pred cccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 776 TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.... +.........+..+.+++.+||..||.+||++.++++.
T Consensus 229 ~~~~---~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 229 RDNL---PPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HhhC---CcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 0000 00000112235567889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=278.70 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=199.8
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|++..+++.||+|.+..... ...+.+.+|++++++++|||++++++++.... ..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSD-----SLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCC-----EEE
Confidence 58889999999999999999988899999999975543 34567899999999999999999999976544 889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++.... .+++..+..++.|++.|+.|||+. ||+||||||+||+++.++.+||+|||.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~ 146 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVA 146 (254)
T ss_pred EEEecCCCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccc
Confidence 9999999999999997653 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
......... .....|+..|+|||...+..++.++|||+ .|+++++++++..|+...... .
T Consensus 147 ~~~~~~~~~--------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~----------lG~~l~~l~~g~~p~~~~~~~--~ 206 (254)
T cd06627 147 TKLNDVSKD--------DASVVGTPYWMAPEVIEMSGASTASDIWS----------LGCTVIELLTGNPPYYDLNPM--A 206 (254)
T ss_pred eecCCCccc--------ccccccchhhcCHhhhcCCCCCcchhHHH----------HHHHHHHHHhCCCCCCCccHH--H
Confidence 876543211 12245899999999988878899999999 788888888888776422211 0
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
......... ....+...+..+.+++.+||..+|++|||+.+++.
T Consensus 207 ~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 207 ALFRIVQDD------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HHHHHhccC------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 000000000 01112234567889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=282.83 Aligned_cols=258 Identities=21% Similarity=0.277 Sum_probs=194.3
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
+|++.+.||.|++|.||+|++..+++.||||.++.... ...+.+.+|++++++++||||+++++++...+ ..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-----KLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-----cEEE
Confidence 58899999999999999999998999999999975533 23456788999999999999999999976654 7899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++ +|.+++..... ...+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||.+.
T Consensus 76 v~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~ 148 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHGV---RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148 (284)
T ss_pred EEecCCc-cHHHHHHhcCC---CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhh
Confidence 9999985 89998875432 12589999999999999999999999 99999999999999999999999999997
Q ss_pred ccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc--
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD-- 767 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~-- 767 (833)
....... ......+++.|+|||++.+ ..++.++|||+ +|+++++++++..|+...+..+
T Consensus 149 ~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~s----------lG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 149 AFGIPVN--------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWS----------VGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred hhcCCcc--------ccccccccccccChHHhcCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCcHHHH
Confidence 5533211 1112357899999998765 45788999999 7778888888877654221100
Q ss_pred -----------ccchhhhcc-----ccch--hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 -----------PSLLMEVMT-----NNSM--IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 -----------~~~~~~~~~-----~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
......... .... .........+..+..+.+++.+|++.||++||++.|+++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 0000 000000111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=282.03 Aligned_cols=244 Identities=23% Similarity=0.282 Sum_probs=190.3
Q ss_pred eccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 539 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
||+|+||+||+|.+..+++.||+|.+.... ......+.+|++++++++||||+++++++...+ ..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKD-----DLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCC-----eEEEEEecC
Confidence 689999999999999899999999986432 223445678999999999999999999865544 889999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++++|.+++...... .+++.++..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||.+......
T Consensus 76 ~~~~L~~~l~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~ 148 (277)
T cd05577 76 NGGDLKYHIYNVGEP----GFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG 148 (277)
T ss_pred CCCcHHHHHHHcCcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC
Confidence 999999999765432 589999999999999999999999 9999999999999999999999999998765431
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc-ccccchhhh
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI-VDPSLLMEV 774 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~-~~~~~~~~~ 774 (833)
.. .....++..|+|||++.+..++.++|||| .|+++++++++..|+..... .........
T Consensus 149 ~~---------~~~~~~~~~y~~PE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 209 (277)
T cd05577 149 KK---------IKGRAGTPGYMAPEVLQGEVYDFSVDWFA----------LGCTLYEMIAGRSPFRQRKEKVEKEELKRR 209 (277)
T ss_pred Cc---------cccccCCCCcCCHHHhcCCCCCchhhhHH----------HHHHHHHHhhCCCCCCCCcccccHHHHHhc
Confidence 11 11235788999999998888999999999 78889999999888753221 111110000
Q ss_pred ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHH
Q 040925 775 MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVA 819 (833)
Q Consensus 775 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 819 (833)
... .....+..+++.+.+++.+||+.||++|| ++.++++
T Consensus 210 ~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 210 TLE------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccc------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 000 01111223466788999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=278.63 Aligned_cols=253 Identities=22% Similarity=0.334 Sum_probs=201.7
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|.+..++..||+|++..... ...+.+.+|++++++++|||++++++.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 58889999999999999999988899999999975433 3456789999999999999999999986554 4899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++...... ...+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~ 150 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKE--GKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGIS 150 (258)
T ss_pred EEEEecCCCcHHHHHHHhhcc--CCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccce
Confidence 999999999999999875311 12689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
........ ......|++.|+|||...+..++.++|+|| .|..++++.++..|+...+. +.
T Consensus 151 ~~~~~~~~--------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s----------lG~~~~~l~~g~~p~~~~~~--~~ 210 (258)
T cd08215 151 KVLSSTVD--------LAKTVVGTPYYLSPELCQNKPYNYKSDIWS----------LGCVLYELCTLKHPFEGENL--LE 210 (258)
T ss_pred eecccCcc--------eecceeeeecccChhHhccCCCCccccHHH----------HHHHHHHHHcCCCCCCCCcH--HH
Confidence 76544321 111245899999999988888999999999 77788888888777653321 11
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... ...+..++..+.+++.+||..+|++|||+.|+++.
T Consensus 211 ~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 211 LALKILKGQY------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred HHHHHhcCCC------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111111110 11122345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=277.60 Aligned_cols=250 Identities=27% Similarity=0.380 Sum_probs=201.5
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
+|+..+.||+|++|.||+|.+..+++.||+|+++.......+.+.+|++++++++||+|+++++++.... ..+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-----ELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEEEE
Confidence 4888899999999999999998889999999997655445678999999999999999999999876554 78999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
|||+++++|.+++..... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQ-----TLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred EecCCCCcHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 999999999999877531 689999999999999999999998 999999999999999999999999999986
Q ss_pred cCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccch
Q 040925 692 LSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771 (833)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~ 771 (833)
...... .....|+..|+|||++.+..++.++|+|| +|.++++++++..|+...+.......
T Consensus 148 ~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~p~~~~~~~~~~~~ 208 (253)
T cd05122 148 LSDTKA---------RNTMVGTPYWMAPEVINGKPYDYKADIWS----------LGITAIELAEGKPPYSELPPMKALFK 208 (253)
T ss_pred cccccc---------ccceecCCcccCHHHHcCCCCCccccHHH----------HHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 654321 12345889999999998888999999999 78889999998887653321111000
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
. ..... ........++..+.+++.+||..||++|||+.|+++
T Consensus 209 ~--~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 209 I--ATNGP----PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred H--HhcCC----CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 00000 001111113567899999999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=287.84 Aligned_cols=259 Identities=17% Similarity=0.234 Sum_probs=187.0
Q ss_pred ceeccC--cceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQG--SFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
..||+| +||+||+|++..+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-----~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-----WLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-----ceEEEE
Confidence 456666 899999999998999999999875432 23467889999999999999999999976554 789999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|++.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+...
T Consensus 79 e~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 79 PFMAYGSANSLLKTYFPE----GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred ecccCCCHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 999999999998865422 588999999999999999999999 9999999999999999999999999865433
Q ss_pred CcccccccccCCCccccccccccccCccccCCC--CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS--EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
......... .........++..|||||++.+. .++.++|||| +|+++++++++..|+...... ..
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws----------lG~~l~el~~g~~p~~~~~~~--~~ 218 (328)
T cd08226 152 VRNGQKAKV-VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS----------VGITACELATGRVPFQDMLRT--QM 218 (328)
T ss_pred hccCccccc-cccccccccCccCccChhhhcCCCCCCCchhhHHH----------HHHHHHHHHhCCCCCCCcChH--HH
Confidence 221110000 00001112356779999998763 4789999999 666667777766665311100 00
Q ss_pred hhhhccc----------------------------------------cchhhhhhhhchHHHHHHHHHHhhccCCCCCCC
Q 040925 771 LMEVMTN----------------------------------------NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFE 810 (833)
Q Consensus 771 ~~~~~~~----------------------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 810 (833)
....... ..............+...+.+++.+||..||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 298 (328)
T cd08226 219 LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEK 298 (328)
T ss_pred HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCccc
Confidence 0000000 000000011123446778999999999999999
Q ss_pred CCCHHHHHHH
Q 040925 811 RMDMRDVVAK 820 (833)
Q Consensus 811 RPt~~eil~~ 820 (833)
|||++|+++.
T Consensus 299 Rpta~e~l~~ 308 (328)
T cd08226 299 RPSASSLLSH 308 (328)
T ss_pred CCCHHHHhhC
Confidence 9999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-33 Score=296.66 Aligned_cols=258 Identities=23% Similarity=0.336 Sum_probs=201.5
Q ss_pred CccCceeccCcceEEEEEEECCCce----EEEEEEeecc-CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEM----IVAVKVINLK-YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.+..++||+|+||+||+|.+-..|+ +||+|++... ......++.+|+-+|.+++|||+++++|+|..+.
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~------ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST------ 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch------
Confidence 3445899999999999999865544 6899988643 3345678999999999999999999999987653
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
..+|++|++.|+|.+|++.++. .+-....+.|..|||+||.|||.+ ++|||||-.+|||+..-..+||.|||
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~-----~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg 843 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRD-----NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG 843 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhc-----cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence 7799999999999999998765 688889999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+....+...-.. .+..-.+.|||=|.+....|+.++||||+|+..|++.++|...|.- .. ..++.|
T Consensus 844 la~ll~~d~~ey~~------~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g---i~---~~eI~d 911 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSA------PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG---IP---AEEIPD 911 (1177)
T ss_pred hhhccCcccccccc------cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC---CC---HHHhhH
Confidence 99987664432211 1223467899999999999999999999655555555554332210 00 111111
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.. ....+-..++-|+-.+..++.+||..|++.||+++++.+.+.++.++
T Consensus 912 ------ll-----e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 912 ------LL-----EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ------HH-----hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 00 01112234556788899999999999999999999999999988754
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=291.16 Aligned_cols=269 Identities=20% Similarity=0.245 Sum_probs=201.1
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|+...+++.||+|++.... ....+.+.+|+++++.++||||+++++++...........|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999998889999999987543 33456789999999999999999999987655333334689
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++ ++|.+++.... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.++|+|||.+
T Consensus 81 lv~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~ 150 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLA 150 (330)
T ss_pred EEecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCce
Confidence 9999997 58999987654 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc--
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV-- 766 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~-- 766 (833)
......... ........+|+.|+|||++.+. .++.++|+|| +|+.+++++++..|+......
T Consensus 151 ~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s----------lG~il~~l~~g~~pf~~~~~~~~ 215 (330)
T cd07834 151 RGVDPDEDE-----KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWS----------VGCIFAELLTRKPLFPGRDYIDQ 215 (330)
T ss_pred Eeecccccc-----cccccccccccCcCCceeeecccCCCcchhHHH----------HHHHHHHHHcCCCCcCCCCHHHH
Confidence 876543210 0112234589999999998887 7899999999 666677777766655311100
Q ss_pred -------------------cccchhhhcccc-chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH--HHHh
Q 040925 767 -------------------DPSLLMEVMTNN-SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK--LCHT 824 (833)
Q Consensus 767 -------------------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~i 824 (833)
............ ............+.+..+.+++.+||+++|++|||++++++. ++.+
T Consensus 216 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 000000000000 000000001112245678999999999999999999999985 5544
Q ss_pred h
Q 040925 825 R 825 (833)
Q Consensus 825 ~ 825 (833)
.
T Consensus 296 ~ 296 (330)
T cd07834 296 H 296 (330)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=285.61 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=193.6
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
|+..+.||+|+||.||+|++..++..||+|.+..... .....+.+|++++++++|||++++++++.... ..+
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 101 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-----TAW 101 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-----eEE
Confidence 7778899999999999999988999999999864322 22356888999999999999999999976554 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++ |++.+++..... .+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.+||+|||++
T Consensus 102 lv~e~~~-g~l~~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~ 172 (317)
T cd06635 102 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 172 (317)
T ss_pred EEEeCCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCc
Confidence 9999997 588887764332 689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
...... ....|++.|+|||++. +..++.++|||| +|+++++++++..|+...+..
T Consensus 173 ~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~s----------lGvil~el~~g~~p~~~~~~~ 230 (317)
T cd06635 173 SIASPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWS----------LGITCIELAERKPPLFNMNAM 230 (317)
T ss_pred cccCCc------------ccccCCccccChhhhhcCCCCCCCccccHHH----------HHHHHHHHHhCCCCCCCccHH
Confidence 754321 1235889999999863 456889999999 788888898888876422111
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
........... .......+++.+.+++.+||+.+|.+||++.++++...
T Consensus 231 --~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 231 --SALYHIAQNES-----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred --HHHHHHHhccC-----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00001111000 11112345667899999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-35 Score=319.15 Aligned_cols=420 Identities=26% Similarity=0.341 Sum_probs=287.6
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcc
Q 040925 3 TLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82 (833)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~ 82 (833)
.+|+++..++ .+|..+-.-..++.|+++.|-+...+-+.....-+|+.|||++|+++ ..|..+..+.+|+.|+++.|.
T Consensus 2 ~vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~ 79 (1081)
T KOG0618|consen 2 HVDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNY 79 (1081)
T ss_pred CcccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhh
Confidence 3678888888 78887777777999999999885544444555666999999999998 789999999999999999999
Q ss_pred cccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccc-cCCCCCC
Q 040925 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQN-NLGTGTA 161 (833)
Q Consensus 83 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~ 161 (833)
|. .+|... ..+.+|++|.|.+|++. ..|..+..+.+|++|++|.|++.. .|..+..++.++++..++| .+..
T Consensus 80 i~-~vp~s~-~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~~-~Pl~i~~lt~~~~~~~s~N~~~~~--- 152 (1081)
T KOG0618|consen 80 IR-SVPSSC-SNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFGP-IPLVIEVLTAEEELAASNNEKIQR--- 152 (1081)
T ss_pred Hh-hCchhh-hhhhcchhheeccchhh-cCchhHHhhhcccccccchhccCC-CchhHHhhhHHHHHhhhcchhhhh---
Confidence 98 788444 68899999999999887 788899999999999999999884 4556778888888888888 2211
Q ss_pred CCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCC------------------
Q 040925 162 TDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLV------------------ 223 (833)
Q Consensus 162 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~------------------ 223 (833)
++. ..++.++|..|.+.+.++..+..+.. .|+|++|.+... .+.++.
T Consensus 153 --------lg~-~~ik~~~l~~n~l~~~~~~~i~~l~~---~ldLr~N~~~~~---dls~~~~l~~l~c~rn~ls~l~~~ 217 (1081)
T KOG0618|consen 153 --------LGQ-TSIKKLDLRLNVLGGSFLIDIYNLTH---QLDLRYNEMEVL---DLSNLANLEVLHCERNQLSELEIS 217 (1081)
T ss_pred --------hcc-ccchhhhhhhhhcccchhcchhhhhe---eeecccchhhhh---hhhhccchhhhhhhhcccceEEec
Confidence 111 11555555555555555555544432 355555544411 111111
Q ss_pred ------------------------CCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEee
Q 040925 224 ------------------------NLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELS 279 (833)
Q Consensus 224 ------------------------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 279 (833)
+|++++++.|++++ .|++++.+.+|+.|+..+|.++ .+|..+...++|+.|.+.
T Consensus 218 g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~ 295 (1081)
T KOG0618|consen 218 GPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAA 295 (1081)
T ss_pred CcchheeeeccCcceeeccccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhh
Confidence 33444444444442 2244444444444444444443 333334444444444444
Q ss_pred cccccCCCCCCCCCCCccceeecCCceecccCCccccccccc-ceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCC
Q 040925 280 SNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTL-SLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSG 358 (833)
Q Consensus 280 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l-l~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 358 (833)
+|.+. -+|.....+++|++|+|..|+|. .+|..++..... ++.|+.+.|.+....-..=...+.|+.|++.+|.++.
T Consensus 296 ~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd 373 (1081)
T KOG0618|consen 296 YNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTD 373 (1081)
T ss_pred hhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccc
Confidence 44444 33444455555666666666655 555544443333 3445555555552221111235678899999999998
Q ss_pred CCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCcc
Q 040925 359 VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVF 438 (833)
Q Consensus 359 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 438 (833)
..-..+.+..+|+.|+|++|+|..++...+.++..|++|+||+|+++ .+|..+.++..|++|...+|++.+.| ....+
T Consensus 374 ~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l 451 (1081)
T KOG0618|consen 374 SCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQL 451 (1081)
T ss_pred cchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhc
Confidence 77778999999999999999999777778899999999999999999 68899999999999999999999876 66778
Q ss_pred CCCccccccCCcCC
Q 040925 439 SNKTKISLQGNMKL 452 (833)
Q Consensus 439 ~~~~~l~l~~N~~~ 452 (833)
..++.++++-|.-.
T Consensus 452 ~qL~~lDlS~N~L~ 465 (1081)
T KOG0618|consen 452 PQLKVLDLSCNNLS 465 (1081)
T ss_pred CcceEEecccchhh
Confidence 88888999888543
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=279.71 Aligned_cols=251 Identities=24% Similarity=0.283 Sum_probs=200.5
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|++..+++.||+|.+.... ......+.+|++++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 5888999999999999999999899999999987432 23345678899999999999999999886544 4899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++...... ...+++..++.++.|++.||+|||+. |++|+||+|+||+++.++.+||+|||++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~ 150 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGIS 150 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccch
Confidence 999999999999998763321 12689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
........ ....|++.|+|||...+..++.++|+|| .|..++++.++..|+...+.. .
T Consensus 151 ~~~~~~~~----------~~~~~~~~~~~Pe~~~~~~~~~~~D~~s----------lG~~~~~l~~g~~p~~~~~~~--~ 208 (256)
T cd08530 151 KVLKKNMA----------KTQIGTPHYMAPEVWKGRPYSYKSDIWS----------LGCLLYEMATFAPPFEARSMQ--D 208 (256)
T ss_pred hhhccCCc----------ccccCCccccCHHHHCCCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCHH--H
Confidence 87654311 1134889999999999888999999999 788888998888886532211 1
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......... ....+..++..+.+++.+||..+|++|||+.|+++.
T Consensus 209 ~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 209 LRYKVQRGK------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHHHHhcCC------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111111111 011223456778999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=277.30 Aligned_cols=254 Identities=24% Similarity=0.346 Sum_probs=203.5
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+|++.+.||+|++|.||+|.+..+++.|++|+++.... ...+.+.+|++++++++||||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 47888999999999999999998999999999975532 34578899999999999999999999976541 24789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++.... .+++..++.++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+
T Consensus 78 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~ 148 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCA 148 (260)
T ss_pred EEEEecCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccE
Confidence 9999999999999998654 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
......... .......++..|+|||...+...+.++|||| +|+++++++++..|+...+.. ..
T Consensus 149 ~~~~~~~~~------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~p~~~~~~~-~~ 211 (260)
T cd06606 149 KRLGDIETG------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWS----------LGCTVIEMATGKPPWSELGNP-MA 211 (260)
T ss_pred Eeccccccc------ccccCCCCCccccCHhhhcCCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCch-HH
Confidence 876553211 0112245889999999998888999999999 788899999988887643300 00
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
....... .......+...+..+.+++.+|+..||++||++.|++.
T Consensus 212 ~~~~~~~-----~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 212 ALYKIGS-----SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHHhccc-----cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0000000 00011122334678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=286.03 Aligned_cols=260 Identities=20% Similarity=0.183 Sum_probs=185.6
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
.+.+|.| |.||.++...+++.||||+++.. .....+.+.+|++++++++||||+++++++...+ ..+++||
T Consensus 7 ~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~-----~~~~~~e 79 (314)
T cd08216 7 GKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDS-----ELYVVSP 79 (314)
T ss_pred hHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCC-----eEEEEEe
Confidence 3444444 45555555558999999999754 2334568999999999999999999999865544 7899999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
|+++|+|.+++...... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.+....
T Consensus 80 ~~~~~~l~~~l~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~ 152 (314)
T cd08216 80 LMAYGSCEDLLKTHFPE----GLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMI 152 (314)
T ss_pred ccCCCCHHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeec
Confidence 99999999999865322 588999999999999999999999 99999999999999999999999999887554
Q ss_pred cccccccccCCCccccccccccccCccccCC--CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc-
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL- 770 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~- 770 (833)
....... ..........++..|+|||++.+ ..++.++|||| +|+++++++++..|+..........
T Consensus 153 ~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws----------~G~il~el~~g~~pf~~~~~~~~~~~ 221 (314)
T cd08216 153 KHGKRQR-VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYS----------VGITACELANGHVPFKDMPATQMLLE 221 (314)
T ss_pred ccccccc-ccccccccccccccccCHHHhcCCCCCCCcchhHHH----------HHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 3221100 01111223457889999998865 35889999999 6777777777777654211000000
Q ss_pred --------------hhhh---cc-------ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 --------------LMEV---MT-------NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 --------------~~~~---~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.... .. ...............+...+.+++.+||..||++|||++|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred HHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00 00000001111223345678899999999999999999999876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=280.16 Aligned_cols=243 Identities=21% Similarity=0.237 Sum_probs=185.2
Q ss_pred eeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHH---HhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEA---LRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 538 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
.||+|+||.||+|.+..+++.||+|.+...... ....+..|..+ ++...||+|+++++++...+ ..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-----KLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCC-----EEEEE
Confidence 489999999999999888999999998643211 12223444443 34457999999998865544 89999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
|||+++|+|.+++.... .+++..++.++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++..
T Consensus 76 ~e~~~g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~ 146 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 146 (278)
T ss_pred EecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccc
Confidence 99999999999987543 689999999999999999999999 999999999999999999999999999875
Q ss_pred cCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 692 LSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
..... .....|+..|+|||++.+. .++.++|||| .|+++++++++..|+......+...
T Consensus 147 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------~G~~l~~l~~g~~p~~~~~~~~~~~ 206 (278)
T cd05606 147 FSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFS----------LGCMLFKLLRGHSPFRQHKTKDKHE 206 (278)
T ss_pred cCccC----------CcCcCCCcCCcCcHHhcCCCCCCcccchHh----------HHHHHHHHHhCCCCCCCCCccchHH
Confidence 43221 1123589999999998754 6899999999 8888999999998875332111111
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
........ ....+..++..+.+++.+|+..+|++|| ++.++++.
T Consensus 207 ~~~~~~~~------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 207 IDRMTLTM------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred HHHHhhcc------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 11110000 0111222456788999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-34 Score=267.33 Aligned_cols=255 Identities=23% Similarity=0.275 Sum_probs=191.4
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeEEEE
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
...||.|+||+|++..++.+|+..|||+++.... .+.+++..|.+...+- +.||||++||.+...+ ..|+.||
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-----dcWiCME 143 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-----DCWICME 143 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-----ceeeeHH
Confidence 3579999999999999999999999999986544 4567788888875555 6999999999975544 7899999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
.|+ .|+..+.+.-.. .....+++.-.-.|..-.++||.||.+.. .|||||+||+|||++..|.+||||||.+....
T Consensus 144 LMd-~SlDklYk~vy~-vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYS-VQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHh-hhHHHHHHHHHH-HHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 996 477655442110 11226888888999999999999999875 99999999999999999999999999997664
Q ss_pred cccccccccCCCccccccccccccCccccCC--CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccch
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~ 771 (833)
+.-.. +..+|..+|||||.+.. ..|+.+||+|| .|++++|.++|.+|+.-++-+-..+.
T Consensus 220 ~SiAk---------T~daGCrpYmAPERi~p~~~gyDiRSDvWS----------LGITL~EvAtG~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 220 DSIAK---------TVDAGCRPYMAPERIDPSDKGYDIRSDVWS----------LGITLYEVATGNFPYRKWDSVFEQLC 280 (361)
T ss_pred HHHHh---------hhccCCccccChhccCCccCCcchhhhhhh----------hcceEeeeecCCCCcchHHHHHHHHH
Confidence 43221 12368999999997653 34899999999 88888899999998764333222222
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.-+. .......... ..-++...+..++..|+.+|-++||...++.+.
T Consensus 281 ~Vv~-gdpp~l~~~~-~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 281 QVVI-GDPPILLFDK-ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHc-CCCCeecCcc-cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2221 1111110111 111256678899999999999999999998764
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=306.19 Aligned_cols=265 Identities=19% Similarity=0.180 Sum_probs=180.7
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCc-eEEEEEEee--------------c---cCCcchhHHHHHHHHHhhcCCCcc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDE-MIVAVKVIN--------------L---KYKGASRSFVAECEALRNIRHRNL 590 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~--------------~---~~~~~~~~~~~E~~~l~~l~h~ni 590 (833)
..++|++.+.||+|+||+||+|..+... ..+++|.+. . ........+.+|++++++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998764322 222222110 0 111223567899999999999999
Q ss_pred ceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 591 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
+++++++...+ ..|+|||++. +++.+++........ ......+++.|+.|++.||+|||+. +||||||||
T Consensus 226 v~l~~~~~~~~-----~~~lv~e~~~-~~l~~~l~~~~~~~~-~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP 295 (501)
T PHA03210 226 LKIEEILRSEA-----NTYMITQKYD-FDLYSFMYDEAFDWK-DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKL 295 (501)
T ss_pred CcEeEEEEECC-----eeEEEEeccc-cCHHHHHhhcccccc-ccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 99999976655 7899999995 588887764332111 1234667889999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+|||++.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||| +|+++
T Consensus 296 ~NILl~~~~~vkL~DFGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lGvil 358 (501)
T PHA03210 296 ENIFLNCDGKIVLGDFGTAMPFEKERE-------AFDYGWVGTVATNSPEILAGDGYCEITDIWS----------CGLIL 358 (501)
T ss_pred HHEEECCCCCEEEEeCCCceecCcccc-------cccccccCCcCCCCchhhcCCCCCcHHHHHH----------HHHHH
Confidence 999999999999999999986644221 1122356999999999999999999999999 55566
Q ss_pred HHHHHHhCCCcccccccc----------------cc------hhhhccccchh----hhhhhhchHHHHHHHHHHhhccC
Q 040925 751 HEFAKTALPEKVMEIVDP----------------SL------LMEVMTNNSMI----QEDKRVKTEECLNAIIRTGVLCS 804 (833)
Q Consensus 751 ~~~~~~~~p~~~~~~~~~----------------~~------~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl 804 (833)
++++++..++......++ .+ ..+.+...... ...........+..+.+++.+|+
T Consensus 359 ~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL 438 (501)
T PHA03210 359 LDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKML 438 (501)
T ss_pred HHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHh
Confidence 666655432210000000 00 00000000000 00000001112345678899999
Q ss_pred CCCCCCCCCHHHHHHH
Q 040925 805 MESPFERMDMRDVVAK 820 (833)
Q Consensus 805 ~~dP~~RPt~~eil~~ 820 (833)
+.||++|||+.|+++.
T Consensus 439 ~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 439 TFDWHLRPGAAELLAL 454 (501)
T ss_pred ccCcccCcCHHHHhhC
Confidence 9999999999999874
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=282.28 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=193.7
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
|++.+.||+|++|.||+|++..+++.||+|+++... ......+.+|++++++++|||++++++++.... .+..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 678899999999999999999889999999997653 333457889999999999999999999986551 247999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++ +|.+++..... .+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||.+.
T Consensus 78 v~e~~~~-~l~~~~~~~~~-----~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~ 148 (287)
T cd07840 78 VFEYMDH-DLTGLLDSPEV-----KFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR 148 (287)
T ss_pred Eeccccc-cHHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEcccccee
Confidence 9999974 99998876531 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc--
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD-- 767 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~-- 767 (833)
....... .......++..|+|||.+.+ ..++.++|||| +|+++++++++..|+......+
T Consensus 149 ~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~s----------lG~~l~el~t~~~p~~~~~~~~~~ 211 (287)
T cd07840 149 PYTKRNS-------ADYTNRVITLWYRPPELLLGATRYGPEVDMWS----------VGCILAELFLGKPIFQGSTELEQL 211 (287)
T ss_pred eccCCCc-------ccccccccccccCCceeeEccccCChHHHHHH----------HHHHHHHHHhCCCCCCCCChHHHH
Confidence 6644321 01112357889999997665 45789999999 6777777777766654211100
Q ss_pred -----------ccchhhh--------ccccchhhhhhhhchHH-HHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 -----------PSLLMEV--------MTNNSMIQEDKRVKTEE-CLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 -----------~~~~~~~--------~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+...... ...........+....+ ++..+.+++.+||..+|++|||++++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000 00000000000011111 26778999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=283.67 Aligned_cols=259 Identities=23% Similarity=0.305 Sum_probs=192.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|++|.||+|++..+++.||+|.++.... ...+.+.+|++++++++||||+++++++.... ..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEK-----RL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCC-----eE
Confidence 579999999999999999999998999999999864422 23456889999999999999999999976544 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-CCcEEEcccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVCDFG 687 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfG 687 (833)
++||||++ +++.+++...... .+++..+..++.|++.||+|||+. +++||||+|+||+++. ++.+||+|||
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg 148 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDF----AKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFG 148 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCC----CcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccc
Confidence 99999996 5888887654321 467888999999999999999999 9999999999999985 5579999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
++........ ......|++.|+|||++.+. .++.++|||| .|+++++++++..|+...+..
T Consensus 149 ~~~~~~~~~~--------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~s----------lG~i~~~l~tg~~pf~~~~~~ 210 (294)
T PLN00009 149 LARAFGIPVR--------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWS----------VGCIFAEMVNQKPLFPGDSEI 210 (294)
T ss_pred cccccCCCcc--------ccccCceeecccCHHHHhCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCHH
Confidence 9975533211 11123578999999987664 5789999999 778888888887776422111
Q ss_pred cccchh-hhccc-------------------cchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLM-EVMTN-------------------NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~-~~~~~-------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+..... ..... ...............+..+.+++.+|++.||++||++.++++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 211 DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred HHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00000 0000000001112345668899999999999999999999874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=280.63 Aligned_cols=256 Identities=19% Similarity=0.231 Sum_probs=189.2
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCceEeE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
|++.+.||+|++|.||+|....+++.||+|+++.... .......+|+.+++++. ||||+++++++.+.. .+..++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~---~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRK---TGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCC---CCcEEE
Confidence 6788999999999999999998999999999875422 22334567899999985 999999999986541 247899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||++ |++.+.+..... .+++.+++.++.|++.||+|||+. +++||||||+||+++. +.+||+|||.++
T Consensus 78 v~e~~~-~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~ 147 (282)
T cd07831 78 VFELMD-MNLYELIKGRKR-----PLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCR 147 (282)
T ss_pred EEecCC-ccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccc
Confidence 999997 588888865431 689999999999999999999999 9999999999999999 999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccC-CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc--
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD-- 767 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~-- 767 (833)
....... .....+++.|+|||++. +..++.++|||| .|+++++++++..|+...+..+
T Consensus 148 ~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lGv~l~el~~~~~p~~~~~~~~~~ 208 (282)
T cd07831 148 GIYSKPP---------YTEYISTRWYRAPECLLTDGYYGPKMDIWA----------VGCVFFEILSLFPLFPGTNELDQI 208 (282)
T ss_pred ccccCCC---------cCCCCCCcccCChhHhhcCCCCCcchhHHH----------HHHHHHHHHcCCcCCCCCCHHHHH
Confidence 6543211 11235889999999764 455788999999 6777777777766653221110
Q ss_pred -----------ccchhhhcccc---ch----hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 -----------PSLLMEVMTNN---SM----IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 -----------~~~~~~~~~~~---~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+.+........ .. ...........++..+.+++.+||.+||++|||++++++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 00 0000011123457889999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=283.45 Aligned_cols=266 Identities=21% Similarity=0.290 Sum_probs=195.8
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCC----
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTD---- 601 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 601 (833)
...++|++.+.||+|++|.||+|++..+++.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 456789999999999999999999998899999999975432 23356788999999999999999999876543
Q ss_pred -CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc
Q 040925 602 -FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV 680 (833)
Q Consensus 602 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 680 (833)
..+....++||||+++ ++.+.+..... .+++..++.++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~ 154 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLV-----HFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQ 154 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCc
Confidence 1223478999999975 77777765421 689999999999999999999999 9999999999999999999
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
+||+|||.+........ .......+++.|+|||++.+ ..++.++|||| +|++++++.++..|
T Consensus 155 ~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s----------lG~~~~el~~g~~~ 217 (302)
T cd07864 155 IKLADFGLARLYNSEES-------RPYTNKVITLWYRPPELLLGEERYGPAIDVWS----------CGCILGELFTKKPI 217 (302)
T ss_pred EEeCcccccccccCCcc-------cccccceeccCccChHHhcCCCCCCchhHHHH----------HHHHHHHHHhCCCC
Confidence 99999999986543221 01112346888999998764 35788999999 67777777777666
Q ss_pred Ccccccccc-------------cchhhhcccc--------chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHH
Q 040925 760 EKVMEIVDP-------------SLLMEVMTNN--------SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVV 818 (833)
Q Consensus 760 ~~~~~~~~~-------------~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil 818 (833)
+...+..+. ....+..... .......+......+..+.+++.+||..||++|||+++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 297 (302)
T cd07864 218 FQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297 (302)
T ss_pred CCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 542211100 0000000000 0000000111123467889999999999999999999997
Q ss_pred H
Q 040925 819 A 819 (833)
Q Consensus 819 ~ 819 (833)
+
T Consensus 298 ~ 298 (302)
T cd07864 298 N 298 (302)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=290.87 Aligned_cols=264 Identities=20% Similarity=0.249 Sum_probs=193.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC--------
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDF-------- 602 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------- 602 (833)
++|++.+.||.|+||.||+|.+..+++.||+|.+........+.+.+|++++++++||||+++++++.....
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 689999999999999999999999999999999976655556778999999999999999999987654321
Q ss_pred -CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-CCc
Q 040925 603 -KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-DMV 680 (833)
Q Consensus 603 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~ 680 (833)
......++||||++ ++|.+++... .+++..++.++.|++.||.|||+. ||+||||||+||+++. ++.
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~ 153 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLV 153 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCce
Confidence 11235799999997 5999888643 588999999999999999999999 9999999999999974 557
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
+||+|||.++......... .......|+..|+|||++.+ ..++.++|||| +|++++++.++..|
T Consensus 154 ~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwS----------lGvil~el~~g~~p 218 (342)
T cd07854 154 LKIGDFGLARIVDPHYSHK-----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA----------AGCIFAEMLTGKPL 218 (342)
T ss_pred EEECCcccceecCCccccc-----cccccccccccccCHHHHhCccccCchhhHHH----------HHHHHHHHHhCCCC
Confidence 8999999997653321110 11112357899999997654 56888999999 77778888888777
Q ss_pred Cccccccc-------------ccchhhh-------cc-ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHH
Q 040925 760 EKVMEIVD-------------PSLLMEV-------MT-NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVV 818 (833)
Q Consensus 760 ~~~~~~~~-------------~~~~~~~-------~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil 818 (833)
+......+ +...... .. ...................+.+++.+||..||++|||++|++
T Consensus 219 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 219 FAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred CCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 64211000 0000000 00 000000000001122456788999999999999999999998
Q ss_pred HH
Q 040925 819 AK 820 (833)
Q Consensus 819 ~~ 820 (833)
+.
T Consensus 299 ~h 300 (342)
T cd07854 299 MH 300 (342)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=278.84 Aligned_cols=244 Identities=20% Similarity=0.250 Sum_probs=186.4
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHH-hhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEAL-RNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|++|.||+|.+..+++.||+|+++.... .....+..|..++ ...+|||++++++++...+ ..++||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD-----YLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC-----eEEEEE
Confidence 579999999999999988899999999864321 1123345555544 4458999999999976544 899999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++...
T Consensus 77 e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 147 (260)
T cd05611 77 EYLNGGDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNG 147 (260)
T ss_pred eccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceec
Confidence 9999999999997654 688999999999999999999999 9999999999999999999999999998754
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
.. .....|++.|+|||...+..++.++|||| .|++++++.++..|+..... .....
T Consensus 148 ~~------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~p~~~~~~--~~~~~ 203 (260)
T cd05611 148 LE------------NKKFVGTPDYLAPETILGVGDDKMSDWWS----------LGCVIFEFLFGYPPFHAETP--DAVFD 203 (260)
T ss_pred cc------------cccCCCCcCccChhhhcCCCCcchhhhHH----------HHHHHHHHHHCCCCCCCCCH--HHHHH
Confidence 32 11235889999999998888999999999 78889999999888753221 01111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
......... .......++..+.+++.+||+.||++|||+.++.+.+
T Consensus 204 ~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 204 NILSRRINW---PEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHhcccCC---CCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 111100000 0111123567889999999999999999776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=287.76 Aligned_cols=263 Identities=19% Similarity=0.259 Sum_probs=194.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCC-CCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDF-KGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 606 (833)
.++|.+.+.||+|++|.||+|++..+++.||+|+++... ......+.+|++++++++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999998899999999986432 2223567899999999999999999998765431 2234
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+.. ++.++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH--------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred eEEEEeccccc-CHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence 57999999964 78776532 578999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|+++..... .....||+.|+|||++.+ ..++.++|||| +|+++++++++..|+...+.
T Consensus 162 g~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lGvil~el~~g~~pf~~~~~ 220 (342)
T cd07879 162 GLARHADAE-----------MTGYVVTRWYRAPEVILNWMHYNQTVDIWS----------VGCIMAEMLTGKTLFKGKDY 220 (342)
T ss_pred CCCcCCCCC-----------CCCceeeecccChhhhcCccccCchHHHHH----------HHHHHHHHHhCCCCCCCCCH
Confidence 998754321 112458899999998766 46889999999 77778888887777642211
Q ss_pred cc-------------ccchh--------hhccc-cchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH--H
Q 040925 766 VD-------------PSLLM--------EVMTN-NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK--L 821 (833)
Q Consensus 766 ~~-------------~~~~~--------~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L 821 (833)
.+ +.+.. ..... ............+.....+.+++.+||+.||++||+++|++.. +
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f 300 (342)
T cd07879 221 LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF 300 (342)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence 10 00000 00000 0000000000011234568899999999999999999999865 5
Q ss_pred HHhh
Q 040925 822 CHTR 825 (833)
Q Consensus 822 ~~i~ 825 (833)
+...
T Consensus 301 ~~~~ 304 (342)
T cd07879 301 DSFR 304 (342)
T ss_pred hhcc
Confidence 5543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=280.58 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=192.0
Q ss_pred eccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 539 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
||+|++|.||+|++..+++.||+|++..... ...+.+.+|++++++++||||+++++.+... ...|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-----KNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-----cEEEEEEecC
Confidence 6899999999999998899999999864432 3456788999999999999999999886443 4899999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~ 146 (265)
T cd05579 76 PGGDLASLLENVG------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVR 146 (265)
T ss_pred CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccC
Confidence 9999999998654 689999999999999999999999 9999999999999999999999999998754332
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhc
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVM 775 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~ 775 (833)
................++..|+|||+..+..++.++|||| +|+.+++++++..|+..... ........
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~s----------lG~~~~~l~~g~~p~~~~~~--~~~~~~~~ 214 (265)
T cd05579 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWS----------LGCILYEFLVGIPPFHGETP--EEIFQNIL 214 (265)
T ss_pred cccccccccccccCcccCccccCHHHhcCCCCCcchhhHH----------HHHHHHHHHhCCCCCCCCCH--HHHHHHHh
Confidence 1110000011122346889999999998888999999999 78888999998888653221 11111111
Q ss_pred cccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 776 TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
..... .......+..+.+++.+||+.+|++|||+.++.+.+
T Consensus 215 ~~~~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 215 NGKIE-----WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred cCCcC-----CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 10100 001111267789999999999999999995554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=286.80 Aligned_cols=265 Identities=21% Similarity=0.292 Sum_probs=195.7
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 605 (833)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++++ +||||+++++++...+ .
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~---~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN---D 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC---C
Confidence 456899999999999999999999888999999988532 222345677899999999 9999999999875432 3
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||++ ++|.+++... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d 150 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLAD 150 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEee
Confidence 46899999997 5999988753 478889999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
||.+.......... .........||+.|+|||++.+ ..++.++|||| +|+++++++++..|+....
T Consensus 151 ~g~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~s----------lG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 151 FGLARSLSELEENP---ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWS----------VGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccchhccccccccc---cCcchhcccccccccCceeeeccccccccchHHH----------HHHHHHHHHhCCCCCCCCC
Confidence 99998664432110 0112223568999999998754 45788999999 7777888888877653211
Q ss_pred ccccc---------------------chhhhccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPS---------------------LLMEVMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~---------------------~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..+.. .......... ............++.++.+++.+||+.||++|||+.++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 218 TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 11000 0000000000 00000000111245678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=277.51 Aligned_cols=258 Identities=22% Similarity=0.308 Sum_probs=193.8
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhc---CCCccceEeeEeecCCCCCCce
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNI---RHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 607 (833)
|++.+.||+|++|.||+|++..+++.||+|+++.... .....+.+|+.+++++ +||||+++++++...+..+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 6788999999999999999988899999999974422 2234567788887776 5999999999987765334445
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.+++|||++ ++|.+++...... .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~----~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg 152 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKP----GLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFG 152 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccC
Confidence 899999997 4899988764422 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
.+........ .....++..|+|||++.+..++.++|||| +|++++++.++..|+......+
T Consensus 153 ~~~~~~~~~~---------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s----------~G~~l~~l~~~~~~~~~~~~~~ 213 (287)
T cd07838 153 LARIYSFEMA---------LTSVVVTLWYRAPEVLLQSSYATPVDMWS----------VGCIFAELFRRRPLFRGTSEAD 213 (287)
T ss_pred cceeccCCcc---------cccccccccccChHHhccCCCCCcchhhh----------HHHHHHHHHhCCCcccCCChHH
Confidence 9976543211 11234789999999999888999999999 6777777777765543211100
Q ss_pred ccchhhhcc--------------------ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 PSLLMEVMT--------------------NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 ~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
....... ..............+....+.+++.+||..||++||+++|++.
T Consensus 214 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 214 --QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred --HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000 0000000011112345677889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-32 Score=267.01 Aligned_cols=266 Identities=20% Similarity=0.265 Sum_probs=197.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-C-C----ccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-H-R----NLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~~~~~~~~~~~~ 603 (833)
.++|.++..+|+|.||.|-++.+.+++..||||+++.. ....+...-|+++++++. + | -+|.+.+| |+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w-----Fd 161 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDW-----FD 161 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh-----hh
Confidence 67999999999999999999999999999999999743 234566788999999994 2 2 36777777 44
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC------
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH------ 677 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~------ 677 (833)
..++.|+|+|.+ |-|+++++..+... +++...++.+++|++++++|||+. +++|-||||+||++..
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~----~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~ 233 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYI----PFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKT 233 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCcc----ccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEE
Confidence 456999999998 55999999987643 799999999999999999999999 9999999999999832
Q ss_pred --------------CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCcc
Q 040925 678 --------------DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAV 743 (833)
Q Consensus 678 --------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~ 743 (833)
+..+|++|||.|++..... ..++.|..|+|||++.+-.++.++||||.||.+.++
T Consensus 234 ~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El 302 (415)
T KOG0671|consen 234 YNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL 302 (415)
T ss_pred eccCCccceeccCCCcceEEEecCCcceeccCc-----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence 2358999999998654322 246789999999999999999999999999999887
Q ss_pred ccCCcc-----------HHHHHHHhCCCcccccc-----------c---ccchh--hhccccchhhhhhhhchHHHHHHH
Q 040925 744 FNEGHS-----------LHEFAKTALPEKVMEIV-----------D---PSLLM--EVMTNNSMIQEDKRVKTEECLNAI 796 (833)
Q Consensus 744 ~~~g~~-----------l~~~~~~~~p~~~~~~~-----------~---~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l 796 (833)
|.+-.. +-|.+-|..|..+.... | ..... .................+.....+
T Consensus 303 ytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 303 YTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred eccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 754221 22223333343321111 0 00000 000000000111112233445679
Q ss_pred HHHhhccCCCCCCCCCCHHHHHHH
Q 040925 797 IRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 797 ~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+++.+|+..||.+|+|+.|++..
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHHccCccccccHHHHhcC
Confidence 999999999999999999999864
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=285.97 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=195.4
Q ss_pred HHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 525 ELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 525 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
++...+++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~- 82 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL- 82 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC-
Confidence 34456789999999999999999999999999999999885432 223467889999999999999999999875432
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
...++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||+|+||++++++.+|
T Consensus 83 ---~~~~lv~e~~-~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~ 148 (328)
T cd07856 83 ---EDIYFVTELL-GTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLK 148 (328)
T ss_pred ---CcEEEEeehh-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEE
Confidence 3688999999 56999888643 578888899999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
|+|||.+...... .....+++.|+|||++.+ ..++.++|||| +|+++++++++..|+.
T Consensus 149 l~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lG~il~el~tg~~~f~ 207 (328)
T cd07856 149 ICDFGLARIQDPQ-----------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWS----------AGCIFAEMLEGKPLFP 207 (328)
T ss_pred eCccccccccCCC-----------cCCCcccccccCceeeeccCCcCcHHHHHH----------HHHHHHHHHhCCCCCC
Confidence 9999998754321 112357889999998765 56899999999 7777888888776654
Q ss_pred ccccccc-------------cchhh--------hccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 762 VMEIVDP-------------SLLME--------VMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 762 ~~~~~~~-------------~~~~~--------~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
..+.... ++... ...... ............++..+.+++.+||+.+|++|||+++++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 208 GKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 2211000 00000 000000 0000000011123567899999999999999999999976
Q ss_pred H
Q 040925 820 K 820 (833)
Q Consensus 820 ~ 820 (833)
.
T Consensus 288 ~ 288 (328)
T cd07856 288 H 288 (328)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=282.86 Aligned_cols=256 Identities=24% Similarity=0.327 Sum_probs=201.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 606 (833)
++|.+.+.||+|++|.||+|+...+++.||+|++.... ....+.+.+|++++++++ ||||+++++++... +
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-----~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-----E 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-----c
Confidence 36899999999999999999999899999999986431 223467889999999998 99999999986444 4
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++++|.+++.... .+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++++||
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df 146 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDF 146 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCC
Confidence 8999999999999999998754 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccc------------cCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 687 GLAKFLSDHQLDTAV------------KTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 687 G~a~~~~~~~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
|++............ ..........|+..|+|||+..+..++.++|||| .|..+++++
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~s----------lG~~l~~l~ 216 (280)
T cd05581 147 GTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWA----------LGCIIYQML 216 (280)
T ss_pred ccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHH----------HHHHHHHHH
Confidence 999866543321100 0012223456899999999988888999999999 788888888
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH----HHHHH
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM----RDVVA 819 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~eil~ 819 (833)
++..|+...... ........ .....+...++.+.+++.+||..||++|||+ +++++
T Consensus 217 ~g~~p~~~~~~~--~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 217 TGKPPFRGSNEY--LTFQKILK-------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred hCCCCCCCccHH--HHHHHHHh-------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 888886533211 00001100 0111223346678899999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=282.58 Aligned_cols=254 Identities=20% Similarity=0.306 Sum_probs=192.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|++|.||+|++..+++.||||.++.... .....+..|+.++.+.. ||||+++++++.... .
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~ 88 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDS-----D 88 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCC-----e
Confidence 4678999999999999999999998899999999975432 23455677887777775 999999999976554 7
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||++ +++.+++..... .+++..+..++.|++.|++|||+.. +|+||||+|+||++++++.+||+|||
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg 160 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFG 160 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccc
Confidence 999999985 478777765332 6899999999999999999999732 89999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCC----CCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE----ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
++........ .....+++.|+|||++.+.. ++.++|||| +|+++++++++..|+...
T Consensus 161 ~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~s----------lG~il~el~~g~~p~~~~ 221 (296)
T cd06618 161 ISGRLVDSKA---------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWS----------LGISLVELATGQFPYKNC 221 (296)
T ss_pred cchhccCCCc---------ccCCCCCccccCHhhcCCCCCccccccchhHHH----------HHHHHHHHHhCCCCCCcc
Confidence 9876543211 11234788999999987554 788999999 888889999988887532
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... ............. .......++.++.+++.+||..||++||+++++++.
T Consensus 222 ~~~-~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 222 KTE-FEVLTKILQEEPP----SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred hhH-HHHHHHHhcCCCC----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110 0111111111000 000111245678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=280.02 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=195.0
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
|++.+.||+|++|.||+|....+++.+|+|.++.... .....+.+|++++++++||||+++++++... ...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 6778999999999999999988999999999875432 2346788999999999999999999986554 48999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++ ++.+++..... .+++.+++.++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||.+.
T Consensus 76 v~e~~~~-~l~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~ 146 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQR-----GLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLAR 146 (283)
T ss_pred EEeccCC-CHHHHHHhhcc-----cCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence 9999975 89888876431 689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc-
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP- 768 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~- 768 (833)
....... ......++..|+|||.+.+. .++.++|+|| .|+++++++++..++...+..+.
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~s----------lG~~l~~l~tg~~~~~~~~~~~~~ 208 (283)
T cd05118 147 SFGSPVR--------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWS----------VGCIFAELLSRRPLFPGKSEIDQL 208 (283)
T ss_pred ecCCCcc--------cccCccCcccccCcHHHhcCCCCCchhHHHH----------HHHHHHHHHhCCCCCCCCCHHHHH
Confidence 6654320 11123588899999988776 7899999999 67777777777766532211110
Q ss_pred ------------cchhhhcc--------ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 769 ------------SLLMEVMT--------NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 769 ------------~~~~~~~~--------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
........ .............++++..+.+++.+||+.||.+||++++++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 209 FKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000 0000000001122346778999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=285.61 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=192.0
Q ss_pred CCccCceeccCcceEEEEEEECCC--ceEEEEEEeeccCC--cchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCc
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGED--EMIVAVKVINLKYK--GASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 606 (833)
+|++.+.||+|+||.||+|++..+ +..||+|+++.... ...+.+.+|+++++++ +||||+++++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 488899999999999999999877 88999999864322 2245678899999999 5999999998754331 2234
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..+++|||+. ++|.+++.... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Df 149 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDF 149 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcC
Confidence 6789999986 69999987544 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|.++........ .........||+.|+|||+..+ ..++.++|||| .|+++++++++..|+...+.
T Consensus 150 g~a~~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~s----------lGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 150 GLARGFSENPGE----NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWS----------VGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred CCceeccccccc----ccccccCcccCccccCcHHHhCCCCCCcHHHHHH----------HHHHHHHHHhCCcCCCCCCH
Confidence 999866543211 1111223568999999998765 56899999999 67777777777666542110
Q ss_pred c-------------cccchhhhcccc-------c-hhh-hhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 V-------------DPSLLMEVMTNN-------S-MIQ-EDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~-------------~~~~~~~~~~~~-------~-~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. +........... . ... .............+.+++.+|++.||++|||+.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000000000000 0 000 00000011124678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=284.09 Aligned_cols=271 Identities=20% Similarity=0.256 Sum_probs=194.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCCCccceEeeEeecCCC---CC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRHRNLIKIITICSSTDF---KG 604 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 604 (833)
.++|++.+.||+|++|.||+|++..+++.||+|++...... ....+.+|++++++++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 57899999999999999999999989999999998644322 23467889999999999999999988654331 12
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
....++||||+++ ++.+.+..... .+++.++..++.|+++||+|||+. +|+||||||+||++++++.+||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~-----~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 157 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSV-----KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIA 157 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEC
Confidence 3467999999974 78777765321 689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCccccccccc---CCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 685 DFGLAKFLSDHQLDTAVK---TPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
|||+++............ .........|++.|+|||++.+ ..++.++|||| +|+++++++++..|+
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lG~il~el~~g~~~~ 227 (311)
T cd07866 158 DFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWG----------IGCVFAEMFTRRPIL 227 (311)
T ss_pred cCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHH----------HHHHHHHHHhCCCCC
Confidence 999998654432211100 1112234568899999998765 35789999999 777778887777665
Q ss_pred cccccccc--------------cc-----hhhhc--cccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 761 KVMEIVDP--------------SL-----LMEVM--TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 761 ~~~~~~~~--------------~~-----~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
......+. .+ ..... .......+..........+.+.+++.+|+..||++|||+.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 31110000 00 00000 00000000000111223467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=305.67 Aligned_cols=261 Identities=21% Similarity=0.238 Sum_probs=206.6
Q ss_pred hHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeec
Q 040925 523 YAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSS 599 (833)
Q Consensus 523 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 599 (833)
..++.-..++|.+++.||+|+||.|..++++.+++.||+|++... ......-|..|-.+|..-+.+-|+.++..
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyA--- 143 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYA--- 143 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHH---
Confidence 456666778999999999999999999999999999999999753 23344678999999999999999999877
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
|++..+.|+|||||+||+|-.++.... ++++..++.|+..|+-||.-+|+. |+|||||||+|||+|..|
T Consensus 144 --FQD~~~LYlVMdY~pGGDlltLlSk~~------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~G 212 (1317)
T KOG0612|consen 144 --FQDERYLYLVMDYMPGGDLLTLLSKFD------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSG 212 (1317)
T ss_pred --hcCccceEEEEecccCchHHHHHhhcC------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccC
Confidence 455559999999999999999998875 699999999999999999999999 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccC----C-CCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM----G-SEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
.+||+|||.+..+..++... +...+|||-|++||+++ + +.|+..+|+|| .|+.+|||+
T Consensus 213 HikLADFGsClkm~~dG~V~-------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWS----------lGV~~YEMl 275 (1317)
T KOG0612|consen 213 HIKLADFGSCLKMDADGTVR-------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWS----------LGVFMYEML 275 (1317)
T ss_pred cEeeccchhHHhcCCCCcEE-------eccccCCCCccCHHHHHhhcCCccccCCccchhh----------hHHHHHHHH
Confidence 99999999998877543322 22357999999999875 2 56899999999 888999999
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC---HHHHHHH
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD---MRDVVAK 820 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~ 820 (833)
.|.-|+-....+...-..--.+....++ .. .+++....++|.+.+ -+|+.|-. ++++-.+
T Consensus 276 yG~TPFYadslveTY~KIm~hk~~l~FP--~~---~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 276 YGETPFYADSLVETYGKIMNHKESLSFP--DE---TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred cCCCcchHHHHHHHHHHHhchhhhcCCC--cc---cccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 9999886544443322211111122111 11 224555666666655 57888887 8877654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=285.76 Aligned_cols=265 Identities=19% Similarity=0.288 Sum_probs=191.8
Q ss_pred cCCcc-CceeccCcceEEEEEEECCCceEEEEEEeeccCCcc--------------hhHHHHHHHHHhhcCCCccceEee
Q 040925 531 GEFSS-SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA--------------SRSFVAECEALRNIRHRNLIKIIT 595 (833)
Q Consensus 531 ~~y~~-~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~~ 595 (833)
++|.. .+.||+|+||.||+|.+..+++.||||.++...... ...+.+|++++++++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 46654 477999999999999998899999999986432211 124778999999999999999999
Q ss_pred EeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee
Q 040925 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL 675 (833)
Q Consensus 596 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll 675 (833)
++...+ ..++||||++ |+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 88 ~~~~~~-----~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill 152 (335)
T PTZ00024 88 VYVEGD-----FINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFI 152 (335)
T ss_pred EEecCC-----cEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEE
Confidence 976544 8999999997 69999987643 689999999999999999999999 99999999999999
Q ss_pred cCCCcEEEcccccccccCcccccccc------cCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCc
Q 040925 676 DHDMVAHVCDFGLAKFLSDHQLDTAV------KTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGH 748 (833)
Q Consensus 676 ~~~~~~kL~DfG~a~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~ 748 (833)
+.++.+||+|||.+............ ..........+++.|+|||++.+. .++.++|||| .|+
T Consensus 153 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s----------lG~ 222 (335)
T PTZ00024 153 NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWS----------VGC 222 (335)
T ss_pred CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHH----------HHH
Confidence 99999999999999766522111000 001111223578899999988764 4689999999 677
Q ss_pred cHHHHHHHhCCCcccccccccc-hhhhcc------------------ccchhhhhhhhchHHHHHHHHHHhhccCCCCCC
Q 040925 749 SLHEFAKTALPEKVMEIVDPSL-LMEVMT------------------NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPF 809 (833)
Q Consensus 749 ~l~~~~~~~~p~~~~~~~~~~~-~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 809 (833)
++++++++..|+...+..+... ...... ................+..+.+++.+||..||+
T Consensus 223 ~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 302 (335)
T PTZ00024 223 IFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302 (335)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCch
Confidence 7778877776654221110000 000000 000000000011122356788999999999999
Q ss_pred CCCCHHHHHHH
Q 040925 810 ERMDMRDVVAK 820 (833)
Q Consensus 810 ~RPt~~eil~~ 820 (833)
+|||++|++..
T Consensus 303 ~R~s~~~~l~~ 313 (335)
T PTZ00024 303 ERISAKEALKH 313 (335)
T ss_pred hccCHHHHhcC
Confidence 99999999863
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=281.17 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=192.0
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.|+..+.||+|++|.||+|++..++..||+|.+.... ....+++.+|+++++.++|+|++++++++.... ..
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 90 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----TA 90 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC-----ee
Confidence 4777889999999999999999889999999986432 223356788999999999999999999976554 78
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+. |++.+++..... .+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 91 ~lv~e~~~-~~l~~~~~~~~~-----~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 91 WLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred EEEEEccC-CCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccc
Confidence 99999996 688887754331 588999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
+...... ....|++.|+|||++. ...++.++|||| +|+++++++++..|+...+.
T Consensus 162 ~~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~s----------lG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 162 ASIMAPA------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWS----------LGITCIELAERKPPLFNMNA 219 (308)
T ss_pred ceeecCc------------ccccCCccccCHHHHhhcccCCCCcccchHH----------HHHHHHHHHcCCCCCccccH
Confidence 8754321 1235889999999864 356788999999 77788888888877542211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
... ......... .......++..+.+++.+||..+|++||+++++++.-
T Consensus 220 ~~~--~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 220 MSA--LYHIAQNES-----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred HHH--HHHHhhcCC-----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 110 000000000 1111223566788999999999999999999998763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=286.47 Aligned_cols=262 Identities=19% Similarity=0.244 Sum_probs=195.0
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCC-C
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDF-K 603 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~ 603 (833)
....++|++.+.||+|++|.||+|.+..++..||||++..... ...+.+.+|++++++++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3356789999999999999999999998999999999864322 223568899999999999999999998754431 1
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
.....++||||+ +++|.+++... .+++..++.++.|+++||+|||+. ||+||||||+||+++.++.+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 223568999999 67999888643 589999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
+|||++...... .....+++.|+|||++.+ ..++.++|+|| .|+++++++++..|+..
T Consensus 160 ~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~ll~~l~~g~~pf~~ 218 (343)
T cd07880 160 LDFGLARQTDSE-----------MTGYVVTRWYRAPEVILNWMHYTQTVDIWS----------VGCIMAEMLTGKPLFKG 218 (343)
T ss_pred eecccccccccC-----------ccccccCCcccCHHHHhCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCC
Confidence 999999754321 112357899999998765 45888999999 77777888877776642
Q ss_pred cccccc-------------cchhh--------hccccchh-hhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 763 MEIVDP-------------SLLME--------VMTNNSMI-QEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 763 ~~~~~~-------------~~~~~--------~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....+. .+... ........ ..........+...+.+++.+|++.||++|||+.++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 219 HDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 211000 00000 00000000 000000112345568899999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=279.46 Aligned_cols=245 Identities=26% Similarity=0.343 Sum_probs=190.6
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
|...+.||+|++|.||+|++..+++.||+|.+..... ...+.+.+|++++++++|||++++++++.+.. ..+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEH-----TAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EEE
Confidence 6667889999999999999988999999999864322 22356788999999999999999999976654 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+. |++.+++..... .+++.+++.++.|++.|++|||+. |++||||||+||+++.++.+||+|||++
T Consensus 98 lv~e~~~-~~l~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~ 168 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKK-----PLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA 168 (313)
T ss_pred EEEecCC-CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCC
Confidence 9999996 588887765432 589999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
...... ....|+..|+|||++. ...++.++|||| +|++++++.++..|+...+..
T Consensus 169 ~~~~~~------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s----------lGvil~el~~g~~p~~~~~~~ 226 (313)
T cd06633 169 SKSSPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWS----------LGITCIELAERKPPLFNMNAM 226 (313)
T ss_pred cccCCC------------CCccccccccChhhccccCCCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCChH
Confidence 643211 1245899999999874 456888999999 788888888888776432211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... ........ .......++..+.+++.+||+.+|.+||++.+++..
T Consensus 227 ~~~--~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 227 SAL--YHIAQNDS-----PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HHH--HHHHhcCC-----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 00000000 011122344568899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=257.56 Aligned_cols=265 Identities=19% Similarity=0.239 Sum_probs=201.9
Q ss_pred hHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCC
Q 040925 523 YAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTD 601 (833)
Q Consensus 523 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 601 (833)
+.++-+-++ +.||+|+|+.|--++...++..||||++.+.......++.+|++++.+.+ |+||+++++++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF---- 145 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF---- 145 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh----
Confidence 455555554 68999999999999999999999999998776667789999999999996 99999999995
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC--
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-- 679 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 679 (833)
++...+|+|||-|.||+|..+|.++. .+++.++.++..+|+.||.|||.+ ||.|||+||+|||-.+-.
T Consensus 146 -Edd~~FYLVfEKm~GGplLshI~~~~------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~v 215 (463)
T KOG0607|consen 146 -EDDTRFYLVFEKMRGGPLLSHIQKRK------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKV 215 (463)
T ss_pred -cccceEEEEEecccCchHHHHHHHhh------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCc
Confidence 44459999999999999999999876 799999999999999999999999 999999999999986543
Q ss_pred -cEEEcccccccccCcccccccccCCCccccccccccccCccccC---C--CCCCcccccccCCcCCCccccCCccHHHH
Q 040925 680 -VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---G--SEASMTGDIFTGRRPIDAVFNEGHSLHEF 753 (833)
Q Consensus 680 -~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~Di~s~~~~~~~~~~~g~~l~~~ 753 (833)
-+|||||.++.-+.....-....+ ....+.+|+..|||||+.. + ..|+.+.|.|| .|+++|-|
T Consensus 216 sPvKiCDfDLgSg~k~~~~~spast-P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwS----------LGvIlYIm 284 (463)
T KOG0607|consen 216 SPVKICDFDLGSGIKLNNDCSPAST-PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWS----------LGVILYIM 284 (463)
T ss_pred CceeeeccccccccccCCCCCCCCC-ccccCcccchhhcchhHHhhhccccccccccccHHH----------HHHHHHHH
Confidence 589999988764432221111111 2223467999999999632 2 34777888888 89999999
Q ss_pred HHHhCCCcccccccccch------------hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 754 AKTALPEKVMEIVDPSLL------------MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 754 ~~~~~p~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
+.|..|+.-.-..|-.|- .+.++..... .+......++.+..+++...+.+||.+|-++.+++.
T Consensus 285 LsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYe--FPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 285 LSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYE--FPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCc--CChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 999988752111222211 1111111111 112233456777889999999999999999999876
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=277.42 Aligned_cols=256 Identities=22% Similarity=0.271 Sum_probs=189.4
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-chhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCceEeE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-ASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
|++.+.||+|++|.||+|+...+++.||+|++...... ......+|+..+++++ ||||+++++++... +..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-----~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN-----DELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-----CcEEE
Confidence 67889999999999999999888999999998644322 2234567999999999 99999999997554 48899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+ +|+|.+++...... .+++.++..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||.+.
T Consensus 76 v~e~~-~~~l~~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGK----PFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred EEecC-CCCHHHHHHhcccc----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 99999 78999988765421 689999999999999999999999 99999999999999999999999999997
Q ss_pred ccCcccccccccCCCccccccccccccCccccC-CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
....... .....|+..|+|||++. ...++.++|+|| +|++++++.++..|+......+..
T Consensus 148 ~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s----------~G~~l~el~~g~~~~~~~~~~~~~ 208 (283)
T cd07830 148 EIRSRPP---------YTDYVSTRWYRAPEILLRSTSYSSPVDIWA----------LGCIMAELYTLRPLFPGSSEIDQL 208 (283)
T ss_pred eccCCCC---------cCCCCCcccccCceeeecCcCcCCccchhh----------HHHHHHHHHhCCCccCCCChHHHH
Confidence 6543211 11245889999999874 455789999999 677777777776554321111000
Q ss_pred c-------------h------hhhccccchhh--hhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 L-------------L------MEVMTNNSMIQ--EDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~-------------~------~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. . ........... .......+.....+.+++.+||+.||++|||++|++..
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 209 YKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred HHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0 0 00000000000 00000011124678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.3e-32 Score=270.90 Aligned_cols=264 Identities=22% Similarity=0.286 Sum_probs=197.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-------CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-------KGASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
++|-....||+|+|+.||+|.+-..++.||||+-.... ....+...+|.+|.+.+.||.||++|+|+.-+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt-- 540 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT-- 540 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc--
Confidence 46888899999999999999999889999999864321 112345778999999999999999999985443
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec---CCCc
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD---HDMV 680 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~ 680 (833)
+.+|-|+|||+|-+|.-|++.++ .+++.+++.|+.||+.||.||.+. .|+|||-||||.|||+- ..|.
T Consensus 541 --dsFCTVLEYceGNDLDFYLKQhk------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGe 611 (775)
T KOG1151|consen 541 --DSFCTVLEYCEGNDLDFYLKQHK------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGE 611 (775)
T ss_pred --ccceeeeeecCCCchhHHHHhhh------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccce
Confidence 57899999999999999999876 789999999999999999999987 78999999999999994 4578
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCC----CCCCcccccccCCcCCCccccCCccHHHHHHH
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG----SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
+||.|||+++.+.++...... ....+....||.+|.+||.+.- .+.+.|+|||| .|+++|..+.|
T Consensus 612 IKITDFGLSKIMdddSy~~vd-GmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWS----------vGVIFyQClYG 680 (775)
T KOG1151|consen 612 IKITDFGLSKIMDDDSYNSVD-GMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWS----------VGVIFYQCLYG 680 (775)
T ss_pred eEeeecchhhhccCCccCccc-ceeeecccCceeeecCcceeecCCCCCccccceeeEe----------eehhhhhhhcc
Confidence 999999999998876543221 2233445689999999997643 35789999999 56666666677
Q ss_pred hCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 757 ALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.-|+.-...-..-+....+-+........ -+.+..+...+|++|+++.-++|....++..
T Consensus 681 rKPFGhnqsQQdILqeNTIlkAtEVqFP~---KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 681 RKPFGHNQSQQDILQENTILKATEVQFPP---KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred CCCCCCchhHHHHHhhhchhcceeccCCC---CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 77765211100000000011110001011 1123445678999999999999988877754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=283.02 Aligned_cols=266 Identities=19% Similarity=0.274 Sum_probs=197.3
Q ss_pred hHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecC
Q 040925 523 YAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSST 600 (833)
Q Consensus 523 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 600 (833)
..++....++|++.+.||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 35566678999999999999999999999988999999999864322 2245678899999999999999999987543
Q ss_pred C-CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 601 D-FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 601 ~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
. +......+++++++ +++|.+++... .+++..++.++.|+++||+|||+. +|+||||||+||++++++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence 2 12234578888887 67999888643 588999999999999999999999 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhC
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTAL 758 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~ 758 (833)
.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||| +|++++++.++..
T Consensus 158 ~~kl~dfg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws----------lG~il~el~~g~~ 216 (345)
T cd07877 158 ELKILDFGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS----------VGCIMAELLTGRT 216 (345)
T ss_pred CEEEeccccccccccc-----------ccccccCCCccCHHHHhCccCCCchhhHHH----------HHHHHHHHHhCCC
Confidence 9999999998754321 112458899999998766 56888999999 7777888888777
Q ss_pred CCcccccccc-------------cchhhhcccc---ch--hhhhhhhc----hHHHHHHHHHHhhccCCCCCCCCCCHHH
Q 040925 759 PEKVMEIVDP-------------SLLMEVMTNN---SM--IQEDKRVK----TEECLNAIIRTGVLCSMESPFERMDMRD 816 (833)
Q Consensus 759 p~~~~~~~~~-------------~~~~~~~~~~---~~--~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~e 816 (833)
|+...+.... .......... .. ........ ....+..+.+++.+|++.||++|||+.+
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 296 (345)
T cd07877 217 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296 (345)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHH
Confidence 6532111000 0000000000 00 00000000 0012456789999999999999999999
Q ss_pred HHHH
Q 040925 817 VVAK 820 (833)
Q Consensus 817 il~~ 820 (833)
+++.
T Consensus 297 ~l~h 300 (345)
T cd07877 297 ALAH 300 (345)
T ss_pred HhcC
Confidence 9875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=278.46 Aligned_cols=255 Identities=19% Similarity=0.234 Sum_probs=195.3
Q ss_pred CCccCceeccCcceEEEEEEEC---CCceEEEEEEeeccC----CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKY----KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFK 603 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 603 (833)
+|++.+.||+|++|.||+|+.. .+++.||||+++... ....+.+.+|++++.++ +||+|+++++.+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--- 77 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD--- 77 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC---
Confidence 4788899999999999999864 357889999986432 12345688999999999 599999999886544
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
...++||||+++|+|.+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|
T Consensus 78 --~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l 146 (288)
T cd05583 78 --TKLHLILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVL 146 (288)
T ss_pred --CEEEEEEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEE
Confidence 37899999999999999987543 688999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCC--CCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE--ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
+|||+++........ ......|++.|+|||...+.. .+.++|||| +|+++++++++..|+.
T Consensus 147 ~dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~s----------lG~il~el~tg~~p~~ 209 (288)
T cd05583 147 TDFGLSKEFLAEEEE-------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWS----------LGVLTFELLTGASPFT 209 (288)
T ss_pred EECcccccccccccc-------ccccccCCccccCHHHhcCCCCCCcchhhhHH----------HHHHHHHHHhCCCCcc
Confidence 999998765432111 112245899999999987655 788999999 7888899999888865
Q ss_pred ccccc--cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 762 VMEIV--DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 762 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
..... ........... ....+..++..+.+++.+||+.||++|||+.++.+.+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 210 VDGEQNSQSEISRRILKS-------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred cCcccchHHHHHHHHHcc-------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 22110 01111111111 0111223456788999999999999999988887665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=276.93 Aligned_cols=251 Identities=20% Similarity=0.287 Sum_probs=192.6
Q ss_pred CCccCceeccCcceEEEEEEEC---CCceEEEEEEeeccC----CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKY----KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFK 603 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 603 (833)
+|++.+.||+|+||.||+|+.. .+|+.||+|+++... ....+.+.+|+++++++ +|++|+++++++...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--- 77 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD--- 77 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC---
Confidence 4888999999999999999874 478899999997432 12345678899999999 599999999886544
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
...++||||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||
T Consensus 78 --~~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl 146 (290)
T cd05613 78 --TKLHLILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 146 (290)
T ss_pred --CeEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEE
Confidence 37899999999999999997654 688999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCC--CCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS--EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
+|||++......... ......|+..|+|||++.+. .++.++|||| +|+++++++++..|+.
T Consensus 147 ~dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~s----------lG~~l~~ll~g~~p~~ 209 (290)
T cd05613 147 TDFGLSKEFHEDEVE-------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWS----------MGVLMYELLTGASPFT 209 (290)
T ss_pred eeCccceeccccccc-------ccccccCCcccCChhhccCCCCCCCccccHHH----------HHHHHHHHhcCCCCCC
Confidence 999999765432211 11134589999999987653 4678899999 7888889998888865
Q ss_pred cccccc--ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 762 VMEIVD--PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 762 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
...... .......... ....+..+...+.+++.+||..||++|| +++++++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 210 VDGEKNSQAEISRRILKS-------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred cCCccccHHHHHHHhhcc-------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 221110 0110110000 0111233456788999999999999997 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=273.74 Aligned_cols=252 Identities=20% Similarity=0.228 Sum_probs=192.4
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-----CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-----KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
+|.+.+.||+|+||.||+|++...+..+++|+++... ......+..|+.++++++||||+++++++... .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence 5889999999999999999998777777777765321 12334577899999999999999999986544 3
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++++|.+++...... ...+++.+++.++.|++.|+.|||+. +++|+||||+||+++. +.+||+||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~ 149 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDF 149 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeeccc
Confidence 789999999999999988653211 12689999999999999999999999 9999999999999975 57999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|.+........ ......|++.|+|||...+..++.++|+|| +|+++++++++..|+.....
T Consensus 150 g~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~s----------lG~~~~~l~~~~~~~~~~~~- 210 (260)
T cd08222 150 GVSRLLMGSCD--------LATTFTGTPYYMSPEALKHQGYDSKSDIWS----------LGCILYEMCCLAHAFEGQNF- 210 (260)
T ss_pred CceeecCCCcc--------cccCCCCCcCccCHHHHccCCCCchhhHHH----------HHHHHHHHHhCCCCCCCccH-
Confidence 99876543211 111245889999999988888899999999 77888888888877642111
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... .....+..++..+.+++.+||..||++||++.|+++.
T Consensus 211 -~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 211 -LSVVLRIVEG------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred -HHHHHHHHcC------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1111111100 0111234456788999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=304.28 Aligned_cols=147 Identities=31% Similarity=0.450 Sum_probs=131.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|.+.+.||+|+||.||+|.+..+++.||||+++.... .....+..|+.+++.++||||+++++++....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----- 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN----- 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC-----
Confidence 4689999999999999999999998999999999974322 22367889999999999999999998865544
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||+++++|.+++.... .+++..++.|+.||+.||+|||+. +||||||||+|||++.++.+||+||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DF 148 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDF 148 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeC
Confidence 8999999999999999997654 578899999999999999999999 9999999999999999999999999
Q ss_pred cccc
Q 040925 687 GLAK 690 (833)
Q Consensus 687 G~a~ 690 (833)
|+++
T Consensus 149 Gls~ 152 (669)
T cd05610 149 GLSK 152 (669)
T ss_pred CCCc
Confidence 9986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.06 Aligned_cols=255 Identities=25% Similarity=0.322 Sum_probs=193.0
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
|+..+.||+|++|.||+|+...+++.||+|.+.... ....+.+..|++++++++|+|++++++++... ...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 667789999999999999999889999999997543 33346788899999999999999999996554 48999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||++ ++|.+++..... .+++..++.++.|++.||+|||+. +|+||||+|+||++++++.+||+|||.+.
T Consensus 76 v~e~~~-~~l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~ 146 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRPG-----PLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLAR 146 (282)
T ss_pred EecCcC-cCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCccc
Confidence 999997 599999987531 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc-
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP- 768 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~- 768 (833)
....... ......++..|+|||++.+. .++.++|||| +|++++++.++..|+......+.
T Consensus 147 ~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~s----------lG~~l~~l~~~~~~~~~~~~~~~~ 208 (282)
T cd07829 147 AFGIPLR--------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWS----------VGCIFAEMITGKPLFPGDSEIDQL 208 (282)
T ss_pred ccCCCcc--------ccCccccCcCcCChHHhcCCcCCCccccHHH----------HHHHHHHHHhCCCCCCCccHHHHH
Confidence 6543221 11123467889999988766 7899999999 77777777777666542211100
Q ss_pred ------------cchhhhc-----cccc--hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 769 ------------SLLMEVM-----TNNS--MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 769 ------------~~~~~~~-----~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
....... .... ..........+..+..+.+++.+||..||++||++++++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 209 FKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000 0000 0000000111223567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=282.47 Aligned_cols=260 Identities=20% Similarity=0.276 Sum_probs=194.5
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCC-CCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDF-KGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 605 (833)
..++|++.+.||+|++|.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+. ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4568999999999999999999999899999999986432 2233567789999999999999999987654431 222
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++|+||+ +++|.+++... .+++..++.++.|+++||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~d 161 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILD 161 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcc
Confidence 3489999999 56999998753 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
||++...... .....++..|+|||.+.+ ..++.++|||| +|++++++.++..|+...+
T Consensus 162 fg~~~~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~Dvws----------lGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 162 FGLARHTDDE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS----------VGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred cccccccccc-----------ccCCcccccccCHHHHhCCCCCCchHhHHH----------HHHHHHHHHhCCCCCCCCC
Confidence 9999765332 112358899999998765 36789999999 7788888888877764221
Q ss_pred ccc-------------ccchhhhcccc---ch--hhhhhh----hchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVD-------------PSLLMEVMTNN---SM--IQEDKR----VKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~-------------~~~~~~~~~~~---~~--~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..+ +.+........ .. .....+ .....+++.+.+++.+||..||++|||+.||++.
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 221 HIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred hHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 110 00000000000 00 000000 0011235678999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=298.55 Aligned_cols=269 Identities=23% Similarity=0.368 Sum_probs=205.6
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEECC-------CceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeE
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGE-------DEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITI 596 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 596 (833)
++...++..+.+.+|+|.||.|++|.... ....||||..+.... .+.+.+..|+++|+.+ +||||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 33444455667799999999999997531 256799999975533 3457899999999999 59999999999
Q ss_pred eecCCCCCCceEeEEEEecCCCChhhhhccCC-C-cccc--------ccCCHHHHHHHHHHHHHHHHHHhhcCCCCceee
Q 040925 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD-D-QVEV--------CKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHG 666 (833)
Q Consensus 597 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~-~~~~--------~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~ 666 (833)
|.... ..++|+||++.|+|.+++...+ . .... ..++..+.+.++.|||.|++||++. ++|||
T Consensus 371 ~t~~~-----~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHR 442 (609)
T KOG0200|consen 371 CTQDG-----PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHR 442 (609)
T ss_pred eccCC-----ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccch
Confidence 97643 7899999999999999998876 0 0000 1388999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccc--cccccCccccCCCCCCcccccccCCcCCCccc
Q 040925 667 DLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG--TVGYVAPEYGMGSEASMTGDIFTGRRPIDAVF 744 (833)
Q Consensus 667 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~ 744 (833)
|+..+|||+.++..+||+|||+|+........... +..| ...|||||.+....|+.++||||+|+..|+++
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eif 515 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTK-------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIF 515 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEec-------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHh
Confidence 99999999999999999999999965543322211 1123 23599999999999999999999888888888
Q ss_pred cCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 745 NEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 745 ~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
+.|...|.- .+ ....+ .+.... ......+..|.+++.++|..||+.+|++||++.|+.+.++..
T Consensus 516 sLG~~PYp~----~~------~~~~l-~~~l~~-----G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 516 TLGGTPYPG----IP------PTEEL-LEFLKE-----GNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred hCCCCCCCC----CC------cHHHH-HHHHhc-----CCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 877665521 00 00111 111111 111234556788899999999999999999999999999985
Q ss_pred h
Q 040925 825 R 825 (833)
Q Consensus 825 ~ 825 (833)
.
T Consensus 580 l 580 (609)
T KOG0200|consen 580 L 580 (609)
T ss_pred H
Confidence 4
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=265.55 Aligned_cols=237 Identities=26% Similarity=0.291 Sum_probs=189.3
Q ss_pred eccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEec
Q 040925 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615 (833)
Q Consensus 539 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 615 (833)
||.|++|.||+|.+..+++.||+|.++.... ...+.+..|+.++++++||||+++++.+... ...++||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-----EKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-----CeeEEEEecC
Confidence 6899999999999988899999999875432 2345788999999999999999999886544 4899999999
Q ss_pred CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcc
Q 040925 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695 (833)
Q Consensus 616 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 695 (833)
++++|.+++.... .+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 76 ~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~ 146 (250)
T cd05123 76 PGGELFSHLSKEG------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSE 146 (250)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccC
Confidence 9999999998654 589999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhc
Q 040925 696 QLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVM 775 (833)
Q Consensus 696 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~ 775 (833)
. .......|+..|+|||...+...+.++|+|+ +|..++++.++..|+...+. ........
T Consensus 147 ~--------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~s----------lG~~~~~l~~g~~p~~~~~~--~~~~~~~~ 206 (250)
T cd05123 147 G--------SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWS----------LGVLLYEMLTGKPPFYAEDR--KEIYEKIL 206 (250)
T ss_pred C--------CcccCCcCCccccChHHhCCCCCCchhhHHH----------HHHHHHHHHHCCCCCCCCCH--HHHHHHHh
Confidence 1 1112345889999999998888899999999 78888899888888753321 11111111
Q ss_pred cccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHH
Q 040925 776 TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRD 816 (833)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 816 (833)
... ...+...+..+.+++.+||..||++|||+.+
T Consensus 207 ~~~-------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 207 KDP-------LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred cCC-------CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 111 1112223567889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=265.52 Aligned_cols=242 Identities=22% Similarity=0.260 Sum_probs=194.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 605 (833)
..+|..+.+||+|+||.|.+|..+++.+.||||+++.. ...+.+--..|-++|+-- +-|.+++++.++...+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD---- 423 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD---- 423 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh----
Confidence 34799999999999999999999999999999999754 223344456678888776 5788999988855544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..|+||||+.||+|--+|++.+ ++.++.+..++..||-||-|||++ |||.||||.+|||+|.+|.+||+|
T Consensus 424 -RLyFVMEyvnGGDLMyhiQQ~G------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~D 493 (683)
T KOG0696|consen 424 -RLYFVMEYVNGGDLMYHIQQVG------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIAD 493 (683)
T ss_pred -heeeEEEEecCchhhhHHHHhc------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeee
Confidence 9999999999999999998766 688899999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++.---+ ...+..++|||.|+|||++..++|+.++|+|+ +|+.+||++.|..|+.-.+
T Consensus 494 FGmcKEni~~--------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa----------~GVLLyEmlaGQpPFdGeD- 554 (683)
T KOG0696|consen 494 FGMCKENIFD--------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA----------FGVLLYEMLAGQPPFDGED- 554 (683)
T ss_pred cccccccccC--------CcceeeecCCCcccccceEEecccccchhHHH----------HHHHHHHHHcCCCCCCCCC-
Confidence 9999743221 12234579999999999999999999999999 8999999999999976322
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM 812 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 812 (833)
..++....+... -..+...+.+...++...+.+.|.+|.
T Consensus 555 -E~elF~aI~ehn-------vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 555 -EDELFQAIMEHN-------VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -HHHHHHHHHHcc-------CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 111111111111 112334566777888889999999995
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=272.71 Aligned_cols=412 Identities=20% Similarity=0.204 Sum_probs=296.1
Q ss_pred EEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECC-Ccc
Q 040925 4 LAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLA-LNR 82 (833)
Q Consensus 4 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~-~N~ 82 (833)
.+.++-+|+ .+|..+.. .-+.|+|..|.|+.+.|++|+.+++|+.||||+|.|+.+-|++|.++.+|..|-+- +|+
T Consensus 51 VdCr~~GL~-eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 456677787 67776665 67889999999999999999999999999999999999999999999998766554 599
Q ss_pred cccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCC
Q 040925 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTAT 162 (833)
Q Consensus 83 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 162 (833)
|+ .+|.++|.+|..|+.|.+.-|++..+....|..|++|..|.|..|.+..+...+|.++..++.+.+..|.+-..-.-
T Consensus 128 I~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL 206 (498)
T KOG4237|consen 128 IT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNL 206 (498)
T ss_pred hh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccccc
Confidence 98 99999999999999999999999988899999999999999999999999999999999999999999974221100
Q ss_pred ------CcccccccCCCCCCCEEEccCCcCcccCChhHhhhccc-ccEEEccCccccccCChhhhcCCCCCeEeccCCcc
Q 040925 163 ------DLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSST-VINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQL 235 (833)
Q Consensus 163 ------~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~-l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l 235 (833)
.-..+..+++..-..-..|.++++..+-+..+...... ...+....+....-....|..+++|+.|+|++|+|
T Consensus 207 ~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i 286 (498)
T KOG4237|consen 207 PWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKI 286 (498)
T ss_pred chhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCcc
Confidence 00011223344444445555555554434333322111 11223333333333335799999999999999999
Q ss_pred cccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceeccc-----
Q 040925 236 HGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGA----- 310 (833)
Q Consensus 236 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~----- 310 (833)
+.+-+.+|.++.++++|.|..|+|..+....|.++..|++|+|.+|+|+.+.|.+|..+.+|.+|+|-.|.+--.
T Consensus 287 ~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~w 366 (498)
T KOG4237|consen 287 TRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAW 366 (498)
T ss_pred chhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHH
Confidence 999999999999999999999999988888899999999999999999999999999999999999988876410
Q ss_pred CCcc----------cccccccceeeecCCCccCCC---CCcccc---------cCCCc-CEEeccCCcCCCCCCccccCC
Q 040925 311 LPHQ----------LLSITTLSLYLDLSNNLLNGS---LPLQVG---------HLKNL-VILDISSNQFSGVIPGTLSTC 367 (833)
Q Consensus 311 ~p~~----------~~~~~~ll~~L~ls~N~l~~~---~~~~~~---------~l~~L-~~L~ls~N~l~~~~~~~~~~l 367 (833)
+-++ -+.-+..++.+.++.+.+... .|+..+ ..+-+ ++..-|++.++ .+|..+-
T Consensus 367 l~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP-- 443 (498)
T KOG4237|consen 367 LGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP-- 443 (498)
T ss_pred HHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--
Confidence 0000 011111123333433332211 111110 01111 11223333333 2222111
Q ss_pred CCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccC
Q 040925 368 VCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYN 426 (833)
Q Consensus 368 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N 426 (833)
..-.+|++.+|.++. +|.. .+.+| .+|+++|+++...-..|.+++.|.+|-|++|
T Consensus 444 ~d~telyl~gn~~~~-vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 444 VDVTELYLDGNAITS-VPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred chhHHHhcccchhcc-cCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 134578888998884 4444 56677 8899999998777778888899988888876
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=262.60 Aligned_cols=220 Identities=19% Similarity=0.103 Sum_probs=172.6
Q ss_pred CcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEecCCCChh
Q 040925 542 GSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLK 621 (833)
Q Consensus 542 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 621 (833)
|.+|.||+|++..+++.||+|+++... ...+|...+....||||+++++++...+ ..++||||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSED-----SVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCC-----eEEEEEecCCCCCHH
Confidence 899999999999999999999996432 2344555556667999999999865544 899999999999999
Q ss_pred hhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcccccccc
Q 040925 622 DWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701 (833)
Q Consensus 622 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 701 (833)
+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.......
T Consensus 74 ~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----- 139 (237)
T cd05576 74 SHISKFL------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----- 139 (237)
T ss_pred HHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----
Confidence 9987653 589999999999999999999999 99999999999999999999999999886553321
Q ss_pred cCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchh
Q 040925 702 KTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMI 781 (833)
Q Consensus 702 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 781 (833)
....++..|+|||+..+..++.++|+|| .|+++++++++..+..... ....... .
T Consensus 140 ------~~~~~~~~y~aPE~~~~~~~~~~~Dvws----------lG~il~el~~g~~~~~~~~----~~~~~~~--~--- 194 (237)
T cd05576 140 ------DGEAVENMYCAPEVGGISEETEACDWWS----------LGAILFELLTGKTLVECHP----SGINTHT--T--- 194 (237)
T ss_pred ------ccCCcCccccCCcccCCCCCCchhhHHH----------HHHHHHHHHHCcchhhcCc----hhccccc--c---
Confidence 1234677899999988888999999999 7778888888765533110 0000000 0
Q ss_pred hhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 782 QEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 782 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
...+..+++.+.+++.+|++.||++|||+
T Consensus 195 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 195 ----LNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred ----cCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 00112245678899999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-31 Score=278.83 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=198.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|+...++|+|.||.||+|+++.+++..|+|+++...........+|+-+++..+|||||.++|-+...+ ..|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-----klw 88 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-----KLW 88 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-----CcE
Confidence 458999999999999999999999999999999999887777888899999999999999999999864443 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+.||||.+|+|++.-+..+ ++++.++...++..++|++|||+. |-+|||||-.||++++.|.+|++|||.+
T Consensus 89 icMEycgggslQdiy~~Tg------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvs 159 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTG------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVS 159 (829)
T ss_pred EEEEecCCCcccceeeecc------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCch
Confidence 9999999999999888766 799999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccccCCCccccccccccccCcccc---CCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYG---MGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
..+.. +-.+..++.||++|||||+. +.+.|...+|||+.+ ++..|+..-..|-......
T Consensus 160 aqita--------ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~g----------itAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 160 AQITA--------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALG----------ITAIELGELQPPLFDLHPM 221 (829)
T ss_pred hhhhh--------hhhhhhcccCCccccchhHHHHHhcccccccccccccc----------cchhhhhhcCCcccccchH
Confidence 76543 23344567899999999974 356699999999944 4444443333332110000
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
..-+ .+.+.. .++..........+.+-+++..|+.++|++|||++.++.
T Consensus 222 r~l~---LmTkS~-~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 222 RALF---LMTKSG-FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HHHH---HhhccC-CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 0000 111111 111111112223556778899999999999999998765
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=251.34 Aligned_cols=250 Identities=21% Similarity=0.269 Sum_probs=196.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|...+.||+|+|++|..++.+.+.+.||+|++++. ..++.+-...|-.+..+- +||.+|-++.++.. +
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-----e 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-----E 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-----c
Confidence 46899999999999999999999999999999999754 334455677788887776 69999999988544 4
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++|.||++||+|--++++++ +++++.++.+...|+-||.|||++ |||.||+|.+|+++|.+|.+||.|
T Consensus 324 srlffvieyv~ggdlmfhmqrqr------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltd 394 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTD 394 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhh------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecc
Confidence 48999999999999988887765 799999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
+|+++.--. ....+..++|||.|+|||++.+.+|...+|+|+ .|+.++|++.+..|+.+...
T Consensus 395 ygmcke~l~--------~gd~tstfcgtpnyiapeilrgeeygfsvdwwa----------lgvlmfemmagrspfdivgm 456 (593)
T KOG0695|consen 395 YGMCKEGLG--------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA----------LGVLMFEMMAGRSPFDIVGM 456 (593)
T ss_pred cchhhcCCC--------CCcccccccCCCcccchhhhcccccCceehHHH----------HHHHHHHHHcCCCCcceecC
Confidence 999974322 222344589999999999999999999999999 88899999999999885554
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM 812 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 812 (833)
-.+....+-.--........+ .+...+-....++..-+++||.+|.
T Consensus 457 ~n~d~ntedylfqvilekqir-iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 457 DNPDMNTEDYLFQVILEKQIR-IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred CCcccchhHHHHHHHhhhccc-ccceeehhhHHHHHHhhcCCcHHhc
Confidence 333332111100000000000 1111233445677788999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=234.81 Aligned_cols=208 Identities=23% Similarity=0.330 Sum_probs=167.9
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCC
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFK 603 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 603 (833)
++...++......||+|+||.|-+.++..+|...|+|.++..- .+..++...|+.+..+. .+|.+|++||....
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r---- 116 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR---- 116 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc----
Confidence 4444556666789999999999999999999999999997543 33456788899887766 69999999997543
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
....++.||.|+- ||..+..+--..+ ..+++..+-+|+..+.+||.|||++. .+||||+||+|||++.+|++|+
T Consensus 117 -egdvwIcME~M~t-Sldkfy~~v~~~g--~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKi 190 (282)
T KOG0984|consen 117 -EGDVWICMELMDT-SLDKFYRKVLKKG--GTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKI 190 (282)
T ss_pred -cccEEEeHHHhhh-hHHHHHHHHHhcC--CcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEE
Confidence 3489999999964 8876654322111 16899999999999999999999986 8999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccC----CCCCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM----GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
||||.+....+.-..+ -..|...|||||.+. ...|+.++|||| .|.++.|+++..+|
T Consensus 191 CDFGIsG~L~dSiAkt---------~daGCkpYmaPEri~~e~n~~gY~vksDvWS----------LGItmiElA~lr~P 251 (282)
T KOG0984|consen 191 CDFGISGYLVDSIAKT---------MDAGCKPYMAPERINPELNQKGYSVKSDVWS----------LGITMIEMAILRFP 251 (282)
T ss_pred cccccceeehhhhHHH---------HhcCCCccCChhhcCcccCcccceeehhhhh----------hhhhhhhhhhcccc
Confidence 9999998765532211 134888999999764 346999999999 88999999999999
Q ss_pred Ccc
Q 040925 760 EKV 762 (833)
Q Consensus 760 ~~~ 762 (833)
+..
T Consensus 252 Y~~ 254 (282)
T KOG0984|consen 252 YES 254 (282)
T ss_pred ccc
Confidence 763
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=272.07 Aligned_cols=241 Identities=21% Similarity=0.182 Sum_probs=193.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++.|.....+|.|+|+.|-.+.+..+++..+||++... ..+..+|+.++... +||||+++.+.+.+. .+.
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~-----~~~ 391 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDG-----KEI 391 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCC-----cee
Confidence 55788888999999999999999999999999999644 23445678777776 699999999996544 499
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee-cCCCcEEEcccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL-DHDMVAHVCDFG 687 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kL~DfG 687 (833)
|+|||++.||-+.+.+...+ .....+..|+.+|+.|+.|||++ ||||||+||+|||+ +..+.++|+|||
T Consensus 392 ~~v~e~l~g~ell~ri~~~~-------~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG 461 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP-------EFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFG 461 (612)
T ss_pred eeeehhccccHHHHHHHhcc-------hhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEec
Confidence 99999999988877776553 22377788999999999999999 99999999999999 689999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
.++..... ....+-|..|.|||+....+|+.++|||| .|+.+|+|++|..|+.....-
T Consensus 462 ~a~~~~~~-----------~~tp~~t~~y~APEvl~~~~yt~acD~WS----------LGvlLy~ML~G~tp~~~~P~~- 519 (612)
T KOG0603|consen 462 FWSELERS-----------CDTPALTLQYVAPEVLAIQEYTEACDWWS----------LGVLLYEMLTGRTLFAAHPAG- 519 (612)
T ss_pred hhhhCchh-----------hcccchhhcccChhhhccCCCCcchhhHH----------HHHHHHHHHhCCCccccCCch-
Confidence 99876553 11235688999999999999999999999 899999999999987633211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
-.+. ..+.. ......+++..++++.+||+.||.+||+|.++...
T Consensus 520 ~ei~-~~i~~--------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 520 IEIH-TRIQM--------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred HHHH-HhhcC--------CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1111 11111 01114567788999999999999999999999754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=256.31 Aligned_cols=136 Identities=25% Similarity=0.450 Sum_probs=120.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-----C---CccceEeeEeecCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-----H---RNLIKIITICSSTDF 602 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~~ 602 (833)
++|.+.++||.|.|++||+|.+..+.+.||+|+++.. ....+....|+++|++++ | ..||+++++|...+
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG- 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG- 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC-
Confidence 6899999999999999999999999999999999733 334567889999999993 2 47999999998876
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL 675 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll 675 (833)
....++|||+|+. |-+|..+|.....+ .++...+++|++||+.||.|||..| ||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr----Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR----GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCC----CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4456899999999 56999999887655 7999999999999999999999998 99999999999998
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=283.01 Aligned_cols=267 Identities=18% Similarity=0.136 Sum_probs=165.5
Q ss_pred HhcCCccCceeccCcceEEEEEEECCC----ceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCC-CC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGED----EMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTD-FK 603 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~ 603 (833)
..++|++.+.||+|+||.||+|++..+ +..||+|++.... ..+....| .+++..+.+++.+...+.... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999888 8999999875321 11111111 112222233332222211110 12
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCcc--------------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCC
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQV--------------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLK 669 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlk 669 (833)
.....++||||+++++|.+++....... .........+..++.|++.||+|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 3457899999999999999987543110 000112345678999999999999999 99999999
Q ss_pred CCCeeecC-CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCC----------------------
Q 040925 670 PSNVLLDH-DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE---------------------- 726 (833)
Q Consensus 670 p~NIll~~-~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------- 726 (833)
|+|||++. ++.+||+|||+|+....... .......||+.|||||.+....
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999986 57999999999986543211 1122357899999999653322
Q ss_pred CCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc-----cc---ccc--chhhhccccchhhhhhh--hchHHHHH
Q 040925 727 ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME-----IV---DPS--LLMEVMTNNSMIQEDKR--VKTEECLN 794 (833)
Q Consensus 727 ~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~-----~~---~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~ 794 (833)
++.++|||| .|+++++++.+..+..... .+ +.. .......... ...... ........
T Consensus 356 ~~~k~DVwS----------lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~d~~~~ 424 (566)
T PLN03225 356 LPDRFDIYS----------AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRA-SPDLRRGFEVLDLDGG 424 (566)
T ss_pred CCCCcccHH----------HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcccc-chhhhhhhhhccccch
Confidence 233447666 7777778776555432100 00 000 0000000000 000000 00001123
Q ss_pred HHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 795 AIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 795 ~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
...+++.+|+..||++|||++|++++
T Consensus 425 ~~~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 425 AGWELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhCC
Confidence 45589999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=274.37 Aligned_cols=250 Identities=26% Similarity=0.293 Sum_probs=183.1
Q ss_pred CccCceeccCcce-EEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeE
Q 040925 533 FSSSNMIGQGSFG-YVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 533 y~~~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
|...+.+|.|+.| .||+|.+ .++.||||++- .+..+.+.+|+..++.- .|||||++|+.-. +..+.|+
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll---~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~-----d~qF~YI 580 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL---EEFFDFAQREIQLLQESDEHPNVIRYYCSEQ-----DRQFLYI 580 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHh---hHhHHHHHHHHHHHHhccCCCceEEEEeecc-----CCceEEE
Confidence 3444788999997 5899999 58899999984 23445678999999998 4999999998743 3459999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---C--CcEEEcc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---D--MVAHVCD 685 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kL~D 685 (833)
+.|.|. .+|.+++...... .........+.+..|++.||++||+. +||||||||.||||+. + .+++|+|
T Consensus 581 alELC~-~sL~dlie~~~~d--~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSD 654 (903)
T KOG1027|consen 581 ALELCA-CSLQDLIESSGLD--VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISD 654 (903)
T ss_pred EehHhh-hhHHHHHhccccc--hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecc
Confidence 999997 5999999985211 11122245678899999999999998 9999999999999976 3 4799999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++........ .....+..||-+|+|||++....-+.++||||.||.|+.+.+.|...+.-...
T Consensus 655 fglsKkl~~~~sS-----~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~--------- 720 (903)
T KOG1027|consen 655 FGLSKKLAGGKSS-----FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE--------- 720 (903)
T ss_pred cccccccCCCcch-----hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH---------
Confidence 9999988664432 12234567999999999999988899999999999998877776543321111
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
-+..+......... -. ...++ ...++|.+|+++||..||+|.+|+.+
T Consensus 721 R~~NIl~~~~~L~~-----L~-~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 721 RQANILTGNYTLVH-----LE-PLPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred hhhhhhcCccceee-----ec-cCchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 01111000000000 00 01112 56799999999999999999999753
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-31 Score=267.69 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=202.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.+++++..||-|+||.|-++........+|+|.+++. .....+.+..|-.||...+.|.||++|-.+. +..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr-----d~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR-----DSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc-----cchh
Confidence 3556677899999999999998766656899988644 3344567889999999999999999998854 4459
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
+|++||-|-||.+...+.+++ .++...++.++..+++|++|||++ +||.|||||+|.+++.+|.+||.|||
T Consensus 495 vYmLmEaClGGElWTiLrdRg------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFG 565 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFG 565 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehh
Confidence 999999999999999999876 789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+.+.... ++-.++|||.|.|||++.+...+.++|.|+ .|+.+||+++|..|+...+
T Consensus 566 FAKki~~g~---------KTwTFcGTpEYVAPEIILnKGHD~avDyWa----------LGIli~ELL~G~pPFs~~d--- 623 (732)
T KOG0614|consen 566 FAKKIGSGR---------KTWTFCGTPEYVAPEIILNKGHDRAVDYWA----------LGILIYELLTGSPPFSGVD--- 623 (732)
T ss_pred hHHHhccCC---------ceeeecCCcccccchhhhccCcchhhHHHH----------HHHHHHHHHcCCCCCCCCc---
Confidence 999886643 233578999999999999999999999999 8899999999999987433
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
|-.....+-+.. ..-..+..+.+...+++.+....+|.+|-. +.+|-++
T Consensus 624 pmktYn~ILkGi----d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 624 PMKTYNLILKGI----DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred hHHHHHHHHhhh----hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 222222111111 111223445666778888999999999975 5555443
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=261.26 Aligned_cols=210 Identities=21% Similarity=0.264 Sum_probs=174.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.-|..++.||-|+||+|.++...++...||+|.+++.+. .....++.|.+||+.-..+-||++|..| ++++.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence 458888999999999999999999999999999975432 2335678899999999999999999774 44559
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||+|++||++-.++-+.+ .+.+.-++.++..+..|+++.|.. |+|||||||+|||||.||.+||.|||
T Consensus 704 LYFVMdYIPGGDmMSLLIrmg------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFG 774 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMG------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFG 774 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhc------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecc
Confidence 999999999999999988765 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCc---------cc------cc------c-------------cccCCCccccccccccccCccccCCCCCCccccc
Q 040925 688 LAKFLSD---------HQ------LD------T-------------AVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDI 733 (833)
Q Consensus 688 ~a~~~~~---------~~------~~------~-------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 733 (833)
++.-+.- .. +. . ...........+||+.|+|||++....|+..+|+
T Consensus 775 LCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw 854 (1034)
T KOG0608|consen 775 LCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW 854 (1034)
T ss_pred ccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh
Confidence 9853211 00 00 0 0000111235689999999999999999999999
Q ss_pred ccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 734 FTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 734 ~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|| .|+++|||+.|..|+....
T Consensus 855 ws----------~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 855 WS----------VGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred hH----------hhHHHHHHhhCCCCccCCC
Confidence 99 8899999999999986443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=268.34 Aligned_cols=282 Identities=16% Similarity=0.181 Sum_probs=185.3
Q ss_pred HhcCCccCceeccCcceEEEEEEEC----------------CCceEEEEEEeeccCCcchh--------------HHHHH
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLG----------------EDEMIVAVKVINLKYKGASR--------------SFVAE 578 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E 578 (833)
..++|++.++||+|+||.||+|... ..++.||||+++.......+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3668999999999999999999752 24567999998654322222 23446
Q ss_pred HHHHhhcCCCc-----cceEeeEeecCCC---CCCceEeEEEEecCCCChhhhhccCCCc------------------cc
Q 040925 579 CEALRNIRHRN-----LIKIITICSSTDF---KGTDFKAFVFEYMENGSLKDWLHQSDDQ------------------VE 632 (833)
Q Consensus 579 ~~~l~~l~h~n-----iv~~~~~~~~~~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~ 632 (833)
+.++.+++|.+ +++++++|..... ...+..++||||+++|+|.++++..... ..
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 77777776654 4677777754321 1234689999999999999998753210 01
Q ss_pred cccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccc
Q 040925 633 VCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712 (833)
Q Consensus 633 ~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~g 712 (833)
...+++..++.++.|++.||.|+|+. +|+||||||+||+++.++.+||+|||++.......... .....+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-------~~~g~~ 372 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-------PLYGML 372 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-------ccccCC
Confidence 12356788999999999999999999 99999999999999999999999999997553321100 111235
Q ss_pred cccccCccccCCCCCCccccc---cc---------CCcCCCccccCCccHHHHHHHhC-CCcccccccccchh--hhccc
Q 040925 713 TVGYVAPEYGMGSEASMTGDI---FT---------GRRPIDAVFNEGHSLHEFAKTAL-PEKVMEIVDPSLLM--EVMTN 777 (833)
Q Consensus 713 t~~y~aPE~~~~~~~~~~~Di---~s---------~~~~~~~~~~~g~~l~~~~~~~~-p~~~~~~~~~~~~~--~~~~~ 777 (833)
|+.|+|||.+.....+..++. |+ +.....|+|+.|++++++..+.. |............. .....
T Consensus 373 tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~ 452 (507)
T PLN03224 373 DPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR 452 (507)
T ss_pred CcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH
Confidence 899999998765544444332 21 22224577789999999988765 33211111111100 00000
Q ss_pred --cchhhhhhhhchHHHHHHHHHHhhccCCCCC---CCCCCHHHHHHH
Q 040925 778 --NSMIQEDKRVKTEECLNAIIRTGVLCSMESP---FERMDMRDVVAK 820 (833)
Q Consensus 778 --~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~eil~~ 820 (833)
........-.......+...+++.+++..+| .+|+|++|++++
T Consensus 453 ~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 453 WRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000000001122345678899999999866 689999999864
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-31 Score=259.93 Aligned_cols=388 Identities=19% Similarity=0.217 Sum_probs=301.8
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCC-CcccccCCccccCCCCCcEEECCC
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAE-NKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
.+++|..|+|+.+.|.+|+.++.|++|||++|.|+.+-|++|.++++|.+|-+.+ |+|+.+..++|.+|.+|+.|.+.-
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNa 149 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNA 149 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcCh
Confidence 4789999999988888999999999999999999999999999999999988877 999988899999999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCc------------cccccCcCccCCCcCce
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQ------------FKGNVSIDFSSLKNLLW 148 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~------------i~~~~~~~~~~l~~L~~ 148 (833)
|++. .++.++|..+++|..|.|.+|.+..+.-.+|..+.+++.+++..|. +....+..+++.+...-
T Consensus 150 n~i~-Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p 228 (498)
T KOG4237|consen 150 NHIN-CIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSP 228 (498)
T ss_pred hhhc-chhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecch
Confidence 9998 8999999999999999999999985555599999999999999998 33344556677777777
Q ss_pred EecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeE
Q 040925 149 LNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGF 228 (833)
Q Consensus 149 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L 228 (833)
..|.++++..+....+ ...+.++..=..+.+...+..|..-+.-...++.|+|++|+|+.+.+.+|.++..+++|
T Consensus 229 ~rl~~~Ri~q~~a~kf-----~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL 303 (498)
T KOG4237|consen 229 YRLYYKRINQEDARKF-----LCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQEL 303 (498)
T ss_pred HHHHHHHhcccchhhh-----hhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhh
Confidence 7777777776655422 22222332223333434457776666666678889999999999999999999999999
Q ss_pred eccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeeccccc---------------CCCCCCCCC
Q 040925 229 GAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ---------------GNIPSSLGN 293 (833)
Q Consensus 229 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---------------~~~~~~~~~ 293 (833)
.|..|+|..+....|.++..|+.|+|.+|+|+...|.+|..+..|.+|+|-.|.+. +.....-+.
T Consensus 304 ~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq 383 (498)
T KOG4237|consen 304 YLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPRCQ 383 (498)
T ss_pred hcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCCCC
Confidence 99999999888889999999999999999999999999999999999999887653 111000111
Q ss_pred -CCccceeecCCceecc---cCCccccc---------ccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCC
Q 040925 294 -CQNLMSFTASQNKLTG---ALPHQLLS---------ITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360 (833)
Q Consensus 294 -l~~L~~L~l~~N~l~~---~~p~~~~~---------~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~ 360 (833)
-..++.+.++++.+.. ..|+.... .+-+-+...-|+..++ .+|..+ -..-++|++.+|.++ .+
T Consensus 384 ~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~i--P~d~telyl~gn~~~-~v 459 (498)
T KOG4237|consen 384 SPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGI--PVDVTELYLDGNAIT-SV 459 (498)
T ss_pred CCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCC--CchhHHHhcccchhc-cc
Confidence 1246677777666541 12222111 1111123456666666 445443 245778999999998 55
Q ss_pred CccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCc
Q 040925 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402 (833)
Q Consensus 361 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 402 (833)
|+. .+.+| .+|+|+|++.......|.++++|.+|-||+|
T Consensus 460 p~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 460 PDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred CHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 655 66677 8999999999888889999999999999886
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=250.34 Aligned_cols=239 Identities=26% Similarity=0.331 Sum_probs=189.9
Q ss_pred cceEEEEEEECCCceEEEEEEeeccCCcc-hhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEecCCCChh
Q 040925 543 SFGYVYKGTLGEDEMIVAVKVINLKYKGA-SRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLK 621 (833)
Q Consensus 543 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~ 621 (833)
+||.||+|+..++++.||+|++....... .+.+.+|++.+++++|+||+++++++.... ..+++|||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDED-----KLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCC-----EEEEEEeCCCCCCHH
Confidence 58999999999889999999997654444 678999999999999999999999976554 889999999999999
Q ss_pred hhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcccccccc
Q 040925 622 DWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701 (833)
Q Consensus 622 ~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 701 (833)
+++.... .+++..++.++.++++|+.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 ~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----- 141 (244)
T smart00220 76 DLLKKRG------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----- 141 (244)
T ss_pred HHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-----
Confidence 9997653 378999999999999999999999 99999999999999999999999999998765432
Q ss_pred cCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchh
Q 040925 702 KTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMI 781 (833)
Q Consensus 702 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 781 (833)
......++..|+|||...+..++.++|||+ .|..++++.++..|+.... +.....+........
T Consensus 142 ----~~~~~~~~~~~~~pE~~~~~~~~~~~Di~s----------lG~~l~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~ 205 (244)
T smart00220 142 ----LLTTFVGTPEYMAPEVLLGKGYGKAVDVWS----------LGVILYELLTGKPPFPGDD--QLLELFKKIGKPKPP 205 (244)
T ss_pred ----ccccccCCcCCCCHHHHccCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCC--cHHHHHHHHhccCCC
Confidence 112345889999999998888999999999 7888888888877764321 111111111111000
Q ss_pred hhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 782 QEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 782 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.......++..+.+++.+||..+|++||++.++++
T Consensus 206 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 206 ---FPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ---CccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 00000014567899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=242.51 Aligned_cols=274 Identities=21% Similarity=0.279 Sum_probs=211.1
Q ss_pred hHHHHHHhcCCccCceeccCcceEEEEEEECCC-----ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeE
Q 040925 523 YAELSKATGEFSSSNMIGQGSFGYVYKGTLGED-----EMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITI 596 (833)
Q Consensus 523 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~ 596 (833)
.+++.....+++....+-+|.||.||+|.+++. .+.|-||.++.... -....+..|...+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 466777778888889999999999999977643 33466777764422 234678899999999999999999999
Q ss_pred eecCCCCCCceEeEEEEecCCCChhhhhccCCC--ccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCee
Q 040925 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD--QVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVL 674 (833)
Q Consensus 597 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIl 674 (833)
+.+. ....++++.++.-|+|..++...+. ......++..+...++.|++.|++|||.+ +|||.||..+|.+
T Consensus 356 ~ie~----~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCv 428 (563)
T KOG1024|consen 356 SIED----YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCV 428 (563)
T ss_pred Eeec----cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcce
Confidence 8653 3578899999999999999983221 11223677888999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 675 LDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 675 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
||+..++||+|=.+++..-+.... ....+......||+||.+....|+.++|+|| +|+.+||++
T Consensus 429 Idd~LqVkltDsaLSRDLFP~DYh------cLGDnEnRPvkWMslEal~n~~yssasDvWs----------fGVllWELm 492 (563)
T KOG1024|consen 429 IDDQLQVKLTDSALSRDLFPGDYH------CLGDNENRPVKWMSLEALQNSHYSSASDVWS----------FGVLLWELM 492 (563)
T ss_pred ehhheeEEeccchhccccCccccc------ccCCCCCCcccccCHHHHhhhhhcchhhhHH----------HHHHHHHHH
Confidence 999999999999999876543321 1112233567899999999999999999999 556666655
Q ss_pred HH-hCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 755 KT-ALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 755 ~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
+- ..|+. .+||..+..+.+... .-..+-.|++++..+|.-||..+|++||+++|++.-|.+....
T Consensus 493 tlg~~Pya---eIDPfEm~~ylkdGy-----RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 493 TLGKLPYA---EIDPFEMEHYLKDGY-----RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred hcCCCCcc---ccCHHHHHHHHhccc-----eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 53 23322 245555544443322 2234556899999999999999999999999999999887654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.4e-29 Score=256.58 Aligned_cols=191 Identities=23% Similarity=0.353 Sum_probs=162.2
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--------CcchhHHHHHHHHHhhcC---CCccceEeeEe
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--------KGASRSFVAECEALRNIR---HRNLIKIITIC 597 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~ 597 (833)
...+|+..+.+|.|+||.|+.|.++.....|+||.+.+.. ......+--|+.||..++ |+||+++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457999999999999999999999999999999986431 111234567999999997 99999999995
Q ss_pred ecCCCCCCceEeEEEEec-CCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 598 SSTDFKGTDFKAFVFEYM-ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 598 ~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
.++ +++|++||-. ++.+|.++|..+. .+++.++..|++|++.|+++||+. ||||||||-+|+.++
T Consensus 639 Edd-----d~yyl~te~hg~gIDLFd~IE~kp------~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd 704 (772)
T KOG1152|consen 639 EDD-----DYYYLETEVHGEGIDLFDFIEFKP------RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVD 704 (772)
T ss_pred ecC-----CeeEEEecCCCCCcchhhhhhccC------ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEe
Confidence 554 4999999975 5679999999876 799999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCcc
Q 040925 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAV 743 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~ 743 (833)
.+|-+||+|||.|........+ .++||..|.|||++.|.+| ...-|||+.|+.++.+
T Consensus 705 ~~g~~klidfgsaa~~ksgpfd----------~f~gtv~~aapevl~g~~y~gk~qdiwalgillyti 762 (772)
T KOG1152|consen 705 SNGFVKLIDFGSAAYTKSGPFD----------VFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTI 762 (772)
T ss_pred cCCeEEEeeccchhhhcCCCcc----------eeeeeccccchhhhCCCccCCCcchhhhhhheeeEE
Confidence 9999999999999877665443 3569999999999999887 4567999966655543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-30 Score=241.60 Aligned_cols=197 Identities=22% Similarity=0.334 Sum_probs=161.5
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+.+..+.||-|+||.||.+++..+|+.||+|++.... -...+++.+|+.++..++|.|++..+++........=.++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455689999999999999999999999999985322 22357899999999999999999999886554422223578
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+++|.+.. +|.++|-.-+ .++...+.-+.+||++||+|||+. +|.||||||.|.+++.+..+||||||+|
T Consensus 134 V~TELmQS-DLHKIIVSPQ------~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLA 203 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQ------ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLA 203 (449)
T ss_pred HHHHHHHh-hhhheeccCC------CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccc
Confidence 89999964 8999887654 788899999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCcccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFN 745 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~ 745 (833)
+.-..+.. ...+..+-|.+|+|||+++|. .|+.+.||||.||.|.++..
T Consensus 204 Rvee~d~~-------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 204 RTWDQRDR-------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred cccchhhh-------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh
Confidence 86544321 112234578899999999885 49999999998888877643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=244.78 Aligned_cols=278 Identities=18% Similarity=0.226 Sum_probs=204.3
Q ss_pred ccchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC------CCccceE
Q 040925 520 MVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR------HRNLIKI 593 (833)
Q Consensus 520 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~ 593 (833)
.|.+.--+.-..+|.+....|+|-||+|.+|.+...|..||||+++.. +...+.=.+|+++|++|+ --|++++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 334433344557899999999999999999999988999999999743 333455678999999994 3578888
Q ss_pred eeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCe
Q 040925 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNV 673 (833)
Q Consensus 594 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NI 673 (833)
+..|. ..++.|+|+|-+. .+|.++++..+... .+....+..++.|+.-||..|... ||+|.||||+||
T Consensus 500 ~r~F~-----hknHLClVFE~Ls-lNLRevLKKyG~nv---GL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNi 567 (752)
T KOG0670|consen 500 FRHFK-----HKNHLCLVFEPLS-LNLREVLKKYGRNV---GLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNI 567 (752)
T ss_pred HHHhh-----hcceeEEEehhhh-chHHHHHHHhCccc---ceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccce
Confidence 87744 4459999999986 59999999876543 688899999999999999999998 999999999999
Q ss_pred eecCC-CcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH--
Q 040925 674 LLDHD-MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL-- 750 (833)
Q Consensus 674 ll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l-- 750 (833)
|+++. ..+||||||.|..+....... +.-+..|.|||++.|-+|+...|+||.||.+|++|++.+.+
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~eneitP----------YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASENEITP----------YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred EeccCcceeeeccCccccccccccccH----------HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 99865 479999999999877654322 34567899999999999999999999999999998754321
Q ss_pred ---------HHHHHHhCCCcc-------cccccccch-----------hhhccccchhhhh------------hhhchHH
Q 040925 751 ---------HEFAKTALPEKV-------MEIVDPSLL-----------MEVMTNNSMIQED------------KRVKTEE 791 (833)
Q Consensus 751 ---------~~~~~~~~p~~~-------~~~~~~~~~-----------~~~~~~~~~~~~~------------~~~~~~~ 791 (833)
+.-+.|.+|..+ .+-+|..+. .+...-.....+. .......
T Consensus 638 ~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~ 717 (752)
T KOG0670|consen 638 RTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPK 717 (752)
T ss_pred CCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHH
Confidence 111334444221 011111110 0000000001110 0011223
Q ss_pred HHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 792 CLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 792 ~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
...++.+|+..|+..||++|.|..|.+++
T Consensus 718 ~~~~~rdLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 718 IVQQLRDLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence 56788999999999999999999998864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-28 Score=222.46 Aligned_cols=187 Identities=20% Similarity=0.373 Sum_probs=157.0
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCce
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 607 (833)
..++|++.+++|+|.|++||.|....+.+.++||++++. ..+.+.+|+.|++.++ ||||++++++..++. +..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---ccC
Confidence 356899999999999999999999889999999999743 4567899999999997 999999999987654 456
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-cEEEccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCDF 686 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Df 686 (833)
..+|+||+.+.+...+.. .++...++.++.+++.||.|+|+. ||.|||+||.|++||... .++|+|+
T Consensus 110 paLiFE~v~n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYP---------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred chhHhhhhccccHHHHhh---------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence 789999999887776654 578889999999999999999999 999999999999999754 7999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDA 742 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~ 742 (833)
|+|.++-+.... .-.+.+..|.-||.+.. +.|+..-|+||.||.+..
T Consensus 178 GLAEFYHp~~eY---------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~ 225 (338)
T KOG0668|consen 178 GLAEFYHPGKEY---------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 225 (338)
T ss_pred chHhhcCCCcee---------eeeeehhhcCCchheeechhccccHHHHHHHHHHHH
Confidence 999877543221 11346788899998765 558999999997776544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=223.60 Aligned_cols=254 Identities=19% Similarity=0.233 Sum_probs=190.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+.|.+.+.+|+|.||.+-+|+++.++..+|+|.+.... ...++|.+|...--.+. |.||+.-|++. |+..+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Yv 98 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAYV 98 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceEE
Confidence 46999999999999999999999999999999997543 34678999988777774 99999988775 56667899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec--CCCcEEEcccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD--HDMVAHVCDFG 687 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DfG 687 (833)
++|||+|.|+|..-+... .+.+....+++.|++.|+.|||++ ++||||||.+||||- +..++|+||||
T Consensus 99 F~qE~aP~gdL~snv~~~-------GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG 168 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEAA-------GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFG 168 (378)
T ss_pred EeeccCccchhhhhcCcc-------cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecc
Confidence 999999999999988764 477888999999999999999999 999999999999983 34589999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC---C--CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG---S--EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
.++..+..-. ....+..|.|||.... + ...+.+|||. +|++++..++|.+||..
T Consensus 169 ~t~k~g~tV~-----------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~Wq----------fGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 169 LTRKVGTTVK-----------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQ----------FGIIFFYCLTGKFPWQK 227 (378)
T ss_pred cccccCceeh-----------hhhhhcccCCcHHHhhccccceEecccccchh----------eeeeeeeeecCCCcchh
Confidence 9986543211 1235678999996432 2 2567788888 77777778888888885
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
..+.|+....-...........++ ....+.+...++..+-+.++|++|--..++.++-
T Consensus 228 a~~~d~~Y~~~~~w~~rk~~~~P~-~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 228 ASIMDKPYWEWEQWLKRKNPALPK-KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred hhccCchHHHHHHHhcccCccCch-hhcccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 555665553222111111111111 1222455677888889999999996655555543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-26 Score=227.74 Aligned_cols=211 Identities=30% Similarity=0.483 Sum_probs=178.9
Q ss_pred eccCcceEEEEEEECCCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEecCC
Q 040925 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMEN 617 (833)
Q Consensus 539 lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 617 (833)
||+|++|.||+|+...+++.+++|++...... ..+.+.+|++.++.++|++|+++++++.... ..+++|||+++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDEN-----HLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCC-----eEEEEEecCCC
Confidence 68999999999999877999999999754332 3467999999999999999999999976543 88999999999
Q ss_pred CChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-CCcEEEcccccccccCccc
Q 040925 618 GSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVCDFGLAKFLSDHQ 696 (833)
Q Consensus 618 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~~~~~~~ 696 (833)
++|.+++.... ..+++..++.++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+.......
T Consensus 76 ~~l~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~ 147 (215)
T cd00180 76 GSLKDLLKENE-----GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK 147 (215)
T ss_pred CcHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCc
Confidence 99999998652 1588999999999999999999999 9999999999999999 8999999999998654432
Q ss_pred ccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhc
Q 040925 697 LDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVM 775 (833)
Q Consensus 697 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~ 775 (833)
. ......+...|++||..... .++.++|+|+ .|..++++
T Consensus 148 ~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~----------lg~~~~~l---------------------- 187 (215)
T cd00180 148 S--------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS----------LGVILYEL---------------------- 187 (215)
T ss_pred c--------hhhcccCCCCccChhHhcccCCCCchhhhHH----------HHHHHHHH----------------------
Confidence 1 11123478899999998776 7889999999 66666665
Q ss_pred cccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 776 TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 776 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..+.+++..|+..||++||+++++++.
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356789999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-27 Score=228.04 Aligned_cols=192 Identities=21% Similarity=0.249 Sum_probs=161.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCC-CCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFK-GTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~~ 607 (833)
.+|.-.+.+|.|.. .|..|.+.-.++.||+|++... .....++..+|...+..++|+||++++.++...... .-..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46788889999998 7888888778999999998644 233457889999999999999999999987654321 2235
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+|||||. ++|.+.+.. .++-.++..+..|++.|++|||+. ||+||||||+||++..++.+||.|||
T Consensus 96 ~y~v~e~m~-~nl~~vi~~--------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVILM--------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HHHHHHhhh-hHHHHHHHH--------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence 799999996 599999883 577889999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVF 744 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~ 744 (833)
+|+..... -..+.++.|..|.|||++.+..+.+.+||||.||.+.++.
T Consensus 164 ~ar~e~~~---------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli 211 (369)
T KOG0665|consen 164 LARTEDTD---------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELI 211 (369)
T ss_pred hhcccCcc---------cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHh
Confidence 99865433 1233467999999999999988999999999888887654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-26 Score=230.86 Aligned_cols=276 Identities=24% Similarity=0.326 Sum_probs=191.0
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEECC---CceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCC
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGE---DEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTD 601 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 601 (833)
+......|..+++||+|.|+.||+|++.. .++.||+|.+... ....++.+|++.|..+. +.||+++.+++...
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn- 107 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN- 107 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccC-
Confidence 33445679999999999999999999876 7889999999643 34567999999999995 99999999985544
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-CCc
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-DMV 680 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~ 680 (833)
+.+++||||++..+..++.. .++..++..+++.+..||+++|.. |||||||||+|++.+. .+.
T Consensus 108 ----d~v~ivlp~~~H~~f~~l~~---------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~r 171 (418)
T KOG1167|consen 108 ----DQVAIVLPYFEHDRFRDLYR---------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQR 171 (418)
T ss_pred ----CeeEEEecccCccCHHHHHh---------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCC
Confidence 49999999999988888876 477889999999999999999999 9999999999999975 457
Q ss_pred EEEcccccccccCccc----------------------------------ccc--cccCCCccccccccccccCccccCC
Q 040925 681 AHVCDFGLAKFLSDHQ----------------------------------LDT--AVKTPSSSIGLKGTVGYVAPEYGMG 724 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~----------------------------------~~~--~~~~~~~~~~~~gt~~y~aPE~~~~ 724 (833)
-.|+|||+|....... ... ............||++|+|||++..
T Consensus 172 g~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k 251 (418)
T KOG1167|consen 172 GVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFR 251 (418)
T ss_pred ceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhh
Confidence 8999999997221100 000 0011112234689999999999776
Q ss_pred C-CCCcccccccCCcCCCccccC----------CccHHHHHHHhCC----------Cc--ccc--c--ccccchh-----
Q 040925 725 S-EASMTGDIFTGRRPIDAVFNE----------GHSLHEFAKTALP----------EK--VME--I--VDPSLLM----- 772 (833)
Q Consensus 725 ~-~~~~~~Di~s~~~~~~~~~~~----------g~~l~~~~~~~~p----------~~--~~~--~--~~~~~~~----- 772 (833)
. ..+++.||||.|+++-.+.+. -..+.|+++-.-+ .. ..+ . ..++...
T Consensus 252 ~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~ 331 (418)
T KOG1167|consen 252 CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETL 331 (418)
T ss_pred ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhcc
Confidence 4 478999999877665322111 1122333222111 00 000 0 0001100
Q ss_pred --hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 773 --EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 773 --~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+............+...+..+..+.+++.+|++.||.+|.|+++.++.
T Consensus 332 ~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 332 HIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 001110000011222233344578999999999999999999999875
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-25 Score=232.92 Aligned_cols=185 Identities=20% Similarity=0.195 Sum_probs=138.8
Q ss_pred HHHHHhcCCccCceeccCcceEEEEEEECC-CceEEEEEEeeccC-----CcchhHHHHHHHHHhhcCCCccce-EeeEe
Q 040925 525 ELSKATGEFSSSNMIGQGSFGYVYKGTLGE-DEMIVAVKVINLKY-----KGASRSFVAECEALRNIRHRNLIK-IITIC 597 (833)
Q Consensus 525 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~-~~~~~ 597 (833)
......++|++.+.||+|+||+||+|++.. +++.||||++.... ....+.+.+|++++++++|+|++. ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 344556789999999999999999999875 67888999875321 123456899999999999999985 4332
Q ss_pred ecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCC-CCCCeeec
Q 040925 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDL-KPSNVLLD 676 (833)
Q Consensus 598 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dl-kp~NIll~ 676 (833)
+..++||||++|++|... .. .. ...++.|+++||+|||+. ||+|||| ||+||+++
T Consensus 91 --------~~~~LVmE~~~G~~L~~~-~~---------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~ 146 (365)
T PRK09188 91 --------GKDGLVRGWTEGVPLHLA-RP---------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMG 146 (365)
T ss_pred --------CCcEEEEEccCCCCHHHh-Cc---------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEc
Confidence 246899999999999732 11 11 146788999999999999 9999999 99999999
Q ss_pred CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCC------CCcccccc
Q 040925 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE------ASMTGDIF 734 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Di~ 734 (833)
.++.+||+|||+|+.+...................+++.|+|||++...+ .+..+|-|
T Consensus 147 ~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 147 PDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999999999999775543222111112223577999999999876432 23446666
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=262.03 Aligned_cols=339 Identities=22% Similarity=0.252 Sum_probs=194.5
Q ss_pred CCccccCCCCCCEEEccCCc------ccccCCccCCCC-CCCCEEEcCCCcccccCCccccCCCCCcEEECCCccccccc
Q 040925 15 LPDFVGNLSDLEVIRIMGNS------LGGKIPTTLGLL-RNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNL 87 (833)
Q Consensus 15 ~~~~~~~l~~L~~L~l~~n~------l~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 87 (833)
.+.+|.++.+|+.|.+.++. +...+|+.|..+ .+|+.|++.+|.++ .+|..| ...+|+.|+|++|++. .+
T Consensus 550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L 626 (1153)
T PLN03210 550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL 626 (1153)
T ss_pred cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence 34567777777777775543 223455656555 35777777777776 556666 4567777777777776 55
Q ss_pred CchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccc-cCCCCCCCCccc
Q 040925 88 PFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQN-NLGTGTATDLDF 166 (833)
Q Consensus 88 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~ 166 (833)
+..+ ..+++|+.|+|++|.....+| .++.+++|++|+|++|......+..+..+++|+.|++++| .+..++..
T Consensus 627 ~~~~-~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~---- 700 (1153)
T PLN03210 627 WDGV-HSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG---- 700 (1153)
T ss_pred cccc-ccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc----
Confidence 5443 567777777777665433455 3666777777777776544445556677777777777764 34443321
Q ss_pred ccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCC
Q 040925 167 VTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGEL 246 (833)
Q Consensus 167 ~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 246 (833)
.++++|+.|+|++|.....+|.. ..+|++|++++|.+. .+|..+ .+
T Consensus 701 ----i~l~sL~~L~Lsgc~~L~~~p~~----------------------------~~nL~~L~L~~n~i~-~lP~~~-~l 746 (1153)
T PLN03210 701 ----INLKSLYRLNLSGCSRLKSFPDI----------------------------STNISWLDLDETAIE-EFPSNL-RL 746 (1153)
T ss_pred ----CCCCCCCEEeCCCCCCccccccc----------------------------cCCcCeeecCCCccc-cccccc-cc
Confidence 15667777777776544333321 223444444444444 223222 34
Q ss_pred CCCCEEEcccccCc-------ccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCccccccc
Q 040925 247 KNLQKLCLFRNFLQ-------GRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSIT 319 (833)
Q Consensus 247 ~~L~~L~L~~N~l~-------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 319 (833)
++|++|++.++... ...+..+...++|+.|+|++|.....+|..++++++|+.|++++|...+.+|..+ .+.
T Consensus 747 ~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~ 825 (1153)
T PLN03210 747 ENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLE 825 (1153)
T ss_pred cccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-Ccc
Confidence 44444444442211 1111112223456666666665544555566666666666666554333555443 333
Q ss_pred ccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecC-CccccccCccccCCCCCCeEE
Q 040925 320 TLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISS-NSFHGVIPLSLSFLKSIKELN 398 (833)
Q Consensus 320 ~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~ 398 (833)
++ +.|++++|..-..+|.. .++|+.|+|++|.++ .+|..+..+++|+.|+|++ |++. .+|..+..+++|+.|+
T Consensus 826 sL-~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~ 899 (1153)
T PLN03210 826 SL-ESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVD 899 (1153)
T ss_pred cc-CEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeee
Confidence 33 55666665433334432 356777777777776 4566777777777777777 4455 3555667777777777
Q ss_pred ccCcc
Q 040925 399 VSSNN 403 (833)
Q Consensus 399 l~~N~ 403 (833)
+++|.
T Consensus 900 l~~C~ 904 (1153)
T PLN03210 900 FSDCG 904 (1153)
T ss_pred cCCCc
Confidence 77764
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=247.24 Aligned_cols=262 Identities=28% Similarity=0.346 Sum_probs=148.4
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
..|+|++|+|+ .+|+.+.. +|+.|++++|+|+ .+|. .+++|++|+|++|+|+. +|.. .++|+.|+|++|
T Consensus 204 ~~LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N 272 (788)
T PRK15387 204 AVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSN 272 (788)
T ss_pred cEEEcCCCCCC-cCCcchhc--CCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccCC
Confidence 35777777777 56666653 6777777777774 3443 24677777777777773 4432 356777777777
Q ss_pred ccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCC
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTA 161 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 161 (833)
.++ .+|. ...+|+.|+|++|+++ .+|.. +++|++|+|++|+|++++. . ..+|+.|++++|+|+.++.
T Consensus 273 ~L~-~Lp~----lp~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~N~L~~LP~ 339 (788)
T PRK15387 273 PLT-HLPA----LPSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLASLPA-L---PSELCKLWAYNNQLTSLPT 339 (788)
T ss_pred chh-hhhh----chhhcCEEECcCCccc-ccccc---ccccceeECCCCccccCCC-C---cccccccccccCccccccc
Confidence 776 5553 1255677777777776 34432 3567777777777776543 1 2346666777777765442
Q ss_pred CCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCc
Q 040925 162 TDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPD 241 (833)
Q Consensus 162 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 241 (833)
. ..+|++|+|++|+|+ .+|.. + .+|+.|++++|+|.. +|.
T Consensus 340 l----------p~~Lq~LdLS~N~Ls-~LP~l----p------------------------~~L~~L~Ls~N~L~~-LP~ 379 (788)
T PRK15387 340 L----------PSGLQELSVSDNQLA-SLPTL----P------------------------SELYKLWAYNNRLTS-LPA 379 (788)
T ss_pred c----------ccccceEecCCCccC-CCCCC----C------------------------cccceehhhcccccc-Ccc
Confidence 0 135667777777766 33321 1 234445555555553 232
Q ss_pred cccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCccccccccc
Q 040925 242 AIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTL 321 (833)
Q Consensus 242 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l 321 (833)
. ..+|+.|+|++|.|++ +|.. .++|+.|++++|+|++ +|..+ .+|+.|++++|+|+ .+|..++.+..+
T Consensus 380 l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L 447 (788)
T PRK15387 380 L---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSE 447 (788)
T ss_pred c---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCC
Confidence 2 1345555555555553 3322 2345556666666553 33321 24555666666665 556555555555
Q ss_pred ceeeecCCCccCCCCCccc
Q 040925 322 SLYLDLSNNLLNGSLPLQV 340 (833)
Q Consensus 322 l~~L~ls~N~l~~~~~~~~ 340 (833)
..|+|++|.+++..+..+
T Consensus 448 -~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 448 -TTVNLEGNPLSERTLQAL 465 (788)
T ss_pred -CeEECCCCCCCchHHHHH
Confidence 456666666665544444
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-23 Score=258.22 Aligned_cols=306 Identities=22% Similarity=0.244 Sum_probs=140.0
Q ss_pred CccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEeccccc-CCCCCCCCcccccccCCCCC
Q 040925 97 NLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNN-LGTGTATDLDFVTFLTNCSS 175 (833)
Q Consensus 97 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~l~~l~~ 175 (833)
+|+.|++.+|.+. .+|..| .+.+|++|+|++|++..+ +..+..+++|++|+|+++. +..++ .+..+++
T Consensus 590 ~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L-~~~~~~l~~Lk~L~Ls~~~~l~~ip--------~ls~l~~ 658 (1153)
T PLN03210 590 KLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKL-WDGVHSLTGLRNIDLRGSKNLKEIP--------DLSMATN 658 (1153)
T ss_pred ccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccccc-ccccccCCCCCEEECCCCCCcCcCC--------ccccCCc
Confidence 3555555555554 334444 345555555555555432 2234455555555555432 22221 1344555
Q ss_pred CCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcc
Q 040925 176 LKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLF 255 (833)
Q Consensus 176 L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 255 (833)
|++|+|++|.....+|..+.++.. |+.|++++|...+.+|..+ ++++|+.|++++|.....+|+. ..+|++|+|+
T Consensus 659 Le~L~L~~c~~L~~lp~si~~L~~-L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~ 733 (1153)
T PLN03210 659 LETLKLSDCSSLVELPSSIQYLNK-LEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLD 733 (1153)
T ss_pred ccEEEecCCCCccccchhhhccCC-CCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecC
Confidence 555555555433344444443332 3444444432222333333 4556666666666544344432 2456666666
Q ss_pred cccCcccCCccccCCCCCCeEEeeccccc-------CCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecC
Q 040925 256 RNFLQGRIPSGLGNLTKLANLELSSNSLQ-------GNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLS 328 (833)
Q Consensus 256 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-------~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls 328 (833)
+|.+. .+|..+ .+++|+.|++.++... ...+..+...++|+.|++++|...+.+|..+..+..+ +.|+++
T Consensus 734 ~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L-~~L~Ls 810 (1153)
T PLN03210 734 ETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKL-EHLEIE 810 (1153)
T ss_pred CCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCC-CEEECC
Confidence 66665 344433 3555666666553221 1111112223455555555554444455555444444 445555
Q ss_pred CCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCc
Q 040925 329 NNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408 (833)
Q Consensus 329 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 408 (833)
+|..-+.+|..+ ++++|+.|++++|......|.. ..+|+.|+|++|.++ .+|.++..+++|+.|+|++|+-...+
T Consensus 811 ~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l 885 (1153)
T PLN03210 811 NCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRV 885 (1153)
T ss_pred CCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCcc
Confidence 543222344333 4455555555554332222221 234555555555554 23444555555555555542222234
Q ss_pred hhhhcCCCCCceEECccC
Q 040925 409 PEFLKNLSVLEFLSLSYN 426 (833)
Q Consensus 409 p~~l~~l~~L~~L~l~~N 426 (833)
|..+..+++|+.++++++
T Consensus 886 ~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 886 SLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CcccccccCCCeeecCCC
Confidence 444445555555555444
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.7e-24 Score=244.54 Aligned_cols=265 Identities=26% Similarity=0.326 Sum_probs=137.5
Q ss_pred CCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEc
Q 040925 48 NLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDL 127 (833)
Q Consensus 48 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 127 (833)
+-..|+|++|.++ .+|..+. ++|+.|++++|+|+ .+|. ..++|++|+|++|+|+. +|.. .++|+.|+|
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L 269 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPVL---PPGLLELSI 269 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence 3445555555555 3444443 25555555555555 4543 23556666666666652 3322 245566666
Q ss_pred ccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEcc
Q 040925 128 SVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIG 207 (833)
Q Consensus 128 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~ 207 (833)
++|.|+.++. -.++|+.|+|++|+|+.++. ..++|+.|+|++|+++ .+|. ++.
T Consensus 270 s~N~L~~Lp~----lp~~L~~L~Ls~N~Lt~LP~----------~p~~L~~LdLS~N~L~-~Lp~----lp~-------- 322 (788)
T PRK15387 270 FSNPLTHLPA----LPSGLCKLWIFGNQLTSLPV----------LPPGLQELSVSDNQLA-SLPA----LPS-------- 322 (788)
T ss_pred cCCchhhhhh----chhhcCEEECcCCccccccc----------cccccceeECCCCccc-cCCC----Ccc--------
Confidence 6666654432 12345556666666654432 1245666666666665 2232 111
Q ss_pred CccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCC
Q 040925 208 RNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNI 287 (833)
Q Consensus 208 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 287 (833)
+|+.|++++|++++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++|+|.. +
T Consensus 323 ----------------~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-L 377 (788)
T PRK15387 323 ----------------ELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-L 377 (788)
T ss_pred ----------------cccccccccCcccc-cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-C
Confidence 23333444444432 2211 1244555555555542 2321 1344445555555542 3
Q ss_pred CCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCC
Q 040925 288 PSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTC 367 (833)
Q Consensus 288 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l 367 (833)
|.. ..+|+.|++++|+|+ .+|... .. ++.|++++|.+++ +|.. ..+|+.|++++|+|+ .+|..+..+
T Consensus 378 P~l---~~~L~~LdLs~N~Lt-~LP~l~---s~-L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L 444 (788)
T PRK15387 378 PAL---PSGLKELIVSGNRLT-SLPVLP---SE-LKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHL 444 (788)
T ss_pred ccc---ccccceEEecCCccc-CCCCcc---cC-CCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhc
Confidence 322 134555555555555 344321 12 2556777777663 4432 245677888888887 567778888
Q ss_pred CCCcEEeecCCccccccCcccc
Q 040925 368 VCLEYLDISSNSFHGVIPLSLS 389 (833)
Q Consensus 368 ~~L~~L~Ls~N~l~~~~~~~~~ 389 (833)
++|+.|+|++|+|++..+..+.
T Consensus 445 ~~L~~LdLs~N~Ls~~~~~~L~ 466 (788)
T PRK15387 445 SSETTVNLEGNPLSERTLQALR 466 (788)
T ss_pred cCCCeEECCCCCCCchHHHHHH
Confidence 8888888888888876665553
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=9e-24 Score=214.17 Aligned_cols=199 Identities=32% Similarity=0.461 Sum_probs=169.3
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
|++.+.||+|++|.||+|...++++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++.... ..+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~-----~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPE-----PLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCC-----ceEEE
Confidence 56778999999999999999988899999999765444 5678999999999999999999999875544 78999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
+||+++++|.+++..... .+++..+..++.+++.++.|||+. +++|+|++|+||+++.++.++|+|||.+..
T Consensus 76 ~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~ 147 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-----KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARF 147 (225)
T ss_pred EeccCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeE
Confidence 999999999999987541 178999999999999999999999 999999999999999999999999999987
Q ss_pred cCcccccccccCCCccccccccccccCcccc-CCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 692 LSDHQLDTAVKTPSSSIGLKGTVGYVAPEYG-MGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
...... .......++..|++||.. ....++.++|+|+ +|..++++.++..|+.
T Consensus 148 ~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~----------lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 148 IHRDLA-------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWS----------LGVILYELLWGPEPFS 201 (225)
T ss_pred ecCccc-------ccccceeccCCcCCHhHhcCCCCCCchhhHHH----------HHHHHHHHHHCCCCcc
Confidence 654320 011234578899999988 6667888999999 7788899998888764
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.5e-23 Score=200.01 Aligned_cols=269 Identities=20% Similarity=0.267 Sum_probs=208.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
-.|++.++||+|+||+++.|+.--++++||||.-... ...-.+..|.+.++.|. .++|..+|.+..+. .+-.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG-----~~Ni 100 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG-----KYNI 100 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeecccc-----chhh
Confidence 3799999999999999999999989999999986433 23456888999999985 79999998775443 3678
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-----cEEEc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-----VAHVC 684 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kL~ 684 (833)
+|||.. |.||+|+..-.++ .++..++..+|.|++.-++|+|++ .+|.|||||+|+||+.-+ .+.++
T Consensus 101 LVidLL-GPSLEDLFD~CgR-----~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGR-----RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcC-----cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence 999998 7899999987654 799999999999999999999999 999999999999997543 68999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+|+.+.++....... -....+..||.+||+-....|.+.+.+.|+=+ .|.++..++.|.+||.-..
T Consensus 172 DFGmAK~YrDp~TkqHIP-YrE~KSLsGTARYMSINTHlGrEQSRRDDLEa----------LGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIP-YREHKSLSGTARYMSINTHLGREQSRRDDLEA----------LGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred eccchhhhcCccccccCc-cccccccccceeeeEeeccccchhhhhhhHHH----------hhhhhhhhccCCCcccccc
Confidence 999999988776544432 22345678999999999999999999988555 7888888899999987433
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
........+.+.......+. +...+.++.++..-+.-.-..+-.+-|..+-+...+..+.+.
T Consensus 241 A~tnK~kYeKIGe~Kr~T~i-~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 241 ADTNKEKYEKIGETKRSTPI-EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred CcchHHHHHHhccccccCCH-HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 33333333333322222221 222345677777777777778999999988887777666543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-23 Score=217.62 Aligned_cols=269 Identities=20% Similarity=0.253 Sum_probs=196.1
Q ss_pred CCccCceeccCcceEEEEEEECCCc-eEEEEEEeeccCCcchhHHHHHHHHHhhcCC----CccceEeeEeecCCCCCCc
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDE-MIVAVKVINLKYKGASRSFVAECEALRNIRH----RNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 606 (833)
+|.+.+.||+|+||.||.|.+..++ ..+|+|............+..|..++..+.. +++..+++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 7999999999999999999987664 6789998765433333378889999999963 68888888763 2334
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-----CcE
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-----MVA 681 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~ 681 (833)
+.++||+.+ |.+|.++......+ .++..++.+++.|++.+|+++|+. |++||||||+|++++.. ..+
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~----~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPG----RFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCC----CcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceE
Confidence 789999998 67999988665522 799999999999999999999999 99999999999999865 369
Q ss_pred EEccccccc--ccCcccccccccCCCc-cccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhC
Q 040925 682 HVCDFGLAK--FLSDHQLDTAVKTPSS-SIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTAL 758 (833)
Q Consensus 682 kL~DfG~a~--~~~~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~ 758 (833)
.|.|||+|+ ......... ...... ...+.||..|+++.+..+.+.+.+.|+|| ....+.++..+..
T Consensus 167 ~llDfGlar~~~~~~~~~~~-~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles----------~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGN-LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLES----------LFYMLLELLKGSL 235 (322)
T ss_pred EEEecCCCccccccCCCCcc-cccCCCCccCCCCccccccHHHhCCCccCCchhhhh----------HHHHHHHHhcCCC
Confidence 999999998 332222111 011111 23467999999999999999999999999 6667888888888
Q ss_pred CCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 759 PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 759 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
||...+..+................ .....+..+.++...+-..+..++|....+.+.++.....
T Consensus 236 PW~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 236 PWEALEMTDLKSKFEKDPRKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred CCccccccchHHHHHHHhhhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 8853332211111100000000000 1111344566666666668999999999999998777654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=193.15 Aligned_cols=271 Identities=22% Similarity=0.265 Sum_probs=199.1
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCC-CccceEeeEeecCCCCCCce
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRH-RNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~ 607 (833)
..+.|.++++||+|+||.+|.|....+|+.||+|+-+... ....+..|..+.+.+++ ..|..+..|..+. .+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~-----~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEK-----DY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcccc-----cc
Confidence 4578999999999999999999999999999999875332 23467889999999974 6777777664443 37
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CCcEEEc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVC 684 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~ 684 (833)
-.+||+.. |.||+++..-... .++..+++.++-|++.-++|+|.+ ++|||||||+|+|++- ...+.++
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R-----~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSR-----RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhh-----hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEE
Confidence 78999998 7899998875543 689999999999999999999999 9999999999999963 3479999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+|+.+.+........ ........||.+|.+-....+.+.+...|+=| .|.++..+..+.+||.-..
T Consensus 157 DFGLaKky~d~~t~~HIp-yre~r~ltGTaRYASinAh~g~eqSRRDDmeS----------vgYvLmYfnrG~LPWQglk 225 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIP-YREDRNLTGTARYASINAHLGIEQSRRDDMES----------VGYVLMYFNRGSLPWQGLK 225 (341)
T ss_pred eccchhhhccccccccCc-cccCCccceeeeehhhhhhhhhhhhhhhhhhh----------hcceeeeeecCCCcccccc
Confidence 999999876644333221 12233467999999988888877888888666 5555556666777776333
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
........+.+.......+ .+.-.+.+|.++.-.+..|-..--++-|...-+.+.+..+...
T Consensus 226 a~tk~QKyEkI~EkK~s~~-ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 226 AATKKQKYEKISEKKMSTP-IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred hhhHHHHHHHHHHhhcCCC-HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 2222222222222211111 1222345667778888889999999999987777766655544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-23 Score=251.96 Aligned_cols=208 Identities=13% Similarity=0.148 Sum_probs=136.5
Q ss_pred hcCC-CccceEeeEeecCCCC--CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 040925 584 NIRH-RNLIKIITICSSTDFK--GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQ 660 (833)
Q Consensus 584 ~l~h-~niv~~~~~~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~ 660 (833)
.++| +||.++++++...... ....++.+|||+ +++|.+++.... ..+++.+++.+++||++||+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~-- 99 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAAHSQ-- 99 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHHHhC--
Confidence 4456 6888888876333211 123567788988 569999997532 1589999999999999999999999
Q ss_pred CCceeeCCCCCCeeecCCC-------------------cEEEcccccccccCcccc------ccccc--CCCcccccccc
Q 040925 661 PPMVHGDLKPSNVLLDHDM-------------------VAHVCDFGLAKFLSDHQL------DTAVK--TPSSSIGLKGT 713 (833)
Q Consensus 661 ~~ivH~Dlkp~NIll~~~~-------------------~~kL~DfG~a~~~~~~~~------~~~~~--~~~~~~~~~gt 713 (833)
||+||||||+|||++..+ .+|++|||+++....... ..... ........+||
T Consensus 100 -gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 100 -GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred -CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 999999999999996544 455666666543211000 00000 00011224689
Q ss_pred ccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHH
Q 040925 714 VGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECL 793 (833)
Q Consensus 714 ~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 793 (833)
+.|||||++.+..++.++|||| +|+++||++++..|...... .......... ++ ......
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwS----------lGviL~ELl~~~~~~~~~~~----~~~~~~~~~~--~~----~~~~~~ 238 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYR----------LGVLLFELFCPVSSREEKSR----TMSSLRHRVL--PP----QILLNW 238 (793)
T ss_pred cceEChhhhccCCCCchhhhhh----------HHHHHHHHhhCCCchhhHHH----HHHHHHHhhc--Ch----hhhhcC
Confidence 9999999999999999999999 77778888776555331110 0000000000 00 001112
Q ss_pred HHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 794 NAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 794 ~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....+++.+||++||.+|||+.|+++.
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 345678889999999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-22 Score=195.07 Aligned_cols=169 Identities=20% Similarity=0.206 Sum_probs=127.5
Q ss_pred CChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcccc
Q 040925 618 GSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL 697 (833)
Q Consensus 618 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~ 697 (833)
|||.+++...+. .+++.+++.|+.|++.||+|||+. + ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVRGR-----PLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-
Confidence 689999986432 699999999999999999999999 6 999999999999999 99987654321
Q ss_pred cccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccc
Q 040925 698 DTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTN 777 (833)
Q Consensus 698 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~ 777 (833)
..||+.|||||++.+..++.++|||| +|+++|+++++..|+........ ........
T Consensus 64 ------------~~g~~~y~aPE~~~~~~~~~~~DiwS----------lG~il~elltg~~p~~~~~~~~~-~~~~~~~~ 120 (176)
T smart00750 64 ------------SRVDPYFMAPEVIQGQSYTEKADIYS----------LGITLYEALDYELPYNEERELSA-ILEILLNG 120 (176)
T ss_pred ------------CCCcccccChHHhcCCCCcchhhHHH----------HHHHHHHHHhCCCCccccchhcH-HHHHHHHH
Confidence 14899999999999999999999999 88899999999988753221111 11111111
Q ss_pred cchhhhhhhhchHHHHH--HHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 778 NSMIQEDKRVKTEECLN--AIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 778 ~~~~~~~~~~~~~~~~~--~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
.....+..+........ .+.+++.+||..||++|||+.|+++.+..+..
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11111111122233333 68999999999999999999999999877754
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-22 Score=229.89 Aligned_cols=139 Identities=19% Similarity=0.332 Sum_probs=82.3
Q ss_pred CCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEc
Q 040925 24 DLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI 103 (833)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 103 (833)
+...|+++++.++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+++ .+|..+. ++|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~---~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP---DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh---ccccEEEC
Confidence 4566667766663 3555443 46667777777776 3444443 36777777777766 5665432 35677777
Q ss_pred cCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccC
Q 040925 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLAD 183 (833)
Q Consensus 104 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 183 (833)
++|++. .+|..+. ++|+.|+|++|+|+.++. .+. ++|+.|+|++|+|+.++.. + .++|+.|++++
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~LP~-~l~--~sL~~L~Ls~N~Lt~LP~~-------l--p~sL~~L~Ls~ 313 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKISCLPE-NLP--EELRYLSVYDNSIRTLPAH-------L--PSGITHLNVQS 313 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccCcccc-ccC--CCCcEEECCCCccccCccc-------c--hhhHHHHHhcC
Confidence 777766 4454442 467777777777765443 222 3677777777777654421 1 13566666777
Q ss_pred CcCc
Q 040925 184 NQFG 187 (833)
Q Consensus 184 N~l~ 187 (833)
|+++
T Consensus 314 N~Lt 317 (754)
T PRK15370 314 NSLT 317 (754)
T ss_pred Cccc
Confidence 7666
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.3e-23 Score=231.13 Aligned_cols=258 Identities=19% Similarity=0.223 Sum_probs=191.6
Q ss_pred ccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcc---hhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 534 SSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGA---SRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 534 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.....+|.|++|.|+.+......+.++.|.++.. .... ...+..|+.+-..++|||++..+..+.+.. .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----G 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----c
Confidence 3457899999998888888766666666655421 1111 122566777888889999988877754443 3
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
..-+||||++ +|..++.... .++..++..++.|++.|++|+|+. ||.|||+||+|+++..+|.+||+|||
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNG------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred chhhhhcccH-HHHHHHhccc------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence 3344999999 9999998763 578889999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcc-cccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMT-GDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
.+....-+... ......+++|+.+|+|||++.+.+|.+. .|||| .|+++..|..+..||......
T Consensus 466 ~~~vf~~~~e~----~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS----------~~ii~~~m~~~~~~Wk~a~~~ 531 (601)
T KOG0590|consen 466 AASVFRYPWEK----NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWS----------CGIIYICMILGRFPWKVAKKS 531 (601)
T ss_pred cceeeccCcch----hhhhhcCcccCCcCcCcccccccccCcchhhhhh----------ccceEEEEecCCCcccccccc
Confidence 98765433221 1234456889999999999999998754 79999 555666667777777766555
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
|................+........+.....++.++++.||.+|.|+++|++.
T Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 532 DNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 554322222222223333334445567778899999999999999999999864
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-22 Score=229.25 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=140.3
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEE
Q 040925 47 RNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLD 126 (833)
Q Consensus 47 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 126 (833)
.+.+.|+|++++++ .+|..+. ++|+.|+|++|+|+ .+|...+ ++|+.|+|++|.++ .+|..+. .+|+.|+
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence 45677778777777 4565553 46777777777777 6776554 46777777777776 3455442 4677777
Q ss_pred cccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEc
Q 040925 127 LSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGI 206 (833)
Q Consensus 127 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l 206 (833)
|++|+|..++.. +. ++|+.|+|++|+|+.++.. +. ++|+.|+|++|+|+ .+|..+.
T Consensus 248 Ls~N~L~~LP~~-l~--s~L~~L~Ls~N~L~~LP~~-------l~--~sL~~L~Ls~N~Lt-~LP~~lp----------- 303 (754)
T PRK15370 248 LSINRITELPER-LP--SALQSLDLFHNKISCLPEN-------LP--EELRYLSVYDNSIR-TLPAHLP----------- 303 (754)
T ss_pred CcCCccCcCChh-Hh--CCCCEEECcCCccCccccc-------cC--CCCcEEECCCCccc-cCcccch-----------
Confidence 777777755432 22 3567777777777654431 11 35666677666666 2332211
Q ss_pred cCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCC
Q 040925 207 GRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN 286 (833)
Q Consensus 207 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 286 (833)
++|+.|++++|++.. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .
T Consensus 304 ----------------~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~ 360 (754)
T PRK15370 304 ----------------SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-V 360 (754)
T ss_pred ----------------hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-c
Confidence 245555666666653 333221 456666666666663 444443 46666666666665 3
Q ss_pred CCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcc----cccCCCcCEEeccCCcCC
Q 040925 287 IPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQ----VGHLKNLVILDISSNQFS 357 (833)
Q Consensus 287 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~----~~~l~~L~~L~ls~N~l~ 357 (833)
+|..+. ++|+.|++++|+++ .+|..+.. .++.|++++|+++ .+|.. ++.++++..|++.+|.++
T Consensus 361 LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~---sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 361 LPETLP--PTITTLDVSRNALT-NLPENLPA---ALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CChhhc--CCcCEEECCCCcCC-CCCHhHHH---HHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 444332 45666666666665 44543321 1245555555555 33332 223355556666666554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=190.28 Aligned_cols=141 Identities=18% Similarity=0.148 Sum_probs=109.3
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCCcc---------h-----------------hHHHHHHHHHhhcCCCc
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA---------S-----------------RSFVAECEALRNIRHRN 589 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---------~-----------------~~~~~E~~~l~~l~h~n 589 (833)
...||+|++|.||+|... +|+.||||+++...... . .....|++.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999997 89999999997542111 0 12235999999998877
Q ss_pred cceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHH-hhcCCCCceeeCC
Q 040925 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDL 668 (833)
Q Consensus 590 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~~~~ivH~Dl 668 (833)
+.....+.. . ..++||||++++++........ .+++.++..++.|++.+|.|+ |+. ||+||||
T Consensus 81 v~~p~~~~~-~------~~~iVmE~i~g~~l~~~~~~~~------~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 81 IPCPEPILL-K------SHVLVMEFIGDDGWAAPRLKDA------PLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred CCCCcEEEe-c------CCEEEEEEeCCCCCcchhhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 644333211 1 2379999999877765433222 688999999999999999999 688 9999999
Q ss_pred CCCCeeecCCCcEEEcccccccccCc
Q 040925 669 KPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 669 kp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
||+||+++ ++.++|+|||+|.....
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccCCC
Confidence 99999998 57899999999975433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=184.03 Aligned_cols=140 Identities=21% Similarity=0.194 Sum_probs=111.2
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCCcc--------------------------hhHHHHHHHHHhhcCCCc
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA--------------------------SRSFVAECEALRNIRHRN 589 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~n 589 (833)
...||+|++|.||+|++. +|+.||||+++...... ...+..|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999997542110 112357899999999998
Q ss_pred cceEeeEeecCCCCCCceEeEEEEecCCCChhhh-hccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeC
Q 040925 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDW-LHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGD 667 (833)
Q Consensus 590 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~D 667 (833)
+.....+... ..++||||++|+++... +.. . .++..++..++.|++.++.++|+ . ||+|||
T Consensus 81 i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~-~------~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD 143 (190)
T cd05145 81 VPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKD-V------PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD 143 (190)
T ss_pred CCCceEEEec-------CCEEEEEEecCCCchhhhhhh-c------cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 7544443221 24799999998755433 322 1 57788999999999999999999 8 999999
Q ss_pred CCCCCeeecCCCcEEEcccccccccCc
Q 040925 668 LKPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 668 lkp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
|||+||+++ ++.++|+|||+|+....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecCC
Confidence 999999998 88999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-22 Score=190.48 Aligned_cols=248 Identities=20% Similarity=0.283 Sum_probs=187.3
Q ss_pred ccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 534 SSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 534 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
....+|.+...|+.|+|++. |..+++|++... .....++|..|.-.++-+.||||+.++|.|..+. ...++
T Consensus 193 nl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-----nlv~i 265 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-----NLVII 265 (448)
T ss_pred hhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-----CceEe
Confidence 34467889999999999996 445777877533 3334578999999999999999999999998776 88999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc--ccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC--DFGLA 689 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~--DfG~a 689 (833)
..||+.|+|+.++++...- .++..++.+++.++++|++|||+.. |-|----+.+..+++|++.+++|. |--++
T Consensus 266 sq~mp~gslynvlhe~t~v----vvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfs 340 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSV----VVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFS 340 (448)
T ss_pred eeeccchHHHHHHhcCccE----EEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceee
Confidence 9999999999999987643 5788899999999999999999983 333344589999999999988774 32222
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCC---CcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA---SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
.. ..+..-.|.||+||.++..+. ..++|+|| +.+.++|+.+..+|+......
T Consensus 341 fq---------------e~gr~y~pawmspealqrkped~n~raadmws----------faillwel~trevpfadlspm 395 (448)
T KOG0195|consen 341 FQ---------------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWS----------FAILLWELNTREVPFADLSPM 395 (448)
T ss_pred ee---------------ccccccCcccCCHHHHhcCchhcchhhhhHHH----------HHHHHHHhhccccccccCCch
Confidence 11 112346789999999877653 35789888 677788889999887643333
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
.-.+..... ......++.....+.+++.-|+..||.+||.++.|+-.|+++.
T Consensus 396 ecgmkiale-------glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 396 ECGMKIALE-------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhhhhhc-------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 222221111 0111224456778889999999999999999999999998864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.8e-20 Score=183.07 Aligned_cols=170 Identities=15% Similarity=0.150 Sum_probs=130.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhH---------HHHHHHHHhhcCCCccceEeeEeecC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS---------FVAECEALRNIRHRNLIKIITICSST 600 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~~~ 600 (833)
.++|++.+.+|.|+||.||++.. ++..+|+|.++.......+. +.+|+..+.++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 57899999999999999999766 46679999997554333322 68999999999999999999886543
Q ss_pred CC---CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC
Q 040925 601 DF---KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH 677 (833)
Q Consensus 601 ~~---~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 677 (833)
.. ......++||||++|.+|.++.. ++. ....+++.++..+|+. |++|||+||+||+++.
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 21 11346899999999999988732 222 2456999999999999 9999999999999999
Q ss_pred CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcC
Q 040925 678 DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRP 739 (833)
Q Consensus 678 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~ 739 (833)
+| ++|+|||.+........ ...+.....+..++|+|+.|+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a--------------------~d~~vler~y~~~~di~~lg~~ 211 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKA--------------------KDRIDLERHYGIKNEIKDLGYY 211 (232)
T ss_pred CC-EEEEECCCcccccchhh--------------------HHHHHHHhHhcccccccceeEe
Confidence 88 99999998875432211 0113444557789999995544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=176.78 Aligned_cols=140 Identities=18% Similarity=0.302 Sum_probs=109.6
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-----CCCccceEeeEeecCCCCCCce
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-----RHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~ 607 (833)
+.-.+.||+|++|.||. ++.++.. +||++........+.+.+|+.+++.+ .||||++++|++.+.. +.+.
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeE
Confidence 34457999999999995 6666665 69998765444567899999999999 5799999999986653 2234
Q ss_pred -EeEEEEe--cCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHH-HHHhhcCCCCceeeCCCCCCeeecC----CC
Q 040925 608 -KAFVFEY--MENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM-EYLHHHCQPPMVHGDLKPSNVLLDH----DM 679 (833)
Q Consensus 608 -~~lv~e~--~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL-~~LH~~~~~~ivH~Dlkp~NIll~~----~~ 679 (833)
..+|||| +++|||.+++.+. .+++. ..++.|++.++ +|||+. +|+||||||+||+++. ++
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~-------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC-------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEV 146 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc-------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCC
Confidence 3478999 5579999999753 34444 35678888888 999999 9999999999999974 34
Q ss_pred cEEEcccccc
Q 040925 680 VAHVCDFGLA 689 (833)
Q Consensus 680 ~~kL~DfG~a 689 (833)
.++|+||+.+
T Consensus 147 ~~~LiDg~G~ 156 (210)
T PRK10345 147 IPVVCDNIGE 156 (210)
T ss_pred cEEEEECCCC
Confidence 8999995444
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=7.5e-19 Score=190.39 Aligned_cols=262 Identities=28% Similarity=0.394 Sum_probs=189.4
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcCCC-ccceEeeEeecCCCCCCceE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHR-NLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~ 608 (833)
|.+.+.||.|+||.||++.+. ..+|+|.+...... ....+.+|+.+++.+.|+ +++++++++.... ..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~-----~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEG-----SL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCC-----EE
Confidence 677889999999999999987 67899999755333 357799999999999988 7999999974433 57
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-cEEEcccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCDFG 687 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfG 687 (833)
+++++|+.++++.+++...... ..++......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg 147 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFG 147 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccC
Confidence 9999999999999777754321 2588899999999999999999999 999999999999999988 79999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC---CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG---SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
.++............ .......||..|+|||...+ ..++...|+|+ .|..++++..+..|+....
T Consensus 148 ~~~~~~~~~~~~~~~--~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s----------~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 148 LAKLLPDPGSTSSIP--ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS----------LGITLYELLTGLPPFEGEK 215 (384)
T ss_pred cceecCCCCcccccc--ccccccccccccCCHHHhcCCCCCCCCchHhHHH----------HHHHHHHHHhCCCCCCCCC
Confidence 998554432111000 12334679999999999887 57899999997 5566777777777743222
Q ss_pred cc-cccchhhhccccchh--h-hhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IV-DPSLLMEVMTNNSMI--Q-EDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~-~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. ........+...... . .............+.+++..|+..+|..|.++.+....
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 216 NSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 10 000000111100000 0 00000001123567888999999999999998887664
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.6e-19 Score=169.64 Aligned_cols=191 Identities=15% Similarity=0.062 Sum_probs=133.1
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCC----cchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCce
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK----GASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 607 (833)
+.+...|++|+||+||.+.. .+.+++.+.+..... .....+.+|+++|+++. |++|++++++. .
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~ 72 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------G 72 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------C
Confidence 34568999999999998766 577788777753322 11235789999999995 58899998861 4
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCC-CCCCeeecCCCcEEEccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDL-KPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kL~Df 686 (833)
.+++|||++|.+|.+.... ....++.|++.+|.++|+. ||+|||| ||+||+++.++.++|+||
T Consensus 73 ~~lvmeyI~G~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDF 136 (218)
T PRK12274 73 RHLDRSYLAGAAMYQRPPR-------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDF 136 (218)
T ss_pred EEEEEeeecCccHHhhhhh-------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEEC
Confidence 6899999999888754321 1134778999999999999 9999999 799999999999999999
Q ss_pred ccccccCccccc------ccccCCCccccccccccccCccccCCC-CCC-cccccccCCcCCCccccCCccHHHHHHHhC
Q 040925 687 GLAKFLSDHQLD------TAVKTPSSSIGLKGTVGYVAPEYGMGS-EAS-MTGDIFTGRRPIDAVFNEGHSLHEFAKTAL 758 (833)
Q Consensus 687 G~a~~~~~~~~~------~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~ 758 (833)
|+|......... .....- ...-...++.|++|+...-- ..+ ...++++ .|..+|.++++.+
T Consensus 137 G~A~~~~~~~~~~r~L~~rDl~~l-lk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~----------~g~~~~~~~~~~~ 205 (218)
T PRK12274 137 QLAVRGNPRARWMRLLAREDLRHL-LKHKRMYCPAALTPVERRVLKRTSWIRELWFA----------TGKPVYRFVTRRV 205 (218)
T ss_pred CCceecCCcchHHHHHHHHHHHHH-HHHHHhcCCCCCCHHHHhhhccchhHHHHHHH----------hcchHHHHHhccC
Confidence 999854432210 000000 00112367788888742211 122 3334334 7888899999887
Q ss_pred CCc
Q 040925 759 PEK 761 (833)
Q Consensus 759 p~~ 761 (833)
+..
T Consensus 206 ~~~ 208 (218)
T PRK12274 206 LHW 208 (218)
T ss_pred Ccc
Confidence 754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.6e-20 Score=181.94 Aligned_cols=206 Identities=19% Similarity=0.245 Sum_probs=136.4
Q ss_pred CCCccceEeeEeecCC----------------------CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHH
Q 040925 586 RHRNLIKIITICSSTD----------------------FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVN 643 (833)
Q Consensus 586 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 643 (833)
+|||||+++++|.+.- .......|+||..++. +|++++..+ ..+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-------~~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-------HRSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-------CCchHHHHH
Confidence 5999999998875421 1224568999999975 999999876 356677888
Q ss_pred HHHHHHHHHHHHhhcCCCCceeeCCCCCCeee--cCCC--cEEEcccccccccCcccccccccCCCccccccccccccCc
Q 040925 644 IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL--DHDM--VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAP 719 (833)
Q Consensus 644 i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 719 (833)
++.|+++|+.|||.+ ||.|||+|++||++ |+|+ .+.++|||++-........-...+. ....-|...-|||
T Consensus 346 ~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~--~Vd~GGNa~lmAP 420 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESD--EVDLGGNAKLMAP 420 (598)
T ss_pred HHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccc--cccCCCcceecch
Confidence 999999999999999 99999999999998 4444 6889999998654432222111111 1123478889999
Q ss_pred cccCCCC------CCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHH
Q 040925 720 EYGMGSE------ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECL 793 (833)
Q Consensus 720 E~~~~~~------~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 793 (833)
|+....+ --.|+|.|+.|...+++|.....+|. .|. . ..+.+- +... .-...++.++
T Consensus 421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~--rGe-----m-~L~~r~---Yqe~------qLPalp~~vp 483 (598)
T KOG4158|consen 421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK--RGE-----M-LLDTRT---YQES------QLPALPSRVP 483 (598)
T ss_pred hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc--cch-----h-eechhh---hhhh------hCCCCcccCC
Confidence 9865432 23578989855544444444333333 000 0 011100 0000 0112245567
Q ss_pred HHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 794 NAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 794 ~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
+.+.+++...+++||++|++..-....+
T Consensus 484 p~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 484 PVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred hHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 7888999999999999999976555443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3e-21 Score=170.69 Aligned_cols=177 Identities=26% Similarity=0.439 Sum_probs=131.0
Q ss_pred CCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceee
Q 040925 246 LKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYL 325 (833)
Q Consensus 246 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L 325 (833)
+.+++.|.||+|+++ .+|..++.+.+|+.|++++|+|+ ..|..++.++.|+ .|
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr-------------------------~l 84 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLR-------------------------IL 84 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhh-------------------------he
Confidence 344555555555555 44445555555555555555555 4444455555444 45
Q ss_pred ecCCCccCCCCCcccccCCCcCEEeccCCcCCC-CCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCccc
Q 040925 326 DLSNNLLNGSLPLQVGHLKNLVILDISSNQFSG-VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNL 404 (833)
Q Consensus 326 ~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 404 (833)
+++-|++. +.|..|+.++.|+.|||++|.+.. ..|+.|-.+..|+.|+|++|.+. .+|...+++++|+.|.+.+|.+
T Consensus 85 nvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 85 NVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred ecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence 55555555 778888889999999999988864 67888888999999999999998 7788899999999999999998
Q ss_pred CCCchhhhcCCCCCceEECccCcCccccCCCCcc---CCCccccccCCcCC
Q 040925 405 SGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVF---SNKTKISLQGNMKL 452 (833)
Q Consensus 405 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~---~~~~~l~l~~N~~~ 452 (833)
- .+|+.++.++.|+.|.+++|.++-.||..+.+ .+.....+..|||.
T Consensus 163 l-~lpkeig~lt~lrelhiqgnrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 163 L-SLPKEIGDLTRLRELHIQGNRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred h-hCcHHHHHHHHHHHHhcccceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 8 68899999999999999999999999887654 34455667888885
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=174.95 Aligned_cols=144 Identities=19% Similarity=0.155 Sum_probs=113.4
Q ss_pred CCccCceeccCcceEEEEEE-ECCCceEEEEEEeeccCCc------------------------chhHHHHHHHHHhhcC
Q 040925 532 EFSSSNMIGQGSFGYVYKGT-LGEDEMIVAVKVINLKYKG------------------------ASRSFVAECEALRNIR 586 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 586 (833)
.|++.+.||+|++|.||+|. +..+|+.||+|+++..... ....+.+|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 6568999999999743210 0123568999999997
Q ss_pred CC--ccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC-c
Q 040925 587 HR--NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP-M 663 (833)
Q Consensus 587 h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~-i 663 (833)
+. .+.+++++ . ..++||||++++++........ .....++..++.|++.++++||+. | |
T Consensus 109 ~~~i~~p~~~~~---~------~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---g~i 170 (237)
T smart00090 109 EAGVPVPKPIAW---R------RNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYKE---GEL 170 (237)
T ss_pred hcCCCCCeeeEe---c------CceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHhc---CCE
Confidence 53 34455543 1 2479999999988876653322 355667789999999999999999 9 9
Q ss_pred eeeCCCCCCeeecCCCcEEEcccccccccCc
Q 040925 664 VHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 664 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
+||||||+||+++ ++.++|+|||.|.....
T Consensus 171 iH~Dikp~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 171 VHGDLSEYNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EeCCCChhhEEEE-CCCEEEEEChhhhccCC
Confidence 9999999999999 88999999999875443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-20 Score=202.46 Aligned_cols=154 Identities=22% Similarity=0.320 Sum_probs=79.2
Q ss_pred EEEcCCCcCc-ccCCccccCCCCCCEEEccCCccccc----CCccCCCCCCCCEEEcCCCcccc------cCCccccCCC
Q 040925 3 TLAVNDNYLT-GQLPDFVGNLSDLEVIRIMGNSLGGK----IPTTLGLLRNLVSLNVAENKFSG------MFPRSICNIS 71 (833)
Q Consensus 3 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~i~~------~~~~~~~~l~ 71 (833)
.|+|..+.++ ...+..|..+..|+.|+++++.++.. ++..+...++|++|+++++.+.+ ..+..|..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4667777776 34445566666677777777776332 34445566667777777766651 2233455556
Q ss_pred CCcEEECCCcccccccCchhhcCCCC---ccEEEccCCccee----eCCccccCC-CCCcEEEcccCcccccc----CcC
Q 040925 72 SLELIQLALNRFSGNLPFDIVVNLPN---LKALAIGGNNFFG----SIPYSLSNA-SNLELLDLSVNQFKGNV----SID 139 (833)
Q Consensus 72 ~L~~L~L~~N~l~~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~i~~~~----~~~ 139 (833)
+|+.|++++|.+.+ .....|..+.+ |++|++++|++++ .+...+..+ ++|++|+|++|.+++.. ...
T Consensus 82 ~L~~L~l~~~~~~~-~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 82 GLQELDLSDNALGP-DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred ceeEEEccCCCCCh-hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 66666666666542 22222233333 5555555555541 112223334 55555555555554211 112
Q ss_pred ccCCCcCceEecccccCC
Q 040925 140 FSSLKNLLWLNLEQNNLG 157 (833)
Q Consensus 140 ~~~l~~L~~L~L~~N~l~ 157 (833)
|..+++|++|+|++|.++
T Consensus 161 ~~~~~~L~~L~l~~n~l~ 178 (319)
T cd00116 161 LRANRDLKELNLANNGIG 178 (319)
T ss_pred HHhCCCcCEEECcCCCCc
Confidence 333444555555554443
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-20 Score=197.99 Aligned_cols=285 Identities=23% Similarity=0.287 Sum_probs=153.6
Q ss_pred EEECCCcccccccCchhhcCCCCccEEEccCCccee----eCCccccCCCCCcEEEcccCccccc------cCcCccCCC
Q 040925 75 LIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFG----SIPYSLSNASNLELLDLSVNQFKGN------VSIDFSSLK 144 (833)
Q Consensus 75 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~------~~~~~~~l~ 144 (833)
.|+|+.+.+++.--...|..+.+|+.|++++|.++. .++..+...++|++|+++++.+.+. ....|..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 467777777633334556777778888888888743 2444566677788888888776521 122345566
Q ss_pred cCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcC-C
Q 040925 145 NLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNL-V 223 (833)
Q Consensus 145 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l-~ 223 (833)
+|+.|++++|.+....... +...... ++|++|++++|++++.... .+...+..+ +
T Consensus 82 ~L~~L~l~~~~~~~~~~~~--~~~l~~~-~~L~~L~ls~~~~~~~~~~---------------------~l~~~l~~~~~ 137 (319)
T cd00116 82 GLQELDLSDNALGPDGCGV--LESLLRS-SSLQELKLNNNGLGDRGLR---------------------LLAKGLKDLPP 137 (319)
T ss_pred ceeEEEccCCCCChhHHHH--HHHHhcc-CcccEEEeeCCccchHHHH---------------------HHHHHHHhCCC
Confidence 6666666666664321110 1111112 3466666666665521111 112234444 6
Q ss_pred CCCeEeccCCcccc----cCCccccCCCCCCEEEcccccCccc----CCccccCCCCCCeEEeecccccCC----CCCCC
Q 040925 224 NLIGFGAEENQLHG----TIPDAIGELKNLQKLCLFRNFLQGR----IPSGLGNLTKLANLELSSNSLQGN----IPSSL 291 (833)
Q Consensus 224 ~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~ 291 (833)
+|+.|++++|.+++ ..+..+..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+.+. ++..+
T Consensus 138 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~ 217 (319)
T cd00116 138 ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETL 217 (319)
T ss_pred CceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHh
Confidence 67777777777663 2334455666777777777777632 223344556777777777776533 22345
Q ss_pred CCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCC----CCCccccCC
Q 040925 292 GNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSG----VIPGTLSTC 367 (833)
Q Consensus 292 ~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~----~~~~~~~~l 367 (833)
..+++|+.|++++|.+++.....+... .....+.|+.|++++|.++. .....+..+
T Consensus 218 ~~~~~L~~L~ls~n~l~~~~~~~l~~~--------------------~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~ 277 (319)
T cd00116 218 ASLKSLEVLNLGDNNLTDAGAAALASA--------------------LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEK 277 (319)
T ss_pred cccCCCCEEecCCCcCchHHHHHHHHH--------------------HhccCCCceEEEccCCCCCcHHHHHHHHHHhcC
Confidence 556667777777776653111111110 00013456666666665541 122234444
Q ss_pred CCCcEEeecCCccccc----cCccccCC-CCCCeEEccCcc
Q 040925 368 VCLEYLDISSNSFHGV----IPLSLSFL-KSIKELNVSSNN 403 (833)
Q Consensus 368 ~~L~~L~Ls~N~l~~~----~~~~~~~l-~~L~~L~l~~N~ 403 (833)
++|+++++++|.+... ....+... +.|++|++.+|.
T Consensus 278 ~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 278 ESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS 318 (319)
T ss_pred CCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence 5666666666666533 22233333 556666666554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.5e-20 Score=164.84 Aligned_cols=165 Identities=32% Similarity=0.507 Sum_probs=132.4
Q ss_pred hhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCcc
Q 040925 218 GIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNL 297 (833)
Q Consensus 218 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 297 (833)
.+-++.+.+.|.|++|+++ ..|..+..+.+|+.|++++|+|. ..|..++.+++|+.|+++-|++. ..|..|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 3446677888999999999 56677899999999999999998 68899999999999999999998 899999999999
Q ss_pred ceeecCCceecc-cCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeec
Q 040925 298 MSFTASQNKLTG-ALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDIS 376 (833)
Q Consensus 298 ~~L~l~~N~l~~-~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls 376 (833)
+.|+|++|.+.+ .+|..++.+..+ +-|+|+.|.+. ++|..++++++|+.|.+..|.+- ..|..++.+++|++|++.
T Consensus 105 evldltynnl~e~~lpgnff~m~tl-ralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTL-RALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred hhhhccccccccccCCcchhHHHHH-HHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence 999999999873 467777777776 66777777777 67777777777777777777776 566677777777777777
Q ss_pred CCccccccCcccc
Q 040925 377 SNSFHGVIPLSLS 389 (833)
Q Consensus 377 ~N~l~~~~~~~~~ 389 (833)
+|+++ +.|..++
T Consensus 182 gnrl~-vlppel~ 193 (264)
T KOG0617|consen 182 GNRLT-VLPPELA 193 (264)
T ss_pred cceee-ecChhhh
Confidence 77776 4443333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-19 Score=201.59 Aligned_cols=255 Identities=21% Similarity=0.224 Sum_probs=180.2
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHH--HhhcCCCccceEeeEeecCCCCCCceE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEA--LRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
+|...+.||++.|=+|.+|+++ .|. |+||++-... .-..+.+.++++- ...++|||++.+.-+- ......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~-----~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL-----VTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH-----HhhHHH
Confidence 5778899999999999999997 455 8999985443 2233444444333 4445899999887652 233467
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
|+|=+|..+ +|+|.+..++ -+...+.+-|+.|++.||..+|.. ||+|||||.+||||+.=.-+.|+||..
T Consensus 97 ylvRqyvkh-nLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAs 166 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFAS 166 (1431)
T ss_pred HHHHHHHhh-hhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccc
Confidence 888899976 9999998765 678888899999999999999999 999999999999999988999999976
Q ss_pred cccc--CcccccccccCCCccccccccccccCccccCC----------CC-CCcccccccCCcCCCccccCCccHHHHHH
Q 040925 689 AKFL--SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG----------SE-ASMTGDIFTGRRPIDAVFNEGHSLHEFAK 755 (833)
Q Consensus 689 a~~~--~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~-~~~~~Di~s~~~~~~~~~~~g~~l~~~~~ 755 (833)
-+.. +.+..... .........-..|.|||.+.. .. .+++-||||.||.+.++|..|..++++..
T Consensus 167 FKPtYLPeDNPadf---~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ 243 (1431)
T KOG1240|consen 167 FKPTYLPEDNPADF---TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ 243 (1431)
T ss_pred cCCccCCCCCcccc---eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH
Confidence 5432 11111000 000111122346999996543 12 56778999999998888888888877644
Q ss_pred HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 756 TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 756 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
-. .+......+++...+.+.. ..+..++..|++.||++|-++++.++.-..
T Consensus 244 L~-aYr~~~~~~~e~~Le~Ied----------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 244 LL-AYRSGNADDPEQLLEKIED----------------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HH-hHhccCccCHHHHHHhCcC----------------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 32 2222223344443332221 246788899999999999999999988443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.5e-18 Score=171.46 Aligned_cols=240 Identities=20% Similarity=0.222 Sum_probs=150.3
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcC----------CCccceEeeEeec
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIR----------HRNLIKIITICSS 599 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~----------h~niv~~~~~~~~ 599 (833)
+...+.||.|+++.||.+++.++++.+|||++...... ..+.+.+|.-....+. |-.++.-++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 45668999999999999999999999999998644322 2356666665555432 2223333333221
Q ss_pred CCC-------CCCc-----eEeEEEEecCCCChhhhhccCCCccc-cccCCHHHHHHHHHHHHHHHHHHhhcCCCCceee
Q 040925 600 TDF-------KGTD-----FKAFVFEYMENGSLKDWLHQSDDQVE-VCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHG 666 (833)
Q Consensus 600 ~~~-------~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~ 666 (833)
... .+.. ..+++|+-+. +||.+++..-..... ........+..+..|+++.+++||+. |+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 110 0011 2367888885 599888653111000 11344555677779999999999999 99999
Q ss_pred CCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCC--------CCCCcccccccCCc
Q 040925 667 DLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--------SEASMTGDIFTGRR 738 (833)
Q Consensus 667 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~s~~~ 738 (833)
||||+|++++.+|.++|+||+.....+..... ...+..|.+||.... ..++.+.|.|+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~--- 235 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQ--- 235 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHH---
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-----------cCCCcccCChhhhhhhcccCcccceeeeccCHHH---
Confidence 99999999999999999999988765543221 124577999996533 24788889888
Q ss_pred CCCccccCCccHHHHHHHhCCCcccc-cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCC
Q 040925 739 PIDAVFNEGHSLHEFAKTALPEKVME-IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFER 811 (833)
Q Consensus 739 ~~~~~~~~g~~l~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 811 (833)
.|+++|.+..+.+|+.... ..++... -.... +.++.+..+|..++++||.+|
T Consensus 236 -------LG~~ly~lWC~~lPf~~~~~~~~~~~~-------------f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 236 -------LGITLYSLWCGRLPFGLSSPEADPEWD-------------FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -------HHHHHHHHHHSS-STCCCGGGSTSGGG-------------GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred -------HHHHHHHHHHccCCCCCCCcccccccc-------------chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 8889999999999987332 2222210 01112 578889999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-17 Score=190.49 Aligned_cols=254 Identities=19% Similarity=0.185 Sum_probs=176.1
Q ss_pred HHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC---CCccceEeeEeecCC
Q 040925 525 ELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR---HRNLIKIITICSSTD 601 (833)
Q Consensus 525 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~ 601 (833)
+.+.....|.|.+.+|+|+||+||+|+... |+.||+|+-+.... -+|.-=.+++.+|+ -+.|+++...+...
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~- 766 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQ- 766 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccC-
Confidence 444455679999999999999999999985 99999999764432 22222334444554 23344444332222
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC----
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---- 677 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---- 677 (833)
+.-++|+||.+.|||.+++...+ .++|.-++.++.|+++-+++||.. +|||+||||+|.+|..
T Consensus 767 ----~~S~lv~ey~~~Gtlld~~N~~~------~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 767 ----NASVLVSEYSPYGTLLDLINTNK------VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred ----CcceeeeeccccccHHHhhccCC------CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCC
Confidence 25679999999999999999554 689999999999999999999999 9999999999999942
Q ss_pred ---CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 678 ---DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 678 ---~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
...++|+|||.+..+.--. ......+.++|-.+-.+|+..|.++++.+|.|- ...+++-++
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp------~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfG----------lAa~~h~mL 897 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFP------DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFG----------LAATVHVML 897 (974)
T ss_pred CCcccceEEEecccceeeeEcC------CCcEEeeeeccccchhHHHhcCCCCchhhhhHH----------HHHHHHHHH
Confidence 3369999999997653311 112334567899999999999999999999654 455666666
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
.|.+-. ..+...+.-.. ..+|..-.+. +-++...+|+.|-..=|...++...++++..
T Consensus 898 FG~y~q----~~~g~~~~~~~-------~~~Ry~~~~~---W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~ 955 (974)
T KOG1166|consen 898 FGKYME----VKNGSSWMVKT-------NFPRYWKRDM---WNKFFDLLLNPDCDTLPNLQELRTELEEVLA 955 (974)
T ss_pred HHHHHH----hcCCcceeccc-------cchhhhhHHH---HHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence 666543 11111100000 0112222222 3455556666666667888888888887754
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-17 Score=178.91 Aligned_cols=216 Identities=26% Similarity=0.384 Sum_probs=159.2
Q ss_pred HhhcCCCccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 040925 582 LRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQP 661 (833)
Q Consensus 582 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~ 661 (833)
|+.+.|.|+.+++|.+.+.. ..++|.+||..|+|.|.+..... .+++.-...++++|+.||+|+|..
T Consensus 1 l~~l~h~n~~~f~g~~~~~~-----~~~~i~~~c~rGsl~D~i~~~~~-----~~d~~F~~s~~rdi~~Gl~ylh~s--- 67 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGP-----EMIVIWEYCSRGSLLDILSNEDI-----KLDYFFILSFIRDISKGLAYLHNS--- 67 (484)
T ss_pred CcccchhhhhhheeeEecCC-----ceEEEEeeecCccHHhHHhcccc-----CccHHHHHHHHHHHHHHHHHHhcC---
Confidence 46788999999999987764 88999999999999999987432 689999999999999999999998
Q ss_pred Cc-eeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCC-------CCccccc
Q 040925 662 PM-VHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-------ASMTGDI 733 (833)
Q Consensus 662 ~i-vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di 733 (833)
+| .|+.+++.|.++|....+||+|||+......... ........-..-|.|||.+.+.. .+.++||
T Consensus 68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi 141 (484)
T KOG1023|consen 68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAE------PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI 141 (484)
T ss_pred cceeeeeeccccceeeeeEEEEechhhhccccccccc------ccccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence 55 9999999999999999999999999876643100 00111122456799999887642 3556777
Q ss_pred ccCCcCCCccccCCccHHHHHHHhCCCcccc-cccccchhhhccccchhhhhhhhc-hHHHHHHHHHHhhccCCCCCCCC
Q 040925 734 FTGRRPIDAVFNEGHSLHEFAKTALPEKVME-IVDPSLLMEVMTNNSMIQEDKRVK-TEECLNAIIRTGVLCSMESPFER 811 (833)
Q Consensus 734 ~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~R 811 (833)
|| +|++++|++....|+.... ..++......+.+.......+... ..+.++.+..++.+||..+|++|
T Consensus 142 Ys----------~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~r 211 (484)
T KOG1023|consen 142 YS----------FGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKR 211 (484)
T ss_pred eh----------HHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhC
Confidence 77 8899999999998887322 222211111111101100111111 11556679999999999999999
Q ss_pred CCHHHHHHHHHHhhh
Q 040925 812 MDMRDVVAKLCHTRE 826 (833)
Q Consensus 812 Pt~~eil~~L~~i~~ 826 (833)
|++++|...++.+..
T Consensus 212 Ps~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 212 PSIEQIRSKLLTINK 226 (484)
T ss_pred ccHHHHHhhhhhhcc
Confidence 999999998887765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-17 Score=162.53 Aligned_cols=134 Identities=22% Similarity=0.344 Sum_probs=110.3
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCCc--------chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--------ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
+.||+|++|.||+|.+ .+..|++|+....... ....+.+|++++..+.|+++.....++.... ..
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence 5799999999999988 5677999986533211 1245788999999999998876666654333 57
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++|++|.+++.... + .+..++.+++.+|.++|+. +++|||++|+||+++ ++.++++|||.
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~---------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG---------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc---------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 89999999999999986432 2 7889999999999999999 999999999999999 78999999999
Q ss_pred ccc
Q 040925 689 AKF 691 (833)
Q Consensus 689 a~~ 691 (833)
+..
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-17 Score=159.80 Aligned_cols=144 Identities=24% Similarity=0.199 Sum_probs=111.5
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc----------------------chhHHHHHHHHHh
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG----------------------ASRSFVAECEALR 583 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 583 (833)
+.....-|.+.+.||+|++|.||+|... +|+.||||+++..... ....+..|..++.
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3333334888899999999999999886 7999999987643210 0123677899999
Q ss_pred hcCCC--ccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 040925 584 NIRHR--NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQP 661 (833)
Q Consensus 584 ~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~ 661 (833)
.+.|+ .+++.++. ...++||||++|++|.++... .....++.+++.++.++|+.
T Consensus 89 ~l~~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~~--- 144 (198)
T cd05144 89 ALYEEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYKH--- 144 (198)
T ss_pred HHHHcCCCCCceeec---------CCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHHC---
Confidence 99877 44444432 145899999999998765431 23457889999999999999
Q ss_pred CceeeCCCCCCeeecCCCcEEEcccccccccCc
Q 040925 662 PMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 662 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
||+||||||+||++++++.++|+|||.+.....
T Consensus 145 gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 145 GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-16 Score=180.92 Aligned_cols=140 Identities=26% Similarity=0.339 Sum_probs=110.3
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc-CC-------cchhHHHHHHHHHhhcCCCccceEeeEee
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK-YK-------GASRSFVAECEALRNIRHRNLIKIITICS 598 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 598 (833)
......|...+.||+|+||.||+|.+... .+++|+.... .. ...+.+.+|+++++.++|++++....++.
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 33445567789999999999999988643 3444432211 11 11246889999999999999988776654
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
... ..++||||+++++|.+++. ....++.|++++|.|||+. +++|||+||+||++ ++
T Consensus 407 ~~~-----~~~lv~E~~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~ 463 (535)
T PRK09605 407 DPE-----EKTIVMEYIGGKDLKDVLE--------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RD 463 (535)
T ss_pred eCC-----CCEEEEEecCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-EC
Confidence 433 5689999999999998774 2457899999999999999 99999999999999 67
Q ss_pred CcEEEcccccccc
Q 040925 679 MVAHVCDFGLAKF 691 (833)
Q Consensus 679 ~~~kL~DfG~a~~ 691 (833)
+.++|+|||+++.
T Consensus 464 ~~~~liDFGla~~ 476 (535)
T PRK09605 464 DRLYLIDFGLGKY 476 (535)
T ss_pred CcEEEEeCccccc
Confidence 8999999999975
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=157.25 Aligned_cols=130 Identities=25% Similarity=0.386 Sum_probs=103.0
Q ss_pred eeccCcceEEEEEEECCCceEEEEEEeeccCC-c-------chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-G-------ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 538 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.||+|++|.||+|.+ ++..|++|+...... . ....+.+|++++..++|+++.....++...+ ..+
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-----NKT 73 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-----CCE
Confidence 479999999999986 567899998643211 1 1245778999999998876544443433222 468
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++|++|.+++.... . .++.+++.+|.++|+. +++|||++|+||+++ ++.++++|||++
T Consensus 74 lv~e~~~g~~l~~~~~~~~------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred EEEEEECCccHHHHHhhcH------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 9999999999998875421 1 7899999999999999 999999999999999 889999999998
Q ss_pred cc
Q 040925 690 KF 691 (833)
Q Consensus 690 ~~ 691 (833)
..
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 74
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=5e-18 Score=181.28 Aligned_cols=225 Identities=20% Similarity=0.198 Sum_probs=175.6
Q ss_pred eccCcceEEEEEEE---CCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCceEeEEE
Q 040925 539 IGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 539 lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+|.|+||.|+++.. .+.+..+|+|+.+..... .......|..++..++ ||.+|++...+.. ....++++
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~l 76 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLIL 76 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHhh
Confidence 68999999997654 345777899988644321 1124566888888887 9999999877544 44889999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
+|..+|.+...+.... .+++.....+...++-|++++|+. +|+|||+|++||+++.+|.+|+.|||.++..
T Consensus 77 d~~rgg~lft~l~~~~------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~ 147 (612)
T KOG0603|consen 77 DFLRGGDLFTRLSKEV------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEA 147 (612)
T ss_pred hhcccchhhhccccCC------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHh
Confidence 9999999999888765 678888889999999999999999 9999999999999999999999999999866
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
-.... .+||..|||||++. ....++|.|| +|+..++++++..|+.. ....
T Consensus 148 v~~~~------------~cgt~eymApEI~~--gh~~a~D~ws----------~gvl~felltg~~pf~~------~~~~ 197 (612)
T KOG0603|consen 148 VKEKI------------ACGTYEYRAPEIIN--GHLSAADWWS----------FGVLAFELLTGTLPFGG------DTMK 197 (612)
T ss_pred Hhhhh------------cccchhhhhhHhhh--ccCCcccchh----------hhhhHHHHhhCCCCCch------HHHH
Confidence 54322 16999999999987 4677889888 88899999999998764 1111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
.... .....+.+......+++..+...+|..|--.
T Consensus 198 ~Il~-------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 198 RILK-------AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHhh-------hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1111 1122344556667788888999999999754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.4e-17 Score=172.74 Aligned_cols=249 Identities=22% Similarity=0.225 Sum_probs=153.2
Q ss_pred CCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEee-------EeecC
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIIT-------ICSST 600 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-------~~~~~ 600 (833)
.+.+.+..+..+++.++...-..+ .+.++.|..+...........+++-.+.... |+..+. .+ .....
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~-~d~~~s~~~~~~~~ 323 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSIL-EDLRPSLFESSKRN 323 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccc-cCCCCchhhhcccc
Confidence 344555556666666655443322 2333333333222122233344444444443 443322 11 11111
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV 680 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 680 (833)
......+.|+.|++|...+|.+++...+.. +.-++.....++.|++.|+.| + +.+|||+||.||+...+..
T Consensus 324 ~v~~~~~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 324 KVGKKVYLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred ccccccchhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchh
Confidence 111234688999999999999999865432 256788899999999999999 6 8999999999999999999
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
+||.|||+........ +........+..+||..||+||.+.+..|+.++|||+ .|.+++|+....-..
T Consensus 395 ~kIgDFgl~ts~~~~~--~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIya----------LGlil~EL~~~f~T~ 462 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDE--TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYA----------LGLILAELLIQFSTQ 462 (516)
T ss_pred hhhhhhhheeecccCC--cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhh----------HHHHHHHHHHHhccH
Confidence 9999999998765543 1111223344578999999999999999999999999 555555554421110
Q ss_pred ----c-ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHH
Q 040925 761 ----K-VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDV 817 (833)
Q Consensus 761 ----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 817 (833)
. ..++-|..+-.. ...++ +.-..++.+++.+.|.+||++.+.
T Consensus 463 ~er~~t~~d~r~g~ip~~--------------~~~d~-p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 463 FERIATLTDIRDGIIPPE--------------FLQDY-PEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHHHhhhhhhcCCCChH--------------HhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence 0 111111111000 00111 123478889999999999954443
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=149.81 Aligned_cols=137 Identities=23% Similarity=0.266 Sum_probs=99.5
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCCcc--hhH----------------------HHHHHHHHhhcCCC--c
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA--SRS----------------------FVAECEALRNIRHR--N 589 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--n 589 (833)
.+.||+|+||.||+|.+. +++.||||+++...... ... ...|.+.+.++.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999987 78999999987432111 111 13566666666443 3
Q ss_pred cceEeeEeecCCCCCCceEeEEEEecCCCChhhh-hccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeC
Q 040925 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDW-LHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGD 667 (833)
Q Consensus 590 iv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~D 667 (833)
+.+.+++ ...++||||++++++... +... ... .++..++.+++.++.++|. . +|+|||
T Consensus 81 ~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~-------~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 81 VPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDV-------RLL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred CCceEec---------CCCEEEEEEeCCCCccChhhhhh-------hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 4444443 135899999998654321 1111 011 5678899999999999999 7 999999
Q ss_pred CCCCCeeecCCCcEEEcccccccccCc
Q 040925 668 LKPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 668 lkp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
|||+||+++ ++.++++|||.+.....
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CChhhEEEE-CCcEEEEECcccccccC
Confidence 999999999 89999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=8.4e-15 Score=147.77 Aligned_cols=138 Identities=17% Similarity=0.131 Sum_probs=105.3
Q ss_pred ceec-cCcceEEEEEEECCCceEEEEEEeeccC-------------CcchhHHHHHHHHHhhcCCCcc--ceEeeEeecC
Q 040925 537 NMIG-QGSFGYVYKGTLGEDEMIVAVKVINLKY-------------KGASRSFVAECEALRNIRHRNL--IKIITICSST 600 (833)
Q Consensus 537 ~~lg-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~ 600 (833)
..|| .|+.|+||.++.. +..+|||.+.... ......+.+|++++.+++|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4687 8899999999874 6779999885321 1123567889999999998775 6777764332
Q ss_pred CCCCCceEeEEEEecCC-CChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 601 DFKGTDFKAFVFEYMEN-GSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
. ......++||||++| .+|.+++... .++.. .+.+++.++.+||+. ||+||||||+|||++.++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~~-------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQEA-------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDG 179 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhcC-------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCC
Confidence 1 111123699999997 6999988643 34443 356899999999999 999999999999999999
Q ss_pred cEEEcccccccc
Q 040925 680 VAHVCDFGLAKF 691 (833)
Q Consensus 680 ~~kL~DfG~a~~ 691 (833)
.++|+|||.+..
T Consensus 180 ~v~LIDfg~~~~ 191 (239)
T PRK01723 180 KFWLIDFDRGEL 191 (239)
T ss_pred CEEEEECCCccc
Confidence 999999999874
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=137.33 Aligned_cols=135 Identities=21% Similarity=0.292 Sum_probs=111.2
Q ss_pred cCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCC--CccceEeeEeecCCCCCCceEeEEE
Q 040925 535 SSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRH--RNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 535 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.+.||+|.++.||++...+ ..+++|.++.... ...+.+|+.+++.++| ..+++++++.... +..+++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~ 72 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLM 72 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEE
Confidence 45789999999999999853 6799999864432 4678999999999976 5889988875433 4789999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
||++++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 73 e~~~g~~~~~~-------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 73 EWIEGETLDEV-------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EecCCeecccC-------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99998777643 3456677899999999999986444799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.3e-16 Score=175.56 Aligned_cols=215 Identities=25% Similarity=0.286 Sum_probs=143.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.+|..++.|..|+||.||.++++.+.+.+|+|+-+ +. .+ ++ ||..+-+ ..+.
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNk-q~-----li------lR-----nilt~a~-----------npfv 134 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK-QN-----LI------LR-----NILTFAG-----------NPFV 134 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccc-cc-----hh------hh-----ccccccC-----------Ccce
Confidence 57999999999999999999999999999995432 11 11 11 1222111 2223
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
| |+-...++..+ +++. +++.+++|+|+. ||+|||+||+|.+|..-|.+|+.|||+++
T Consensus 135 v------gDc~tllk~~g------~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 135 V------GDCATLLKNIG------PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSK 191 (1205)
T ss_pred e------chhhhhcccCC------CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhh
Confidence 3 44455555433 2222 227899999999 99999999999999999999999999987
Q ss_pred ccCccccc-------ccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 691 FLSDHQLD-------TAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 691 ~~~~~~~~-------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
........ ......-....++|||.|+|||++..+.|...+|+|+ .|.++|++..+.+|+.-.
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwa----------mGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWA----------MGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHH----------HHHHHHHHheeeeeccCC
Confidence 53211100 0000111223568999999999999999999999999 788888888888886521
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM 812 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 812 (833)
. ..++...++......... .+..+.+..+++.+.++.+|..|-
T Consensus 262 t--peelfg~visd~i~wpE~----dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 262 T--PEELFGQVISDDIEWPEE----DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred C--HHHHHhhhhhhhcccccc----CcCCCHHHHHHHHHHHHhChHhhc
Confidence 0 011222222222222222 223456678888999999999996
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.6e-15 Score=169.75 Aligned_cols=257 Identities=23% Similarity=0.262 Sum_probs=185.0
Q ss_pred hcCCccCceeccCcceEEEEEEEC-CCceEEEEEEeeccC--CcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLG-EDEMIVAVKVINLKY--KGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 605 (833)
...|.+.+.||+|+++.|-.+... .....+|+|.+.... .........|..+-..+. |+|++++++.....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~---- 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR---- 94 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc----
Confidence 346888889999999999988774 345567777775432 223345556788877776 999999999855544
Q ss_pred ceEeEEEEecCCCChhhhh-ccCCCccccccCCHHHHHHHHHHHHHHHHHHh-hcCCCCceeeCCCCCCeeecCCC-cEE
Q 040925 606 DFKAFVFEYMENGSLKDWL-HQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH-HHCQPPMVHGDLKPSNVLLDHDM-VAH 682 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l-~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~k 682 (833)
..+++++|..+|++.+.+ ..... ..+...+..+..|+..|+.|+| .. ++.|||+||+|.+++..+ ..|
T Consensus 95 -~~~~~~~~s~g~~~f~~i~~~~~~-----~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~ 165 (601)
T KOG0590|consen 95 -SYLLSLSYSDGGSLFSKISHPDST-----GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALK 165 (601)
T ss_pred -ccccccCcccccccccccccCCcc-----CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCccc
Confidence 889999999999999988 33221 4566778889999999999999 77 999999999999999999 999
Q ss_pred EcccccccccCc-ccccccccCCCccccccc-cccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 683 VCDFGLAKFLSD-HQLDTAVKTPSSSIGLKG-TVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 683 L~DfG~a~~~~~-~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
++|||+|..+.. ... .......+| ++.|+|||...+. -.....|+|| .|+++..+.++..|
T Consensus 166 ~~df~~At~~~~~~g~------~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S----------~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 166 IADFGLATAYRNKNGA------ERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWS----------LGIVLSAMLTGELP 229 (601)
T ss_pred CCCchhhccccccCCc------ceeeecccCCCCCCCCcccccchhhcCCCccccc----------ccccccccccCCCC
Confidence 999999987655 221 122234567 9999999998874 4567789998 66667777777777
Q ss_pred CcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
+......+..... ++... ................+++.+++..+|+.|.+.+++..
T Consensus 230 ~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 230 WDFPSRKDGRYSS-WKSNK---GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccccccee-ecccc---cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 7644433322111 11111 00001112334456678888999999999999988754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.2e-13 Score=158.97 Aligned_cols=118 Identities=32% Similarity=0.538 Sum_probs=102.0
Q ss_pred CcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECc
Q 040925 345 NLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLS 424 (833)
Q Consensus 345 ~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~ 424 (833)
.++.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999899999999999999999999999999999999999999
Q ss_pred cCcCccccCCC--CccCCCccccccCCcCCCCCcccCCCCCCC
Q 040925 425 YNHFEGEVPTK--GVFSNKTKISLQGNMKLCGGIDELHLPSCP 465 (833)
Q Consensus 425 ~N~l~~~~~~~--~~~~~~~~l~l~~N~~~c~~~~~~~~~~~~ 465 (833)
+|++++..|.. ..+..+..+++.+|+.+|+.+. .+.|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~---l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG---LRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCC---CCCCc
Confidence 99999888864 2234556788999999998643 35664
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.9e-15 Score=158.44 Aligned_cols=178 Identities=30% Similarity=0.481 Sum_probs=110.9
Q ss_pred CCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecC
Q 040925 224 NLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTAS 303 (833)
Q Consensus 224 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~ 303 (833)
--...+|+.|++. .+|..+..+..|+.|.|.+|.|. .+|..++++..|++|||+.|+++ ..|..++.|+ |+.|-++
T Consensus 76 dt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~s 151 (722)
T KOG0532|consen 76 DTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVS 151 (722)
T ss_pred chhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEe
Confidence 3445566666666 55666666666666666666666 56666666666666666666666 5555566555 6666666
Q ss_pred CceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccc
Q 040925 304 QNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV 383 (833)
Q Consensus 304 ~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 383 (833)
+|+++ .+|+.+....++ ..||.+.|.+. .+|..++++.+|+.|.+..|++. ..|..+..| .|..||+|.|++. .
T Consensus 152 NNkl~-~lp~~ig~~~tl-~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~ 225 (722)
T KOG0532|consen 152 NNKLT-SLPEEIGLLPTL-AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-Y 225 (722)
T ss_pred cCccc-cCCcccccchhH-HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-e
Confidence 66666 566666644444 45666666666 55666666666777777777666 334445533 3666677777766 5
Q ss_pred cCccccCCCCCCeEEccCcccCCCchhhh
Q 040925 384 IPLSLSFLKSIKELNVSSNNLSGQIPEFL 412 (833)
Q Consensus 384 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~l 412 (833)
+|..|..|+.|++|-|.+|.+. .+|..+
T Consensus 226 iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 226 LPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred cchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 5666666777777777777766 444443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.46 E-value=7.1e-15 Score=154.15 Aligned_cols=182 Identities=31% Similarity=0.501 Sum_probs=121.2
Q ss_pred CCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCE
Q 040925 172 NCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQK 251 (833)
Q Consensus 172 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 251 (833)
.++.-...||+.|++. ++|..++.+.. +..+.+..|.|. .+|..++++..|++|+|+.|+++ ..|..++.|+ |+.
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~-Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkv 147 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVS-LESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKV 147 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHH-HHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-cee
Confidence 3444455666777766 56655555443 344455555555 66667777777777777777777 5666666554 777
Q ss_pred EEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCc
Q 040925 252 LCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNL 331 (833)
Q Consensus 252 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~ 331 (833)
|-+++|+++ .+|+.++.+..|..||.+.|.|. .+|..++++.+|+.|.+..|++. .+|+.++.++ + ..||+|.|+
T Consensus 148 li~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-L-i~lDfScNk 222 (722)
T KOG0532|consen 148 LIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-L-IRLDFSCNK 222 (722)
T ss_pred EEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-e-eeeecccCc
Confidence 777777777 56666777777777777777777 56666777777777777777777 6777666333 3 457777777
Q ss_pred cCCCCCcccccCCCcCEEeccCCcCCCCCCcccc
Q 040925 332 LNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLS 365 (833)
Q Consensus 332 l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 365 (833)
++ .+|..|.+++.|++|-|.+|.++ .+|..++
T Consensus 223 is-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 223 IS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred ee-ecchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 76 66777777777777777777776 4555444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-13 Score=152.35 Aligned_cols=195 Identities=35% Similarity=0.504 Sum_probs=112.0
Q ss_pred EEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCC-CCcEEEcccCccccccCcCccCCCcCceEeccc
Q 040925 75 LIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS-NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQ 153 (833)
Q Consensus 75 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~ 153 (833)
.|+++.|++...+. . ...++.++.|++.+|.++ .++.....+. +|+.|++++|+|..++ ..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~~-~-~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l~-~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNIS-E-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLP-SPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCch-h-hhcccceeEEecCCcccc-cCccccccchhhcccccccccchhhhh-hhhhccccccccccCC
Confidence 57777777631222 2 235577888888888887 4444555553 7888888888887543 4567788888888888
Q ss_pred ccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCC
Q 040925 154 NNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEEN 233 (833)
Q Consensus 154 N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N 233 (833)
|+++.++.. ...+++|+.|++++|+++ .+|..+. ....+.++.+++|.+. ..+..+.++.++..|.+.+|
T Consensus 173 N~l~~l~~~-------~~~~~~L~~L~ls~N~i~-~l~~~~~-~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n 242 (394)
T COG4886 173 NDLSDLPKL-------LSNLSNLNNLDLSGNKIS-DLPPEIE-LLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNN 242 (394)
T ss_pred chhhhhhhh-------hhhhhhhhheeccCCccc-cCchhhh-hhhhhhhhhhcCCcce-ecchhhhhcccccccccCCc
Confidence 888766542 236778888888888887 4554431 1122334444444322 33444445555555555555
Q ss_pred cccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCC
Q 040925 234 QLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN 286 (833)
Q Consensus 234 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 286 (833)
++. ..+..++.++++++|++++|.++.+.+ ++.+.+++.|++++|.+...
T Consensus 243 ~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~ 292 (394)
T COG4886 243 KLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNA 292 (394)
T ss_pred eee-eccchhccccccceecccccccccccc--ccccCccCEEeccCcccccc
Confidence 544 224444444555555555555542211 44455555555555554433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.3e-13 Score=148.21 Aligned_cols=143 Identities=20% Similarity=0.260 Sum_probs=101.0
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCCcch----------------------------------------hHH
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS----------------------------------------RSF 575 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~ 575 (833)
.+.||+|++|+||+|+.+ +|+.||||+.++...... -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999987 789999999864321000 024
Q ss_pred HHHHHHHhhcC----CCccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHH-
Q 040925 576 VAECEALRNIR----HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS- 650 (833)
Q Consensus 576 ~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~- 650 (833)
.+|++.+.+++ |..-+.+-.++.+. ....++||||++|++|.++...... .. ....++.+++.
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~-----~~---~~~~ia~~~~~~ 268 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEA-----GL---DRKALAENLARS 268 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhc-----CC---CHHHHHHHHHHH
Confidence 55666666652 32223333333221 2346899999999999887653211 12 23456666666
Q ss_pred HHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCc
Q 040925 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 651 gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
.+..+|.. |++|+|+||.||+++.++.++++|||++..++.
T Consensus 269 ~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 269 FLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 47888988 999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.4e-13 Score=151.74 Aligned_cols=243 Identities=33% Similarity=0.422 Sum_probs=161.5
Q ss_pred CCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCc---cEEEccCCcceeeCCccccCCCCCcEE
Q 040925 49 LVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL---KALAIGGNNFFGSIPYSLSNASNLELL 125 (833)
Q Consensus 49 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L---~~L~L~~N~l~~~~~~~~~~l~~L~~L 125 (833)
-..+.+.++... ..+..+.....+....-+.+... +....+.++ ..|++..|++. ........++.++.|
T Consensus 49 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l-----~~~~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~~l~~L 121 (394)
T COG4886 49 RLALNLSSNTLL-LLPSSLSRLLSLDLLSPSGISSL-----DGSENLLNLLPLPSLDLNLNRLR-SNISELLELTNLTSL 121 (394)
T ss_pred hhcccCCcchhh-hhhcchhhhhhhcccCcCCcccc-----cccccccCCCCCceeeccccccc-cCchhhhcccceeEE
Confidence 344555555554 55555655555554444322211 111223333 47999999985 334456677899999
Q ss_pred EcccCccccccCcCccCCC-cCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEE
Q 040925 126 DLSVNQFKGNVSIDFSSLK-NLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINF 204 (833)
Q Consensus 126 ~L~~N~i~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L 204 (833)
++.+|+++.+++ ....++ +|+.|++++|.+..++ ..+..+++|+.|++++|+++ .+|...+.. ..+..|
T Consensus 122 ~l~~n~i~~i~~-~~~~~~~nL~~L~l~~N~i~~l~-------~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~-~~L~~L 191 (394)
T COG4886 122 DLDNNNITDIPP-LIGLLKSNLKELDLSDNKIESLP-------SPLRNLPNLKNLDLSFNDLS-DLPKLLSNL-SNLNNL 191 (394)
T ss_pred ecCCcccccCcc-ccccchhhcccccccccchhhhh-------hhhhccccccccccCCchhh-hhhhhhhhh-hhhhhe
Confidence 999999997765 344553 9999999999998764 23678999999999999999 666554433 236667
Q ss_pred EccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeeccccc
Q 040925 205 GIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ 284 (833)
Q Consensus 205 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 284 (833)
++++|++. .+|.....+.+|++|++++|.+. ..+..+..+.++..|.+.+|++. ..+..+..++++++|++++|+++
T Consensus 192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~ 268 (394)
T COG4886 192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS 268 (394)
T ss_pred eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc
Confidence 77777777 45555555566777777777544 35566677777777777777776 33566667777777777777776
Q ss_pred CCCCCCCCCCCccceeecCCceecccCCc
Q 040925 285 GNIPSSLGNCQNLMSFTASQNKLTGALPH 313 (833)
Q Consensus 285 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 313 (833)
...+ ++.+.+++.|++++|.+....|.
T Consensus 269 ~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 269 SISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cccc--ccccCccCEEeccCccccccchh
Confidence 4333 66777777777777777644443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=6.5e-13 Score=147.06 Aligned_cols=150 Identities=17% Similarity=0.190 Sum_probs=100.1
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc----------------------------------chh-
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG----------------------------------ASR- 573 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----------------------------------~~~- 573 (833)
....|+. +.||+|++|+||+|+.+++|+.||||+.++.-.. ..+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3446776 7999999999999999877999999999744110 001
Q ss_pred -----HHHHHHHHHhhcC----CCccceEeeEeecCCCCCCceEeEEEEecCCCChhhhh--ccCCCccccccCCHHHHH
Q 040925 574 -----SFVAECEALRNIR----HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEVCKLSLIQRV 642 (833)
Q Consensus 574 -----~~~~E~~~l~~l~----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~l~~~~~~ 642 (833)
++.+|+..+.+++ +...+.+-.++.+ -....++||||++|+.+.++- ...+. ....+....+.
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~g~--d~~~la~~~v~ 270 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAAGT--DMKLLAERGVE 270 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhcCC--CHHHHHHHHHH
Confidence 2445555555552 3333333333322 123568999999999998752 22211 11123344444
Q ss_pred HHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC----cEEEcccccccccCcc
Q 040925 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM----VAHVCDFGLAKFLSDH 695 (833)
Q Consensus 643 ~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DfG~a~~~~~~ 695 (833)
.++.|+. .. |++|+|+||.||+++.++ +++++|||++..++..
T Consensus 271 ~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 271 VFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 4555543 45 999999999999999988 9999999999877553
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=9.2e-13 Score=129.52 Aligned_cols=214 Identities=21% Similarity=0.298 Sum_probs=143.3
Q ss_pred HHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhc
Q 040925 579 CEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658 (833)
Q Consensus 579 ~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~ 658 (833)
..-+-++-|.|+|+++.|+.+..+++.....++.|||+.|++.+++++...... .+......+|+-||+.||.|||+.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~--a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQK--ALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhh--hhhHHHHHHHHHHHHhhhhhhhcc
Confidence 344556679999999999988877777788999999999999999987654322 577788889999999999999997
Q ss_pred CCCCceeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCc
Q 040925 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRR 738 (833)
Q Consensus 659 ~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~ 738 (833)
.|+|+|+++..+-|++..+|-+|+.--.-........ .. . ......-.+-++|.|||.-.....+.++|||+
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~-~~--~-~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~--- 267 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVN-ST--R-EAEKSVNTSLPGFSAPESGTTTNTTGASDIYK--- 267 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCccccchhhh-hh--h-HhhhhccccCCccccCCcCcccccccchhhhh---
Confidence 7899999999999999999988875221111100000 00 0 00011123678999999866666778899888
Q ss_pred CCCccccCCccHHHHHHHhCCCc-ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHH
Q 040925 739 PIDAVFNEGHSLHEFAKTALPEK-VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDV 817 (833)
Q Consensus 739 ~~~~~~~~g~~l~~~~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 817 (833)
+|+...++..+..-.. -...+.++.. +.+..... + ...=..++..|++..|..||+|+++
T Consensus 268 -------fgmcAlemailEiq~tnseS~~~~ee~---ia~~i~~l-------e--n~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 268 -------FGMCALEMAILEIQSTNSESKVEVEEN---IANVIIGL-------E--NGLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred -------hhHHHHHHHHheeccCCCcceeehhhh---hhhheeec-------c--CccccCcCcccccCCCCCCcchhhh
Confidence 6666666666655322 1111111110 00000000 0 0011356788999999999999998
Q ss_pred HHHH
Q 040925 818 VAKL 821 (833)
Q Consensus 818 l~~L 821 (833)
+.+.
T Consensus 329 lfHp 332 (458)
T KOG1266|consen 329 LFHP 332 (458)
T ss_pred hcCc
Confidence 7653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.8e-11 Score=117.46 Aligned_cols=139 Identities=19% Similarity=0.216 Sum_probs=100.6
Q ss_pred CceeccCcceEEEEEEECC------CceEEEEEEeeccC------------C----------cchhHH----HHHHHHHh
Q 040925 536 SNMIGQGSFGYVYKGTLGE------DEMIVAVKVINLKY------------K----------GASRSF----VAECEALR 583 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~------~~~~vavK~~~~~~------------~----------~~~~~~----~~E~~~l~ 583 (833)
...||.|--+.||.|...+ .+..+|||+.+... + ...+.+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998653 35789999886321 0 001122 38999999
Q ss_pred hcC--CCccceEeeEeecCCCCCCceEeEEEEecCCCChhh-hhccCCCccccccCCHHHHHHHHHHHHHHHHHH-hhcC
Q 040925 584 NIR--HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKD-WLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL-HHHC 659 (833)
Q Consensus 584 ~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~ 659 (833)
++. .-++.+.+++ ...++||||+.+..+.. .++.. .++..+...+..+++.+|..+ |..
T Consensus 82 rl~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd~-------~~~~~~~~~i~~~i~~~l~~l~H~~- 144 (197)
T cd05146 82 RMQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKDA-------KLNDEEMKNAYYQVLSMMKQLYKEC- 144 (197)
T ss_pred HHHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhcc-------ccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 995 3566677764 14579999997643321 22211 344556677889999999999 788
Q ss_pred CCCceeeCCCCCCeeecCCCcEEEcccccccccCc
Q 040925 660 QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 660 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
|+||+|+++.||+++ ++.++++|||.|.....
T Consensus 145 --glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 145 --NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred --CeecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 999999999999996 56899999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2e-12 Score=139.14 Aligned_cols=247 Identities=25% Similarity=0.268 Sum_probs=175.1
Q ss_pred CCccCceecc--CcceEEEEEEE--CCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCC
Q 040925 532 EFSSSNMIGQ--GSFGYVYKGTL--GEDEMIVAVKVINLKYK--GASRSFVAECEALRNIR-HRNLIKIITICSSTDFKG 604 (833)
Q Consensus 532 ~y~~~~~lg~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 604 (833)
.|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... .....-.+|+...+.++ |++.++.+.. +++
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~-----~e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA-----WEG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcc-----ccc
Confidence 4667789999 99999999998 88899999998543322 33344466777777775 9999996665 455
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHH----HHHHHhhcCCCCceeeCCCCCCeeecCC-C
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS----AMEYLHHHCQPPMVHGDLKPSNVLLDHD-M 679 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~----gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~ 679 (833)
.+..++-+|++. .++.++...... .++....+.+..+... |+.++|+. +++|-|+||+||+...+ .
T Consensus 190 ~~~lfiqtE~~~-~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 190 SGILFIQTELCG-ESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWT 260 (524)
T ss_pred CCcceeeecccc-chhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccc
Confidence 568889999995 689988876542 3778888888888888 99999999 99999999999999999 8
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
..+++|||+...+.+........ ......|...|++||...+ -++.++|||+ .|.++.+...+...
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~---~~~r~~~~~~Y~~ke~~~~-l~~~~~di~s----------l~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFK---VSKRPEGDCIYAAKELLNG-LATFASDIFS----------LGEVILEAILGSHL 326 (524)
T ss_pred eeecCCcceeEEccCCcccccee---eeecCCCCceEeChhhhcc-ccchHhhhcc----------hhhhhHhhHhhccc
Confidence 89999999999887765432221 1123358889999997655 5788899888 55555555444433
Q ss_pred Cccc-----ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 760 EKVM-----EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 760 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.... ...+.... .....+....++...+..++..+|..|++++.+..
T Consensus 327 ~~~g~~~~W~~~r~~~i-------------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 327 PSVGKNSSWSQLRQGYI-------------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccCCCCCCccccccccC-------------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 2211 11111110 00001111223344778899999999999887754
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.1e-12 Score=121.27 Aligned_cols=127 Identities=24% Similarity=0.335 Sum_probs=40.8
Q ss_pred ccCCCCCCEEEccCCcccccCCccCC-CCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCC
Q 040925 19 VGNLSDLEVIRIMGNSLGGKIPTTLG-LLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPN 97 (833)
Q Consensus 19 ~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~ 97 (833)
+.+...++.|+|++|.|+.+ . .++ .+.+|+.|+|++|.|+.+ +.+..+++|++|++++|+|+ .++..+...+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I-e-~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI-E-NLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccccc-c-chhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 44444677777777777432 2 355 467777777777777743 24677777777777777776 555444445777
Q ss_pred ccEEEccCCcceeeCC-ccccCCCCCcEEEcccCccccccC---cCccCCCcCceEe
Q 040925 98 LKALAIGGNNFFGSIP-YSLSNASNLELLDLSVNQFKGNVS---IDFSSLKNLLWLN 150 (833)
Q Consensus 98 L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~ 150 (833)
|++|+|++|+|..... ..++.+++|++|+|.+|.++.... ..+..+++|+.||
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeC
Confidence 7777777777764221 345667777777777777763321 1234455555554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.29 E-value=2e-11 Score=117.55 Aligned_cols=131 Identities=18% Similarity=0.162 Sum_probs=96.3
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCcc-ceEeeEeecCCCCCCceEeEEEEe
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNL-IKIITICSSTDFKGTDFKAFVFEY 614 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 614 (833)
++.++.|.++.||+++.. +..|++|....... ....+.+|+.+++.+.+.++ .+++++.. . ..++||||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~-----~~~lv~e~ 72 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--E-----TGVLITEF 72 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--C-----CCeEEEEe
Confidence 467899999999999874 77899999754322 23356889999999865444 45554421 1 24799999
Q ss_pred cCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC--CCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 615 MENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC--QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 615 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
++|.++.+. . . ....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+..
T Consensus 73 i~G~~l~~~----~------~----~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 73 IEGSELLTE----D------F----SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cCCCccccc----c------c----cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 999887643 0 0 11235678999999999982 11259999999999998 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.1e-12 Score=123.06 Aligned_cols=130 Identities=28% Similarity=0.289 Sum_probs=44.7
Q ss_pred CCCCCCCCEEEcCCCcccccCCcccc-CCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccc-cCCC
Q 040925 43 LGLLRNLVSLNVAENKFSGMFPRSIC-NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL-SNAS 120 (833)
Q Consensus 43 ~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~ 120 (833)
+.+..++++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+ .++. +..+++|++|+|++|+|+.+ +..+ ..++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~~--l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp 88 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLEG--LPGLPRLKTLDLSNNRISSI-SEGLDKNLP 88 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---TT------TT--EEE--SS---S--CHHHHHH-T
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCc-cccC--ccChhhhhhcccCCCCCCcc-ccchHHhCC
Confidence 44455678888888888743 2454 5778888888888887 5542 56677888888888888743 3333 3577
Q ss_pred CCcEEEcccCccccccC-cCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEc
Q 040925 121 NLELLDLSVNQFKGNVS-IDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSL 181 (833)
Q Consensus 121 ~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L 181 (833)
+|++|+|++|+|..+.. ..+..+++|+.|+|.+|.++.-+. --...+..+|+|+.||-
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~---YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKN---YRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTT---HHHHHHHH-TT-SEETT
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhh---HHHHHHHHcChhheeCC
Confidence 78888888888776544 345667777777777777754321 11233556677777653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.9e-13 Score=137.21 Aligned_cols=210 Identities=23% Similarity=0.254 Sum_probs=116.9
Q ss_pred cCCCCCCEEEccCCcccccCC--ccCCCCCCCCEEEcCCCcccccC--CccccCCCCCcEEECCCcccccccCchhhcCC
Q 040925 20 GNLSDLEVIRIMGNSLGGKIP--TTLGLLRNLVSLNVAENKFSGMF--PRSICNISSLELIQLALNRFSGNLPFDIVVNL 95 (833)
Q Consensus 20 ~~l~~L~~L~l~~n~l~~~~~--~~~~~l~~L~~L~L~~n~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l 95 (833)
+++..|+.+.|.+..+. ..+ +....+++++.||||+|-+.... -.-...|++|+.|+||.|++........-..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45566777777777773 333 35566777777777777665322 23345567777777777776533333333355
Q ss_pred CCccEEEccCCcceee-CCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCC
Q 040925 96 PNLKALAIGGNNFFGS-IPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCS 174 (833)
Q Consensus 96 ~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~ 174 (833)
+.|+.|.|+.|.++.. +-......++|+.|+|+.|.+-.+....+.-+..|+.|+|++|++-+.+. ......++
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~-----~~~~~~l~ 271 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQ-----GYKVGTLP 271 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccccccc-----cccccccc
Confidence 6666666666666521 12223445666666666664333444455555666666666666543221 12344555
Q ss_pred CCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCccccc-CCcc-----ccCCCC
Q 040925 175 SLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGT-IPDA-----IGELKN 248 (833)
Q Consensus 175 ~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~-----~~~l~~ 248 (833)
.|..|+++.+.+. ++ .|+. ...+++
T Consensus 272 ~L~~Lnls~tgi~-------------------------------------------------si~~~d~~s~~kt~~f~k 302 (505)
T KOG3207|consen 272 GLNQLNLSSTGIA-------------------------------------------------SIAEPDVESLDKTHTFPK 302 (505)
T ss_pred chhhhhccccCcc-------------------------------------------------hhcCCCccchhhhccccc
Confidence 5555555555544 21 1111 234567
Q ss_pred CCEEEcccccCccc-CCccccCCCCCCeEEeeccccc
Q 040925 249 LQKLCLFRNFLQGR-IPSGLGNLTKLANLELSSNSLQ 284 (833)
Q Consensus 249 L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~ 284 (833)
|++|+++.|+|... .-+.+..+.+|+.|....|.+.
T Consensus 303 L~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 303 LEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 77777777777521 1123445667777777777776
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=8.7e-13 Score=127.76 Aligned_cols=136 Identities=26% Similarity=0.285 Sum_probs=89.7
Q ss_pred CCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCC
Q 040925 291 LGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCL 370 (833)
Q Consensus 291 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L 370 (833)
....+.|++++||+|.|+ .+.++..-.+.+ +.|++|+|.|.. +. .+..|++|+.||||+|.++ ...++-..+.+.
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pki-r~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKL-RRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccce-eEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 344556777777777776 566555555555 667777777762 22 3667777777777777776 445556667777
Q ss_pred cEEeecCCccccccCccccCCCCCCeEEccCcccCCCc-hhhhcCCCCCceEECccCcCccccC
Q 040925 371 EYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI-PEFLKNLSVLEFLSLSYNHFEGEVP 433 (833)
Q Consensus 371 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~~ 433 (833)
+.|.|+.|.|.+. ..+..+-+|..||+++|+|.... -..+++++-|+.+.|.+|++.+.+.
T Consensus 355 KtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 355 KTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred eeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 7777777777643 24566677777777777776321 2456777777777777777776654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=7.9e-13 Score=145.83 Aligned_cols=247 Identities=27% Similarity=0.325 Sum_probs=179.2
Q ss_pred cCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCcc
Q 040925 20 GNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLK 99 (833)
Q Consensus 20 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~ 99 (833)
..+..++.+++..|.|. .+-..++.+++|+.|++.+|+|.. +...+..+++|+.|+|++|.|+ .+.. +..++.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~-~i~~--l~~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKIT-KLEG--LSTLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccc-cccc--hhhccchh
Confidence 45677888889999994 455668889999999999999984 3434888999999999999998 4432 45677899
Q ss_pred EEEccCCcceeeCCccccCCCCCcEEEcccCccccccC-cCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCE
Q 040925 100 ALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVS-IDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKA 178 (833)
Q Consensus 100 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~ 178 (833)
.|++++|.|+. ...|..+.+|+.+++++|++..+.. . ...+.+|+.+.+++|.+..+.. +..+..+..
T Consensus 144 ~L~l~~N~i~~--~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~--------~~~~~~l~~ 212 (414)
T KOG0531|consen 144 ELNLSGNLISD--ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEG--------LDLLKKLVL 212 (414)
T ss_pred hheeccCcchh--ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccc--------hHHHHHHHH
Confidence 99999999973 3456779999999999999997776 3 5788999999999999977543 334455556
Q ss_pred EEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCC--CCCeEeccCCcccccCCccccCCCCCCEEEccc
Q 040925 179 LSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLV--NLIGFGAEENQLHGTIPDAIGELKNLQKLCLFR 256 (833)
Q Consensus 179 L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 256 (833)
+++..|.++..-+ +..+. +|+.+++++|.+.. .+..+..+.++..|++.+
T Consensus 213 ~~l~~n~i~~~~~---------------------------l~~~~~~~L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~ 264 (414)
T KOG0531|consen 213 LSLLDNKISKLEG---------------------------LNELVMLHLRELYLSGNRISR-SPEGLENLKNLPVLDLSS 264 (414)
T ss_pred hhcccccceeccC---------------------------cccchhHHHHHHhcccCcccc-ccccccccccccccchhh
Confidence 6788887762111 11111 47778888888773 335666778888888888
Q ss_pred ccCcccCCccccCCCCCCeEEeecccccCC---CCC-CCCCCCccceeecCCceecccCC
Q 040925 257 NFLQGRIPSGLGNLTKLANLELSSNSLQGN---IPS-SLGNCQNLMSFTASQNKLTGALP 312 (833)
Q Consensus 257 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~~~-~~~~l~~L~~L~l~~N~l~~~~p 312 (833)
|.+... ..+.....+..+.+..|.+... ... .....+.+..+.+..|.+....+
T Consensus 265 n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 265 NRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred cccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 888743 3355667777777777776522 111 14556778888888888774443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=9.4e-13 Score=145.23 Aligned_cols=267 Identities=28% Similarity=0.297 Sum_probs=193.7
Q ss_pred CCCCEEEccCCcccccCCccC-CCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEE
Q 040925 23 SDLEVIRIMGNSLGGKIPTTL-GLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKAL 101 (833)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~~-~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L 101 (833)
+.++.++...+.+.. ...+ ..+..++.+++..|.|. ..-..+..+.+|+.|++.+|+|. .+... +..+++|++|
T Consensus 49 ~~~~~~~~~~~~~~~--~~~~~~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~-l~~~~~L~~L 123 (414)
T KOG0531|consen 49 SDLEEIDLIFNLDGS--DEDLVESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENL-LSSLVNLQVL 123 (414)
T ss_pred chhhhhcchhccccc--hhhhHHHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccc-hhhhhcchhe
Confidence 356667777766622 2222 56788888999999998 45666899999999999999998 55432 4679999999
Q ss_pred EccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEc
Q 040925 102 AIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSL 181 (833)
Q Consensus 102 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L 181 (833)
+|++|.|+.+. .+..++.|+.|++++|.|+.+. .|..+++|+.+++++|.+..+... . ...+.+++.+++
T Consensus 124 ~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~~--~~~~l~~L~~l~l~~n~i~~ie~~-----~-~~~~~~l~~l~l 193 (414)
T KOG0531|consen 124 DLSFNKITKLE--GLSTLTLLKELNLSGNLISDIS--GLESLKSLKLLDLSYNRIVDIEND-----E-LSELISLEELDL 193 (414)
T ss_pred ecccccccccc--chhhccchhhheeccCcchhcc--CCccchhhhcccCCcchhhhhhhh-----h-hhhccchHHHhc
Confidence 99999998554 4677888999999999999654 566699999999999999876541 1 357889999999
Q ss_pred cCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCC--CCCEEEcccccC
Q 040925 182 ADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELK--NLQKLCLFRNFL 259 (833)
Q Consensus 182 s~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~--~L~~L~L~~N~l 259 (833)
++|.+.. ...+..+..+..+++..|.+..+-+ +..+. +|+.+++++|.+
T Consensus 194 ~~n~i~~---------------------------i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i 244 (414)
T KOG0531|consen 194 GGNSIRE---------------------------IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRI 244 (414)
T ss_pred cCCchhc---------------------------ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCcc
Confidence 9998861 1222333344455788888874332 22233 389999999999
Q ss_pred cccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceeccc---CCcc-cccccccceeeecCCCccCCC
Q 040925 260 QGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGA---LPHQ-LLSITTLSLYLDLSNNLLNGS 335 (833)
Q Consensus 260 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~---~p~~-~~~~~~ll~~L~ls~N~l~~~ 335 (833)
. ..+..+..+.++..|++.+|++... ..+...+.+..+.+..|.+... .... ......+ +.+.+..|.+...
T Consensus 245 ~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 320 (414)
T KOG0531|consen 245 S-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTL-VTLTLELNPIRKI 320 (414)
T ss_pred c-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccc-cccccccCccccc
Confidence 8 4557788899999999999999754 3356677788888888887622 1111 2333333 5677777777654
Q ss_pred CC
Q 040925 336 LP 337 (833)
Q Consensus 336 ~~ 337 (833)
.+
T Consensus 321 ~~ 322 (414)
T KOG0531|consen 321 SS 322 (414)
T ss_pred cc
Confidence 43
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=3e-11 Score=139.18 Aligned_cols=112 Identities=35% Similarity=0.479 Sum_probs=104.2
Q ss_pred ceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccC
Q 040925 322 SLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401 (833)
Q Consensus 322 l~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 401 (833)
+..|+|++|.+.+.+|..++.+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 36799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCchhhhcCC-CCCceEECccCcCccccC
Q 040925 402 NNLSGQIPEFLKNL-SVLEFLSLSYNHFEGEVP 433 (833)
Q Consensus 402 N~l~~~~p~~l~~l-~~L~~L~l~~N~l~~~~~ 433 (833)
|++++.+|..+..+ .++..+++.+|+..|..|
T Consensus 500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CcccccCChHHhhccccCceEEecCCccccCCC
Confidence 99999999998764 467789999998877655
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.1e-13 Score=132.83 Aligned_cols=138 Identities=20% Similarity=0.276 Sum_probs=83.2
Q ss_pred CCCCeEEeecccccCCC----CCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCc
Q 040925 271 TKLANLELSSNSLQGNI----PSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNL 346 (833)
Q Consensus 271 ~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L 346 (833)
++|+++...+|++.... ...|...+.|+.+.++.|.|. |... + .....|..++.|
T Consensus 157 ~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~---~eG~-----------------~-al~eal~~~~~L 215 (382)
T KOG1909|consen 157 PKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIR---PEGV-----------------T-ALAEALEHCPHL 215 (382)
T ss_pred cceEEEEeeccccccccHHHHHHHHHhccccceEEEeccccc---Cchh-----------------H-HHHHHHHhCCcc
Confidence 55666666666665321 224445555666666555553 1111 0 123456677888
Q ss_pred CEEeccCCcCCC----CCCccccCCCCCcEEeecCCccccccCccc-----cCCCCCCeEEccCcccCC----Cchhhhc
Q 040925 347 VILDISSNQFSG----VIPGTLSTCVCLEYLDISSNSFHGVIPLSL-----SFLKSIKELNVSSNNLSG----QIPEFLK 413 (833)
Q Consensus 347 ~~L~ls~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~L~l~~N~l~~----~~p~~l~ 413 (833)
+.|||..|-++. ....++..+++|++|++++|.+..--..+| ...++|+.|.+.+|.|+. .+...+.
T Consensus 216 evLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ 295 (382)
T KOG1909|consen 216 EVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMA 295 (382)
T ss_pred eeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHh
Confidence 888888888753 233456777788888888887764322222 335778888888888763 2233445
Q ss_pred CCCCCceEECccCcCc
Q 040925 414 NLSVLEFLSLSYNHFE 429 (833)
Q Consensus 414 ~l~~L~~L~l~~N~l~ 429 (833)
..+.|..|+|++|.+.
T Consensus 296 ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 296 EKPDLEKLNLNGNRLG 311 (382)
T ss_pred cchhhHHhcCCccccc
Confidence 5677778888887773
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.17 E-value=9e-12 Score=120.82 Aligned_cols=199 Identities=24% Similarity=0.188 Sum_probs=135.4
Q ss_pred ccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCC-ceecccCCccccccccc
Q 040925 243 IGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQ-NKLTGALPHQLLSITTL 321 (833)
Q Consensus 243 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~~~~~~~l 321 (833)
+.-+.+|+.+.++++.-.. +.+....-+.|+++...+.-++. .|. +-..+.+....-+. .-.+|..-..+-.+..+
T Consensus 210 l~~f~~l~~~~~s~~~~~~-i~~~~~~kptl~t~~v~~s~~~~-~~~-l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~L 286 (490)
T KOG1259|consen 210 LNAFRNLKTLKFSALSTEN-IVDIELLKPTLQTICVHNTTIQD-VPS-LLPETILADPSGSEPSTSNGSALVSADTWQEL 286 (490)
T ss_pred hHHhhhhheeeeeccchhh-eeceeecCchhheeeeecccccc-ccc-ccchhhhcCccCCCCCccCCceEEecchHhhh
Confidence 3444556666666554331 12222233567777766655541 111 11112222111111 11112222233334444
Q ss_pred ceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccC
Q 040925 322 SLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401 (833)
Q Consensus 322 l~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 401 (833)
..+|||+|.|+ .+.++..-++.++.|++|+|.|..+ +.++.+++|+.||||+|.++ ...++-..+-++++|.|+.
T Consensus 287 -telDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 287 -TELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred -hhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhh
Confidence 67999999999 6777888899999999999999854 34999999999999999999 5667788899999999999
Q ss_pred cccCCCchhhhcCCCCCceEECccCcCcccc--CCCCccCCCccccccCCcC
Q 040925 402 NNLSGQIPEFLKNLSVLEFLSLSYNHFEGEV--PTKGVFSNKTKISLQGNMK 451 (833)
Q Consensus 402 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~--~~~~~~~~~~~l~l~~N~~ 451 (833)
|.|... ..++.+.+|..||+++|++...- ..+|.++-+..+.+.+||.
T Consensus 362 N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 362 NKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred hhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 999743 46889999999999999998644 3457888888999999974
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.2e-12 Score=128.55 Aligned_cols=88 Identities=25% Similarity=0.211 Sum_probs=42.3
Q ss_pred CCCCccEEEccCCcceeeCC--ccccCCCCCcEEEcccCccccccCc--CccCCCcCceEecccccCCCCCCCCcccccc
Q 040925 94 NLPNLKALAIGGNNFFGSIP--YSLSNASNLELLDLSVNQFKGNVSI--DFSSLKNLLWLNLEQNNLGTGTATDLDFVTF 169 (833)
Q Consensus 94 ~l~~L~~L~L~~N~l~~~~~--~~~~~l~~L~~L~L~~N~i~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 169 (833)
++.+|+...|.+..+. ..+ .....+++++.||||+|-+..+.+- ....|++|+.|+|+.|++.........
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~---- 193 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTT---- 193 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccch----
Confidence 3444555555555553 222 2344555556666666555433321 234555555555555555443222111
Q ss_pred cCCCCCCCEEEccCCcCc
Q 040925 170 LTNCSSLKALSLADNQFG 187 (833)
Q Consensus 170 l~~l~~L~~L~Ls~N~l~ 187 (833)
..+++|+.|.|+.|.++
T Consensus 194 -~~l~~lK~L~l~~CGls 210 (505)
T KOG3207|consen 194 -LLLSHLKQLVLNSCGLS 210 (505)
T ss_pred -hhhhhhheEEeccCCCC
Confidence 13455555555555554
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.8e-12 Score=128.98 Aligned_cols=255 Identities=17% Similarity=0.240 Sum_probs=128.4
Q ss_pred ccCCCCCCEEEccCCcccc----cCCccCCCCCCCCEEEcCCCcc---ccc-------CCccccCCCCCcEEECCCcccc
Q 040925 19 VGNLSDLEVIRIMGNSLGG----KIPTTLGLLRNLVSLNVAENKF---SGM-------FPRSICNISSLELIQLALNRFS 84 (833)
Q Consensus 19 ~~~l~~L~~L~l~~n~l~~----~~~~~~~~l~~L~~L~L~~n~i---~~~-------~~~~~~~l~~L~~L~L~~N~l~ 84 (833)
+-....++.|+|+||.+.. .+...+.+.++|+..++|+--- ... +.+++..+++|++||||.|-+.
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G 105 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFG 105 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccC
Confidence 4445566677777777632 2233345556666666665221 111 1233444555666666665553
Q ss_pred cccC---chhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCC
Q 040925 85 GNLP---FDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTA 161 (833)
Q Consensus 85 ~~~~---~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 161 (833)
-.-+ .+.+....+|++|+|.+|.+.-.--..++. .|.+|. .++ -..+-++|+.+...+|++...+.
T Consensus 106 ~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~-~~k--------k~~~~~~Lrv~i~~rNrlen~ga 174 (382)
T KOG1909|consen 106 PKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA-VNK--------KAASKPKLRVFICGRNRLENGGA 174 (382)
T ss_pred ccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH-HHh--------ccCCCcceEEEEeeccccccccH
Confidence 1111 122334445555555555443110011110 111111 000 11223456666666666655444
Q ss_pred CCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccc----
Q 040925 162 TDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHG---- 237 (833)
Q Consensus 162 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~---- 237 (833)
.. +...|...+.|+.+.++.|.|. |+.+ ......|..+++|+.|||.+|-++.
T Consensus 175 ~~--~A~~~~~~~~leevr~~qN~I~---~eG~------------------~al~eal~~~~~LevLdl~DNtft~egs~ 231 (382)
T KOG1909|consen 175 TA--LAEAFQSHPTLEEVRLSQNGIR---PEGV------------------TALAEALEHCPHLEVLDLRDNTFTLEGSV 231 (382)
T ss_pred HH--HHHHHHhccccceEEEeccccc---Cchh------------------HHHHHHHHhCCcceeeecccchhhhHHHH
Confidence 32 2344555566666666666654 1111 0223456666777777777776653
Q ss_pred cCCccccCCCCCCEEEcccccCcccCCccc-----cCCCCCCeEEeecccccCC----CCCCCCCCCccceeecCCcee
Q 040925 238 TIPDAIGELKNLQKLCLFRNFLQGRIPSGL-----GNLTKLANLELSSNSLQGN----IPSSLGNCQNLMSFTASQNKL 307 (833)
Q Consensus 238 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l 307 (833)
.+..++..+++|++|++++|.++.....+| ...++|+.|.|.+|.|+.. +...+...+.|..|+|++|++
T Consensus 232 ~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 232 ALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 234455666777777777777765433332 1356777777777777622 222344466777777777777
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.4e-11 Score=128.88 Aligned_cols=250 Identities=18% Similarity=0.112 Sum_probs=166.5
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEEC-CCceEEEEEEeeccCCcch--hHHHHHHHHHhhc-CCCccceEeeEeecCC
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLG-EDEMIVAVKVINLKYKGAS--RSFVAECEALRNI-RHRNLIKIITICSSTD 601 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 601 (833)
......+|..+..||.|.|+.|+.+..+ .++..|++|.......... ..-..|+.+...+ .|.+++..+..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 4455678999999999999999998766 6788999998864433322 2234566666666 4888887665543332
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-Cc
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MV 680 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 680 (833)
..|+=-|||++++....+.-.. .+++..++++..|++.++.++|+. .++|+|+||+||++..+ +.
T Consensus 340 -----~~~ip~e~~~~~s~~l~~~~~~------~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 340 -----QGYIPLEFCEGGSSSLRSVTSQ------MLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFF 405 (524)
T ss_pred -----cccCchhhhcCcchhhhhHHHH------hcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhh
Confidence 5668889999998877663222 678889999999999999999999 99999999999999886 78
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccc-cCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhC-
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY-VAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTAL- 758 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~- 758 (833)
.++.|||++..+.-..... ..++..| .+|+......+..++|++|.+..+.+ ..++..
T Consensus 406 ~~~~~~~~~t~~~~~~~~~----------~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e----------~~~~~~l 465 (524)
T KOG0601|consen 406 SKLGDFGCWTRLAFSSGVF----------HHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDE----------AITGSPL 465 (524)
T ss_pred hhccccccccccceecccc----------cccccccccchhhccccccccccccccccccccc----------cccCccc
Confidence 8999999986432211100 1133444 35666666778899999996655543 222221
Q ss_pred CCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 759 PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 759 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
++.... . ........ +........+..+...+...++..||.+.+.....+
T Consensus 466 s~~~~~-~-----~~i~~~~~-------p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 466 SESGVQ-S-----LTIRSGDT-------PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred Cccccc-c-----eeeecccc-------cCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111000 0 00000000 001111245666777789999999999988765443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.6e-10 Score=101.39 Aligned_cols=129 Identities=28% Similarity=0.411 Sum_probs=93.4
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEe-eccCCc-------chhHHHHHHHHHhhcCCC--ccceEeeEeecCCCCCCc
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVI-NLKYKG-------ASRSFVAECEALRNIRHR--NLIKIITICSSTDFKGTD 606 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~-~~~~~~-------~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~ 606 (833)
..+++|+-+.+|.+.+. |..+++|.= ++.... ...+..+|++++++++-- ++..++++ +. .
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~-----~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DP-----D 72 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cC-----C
Confidence 46789999999999774 444666642 221111 124678899999998643 33444444 22 2
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
...++|||++|-.|.+++... ...++..+-.-+.-||.. ||||+|+.++||+++.+. +.++||
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDf 135 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDF 135 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEEC
Confidence 557999999998899888754 134566666777789999 999999999999997665 999999
Q ss_pred ccccc
Q 040925 687 GLAKF 691 (833)
Q Consensus 687 G~a~~ 691 (833)
|++..
T Consensus 136 GLg~~ 140 (204)
T COG3642 136 GLGEF 140 (204)
T ss_pred Ccccc
Confidence 99973
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.9e-10 Score=111.25 Aligned_cols=145 Identities=23% Similarity=0.321 Sum_probs=110.5
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCC--CccceEeeEeecCCCCCCceEeEEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRH--RNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
+.++.|..+.||+++.. +|+.+++|....... .....+.+|+++++.+++ ..+.+++.+..... ..+..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEE
Confidence 57899999999999885 367899999764322 134678999999999975 44677777754322 1125689999
Q ss_pred ecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------
Q 040925 614 YMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC---------------------------------- 659 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~---------------------------------- 659 (833)
|++|+++.+.+.. . .++..+...++.+++++|+.||+..
T Consensus 81 ~i~G~~l~~~~~~-~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 81 RVDGRVLRDRLLR-P------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred EeCCEecCCCCCC-C------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 9999888876542 1 4677788888889999999998531
Q ss_pred -------------------CCCceeeCCCCCCeeecC--CCcEEEcccccccc
Q 040925 660 -------------------QPPMVHGDLKPSNVLLDH--DMVAHVCDFGLAKF 691 (833)
Q Consensus 660 -------------------~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~ 691 (833)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66789999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-09 Score=99.67 Aligned_cols=142 Identities=23% Similarity=0.324 Sum_probs=100.9
Q ss_pred cCceeccCcceEEEEEEECCCceEEEEEE-eeccCC-------cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 535 SSNMIGQGSFGYVYKGTLGEDEMIVAVKV-INLKYK-------GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 535 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
....+-+|+-+.|+++.+. |+.+.||. +.+... -..++..+|++.+.++.--.|.--.-++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----
Confidence 5678899999999999984 67766764 222211 12357889999999986333322222222222
Q ss_pred eEeEEEEecCC-CChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC---cEE
Q 040925 607 FKAFVFEYMEN-GSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM---VAH 682 (833)
Q Consensus 607 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~k 682 (833)
.-.++|||++| .++.+++...... .........++.+|-+.+.-||.. +|||+||..+||++..++ .+.
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~----~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMED----ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccC----cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceE
Confidence 45799999976 3788888765432 233334477888999999999999 999999999999997665 468
Q ss_pred Eccccccc
Q 040925 683 VCDFGLAK 690 (833)
Q Consensus 683 L~DfG~a~ 690 (833)
++|||++.
T Consensus 157 lIdfgls~ 164 (229)
T KOG3087|consen 157 LIDFGLSS 164 (229)
T ss_pred EEeecchh
Confidence 99999985
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.9e-10 Score=88.87 Aligned_cols=57 Identities=42% Similarity=0.610 Sum_probs=22.0
Q ss_pred CcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccC
Q 040925 73 LELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVN 130 (833)
Q Consensus 73 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 130 (833)
|++|++++|+++ .+|.++|.++++|++|+|++|.++.+.|..|.++++|++|++++|
T Consensus 3 L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 333333333333 333333333333333333333333333333333333333333333
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.7e-10 Score=87.94 Aligned_cols=61 Identities=44% Similarity=0.579 Sum_probs=53.4
Q ss_pred CCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccC
Q 040925 96 PNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156 (833)
Q Consensus 96 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 156 (833)
|+|++|+|++|+|+.+.+..|.++++|++|++++|+|+.+++.+|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5788899999999887778899999999999999999988888899888888888888875
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.7e-09 Score=102.17 Aligned_cols=126 Identities=24% Similarity=0.235 Sum_probs=83.1
Q ss_pred EEEEEEECCCceEEEEEEeeccCC-------------c-------------chhHHHHHHHHHhhcCCC--ccceEeeEe
Q 040925 546 YVYKGTLGEDEMIVAVKVINLKYK-------------G-------------ASRSFVAECEALRNIRHR--NLIKIITIC 597 (833)
Q Consensus 546 ~Vy~~~~~~~~~~vavK~~~~~~~-------------~-------------~~~~~~~E~~~l~~l~h~--niv~~~~~~ 597 (833)
.||.|... +|..+|||+.+.... . ......+|.+.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 48999886 788999999863210 0 013467899999999754 567777652
Q ss_pred ecCCCCCCceEeEEEEecC--CCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHH-hhcCCCCceeeCCCCCCee
Q 040925 598 SSTDFKGTDFKAFVFEYME--NGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVL 674 (833)
Q Consensus 598 ~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~L-H~~~~~~ivH~Dlkp~NIl 674 (833)
..++||||++ |..+..+... .++......++.+++..+..+ |.. ||+|+|+.+.||+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~--------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl 139 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV--------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL 139 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC--------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred ---------CCEEEEEecCCCccchhhHHhc--------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence 2379999998 5445443332 122344566778888866664 677 9999999999999
Q ss_pred ecCCCcEEEcccccccccC
Q 040925 675 LDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 675 l~~~~~~kL~DfG~a~~~~ 693 (833)
++++ .+.++|||.|....
T Consensus 140 v~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp EETT-CEEE--GTTEEETT
T ss_pred eecc-eEEEEecCcceecC
Confidence 9887 99999999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.4e-09 Score=116.45 Aligned_cols=127 Identities=18% Similarity=0.223 Sum_probs=105.2
Q ss_pred EEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCC
Q 040925 549 KGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD 628 (833)
Q Consensus 549 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~ 628 (833)
.|..+.++.+|.|.+.+...........+-+..++.++||||+++++.+. ..+..|+|+|.+. .|..++++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-----~~~~~ylvTErV~--Pl~~~lk~l- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-----EEGTLYLVTERVR--PLETVLKEL- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-----ccCceEEEeeccc--cHHHHHHHh-
Confidence 46667788999999987655544566788889999999999999998844 3448999999984 688888753
Q ss_pred CccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 629 DQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 629 ~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
....+..-+.||+.||.|||..+ +++|++|.-+-|+++..|..||++|..+....
T Consensus 102 --------~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 102 --------GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred --------HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 35567778899999999999776 99999999999999999999999999886543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=6.1e-09 Score=101.76 Aligned_cols=137 Identities=26% Similarity=0.215 Sum_probs=101.5
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCC----------------------cchhHHHHHHHHHhhcCCC--
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK----------------------GASRSFVAECEALRNIRHR-- 588 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~-- 588 (833)
+.+...||-|--|.||.|... .|.++|||.=+.... .......+|.++|.++...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 445689999999999999997 788999996542210 0123578899999999754
Q ss_pred ccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCC
Q 040925 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDL 668 (833)
Q Consensus 589 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dl 668 (833)
.|.+.+++ +...+||||++|--|...- ++......++..|++-+.-.-.. ||||+|+
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r-----------~~~en~~~il~~il~~~~~~~~~---GiVHGDl 228 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLR-----------LDVENPDEILDKILEEVRKAYRR---GIVHGDL 228 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeeccc-----------CcccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence 77777665 3568999999986555432 22334445566666666666667 9999999
Q ss_pred CCCCeeecCCCcEEEcccccccccC
Q 040925 669 KPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 669 kp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
.+=||++++||.+.++||--+....
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred chheEEEecCCCEEEEeCcccccCC
Confidence 9999999999999999997765443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.3e-09 Score=128.26 Aligned_cols=129 Identities=20% Similarity=0.247 Sum_probs=72.7
Q ss_pred CCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCc--ccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccE
Q 040925 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENK--FSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKA 100 (833)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~--i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~ 100 (833)
...+...+.+|.+ ..++..... ++|++|-+.+|. +..+.++.|..++.|+.||||+|.--+.+|..+ +.|-+|++
T Consensus 523 ~~~rr~s~~~~~~-~~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I-~~Li~Lry 599 (889)
T KOG4658|consen 523 NSVRRMSLMNNKI-EHIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSI-GELVHLRY 599 (889)
T ss_pred hheeEEEEeccch-hhccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHH-hhhhhhhc
Confidence 4555666666666 333333322 356666666664 443444445566666666666655433555444 45666666
Q ss_pred EEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEeccccc
Q 040925 101 LAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNN 155 (833)
Q Consensus 101 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 155 (833)
|+|++..+. .+|..+++|..|.+|++..+.-....++....|.+|++|.+-.-.
T Consensus 600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 666666665 556666666666666666665444445555556666666655443
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=5.1e-10 Score=131.56 Aligned_cols=125 Identities=23% Similarity=0.252 Sum_probs=102.8
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCc--ccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 3 TLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNS--LGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~--l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
...+-+|.+. .++.+..+ +.|++|-+.+|. +....++.|..++.|++|||++|.=-+.+|..+++|-+|++|+|++
T Consensus 527 r~s~~~~~~~-~~~~~~~~-~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~ 604 (889)
T KOG4658|consen 527 RMSLMNNKIE-HIAGSSEN-PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSD 604 (889)
T ss_pred EEEEeccchh-hccCCCCC-CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccC
Confidence 4455566665 44444444 379999999996 6566666788999999999999887678999999999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCc
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQ 131 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 131 (833)
..++ .+|..+ .+|.+|.+|++..+.-...+|.....|++|++|.+-.-.
T Consensus 605 t~I~-~LP~~l-~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 605 TGIS-HLPSGL-GNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred CCcc-ccchHH-HHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 9998 888766 789999999999988766778888889999999998766
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.7e-08 Score=101.43 Aligned_cols=146 Identities=14% Similarity=0.025 Sum_probs=100.8
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCC-----------cchhHHHHHHHHHhhcCCCc--cceEeeEeecCCCC
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-----------GASRSFVAECEALRNIRHRN--LIKIITICSSTDFK 603 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~ 603 (833)
+.+-......|+++.. .|+.|.||....... .....+.+|.+.+.++...+ +++..++.......
T Consensus 28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 3444444455777766 567899997742221 11124789999998884322 33444444322111
Q ss_pred CCceEeEEEEecCCC-ChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-----
Q 040925 604 GTDFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH----- 677 (833)
Q Consensus 604 ~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~----- 677 (833)
....-++|||++++. +|.+++...... ..+...+..++.+++..++-||.. ||+|+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~----~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~ 178 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATN----PPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGR 178 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCC
Confidence 123568999999875 799998542211 455677789999999999999999 9999999999999975
Q ss_pred --CCcEEEcccccccc
Q 040925 678 --DMVAHVCDFGLAKF 691 (833)
Q Consensus 678 --~~~~kL~DfG~a~~ 691 (833)
++.+.++||+.+..
T Consensus 179 ~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 179 EEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCCceEEEEECCcccc
Confidence 46899999998863
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=3e-08 Score=104.51 Aligned_cols=148 Identities=15% Similarity=0.154 Sum_probs=116.4
Q ss_pred cceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEecCC-CChh
Q 040925 543 SFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMEN-GSLK 621 (833)
Q Consensus 543 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-gsL~ 621 (833)
...+.|++...-+|..|++|+++............-+++++++.|+|||++..++....|. ....++|++|+++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~-D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFG-DLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccC-cceEEEEEecCCCCchHH
Confidence 4468899999999999999999533333333445568889999999999999998755443 3478999999986 5677
Q ss_pred hhhccCCCc---------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 622 DWLHQSDDQ---------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 622 ~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
++-...... ......++...|.++.|+..||.++|+. |..-+-|.|.+|+++.+.+++|...|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 766543321 2233678899999999999999999999 9999999999999999999999888877654
Q ss_pred Cc
Q 040925 693 SD 694 (833)
Q Consensus 693 ~~ 694 (833)
..
T Consensus 444 ~~ 445 (655)
T KOG3741|consen 444 QE 445 (655)
T ss_pred cC
Confidence 43
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.2e-09 Score=123.75 Aligned_cols=258 Identities=19% Similarity=0.201 Sum_probs=169.8
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
...+++.+.+-+.+|+++.++.+.-..+|...+.|+..... ....+....+-.+.-..+||-++....- +.-
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-----~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-----FPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-----CCC
Confidence 35567888889999999999999888777666666653221 1122233333333333345666654332 122
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
....++||+|+.+++|...++..+ ..+..-.+.....+..+.+|||+. .+.|||++|.|++...++..++.
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~ 946 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSG------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLT 946 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCC------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccC
Confidence 335789999999999999988765 344555566677788999999998 89999999999999999999999
Q ss_pred ccccccccCcccccc---------------------ccc--CCCccccccccccccCccccCCCCCCcccccccCCcCCC
Q 040925 685 DFGLAKFLSDHQLDT---------------------AVK--TPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPID 741 (833)
Q Consensus 685 DfG~a~~~~~~~~~~---------------------~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~ 741 (833)
|||......--.... ... .........||+.|.|||...+......+|+|+
T Consensus 947 ~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~------ 1020 (1205)
T KOG0606|consen 947 DFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWS------ 1020 (1205)
T ss_pred ccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhh------
Confidence 998443321110000 000 001233568999999999999999999999998
Q ss_pred ccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHH
Q 040925 742 AVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMR 815 (833)
Q Consensus 742 ~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 815 (833)
.|+.+++..++..|+.....- .......... ..+..-+.+......+++...+..+|.+|-.+.
T Consensus 1021 ----~g~~l~e~l~g~pp~na~tpq--~~f~ni~~~~----~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1021 ----SGVCLFEVLTGIPPFNAETPQ--QIFENILNRD----IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred ----hhhhhhhhhcCCCCCCCcchh--hhhhccccCC----CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 788888888888876522110 0111111111 111112233445567777888889999997765
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.3e-10 Score=125.78 Aligned_cols=183 Identities=28% Similarity=0.281 Sum_probs=91.7
Q ss_pred CccccCCCCCCEEEcccccCcccCCccccCC-CCCCeEEeeccccc---CCCC---CCCCC---CCccceeecCCceecc
Q 040925 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNL-TKLANLELSSNSLQ---GNIP---SSLGN---CQNLMSFTASQNKLTG 309 (833)
Q Consensus 240 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~---~~~~---~~~~~---l~~L~~L~l~~N~l~~ 309 (833)
|-.+..+.+|+.|.|.++.|.. ..++..+ ..|++|...+ .++ .++. ..+++ ...|.+.+.+.|++.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~~-Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~- 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICHN-SLDALRHVFASCGGDISNSPVWNKLATASFSYNRLV- 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhhc-cHHHHHHHHHHhccccccchhhhhHhhhhcchhhHH-
Confidence 4345566777777777777763 1222221 2344444332 111 0000 11111 124555566666665
Q ss_pred cCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCcccc
Q 040925 310 ALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLS 389 (833)
Q Consensus 310 ~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 389 (833)
.+...+.-++.+ +.|+|++|+++.. . .+..++.|+.|||++|.++.++--...++. |+.|.|++|.++... .+.
T Consensus 178 ~mD~SLqll~al-e~LnLshNk~~~v-~-~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL~--gie 251 (1096)
T KOG1859|consen 178 LMDESLQLLPAL-ESLNLSHNKFTKV-D-NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTLR--GIE 251 (1096)
T ss_pred hHHHHHHHHHHh-hhhccchhhhhhh-H-HHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhhh--hHH
Confidence 444444433333 5566666666522 2 455566666666666666533333334444 666666666665332 345
Q ss_pred CCCCCCeEEccCcccCCCc-hhhhcCCCCCceEECccCcCcccc
Q 040925 390 FLKSIKELNVSSNNLSGQI-PEFLKNLSVLEFLSLSYNHFEGEV 432 (833)
Q Consensus 390 ~l~~L~~L~l~~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~ 432 (833)
+|.+|+-||+++|-|++.. -..+..|..|+.|+|.+|++.|.+
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 5666666666666665421 122344555666666666665544
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.68 E-value=3.4e-10 Score=122.54 Aligned_cols=123 Identities=30% Similarity=0.288 Sum_probs=60.1
Q ss_pred eecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCccc
Q 040925 325 LDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNL 404 (833)
Q Consensus 325 L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l 404 (833)
.+.++|++. ....++.-++.|+.|||++|+++... .+..|+.|++|||++|.++.++--...++. |+.|+++||.+
T Consensus 169 a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l 244 (1096)
T KOG1859|consen 169 ASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNAL 244 (1096)
T ss_pred hhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeecccHH
Confidence 445555555 44444555555555555555554332 455555555555555555533333333333 55555555555
Q ss_pred CCCchhhhcCCCCCceEECccCcCccccCC--CCccCCCccccccCCcCCC
Q 040925 405 SGQIPEFLKNLSVLEFLSLSYNHFEGEVPT--KGVFSNKTKISLQGNMKLC 453 (833)
Q Consensus 405 ~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~--~~~~~~~~~l~l~~N~~~c 453 (833)
+.. ..+.+|.+|+.||+++|-|.+--.. .+.+..+..+.++|||..|
T Consensus 245 ~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c 293 (1096)
T KOG1859|consen 245 TTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCC 293 (1096)
T ss_pred Hhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcccc
Confidence 432 2344555555555555555432211 1334444555555555444
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=3.5e-07 Score=90.43 Aligned_cols=110 Identities=25% Similarity=0.298 Sum_probs=85.6
Q ss_pred hhHHHHHHHHHhhcC--CCccceEeeEeecCCCCCCceEeEEEEecCCC-ChhhhhccCCCccccccCCHHHHHHHHHHH
Q 040925 572 SRSFVAECEALRNIR--HRNLIKIITICSSTDFKGTDFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648 (833)
Q Consensus 572 ~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi 648 (833)
.....+|.+.+.++. .=.+.+.+++...... .....++|+|++++. +|.+++.... ..+......++.++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~-~~~~s~lite~l~~~~~L~~~~~~~~------~~~~~~~~~ll~~l 127 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKG-GGYRSYLITEALPGAQDLRDLLQQWE------QLDPSQRRELLRAL 127 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC-CceeEEEEEEeCCCcccHHHHHHhhc------ccchhhHHHHHHHH
Confidence 356888999888885 3335566666544321 123568999999874 7999987643 24566778899999
Q ss_pred HHHHHHHhhcCCCCceeeCCCCCCeeecCCC---cEEEcccccccc
Q 040925 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM---VAHVCDFGLAKF 691 (833)
Q Consensus 649 ~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfG~a~~ 691 (833)
+..++-||+. ||+|+|++|.|||++.++ .+.++||+-++.
T Consensus 128 ~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 128 ARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999 999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.2e-08 Score=109.68 Aligned_cols=157 Identities=15% Similarity=0.212 Sum_probs=108.2
Q ss_pred HHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCcccccc-cccCCCccccccccccccCccccCCC
Q 040925 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT-AVKTPSSSIGLKGTVGYVAPEYGMGS 725 (833)
Q Consensus 647 qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~ 725 (833)
+++.|+.|+|... ++||++|.|++|.+++.+..||+.|+++.....+.... ...++....-..-...|.|||++.+.
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4559999999885 99999999999999999999999999887654422111 11111111123356789999999998
Q ss_pred CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCC
Q 040925 726 EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSM 805 (833)
Q Consensus 726 ~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 805 (833)
..+.++|+||.|+.++.+|..|..+.....+..........+..- ........+.++.+-+.+++.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~--------------~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG--------------AFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc--------------cccccccCcHHHHHHHHHHhc
Confidence 899999999999999999988877665433222222111111100 011123456777888888999
Q ss_pred CCCCCCCCHHHHHH
Q 040925 806 ESPFERMDMRDVVA 819 (833)
Q Consensus 806 ~dP~~RPt~~eil~ 819 (833)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998777643
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.61 E-value=5.1e-07 Score=87.00 Aligned_cols=141 Identities=18% Similarity=0.241 Sum_probs=94.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhH---------HHHHHHHHhhcC---CCccceEeeEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS---------FVAECEALRNIR---HRNLIKIITIC 597 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~~~~~~ 597 (833)
.++|.+.+.+-......|.+... +|..+++|..+.......+. ..+++..+.+++ -...+.++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 46788888888888888888777 56789999987544332222 233444444443 22333333332
Q ss_pred ecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC
Q 040925 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH 677 (833)
Q Consensus 598 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 677 (833)
.-..+.-....+++|||++|..|.++.. +++ .++..+++++.-+|.. |++|+|..|.|+++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEEC
Confidence 2222223345678999999987776532 222 2445677889999999 9999999999999986
Q ss_pred CCcEEEccccccc
Q 040925 678 DMVAHVCDFGLAK 690 (833)
Q Consensus 678 ~~~~kL~DfG~a~ 690 (833)
++ ++++||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 54 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.3e-09 Score=103.34 Aligned_cols=205 Identities=18% Similarity=0.166 Sum_probs=95.5
Q ss_pred CCCcEEECCCcccccccC--chhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcC-ccCCCcCc
Q 040925 71 SSLELIQLALNRFSGNLP--FDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLL 147 (833)
Q Consensus 71 ~~L~~L~L~~N~l~~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~ 147 (833)
+.++.|||.+|.|+ ... ..+..++|.|+.|+|+.|.+...+...-..+.+|++|-|.+..+......+ +..++.++
T Consensus 71 ~~v~elDL~~N~iS-dWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 71 TDVKELDLTGNLIS-DWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhcccchhc-cHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 44555555555554 221 123445566666666666554322221134456666666665554333322 34455555
Q ss_pred eEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCe
Q 040925 148 WLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIG 227 (833)
Q Consensus 148 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~ 227 (833)
.|+++.|++......+-..- ..-+.+++|++..|... +.++-|++. .-++++..
T Consensus 150 elHmS~N~~rq~n~Dd~c~e---~~s~~v~tlh~~~c~~~----------------~w~~~~~l~-------r~Fpnv~s 203 (418)
T KOG2982|consen 150 ELHMSDNSLRQLNLDDNCIE---DWSTEVLTLHQLPCLEQ----------------LWLNKNKLS-------RIFPNVNS 203 (418)
T ss_pred hhhhccchhhhhcccccccc---ccchhhhhhhcCCcHHH----------------HHHHHHhHH-------hhcccchh
Confidence 56555554332211110000 01123333433333221 001111111 22345555
Q ss_pred EeccCCccccc-CCccccCCCCCCEEEcccccCccc-CCccccCCCCCCeEEeecccccCCCCC------CCCCCCccce
Q 040925 228 FGAEENQLHGT-IPDAIGELKNLQKLCLFRNFLQGR-IPSGLGNLTKLANLELSSNSLQGNIPS------SLGNCQNLMS 299 (833)
Q Consensus 228 L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~ 299 (833)
+.+..|.+... ....+..++.+-.|+|+.|+|.+- .-+++.++++|..|.+++|.+...... .++.+++++.
T Consensus 204 v~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l~~~err~llIaRL~~v~v 283 (418)
T KOG2982|consen 204 VFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPLRGGERRFLLIARLTKVQV 283 (418)
T ss_pred eeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccccCCcceEEEEeeccceEE
Confidence 55666655432 223455556666777777776532 124566677777777777766533221 2456677776
Q ss_pred eec
Q 040925 300 FTA 302 (833)
Q Consensus 300 L~l 302 (833)
|+=
T Consensus 284 LNG 286 (418)
T KOG2982|consen 284 LNG 286 (418)
T ss_pred ecC
Confidence 653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=9.6e-07 Score=84.93 Aligned_cols=144 Identities=18% Similarity=0.139 Sum_probs=104.1
Q ss_pred eeccCcceEEEEEEECCCceEEEEEEeecc------CCcchhHHHHHHHHHhhcCC--CccceEeeEeecCCCCCCceEe
Q 040925 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLK------YKGASRSFVAECEALRNIRH--RNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 538 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~ 609 (833)
--|+||.+-|++.... |..+-+|.-... .+.....|.+|...+.++.. -.+.+.. ++........-.-+
T Consensus 25 N~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 25 NYRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred CcCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 3467999999998875 336778876411 12345689999999999953 2244444 32222112233468
Q ss_pred EEEEecCC-CChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc--EEEccc
Q 040925 610 FVFEYMEN-GSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV--AHVCDF 686 (833)
Q Consensus 610 lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Df 686 (833)
+|+|-+++ -||.+++...... +.+......+..+++..++-||+. |+.|+|+.+.||+++.++. ++++||
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~----~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDl 174 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVS----PYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDL 174 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcC----CcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEh
Confidence 99998753 4888888654321 467778889999999999999999 9999999999999986666 999999
Q ss_pred ccccc
Q 040925 687 GLAKF 691 (833)
Q Consensus 687 G~a~~ 691 (833)
.-++.
T Consensus 175 Ek~r~ 179 (216)
T PRK09902 175 EKSRR 179 (216)
T ss_pred hccch
Confidence 87653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.8e-07 Score=86.49 Aligned_cols=156 Identities=21% Similarity=0.229 Sum_probs=107.2
Q ss_pred CccchHHHHHHhcCCccCceec---cCcceEEEEEEECCCceEEEEEEeeccCCc-------------------ch----
Q 040925 519 PMVSYAELSKATGEFSSSNMIG---QGSFGYVYKGTLGEDEMIVAVKVINLKYKG-------------------AS---- 572 (833)
Q Consensus 519 ~~~~~~~~~~~~~~y~~~~~lg---~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------------------~~---- 572 (833)
-..+...+.....+..+....| .|.-+.||+|... ++..||||+++..... ..
T Consensus 33 D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv 111 (268)
T COG1718 33 DKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV 111 (268)
T ss_pred hhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence 3456667777777777766655 5566689999874 7889999998743211 00
Q ss_pred -hHHHHHHHHHhhcC--CCccceEeeEeecCCCCCCceEeEEEEecCCC-ChhhhhccCCCccccccCCHHHHHHHHHHH
Q 040925 573 -RSFVAECEALRNIR--HRNLIKIITICSSTDFKGTDFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648 (833)
Q Consensus 573 -~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi 648 (833)
.-..+|+.-|.++. +-.+.+-+++. .-.+||||+... .-.-.++.- ++...+...+..++
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~---------~nVLvMEfIg~~g~pAP~LkDv-------~~e~~e~~~~~~~~ 175 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFR---------NNVLVMEFIGDDGLPAPRLKDV-------PLELEEAEGLYEDV 175 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeec---------CCeEEEEeccCCCCCCCCcccC-------CcCchhHHHHHHHH
Confidence 11357888888873 45555665542 357999999542 111111111 23333677788889
Q ss_pred HHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCc
Q 040925 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 649 ~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
++++.-|-..+ ++||+||+.=|||+. ++.+.|+|||-|....+
T Consensus 176 v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 176 VEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred HHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 99998888733 999999999999998 88999999999876554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=3.1e-07 Score=101.55 Aligned_cols=141 Identities=20% Similarity=0.261 Sum_probs=93.3
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCC----------------------c----c--------------hhHHH
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK----------------------G----A--------------SRSFV 576 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~----~--------------~~~~~ 576 (833)
+.|+.++-|+||+|+.+ +|+.||||+.++.-. . . .-++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 68899999999999998 699999999864310 0 0 01245
Q ss_pred HHHHHHhhcC-----CCccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHH
Q 040925 577 AECEALRNIR-----HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651 (833)
Q Consensus 577 ~E~~~l~~l~-----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~g 651 (833)
+|+.-+.+++ .|. +++=.++ .+.+....++|||++|-.+.+...-... ..+...+ +..++++
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~----we~t~~~VLtmE~i~Gi~i~d~~~l~~~-----g~d~k~i---a~~~~~~ 276 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVY----WEYTTRRVLTMEWIDGIKISDIAALKSA-----GIDRKEL---AELLVRA 276 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceee----hhccCCcEEEEEeeCCEecccHHHHHhc-----CCCHHHH---HHHHHHH
Confidence 6666666662 233 2222232 2223467899999999888887432221 2442222 2222222
Q ss_pred -HHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCc
Q 040925 652 -MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 652 -L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 694 (833)
+..+-.. |++|+|..|.||+++.+|.+.+.|||+...+++
T Consensus 277 f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 277 FLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2222334 999999999999999999999999999987765
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 833 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 1e-40 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-40 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-32 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-31 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-20 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-17 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-16 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-15 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-15 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-15 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-14 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-12 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 9e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-11 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-11 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 8e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-10 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 8e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-09 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-08 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-08 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 2e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 3e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 7e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-08 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-08 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-08 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-07 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-07 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-07 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-07 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-07 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-07 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-07 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-06 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 3e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-06 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-06 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 6e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 9e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 1e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-05 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-05 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 7e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 7e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-05 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-05 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 7e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 8e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 1e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-04 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-04 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-04 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-04 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-04 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-04 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-04 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-04 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 5e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-04 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 5e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-04 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-04 | ||
| 2z7x_A | 549 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 7e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Z7X|A Chain A, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 549 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 411 bits (1058), Expect = e-132
Identities = 137/479 (28%), Positives = 220/479 (45%), Gaps = 23/479 (4%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPT-TLGLLRNLVSLNVAENKF 59
L L ++ N+ G +P F G+ S LE + + N+ G++P TL +R L L+++ N+F
Sbjct: 296 LTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355
Query: 60 SGMFPRSICNIS-SLELIQLALNRFSGNLPFDIVVN-LPNLKALAIGGNNFFGSIPYSLS 117
SG P S+ N+S SL + L+ N FSG + ++ N L+ L + N F G IP +LS
Sbjct: 356 SGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLS 415
Query: 118 NASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLK 177
N S L L LS N G + SL L L L N L G L +L+
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNML-EGE-----IPQELMYVKTLE 469
Query: 178 ALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLH 236
L L N GE+P ++N ++ I+ + N+++G IP I L NL N
Sbjct: 470 TLILDFNDLTGEIPSGLSNCTNLNWIS--LSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527
Query: 237 GTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQN 296
G IP +G+ ++L L L N G IP+ + + +++N + G + N
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGM 583
Query: 297 LMSFTASQN--KLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSN 354
+ N + G QL ++T + ++++ + G + +++ LD+S N
Sbjct: 584 KKECHGAGNLLEFQGIRSEQLNRLSTRN-PCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642
Query: 355 QFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKN 414
SG IP + + L L++ N G IP + L+ + L++SSN L G+IP+ +
Sbjct: 643 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSA 702
Query: 415 LSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGSRKPK 473
L++L + LS N+ G +P G F N LCG LP C +
Sbjct: 703 LTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG----YPLPRCDPSNADGYA 757
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 358 bits (922), Expect = e-112
Identities = 124/443 (27%), Positives = 205/443 (46%), Gaps = 24/443 (5%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+ + N + + +L+ LE + + + + G + +L SL+++ N S
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLS 113
Query: 61 GMFP--RSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL-- 116
G S+ + S L+ + ++ N + L +L+ L + N+ G+
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173
Query: 117 -SNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSS 175
L+ L +S N+ G +D S NL +L++ NN + + FL +CS+
Sbjct: 174 SDGCGELKHLAISGNKISG--DVDVSRCVNLEFLDVSSNNF-STG------IPFLGDCSA 224
Query: 176 LKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQ 234
L+ L ++ N+ G+ +I+ + ++N I NQ G IPP L +L EN+
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLN--ISSNQFVGPIPPL--PLKSLQYLSLAENK 280
Query: 235 LHGTIPDAI-GELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIP-SSLG 292
G IPD + G L L L N G +P G+ + L +L LSSN+ G +P +L
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340
Query: 293 NCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGH--LKNLVILD 350
+ L S N+ +G LP L +++ L LDLS+N +G + + L L
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 351 ISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPE 410
+ +N F+G IP TLS C L L +S N G IP SL L +++L + N L G+IP+
Sbjct: 401 LQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQ 460
Query: 411 FLKNLSVLEFLSLSYNHFEGEVP 433
L + LE L L +N GE+P
Sbjct: 461 ELMYVKTLETLILDFNDLTGEIP 483
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = 2e-97
Identities = 131/448 (29%), Positives = 195/448 (43%), Gaps = 26/448 (5%)
Query: 20 GNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLA 79
++ +++ N + ++L L L SL ++ + +G +SL + L+
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 80 LNRFSGNLPFDI-VVNLPNLKALAIGGNNFFGSIPYS-LSNASNLELLDLSVNQFKGNVS 137
N SG + + + LK L + N S ++LE+LDLS N G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 138 IDF---SSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSI 194
+ + L L + N + +G ++ C +L+ L ++ N F +P +
Sbjct: 169 VGWVLSDGCGELKHLAISGNKI-SGDVD-------VSRCVNLEFLDVSSNNFSTGIP-FL 219
Query: 195 ANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCL 254
+ S+ + + I N++SG I L NQ G IP LK+LQ L L
Sbjct: 220 GDCSA-LQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSL 276
Query: 255 FRNFLQGRIPSGL-GNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPH 313
N G IP L G L L+LS N G +P G+C L S S N +G LP
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336
Query: 314 QLLS-ITTLSLYLDLSNNLLNGSLPLQVGHLK-NLVILDISSNQFSGVIPGTLSTCVC-- 369
L + L LDLS N +G LP + +L +L+ LD+SSN FSG I L
Sbjct: 337 DTLLKMRGLK-VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 370 LEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE 429
L+ L + +N F G IP +LS + L++S N LSG IP L +LS L L L N E
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 430 GEVPTK-GVFSNKTKISLQGNMKLCGGI 456
GE+P + + L N L G I
Sbjct: 456 GEIPQELMYVKTLETLILDFN-DLTGEI 482
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-67
Identities = 92/329 (27%), Positives = 144/329 (43%), Gaps = 27/329 (8%)
Query: 118 NASNLELLDLSVNQFK---GNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCS 174
+ +DLS VS SL L L L +++ G+ V+ +
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHI-NGS------VSGFKCSA 100
Query: 175 SLKALSLADNQFGGELP--HSIANLSS-TVINFGIGRNQISGTIP-PGIRNLVNLIGFGA 230
SL +L L+ N G + S+ + S +N + N + G L +L
Sbjct: 101 SLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLN--VSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 231 EENQLHGTIPDAI---GELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNI 287
N + G L+ L + N + G + + L L++SSN+ I
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI 216
Query: 288 PSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLV 347
P LG+C L S NKL+G + + T L L++S+N G +P LK+L
Sbjct: 217 P-FLGDCSALQHLDISGNKLSGDFSRAISTCTELK-LLNISSNQFVGPIPP--LPLKSLQ 272
Query: 348 ILDISSNQFSGVIPGTLST-CVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG 406
L ++ N+F+G IP LS C L LD+S N F+G +P ++ L +SSNN SG
Sbjct: 273 YLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSG 332
Query: 407 QIP-EFLKNLSVLEFLSLSYNHFEGEVPT 434
++P + L + L+ L LS+N F GE+P
Sbjct: 333 ELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-40
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 13/227 (5%)
Query: 244 GELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTAS 303
++ ++ N + S L +LT L +L LS++ + G++ +L S S
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 304 QNKLTGALP--HQLLSITTLSLYLDLSNNLLNGSLPLQVG-HLKNLVILDISSNQFSGVI 360
+N L+G + L S + L +L++S+N L+ + G L +L +LD+S+N SG
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLK-FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167
Query: 361 PGTLSTCVC---LEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSV 417
L++L IS N G + +S +++ L+VSSNN S IP + S
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVDVSR--CVNLEFLDVSSNNFSTGIPFLG-DCSA 224
Query: 418 LEFLSLSYNHFEGEVPTK-GVFSNKTKISLQGNMKLCGGIDELHLPS 463
L+ L +S N G+ + +++ N + G I L L S
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLNISSN-QFVGPIPPLPLKS 270
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = 5e-97
Identities = 80/308 (25%), Positives = 131/308 (42%), Gaps = 14/308 (4%)
Query: 164 LDFVTFLTNCSSL----KALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGT--IPP 217
L L N ++L + + G L + V N + + IP
Sbjct: 12 LQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYR-VNNLDLSGLNLPKPYPIPS 70
Query: 218 GIRNLVNLIGFG-AEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANL 276
+ NL L N L G IP AI +L L L + + G IP L + L L
Sbjct: 71 SLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130
Query: 277 ELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSL 336
+ S N+L G +P S+ + NL+ T N+++GA+P S + L + +S N L G +
Sbjct: 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI 190
Query: 337 PLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKE 396
P +L NL +D+S N G + + + ++ NS + + K++
Sbjct: 191 PPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNG 248
Query: 397 LNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGI 456
L++ +N + G +P+ L L L L++S+N+ GE+P G + N LCG
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGS- 307
Query: 457 DELHLPSC 464
LP+C
Sbjct: 308 ---PLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 7e-62
Identities = 76/308 (24%), Positives = 118/308 (38%), Gaps = 41/308 (13%)
Query: 33 NSLGGKIPTTLGLLRNLVSLNVAENKFSGMF--PRSICNISSLELIQLA-LNRFSGNLPF 89
+ G + T + +L+++ + P S+ N+ L + + +N G +P
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 90 DIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWL 149
I L L L I N G+IP LS L LD S N G ++ S
Sbjct: 96 AI-AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG--TLPPS-------- 144
Query: 150 NLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRN 209
+++ +L ++ N+ G +P S + S + I RN
Sbjct: 145 --------------------ISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 210 QISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGN 269
+++G IPP NL NL N L G G KN QK+ L +N L + +G
Sbjct: 185 RLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGL 242
Query: 270 LTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPH--QLLSITTLSLYLDL 327
L L+L +N + G +P L + L S S N L G +P L +
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAY---A 299
Query: 328 SNNLLNGS 335
+N L GS
Sbjct: 300 NNKCLCGS 307
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 2e-46
Identities = 68/259 (26%), Positives = 106/259 (40%), Gaps = 37/259 (14%)
Query: 1 LQTLAV-NDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKF 59
L L + N L G +P + L+ L + I ++ G IP L ++ LV+L+ + N
Sbjct: 78 LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL 137
Query: 60 SGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL-KALAIGGNNFFGSIPYSLSN 118
SG P SI ++ +L I NR SG +P + L ++ I N G IP + +N
Sbjct: 138 SGTLPPSISSLPNLVGITFDGNRISGAIPDSYG-SFSKLFTSMTISRNRLTGKIPPTFAN 196
Query: 119 ASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKA 178
NL +DLS N +G+ S+ F S KN ++L +N+L
Sbjct: 197 L-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL---------------------- 233
Query: 179 LSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGT 238
+L + + + + N+I GT+P G+ L L N L G
Sbjct: 234 --------AFDLG-KVGLSKN-LNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGE 283
Query: 239 IPDAIGELKNLQKLCLFRN 257
IP G L+ N
Sbjct: 284 IP-QGGNLQRFDVSAYANN 301
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 5e-76
Identities = 101/315 (32%), Positives = 151/315 (47%), Gaps = 44/315 (13%)
Query: 522 SYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECE 580
S EL A+ FS+ N++G+G FG VYKG L D +VAVK + + G F E E
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 581 ALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQ 640
+ HRNL+++ C + + V+ YM NGS+ L + + L +
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTER-----LLVYPYMANGSVASCLRERPESQ--PPLDWPK 132
Query: 641 RVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTA 700
R IA+ A + YLH HC P ++H D+K +N+LLD + A V DFGLAK + DT
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK--DTH 190
Query: 701 VKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDAVF---NEG 747
V T ++GT+G++APEY ++S D+F TG+R D ++
Sbjct: 191 VTT-----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 748 HSLHEFAKTALPE-KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSME 806
L ++ K L E K+ +VD L +E + +I+ +LC+
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNY--------------KDEEVEQLIQVALLCTQS 291
Query: 807 SPFERMDMRDVVAKL 821
SP ER M +VV L
Sbjct: 292 SPMERPKMSEVVRML 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 5e-74
Identities = 74/467 (15%), Positives = 140/467 (29%), Gaps = 55/467 (11%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L +N + + I + N++ + + L L + + F
Sbjct: 161 LIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFV 219
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ E + NL +L + + +P L
Sbjct: 220 AENICEAWENENSEY-----AQQYKTEDLKWD-NLKDLTDVEVYNCPNLTKLPTFLKALP 273
Query: 121 NLELLDLSVNQFKGNVSI--------DFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTN 172
++L++++ N+ + D + + + + NNL T T L
Sbjct: 274 EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE-----TSLQK 328
Query: 173 CSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGI-RNLVNLIGFGA 230
L L NQ G+LP + + +N + NQI+ IP +
Sbjct: 329 MKKLGMLECLYNQLEGKLP-AFGSEIKLASLN--LAYNQITE-IPANFCGFTEQVENLSF 384
Query: 231 EENQLHGTIPDA--IGELKNLQKLCLFRNFLQG-------RIPSGLGNLTKLANLELSSN 281
N+L IP+ + + + N + + ++++ LS+N
Sbjct: 385 AHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNN 443
Query: 282 SLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL-------YLDLSNNLLNG 334
+ L S N LT +P L + +DL N L
Sbjct: 444 QISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
Query: 335 SLP-LQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDI------SSNSFHGVIPLS 387
+ L LV +D+S N FS P L+ I N P
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561
Query: 388 LSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434
++ S+ +L + SN++ + N + L + N +
Sbjct: 562 ITLCPSLTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISIDLS 605
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 1e-71
Identities = 74/459 (16%), Positives = 135/459 (29%), Gaps = 53/459 (11%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+ N +T + V L+ L + + + N +
Sbjct: 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQY 238
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNF--------FGSI 112
N+ L +++ LP + LP ++ + + N
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK-ALPEMQLINVACNRGISGEQLKDDWQA 297
Query: 113 PYSLSNASNLELLDLSVNQFK-GNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLT 171
++++ + N K V +K L L N L G
Sbjct: 298 LADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL-EGKLPAF------G 350
Query: 172 NCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPP--GIRNLVNLIGFG 229
+ L +L+LA NQ +P + + V N N++ IP +++ +
Sbjct: 351 SEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAID 408
Query: 230 AEENQLHG-------TIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNS 282
N++ + + N+ + L N + + L+++ L N
Sbjct: 409 FSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNM 468
Query: 283 LQG-------NIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL-YLDLSNNLLNG 334
L + + N L S NKLT L + T L +DLS N +
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK 527
Query: 335 SLPLQVGHLKNLVILDI------SSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSL 388
P Q + L I N+ P ++ C L L I SN V
Sbjct: 528 -FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNE--- 583
Query: 389 SFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNH 427
+I L++ N ++ L Y+
Sbjct: 584 KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 6e-69
Identities = 69/441 (15%), Positives = 134/441 (30%), Gaps = 46/441 (10%)
Query: 20 GNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSG----MFPRSICNISSLEL 75
+ + + + G G++P +G L L L + + P+ I S E
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 76 IQLALNRFSGNLPFDI-VVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKG 134
Q + + +L I + SI S + N
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 135 NVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSI 194
VS L L + + C + + + Q
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPF-----------VAENICEAWENENSEYAQQYKTEDLKW 245
Query: 195 ANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLH--------GTIPDAIGEL 246
NL + + + +P ++ L + N+
Sbjct: 246 DNLKD-LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVG 304
Query: 247 KNLQKLCLFRNFLQ-GRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQN 305
+ +Q + + N L+ + + L + KL LE N L+G +P + G+ L S + N
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYN 363
Query: 306 KLTGALPHQLLSITTLSLYLDLSNNLLNGSLP--LQVGHLKNLVILDISSNQFSGV---- 359
++T +P T L ++N L +P + + +D S N+ V
Sbjct: 364 QITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKN 421
Query: 360 ---IPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG-------QIP 409
+ T + + +++S+N S + +N+ N L+
Sbjct: 422 FDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDEN 481
Query: 410 EFLKNLSVLEFLSLSYNHFEG 430
E KN +L + L +N
Sbjct: 482 ENFKNTYLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 5e-66
Identities = 70/454 (15%), Positives = 144/454 (31%), Gaps = 57/454 (12%)
Query: 1 LQTLAVNDNYLTGQ----LPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLR--NLVSLNV 54
L+ LA+ + P + E + M +L+ +
Sbjct: 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCI 166
Query: 55 AENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPY 114
+ +S I N + + + + L L+ +G + F
Sbjct: 167 NSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAV-MRLTKLRQFYMGNSPFVAENIC 224
Query: 115 SLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCS 174
N E + + +LK+L + + T TFL
Sbjct: 225 EAWENENSEYAQQY-----KTEDLKWDNLKDLTDVEVYNCPNLT------KLPTFLKALP 273
Query: 175 SLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQ 234
++ +++A N+ + + + N
Sbjct: 274 EMQLINVACNRG-----------------ISGEQLKDDWQALADAPVGEKIQIIYIGYNN 316
Query: 235 L-HGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGN 293
L + ++ ++K L L N L+G++P+ G+ KLA+L L+ N + + G
Sbjct: 317 LKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANFCGF 375
Query: 294 CQNLMSFTASQNKLTGALPHQLLSITTLS--LYLDLSNNLLNG-------SLPLQVGHLK 344
+ + + + + NKL +P + ++S +D S N + L
Sbjct: 376 TEQVENLSFAHNKLKY-IP-NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGI 433
Query: 345 NLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV-------IPLSLSFLKSIKEL 397
N+ +++S+NQ S ST L +++ N + + + +
Sbjct: 434 NVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSI 493
Query: 398 NVSSNNLSGQIPEF-LKNLSVLEFLSLSYNHFEG 430
++ N L+ +F L L + LSYN F
Sbjct: 494 DLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK 527
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 2e-65
Identities = 57/422 (13%), Positives = 131/422 (31%), Gaps = 41/422 (9%)
Query: 33 NSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIV 92
+ G + +L + L++ SG P +I ++ LE++ L + N
Sbjct: 67 DMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGP 126
Query: 93 VNLPNLKALA---IGGNNFFGSIPYSLSNA--SNLELLDLSVNQFKGNVSIDFSSLKNLL 147
+ + ++ + S+L ++ + + ++
Sbjct: 127 KGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 148 WLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIG 207
+ NN+ + + + L+ + ++ F E +
Sbjct: 187 QIGQLSNNITFVSKA-------VMRLTKLRQFYMGNSPFVAENICEAWENEN------SE 233
Query: 208 RNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFL-------- 259
Q T NL +L +P + L +Q + + N
Sbjct: 234 YAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKD 293
Query: 260 QGRIPSGLGNLTKLANLELSSNSLQ-GNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSI 318
+ + K+ + + N+L+ + +SL + L N+L G LP +
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP----AF 349
Query: 319 TTLS--LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGT-LSTCVCLEYLDI 375
+ L+L+ N + G + + L + N+ + + + +D
Sbjct: 350 GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDF 409
Query: 376 SSNSFHGV-------IPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHF 428
S N V + + ++ +N+S+N +S E S L ++L N
Sbjct: 410 SYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNML 469
Query: 429 EG 430
Sbjct: 470 TE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 1e-64
Identities = 74/436 (16%), Positives = 129/436 (29%), Gaps = 50/436 (11%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+ + ++ + + E L++L + V
Sbjct: 208 LRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNL 262
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDI-------VVNLPNLKALAIGGNNFF-GSI 112
P + + ++LI +A NR ++ + IG NN +
Sbjct: 263 TKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPV 322
Query: 113 PYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTN 172
SL L +L+ NQ +G + F S L LNL N + T++ F
Sbjct: 323 ETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQI-----TEIP-ANFCGF 375
Query: 173 CSSLKALSLADNQFGGELPH--SIANLSS-TVINFGIGRNQISG-------TIPPGIRNL 222
++ LS A N+ +P+ ++S + I+ N+I + P
Sbjct: 376 TEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAID--FSYNEIGSVDGKNFDPLDPTPFKG 432
Query: 223 VNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQG-------RIPSGLGNLTKLAN 275
+N+ NQ+ + L + L N L N L +
Sbjct: 433 INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTS 492
Query: 276 LELSSNSLQGNIPS-SLGNCQNLMSFTASQNKLTGALPHQLLSITTL-----SLYLDLSN 329
++L N L L+ S N + P Q L+ +TL D
Sbjct: 493 IDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQG 551
Query: 330 NLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLS 389
N P + +L L I SN V + LDI N + +
Sbjct: 552 NRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN---ISVLDIKDNPNISIDLSYVC 608
Query: 390 FLKSIKELNVSSNNLS 405
+ +
Sbjct: 609 PYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 7e-45
Identities = 45/320 (14%), Positives = 102/320 (31%), Gaps = 30/320 (9%)
Query: 126 DLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQ 185
+ ++ + + +S + L+LE +G D + + L+ L+L +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGA-SGRVPD-----AIGQLTELEVLALGSHG 116
Query: 186 FGG----ELPHSIANLSSTVINFGIGRNQISGTIPPGI--RNLVNLIGFGAEENQLHGTI 239
P I+ S R T + +LI + +I
Sbjct: 117 EKVNERLFGPKGISANMSDEQKQ-KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSI 175
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMS 299
+ ++ N + + + LTKL + ++ +N
Sbjct: 176 KKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-- 232
Query: 300 FTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQF--- 356
+ + ++ L+ +++ N LP + L + +++++ N+
Sbjct: 233 ---EYAQQYKTEDLKWDNLKDLT-DVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 357 -----SGVIPGTLSTCVCLEYLDISSNSF-HGVIPLSLSFLKSIKELNVSSNNLSGQIPE 410
++ + I N+ + SL +K + L N L G++P
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA 348
Query: 411 FLKNLSVLEFLSLSYNHFEG 430
F + L L+L+YN
Sbjct: 349 F-GSEIKLASLNLAYNQITE 367
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-19
Identities = 22/167 (13%), Positives = 48/167 (28%), Gaps = 8/167 (4%)
Query: 275 NLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNG 334
N + SL + + + +G +P + +T L L L ++
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELE-VLALGSHGEKV 119
Query: 335 ----SLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVC--LEYLDISSNSFHGVIPLSL 388
P + + + L I+S+ I S
Sbjct: 120 NERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSS 179
Query: 389 SFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK 435
++ SNN++ + + + L+ L + + F E +
Sbjct: 180 RITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICE 225
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 30/152 (19%), Positives = 47/152 (30%), Gaps = 14/152 (9%)
Query: 1 LQTLAVNDNYLTGQLPD--FVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSL------ 52
L ++ + N LT L D L L I + NS PT L
Sbjct: 490 LTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547
Query: 53 NVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSI 112
+ N+ +P I SL +Q+ N + I PN+ L I N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI---TPNISVLDIKDNPNISID 603
Query: 113 PYSLSNASNLELLDLSVNQFKGNVSIDFSSLK 144
+ + L ++ + D +K
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQDIRGCDALDIK 635
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 15/131 (11%), Positives = 39/131 (29%), Gaps = 7/131 (5%)
Query: 326 DLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHG--- 382
+ ++ + + + L + SG +P + LE L + S+
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 383 -VIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSV--LEFLSLSYNHFEGEVPT-KGVF 438
P +S S ++ + ++ L ++ + + + +
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
Query: 439 SNKTKISLQGN 449
T+I N
Sbjct: 183 LKDTQIGQLSN 193
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-05
Identities = 12/73 (16%), Positives = 29/73 (39%)
Query: 362 GTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFL 421
G + + + + +SL+ + L++ SG++P+ + L+ LE L
Sbjct: 51 GFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVL 110
Query: 422 SLSYNHFEGEVPT 434
+L + +
Sbjct: 111 ALGSHGEKVNERL 123
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 254 bits (650), Expect = 7e-74
Identities = 95/471 (20%), Positives = 168/471 (35%), Gaps = 27/471 (5%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L +L V N ++ P+ L L+V+ + N L T NL L++ N
Sbjct: 51 LTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQ 110
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ +L + L+ N S V L NL+ L + N L +
Sbjct: 111 KIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169
Query: 121 N--LELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKA 178
N L+ L+LS NQ K F ++ L L L L + + + +S++
Sbjct: 170 NSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL---GPSLTEKLCLELANTSIRN 226
Query: 179 LSLADNQFGGELPHSIANLSST-VINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHG 237
LSL+++Q + L T + + N ++ L L F E N +
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 238 TIPDAIGELKNLQKLCLFRNFLQGRI---------PSGLGNLTKLANLELSSNSLQGNIP 288
++ L N++ L L R+F + I L L +L + N + G
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 289 SSLGNCQNLMSFTASQNKLTGA--LPHQLLSITTLSL-YLDLSNNLLNGSLPLQVGHLKN 345
+ NL + S + + +S+ L L+L+ N ++ L +
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406
Query: 346 LVILDISSNQFSGVIPG-TLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNL 404
L +LD+ N+ + G + + +S N + + S + + S++ L + L
Sbjct: 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL 466
Query: 405 SG--QIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGNM 450
P + L L L LS N+ + K + LQ N
Sbjct: 467 KNVDSSPSPFQPLRNLTILDLSNNNIANIND--DMLEGLEKLEILDLQHNN 515
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-68
Identities = 97/475 (20%), Positives = 172/475 (36%), Gaps = 41/475 (8%)
Query: 1 LQTLAVNDNYLTGQLPDFVG---NLSDLEVIRIMGNSLGGKIPTTLGLLR--NLVSLNVA 55
L L +N+ L L + + + + + + + L TT L+ NL L+++
Sbjct: 197 LFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLS 256
Query: 56 ENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKAL---------AIGGN 106
N + + S + LE L N L + L N++ L +I
Sbjct: 257 YNNLNVVGNDSFAWLPQLEYFFLEYNNIQH-LFSHSLHGLFNVRYLNLKRSFTKQSISLA 315
Query: 107 NFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDF 166
+ +S LE L++ N G S F+ L NL +L+L + T T+ F
Sbjct: 316 SLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETF 375
Query: 167 VTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPG-IRNLVN 224
V+ S L L+L N+ + + L V++ G N+I + R L N
Sbjct: 376 VSL--AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLG--LNEIGQELTGQEWRGLEN 431
Query: 225 LIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQG--RIPSGLGNLTKLANLELSSNS 282
+ N+ ++ + +LQ+L L R L+ PS L L L+LS+N+
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 283 LQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGH 342
+ L + L N L L + G +
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLA-----------------RLWKHANPGGPIYFLKG 534
Query: 343 LKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402
L +L IL++ SN F + L+ +D+ N+ + + + S+K LN+ N
Sbjct: 535 LSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 403 NLSGQIPE-FLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGI 456
++ + F L L + +N F+ + F N + +L
Sbjct: 595 LITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-64
Identities = 95/471 (20%), Positives = 166/471 (35%), Gaps = 34/471 (7%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+ + LT Q+PD + +++ V+ + N L L SL+V N S
Sbjct: 6 HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ P + L+++ L N S L NL L + N+
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
NL LDLS N L+NL L L N + + +LD SSLK L
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF----ANSSLKKLE 177
Query: 181 LADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIR---NLVNLIGFGAEENQLH 236
L+ NQ P + + + Q+ ++ + ++ +QL
Sbjct: 178 LSSNQIKEFSPGCFHAIGRLFGLF--LNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 237 GTIPDAIGELK--NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNC 294
T LK NL L L N L L +L L N++Q SL
Sbjct: 236 TTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGL 295
Query: 295 QNLMSFTASQNKLTGALPH-QLLSITTLSL-------YLDLSNNLLNGSLPLQVGHLKNL 346
N+ ++ ++ L I S +L++ +N + G L NL
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355
Query: 347 VILDISSNQFS--GVIPGTLSTCVC--LEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402
L +S++ S + T + L L+++ N + + S+L ++ L++ N
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN 415
Query: 403 NLSGQIP-EFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
+ ++ + + L + + LSYN + F+ + L+
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTR--NSFALVPSLQRLMLRRV 464
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-59
Identities = 81/396 (20%), Positives = 138/396 (34%), Gaps = 29/396 (7%)
Query: 68 CNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDL 127
C +S E+ + + + +P D+ N+ L + N + + S L LD+
Sbjct: 2 CTVS-HEVADCSHLKLT-QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDV 56
Query: 128 SVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFG 187
N L L LNL+ N L + + C++L L L N
Sbjct: 57 GFNTISKLEPELCQKLPMLKVLNLQHNEL-SQLSDKT-----FAFCTNLTELHLMSNSIQ 110
Query: 188 GELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGEL 246
+ + ++ + N +S T L NL N++ + +
Sbjct: 111 KIKNNPFVKQKNLITLD--LSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
Query: 247 KN--LQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTA-- 302
N L+KL L N ++ P + +L L L++ L ++ L S
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 303 -SQNKLTGALPHQLLSITTLSL-YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
S ++L+ L + +L LDLS N LN L L + N +
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 361 PGTLSTCVCLEYLD---------ISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEF 411
+L + YL+ IS S + S +LK ++ LN+ N++ G
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
Query: 412 LKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQ 447
L L++LSLS + T F + L
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH 384
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 44/207 (21%), Positives = 74/207 (35%), Gaps = 11/207 (5%)
Query: 248 NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKL 307
+ + L ++P L T + L L+ N L+ ++ L S N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 308 TGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTC 367
+ P + L L+L +N L+ NL L + SN +
Sbjct: 62 SKLEPELCQKLPMLK-VLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 368 VCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLK--NLSVLEFLSLSY 425
L LD+S N + L++++EL +S+N + E L S L+ L LS
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 426 NHFEGEVPTKGVFSNKTK---ISLQGN 449
N + P G F + + L
Sbjct: 181 NQIKEFSP--GCFHAIGRLFGLFLNNV 205
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 2e-72
Identities = 90/461 (19%), Positives = 171/461 (37%), Gaps = 21/461 (4%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSL-GGKIPTTLGLLRNLVSLNVAENKF 59
LQ L + L +G+L L+ + + N + K+P L NL L+++ NK
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 60 SGMFPRSICNISSLELIQLALNRFSGNLPFDI--VVNLPNLKALAIGGNNFFGSIPY-SL 116
++ + + + L+ L+L+ + F L L + N ++ +
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCI 221
Query: 117 SNASNLELLDLSVNQFKGNVSI---DFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNC 173
+ LE+ L + +F+ ++ D S+L+ L L +E+ L D +
Sbjct: 222 QGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCL 281
Query: 174 SSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEEN 233
+++ + SL S + + + + +++L L
Sbjct: 282 TNVSSFSLVSVTIERVKDFS---YNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FT 333
Query: 234 QLHGTIPDAIGELKNLQKLCLFRNFLQ--GRIPSGLGNLTKLANLELSSNSLQGNIPSSL 291
G + +L +L+ L L RN L G T L L+LS N + + S+
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 292 GNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDI 351
+ L + L + +YLD+S+ + L +L +L +
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM 452
Query: 352 SSNQFSGVI-PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPE 410
+ N F P + L +LD+S + P + + L S++ LN+S NN
Sbjct: 453 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 512
Query: 411 FLKNLSVLEFLSLSYNHFEGEVPT--KGVFSNKTKISLQGN 449
K L+ L+ L S NH + S+ ++L N
Sbjct: 513 PYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 4e-63
Identities = 93/477 (19%), Positives = 155/477 (32%), Gaps = 51/477 (10%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+ L ++ N L + +L+V+ + + L +L +L + N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNF-FGSIPYSLSNA 119
+ + +SSL+ + + L + +L LK L + N +P SN
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNL----LWLNLEQNNLGTGTATDLDFVTFLTNCSS 175
+NLE LDLS N+ + D L + L L+L N + + F
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-----NFIQPGAF--KEIR 201
Query: 176 LKALSLADNQFGGELP-HSIANLSSTVI-----NFGIGRNQISGTIPPGIRNLVNLIGFG 229
L L+L +N + I L+ + + + L NL
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 230 AEENQL---HGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSL--- 283
L I D L N+ L ++ +LEL +
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQF 319
Query: 284 ----------------QGNIPSSLGNCQNLMSFTASQNKLT--GALPHQLLSITTLSLYL 325
+G S + +L S+N L+ G T+L YL
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK-YL 378
Query: 326 DLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIP-GTLSTCVCLEYLDISSNSFHGVI 384
DLS N + + L+ L LD + + + L YLDIS
Sbjct: 379 DLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAF 437
Query: 385 PLSLSFLKSIKELNVSSNNLSGQI-PEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSN 440
+ L S++ L ++ N+ P+ L L FL LS E P F++
Sbjct: 438 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP--TAFNS 492
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 6e-58
Identities = 80/443 (18%), Positives = 150/443 (33%), Gaps = 40/443 (9%)
Query: 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82
+ + + N L + L L+++ + + + ++S L + L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKG-NVSIDFS 141
L L +L+ L N + + + L+ L+++ N + + FS
Sbjct: 88 IQS-LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 142 SLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTV 201
+L NL L+L N + + TDL + + +L L+ N P + +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL--LNLSLDLSLNPMNFIQPGAFKEIRLHK 204
Query: 202 INFGIGRNQISGTIPPG-IRNLVNL------IGFGAEENQLHGTIPDAIGELKNLQKLCL 254
+ + N S + I+ L L +G E L A+ L NL
Sbjct: 205 LT--LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 255 ---FRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGAL 311
+ ++ I LT +++ L S +++ S K
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFP 320
Query: 312 PHQLLSITTLSL------------------YLDLSNNLLN--GSLPLQVGHLKNLVILDI 351
+L S+ L+ +LDLS N L+ G +L LD+
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 352 SSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLS-LSFLKSIKELNVSSNNLSGQIPE 410
S N + LE+LD ++ + S L+++ L++S +
Sbjct: 381 SFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 411 FLKNLSVLEFLSLSYNHFEGEVP 433
LS LE L ++ N F+
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 9e-57
Identities = 93/476 (19%), Positives = 161/476 (33%), Gaps = 60/476 (12%)
Query: 1 LQTLAVNDNYLTG-QLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLR------------ 47
L+ L V N + +LP++ NL++LE + + N + T L +L
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 48 ---------------NLVSLNVAENKFSGMFPRSIC-NISSLELIQLALNRFSG--NLPF 89
L L + N S ++ ++ LE+ +L L F NL
Sbjct: 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 90 DIVVNLPNLKALAIGGNN------FFGSIPYSLSNASNLELLDLSVNQFKGNVSIDF-SS 142
L L L I + I + +N+ L + +
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG 305
Query: 143 LKNLLWLNLEQNNLGTGTATDLDFVTFL----------TNCSSLKALSLADNQ--FGGEL 190
++L +N + T L +TF + SL+ L L+ N F G
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365
Query: 191 PHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP-DAIGELKN 248
S +S ++ + N + T+ L L + + L L+N
Sbjct: 366 SQSDFGTTSLKYLD--LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 249 LQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNI-PSSLGNCQNLMSFTASQNKL 307
L L + + L+ L L+++ NS Q N P +NL SQ +L
Sbjct: 423 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 308 TGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTC 367
P S+++L L++S+N L +L +LD S N L
Sbjct: 483 EQLSPTAFNSLSSLQ-VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541
Query: 368 VC-LEYLDISSNSFHGVIPLS--LSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
L +L+++ N F L ++K ++L V + P + + VL
Sbjct: 542 PSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-44
Identities = 76/421 (18%), Positives = 139/421 (33%), Gaps = 56/421 (13%)
Query: 67 ICNISSLE--LIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLEL 124
+ + ++ ++L + NLP + K L + N YS + L++
Sbjct: 4 VEVVPNITYQCMELNFYKIPDNLP-------FSTKNLDLSFNPLRHLGSYSFFSFPELQV 56
Query: 125 LDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADN 184
LDLS + + + SL +L L L N + L F + SSL+ L +
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI-----QSLALGAF-SGLSSLQKLVAVET 110
Query: 185 QFGGELPHSIANLSS-TVINFGIGRNQI-SGTIPPGIRNLVNLIGFGAEENQLHGTIPDA 242
I +L + +N + N I S +P NL NL N++
Sbjct: 111 NLASLENFPIGHLKTLKELN--VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 243 IGELKNLQKLC----LFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNC---- 294
+ L + L L N + I G +L L L +N N+ +
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 295 ---QNLMSFTASQNKLTGALPHQLLSITTLSL-YLDLS-NNLLNGSLPLQVGHLKNLVIL 349
+ ++ ++ L L + L++ L+ + + L N+
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 350 DISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLS-------------------F 390
+ S V S ++L++ + F L L
Sbjct: 288 SLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345
Query: 391 LKSIKELNVSSNNLS--GQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQG 448
L S++ L++S N LS G + + L++L LS+N + Q
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQH 405
Query: 449 N 449
+
Sbjct: 406 S 406
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 3e-66
Identities = 92/318 (28%), Positives = 137/318 (43%), Gaps = 55/318 (17%)
Query: 522 SYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEA 581
+L +AT F +IG G FG VYKG L D VA+K + F E E
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 582 LRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQR 641
L RH +L+ +I C + +++YMENG+LK L+ SD +S QR
Sbjct: 89 LSFCRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYGSDLPTM--SMSWEQR 141
Query: 642 VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701
+ I I A + YLH ++H D+K N+LLD + V + DFG++K ++ T +
Sbjct: 142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD-QTHL 197
Query: 702 KTPSSSIGLKGTVGYVAPEYGMGSEASMTG------DIF----------TGRRPIDAVFN 745
T +KGT+GY+ PEY + G D++ R I
Sbjct: 198 ST-----VVKGTLGYIDPEY------FIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246
Query: 746 EG-HSLHEFAKTALPE-KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLC 803
+L E+A + ++ +IVDP+L ++ E L T V C
Sbjct: 247 REMVNLAEWAVESHNNGQLEQIVDPNLADKI--------------RPESLRKFGDTAVKC 292
Query: 804 SMESPFERMDMRDVVAKL 821
S +R M DV+ KL
Sbjct: 293 LALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 4e-62
Identities = 80/328 (24%), Positives = 128/328 (39%), Gaps = 70/328 (21%)
Query: 522 SYAELSKATGEFSS------SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--- 572
S+ EL T F N +G+G FG VYKG + + VAVK + +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEEL 73
Query: 573 -RSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV 631
+ F E + + +H NL++++ S D V+ YM NGSL D L D
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDL-----CLVYVYMPNGSLLDRLSCLDGTP 128
Query: 632 EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691
LS R IA A+ + +LH + +H D+K +N+LLD A + DFGLA+
Sbjct: 129 ---PLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR- 181
Query: 692 LSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTG------DIF----------T 735
S+ T + + + GT Y+APE + G DI+ T
Sbjct: 182 ASEKFAQTVMTS-----RIVGTTAYMAPEA-------LRGEITPKSDIYSFGVVLLEIIT 229
Query: 736 GRRPIDAVFNEGHSLHEFAKTALPEK--VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECL 793
G +D L + + E+ + + +D + N++ + +
Sbjct: 230 GLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKM------NDADSTSVEAM------ 276
Query: 794 NAIIRTGVLCSMESPFERMDMRDVVAKL 821
C E +R D++ V L
Sbjct: 277 ---YSVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 4e-62
Identities = 87/485 (17%), Positives = 170/485 (35%), Gaps = 46/485 (9%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L TL + N L + L+ + + + L + L SL + N S
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIG-GNNFFGSIPYSLSNA 119
+ L+++ N L + + +L L++ N I ++
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDS 201
Query: 120 SNLELLDLSVNQFKGNV--SIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNC-SSL 176
+ + L+ Q + + S++++L E + D+ F C S+
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD-----EDISPAVFEGLCEMSV 256
Query: 177 KALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQL 235
++++L + F ++ S ++ + +S +P G+ L L N+
Sbjct: 257 ESINLQKHYFFNISSNTFHCFSGLQELD--LTATHLS-ELPSGLVGLSTLKKLVLSANKF 313
Query: 236 HGTIPDAIGELKNLQKLCLFRNFLQGRIPSG---------------------------LG 268
+ +L L + N + + +G L
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373
Query: 269 NLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLS 328
NL+ L +L LS N + C L + +L L L+LS
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433
Query: 329 NNLLNGSLPLQVGHLKNLVILDISSNQFSGVI---PGTLSTCVCLEYLDISSNSFHGVIP 385
++LL+ S L L L++ N F +L T LE L +S +
Sbjct: 434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493
Query: 386 LSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK-GVFSNKTKI 444
+ + LK + +++S N L+ E L +L + +L+L+ NH +P+ + S + I
Sbjct: 494 HAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTI 552
Query: 445 SLQGN 449
+L+ N
Sbjct: 553 NLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 1e-60
Identities = 93/462 (20%), Positives = 165/462 (35%), Gaps = 23/462 (4%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+ L + N L L +L + + + T L +L + N
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
M ++ +L+ + S + F + N L++L +G N+
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISS-IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTE 153
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNL--LWLNLEQNNLGTGTATDLDFVTFLTNCSSLKA 178
L++LD N D SSL+ L LNL N++ ++ F + + ++
Sbjct: 154 KLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-----AGIEPGAF--DSAVFQS 206
Query: 179 LSLADNQFGGELPHSIANLSSTVINFG----IGRNQISGTIPPGIRNLVNLIGFGAEENQ 234
L+ Q + + N + + G + IS + G+ + ++ +++
Sbjct: 207 LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM-SVESINLQKHY 265
Query: 235 LHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNC 294
+ LQ+L L L +PSGL L+ L L LS+N + S N
Sbjct: 266 FFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNF 324
Query: 295 QNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGS--LPLQVGHLKNLVILDIS 352
+L + N L L LDLS++ + S LQ+ +L +L L++S
Sbjct: 325 PSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLS 384
Query: 353 SNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLS-LSFLKSIKELNVSSNNLSGQIPEF 411
N+ + C LE LD++ S L +K LN+S + L +
Sbjct: 385 YNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQL 444
Query: 412 LKNLSVLEFLSLSYNHFEGEVPTK-GVFSNKTK---ISLQGN 449
L L+ L+L NHF K + + L
Sbjct: 445 FDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFC 486
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-56
Identities = 90/467 (19%), Positives = 156/467 (33%), Gaps = 49/467 (10%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+ L ++ + N LE + + N + L L+ N
Sbjct: 107 LKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166
Query: 61 GMFPRSICNISSLELIQLALNR-FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA 119
+ + ++ + L LN + + ++L GG I L N+
Sbjct: 167 YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAF-DSAVFQSLNFGGTQNLLVIFKGLKNS 225
Query: 120 S----------------------------NLELLDLSVNQFKGNVSIDFSSLKNLLWLNL 151
+ ++E ++L + F S F L L+L
Sbjct: 226 TIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDL 285
Query: 152 EQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQ 210
+L + L S+LK L L+ N+F S +N S T ++ I N
Sbjct: 286 TATHLSE-------LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLS--IKGNT 336
Query: 211 ISGTIPPG-IRNLVNLIGFGAEENQLH--GTIPDAIGELKNLQKLCLFRNFLQGRIPSGL 267
+ G + NL NL + + + L +LQ L L N
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 268 GNLTKLANLELSSNSLQGNIP-SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLD 326
+L L+L+ L+ S N L S + L + + L +L+
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL-QHLN 455
Query: 327 LSNNLLNGSLPLQVG---HLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV 383
L N + L L IL +S S + ++ + ++D+S N
Sbjct: 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 384 IPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEG 430
+LS LK I LN++SN++S +P L LS ++L N +
Sbjct: 516 SIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 1e-52
Identities = 85/439 (19%), Positives = 158/439 (35%), Gaps = 22/439 (5%)
Query: 22 LSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81
+ E + N L TT L NL L++ + + + + L+ + L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFS 141
+ + LK L L N LE L L N
Sbjct: 92 PLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGF 150
Query: 142 SLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTV 201
+ L L+ + N + + D+ L ++L L+L N G P + +
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMS---SLQQATNLS-LNLNGNDIAGIEPGAFDSAVFQS 206
Query: 202 INFGIGRNQISGTIPPGIRN--LVNLIGFGAEENQLHGTIPDAIGELK--NLQKLCLFRN 257
+NF G Q I G++N + +L E+ P L +++ + L ++
Sbjct: 207 LNF--GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKH 264
Query: 258 FLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLS 317
+ + + L L+L++ L +PS L L S NK +
Sbjct: 265 YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323
Query: 318 ITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQ--FSGVIPGTLSTCVCLEYLD 374
+L+ +L + N L +L+NL LD+S + S L L+ L+
Sbjct: 324 FPSLT-HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382
Query: 375 ISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPE-FLKNLSVLEFLSLSYNHFEGEVP 433
+S N + + ++ L+++ L + + +NL +L+ L+LS++ +
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 434 TKGVFSNKTK---ISLQGN 449
+F ++LQGN
Sbjct: 443 --QLFDGLPALQHLNLQGN 459
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 8e-48
Identities = 78/392 (19%), Positives = 125/392 (31%), Gaps = 27/392 (6%)
Query: 68 CNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDL 127
+ L LN G LP + + L N + S NL LDL
Sbjct: 12 EVNKTYNCENLGLNEIPGTLP-------NSTECLEFSFNVLPTIQNTTFSRLINLTFLDL 64
Query: 128 SVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFG 187
+ Q F S L L L N L + + +LK L
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPL-----IFMAETAL-SGPKALKHLFFIQTGIS 118
Query: 188 GELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGEL 246
+ N + + +G N IS P L + N +H + + L
Sbjct: 119 SIDFIPLHNQKTLESLY--LGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSL 176
Query: 247 KNLQ--KLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNC--QNLMSFTA 302
+ L L N + G I G + +L I L N Q+L T
Sbjct: 177 QQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235
Query: 303 SQNKLTGALPHQLLSITTLSL-YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIP 361
P + +S+ ++L + L LD+++ S +P
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LP 294
Query: 362 GTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI-PEFLKNLSVLEF 420
L L+ L +S+N F + +S S S+ L++ N ++ L+NL L
Sbjct: 295 SGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRE 354
Query: 421 LSLSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
L LS++ E N + ++L N
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 1e-44
Identities = 79/420 (18%), Positives = 145/420 (34%), Gaps = 34/420 (8%)
Query: 1 LQTLAVNDNYLTGQLPDFVGN--LSDLEVIRIMGNSLGGKIPTTLGLLR--NLVSLNVAE 56
Q+L + + N + L + P L ++ S+N+ +
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263
Query: 57 NKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL 116
+ F + + S L+ + L S LP +V L LK L + N F S
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELP-SGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 117 SNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSS 175
SN +L L + N + + +L+NL L+L +++ T +L N S
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL----RNLSH 377
Query: 176 LKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEEN 233
L++L+L+ N+ + +++ ++ +NL L +
Sbjct: 378 LQSLNLSYNEPLSLKTEAFKECPQLELLDLA--FTRLKVKDAQSPFQNLHLLKVLNLSHS 435
Query: 234 QLHGTIPDAIGELKNLQKLCLFRNFLQGRI---PSGLGNLTKLANLELSSNSLQGNIPSS 290
L + L LQ L L N + L L +L L LS L +
Sbjct: 436 LLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA 495
Query: 291 LGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILD 350
+ + + S N+LT + LS +YL+L++N ++ LP + L ++
Sbjct: 496 FTSLKMMNHVDLSHNRLTS-SSIEALSHLK-GIYLNLASNHISIILPSLLPILSQQRTIN 553
Query: 351 ISSNQFSGVIPGTLSTCVC-----LEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLS 405
+ N C C LE+ + ++ + +S LS
Sbjct: 554 LRQNPL---------DCTCSNIYFLEWYKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-41
Identities = 68/354 (19%), Positives = 123/354 (34%), Gaps = 43/354 (12%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
N IP +L ++ E L+ S N + FS L NL +L+L + + +
Sbjct: 21 NLGLNEIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQI-----YWIH 73
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNL 225
TF + L L L N + + L
Sbjct: 74 EDTF-QSQHRLDTLVLT-------------------------ANPLIFMAETALSGPKAL 107
Query: 226 IGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQG 285
+ + + K L+ L L N + KL L+ +N++
Sbjct: 108 KHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
Query: 286 NIPSSLGNCQNL--MSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHL 343
+ + Q +S + N + G P S SL + NLL L+ +
Sbjct: 168 LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTI 227
Query: 344 KNLVILDISSNQFSGVIPGTLSTCVC--LEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401
++L + + P +E +++ + F + + ++EL++++
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 402 NNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGNMKL 452
+LS ++P L LS L+ L LS N FE + SN +S++GN K
Sbjct: 288 THLS-ELPSGLVGLSTLKKLVLSANKFEN--LCQISASNFPSLTHLSIKGNTKR 338
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 7e-57
Identities = 74/476 (15%), Positives = 133/476 (27%), Gaps = 68/476 (14%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L A+N N + I + N + I + L L + A + F+
Sbjct: 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFT 461
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
E + N NL +L + + +P L +
Sbjct: 462 Y-----DNIAVDWEDANSDYAKQYENEELSWS-NLKDLTDVELYNCPNMTQLPDFLYDLP 515
Query: 121 NLELLDLSVNQFKG---------NVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLT 171
L+ L+++ N+ ++ D + + + NNL + L
Sbjct: 516 ELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL-----EEFPASASLQ 570
Query: 172 NCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGI-RNLVNLIGFG 229
L L N+ + T + + NQI IP + G G
Sbjct: 571 KMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLK--LDYNQIE-EIPEDFCAFTDQVEGLG 625
Query: 230 AEENQLHGTIPDA--IGELKNLQKLCLFRNFLQGRIPS-----GLGNLTKLANLELSSNS 282
N+L IP+ + + + N + + + + LS N
Sbjct: 626 FSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684
Query: 283 LQGNIPSSLGNCQNLMSFTASQNKLT-------GALPHQLLSITTLSLYLDLSNNLLNGS 335
+Q + + S N +T + L+ +DL N L S
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT-TIDLRFNKLT-S 742
Query: 336 LP--LQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKS 393
L + L L +D+S N FS P L+ I
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQ--------------- 786
Query: 394 IKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
+ N + Q P + L L + N +V + + + + N
Sbjct: 787 ---RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD-EKLTPQLYILDIADN 837
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-53
Identities = 70/450 (15%), Positives = 126/450 (28%), Gaps = 79/450 (17%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+ + NL DL + + ++P L L L SLN+A N+
Sbjct: 469 WEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGI 528
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ +
Sbjct: 529 SAAQ----------------------------------------LKADWTRLADDEDTGP 548
Query: 121 NLELLDLSVNQFKG-NVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL 179
+++ + N + S + L L+ N + + L L
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRH--------LEAFGTNVKLTDL 600
Query: 180 SLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPP--GIRNLVNLIGFGAEENQLHG 237
L NQ E+P + V G N++ IP +++ + N++
Sbjct: 601 KLDYNQI-EEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS 658
Query: 238 TIPDA-----IGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ-------G 285
+ + N + L N +Q + ++ + LS+N +
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 286 NIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL-YLDLSNNLLNGSLPLQVGHLK 344
+ N L + NKLT L + T L +D+S N + S P Q +
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSS 776
Query: 345 NLVILDI------SSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELN 398
L I N+ P ++TC L L I SN V + L+
Sbjct: 777 QLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDE---KLTPQLYILD 833
Query: 399 VSSNNL-SGQIPEFLKNLSVLEFLSLSYNH 427
++ N S + + L Y+
Sbjct: 834 IADNPNISIDVTSVCPYIE-AGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-52
Identities = 60/416 (14%), Positives = 118/416 (28%), Gaps = 33/416 (7%)
Query: 33 NSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIV 92
+ G + L + L++A G P +I ++ L+++ + + +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 93 VNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLE 152
L + L L L DL + N + + + L
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 153 QNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQIS 212
Q T T + + + L+ + A++ F + ++ +
Sbjct: 429 QIGNLTNRITFIS--KAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN------SDYAKQY 480
Query: 213 GTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQG---------RI 263
NL +L +PD + +L LQ L + N R+
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540
Query: 264 PSGLGNLTKLANLELSSNSLQG-NIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS 322
K+ + N+L+ +SL L NK+ L + T
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLE----AFGTNV 595
Query: 323 --LYLDLSNNLLNGSLPLQVG-HLKNLVILDISSNQFSGVIPGT-LSTCVCLEYLDISSN 378
L L N + +P + L S N+ + + + +D S N
Sbjct: 596 KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYN 654
Query: 379 SFHGVIP-----LSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE 429
+ + + +S N + E S + + LS N
Sbjct: 655 KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 145 bits (366), Expect = 7e-36
Identities = 43/298 (14%), Positives = 90/298 (30%), Gaps = 27/298 (9%)
Query: 169 FLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIG 227
L N + LSLA G +P +I L+ V++ G + + + +
Sbjct: 318 DLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLS--FGTHSETVSGRLFGDEELTPDM 375
Query: 228 FGAEENQLHGTIP-DAIGELKNLQKLCLFRNFLQ-----GRIPSGLGNLTKLANLELSSN 281
++++ + + L L ++ + I K + +N
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTN 435
Query: 282 SLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVG 341
+ I ++ L + + T +I + + L
Sbjct: 436 RITF-ISKAIQRLTKLQIIYFANSPFTY------DNIAVDWEDANSDYAKQYENEELSWS 488
Query: 342 HLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV---------IPLSLSFLK 392
+LK+L +++ + +P L L+ L+I+ N +
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548
Query: 393 SIKELNVSSNNLSG-QIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
I+ + NNL L+ + L L +N + G T + L N
Sbjct: 549 KIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLTDLKLDYN 605
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-35
Identities = 53/372 (14%), Positives = 111/372 (29%), Gaps = 42/372 (11%)
Query: 99 KALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGT 158
+AL ++ + ++ N + ++ + +D + + L+L
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNF-NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 159 GTATDLDFVTFLTNCSSLKALSLADNQ--------FGGELPHSIANLSSTVINFGIGRNQ 210
+ + LK LS + EL ++ I +
Sbjct: 338 RVPDA------IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHY--KK 389
Query: 211 ISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNL 270
+ + L ++ D+ LK+ Q L N + I + L
Sbjct: 390 MFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLT-NRITF-ISKAIQRL 447
Query: 271 TKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNN 330
TKL + +++ + + N K ++ L+ ++L N
Sbjct: 448 TKLQIIYFANSPFTYDNIAVDWEDANS-----DYAKQYENEELSWSNLKDLT-DVELYNC 501
Query: 331 LLNGSLPLQVGHLKNLVILDISSNQFSGV---------IPGTLSTCVCLEYLDISSNSFH 381
LP + L L L+I+ N+ + T ++ + N+
Sbjct: 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE 561
Query: 382 GV-IPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSN 440
SL + + L+ N + + F L L L YN E E+P + +
Sbjct: 562 EFPASASLQKMVKLGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIE-EIP-EDFCAF 617
Query: 441 KTK---ISLQGN 449
+ + N
Sbjct: 618 TDQVEGLGFSHN 629
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-30
Identities = 46/303 (15%), Positives = 87/303 (28%), Gaps = 32/303 (10%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L N + L F G L +++ N + + L + NK
Sbjct: 575 LGLLDCVHNKVR-HLEAF-GTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK 632
Query: 61 GMFPR--SICNISSLELIQLALNRFSGNLPFDIVVNLP-----NLKALAIGGNNFFGSIP 113
P + ++ + + + N+ +I ++ N + + N
Sbjct: 633 Y-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPT 690
Query: 114 YSLSNASNLELLDLSVNQFK-------GNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDF 166
+ S + + LS N ++ + L ++L N L T L
Sbjct: 691 ELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-----TSLSD 745
Query: 167 VTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVI-----NFGIGRNQISGTIPPGIRN 221
T L + ++ N F P N S N+I P GI
Sbjct: 746 DFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT 804
Query: 222 LVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSN 281
+LI N + + + + L L + N + + + L +
Sbjct: 805 CPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYD 861
Query: 282 SLQ 284
Q
Sbjct: 862 KTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 13/118 (11%), Positives = 38/118 (32%), Gaps = 1/118 (0%)
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
LD + ++ + + + + + L + L+++ G++
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339
Query: 409 PEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPS 466
P+ + L+ L+ LS + G +S + ++ ++ L
Sbjct: 340 PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-54
Identities = 84/445 (18%), Positives = 161/445 (36%), Gaps = 34/445 (7%)
Query: 1 LQTLAVNDNYLTG-QLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNL----VSLNVA 55
L+ L V N++ +LP + NL++L + + N + L LR +SL+++
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 56 ENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYS 115
N + ++ I L + L N S N+ + NL L + F
Sbjct: 190 LNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 116 LSNASNLE--------LLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFV 167
+ S +E L+ + + F L N+ ++L ++ +
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--------L 300
Query: 168 TFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIG 227
+ ++LS+ Q + L S + N+ S I L +L
Sbjct: 301 EDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLT----MNKGS--ISFKKVALPSLSY 354
Query: 228 FGAEENQLHGTIPDAIGELK--NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQG 285
N L + + +L +L+ L L N + + L +L +L+ ++L+
Sbjct: 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKR 413
Query: 286 NIP-SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV-GHL 343
S+ + + L+ S L +T+L+ L ++ N + V +
Sbjct: 414 VTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLN-TLKMAGNSFKDNTLSNVFANT 472
Query: 344 KNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNN 403
NL LD+S Q + G T L+ L++S N+ + + L S+ L+ S N
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 404 LSGQIPEFLKNLSVLEFLSLSYNHF 428
+ L F +L+ N
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-53
Identities = 95/484 (19%), Positives = 157/484 (32%), Gaps = 45/484 (9%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L + N + P L+ LE + + L +G L L LNVA N
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141
Query: 61 GM-FPRSICNISSLELIQLALNRFSG----------NLPFDIVV---------------- 93
P N+++L + L+ N P +
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF 201
Query: 94 NLPNLKALAIGGNNFFGSIP-YSLSNASNLELLDLSVNQFKGNVSI---DFSSLKNLLWL 149
L L + GN +I L N + L + L + +FK ++ + S ++ L +
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261
Query: 150 NLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRN 209
+++ L D V F +++ A+SLA L + ++ I R
Sbjct: 262 TIDEFRLTYTNDFSDDIVKF-HCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLS--IIRC 317
Query: 210 QISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGN 269
Q+ + L +L G+I L +L L L RN L +
Sbjct: 318 QLKQFPTLDLPFLKSL-----TLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSD 372
Query: 270 L--TKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDL 327
L L +L+LS N + ++ + L + L LYLD+
Sbjct: 373 LGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDI 431
Query: 328 SNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIP-GTLSTCVCLEYLDISSNSFHGVIPL 386
S L +L L ++ N F + L +LD+S +
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
Query: 387 SLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVP-TKGVFSNKTKIS 445
L ++ LN+S NNL L L L S+N E + + +
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN 551
Query: 446 LQGN 449
L N
Sbjct: 552 LTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-51
Identities = 93/466 (19%), Positives = 149/466 (31%), Gaps = 33/466 (7%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
LQ L ++ + L L + + GN + P + L +L +L E K +
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ I + +L+ + +A N NL NL + + N L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 121 NLEL----LDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSL 176
LD+S+N F + L L L N + T L N + L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFN-----SSNIMKTCLQNLAGL 231
Query: 177 KALSLADNQFGGEL------PHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFG 229
L +F E P + L T+ F + L N+
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS 291
Query: 230 AEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPS 289
+ + + + Q L + R L+ L L L L+ N +I
Sbjct: 292 LAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKS---LTLTMNKG--SISF 344
Query: 290 SLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL-YLDLSNNLLNGSLPLQVGHLKNLVI 348
+L S+N L+ + + T SL +LDLS N + L+ L
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH 403
Query: 349 LDISSNQFSGVIP-GTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQ 407
LD + V + L YLDIS + L S+ L ++ N+
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463
Query: 408 IP-EFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
N + L FL LS E GVF + +++ N
Sbjct: 464 TLSNVFANTTNLTFLDLSKCQLEQISW--GVFDTLHRLQLLNMSHN 507
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 4e-50
Identities = 80/461 (17%), Positives = 153/461 (33%), Gaps = 43/461 (9%)
Query: 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82
S + I + N L + L L+++ + + ++ + L + L N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKG-NVSIDFS 141
L +L+ L + + L+ L+++ N + FS
Sbjct: 92 IQS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 142 SLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTV 201
+L NL+ ++L N + T T DL F+ +L ++ N + +
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQ--VNLSLDMSLNPIDFIQDQAFQGIKLHE 208
Query: 202 INFGIGRNQISGTIPPG-IRNLVNL------IGFGAEENQLHGTIPDAIGELKNLQKLCL 254
+ + N S I ++NL L +G +E L P + L ++
Sbjct: 209 LT--LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEF 266
Query: 255 F--RNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALP 312
L ++ + L+ S+ + S + + +L
Sbjct: 267 RLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPT 324
Query: 313 HQLLSITTLSL------------------YLDLSNNLLN--GSLPLQVGHLKNLVILDIS 352
L + +L+L YLDLS N L+ G +L LD+S
Sbjct: 325 LDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 353 SNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLS-LSFLKSIKELNVSSNNLSGQIPEF 411
N ++ L++LD ++ V S L+ + L++S N
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 412 LKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
L+ L L ++ N F+ + VF+N T + L
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLS-NVFANTTNLTFLDLSKC 483
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 59/358 (16%), Positives = 112/358 (31%), Gaps = 31/358 (8%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
+ +P + S+ + +DLS N K S FS+ L WL+L + + ++
Sbjct: 20 DQKLSKVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEI-----ETIE 72
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVN 224
+ L L L N P S + L+S + +++ I L+
Sbjct: 73 DKAW-HGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV--AVETKLASLESFPIGQLIT 129
Query: 225 LIGFGAEENQLHG-TIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLAN----LELS 279
L N +H +P L NL + L N++Q + L L + L++S
Sbjct: 130 LKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 280 SNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQ 339
N + I L T N + + L L L+
Sbjct: 190 LNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 340 V------GHLKNLVI--LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFL 391
+ L ++ I ++ + + ++ S + +
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKH 306
Query: 392 KSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
+ L++ L L L+ L+L+ N K + + + L N
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPF---LKSLTLTMNKGSI-SFKKVALPSLSYLDLSRN 360
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 56/250 (22%), Positives = 94/250 (37%), Gaps = 15/250 (6%)
Query: 188 GELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGEL 246
G L I + + ++S +P I + N+ N L +
Sbjct: 2 GSLNPCIEVVPNITYQ--CMDQKLS-KVPDDIPSSTKNID---LSFNPLKILKSYSFSNF 55
Query: 247 KNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNK 306
LQ L L R ++ L L+NL L+ N +Q P S +L + A + K
Sbjct: 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115
Query: 307 LTGALPHQLLSITTLSLYLDLSNNLLNG-SLPLQVGHLKNLVILDISSNQFSGVIPGTLS 365
L + + TL L++++N ++ LP +L NLV +D+S N + L
Sbjct: 116 LASLESFPIGQLITLK-KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 366 ----TCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPE-FLKNLSVLEF 420
LD+S N + + + + EL + N S I + L+NL+ L
Sbjct: 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHV 233
Query: 421 LSLSYNHFEG 430
L F+
Sbjct: 234 HRLILGEFKD 243
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 36/168 (21%), Positives = 62/168 (36%), Gaps = 9/168 (5%)
Query: 285 GNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLK 344
G++ + N+ ++ KL+ +P + S T +DLS N L +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPSSTK---NIDLSFNPLKILKSYSFSNFS 56
Query: 345 NLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNL 404
L LD+S + + L L ++ N P S S L S++ L L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 405 SGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
+ + L L+ L++++N FSN T + L N
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLTNLVHVDLSYN 163
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 1e-52
Identities = 69/331 (20%), Positives = 118/331 (35%), Gaps = 63/331 (19%)
Query: 522 SYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECE- 580
L + + +G FG V+K L + VAVK+ +S+ E E
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEY--VAVKIFP---IQDKQSWQNEYEV 69
Query: 581 -ALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLI 639
+L ++H N+++ I D + + E GSL D+L + +S
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDL-WLITAFHEKGSLSDFLKAN-------VVSWN 121
Query: 640 QRVNIAIDVASAMEYLHHH-------CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692
+ +IA +A + YLH +P + H D+K NVLL +++ A + DFGLA
Sbjct: 122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF 181
Query: 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-----EASMTGDIF----------TGR 737
+ + + G GT Y+APE G+ +A + D++ +
Sbjct: 182 EAGK------SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 738 RPIDAVFNEGHSLHEFAKTALP--EKVMEIV-----DPSLLMEVMTNNSMIQEDKRVKTE 790
D +E E P E + E+V P L +
Sbjct: 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVL-------------RDYWQKH 282
Query: 791 ECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
+ + T C R+ V ++
Sbjct: 283 AGMAMLCETIEECWDHDAEARLSAGCVGERI 313
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-51
Identities = 72/330 (21%), Positives = 126/330 (38%), Gaps = 50/330 (15%)
Query: 522 SYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECE- 580
+ +E S +IG+G +G VYKG+L E VAVKV + + ++F+ E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERP--VAVKVFSFANR---QNFINEKNI 58
Query: 581 -ALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLI 639
+ + H N+ + I G V EY NGSL +L +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-------TSDWV 111
Query: 640 QRVNIAIDVASAMEYLH------HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
+A V + YLH H +P + H DL NVL+ +D + DFGL+ L+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-------EASMTGDIFTG--------RR 738
++L + +++I GT+ Y+APE G+ A D++ R
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 739 PIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKR-------VKTEE 791
D E ++ + + P+ E M + +E +R +
Sbjct: 232 CTDLFPGESVPEYQ-----MAFQTEVGNHPTF--EDMQ-VLVSREKQRPKFPEAWKENSL 283
Query: 792 CLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
+ ++ T C + R+ + ++
Sbjct: 284 AVRSLKETIEDCWDQDAEARLTAQXAEERM 313
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-48
Identities = 94/427 (22%), Positives = 163/427 (38%), Gaps = 44/427 (10%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+ +T + +L + ++ + K + L NL +N + N+ +
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLT 81
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ P + N++ L I + N+ + P NL NL L + N P L N +
Sbjct: 82 DITP--LKNLTKLVDILMNNNQIADITPLA---NLTNLTGLTLFNNQITDIDP--LKNLT 134
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
NL L+LS N S L +L L+ N + L N ++L+ L
Sbjct: 135 NLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--------LANLTTLERLD 183
Query: 181 LADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239
++ N+ +A L++ + NQIS P + L NL NQL
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLI--ATNNQISDITP--LGILTNLDELSLNGNQL--KD 235
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMS 299
+ L NL L L N + + L LTKL L+L +N + S L L +
Sbjct: 236 IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISN--ISPLAGLTALTN 291
Query: 300 FTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGV 359
++N+L P + ++ L+ YL L N ++ P+ L L L +N+ S V
Sbjct: 292 LELNENQLEDISP--ISNLKNLT-YLTLYFNNISDISPV--SSLTKLQRLFFYNNKVSDV 346
Query: 360 IPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLE 419
L+ + +L N + PL+ L I +L ++ + + N+S+
Sbjct: 347 SS--LANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQAWTNAPVNYKANVSIPN 402
Query: 420 FLSLSYN 426
+
Sbjct: 403 TVKNVTG 409
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-47
Identities = 101/429 (23%), Positives = 168/429 (39%), Gaps = 42/429 (9%)
Query: 21 NLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80
L++ + ++ + L + +L + +++L I +
Sbjct: 22 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 77
Query: 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDF 140
N+ + P NL L + + N P L+N +NL L L NQ
Sbjct: 78 NQLTDITPLK---NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITD--IDPL 130
Query: 141 SSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSST 200
+L NL L L N + +D+ L+ +SL+ LS NQ P +ANL++
Sbjct: 131 KNLTNLNRLELSSNTI-----SDISA---LSGLTSLQQLSF-GNQVTDLKP--LANLTT- 178
Query: 201 VINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQ 260
+ I N++S + L NL A NQ+ P +G L NL +L L N L+
Sbjct: 179 LERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234
Query: 261 GRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITT 320
L +LT L +L+L++N + P L L N+++ P L +T
Sbjct: 235 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTA 288
Query: 321 LSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSF 380
L+ L+L+ N L P+ +LKNL L + N S + P +S+ L+ L +N
Sbjct: 289 LT-NLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
Query: 381 HGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSN 440
V L+ L +I L+ N +S P L NL+ + L L+ + +
Sbjct: 344 SDVSSLA--NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399
Query: 441 KTKISLQGN 449
Sbjct: 400 IPNTVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-45
Identities = 102/455 (22%), Positives = 174/455 (38%), Gaps = 63/455 (13%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+ TL + + D V L++L I N L P L L LV + + N+ +
Sbjct: 48 VTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 103
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ P + N+++L + L N+ + P NL NL L + N S +LS +
Sbjct: 104 DITP--LANLTNLTGLTLFNNQITDIDPLK---NLTNLNRLELSSNTI--SDISALSGLT 156
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
+L+ L ++L L L++ N + +D+ L ++L++L
Sbjct: 157 SLQQLSFGNQVTD---LKPLANLTTLERLDISSNKV-----SDISV---LAKLTNLESLI 205
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+NQ P + L++ + + NQ+ + +L NL NQ+ P
Sbjct: 206 ATNNQISDITP--LGILTN-LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 260
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ L L +L L N + S L LT L NLEL+ N L+ P + N +NL
Sbjct: 261 --LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYL 314
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
T N ++ P + S+T L L NN ++ L +L N+ L NQ S +
Sbjct: 315 TLYFNNISDISP--VSSLTKLQ-RLFFYNNKVSDVSSL--ANLTNINWLSAGHNQISDLT 369
Query: 361 PGTLSTCVCLEYLDISSNSFHG----------------------VIPLSLSFLKSIKELN 398
P L+ + L ++ ++ + P ++S S E +
Sbjct: 370 P--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPD 427
Query: 399 VSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVP 433
++ N S E S + F G V
Sbjct: 428 ITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-38
Identities = 91/352 (25%), Positives = 144/352 (40%), Gaps = 35/352 (9%)
Query: 98 LKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLG 157
L + I + I + + + L VS + L + L ++ +
Sbjct: 3 LGSATITQDTPINQIF-TDTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGI- 58
Query: 158 TGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPP 217
+D V +L N L ++ ++NQ P + NL+ +++ + NQI+ P
Sbjct: 59 ----KSIDGVEYLNN---LTQINFSNNQLTDITP--LKNLTK-LVDILMNNNQIADITP- 107
Query: 218 GIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLE 277
+ NL NL G NQ+ T D + L NL +L L N + S L LT L L
Sbjct: 108 -LANLTNLTGLTLFNNQI--TDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLS 162
Query: 278 LSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLP 337
+ L N L S NK++ L +T L L +NN ++ P
Sbjct: 163 FGNQVTD---LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLE-SLIATNNQISDITP 216
Query: 338 LQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKEL 397
L G L NL L ++ NQ + GTL++ L LD+++N + P LS L + EL
Sbjct: 217 L--GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 270
Query: 398 NVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
+ +N +S P L L+ L L L+ N E + N T ++L N
Sbjct: 271 KLGANQISNISP--LAGLTALTNLELNENQLED-ISPISNLKNLTYLTLYFN 319
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-36
Identities = 94/409 (22%), Positives = 152/409 (37%), Gaps = 57/409 (13%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L + +N+N + + NL++L + + N + L L NL L ++ N S
Sbjct: 92 LVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQI--TDIDPLKNLTNLNRLELSSNTIS 147
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
++ ++SL+ + N+ + P NL L+ L I N S L+ +
Sbjct: 148 D--ISALSGLTSLQQLSFG-NQVTDLKPLA---NLTTLERLDISSNKV--SDISVLAKLT 199
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
NLE L + NQ L NL L+L N L D+ L + ++L L
Sbjct: 200 NLESLIATNNQISD--ITPLGILTNLDELSLNGNQL-----KDIGT---LASLTNLTDLD 249
Query: 181 LADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239
LA+NQ P ++ L+ T + +G NQIS P + L L ENQL
Sbjct: 250 LANNQISNLAP--LSGLTKLTELK--LGANQISNISP--LAGLTALTNLELNENQLEDIS 303
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIP--------------------SGLGNLTKLANLELS 279
P I LKNL L L+ N + P S L NLT + L
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAG 361
Query: 280 SNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQ 339
N + P L N + + T A + +++ + +++ L+ P
Sbjct: 362 HNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI---APAT 416
Query: 340 VGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSL 388
+ + DI+ N S T + + +F G + L
Sbjct: 417 ISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 21/130 (16%), Positives = 45/130 (34%), Gaps = 9/130 (6%)
Query: 320 TLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNS 379
L + +N L + + + + + + L
Sbjct: 2 PLGSATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 380 FHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFS 439
+ + +L ++ ++N S+N L+ P LKNL+ L + ++ N P +
Sbjct: 58 IKSIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLAN-LT 112
Query: 440 NKTKISLQGN 449
N T ++L N
Sbjct: 113 NLTGLTLFNN 122
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-45
Identities = 61/185 (32%), Positives = 93/185 (50%), Gaps = 23/185 (12%)
Query: 539 IGQGSFGYVYKGTL-GEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIIT 595
IG GSFG V++ G D VAVK++ + A F+ E ++ +RH N++ +
Sbjct: 45 IGAGSFGTVHRAEWHGSD---VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ + V EY+ GSL LH+S + +L +R+++A DVA M YL
Sbjct: 102 AVTQPPNL-----SIVTEYLSRGSLYRLLHKSGARE---QLDERRRLSMAYDVAKGMNYL 153
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
H+ PP+VH +LK N+L+D VCDFGL++ + T SS GT
Sbjct: 154 HN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--------TFLSSKSAAGTPE 204
Query: 716 YVAPE 720
++APE
Sbjct: 205 WMAPE 209
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-45
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 42/222 (18%)
Query: 532 EFSSSNMIGQGSFGYVYKGTL-GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNL 590
E ++G+G+FG V K +D VA+K ++ + ++F+ E L + H N+
Sbjct: 9 EIEVEEVVGRGAFGVVCKAKWRAKD---VAIKQ--IESESERKAFIVELRQLSRVNHPNI 63
Query: 591 IKIITICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
+K G V EY E GSL + LH ++ + + ++ +
Sbjct: 64 VK---------LYGACLNPVCLVMEYAEGGSLYNVLHGAE---PLPYYTAAHAMSWCLQC 111
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
+ + YLH ++H DLKP N+LL V +CDFG A + H
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----------M 160
Query: 708 IGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRP 739
KG+ ++APE GS S D+F T R+P
Sbjct: 161 TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP 202
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 46/222 (20%)
Query: 537 NMIGQGSFGYVYKGTL-GEDEMIVAVKVINLKYKGA--SRSFVAECEALRNIRHRNLIKI 593
+ + G ++KG G D + VKV+ ++ SR F EC LR H N++ +
Sbjct: 16 TKLNENHSGELWKGRWQGND---IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
+ C S + +M GSL + LH+ + + Q V A+D+A M
Sbjct: 73 LGACQSPP---APHPTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDMARGMA 125
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
+LH +P + L +V++D DM A + + G
Sbjct: 126 FLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP-------------GRMYA 171
Query: 714 VGYVAPE------YGMGSEASMTGDIF----------TGRRP 739
+VAPE ++ D++ T P
Sbjct: 172 PAWVAPEALQKKPEDTNRRSA---DMWSFAVLLWELVTREVP 210
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-43
Identities = 80/379 (21%), Positives = 152/379 (40%), Gaps = 36/379 (9%)
Query: 49 LVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNF 108
+L + +FP +++ L + + + L ++ L + G
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEKV 56
Query: 109 FGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVT 168
SI + +NLE L+L+ NQ S+L L L + N + TD+
Sbjct: 57 -ASIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKI-----TDISA-- 105
Query: 169 FLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGF 228
L N ++L+ L L ++ +ANL+ + + +G N + + N+ L
Sbjct: 106 -LQNLTNLRELYLNEDNISD--ISPLANLTK-MYSLNLGANHNL-SDLSPLSNMTGLNYL 160
Query: 229 GAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIP 288
E+++ P I L +L L L N ++ S L +LT L N + P
Sbjct: 161 TVTESKVKDVTP--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP 216
Query: 289 SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVI 348
+ N L S NK+T P L +++ L+ +L++ N ++ + L L +
Sbjct: 217 --VANMTRLNSLKIGNNKITDLSP--LANLSQLT-WLEIGTNQISDINAV--KDLTKLKM 269
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
L++ SNQ S + L+ L L +++N + L ++ L +S N+++
Sbjct: 270 LNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIR 327
Query: 409 PEFLKNLSVLEFLSLSYNH 427
P L +LS ++ +
Sbjct: 328 P--LASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-42
Identities = 83/405 (20%), Positives = 158/405 (39%), Gaps = 60/405 (14%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
TLA + PD +L++ + S+ + L ++ L VA K +
Sbjct: 2 AATLATLPAPINQIFPD--ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ I +++LE + L N+ + P NL L L IG N + +L N +
Sbjct: 58 SIQG--IEYLTNLEYLNLNGNQITDISPLS---NLVKLTNLYIGTNKI--TDISALQNLT 110
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
NL L L+ + ++L + LNL N+ + ++ L+N + L L+
Sbjct: 111 NLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-------DLSPLSNMTGLNYLT 161
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ +++ P IANL+ + + + NQI P + +L +L F A NQ+ P
Sbjct: 162 VTESKVKDVTP--IANLTD-LYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP 216
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ + L L + N + S L NL++L LE+ +N + +++ + L
Sbjct: 217 --VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLK-- 268
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
L++ +N ++ L +L L L +++NQ
Sbjct: 269 -----------------------MLNVGSNQISDISVL--NNLSQLNSLFLNNNQLGNED 303
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLS 405
+ L L +S N + P L+ L + + ++ +
Sbjct: 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 1e-34
Identities = 73/354 (20%), Positives = 130/354 (36%), Gaps = 60/354 (16%)
Query: 98 LKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLG 157
LA P ++ + L + L+++ L + +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKV- 56
Query: 158 TGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPP 217
+ + +LTN L+ L+L NQ I+ P
Sbjct: 57 ----ASIQGIEYLTN---LEYLNLNGNQ-------------------------ITDISP- 83
Query: 218 GIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLE 277
+ NLV L N++ T A+ L NL++L L + + S L NLTK+ +L
Sbjct: 84 -LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLN 138
Query: 278 LSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL--YLDLSNNLLNGS 335
L +N ++ S L N L T +++K+ + I L+ L L+ N +
Sbjct: 139 LGANHNLSDL-SPLSNMTGLNYLTVTESKVKD-----VTPIANLTDLYSLSLNYNQIEDI 192
Query: 336 LPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIK 395
PL L +L NQ + + P ++ L L I +N + PL+ L +
Sbjct: 193 SPL--ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLA--NLSQLT 246
Query: 396 ELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
L + +N +S +K+L+ L+ L++ N ++ S + L N
Sbjct: 247 WLEIGTNQISD--INAVKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNN 297
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-43
Identities = 85/440 (19%), Positives = 161/440 (36%), Gaps = 23/440 (5%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLG-GKIPTTLGLLRNLVSLNVAENKF 59
LQ L + L +G+L L+ + + N + K+P L NL L+++ NK
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 60 SGMFPRSICNISSLELIQLALNRFSGN----LPFDIVVNLPNLKALAIGGNNFFGSIP-Y 114
++ + + + L+ L+L+ S N + + L L + N ++
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLD-LSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKT 219
Query: 115 SLSNASNLELLDLSVNQFKGN---VSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLT 171
+ + LE+ L + +F+ D S+L+ L L +E+ L D +
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 172 NCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAE 231
+++ + SL S + Q ++ L
Sbjct: 280 CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFT------ 333
Query: 232 ENQLHGTIPDAIGELKNLQKLCLFRNFLQ--GRIPSGLGNLTKLANLELSSNSLQGNIPS 289
N+ + +L +L+ L L RN L G T L L+LS N + + S
Sbjct: 334 SNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSS 390
Query: 290 SLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVIL 349
+ + L + L + +YLD+S+ + L +L +L
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 350 DISSNQFSGVI-PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
++ N F P + L +LD+S + P + + L S++ LN++SN L
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVP 510
Query: 409 PEFLKNLSVLEFLSLSYNHF 428
L+ L+ + L N +
Sbjct: 511 DGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-42
Identities = 97/491 (19%), Positives = 166/491 (33%), Gaps = 58/491 (11%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+ L ++ N L + +L+V+ + + L +L +L + N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNF-FGSIPYSLSNA 119
+ + +SSL+ + + +L + +L LK L + N +P SN
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNL----LWLNLEQNNLGTGTATDLDFVTFLTNCSS 175
+NLE LDLS N+ + D L + L L+L N + + F
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-----NFIQPGAF--KEIR 201
Query: 176 LKALSLADNQFGGELPH-SIANLSST-----VINFGIGRNQISGTIPPGIRNLVNLIGFG 229
L L+L +N + I L+ V+ + + L NL
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261
Query: 230 AEENQLHG---TIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN 286
L I D L N+ L ++ R+ N +LEL +
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYN-FGWQHLELVNCKFGQF 319
Query: 287 IPSSLGNCQNLMSFTASQNKLTGALP-HQLLSITTLSL---------------------- 323
L + + L T + NK A L S+ L L
Sbjct: 320 PTLKLKSLKRL---TFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK 376
Query: 324 YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIP-GTLSTCVCLEYLDISSNSFHG 382
YLDLS N + ++ L+ L LD + + + L YLDIS
Sbjct: 377 YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 383 VIPLSLSFLKSIKELNVSSNNLSGQI-PEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNK 441
+ L S++ L ++ N+ P+ L L FL LS E ++ F++
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLS-PTAFNSL 493
Query: 442 TK---ISLQGN 449
+ +++ N
Sbjct: 494 SSLQVLNMASN 504
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-40
Identities = 103/488 (21%), Positives = 169/488 (34%), Gaps = 52/488 (10%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
LQ L ++ + +LS L + + GN + L +L L E +
Sbjct: 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ I ++ +L+ + +A N + NL NL+ L + N L
Sbjct: 114 SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 121 NLEL----LDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSL 176
+ L LDLS+N F + L L L N T + + L
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMK-----TCIQGLAGL 227
Query: 177 KALSLADNQFGGE------LPHSIANLSS-TVINFGIGRNQISGTIPPGI-RNLVNLIGF 228
+ L +F E ++ L + T+ F + + L N+ F
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 229 GAEENQLHGTIPDAIGE--------------------LKNLQKLCLFRNFLQGRIPSGLG 268
+ + D LK+L++L N S +
Sbjct: 288 SLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN-AFSEV- 344
Query: 269 NLTKLANLELSSNSLQ--GNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLD 326
+L L L+LS N L G S +L S N + + L + L +LD
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLE-HLD 402
Query: 327 LSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI- 384
++ L V L+NL+ LDIS G + LE L ++ NSF
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 385 PLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK- 443
P + L+++ L++S L P +LS L+ L+++ N + VP G+F T
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVP-DGIFDRLTSL 520
Query: 444 --ISLQGN 449
I L N
Sbjct: 521 QKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 5e-39
Identities = 83/462 (17%), Positives = 156/462 (33%), Gaps = 44/462 (9%)
Query: 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82
+ + + N L + L L+++ + + + ++S L + L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFK-GNVSIDFS 141
+L L +L+ L N + + + L+ L+++ N + + FS
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 142 SLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTV 201
+L NL L+L N + + TDL + + +L L+ N P + +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL--LNLSLDLSLNPMNFIQPGAFKEIRLHK 204
Query: 202 INFGIGRNQISGTIPPG-IRNLVNL------IGFGAEENQLHGTIPDAIGELKNLQKLCL 254
+ + N S + I+ L L +G E L A+ L NL
Sbjct: 205 LT--LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 255 FRNFLQG---RIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGAL 311
+L I LT +++ L S +++ + N K
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFP 320
Query: 312 PHQLLSITTLSL------------------YLDLSNNLLN--GSLPLQVGHLKNLVILDI 351
+L S+ L+ +LDLS N L+ G +L LD+
Sbjct: 321 TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 352 SSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLS-LSFLKSIKELNVSSNNLSGQIPE 410
S N + LE+LD ++ + S L+++ L++S +
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG 439
Query: 411 FLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
LS LE L ++ N F+ +F+ + L
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFL-PDIFTELRNLTFLDLSQC 480
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-25
Identities = 71/387 (18%), Positives = 123/387 (31%), Gaps = 37/387 (9%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
F IP +L + + LDLS N + S F S L L+L + + ++
Sbjct: 16 ELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-----QTIE 68
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVN 224
+ + S L L L N + + LSS + ++ I +L
Sbjct: 69 DGAY-QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV--AVETNLASLENFPIGHLKT 125
Query: 225 LIGFGAEENQL-HGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKL----ANLELS 279
L N + +P+ L NL+ L L N +Q + L L ++ +L+LS
Sbjct: 126 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185
Query: 280 SNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQL------LSITTLSLYLDLSNNLLN 333
N + I L T N + + L + L L + L
Sbjct: 186 LNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 334 GSLPLQVGHLKNLVILDISSNQ---FSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSF 390
+ L NL I + + I + + + S + V S+
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSY 302
Query: 391 LKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNM 450
+ L + + LK+L L + N G ++ + + L N
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLT---FTSNKG-GNAFSEVDLPSLEFLDLSRN- 357
Query: 451 KLCGGIDELHLPSCPSKGSRKPKIILL 477
G+ S G+ K + L
Sbjct: 358 ----GLSFKGCCSQSDFGTTSLKYLDL 380
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-17
Identities = 33/150 (22%), Positives = 57/150 (38%), Gaps = 8/150 (5%)
Query: 303 SQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPG 362
+ +P L T LDLS N L L +LD+S + + G
Sbjct: 15 MELNFY-KIPDNLPFSTK---NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG 70
Query: 363 TLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLS 422
+ L L ++ N + + S L S+++L NL+ + +L L+ L+
Sbjct: 71 AYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 130
Query: 423 LSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
+++N + FSN T + L N
Sbjct: 131 VAHNLIQ-SFKLPEYFSNLTNLEHLDLSSN 159
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 48/191 (25%), Positives = 85/191 (44%), Gaps = 24/191 (12%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECE--ALRNIRHRNLIKII 594
+G+G +G V++G+ + VAVK+ + + + +S+ E E +RH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQGEN--VAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFI 68
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
++ T + Y E GSL D+L + L + + I + +AS + +
Sbjct: 69 ASDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAH 120
Query: 655 LH-----HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
LH +P + H DLK N+L+ + + D GLA S + + +
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS----QSTNQLDVGNNP 176
Query: 710 LKGTVGYVAPE 720
GT Y+APE
Sbjct: 177 RVGTKRYMAPE 187
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 50/201 (24%), Positives = 85/201 (42%), Gaps = 36/201 (17%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVI-------NLKYKGASRSFVAECEALRN 584
E IG+G FG V+KG L +D+ +VA+K + + + F E + N
Sbjct: 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 585 IRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI 644
+ H N++K+ + + V E++ G L L + ++ +
Sbjct: 80 LNHPNIVKLYGLM-------HNPPRMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRL 127
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD-----HDMVAHVCDFGLAKFLSDHQLDT 699
+D+A +EY+ + PP+VH DL+ N+ L + A V DFGL++
Sbjct: 128 MLDIALGIEYM-QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH----- 181
Query: 700 AVKTPSSSIGLKGTVGYVAPE 720
S GL G ++APE
Sbjct: 182 ------SVSGLLGNFQWMAPE 196
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 1e-42
Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECE--ALRNIRHRNLIKII 594
IG+G FG V++G +E VAVK+ + + + RS+ E E +RH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWRGEE--VAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFI 102
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ + T V +Y E+GSL D+L++ +++ + +A+ AS + +
Sbjct: 103 AADNKDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAH 154
Query: 655 LH-----HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
LH +P + H DLK N+L+ + + D GLA D DT P+ +
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH-DSATDTIDIAPNHRV- 212
Query: 710 LKGTVGYVAPE 720
GT Y+APE
Sbjct: 213 --GTKRYMAPE 221
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 48/191 (25%), Positives = 73/191 (38%), Gaps = 24/191 (12%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECE--ALRNIRHRNLIKII 594
IG+G +G V+ G ++ VAVKV S+ E E +RH N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWRGEK--VAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFI 97
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
T + +Y ENGSL D+L + L + +A S + +
Sbjct: 98 AADIKGTGSWTQL-YLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCH 149
Query: 655 LH-----HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
LH +P + H DLK N+L+ + + D GLA +
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI----SDTNEVDIPPNT 205
Query: 710 LKGTVGYVAPE 720
GT Y+ PE
Sbjct: 206 RVGTKRYMPPE 216
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-42
Identities = 93/470 (19%), Positives = 172/470 (36%), Gaps = 35/470 (7%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
LQ L + + + D +L LE + + N L + G L +L LN+ N +
Sbjct: 52 LQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
Query: 61 GMFPRSIC-NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA 119
+ S+ N+++L+ +++ + L +L L I + SL +
Sbjct: 112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCS--SLK 177
++ L L +++ + I L ++ +L L NL + L + + +
Sbjct: 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
Query: 178 ALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRN---------LVNLIGF 228
L D F L L + + F G P + V +
Sbjct: 232 GSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRL 291
Query: 229 GAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLG-NLTKLANLELSSNSLQGNI 287
+ L + L+ ++++ + + + +P +L L L+LS N +
Sbjct: 292 HIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEY 350
Query: 288 ---PSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS--LYLDLSNNLLNGSLPLQVGH 342
+ G +L + SQN L ++ + TL LD+S N + +P
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQW 408
Query: 343 LKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402
+ + L++SS V T LE LD+S+N+ L L L+ EL +S N
Sbjct: 409 PEKMRFLNLSSTGIRVVKTCIPQT---LEVLDVSNNNL-DSFSLFLPRLQ---ELYISRN 461
Query: 403 NLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKIS---LQGN 449
L +P+ VL + +S N + G+F T + L N
Sbjct: 462 KLK-TLPDAS-LFPVLLVMKISRNQL--KSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-33
Identities = 59/376 (15%), Positives = 126/376 (33%), Gaps = 22/376 (5%)
Query: 71 SSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVN 130
++++ + L+ N+ + + + NL+ L + + + + +LE LDLS N
Sbjct: 26 AAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 131 QFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGEL 190
S F L +L +LNL N L + N ++L+ L + + + E+
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPY-----QTLGVTSLFPNLTNLQTLRIGNVETFSEI 139
Query: 191 P-HSIANLSS-TVINFGIGRNQISGTIPPG-IRNLVNLIGFGAEENQLHGTIPDAIGELK 247
A L+S + I + ++++ ++ ++ + L
Sbjct: 140 RRIDFAGLTSLNELE--IKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 248 NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKL 307
+++ L L L S L + ++ + S L+ +
Sbjct: 197 SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILE---- 252
Query: 308 TGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTC 367
L TL+ D + + + L + L I + S
Sbjct: 253 ---LSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309
Query: 368 VCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI---PEFLKNLSVLEFLSLS 424
++ + + ++ V LKS++ L++S N + + L+ L LS
Sbjct: 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369
Query: 425 YNHFEGEVPTKGVFSN 440
NH T +
Sbjct: 370 QNHLRSMQKTGEILLT 385
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 4e-32
Identities = 73/437 (16%), Positives = 150/437 (34%), Gaps = 25/437 (5%)
Query: 20 GNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLA 79
G + ++ + + N + L NL L + ++ + + + ++ SLE + L+
Sbjct: 23 GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLS 82
Query: 80 LNRFSGNLPFDIVVNLPNLKALAIGGNNFFG-SIPYSLSNASNLELLDLS-VNQFKGNVS 137
N S +L L +LK L + GN + + N +NL+ L + V F
Sbjct: 83 DNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR 141
Query: 138 IDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANL 197
IDF+ L +L L ++ +L + L + + L+L ++ L A++
Sbjct: 142 IDFAGLTSLNELEIKALSLRNYQSQSLK------SIRDIHHLTLHLSES-AFLLEIFADI 194
Query: 198 SSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRN 257
S+V + ++ + + ++ EL L + L +
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254
Query: 258 FLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLS 317
++ + T + + + + Q L L
Sbjct: 255 EVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308
Query: 318 ITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGT---LSTCVCLEYLD 374
+ + + + N+ + HLK+L LD+S N L+ L
Sbjct: 309 LEKVK-RITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367
Query: 375 ISSNSFHGVIPLSLSF--LKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEV 432
+S N + LK++ L++S N +P+ + + FL+LS V
Sbjct: 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VV 425
Query: 433 PTKGVFSNKTKISLQGN 449
T + + + N
Sbjct: 426 KT-CIPQTLEVLDVSNN 441
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 3e-31
Identities = 72/418 (17%), Positives = 143/418 (34%), Gaps = 44/418 (10%)
Query: 1 LQTLAVNDNYLTG-QLPDFVGNLSDLEVIRIMGNSLGGKIP-TTLGLLRNLVSLNVAENK 58
L+ L + N + NL++L+ +RI +I L +L L +
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS 159
Query: 59 FSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNN---FFGSIPYS 115
+S+ +I + + L L+ + L L +++ L + N F S
Sbjct: 160 LRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPV 218
Query: 116 LSNASNLELLDLSVNQFKGNVSIDFSSLKNLLW-------LNLEQNNLGTGTATDLDFVT 168
+S ++ L + + L + + N LG ++ D V+
Sbjct: 219 DEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVS 278
Query: 169 FLTN--CSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGI-RNLVN 224
L +++ L + +L + L I + +++ +P ++L +
Sbjct: 279 ELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT--VENSKVF-LVPCSFSQHLKS 335
Query: 225 LIGFGAEENQLHGTI---PDAIGELKNLQKLCLFRNFLQ--GRIPSGLGNLTKLANLELS 279
L EN + G +LQ L L +N L+ + L L L +L++S
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDIS 395
Query: 280 SNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL---------------- 323
N+ +P S + + S + ++ L +
Sbjct: 396 RNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQ 454
Query: 324 YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH 381
L +S N L +LP L+++ IS NQ V G L+ + + +N +
Sbjct: 455 ELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-19
Identities = 46/259 (17%), Positives = 86/259 (33%), Gaps = 33/259 (12%)
Query: 172 NCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPG-IRNLVNLIGFGA 230
+C + F +P + L++ + + + N+I+ I G +R NL
Sbjct: 3 SCDASGVCDGRSRSFT-SIP---SGLTAAMKSLDLSFNKIT-YIGHGDLRACANLQVLIL 57
Query: 231 EENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQG-NIPS 289
+ ++++ DA L +L+ L L N L S G L+ L L L N Q + S
Sbjct: 58 KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 290 SLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVI 348
N NL L + N + L +L
Sbjct: 118 LFPNLTNL-------------------------QTLRIGNVETFSEIRRIDFAGLTSLNE 152
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
L+I + +L + + +L + + ++ + L S++ L + NL+
Sbjct: 153 LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQ 212
Query: 409 PEFLKNLSVLEFLSLSYNH 427
L V +
Sbjct: 213 FSPLPVDEVSSPMKKLAFR 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 29/119 (24%), Positives = 56/119 (47%), Gaps = 4/119 (3%)
Query: 325 LDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI 384
D + S+P + + LD+S N+ + + G L C L+ L + S+ + +
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 385 PLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK 443
+ L S++ L++S N+LS + LS L++L+L N ++ + +F N T
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTN 124
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 5e-42
Identities = 62/227 (27%), Positives = 94/227 (41%), Gaps = 44/227 (19%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIITI 596
IG GSFG VYKG D VAVK++N+ ++F E LR RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
++ A V ++ E SL LH S+ K + + ++IA A M+YLH
Sbjct: 89 STAPQL------AIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLH 137
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
++H DLK +N+ L D + DFGLA S + G++ +
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL------SGSILW 188
Query: 717 VAPE------YGMGSEAS------------MTGDI-FTGRRPIDAVF 744
+APE S S MTG + ++ D +
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 55/226 (24%), Positives = 85/226 (37%), Gaps = 48/226 (21%)
Query: 537 NMIGQGSFGYVYKGTL-GEDEMIVAVKVINLK----YKGASRSFVAECEALRNIRHRNLI 591
+IG G FG VY+ G++ VAVK + E + ++H N+I
Sbjct: 13 EIIGIGGFGKVYRAFWIGDE---VAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ +C K + V E+ G L L ++ VN A+ +A
Sbjct: 70 ALRGVCL----KEPNL-CLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARG 117
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLD--------HDMVAHVCDFGLAKFLSDHQLDTAVKT 703
M YLH P++H DLK SN+L+ + + + DFGLA+ +A
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA-- 175
Query: 704 PSSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRP 739
G ++APE S S D++ TG P
Sbjct: 176 --------GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 51/188 (27%), Positives = 84/188 (44%), Gaps = 19/188 (10%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G+G FG K T E ++ +K + + R+F+ E + +R + H N++K I +
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
K F+ EY++ G+L+ + D Q QRV+ A D+AS M YLH
Sbjct: 78 ----KDKRL-NFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDIASGMAYLHSM 127
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTA------VKTPSSSIGLKG 712
++H DL N L+ + V DFGLA+ + D + + G
Sbjct: 128 ---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 713 TVGYVAPE 720
++APE
Sbjct: 185 NPYWMAPE 192
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 46/186 (24%), Positives = 76/186 (40%), Gaps = 22/186 (11%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKII 594
+IG+G FG VY G + VA+++I+++ ++F E A R RH N++ +
Sbjct: 39 ELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
C S A + + +L + + L + + IA ++ M Y
Sbjct: 96 GACMSPPHL-----AIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGY 145
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH ++H DLK NV D+ V + DFGL Q G +
Sbjct: 146 LH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQN---GWL 198
Query: 715 GYVAPE 720
++APE
Sbjct: 199 CHLAPE 204
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-40
Identities = 86/461 (18%), Positives = 155/461 (33%), Gaps = 35/461 (7%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKI-PTTLGLLRNLVSLNVAENKF 59
+ L ++ NY+ L L+++ + I L NL L++ +K
Sbjct: 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI 85
Query: 60 SGMFPRSICNISSLELIQLALNRFS-GNLPFDIVVNLPNLKALAIGGNNFFG-SIPYSLS 117
+ P + + L ++L S L NL L L + N + S
Sbjct: 86 YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFG 145
Query: 118 NASNLELLDLSVNQFKGNVSIDFSSL--KNLLWLNLEQNNLGTGTATDLDFVTFLTNCSS 175
++L+ +D S NQ + L K L + +L N+L V + +
Sbjct: 146 KLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL-----YSRVSVDWGKCMNP 200
Query: 176 LKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQL 235
+ + L G N + I G N IS + + +++G G + +
Sbjct: 201 FRNMVLEILDVSG-------NGWTVDIT-GNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252
Query: 236 HGTIPDAIGELK--NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGN 293
+ L +++ L L F+ L L L L+ N + +
Sbjct: 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYG 312
Query: 294 CQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISS 353
NL S N L + ++ Y+DL N + L+ L LD+
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVA-YIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371
Query: 354 NQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG-QIPEFL 412
N + T+ + + +S N + ++L + +++S N L I FL
Sbjct: 372 NALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFL 422
Query: 413 KNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKI---SLQGNM 450
+ L+ L L+ N F S + L NM
Sbjct: 423 LRVPHLQILILNQNRFS-SCSGDQTPSENPSLEQLFLGENM 462
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-39
Identities = 69/388 (17%), Positives = 136/388 (35%), Gaps = 39/388 (10%)
Query: 46 LRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGG 105
L L ++ N + S + L+L++L + + NLPNL+ L +G
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID--FSSLKNLLWLNLEQNNLGTGTATD 163
+ + P + +L L L V D F +LK L L+L +N +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI-----RS 137
Query: 164 LDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINF-GIGRNQISGTIPPGIRNL 222
L +SLK++ + NQ H + L ++F + N + +
Sbjct: 138 LYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKC 197
Query: 223 VNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNS 282
+N L+ L + N I SN+
Sbjct: 198 MNPF------------------RNMVLEILDVSGNGWTVDITG------------NFSNA 227
Query: 283 LQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL-YLDLSNNLLNGSLPLQVG 341
+ + SL ++M + + + + S+ +LDLS+ +
Sbjct: 228 ISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFE 287
Query: 342 HLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401
LK+L +L+++ N+ + + L+ L++S N + + L + +++
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 402 NNLSGQIPEFLKNLSVLEFLSLSYNHFE 429
N+++ + K L L+ L L N
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-27
Identities = 86/454 (18%), Positives = 154/454 (33%), Gaps = 73/454 (16%)
Query: 1 LQTLAVNDNYLTGQLPD-FVGNLSDLEVIRIM-----------GNSLGGKIPTTLGLLR- 47
L+ L V+ N T + F +S + ++ +++ T L
Sbjct: 206 LEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR 265
Query: 48 -NLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGN 106
++ L+++ + R + L+++ LA N+ + + + L NL+ L + N
Sbjct: 266 SSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYN 324
Query: 107 NFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDF 166
+ + +DL N F L+ L L+L N L
Sbjct: 325 LLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL---------- 374
Query: 167 VTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISG-TIPPGIRNLVNL 225
T + S+ + L+ N+ ++ ++ T + N++ I + + +L
Sbjct: 375 -TTIHFIPSIPDIFLSGNKL-----VTLPKINLTANLIHLSENRLENLDILYFLLRVPHL 428
Query: 226 IGFGAEENQLHGTIPDAI-GELKNLQKLCLFRNFLQGRIPSGL-----GNLTKLANLELS 279
+N+ D E +L++L L N LQ + L L+ L L L+
Sbjct: 429 QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLN 488
Query: 280 SNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQ 339
N L P + L L L++N L L
Sbjct: 489 HNYLNSLPPGVFSHLTAL-------------------------RGLSLNSNRLT-VLSHN 522
Query: 340 VGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNV 399
NL ILDIS NQ P + L LDI+ N F LS +F+ + NV
Sbjct: 523 D-LPANLEILDISRNQLLAPNPDVFVS---LSVLDITHNKFICECELS-TFINWLNHTNV 577
Query: 400 SSNNLSGQI----PEFLKNLSVLEFLSLSYNHFE 429
+ I P+ +S+ + + E
Sbjct: 578 TIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEE 611
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 6e-11
Identities = 23/117 (19%), Positives = 40/117 (34%), Gaps = 5/117 (4%)
Query: 325 LDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI 384
L +P L L +S N V + L+ L++ S I
Sbjct: 9 AFYRFCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTI 64
Query: 385 -PLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSN 440
+ L +++ L++ S+ + P+ + L L L L + V G F N
Sbjct: 65 DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-39
Identities = 52/330 (15%), Positives = 110/330 (33%), Gaps = 31/330 (9%)
Query: 109 FGSIPYSLSNASNLELLDLSVNQFKGNVSI--DFSSLKNLLWLNLEQNNLGTGTATDLDF 166
GS + ++S E L G+ ++ L N
Sbjct: 1 MGSSHHHHHHSSGRENLYFQ-----GSTALRPYHDVLSQWQRHYNADRNR-------WHS 48
Query: 167 VTFLTNCSSLKALSLADNQFGGELPHSIANLSST-VINFGIGRNQISGTIPPGIRNLVNL 225
N ++ + + + + + + + + P L +L
Sbjct: 49 AWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106
Query: 226 IGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQG 285
+ L +PD + + L+ L L RN L+ +P+ + +L +L L + +
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164
Query: 286 NIPSSLGNC---------QNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSL 336
+P L + NL S + +LP + ++ L L + N+ L+ +L
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLK-SLKIRNSPLS-AL 221
Query: 337 PLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKE 396
+ HL L LD+ P L+ L + S +PL + L +++
Sbjct: 222 GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEK 281
Query: 397 LNVSSNNLSGQIPEFLKNLSVLEFLSLSYN 426
L++ ++P + L + + +
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-38
Identities = 59/329 (17%), Positives = 105/329 (31%), Gaps = 28/329 (8%)
Query: 94 NLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQ 153
+ + L G+ LS D + ++ N
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWR----QANSNNPQIETRTG 65
Query: 154 NNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISG 213
L D + T AL L + P LS + + I +
Sbjct: 66 RAL----KATADLLEDATQ-PGRVALELRSVPLP-QFPDQAFRLSH-LQHMTIDAAGLM- 117
Query: 214 TIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGN---- 269
+P ++ L N L +P +I L L++L + +P L +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 270 -----LTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLY 324
L L +L L ++ ++P+S+ N QNL S + L+ AL + + L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLE-E 233
Query: 325 LDLSNNLLNGSLPLQVGHLKNLVILDISS-NQFSGVIPGTLSTCVCLEYLDISSNSFHGV 383
LDL + P G L L + + +P + LE LD+
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 384 IPLSLSFLKSIKELNVSSNNLSGQIPEFL 412
+P ++ L + + V +L Q+ +
Sbjct: 293 LPSLIAQLPANCIILV-PPHLQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-35
Identities = 55/353 (15%), Positives = 99/353 (28%), Gaps = 48/353 (13%)
Query: 13 GQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISS 72
G + S E + G++ L + + + N ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57
Query: 73 LELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQF 132
++ P AL + P S+L+ + +
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGL 116
Query: 133 KGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPH 192
+ L L L +N L A+ + + + L+ LS+ ELP
Sbjct: 117 M-ELPDTMQQFAGLETLTLARNPLRALPAS-------IASLNRLRELSIRACPELTELPE 168
Query: 193 SIANLSSTVINFG--------IGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIG 244
+A+ ++ + G + I ++P I NL NL + L + AI
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226
Query: 245 ELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQ 304
L L++L L P G L L L S +P + L
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLE------ 280
Query: 305 NKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFS 357
LDL + LP + L I+ + + +
Sbjct: 281 -------------------KLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-31
Identities = 53/324 (16%), Positives = 96/324 (29%), Gaps = 17/324 (5%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+ L + D + N
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK 69
Query: 61 GMFPRSICNISSLELIQLALNRFS-GNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA 119
+ + + + L L P D L +L+ + I +P ++
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLPQFP-DQAFRLSHLQHMTIDAAGL-MELPDTMQQF 126
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGT---GTATDLDFVTFLTNCSSL 176
+ LE L L+ N + + +SL L L++ T D +L
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185
Query: 177 KALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLH 236
++L L LP SIANL + + + I + +S + P I +L L
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQN-LKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 237 GTIPDAIGELKNLQKLCLF-RNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQ 295
P G L++L L + L +P + LT+L L+L +PS +
Sbjct: 243 RNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLP 301
Query: 296 NLMSFTASQNKLTGALPHQLLSIT 319
+ H+ ++
Sbjct: 302 ANCIILVPPHLQAQLDQHRPVARP 325
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 43/274 (15%), Positives = 80/274 (29%), Gaps = 30/274 (10%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L + L Q PD LS L+ + I L ++P T+ L +L +A N
Sbjct: 83 RVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
P SI +++ L + + LP + +
Sbjct: 141 A-LPASIASLNRLRELSIRACPELTELPEPL-------------AST---DASGEHQGLV 183
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
NL+ L L + ++ ++L+NL L + + L + + L+ L
Sbjct: 184 NLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-------LGPAIHHLPKLEELD 235
Query: 181 LADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239
L P + + + + T+P I L L +
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILK-DCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKL 273
P I +L + + +
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 43/276 (15%), Positives = 80/276 (28%), Gaps = 47/276 (17%)
Query: 169 FLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGF 228
+ S + L + ++ ++ N N
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNA-----DRNRWHSAWRQANSNNPQIE 61
Query: 229 GAEENQLHGTIPDAIGELK--NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN 286
L D + + L L L + P L+ L ++ + + L
Sbjct: 62 TRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 287 IPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNL 346
+P ++ L L L+ N L +LP + L L
Sbjct: 119 LPDTMQQFAGLE-------------------------TLTLARNPLR-ALPASIASLNRL 152
Query: 347 VILDISSNQFSGVIP---------GTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKEL 397
L I + +P G V L+ L + +P S++ L+++K L
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL 211
Query: 398 NVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVP 433
+ ++ LS + + +L LE L L P
Sbjct: 212 KIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 16/124 (12%), Positives = 32/124 (25%), Gaps = 11/124 (8%)
Query: 309 GALPHQLLSITTL-SLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTC 367
G+ H + +LY S L + + D + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALR--PYHDVLSQWQRHYNADRNRWHSAWRQAN----- 54
Query: 368 VCLEYLDISSNSFHGVIPLSLSFLKSIK--ELNVSSNNLSGQIPEFLKNLSVLEFLSLSY 425
++ + L L + S L Q P+ LS L+ +++
Sbjct: 55 SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 426 NHFE 429
Sbjct: 114 AGLM 117
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 5e-39
Identities = 62/417 (14%), Positives = 126/417 (30%), Gaps = 29/417 (6%)
Query: 15 LPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLE 74
+ + N + ++ ++ +SL + + N+ L+++ N S + + + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 75 LIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKG 134
L+ L+ N L + +L L+ L + N L ++E L + N
Sbjct: 62 LLNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 135 NVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGG-ELPHS 193
+ S + + L N + T L + S ++ L L N+
Sbjct: 113 --RVSCSRGQGKKNIYLANNKI-----TMLRDLDE-GCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 194 IANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKL 252
A+ + +N + N I + + L N+L + + +
Sbjct: 165 AASSDTLEHLN--LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 253 CLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ-GNIPSSLGNCQNLMSFTASQNKLTGAL 311
L N L I L L + +L N G + Q + + K
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 312 PHQLLSITTLSLYLDLSNNLLNGSLP--LQVGHLKNLVILDISSNQFSGVIPGTLSTCVC 369
+ ++ TL Y L L K +L ++ +
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETER-LECERENQAR 337
Query: 370 LEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYN 426
+D + VI ++ L L Q+ + + L+
Sbjct: 338 QREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 2e-31
Identities = 60/368 (16%), Positives = 115/368 (31%), Gaps = 33/368 (8%)
Query: 90 DIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWL 149
+I N K + ++ ++ +A N++ LDLS N + D + L L
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 150 NLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGR 208
NL N L L + S+L+ L L +N + S ++
Sbjct: 64 NLSSNVLYE--------TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLH--AAN 108
Query: 209 NQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQG-RIPSG 266
N IS + + N+ N++ G +Q L L N +
Sbjct: 109 NNIS-RVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 267 LGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLD 326
+ L +L L N + ++ + L + S NKL + + S ++ ++
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVT-WIS 220
Query: 327 LSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPL 386
L NN L + + +NL D+ N F + ++ + +
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQ 278
Query: 387 SLSFLKSIKELNVSSNNLSGQIPEFLKNLSVL-----EFLSLSYNHFEGEVPTKGVFSNK 441
+ + + F L L LS + E + + +
Sbjct: 279 NEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQ 338
Query: 442 TKISLQGN 449
+I
Sbjct: 339 REIDALKE 346
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-31
Identities = 51/321 (15%), Positives = 112/321 (34%), Gaps = 26/321 (8%)
Query: 111 SIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFL 170
+I N + ++ ++ + K ++ S N+ L+L N L + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL-----SQISAADL- 54
Query: 171 TNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFG 229
+ L+ L+L+ N E + +LS+ ++ + N + + G ++ L
Sbjct: 55 APFTKLELLNLSSNVL-YETL-DLESLSTLRTLD--LNNNYVQ-ELLVGP-SIETLH--- 105
Query: 230 AEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQG-NIP 288
A N + + + + + + L N + G +++ L+L N + N
Sbjct: 106 AANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 289 SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVI 348
+ L N + + + L LDLS+N L + + +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVK-GQVVFAKLK-TLDLSSNKLA-FMGPEFQSAAGVTW 218
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
+ + +N+ +I L LE+ D+ N FH F K+ + V+ +
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLT 276
Query: 409 PEFLKNLSVLEFLSLSYNHFE 429
+ + +V E
Sbjct: 277 GQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-23
Identities = 41/214 (19%), Positives = 79/214 (36%), Gaps = 17/214 (7%)
Query: 239 IPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLM 298
I + + + + L+ + S + + L+LS N L + L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 299 SFTASQNKLTGALPHQLLSITTLS--LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQF 356
S N L + L + +LS LDL+NN + ++ ++ L ++N
Sbjct: 62 LLNLSSNVLY-----ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 357 SGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG-QIPEFLKNL 415
S V + + +++N + L ++ L++ N + E +
Sbjct: 112 SRVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 416 SVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
LE L+L YN +V + VF+ + L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSN 201
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-39
Identities = 91/441 (20%), Positives = 153/441 (34%), Gaps = 79/441 (17%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGG------------KIPTTLGLLRN 48
+ P G ++ V R+ +P +
Sbjct: 36 KTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPP---H 92
Query: 49 LVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNF 108
L SL + N + P ++ SL + L S P L+ L + NN
Sbjct: 93 LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP--------LLEYLGVS-NNQ 142
Query: 109 FGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVT 168
+P L N+S L+++D+ N K + +L ++ N L +L
Sbjct: 143 LEKLP-ELQNSSFLKIIDVDNNSLK---KL-PDLPPSLEFIAAGNNQL-----EELPE-- 190
Query: 169 FLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGF 228
L N L A+ +N +LP +L + G N + P ++NL L
Sbjct: 191 -LQNLPFLTAIYADNNSLK-KLPDLPLSLE----SIVAGNNIL--EELPELQNLPFLTTI 242
Query: 229 GAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIP 288
A+ N L T+PD +L+ L + N+L +P +LT L ++S N +
Sbjct: 243 YADNNLLK-TLPD---LPPSLEALNVRDNYLT-DLPELPQSLTFL---DVSENIFS-GLS 293
Query: 289 SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVI 348
N L AS N++ +L S+ L ++SNN L LP L
Sbjct: 294 ELPPNLYYL---NASSNEIR-SLCDLPPSLEEL----NVSNNKLI-ELP---ALPPRLER 341
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
L S N + +P L+ L + N P ++ ++ N+ ++
Sbjct: 342 LIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLR-----MNSHLAEV 391
Query: 409 PEFLKNLSVLEFLSLSYNHFE 429
PE +NL L + N
Sbjct: 392 PELPQNLKQL---HVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-38
Identities = 92/429 (21%), Positives = 155/429 (36%), Gaps = 71/429 (16%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
LQ + + LT ++P N+ + P G R + +
Sbjct: 13 LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRL------ 65
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
C ++L S +LP P+L++L N+ +P +
Sbjct: 66 -----RDCLDRQAHELELNNLGLS-SLP----ELPPHLESLVASCNS-LTELPELPQSLK 114
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
+L + + ++ L +L + N L + L N S LK +
Sbjct: 115 SLLVDNNNLKALSDL-------PPLLEYLGVSNNQLEK--------LPELQNSSFLKIID 159
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ +N +LP +L G NQ+ P ++NL L A+ N L +P
Sbjct: 160 VDNNSL-KKLPDLPPSL----EFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLP 211
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
D +L+ + N L L NL L + +N L+ +P + + L
Sbjct: 212 D---LPLSLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL--- 262
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
N LT LP S+T LD+S N+ + L NL L+ SSN+ +
Sbjct: 263 NVRDNYLT-DLPELPQSLTF----LDVSENIFS-GLS---ELPPNLYYLNASSNEIR-SL 312
Query: 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
+ LE L++S+N +P L + L S N+L+ ++PE +NL
Sbjct: 313 CDLPPS---LEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQNLKQ--- 361
Query: 421 LSLSYNHFE 429
L + YN
Sbjct: 362 LHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-31
Identities = 63/353 (17%), Positives = 119/353 (33%), Gaps = 66/353 (18%)
Query: 93 VNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLE 152
V+ L+ +N +P N + + ++++ N + + L
Sbjct: 8 VSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLR 66
Query: 153 QNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQIS 212
L L + LP +L S N ++
Sbjct: 67 DC-----------------LDRQAHELELNNLGL-SSLPELPPHLES----LVASCNSLT 104
Query: 213 GTIPPGIRNLVNLIGFGAEENQLHG----------------TIPDAIGELKNLQKLCLFR 256
+P ++L +L+ L +P+ + L+ + +
Sbjct: 105 -ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE-LQNSSFLKIIDVDN 162
Query: 257 NFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLL 316
N L+ ++P +L + +N L+ +P L N L + A N L LP L
Sbjct: 163 NSLK-KLPDLPPSLEF---IAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPL 215
Query: 317 SITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDIS 376
S+ + + NN+L LP ++ +L L + +N +P + LE L++
Sbjct: 216 SLES----IVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVR 265
Query: 377 SNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE 429
N + L +S+ L+VS N S + E N L +L+ S N
Sbjct: 266 DNYLTDLPEL----PQSLTFLDVSENIFS-GLSELPPN---LYYLNASSNEIR 310
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 80/409 (19%), Positives = 132/409 (32%), Gaps = 76/409 (18%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L++L + N LT +LP+ +L L V +L L L L V+ N+
Sbjct: 93 LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-------LPPLLEYLGVSNNQLE 144
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
P + N S L++I + N LP P+L+ +A G NN +P L N
Sbjct: 145 K-LP-ELQNSSFLKIIDVDNNSLK-KLP----DLPPSLEFIAAG-NNQLEELP-ELQNLP 195
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L + N K + +L + N L + L N L +
Sbjct: 196 FLTAIYADNNSLK---KL-PDLPLSLESIVAGNNILEE--------LPELQNLPFLTTIY 243
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+N LP +L + + N ++ +P ++L L + L P
Sbjct: 244 ADNNLLK-TLPDLPPSLEA----LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297
Query: 241 -------------DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNI 287
+L++L + N L +P+ L +L S N L +
Sbjct: 298 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EV 352
Query: 288 PSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL---------------YLDLSNNLL 332
P N + L N L P S+ L + L + N L
Sbjct: 353 PELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL 408
Query: 333 NGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH 381
P +++L ++S + T LE + H
Sbjct: 409 R-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-24
Identities = 55/264 (20%), Positives = 97/264 (36%), Gaps = 48/264 (18%)
Query: 215 IPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNL---- 270
I P + L + L +P +K+ + + + P G G
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 271 ---------TKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTL 321
+ LEL++ L ++P + ++L AS N LT LP S+ +L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSL 116
Query: 322 SL----------------YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLS 365
+ YL +SNN L LP ++ + L I+D+ +N +P
Sbjct: 117 LVDNNNLKALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 366 TCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSY 425
+ LE++ +N +P L L + + +N+L ++P+ + LE +
Sbjct: 174 S---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGN 224
Query: 426 NHFEGEVPTKGVFSNKTKISLQGN 449
N E E+P T I N
Sbjct: 225 NILE-ELPELQNLPFLTTIYADNN 247
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-36
Identities = 77/366 (21%), Positives = 136/366 (37%), Gaps = 34/366 (9%)
Query: 86 NLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKN 145
NL +D V ++ + +FG +L+N +++ + + + S +
Sbjct: 16 NLQYDCV--FYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMRKLPAALLDSFRQ 70
Query: 146 LLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINF 204
+ LNL + ++D F +++ L + N PH N+ TV+
Sbjct: 71 VELLNLNDLQI-----EEIDTYAF-AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV- 123
Query: 205 GIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRI 263
+ RN +S ++P GI N L N L D +LQ L L N L +
Sbjct: 124 -LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HV 180
Query: 264 PSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL 323
L + L + +S N L S+L + AS N + + +T L
Sbjct: 181 D--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTIL-- 231
Query: 324 YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV 383
L +N L + + LV +D+S N+ ++ LE L IS+N
Sbjct: 232 --KLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 286
Query: 384 IPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK 443
+ L + ++K L++S N+L + LE L L +N +
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKN 343
Query: 444 ISLQGN 449
++L N
Sbjct: 344 LTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 76/395 (19%), Positives = 135/395 (34%), Gaps = 55/395 (13%)
Query: 21 NLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80
L++ +++ +++ L R + LN+ + + + + +++ + +
Sbjct: 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102
Query: 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIP-YSLSNASNLELLDLSVNQFKGNVSID 139
N LP + N+P L L + N+ S+P N L L +S N +
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERND-LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 140 FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS 199
F + +L L L N L T +D SL +++ N ++A +
Sbjct: 161 FQATTSLQNLQLSSNRL-----THVDLSLI----PSLFHANVSYNLL-----STLAIPIA 206
Query: 200 TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFL 259
V N I+ + + L L L N L
Sbjct: 207 -VEELDASHNSIN-VVRGPV--------------------------NVELTILKLQHNNL 238
Query: 260 QGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSIT 319
+ L N L ++LS N L+ + Q L S N+L AL I
Sbjct: 239 TD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295
Query: 320 TLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNS 379
TL LDLS+N L + L L + N + T T L+ L +S N
Sbjct: 296 TLK-VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT---LKNLTLSHND 350
Query: 380 FHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKN 414
+ +L +++ V + +I L++
Sbjct: 351 WDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-24
Identities = 60/318 (18%), Positives = 109/318 (34%), Gaps = 30/318 (9%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+Q L + N + P N+ L V+ + N L L +L+++ N
Sbjct: 95 IQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE 154
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ + +SL+ +QL+ NR + ++ +P+L + N +L+
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLT-HVDLS---LIPSLFHANVSYNLL-----STLAIPI 205
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
+E LD S N + L L L+ NNL +L N L +
Sbjct: 206 AVEELDASHNSIN---VVRGPVNVELTILKLQHNNLTD--------TAWLLNYPGLVEVD 254
Query: 181 LADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239
L+ N+ + H + + I N++ + + + L N L +
Sbjct: 255 LSYNELEKIMYHPFVKMQRLERLY--ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HV 310
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMS 299
+ L+ L L N + + L L NL LS N N +L +N+
Sbjct: 311 ERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALF--RNVAR 365
Query: 300 FTASQNKLTGALPHQLLS 317
+ +QL
Sbjct: 366 PAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 6e-21
Identities = 48/238 (20%), Positives = 83/238 (34%), Gaps = 15/238 (6%)
Query: 214 TIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTK 272
I ++ + L N + + + ++ ++P+ L + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 273 LANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLL 332
+ L L+ ++ + + N + LP + L L L N L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 333 NGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFL 391
+ SLP + + L L +S+N + T L+ L +SSN + LS +
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLI 185
Query: 392 KSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
S+ NVS N LS L +E L S+N V V T + LQ N
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHN 236
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-35
Identities = 53/346 (15%), Positives = 109/346 (31%), Gaps = 34/346 (9%)
Query: 15 LPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLE 74
+ + N + ++ ++ +SL + + N+ L+++ N S + + + LE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 75 LIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKG 134
L+ L+ N L + +L L+ L + N L ++E L + N
Sbjct: 62 LLNLSSNVLYETLDLE---SLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 135 NVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGG-ELPHS 193
+ S + + L N + T L + S ++ L L N+
Sbjct: 113 --RVSCSRGQGKKNIYLANNKI-----TMLRDLDE-GCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 194 IANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKL 252
A+ + +N + N I + + L N+L + + +
Sbjct: 165 AASSDTLEHLN--LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219
Query: 253 CLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ-GNIPSSLGNCQNLMSFTASQNKLTGAL 311
L N L I L L + +L N G + Q + + K
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 312 PHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFS 357
+ ++ TL Y LP ++ + +
Sbjct: 279 NEEECTVPTLGHY----GAYCCEDLP----APFADRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 51/318 (16%), Positives = 112/318 (35%), Gaps = 26/318 (8%)
Query: 111 SIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFL 170
+I N + ++ ++ + K ++ S N+ L+L N L + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPL-----SQISAADL- 54
Query: 171 TNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFG 229
+ L+ L+L+ N E + +LS+ ++ + N + + G ++ L
Sbjct: 55 APFTKLELLNLSSNVL-YETL-DLESLSTLRTLD--LNNNYVQ-ELLVG-PSIETLH--- 105
Query: 230 AEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQG-NIP 288
A N + + + + + + L N + G +++ L+L N + N
Sbjct: 106 AANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162
Query: 289 SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVI 348
+ L N + + + L LDLS+N L + + +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKG-QVVFAKLK-TLDLSSNKLA-FMGPEFQSAAGVTW 218
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
+ + +N+ +I L LE+ D+ N FH L F K+ + V+ +
Sbjct: 219 ISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLT 276
Query: 409 PEFLKNLSVLEFLSLSYN 426
+ + +V
Sbjct: 277 GQNEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 41/214 (19%), Positives = 79/214 (36%), Gaps = 17/214 (7%)
Query: 239 IPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLM 298
I + + + + L+ + S + + L+LS N L + L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 299 SFTASQNKLTGALPHQLLSITTLS--LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQF 356
S N L + L + +LS LDL+NN + ++ ++ L ++N
Sbjct: 62 LLNLSSNVLY-----ETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI 111
Query: 357 SGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG-QIPEFLKNL 415
S V + + +++N + L ++ L++ N + E +
Sbjct: 112 SRVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 416 SVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
LE L+L YN +V + VF+ + L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSN 201
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 18/95 (18%), Positives = 41/95 (43%), Gaps = 2/95 (2%)
Query: 335 SLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSI 394
++ + I ++ + + + ++ LD+S N + L+ +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 395 KELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE 429
+ LN+SSN L + + ++LS L L L+ N+ +
Sbjct: 61 ELLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 25/157 (15%), Positives = 57/157 (36%), Gaps = 7/157 (4%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGG-KIPTTLGLLRNLVSLNVAENKF 59
+ + + +N +T G S ++ + + N + L LN+ N
Sbjct: 122 KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI 181
Query: 60 SGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA 119
+ + L+ + L+ N+ + + + + + +++ N I +L +
Sbjct: 182 Y-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEF-QSAAGVTWISLRNNK-LVLIEKALRFS 236
Query: 120 SNLELLDLSVNQFK-GNVSIDFSSLKNLLWLNLEQNN 155
NLE DL N F G + FS + + + +
Sbjct: 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK 273
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-34
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 14/162 (8%)
Query: 537 NMIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRN 589
++G+G FG V +G L + VAVK +K +S+ F++E +++ H N
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+I+++ +C +G + +M+ G L +L S + + L + +D+A
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 650 SAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
MEYL + + +H DL N +L DM V DFGL+K
Sbjct: 158 LGMEYLSNRNF----LHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 77/366 (21%), Positives = 136/366 (37%), Gaps = 34/366 (9%)
Query: 86 NLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKN 145
NL +D V ++ + +FG +L+N +++ + + + S +
Sbjct: 22 NLQYDCV--FYDVHIDMQTQDVYFGFEDITLNN---QKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 146 LLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINF 204
+ LNL + ++D F +++ L + N PH N+ TV+
Sbjct: 77 VELLNLNDLQI-----EEIDTYAF-AYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV- 129
Query: 205 GIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRI 263
+ RN +S ++P GI N L N L D +LQ L L N L +
Sbjct: 130 -LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HV 186
Query: 264 PSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL 323
L + L + +S N L S+L + AS N + + +T L
Sbjct: 187 D--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSINVVRGPVNVELTIL-- 237
Query: 324 YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV 383
L +N L + + LV +D+S N+ ++ LE L IS+N
Sbjct: 238 --KLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-A 292
Query: 384 IPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK 443
+ L + ++K L++S N+L + LE L L +N +
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKN 349
Query: 444 ISLQGN 449
++L N
Sbjct: 350 LTLSHN 355
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-30
Identities = 77/398 (19%), Positives = 139/398 (34%), Gaps = 61/398 (15%)
Query: 21 NLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80
L++ +++ +++ L R + LN+ + + + + +++ + +
Sbjct: 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108
Query: 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIP-YSLSNASNLELLDLSVNQFKGNVSID 139
N LP + N+P L L + N+ S+P N L L +S N + I+
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERND-LSSLPRGIFHNTPKLTTLSMSNNNLE---RIE 163
Query: 140 ---FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIAN 196
F + +L L L N L T +D SL +++ N
Sbjct: 164 DDTFQATTSLQNLQLSSNRL-----THVDLSLI----PSLFHANVSYNL----------- 203
Query: 197 LSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFR 256
LS+ + + + A N ++ + + L L L
Sbjct: 204 LST-------------------LAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQH 241
Query: 257 NFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLL 316
N L + L N L ++LS N L+ + Q L S N+L AL
Sbjct: 242 NNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQ 298
Query: 317 SITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDIS 376
I TL LDLS+N L + L L + N + T T L+ L +S
Sbjct: 299 PIPTLK-VLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT---LKNLTLS 353
Query: 377 SNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKN 414
N + +L +++ V + +I L++
Sbjct: 354 HNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 3e-15
Identities = 41/235 (17%), Positives = 81/235 (34%), Gaps = 27/235 (11%)
Query: 238 TIPDAIGELKNLQKLCLFRN----FLQGRIPSGL--GNLTKLANLELSSNSLQGNIPSSL 291
P+ NLQ C+F + + G L + +++++ + L
Sbjct: 12 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 71
Query: 292 GNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILD 350
+ + + + ++ + T+ L + N + LP V ++ L +L
Sbjct: 72 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQ-KLYMGFNAIR-YLPPHVFQNVPLLTVLV 129
Query: 351 ISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPE 410
+ N S + G L L +S+N+ + + S++ L +SSN L+
Sbjct: 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLS 189
Query: 411 FLKNLSV----------------LEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
+ +L +E L S+N V V T + LQ N
Sbjct: 190 LIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHN 242
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 23/157 (14%), Positives = 56/157 (35%), Gaps = 5/157 (3%)
Query: 296 NLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQ 355
+ + L + + + + + L N I+ ++
Sbjct: 3 GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62
Query: 356 FSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNL 415
+ L + +E L+++ + + ++ +I++L + N + P +N+
Sbjct: 63 MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122
Query: 416 SVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
+L L L N +P +G+F N K +S+ N
Sbjct: 123 PLLTVLVLERNDLS-SLP-RGIFHNTPKLTTLSMSNN 157
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 15/163 (9%)
Query: 537 NMIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRN 589
M+G+G FG V + L + VAVK+ LK + S F+ E ++ H +
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKM--LKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 590 LIKIITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
+ K++ + + KG + +M++G L +L S L L V +D+
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 649 ASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
A MEYL + +H DL N +L DM V DFGL++
Sbjct: 147 ACGMEYLSSRNF----IHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 3e-32
Identities = 48/224 (21%), Positives = 91/224 (40%), Gaps = 36/224 (16%)
Query: 532 EFSSSNMIGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIR 586
EF ++G G+FG VYKG + ++ VA+K + + + E + ++
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
+ ++ +++ IC ++ + + + M G L D++ + D + +N +
Sbjct: 76 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN-----IGSQYLLNWCV 124
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
+A M YL +VH DL NVL+ + DFGLAK L +
Sbjct: 125 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYHAEGG 179
Query: 707 SIGLKGTVGYVAPE---YGMGSEAS---MTG----DIFT-GRRP 739
+ +K A E + + + S G ++ T G +P
Sbjct: 180 KVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 68/222 (30%), Positives = 98/222 (44%), Gaps = 45/222 (20%)
Query: 539 IGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGAS----RSFVAECEALRNIRHRNLI 591
IG G G V G L G+ ++ VA+K + G + R F++E + H N+I
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALK---AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 592 KIITICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
++ + T + V EYMENGSL +L D Q +++Q V + V
Sbjct: 114 RLEGVV-------TRGRLAMIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVG 161
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
+ M YL VH DL NVL+D ++V V DFGL++ L D D A T I
Sbjct: 162 AGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-DAAYTTTGGKIP 217
Query: 710 LKGTVGYVAPE---YGMGSEAS--------MTGDIFT-GRRP 739
++ T APE + S AS M ++ G RP
Sbjct: 218 IRWT----APEAIAFRTFSSASDVWSFGVVMW-EVLAYGERP 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 66/223 (29%), Positives = 100/223 (44%), Gaps = 47/223 (21%)
Query: 539 IGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGAS----RSFVAECEALRNIRHRNLI 591
+G G FG V G L + E+ VA+K + G + R F+ E + H N+I
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 592 KIITICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
++ + T K V EYMENGSL +L + D Q ++IQ V + +A
Sbjct: 110 RLEGVV-------TKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIA 157
Query: 650 SAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
S M+YL VH DL N+L++ ++V V DFGL + L D + A T I
Sbjct: 158 SGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-EAAYTTRGGKI 212
Query: 709 GLKGTVGYVAPE---YGMGSEAS--------MTGDIFT-GRRP 739
++ T +PE Y + AS + ++ + G RP
Sbjct: 213 PIRWT----SPEAIAYRKFTSASDVWSYGIVLW-EVMSYGERP 250
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 58/219 (26%), Positives = 83/219 (37%), Gaps = 38/219 (17%)
Query: 539 IGQGSFGYVYKGTL---GEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIK 592
+G GSFG V +G + VAVK + A F+ E A+ ++ HRNLI+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + + K V E GSL D L + L A+ VA M
Sbjct: 86 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQGH-----FLLGTLSRYAVQVAEGM 134
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
YL +H DL N+LL + + DFGL + L + D V +
Sbjct: 135 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-DHYVMQEHRKVPFAW 190
Query: 713 TVGYVAPE---YGMGSEAS--------MTGDIFT-GRRP 739
APE S AS + ++FT G+ P
Sbjct: 191 C----APESLKTRTFSHASDTWMFGVTLW-EMFTYGQEP 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-31
Identities = 59/283 (20%), Positives = 107/283 (37%), Gaps = 37/283 (13%)
Query: 466 SKGSRKPKIILLKVLIPVAVSSL----ILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMV 521
R+ + +L+P L + T +Y + F + + +
Sbjct: 12 HHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSAL 71
Query: 522 S---YAELSKATGEFSSSN-----MIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKG 570
+ + SS +IG+G FG VY GTL ++ AVK +N
Sbjct: 72 NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDI 131
Query: 571 ASRS-FVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD 629
S F+ E +++ H N++ ++ IC +G+ V YM++G L++++
Sbjct: 132 GEVSQFLTEGIIMKDFSHPNVLSLLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETH 187
Query: 630 QVEVCKLSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688
++ + + VA M++L VH DL N +LD V DFGL
Sbjct: 188 N-----PTVKDLIGFGLQVAKGMKFLASKKF----VHRDLAARNCMLDEKFTVKVADFGL 238
Query: 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE---YGMGSEAS 728
A+ + D + D+ + + +K A E + S
Sbjct: 239 ARDMYDKEFDSVHNKTGAKLPVKWM----ALESLQTQKFTTKS 277
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 76/338 (22%), Positives = 121/338 (35%), Gaps = 52/338 (15%)
Query: 97 NLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156
L +G + ++P L ++ L + N S+ + L L + N L
Sbjct: 41 GNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT---SLP-ALPPELRTLEVSGNQL 93
Query: 157 GTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIP 216
T L L S LP + L I NQ++ ++P
Sbjct: 94 -----TSLP--VLPPGLLELSIFSNPLTH----LPALPSGLCK----LWIFGNQLT-SLP 137
Query: 217 PGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANL 276
L L +NQL ++P L KL + N L +P L +L
Sbjct: 138 VLPPGLQELS---VSDNQL-ASLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQEL--- 186
Query: 277 ELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSL 336
+S N L ++P+ L A N+LT +LP + L +S N L SL
Sbjct: 187 SVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPALPSGLKEL----IVSGNRLT-SL 236
Query: 337 PLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKE 396
P+ LK L +S N+ + +P S L L + N +P SL L S
Sbjct: 237 PVLPSELKEL---MVSGNRLTS-LPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETT 288
Query: 397 LNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434
+N+ N LS + + L+ ++ S F+ +
Sbjct: 289 VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-30
Identities = 71/338 (21%), Positives = 121/338 (35%), Gaps = 56/338 (16%)
Query: 67 ICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLD 126
C + ++ + + + LP + ++ L I NN S+P L L+
Sbjct: 36 ACLNNGNAVLNVGESGLT-TLPDCL---PAHITTLVIPDNNL-TSLPALPPE---LRTLE 87
Query: 127 LSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186
+S NQ ++ + L L + +L S L L + NQ
Sbjct: 88 VSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-------------LPSGLCKLWIFGNQL 133
Query: 187 GGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGEL 246
LP L + NQ++ ++P L L A NQL ++P
Sbjct: 134 T-SLPVLPPGLQE----LSVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPS-- 181
Query: 247 KNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNK 306
LQ+L + N L +P+ L L +N L ++P+ + L S N+
Sbjct: 182 -GLQELSVSDNQLA-SLPTLPSELY---KLWAYNNRLT-SLPALPSGLKEL---IVSGNR 232
Query: 307 LTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLST 366
LT +LP + L +S N L SLP+ L+ L + NQ + +P +L
Sbjct: 233 LT-SLPVLPSELKEL----MVSGNRLT-SLPMLPS---GLLSLSVYRNQLT-RLPESLIH 282
Query: 367 CVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNL 404
+++ N +L L+ I S +
Sbjct: 283 LSSETTVNLEGNPL---SERTLQALREITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-28
Identities = 68/330 (20%), Positives = 108/330 (32%), Gaps = 47/330 (14%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+TL V+ N LT LP L +L + L L L L + N+ +
Sbjct: 83 LRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPA-------LPSGLCKLWIFGNQLT 134
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
P + L + L L L A NN S+P S
Sbjct: 135 S-LPVLPPGLQELSVSDNQLASLPALPS-----ELCKLWAY----NNQLTSLPMLPSG-- 182
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L+ L +S NQ S+ + L L N L T L S LK L
Sbjct: 183 -LQELSVSDNQLA---SLP-TLPSELYKLWAYNNRL-----TSLP-----ALPSGLKELI 227
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
++ N+ LP + L + N+++ ++P L++L NQL +P
Sbjct: 228 VSGNRLT-SLPVLPSELK----ELMVSGNRLT-SLPMLPSGLLSLS---VYRNQLT-RLP 277
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+++ L + + L N L R L +T S+ + L
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL- 336
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNN 330
A+ + L A + ++ N
Sbjct: 337 -AAADWLVPAREGEPAPADRWHMFGQEDNA 365
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 6e-28
Identities = 72/370 (19%), Positives = 118/370 (31%), Gaps = 77/370 (20%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L V ++ LT LPD + + + I N+L +P L +L V+ N+ +
Sbjct: 42 NAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPP---ELRTLEVSGNQLT 94
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
P + L + L + L L I GN S+P
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTH--------LPALPSGLCKLWIFGNQL-TSLPVLPPG-- 142
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L+ L +S NQ S+ + L L N L T L S L+ LS
Sbjct: 143 -LQELSVSDNQLA---SLP-ALPSELCKLWAYNNQL-----TSLP-----MLPSGLQELS 187
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
++DNQ LP + L N+++ ++P L LI N+L ++P
Sbjct: 188 VSDNQLA-SLPTLPSELY----KLWAYNNRLT-SLPALPSGLKELI---VSGNRL-TSLP 237
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
L++L + N L +P L L + N L +P SL + +
Sbjct: 238 VLPS---ELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSET-- 287
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI 360
++L N L+ + + + +F
Sbjct: 288 -----------------------TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAG 324
Query: 361 PGTLSTCVCL 370
L
Sbjct: 325 ASAPRETRAL 334
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 19/105 (18%), Positives = 35/105 (33%), Gaps = 8/105 (7%)
Query: 325 LDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI 384
+ S ++ +L++ + + +P L + L I N+ +
Sbjct: 21 AEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SL 76
Query: 385 PLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE 429
P L++ L VS N L+ +P L L S H
Sbjct: 77 PALPPELRT---LEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP 117
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 66/223 (29%), Positives = 104/223 (46%), Gaps = 46/223 (20%)
Query: 539 IGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGAS----RSFVAECEALRNIRHRNL 590
IG G FG VYKG L G+ E+ VA+K + G + F+ E + H N+
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK---AGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 591 IKIITICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
I++ + + +K + EYMENG+L +L + D + S++Q V + +
Sbjct: 109 IRLEGVI-------SKYKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGMLRGI 156
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
A+ M+YL + VH DL N+L++ ++V V DFGL++ L D + T I
Sbjct: 157 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EATYTTSGGKI 212
Query: 709 GLKGTVGYVAPE---YGMGSEAS--------MTGDIFT-GRRP 739
++ T APE Y + AS M ++ T G RP
Sbjct: 213 PIRWT----APEAISYRKFTSASDVWSFGIVMW-EVMTYGERP 250
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 25/200 (12%)
Query: 537 NMIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIK 592
+IG+G FG VY GTL ++ AVK +N S F+ E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
++ IC +G+ V YM++G L++++ ++ + + VA M
Sbjct: 91 LLGIC--LRSEGSPL--VVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAKGM 141
Query: 653 EYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+YL VH DL N +LD V DFGLA+ + D + + + + +K
Sbjct: 142 KYLASKKF----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 712 GTVGYVAPE---YGMGSEAS 728
A E + S
Sbjct: 198 WM----ALESLQTQKFTTKS 213
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 17/163 (10%)
Query: 539 IGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKII 594
+G+G+FG V +VAVK + R F E + L+ + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ + V EY+ +G L+D+L + + L + + + + MEY
Sbjct: 91 GVSYGPGRQSL---RLVMEYLPSGCLRDFLQRHRAR-----LDASRLLLYSSQICKGMEY 142
Query: 655 LH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
L C VH DL N+L++ + + DFGLAK L +
Sbjct: 143 LGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-31
Identities = 53/197 (26%), Positives = 93/197 (47%), Gaps = 31/197 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIITI 596
+G G +G VY+G + + VAVK + + F+ E ++ I+H NL++++ +
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 597 CSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
C T F + E+M G+L D+L + + Q ++S + + +A ++SAMEY
Sbjct: 285 C-------TREPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEY 333
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
L +H +L N L+ + + V DFGL++ ++ DT + +K T
Sbjct: 334 LEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWT- 386
Query: 715 GYVAPE---YGMGSEAS 728
APE Y S S
Sbjct: 387 ---APESLAYNKFSIKS 400
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-31
Identities = 69/349 (19%), Positives = 124/349 (35%), Gaps = 43/349 (12%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
F ++P + + LLDL N+ K +F+S +L L L +N + + ++
Sbjct: 20 RKRFVAVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-----SAVE 72
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVN 224
F N +L+ L L N+ IP G+ L N
Sbjct: 73 PGAF-NNLFNLRTLGLRSNRLK--------------------------LIPLGVFTGLSN 105
Query: 225 LIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSNSL 283
L EN++ + +L NL+ L + N L I L L L L +L
Sbjct: 106 LTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL 164
Query: 284 QGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHL 343
+L + L+ + A+ L++S+ ++ +
Sbjct: 165 TSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYG 223
Query: 344 KNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNN 403
NL L I+ + V + V L +L++S N + L L ++E+ +
Sbjct: 224 LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQ 283
Query: 404 LSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
L+ P + L+ L L++S N + + VF + + L N
Sbjct: 284 LAVVEPYAFRGLNYLRVLNVSGNQLT-TLE-ESVFHSVGNLETLILDSN 330
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-29
Identities = 66/317 (20%), Positives = 123/317 (38%), Gaps = 22/317 (6%)
Query: 96 PNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID---FSSLKNLLWLNLE 152
+ L +G N ++ +LE L+L+ N +++ F++L NL L L
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS---AVEPGAFNNLFNLRTLGLR 88
Query: 153 QNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQI 211
N L + F T S+L L +++N+ L + +L + + +G N +
Sbjct: 89 SNRL-----KLIPLGVF-TGLSNLTKLDISENKIVILLDYMFQDLYNLKSLE--VGDNDL 140
Query: 212 SGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGN 269
I L +L E+ L +A+ L L L L + I
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKR 198
Query: 270 LTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSN 329
L +L LE+S + + NL S + + LT A+P+ + +L+LS
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSY 257
Query: 330 NLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSL 388
N ++ ++ + L L + + Q + V P L L++S N +
Sbjct: 258 NPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVF 316
Query: 389 SFLKSIKELNVSSNNLS 405
+ +++ L + SN L+
Sbjct: 317 HSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 68/312 (21%), Positives = 107/312 (34%), Gaps = 11/312 (3%)
Query: 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82
++ ++ + N + +L L + EN S + P + N+ +L + L NR
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSS 142
+P + L NL L I N + Y + NL+ L++ N FS
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 143 LKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVI 202
L +L L LE+ NL T + ++ L L L +S L +
Sbjct: 151 LNSLEQLTLEKCNL-----TSIPTEAL-SHLHGLIVLRLRHLNINAIRDYSFKRLYR-LK 203
Query: 203 NFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGR 262
I T+ P +NL L A+ L L+ L L N +
Sbjct: 204 VLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-T 262
Query: 263 IPSG-LGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTL 321
I L L +L ++L L P + L S N+LT L +
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGN 321
Query: 322 SLYLDLSNNLLN 333
L L +N L
Sbjct: 322 LETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-24
Identities = 63/289 (21%), Positives = 109/289 (37%), Gaps = 18/289 (6%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+ L +N+N ++ P NL +L + + N L L NL L+++ENK
Sbjct: 58 LEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV 117
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIP-YSLSNA 119
+ ++ +L+ +++ N + L +L+ L + N SIP +LS+
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCN-LTSIPTEALSHL 175
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL 179
L +L L F L L L + + +L +L
Sbjct: 176 HGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN------CLYGLNLTSL 229
Query: 180 SLADNQFGGELPH-SIANLSS-TVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLH 236
S+ +P+ ++ +L +N + N IS TI + L+ L QL
Sbjct: 230 SITHCNL-TAVPYLAVRHLVYLRFLN--LSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285
Query: 237 GTIPDAIGELKNLQKLCLFRNFLQGRIPSGL-GNLTKLANLELSSNSLQ 284
P A L L+ L + N L + + ++ L L L SN L
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 47/200 (23%), Positives = 82/200 (41%), Gaps = 25/200 (12%)
Query: 537 NMIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIK 592
+IG+G FG VY G ++ + A+K ++ + F+ E +R + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+I I +G + YM +G L ++ ++ ++ + VA M
Sbjct: 87 LIGIM--LPPEGLPH--VLLPYMCHGDLLQFIRSPQRN-----PTVKDLISFGLQVARGM 137
Query: 653 EYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
EYL VH DL N +LD V DFGLA+ + D + + + + + +K
Sbjct: 138 EYLAEQKF----VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193
Query: 712 GTVGYVAPE---YGMGSEAS 728
T A E + S
Sbjct: 194 WT----ALESLQTYRFTTKS 209
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-31
Identities = 69/418 (16%), Positives = 140/418 (33%), Gaps = 51/418 (12%)
Query: 32 GNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDI 91
+ + L L SL+ + + M I ++ L + N + L
Sbjct: 27 AFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNIT-TLDL-- 81
Query: 92 VVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNL 151
NL LA N ++ ++ + L L+ N+ +D S L +LN
Sbjct: 82 -SQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNC 134
Query: 152 EQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQI 211
+N L T++D +++ + L L N+ +L + + + N+I
Sbjct: 135 ARNTL-----TEID----VSHNTQLTELDCHLNKKITKLD--VTPQTQ-LTTLDCSFNKI 182
Query: 212 SGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLT 271
+ + + L + N + + + + L L N L I + LT
Sbjct: 183 T-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLT 233
Query: 272 KLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNL 331
+L + S N L + S L + Q L + +T + +
Sbjct: 234 QLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLLE------IDLTHNTQLIYFQAEG 284
Query: 332 LNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFL 391
L V H L +LD + + + LS L YL +++ L +S
Sbjct: 285 CRKIKELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELTE---LDVSHN 338
Query: 392 KSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
+K L+ + ++ + + L + +P + + +N I++ +
Sbjct: 339 TKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPD 393
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 64/408 (15%), Positives = 125/408 (30%), Gaps = 54/408 (13%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L +L +++ +T + L+ L + N++ + L NL L NK +
Sbjct: 44 LTSLDCHNSSIT-DMTGI-EKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT 98
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ + ++ L + N+ + L P L L N + +
Sbjct: 99 NL---DVTPLTKLTYLNCDTNKLT-KLDVS---QNPLLTYLNCARNTL-----TEIDVSH 146
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
N +L +L + K +D + L L+ N + T+LD + L L+
Sbjct: 147 NTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKI-----TELDV----SQNKLLNRLN 197
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
N +L + + N+++ I + L L F N L +
Sbjct: 198 CDTNNIT-KLD--LNQNIQ-LTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD 249
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ L L L + L I L + T+L + + + L
Sbjct: 250 --VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRK--IKELDVTHNTQLYLL 302
Query: 301 TASQNKLTGALPHQLLSITTLS--LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSG 358
+T L ++ +YL L+N L L + H L L +
Sbjct: 303 DCQAAGITE------LDLSQNPKLVYLYLNNTELT-ELDV--SHNTKLKSLSCVNAHIQD 353
Query: 359 VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG 406
+ L + + +L+ ++ + G
Sbjct: 354 FSS--VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 57/358 (15%), Positives = 113/358 (31%), Gaps = 51/358 (14%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L N LT ++ V + + L + N K+ + L +L+ + NK +
Sbjct: 129 LTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ + L + N + L + L L N I ++ +
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNIT-KLDLN---QNIQLTFLDCSSNKL-TEID--VTPLT 233
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L D SVN +D S+L L L+ Q +L ++D LT+ + L
Sbjct: 234 QLTYFDCSVNPLT---ELDVSTLSKLTTLHCIQTDL-----LEID----LTHNTQLIYFQ 281
Query: 181 LADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239
+ EL + + + +++ I+ + + L+ +L +
Sbjct: 282 AEGCRKIKELD--VTHNTQLYLLD--CQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL 333
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMS 299
+ L+ L +Q S +G + L N + +L N
Sbjct: 334 D--VSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTN------ 383
Query: 300 FTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFS 357
N LT A+ LL + ++ + + + + F+
Sbjct: 384 -----NSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFT 436
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 539 IGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKII 594
+G+G+FG V +VAVK + + R F E E L++++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+C S + + EY+ GSL+D+L + ++ + I+ + + MEY
Sbjct: 78 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEY 129
Query: 655 LH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
L +H DL N+L++++ + DFGL K L +
Sbjct: 130 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 539 IGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKI 593
+G+G FG V VAVK + + G + E E LRN+ H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
IC+ G + E++ +GSLK++L ++ ++ ++L Q++ A+ + M+
Sbjct: 89 KGICTEDGGNGI---KLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYAVQICKGMD 140
Query: 654 YLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
YL VH DL NVL++ + + DFGL K + +
Sbjct: 141 YLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 58/218 (26%), Positives = 100/218 (45%), Gaps = 43/218 (19%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIITI 596
+G G +G VY+G + + VAVK + + F+ E ++ I+H NL++++ +
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 597 CSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
C T F + E+M G+L D+L + + Q ++S + + +A ++SAMEY
Sbjct: 78 C-------TREPPFYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEY 126
Query: 655 L-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
L + +H DL N L+ + + V DFGL++ ++ DT + +K T
Sbjct: 127 LEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWT 179
Query: 714 VGYVAPE---YGMGSEAS--------MTGDIFT-GRRP 739
APE Y S S + +I T G P
Sbjct: 180 ----APESLAYNKFSIKSDVWAFGVLLW-EIATYGMSP 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 42/163 (25%), Positives = 75/163 (46%), Gaps = 17/163 (10%)
Query: 539 IGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKII 594
+G+G+FG V +VAVK + + R F E E L++++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+C S + + EY+ GSL+D+L + ++ + I+ + + MEY
Sbjct: 109 GVCYSAGRRNL---KLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGMEY 160
Query: 655 LH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
L +H DL N+L++++ + DFGL K L +
Sbjct: 161 LGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITIC 597
IG+G+FG V+ G L D +VAVK F+ E L+ H N++++I +C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 598 SSTD--FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ + V E ++ G +L +L + + + D A+ MEYL
Sbjct: 182 TQKQPIY-------IVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYL 229
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
+H DL N L+ V + DFG+++ +D
Sbjct: 230 ESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 39/161 (24%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 539 IGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKII 594
+G+G FG VY+G +++ VAVK ++ F++E ++N+ H +++K+I
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
I + E G L +L ++ + L ++ V ++ + AM Y
Sbjct: 80 GIIEEEPTW------IIMELYPYGELGHYLERNKNS-----LKVLTLVLYSLQICKAMAY 128
Query: 655 L-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
L +C VH D+ N+L+ + DFGL++++ D
Sbjct: 129 LESINC----VHRDIAVRNILVASPECVKLGDFGLSRYIED 165
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-30
Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 19/168 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIR 586
EF ++G G+FG VYKG + ++ VA+K + + + E + ++
Sbjct: 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
+ ++ +++ IC ++ + + + M G L D++ + D + +N +
Sbjct: 76 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDN-----IGSQYLLNWCV 124
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
+A M YL +VH DL NVL+ + DFGLAK L
Sbjct: 125 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 36/217 (16%)
Query: 539 IGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKI 593
+G G FG V+KG ++ V +KVI K S A+ ++ H +++++
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
+ +C + + V +Y+ GSL D + Q L +N + +A M
Sbjct: 81 LGLCPGSSLQ------LVTQYLPLGSLLDHVRQHRGA-----LGPQLLLNWGVQIAKGMY 129
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YL H MVH +L NVLL V DFG+A L D + + +K
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWM 184
Query: 714 VGYVAPE---YGMGSEAS---MTG----DIFT-GRRP 739
A E +G + S G ++ T G P
Sbjct: 185 ----ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 38/164 (23%), Positives = 67/164 (40%), Gaps = 26/164 (15%)
Query: 539 IGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGAS----RSFVAECEALRNIRHRNLI 591
IG+G FG V++G + VA+K S F+ E +R H +++
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
K+I + + + E G L+ +L L L + A +++A
Sbjct: 80 KLIGVITENPVW------IIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTA 128
Query: 652 MEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
+ YL VH D+ NVL+ + + DFGL++++ D
Sbjct: 129 LAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 38/160 (23%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 539 IGQGSFGYVYKGTL--GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKIIT 595
+G G+FG V +G + ++ VA+KV+ + A + E + + + + ++++I
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+C + V E G L +L ++ + + + V+ M+YL
Sbjct: 78 VCQAEALM------LVMEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMKYL 126
Query: 656 -HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
+ VH DL NVLL + A + DFGL+K L
Sbjct: 127 EEKNF----VHRDLAARNVLLVNRHYAKISDFGLSKALGA 162
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 45/163 (27%), Positives = 75/163 (46%), Gaps = 25/163 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIITI 596
+G G FG V G + VA+K+I +G+ F+ E + + N+ H L+++ +
Sbjct: 32 LGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 597 CSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
C T + + EYM NG L ++L + + Q + + DV AMEY
Sbjct: 88 C-------TKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEY 135
Query: 655 L-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
L +H DL N L++ V V DFGL++++ D +
Sbjct: 136 LESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 49/164 (29%), Positives = 71/164 (43%), Gaps = 20/164 (12%)
Query: 539 IGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKI 593
+G+G FG V +VAVK + RS + E + LR + H ++IK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
C V EY+ GSL+D+L + + L Q + A + M
Sbjct: 99 KGCCEDAGAASL---QLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMA 148
Query: 654 YLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
YLH H +H DL NVLLD+D + + DFGLAK + +
Sbjct: 149 YLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 22/178 (12%)
Query: 519 PMVSYAELSKATGEFSSS-----NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASR 573
+ + E ++ + IG+G FG V G ++ VAVK +K ++
Sbjct: 4 SVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC--IKNDATAQ 59
Query: 574 SFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEV 633
+F+AE + +RH NL++++ + + V EYM GSL D+L
Sbjct: 60 AFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRS--- 112
Query: 634 CKLSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
L + ++DV AMEYL ++ VH DL NVL+ D VA V DFGL K
Sbjct: 113 -VLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 42/161 (26%), Positives = 82/161 (50%), Gaps = 21/161 (13%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIITI 596
+G G FG V+ G VAVK + +G+ +F+AE ++ ++H+ L+++ +
Sbjct: 21 LGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL- 655
+ + EYMENGSL D+L KL++ + +++A +A M ++
Sbjct: 77 VTQEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIE 126
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
+ +H DL+ +N+L+ + + DFGLA+ + D++
Sbjct: 127 ERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 25/163 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIITI 596
IG G FG V+ G ++ VA+K I +GA F+ E E + + H L+++ +
Sbjct: 16 IGSGQFGLVHLGYW-LNKDKVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 597 CSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
C + V E+ME+G L D+L + + + +DV M Y
Sbjct: 72 C-------LEQAPICLVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAY 119
Query: 655 L-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
L +H DL N L+ + V V DFG+ +F+ D Q
Sbjct: 120 LEEACV----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 45/218 (20%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIITI 596
+G G FG V G + + VAVK+I +G+ F E + + + H L+K +
Sbjct: 16 LGSGQFGVVKLGKW-KGQYDVAVKMIK---EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 597 CSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
C + V EY+ NG L ++L L Q + + DV M +
Sbjct: 72 C-------SKEYPIYIVTEYISNGCLLNYLRSHGKG-----LEPSQLLEMCYDVCEGMAF 119
Query: 655 L-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
L H +H DL N L+D D+ V DFG+ +++ D D V + + +K +
Sbjct: 120 LESHQF----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQYVSSVGTKFPVKWS 172
Query: 714 VGYVAPE---YGMGSEAS--------MTGDIFT-GRRP 739
APE Y S S M ++F+ G+ P
Sbjct: 173 ----APEVFHYFKYSSKSDVWAFGILMW-EVFSLGKMP 205
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 72/401 (17%), Positives = 135/401 (33%), Gaps = 44/401 (10%)
Query: 48 NLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNN 107
++ ++++ N + + S + L+ +++ + + L +L L + N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 108 FFGSIPYS-LSNASNLELLDLSVNQFKGNVSID--FSSLKNLLWLNLEQNNLGTGTATDL 164
F + + +NLE+L L+ G V F L +L L L NN+ +
Sbjct: 91 F-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNI-----KKI 144
Query: 165 DFVTFLTNCSSLKALSLADNQFGGELPHSIANLSST-VINFGIGRNQISGTIPPGIRNLV 223
+F N L L N+ + N + +
Sbjct: 145 QPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDM--------- 195
Query: 224 NLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG---LGNLTKLANLELSS 280
E L + ++ L L N + + TK+ +L LS+
Sbjct: 196 -------NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248
Query: 281 N-----SLQGNIPSSLGNCQ-------NLMSFTASQNKLTGALPHQLLSITTLSLYLDLS 328
+ S N + + S++K+ AL + S T L L+
Sbjct: 249 SYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLA 307
Query: 329 NNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLS 387
N +N + L +L+ L++S N + LE LD+S N + S
Sbjct: 308 QNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQS 366
Query: 388 LSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHF 428
L ++KEL + +N L L+ L+ + L N +
Sbjct: 367 FLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-27
Identities = 72/392 (18%), Positives = 139/392 (35%), Gaps = 26/392 (6%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPT-TLGLLRNLVSLNVAENKF 59
+ + ++ N + L DL+ +++ + G I T L +L+ L + N+F
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 60 SGMFPRSICNISSLELIQLALNRF-SGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL-S 117
+ + +++LE++ L L + L +L+ L + NN P S
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
Query: 118 NASNLELLDLSVNQFKGNVSIDFSSL--KNLLWLNLEQNNLGTGTATDLDFVTF--LTNC 173
N +LDL+ N+ K D + K+ L L L L +
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 174 SSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEEN 233
+S+ L L+ N F + + + I I + +G
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGT------------KIQSLILSNSYNMGSSFGHT 259
Query: 234 QLHGTIPDAIGELK--NLQKLCLFRNFLQGRIPSGL-GNLTKLANLELSSNSLQGNIPSS 290
L+ ++ L ++ + + + + T L L L+ N + ++
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318
Query: 291 LGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVIL 349
+L+ SQN L ++ ++ LDLS N + +L Q L NL L
Sbjct: 319 FWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKEL 376
Query: 350 DISSNQFSGVIPGTLSTCVCLEYLDISSNSFH 381
+ +NQ V G L+ + + +N +
Sbjct: 377 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 47/292 (16%), Positives = 91/292 (31%), Gaps = 39/292 (13%)
Query: 192 HSIANLSSTVINFGIGRNQISGTIPPG-IRNLVNLIGFGAEENQLHGTIP-DAIGELKNL 249
H + L + V + N I+ + L +L E+ I + L +L
Sbjct: 23 HQVPELPAHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSL 81
Query: 250 QKLCLFRNFLQGRIPSG-LGNLTKLANLELSSNSLQGNI--PSSLGNCQNLMSFTASQNK 306
L L N ++ +G L L L L+ +L G + + +L N
Sbjct: 82 IILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 307 LTGALPHQLL-SITTLSLYLDLSNNLLN----------GSLPLQVGHLKNLVILDISSNQ 355
+ P ++ LDL+ N + + L ++ + D++
Sbjct: 141 IKKIQPASFFLNMRRFH-VLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199
Query: 356 FSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKN- 414
G + LD+S N F + + ++ + S + +
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 415 --------------LSVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
S ++ LS + + K VFS+ T ++L N
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALL-KSVFSHFTDLEQLTLAQN 309
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 39/158 (24%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G FG V+ T VAVK + + +F+AE ++ ++H L+K+ + +
Sbjct: 196 LGAGQFGEVWMATY-NKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+ E+M GSL D+L + K L + ++ + +A M ++
Sbjct: 254 KEPI------YIITEFMAKGSLLDFLKSDEGS----KQPLPKLIDFSAQIAEGMAFIEQR 303
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
+H DL+ +N+L+ +V + DFGLA+ + D++
Sbjct: 304 N---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 48/195 (24%), Positives = 92/195 (47%), Gaps = 18/195 (9%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASR-SFVAECEALRNIRHRNLIK---- 592
+G+G FG V++ D+ A+K I L + +R + E +AL + H +++
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 593 IITICSSTDFKGTDFKAFVF---EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+ ++ + + K +++ + +LKDW++ + + + ++I + +A
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG---RCTIEERERSVCLHIFLQIA 128
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
A+E+LH ++H DLKPSN+ D V V DFGL + + + V TP +
Sbjct: 129 EAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 710 LK----GTVGYVAPE 720
GT Y++PE
Sbjct: 186 RHTGQVGTKLYMSPE 200
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 22/186 (11%)
Query: 511 TSPMEKQFPMVSYAELSKATGEFSSS-----NMIGQGSFGYVYKGTLGEDEMIVAVKVIN 565
P + + + E ++ + IG+G FG V G ++ VAVK
Sbjct: 168 IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNK--VAVKC-- 223
Query: 566 LKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLH 625
+K +++F+AE + +RH NL++++ + + V EYM GSL D+L
Sbjct: 224 IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLR 279
Query: 626 QSDDQVEVCKLSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684
L + ++DV AMEYL ++ VH DL NVL+ D VA V
Sbjct: 280 SRGRS----VLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVS 331
Query: 685 DFGLAK 690
DFGL K
Sbjct: 332 DFGLTK 337
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 42/167 (25%), Positives = 73/167 (43%), Gaps = 28/167 (16%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRN 589
+GQGSFG VY+G E E VA+K +N + AS F+ E ++ +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASVMKEFNCHH 89
Query: 590 LIKIITICSSTDFKGTDFKAF-VFEYMENGSLKDWL----HQSDDQVEVCKLSLIQRVNI 644
+++++ + S + E M G LK +L + + SL + + +
Sbjct: 90 VVRLLGVVSQGQ------PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 645 AIDVASAMEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
A ++A M YL+ + VH DL N ++ D + DFG+ +
Sbjct: 144 AGEIADGMAYLNANKF----VHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 25/200 (12%)
Query: 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN-LKYKGASRSFVAECEALRNI 585
S + + S+++GQG+ V++G + + A+KV N + + + E E L+ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
H+N++K+ I + T K + E+ GSL L + L + + +
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVL 118
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCDFGLAKFLSD-HQLDTA 700
DV M +L + +VH ++KP N++ D V + DFG A+ L D Q +
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 701 VKTPSSSIGLKGTVGYVAPE 720
GT Y+ P+
Sbjct: 176 Y----------GTEEYLHPD 185
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 34/176 (19%), Positives = 76/176 (43%), Gaps = 34/176 (19%)
Query: 539 IGQGSFGYVYKGTL-------GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+GQG+F ++KG E V +KV++ ++ S SF + + H++L+
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 592 KIITICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+C V E+++ GSL +L ++ + ++++ ++ +A +A
Sbjct: 76 LNYGVC-------VCGDENILVQEFVKFGSLDTYLKKNKNC-----INILWKLEVAKQLA 123
Query: 650 SAMEYL-HHHCQPPMVHGDLKPSNVLLDHD--------MVAHVCDFGLAKFLSDHQ 696
+AM +L + +HG++ N+LL + + D G++ +
Sbjct: 124 AAMHFLEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 53/218 (24%), Positives = 87/218 (39%), Gaps = 39/218 (17%)
Query: 539 IGQGSFGYVYKGTL--GEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKII 594
+G G+FG V KG + VAVK++ + +AE ++ + + ++++I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
IC + + V E E G L +L Q+ + + + V+ M+Y
Sbjct: 85 GICEAESWM------LVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKY 132
Query: 655 L-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
L + VH DL NVLL A + DFGL+K L + + +K
Sbjct: 133 LEESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALRADE-NYYKAQTHGKWPVKWY 187
Query: 714 VGYVAPE---YGMGSEAS--------MTGDIFT-GRRP 739
APE Y S S M + F+ G++P
Sbjct: 188 ----APECINYYKFSSKSDVWSFGVLMW-EAFSYGQKP 220
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 47/230 (20%), Positives = 88/230 (38%), Gaps = 28/230 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G+G F YV D A+K I + E + R H N+++++
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA--Y 94
Query: 599 STDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+G +A+ + + + G+L + + + D+ L+ Q + + + + +E +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN--FLTEDQILWLLLGICRGLEAIH- 151
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS-DHQLDTAVKTPSSSIGLKGTVGY 716
H DLKP+N+LL + + D G + T + T+ Y
Sbjct: 152 --AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
Query: 717 VAPE------YGMGSEASMTGDI----------FTGRRPIDAVFNEGHSL 750
APE + + E + D+ G P D VF +G S+
Sbjct: 210 RAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 47/208 (22%), Positives = 79/208 (37%), Gaps = 23/208 (11%)
Query: 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR 586
+ +F ++GQG+FG V K D A+K I + + ++E L ++
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLN 60
Query: 587 HRNLIKIITICSSTDFKGTDFKA--------FVFEYMENGSLKDWLHQSDDQVEVCKLSL 638
H+ +++ A EY ENG+L D +H E
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-----ENLNQQR 115
Query: 639 IQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLD 698
+ + + A+ Y+H ++H DLKP N+ +D + DFGLAK +
Sbjct: 116 DEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 699 TAVKTPSSSIGLK------GTVGYVAPE 720
+ + + GT YVA E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATE 200
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-29
Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 15/158 (9%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+GQG FG V+ GT VA+K + + +F+ E + ++ +RH L+++ + S
Sbjct: 192 LGQGCFGEVWMGTW-NGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
V EYM GSL D+L + L L Q V++A +AS M Y+
Sbjct: 250 EEPI------YIVTEYMSKGSLLDFLKGETGKY----LRLPQLVDMAAQIASGMAYVERM 299
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
VH DL+ +N+L+ ++V V DFGLA+ + D++
Sbjct: 300 N---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-28
Identities = 54/191 (28%), Positives = 87/191 (45%), Gaps = 22/191 (11%)
Query: 511 TSPMEKQFPMVSYAELSKATGEFSSS-----NMIGQGSFGYVYKGTLGEDEMIVAVKVIN 565
T+ P L+K E +GQG FG V+ GT VA+K +
Sbjct: 244 TTVCPTSKPQTQG--LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK 300
Query: 566 LKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLH 625
+ +F+ E + ++ +RH L+++ + S V EYM GSL D+L
Sbjct: 301 PGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI------YIVTEYMSKGSLLDFLK 353
Query: 626 QSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685
+ L L Q V++A +AS M Y+ VH DL+ +N+L+ ++V V D
Sbjct: 354 GETGK----YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD 406
Query: 686 FGLAKFLSDHQ 696
FGLA+ + D++
Sbjct: 407 FGLARLIEDNE 417
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 52/217 (23%), Positives = 87/217 (40%), Gaps = 38/217 (17%)
Query: 539 IGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKII 594
IG+G FG V++G M VA+K + R F+ E +R H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ + + E G L+ +L L L + A +++A+ Y
Sbjct: 458 GVITENPV------WIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAY 506
Query: 655 LH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
L VH D+ NVL+ + + DFGL++++ D T K + +K
Sbjct: 507 LESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMED---STYYKASKGKLPIKWM 559
Query: 714 VGYVAPE---YGMGSEAS---MTG----DIFT-GRRP 739
APE + + AS M G +I G +P
Sbjct: 560 ----APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 34/174 (19%)
Query: 537 NMIGQGSFGYVYKGTL--GEDEMIVAVKVINLKYKGASRS----FVAECEALRNI-RHRN 589
++IG+G+FG V K + M A+K +K + AS+ F E E L + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR--MK-EYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 590 LIKIITICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQS----------DDQVEVCKLS 637
+I ++ C EY +G+L D+L +S LS
Sbjct: 88 IINLLGAC-------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 140
Query: 638 LIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
Q ++ A DVA M+YL +H DL N+L+ + VA + DFGL++
Sbjct: 141 SQQLLHFAADVARGMDYLSQKQF----IHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 38/190 (20%), Positives = 79/190 (41%), Gaps = 11/190 (5%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKII-- 594
++ +G F +VY+ A+K + + +R+ + E ++ + H N+++
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ + + + G L ++L + + + LS + I A+++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG---PLSCDTVLKIFYQTCRAVQH 151
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS----IGL 710
+H +PP++H DLK N+LL + +CDFG A +S + + + I
Sbjct: 152 MHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 711 KGTVGYVAPE 720
T Y PE
Sbjct: 211 NTTPMYRTPE 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-28
Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 25/200 (12%)
Query: 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN-LKYKGASRSFVAECEALRNI 585
S + + S+++GQG+ V++G + + A+KV N + + + E E L+ +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
H+N++K+ I + T K + E+ GSL L + L + + +
Sbjct: 65 NHKNIVKLFAI---EEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVL 118
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCDFGLAKFLSD-HQLDTA 700
DV M +L + +VH ++KP N++ D V + DFG A+ L D Q +
Sbjct: 119 RDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL 175
Query: 701 VKTPSSSIGLKGTVGYVAPE 720
GT Y+ P+
Sbjct: 176 Y----------GTEEYLHPD 185
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 30/168 (17%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRN 589
+G G+FG VY+G + + VAVK + + S F+ E + H+N
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 94
Query: 590 LIKIITICSSTD--FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK-LSLIQRVNIAI 646
+++ I + + F + E M G LK +L ++ + L+++ +++A
Sbjct: 95 IVRCIGVSLQSLPRF-------ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 647 DVASAMEYL-HHHCQPPMVHGDLKPSNVLLD---HDMVAHVCDFGLAK 690
D+A +YL +H +H D+ N LL VA + DFG+A+
Sbjct: 148 DIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 30/170 (17%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIK 592
+G+ FG VYKG L GE VA+K + K +G R F E ++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 593 IITICSSTD--FKGTDFKAFVFEYMENGSLKDWL----------HQSDDQVEVCKLSLIQ 640
++ + + +F Y +G L ++L DD+ L
Sbjct: 77 LLGVVTKDQPLS-------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 641 RVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
V++ +A+ MEYL HH VH DL NVL+ + + D GL
Sbjct: 130 FVHLVAQIAAGMEYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 47/217 (21%), Positives = 86/217 (39%), Gaps = 37/217 (17%)
Query: 539 IGQGSFGYVYKGTL--GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKIIT 595
+G G+FG V +G + ++ VA+KV+ + A + E + + + + ++++I
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+C + V E G L +L ++ + + + V+ M+YL
Sbjct: 404 VCQAEALM------LVMEMAGGGPLHKFLVGKREE-----IPVSNVAELLHQVSMGMKYL 452
Query: 656 -HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
+ VH +L NVLL + A + DFGL+K L + LK
Sbjct: 453 EEKNF----VHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWY- 506
Query: 715 GYVAPE---YGMGSEAS--------MTGDIFT-GRRP 739
APE + S S M + + G++P
Sbjct: 507 ---APECINFRKFSSRSDVWSYGVTMW-EALSYGQKP 539
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 46/182 (25%), Positives = 74/182 (40%), Gaps = 44/182 (24%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRN 589
+G+G FG V K T VAVK+ LK + AS S ++E L+ + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LK-ENASPSELRDLLSEFNVLKQVNHPH 87
Query: 590 LIKIITICSSTD--FKGTDFKAFVFEYMENGSLKDWL------------------HQSDD 629
+IK+ CS + EY + GSL+ +L S D
Sbjct: 88 VIKLYGACSQDGPLL-------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 630 QVEVCKLSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688
+ L++ ++ A ++ M+YL VH DL N+L+ + DFGL
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKL----VHRDLAARNILVAEGRKMKISDFGL 196
Query: 689 AK 690
++
Sbjct: 197 SR 198
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 49/169 (28%), Positives = 79/169 (46%), Gaps = 29/169 (17%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKI 593
+G+G+FG V+ +D+M+VAVK + A + F E E L N++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 594 ITICSSTD--FKGTDFKAFVFEYMENGSLKDWL----------HQSDDQVEVCKLSLIQR 641
+C D VFEYM++G L +L + +L L Q
Sbjct: 83 YGVCGDGDPLI-------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 642 VNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
++IA +AS M YL H VH DL N L+ +++ + DFG++
Sbjct: 136 LHIASQIASGMVYLASQHF----VHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 32/173 (18%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS----FVAECEALRNI-RHR 588
+G+G+FG V + VAVK++ +GA+ S ++E + L +I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL----------HQSDDQVEVCKLSL 638
N++ ++ C+ + E+ + G+L +L + + + L+L
Sbjct: 92 NVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 639 IQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+ + VA ME+L C +H DL N+LL V +CDFGLA+
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC----IHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 44/206 (21%), Positives = 82/206 (39%), Gaps = 33/206 (16%)
Query: 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR 586
+ +F +IG G FG V+K D +K + + A R E +AL +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLD 62
Query: 587 HRNLIK--------IITICSSTDFKGTDFKAFVF---EYMENGSLKDWLHQSDDQVEVCK 635
H N++ +S+ +F E+ + G+L+ W+ + + K
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----K 118
Query: 636 LSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL-SD 694
L + + + + ++Y+H +++ DLKPSN+ L + DFGL L +D
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND 175
Query: 695 HQLDTAVKTPSSSIGLKGTVGYVAPE 720
+ + T Y++PE
Sbjct: 176 GKRTRSKGTLR----------YMSPE 191
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 48/187 (25%), Positives = 77/187 (41%), Gaps = 21/187 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIITI 596
IG+GSF VYKG E + VA + + S + F E E L+ ++H N+++
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
ST KG V E M +G+LK +L + + + + +++LH
Sbjct: 94 WESTV-KGKKCIVLVTELMTSGTLKTYLK------RFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 657 HHCQPPMVHGDLKPSNVLLDH-DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
PP++H DLK N+ + + D GLA + GT
Sbjct: 147 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----------VIGTPE 195
Query: 716 YVAPEYG 722
++APE
Sbjct: 196 FMAPEMY 202
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 49/200 (24%), Positives = 83/200 (41%), Gaps = 22/200 (11%)
Query: 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-ECEALRNI 585
++ G + +G G FGYV + + VA+K + +R E + ++ +
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 586 RHRNLIKII-TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI 644
H N++ D EY E G L+ +L+Q ++ C L +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN---CCGLKEGPIRTL 126
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVCDFGLAKFLSD-HQLDTA 700
D++SA+ YLH + ++H DLKP N++L ++ + D G AK L
Sbjct: 127 LSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF 183
Query: 701 VKTPSSSIGLKGTVGYVAPE 720
V GT+ Y+APE
Sbjct: 184 V----------GTLQYLAPE 193
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 33/171 (19%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS----FVAECEALRNI-RHR 588
+G G+FG V + T + + VAVK+ LK A ++E + + ++ +H
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKM--LK-STAHADEKEALMSELKIMSHLGQHE 110
Query: 589 NLIKIITICSSTDFKGTDFKAFV-FEYMENGSLKDWL--------HQSDDQVEVCKLSLI 639
N++ ++ C+ V EY G L ++L + S
Sbjct: 111 NIVNLLGACTHGG------PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR 164
Query: 640 QRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
++ + VA M +L +C +H D+ NVLL + VA + DFGLA
Sbjct: 165 DLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 28/168 (16%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKI 593
+G+G+FG V+ +D+M+VAVK + + A + F E E L ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 594 ITICSSTD--FKGTDFKAFVFEYMENGSLKDWL---------HQSDDQVEVCKLSLIQRV 642
+C+ VFEYM +G L +L + V L L Q +
Sbjct: 109 FGVCTEGRPLL-------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL 161
Query: 643 NIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
+A VA+ M YL H VH DL N L+ +V + DFG++
Sbjct: 162 AVASQVAAGMVYLAGLHF----VHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 43/175 (24%), Positives = 73/175 (41%), Gaps = 37/175 (21%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS----FVAECEALRNI-RHR 588
+G G+FG V + T + M VAVK++ A + ++E + L + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK---PSAHLTEREALMSELKVLSYLGNHM 87
Query: 589 NLIKIITICSSTDFKGTDFKAFV-FEYMENGSLKDWL------------HQSDDQVEVCK 635
N++ ++ C+ V EY G L ++L + + +
Sbjct: 88 NIVNLLGACTIGG------PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 636 LSLIQRVNIAIDVASAMEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
L L ++ + VA M +L +C +H DL N+LL H + +CDFGLA
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLA 192
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 51/226 (22%)
Query: 538 MIGQGSFGYVYKGTLGEDEMI----VAVKVINLKYKG---ASRSFVAECEALRNIRHRNL 590
I G G++Y L D + V +K L + G A +AE + L + H ++
Sbjct: 87 CIAHGGLGWIY---LALDRNVNGRPVVLKG--LVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
++I TD G V EY+ SLK Q KL + + + +++
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILP 193
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
A+ YLH +V+ DLKP N++L + + + D G + +
Sbjct: 194 ALSYLHSI---GLVYNDLKPENIMLTEEQLK-LIDLGAVSRI----------NSFGYLY- 238
Query: 711 KGTVGYVAPEYGMG--SEASMTGDIF----------TGRRPIDAVF 744
GT G+ APE + A+ DI+ + +
Sbjct: 239 -GTPGFQAPEIVRTGPTVAT---DIYTVGRTLAALTLDLPTRNGRY 280
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 86/443 (19%), Positives = 164/443 (37%), Gaps = 24/443 (5%)
Query: 1 LQTLAVNDNYLTGQLPDFV-GNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKF 59
L+ L ++ N + L V +LE + + N L KI NL L+++ N F
Sbjct: 47 LRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAF 102
Query: 60 SGM-FPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSI-PYSLS 117
+ + N+S L+ + L+ + +L K L + G + P L
Sbjct: 103 DALPICKEFGNMSQLKFLGLSTTHLE-KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQ 161
Query: 118 N--ASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSS 175
+ +L ++ + +F + + ++ NL N++ + L + L
Sbjct: 162 DFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPK 221
Query: 176 LKALSLADNQFGGELPHSIANL--SSTVINFGIGRNQISGTIPPGI-----RNLVNLIGF 228
L L+L + + I L +TV F I ++ G + +L L
Sbjct: 222 LSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIH 281
Query: 229 GAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIP 288
+ N+ + + ++ +L+ S+N L +
Sbjct: 282 QVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341
Query: 289 SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS--LYLDLSNNLLNGSLPLQV-GHLKN 345
+ G+ L + N+L L T + LD+S N ++ K+
Sbjct: 342 ENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS 400
Query: 346 LVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLS 405
L+ L++SSN + I L ++ LD+ SN IP + L++++ELNV+SN L
Sbjct: 401 LLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK 457
Query: 406 GQIPEFLKNLSVLEFLSLSYNHF 428
L+ L+ + L N +
Sbjct: 458 SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 81/399 (20%), Positives = 141/399 (35%), Gaps = 27/399 (6%)
Query: 1 LQTLAVNDNYLTGQLPD--FVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNL-VSLNVAEN 57
L+ L ++ N LP GN+S L+ + + L + L V L + E
Sbjct: 92 LKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150
Query: 58 KFSGMFPRSICNISSLEL-IQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL 116
P + + ++ L I N+ + V + NL+ I Y L
Sbjct: 151 YGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL 210
Query: 117 SNASNLELLDLSVNQFKGNVSIDFSSL---------KNLLWLNLEQNNLGTGTATDLDFV 167
S + L+ N N+ ++S + + ++ L G DF
Sbjct: 211 SILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL-QGQLDFRDFD 269
Query: 168 TFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIG 227
T+ +L + + FG + S+ I + + +
Sbjct: 270 YSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIK-NFTVSGTRMVHMLCPSKISPFLH 328
Query: 228 FGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQ--GRIPSGLGNLTKLANLELSSNSLQG 285
N L T+ + G L L+ L L N L+ +I + L L++S NS+
Sbjct: 329 LDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSY 388
Query: 286 NIPSSLGNCQNLMSFTA---SQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGH 342
+ G+C S + S N LT + L LDL +N + S+P QV
Sbjct: 389 DEKK--GDCSWTKSLLSLNMSSNILTDTIFRCLPPRIK---VLDLHSNKIK-SIPKQVVK 442
Query: 343 LKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH 381
L+ L L+++SNQ V G L+ + + +N +
Sbjct: 443 LEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-24
Identities = 76/421 (18%), Positives = 139/421 (33%), Gaps = 52/421 (12%)
Query: 71 SSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVN 130
++ ++ N S L +++L L+ L I N LE LDLS N
Sbjct: 21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 131 QFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGEL 190
+ I NL L+L N L N S LK L L+
Sbjct: 80 KLV---KISCHPTVNLKHLDLSFNAF-----DALPICKEFGNMSQLKFLGLSTTHLEKSS 131
Query: 191 PHSIANLSSTVINFGIGRNQISGTIPPGIRNLV--NLIGFGAEENQLHGTIPDAIGELKN 248
IA+L+ + + +G P G+++ +L + H + ++ + N
Sbjct: 132 VLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVAN 191
Query: 249 LQ----KLCLFRNFLQGRI--PSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMS--- 299
L+ K L N + + L KL+NL L++ N + +
Sbjct: 192 LELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWY 251
Query: 300 FTASQNKLTGALPHQLLSITTLSL----YLDLSNNLL----------------------- 332
F+ S KL G L + + SL + +++
Sbjct: 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
Query: 333 NGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSF- 390
+ + + + LD S+N + + LE L + N + ++
Sbjct: 312 TRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTT 371
Query: 391 -LKSIKELNVSSNNLSGQIP-EFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQG 448
+KS+++L++S N++S L L++S N + + L
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL-PPRIKVLDLHS 430
Query: 449 N 449
N
Sbjct: 431 N 431
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 7e-13
Identities = 44/162 (27%), Positives = 65/162 (40%), Gaps = 8/162 (4%)
Query: 303 SQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPG 362
S+N L +P L TT L++S N ++ + L L IL IS N+ +
Sbjct: 8 SKNGLI-HVPKDLSQKTT---ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 363 TLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNL-SGQIPEFLKNLSVLEFL 421
LEYLD+S N +S ++K L++S N + I + N+S L+FL
Sbjct: 64 VFKFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120
Query: 422 SLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPS 463
LS H E N +K+ L D L
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQD 162
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 42/168 (25%), Positives = 76/168 (45%), Gaps = 30/168 (17%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRN 589
+G G+FG VY+G + + VAVK + + S F+ E + H+N
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEALIISKFNHQN 135
Query: 590 LIKIITICSSTD--FKGTDFKAFVFEYMENGSLKDWLHQS-DDQVEVCKLSLIQRVNIAI 646
+++ I + + F + E M G LK +L ++ + L+++ +++A
Sbjct: 136 IVRCIGVSLQSLPRF-------ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 647 DVASAMEYL-HHHCQPPMVHGDLKPSNVLLD---HDMVAHVCDFGLAK 690
D+A +YL +H +H D+ N LL VA + DFG+A+
Sbjct: 189 DIACGCQYLEENHF----IHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 5e-27
Identities = 43/176 (24%), Positives = 79/176 (44%), Gaps = 37/176 (21%)
Query: 539 IGQGSFGYVYKGTL-------GEDEMIVAVKVINLKYKGASRS----FVAECEALRNI-R 586
+G+G+FG V ++ + VAVK++ A+ V+E E ++ I +
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99
Query: 587 HRNLIKIITICSSTDFKGTDFKAF-VFEYMENGSLKDWL----------HQSDDQVEVCK 635
H+N+I ++ C+ + + EY G+L+++L ++V +
Sbjct: 100 HKNIINLLGACTQDG------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 636 LSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++ V+ +A MEYL C +H DL NVL+ + V + DFGLA+
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 46/176 (26%), Positives = 79/176 (44%), Gaps = 37/176 (21%)
Query: 539 IGQGSFGYVYKGTL-------GEDEMIVAVKVINLKYKGASRS----FVAECEALRNI-R 586
+G+G FG V ++ + VAVK+ LK A+ V+E E ++ I +
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LK-DDATEKDLSDLVSEMEMMKMIGK 145
Query: 587 HRNLIKIITICSSTDFKGTDFKAFV-FEYMENGSLKDWL----------HQSDDQVEVCK 635
H+N+I ++ C+ +V EY G+L+++L ++V +
Sbjct: 146 HKNIINLLGACTQDG------PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 636 LSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++ V+ +A MEYL C +H DL NVL+ + V + DFGLA+
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 42/180 (23%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS----FVAECEALRNI-RHR 588
+G G+FG V T + VAVK+ LK + A S ++E + + + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKM--LK-EKADSSEREALMSELKMMTQLGSHE 109
Query: 589 NLIKIITICSSTDFKGTDFKAFV-FEYMENGSLKDWL-----------------HQSDDQ 630
N++ ++ C+ + ++ FEY G L ++L + +++
Sbjct: 110 NIVNLLGACTLSG------PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 631 VEVCKLSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
++ L+ + A VA ME+L C VH DL NVL+ H V +CDFGLA
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSC----VHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 29/189 (15%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNL--IK 592
IG G V++ L E + I A+K +NL+ S+ E L ++ + I+
Sbjct: 15 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 593 IITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ D++ TD + V E N L WL + + +R + ++ A
Sbjct: 74 LY------DYEITDQYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEA 120
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+ +H H +VH DLKP+N L+ M+ + DFG+A + +
Sbjct: 121 VHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QV 170
Query: 712 GTVGYVAPE 720
GTV Y+ PE
Sbjct: 171 GTVNYMPPE 179
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 29/189 (15%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNL--IK 592
IG G V++ L E + I A+K +NL+ S+ E L ++ + I+
Sbjct: 34 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 593 IITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ D++ TD + V E N L WL + + +R + ++ A
Sbjct: 93 LY------DYEITDQYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEA 139
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+ +H H +VH DLKP+N L+ M+ + DFG+A + +
Sbjct: 140 VHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QV 189
Query: 712 GTVGYVAPE 720
GTV Y+ PE
Sbjct: 190 GTVNYMPPE 198
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 44/182 (24%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRN 589
IG+G+FG V++ E +VAVK+ LK + AS F E + + N
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LK-EEASADMQADFQREAALMAEFDNPN 111
Query: 590 LIKIITICSSTD--FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK------------ 635
++K++ +C+ +FEYM G L ++L
Sbjct: 112 IVKLLGVCAVGKPMC-------LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 636 ------LSLIQRVNIAIDVASAMEYLH-HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688
LS +++ IA VA+ M YL VH DL N L+ +MV + DFGL
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKF----VHRDLATRNCLVGENMVVKIADFGL 220
Query: 689 AK 690
++
Sbjct: 221 SR 222
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 37/176 (21%)
Query: 539 IGQGSFGYVYKGTL-------GEDEMIVAVKVINLKYKGASRS----FVAECEALRNI-R 586
+G+G+FG V VAVK++ A+ ++E E ++ I +
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133
Query: 587 HRNLIKIITICSSTDFKGTDFKAFV-FEYMENGSLKDWL----------HQSDDQVEVCK 635
H+N+I ++ C+ +V EY G+L+++L + +
Sbjct: 134 HKNIINLLGACTQDG------PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 636 LSLIQRVNIAIDVASAMEYL-HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
LS V+ A VA MEYL C +H DL NVL+ D V + DFGLA+
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 39/203 (19%), Positives = 81/203 (39%), Gaps = 42/203 (20%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN----LKYKGASRSFVA-------------ECEA 581
+ QG F + +D A+K K + ++S E +
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 582 LRNIRHRNLIKIITICSSTD--FKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEVCKLS 637
+ +I++ + I ++ D + ++EYMEN S+ + D+ C +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVY-------IIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 638 LIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL 697
+ I V ++ Y+H+ + H D+KPSN+L+D + + DFG ++++ D ++
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 698 DTAVKTPSSSIGLKGTVGYVAPE 720
+ T ++ PE
Sbjct: 208 KGSRGTYE----------FMPPE 220
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 29/189 (15%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNL--IK 592
IG G V++ L E + I A+K +NL+ S+ E L ++ + I+
Sbjct: 62 KQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 593 IITICSSTDFKGTDFKAFVF-EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ D++ TD ++ E N L WL + + +R + ++ A
Sbjct: 121 LY------DYEITDQYIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEA 167
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+ +H H +VH DLKP+N L+ M+ + DFG+A + +
Sbjct: 168 VHTIHQHG---IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDS------QV 217
Query: 712 GTVGYVAPE 720
G V Y+ PE
Sbjct: 218 GAVNYMPPE 226
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 69/330 (20%), Positives = 117/330 (35%), Gaps = 49/330 (14%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
+ +P L + LLDL N+ DF +LKNL L L N + + +
Sbjct: 40 DLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-----SKIS 92
Query: 166 FVTFLTNCSSLKALSLADNQ---FGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RN 221
F L+ L L+ NQ ++P ++ L + N+I+ + +
Sbjct: 93 PGAF-APLVKLERLYLSKNQLKELPEKMPKTLQELR-------VHENEIT-KVRKSVFNG 143
Query: 222 LVNLIGFGAEENQLHGTI--PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELS 279
L +I N L + A +K L + + + IP GL L L L
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLD 200
Query: 280 SNSLQGNIPS-SLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPL 338
N + + + SL NL S N ++ L + L L L+NN L +P
Sbjct: 201 GNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR-ELHLNNNKLV-KVPG 257
Query: 339 QVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELN 398
+ K + ++ + +N S I SN F P + S ++
Sbjct: 258 GLADHKYIQVVYLHNNNIS----------------AIGSNDFCP--PGYNTKKASYSGVS 299
Query: 399 VSSNNLS-GQIPEFL-KNLSVLEFLSLSYN 426
+ SN + +I + + V + L
Sbjct: 300 LFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 54/274 (19%), Positives = 102/274 (37%), Gaps = 31/274 (11%)
Query: 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82
D ++ + N + L+NL +L + NK S + P + + LE + L+ N+
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID--- 139
LP + L+ L + N + + + +++L N K + I+
Sbjct: 112 LK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK-SSGIENGA 166
Query: 140 FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS 199
F +K L ++ + N+ T + SL L L N+ S+ L++
Sbjct: 167 FQGMKKLSYIRIADTNI-----TTIPQGLP----PSLTELHLDGNKITKVDAASLKGLNN 217
Query: 200 -TVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRN 257
+ + N IS + G N +L N+L +P + + K +Q + L N
Sbjct: 218 LAKLG--LSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 273
Query: 258 FLQGRIPSG-------LGNLTKLANLELSSNSLQ 284
+ I S + + L SN +Q
Sbjct: 274 NIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 57/285 (20%), Positives = 104/285 (36%), Gaps = 37/285 (12%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L TL + +N ++ P L LE + + N L ++P + + L L V EN+ +
Sbjct: 78 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT 134
Query: 61 GMFPRSICNISSLELIQLALNRF-SGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA 119
+ ++ + +++L N S + + L + I N +IP L
Sbjct: 135 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQGLP-- 191
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL 179
+L L L N+ + L NL L L N++ + +D + N L+ L
Sbjct: 192 PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI-----SAVDNGSL-ANTPHLREL 245
Query: 180 SLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGT 238
L +N+ ++P +A+ V+ N IS I F
Sbjct: 246 HLNNNKL-VKVPGGLADHKYIQVVYL--HNNNIS-AIGSND--------FCP-------- 285
Query: 239 IPDAIGELKNLQKLCLFRNFLQ-GRIPSGL-GNLTKLANLELSSN 281
P + + + LF N +Q I + A ++L +
Sbjct: 286 -PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 46/189 (24%), Positives = 75/189 (39%), Gaps = 21/189 (11%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIIT 595
IG GS+G K D I+ K ++ + + V+E LR ++H N I+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN---IVR 69
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ V EY E G L + + + + + + + + A++
Sbjct: 70 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV--LRVMTQLTLALKEC 127
Query: 656 H--HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ--LDTAVKTPSSSIGLK 711
H ++H DLKP+NV LD + DFGLA+ L+ T V TP
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPY------ 181
Query: 712 GTVGYVAPE 720
Y++PE
Sbjct: 182 ----YMSPE 186
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 28/258 (10%), Positives = 59/258 (22%), Gaps = 40/258 (15%)
Query: 498 YARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEM 557
++ + + V + + + LS+ + + G V+ E
Sbjct: 29 ALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 558 IVAVKVINLKYKGAS---RSFVAECEALRNIRHRNLI---------------------KI 593
A+KV + + + A + +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEV-CKLSLIQRVNIAIDVASAM 652
+ D + L+ D ++ + +
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
L +VHG P N+ + D + D K +
Sbjct: 208 ANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA-----------LWKVGTRGPASSV 253
Query: 713 TVGYVAPEYGMGSEASMT 730
V Y E+ S A+ T
Sbjct: 254 PVTYAPREFLNASTATFT 271
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 56/242 (23%), Positives = 90/242 (37%), Gaps = 16/242 (6%)
Query: 215 IPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGR-IPSG-LGNLTK 272
IP L L E N+L +L L KL L N L + S T
Sbjct: 26 IPSSATRL-EL-----ESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 273 LANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLL 332
L L+LS N + + S+ + L + L + +YLD+S+
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 333 NGSLPLQV-GHLKNLVILDISSNQF-SGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSF 390
+ L +L +L ++ N F +P + L +LD+S + P + +
Sbjct: 139 R-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 391 LKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT---KGVFSNKTKISLQ 447
L S++ LN+S NN K L+ L+ L S NH + S+ ++L
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLT 256
Query: 448 GN 449
N
Sbjct: 257 QN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-23
Identities = 64/324 (19%), Positives = 107/324 (33%), Gaps = 46/324 (14%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
+ S+P + S+ L+L N+ + F L L L+L N L
Sbjct: 16 SKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS 73
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNL 225
+SLK L L+ N T+ L L
Sbjct: 74 D----FGTTSLKYLDLSFNGV--------------------------ITMSSNFLGLEQL 103
Query: 226 IGFGAEENQLHGTIPD--AIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSNS 282
+ + L + + L+NL L + + +G L+ L L+++ NS
Sbjct: 104 EHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNS 161
Query: 283 LQGNIPS-SLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV- 340
Q N +NL SQ +L L + + L++S+N SL
Sbjct: 162 FQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPY 219
Query: 341 GHLKNLVILDISSNQFSGVIPGTLSTCVC-LEYLDISSNSFH---GVIPLSLSFLKSIKE 396
L +L +LD S N L L +L+++ N F L ++K ++
Sbjct: 220 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF-LQWIKDQRQ 278
Query: 397 LNVSSNNLSGQIPEFLKNLSVLEF 420
L V + P + + VL
Sbjct: 279 LLVEVERMECATPSDKQGMPVLSL 302
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 49/241 (20%), Positives = 98/241 (40%), Gaps = 11/241 (4%)
Query: 195 ANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLH--GTIPDAIGELKNLQK 251
+ S+ + N++ ++P G+ L L N L G + +L+
Sbjct: 24 TGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKY 82
Query: 252 LCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSL-GNCQNLMSFTASQNKLTGA 310
L L N + + S L +L +L+ ++L+ S+ + +NL+ S
Sbjct: 83 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-V 140
Query: 311 LPHQLLSITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVC 369
+ + + + L ++ N + + L+NL LD+S Q + P ++
Sbjct: 141 AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 200
Query: 370 LEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPE--FLKNLSVLEFLSLSYNH 427
L+ L++S N+F + L S++ L+ S N++ + S L FL+L+ N
Sbjct: 201 LQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQND 259
Query: 428 F 428
F
Sbjct: 260 F 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-20
Identities = 51/253 (20%), Positives = 87/253 (34%), Gaps = 20/253 (7%)
Query: 39 IPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFS-GNLPFDIVVNLPN 97
+PT G+ + L + NK + ++ L + L+ N S +
Sbjct: 22 VPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 98 LKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLEQNNL 156
LK L + N ++ + LE LD + K F SL+NL++L++ +
Sbjct: 80 LKYLDLSFNG-VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 157 GTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSI-ANLSS-TVINFGIGRNQISGT 214
F SSL+ L +A N F I L + T ++ + + Q+
Sbjct: 139 -----RVAFNGIF-NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD--LSQCQLE-Q 189
Query: 215 IPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGL--GNLT 271
+ P +L +L N L +LQ L N + +
Sbjct: 190 LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPS 248
Query: 272 KLANLELSSNSLQ 284
LA L L+ N
Sbjct: 249 SLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 44/188 (23%), Positives = 78/188 (41%), Gaps = 9/188 (4%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPT-TLGLLRNLVSLNVAENKF 59
L+ L ++ N + + L LE + ++L LRNL+ L+++
Sbjct: 80 LKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 60 SGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIP-YSLSN 118
F +SSLE++++A N F N DI L NL L + + + ++
Sbjct: 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ-LEQLSPTAFNS 197
Query: 119 ASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKA 178
S+L++L++S N F + + L +L L+ N++ SSL
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI-----MTSKKQELQHFPSSLAF 252
Query: 179 LSLADNQF 186
L+L N F
Sbjct: 253 LNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 50/223 (22%), Positives = 86/223 (38%), Gaps = 14/223 (6%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGK--IPTTLGLLRNLVSLNVAENK 58
L + N L L+ L + + N L K + +L L+++ N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 59 FSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSN 118
M + + LE + + F + ++L NL L I + + +
Sbjct: 90 VITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 148
Query: 119 ASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLK 177
S+LE+L ++ N F+ N D F+ L+NL +L+L Q L L F + SSL+
Sbjct: 149 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-----EQLSPTAF-NSLSSLQ 202
Query: 178 ALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGI 219
L+++ N F L+S V++ N I T
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLD--YSLNHIM-TSKKQE 242
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 31/196 (15%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK-YKGASRSFVAECEALRNI-RHRN 589
F +++G G+ G + + ++ VAVK I + + A R E + LR H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADR----EVQLLRESDEHPN 79
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+I+ C+ K F+ E +L++++ Q D ++ + +
Sbjct: 80 VIRYF--CT---EKDRQFQYIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTT 128
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLL-----DHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
S + +LH +VH DLKP N+L+ + A + DFGL K L+ + +
Sbjct: 129 SGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR-----HSF 180
Query: 705 SSSIGLKGTVGYVAPE 720
S G+ GT G++APE
Sbjct: 181 SRRSGVPGTEGWIAPE 196
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 49/185 (26%), Positives = 78/185 (42%), Gaps = 27/185 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G+F V+ + A+K I S E L+ I+H N++ + I
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-- 74
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
++ T V + + G L D + +E + + V SA++YLH +
Sbjct: 75 ---YESTTHYYLVMQLVSGGELFDRI------LERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 659 CQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
+VH DLKP N+L + + + DFGL+K + + TA GT G
Sbjct: 126 G---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC----------GTPG 172
Query: 716 YVAPE 720
YVAPE
Sbjct: 173 YVAPE 177
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 53/221 (23%), Positives = 89/221 (40%), Gaps = 42/221 (19%)
Query: 539 IGQGSFGYVYKGT---LGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIK 592
+G G VY L VA+K I + + + F E + H+N++
Sbjct: 19 LGGGGMSTVYLAEDTILNIK---VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 593 IITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+I D D + V EY+E +L +++ LS+ +N +
Sbjct: 76 MI------DVDEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDG 123
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+++ H +VH D+KP N+L+D + + DFG+AK LS+ L T ++ +
Sbjct: 124 IKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-----TQTNHV--L 173
Query: 712 GTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDA 742
GTV Y +PE G DI+ G P +
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 56/214 (26%), Positives = 78/214 (36%), Gaps = 33/214 (15%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITI 596
+G+GSFG V++ + AVK + L+ V E A + I
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-----VFRVEELVACAGLSSPR----IVP 114
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
+G F+ E +E GSL + Q E +EYLH
Sbjct: 115 LYGAVREGPWVNIFM-ELLEGGSLGQLIKQMGCLPE----DRAL--YYLGQALEGLEYLH 167
Query: 657 HHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
++HGD+K NVLL D A +CDFG A L L ++ T + GT
Sbjct: 168 TRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY---IPGTET 221
Query: 716 YVAPEYGMGSEASMTGDI----------FTGRRP 739
++APE MG DI G P
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 64/346 (18%), Positives = 116/346 (33%), Gaps = 80/346 (23%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
+ ++P +S + LLDL N DF L++L L L N + + +
Sbjct: 42 DLGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI-----SKIH 94
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNL 225
F + L+ L ++ N L IPP +
Sbjct: 95 EKAF-SPLRKLQKLYISKNH-----------LVE---------------IPPNL------ 121
Query: 226 IGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSNSLQ 284
+L +L + N ++ ++P G L + +E+ N L+
Sbjct: 122 --------------------PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE 160
Query: 285 -GNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL-YLDLSNNLLNGSLPLQV-G 341
+ L S+ KLT +P L +L L L +N + ++ L+
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPE----TLNELHLDHNKIQ-AIELEDLL 214
Query: 342 HLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401
L L + NQ + G+LS L L + +N +P L LK ++ + + +
Sbjct: 215 RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273
Query: 402 NNLSGQIPE-------FLKNLSVLEFLSLSYNHFEGEVPTKGVFSN 440
NN++ ++ F + +SL N F
Sbjct: 274 NNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-23
Identities = 58/264 (21%), Positives = 97/264 (36%), Gaps = 18/264 (6%)
Query: 195 ANLSSTVINFGIGRNQISGTIPPG-IRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLC 253
+S + N IS + + L +L N++ A L+ LQKL
Sbjct: 50 KEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY 108
Query: 254 LFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT-GALP 312
+ +N L IP L + L L + N ++ +N+ N L
Sbjct: 109 ISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE 165
Query: 313 HQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEY 372
L+ YL +S L G + + L L + N+ + L L
Sbjct: 166 PGAFDGLKLN-YLRISEAKLTG---IPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYR 221
Query: 373 LDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE--- 429
L + N + SLSFL +++EL++ +N LS ++P L +L +L+ + L N+
Sbjct: 222 LGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVG 280
Query: 430 ----GEVPTKGVFSNKTKISLQGN 449
V + ISL N
Sbjct: 281 VNDFCPVGFGVKRAYYNGISLFNN 304
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 53/345 (15%), Positives = 106/345 (30%), Gaps = 79/345 (22%)
Query: 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82
D ++ + N + L++L +L + NK S + ++ + L+ + ++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID--- 139
+P ++ +L L I N S N+ +++ N + N +
Sbjct: 114 LV-EIPPNL---PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLE-NSGFEPGA 168
Query: 140 FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS 199
F L L +L + + L T + +L L L
Sbjct: 169 FDGL-KLNYLRISEAKL-----TGIPKDLP----ETLNELHLD----------------- 201
Query: 200 TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFL 259
N+I I + L +L L N +
Sbjct: 202 --------HNKIQ-AIELE-----------------------DLLRYSKLYRLGLGHNQI 229
Query: 260 QGRIPSG-LGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT----GALPHQ 314
+ I +G L L L L L +N L +P+ L + + L N +T
Sbjct: 230 R-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPV 287
Query: 315 LLSITTLSL-YLDLSNNLLNGSLPLQVG---HLKNLVILDISSNQ 355
+ + L NN + +Q + + + + + +
Sbjct: 288 GFGVKRAYYNGISLFNNPVP-YWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 47/285 (16%), Positives = 91/285 (31%), Gaps = 38/285 (13%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L + +N ++ L L+ + I N L +IP L +LV L + +N+
Sbjct: 80 LYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR 136
Query: 61 GMFPRSICNISSLELIQLALNRF-SGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA 119
+ + ++ I++ N + L L L I IP L
Sbjct: 137 KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAK-LTGIPKDL--P 192
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL 179
L L L N+ + D L L L N + ++ + + +L+ L
Sbjct: 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI-----RMIENGSL-SFLPTLREL 246
Query: 180 SLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGT 238
L +N+ +P + +L V+ N I+ + F +
Sbjct: 247 HLDNNKL-SRVPAGLPDLKLLQVVYL--HTNNIT-KVGVND--------FCPVGFGV--- 291
Query: 239 IPDAIGELKNLQKLCLFRNFLQ-GRIPSGL-GNLTKLANLELSSN 281
+ + LF N + + +T ++ +
Sbjct: 292 ------KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 43/211 (20%), Positives = 78/211 (36%), Gaps = 34/211 (16%)
Query: 522 SYAELSKATGEFSSSNM--------IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS- 572
+ + T +M IG+GSFG ED +K IN+ +
Sbjct: 7 HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66
Query: 573 -RSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV 631
E L N++H N+++ F+ V +Y E G L ++
Sbjct: 67 REESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRINAQKGV- 120
Query: 632 EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691
Q ++ + + A++++H ++H D+K N+ L D + DFG+A+
Sbjct: 121 ---LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARV 174
Query: 692 LSDHQ--LDTAVKTPSSSIGLKGTVGYVAPE 720
L+ + TP Y++PE
Sbjct: 175 LNSTVELARACIGTPY----------YLSPE 195
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 50/223 (22%), Positives = 86/223 (38%), Gaps = 44/223 (19%)
Query: 538 MIGQGSFGYVYKGT---LGEDEMIVAVKVINLKYKGASRSFVA----ECEALRNIRHRNL 590
++G+G G VY+ VA+K+++ + F E ++ ++
Sbjct: 41 LVGRGGMGDVYEAEDTVRERI---VALKLMSETL-SSDPVFRTRMQREARTAGRLQEPHV 96
Query: 591 IKIITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
+ I DF D + + + L L + L+ + V I +
Sbjct: 97 VPIH------DFGEIDGQLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIG 144
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
SA++ H H D+KP N+L+ D A++ DFG+A +D +L T +
Sbjct: 145 SALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKL-----TQLGNT- 195
Query: 710 LKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDA 742
GT+ Y+APE S A+ DI+ TG P
Sbjct: 196 -VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 1e-23
Identities = 54/312 (17%), Positives = 93/312 (29%), Gaps = 58/312 (18%)
Query: 73 LELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQF 132
L Q + D + A+ G N E + L
Sbjct: 11 FSLSQNSFYNTISGTYADYFSAWDKWEKQALPGEN-------------RNEAVSL----- 52
Query: 133 KGNVSIDFSSLKNLLWLNLEQNNLGTGTATDL-DFVTFLTNCSSLKALSLADNQFGGELP 191
+ + L L + NL + L D + + L + N LP
Sbjct: 53 -----LKECLINQFSELQLNRLNL-----SSLPDNL-----PPQITVLEITQNAL-ISLP 96
Query: 192 HSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQK 251
A+L N++S T+P +L +L + NQL +P+ L+
Sbjct: 97 ELPASLE----YLDACDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPA---LLEY 144
Query: 252 LCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTG-- 309
+ N L +P +L L + +N L +P + + L S N L
Sbjct: 145 INADNNQLT-MLPELPTSLEV---LSVRNNQLTF-LPELPESLEAL---DVSTNLLESLP 196
Query: 310 ALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVC 369
A+P + ++ N + +P + L + + N S I +LS
Sbjct: 197 AVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255
Query: 370 LEYLDISSNSFH 381
F
Sbjct: 256 QPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 56/331 (16%), Positives = 109/331 (32%), Gaps = 42/331 (12%)
Query: 9 NYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTL--GLLRNLVSLNVAENKFSGMFPRS 66
N ++G D+ E + G + + + L L+ L + S P +
Sbjct: 20 NTISGTYADYFSAWDKWEKQALPGENRN-EAVSLLKECLINQFSELQLNRLNLSS-LPDN 77
Query: 67 ICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLD 126
+ + ++++ N +LP +L+ L N ++P ++ L+ LD
Sbjct: 78 LP--PQITVLEITQNALI-SLP----ELPASLEYLDACDNRL-STLPELPAS---LKHLD 126
Query: 127 LSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186
+ NQ + L ++N + N L +SL+ LS+ +NQ
Sbjct: 127 VDNNQLT---MLP-ELPALLEYINADNNQL----------TMLPELPTSLEVLSVRNNQL 172
Query: 187 GGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNL----IGFGAEENQLHGTIPDA 242
LP +L ++ + N + ++P + I F EN++ IP+
Sbjct: 173 T-FLPELPESL--EALD--VSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPEN 225
Query: 243 IGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTA 302
I L + L N L RI L T + ++ N + A
Sbjct: 226 ILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADA 283
Query: 303 SQNKLTGALPHQLLSITTLSLYLDLSNNLLN 333
+ I + + +N
Sbjct: 284 VTAWFPENKQSDVSQIWHAFEHEEHANTFSA 314
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 60/328 (18%), Positives = 105/328 (32%), Gaps = 71/328 (21%)
Query: 111 SIPYSLSNASNLELLDLSVNQFKG---NVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFV 167
SI ++N +L + N G + + + +N V
Sbjct: 2 SIMLPINNNFSLSQ-NSFYNTISGTYADYFSAWDKWEKQALPGENRNEA----------V 50
Query: 168 TFLTNC--SSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNL 225
+ L C + L L LP ++ + I +N + ++P +L L
Sbjct: 51 SLLKECLINQFSELQLNRLNLS-SLPDNLP---PQITVLEITQNALI-SLPELPASLEYL 105
Query: 226 IGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQG 285
A +N+L T+P+ +L+ L + N L +P L + +N L
Sbjct: 106 D---ACDNRLS-TLPELPA---SLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLT- 153
Query: 286 NIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKN 345
+P + L + N+LT LP S+ L D+S NLL SLP +
Sbjct: 154 MLPELPTS---LEVLSVRNNQLT-FLPELPESLEAL----DVSTNLLE-SLPAVPVRNHH 204
Query: 346 L----VILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401
+ N+ + IP ++ L + +
Sbjct: 205 SEETEIFFRCRENRIT-------------------------HIPENILSLDPTCTIILED 239
Query: 402 NNLSGQIPEFLKNLSVLEFLSLSYNHFE 429
N LS +I E L + +F
Sbjct: 240 NPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 39/209 (18%)
Query: 527 SKATGEFSS----SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---------YKGASR 573
S +T F ++G+G V + AVK+I++ +
Sbjct: 9 SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68
Query: 574 SFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVE 632
+ + E + LR + H N+I++ ++ F VF+ M+ G L D+L E
Sbjct: 69 ATLKEVDILRKVSGHPNIIQLKDT-----YETNTFFFLVFDLMKKGELFDYL------TE 117
Query: 633 VCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692
LS + I + + LH +VH DLKP N+LLD DM + DFG + L
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL 174
Query: 693 SD-HQLDTAVKTPSSSIGLKGTVGYVAPE 720
+L GT Y+APE
Sbjct: 175 DPGEKLREVC----------GTPSYLAPE 193
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 38/253 (15%), Positives = 70/253 (27%), Gaps = 35/253 (13%)
Query: 500 RKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIV 559
+ +A V TS P +EL + ++GQ + T E
Sbjct: 47 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 106
Query: 560 AVKVINLKYKGAS---RSFVAECEALRNIRH----------------RNLIKIITICSST 600
V V + S + E LR +R +L+K
Sbjct: 107 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 166
Query: 601 DFKGTDFKAFVFEY-----MENGSLKDWLHQSDDQVEVCK-LSLIQRVNIAIDVASAMEY 654
+ + +V +L+ + K L R+ + + V +
Sbjct: 167 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 226
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LHH+ +VH L+P +++LD + F + +P
Sbjct: 227 LHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAV-----SPIGR--GFAPP 276
Query: 715 GYVAPEYGMGSEA 727
A +
Sbjct: 277 ETTAERMLPFGQH 289
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 59/236 (25%), Positives = 90/236 (38%), Gaps = 38/236 (16%)
Query: 499 ARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSS----SNMIGQGSFGYVYKGTLGE 554
A+K AQ + + A EF ++IG+G V +
Sbjct: 58 AKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA 117
Query: 555 DEMIVAVKVINL-KYKGASRSFVAECEALRN--------IRHRNLIKIITICSSTDFKGT 605
AVK++ + + + EA R H ++I +I S+ F
Sbjct: 118 TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM-- 175
Query: 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVH 665
VF+ M G L D+L E LS + +I + A+ +LH + +VH
Sbjct: 176 ---FLVFDLMRKGELFDYL------TEKVALSEKETRSIMRSLLEAVSFLHANN---IVH 223
Query: 666 GDLKPSNVLLDHDMVAHVCDFGLAKFLSD-HQLDTAVKTPSSSIGLKGTVGYVAPE 720
DLKP N+LLD +M + DFG + L +L GT GY+APE
Sbjct: 224 RDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC----------GTPGYLAPE 269
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-23
Identities = 66/305 (21%), Positives = 97/305 (31%), Gaps = 69/305 (22%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINL-KYKGASRSFVAECEALR-NIRHRNL 590
S ++G GS G V + VAVK + + A E + L + H N+
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRP-VAVKRMLIDFCDIALM----EIKLLTESDDHPNV 71
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK-LSLIQRVNIAIDVA 649
I+ F E +L+D + + E K +++ +A
Sbjct: 72 IRYYCS-----ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC-------------DFGLAKFLSDHQ 696
S + +LH ++H DLKP N+L+ DFGL K L Q
Sbjct: 126 SGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 697 LDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTG-------DIF-----------TGRR 738
+ S GT G+ APE S T DIF G+
Sbjct: 183 SSFRTNLNNPS----GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
Query: 739 P-------IDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQED--KRVKT 789
P + SL E + E D L+ + MI D KR
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD--LI------SQMIDHDPLKRPTA 290
Query: 790 EECLN 794
+ L
Sbjct: 291 MKVLR 295
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 76/442 (17%), Positives = 153/442 (34%), Gaps = 24/442 (5%)
Query: 1 LQTLAVNDNYLTGQLPDFV-GNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKF 59
L+ L ++ N + L V DLE + + N L I + +L L+++ N F
Sbjct: 78 LRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDF 133
Query: 60 SGMFPRSIC--NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLS 117
+ P N++ L + L+ +F L V +L L +
Sbjct: 134 DVL-PVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
Query: 118 NASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD-FVTFLTNCSSL 176
N +L L + S+ L L L L L F++ LT +L
Sbjct: 192 QIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTL 251
Query: 177 KALSLADNQFGGELPHSIANL--SSTVINFGIGRNQISGTIPPGI-----RNLVNLIGFG 229
++L + + + V I I+ I L +L+
Sbjct: 252 LNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEH 311
Query: 230 AEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPS 289
+ + + L + + + L + N ++
Sbjct: 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371
Query: 290 SLGNCQNLMSFTASQNKLTGALP---HQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNL 346
+ L + +N L ++++L N+L + + +++
Sbjct: 372 GCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430
Query: 347 VILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG 406
++L++SSN +G + L ++ LD+ +N IP ++ L++++ELNV+SN L
Sbjct: 431 LVLNLSSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS 487
Query: 407 QIPEFLKNLSVLEFLSLSYNHF 428
L+ L+++ L N +
Sbjct: 488 VPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 64/391 (16%), Positives = 128/391 (32%), Gaps = 44/391 (11%)
Query: 71 SSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL-SNASNLELLDLSV 129
+ + L+ N S L + L L+ L + N S+ + + +LE LD+S
Sbjct: 52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQDLEYLDVSH 109
Query: 130 NQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGE 189
N+ + +I + +L L+L N+ L N + L L L+ +F
Sbjct: 110 NRLQ---NISCCPMASLRHLDLSFNDF-----DVLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 190 LPHSIANLSSTVINFGIGRNQISGTIPPGIR--NLVNLIGFGAEENQLHGTIPDAIGELK 247
+A+L + I + I G ++ N L + + ++ L
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 248 NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQN--LMSFTASQN 305
+LQ L+N++L+ + Q + + L++ T
Sbjct: 222 HLQ----------------------LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259
Query: 306 KLTGALPHQLLSITTLS--LYLDLSNNLLNG-----SLPLQVGHLKNLVILDISSNQFSG 358
+ T +L YL++ N + LK+L+I + + F
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319
Query: 359 VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVL 418
S + +S + + + S LN + N + + + L L
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379
Query: 419 EFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
+ L L N + + N + +
Sbjct: 380 QTLILQRNGLKNFFKVALMTKNMSSLETLDV 410
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 3e-18
Identities = 66/421 (15%), Positives = 135/421 (32%), Gaps = 52/421 (12%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGL------LRNLVSLNV 54
L+ L V+ N L + ++ L + + N L + L L L +
Sbjct: 102 LEYLDVSHNRLQN-ISC--CPMASLRHLDLSFNDF-----DVLPVCKEFGNLTKLTFLGL 153
Query: 55 AENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI-----GGNNFF 109
+ KF + + ++ L L + L+ S ++ +L + + F
Sbjct: 154 SAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFS 210
Query: 110 GSIPYSLSNASNLEL--LDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFV 167
+ S++ +L+L + L+ + ++ + LN+ ++ T +
Sbjct: 211 VQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF 270
Query: 168 TFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINF----GIGRNQISGTIPPGIRNLV 223
F ++ L++ + + S T + + +
Sbjct: 271 QFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFA 329
Query: 224 NLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSL 283
+ + + L +N + G L +L L L N L
Sbjct: 330 EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
Query: 284 Q--GNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNG------- 334
+ + N +L + S N L + + L L+LS+N+L G
Sbjct: 390 KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP 449
Query: 335 --------------SLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSF 380
S+P V HL+ L L+++SNQ V G L+Y+ + N +
Sbjct: 450 PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPW 509
Query: 381 H 381
Sbjct: 510 D 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-18
Identities = 73/403 (18%), Positives = 137/403 (33%), Gaps = 33/403 (8%)
Query: 46 LRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGG 105
L L L ++ N+ + LE + ++ NR N+ + +L+ L +
Sbjct: 75 LSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC---PMASLRHLDLSF 130
Query: 106 NNFFGSIPYS--LSNASNLELLDLSVNQFKGNVSIDFSSLKNL----LWLNLEQNNLGTG 159
N+F +P N + L L LS +F+ +D + +L + L+L ++ G
Sbjct: 131 NDF-DVLPVCKEFGNLTKLTFLGLSAAKFR---QLDLLPVAHLHLSCILLDLVSYHIKGG 186
Query: 160 TATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI 219
L SL Q + +++ +L + I Q T +
Sbjct: 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSV-NALGHLQLSNIKLNDENCQRLMTFLSEL 245
Query: 220 R---NLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANL 276
L+N+ E + ++ L ++ + RI ++ A
Sbjct: 246 TRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALK 305
Query: 277 ELSSNSLQGNIPSSLGNC-------QNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSN 329
L ++ + N+ + S + S T +L+ +
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFT---FLNFTQ 362
Query: 330 NLLNGSLPLQVGHLKNLVILDISSNQFSGV--IPGTLSTCVCLEYLDISSNSF-HGVIPL 386
N+ S+ LK L L + N + LE LD+S NS
Sbjct: 363 NVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDR 422
Query: 387 SLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE 429
+ ++ +SI LN+SSN L+G + F ++ L L N
Sbjct: 423 TCAWAESILVLNLSSNMLTGSV--FRCLPPKVKVLDLHNNRIM 463
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 31/112 (27%), Positives = 49/112 (43%), Gaps = 8/112 (7%)
Query: 318 ITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDIS 376
+ + L LS N ++ L + L L +L +S N+ + LEYLD+S
Sbjct: 50 LPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108
Query: 377 SNSFHGVIPLSLSFLKSIKELNVSSNNLS--GQIPEFLKNLSVLEFLSLSYN 426
N +S + S++ L++S N+ EF NL+ L FL LS
Sbjct: 109 HNRLQN---ISCCPMASLRHLDLSFNDFDVLPVCKEF-GNLTKLTFLGLSAA 156
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 46/201 (22%), Positives = 82/201 (40%), Gaps = 25/201 (12%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASR---SFVAECEALRNIRHRNLIKII 594
IG+G F VY+ D + VA+K + + ++ + E + L+ + H N +I
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN---VI 95
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+S F + V E + G L + Q + + + + SA+E+
Sbjct: 96 KYYAS--FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW--KYFVQLCSALEH 151
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH--QLDTAVKTPSSSIGLKG 712
+H ++H D+KP+NV + V + D GL +F S + V TP
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY------- 201
Query: 713 TVGYVAPEYGMGSEASMTGDI 733
Y++PE + + DI
Sbjct: 202 ---YMSPERIHENGYNFKSDI 219
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 49/225 (21%), Positives = 87/225 (38%), Gaps = 35/225 (15%)
Query: 500 RKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIV 559
S + + P K++ + +LSK ++G G G V +
Sbjct: 6 HHHSSGLEVLFQGPEPKKYAVTDDYQLSK--------QVLGLGVNGKVLECFHRRTGQKC 57
Query: 560 AVKVINLKYKGASRSFVAECEAL-RNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENG 618
A+K++ A + E + + +++ I+ + + + E ME G
Sbjct: 58 ALKLLY-DSPKARQ----EVDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGG 111
Query: 619 SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL--- 675
L + + DQ + + I D+ +A+++LH H + H D+KP N+L
Sbjct: 112 ELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSK 164
Query: 676 DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
+ D V + DFG AK + + L T T YVAPE
Sbjct: 165 EKDAVLKLTDFGFAKETTQNALQTPC----------YTPYYVAPE 199
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-23
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 32/215 (14%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITIC 597
++G+G++G VY G +++ +A+K I + S+ E ++++H+N I
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN----IVQY 84
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+ + K F+ E + GSL L ++ + I + ++YLH
Sbjct: 85 LGSFSENGFIKIFM-EQVPGGSLSALLRSKWGPLKDNE-QTIG--FYTKQILEGLKYLHD 140
Query: 658 HCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
+ +VH D+K NVL++ + V + DFG +K L+ + GT+ Y
Sbjct: 141 NQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--------PCTETFTGTLQY 189
Query: 717 VAPE--YGMGSEASMTGDI----------FTGRRP 739
+APE DI TG+ P
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 43/201 (21%), Positives = 70/201 (34%), Gaps = 44/201 (21%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNI-RHR 588
F + +G GS+G V+K ED + AVK ++G +AE + + +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 589 NLIKIITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQ-----SDDQVEVCKLSLI 639
++ + + E SL+ + QV
Sbjct: 118 CCVR---------LEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQV-------- 159
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT 699
D A+ +LH +VH D+KP+N+ L + DFGL L
Sbjct: 160 --WGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELG------ 208
Query: 700 AVKTPSSSIGLKGTVGYVAPE 720
T + +G Y+APE
Sbjct: 209 ---TAGAGEVQEGDPRYMAPE 226
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 8e-23
Identities = 56/265 (21%), Positives = 95/265 (35%), Gaps = 63/265 (23%)
Query: 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASR-SFVAECEALRNI 585
S+ +F +G+G FG V++ D+ A+K I L + +R + E +AL +
Sbjct: 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL 61
Query: 586 RHRNLIKIITICSSTDFKGTDFKAF----------------------------------- 610
H +++ T + +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 611 -----------------VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
+ +LKDW+++ + ++I I +A A+E
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED---REHGVCLHIFIQIAEAVE 178
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK-- 711
+LH ++H DLKPSN+ D V V DFGL + + + V TP +
Sbjct: 179 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG 235
Query: 712 --GTVGYVAPEYGMGSEASMTGDIF 734
GT Y++PE G+ S DIF
Sbjct: 236 QVGTKLYMSPEQIHGNNYSHKVDIF 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 43/221 (19%), Positives = 85/221 (38%), Gaps = 34/221 (15%)
Query: 538 MIGQGSFGYVYKGT---LGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLI 591
++G G V+ D VAVKV+ F E + + H ++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRD---VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ + V EY++ +L+D +H ++ + + + D A
Sbjct: 76 AVYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQA 128
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+ + H + ++H D+KP+N+++ V DFG+A+ ++D T ++++
Sbjct: 129 LNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD---SGNSVTQTAAV--I 180
Query: 712 GTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDA 742
GT Y++PE G D++ TG P
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 100 bits (249), Expect = 1e-22
Identities = 40/249 (16%), Positives = 72/249 (28%), Gaps = 44/249 (17%)
Query: 500 RKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIV 559
+ +A V TS P +EL + ++GQ + T E
Sbjct: 42 YMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 560 AVKVINLKYKGAS----------------RSFVAECEALRNIRHRNLIKIITICSS---- 599
V V + S R + +A ++R ++
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 600 ---TDFKGTDFKAFVFEYM----ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
D + + F Y + + L + L R+ + + V +
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK--SLVHHARLQLTLQVIRLL 219
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
LHH+ +VH L+P +++LD + F D A S
Sbjct: 220 ASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGARVVSS------V 264
Query: 713 TVGYVAPEY 721
+ G+ PE
Sbjct: 265 SRGFEPPEL 273
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 2e-22
Identities = 54/193 (27%), Positives = 84/193 (43%), Gaps = 31/193 (16%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-ECEALRNIR-HRNLIKIIT 595
++G+G+ V AVK+I K G RS V E E L + HRN++++I
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD-----DQVEVCKLSLIQRVNIAIDVAS 650
F+ D VFE M GS+ +H+ + V + DVAS
Sbjct: 79 F-----FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ-----------DVAS 122
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
A+++LH+ + H DLKP N+L + +CDF L + + + + TP
Sbjct: 123 ALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179
Query: 708 IGLKGTVGYVAPE 720
G+ Y+APE
Sbjct: 180 TPC-GSAEYMAPE 191
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 40/197 (20%), Positives = 75/197 (38%), Gaps = 33/197 (16%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRH 587
+ +G+G F ++ + + + + A K++ L E R++ H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEVCKLSLIQRVNIA 645
++++ F+ DF V E SL + ++ + E L Q
Sbjct: 75 QHVVGFHGF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY-LRQ----- 123
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS--DHQLDTAVKT 703
+ +YLH + ++H DLK N+ L+ D+ + DFGLA + + T
Sbjct: 124 --IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178
Query: 704 PSSSIGLKGTVGYVAPE 720
P+ Y+APE
Sbjct: 179 PN----------YIAPE 185
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 66/323 (20%), Positives = 106/323 (32%), Gaps = 87/323 (26%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
+P + SN L+L N + + F L +L L L +N++ ++
Sbjct: 63 RRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI-----RQIE 115
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNL 225
F +SL L L DN L+ IP G
Sbjct: 116 VGAF-NGLASLNTLELFDNW-----------LTV---------------IPSG------- 141
Query: 226 IGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSS-NSL 283
A L L++L L N ++ IPS + L L+L L
Sbjct: 142 ----------------AFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKL 184
Query: 284 QGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHL 343
+ + NL YL+L + +P + L
Sbjct: 185 EYISEGAFEGLFNL-------------------------KYLNLGMCNIK-DMP-NLTPL 217
Query: 344 KNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNN 403
L L++S N F + PG+ L+ L + ++ + + L S+ ELN++ NN
Sbjct: 218 VGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNN 277
Query: 404 LSGQIPEFLKNLSVLEFLSLSYN 426
LS + L L L L +N
Sbjct: 278 LSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 8e-19
Identities = 56/257 (21%), Positives = 92/257 (35%), Gaps = 33/257 (12%)
Query: 39 IPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL 98
+P G+ N LN+ EN + + ++ LE++QL N + L +L
Sbjct: 69 VPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASL 125
Query: 99 KALAIGGNNFFGSIP-YSLSNASNLELLDLSVNQFKGNVSID---FSSLKNLLWLNLEQN 154
L + N IP + S L L L N + SI F+ + +L+ L+L +
Sbjct: 126 NTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIE---SIPSYAFNRVPSLMRLDLGEL 181
Query: 155 N----LGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRN 209
+ G +LK L+L ++P+ + L + + N
Sbjct: 182 KKLEYISEGA---------FEGLFNLKYLNLGMCNI-KDMPN-LTPLVGLEELE--MSGN 228
Query: 210 QISGTIPPG-IRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-L 267
I PG L +L +Q+ +A L +L +L L N L +P
Sbjct: 229 HFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLF 286
Query: 268 GNLTKLANLELSSNSLQ 284
L L L L N
Sbjct: 287 TPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 8e-17
Identities = 44/205 (21%), Positives = 80/205 (39%), Gaps = 10/205 (4%)
Query: 238 TIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNL 297
+P I N + L L N +Q +L L L+L NS++ + +L
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125
Query: 298 MSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDISS-NQ 355
+ N LT +P + L L NN + S+P + +L+ LD+ +
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKK 183
Query: 356 FSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNL 415
+ G L+YL++ + +P +L+ L ++EL +S N+ P L
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGL 241
Query: 416 SVLEFLSLSYNHFEGEVPTKGVFSN 440
S L+ L + + + + F
Sbjct: 242 SSLKKLWVMNSQVS-LIE-RNAFDG 264
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 42/187 (22%), Positives = 71/187 (37%), Gaps = 12/187 (6%)
Query: 1 LQTLAVNDNYLTGQLPDFV-GNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKF 59
L+ L + N + Q+ L+ L + + N L L L L + N
Sbjct: 101 LEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPI 159
Query: 60 SGMFPRSICNISSLELIQLA-LNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSN 118
+ + + SL + L L + + L NLK L +G N +P +L+
Sbjct: 160 ESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTP 216
Query: 119 ASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKA 178
LE L++S N F F L +L L + + + + ++ F +SL
Sbjct: 217 LVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQV-----SLIERNAF-DGLASLVE 270
Query: 179 LSLADNQ 185
L+LA N
Sbjct: 271 LNLAHNN 277
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 61/252 (24%), Positives = 94/252 (37%), Gaps = 53/252 (21%)
Query: 486 SSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGEFSS----SNMIGQ 541
L++ I + R F D + ++ S S +G
Sbjct: 96 KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQ----------SVYPKALRDEYIMSKTLGS 145
Query: 542 GSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA---------ECEALRNIRHRNLIK 592
G+ G V + VA+++I+ K K A S E E L+ + H +IK
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
I + D+ V E ME G L D + V +L + A+
Sbjct: 205 IKNFFDAEDY------YIVLELMEGGELFDKV------VGNKRLKEATCKLYFYQMLLAV 252
Query: 653 EYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQ-LDTAVKTPSSSI 708
+YLH + ++H DLKP NVLL + D + + DFG +K L + + T
Sbjct: 253 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC------- 302
Query: 709 GLKGTVGYVAPE 720
GT Y+APE
Sbjct: 303 ---GTPTYLAPE 311
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 29/195 (14%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRH 587
+ +G+G F ++ + + + + A K++ L E R++ H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEVCKLSLIQRVNIA 645
++++ F+ DF V E SL + ++ + E L Q
Sbjct: 101 QHVVGFHGF-----FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY-LRQ----- 149
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
+ +YLH + ++H DLK N+ L+ D+ + DFGLA + K
Sbjct: 150 --IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKV-- 200
Query: 706 SSIGLKGTVGYVAPE 720
L GT Y+APE
Sbjct: 201 ----LCGTPNYIAPE 211
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 4e-22
Identities = 44/193 (22%), Positives = 77/193 (39%), Gaps = 27/193 (13%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRH 587
+F +G+G FG VY + + I+A+KV+ L+ G E E ++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAID 647
N++++ F + EY G++ L + K + +
Sbjct: 69 PNILRLYGY-----FHDATRVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITE 117
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
+A+A+ Y H ++H D+KP N+LL + DFG + +
Sbjct: 118 LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-------- 166
Query: 708 IGLKGTVGYVAPE 720
L GT+ Y+ PE
Sbjct: 167 --LCGTLDYLPPE 177
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 60/327 (18%), Positives = 109/327 (33%), Gaps = 57/327 (17%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
+ SIP L+ ++ LDLS N+ + D NL L L N + ++
Sbjct: 40 SGSLNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-----NTIE 92
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVN 224
+F ++ SL+ L L+ N LS+ + + L +
Sbjct: 93 EDSF-SSLGSLEHLDLSYNY-----------LSN---------------LSSSWFKPLSS 125
Query: 225 LIGFGAEENQLHGTIPDAI--GELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSN 281
L N T+ + L LQ L + +I LT L LE+ ++
Sbjct: 126 LTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184
Query: 282 SLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVG 341
LQ P SL + QN+ + L ++ + ++
Sbjct: 185 DLQSYEPKSLKSIQNVSHLILHMKQHI-----------------LLLEIFVDVTSSVECL 227
Query: 342 HLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401
L++ + ++ S +L + I+ S + L+ + + EL S
Sbjct: 228 ELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSR 286
Query: 402 NNLSGQIPEFLKNLSVLEFLSLSYNHF 428
N L L+ L+ + L N +
Sbjct: 287 NQLKSVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 62/323 (19%), Positives = 108/323 (33%), Gaps = 45/323 (13%)
Query: 64 PRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLE 123
IC SS L ++P + +K+L + N L NL+
Sbjct: 32 RNGICKGSSGSL---------NSIPSGL---TEAVKSLDLSNNRITYISNSDLQRCVNLQ 79
Query: 124 LLDLSVNQFKGNVSID---FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L L+ N +I+ FSSL +L L+L N L ++L F SSL L+
Sbjct: 80 ALVLTSNGIN---TIEEDSFSSLGSLEHLDLSYNYL-----SNLSSSWF-KPLSSLTFLN 130
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTI 239
L N + S+ + + + +G I L L + + L
Sbjct: 131 LLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGL-GNLTKLANLELSSNSLQGNIPSSLGNCQNLM 298
P ++ ++N+ L L + + + LEL L S L
Sbjct: 191 PKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSEL------- 242
Query: 299 SFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSG 358
T N L + + +++ L + + + L+ L+ S NQ
Sbjct: 243 -STGETNSLIKKFTFR---------NVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291
Query: 359 VIPGTLSTCVCLEYLDISSNSFH 381
V G L+ + + +N +
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 6e-21
Identities = 52/270 (19%), Positives = 98/270 (36%), Gaps = 21/270 (7%)
Query: 195 ANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLC 253
+ L+ V + + N+I+ I + VNL N ++ D+ L +L+ L
Sbjct: 48 SGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106
Query: 254 LFRNFLQGRIPSGL-GNLTKLANLELSSNSLQGNIPSSL-GNCQNLMSFTASQNKLTGAL 311
L N+L + S L+ L L L N + +SL + L +
Sbjct: 107 LSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 312 PHQLLSITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCL 370
+ + T L++ + L S + ++N+ L + Q ++ + +
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSV 224
Query: 371 EYLDISSN--------SFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLS 422
E L++ SL + + + ++ +L Q+ + L +S L L
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELE 283
Query: 423 LSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
S N + VP G+F T I L N
Sbjct: 284 FSRNQLKS-VP-DGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 48/286 (16%), Positives = 101/286 (35%), Gaps = 27/286 (9%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+++L +++N +T + +L+ + + N + + L +L L+++ N S
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPY-SLSNA 119
+ +SSL + L N + + +L L+ L +G + F I +
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL 179
+ LE L++ + + S++N+ L L L + SS++ L
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH-----ILLLEIFV-DVTSSVECL 227
Query: 180 SLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239
L D +++S + + L +
Sbjct: 228 ELRDTDLD-----------------TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QV 269
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSNSLQ 284
+ ++ L +L RN L+ +P G LT L + L +N
Sbjct: 270 MKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 8e-22
Identities = 33/200 (16%), Positives = 69/200 (34%), Gaps = 31/200 (15%)
Query: 537 NMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+++G+G+F VY+ T G +++ +KV E L+ +
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
K + + V E G+L + ++ + E + ++ A+ +
Sbjct: 131 KFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV-MPQGLVISFAMRMLYM 184
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH-----------VCDFGLAKFLSDHQLDTA 700
+E +H ++HGD+KP N +L + + + D G + + T
Sbjct: 185 IEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 701 VKTPSSSIGLKGTVGYVAPE 720
T G+ E
Sbjct: 242 FTA------KCETSGFQCVE 255
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 37/194 (19%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN--------LKYKGASRSFVAECEALRNIRHRNL 590
+G G+ G V + VA+K+I+ + + + E E L+ + H +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
IKI + D+ V E ME G L D + V +L +
Sbjct: 78 IKIKNFFDAEDY------YIVLELMEGGELFDKV------VGNKRLKEATCKLYFYQMLL 125
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQ-LDTAVKTPSS 706
A++YLH + ++H DLKP NVLL + D + + DFG +K L + + T
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC----- 177
Query: 707 SIGLKGTVGYVAPE 720
GT Y+APE
Sbjct: 178 -----GTPTYLAPE 186
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 54/215 (25%), Positives = 81/215 (37%), Gaps = 12/215 (5%)
Query: 215 IPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKL 273
IP + + L N++ + +NL L L N L RI + L L
Sbjct: 30 IPAASQRI-FL-----HGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82
Query: 274 ANLELSSNSLQGNIPSS-LGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLL 332
L+LS N+ ++ + L + + L L L YL L +N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 333 NGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFL 391
+LP L NL L + N+ S V L+ L + N V P + L
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDL 200
Query: 392 KSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYN 426
+ L + +NNLS E L L L++L L+ N
Sbjct: 201 GRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 60/332 (18%), Positives = 106/332 (31%), Gaps = 75/332 (22%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
++P + + + + L N+ + F + +NL L L N L +D
Sbjct: 20 QQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-----ARID 72
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVN 224
F T + L+ L L+DN Q+ ++ P L
Sbjct: 73 AAAF-TGLALLEQLDLSDN------------------------AQLR-SVDPATFHGLGR 106
Query: 225 LIGFGAEENQLHGTIP-DAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSNS 282
L + L + L LQ L L N LQ +P +L L +L L N
Sbjct: 107 LHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNR 164
Query: 283 LQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV-G 341
+ + +L L L N + +
Sbjct: 165 ISSVPERAFRGLHSLD-------------------------RLLLHQNRVA-HVHPHAFR 198
Query: 342 HLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH---GVIPLSLSFLKSIKELN 398
L L+ L + +N S + L+ L+YL ++ N + PL +++
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW----AWLQKFR 254
Query: 399 VSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEG 430
SS+ + +P+ L + L+ N +G
Sbjct: 255 GSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 53/252 (21%), Positives = 85/252 (33%), Gaps = 45/252 (17%)
Query: 39 IPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL 98
+P G+ + + N+ S + S +L ++ L N + + L L
Sbjct: 26 VPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALL 82
Query: 99 KALAIGGNNFFGSIP-YSLSNASNLELLDLSVNQFKGNVSID---FSSLKNLLWLNLEQN 154
+ L + N S+ + L L L + + F L L +L L+ N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ---ELGPGLFRGLAALQYLYLQDN 139
Query: 155 NLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGT 214
L L TF + +L L L N+IS +
Sbjct: 140 AL-----QALPDDTF-RDLGNLTHLFL-------------------------HGNRIS-S 167
Query: 215 IPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTK 272
+P R L +L +N++ P A +L L L LF N L +P+ L L
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRA 226
Query: 273 LANLELSSNSLQ 284
L L L+ N
Sbjct: 227 LQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 39/192 (20%), Positives = 64/192 (33%), Gaps = 9/192 (4%)
Query: 262 RIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTL 321
+P G+ + L N + +S C+NL N L + L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 322 SLYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSF 380
LDLS+N S+ L L L + + PG L+YL + N+
Sbjct: 83 E-QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 381 HGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSN 440
+ + L ++ L + N +S + L L+ L L N V F +
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVH-PHAFRD 199
Query: 441 KTK---ISLQGN 449
+ + L N
Sbjct: 200 LGRLMTLYLFAN 211
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-21
Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 25/187 (13%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN-LKYKGASRSFVAECEALRNIRHRNLIKIITIC 597
+G G+FG V+ + +K IN + + AE E L+++ H N+IKI +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
F+ V E E G L + + + + + LS + + +A+ Y H
Sbjct: 89 ----FEDYHNMYIVMETCEGGELLERIVSAQARGK--ALSEGYVAELMKQMMNALAYFHS 142
Query: 658 HCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQ-LDTAVKTPSSSIGLKGT 713
+VH DLKP N+L + DFGLA+ + A GT
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA----------GT 189
Query: 714 VGYVAPE 720
Y+APE
Sbjct: 190 ALYMAPE 196
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 45/300 (15%), Positives = 79/300 (26%), Gaps = 37/300 (12%)
Query: 116 LSNASNLELLDLSVNQFKGNVSI-DFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCS 174
+LE L V+ D +L L + + + L + S
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARI---PSRILFGALRVLGIS 95
Query: 175 SLKALSLADNQFGGELPHSIANLSST-VINFGIGRNQISGTIPPGIRNLVNLIGFGAEEN 233
L+ L+L + + G P + + + + + + L +
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWL------- 147
Query: 234 QLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGN 293
L+ L + + + L+ L+LS N G
Sbjct: 148 ------------KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195
Query: 294 CQ----NLMSFTASQNKLTGALPHQLLSITTLSL--YLDLSNNLLNGSLPLQV-GHLKNL 346
C L + LDLS+N L + L
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQL 255
Query: 347 VILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG 406
L++S V G + L LD+S N S L + L++ N
Sbjct: 256 NSLNLSFTGLKQVPKGLPAK---LSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 56/216 (25%), Positives = 80/216 (37%), Gaps = 19/216 (8%)
Query: 248 NLQKLCLFRNFLQGRIPSGLGNLT--KLANLELSSNSLQG--NIPSSLGNC--QNLMSFT 301
LQ+L L + G P L T L L L + S + L L +
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLS 155
Query: 302 ASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPL----QVGHLKNLVILDISSNQF- 356
+Q Q+ LS LDLS+N G L L +L + +
Sbjct: 156 IAQAHSLNFSCEQVRVFPALS-TLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 357 --SGVIPGTLSTCVCLEYLDISSNSFHGVIP-LSLSFLKSIKELNVSSNNLSGQIPEFLK 413
SGV + V L+ LD+S NS S + + LN+S L Q+P+ L
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL- 272
Query: 414 NLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
+ L L LSYN + P+ +SL+GN
Sbjct: 273 -PAKLSVLDLSYNRLD-RNPSPDELPQVGNLSLKGN 306
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 35/192 (18%), Positives = 56/192 (29%), Gaps = 15/192 (7%)
Query: 257 NFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSS---LGNCQNLMSFTASQNKLTGALPH 313
+ + L L + + + I + L T ++TG P
Sbjct: 54 TEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113
Query: 314 QLLSITTLSL-YLDLSNNLLNGSLP----LQVGHLKNLVILDISSNQFSGVIPGTLSTCV 368
LL T L L+L N LQ L +L I+ +
Sbjct: 114 PLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173
Query: 369 CLEYLDISSNSFHGVIPLSLSF----LKSIKELNVSSNN---LSGQIPEFLKNLSVLEFL 421
L LD+S N G L + +++ L + + SG L+ L
Sbjct: 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGL 233
Query: 422 SLSYNHFEGEVP 433
LS+N
Sbjct: 234 DLSHNSLRDAAG 245
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 40/212 (18%), Positives = 62/212 (29%), Gaps = 26/212 (12%)
Query: 1 LQTLAVNDNYLTGQLP--DFVGNLSDLEVIRIMGNSLGGKIPTTLGL----LRNLVSLNV 54
LQ L + + +TG P DL ++ + S + L L L++
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 55 AENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVV---NLPNLKALAIGGNNF--- 108
A+ + +L + L+ N G + P L+ LA+
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 109 FGSIPYSLSNASNLELLDLSVNQFKGNV-SIDFSSLKNLLWLNLEQNNLGTGTAT----- 162
G + L+ LDLS N + + L LNL L
Sbjct: 217 SGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKL 276
Query: 163 --------DLDFVTFLTNCSSLKALSLADNQF 186
LD + LSL N F
Sbjct: 277 SVLDLSYNRLDRNPSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 41/226 (18%), Positives = 66/226 (29%), Gaps = 19/226 (8%)
Query: 46 LRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNL-----PNLKA 100
+ L L + + +G P + + +L L L S + L P LK
Sbjct: 94 ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153
Query: 101 LAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFS----SLKNLLWLNLEQNNL 156
L+I + + L LDLS N G + + L L L +
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213
Query: 157 GTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIP 216
L+ L L+ N + S + + + + +P
Sbjct: 214 ---ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVP 269
Query: 217 PGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQG 261
G+ L L N+L P EL + L L N
Sbjct: 270 KGLPAKLSVLD---LSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 57/291 (19%), Positives = 111/291 (38%), Gaps = 38/291 (13%)
Query: 141 SSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLS-- 198
+L N + + ++N+ TD + + LS +I +
Sbjct: 16 PALANAIKIAAGKSNV-----TDT---VTQADLDGITTLSAFGTGV-----TTIEGVQYL 62
Query: 199 STVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNF 258
+ +I + NQI+ + P ++NL + N L AI L++++ L L
Sbjct: 63 NNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQ 118
Query: 259 LQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSI 318
+ + L L+ L L L N + NI S L NL + +++ L +
Sbjct: 119 ITD--VTPLAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS-----DLTPL 169
Query: 319 TTLSL--YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDIS 376
LS L +N ++ PL L NL+ + + +NQ S V P L+ L + ++
Sbjct: 170 ANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
Query: 377 SNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI-PEFLKNLSVLEFLSLSYN 426
+ + + + + ++ NV I P + + +L++N
Sbjct: 226 NQT---ITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 55/241 (22%), Positives = 91/241 (37%), Gaps = 20/241 (8%)
Query: 209 NQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLG 268
I+ P L N I A ++ + T+ +L + L F + I G+
Sbjct: 7 TAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQ 60
Query: 269 NLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLS 328
L L LEL N + ++ + L N + S N L + + ++ LDL+
Sbjct: 61 YLNNLIGLELKDNQIT-DL-APLKNLTKITELELSGNPLKNVSA--IAGLQSIK-TLDLT 115
Query: 329 NNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSL 388
+ + PL L NL +L + NQ + + P L+ L+YL I + + PL+
Sbjct: 116 STQITDVTPLA--GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLA- 170
Query: 389 SFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQG 448
L + L N +S L +L L + L N P SN ++L
Sbjct: 171 -NLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLAN-TSNLFIVTLTN 226
Query: 449 N 449
Sbjct: 227 Q 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 46/220 (20%), Positives = 89/220 (40%), Gaps = 18/220 (8%)
Query: 230 AEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPS 289
+ ++ PD L N K+ ++ + +L + L + I
Sbjct: 4 TQPTAINVIFPDP--ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-E 57
Query: 290 SLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVIL 349
+ NL+ N++T P L ++T ++ L+LS N L + L+++ L
Sbjct: 58 GVQYLNNLIGLELKDNQITDLAP--LKNLTKIT-ELELSGNPLKNVSAI--AGLQSIKTL 112
Query: 350 DISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIP 409
D++S Q + V P L+ L+ L + N + PL+ L +++ L++ + +S
Sbjct: 113 DLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSD--L 166
Query: 410 EFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
L NLS L L N ++ N ++ L+ N
Sbjct: 167 TPLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNN 205
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 51/293 (17%), Positives = 100/293 (34%), Gaps = 33/293 (11%)
Query: 69 NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLS 128
+++ I + + + +L + L+ G +I + +NL L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA---DLDGITTLSAFGTGV-TTIE-GVQYLNNLIGLELK 71
Query: 129 VNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGG 188
NQ +++ +L + L L N L ++ + L + +K L L Q
Sbjct: 72 DNQIT-DLA-PLKNLTKITELELSGNPL-----KNVSAIAGLQS---IKTLDLTSTQI-- 119
Query: 189 ELPHSIANLS--STVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGEL 246
+ L+ S + + NQI+ + L NL Q+ + + L
Sbjct: 120 ---TDVTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQV--SDLTPLANL 172
Query: 247 KNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNK 306
L L N + S L +L L + L +N + S L N NL T +
Sbjct: 173 SKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQT 228
Query: 307 LTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGV 359
+T ++ ++ S + P + +++ N S +
Sbjct: 229 ITNQPVFYNNNLVVPNVVKGPSGAPIA---PATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 61/364 (16%), Positives = 130/364 (35%), Gaps = 86/364 (23%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
+A + +T +L + + G + + L NL+ L + +N+
Sbjct: 21 AIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQ-- 74
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
I +++ L+ NL + L + GN +++
Sbjct: 75 ------ITDLAPLK-------------------NLTKITELELSGNPL--KNVSAIAGLQ 107
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
+++ LDL+ Q + L NL L L+ N + T++ L ++L+ LS
Sbjct: 108 SIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQI-----TNIS---PLAGLTNLQYLS 157
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
+ + Q +++L+ + NL L A++N++ +
Sbjct: 158 IGNAQ--------VSDLT-------------------PLANLSKLTTLKADDNKI--SDI 188
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ L NL ++ L N + S L N + L + L++ ++ N P N NL+
Sbjct: 189 SPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTIT-NQPVFYNN--NLVVP 243
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHL----KNLVILDISSNQF 356
+ ++ T+S ++ L +L + ++ V ++ F
Sbjct: 244 NVVKGPSG-----APIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPF 298
Query: 357 SGVI 360
SG +
Sbjct: 299 SGTV 302
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 32/189 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASR---SFVAECEALRNIRHRNLIKIIT 595
+G+GSFG V K + AVKVIN K ++ + + E E L+ + H N++K+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
I + + V E G L D + ++ + S I V S + Y+
Sbjct: 89 I-----LEDSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGITYM 137
Query: 656 HHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLS-DHQLDTAVKTPSSSIGLK 711
H H +VH DLKP N+LL + D + DFGL+ + ++ +
Sbjct: 138 HKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI---------- 184
Query: 712 GTVGYVAPE 720
GT Y+APE
Sbjct: 185 GTAYYIAPE 193
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 52/263 (19%), Positives = 91/263 (34%), Gaps = 51/263 (19%)
Query: 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRN 584
S+ T EF IG G FG V+K D I A+K G+ ++ + E A
Sbjct: 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAV 66
Query: 585 I-RHRNLIKIITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLI 639
+ +H ++++ + + EY GSL D + ++ + K + +
Sbjct: 67 LGQHSHVVR---------YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAEL 117
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT 699
+ ++ + V + Y+H +VH D+KPSN+ + + + +
Sbjct: 118 K--DLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
Query: 700 A-------VKTPSSSIGLKGTVGYVAPE-----YGMGSEASMTGDIF----------TGR 737
V SS +G ++A E Y +A DIF
Sbjct: 173 FKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKA----DIFALALTVVCAAGAE 228
Query: 738 RPIDAVFNEGHSLHEFAKTALPE 760
G HE + LP
Sbjct: 229 PL----PRNGDQWHEIRQGRLPR 247
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 42/193 (21%), Positives = 79/193 (40%), Gaps = 27/193 (13%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRH 587
+F +G+G FG VY +++ I+A+KV+ L+ +G E E ++RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAID 647
N++++ F + E+ G L L + + + +
Sbjct: 74 PNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEE 122
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
+A A+ Y H ++H D+KP N+L+ + + DFG + + T
Sbjct: 123 LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-------- 171
Query: 708 IGLKGTVGYVAPE 720
+ GT+ Y+ PE
Sbjct: 172 --MCGTLDYLPPE 182
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 67/323 (20%), Positives = 113/323 (34%), Gaps = 87/323 (26%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
+P +S +N LL+L NQ + F L++L L L +N++ ++
Sbjct: 52 RKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-----RTIE 104
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNL 225
F ++L L L DN+ L++ IP G
Sbjct: 105 IGAF-NGLANLNTLELFDNR-----------LTT---------------IPNG------- 130
Query: 226 IGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGL-GNLTKLANLELSS-NSL 283
A L L++L L N ++ IPS + L L+L L
Sbjct: 131 ----------------AFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRL 173
Query: 284 QGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHL 343
+ NL YL+L+ L +P + L
Sbjct: 174 SYISEGAFEGLSNLR-------------------------YLNLAMCNLR-EIP-NLTPL 206
Query: 344 KNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNN 403
L LD+S N S + PG+ + L+ L + + + + L+S+ E+N++ NN
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
Query: 404 LSGQIPEFLKNLSVLEFLSLSYN 426
L+ + L LE + L +N
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-19
Identities = 59/257 (22%), Positives = 104/257 (40%), Gaps = 33/257 (12%)
Query: 39 IPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL 98
+P G+ N LN+ EN+ + S ++ LE++QL+ N + L NL
Sbjct: 58 VPD--GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANL 114
Query: 99 KALAIGGNNFFGSIPY-SLSNASNLELLDLSVNQFKGNVSID---FSSLKNLLWLNLEQN 154
L + N +IP + S L+ L L N + SI F+ + +L L+L +
Sbjct: 115 NTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIE---SIPSYAFNRIPSLRRLDLGEL 170
Query: 155 N----LGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRN 209
+ G S+L+ L+LA E+P+ + L ++ + N
Sbjct: 171 KRLSYISEGA---------FEGLSNLRYLNLAMCNL-REIPN-LTPLIKLDELD--LSGN 217
Query: 210 QISGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-L 267
+S I PG + L++L ++Q+ +A L++L ++ L N L +P
Sbjct: 218 HLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLF 275
Query: 268 GNLTKLANLELSSNSLQ 284
L L + L N
Sbjct: 276 TPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 44/186 (23%), Positives = 71/186 (38%), Gaps = 10/186 (5%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+ L ++ N++ L++L + + N L L L L + N
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE 149
Query: 61 GMFPRSICNISSLELIQLA-LNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA 119
+ + I SL + L L R S + L NL+ L + N IP +L+
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCN-LREIP-NLTPL 206
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL 179
L+ LDLS N F L +L L + Q+ + ++ F N SL +
Sbjct: 207 IKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQI-----QVIERNAF-DNLQSLVEI 260
Query: 180 SLADNQ 185
+LA N
Sbjct: 261 NLAHNN 266
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-11
Identities = 27/125 (21%), Positives = 49/125 (39%), Gaps = 6/125 (4%)
Query: 303 SQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPG 362
+ L +P + + T L+L N + HL++L IL +S N + G
Sbjct: 51 VRKNLR-EVPDGISTNTR---LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIG 106
Query: 363 TLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFL-KNLSVLEFL 421
+ L L++ N + + +L +KEL + +N + IP + + L L
Sbjct: 107 AFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165
Query: 422 SLSYN 426
L
Sbjct: 166 DLGEL 170
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 4e-21
Identities = 44/189 (23%), Positives = 76/189 (40%), Gaps = 32/189 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA---ECEALRNIRHRNLIKIIT 595
+G+G+F V + + A K+IN K ++R F E R ++H N++++
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ F VF+ + G L + + V S + + ++ Y
Sbjct: 73 S-----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYC 121
Query: 656 HHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSD-HQLDTAVKTPSSSIGLK 711
H + +VH +LKP N+LL + DFGLA ++D
Sbjct: 122 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---------- 168
Query: 712 GTVGYVAPE 720
GT GY++PE
Sbjct: 169 GTPGYLSPE 177
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 48/186 (25%), Positives = 68/186 (36%), Gaps = 28/186 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG+GS+G V + A K I + F E E ++++ H N+I++
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET-- 74
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
F+ V E G L + + V I DV SA+ Y H
Sbjct: 75 ---FEDNTDIYLVMELCTGGELFERV------VHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 659 CQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSD-HQLDTAVKTPSSSIGLKGTV 714
+ H DLKP N L D + DFGLA + T V GT
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----------GTP 172
Query: 715 GYVAPE 720
YV+P+
Sbjct: 173 YYVSPQ 178
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 52/207 (25%), Positives = 81/207 (39%), Gaps = 39/207 (18%)
Query: 525 ELSKATGEFSS----SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECE 580
+L + + +F+ IG GS+ + M AVK+I+ + + E E
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EIE 67
Query: 581 AL-RNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLI 639
L R +H N+I + + + + V E M+ G L D + + S
Sbjct: 68 ILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKI------LRQKFFSER 116
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCDFGLAKFLSDH 695
+ + + +EYLH +VH DLKPSN+L + +CDFG AK L
Sbjct: 117 EASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173
Query: 696 Q--LDTAVKTPSSSIGLKGTVGYVAPE 720
L T T +VAPE
Sbjct: 174 NGLLMTPC----------YTANFVAPE 190
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 49/211 (23%), Positives = 83/211 (39%), Gaps = 53/211 (25%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN----LKYKGASRSFVA----------------- 577
IG+GS+G V D A+KV++ ++ G R
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 578 -----ECEALRNIRHRNLIKIITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQV 631
E L+ + H N++K++ + + + VFE + G + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDP----NEDHLYMVFELVNQGPVME-------VP 129
Query: 632 EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691
+ LS Q D+ +EYLH+ ++H D+KPSN+L+ D + DFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 692 L--SDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
SD L V TP+ ++APE
Sbjct: 187 FKGSDALLSNTVGTPA----------FMAPE 207
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 48/187 (25%), Positives = 78/187 (41%), Gaps = 31/187 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRHRNLIKIIT 595
IG+G+F V VA+K+I+ L + F E ++ + H N++K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81
Query: 596 ICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ T+ + + EY G + D+L V ++ + + + SA++Y
Sbjct: 82 VIE------TEKTLYLIMEYASGGEVFDYL------VAHGRMKEKEARSKFRQIVSAVQY 129
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL-AKFLSDHQLDTAVKTPSSSIGLKGT 713
H +VH DLK N+LLD DM + DFG +F +LD P
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP-------- 178
Query: 714 VGYVAPE 720
Y APE
Sbjct: 179 --YAAPE 183
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 91.4 bits (228), Expect = 2e-20
Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 34/198 (17%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRH 587
+F N++G+GSF VY+ + VA+K+I+ + G + E + ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD---DQVEVCKLSLIQRVNI 644
+++++ F+ +++ V E NG + +L + E + Q
Sbjct: 71 PSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF-MHQ---- 120
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS--DHQLDTAVK 702
+ + M YLH H ++H DL SN+LL +M + DFGLA L + T
Sbjct: 121 ---IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--- 171
Query: 703 TPSSSIGLKGTVGYVAPE 720
L GT Y++PE
Sbjct: 172 -------LCGTPNYISPE 182
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.2 bits (236), Expect = 2e-20
Identities = 53/258 (20%), Positives = 91/258 (35%), Gaps = 34/258 (13%)
Query: 176 LKALSLADNQFGGELPHSIANLSS--TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEEN 233
+ I + I + + ++ + L ++ A +
Sbjct: 1 MGETITVSTPI-----KQIFPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS 53
Query: 234 QLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGN 293
+ ++ I L N+ KL L N L I L NL L L L N ++ ++ SSL +
Sbjct: 54 DIK-SV-QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKD 107
Query: 294 CQNLMSFTASQNKLTGALPHQLLSITTLS-----LYLDLSNNLLNGSLPLQVGHLKNLVI 348
+ L S + N ++ I L L L NN + L L L
Sbjct: 108 LKKLKSLSLEHNGIS--------DINGLVHLPQLESLYLGNNKITDITVLS--RLTKLDT 157
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408
L + NQ S ++P L+ L+ L +S N + L+ LK++ L + S +
Sbjct: 158 LSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKP 213
Query: 409 PEFLKNLSVLEFLSLSYN 426
NL V + +
Sbjct: 214 INHQSNLVVPNTVKNTDG 231
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 94.0 bits (233), Expect = 5e-20
Identities = 54/358 (15%), Positives = 111/358 (31%), Gaps = 69/358 (19%)
Query: 116 LSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSS 175
+ +L V+ + L ++ + +++ + + +L N
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDI-----KSVQGIQYLPN--- 66
Query: 176 LKALSLADNQFGGELPHSIANLSS----TVINFGIGRNQISGTIPPGIRNLVNLIGFGAE 231
+ L L N+ I L++ + N+I + +++L L E
Sbjct: 67 VTKLFLNGNKL-----TDIKPLTNLKNLGWLFLD--ENKIK-DLSS-LKDLKKLKSLSLE 117
Query: 232 ENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSL 291
N + + + + L L+ L L N + + L LTKL L L N + +I L
Sbjct: 118 HNGI--SDINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DI-VPL 171
Query: 292 GNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDI 351
L + S+N ++ + L+ LKNL +L++
Sbjct: 172 AGLTKLQNLYLSKNHIS--------DLRALA-------------------GLKNLDVLEL 204
Query: 352 SSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEF 411
S + S V + + S P +S ++ NV +
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNE-- 260
Query: 412 LKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGS 469
+S + K F + L+ + +D + + G+
Sbjct: 261 ---------VSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIKTKVEAGT 309
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 8e-17
Identities = 54/282 (19%), Positives = 104/282 (36%), Gaps = 34/282 (12%)
Query: 46 LRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDI--VVNLPNLKALAI 103
+ N+ + + ++S++ I + + + LPN+ L +
Sbjct: 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-----SVQGIQYLPNVTKLFL 72
Query: 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLEQNNLGTGTAT 162
GN I L+N NL L L N+ K + LK L L+LE N + +
Sbjct: 73 NGNKL-TDIK-PLTNLKNLGWLFLDENKIK---DLSSLKDLKKLKSLSLEHNGI-----S 122
Query: 163 DLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRN 221
D++ L + L++L L +N+ ++ L+ ++ + NQIS I P +
Sbjct: 123 DING---LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLS--LEDNQIS-DIVP-LAG 173
Query: 222 LVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSN 281
L L +N + + A+ LKNL L LF + + NL ++ +
Sbjct: 174 LTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
Query: 282 SLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL 323
SL P + + + + + +++
Sbjct: 232 SLV--TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTI 271
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 32/156 (20%), Positives = 63/156 (40%), Gaps = 11/156 (7%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L +++N + L +L L+ + + N + L L L SL + NK +
Sbjct: 89 LGWLFLDENKIK-DLSSL-KDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKIT 144
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ + ++ L+ + L N+ S +P L L+ L + N+ S +L+
Sbjct: 145 DI--TVLSRLTKLDTLSLEDNQISDIVPLA---GLTKLQNLYLSKNHI--SDLRALAGLK 197
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156
NL++L+L + S+L + +L
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 47/189 (24%), Positives = 72/189 (38%), Gaps = 36/189 (19%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG G+FG + +VAVK I + + E R++RH N+++ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEVCKL--SLIQRVNIAIDVASAMEY 654
+ T A + EY G L + + + E L+ S + Y
Sbjct: 87 TP----THL-AIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----------SGVSY 131
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAH--VCDFGLAK-FLSDHQLDTAVKTPSSSIGLK 711
H + H DLK N LLD +CDFG +K + Q + V TP+
Sbjct: 132 CHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------ 182
Query: 712 GTVGYVAPE 720
Y+APE
Sbjct: 183 ----YIAPE 187
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 3e-20
Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 32/207 (15%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-ECEALRNIRHRNL 590
+F + +G G+ G V+K + +++A K+I+L+ K A R+ + E + L +
Sbjct: 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 591 IKIITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
+ F G + E+M+ GSL L ++ ++ ++I
Sbjct: 94 VG---------FYGAFYSDGEISICMEHMDGGSLDQVLKKAG------RIPEQILGKVSI 138
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
V + YL + ++H D+KPSN+L++ +CDFG++ L D ++ V
Sbjct: 139 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----- 191
Query: 707 SIGLKGTVGYVAPEYGMGSEASMTGDI 733
GT Y++PE G+ S+ DI
Sbjct: 192 -----GTRSYMSPERLQGTHYSVQSDI 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 33/188 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITIC 597
+G+GSF K + AVK+I+ + + ++ E AL+ H N++K+ +
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEV- 74
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
F V E + G L + + S + I + SA+ ++H
Sbjct: 75 ----FHDQLHTFLVMELLNGGEL------FERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 658 HCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQ--LDTAVKTPSSSIGLKG 712
+VH DLKP N+L + ++ + DFG A+ L T
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC----------F 171
Query: 713 TVGYVAPE 720
T+ Y APE
Sbjct: 172 TLHYAAPE 179
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-20
Identities = 57/187 (30%), Positives = 86/187 (45%), Gaps = 30/187 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA----ECEALRNIRHRNLIKII 594
+G G+FG V G VAVK++N + K S V E + L+ RH ++IK+
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ S+ F V EY+ G L D++ + ++ ++ + + SA++Y
Sbjct: 78 QVIST---PTDFF--MVMEYVSGGELFDYI------CKHGRVEEMEARRLFQQILSAVDY 126
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL-AKFLSDHQLDTAVKTPSSSIGLKGT 713
H H +VH DLKP NVLLD M A + DFGL L T+ +P+
Sbjct: 127 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-------- 175
Query: 714 VGYVAPE 720
Y APE
Sbjct: 176 --YAAPE 180
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 6e-20
Identities = 43/188 (22%), Positives = 71/188 (37%), Gaps = 31/188 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-ECEALRNIRHRNLIKIIT-I 596
+G+G++G V E VAVK++++K + E + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEVCKL--SLIQRVNIAIDVASAM 652
EY G L D + + + + L+ + +
Sbjct: 75 REGNIQ------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGV 118
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
YLH + H D+KP N+LLD + DFGLA + + + G
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------G 169
Query: 713 TVGYVAPE 720
T+ YVAPE
Sbjct: 170 TLPYVAPE 177
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-20
Identities = 44/189 (23%), Positives = 76/189 (40%), Gaps = 32/189 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA---ECEALRNIRHRNLIKIIT 595
+G+G+F V + + A K+IN K ++R F E R ++H N++++
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ F VF+ + G L + + V S + + ++ Y
Sbjct: 96 S-----IQEESFHYLVFDLVTGGELFEDI------VAREFYSEADASHCIQQILESIAYC 144
Query: 656 HHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSD-HQLDTAVKTPSSSIGLK 711
H + +VH +LKP N+LL + DFGLA ++D
Sbjct: 145 HSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA---------- 191
Query: 712 GTVGYVAPE 720
GT GY++PE
Sbjct: 192 GTPGYLSPE 200
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-20
Identities = 42/192 (21%), Positives = 75/192 (39%), Gaps = 26/192 (13%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
S + ++G G FG V+K + +A K+I + E + + H NLI
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
++ F+ + V EY++ G L D + L+ + + +
Sbjct: 150 QLYDA-----FESKNDIVLVMEYVDGGELFDRIIDES-----YNLTELDTILFMKQICEG 199
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLS-DHQLDTAVKTPSSSI 708
+ ++H ++H DLKP N+L + + DFGLA+ +L
Sbjct: 200 IRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF------- 249
Query: 709 GLKGTVGYVAPE 720
GT ++APE
Sbjct: 250 ---GTPEFLAPE 258
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 45/223 (20%), Positives = 72/223 (32%), Gaps = 53/223 (23%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLK-----YKGASRSFVAECEALRNIRHRNLIKI 593
IGQGS+G V + I A+K++N E ++ + H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRV----------- 642
+ ++ + V E G L D L+ D + +
Sbjct: 94 YEV-----YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 643 -----------------------NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679
NI + SA+ YLH+ + H D+KP N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 680 VAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
+ DFGL+K GT +VAPE
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMT----TKAGTPYFVAPE 244
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 55/220 (25%), Positives = 87/220 (39%), Gaps = 35/220 (15%)
Query: 512 SPMEKQFPMVSYAELSKATGEFSS----SNMIGQGSFGYVYKGTLGEDEMIVAVKVIN-- 565
M + +T FS ++G+GSFG V AVKVI+
Sbjct: 3 GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62
Query: 566 -LKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWL 624
+K K S + E + L+ + H N++K+ F+ + V E G L D +
Sbjct: 63 QVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI 117
Query: 625 HQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVA 681
+ + S + I V S + Y+H + +VH DLKP N+LL D
Sbjct: 118 ------ISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANI 168
Query: 682 HVCDFGLAKFL-SDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
+ DFGL+ + ++ + GT Y+APE
Sbjct: 169 RIIDFGLSTHFEASKKMKDKI----------GTAYYIAPE 198
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 49/203 (24%), Positives = 79/203 (38%), Gaps = 40/203 (19%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA---------ECEA 581
++S+ + +G G+FG+V+ E V VK I K K ++ E
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 582 LRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGS-LKDWL--HQSDDQVEVCKLSL 638
L + H N+IK++ I F+ F V E +G L ++ H D+ +
Sbjct: 83 LSRVEHANIIKVLDI-----FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYI-F 136
Query: 639 IQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL-AKFLSDHQL 697
Q + SA+ YL ++H D+K N+++ D + DFG A
Sbjct: 137 RQ-------LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF 186
Query: 698 DTAVKTPSSSIGLKGTVGYVAPE 720
T GT+ Y APE
Sbjct: 187 YTFC----------GTIEYCAPE 199
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 43/188 (22%), Positives = 71/188 (37%), Gaps = 31/188 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-ECEALRNIRHRNLIKIIT-I 596
+G+G++G V E VAVK++++K + E + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWL--HQSDDQVEVCKL--SLIQRVNIAIDVASAM 652
EY G L D + + + + L+ + +
Sbjct: 75 REGNIQ------YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----------AGV 118
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
YLH + H D+KP N+LLD + DFGLA + + + G
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC------G 169
Query: 713 TVGYVAPE 720
T+ YVAPE
Sbjct: 170 TLPYVAPE 177
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 41/185 (22%), Positives = 72/185 (38%), Gaps = 26/185 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G+FG V++ + K IN Y + E + + H LI +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-- 116
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
F+ + E++ G L D + D K+S + +N ++++H H
Sbjct: 117 ---FEDKYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 168
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQ-LDTAVKTPSSSIGLKGTVG 715
+VH D+KP N++ + + V DFGLA L+ + + T
Sbjct: 169 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATA----------E 215
Query: 716 YVAPE 720
+ APE
Sbjct: 216 FAAPE 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 36/159 (22%), Positives = 71/159 (44%), Gaps = 10/159 (6%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIIT 595
+G G++ VYKG + VA+K + L + G + + E ++ ++H N++++
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ + + VFE+M+N LK ++ L L + + +
Sbjct: 71 VIHT---ENKLT--LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
H + ++H DLKP N+L++ + DFGLA+
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 57/192 (29%), Positives = 83/192 (43%), Gaps = 34/192 (17%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINL-KYKGASRSFVA-ECEALRNIRHRNLIKII 594
M+G+GSFG V K + AVKVIN K S + E E L+ + H N++K+
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 595 TICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
I D +F V E G L D + ++ + S I V S +
Sbjct: 88 EILE-------DSSSFYIVGELYTGGELFDEI------IKRKRFSEHDAARIIKQVFSGI 134
Query: 653 EYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLS-DHQLDTAVKTPSSSI 708
Y+H H +VH DLKP N+LL + D + DFGL+ + ++ +
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI------- 184
Query: 709 GLKGTVGYVAPE 720
GT Y+APE
Sbjct: 185 ---GTAYYIAPE 193
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 44/194 (22%), Positives = 72/194 (37%), Gaps = 42/194 (21%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITIC 597
+G G G V + + A+K++ A R E E + ++++I+ +
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 124
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV-------EVCKLSLIQRVNIAIDVAS 650
+ G V E ++ G L + DQ E+ K +
Sbjct: 125 -ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-----------SIGE 172
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQ-LDTAVKTPSS 706
A++YLH + H D+KP N+L + + + DFG AK + H L T
Sbjct: 173 AIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC----- 224
Query: 707 SIGLKGTVGYVAPE 720
T YVAPE
Sbjct: 225 -----YTPYYVAPE 233
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 39/178 (21%), Positives = 72/178 (40%), Gaps = 23/178 (12%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK 592
+ +G G+FG VYK E + A KVI K + ++ E E L H ++K
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 593 IITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
G + + E+ G++ + + D + ++ ++ R +
Sbjct: 81 ---------LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QM 126
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL--DTAVKTP 704
A+ +LH ++H DLK NVL+ + + DFG++ D+ + TP
Sbjct: 127 LEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTP 181
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 4e-19
Identities = 41/186 (22%), Positives = 71/186 (38%), Gaps = 28/186 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-ECEALRNIRHRNLIKIITIC 597
+G G+FG V++ T A K + + + V E + + +RH L+ +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPTLVNLHDA- 222
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
F+ + ++E+M G L + + E K+S + V V + ++H
Sbjct: 223 ----FEDDNEMVMIYEFMSGGELFEKVAD-----EHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQ-LDTAVKTPSSSIGLKGTV 714
+ VH DLKP N++ + DFGL L Q + T
Sbjct: 274 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---------- 320
Query: 715 GYVAPE 720
+ APE
Sbjct: 321 EFAAPE 326
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-19
Identities = 50/205 (24%), Positives = 83/205 (40%), Gaps = 34/205 (16%)
Query: 526 LSKATGEFSS----SNMIGQGSFGYVYKGTLGEDEMIVAVKVINL-KYKGASRSFVA-EC 579
++ G S +G G++G V + A+K+I +S S + E
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 580 EALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLI 639
L+ + H N++K+ F+ V E + G L D + + K + +
Sbjct: 88 AVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEI------IHRMKFNEV 136
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQ 696
I V S + YLH H +VH DLKP N+LL + D + + DFGL+ + +
Sbjct: 137 DAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 697 -LDTAVKTPSSSIGLKGTVGYVAPE 720
+ + GT Y+APE
Sbjct: 194 KMKERL----------GTAYYIAPE 208
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 57/187 (30%), Positives = 84/187 (44%), Gaps = 30/187 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA----ECEALRNIRHRNLIKII 594
+G G+FG V G VAVK++N + K S V E + L+ RH ++IK+
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ S+ F V EY+ G L D++ + +L + + + S ++Y
Sbjct: 83 QVIST---PSDIF--MVMEYVSGGELFDYI------CKNGRLDEKESRRLFQQILSGVDY 131
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL-AKFLSDHQLDTAVKTPSSSIGLKGT 713
H H +VH DLKP NVLLD M A + DFGL L T+ +P+
Sbjct: 132 CHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN-------- 180
Query: 714 VGYVAPE 720
Y APE
Sbjct: 181 --YAAPE 185
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 45/210 (21%), Positives = 80/210 (38%), Gaps = 35/210 (16%)
Query: 511 TSPMEKQFPMVSYAELSKA----------TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVA 560
T + Q +V++ + A S IG+GS G V VA
Sbjct: 15 TENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVA 74
Query: 561 VKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA----FVFEYME 616
VK+++L+ + E +R+ +H N+++ + + E+++
Sbjct: 75 VKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---------MYKSYLVGEELWVLMEFLQ 125
Query: 617 NGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676
G+L D V +L+ Q + V A+ YLH ++H D+K ++LL
Sbjct: 126 GGAL-------TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLT 175
Query: 677 HDMVAHVCDFGLAKFLSDHQL--DTAVKTP 704
D + DFG +S + V TP
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKSLVGTP 205
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 43/193 (22%), Positives = 76/193 (39%), Gaps = 32/193 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA------ECEALRNIRHRNLIK 592
IG+G F V + E AVK+++ K S ++ E ++H ++++
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVD-VAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
++ SS VFE+M+ L + + D V S + + A+
Sbjct: 91 LLETYSS-----DGMLYMVFEFMDGADLCFEIVKRADAGFV--YSEAVASHYMRQILEAL 143
Query: 653 EYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQ--LDTAVKTPSSS 707
Y H + ++H D+KP VLL ++ + FG+A L + V
Sbjct: 144 RYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV------ 194
Query: 708 IGLKGTVGYVAPE 720
GT ++APE
Sbjct: 195 ----GTPHFMAPE 203
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 41/178 (23%), Positives = 73/178 (41%), Gaps = 25/178 (14%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK 592
++ IGQG+ G VY VA++ +NL+ + + E +R ++ N++
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 593 IITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
+ + V EY+ GSL D + + + Q + +
Sbjct: 82 ---------YLDSYLVGDELWVVMEYLAGGSLTDVVTE-------TCMDEGQIAAVCREC 125
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL--DTAVKTP 704
A+E+LH + ++H D+K N+LL D + DFG ++ Q T V TP
Sbjct: 126 LQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-19
Identities = 33/190 (17%), Positives = 71/190 (37%), Gaps = 13/190 (6%)
Query: 238 TIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNL 297
IPD+ K L ++ + + +LT + L++ ++ ++ + + N+
Sbjct: 16 NIPDS--TFKAYLNGLLGQSSTANITEAQMNSLT---YITLANINVT-DL-TGIEYAHNI 68
Query: 298 MSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFS 357
T + T P + ++ L L + + + L +L +LDIS +
Sbjct: 69 KDLTINNIHATNYNP--ISGLSNLE-RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD 125
Query: 358 GVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSV 417
I ++T + +D+S N I L L +K LN+ + + +++
Sbjct: 126 DSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPK 182
Query: 418 LEFLSLSYNH 427
L L
Sbjct: 183 LNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 29/164 (17%), Positives = 65/164 (39%), Gaps = 8/164 (4%)
Query: 243 IGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTA 302
++ +L + L + + +G+ + +L +++ N + + NL
Sbjct: 40 EAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRI 95
Query: 303 SQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPG 362
+T L +T+L+ LD+S++ + S+ ++ L + +D+S N I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLT-LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 363 TLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG 406
L T L+ L+I + H + + +L S + G
Sbjct: 155 -LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 33/240 (13%), Positives = 68/240 (28%), Gaps = 63/240 (26%)
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL 179
S + + +I + + +L ++ L N+ TDL + + N +K L
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV-----TDLTGIEYAHN---IKDL 71
Query: 180 SLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239
++ + N + I L NL +
Sbjct: 72 TINNIH--------ATNYN-------------------PISGLSNLERLRIMGKDVTSDK 104
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMS 299
+ L +L L + + I + + L K+ +++LS N +I L L
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELK- 162
Query: 300 FTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGV 359
L++ + ++ ++ L L S G
Sbjct: 163 ------------------------SLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 28/194 (14%), Positives = 69/194 (35%), Gaps = 21/194 (10%)
Query: 94 NLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLE 152
+G ++ + + + ++L + L+ + N+ L +
Sbjct: 21 TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVT---DLTGIEYAHNIKDLTIN 74
Query: 153 QNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQI 211
+ T+ + ++ L+N L+ L + + +++ L+S T+++ I +
Sbjct: 75 NIHA-----TNYNPISGLSN---LERLRIMGKDVTSDKIPNLSGLTSLTLLD--ISHSAH 124
Query: 212 SGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLT 271
+I I L + N I + L L+ L + + + G+ +
Sbjct: 125 DDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHD--YRGIEDFP 181
Query: 272 KLANLELSSNSLQG 285
KL L S ++ G
Sbjct: 182 KLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-14
Identities = 29/170 (17%), Positives = 62/170 (36%), Gaps = 14/170 (8%)
Query: 20 GNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLA 79
++ L I + ++ T + N+ L + + P I +S+LE +++
Sbjct: 41 AQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIM 96
Query: 80 LNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID 139
+ + ++ L +L L I + SI ++ + +DLS N ++
Sbjct: 97 GKDVTSDKIPNLS-GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-P 154
Query: 140 FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGE 189
+L L LN++ + + D + L L GG+
Sbjct: 155 LKTLPELKSLNIQFDGV-----HDYRGIEDFPK---LNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 29/172 (16%), Positives = 62/172 (36%), Gaps = 15/172 (8%)
Query: 42 TLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKAL 101
T + +L + +A + + I +++ + + + P L NL+ L
Sbjct: 39 TEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNPIS---GLSNLERL 93
Query: 102 AIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTA 161
I G + +LS ++L LLD+S + ++ ++L + ++L N T
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD-- 151
Query: 162 TDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISG 213
+ L LK+L++ + I + + I G
Sbjct: 152 -----IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPK-LNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 17/121 (14%), Positives = 48/121 (39%), Gaps = 5/121 (4%)
Query: 333 NGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLK 392
+ + + + +L + +++ + + + ++ L I++ P+S L
Sbjct: 33 SSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNPISG--LS 88
Query: 393 SIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK-GVFSNKTKISLQGNMK 451
+++ L + +++ L L+ L L +S++ + + TK I L N
Sbjct: 89 NLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 452 L 452
+
Sbjct: 149 I 149
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 25/157 (15%), Positives = 53/157 (33%), Gaps = 30/157 (19%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
++ L +N+ + T + + LS+LE +RIMG + L L +L L+++ +
Sbjct: 68 IKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH- 124
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
++ + LP + ++ + N I L
Sbjct: 125 -----DDSILTKIN-------------------TLPKVNSIDLSYNGAITDIM-PLKTLP 159
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLG 157
L+ L++ + + L L +G
Sbjct: 160 ELKSLNIQFDGVH-DYR-GIEDFPKLNQLYAFSQTIG 194
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-19
Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 16/186 (8%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKIITIC 597
IG G+ V + VA+K INL+ S + E +A+ H N++
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY--YT 80
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI---DVASAMEY 654
S + V + + GS+ D + + E L + IA +V +EY
Sbjct: 81 SF--VVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVLEGLEY 136
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH + Q +H D+K N+LL D + DFG++ FL+ T K + + GT
Sbjct: 137 LHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV---GTP 190
Query: 715 GYVAPE 720
++APE
Sbjct: 191 CWMAPE 196
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 40/186 (21%), Positives = 75/186 (40%), Gaps = 29/186 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-ECEALRNIRHRNLIKIITIC 597
+G+G FG V++ + K + K KG + V E L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILHLHES- 69
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
F+ + +FE++ + + ++ S +L+ + V+ V A+++LH
Sbjct: 70 ----FESMEELVMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHS 120
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQ-LDTAVKTPSSSIGLKGTV 714
H + H D++P N++ + + +FG A+ L P
Sbjct: 121 H---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP---------- 167
Query: 715 GYVAPE 720
Y APE
Sbjct: 168 EYYAPE 173
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 9e-19
Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 21/167 (12%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNL 590
+ + +G+G++ VYKG + +VA+K I L+++ GA + + E L++++H N+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD---DQVEVCKLSLIQRVNIAID 647
+ + I + + + VFEY++ LK +L + V KL L Q +
Sbjct: 63 VTLHDIIHT---EKSLT--LVFEYLDK-DLKQYLDDCGNIINMHNV-KLFLFQLL----- 110
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
+ Y H ++H DLKP N+L++ + DFGLA+ S
Sbjct: 111 --RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI 152
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 40/189 (21%), Positives = 68/189 (35%), Gaps = 31/189 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITI 596
+G+G+F V + A +IN K + E R ++H N++++
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
S +F+ + G L + + V S + + A+ + H
Sbjct: 79 ISE-----EGHHYLIFDLVTGGELFEDI------VAREYYSEADASHCIQQILEAVLHCH 127
Query: 657 HHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQ--LDTAVKTPSSSIGLK 711
+VH +LKP N+LL + DFGLA + Q
Sbjct: 128 QMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA---------- 174
Query: 712 GTVGYVAPE 720
GT GY++PE
Sbjct: 175 GTPGYLSPE 183
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 15/186 (8%)
Query: 514 MEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASR 573
M KQ+ V + + ++ IGQG+FG V+K + VA+K + ++ +
Sbjct: 1 MAKQYDSVECPFCDEVS-KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGF 59
Query: 574 SFVA--ECEALRNIRHRNLIKIITICSSTDFKGTDFKA---FVFEYMENGSLKDWLHQSD 628
A E + L+ ++H N++ +I IC + K VF++ E+ L L
Sbjct: 60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL 118
Query: 629 DQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688
K +L + + + + + Y+H + ++H D+K +NVL+ D V + DFGL
Sbjct: 119 -----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170
Query: 689 AKFLSD 694
A+ S
Sbjct: 171 ARAFSL 176
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 26/170 (15%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINL--KYKGASRSFVAECEALRNIRHRNL 590
++ + +IG GSFG VY+ L + +VA+K + ++K R E + +R + H N+
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--R----ELQIMRKLDHCNI 109
Query: 591 IKII-TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ-----VEVCKLSLIQRVNI 644
+++ SS + K + V +Y+ ++ V KL + Q
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQ---- 164
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCDFGLAKFLS 693
+ ++ Y+H + H D+KP N+LLD D V +CDFG AK L
Sbjct: 165 ---LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 54/218 (24%), Positives = 83/218 (38%), Gaps = 49/218 (22%)
Query: 526 LSKATGEFSS----SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA---- 577
+ K G+ +G G++G V A+KVI R
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 578 ---------ECEALRNIRHRNLIKIITICSSTDFKGTDFKAF--VFEYMENGSLKDWLHQ 626
E L+++ H N+IK+ + D K F V E+ E G L + +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFE-------DKKYFYLVTEFYEGGELFEQI-- 137
Query: 627 SDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHV 683
+ K NI + S + YLH H +VH D+KP N+LL + + +
Sbjct: 138 ----INRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKI 190
Query: 684 CDFGLAKFL-SDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
DFGL+ F D++L + GT Y+APE
Sbjct: 191 VDFGLSSFFSKDYKLRDRL----------GTAYYIAPE 218
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 51/203 (25%), Positives = 80/203 (39%), Gaps = 47/203 (23%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFV----AECEALRNIRHR 588
F ++G+GSF V A+K++ K + V E + + + H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILE-KRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI---- 644
+K+ + F+ + F Y +NG L L I+++
Sbjct: 91 FFVKLY--FT---FQDDEKLYFGLSYAKNGEL---------------LKYIRKIGSFDET 130
Query: 645 -----AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQL 697
++ SA+EYLH ++H DLKP N+LL+ DM H+ DFG AK LS
Sbjct: 131 CTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESK 185
Query: 698 DTAVKTPSSSIGLKGTVGYVAPE 720
+ GT YV+PE
Sbjct: 186 QARANS------FVGTAQYVSPE 202
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 43/191 (22%), Positives = 75/191 (39%), Gaps = 36/191 (18%)
Query: 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHR 588
G F ++G G++G VYKG + + A+KV+++ E L+ HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHR 81
Query: 589 NLIKIITICSSTDFKGTDFKA----------FVFEYMENGSLKDWLHQSDDQVEVCKLSL 638
N+ + G K V E+ GS+ D + +
Sbjct: 82 NIAT---------YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT------- 125
Query: 639 IQRVNIAI---DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695
++ IA ++ + +LH H ++H D+K NVLL + + DFG++ L
Sbjct: 126 LKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 696 QL--DTAVKTP 704
+T + TP
Sbjct: 183 VGRRNTFIGTP 193
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 44/195 (22%), Positives = 76/195 (38%), Gaps = 39/195 (20%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVA-ECEALRNIRHRNLIK-- 592
+G+GS+G V + E AVK++ L+ + V E + LR +RH+N+I+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 593 -IITICSSTDFKGTDFKAFVFEYMENGS--LKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
++ V EY G + D + + + + Q +
Sbjct: 73 DVLYNEEKQKM------YMVMEYCVCGMQEMLDSVPEK-------RFPVCQAHGYFCQLI 119
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA----KFLSDHQLDTAVKTPS 705
+EYLH +VH D+KP N+LL + G+A F +D T+ +P+
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 706 SSIGLKGTVGYVAPE 720
+ PE
Sbjct: 177 ----------FQPPE 181
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 51/187 (27%), Positives = 76/187 (40%), Gaps = 32/187 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFV-AECEALRNIRHRNLIKIITIC 597
+G+G+ VY+ + A+KV+ K + V E L + H N+IK+ I
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLKEI- 116
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
F+ + V E + G L D + VE S + + A+ YLH
Sbjct: 117 ----FETPTEISLVLELVTGGELFDRI------VEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 658 HCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQ-LDTAVKTPSSSIGLKGT 713
+ +VH DLKP N+L D + DFGL+K + + T GT
Sbjct: 167 NG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC----------GT 213
Query: 714 VGYVAPE 720
GY APE
Sbjct: 214 PGYCAPE 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-18
Identities = 47/193 (24%), Positives = 71/193 (36%), Gaps = 35/193 (18%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA------ECEALRNIRHRNLIK 592
+G G F V K + A K I + ASR V+ E LR + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + ++ + E + G L D+L + LS + + + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGV 128
Query: 653 EYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCDFGLAKFLSDHQ-LDTAVKTPSSS 707
YLH + H DLKP N++L + DFGLA + D TP
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP--- 182
Query: 708 IGLKGTVGYVAPE 720
+VAPE
Sbjct: 183 -------EFVAPE 188
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 47/193 (24%), Positives = 70/193 (36%), Gaps = 35/193 (18%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA------ECEALRNIRHRNLIK 592
+G G F V K + A K I + ASR V E LR + H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + ++ + E + G L D+L + LS + + + +
Sbjct: 80 LHDV-----YENRTDVVLILELVSGGELFDFL------AQKESLSEEEATSFIKQILDGV 128
Query: 653 EYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCDFGLAKFLSDHQ-LDTAVKTPSSS 707
YLH + H DLKP N++L + DFGLA + D TP
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTP--- 182
Query: 708 IGLKGTVGYVAPE 720
+VAPE
Sbjct: 183 -------EFVAPE 188
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 5e-18
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 24/224 (10%)
Query: 513 PMEKQFPMVSYAELSKATGEFSSSNM-IGQGSFGYVYKGT--LGEDEMIVAVKVINLKYK 569
M+ F + +E + F +G+G++G+VYK G+D+ A+K I +
Sbjct: 2 KMDYDFKVKLSSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGT 59
Query: 570 GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF-VFEYMEN--GSLKDWLHQ 626
G S S E LR ++H N+I + + S D K + +F+Y E+ + +
Sbjct: 60 GISMSACREIALLRELKHPNVISLQKVFLSH----ADRKVWLLFDYAEHDLWHIIKFHRA 115
Query: 627 SDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH---- 682
S + +L ++ + + YLH + ++H DLKP+N+L+ +
Sbjct: 116 SKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172
Query: 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE 726
+ D G A+ + +K + + T Y APE +G+
Sbjct: 173 IADMGFARLFNSP-----LKPLADLDPVVVTFWYRAPELLLGAR 211
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 7e-18
Identities = 42/157 (26%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITI 596
IG+GS+G V+K + IVA+K + + E L+ ++H NL+ ++ +
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
K VFEY + LH+ D L++ +I A+ + H
Sbjct: 71 FRR---KRRLH--LVFEYCD----HTVLHELDRYQRGVPEHLVK--SITWQTLQAVNFCH 119
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
H +H D+KP N+L+ V +CDFG A+ L+
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 63/273 (23%), Positives = 96/273 (35%), Gaps = 58/273 (21%)
Query: 111 SIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFL 170
IP +L + + LDLS N + S F S L L+L + + ++ +
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-----QTIEDGAY- 72
Query: 171 TNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFG 229
+ S L L L N + S + G L +L
Sbjct: 73 QSLSHLSTLILTGNP-----------IQS---------------LALGAFSGLSSLQKLV 106
Query: 230 AEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGL-GNLTKLANLELSSNSLQGNIP 288
A E L IG LK L++L + N +Q NLT L +L+LSSN +Q +I
Sbjct: 107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIY 165
Query: 289 SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVI 348
L L + L+L LDLS N +N + L
Sbjct: 166 C-------------------TDLRV-LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKE 204
Query: 349 LDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH 381
L + +NQ V G L+ + + +N +
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 3e-14
Identities = 58/225 (25%), Positives = 90/225 (40%), Gaps = 26/225 (11%)
Query: 239 IPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSNSLQGNIP----SSLGN 293
IPD + + + L L N L+ + S + +L L+LS +Q I SL +
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77
Query: 294 CQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDIS 352
L+ + N + +L S + L L SL GHLK L L+++
Sbjct: 78 LSTLI---LTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVA 132
Query: 353 SNQFSGVI-PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIK----ELNVSSNNLSGQ 407
N P S LE+LD+SSN + L L + L++S N ++
Sbjct: 133 HNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-F 191
Query: 408 IPEFLKNLSVLEFLSLSYNHFEGEVPTKGVF---SNKTKISLQGN 449
I L+ L+L N + VP G+F ++ KI L N
Sbjct: 192 IQPGAFKEIRLKELALDTNQLK-SVP-DGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 50/223 (22%), Positives = 88/223 (39%), Gaps = 28/223 (12%)
Query: 71 SSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL-SNASNLELLDLSV 129
S + + L+ N +L + P L+ L + +I + S+L L L+
Sbjct: 28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTG 85
Query: 130 NQFKGNVSID---FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186
N + S+ FS L +L L + NL L+ + +LK L++A N
Sbjct: 86 NPIQ---SLALGAFSGLSSLQKLVAVETNL-----ASLENFPI-GHLKTLKELNVAHNLI 136
Query: 187 GG-ELPHSIANLSS-TVINFGIGRNQISGTIPPGI-RNLVNLIGFGAE----ENQLHGTI 239
+LP +NL++ ++ N+I +I R L + N ++ I
Sbjct: 137 QSFKLPEYFSNLTNLEHLDLS--SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FI 192
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSN 281
+ L++L L N L+ +P G LT L + L +N
Sbjct: 193 QPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 32/176 (18%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKIITIC 597
IG+GSFG V+KG + +VA+K+I+L+ E L + K
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK----- 84
Query: 598 SSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI---DVAS 650
+ G+ K + EY+ GS D L + + IA ++
Sbjct: 85 ----YYGSYLKDTKLWIIMEYLGGGSALDLL----------EPGPLDETQIATILREILK 130
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL--DTAVKTP 704
++YLH +H D+K +NVLL + DFG+A L+D Q+ +T V TP
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTP 183
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 9e-18
Identities = 45/192 (23%), Positives = 76/192 (39%), Gaps = 18/192 (9%)
Query: 510 DTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK 569
S M + K F M GQG+FG V G M VA+K + +
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR 61
Query: 570 GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD--FKAFVFEYMENGSLKDWLHQS 627
+R + + L + H N++++ + + + + V EY+ + +L
Sbjct: 62 FRNRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNY 119
Query: 628 DDQ-----VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD-HDMVA 681
+ + K+ L Q + ++ LH + H D+KP NVL++ D
Sbjct: 120 YRRQVAPPPILIKVFLFQ-------LIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL 171
Query: 682 HVCDFGLAKFLS 693
+CDFG AK LS
Sbjct: 172 KLCDFGSAKKLS 183
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 48/294 (16%), Positives = 97/294 (32%), Gaps = 58/294 (19%)
Query: 116 LSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSS 175
+ +L V+ + L ++ + +++ + + +L N
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDI-----KSVQGIQYLPN--- 69
Query: 176 LKALSLADNQFGGELPHSIANLSS----TVINFGIGRNQISGTIPPGIRNLVNLIGFGAE 231
+ L L N+ I L++ + N++ + +++L L E
Sbjct: 70 VTKLFLNGNKL-----TDIKPLANLKNLGWLFLD--ENKVK-DLSS-LKDLKKLKSLSLE 120
Query: 232 ENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSL 291
N + + + + L L+ L L N + + L LTKL L L N + +I L
Sbjct: 121 HNGI--SDINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DI-VPL 174
Query: 292 GNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDI 351
L + S+N ++ + L+ LKNL +L++
Sbjct: 175 AGLTKLQNLYLSKNHIS--------DLRALA-------------------GLKNLDVLEL 207
Query: 352 SSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLS 405
S + S V + + S V P +S ++ NV +
Sbjct: 208 FSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 51/228 (22%), Positives = 87/228 (38%), Gaps = 21/228 (9%)
Query: 201 VINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQ 260
I + + ++ + L ++ A + + I L N+ KL L N L
Sbjct: 26 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGNKLT 81
Query: 261 GRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITT 320
I L NL L L L N ++ ++ SSL + + L S + N ++ + +
Sbjct: 82 -DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-----DINGLVH 132
Query: 321 LSL--YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSN 378
L L L NN + L L L L + NQ S ++P L+ L+ L +S N
Sbjct: 133 LPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188
Query: 379 SFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYN 426
+ L+ LK++ L + S + NL V + +
Sbjct: 189 HISDLRALA--GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 234
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 62/306 (20%), Positives = 106/306 (34%), Gaps = 40/306 (13%)
Query: 64 PRSICNISSLE-LIQLALNRFSGNLPFDIVV--NLPNLKALAIGGNNFFGSIPYSLSNAS 120
P I I S + + + D V L ++ + ++ S+ +
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDI-KSVQ-GIQYLP 68
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
N+ L L+ N+ ++ ++LKNL WL L++N + DL L + LK+LS
Sbjct: 69 NVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKV-----KDLSS---LKDLKKLKSLS 118
Query: 181 LADNQFGGELPHSIANLS--STVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGT 238
L N I L + + +G N+I T + L L E+NQ+ +
Sbjct: 119 LEHNGI-----SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI--S 169
Query: 239 IPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLM 298
+ L LQ L L +N + L L L LEL S + N
Sbjct: 170 DIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 227
Query: 299 SFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHL----KNLVILDISSN 354
+ + L + +S D + LP + V + +
Sbjct: 228 TVKNTDGSLV--------TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKA 279
Query: 355 QFSGVI 360
+F G +
Sbjct: 280 RFHGRV 285
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 28/240 (11%)
Query: 46 LRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGG 105
+ N+ + + ++S++ I + LPN+ L + G
Sbjct: 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ---YLPNVTKLFLNG 77
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLEQNNLGTGTATDL 164
N I L+N NL L L N+ K + LK L L+LE N + +D+
Sbjct: 78 NKL-TDIK-PLANLKNLGWLFLDENKVK---DLSSLKDLKKLKSLSLEHNGI-----SDI 127
Query: 165 DFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGIRNLV 223
+ L + L++L L +N+ ++ L+ ++ + NQIS I P + L
Sbjct: 128 NG---LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLS--LEDNQIS-DIVP-LAGLT 178
Query: 224 NLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSL 283
L +N + + A+ LKNL L LF + + NL ++ + SL
Sbjct: 179 KLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 20/160 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITI 596
+G+GS+G V K + IVA+K K + + E + L+ +RH NL+ ++ +
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV--EVCKLSLIQRVNIAIDVASAMEY 654
C K + VFE++++ ++ D L + + +V + L Q + + + +
Sbjct: 93 CKK---KKRWY--LVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ-------IINGIGF 139
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
H H ++H D+KP N+L+ V +CDFG A+ L+
Sbjct: 140 CHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 49/193 (25%), Positives = 71/193 (36%), Gaps = 35/193 (18%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA------ECEALRNIRHRNLIK 592
+G G F V K A K I + +SR V+ E LR IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ I F+ + E + G L D+L E L+ + + +
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGELFDFL------AEKESLTEDEATQFLKQILDGV 121
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAH----VCDFGLAKFLSDHQ-LDTAVKTPSSS 707
YLH + H DLKP N++L V + + DFG+A + TP
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP--- 175
Query: 708 IGLKGTVGYVAPE 720
+VAPE
Sbjct: 176 -------EFVAPE 181
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 22/163 (13%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKII 594
IG+G++G V+K E IVA+K + L G S + E L+ ++H+N++++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD---DQVEVCKLSLIQRVNIAIDVASA 651
+ S VFE+ + LK + + D V K L Q +
Sbjct: 68 DVLHS---DKKLT--LVFEFCDQ-DLKKYFDSCNGDLDPEIV-KSFLFQ-------LLKG 113
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
+ + H ++H DLKP N+L++ + + +FGLA+
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 51/187 (27%), Positives = 83/187 (44%), Gaps = 31/187 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA----ECEALRNIRHRNLIKII 594
+G+GSFG V T + + VA+K I+ + E L+ +RH ++IK+
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ ++ V EY G L D++ VE +++ + + A+EY
Sbjct: 76 DVITT---PTDIV--MVIEYA-GGELFDYI------VEKKRMTEDEGRRFFQQIICAIEY 123
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL-AKFLSDHQLDTAVKTPSSSIGLKGT 713
H H +VH DLKP N+LLD ++ + DFGL + L T+ +P+
Sbjct: 124 CHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPN-------- 172
Query: 714 VGYVAPE 720
Y APE
Sbjct: 173 --YAAPE 177
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 25/178 (14%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK 592
F +G+GS+G VYK E IVA+K + + + + + E ++ +++K
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVK 88
Query: 593 IITICSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
+ G+ FK V EY GS+ D + + + +++ I +
Sbjct: 89 ---------YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ-----ST 134
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL--DTAVKTP 704
+EYLH +H D+K N+LL+ + A + DFG+A L+D +T + TP
Sbjct: 135 LKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTP 189
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 40/161 (24%), Positives = 76/161 (47%), Gaps = 17/161 (10%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKII 594
IG+G++G VYK +VA+K I L + G + + E L+ + H N++K++
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 595 TICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
+ + + K + VFE++ LK ++ D + + L + + +
Sbjct: 69 DVIHTEN------KLYLVFEFLHQ-DLKKFM----DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
+ H H ++H DLKP N+L++ + + DFGLA+
Sbjct: 118 FCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 46/245 (18%), Positives = 83/245 (33%), Gaps = 12/245 (4%)
Query: 214 TIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLT 271
IP + RN + L +L A +L+K+ + +N + I + NL
Sbjct: 23 EIPSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLP 79
Query: 272 KLANLELS-SNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNN 330
KL + + +N+L P + N NL S + LP + + LD+ +N
Sbjct: 80 KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDN 138
Query: 331 LLNGSLPLQV--GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSL 388
+ ++ G VIL ++ N + + E +N+ +
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 389 SFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQG 448
L++S + L+NL L S ++PT + SL
Sbjct: 199 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTY 255
Query: 449 NMKLC 453
C
Sbjct: 256 PSHCC 260
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 49/246 (19%), Positives = 88/246 (35%), Gaps = 14/246 (5%)
Query: 39 IPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL 98
IP+ L RN + L K + + LE I+++ N + D+ NLP L
Sbjct: 24 IPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 81
Query: 99 KALAIGGNNFFGSIPYS-LSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLG 157
+ I N I N NL+ L +S K + + L+++ N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNI-- 139
Query: 158 TGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPP 217
++ +F+ L L N E+ +S N + N + +P
Sbjct: 140 --NIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLE-ELPN 195
Query: 218 GI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANL 276
+ + ++H ++P L+NL+KL + ++P+ L L L
Sbjct: 196 DVFHGASGPVILDISRTRIH-SLPSYG--LENLKKLRARSTYNLKKLPT-LEKLVALMEA 251
Query: 277 ELSSNS 282
L+ S
Sbjct: 252 SLTYPS 257
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 2e-17
Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 20/165 (12%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINL-KYKGASRSFVAECEALRNI---------R 586
IG G++G VYK VA+K + + G +R +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL--PISTVREVALLRRLEAFE 72
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H N+++++ +C+++ VFE+++ L+ +L D+ L ++
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKDLMR 127
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691
+++LH +C +VH DLKP N+L+ + DFGLA+
Sbjct: 128 QFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-17
Identities = 66/379 (17%), Positives = 107/379 (28%), Gaps = 92/379 (24%)
Query: 120 SNLELLDLSVNQFKGN-VSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKA 178
+++ LD+ + + L+ + L+ L D+ L +L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA--LRVNPALAE 60
Query: 179 LSLADNQFGGE----LPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQ 234
L+L N+ G + + S + + ++G G
Sbjct: 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGA--------------GCGV-- 104
Query: 235 LHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNL--------TKLANLELSSNSLQ-- 284
+ + L LQ+L L N L +GL L +L L+L SL
Sbjct: 105 ----LSSTLRTLPTLQELHLSDNLLG---DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAA 157
Query: 285 --GNIPSSLGNCQNLMSFTASQNK--------LTGALPHQLLSITTLSL----------- 323
+ S L + T S N L L + L L
Sbjct: 158 SCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCR 217
Query: 324 -------------YLDLSNNLL--NGSLPLQVGHLK---NLVILDISSNQFSGV----IP 361
L L +N L G L G L L L I + +
Sbjct: 218 DLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLC 277
Query: 362 GTLSTCVCLEYLDISSNSFH--GVIPLSLSFLK---SIKELNVSSNNLSGQ----IPEFL 412
L L+ L ++ N G L + L+ ++ L V S + + L
Sbjct: 278 RVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVL 337
Query: 413 KNLSVLEFLSLSYNHFEGE 431
L L +S N E
Sbjct: 338 AQNRFLLELQISNNRLEDA 356
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-16
Identities = 70/447 (15%), Positives = 131/447 (29%), Gaps = 78/447 (17%)
Query: 23 SDLEVIRIMGNSLGGK-IPTTLGLLRNLVSLNVAENKFSGMFPRSICNI----SSLELIQ 77
D++ + I L L LL+ + + + + + I + +L +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 78 LALNRFSGN----LPFDIVVNLPNLKALAIGGNNF----FGSIPYSLSNASNLELLDLSV 129
L N + + ++ L++ G + +L L+ L LS
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 130 NQFKGNVSIDFSSL-----KNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADN 184
N L L LE +L + L V L K L++++N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV--LRAKPDFKELTVSNN 180
Query: 185 QFGGE----LPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
L + + + + ++ R+L
Sbjct: 181 DINEAGVRVLCQGLKDSPCQLEALKLESCGVT---SDNCRDLCG---------------- 221
Query: 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSF 300
+ +L++L L N L + L + L + + ++ G C +L
Sbjct: 222 -IVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKG-CGDLCRV 279
Query: 301 TASQNKLTGALPHQLLSITTLSLYLDLSNNLL--NGSLPLQVG---HLKNLVILDISSNQ 355
++ L L L+ N L G+ L L L + S
Sbjct: 280 LRAKESLK---------------ELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCS 324
Query: 356 FSGV----IPGTLSTCVCLEYLDISSNSFH--GVIPLSLSFLK---SIKELNVSSNNLSG 406
F+ L+ L L IS+N GV L + ++ L ++ ++S
Sbjct: 325 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384
Query: 407 Q----IPEFLKNLSVLEFLSLSYNHFE 429
+ L L L LS N
Sbjct: 385 SSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 68/405 (16%), Positives = 131/405 (32%), Gaps = 66/405 (16%)
Query: 71 SSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNF----FGSIPYSLSNASNLELLD 126
++ + + S +++ L + + + I +L L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 127 LSVNQFKGN-VSIDFSSLKN----LLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSL 181
L N+ V L+ + L+L+ L L + L +L+ L L
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL--SSTLRTLPTLQELHL 120
Query: 182 ADNQFGGE----LPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHG 237
+DN G L + + + + +S L
Sbjct: 121 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS---AASCEPLA-------------- 163
Query: 238 TIPDAIGELKNLQKLCLFRNFLQGR----IPSGLGNLT-KLANLELSSNSLQ----GNIP 288
+ + ++L + N + + GL + +L L+L S + ++
Sbjct: 164 ---SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLC 220
Query: 289 SSLGNCQNLMSFTASQNKLTG----ALPHQLLSITTLSLYLDLSNNLLN----GSLPLQV 340
+ + +L NKL L LL ++ L + + G L +
Sbjct: 221 GIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVL 280
Query: 341 GHLKNLVILDISSNQF--SGV--IPGTLSTCVC-LEYLDISSNSF--HGVIPLS--LSFL 391
++L L ++ N+ G + TL C LE L + S SF S L+
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQN 340
Query: 392 KSIKELNVSSNNLSG----QIPEFLK-NLSVLEFLSLSYNHFEGE 431
+ + EL +S+N L ++ + L SVL L L+
Sbjct: 341 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-11
Identities = 78/438 (17%), Positives = 141/438 (32%), Gaps = 103/438 (23%)
Query: 25 LEVIRIMGNSLGGK----IPTTLGLLRNLVSLNVAENKFSGMFPRSICNI-----SSLEL 75
++ + + L G + +TL L L L++++N + +C LE
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146
Query: 76 IQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGN 135
+QL S + + LA L + + L +S N
Sbjct: 147 LQLEYCSLSAA----------SCEPLASV-----------LRAKPDFKELTVSNNDINEA 185
Query: 136 VSIDFS-SLK----NLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGE- 189
LK L L LE + + DL + + + +SL+ L+L N+ G
Sbjct: 186 GVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI--VASKASLRELALGSNKLGDVG 243
Query: 190 ---LPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGEL 246
L + + SS + I I+ G +L +
Sbjct: 244 MAELCPGLLHPSSRLRTLWIWECGIT---AKGCGDLCR-----------------VLRAK 283
Query: 247 KNLQKLCLFRNFLQG----RIPSGLGN-LTKLANLELSSNSLQG----NIPSSLGNCQNL 297
++L++L L N L + L +L +L + S S + S L + L
Sbjct: 284 ESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343
Query: 298 MSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFS 357
+ S N+L A + L L L +L ++ S
Sbjct: 344 LELQISNNRLEDA------GVRELCQGLGQPG--------------SVLRVLWLADCDVS 383
Query: 358 GV----IPGTLSTCVCLEYLDISSNSFH--GVIPLSLSFLKS---IKELNVSSNNLSGQ- 407
+ TL L LD+S+N G++ L S + +++L + S +
Sbjct: 384 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 443
Query: 408 ---IPEFLKNLSVLEFLS 422
+ K+ L +S
Sbjct: 444 EDRLQALEKDKPSLRVIS 461
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 46/193 (23%), Positives = 72/193 (37%), Gaps = 35/193 (18%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA------ECEALRNIRHRNLIK 592
+G G F V K + A K I + +SR V+ E L+ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + ++ + E + G L D+L E L+ + + + +
Sbjct: 79 LHEV-----YENKTDVILILELVAGGELFDFL------AEKESLTEEEATEFLKQILNGV 127
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAH----VCDFGLAKFLSDHQ-LDTAVKTPSSS 707
YLH + H DLKP N++L V + DFGLA +
Sbjct: 128 YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF------ 178
Query: 708 IGLKGTVGYVAPE 720
GT +VAPE
Sbjct: 179 ----GTPEFVAPE 187
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 17/160 (10%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKII 594
+G+G++G VYK + IVA+K I L + G + + E L+ + H N++ +I
Sbjct: 27 EKVGEGTYGVVYKAKDSQGR-IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ S + VFE+ME LK L D+ + S I+ + + +
Sbjct: 86 DVIHS---ERCLT--LVFEFMEK-DLKKVL---DENKTGLQDSQIK--IYLYQLLRGVAH 134
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
H H ++H DLKP N+L++ D + DFGLA+
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 31/189 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS-FVAECE-ALRNIRHRNLIKIITI 596
+G+G++G V K I+AVK I + + + + ++R + +
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVT---- 70
Query: 597 CSSTDFKGTDFK----AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
F G F+ E M + SL + Q D+ + ++ + IA+ + A+
Sbjct: 71 -----FYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKAL 122
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD-HQLDTAVKTPSSSIGLK 711
E+LH ++H D+KPSNVL++ +CDFG++ +L D D
Sbjct: 123 EHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA---------- 170
Query: 712 GTVGYVAPE 720
G Y+APE
Sbjct: 171 GCKPYMAPE 179
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-17
Identities = 45/170 (26%), Positives = 78/170 (45%), Gaps = 27/170 (15%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINL--KYKGASRSFVAECEALRNIRHRNL 590
+++ +IG GSFG V++ L E + VA+K + ++K R E + +R ++H N+
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN--R----ELQIMRIVKHPNV 94
Query: 591 IKII-TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ-----VEVCKLSLIQRVNI 644
+ + S+ D K F V EY+ ++ + + KL + Q
Sbjct: 95 VDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQ---- 149
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCDFGLAKFLS 693
+ ++ Y+H + H D+KP N+LLD V + DFG AK L
Sbjct: 150 ---LLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI 193
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 21/164 (12%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-----GASRSFVAECEALRNIRHRNLI 591
+ +G+G F VYK IVA+K I L ++ G +R+ + E + L+ + H N+I
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 592 KIITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
++ D G VF++ME L+ + D V S I+ +
Sbjct: 76 GLL------DAFGHKSNISLVFDFMET-DLEVII---KDNSLVLTPSHIK--AYMLMTLQ 123
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
+EYLH H ++H DLKP+N+LLD + V + DFGLAK
Sbjct: 124 GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS 164
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 6e-17
Identities = 41/198 (20%), Positives = 70/198 (35%), Gaps = 38/198 (19%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-------ECEALRNIRHR--N 589
+G G FG VY G D + VA+K + K + + + E L+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 590 LIKIITICSSTDFKGTDFKAF-VFEYMEN-GSLKDWLHQSDDQVEVCKLSLIQRVNIAID 647
+I+++ D+ + E E L D++ E L +
Sbjct: 110 VIRLL------DWFERPDSFVLILERPEPVQDLFDFI------TERGALQEELARSFFWQ 157
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
V A+ + H+ ++H D+K N+L+D + + DFG L D
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----- 209
Query: 707 SIGLKGTVGYVAPEYGMG 724
GT Y PE+
Sbjct: 210 -----GTRVYSPPEWIRY 222
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 46/199 (23%), Positives = 76/199 (38%), Gaps = 42/199 (21%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVA-------ECEALRNIR---- 586
++G+G FG V+ G D + VA+KVI + + S ++ E L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 587 HRNLIKIITICSSTDFKGTDFKAF-VFEYMENGS-LKDWLHQSDDQVE-VCKLSLIQRVN 643
H +I+++ D+ T V E L D++ + E + Q
Sbjct: 97 HPGVIRLL------DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQ--- 147
Query: 644 IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCDFGLAKFLSDHQLDTAVK 702
V +A+++ H +VH D+K N+L+D A + DFG L D
Sbjct: 148 ----VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD- 199
Query: 703 TPSSSIGLKGTVGYVAPEY 721
GT Y PE+
Sbjct: 200 ---------GTRVYSPPEW 209
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 8e-17
Identities = 43/166 (25%), Positives = 77/166 (46%), Gaps = 29/166 (17%)
Query: 537 NMIGQGSFGYVYKG--TLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIK 592
IG+G++G VYK GE A+K I L+ + G + + E L+ ++H N++K
Sbjct: 8 EKIGEGTYGVVYKAQNNYGE---TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 593 IITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSD---DQVEVCKLSLIQRVNIAIDV 648
+ + + + VFE+++ LK L + + V K L+Q +
Sbjct: 65 LYDVIHTKK------RLVLVFEHLDQ-DLKKLLDVCEGGLESVTA-KSFLLQ-------L 109
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD 694
+ + Y H ++H DLKP N+L++ + + DFGLA+
Sbjct: 110 LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 8e-17
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 24/166 (14%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKII 594
+G+G++G VYK VA+K I L+++ G + + E L+ ++HRN+I++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD-QVEVCKLSLIQRVNIAIDVASAME 653
++ +FEY EN LK ++ ++ D + V K L Q + + +
Sbjct: 100 SVIHH---NHRLH--LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ-------LINGVN 146
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAH-----VCDFGLAKFLSD 694
+ H +H DLKP N+LL + + DFGLA+
Sbjct: 147 FCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 44/191 (23%), Positives = 77/191 (40%), Gaps = 34/191 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS-FVAECE-ALRNIRHRNLIKIITI 596
IG+G++G V K I+AVK I + + + + +R+ +++
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQ---- 85
Query: 597 CSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
F G F+ E M K + + +V ++ + I + A+
Sbjct: 86 -----FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKAL 138
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
+L + + ++H D+KPSN+LLD +CDFG++ L D SI
Sbjct: 139 NHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD------------SIAKTR 184
Query: 713 TVG---YVAPE 720
G Y+APE
Sbjct: 185 DAGCRPYMAPE 195
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 39/188 (20%), Positives = 70/188 (37%), Gaps = 32/188 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS-FVAECEAL-RNIRHRNLIKIITI 596
+G G+ G V+K + ++AVK + + + + + ++ +++
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQ---- 88
Query: 597 CSSTDFKGTDFKA----FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
GT E M + K E + + + + + A+
Sbjct: 89 -----CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERI----LGK--MTVAIVKAL 137
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
YL ++H D+KPSN+LLD +CDFG++ L D K S G
Sbjct: 138 YYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLV----DDKAKD--RSA---G 186
Query: 713 TVGYVAPE 720
Y+APE
Sbjct: 187 CAAYMAPE 194
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 2e-16
Identities = 40/195 (20%), Positives = 66/195 (33%), Gaps = 35/195 (17%)
Query: 539 IGQG--SFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFV----AECEALRNIRHRNLIK 592
IG+G V V V+ INL+ S V E + H N++
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLE--ACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV--EVCKLSLIQRVNIAI---D 647
+ F + V +M GS KD + E+ IA
Sbjct: 91 YR--AT---FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---------IAYILQG 136
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL--DTAVKTPS 705
V A++Y+HH VH +K S++L+ D ++ + H P
Sbjct: 137 VLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 706 SSIGLKGTVGYVAPE 720
S+ + +++PE
Sbjct: 194 YSV---KVLPWLSPE 205
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 37/189 (19%), Positives = 68/189 (35%), Gaps = 29/189 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHR-NLIKIIT 595
+G+G F V + A K + + +G + E L + +I +
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ ++ T + EY G + + +S + + + + YL
Sbjct: 97 V-----YENTSEIILILEYAAGGEIFSLCLPELAE----MVSENDVIRLIKQILEGVYYL 147
Query: 656 HHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQ-LDTAVKTPSSSIGLK 711
H + +VH DLKP N+LL + DFG+++ + L +
Sbjct: 148 HQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM---------- 194
Query: 712 GTVGYVAPE 720
GT Y+APE
Sbjct: 195 GTPEYLAPE 203
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-16
Identities = 49/217 (22%), Positives = 88/217 (40%), Gaps = 33/217 (15%)
Query: 501 KRRSAQKFVDTSPMEKQFPMVSYAELSKA------TGEFSSSNMIGQGSFGYVYKGTLGE 554
+ Q +D P + + ++++ FS IG GSFG VY
Sbjct: 18 ENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVR 77
Query: 555 DEMIVAVKVINLKYKGAS---RSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA-- 609
+ +VA+K ++ K ++ + + E L+ +RH N I+ ++G +
Sbjct: 78 NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---------YRGCYLREHT 128
Query: 610 --FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGD 667
V EY GS D L ++ +++ + + YLH H M+H D
Sbjct: 129 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTH-----GALQGLAYLHSH---NMIHRD 179
Query: 668 LKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
+K N+LL + + DFG A ++ ++ V TP
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIMA--PANSFVGTP 214
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 22/158 (13%), Positives = 47/158 (29%), Gaps = 27/158 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMI---VAVKVINLKYKGASRS---FVAECEALRNIRHRNLIK 592
G ++ D + VA+ ++ + ++ L I + +
Sbjct: 39 HGGVPPLQFWQAL---DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 593 IITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
++ D T V E++ GSL++ S S + + +A+A
Sbjct: 96 VL------DVVHTRAGGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAA 141
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
+ H + PS V + D +
Sbjct: 142 ADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 38/169 (22%), Positives = 72/169 (42%), Gaps = 32/169 (18%)
Query: 537 NMIGQGSFGYVYKGT-LGEDEMIVAVKVINLKYKGASRSFVAECE-----ALRNI----- 585
IG+G++G V+K L VA+K + ++ E +R +
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ---------TGEEGMPLSTIREVAVLRH 67
Query: 586 ----RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQR 641
H N++++ +C+ + VFE+++ L +L D+V +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL----DKVPEPGVPTETI 122
Query: 642 VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++ + +++LH H +VH DLKP N+L+ + DFGLA+
Sbjct: 123 KDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 49/185 (26%), Positives = 70/185 (37%), Gaps = 17/185 (9%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165
++P L + +L LS N L LNL++ L T L
Sbjct: 19 KRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-----TKLQ 71
Query: 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVN 224
L L L L+ NQ LP L + + + N+++ ++P G R L
Sbjct: 72 VDGTLPV---LGTLDLSHNQL-QSLPLLGQTLPALTV-LDVSFNRLT-SLPLGALRGLGE 125
Query: 225 LIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGL-GNLTKLANLELSSNSL 283
L + N+L P + L+KL L N L +P+GL L L L L NSL
Sbjct: 126 LQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSL 184
Query: 284 QGNIP 288
IP
Sbjct: 185 Y-TIP 188
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 55/192 (28%), Positives = 84/192 (43%), Gaps = 16/192 (8%)
Query: 263 IPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALP--HQLLSITT 320
+P L L LS N L ++L L + +LT L L + T
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPVLGT 81
Query: 321 LSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSF 380
L DLS+N L SLPL L L +LD+S N+ + + G L L+ L + N
Sbjct: 82 L----DLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136
Query: 381 HGVIPLSLSFLKSIKELNVSSNNLSGQIPEFL-KNLSVLEFLSLSYNHFEGEVPTKGVFS 439
+ P L+ +++L++++NNL+ ++P L L L+ L L N +P KG F
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IP-KGFFG 193
Query: 440 NK--TKISLQGN 449
+ L GN
Sbjct: 194 SHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 43/213 (20%), Positives = 65/213 (30%), Gaps = 40/213 (18%)
Query: 71 SSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVN 130
++ L+ N ++ L L + + L LDLS N
Sbjct: 31 KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAEL-TKLQ-VDGTLPVLGTLDLSHN 87
Query: 131 QFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGEL 190
Q + ++ + +L L L++ N L T L L+ L L N+
Sbjct: 88 QLQ-SLPLLGQTLPALTVLDVSFNRL-----TSLPLGAL-RGLGELQELYLKGNE----- 135
Query: 191 PHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAI-GELKN 248
L + +PPG+ L N L +P + L+N
Sbjct: 136 ------LKT---------------LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLEN 173
Query: 249 LQKLCLFRNFLQGRIPSGLGNLTKLANLELSSN 281
L L L N L IP G L L N
Sbjct: 174 LDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 46/225 (20%), Positives = 72/225 (32%), Gaps = 50/225 (22%)
Query: 39 IPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL 98
+P L ++ L+++EN ++ + L + L + + L L
Sbjct: 25 LPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 99 KALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID---FSSLKNLLWLNLEQNN 155
+N S+P L +LD+S N+ S+ L L L L+ N
Sbjct: 83 DL----SHNQLQSLPLLGQTLPALTVLDVSFNRLT---SLPLGALRGLGELQELYLKGNE 135
Query: 156 LGTGTATDLDFVTF--LTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISG 213
L L L+ LSLA+N L+
Sbjct: 136 L-----KTLPPGLLTPTPK---LEKLSLANNN-----------LTE-------------- 162
Query: 214 TIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRN 257
+P G+ L NL +EN L+ TIP L L N
Sbjct: 163 -LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 35/160 (21%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L +++N L + + L + + L K+ L L +L+++ N+
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVDGT-LPVLGTLDLSHNQLQ 90
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL-SNA 119
P + +L ++ ++ NR + +LP + L L+ L + GN ++P L +
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNE-LKTLPPGLLTPT 147
Query: 120 SNLELLDLSVNQFKGNVSID---FSSLKNLLWLNLEQNNL 156
LE L L+ N + + L+NL L L++N+L
Sbjct: 148 PKLEKLSLANNNLT---ELPAGLLNGLENLDTLLLQENSL 184
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-15
Identities = 52/226 (23%), Positives = 87/226 (38%), Gaps = 30/226 (13%)
Query: 501 KRRSAQKFVDTSPMEKQFPMVSYAELSKATGE-FSSSNMIGQGSFGYVYKGTLGEDEMIV 559
++D S +F + E T F ++G+G FG V + +
Sbjct: 154 SVAPFADYLD-SIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMY 212
Query: 560 AVKVIN---LKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYME 616
A K + +K + + E + L + R ++++ + ++ D V M
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF---VVSLAYA--YETKDALCLVLTLMN 267
Query: 617 NGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676
G LK ++ + V A ++ +E LH +V+ DLKP N+LLD
Sbjct: 268 GGDLKFHIYHMGQAG----FPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLD 320
Query: 677 HDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
H+ D GLA + + Q G GTVGY+APE
Sbjct: 321 DH--GHIRISDLGLAVHVPEGQTIK---------GRVGTVGYMAPE 355
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 42/195 (21%), Positives = 78/195 (40%), Gaps = 30/195 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFV--------AECEALRNIRHRNL 590
IG G FG +Y A V+ ++Y+ F A+ + ++ R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 591 IKIITI-----CSSTDFKGTDFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVNI 644
+ + I T+FKG ++ V E + G L+ Q+ + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG------TFKKSTVLQL 156
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQLDTAV 701
I + +EY+H + VHGD+K +N+LL + D V ++ D+GL+ +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV-YLADYGLSYRYCPNGNHKQY 212
Query: 702 KTPSSSIGLKGTVGY 716
+ + G GT+ +
Sbjct: 213 Q-ENPRKGHNGTIEF 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 41/168 (24%), Positives = 70/168 (41%), Gaps = 36/168 (21%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL-KYKGASRSFVAECEALRNIR-HRNLIKII-T 595
+G+G + V++ + V VK++ K K R E + L N+R N+I +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITLADI 99
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ-SDDQV-----EVCKLSLIQRVNIAIDVA 649
+ A VFE++ N K +D + E+ K
Sbjct: 100 VKDPVSRT----PALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILK-------------- 141
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAKFLSDHQ 696
A++Y H ++H D+KP NV++DH+ + D+GLA+F Q
Sbjct: 142 -ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 4e-15
Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 33/228 (14%)
Query: 501 KRRSAQKFVDTSPMEKQFPMVSYAELSKATGE--FSSSNMIGQGSFGYVYKGTLGEDEMI 558
+ QKF++ S +F EL+ FS +IG+G FG VY + +
Sbjct: 158 RGDVFQKFIE-SDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKM 216
Query: 559 VAVKVIN---LKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615
A+K ++ +K K + E L + + I+ + + F D +F+ + M
Sbjct: 217 YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA--FHTPDKLSFILDLM 274
Query: 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNI-AIDVASAMEYLHHHCQPPMVHGDLKPSNVL 674
G L L Q E + A ++ +E++H+ +V+ DLKP+N+L
Sbjct: 275 NGGDLHYHLSQHGVFSE-------ADMRFYAAEIILGLEHMHNRF---VVYRDLKPANIL 324
Query: 675 LDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
LD HV D GLA S + +V GT GY+APE
Sbjct: 325 LDEH--GHVRISDLGLACDFSKKKPHASV----------GTHGYMAPE 360
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-15
Identities = 54/221 (24%), Positives = 92/221 (41%), Gaps = 27/221 (12%)
Query: 506 QKFVDTSPMEKQFPMVSYAELSKATGE-FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVI 564
Q+F+D S +F + E + F ++G+G FG V+ + + A K +
Sbjct: 160 QEFLD-SLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL 218
Query: 565 N---LKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLK 621
N LK + + + E + L + R ++ + + F+ V M G ++
Sbjct: 219 NKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA--YA---FETKTDLCLVMTIMNGGDIR 273
Query: 622 DWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681
++ D+ + + + S +E+LH +++ DLKP NVLLD D
Sbjct: 274 YHIYNVDEDNP--GFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDD--G 326
Query: 682 HV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
+V D GLA L Q T G GT G++APE
Sbjct: 327 NVRISDLGLAVELKAGQTKTK--------GYAGTPGFMAPE 359
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 34/190 (17%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRHRNLIKII 594
IG+GSFG V + + + A+K +N + R+ E + ++ + H L+ +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ----SDDQVEVCKLSLIQRVNIAIDVAS 650
S F+ + V + + G L+ L Q ++ V ++ I ++
Sbjct: 82 --YS---FQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV---------KLFIC-ELVM 126
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
A++YL + ++H D+KP N+LLD H+ DF +A L +T + T +
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMA----- 175
Query: 711 KGTVGYVAPE 720
GT Y+APE
Sbjct: 176 -GTKPYMAPE 184
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 44/206 (21%), Positives = 79/206 (38%), Gaps = 37/206 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL---KYKGASRSFVAECEALRNIRHRNLIKIIT 595
IG GS+G+V + ++ +VA+K I R E L + H +++K++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNHDHVVKVLD 119
Query: 596 ICSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ--------SDDQVEVCKLSLIQRVNIA 645
I D + F V E + D + ++ K L
Sbjct: 120 IVIPKDVE--KFDELYVVLEIAD----SD-FKKLFRTPVYLTELH---IKTLLYN----- 164
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
+ ++Y+H ++H DLKP+N L++ D VCDFGLA+ + + + S
Sbjct: 165 --LLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 706 SSIGLKGTVGYVAPEYGMGSEASMTG 731
V + + + +TG
Sbjct: 220 PREDDMNLVTFPHTK---NLKRQLTG 242
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 48/240 (20%), Positives = 94/240 (39%), Gaps = 61/240 (25%)
Query: 500 RKRRSAQKFVDTSPMEKQFPMVSYAELSKATGE-FSSSNMIGQGSFGYVY----KGTLGE 554
RK ++ F+ + ++ + E + +IG+G+FG V K T
Sbjct: 42 RKNKNIDNFL-----SRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKST--- 93
Query: 555 DEMIVAVKVINLKYKGASRS----FVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610
+ A+K+++ K++ RS F E + + ++++ + F+ +
Sbjct: 94 -RKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVVQLF--YA---FQDDRYLYM 146
Query: 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA--------SAMEYLHHHCQPP 662
V EYM G L ++L+ ++ A A++ +H
Sbjct: 147 VMEYMPGGDL---------------VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG--- 188
Query: 663 MVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
+H D+KP N+LLD H+ DFG ++ + V+ + GT Y++PE
Sbjct: 189 FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNK---EGMVRCDT----AVGTPDYISPE 239
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-14
Identities = 48/237 (20%), Positives = 88/237 (37%), Gaps = 53/237 (22%)
Query: 500 RKRRSAQKFVDTSPMEKQFPMVSYAELSKATGE-FSSSNMIGQGSFGYVYKGTLGEDEMI 558
+ + F+ + P+V + + + F +IG+G+F V + + +
Sbjct: 34 AQDKYVADFL-----QWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88
Query: 559 VAVKVIN---LKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYM 615
A+K++N + +G F E + L N R + ++ + F+ ++ V EY
Sbjct: 89 YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH--FA---FQDENYLYLVMEYY 143
Query: 616 ENGSLKDWLHQSDDQVEVCKLSLIQRVNIAID----------VASAMEYLHHHCQPPMVH 665
G L L+L+ + I + A++ +H VH
Sbjct: 144 VGGDL---------------LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVH 185
Query: 666 GDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
D+KP N+LLD H+ DFG L + GT Y++PE
Sbjct: 186 RDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRS-LVAV------GTPDYLSPE 233
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 36/196 (18%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL--KYKGASRSFVAECEALRNIRHRNLIKIITI 596
+G+G++G V T IVA+K I K A R+ E + L++ +H N+I I I
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIITIFNI 77
Query: 597 CSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ-------SDDQVEVCKLSLIQRVNIAID 647
F+ +F + E M+ D LH+ SDD + + Q
Sbjct: 78 QRPDSFE--NFNEVYIIQELMQ----TD-LHRVISTQMLSDDH---IQYFIYQ------- 120
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
A++ LH ++H DLKPSN+L++ + VCDFGLA+ + + D + T S
Sbjct: 121 TLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQS 177
Query: 708 IGLKGTVG---YVAPE 720
+ V Y APE
Sbjct: 178 G-MVEFVATRWYRAPE 192
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 37/197 (18%), Positives = 71/197 (36%), Gaps = 54/197 (27%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G GSFG V + E A+K + + +R E + ++ + H N+IK++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNR----ELDIMKVLDHVNIIKLVDYFY 70
Query: 599 STDFKGTDFKA---------------------------------FVFEYMENGSLKDWLH 625
+T + + EY+ + +L L
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLK 129
Query: 626 QSDDQ-----VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD-HDM 679
+ + + + Q + A+ ++H + H D+KP N+L++ D
Sbjct: 130 SFIRSGRSIPMNLISIYIYQ-------LFRAVGFIHSL---GICHRDIKPQNLLVNSKDN 179
Query: 680 VAHVCDFGLAKFLSDHQ 696
+CDFG AK L +
Sbjct: 180 TLKLCDFGSAKKLIPSE 196
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 44/228 (19%), Positives = 89/228 (39%), Gaps = 49/228 (21%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVI--NLKYKGASRSFVAECEALRNIR--------H 587
+G G F V+ + VA+K++ + Y A+ E + L+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDS 82
Query: 588 RNLIKIITICSSTDFKGTDFK--AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
I+ + + KG + VFE + +L + + + + L +++ I+
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG--IPLIYVKQ--IS 137
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH------VCDFGLAKFLSDHQLDT 699
+ ++Y+H C ++H D+KP NVL++ + D G A + +H
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTN 194
Query: 700 AVKTPSSSIGLKGTVGYVAPE------YGMG----SEASMTGDIFTGR 737
+++T Y +PE +G G S A + ++ TG
Sbjct: 195 SIQTRE----------YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 49/196 (25%), Positives = 74/196 (37%), Gaps = 36/196 (18%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFV----AECEALRNIRH 587
+F +G GSFG V E A+K+++ K K + E L+ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD-KQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV---EVCKLSLIQRVNI 644
L+K+ S FK V EY+ G + + H +
Sbjct: 101 PFLVKLE--FS---FKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARF-------Y 146
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
A + EYLH +++ DLKP N+L+D V DFG AK + +T
Sbjct: 147 AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-------RTW 196
Query: 705 SSSIGLKGTVGYVAPE 720
+ L GT +APE
Sbjct: 197 T----LCGTPEALAPE 208
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 34/156 (21%), Positives = 62/156 (39%), Gaps = 17/156 (10%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITIC 597
+G G G V + + A+K++ A R E E + ++++I+ +
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDVY 80
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+ G V E ++ G L + DQ + + I + A++YLH
Sbjct: 81 -ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHS 135
Query: 658 HCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAK 690
+ H D+KP N+L + + + DFG AK
Sbjct: 136 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 1e-13
Identities = 88/645 (13%), Positives = 186/645 (28%), Gaps = 187/645 (28%)
Query: 90 DIV-VNLPNLKALAIGGNNF-FGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLL 147
DI+ V NF + + + E +D + + S L
Sbjct: 20 DILSVFEDAFVD------NFDCKDVQDMPKSILSKEEIDHIIMS--KD---AVSGTLRLF 68
Query: 148 WLNLEQNN------LGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTV 201
W L + + + F+ + + Q P S
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFL--------MSPIKTEQRQ-----P------SMMT 109
Query: 202 INFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQG 261
+ R+++ + V+ + Q + + A+ EL+ + + + G
Sbjct: 110 RMYIEQRDRLYNDNQVFAKYNVSRL-------QPYLKLRQALLELRPAKNV-----LIDG 157
Query: 262 RIPSGLGNLTKLANLELSSNSLQGNIPS-----SLGNCQNLMSFTASQNKLTGALPHQLL 316
G G T +A S +Q + +L NC + + KL +
Sbjct: 158 --VLGSGK-TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWT 214
Query: 317 S----ITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILD-ISS----NQFSG--------- 358
S + + L + L L + + L++L + + N F+
Sbjct: 215 SRSDHSSNIKLRIHSIQAELRRLLKSKP-YENCLLVLLNVQNAKAWNAFNLSCKILLTTR 273
Query: 359 ------VIPGTLSTCVCLE-----------------YLDISSNSF----HGVIPLSLSFL 391
+ +T + L+ YLD P LS +
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 392 -KSIKE--------LNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKT 442
+SI++ +V+ + L+ I L L E+ + ++ VF
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM-FDRL-------SVFPPSA 385
Query: 443 KISLQ------GNMK--LCGGI-DELHLPSCPSKGSRKPKIILLKVLIPVAVSSLILSSC 493
I ++ + ++LH S K ++ I + S+ L
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP---------SIYLELK 436
Query: 494 LTIVYARKRRSA-QKFVDTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYK--- 549
+ + + + VD Y F S ++I Y Y
Sbjct: 437 VKL---ENEYALHRSIVD-----------HYNIPKT----FDSDDLIPPYLDQYFYSHIG 478
Query: 550 ---GTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606
+ E + +++ L ++ F+ + IRH + +
Sbjct: 479 HHLKNIEHPERMTLFRMVFLDFR-----FLE-----QKIRHDSTAWNASGSILNTL--QQ 526
Query: 607 FKAF---------VFEYMENGSLKDWLHQSDDQVEVCK-LSLIQR 641
K + +E + N ++ D+L + ++ + K L++
Sbjct: 527 LKFYKPYICDNDPKYERLVN-AILDFLPKIEENLICSKYTDLLRI 570
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.8 bits (136), Expect = 3e-08
Identities = 68/492 (13%), Positives = 130/492 (26%), Gaps = 184/492 (37%)
Query: 409 PEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKG 468
F+ N + + K + S + ID +
Sbjct: 27 DAFVDNFDCKDVQDM----------PKSILSKEE-------------IDHI--------- 54
Query: 469 SRKPKIILLKVLIPVAVSSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFP--MVSYAEL 526
++ AVS + + +++ QKFV+ + + M
Sbjct: 55 ----------IMSKDAVSGTLR--LFWTLLSKQEEMVQKFVEEV-LRINYKFLMSPIKTE 101
Query: 527 SKATGEFSSSNMIGQGSFGYV-YKGTLGEDEMIVA---V----KVINLKYKGASRSFVAE 578
+ S Y+ + L D + A V + L+
Sbjct: 102 QRQP----SMMTRM-----YIEQRDRLYNDNQVFAKYNVSRLQPYLKLR----------- 141
Query: 579 CEALRNIR-HRNLI--------K---IITICSSTDFKGT-DFKAFVFEYMENGSLKDWLH 625
+AL +R +N++ K + +C S + DFK F WL+
Sbjct: 142 -QALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF------------WLN 188
Query: 626 ----QSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPS---------- 671
S + V L ++Q++ ID + H + ++
Sbjct: 189 LKNCNSPETV----LEMLQKLLYQID-PNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 672 -NVLLDHDMVAHVCDFGLAK-FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASM 729
N LL +V + F + + T + + + S+
Sbjct: 244 ENCLLVLL---NVQNAKAWNAF--NLSCKILLTTRFKQVTDFLSAATT-------THISL 291
Query: 730 TGDIFTGRRPIDAVFNEGHSLHEFAK------TALPEKVMEIVDP---SLLMEVMTNN-- 778
K LP +V+ +P S++ E + +
Sbjct: 292 D--------HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTT-NPRRLSIIAESIRDGLA 342
Query: 779 -----SMIQEDKRVKT-EECLN--------------AI------IRTGVLCSM--ESPFE 810
+ DK E LN ++ I T +L + +
Sbjct: 343 TWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS 402
Query: 811 RMDMRDVVAKLC 822
D+ VV KL
Sbjct: 403 --DVMVVVNKLH 412
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 6e-08
Identities = 51/365 (13%), Positives = 119/365 (32%), Gaps = 93/365 (25%)
Query: 21 NLSDLEVIRIMGNSLGGKI-PTT-----LGLLRNLVSLNVAENKFSGMFPRSICNISSLE 74
N+ + + L KI TT L + +++ + S
Sbjct: 252 NVQNAKAWNAFN--LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD----EVKS 305
Query: 75 LIQLALNRFSGNLPFDIVVNLPNLKALAIGGN--NFFGSI-PYSLSNASNL-ELLDLSVN 130
L+ L+ +LP +++ P ++ I + + + + N L +++ S+N
Sbjct: 306 LLLKYLDCRPQDLPREVLTTNPRRLSI-IAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364
Query: 131 Q---------------FKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSS 175
F + I L L+W ++ ++ + V L S
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHIPTILLS-LIWFDVIKS-------DVMVVVNKLHKYSL 416
Query: 176 LK------ALSLADNQFGGELPHSIANLSS---TVIN-FGIGRN-QISGTIPPGIRN-LV 223
++ +S+ EL + N + ++++ + I + IPP +
Sbjct: 417 VEKQPKESTISIPSIYL--ELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY 474
Query: 224 NLIGFGAEENQLHGTIPDAIGELKNLQKLCLFR------NFLQGRI---------PSGLG 268
+ IG H + +++ +++ LFR FL+ +I +
Sbjct: 475 SHIGH-------H------LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL 521
Query: 269 NLTKLANLELSSNSLQGNIPSSLGNCQNLMSF--TASQNKLTGALPH----QL-LSITTL 321
N L L+ + N P ++ F +N + + ++ L
Sbjct: 522 NT--LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICS--KYTDLLRIALMAEDE 577
Query: 322 SLYLD 326
+++ +
Sbjct: 578 AIFEE 582
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 51/238 (21%), Positives = 96/238 (40%), Gaps = 55/238 (23%)
Query: 500 RKRRSAQKFVDTSPMEKQFPMVSYAELSKATGE-FSSSNMIGQGSFGYVYKGTLGEDEMI 558
R+ ++ +++ E P S + + E F +IG+G+FG V L + +
Sbjct: 47 RREKNILEYL-----EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKV 101
Query: 559 VAVKVINLKYKGASRS----FVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEY 614
A+K++N K++ R+ F E + L N + + + + F+ + V +Y
Sbjct: 102 FAMKILN-KWEMLKRAETACFREERDVLVNGDSKWITTLH--YA---FQDDNNLYLVMDY 155
Query: 615 MENGSLKDWLHQSDDQVEVCKLSLIQRVNIAID----------VASAMEYLHHHCQPPMV 664
G L L+L+ + + + A++ +H V
Sbjct: 156 YVGGDL---------------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YV 197
Query: 665 HGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
H D+KP N+L+D + H+ DFG L + D V++ GT Y++PE
Sbjct: 198 HRDIKPDNILMDMN--GHIRLADFGSCLKLME---DGTVQSSV----AVGTPDYISPE 246
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 2e-13
Identities = 55/334 (16%), Positives = 102/334 (30%), Gaps = 75/334 (22%)
Query: 146 LLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIA-----NLSST 200
+ +L+ + + T + L S+K + L+ N G E ++
Sbjct: 6 IEGKSLKLDAITTEDEKSV--FAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 201 VINFG-IGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFL 259
+ F I ++ IP +R L+ A+ + L + L N
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLL-----------------QALLKCPKLHTVRLSDNAF 106
Query: 260 QGR----IPSGLGNLTKLANLELSSNSL-------------QGNIPSSLGNCQNLMSFTA 302
+ L T L +L L +N L + + N L S
Sbjct: 107 GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIIC 166
Query: 303 SQNKLTG----ALPHQLLSITTLSLYLDLSNN---------LLNGSLPLQVGHLKNLVIL 349
+N+L S L + + N LL L + + L +L
Sbjct: 167 GRNRLENGSMKEWAKTFQSHRLLH-TVKMVQNGIRPEGIEHLLLEGL----AYCQELKVL 221
Query: 350 DISSNQFSG----VIPGTLSTCVCLEYLDISSNSF--HGVIPLSLSFL----KSIKELNV 399
D+ N F+ + L + L L ++ G + +F ++ L +
Sbjct: 222 DLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281
Query: 400 SSNNLSGQ----IPEFLK-NLSVLEFLSLSYNHF 428
N + + + + L FL L+ N F
Sbjct: 282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 49/301 (16%), Positives = 109/301 (36%), Gaps = 51/301 (16%)
Query: 94 NLPNLKALAIGGNNF----FGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLK----- 144
++K + + GN + ++++ +LE+ + S +L+
Sbjct: 30 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 89
Query: 145 -----NLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS 199
L + L N G L + FL+ + L+ L L +N G P + A ++
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPL--IDFLSKHTPLEHLYLHNNGLG---PQAGAKIAR 144
Query: 200 TVINFGIGRNQISGTIPPGIRNLV---NLIG-FGAEENQLHGTIPDAIGELKNLQKLCLF 255
+ + + + P +R+++ N + +E + L + +
Sbjct: 145 ALQELAVNKKAKN---APPLRSIICGRNRLENGSMKE------WAKTFQSHRLLHTVKMV 195
Query: 256 RNFL-----QGRIPSGLGNLTKLANLELSSNSL--QG--NIPSSLGNCQNLMSFTASQNK 306
+N + + + GL +L L+L N+ G + +L + NL +
Sbjct: 196 QNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL 255
Query: 307 LTG----ALPHQLLSITTLSL-YLDLSNNLLN--GSLPLQ---VGHLKNLVILDISSNQF 356
L+ A+ + + L L L N + L+ + +L+ L+++ N+F
Sbjct: 256 LSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
Query: 357 S 357
S
Sbjct: 316 S 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 56/332 (16%), Positives = 109/332 (32%), Gaps = 71/332 (21%)
Query: 1 LQTLAVNDNYLTGQ----LPDFVGNLSDLEVIRIMGNSLGGK----IPTTLGLLRNLVSL 52
++ ++ + +T + + + ++ I + GN++G + + + ++L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 53 NVAENKFSGMFP----------RSICNISSLELIQLALNRFS--GNLPF-DIVVNLPNLK 99
++ + +++ L ++L+ N F P D + L+
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 100 ALAIGGNNF-------------FGSIPYSLSNASNLELLDLSVNQFKGNVSID-----FS 141
L + N ++ NA L + N+ N S+ F
Sbjct: 126 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMKEWAKTFQ 184
Query: 142 SLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANL---S 198
S + L + + QN + L + L C LK L L DN F ++A
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHL-LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243
Query: 199 STVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKN--LQKLCLFR 256
+ G+ +S GA + DA +L+N LQ L L
Sbjct: 244 PNLRELGLNDCLLSAR--------------GAAA------VVDAFSKLENIGLQTLRLQY 283
Query: 257 NFLQGRIPSGLG-----NLTKLANLELSSNSL 283
N ++ L + L LEL+ N
Sbjct: 284 NEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 40/223 (17%), Positives = 71/223 (31%), Gaps = 38/223 (17%)
Query: 1 LQTLAVNDNYLTGQ----LPDFVGNLSDLEVIRIMGNSLG-------------GKIPTTL 43
L T+ ++DN L DF+ + LE + + N LG +
Sbjct: 96 LHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKA 155
Query: 44 GLLRNLVSLNVAENKFSGMFPRSIC----NISSLELIQLALNRFS----GNLPFDIVVNL 95
L S+ N+ + + L +++ N +L + +
Sbjct: 156 KNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYC 215
Query: 96 PNLKALAIGGNNF----FGSIPYSLSNASNLELLDLSVNQF--KGNVSIDFSSLKN---- 145
LK L + N F ++ +L + NL L L+ +G ++ +
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV-VDAFSKLENI 274
Query: 146 -LLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFG 187
L L L+ N + L V L L L N+F
Sbjct: 275 GLQTLRLQYNEIELDAVRTLKTV-IDEKMPDLLFLELNGNRFS 316
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 49/174 (28%), Positives = 80/174 (45%), Gaps = 18/174 (10%)
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTF--LTNCSSLK 177
++ + LDL N+ S F L L L L N L L F L N L+
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-----QTLPAGIFKELKN---LE 88
Query: 178 ALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLH 236
L + DN+ LP + + + + RNQ+ ++PP + +L L N+L
Sbjct: 89 TLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146
Query: 237 GTIPD-AIGELKNLQKLCLFRNFLQGRIPSGL-GNLTKLANLELSSNSLQGNIP 288
++P +L +L++L L+ N L+ R+P G LT+L L+L +N L+ +P
Sbjct: 147 -SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVP 197
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 51/180 (28%), Positives = 74/180 (41%), Gaps = 21/180 (11%)
Query: 209 NQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGL 267
N++S ++P L L +N+L ELKNL+ L + N LQ +P G+
Sbjct: 47 NKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGV 104
Query: 268 -GNLTKLANLELSSN---SLQGNIPSSLGNCQNLMSFTASQNKLTGALPH----QLLSIT 319
L LA L L N SL + SL L + N+L +LP +L S+
Sbjct: 105 FDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL---SLGYNELQ-SLPKGVFDKLTSLK 160
Query: 320 TLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSN 378
L LY +N L +P L L L + +NQ V G + L+ L + N
Sbjct: 161 ELRLY---NNQL--KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 51/183 (27%), Positives = 70/183 (38%), Gaps = 9/183 (4%)
Query: 248 NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ---GNIPSSLGNCQNLMSFTASQ 304
+ +KL L N L LTKL L L+ N LQ I L N + L +
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETL---WVTD 94
Query: 305 NKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGT 363
NKL ALP + L L N L SLP +V L L L + N+ + G
Sbjct: 95 NKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGV 152
Query: 364 LSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSL 423
L+ L + +N V + L +K L + +N L +L L+ L L
Sbjct: 153 FDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 424 SYN 426
N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 27/108 (25%), Positives = 42/108 (38%), Gaps = 5/108 (4%)
Query: 345 NLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNL 404
+ LD+ SN+ S + L L ++ N + LK+++ L V+ N L
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97
Query: 405 SGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKI---SLQGN 449
L L L L N + +P VF + TK+ SL N
Sbjct: 98 QALPIGVFDQLVNLAELRLDRNQLK-SLPP-RVFDSLTKLTYLSLGYN 143
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 53/203 (26%), Positives = 82/203 (40%), Gaps = 52/203 (25%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFV----AECEALRNIRHR 588
F +G GSFG V+ + A+KV+ K V E L + H
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLK-KEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI---- 644
+I++ + F+ + +Y+E G L SL+++
Sbjct: 67 FIIRMW--GT---FQDAQQIFMIMDYIEGGEL---------------FSLLRKSQRFPNP 106
Query: 645 -----AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQL 697
A +V A+EYLH +++ DLKP N+LLD + H+ DFG AK++ D
Sbjct: 107 VAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKN--GHIKITDFGFAKYVPD--- 158
Query: 698 DTAVKTPSSSIGLKGTVGYVAPE 720
T + L GT Y+APE
Sbjct: 159 ----VTYT----LCGTPDYIAPE 173
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 34/168 (20%), Positives = 58/168 (34%), Gaps = 24/168 (14%)
Query: 265 SGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSL- 323
L L S+ S + +F + + S+ +
Sbjct: 13 FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ--------SLAGMQFF 62
Query: 324 ----YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNS 379
L LS+N ++ PL+ L L L ++ N+ + + L L + +N
Sbjct: 63 TNLKELHLSHNQISDLSPLK--DLTKLEELSVNRNRLKNLNGIPSAC---LSRLFLDNNE 117
Query: 380 FHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNH 427
L LK+++ L++ +N L I L LS LE L L N
Sbjct: 118 LRDTDSLI--HLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 40/223 (17%), Positives = 87/223 (39%), Gaps = 22/223 (9%)
Query: 206 IGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPS 265
+G+ ++ + + L + F + + + + NL++L L N Q S
Sbjct: 26 LGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHN--QISDLS 79
Query: 266 GLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYL 325
L +LTKL L ++ N L+ N+ + + + L N+L L+ + L L
Sbjct: 80 PLKDLTKLEELSVNRNRLK-NL-NGIPSA-CLSRLFLDNNELRDTDS--LIHLKNLE-IL 133
Query: 326 DLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIP 385
+ NN L + L L L +LD+ N+ + L+ + ++D++ +
Sbjct: 134 SIRNNKLKSIVMLG--FLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQK---CVN 186
Query: 386 LSLSFLKSIKELNVSSNNLSGQI--PEFLKNLSVLEFLSLSYN 426
+ + + N + + G+ P ++ N + +
Sbjct: 187 EPVKYQPELYITN-TVKDPDGRWISPYYISNGGSYVDGCVLWE 228
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 38/249 (15%), Positives = 80/249 (32%), Gaps = 35/249 (14%)
Query: 43 LGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDI--VVNLPNLKA 100
L N V N+ + + + +S ++ + + + NLK
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-----SLAGMQFFTNLKE 67
Query: 101 LAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160
L + N + L + + LE L ++ N+ K +++ L L L+ N L
Sbjct: 68 LHLSHNQI-SDLS-PLKDLTKLEELSVNRNRLK---NLNGIPSACLSRLFLDNNEL---- 118
Query: 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLS--STVINFGIGRNQISGTIPPG 218
D L + +L+ LS+ +N+ SI L S + + N+I+
Sbjct: 119 -RDT---DSLIHLKNLEILSIRNNKL-----KSIVMLGFLSKLEVLDLHGNEIT-NTGG- 167
Query: 219 IRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRI-PSGLGNLTKLANLE 277
+ L + + + + + L ++ I P + N +
Sbjct: 168 LTRLKKVNWIDLTGQKC---VNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC 224
Query: 278 LSSNSLQGN 286
+
Sbjct: 225 VLWELPVYT 233
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 20/101 (19%), Positives = 44/101 (43%), Gaps = 8/101 (7%)
Query: 327 LSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPL 386
+N P L N V ++ + ++ ++ + +++ + +
Sbjct: 4 QRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAGM 59
Query: 387 SLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNH 427
F ++KEL++S N +S + LK+L+ LE LS++ N
Sbjct: 60 Q--FFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNR 96
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 71.7 bits (175), Expect = 4e-13
Identities = 39/240 (16%), Positives = 76/240 (31%), Gaps = 28/240 (11%)
Query: 232 ENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSL 291
+QL I + QK C+ +L ELS + S L
Sbjct: 310 NDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSEL 368
Query: 292 GNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLN------------------ 333
+C+ L + + ++ L +
Sbjct: 369 ESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSK 428
Query: 334 --GSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFL 391
+ ++ +L ++ + V+ L + + +LD+S N +P +L+ L
Sbjct: 429 FLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAAL 485
Query: 392 KSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEG--EVPTKGVFSNKTKISLQGN 449
+ ++ L S N L + + NL L+ L L N + + ++LQGN
Sbjct: 486 RCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.5 bits (164), Expect = 9e-12
Identities = 44/341 (12%), Positives = 94/341 (27%), Gaps = 51/341 (14%)
Query: 47 RNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGN 106
V ++ E S F R + S + + L ++ ++ + + +
Sbjct: 245 LCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDL 304
Query: 107 NFFGSIPYSLSNASNLELLDLS-------VNQFKGNVSIDFSSLKNLLWLNLEQNNLGTG 159
+ + + D ++ + L L
Sbjct: 305 PAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVL 364
Query: 160 TATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANL-SSTVINFGIGRNQISGTIPPG 218
+ L +C L+ L + + + L + + P
Sbjct: 365 Q-------SELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDP- 416
Query: 219 IRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLEL 278
+ ++ E +++ L L L + L L + +L+L
Sbjct: 417 ----MRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDL 470
Query: 279 SSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPL 338
S N L+ +P +L + L L S+N L ++
Sbjct: 471 SHNRLR-ALPPALAALRCLEV-------------------------LQASDNALE-NVD- 502
Query: 339 QVGHLKNLVILDISSNQFSGV-IPGTLSTCVCLEYLDISSN 378
V +L L L + +N+ L +C L L++ N
Sbjct: 503 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 7e-10
Identities = 44/249 (17%), Positives = 73/249 (29%), Gaps = 48/249 (19%)
Query: 113 PYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTN 172
+ L +LSV + + + S K L L E L + +
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKW------CLLTIILLMRA 394
Query: 173 CSSLKALSLADNQFGG--ELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGA 230
L F + A + + + N + +R L +L
Sbjct: 395 LDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL-HL----- 448
Query: 231 EENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSS 290
L T+ + +L + L L N L+ +P L L L L+ S N+L+ N+
Sbjct: 449 AHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-G 503
Query: 291 LGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLP--LQVGHLKNLVI 348
+ N L L L NN L + LV+
Sbjct: 504 VANLPRLQ-------------------------ELLLCNNRLQ-QSAAIQPLVSCPRLVL 537
Query: 349 LDISSNQFS 357
L++ N
Sbjct: 538 LNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 10/94 (10%)
Query: 94 NLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLE 152
L + L + N ++P +L+ LE+L S N + ++D ++L L L L
Sbjct: 461 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE---NVDGVANLPRLQELLLC 516
Query: 153 QNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186
N L + L +C L L+L N
Sbjct: 517 NNRL-----QQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 23/108 (21%), Positives = 43/108 (39%), Gaps = 11/108 (10%)
Query: 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSG 61
+ L + LT + + L + + + N L +P L LR L L ++N
Sbjct: 444 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499
Query: 62 MFPRSICNIS---SLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGN 106
++ ++ L+ + L NR + +V+ P L L + GN
Sbjct: 500 ----NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 52/199 (26%), Positives = 79/199 (39%), Gaps = 49/199 (24%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL--KYKGASRSFVAECEALRNIRHRNLIKIITI 596
IG+G++G V +++ VA+K I+ R+ E + L RH N+I I I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 93
Query: 597 CSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ-------SDDQVEVCKLSLIQRVNIAID 647
+ + K V + ME D L++ S+D L Q
Sbjct: 94 IRAPTIE--QMKDVYIVQDLME----TD-LYKLLKTQHLSNDH---ICYFLYQ------- 136
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
+ ++Y+H ++H DLKPSN+LL+ +CDFGLA+ T T
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT---- 189
Query: 708 IGLKGTVGYV------APE 720
YV APE
Sbjct: 190 -------EYVATRWYRAPE 201
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 47/209 (22%), Positives = 76/209 (36%), Gaps = 48/209 (22%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL---KYKGASRSFVAECEALRNIRHRNLIKIIT 595
IG+GS+GYVY E VA+K +N R E L ++ +I++
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKSDYIIRLYD 92
Query: 596 ICSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ--------SDDQVEVCKLSLIQRVNIA 645
+ D F V E + D L + +++ K L
Sbjct: 93 LIIPDDLL--KFDELYIVLEIAD----SD-LKKLFKTPIFLTEEH---IKTILYN----- 137
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
+ ++H + ++H DLKP+N LL+ D VCDFGLA+ ++ + V
Sbjct: 138 --LLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192
Query: 706 SSIGLKGTV--------GYV------APE 720
+ +V APE
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 48/212 (22%), Positives = 82/212 (38%), Gaps = 58/212 (27%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR----------HR 588
+G+G++G V+K +VAVK I +F +A R R H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKI-------FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ-------SDDQVEVCKLSLIQR 641
N++ ++ + + + + VF+YME D LH + + Q
Sbjct: 70 NIVNLLNVLRADNDRDV---YLVFDYME----TD-LHAVIRANILEPVH---KQYVVYQL 118
Query: 642 VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701
+ ++YLH ++H D+KPSN+LL+ + V DFGL++ + + T
Sbjct: 119 IK-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNN 168
Query: 702 KTPSSSIGLKGTV-------GYV------APE 720
S + + YV APE
Sbjct: 169 IPLSINENTENFDDDQPILTDYVATRWYRAPE 200
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 48/241 (19%), Positives = 89/241 (36%), Gaps = 43/241 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMI-----VAVKVIN-----LKYKGASRSFVAECEALRNIRHR 588
IGQG FG +Y + E + VKV L + A+ E ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 589 NLIKIITICS-----STDFKGTDFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRV 642
+K + + D G ++ + + G L+ + + S +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAK-----RFSRKTVL 155
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD--HDMVAHVCDFGLAKFLSDHQLDTA 700
+++ + +EY+H H VHGD+K SN+LL+ + ++ D+GLA + A
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 701 VKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNE--GHSLHEFAKTAL 758
GT+ + + + G S GD+ E G+ + ++ L
Sbjct: 213 YA-ADPKRCHDGTIEFTSIDAHNGVAPSRRGDL------------EILGYCMIQWLTGHL 259
Query: 759 P 759
P
Sbjct: 260 P 260
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 38/165 (23%), Positives = 71/165 (43%), Gaps = 20/165 (12%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVI--NLKYKGASRSFVAECEALRNIRHR---NLIK 592
+IG+GSFG V K + VA+K++ ++ + E L ++R + N +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE---EIRILEHLRKQDKDNTMN 160
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+I + + F+ FE + +L + + ++ Q SL A + +
Sbjct: 161 VIHMLENFTFRN--HICMTFELLSM-NLYELIKKNKFQ----GFSLPLVRKFAHSILQCL 213
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAH--VCDFGLAKFLSDH 695
+ LH + ++H DLKP N+LL + V DFG + +
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR 255
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 42/206 (20%), Positives = 79/206 (38%), Gaps = 54/206 (26%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINL-KYKGASRSFVAECEALRNIRHRNLIKIITI- 596
+G G G V+ + + VA+K I L + + E + +R + H N++K+ I
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVFEIL 77
Query: 597 ------CSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ-------SDDQVEVCKLSLIQR 641
+ T+ + V EYME D L ++ +L + Q
Sbjct: 78 GPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LANVLEQGPLLEEH---ARLFMYQ- 128
Query: 642 VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGLAKFLSDHQLDTA 700
+ ++Y+H ++H DLKP+N+ ++ D+V + DFGLA+ + H
Sbjct: 129 ------LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 701 VKTPSSSIGLKGTVGYV------APE 720
+ + +P
Sbjct: 180 HLS-----------EGLVTKWYRSPR 194
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 32/241 (13%), Positives = 69/241 (28%), Gaps = 35/241 (14%)
Query: 44 GLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI 103
L + +L + E + + N+ ++ I ++++ L NL + + I
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATD 163
I L L +L + L
Sbjct: 88 RNTRNLTYIDPDA-----------------------LKELPLLKFLGIFNTGL-----KM 119
Query: 164 LDFVTFLTNCSSLKALSLADNQFGGELP-HSIANLSSTVINFGIGRNQISGTIPPGIRNL 222
+T + + L + DN + +P ++ L + + + N + ++ N
Sbjct: 120 FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNG 178
Query: 223 VNLIGFGAEENQLHGTIPDAI--GELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSS 280
L +N+ I G L + + + +PS L L L +
Sbjct: 179 TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARN 235
Query: 281 N 281
Sbjct: 236 T 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-12
Identities = 39/217 (17%), Positives = 82/217 (37%), Gaps = 15/217 (6%)
Query: 214 TIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGL-GNLTK 272
++PP + L L E L A L N+ ++ + + ++ S NL+K
Sbjct: 28 SLPPSTQTL-KL-----IETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK 81
Query: 273 LANLELSSNSLQGNIPSS-LGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNL 331
+ ++E+ + I L L L + T + L++++N
Sbjct: 82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNP 141
Query: 332 LNGSLPLQV--GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLS 389
S+P+ G + L + +N F+ V + L+ + ++ N + VI +
Sbjct: 142 YMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTK-LDAVYLNKNKYLTVID-KDA 199
Query: 390 F---LKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSL 423
F L+VS +++ + L++L L +
Sbjct: 200 FGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 9e-05
Identities = 16/114 (14%), Positives = 37/114 (32%), Gaps = 8/114 (7%)
Query: 345 NLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSF--LKSIKELNVSSN 402
+ L + + S + + +S + + S SF L + + + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLE-SHSFYNLSKVTHIEIRNT 90
Query: 403 NLSGQIP-EFLKNLSVLEFLSLSYNHFEGEVPTKGVFSN---KTKISLQGNMKL 452
I + LK L +L+FL + + P + + + N +
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYM 143
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 37/174 (21%), Positives = 76/174 (43%), Gaps = 31/174 (17%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRN 589
+ S +G G++G V VA+K ++ ++ A R++ E L++++H N
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHEN 84
Query: 590 LIKIITICSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ------SDDQVEVCKLSLIQR 641
+I ++ + + +F V +M+ D L + S+++ + + Q
Sbjct: 85 VIGLLDVFTPAS-SLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEK---IQYLVYQ- 134
Query: 642 VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695
+ ++Y+H +VH DLKP N+ ++ D + DFGLA+
Sbjct: 135 ------MLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 48/210 (22%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVI-----NLKYKGASRSFVAECEALRNIRHRNLIKI 593
IG G+ G V E VA+K + N + A R++ E ++ + H+N+I +
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH--AKRAY-RELVLMKCVNHKNIIGL 89
Query: 594 ITICSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ--SDDQVEVCKLSLIQRVNIAIDVA 649
+ + + +F+ V E M+ +L + ++ L Q +
Sbjct: 90 LNVFTP-QKSLEEFQDVYIVMELMDA-NLCQVIQMELDHER---MSYLLYQ-------ML 137
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
+++LH ++H DLKPSN+++ D + DFGLA+ + T
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---------- 184
Query: 710 LKGTVGYV------APEYGMGSEASMTGDI 733
YV APE +G DI
Sbjct: 185 -----PYVVTRYYRAPEVILGMGYKENVDI 209
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 9e-12
Identities = 49/186 (26%), Positives = 75/186 (40%), Gaps = 24/186 (12%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVI---NLKYKGASRSFVAECEALRNIRHRNLIKII 594
++G+G+FG V A+K++ + K + E L+N RH L +
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
S F+ D FV EY G L L + S + ++ SA++Y
Sbjct: 215 --YS---FQTHDRLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDY 263
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
LH +V+ DLK N++LD D + DFGL K + + GT
Sbjct: 264 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK----EGIKDGATMKTFC----GTP 313
Query: 715 GYVAPE 720
Y+APE
Sbjct: 314 EYLAPE 319
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-11
Identities = 38/183 (20%), Positives = 58/183 (31%), Gaps = 43/183 (23%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVIN--LKYKGASRSFVAECEALRNIR---------H 587
I GS+G V G E VA+K + + R +R H
Sbjct: 30 ISSGSYGAVCAGVDSEGIP-VAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 588 RNLIKIITICSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ---------SDDQVEVCKL 636
N++ + I + V E M D L Q S +
Sbjct: 89 PNILGLRDIFVHFEE--PAMHKLYLVTELMRT----D-LAQVIHDQRIVISPQH---IQY 138
Query: 637 SLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQ 696
+ + + LH + +VH DL P N+LL + +CDF LA+ +
Sbjct: 139 FMYH-------ILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 697 LDT 699
T
Sbjct: 189 NKT 191
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 52/269 (19%), Positives = 95/269 (35%), Gaps = 57/269 (21%)
Query: 486 SSLILSSCLTIVYARKRRSAQKFVDTSPMEKQFPMVSYAELSKATGE----FSSSNMIGQ 541
+ ++ C K + S + S E+ +T + + IG
Sbjct: 14 LDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSV-EVGDSTFTVLKRYQNLKPIGS 72
Query: 542 GSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEA---------LRNIRHRNLIK 592
G+ G V + VA+K + SR F + A ++ + H+N+I
Sbjct: 73 GAQGIVCAAYDAVLDRNVAIKKL-------SRPFQNQTHAKRAYRELVLMKCVNHKNIIS 125
Query: 593 IITICSSTDFKGTDFKA--FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
++ + + +F+ V E M+ + L Q +L + + +
Sbjct: 126 LLNVFTPQK-TLEEFQDVYLVMELMDA----N-LCQVIQM----ELDHERMSYLLYQMLC 175
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
+++LH ++H DLKPSN+++ D + DFGLA+ + T
Sbjct: 176 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT----------- 221
Query: 711 KGTVGYV------APEYGMGSEASMTGDI 733
YV APE +G DI
Sbjct: 222 ----PYVVTRYYRAPEVILGMGYKENVDI 246
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 39/169 (23%), Positives = 76/169 (44%), Gaps = 32/169 (18%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIIT 595
+G G++G V + + VAVK ++ ++ A R++ E L++++H N+I ++
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 596 ICSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ-------SDDQVEVCKLSLIQRVNIAI 646
+ + +F V M D L+ +DD + + Q
Sbjct: 96 VFTP-ARSLEEFNDVYLVTHLMG----AD-LNNIVKCQKLTDDH---VQFLIYQ------ 140
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695
+ ++Y+H ++H DLKPSN+ ++ D + DFGLA+ +D
Sbjct: 141 -ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 38/241 (15%), Positives = 81/241 (33%), Gaps = 43/241 (17%)
Query: 539 IGQGSFGYVYKGT--------LGEDEMIVAVKV----INLKYKGASRSFVAECEALRNIR 586
+ + G +Y+ G + ++K+ L + A+ + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 587 HRNLIKIITICSSTDF--KGTDFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVN 643
++ I + F ++ V + G SL+ L S LS +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKH----VLSERSVLQ 163
Query: 644 IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQLDTA 700
+A + A+E+LH + VHG++ N+ + D V + +G A A
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQV-TLAGYGFAFRYCPSGKHVA 219
Query: 701 VKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNE--GHSLHEFAKTAL 758
S +G + +++ + G S D+ + G+ + ++ L
Sbjct: 220 YV-EGSRSPHEGDLEFISMDLHKGCGPSRRSDL------------QSLGYCMLKWLYGFL 266
Query: 759 P 759
P
Sbjct: 267 P 267
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 39/171 (22%), Positives = 72/171 (42%), Gaps = 36/171 (21%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVI-----NLKYKGASRSFVAECEALRNIRHRNLIKI 593
+G G++G V G VA+K + + + A R++ E L+++RH N+I +
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF--AKRAY-RELRLLKHMRHENVIGL 89
Query: 594 ITICSSTDFKGTDFKA--FVFEYMENGSLKDWLHQ-------SDDQVEVCKLSLIQRVNI 644
+ + + D DF V +M D L + +D+ + + Q
Sbjct: 90 LDVFTP-DETLDDFTDFYLVMPFMG----TD-LGKLMKHEKLGEDR---IQFLVYQ---- 136
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDH 695
+ + Y+H ++H DLKP N+ ++ D + DFGLA+
Sbjct: 137 ---MLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 54/162 (33%), Positives = 71/162 (43%), Gaps = 13/162 (8%)
Query: 123 ELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLA 182
E LDL F L L WLNL+ N L T +A D +T L L LA
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGT------LGLA 91
Query: 183 DNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPD 241
+NQ LP + + + + +G NQ+ ++P G+ L L NQL +IP
Sbjct: 92 NNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPA 148
Query: 242 -AIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSN 281
A +L NLQ L L N LQ +P G L KL + L N
Sbjct: 149 GAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 41/157 (26%), Positives = 60/157 (38%), Gaps = 9/157 (5%)
Query: 250 QKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ---GNIPSSLGNCQNLMSFTASQNK 306
+KL L L + LTKL L L N LQ + L L + N+
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTL---GLANNQ 94
Query: 307 LTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLS 365
L +LP + T L L N L SLP V L L L +++NQ + G
Sbjct: 95 LA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD 152
Query: 366 TCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402
L+ L +S+N V + L ++ + + N
Sbjct: 153 KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 31/130 (23%), Positives = 51/130 (39%), Gaps = 9/130 (6%)
Query: 325 LDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI 384
LDL + L L L L++ NQ + G L L +++N +
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 385 PLSLSFLKSIKELNVSSNNLSGQIPE--FLKNLSVLEFLSLSYNHFEGEVPTKGVF---S 439
L + +L + N L +P F + L+ L+ L L+ N + +P G F +
Sbjct: 100 LGVFDHLTQLDKLYLGGNQLKS-LPSGVFDR-LTKLKELRLNTNQLQ-SIPA-GAFDKLT 155
Query: 440 NKTKISLQGN 449
N +SL N
Sbjct: 156 NLQTLSLSTN 165
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 64.3 bits (156), Expect = 1e-10
Identities = 49/221 (22%), Positives = 85/221 (38%), Gaps = 37/221 (16%)
Query: 512 SPMEKQFPMVSYAELSKATGEFSSSN-----MIGQGSFGYVYKGTLGEDEMIVAVKVINL 566
+P EK +S + + ++ ++G+GSFG V + + AVK++
Sbjct: 317 APEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK- 375
Query: 567 KYKGASRSFVAECEALRNI-----RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLK 621
K V + + + L ++ F+ D FV EY+ G L
Sbjct: 376 KDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH--SC---FQTMDRLYFVMEYVNGGDLM 430
Query: 622 DWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681
+ Q + V A ++A + +L +++ DLK NV+LD +
Sbjct: 431 YHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE--G 479
Query: 682 HV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
H+ DFG+ K + V T + GT Y+APE
Sbjct: 480 HIKIADFGMCK----ENIWDGVTTKT----FCGTPDYIAPE 512
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 39/166 (23%), Positives = 73/166 (43%), Gaps = 18/166 (10%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVI--NLKYKGASRSFVAECEALRNIRHR---NLI 591
++IG+GSFG V K ++ VA+K+I + ++ E L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI---EVRLLELMNKHDTEMKY 116
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
I+ + F+ VFE + +L D L ++ + L+L ++ A + +A
Sbjct: 117 YIVHLKRHFMFRN--HLCLVFEMLSY-NLYDLLRNTNFR--GVSLNLTRK--FAQQMCTA 169
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH--VCDFGLAKFLSDH 695
+ +L + ++H DLKP N+LL + + + DFG + L
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 43/197 (21%), Positives = 72/197 (36%), Gaps = 40/197 (20%)
Query: 263 IPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS 322
+P L + T L+LS N+L + + P +L ++
Sbjct: 33 VPQSLPSYTA--LLDLSHNNLS-RLRA-------------------EWTPTRLTNLH--- 67
Query: 323 LYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH 381
L LS+N LN + + + NL LD+SSN + S LE L + +N
Sbjct: 68 -SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV 125
Query: 382 GVIPLSLSFLKSIKELNVSSNNLSGQIPE----FLKNLSVLEFLSLSYNHFEGEVPTKGV 437
V + + +++L +S N +S + P L L L LS N + ++P
Sbjct: 126 VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK-KLP-LTD 182
Query: 438 FSNKTK-----ISLQGN 449
+ L N
Sbjct: 183 LQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 41/182 (22%), Positives = 63/182 (34%), Gaps = 20/182 (10%)
Query: 111 SIPYSLSNASNLELLDLSVNQFKG-NVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTF 169
++P SL S LLDLS N + L NL L L N+L + F
Sbjct: 32 NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-----NFISSEAF 84
Query: 170 LTNCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIPPGI-RNLVNLIG 227
+L+ L L+ N ++L + V+ + N I + ++ L
Sbjct: 85 -VPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLL--LYNNHIV-VVDRNAFEDMAQLQK 140
Query: 228 FGAEENQLHGTIPDAIG---ELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ 284
+NQ+ + I +L L L L N L+ + L L L L
Sbjct: 141 LYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL---YLH 197
Query: 285 GN 286
N
Sbjct: 198 NN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 33/162 (20%), Positives = 62/162 (38%), Gaps = 10/162 (6%)
Query: 1 LQTLAVNDNYLTGQLPDFV-GNLSDLEVIRIMGNSLGGKIPT-TLGLLRNLVSLNVAENK 58
L ++ N L+ ++ L++L + + N L I + + NL L+++ N
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNH 99
Query: 59 FSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIP----Y 114
+ ++ +LE++ L N + + ++ L+ L + N P
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
Query: 115 SLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLE-QNN 155
+ L LLDLS N+ K D L + L NN
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 61.1 bits (147), Expect = 4e-10
Identities = 35/220 (15%), Positives = 59/220 (26%), Gaps = 63/220 (28%)
Query: 513 PMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVI-------- 564
P P K IG+G FG V++ D VA+K+I
Sbjct: 12 PFSHCLPTEKLQRCEK----------IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLV 59
Query: 565 NLKYKGASRSFVAECEALRNI---------RHRNLIKIITIC------------------ 597
N ++ + E + + R I + ++
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 598 -------SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
DF D V E+ G + + SL +I + +
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQLTA 172
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
++ + H DL NVLL + + K
Sbjct: 173 SLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 49/188 (26%), Positives = 76/188 (40%), Gaps = 29/188 (15%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVI---NLKYKGASRSFVAECEALRNIRHRNLIKII 594
++G+G+FG V A+K++ + K V E L+N RH L +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ F+ D FV EY G L L + + + ++ SA+EY
Sbjct: 72 --YA---FQTHDRLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEY 120
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
LH +V+ D+K N++LD D H+ DFGL K + + G
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKD--GHIKITDFGLCK----EGISDGATMKT----FCG 167
Query: 713 TVGYVAPE 720
T Y+APE
Sbjct: 168 TPEYLAPE 175
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 38/175 (21%), Positives = 62/175 (35%), Gaps = 41/175 (23%)
Query: 111 SIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTF- 169
IP +L + + L N K FS K L ++L N + ++L F
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-----SELAPDAFQ 77
Query: 170 -LTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIG 227
L + L +L L N+ ++ +P + L +L
Sbjct: 78 GLRS---LNSLVLYGNK-----------ITE---------------LPKSLFEGLFSLQL 108
Query: 228 FGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSN 281
N+++ DA +L NL L L+ N LQ I G L + + L+ N
Sbjct: 109 LLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 34/169 (20%), Positives = 57/169 (33%), Gaps = 35/169 (20%)
Query: 215 IPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGL-GNLTKL 273
+P I + L E+N + P A K L+++ L N + + L L
Sbjct: 30 LPETITEI-RL-----EQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 274 ANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLN 333
+L L N + LP L L L+ N +N
Sbjct: 83 NSLVLYGNKIT-------------------------ELPKSLFEGLFSLQLLLLNANKIN 117
Query: 334 GSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH 381
L + L NL +L + N+ + GT S ++ + ++ N F
Sbjct: 118 -CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 29/145 (20%), Positives = 61/145 (42%), Gaps = 13/145 (8%)
Query: 263 IPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALP----HQLLSI 318
IP+ L + L N+++ P + + L S N+++ L L S+
Sbjct: 26 IPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSL 82
Query: 319 TTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISS 377
+L LY N + LP + L +L +L +++N+ + + L L +
Sbjct: 83 NSLVLY---GNKI--TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYD 137
Query: 378 NSFHGVIPLSLSFLKSIKELNVSSN 402
N + + S L++I+ ++++ N
Sbjct: 138 NKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 22/108 (20%), Positives = 42/108 (38%), Gaps = 5/108 (4%)
Query: 345 NLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNL 404
+ + + N + PG S L +D+S+N + P + L+S+ L + N +
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92
Query: 405 SGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTK---ISLQGN 449
+ + L L+ L L+ N + F + +SL N
Sbjct: 93 TELPKSLFEGLFSLQLLLLNANKIN-CLR-VDAFQDLHNLNLLSLYDN 138
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 41/195 (21%)
Query: 538 MIGQGSFGYVY---KGTLGEDEMIVAVKVINLKYKGASRSFV---AECEALRNIRHRNLI 591
++GQGSFG V+ K + + + A+KV+ K R V E + L + H ++
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLK-KATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ----SDDQVEVCKLSLIQRVNIAID 647
K+ + F+ + +++ G L L + +++ V + +A +
Sbjct: 90 KLH--YA---FQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV---------KFYLA-E 134
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPS 705
+A A+++LH +++ DLKP N+LLD + H+ DFGL+K +D K S
Sbjct: 135 LALALDHLHSLG---IIYRDLKPENILLDEE--GHIKLTDFGLSK----ESIDHEKKAYS 185
Query: 706 SSIGLKGTVGYVAPE 720
GTV Y+APE
Sbjct: 186 ----FCGTVEYMAPE 196
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 8e-10
Identities = 45/230 (19%), Positives = 76/230 (33%), Gaps = 77/230 (33%)
Query: 532 EFSSSN-----MIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASRS----FVA 577
EF +G+G+FG V + VAVK++ +GA+ S ++
Sbjct: 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMS 74
Query: 578 ECEALRNI-RHRNL-------------IKIIT---------------------------- 595
E + L +I H N+ + +I
Sbjct: 75 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGAR 134
Query: 596 --------------ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQS-DDQVEVCKLSLIQ 640
+ D + + ++E SL D + + + L+L
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEH 194
Query: 641 RVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690
+ + VA ME+L +H DL N+LL V +CDFGLA+
Sbjct: 195 LICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 62/226 (27%), Positives = 93/226 (41%), Gaps = 33/226 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG GSFG +Y GT VA+K+ K E + + ++ I I C
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 599 STDFKGTDFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+ D+ V E + G SL+D + K SL + +A + S +EY+H
Sbjct: 75 AEG----DYNVMVMELL--GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHS 123
Query: 658 HCQPPMVHGDLKPSNVLL---DHDMVAHVCDFGLAKFLSDHQLDTAVKTP-SSSIGLKGT 713
+H D+KP N L+ + ++ DFGLAK D + T P + L GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR--THQHIPYRENKNLTGT 178
Query: 714 VGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759
Y + +G E S RR D + + G+ L F +LP
Sbjct: 179 ARYASINTHLGIEQS--------RR--DDLESLGYVLMYFNLGSLP 214
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 62/231 (26%), Positives = 93/231 (40%), Gaps = 41/231 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI-KIITIC 597
IG G+FG + G VA+K+ K + E + + + I ++
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVY--- 71
Query: 598 SSTDFKGT--DFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ G + A V E + G SL+D L D+ SL + IAI + S MEY
Sbjct: 72 ----YFGPCGKYNAMVLELL--GPSLED-LFDLCDR----TFSLKTVLMIAIQLISRMEY 120
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDM-----VAHVCDFGLAKFLSDHQLDTAVKTP-SSSI 708
+H +++ D+KP N L+ V H+ DF LAK D + T P
Sbjct: 121 VHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE--TKKHIPYREHK 175
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759
L GT Y++ +G E S RR D + GH F + +LP
Sbjct: 176 SLTGTARYMSINTHLGKEQS--------RR--DDLEALGHMFMYFLRGSLP 216
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 45/164 (27%), Positives = 59/164 (35%), Gaps = 36/164 (21%)
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL 179
+N ++L L NQ F SL NL L L N LG D LT L L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD---SLTQ---LTVL 93
Query: 180 SLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGT 238
L NQ L+ +P + LV+L N+L
Sbjct: 94 DLGTNQ-----------LTV---------------LPSAVFDRLVHLKELFMCCNKLT-E 126
Query: 239 IPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSN 281
+P I L +L L L +N L+ IP G L+ L + L N
Sbjct: 127 LPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 36/136 (26%), Positives = 56/136 (41%), Gaps = 10/136 (7%)
Query: 195 ANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAI-GELKNLQKLC 253
A + + + NQI+ P +L+NL NQL +P + L L L
Sbjct: 36 AGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLD 94
Query: 254 LFRNFLQGRIPSGL-GNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALP 312
L N L +PS + L L L + N L +P + +L QN+L ++P
Sbjct: 95 LGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
Query: 313 H----QLLSITTLSLY 324
H +L S+T L+
Sbjct: 152 HGAFDRLSSLTHAYLF 167
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 34/133 (25%), Positives = 47/133 (35%), Gaps = 10/133 (7%)
Query: 250 QKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ---GNIPSSLGNCQNLMSFTASQNK 306
Q L L N + P +L L L L SN L + SL L N+
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVL---DLGTNQ 99
Query: 307 LTGALPHQLL-SITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLS 365
LT LP + + L L + N L LP + L +L L + NQ + G
Sbjct: 100 LT-VLPSAVFDRLVHLK-ELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFD 156
Query: 366 TCVCLEYLDISSN 378
L + + N
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 54/231 (23%), Positives = 89/231 (38%), Gaps = 41/231 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI-KIITIC 597
IG+GSFG +++GT + VA+K + + E + + I +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVY--- 72
Query: 598 SSTDFKGT--DFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ G V + + G SL+D L K S+ A + + ++
Sbjct: 73 ----YFGQEGLHNVLVIDLL--GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQS 121
Query: 655 LHHHCQPPMVHGDLKPSNVLL-----DHDMVAHVCDFGLAKFLSDHQLDTAVKTP-SSSI 708
+H +V+ D+KP N L+ + + +V DFG+ KF D T P
Sbjct: 122 IHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV--TKQHIPYREKK 176
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759
L GT Y++ +G E S RR D + GH F + +LP
Sbjct: 177 NLSGTARYMSINTHLGREQS--------RR--DDLEALGHVFMYFLRGSLP 217
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 42/183 (22%), Positives = 75/183 (40%), Gaps = 38/183 (20%)
Query: 538 MIGQGSFGYVYKGT-LGEDEMIVAVKVI--NLKYKGASRSFVAECEALRNIRHR---NLI 591
+G+G+FG V + + VA+K+I KY+ A+R E L+ I+ + N
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL---EINVLKKIKEKDKENKF 82
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ + +F G FE + + ++L +++ Q L ++ +A + A
Sbjct: 83 LCVLMSDWFNFHG--HMCIAFELLGK-NTFEFLKENNFQP--YPLPHVRH--MAYQLCHA 135
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH-------------------VCDFGLAKFL 692
+ +LH + + H DLKP N+L + V DFG A F
Sbjct: 136 LRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD 192
Query: 693 SDH 695
+H
Sbjct: 193 HEH 195
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 48/190 (25%), Positives = 76/190 (40%), Gaps = 32/190 (16%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-----RHRNLIK 592
M+G+GSFG V+ + A+K + K V + + H L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALK-KDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ C+ F+ + FV EY+ G L + K L + A ++ +
Sbjct: 83 MF--CT---FQTKENLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGL 131
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGL 710
++LH +V+ DLK N+LLD D H+ DFG+ K + KT +
Sbjct: 132 QFLHSK---GIVYRDLKLDNILLDKD--GHIKIADFGMCK----ENMLGDAKTNT----F 178
Query: 711 KGTVGYVAPE 720
GT Y+APE
Sbjct: 179 CGTPDYIAPE 188
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 43/199 (21%), Positives = 86/199 (43%), Gaps = 45/199 (22%)
Query: 538 MIGQGSFGYVY---KGTLGEDEMIVAVKVINLKYKGASRSFVAEC-EALRNIRHRNLIK- 592
++G G++G V+ K + + + A+KV+ K ++ E R + L
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-KATIVQKAKTTEHTRTERQV----LEHI 115
Query: 593 -----IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ----SDDQVEVCKLSLIQRVN 643
++T+ + F+ + +Y+ G L L Q ++ +V ++
Sbjct: 116 RQSPFLVTLHYA--FQTETKLHLILDYINGGELFTHLSQRERFTEHEV---------QIY 164
Query: 644 IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAV 701
+ ++ A+E+LH +++ D+K N+LLD + HV DFGL+K + + A
Sbjct: 165 VG-EIVLALEHLHKL---GIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERA- 217
Query: 702 KTPSSSIGLKGTVGYVAPE 720
GT+ Y+AP+
Sbjct: 218 YD------FCGTIEYMAPD 230
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 57/200 (28%), Positives = 85/200 (42%), Gaps = 52/200 (26%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK----- 592
+IG+GSFG V +E+ AVKV+ K + + RN+ L+K
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQ-KKAILKKKEEKHIMSERNV----LLKNVKHP 99
Query: 593 -IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI------- 644
++ + S F+ D FV +Y+ G L + H +QR
Sbjct: 100 FLVGLHFS--FQTADKLYFVLDYINGGEL--FYH-------------LQRERCFLEPRAR 142
Query: 645 --AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTA 700
A ++ASA+ YLH +V+ DLKP N+LLD H+ DFGL K ++
Sbjct: 143 FYAAEIASALGYLHSL---NIVYRDLKPENILLDSQ--GHIVLTDFGLCK----ENIEHN 193
Query: 701 VKTPSSSIGLKGTVGYVAPE 720
T + GT Y+APE
Sbjct: 194 STTST----FCGTPEYLAPE 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 32/190 (16%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-----RHRNLIK 592
++G+GSFG V + + AVK++ K V + + + L +
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILK-KDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ F+ D FV EY+ G L + Q + V A ++A +
Sbjct: 86 LH--SC---FQTMDRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGL 134
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGL 710
+L +++ DLK NV+LD + H+ DFG+ K + V T +
Sbjct: 135 FFLQSK---GIIYRDLKLDNVMLDSE--GHIKIADFGMCK----ENIWDGVTTKT----F 181
Query: 711 KGTVGYVAPE 720
GT Y+APE
Sbjct: 182 CGTPDYIAPE 191
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 4e-09
Identities = 47/196 (23%), Positives = 84/196 (42%), Gaps = 41/196 (20%)
Query: 538 MIGQGSFGYVY---KGTLGEDEMIVAVKVIN----LKYKGASRSFVAECEALRNIRHRNL 590
++G+G +G V+ K T I A+KV+ ++ + AE L ++H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ----SDDQVEVCKLSLIQRVNIAI 646
+ +I + F+ + EY+ G L L + +D +A
Sbjct: 84 VDLI--YA---FQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA---------CFYLA- 128
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTP 704
+++ A+ +LH +++ DLKP N++L+H HV DFGL K + T
Sbjct: 129 EISMALGHLHQK---GIIYRDLKPENIMLNHQ--GHVKLTDFGLCKE----SIHDGTVTH 179
Query: 705 SSSIGLKGTVGYVAPE 720
+ GT+ Y+APE
Sbjct: 180 T----FCGTIEYMAPE 191
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-09
Identities = 56/378 (14%), Positives = 117/378 (30%), Gaps = 71/378 (18%)
Query: 141 SSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGE----LPHSIAN 196
S + L+L NNL + + +L F +S+ +L+L+ N G + L +A
Sbjct: 19 SIPHGVTSLDLSLNNLYSISTVEL-IQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 197 LSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFR 256
+ + V + + N +S LV + + L L
Sbjct: 78 IPANVTSLNLSGNFLS---YKSSDELVKTL----------------AAIPFTITVLDLGW 118
Query: 257 NFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLL 316
N + S ++S +L+GN L+ L
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKS-SDELIQ----------ILAAIPA 167
Query: 317 SITTLSLYLDLSNNLLNG------SLPLQVGHLKNLVILDISSNQF--SGV--IPGTLST 366
++ + L+L N L + L ++ LD+S+N + S+
Sbjct: 168 NVNS----LNLRGNNLASKNCAELAKFLASIP-ASVTSLDLSANLLGLKSYAELAYIFSS 222
Query: 367 CVC-LEYLDISSNSFHGV----IPLSLSFLKSIKELNVSSNNLSGQ-------IPEFLKN 414
+ L++ N HG + L LK ++ + + + + + N
Sbjct: 223 IPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPN 282
Query: 415 LSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKGSRKPKI 474
+ + + + + +L G D L + ++K +
Sbjct: 283 IQKIILVDKNGKEIHPSH---------SIPISNLIRELSGKADVPSLLNQCLIFAQKHQT 333
Query: 475 ILLKVLIPVAVSSLILSS 492
+ + IP + I +
Sbjct: 334 NIEDLNIPDELRESIQTC 351
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 51/328 (15%), Positives = 110/328 (33%), Gaps = 61/328 (18%)
Query: 117 SNASNLELLDLSVNQFKGNVSIDFSSL-----KNLLWLNLEQNNLGTGTATDLDFVTFLT 171
+ +++ L+LS N S + + N+ LNL N L ++ +L T
Sbjct: 48 NTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL-VKTLAA 106
Query: 172 NCSSLKALSLADNQFGGE----LPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIG 227
++ L L N F + + +NL +++ + + N + L+ ++
Sbjct: 107 IPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG---IKSSDELIQIL- 162
Query: 228 FGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGR----IPSGLGNL-TKLANLELSSNS 282
A N+ L L N L + + L ++ + +L+LS+N
Sbjct: 163 --AAIP-------------ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANL 207
Query: 283 LQGN----IPSSLGNCQN-LMSFTASQNKLTG----ALPHQLLSITTLSLYLDLSNNLLN 333
L + + N ++S N L G L S+ L + L +++
Sbjct: 208 LGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ-TVYLDYDIVK 266
Query: 334 G-------SLPLQVGHLKNLVILDISSNQF--SGVI--------PGTLSTCVCLEYLDIS 376
+L +++ ++++D + + S I + L +
Sbjct: 267 NMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI 326
Query: 377 SNSFHGVIPLSLSFLKSIKELNVSSNNL 404
H L+ ++E + L
Sbjct: 327 FAQKHQTNIEDLNIPDELRESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 29/179 (16%), Positives = 55/179 (30%), Gaps = 27/179 (15%)
Query: 117 SNASNLELLDLSVNQFKGNVSIDFSSL-----KNLLWLNLEQNNLGTGTATDLDFVTFLT 171
S +++ LDLS N + + + +++ LNL N L + +L +
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLL--KD 250
Query: 172 NCSSLKALSLADNQFGGELPHSIANLSS------TVINFGIGRNQISGTIPPGIRNLVNL 225
+ L+ + L + L + +I +I P + NL
Sbjct: 251 SLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH---PSHSIPISNL 307
Query: 226 IGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ 284
I +L G ++ +L CL L +L + L
Sbjct: 308 I------RELSGKA-----DVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLL 355
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 54/287 (18%), Positives = 91/287 (31%), Gaps = 97/287 (33%)
Query: 538 MIGQGSFGYVYKGTLGEDEMI---VAVKVI--NLKYKGASRSFVAECEALRNIR-----H 587
+G G F V+ L D VA+KV+ Y + E L+++R
Sbjct: 44 KLGWGHFSTVW---LSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPND 97
Query: 588 RNLIKIITICSSTDFKGTDFK--AFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVNI 644
N ++ + G + VFE + G L W+ +S+ Q L +++ I
Sbjct: 98 PNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQG--LPLPCVKK--I 151
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLL----------------------------- 675
V ++YLH C+ ++H D+KP N+LL
Sbjct: 152 IQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 676 --------------------DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
+ + D G A ++ H + I T
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--------FTEDI---QTRQ 258
Query: 716 YVAPEYGMGSEASMTGDI----------FTGRRPIDAVFNEGHSLHE 752
Y + E +GS + DI TG + E ++ E
Sbjct: 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDE 305
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 49/222 (22%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 512 SPMEKQFPMVSYAELSKATGEFSSSN-----MIGQGSFGYVYKGTLGEDEMIVAVKVINL 566
S +E++ ++ E KA+ + +IG+GS+ V L + + I A++V+
Sbjct: 28 SGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVK- 86
Query: 567 KYKGASRSFVAECEALRNIRHRNLIK------IITICSSTDFKGTDFKAFVFEYMENGSL 620
K + + +++ + ++ + S F+ FV EY+ G L
Sbjct: 87 KELVNDDEDIDWVQTEKHV----FEQASNHPFLVGLHSC--FQTESRLFFVIEYVNGGDL 140
Query: 621 KDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV 680
+ + KL + +++ A+ YLH +++ DLK NVLLD +
Sbjct: 141 MFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSE-- 189
Query: 681 AHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPE 720
H+ D+G+ K L T + GT Y+APE
Sbjct: 190 GHIKLTDYGMCK----EGLRPGDTTST----FCGTPNYIAPE 223
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 8e-09
Identities = 52/190 (27%), Positives = 80/190 (42%), Gaps = 32/190 (16%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-----RHRNLIK 592
++G+GSFG V + E + AVKV+ K V + I H L +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLK-KDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ C F+ D FV E++ G L + +S + + A ++ SA+
Sbjct: 89 LF--CC---FQTPDRLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISAL 137
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGL 710
+LH +++ DLK NVLLDH+ H DFG+ K + V T +
Sbjct: 138 MFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCK----EGICNGVTTAT----F 184
Query: 711 KGTVGYVAPE 720
GT Y+APE
Sbjct: 185 CGTPDYIAPE 194
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 39/183 (21%), Positives = 73/183 (39%), Gaps = 38/183 (20%)
Query: 538 MIGQGSFGYVYKGT-LGEDEMIVAVKVI--NLKYKGASRSFVAECEALRNIRHR---NLI 591
+G+G+FG V + VAVK++ +Y A+RS E + L ++ +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS---EIQVLEHLNTTDPNSTF 77
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ + + + G VFE + S D++ ++ +L I++ +A + +
Sbjct: 78 RCVQMLEWFEHHG--HICIVFELLGL-STYDFIKENGFLP--FRLDHIRK--MAYQICKS 130
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH-------------------VCDFGLAKFL 692
+ +LH + + H DLKP N+L V DFG A +
Sbjct: 131 VNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD 187
Query: 693 SDH 695
+H
Sbjct: 188 DEH 190
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 34/191 (17%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK----- 592
+IG+GS+ V L + + I A+KV+ K + + +++ +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHV----FEQASNHP 70
Query: 593 -IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
++ + S F+ FV EY+ G L + + KL + +++ A
Sbjct: 71 FLVGLHSC--FQTESRLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLA 122
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIG 709
+ YLH +++ DLK NVLLD + H+ D+G+ K L T +
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSE--GHIKLTDYGMCK----EGLRPGDTTST---- 169
Query: 710 LKGTVGYVAPE 720
GT Y+APE
Sbjct: 170 FCGTPNYIAPE 180
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 41/187 (21%), Positives = 72/187 (38%), Gaps = 42/187 (22%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVI--NLKYKGASRSFVAECEALRNIRHR--NLIKI 593
+G G+FG V +++ AVKV+ KY +++ E + L+ I++ N I
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI---EADILKKIQNDDINNNNI 98
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
+ + +FE + SL + + +++ + I+ I++ A+
Sbjct: 99 VKYHGKFMYYD--HMCLIFEPLGP-SLYEIITRNNYNG--FHIEDIKL--YCIEILKALN 151
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAH-------------------------VCDFGL 688
YL + H DLKP N+LLD + DFG
Sbjct: 152 YLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 689 AKFLSDH 695
A F SD+
Sbjct: 209 ATFKSDY 215
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 21/182 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG GSFG +Y GT + VA+K+ N+K K + E + R ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 599 STDFKGTDFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
D+ V + + G SL+D L + KLSL + +A + + +E++H
Sbjct: 73 VEG----DYNVLVMDLL--GPSLED-LFNFCSR----KLSLKTVLMLADQMINRVEFVHS 121
Query: 658 HCQPPMVHGDLKPSNVLLDHDMVAH---VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
+H D+KP N L+ A+ + DFGLAK D + + L GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIP-YRENKNLTGTA 177
Query: 715 GY 716
Y
Sbjct: 178 RY 179
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 27/116 (23%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 69 NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLS 128
S ++ + L +R + + L+ L+ SI +L + L+ L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIA-NLPKLNKLKKLELS 72
Query: 129 VNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADN 184
N+ G + + NL LNL N + DL + L +LK+L L +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKI-----KDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 25/110 (22%), Positives = 42/110 (38%), Gaps = 6/110 (5%)
Query: 342 HLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401
+K LV+ + SN G + G LE+L + + L L +K+L +S
Sbjct: 18 DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTSIANLPK--LNKLKKLELSD 73
Query: 402 NNLSGQIPEFLKNLSVLEFLSLSYNHFE--GEVPTKGVFSNKTKISLQGN 449
N +SG + + L L+LS N + + N + L
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 9e-05
Identities = 24/136 (17%), Positives = 47/136 (34%), Gaps = 29/136 (21%)
Query: 245 ELKNLQKLCL-FRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTAS 303
++++L L +G++ +L L + L +S+ N L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLK-- 67
Query: 304 QNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGV-IPG 362
L+LS+N ++G L + NL L++S N+ +
Sbjct: 68 --------------------KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIE 107
Query: 363 TLSTCVCLEYLDISSN 378
L L+ LD+ +
Sbjct: 108 PLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 33/128 (25%), Positives = 42/128 (32%), Gaps = 27/128 (21%)
Query: 237 GTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQN 296
G + E + L+ L L I + L L KL LELS N + G + C N
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 297 LMSFTASQNKLTGALPHQLLSITTLSL-----YLDLSNNLLNGSLPLQ---------VGH 342
L S NK+ L +I L LDL N +
Sbjct: 90 LTHLNLSGNKIK-----DLSTIEPLKKLENLKSLDLFNC------EVTNLNDYRENVFKL 138
Query: 343 LKNLVILD 350
L L LD
Sbjct: 139 LPQLTYLD 146
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 4e-08
Identities = 37/150 (24%), Positives = 53/150 (35%), Gaps = 37/150 (24%)
Query: 38 KIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPN 97
K+ TL L+ L ++ N I ISSL + N
Sbjct: 39 KMDATLSTLKACKHLALSTNN--------IEKISSLS-------------------GMEN 71
Query: 98 LKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLEQNNL 156
L+ L++G N I + A LE L +S NQ S+ L NL L + N +
Sbjct: 72 LRILSLGRNL-IKKIENLDAVADTLEELWISYNQIA---SLSGIEKLVNLRVLYMSNNKI 127
Query: 157 GTGTATDLDFVTFLTNCSSLKALSLADNQF 186
T+ + L L+ L LA N
Sbjct: 128 -----TNWGEIDKLAALDKLEDLLLAGNPL 152
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 35/182 (19%), Positives = 67/182 (36%), Gaps = 36/182 (19%)
Query: 249 LQKLCLFRNFLQGRIPSGLGNLTKLANLEL--SSNSLQGNIPSSLGNCQNLMSFTASQNK 306
+ K ++ ++ T+ +EL ++ + ++L + S N
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNN 59
Query: 307 LTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLST 366
+ I++LS ++NL IL + N I +
Sbjct: 60 IE--------KISSLS-------------------GMENLRILSLGRNLIK-KIENLDAV 91
Query: 367 CVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLS--GQIPEFLKNLSVLEFLSLS 424
LE L IS N + + L +++ L +S+N ++ G+I + L L LE L L+
Sbjct: 92 ADTLEELWISYNQIASLSG--IEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLA 148
Query: 425 YN 426
N
Sbjct: 149 GN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 7e-05
Identities = 18/70 (25%), Positives = 35/70 (50%), Gaps = 3/70 (4%)
Query: 360 IPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLE 419
+ TLST ++L +S+N+ + LS +++++ L++ N + +I LE
Sbjct: 40 MDATLSTLKACKHLALSTNNIEKISSLS--GMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 420 FLSLSYNHFE 429
L +SYN
Sbjct: 97 ELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 34/148 (22%), Positives = 54/148 (36%), Gaps = 39/148 (26%)
Query: 112 IPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLEQNNLGTGTATDLDFVTFL 170
+ +LS + L LS N + I S ++NL L+L +N + ++
Sbjct: 40 MDATLSTLKACKHLALSTNNIE---KISSLSGMENLRILSLGRNLI-----KKIE--NLD 89
Query: 171 TNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGA 230
+L+ L ++ NQ IA+LS GI LVNL
Sbjct: 90 AVADTLEELWISYNQ--------IASLS-------------------GIEKLVNLRVLYM 122
Query: 231 EENQLHG-TIPDAIGELKNLQKLCLFRN 257
N++ D + L L+ L L N
Sbjct: 123 SNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 38/192 (19%), Positives = 79/192 (41%), Gaps = 23/192 (11%)
Query: 238 TIPDAIGELKNLQKLCLFRNFLQGRIPSGL-GNLTKLANLELSSNSLQGNIPS----SLG 292
IP+ I + +L L N +G+ L +L + S+N + +I
Sbjct: 25 KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81
Query: 293 NCQNLMSFTASQNKLTGALPHQLL-SITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILD 350
++ + N+L + H++ + +L L L +N + + L ++ +L
Sbjct: 82 GVNEIL---LTSNRLE-NVQHKMFKGLESLK-TLMLRSNRIT-CVGNDSFIGLSSVRLLS 135
Query: 351 ISSNQFSGVIPGTLSTCVCLEYLDISSNSFH---GVIPLSLSFLKSIKELNVSSNNLSGQ 407
+ NQ + V PG T L L++ +N F+ + L + +++ + + N Q
Sbjct: 136 LYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCYLAWLG----EWLRKKRIVTGNPRCQ 191
Query: 408 IPEFLKNLSVLE 419
P FLK + + +
Sbjct: 192 KPYFLKEIPIQD 203
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 31/176 (17%), Positives = 59/176 (33%), Gaps = 42/176 (23%)
Query: 111 SIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLEQNNLGTGTATDLDFVTF 169
IP + L L+ N+F + F L L +N N + TD++ F
Sbjct: 25 KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-----TDIEEGAF 77
Query: 170 --LTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLI 226
+ + + L N+ L + + + + L +L
Sbjct: 78 EGASG---VNEILLTSNR-----------LEN---------------VQHKMFKGLESLK 108
Query: 227 GFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSN 281
N++ D+ L +++ L L+ N + + G L L+ L L +N
Sbjct: 109 TLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 30/117 (25%), Positives = 48/117 (41%), Gaps = 8/117 (6%)
Query: 71 SSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPY-SLSNASNLELLDLSV 129
++L N F+ I LP L+ + NN I + AS + + L+
Sbjct: 32 QYTAELRLNNNEFTVLEATGIFKKLPQLRKINF-SNNKITDIEEGAFEGASGVNEILLTS 90
Query: 130 NQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186
N+ + F L++L L L N + T + +F SS++ LSL DNQ
Sbjct: 91 NRLENVQHKMFKGLESLKTLMLRSNRI-----TCVGNDSF-IGLSSVRLLSLYDNQI 141
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 24/101 (23%), Positives = 36/101 (35%), Gaps = 2/101 (1%)
Query: 329 NNLLNGSLPLQVGHLKNLVILDISSNQFSGVIP-GTLSTCVCLEYLDISSNSFHGVIPLS 387
+ +NL L I + Q + L L L I + V P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 388 LSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHF 428
F + LN+S N L + ++ LS L+ L LS N
Sbjct: 76 FHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 21/97 (21%), Positives = 29/97 (29%), Gaps = 14/97 (14%)
Query: 94 NLPNLKALAIGGNNFFGSIP-YSLSNASNLELLDLSVNQFKGNVSID---FSSLKNLLWL 149
NL L I + L L L + + + + F L L
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR---FVAPDAFHFTPRLSRL 85
Query: 150 NLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186
NL N L L + T SL+ L L+ N
Sbjct: 86 NLSFNAL-----ESLSWKTVQG--LSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 21/102 (20%), Positives = 36/102 (35%), Gaps = 3/102 (2%)
Query: 233 NQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSNSLQGNIPSSL 291
+ +NL +L + + L L +L NL + + L+ P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 292 GNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLN 333
L S N L +L + + +L L LS N L+
Sbjct: 77 HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQ-ELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 4e-05
Identities = 23/105 (21%), Positives = 34/105 (32%), Gaps = 5/105 (4%)
Query: 253 CLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPS-SLGNCQNLMSFTASQNKLTGAL 311
C L L L L + + ++ L L + T ++ L
Sbjct: 15 CTRDGAL--DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72
Query: 312 PHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQF 356
P LS L+LS N L SL + +L L +S N
Sbjct: 73 PDAFHFTPRLS-RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 18/94 (19%), Positives = 32/94 (34%), Gaps = 3/94 (3%)
Query: 64 PRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSI-PYSLSNASNL 122
+ +L + + + +L + L L+ L I + + P + L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-LRFVAPDAFHFTPRL 82
Query: 123 ELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156
L+LS N + L +L L L N L
Sbjct: 83 SRLNLSFNALESLSWKTVQGL-SLQELVLSGNPL 115
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 5e-08
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 7/127 (5%)
Query: 325 LDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI 384
+ L+ L+ + + LD+ + VI +T + +D S N +
Sbjct: 2 VKLTAELIEQAAQYT--NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD 58
Query: 385 PLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE--GEVPTKGVFSNKT 442
L L+ +K L V++N + + L L L L+ N G++ + T
Sbjct: 59 GFPL--LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLT 116
Query: 443 KISLQGN 449
+ + N
Sbjct: 117 YLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 18/95 (18%), Positives = 34/95 (35%), Gaps = 7/95 (7%)
Query: 90 DIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWL 149
++ L A+ +N + L+ L ++ N+ +L +L L
Sbjct: 36 NLGATLDQFDAIDFS-DNEIRKLDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 93
Query: 150 NLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADN 184
L N+L +L + L + SL L + N
Sbjct: 94 ILTNNSL-----VELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 24/155 (15%), Positives = 49/155 (31%), Gaps = 37/155 (23%)
Query: 276 LELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT--GALPHQLLSITTLSLYLDLSNNLLN 333
++L++ ++ N K+ L L + D S+N +
Sbjct: 2 VKLTAELIE-QAAQ-YTNAVRDRELDLRGYKIPVIENLGATLDQFDAI----DFSDNEIR 55
Query: 334 --GSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFL 391
P L+ L L +++N+ + G L L +++N L
Sbjct: 56 KLDGFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN-----------SL 100
Query: 392 KSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYN 426
+ +L + L +L L +L + N
Sbjct: 101 VELGDL------------DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 17/93 (18%), Positives = 29/93 (31%), Gaps = 11/93 (11%)
Query: 94 NLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLE 152
N + L + G I + + +D S N+ + +D F L+ L L +
Sbjct: 17 NAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKTLLVN 72
Query: 153 QNNLGTGTATDLDFVTFLTNCSSLKALSLADNQ 185
N + L L L +N
Sbjct: 73 NNRICRIGEG------LDQALPDLTELILTNNS 99
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 57/429 (13%), Positives = 129/429 (30%), Gaps = 50/429 (11%)
Query: 65 RSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLEL 124
+S I ++ + P ++ P ++++ L +
Sbjct: 35 KSWYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSV-------------ELKGKPHFAD 81
Query: 125 LDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLAD- 183
+L + + G V ++ + + LE+ L TD + + K L L+
Sbjct: 82 FNLVPDGWGGYVYPWIEAMSSS-YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSC 140
Query: 184 NQFGGELPHSIA---------NLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQ 234
F + +IA +L + ++ P +LV+L
Sbjct: 141 EGFSTDGLAAIAATCRNLKELDLRESDVDD--VSGHWLSHFPDTYTSLVSLNISCLASEV 198
Query: 235 LHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN------IP 288
+ + NL+ L L R ++ + L +L L + + +
Sbjct: 199 SFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLS 258
Query: 289 SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSN-NLLNGSLPLQVGHLKNLV 347
+L C+ L + + + LP + L+ L+LS + + L + L
Sbjct: 259 VALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLT-TLNLSYATVQSYDLVKLLCQCPKLQ 317
Query: 348 ILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH-----------GVIPLSLSFLKSIKE 396
L + + STC L L + + G++ +S+ ++
Sbjct: 318 RLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMG-CPKLES 376
Query: 397 LNVSSNNLSGQ-IPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGG 455
+ ++ + +N + L + + I ++ C
Sbjct: 377 VLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPD---YLTLEPLDIGFGAIVEHCKD 433
Query: 456 IDELHLPSC 464
+ L L
Sbjct: 434 LRRLSLSGL 442
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 8e-08
Identities = 26/116 (22%), Positives = 47/116 (40%), Gaps = 7/116 (6%)
Query: 69 NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLS 128
+++ + L + + + NL+ L++ S+ +L L+ L+LS
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISVS-NLPKLPKLKKLELS 79
Query: 129 VNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADN 184
N+ G + + L NL LNL N L D+ + L LK+L L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 26/109 (23%), Positives = 44/109 (40%), Gaps = 6/109 (5%)
Query: 343 LKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402
++ LV+ + SN G I G + V LE+L + + V L L +K+L +S N
Sbjct: 26 VRELVLDNCKSND--GKIEGLTAEFVNLEFLSLINVGLISVSNLPK--LPKLKKLELSEN 81
Query: 403 NLSGQIPEFLKNLSVLEFLSLSYNHFE--GEVPTKGVFSNKTKISLQGN 449
+ G + + L L L+LS N + + + L
Sbjct: 82 RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 27/105 (25%), Positives = 37/105 (35%), Gaps = 29/105 (27%)
Query: 324 YLDLSNNLLN--GSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH 381
+L L N L +LP L L L++S N+ G + L +L++S N
Sbjct: 53 FLSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN--- 105
Query: 382 GVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYN 426
LK I L E LK L L+ L L
Sbjct: 106 --------KLKDISTL------------EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 35/125 (28%), Positives = 41/125 (32%), Gaps = 21/125 (16%)
Query: 237 GTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQN 296
G I E NL+ L L L + S L L KL LELS N + G + N
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 297 LMSFTASQNKLTGALPHQLLSITTLSL--YLDLSNNLLNGSLPLQ---------VGHLKN 345
L S NKL L + L LDL N + L
Sbjct: 97 LTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNC------EVTNLNDYRESVFKLLPQ 148
Query: 346 LVILD 350
L LD
Sbjct: 149 LTYLD 153
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.8 bits (128), Expect = 1e-07
Identities = 33/176 (18%), Positives = 63/176 (35%), Gaps = 14/176 (7%)
Query: 253 CLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNL--MSFTASQNKLTGA 310
Q + L + L NL++ + N ++L +S + +
Sbjct: 154 QEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDI 213
Query: 311 LPHQLLSITTLSLYLDLSNNLLNGSLP-----LQVGHLKNLVILDISSNQFSGVIPGTLS 365
L L ++ L LY+ + + +G + NL L I + V+
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273
Query: 366 TCVC---LEYLDISSNSFH--GVIPL--SLSFLKSIKELNVSSNNLSGQIPEFLKN 414
LE +DIS+ G L + +K +K +N+ N LS ++ + L+
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 54/415 (13%), Positives = 124/415 (29%), Gaps = 65/415 (15%)
Query: 47 RNLVSLNVAENKFSGMFPRSICNIS----SLELIQLALNRFSGNLPFD----IVVNLPNL 98
R + +L + E+ FS + + ++ SLE++ + F+ + I N +L
Sbjct: 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFA-KISPKDLETIARNCRSL 222
Query: 99 KALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGT 158
++ +G + A+NLE + + +L L LG
Sbjct: 223 VSVKVGDFEILELVG-FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR----LGL 277
Query: 159 GTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIA---------NLSSTVINFGIGRN 209
+ + ++ L L E ++ + + + G+
Sbjct: 278 SYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLE-- 335
Query: 210 QISGTIPPGIRNLVNL----IGFGAEENQLHGTIPD----AIGE-LKNLQKLCLFRNFLQ 260
+ + L L G + A+ + + L+ + ++ + +
Sbjct: 336 ----VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDIT 391
Query: 261 GR----IPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLL 316
I + L NL + L ++P G L+
Sbjct: 392 NESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCK--------------- 436
Query: 317 SITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGV-IPGTLSTCVCLEYLDI 375
+ + YL L + L + N+ + + S + C L+ L++
Sbjct: 437 KLRRFAFYLR-QGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEM 495
Query: 376 SSNSF--HGVIPLSLSFLKSIKELNVSSNNLSGQIPEFL---KNLSVLEFLSLSY 425
F + ++ L S++ L V S + + + +E +
Sbjct: 496 RGCCFSERAIAAA-VTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 64/395 (16%), Positives = 121/395 (30%), Gaps = 57/395 (14%)
Query: 65 RSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA----- 119
R I S + + P + PNL++L + G N
Sbjct: 42 RRWFKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVT 101
Query: 120 ----------SNLELLDLSVNQF--KGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFV 167
L+ + + + +L L L+ T +
Sbjct: 102 PWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLD----KCSGFTTDGLL 157
Query: 168 TFLTNCSSLKALSLADNQFGGELPHSIANLSS-----TVINFGI-GRNQIS----GTIPP 217
+ +T+C +K L + ++ F + + L+ V+NF + +IS TI
Sbjct: 158 SIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR 217
Query: 218 GIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLE 277
R+LV++ E +L G A NL++ C +P NL L
Sbjct: 218 NCRSLVSVKVGDFEILELVGFFKAA----ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC 273
Query: 278 LSSNSLQGN--IPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGS 335
S G +P + L L+ L+ N + +
Sbjct: 274 RLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRG 333
Query: 336 LPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSF--HGVIPLSLSFLKS 393
L + + K L L I + ++ G+I L+ +
Sbjct: 334 LEVLAQYCKQLKRLRIER-------------GADEQGMEDEEGLVSQRGLIALAQG-CQE 379
Query: 394 IKELNVSSNNLSGQ----IPEFLKNLSVLEFLSLS 424
++ + V ++++ + I +LKNL + L
Sbjct: 380 LEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLD 414
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 57/234 (24%), Positives = 90/234 (38%), Gaps = 44/234 (18%)
Query: 51 SLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFG 110
N+ + + ++ ++S++ I + + N+ L G N
Sbjct: 23 KANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLPNVRYLAL----GGNKLH 76
Query: 111 SIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFL 170
I +L +NL L L+ NQ + + F L NL L L +N L + D L
Sbjct: 77 DIS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFD---KL 132
Query: 171 TNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFG 229
TN L L+LA NQ L S +P G+ L NL
Sbjct: 133 TN---LTYLNLAHNQ-----------LQS---------------LPKGVFDKLTNLTELD 163
Query: 230 AEENQLHGTIPDAI-GELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSN 281
NQL ++P+ + +L L+ L L++N L+ +P G LT L + L N
Sbjct: 164 LSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 6e-05
Identities = 56/197 (28%), Positives = 84/197 (42%), Gaps = 36/197 (18%)
Query: 269 NLTKLANLELSSNSLQGNIPS--SLGNCQNLMSFTASQNKLTGALP--HQLLSITTLSLY 324
L + + +++ ++ ++ L N + L NKL + +L ++T Y
Sbjct: 39 ELNSIDQIIANNSDIK-SVQGIQYLPNVRYL---ALGGNKLH-DISALKELTNLT----Y 89
Query: 325 LDLSNNLLNGSLPLQVGH-LKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSF--- 380
L L+ N L SLP V L NL L + NQ + G L YL+++ N
Sbjct: 90 LILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSL 148
Query: 381 -HGVIPLSLSF--LKSIKELNVSSNNLSGQIPE--FLKNLSVLEFLSLSYNHFEGEVPTK 435
GV F L ++ EL++S N L +PE F K L+ L+ L L N + VP
Sbjct: 149 PKGV------FDKLTNLTELDLSYNQLQ-SLPEGVFDK-LTQLKDLRLYQNQLKS-VP-D 198
Query: 436 GVFSNKTK---ISLQGN 449
GVF T I L N
Sbjct: 199 GVFDRLTSLQYIWLHDN 215
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 43/162 (26%), Positives = 61/162 (37%), Gaps = 37/162 (22%)
Query: 123 ELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLA 182
LDL N K + F L +L L L N L + + LT+ L L+L+
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFN---KLTS---LTYLNLS 84
Query: 183 DNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPD 241
NQ L S +P G+ L L NQL ++PD
Sbjct: 85 TNQ-----------LQS---------------LPNGVFDKLTQLKELALNTNQLQ-SLPD 117
Query: 242 -AIGELKNLQKLCLFRNFLQGRIPSG-LGNLTKLANLELSSN 281
+L L+ L L++N L+ +P G LT L + L N
Sbjct: 118 GVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 33/140 (23%), Positives = 62/140 (44%), Gaps = 17/140 (12%)
Query: 195 ANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAI-GELKNLQKLC 253
+ + + N + L +L N+L ++P+ + +L +L L
Sbjct: 24 TGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLN 82
Query: 254 LFRNFLQGRIPSGL-GNLTKLANLELSSNSLQGNIPS----SLGNCQNLMSFTASQNKLT 308
L N LQ +P+G+ LT+L L L++N LQ ++P L ++L QN+L
Sbjct: 83 LSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDL---RLYQNQLK 137
Query: 309 GALPH----QLLSITTLSLY 324
++P +L S+ + L+
Sbjct: 138 -SVPDGVFDRLTSLQYIWLH 156
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 39/134 (29%), Positives = 53/134 (39%), Gaps = 11/134 (8%)
Query: 250 QKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ---GNIPSSLGNCQNLMSFTASQNK 306
L L N L+ LT L L L N LQ + + L + L S N+
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYL---NLSTNQ 87
Query: 307 LTGALPHQLL-SITTLSLYLDLSNNLLNGSLPLQV-GHLKNLVILDISSNQFSGVIPGTL 364
L +LP+ + +T L L L+ N L SLP V L L L + NQ V G
Sbjct: 88 LQ-SLPNGVFDKLTQLK-ELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVF 144
Query: 365 STCVCLEYLDISSN 378
L+Y+ + N
Sbjct: 145 DRLTSLQYIWLHDN 158
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 36/142 (25%), Positives = 51/142 (35%), Gaps = 39/142 (27%)
Query: 120 SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTF--LTNCSSLK 177
S+ L+L N+ + F L L L+L QN + L F LT L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-----QSLPDGVFDKLTK---LT 79
Query: 178 ALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLH 236
L L +N+ L S +P G+ L L + NQL
Sbjct: 80 ILYLHENK-----------LQS---------------LPNGVFDKLTQLKELALDTNQLK 113
Query: 237 GTIPD-AIGELKNLQKLCLFRN 257
++PD L +LQK+ L N
Sbjct: 114 -SVPDGIFDRLTSLQKIWLHTN 134
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 31/109 (28%), Positives = 56/109 (51%), Gaps = 5/109 (4%)
Query: 319 TTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSN 378
LYLD N +P ++ + K+L ++D+S+N+ S + + S L L +S N
Sbjct: 32 DVTELYLD-GNQF--TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88
Query: 379 SFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFL-KNLSVLEFLSLSYN 426
+ P + LKS++ L++ N++S +PE +LS L L++ N
Sbjct: 89 RLRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 Length = 264 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 13/91 (14%), Positives = 32/91 (35%), Gaps = 7/91 (7%)
Query: 617 NGSLKDWLHQSDDQVEVCKLSLIQ--RVNIAIDVASAMEYLHHHCQPP----MVHGDLKP 670
+ K + ++ ++E + + + A L + HGD
Sbjct: 134 DHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACL 193
Query: 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701
N+++++ + D G ++D D A+
Sbjct: 194 PNIMVENGRFSGFIDCGRL-GVADRYQDIAL 223
|
| >4fev_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, PP1, protein kinase inhibitor; HET: KAN PP1; 1.89A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4ej7_A* 3r78_A* Length = 272 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 10/42 (23%), Positives = 17/42 (40%), Gaps = 1/42 (2%)
Query: 660 QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701
+ HGD N++ D + D G ++D D A+
Sbjct: 192 DSVVTHGDFSLDNLIFDEGKLIGCIDVGRV-GIADRYQDLAI 232
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* Length = 263 | Back alignment and structure |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 12/73 (16%), Positives = 25/73 (34%), Gaps = 3/73 (4%)
Query: 620 LKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH---CQPPMVHGDLKPSNVLLD 676
L + + ++ + + D ++L + HGDL SN+ +
Sbjct: 139 LAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK 198
Query: 677 HDMVAHVCDFGLA 689
V+ D G +
Sbjct: 199 DGKVSGFIDLGRS 211
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 27/162 (16%), Positives = 58/162 (35%), Gaps = 16/162 (9%)
Query: 279 SSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPL 338
+ ++ + + N L + A + KL L L N
Sbjct: 10 HNRAVLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFH-YEFQNQRFSA 68
Query: 339 QVGHLKNLVILDISSNQFSG----VIPGTLSTCVC-LEYLDISSNSF--HGVIPLSLSFL 391
+V L +L L+++ + + V+ L + L+ ++++S G+ L L
Sbjct: 69 EV--LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTL-LPVF 125
Query: 392 KSIKELNVSSNNLSGQ----IPEFLK-NLSVLEFLSLSYNHF 428
++L + N+L + + + L + + L LS N
Sbjct: 126 LRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPL 167
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 7e-04
Identities = 34/182 (18%), Positives = 61/182 (33%), Gaps = 24/182 (13%)
Query: 270 LTKLANLELSSNSLQGNIPSSLG-----NCQNLMSFTASQNKLTGALPHQLLSITTLSLY 324
L+ L L L+ + + + L + +L A LL + +
Sbjct: 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARK 130
Query: 325 LDLSNNLLNG------SLPLQVGHLKNLVILDISSNQF--SGV--IPGTLSTCVCLEYLD 374
L L N L L + L +S+N +GV + L+ + +L
Sbjct: 131 LGLQLNSLGPEACKDLRDLLLHDQ-CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLS 189
Query: 375 ISSNSF--HGVIPLS--LSFLKSIKELNVSSNNLSGQ----IPEFLKNLSVLEFLSLSYN 426
+ G+ L+ L + ++ELNV+ N + + LE L L +N
Sbjct: 190 LLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFN 249
Query: 427 HF 428
Sbjct: 250 EL 251
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 14/83 (16%), Positives = 29/83 (34%), Gaps = 11/83 (13%)
Query: 620 LKDWLHQSDDQVEVCKLS------LIQRVNIAIDVASAMEYLHHHCQPP-----MVHGDL 668
++ + +Q + KL+ Q + E L QP + H D+
Sbjct: 154 VRSFYNQIEFDNSDDKLTAAFKSFFNQNSAAIHRLVDTSEKLSKKIQPDLDKYVLCHSDI 213
Query: 669 KPSNVLLDHDMVAHVCDFGLAKF 691
NVL+ ++ ++ D+
Sbjct: 214 HAGNVLVGNEESIYIIDWDEPML 236
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 8e-04
Identities = 24/96 (25%), Positives = 40/96 (41%), Gaps = 20/96 (20%)
Query: 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVH 665
D K + Y+ KD + +D +++ + + LH + ++H
Sbjct: 412 DNKRIMMSYINGKLAKDVI---EDNLDIAY-----------KIGEIVGKLHKN---DVIH 454
Query: 666 GDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701
DL SN + D D+ + DFGL K S+ D AV
Sbjct: 455 NDLTTSNFIFDKDLY--IIDFGLGKI-SNLDEDKAV 487
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 833 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.91 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.86 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.84 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.83 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.83 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.79 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.78 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.77 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.76 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.75 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.74 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.74 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.73 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.64 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.62 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.56 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.53 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.53 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.42 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.42 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.42 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 99.41 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.37 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.35 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.13 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.03 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.95 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.67 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.59 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.49 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.48 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.46 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.46 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.42 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.38 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.09 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.94 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.87 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.77 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.76 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.48 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.44 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.43 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.43 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.36 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.3 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.25 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.23 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.11 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.07 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.03 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.02 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.78 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.55 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.13 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 94.75 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.46 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.01 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.62 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.48 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-59 Score=555.46 Aligned_cols=460 Identities=32% Similarity=0.531 Sum_probs=378.6
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|.+++.+|. ++++++|++|++++|++++.+|..|+.+++|++|+|++|++++..|.. .+++|++|+|++
T Consensus 202 L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~ 278 (768)
T 3rgz_A 202 LEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAE 278 (768)
T ss_dssp CCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCS
T ss_pred CCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcC
Confidence 57778888888776666 888888888888888887777878888888888888888877666654 677777777777
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccC-cCccCCCcCceEecccccCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVS-IDFSSLKNLLWLNLEQNNLGTG 159 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~ 159 (833)
|++++.+|..++..+++|++|+|++|.+++..|..|+++++|++|+|++|++++..+ ..|..+++|++|+|++|.++..
T Consensus 279 n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~ 358 (768)
T 3rgz_A 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358 (768)
T ss_dssp SEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEEC
T ss_pred CccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCcc
Confidence 777767777666556888888888888877778888888888888888888773333 4477788888888888777622
Q ss_pred CCCCcc-------------------cccccCC--CCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChh
Q 040925 160 TATDLD-------------------FVTFLTN--CSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPG 218 (833)
Q Consensus 160 ~~~~~~-------------------~~~~l~~--l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~ 218 (833)
.+..+. .+..+.. +++|++|+|++|++++.+|..+.++.. ++.|++++|++++..|..
T Consensus 359 ~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~~ 437 (768)
T 3rgz_A 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSE-LVSLHLSFNYLSGTIPSS 437 (768)
T ss_dssp CCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTT-CCEEECCSSEEESCCCGG
T ss_pred ccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCC-CCEEECcCCcccCcccHH
Confidence 111110 1112222 667888888888888888888877754 788888888888888888
Q ss_pred hhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccc
Q 040925 219 IRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLM 298 (833)
Q Consensus 219 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 298 (833)
|.++++|+.|++++|++.+.+|..|..+++|++|+|++|.+++.+|..|.++++|++|+|++|++++.+|.+|+.+++|+
T Consensus 438 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 517 (768)
T 3rgz_A 438 LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLA 517 (768)
T ss_dssp GGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCC
T ss_pred HhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCC
Confidence 88888899999999988888888888889999999999999888888888899999999999999888888899999999
Q ss_pred eeecCCceecccCCcccccccccceeeecCCCccCCCCCcc---------------------------------------
Q 040925 299 SFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQ--------------------------------------- 339 (833)
Q Consensus 299 ~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~--------------------------------------- 339 (833)
.|++++|++++.+|..+..+..+ ++|++++|.+++.+|..
T Consensus 518 ~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 596 (768)
T 3rgz_A 518 ILKLSNNSFSGNIPAELGDCRSL-IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596 (768)
T ss_dssp EEECCSSCCEEECCGGGGGCTTC-CEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEEC
T ss_pred EEECCCCcccCcCCHHHcCCCCC-CEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccccccccc
Confidence 99999999988888888888887 78999999887766653
Q ss_pred -------------------------------cccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccc
Q 040925 340 -------------------------------VGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSL 388 (833)
Q Consensus 340 -------------------------------~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 388 (833)
|+.+++|+.|||++|++++.+|..|+.+++|+.|+|++|++++.+|..+
T Consensus 597 ~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l 676 (768)
T 3rgz_A 597 QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEV 676 (768)
T ss_dssp TTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred ccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHH
Confidence 3446789999999999999999999999999999999999999999999
Q ss_pred cCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCCCcccCCCCCCCCCC
Q 040925 389 SFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPSCPSKG 468 (833)
Q Consensus 389 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~~~~~~~~~~~~~~ 468 (833)
+.+++|+.|||++|+++|.+|..+..++.|+.||+++|+++|.+|..+.+..+....+.||+.+||.+. +.|+...
T Consensus 677 ~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l----~~C~~~~ 752 (768)
T 3rgz_A 677 GDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPL----PRCDPSN 752 (768)
T ss_dssp GGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTS----CCCCSCC
T ss_pred hCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCC----cCCCCCc
Confidence 999999999999999999999999999999999999999999999999999999999999999999863 3675443
Q ss_pred C
Q 040925 469 S 469 (833)
Q Consensus 469 ~ 469 (833)
.
T Consensus 753 ~ 753 (768)
T 3rgz_A 753 A 753 (768)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-55 Score=522.26 Aligned_cols=443 Identities=36% Similarity=0.569 Sum_probs=340.5
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|++++|.+++..| +..+++|++|++++|++.+.+|. |+.+++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 180 L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~ 256 (768)
T 3rgz_A 180 LKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256 (768)
T ss_dssp CCEEECCSSEEESCCB--CTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCS
T ss_pred CCEEECCCCcccccCC--cccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCC
Confidence 3445555555543322 36777888888888888776776 88888899999999988888888888999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCC-CCCcEEEcccCccccccCcCccCCCcCceEecccccCC-C
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA-SNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLG-T 158 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~ 158 (833)
|++++.+|.. .+++|++|+|++|.+++.+|..+..+ ++|++|+|++|++++..+..|..+++|++|+|++|+++ .
T Consensus 257 n~l~~~~~~~---~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ 333 (768)
T 3rgz_A 257 NQFVGPIPPL---PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333 (768)
T ss_dssp SCCEESCCCC---CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEE
T ss_pred CcccCccCcc---ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCc
Confidence 9888666653 78899999999999988888888775 99999999999999999999999999999999999986 4
Q ss_pred CCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhccc--------------------------ccEEEccCcccc
Q 040925 159 GTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSST--------------------------VINFGIGRNQIS 212 (833)
Q Consensus 159 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~--------------------------l~~L~l~~n~i~ 212 (833)
++. ..+.++++|++|+|++|++++.+|..+.++... ++.|++++|+++
T Consensus 334 ip~------~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 407 (768)
T 3rgz_A 334 LPM------DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407 (768)
T ss_dssp CCH------HHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEE
T ss_pred CCH------HHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccc
Confidence 332 237788999999999999998899888877533 445555555555
Q ss_pred ccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCC
Q 040925 213 GTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLG 292 (833)
Q Consensus 213 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 292 (833)
+.+|..|.++++|+.|++++|++++.+|..|..+++|++|+|++|.+++.+|..|..+++|++|+|++|++++.+|..|.
T Consensus 408 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~ 487 (768)
T 3rgz_A 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS 487 (768)
T ss_dssp EECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGG
T ss_pred cccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHh
Confidence 56666777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCcc---------
Q 040925 293 NCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGT--------- 363 (833)
Q Consensus 293 ~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~--------- 363 (833)
++++|+.|++++|++++.+|..+..+..+ ++|++++|.+++.+|..++.+++|+.|++++|++++.+|..
T Consensus 488 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~ 566 (768)
T 3rgz_A 488 NCTNLNWISLSNNRLTGEIPKWIGRLENL-AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIA 566 (768)
T ss_dssp GCTTCCEEECCSSCCCSCCCGGGGGCTTC-CEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBC
T ss_pred cCCCCCEEEccCCccCCcCChHHhcCCCC-CEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhh
Confidence 77777777777777777777777777766 67777777777777777777777777777777776555543
Q ss_pred -------------------------------------------------------------ccCCCCCcEEeecCCcccc
Q 040925 364 -------------------------------------------------------------LSTCVCLEYLDISSNSFHG 382 (833)
Q Consensus 364 -------------------------------------------------------------~~~l~~L~~L~Ls~N~l~~ 382 (833)
|..+++|+.|+|++|++++
T Consensus 567 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g 646 (768)
T 3rgz_A 567 ANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSG 646 (768)
T ss_dssp CSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBS
T ss_pred hhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccc
Confidence 2334667778888888887
Q ss_pred ccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCC-CccCCCccccccCCcCCCCCcc
Q 040925 383 VIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK-GVFSNKTKISLQGNMKLCGGID 457 (833)
Q Consensus 383 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~l~l~~N~~~c~~~~ 457 (833)
.+|..++.++.|+.|+|++|++++.+|..++++++|+.|||++|++++.+|.. +.+..++.+++++|+ +.|.+|
T Consensus 647 ~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~-l~g~iP 721 (768)
T 3rgz_A 647 YIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNN-LSGPIP 721 (768)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSE-EEEECC
T ss_pred cCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCc-ccccCC
Confidence 88888888888888888888888888888888888888888888888777754 566777788888775 344444
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=505.87 Aligned_cols=451 Identities=22% Similarity=0.227 Sum_probs=397.2
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
+++|+|++|.++++.|.+|+++++|++|+|++|++++..|.+|+.+++|++|+|++|++++..|.+|+++++|++|+|++
T Consensus 35 l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 114 (606)
T 3t6q_A 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ 114 (606)
T ss_dssp CCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTT
T ss_pred CcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccc
Confidence 58899999999988899999999999999999999998999999999999999999999988899999999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCc--eEecccccCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLL--WLNLEQNNLGT 158 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~--~L~L~~N~l~~ 158 (833)
|+++ .+++..|.++++|++|+|++|.+++..+..+..+++|++|+|++|+++++.+..|..+++|+ .|++++|.++.
T Consensus 115 n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~ 193 (606)
T 3t6q_A 115 TGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193 (606)
T ss_dssp SCCS-CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCE
T ss_pred cCcc-cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCc
Confidence 9998 67666788999999999999999875545566699999999999999988888899999988 88888888876
Q ss_pred CCCCCccc---------------------------------------------------------------------ccc
Q 040925 159 GTATDLDF---------------------------------------------------------------------VTF 169 (833)
Q Consensus 159 ~~~~~~~~---------------------------------------------------------------------~~~ 169 (833)
+++..+.. +..
T Consensus 194 ~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~ 273 (606)
T 3t6q_A 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273 (606)
T ss_dssp ECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTT
T ss_pred cChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHH
Confidence 65543221 122
Q ss_pred cCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCC-ccccCCCC
Q 040925 170 LTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP-DAIGELKN 248 (833)
Q Consensus 170 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~ 248 (833)
|.++++|++|++++|+++ .+|..+..+. .++.|++++|.+++..|..+.++++|+.|++++|.+.+.+| ..|..+++
T Consensus 274 ~~~l~~L~~L~l~~n~l~-~lp~~l~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 351 (606)
T 3t6q_A 274 FHCFSGLQELDLTATHLS-ELPSGLVGLS-TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351 (606)
T ss_dssp TTTCTTCSEEECTTSCCS-CCCSSCCSCT-TCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred hccccCCCEEeccCCccC-CCChhhcccc-cCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence 677889999999999998 7888877765 48899999999998888999999999999999999885554 55899999
Q ss_pred CCEEEcccccCcccC--CccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcc-cccccccceee
Q 040925 249 LQKLCLFRNFLQGRI--PSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQ-LLSITTLSLYL 325 (833)
Q Consensus 249 L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~~ll~~L 325 (833)
|++|++++|.+++.. +..+.++++|++|++++|++.+..|..|..+++|+.|++++|++++..|.. +..+..+ +.|
T Consensus 352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L 430 (606)
T 3t6q_A 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL-KVL 430 (606)
T ss_dssp CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTC-CEE
T ss_pred CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccC-CEE
Confidence 999999999998765 778999999999999999999888999999999999999999998766655 5566666 889
Q ss_pred ecCCCccCCCCCcccccCCCcCEEeccCCcCCC---CCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCc
Q 040925 326 DLSNNLLNGSLPLQVGHLKNLVILDISSNQFSG---VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402 (833)
Q Consensus 326 ~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 402 (833)
++++|.+++..|..|..+++|++|++++|++++ ..+..+..+++|++|+|++|++++..|..|..+++|+.|+|++|
T Consensus 431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 510 (606)
T 3t6q_A 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510 (606)
T ss_dssp ECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCC
Confidence 999999998889999999999999999999986 23467999999999999999999999999999999999999999
Q ss_pred ccCCCchhhhcCCCCCceEECccCcCccccCCC-CccCCCccccccCCcCCCCCc
Q 040925 403 NLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK-GVFSNKTKISLQGNMKLCGGI 456 (833)
Q Consensus 403 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~l~l~~N~~~c~~~ 456 (833)
++++..|..+.+++.| .|++++|++++.+|.. +.+..++.+++++|||.|...
T Consensus 511 ~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 511 RLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 9999999999999999 9999999999887764 567888999999999998553
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=490.67 Aligned_cols=446 Identities=21% Similarity=0.183 Sum_probs=376.9
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|++++..+.+|.++++|++|++++|++++..|.+|+.+++|++|+|++|++++..|.+|+++++|++|+|++
T Consensus 34 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~ 113 (606)
T 3vq2_A 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVE 113 (606)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTT
T ss_pred cCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccC
Confidence 68999999999988888999999999999999999988899999999999999999999988899999999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCccee-eCCccccCCCCCcEEEcccCccccccCcCccCCCcCc----eEeccccc
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFG-SIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLL----WLNLEQNN 155 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~----~L~L~~N~ 155 (833)
|+++ .+++..|.++++|++|+|++|.+++ .+|..|+++++|++|+|++|+++++.+..|..+++|+ +|++++|.
T Consensus 114 n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~ 192 (606)
T 3vq2_A 114 TKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNP 192 (606)
T ss_dssp SCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCC
T ss_pred Cccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCC
Confidence 9998 7776778999999999999999986 4699999999999999999999999888888877765 68888888
Q ss_pred CCCCCCCCccc---------------------------------------------------------------------
Q 040925 156 LGTGTATDLDF--------------------------------------------------------------------- 166 (833)
Q Consensus 156 l~~~~~~~~~~--------------------------------------------------------------------- 166 (833)
++.++...+..
T Consensus 193 l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~ 272 (606)
T 3vq2_A 193 IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272 (606)
T ss_dssp CCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCT
T ss_pred cceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccc
Confidence 87655432210
Q ss_pred -----ccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCc
Q 040925 167 -----VTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPD 241 (833)
Q Consensus 167 -----~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 241 (833)
...+..+++|+.|++++|.+. .+| .+..+ ..++.|++++|++ +.+| .+ .+++|+.|++++|+..+..
T Consensus 273 ~~~~~~~~~~~l~~L~~L~l~~~~~~-~l~-~l~~~-~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~-- 344 (606)
T 3vq2_A 273 DFSDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKH-FKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF-- 344 (606)
T ss_dssp TCCGGGGSCGGGTTCSEEEEESCCCC-CCC-CCCTT-CCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--
T ss_pred cccccccccccCCCCCEEEecCccch-hhh-hcccc-ccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--
Confidence 000233455555555555554 344 33333 2467777777777 4555 44 7777888888887554333
Q ss_pred cccCCCCCCEEEcccccCccc--CCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCC-cccccc
Q 040925 242 AIGELKNLQKLCLFRNFLQGR--IPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALP-HQLLSI 318 (833)
Q Consensus 242 ~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~ 318 (833)
.+..+++|++|+|++|.+++. .|..+..+++|++|+|++|.+.+ +|..|..+++|+.|++++|++.+..| ..+..+
T Consensus 345 ~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l 423 (606)
T 3vq2_A 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423 (606)
T ss_dssp CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTC
T ss_pred hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhcc
Confidence 677889999999999999866 37888999999999999999984 66889999999999999999997766 566677
Q ss_pred cccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCC-CCCccccCCCCCcEEeecCCccccccCccccCCCCCCeE
Q 040925 319 TTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSG-VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKEL 397 (833)
Q Consensus 319 ~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 397 (833)
..+ ++|++++|.+++..|..|.++++|++|++++|.+++ ..|..|..+++|++|+|++|++++..|..|..+++|+.|
T Consensus 424 ~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 502 (606)
T 3vq2_A 424 EKL-LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502 (606)
T ss_dssp TTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccC-CEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEE
Confidence 777 899999999998899999999999999999999987 478999999999999999999999999999999999999
Q ss_pred EccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccC-CCccccccCCcCCCCCcc
Q 040925 398 NVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFS-NKTKISLQGNMKLCGGID 457 (833)
Q Consensus 398 ~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~-~~~~l~l~~N~~~c~~~~ 457 (833)
++++|++++..|..+..+++|+.|++++|+++..++....+. .++.+++.+|||.|....
T Consensus 503 ~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp ECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred ECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence 999999999999999999999999999999998777666665 589999999999997654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-53 Score=509.04 Aligned_cols=449 Identities=20% Similarity=0.202 Sum_probs=358.4
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccc-cCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGG-KIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLA 79 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~ 79 (833)
|++|+|++|.+++..|.+|.++++|++|+|++|...+ +.|.+|+.+++|++|+|++|+|++..|.+|.++++|++|+|+
T Consensus 26 l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 105 (844)
T 3j0a_A 26 TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLY 105 (844)
T ss_dssp CCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECT
T ss_pred cCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCc
Confidence 6899999999999999999999999999999995544 448999999999999999999999999999999999999999
Q ss_pred CcccccccCc-hhhcCCCCccEEEccCCcceeeCC-ccccCCCCCcEEEcccCccccccCcCccCC--CcCceEeccccc
Q 040925 80 LNRFSGNLPF-DIVVNLPNLKALAIGGNNFFGSIP-YSLSNASNLELLDLSVNQFKGNVSIDFSSL--KNLLWLNLEQNN 155 (833)
Q Consensus 80 ~N~l~~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l--~~L~~L~L~~N~ 155 (833)
+|.+++.+|. ..|.++++|++|+|++|.+++..+ ..|+++++|++|+|++|+++++.+..|..+ ++|+.|+|++|.
T Consensus 106 ~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~ 185 (844)
T 3j0a_A 106 FCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANS 185 (844)
T ss_dssp TCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSB
T ss_pred CCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCc
Confidence 9999865554 468899999999999999987655 579999999999999999999988899888 899999999998
Q ss_pred CCCCCCCCcccc-cccCCCCCCCEEEccCCcCcccCChhHhhh-------------------------------------
Q 040925 156 LGTGTATDLDFV-TFLTNCSSLKALSLADNQFGGELPHSIANL------------------------------------- 197 (833)
Q Consensus 156 l~~~~~~~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l------------------------------------- 197 (833)
+.......+... ..+.+ .+|++|+|++|++++..|..+...
T Consensus 186 l~~~~~~~~~~~~~~~~~-~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~ 264 (844)
T 3j0a_A 186 LYSRVSVDWGKCMNPFRN-MVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA 264 (844)
T ss_dssp SCCCCCCCCCSSSCTTTT-CCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTT
T ss_pred cccccccchhhcCCcccc-CceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccc
Confidence 876443221100 01111 248888888888877766655532
Q ss_pred cccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEE
Q 040925 198 SSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLE 277 (833)
Q Consensus 198 ~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 277 (833)
...++.|++++|.+.+..+..|..+++|+.|+|++|++.++.|.+|.++++|++|+|++|.+++..|..|.++++|+.|+
T Consensus 265 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 344 (844)
T 3j0a_A 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYID 344 (844)
T ss_dssp TSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEE
T ss_pred cCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEE
Confidence 14578888888888888888888888888888888888888888888888888888888888877788888888888888
Q ss_pred eecccccCCCCCCCCCCCccceeecCCceecccCCc-------------------c----------------------cc
Q 040925 278 LSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPH-------------------Q----------------------LL 316 (833)
Q Consensus 278 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-------------------~----------------------~~ 316 (833)
|++|++.+..+..|.++++|+.|++++|.+++ ++. . +.
T Consensus 345 L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~ 423 (844)
T 3j0a_A 345 LQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLL 423 (844)
T ss_dssp CCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHT
T ss_pred CCCCCCCccChhhhcCCCCCCEEECCCCCCCc-ccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhh
Confidence 88888887777788888888888888888763 221 1 11
Q ss_pred cccccceeeecCCCccCCCCCc-ccccCCCcCEEeccCCcCC-----CCCCccccCCCCCcEEeecCCccccccCccccC
Q 040925 317 SITTLSLYLDLSNNLLNGSLPL-QVGHLKNLVILDISSNQFS-----GVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSF 390 (833)
Q Consensus 317 ~~~~ll~~L~ls~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 390 (833)
.++.+ +.|+|++|++++..+. .+..+++|+.|+|++|.++ +..+..|.++++|+.|+|++|+|++.+|..|..
T Consensus 424 ~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 502 (844)
T 3j0a_A 424 RVPHL-QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSH 502 (844)
T ss_dssp TCTTC-CEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSS
T ss_pred cCCcc-ceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccc
Confidence 22333 4555555555543322 2444566666666666665 334456788888999999999998888888889
Q ss_pred CCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCCCc
Q 040925 391 LKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGI 456 (833)
Q Consensus 391 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~~ 456 (833)
+++|+.|+|++|+|++..|..+. ++|+.|||++|++++.+|.. +.++..+++.+|||.|.+.
T Consensus 503 l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 503 LTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECE 564 (844)
T ss_dssp CCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSS
T ss_pred hhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCcccccc
Confidence 99999999999999887777666 78999999999999888754 6788999999999999665
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-52 Score=493.54 Aligned_cols=454 Identities=21% Similarity=0.193 Sum_probs=295.8
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|.+++..+.+|.++++|++|++++|++++..|..|+.+++|++|+|++|+++++.+.+|+++++|++|+|++
T Consensus 27 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~ 106 (680)
T 1ziw_A 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMS 106 (680)
T ss_dssp CSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCS
T ss_pred CcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCC
Confidence 58899999999987777899999999999999999998899999999999999999999977777899999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCcc--CCCcCceEecccccCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFS--SLKNLLWLNLEQNNLGT 158 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~N~l~~ 158 (833)
|+++ .+++..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+++++.+..|. .+++|++|+|++|.++.
T Consensus 107 n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~ 185 (680)
T 1ziw_A 107 NSIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKE 185 (680)
T ss_dssp SCCC-CCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCC
T ss_pred CccC-ccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccc
Confidence 9998 78878889999999999999999988888999999999999999999988877654 55899999999999887
Q ss_pred CCCCCcccccccC---------------------CCCCCCEEEccCCcCcccCChhHhhhcc-cccEEEccCccccccCC
Q 040925 159 GTATDLDFVTFLT---------------------NCSSLKALSLADNQFGGELPHSIANLSS-TVINFGIGRNQISGTIP 216 (833)
Q Consensus 159 ~~~~~~~~~~~l~---------------------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-~l~~L~l~~n~i~~~~~ 216 (833)
+.+..+.....+. ..++|+.|++++|++++..|..+..+.. .++.|++++|++++..+
T Consensus 186 ~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~ 265 (680)
T 1ziw_A 186 FSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265 (680)
T ss_dssp BCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECT
T ss_pred cChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCc
Confidence 6654332111110 1144555555555555555555444431 35555555555555555
Q ss_pred hhhhcCCCCCeEeccCCcccccCCcc---------------------------------ccCCCCCCEEEcccccCcccC
Q 040925 217 PGIRNLVNLIGFGAEENQLHGTIPDA---------------------------------IGELKNLQKLCLFRNFLQGRI 263 (833)
Q Consensus 217 ~~~~~l~~L~~L~L~~N~l~~~~~~~---------------------------------~~~l~~L~~L~L~~N~l~~~~ 263 (833)
..|..+++|++|++++|++.+..|.. |..+++|++|++++|.+++..
T Consensus 266 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~ 345 (680)
T 1ziw_A 266 DSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345 (680)
T ss_dssp TTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCC
T ss_pred ccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCC
Confidence 55555555555555555444433322 223334444444444444444
Q ss_pred CccccCCCCCCeEEeec----------------------------ccccCCCCCCCCCCCccceeecCCceecccCC---
Q 040925 264 PSGLGNLTKLANLELSS----------------------------NSLQGNIPSSLGNCQNLMSFTASQNKLTGALP--- 312 (833)
Q Consensus 264 ~~~~~~l~~L~~L~L~~----------------------------N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--- 312 (833)
+..|.++++|++|+|++ |++++..|.+|..+++|+.|++++|++++.+|
T Consensus 346 ~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 425 (680)
T 1ziw_A 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425 (680)
T ss_dssp TTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGG
T ss_pred hhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCccc
Confidence 44444443333333322 23333334444555555555555555443333
Q ss_pred ------------------------------------------------cccccccccceeeecCCCccCCCCCcccccCC
Q 040925 313 ------------------------------------------------HQLLSITTLSLYLDLSNNLLNGSLPLQVGHLK 344 (833)
Q Consensus 313 ------------------------------------------------~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~ 344 (833)
..+..+..+ ++|++++|+++++.+..|.+++
T Consensus 426 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L-~~L~Ls~N~l~~i~~~~~~~l~ 504 (680)
T 1ziw_A 426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL-TILDLSNNNIANINDDMLEGLE 504 (680)
T ss_dssp GTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTC-CEEECCSSCCCCCCTTTTTTCT
T ss_pred ccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCC-CEEECCCCCCCcCChhhhcccc
Confidence 222222333 4455555555544444455555
Q ss_pred CcCEEeccCCcCCCCCC--------ccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCC
Q 040925 345 NLVILDISSNQFSGVIP--------GTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLS 416 (833)
Q Consensus 345 ~L~~L~ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~ 416 (833)
+|++|++++|++++..+ ..|.++++|++|+|++|+++.+++..|..+++|+.|+|++|++++..+..|..++
T Consensus 505 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~ 584 (680)
T 1ziw_A 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV 584 (680)
T ss_dssp TCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred ccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCC
Confidence 55555555555543211 1245555555666666666544445566677777777777777766666667777
Q ss_pred CCceEECccCcCccccCCC-C-ccCCCccccccCCcCCCCCc
Q 040925 417 VLEFLSLSYNHFEGEVPTK-G-VFSNKTKISLQGNMKLCGGI 456 (833)
Q Consensus 417 ~L~~L~l~~N~l~~~~~~~-~-~~~~~~~l~l~~N~~~c~~~ 456 (833)
+|+.|++++|.+++.++.. + .+.+++.+++++|||.|...
T Consensus 585 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 585 SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp TCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred CCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 7777777777777665542 2 46788889999999999764
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=483.98 Aligned_cols=424 Identities=21% Similarity=0.184 Sum_probs=373.7
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|+++++.|++|.++++|++|+|++|++++..|..|+.+++|++|+|++|+++++.|..|.++++|++|+|++
T Consensus 59 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~ 138 (606)
T 3t6q_A 59 LTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGS 138 (606)
T ss_dssp CSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCS
T ss_pred ceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCC
Confidence 68999999999988899999999999999999999888899999999999999999999987788899999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCc--EEEcccCcccccc----------------------
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLE--LLDLSVNQFKGNV---------------------- 136 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~--~L~L~~N~i~~~~---------------------- 136 (833)
|+++ .++...+.++++|++|+|++|.+++..|..|+.+++|+ .|++++|+++++.
T Consensus 139 n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~ 217 (606)
T 3t6q_A 139 NHIS-SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLV 217 (606)
T ss_dssp SCCC-CCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHH
T ss_pred Cccc-ccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHH
Confidence 9997 55433445688888888888888877777777777777 6666666655444
Q ss_pred -----------------------------------------------------CcCccCCCcCceEecccccCCCCCCCC
Q 040925 137 -----------------------------------------------------SIDFSSLKNLLWLNLEQNNLGTGTATD 163 (833)
Q Consensus 137 -----------------------------------------------------~~~~~~l~~L~~L~L~~N~l~~~~~~~ 163 (833)
+..|..+++|++|+|++|.++.++
T Consensus 218 ~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~lp--- 294 (606)
T 3t6q_A 218 IFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELP--- 294 (606)
T ss_dssp HHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCSCCC---
T ss_pred HhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccCCCC---
Confidence 344667788888888888887654
Q ss_pred cccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCC-hhhhcCCCCCeEeccCCcccccC--C
Q 040925 164 LDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIP-PGIRNLVNLIGFGAEENQLHGTI--P 240 (833)
Q Consensus 164 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~--~ 240 (833)
..+.++++|++|++++|++++..|..+..++ .++.|++++|.+.+..+ ..+.++++|++|++++|++.+.. +
T Consensus 295 ----~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 369 (606)
T 3t6q_A 295 ----SGLVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369 (606)
T ss_dssp ----SSCCSCTTCCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEEST
T ss_pred ----hhhcccccCCEEECccCCcCcCchhhhhccC-cCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcc
Confidence 3478899999999999999987788888875 48999999999986555 45999999999999999999876 7
Q ss_pred ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCC-CCCCCCccceeecCCceecccCCccccccc
Q 040925 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPS-SLGNCQNLMSFTASQNKLTGALPHQLLSIT 319 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 319 (833)
..|..+++|++|++++|.+.+..|..|..+++|++|++++|++.+..+. .|..+++|+.|++++|.+++..|..+..++
T Consensus 370 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 449 (606)
T 3t6q_A 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLP 449 (606)
T ss_dssp TTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCT
T ss_pred hhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCC
Confidence 8899999999999999999999999999999999999999999977654 499999999999999999977788888888
Q ss_pred ccceeeecCCCccCC---CCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCe
Q 040925 320 TLSLYLDLSNNLLNG---SLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKE 396 (833)
Q Consensus 320 ~ll~~L~ls~N~l~~---~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 396 (833)
.+ ++|++++|.+++ ..+..+..+++|++|++++|++++..|..|..+++|++|+|++|++++..|..+..++.| .
T Consensus 450 ~L-~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~ 527 (606)
T 3t6q_A 450 AL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-Y 527 (606)
T ss_dssp TC-CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-E
T ss_pred CC-CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-E
Confidence 87 899999999986 234679999999999999999999999999999999999999999999999999999999 9
Q ss_pred EEccCcccCCCchhhhcCCCCCceEECccCcCccccCCC
Q 040925 397 LNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK 435 (833)
Q Consensus 397 L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 435 (833)
|++++|++++.+|..+..+++|+.|++++|+|+|.|+..
T Consensus 528 L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~ 566 (606)
T 3t6q_A 528 LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNI 566 (606)
T ss_dssp EECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGH
T ss_pred EECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcH
Confidence 999999999999999999999999999999999998853
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=474.07 Aligned_cols=432 Identities=21% Similarity=0.237 Sum_probs=326.4
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|.+++..+.+|+++++|++|++++|++++..|..|+.+++|++|+|++|.+++..|..|.++++|++|++++
T Consensus 75 L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 154 (680)
T 1ziw_A 75 LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN 154 (680)
T ss_dssp CCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCS
T ss_pred cCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccC
Confidence 56677777777754445677777777777777777666666777777777777777777766677777777777777777
Q ss_pred cccccccCchhhc--CCCCccEEEccCCcceeeCCc--------------------------------------------
Q 040925 81 NRFSGNLPFDIVV--NLPNLKALAIGGNNFFGSIPY-------------------------------------------- 114 (833)
Q Consensus 81 N~l~~~~~~~~~~--~l~~L~~L~L~~N~l~~~~~~-------------------------------------------- 114 (833)
|+++ .++...|. .+++|++|+|++|.+++..|.
T Consensus 155 n~l~-~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~ 233 (680)
T 1ziw_A 155 NKIQ-ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ 233 (680)
T ss_dssp SCCC-CBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSC
T ss_pred Cccc-ccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCc
Confidence 7766 34433322 334555555555554443333
Q ss_pred -------cccCCC--CCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcc--------------------
Q 040925 115 -------SLSNAS--NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD-------------------- 165 (833)
Q Consensus 115 -------~~~~l~--~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------------------- 165 (833)
.|.+++ +|++|+|++|+++++.+..|..+++|++|+|++|+++.+.+..+.
T Consensus 234 l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~ 313 (680)
T 1ziw_A 234 LSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS 313 (680)
T ss_dssp CCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC---
T ss_pred ccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccc
Confidence 333332 377777777777777777777777777777777776654332211
Q ss_pred ---ccc----ccCCCCCCCEEEccCCcCcccCChhHhhhc---------------------------ccccEEEccCccc
Q 040925 166 ---FVT----FLTNCSSLKALSLADNQFGGELPHSIANLS---------------------------STVINFGIGRNQI 211 (833)
Q Consensus 166 ---~~~----~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~---------------------------~~l~~L~l~~n~i 211 (833)
.+. .|..+++|++|++++|++++..|..+.++. ..++.|++++|++
T Consensus 314 ~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l 393 (680)
T 1ziw_A 314 LASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393 (680)
T ss_dssp ---CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCC
T ss_pred cccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCC
Confidence 011 355677777777788877766555554432 2456667777778
Q ss_pred cccCChhhhcCCCCCeEeccCCcccccCC-ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeeccccc--CCCC
Q 040925 212 SGTIPPGIRNLVNLIGFGAEENQLHGTIP-DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ--GNIP 288 (833)
Q Consensus 212 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~~ 288 (833)
+++.|..|.++++|+.|++++|++.+.+| ..|.++++|++|+|++|.+.+..+..|..+++|+.|++++|.+. +..|
T Consensus 394 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p 473 (680)
T 1ziw_A 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSP 473 (680)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSS
T ss_pred CeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCC
Confidence 77778888888888888888888876554 67888888888888888888878888888888888888888876 4678
Q ss_pred CCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCC--------cccccCCCcCEEeccCCcCCCCC
Q 040925 289 SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLP--------LQVGHLKNLVILDISSNQFSGVI 360 (833)
Q Consensus 289 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~--------~~~~~l~~L~~L~ls~N~l~~~~ 360 (833)
..|.++++|+.|++++|++++..|..+..+..+ ++|++++|.+++..+ ..|.++++|++|+|++|+++.++
T Consensus 474 ~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 552 (680)
T 1ziw_A 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKL-EILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIP 552 (680)
T ss_dssp CTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCC
T ss_pred cccccCCCCCEEECCCCCCCcCChhhhcccccc-CEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCC
Confidence 899999999999999999996555667777777 899999999986422 24789999999999999999777
Q ss_pred CccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhc-CCCCCceEECccCcCccccCC
Q 040925 361 PGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLK-NLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 361 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~l~~N~l~~~~~~ 434 (833)
+..|.++++|+.|+|++|+++++++..|..+++|+.|+|++|++++..|..+. .+++|+.|++++|+|.|.|+.
T Consensus 553 ~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~ 627 (680)
T 1ziw_A 553 VEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627 (680)
T ss_dssp TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred HHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence 78899999999999999999988888899999999999999999999998888 899999999999999999985
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=467.03 Aligned_cols=424 Identities=20% Similarity=0.194 Sum_probs=369.2
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|+++++.|.+|.++++|++|+|++|++++..|..|+.+++|++|+|++|++++..+..|+++++|++|+|++
T Consensus 58 L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 137 (606)
T 3vq2_A 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAH 137 (606)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCS
T ss_pred CcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCC
Confidence 78999999999988899999999999999999999988899999999999999999999988889999999999999999
Q ss_pred ccccc-ccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCc----EEEcccCccccccCcCccCCCcCceEeccccc
Q 040925 81 NRFSG-NLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLE----LLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNN 155 (833)
Q Consensus 81 N~l~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 155 (833)
|.+++ .+| ..|.++++|++|+|++|++++..|..|+.+.+|+ +|++++|+++.+++..|... +|++|++++|.
T Consensus 138 n~l~~~~lp-~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~ 215 (606)
T 3vq2_A 138 NFIHSCKLP-AYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNF 215 (606)
T ss_dssp SCCCCCCCC-GGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCC
T ss_pred Ccccceech-HhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCc
Confidence 99983 344 5678999999999999999998888888777665 78888888887777666544 56666666654
Q ss_pred CCC-------------------------------------------------------C------------------CCC
Q 040925 156 LGT-------------------------------------------------------G------------------TAT 162 (833)
Q Consensus 156 l~~-------------------------------------------------------~------------------~~~ 162 (833)
++. + ...
T Consensus 216 ~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~~ 295 (606)
T 3vq2_A 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295 (606)
T ss_dssp SCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEESC
T ss_pred cchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecCc
Confidence 420 0 000
Q ss_pred CcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccC--C
Q 040925 163 DLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI--P 240 (833)
Q Consensus 163 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~ 240 (833)
.+.....+..+++|++|++++|++ +.+| .+ .+ ..++.|++++|...+.. .+..+++|++|++++|++++.. |
T Consensus 296 ~~~~l~~l~~~~~L~~L~l~~n~l-~~lp-~~-~l-~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~ 369 (606)
T 3vq2_A 296 SIKYLEDVPKHFKWQSLSIIRCQL-KQFP-TL-DL-PFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCS 369 (606)
T ss_dssp CCCCCCCCCTTCCCSEEEEESCCC-SSCC-CC-CC-SSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECC
T ss_pred cchhhhhccccccCCEEEcccccC-cccc-cC-CC-CccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchh
Confidence 001112477889999999999999 5888 44 44 56899999999665443 6789999999999999999763 8
Q ss_pred ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCC-CCCCCCCccceeecCCceecccCCccccccc
Q 040925 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIP-SSLGNCQNLMSFTASQNKLTGALPHQLLSIT 319 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 319 (833)
..+..+++|++|+|++|.+++ +|..|.++++|+.|++++|++.+..| ..|..+++|+.|++++|++++..|..+..+.
T Consensus 370 ~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 448 (606)
T 3vq2_A 370 YSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448 (606)
T ss_dssp HHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred hhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCC
Confidence 899999999999999999985 66889999999999999999998877 7899999999999999999988888888888
Q ss_pred ccceeeecCCCccCC-CCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEE
Q 040925 320 TLSLYLDLSNNLLNG-SLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELN 398 (833)
Q Consensus 320 ~ll~~L~ls~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 398 (833)
.+ ++|++++|.+++ ..|..|+.+++|++|++++|++++..|..|..+++|++|+|++|++++..|..|..+++|+.|+
T Consensus 449 ~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 527 (606)
T 3vq2_A 449 SL-NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLD 527 (606)
T ss_dssp TC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEE
T ss_pred CC-CEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEE
Confidence 88 899999999997 4788999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCchhhhcCCC-CCceEECccCcCccccCCC
Q 040925 399 VSSNNLSGQIPEFLKNLS-VLEFLSLSYNHFEGEVPTK 435 (833)
Q Consensus 399 l~~N~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~~~~ 435 (833)
+++|+++ .+|..+..++ +|+.|++++|+|.|.++..
T Consensus 528 l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~ 564 (606)
T 3vq2_A 528 CSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEHQ 564 (606)
T ss_dssp CTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTTH
T ss_pred CCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCccH
Confidence 9999999 5676799987 5999999999999999864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=462.06 Aligned_cols=439 Identities=22% Similarity=0.229 Sum_probs=338.4
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
+++|++++|.+++..+.+|.++++|++|+|++|++++..|..|+.+++|++|+|++|+++++.|.+|.++++|++|++++
T Consensus 30 l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 109 (570)
T 2z63_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (570)
T ss_dssp CCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccc
Confidence 57888888888877778888888888888888888887788888888888888888888877788888888888888888
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceee-CCccccCCCCCcEEEcccCccccccCcCccCCCcC----ceEeccccc
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGS-IPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNL----LWLNLEQNN 155 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L----~~L~L~~N~ 155 (833)
|+++ .++...|.++++|++|+|++|.+++. .|..|+++++|++|++++|+++++.+..|..+++| +.|++++|.
T Consensus 110 n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 110 TNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp SCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred cccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 8887 67766678888888888888888763 58888888888888888888888888888888888 788888888
Q ss_pred CCCCCCCCcccccccCCCCCCCEEEccCCc--------------------------------------------------
Q 040925 156 LGTGTATDLDFVTFLTNCSSLKALSLADNQ-------------------------------------------------- 185 (833)
Q Consensus 156 l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-------------------------------------------------- 185 (833)
++.++... +..+ +|++|++++|.
T Consensus 189 l~~~~~~~------~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~ 261 (570)
T 2z63_A 189 MNFIQPGA------FKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 261 (570)
T ss_dssp CCEECTTT------TTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEE
T ss_pred ceecCHHH------hccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhh
Confidence 87765532 2222 56777776662
Q ss_pred --------CcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccc
Q 040925 186 --------FGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRN 257 (833)
Q Consensus 186 --------l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 257 (833)
+.+.+|..+..+. .++.|++++|.++ .+|..+..+ +|+.|++++|.+. .+|. ..+++|++|++++|
T Consensus 262 l~l~~~~~~~~~~~~~~~~l~-~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n 335 (570)
T 2z63_A 262 FRLAYLDYYLDDIIDLFNCLT-NVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSN 335 (570)
T ss_dssp EEEEETTEEESCSTTTTGGGT-TCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESC
T ss_pred hhhhcchhhhhhchhhhcCcC-cccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCC
Confidence 2222233333322 2455555555555 344444444 5555555555555 2222 24455666666666
Q ss_pred cCcccCCccccCCCCCCeEEeecccccCCC--CCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCC
Q 040925 258 FLQGRIPSGLGNLTKLANLELSSNSLQGNI--PSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGS 335 (833)
Q Consensus 258 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~ 335 (833)
.+.+..+. ..+++|++|++++|++++.. |..+.++++|+.|++++|+++ .+|..+..+..+ ++|++++|.+.+.
T Consensus 336 ~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~l~~L-~~L~l~~n~l~~~ 411 (570)
T 2z63_A 336 KGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL-EHLDFQHSNLKQM 411 (570)
T ss_dssp BSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEE-EEEEEEETCTTC-CEEECTTSEEESC
T ss_pred cccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccc-cccccccccCCC-CEEEccCCccccc
Confidence 55543333 56788888888888887554 667888889999999999988 455557777776 7899999999876
Q ss_pred CC-cccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccc-cccCccccCCCCCCeEEccCcccCCCchhhhc
Q 040925 336 LP-LQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH-GVIPLSLSFLKSIKELNVSSNNLSGQIPEFLK 413 (833)
Q Consensus 336 ~~-~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~ 413 (833)
.+ ..|.++++|++|++++|.+++..|..|.++++|++|+|++|+++ +..|..+..+++|+.|++++|++++..|..+.
T Consensus 412 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 491 (570)
T 2z63_A 412 SEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491 (570)
T ss_dssp TTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTT
T ss_pred cchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhh
Confidence 65 56888999999999999999888999999999999999999997 56788899999999999999999988899999
Q ss_pred CCCCCceEECccCcCccccCCC-CccCCCccccccCCcCCCCCcc
Q 040925 414 NLSVLEFLSLSYNHFEGEVPTK-GVFSNKTKISLQGNMKLCGGID 457 (833)
Q Consensus 414 ~l~~L~~L~l~~N~l~~~~~~~-~~~~~~~~l~l~~N~~~c~~~~ 457 (833)
.+++|+.|++++|++++.++.. ..++.++.+++++|++.|..+.
T Consensus 492 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred cccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 9999999999999999887753 6678889999999999886543
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=479.01 Aligned_cols=428 Identities=20% Similarity=0.216 Sum_probs=356.7
Q ss_pred CcEEEcCCCcCcccC-CccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCcc--ccCCCCCcEEE
Q 040925 1 LQTLAVNDNYLTGQL-PDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRS--ICNISSLELIQ 77 (833)
Q Consensus 1 L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~--~~~l~~L~~L~ 77 (833)
|++|+|++|...+.+ |.+|.++++|++|+|++|++.+..|..|+.+++|++|+|++|.+++..|.. |.++++|++|+
T Consensus 50 L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~ 129 (844)
T 3j0a_A 50 LQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLD 129 (844)
T ss_dssp CSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEE
T ss_pred CeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEE
Confidence 789999999655455 889999999999999999999999999999999999999999999766665 99999999999
Q ss_pred CCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCC--CCCcEEEcccCccccccCcCccCCCc------CceE
Q 040925 78 LALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNA--SNLELLDLSVNQFKGNVSIDFSSLKN------LLWL 149 (833)
Q Consensus 78 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~i~~~~~~~~~~l~~------L~~L 149 (833)
|++|.+++..+...|.++++|++|+|++|.+++..+..|..+ ++|+.|+|++|.+.+..+..+..+++ |+.|
T Consensus 130 Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L 209 (844)
T 3j0a_A 130 LSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209 (844)
T ss_dssp EESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEE
T ss_pred CCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEE
Confidence 999999855556788999999999999999998889999888 89999999999998877777766665 9999
Q ss_pred ecccccCCCCCCCCcc------------------------------cccccCC--CCCCCEEEccCCcCcccCChhHhhh
Q 040925 150 NLEQNNLGTGTATDLD------------------------------FVTFLTN--CSSLKALSLADNQFGGELPHSIANL 197 (833)
Q Consensus 150 ~L~~N~l~~~~~~~~~------------------------------~~~~l~~--l~~L~~L~Ls~N~l~~~~p~~~~~l 197 (833)
+|++|.++......+. ....|.+ .++|+.|+|++|.+.+..|..+..+
T Consensus 210 ~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l 289 (844)
T 3j0a_A 210 DVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289 (844)
T ss_dssp BCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSC
T ss_pred ecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcC
Confidence 9999977543221110 0111222 2678889999998887777777666
Q ss_pred cccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEE
Q 040925 198 SSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLE 277 (833)
Q Consensus 198 ~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 277 (833)
. .++.|++++|+|++..+..|.++++|++|+|++|++.++.|..|.++++|++|+|++|.++++.+..|.++++|++|+
T Consensus 290 ~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 368 (844)
T 3j0a_A 290 K-DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLD 368 (844)
T ss_dssp C-CCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEE
T ss_pred C-CCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEE
Confidence 4 478888899988888888888888899999999988888888888888899999998888877777888888888888
Q ss_pred eecccccCCC------------------CC----------------------CCCCCCccceeecCCceecccCCcc-cc
Q 040925 278 LSSNSLQGNI------------------PS----------------------SLGNCQNLMSFTASQNKLTGALPHQ-LL 316 (833)
Q Consensus 278 L~~N~l~~~~------------------~~----------------------~~~~l~~L~~L~l~~N~l~~~~p~~-~~ 316 (833)
|++|.+++.. |. .+.++++|+.|++++|++++..+.. +.
T Consensus 369 Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 448 (844)
T 3j0a_A 369 LRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPS 448 (844)
T ss_dssp EETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSC
T ss_pred CCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccc
Confidence 8888876421 11 1336789999999999998544432 33
Q ss_pred cccccceeeecCCCccC-----CCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCC
Q 040925 317 SITTLSLYLDLSNNLLN-----GSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFL 391 (833)
Q Consensus 317 ~~~~ll~~L~ls~N~l~-----~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 391 (833)
...++ +.|++++|.++ +..+..|.++++|+.|+|++|.+++.+|..|.++++|+.|+|++|+|+++++..+.
T Consensus 449 ~~~~L-~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-- 525 (844)
T 3j0a_A 449 ENPSL-EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-- 525 (844)
T ss_dssp SCTTC-CBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--
T ss_pred cCCcc-ccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--
Confidence 34444 88999999997 44556789999999999999999999999999999999999999999988887776
Q ss_pred CCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCC
Q 040925 392 KSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK 435 (833)
Q Consensus 392 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 435 (833)
++|+.|+|++|++++..|..+ .+|+.|++++|++.|.|+..
T Consensus 526 ~~L~~L~Ls~N~l~~~~~~~~---~~L~~l~l~~Np~~C~c~~~ 566 (844)
T 3j0a_A 526 ANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELS 566 (844)
T ss_dssp SCCCEEEEEEECCCCCCSCCC---SSCCEEEEEEECCCCSSSCC
T ss_pred ccccEEECCCCcCCCCChhHh---CCcCEEEecCCCcccccccH
Confidence 899999999999999988775 47899999999999999854
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=424.68 Aligned_cols=265 Identities=22% Similarity=0.367 Sum_probs=211.0
Q ss_pred cCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
++|.+.+.||+|+||+||+|++. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 88 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD---- 88 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC----
Confidence 46888999999999999999875 357899999998665556678999999999999999999999987654
Q ss_pred ceEeEEEEecCCCChhhhhccCCC-------ccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDD-------QVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
..++|||||++|+|.+++...+. ......++|.+++.|+.||+.||+|||++ +||||||||+|||++++
T Consensus 89 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 89 -PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGEN 164 (299)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCC
Confidence 78999999999999999986531 01123699999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-Hh
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TA 757 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~ 757 (833)
+.+||+|||+|+......... ......||+.|||||++.+..|+.++|||| +|+++||+++ +.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~------~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS----------~Gvvl~Ellt~G~ 228 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYR------VGGHTMLPIRWMPPESIMYRKFTTESDVWS----------LGVVLWEIFTYGK 228 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEE------ETTTEEECGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTTC
T ss_pred CcEEECCcccceecCCCCcee------ecCceecChhhcCHHHHcCCCCCchhhHHH----------HHHHHHHHHcCCC
Confidence 999999999998665432211 112346999999999999999999999999 7888888887 67
Q ss_pred CCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 758 LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 758 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.|+.... ..+.......... ...++.+++.+.+++.+||+.||++|||++||++.|+++.+.
T Consensus 229 ~Pf~~~~--~~~~~~~i~~~~~------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 229 QPWYQLS--NNEVIECITQGRV------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp CTTTTSC--HHHHHHHHHHTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCC--HHHHHHHHHcCCC------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 7765322 1111111111111 112345677899999999999999999999999999988764
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=419.21 Aligned_cols=265 Identities=26% Similarity=0.366 Sum_probs=206.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.+++++.++||+|+||+||+|++.. .||||+++.... ...+.|.+|++++++++|||||+++|++... .
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~------~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD------N 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC------e
Confidence 4578889999999999999998753 499999975432 2346799999999999999999999987432 4
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++|||||++|+|.+++..... .+++.++..|+.|||.||+|||++ +||||||||+|||+++++.+||+|||
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFG 177 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFG 177 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCS
T ss_pred EEEEEEcCCCCCHHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeecc
Confidence 7899999999999999976542 699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC---CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG---SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
+|+........ ......+||+.|||||++.+ ..|+.++|||| +|+++||++++..|+....
T Consensus 178 la~~~~~~~~~------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS----------~Gvvl~Elltg~~Pf~~~~ 241 (307)
T 3omv_A 178 LATVKSRWSGS------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYS----------YGIVLYELMTGELPYSHIN 241 (307)
T ss_dssp SCBC------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHH----------HHHHHHHHHHSSCTTTTCC
T ss_pred CceecccCCcc------eeecccccCCCccCHHHhhccCCCCCCcHHHhHh----------HHHHHHHHHHCCCCCCCCC
Confidence 99866442211 12234579999999999864 45899999999 8999999999999975322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
. .......+..... .+.....+.++++.+.+++.+||+.||++|||+.||++.|+.++..+.+
T Consensus 242 ~--~~~~~~~~~~~~~-~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk 304 (307)
T 3omv_A 242 N--RDQIIFMVGRGYA-SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK 304 (307)
T ss_dssp C--HHHHHHHHHTTCC-CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred h--HHHHHHHHhcCCC-CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence 1 1111111111110 1111122345677899999999999999999999999999998877654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=426.10 Aligned_cols=265 Identities=23% Similarity=0.358 Sum_probs=205.9
Q ss_pred cCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|.+.++||+|+||+||+|+++ .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~---- 116 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR---- 116 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC----
Confidence 46788899999999999999875 358899999998665556678999999999999999999999986654
Q ss_pred ceEeEEEEecCCCChhhhhccCCCc---------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQ---------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
..|+|||||++|+|.++++..... ....+++|.+++.|+.||+.||+|||+. +||||||||+|||++
T Consensus 117 -~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 117 -PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVG 192 (329)
T ss_dssp -SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEE
T ss_pred -EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEEC
Confidence 789999999999999999865421 1123689999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-
Q 040925 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK- 755 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~- 755 (833)
+++.+||+|||+|+......... ......||+.|||||++.+..|+.++|||| +|+++||+++
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~------~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS----------~Gvvl~Ellt~ 256 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYR------VGGRTMLPIRWMPPESILYRKFTTESDVWS----------FGVVLWEIFTY 256 (329)
T ss_dssp TTTEEEECCCC----------------------CCCCGGGCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHTT
T ss_pred CCCcEEEcccccceeccCCCcce------ecCcccccccccChhhhcCCCCCccccccc----------hHHHHHHHHcC
Confidence 99999999999998764432111 122356999999999999999999999999 7888888887
Q ss_pred HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 756 TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 756 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
+..|+..... ........... ....++.+++.+.+++.+||+.||++|||++||+++|+.+.+.
T Consensus 257 G~~Pf~~~~~--~~~~~~i~~g~------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 257 GKQPWYQLSN--TEAIDCITQGR------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp SCCTTCSSCH--HHHHHHHHHTC------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCH--HHHHHHHHcCC------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 6777652221 11111111111 1112344677899999999999999999999999999998764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=424.18 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=209.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
..|++.++||+|+||+||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+ ..|+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEEE
Confidence 46999999999999999999999999999999998666666678999999999999999999999977655 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
|||||+||+|.+++... .+++.+++.|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 149 vmEy~~gg~L~~~l~~~-------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 218 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 218 (346)
T ss_dssp EECCCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCce
Confidence 99999999999999753 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
.+.... ......+||+.|||||++.+..|+.++|||| .|+++|++++|..|+......+ .
T Consensus 219 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWS----------lGvilyeml~G~~PF~~~~~~~--~ 278 (346)
T 4fih_A 219 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWS----------LGIMVIEMVDGEPPYFNEPPLK--A 278 (346)
T ss_dssp ECCSSS--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCTTTTSCHHH--H
T ss_pred ecCCCC--------CcccccccCcCcCCHHHHCCCCCCcHHHHHH----------HHHHHHHHHHCCCCCCCcCHHH--H
Confidence 765422 1223468999999999999999999999999 8999999999999985322111 1
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ..+.... +........+++.+.+++.+||..||++|||++|+++.
T Consensus 279 ~-~~i~~~~---~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 279 M-KMIRDNL---PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp H-HHHHHSS---CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred H-HHHHcCC---CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1111100 00111223456678999999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=421.97 Aligned_cols=261 Identities=22% Similarity=0.263 Sum_probs=210.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.+.|++.++||+|+||+||+|+++.+|+.||||+++... ...+|+.++++++|||||++++++.+.+ ..|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~-----~~~ 126 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGP-----WVN 126 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETT-----EEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence 456888899999999999999999999999999997432 2247999999999999999999976655 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-cEEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~ 688 (833)
+|||||+||+|.++++..+ .+++.+++.|+.||+.||+|||++ +||||||||+|||++.+| .+||+|||+
T Consensus 127 ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGl 197 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGH 197 (336)
T ss_dssp EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTT
T ss_pred EEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCC
Confidence 9999999999999998654 799999999999999999999999 999999999999999998 699999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
|+.+........ ......++||+.|||||++.+..|+.++|||| .|+++|++++|..|+..... .
T Consensus 198 a~~~~~~~~~~~---~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwS----------lGvilyemltG~~Pf~~~~~--~ 262 (336)
T 4g3f_A 198 ALCLQPDGLGKS---LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS----------SCCMMLHMLNGCHPWTQYFR--G 262 (336)
T ss_dssp CEEC---------------CCCCCCGGGCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSSCSSTTTCC--S
T ss_pred CeEccCCCcccc---eecCCccccCccccCHHHHCCCCCCcHHHHHH----------HHHHHHHHHHCcCCCCCCCH--H
Confidence 987755332111 11123467999999999999999999999999 89999999999999863221 1
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
........... .....++++++.+.+++.+||++||++|||+.|+++.+....+..
T Consensus 263 ~~~~~i~~~~~----~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 263 PLCLKIASEPP----PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp CCHHHHHHSCC----GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHcCCC----CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 12122111111 111223456778899999999999999999999999998876654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=425.81 Aligned_cols=252 Identities=19% Similarity=0.265 Sum_probs=203.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-----~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG-----SL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECC-----EE
Confidence 689999999999999999999999999999999975432 23467999999999999999999999976655 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
|+|||||+||+|.+++...+.. .+++.+++.|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~----~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGl 171 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGV----LFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGI 171 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTE
T ss_pred EEEEeCCCCCcHHHHHHHcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEccccc
Confidence 9999999999999999765432 578999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
|+....... .....+||+.|||||++.+..|+.++|||| .|+++|+++++..|+......
T Consensus 172 a~~~~~~~~--------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwS----------lGvilyemltG~~PF~~~~~~-- 231 (350)
T 4b9d_A 172 ARVLNSTVE--------LARACIGTPYYLSPEICENKPYNNKSDIWA----------LGCVLYELCTLKHAFEAGSMK-- 231 (350)
T ss_dssp ESCCCHHHH--------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHSSCSCCCSSHH--
T ss_pred ceeecCCcc--------cccccCCCccccCHHHHCCCCCCcHHHHHH----------HHHHHHHHHHCCCCCCCcCHH--
Confidence 987654321 112357999999999999999999999999 899999999999998632211
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
........... ...+..+++.+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~i~~~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 232 NLVLKIISGSF------PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp HHHHHHHHTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCC------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111111111 01123356678999999999999999999999864
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=451.73 Aligned_cols=444 Identities=21% Similarity=0.253 Sum_probs=383.0
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|++++..|.+|.++++|++|+|++|++++..|.+|+.+++|++|+|++|+++++.+..|+++++|++|+|++
T Consensus 54 L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~ 133 (570)
T 2z63_A 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 133 (570)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCS
T ss_pred ceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEecCC
Confidence 68999999999988889999999999999999999988899999999999999999999977777899999999999999
Q ss_pred ccccc-ccCchhhcCCCCccEEEccCCcceeeCCccccCCCCC----cEEEcccCccccccCcCccCCCcCceEeccccc
Q 040925 81 NRFSG-NLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNL----ELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNN 155 (833)
Q Consensus 81 N~l~~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~ 155 (833)
|.+++ .+| ..|.++++|++|++++|.+++..+..|+.+++| ++|++++|.++++.+..|..+ +|+.|++++|.
T Consensus 134 n~l~~~~lp-~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~ 211 (570)
T 2z63_A 134 NLIQSFKLP-EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNF 211 (570)
T ss_dssp SCCCCCCCC-GGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCC
T ss_pred CccceecCh-hhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccC-cceeEeccccc
Confidence 99983 244 567899999999999999998888999999999 899999999999999988876 79999998873
Q ss_pred CCC-------------------------------CCCCCc---------------------ccccccCCCCCCCEEEccC
Q 040925 156 LGT-------------------------------GTATDL---------------------DFVTFLTNCSSLKALSLAD 183 (833)
Q Consensus 156 l~~-------------------------------~~~~~~---------------------~~~~~l~~l~~L~~L~Ls~ 183 (833)
... ++...+ ..+..+..+++|++|++++
T Consensus 212 ~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~ 291 (570)
T 2z63_A 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVS 291 (570)
T ss_dssp SCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEES
T ss_pred ccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecC
Confidence 211 100000 1224466789999999999
Q ss_pred CcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccC
Q 040925 184 NQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRI 263 (833)
Q Consensus 184 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 263 (833)
|+++ .+|..+..+ .++.|++++|.+. .+|. ..+++|+.|++++|.+.+..+. ..+++|++|++++|.+++..
T Consensus 292 ~~l~-~l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~ 363 (570)
T 2z63_A 292 VTIE-RVKDFSYNF--GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKG 363 (570)
T ss_dssp CEEC-SCCBCCSCC--CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEE
T ss_pred ccch-hhhhhhccC--CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccc
Confidence 9998 788888877 7999999999998 4444 5789999999999999876655 78899999999999998654
Q ss_pred --CccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCC-cccccccccceeeecCCCccCCCCCccc
Q 040925 264 --PSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALP-HQLLSITTLSLYLDLSNNLLNGSLPLQV 340 (833)
Q Consensus 264 --~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~~~~~ll~~L~ls~N~l~~~~~~~~ 340 (833)
+..+.++++|++|++++|.+.+..+. +..+++|+.|++++|.+++..| ..+..+..+ ++|++++|.+.+..|..|
T Consensus 364 ~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~ 441 (570)
T 2z63_A 364 CCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIF 441 (570)
T ss_dssp EEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTC-CEEECTTSCCEECCTTTT
T ss_pred cccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCC-CEEeCcCCcccccchhhh
Confidence 67889999999999999999965555 9999999999999999996666 355666666 899999999998899999
Q ss_pred ccCCCcCEEeccCCcCC-CCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCc
Q 040925 341 GHLKNLVILDISSNQFS-GVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLE 419 (833)
Q Consensus 341 ~~l~~L~~L~ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~ 419 (833)
.++++|++|++++|.++ +..|..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..|..+..+++|+
T Consensus 442 ~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 521 (570)
T 2z63_A 442 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQ 521 (570)
T ss_dssp TTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCC
T ss_pred hcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCc
Confidence 99999999999999997 57889999999999999999999999899999999999999999999999899999999999
Q ss_pred eEECccCcCccccCCCCc---cCCCccccccCCcCCCCCcc
Q 040925 420 FLSLSYNHFEGEVPTKGV---FSNKTKISLQGNMKLCGGID 457 (833)
Q Consensus 420 ~L~l~~N~l~~~~~~~~~---~~~~~~l~l~~N~~~c~~~~ 457 (833)
.|++++|+++|.+|.... |-......+.+.+ .|.++.
T Consensus 522 ~L~l~~N~~~~~~~~~~~~~~wl~~~~~~~~~~~-~C~~~~ 561 (570)
T 2z63_A 522 KIWLHTNPWDCSCPRIDYLSRWLNKNSQKEQGSA-KCSGSG 561 (570)
T ss_dssp EEECCSSCBCCCTTTTHHHHHHHHHTGGGEESCC-BBTTTC
T ss_pred EEEecCCcccCCCcchHHHHHHHHhccccCCCch-hhCCCC
Confidence 999999999999987532 2222222344444 676553
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-49 Score=459.40 Aligned_cols=415 Identities=20% Similarity=0.269 Sum_probs=312.3
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCC-------------------------------------
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLG------------------------------------- 44 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~------------------------------------- 44 (833)
+.|+|++|+++|.+|.+|++|++|++|+|++|.+. ..+..++
T Consensus 84 ~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~ 162 (636)
T 4eco_A 84 TGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK-VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI 162 (636)
T ss_dssp EEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGG-GTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHH
T ss_pred EEEEecCcccCCcCChHHhcCccceEEECcCCccc-cCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHH
Confidence 57889999999889999999999999999888661 1111111
Q ss_pred ----------------CCCCCCEEEcC--CCcccccCCccccCCCCCcEEECCCcccccc-----------------cCc
Q 040925 45 ----------------LLRNLVSLNVA--ENKFSGMFPRSICNISSLELIQLALNRFSGN-----------------LPF 89 (833)
Q Consensus 45 ----------------~l~~L~~L~L~--~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~-----------------~~~ 89 (833)
....++.+.+. +|++++ +|.+|+++++|++|+|++|++++. +|.
T Consensus 163 ~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~ 241 (636)
T 4eco_A 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE 241 (636)
T ss_dssp HHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred HHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCch
Confidence 11122222222 577887 788888888888888888888853 775
Q ss_pred hhh-cCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCc-ccc-ccCcCccCC------CcCceEecccccCCCCC
Q 040925 90 DIV-VNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQ-FKG-NVSIDFSSL------KNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 90 ~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~-~~~~~~~~l------~~L~~L~L~~N~l~~~~ 160 (833)
.+. .++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ ..|..+..+ ++|++|+|++|+++.++
T Consensus 242 ~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip 321 (636)
T 4eco_A 242 DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321 (636)
T ss_dssp CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCC
T ss_pred hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccC
Confidence 542 278888888888888888888888888888888888887 876 556666665 88888888888887543
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCC-CCeEeccCCcccccC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVN-LIGFGAEENQLHGTI 239 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~~ 239 (833)
. ...+.++++|++|+|++|++++.+| .+..+. .++.|++++|+++ .+|..+.++++ |+.|++++|+++ .+
T Consensus 322 ~-----~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~l 392 (636)
T 4eco_A 322 V-----ETSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YI 392 (636)
T ss_dssp C-----HHHHTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SC
T ss_pred c-----hhhhccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-cc
Confidence 2 0147788888888888888888888 666654 4778888888888 67777888888 888888888888 66
Q ss_pred CccccCCC--CCCEEEcccccCcccCCcccc-------CCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceeccc
Q 040925 240 PDAIGELK--NLQKLCLFRNFLQGRIPSGLG-------NLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGA 310 (833)
Q Consensus 240 ~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 310 (833)
|..+..+. +|++|+|++|.+++..|..|. .+++|++|+|++|+++...+..+..+++|+.|++++|+++ .
T Consensus 393 p~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~ 471 (636)
T 4eco_A 393 PNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-E 471 (636)
T ss_dssp CSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-B
T ss_pred chhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-C
Confidence 77776654 788888888888888887777 7778888888888888554455666888888888888888 7
Q ss_pred CCcccccccc-------cceeeecCCCccCCCCCcccc--cCCCcCEEeccCCcCCCCCCccccCCCCCcEEee------
Q 040925 311 LPHQLLSITT-------LSLYLDLSNNLLNGSLPLQVG--HLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDI------ 375 (833)
Q Consensus 311 ~p~~~~~~~~-------ll~~L~ls~N~l~~~~~~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~L------ 375 (833)
+|...+.... .++.|+|++|.++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus 472 i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~l 549 (636)
T 4eco_A 472 IPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549 (636)
T ss_dssp CCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCT
T ss_pred cCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCccc
Confidence 7766655441 3377888888888 6676665 78888888888888886 6777888888888888
Q ss_pred cCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccC
Q 040925 376 SSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVP 433 (833)
Q Consensus 376 s~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 433 (833)
++|++.+..|..+..+++|+.|+|++|+++ .+|..+. ++|+.||+++|++.+...
T Consensus 550 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKIT--PNISVLDIKDNPNISIDL 604 (636)
T ss_dssp TCCBCCCCCCTTGGGCSSCCEEECCSSCCC-BCCSCCC--TTCCEEECCSCTTCEEEC
T ss_pred ccCcccccChHHHhcCCCCCEEECCCCcCC-ccCHhHh--CcCCEEECcCCCCccccH
Confidence 456677777888888888888888888884 5666554 678888888888776543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=417.38 Aligned_cols=262 Identities=22% Similarity=0.304 Sum_probs=207.0
Q ss_pred cCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
.++++.+.||+|+||+||+|++. .+++.||||+++.... ...++|.+|+.++++++|||||+++|+|...+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~--- 102 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ--- 102 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS---
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC---
Confidence 35677899999999999999974 3578999999975433 34578999999999999999999999986654
Q ss_pred CceEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCee
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVL 674 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIl 674 (833)
..++|||||++|+|.+++...... .....+++.++.+|+.|||.||+|||++ +||||||||+|||
T Consensus 103 --~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NIL 177 (308)
T 4gt4_A 103 --PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVL 177 (308)
T ss_dssp --SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred --EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceE
Confidence 789999999999999999754321 1123689999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 675 LDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 675 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
+++++.+||+|||+|+........ .......||+.|||||++.+..|+.++|||| +|+++||++
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~------~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwS----------fGvvl~El~ 241 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYY------KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS----------YGVVLWEVF 241 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCB------CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCce------eEecccccCCcccCHHHHhCCCCCccchhhh----------HHHHHHHHH
Confidence 999999999999999876543221 1122357999999999999999999999999 778888888
Q ss_pred H-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 755 K-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 755 ~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
+ +..|+.... +..+........ ..+.++++++.+.+++.+||+.||++|||++||+++|+..
T Consensus 242 t~g~~Pf~~~~--~~~~~~~i~~~~------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 242 SYGLQPYCGYS--NQDVVEMIRNRQ------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TTTCCTTTTCC--HHHHHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred hCCCCCCCCCC--HHHHHHHHHcCC------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 7 666764221 111111111111 1123445778899999999999999999999999999864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=445.81 Aligned_cols=434 Identities=20% Similarity=0.183 Sum_probs=350.4
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
++|++++|+++ .+|..+. ++|++|++++|++++..|..|..+++|++|+|++|+|+++.|.+|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 58999999999 6887776 89999999999998888899999999999999999999888999999999999999999
Q ss_pred ccccccCchhhcCCCCccEEEccCCccee-eCCccccCCCCCcEEEcccCccccccCcCccCCCcC--ceEecccccC--
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFG-SIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNL--LWLNLEQNNL-- 156 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~L~~N~l-- 156 (833)
+++ .+|.. .+++|++|+|++|.+++ ..|..|+++++|++|+|++|+|++ ..|..+++| ++|+|++|.+
T Consensus 80 ~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~ 152 (520)
T 2z7x_B 80 KLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG 152 (520)
T ss_dssp CCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred cee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence 998 78876 79999999999999987 468999999999999999999985 468888888 9999999998
Q ss_pred CCCCCCCcccc--------------------cccCCCCCCCEEEccCCc-------CcccCChhHhhhcccccEEEccCc
Q 040925 157 GTGTATDLDFV--------------------TFLTNCSSLKALSLADNQ-------FGGELPHSIANLSSTVINFGIGRN 209 (833)
Q Consensus 157 ~~~~~~~~~~~--------------------~~l~~l~~L~~L~Ls~N~-------l~~~~p~~~~~l~~~l~~L~l~~n 209 (833)
....+..+... ..+.++++|+.|++++|+ +.+.+| .+..+. .++.|++++|
T Consensus 153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~-~L~~L~l~~~ 230 (520)
T 2z7x_B 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNP-KLSNLTLNNI 230 (520)
T ss_dssp SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCT-TCCEEEEEEE
T ss_pred cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhcccc-chhhcccccc
Confidence 43333222111 123457777777777776 554444 444443 4777777777
Q ss_pred cccccCChhhh---cCCCCCeEeccCCcccccCCccc-----cCCCCCCEEEcccccCcccCC-ccccCC---CCCCeEE
Q 040925 210 QISGTIPPGIR---NLVNLIGFGAEENQLHGTIPDAI-----GELKNLQKLCLFRNFLQGRIP-SGLGNL---TKLANLE 277 (833)
Q Consensus 210 ~i~~~~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~l---~~L~~L~ 277 (833)
.+++..+..+. ..++|++|++++|++.+.+|..+ +.+++|+.+++++|.+ .+| ..+..+ .+|+.|+
T Consensus 231 ~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~ 308 (520)
T 2z7x_B 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFT 308 (520)
T ss_dssp EEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEE
T ss_pred ccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEE
Confidence 77654333222 24578888888888887788777 7888888888888888 244 444444 6788888
Q ss_pred eecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCC--CCCcccccCCCcCEEeccCCc
Q 040925 278 LSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNG--SLPLQVGHLKNLVILDISSNQ 355 (833)
Q Consensus 278 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~--~~~~~~~~l~~L~~L~ls~N~ 355 (833)
+++|.+.... .+..+++|++|++++|++++.+|..+..+..+ ++|++++|.+++ ..|..|+.+++|++|++++|.
T Consensus 309 l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~ 385 (520)
T 2z7x_B 309 VSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTEL-ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385 (520)
T ss_dssp EESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSC-CEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSC
T ss_pred cCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCC-CEEEccCCccCccccchHHHhhCCCCCEEECCCCc
Confidence 8888876432 23678899999999999997788888888877 789999999986 345678899999999999999
Q ss_pred CCC-CCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCC
Q 040925 356 FSG-VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 356 l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
+++ +++..|..+++|++|++++|++++..|..+. ++|+.|++++|+++ .+|..+..+++|+.|++++|+++..++.
T Consensus 386 l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~ 462 (520)
T 2z7x_B 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDG 462 (520)
T ss_dssp CBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTT
T ss_pred CCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHH
Confidence 987 4445688899999999999999877766654 78999999999998 6777777999999999999999976665
Q ss_pred -CCccCCCccccccCCcCCCCC
Q 040925 435 -KGVFSNKTKISLQGNMKLCGG 455 (833)
Q Consensus 435 -~~~~~~~~~l~l~~N~~~c~~ 455 (833)
...+.+++.+++++|++.|..
T Consensus 463 ~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 463 IFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp TTTTCTTCCEEECCSSCBCCCH
T ss_pred HhccCCcccEEECcCCCCcccC
Confidence 566788889999999988854
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=448.33 Aligned_cols=436 Identities=21% Similarity=0.271 Sum_probs=307.2
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|++++..|.+|.++++|++|++++|++++..|++|+.+++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 28 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 107 (549)
T 2z81_A 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMG 107 (549)
T ss_dssp CCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTT
T ss_pred ccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCC
Confidence 56777777777766677777777777777777777777777777777777777777777766666677777777777777
Q ss_pred cccccccCchhhcCCCCccEEEccCCc-ceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNN-FFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTG 159 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 159 (833)
|++++.-.+..|.++++|++|+|++|. +....+..|.++++|++|++++|++++..+..|..+++|++|++++|.+..+
T Consensus 108 n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~ 187 (549)
T 2z81_A 108 NPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187 (549)
T ss_dssp CCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTH
T ss_pred CcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCccccc
Confidence 777621122456677777777777776 4444445677777777777777777776777777777777777766665432
Q ss_pred CCCCcccccccCCCCCCCEEEccCCcCcccC--ChhHhhhcccccEEEccCccccccCChh----hhcCCCCCeEeccCC
Q 040925 160 TATDLDFVTFLTNCSSLKALSLADNQFGGEL--PHSIANLSSTVINFGIGRNQISGTIPPG----IRNLVNLIGFGAEEN 233 (833)
Q Consensus 160 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~~l~~L~l~~n~i~~~~~~~----~~~l~~L~~L~L~~N 233 (833)
+. ..+..+++|++|++++|++++.. |..+......++.|++++|.+++..+.. +..+++|+.|++++|
T Consensus 188 ~~------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~ 261 (549)
T 2z81_A 188 LE------IFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDC 261 (549)
T ss_dssp HH------HHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESC
T ss_pred ch------hhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccc
Confidence 21 11334667777777777766421 2222233334555666665555433322 234455555555555
Q ss_pred cccccC-----------------------------------CccccCCCCCCEEEcccccCcccCCccc-cCCCCCCeEE
Q 040925 234 QLHGTI-----------------------------------PDAIGELKNLQKLCLFRNFLQGRIPSGL-GNLTKLANLE 277 (833)
Q Consensus 234 ~l~~~~-----------------------------------~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~ 277 (833)
.+.+.. +..+...++|++|++++|.+. .+|..+ .++++|++|+
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~ 340 (549)
T 2z81_A 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLD 340 (549)
T ss_dssp EEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEE
T ss_pred cccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEE
Confidence 544321 111233457888888888887 566555 5789999999
Q ss_pred eecccccCCCC---CCCCCCCccceeecCCceecccCC---cccccccccceeeecCCCccCCCCCcccccCCCcCEEec
Q 040925 278 LSSNSLQGNIP---SSLGNCQNLMSFTASQNKLTGALP---HQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDI 351 (833)
Q Consensus 278 L~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~p---~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~l 351 (833)
|++|++++..| ..++.+++|+.|++++|++++ +| ..+..+..+ ++|++++|+++ .+|..+..+++|++|++
T Consensus 341 Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~~~l~~L-~~L~Ls~N~l~-~lp~~~~~~~~L~~L~L 417 (549)
T 2z81_A 341 LSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS-MQKTGEILLTLKNL-TSLDISRNTFH-PMPDSCQWPEKMRFLNL 417 (549)
T ss_dssp CCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCC-HHHHHHHGGGCTTC-CEEECTTCCCC-CCCSCCCCCTTCCEEEC
T ss_pred ccCCccccccccchhhhhccccCcEEEccCCcccc-cccchhhhhcCCCC-CEEECCCCCCc-cCChhhcccccccEEEC
Confidence 99999987653 457888999999999999984 33 345666666 78999999998 67888888999999999
Q ss_pred cCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccc
Q 040925 352 SSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGE 431 (833)
Q Consensus 352 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 431 (833)
++|+++.+ |..+ .++|++|+|++|++++.+ ..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|++++.
T Consensus 418 s~N~l~~l-~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~ 488 (549)
T 2z81_A 418 SSTGIRVV-KTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSV 488 (549)
T ss_dssp TTSCCSCC-CTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCC
T ss_pred CCCCcccc-cchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCc
Confidence 99999844 3333 258999999999998653 57889999999999998 4555 46789999999999999998
Q ss_pred cCC-CCccCCCccccccCCcCCCCC
Q 040925 432 VPT-KGVFSNKTKISLQGNMKLCGG 455 (833)
Q Consensus 432 ~~~-~~~~~~~~~l~l~~N~~~c~~ 455 (833)
+|. ...+.+++.+++++|+|.|..
T Consensus 489 ~~~~~~~l~~L~~L~l~~N~~~~~~ 513 (549)
T 2z81_A 489 PDGIFDRLTSLQKIWLHTNPWDCSC 513 (549)
T ss_dssp CTTGGGGCTTCCEEECCSSCBCCCH
T ss_pred CHHHHhcCcccCEEEecCCCccCCC
Confidence 886 467888999999999998854
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-50 Score=414.75 Aligned_cols=250 Identities=20% Similarity=0.304 Sum_probs=208.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++|||||++++++.+.+ .
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----K 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence 5799999999999999999999999999999999743 2334567999999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+|||||+||+|.+++...+ .+++.+++.|+.||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFG 177 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 177 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcC
Confidence 999999999999999998654 799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+.+..... .......+||+.|||||++.+..|+.++|||| .|+++|++++|..|+.....
T Consensus 178 la~~~~~~~~------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWS----------lGvilyeml~G~~PF~~~~~-- 239 (311)
T 4aw0_A 178 TAKVLSPESK------QARANSFVGTAQYVSPELLTEKSACKSSDLWA----------LGCIIYQLVAGLPPFRAGNE-- 239 (311)
T ss_dssp TCEECCTTTT------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHH----------HHHHHHHHHHSSCSSCCSSH--
T ss_pred CceecCCCCC------cccccCcccCcccCCHHHHcCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCH--
Confidence 9987654321 12233568999999999999999999999999 89999999999999863221
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
............. .++.+++++.+++.+||+.||++|||++|++.
T Consensus 240 ~~~~~~i~~~~~~-------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 240 GLIFAKIIKLEYD-------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp HHHHHHHHHTCCC-------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred HHHHHHHHcCCCC-------CCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 1111111111111 12234567889999999999999999998743
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=425.66 Aligned_cols=251 Identities=21% Similarity=0.289 Sum_probs=209.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
+.|++.+.||+|+||.||+|+++.+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+ ..|+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~-----~~~i 225 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGD-----ELWV 225 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECC-----EEEE
Confidence 56999999999999999999999999999999998766666778999999999999999999999977655 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
|||||+||+|.+++... .+++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+
T Consensus 226 VmEy~~gG~L~~~i~~~-------~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~ 295 (423)
T 4fie_A 226 VMEFLEGGALTDIVTHT-------RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA 295 (423)
T ss_dssp EEECCTTEEHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCE
T ss_pred EEeCCCCCcHHHHHhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccce
Confidence 99999999999999753 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
.+.... ......+||+.|||||++.+..|+.++|||| .|+++|++++|..|+......+ .
T Consensus 296 ~~~~~~--------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWS----------lGvilyeml~G~~PF~~~~~~~--~ 355 (423)
T 4fie_A 296 QVSKEV--------PRRKSLVGTPYWMAPELISRLPYGPEVDIWS----------LGIMVIEMVDGEPPYFNEPPLK--A 355 (423)
T ss_dssp ECCSSC--------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCTTTTSCHHH--H
T ss_pred ECCCCC--------ccccccccCcCcCCHHHHCCCCCCcHHHHHH----------HHHHHHHHHHCCCCCCCcCHHH--H
Confidence 765422 1223468999999999999999999999999 8999999999999975322111 1
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ..+.... .........+++.+.+++.+||..||++|||++|+++.
T Consensus 356 ~-~~i~~~~---~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 356 M-KMIRDNL---PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp H-HHHHHSC---CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred H-HHHHcCC---CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1111100 00011122345678899999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=404.87 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=199.9
Q ss_pred CC-ccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 532 EF-SSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y-~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
+| ++.+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++|||||++++++.+.. .+....
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~ 104 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI 104 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEE
Confidence 44 56678999999999999999999999999997442 223467999999999999999999999976531 234578
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceeeCCCCCCeeec-CCCcEEEcc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP--MVHGDLKPSNVLLD-HDMVAHVCD 685 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~D 685 (833)
|+|||||++|+|.+++.+.. .+++..++.|+.||+.||+|||++ + ||||||||+|||++ .++.+||+|
T Consensus 105 ~lvmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~D 175 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEe
Confidence 99999999999999998654 789999999999999999999998 6 99999999999997 479999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+|+..... .....+||+.|||||++.+ .|+.++|||| +|+++|+++++..|+....
T Consensus 176 FGla~~~~~~----------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwS----------lGvilyelltg~~Pf~~~~- 233 (290)
T 3fpq_A 176 LGLATLKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYA----------FGMCMLEMATSEYPYSECQ- 233 (290)
T ss_dssp TTGGGGCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHH----------HHHHHHHHHHSSCTTTTCS-
T ss_pred CcCCEeCCCC----------ccCCcccCccccCHHHcCC-CCCcHHHHHH----------HHHHHHHHHHCCCCCCCCC-
Confidence 9999754321 1234679999999998865 6999999999 8999999999999985221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+.......+...... ...+..+++++.+++.+||+.||++|||++|+++.
T Consensus 234 -~~~~~~~~i~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 234 -NAAQIYRRVTSGVKP----ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -SHHHHHHHHTTTCCC----GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -cHHHHHHHHHcCCCC----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111111111100 01112234568899999999999999999999763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=401.65 Aligned_cols=248 Identities=27% Similarity=0.374 Sum_probs=192.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|++++++++|||||++++++.+.+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~----- 86 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD----- 86 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC-----
Confidence 478999999999999999999999999999999997442 233467999999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||| +|+|.+++...+ .+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 87 ~~~ivmEy~-~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DF 156 (275)
T 3hyh_A 87 EIIMVIEYA-GNELFDYIVQRD------KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADF 156 (275)
T ss_dssp EEEEEEECC-CEEHHHHHHHSC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCS
T ss_pred EEEEEEeCC-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeec
Confidence 899999999 679999998765 799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|+|+...... .....+||+.|||||++.+..+ +.++|||| .|+++|+++++..|+.....
T Consensus 157 Gla~~~~~~~---------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwS----------lGvily~lltg~~PF~~~~~ 217 (275)
T 3hyh_A 157 GLSNIMTDGN---------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWS----------CGVILYVMLCRRLPFDDESI 217 (275)
T ss_dssp SCC------------------------CTTSCHHHHSSSSCCCTHHHHHH----------HHHHHHHHHHSSCSSCCSSH
T ss_pred CCCeecCCCC---------ccCCeeECcccCChhhhcCCCCCCChhhhHH----------HHHHHHHHHHCCCCCCCCCH
Confidence 9998654422 1223579999999999998886 57999999 89999999999999863211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
............ ..+..+++.+.+++.+||+.||++|||++|+++.
T Consensus 218 --~~~~~~i~~~~~-------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 218 --PVLFKNISNGVY-------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp --HHHHHHHHHTCC-------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred --HHHHHHHHcCCC-------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111111111 1122345678899999999999999999999874
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=454.68 Aligned_cols=435 Identities=20% Similarity=0.221 Sum_probs=360.1
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEc-cCCcccccCCccC------------------------------------
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRI-MGNSLGGKIPTTL------------------------------------ 43 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l-~~n~l~~~~~~~~------------------------------------ 43 (833)
++.|+|++|+++|.+|++|++|++|++|+| ++|.+.+..|-..
T Consensus 325 V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~ 404 (876)
T 4ecn_A 325 VTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLL 404 (876)
T ss_dssp EEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHH
T ss_pred EEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHH
Confidence 367999999999999999999999999999 8998766533210
Q ss_pred ---------------CCCCCCCEEEcCC--CcccccCCccccCCCCCcEEECCCccccc-----------------ccCc
Q 040925 44 ---------------GLLRNLVSLNVAE--NKFSGMFPRSICNISSLELIQLALNRFSG-----------------NLPF 89 (833)
Q Consensus 44 ---------------~~l~~L~~L~L~~--n~i~~~~~~~~~~l~~L~~L~L~~N~l~~-----------------~~~~ 89 (833)
.....++.+.+.. |++++ +|..|+++++|+.|+|++|++++ .+|.
T Consensus 405 ~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~ 483 (876)
T 4ecn_A 405 QDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE 483 (876)
T ss_dssp HHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS
T ss_pred HHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCCh
Confidence 1223344444544 88887 89999999999999999999996 3887
Q ss_pred hh-hcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCc-ccc-ccCcCccCC-------CcCceEecccccCCCC
Q 040925 90 DI-VVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQ-FKG-NVSIDFSSL-------KNLLWLNLEQNNLGTG 159 (833)
Q Consensus 90 ~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~-~~~~~~~~l-------~~L~~L~L~~N~l~~~ 159 (833)
.+ |.++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ +++ ..|..|..+ ++|++|+|++|+++.+
T Consensus 484 ~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~i 563 (876)
T 4ecn_A 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEF 563 (876)
T ss_dssp CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBC
T ss_pred hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCcc
Confidence 76 6699999999999999999999999999999999999998 887 455555544 5999999999999854
Q ss_pred CCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCC-CCeEeccCCccccc
Q 040925 160 TATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVN-LIGFGAEENQLHGT 238 (833)
Q Consensus 160 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~-L~~L~L~~N~l~~~ 238 (833)
+. ...+.++++|++|+|++|+++ .+| .+..+. .++.|++++|+++ .+|..+.++++ |+.|+|++|+++ .
T Consensus 564 p~-----~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~-~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~ 633 (876)
T 4ecn_A 564 PA-----SASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV-KLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-Y 633 (876)
T ss_dssp CC-----HHHHTTCTTCCEEECTTSCCC-BCC-CCCTTS-EESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-S
T ss_pred CC-----hhhhhcCCCCCEEECCCCCcc-cch-hhcCCC-cceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-c
Confidence 42 015889999999999999999 888 676665 4889999999999 88888999999 999999999999 6
Q ss_pred CCccccCCCC--CCEEEcccccCcccCCccc---c--CCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccC
Q 040925 239 IPDAIGELKN--LQKLCLFRNFLQGRIPSGL---G--NLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGAL 311 (833)
Q Consensus 239 ~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 311 (833)
+|..|..+.. |+.|+|++|.+.+.+|... . .+++|+.|+|++|+++...+..+..+++|+.|+|++|+++ .+
T Consensus 634 lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~-~i 712 (876)
T 4ecn_A 634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SI 712 (876)
T ss_dssp CCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCS-CC
T ss_pred CchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCC-cc
Confidence 7888887754 9999999999998666432 2 3458999999999999544445568999999999999999 88
Q ss_pred Cccccccc--------ccceeeecCCCccCCCCCcccc--cCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecC----
Q 040925 312 PHQLLSIT--------TLSLYLDLSNNLLNGSLPLQVG--HLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISS---- 377 (833)
Q Consensus 312 p~~~~~~~--------~ll~~L~ls~N~l~~~~~~~~~--~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~---- 377 (833)
|..++... .+ +.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++
T Consensus 713 p~~~~~~~~~~l~nl~~L-~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~l 789 (876)
T 4ecn_A 713 PENSLKPKDGNYKNTYLL-TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA 789 (876)
T ss_dssp CTTSSSCTTSCCTTGGGC-CEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCT
T ss_pred ChHHhccccccccccCCc-cEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCc
Confidence 88776654 44 89999999999 6788887 99999999999999997 688899999999999977
Q ss_pred --CccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCC-ccCCCccccccCCcCCC
Q 040925 378 --NSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKG-VFSNKTKISLQGNMKLC 453 (833)
Q Consensus 378 --N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~-~~~~~~~l~l~~N~~~c 453 (833)
|++.+..|..+..+++|+.|+|++|++ +.+|..+. ++|+.|||++|++....+... .........+.+|++.|
T Consensus 790 s~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~ 865 (876)
T 4ecn_A 790 EGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865 (876)
T ss_dssp TCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSE
T ss_pred ccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccc
Confidence 888889999999999999999999999 57777765 699999999999987654321 12233445566666543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=408.29 Aligned_cols=272 Identities=24% Similarity=0.288 Sum_probs=202.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... .......|+..+.+++|||||+++|+|...+ ......|+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEE
Confidence 4688889999999999999998 588999999964321 1222345666667889999999999987653 12236899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhc-----CCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH-----CQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
|||||++|+|.++++.. .+++..+.+++.|++.||+|||++ ..++||||||||+|||++.++.+||+|
T Consensus 79 V~Ey~~~gsL~~~l~~~-------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EecCCCCCcHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 99999999999999764 589999999999999999999976 245899999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCC------CCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS------EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
||+|+......... .......+||+.|||||++.+. .++.++|||| +|+++||++++..|
T Consensus 152 FGla~~~~~~~~~~----~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS----------~Gvvl~El~tg~~~ 217 (303)
T 3hmm_A 152 LGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA----------MGLVFWEIARRCSI 217 (303)
T ss_dssp CTTCEEEETTTTEE----SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHH----------HHHHHHHHHHTBCB
T ss_pred CCCCccccCCCCce----eeecccccccccccCHHHhcccccccCCccChhHhhhh----------HHHHHHHHHHCCCC
Confidence 99998764432111 1122345799999999998764 4788999999 88899999998766
Q ss_pred Cccccccc----------cc---chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 760 EKVMEIVD----------PS---LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 760 ~~~~~~~~----------~~---~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
+....... +. .....................++++.+.+++.+||+.||++||||.||++.|+++.+
T Consensus 218 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp TTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 43211100 00 000011111111111223344577889999999999999999999999999999876
Q ss_pred h
Q 040925 827 T 827 (833)
Q Consensus 827 ~ 827 (833)
.
T Consensus 298 ~ 298 (303)
T 3hmm_A 298 Q 298 (303)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=436.82 Aligned_cols=419 Identities=20% Similarity=0.215 Sum_probs=357.1
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCccccc-CCccccCCCCCcEEECC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGM-FPRSICNISSLELIQLA 79 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~L~ 79 (833)
|++|++++|++++..|++|.++++|++|++++|++++..|..|+.+++|++|+|++|++++. .|..|.++++|++|+++
T Consensus 52 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~ 131 (549)
T 2z81_A 52 LQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131 (549)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEE
T ss_pred ccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECC
Confidence 78999999999998889999999999999999999888888899999999999999999864 57889999999999999
Q ss_pred CcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCC
Q 040925 80 LNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTG 159 (833)
Q Consensus 80 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~ 159 (833)
+|.+.+.+|...|.++++|++|+|++|.+++..|..|..+++|++|++++|.+..++...+..+++|++|+|++|+++..
T Consensus 132 ~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~ 211 (549)
T 2z81_A 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211 (549)
T ss_dssp ESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTC
T ss_pred CCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccc
Confidence 99955588888899999999999999999999999999999999999999999877766677899999999999999876
Q ss_pred CCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhh---cccccEEEccCccccccC---------------------
Q 040925 160 TATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANL---SSTVINFGIGRNQISGTI--------------------- 215 (833)
Q Consensus 160 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~~l~~L~l~~n~i~~~~--------------------- 215 (833)
+.... .....+++|+.|++++|++++..+..+... ...++.+++++|.+.+..
T Consensus 212 ~~~~~---~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l 288 (549)
T 2z81_A 212 QFSPL---PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288 (549)
T ss_dssp CCCCC---SSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEE
T ss_pred ccccc---chhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccc
Confidence 43221 224567889999999999887666655433 234667777777765421
Q ss_pred --------------ChhhhcCCCCCeEeccCCcccccCCcc-ccCCCCCCEEEcccccCcccCC---ccccCCCCCCeEE
Q 040925 216 --------------PPGIRNLVNLIGFGAEENQLHGTIPDA-IGELKNLQKLCLFRNFLQGRIP---SGLGNLTKLANLE 277 (833)
Q Consensus 216 --------------~~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~ 277 (833)
+..+..+.+|+.|++++|++.. +|.. +..+++|++|+|++|.+++..| ..+..+++|++|+
T Consensus 289 ~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~-ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~ 367 (549)
T 2z81_A 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLV 367 (549)
T ss_dssp ESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCC-CCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEE
T ss_pred cccccchhhhcccchhhhhhcccceEEEeccCcccc-CCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEE
Confidence 1123445689999999999984 5554 4689999999999999997664 3478899999999
Q ss_pred eecccccCCCC--CCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCc
Q 040925 278 LSSNSLQGNIP--SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQ 355 (833)
Q Consensus 278 L~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~ 355 (833)
|++|++++..+ ..+..+++|++|++++|+++ .+|..+..+..+ ++|++++|.++. +|..+ .++|++|++++|+
T Consensus 368 Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L-~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~ 442 (549)
T 2z81_A 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKM-RFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNN 442 (549)
T ss_dssp CTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTC-CEEECTTSCCSC-CCTTS--CTTCSEEECCSSC
T ss_pred ccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccc-cEEECCCCCccc-ccchh--cCCceEEECCCCC
Confidence 99999986543 56889999999999999999 789888877777 899999999984 44443 3689999999999
Q ss_pred CCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCC
Q 040925 356 FSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 356 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
+++.+ ..+++|++|+|++|+|+. +|. ...+++|+.|+|++|++++.+|..+..+++|+.|++++|+|+|.+|.
T Consensus 443 l~~~~----~~l~~L~~L~Ls~N~l~~-ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 443 LDSFS----LFLPRLQELYISRNKLKT-LPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp CSCCC----CCCTTCCEEECCSSCCSS-CCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred hhhhc----ccCChhcEEECCCCccCc-CCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 98653 578999999999999995 454 46799999999999999999999999999999999999999999984
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=447.95 Aligned_cols=417 Identities=18% Similarity=0.202 Sum_probs=348.4
Q ss_pred CCCCEEEccCCcccccCCccCCCCCCCCEEEc-CCCcccccCCccc----------------------------------
Q 040925 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNV-AENKFSGMFPRSI---------------------------------- 67 (833)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L-~~n~i~~~~~~~~---------------------------------- 67 (833)
..++.|+|++|.+.+.+|+.|+.|++|++|+| ++|.+++..|-.-
T Consensus 323 ~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~ 402 (876)
T 4ecn_A 323 GRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSD 402 (876)
T ss_dssp SCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCH
T ss_pred CCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhH
Confidence 57999999999999999999999999999999 9998876532110
Q ss_pred -----------------cCCCCCcEEECCC--cccccccCchhhcCCCCccEEEccCCccee-----------------e
Q 040925 68 -----------------CNISSLELIQLAL--NRFSGNLPFDIVVNLPNLKALAIGGNNFFG-----------------S 111 (833)
Q Consensus 68 -----------------~~l~~L~~L~L~~--N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-----------------~ 111 (833)
.....++.+.+.. |++++ +|.. |.++++|++|+|++|.|++ .
T Consensus 403 l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~-l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~ 480 (876)
T 4ecn_A 403 LLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKA-IQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480 (876)
T ss_dssp HHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGG-GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHH
T ss_pred HHHHHhhhCccccccccccccchhhceeccccCcccc-hhHH-HhcCCCCCEEECcCCcCCCCccccccccccccccccc
Confidence 1222344444444 88985 8864 6899999999999999997 3
Q ss_pred CCcccc--CCCCCcEEEcccCccccccCcCccCCCcCceEeccccc-CCC--CCCCCcccc-cccCCCCCCCEEEccCCc
Q 040925 112 IPYSLS--NASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNN-LGT--GTATDLDFV-TFLTNCSSLKALSLADNQ 185 (833)
Q Consensus 112 ~~~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~--~~~~~~~~~-~~l~~l~~L~~L~Ls~N~ 185 (833)
+|..++ ++++|++|+|++|++.+..|..|.++++|++|+|++|+ ++. ++.. +... ..+..+++|++|+|++|+
T Consensus 481 iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~-i~~L~~~~~~l~~L~~L~Ls~N~ 559 (876)
T 4ecn_A 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD-WTRLADDEDTGPKIQIFYMGYNN 559 (876)
T ss_dssp TTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHH-HHHHHHCTTTTTTCCEEECCSSC
T ss_pred CChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHH-HHhhhhcccccCCccEEEeeCCc
Confidence 888877 99999999999999998999999999999999999998 753 2221 1111 135567799999999999
Q ss_pred CcccCCh--hHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCC-CCEEEcccccCccc
Q 040925 186 FGGELPH--SIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKN-LQKLCLFRNFLQGR 262 (833)
Q Consensus 186 l~~~~p~--~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~l~~~ 262 (833)
++ .+|. .+.++. .++.|++++|+++ .+| .|..+++|+.|+|++|++. .+|..|..+++ |++|+|++|.|+ .
T Consensus 560 L~-~ip~~~~l~~L~-~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~ 633 (876)
T 4ecn_A 560 LE-EFPASASLQKMV-KLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-Y 633 (876)
T ss_dssp CC-BCCCHHHHTTCT-TCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-S
T ss_pred CC-ccCChhhhhcCC-CCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-c
Confidence 99 8998 888876 4899999999999 777 9999999999999999999 78888999999 999999999999 6
Q ss_pred CCccccCCCC--CCeEEeecccccCCCCCCC---C--CCCccceeecCCceecccCCcccc-cccccceeeecCCCccCC
Q 040925 263 IPSGLGNLTK--LANLELSSNSLQGNIPSSL---G--NCQNLMSFTASQNKLTGALPHQLL-SITTLSLYLDLSNNLLNG 334 (833)
Q Consensus 263 ~~~~~~~l~~--L~~L~L~~N~l~~~~~~~~---~--~l~~L~~L~l~~N~l~~~~p~~~~-~~~~ll~~L~ls~N~l~~ 334 (833)
+|..+..++. |+.|+|++|++.+.+|... . .+++|+.|++++|+++ .+|..++ .+..+ +.|+|++|.++.
T Consensus 634 lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L-~~L~Ls~N~L~~ 711 (876)
T 4ecn_A 634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPI-STIILSNNLMTS 711 (876)
T ss_dssp CCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCC-SEEECCSCCCSC
T ss_pred CchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCC-CEEECCCCcCCc
Confidence 8888887755 9999999999998766433 2 3458999999999999 7888877 45555 899999999994
Q ss_pred CCCcccccC-------CCcCEEeccCCcCCCCCCcccc--CCCCCcEEeecCCccccccCccccCCCCCCeEEccC----
Q 040925 335 SLPLQVGHL-------KNLVILDISSNQFSGVIPGTLS--TCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS---- 401 (833)
Q Consensus 335 ~~~~~~~~l-------~~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~---- 401 (833)
+.+..+... ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++
T Consensus 712 ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~l 789 (876)
T 4ecn_A 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDA 789 (876)
T ss_dssp CCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCT
T ss_pred cChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCc
Confidence 433334332 39999999999999 6677776 99999999999999997 688899999999999976
Q ss_pred --cccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCC
Q 040925 402 --NNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCG 454 (833)
Q Consensus 402 --N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~ 454 (833)
|++.+.+|..+.++++|+.|+|++|++.. +|.. ..++++.+++++|++..-
T Consensus 790 s~N~l~~~ip~~l~~L~~L~~L~Ls~N~L~~-Ip~~-l~~~L~~LdLs~N~l~~i 842 (876)
T 4ecn_A 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEK-LTPQLYILDIADNPNISI 842 (876)
T ss_dssp TCCBCCCCCCTTGGGCSSCCEEECCSSCCCB-CCSC-CCSSSCEEECCSCTTCEE
T ss_pred ccccccccChHHHhcCCCCCEEECCCCCCCc-cCHh-hcCCCCEEECCCCCCCcc
Confidence 88899999999999999999999999954 4443 246899999999987543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=414.49 Aligned_cols=277 Identities=21% Similarity=0.302 Sum_probs=214.9
Q ss_pred cchHHHHHHhcCCccCceeccCcceEEEEEEECCC-----ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCC-CccceE
Q 040925 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGED-----EMIVAVKVINLKYK-GASRSFVAECEALRNIRH-RNLIKI 593 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~ 593 (833)
++.++++...++|++.+.||+|+||+||+|++... ++.||||+++.... ...+.+.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 34455666678999999999999999999998643 47899999975433 234679999999999975 999999
Q ss_pred eeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 040925 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPM 663 (833)
Q Consensus 594 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 663 (833)
+|+|...+ ...++|||||++|+|.++++..... .....+++.++..|+.|||.||+|||++ +|
T Consensus 134 ~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~i 206 (353)
T 4ase_A 134 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC 206 (353)
T ss_dssp EEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ce
Confidence 99985432 3689999999999999999764321 0122589999999999999999999999 99
Q ss_pred eeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCcc
Q 040925 664 VHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAV 743 (833)
Q Consensus 664 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~ 743 (833)
|||||||+|||+++++.+||+|||+|+.+...... .......||+.|||||++.+..|+.++||||
T Consensus 207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~------~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS-------- 272 (353)
T 4ase_A 207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWS-------- 272 (353)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHH--------
T ss_pred ecCccCccceeeCCCCCEEECcchhhhhcccCCCc------eeeccccccccccCHHHHhcCCCCCcccEee--------
Confidence 99999999999999999999999999876443211 1122357999999999999999999999999
Q ss_pred ccCCccHHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 744 FNEGHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 744 ~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
+|+++||+++ +..|+..... +..+........ ....++.+++++.+++.+||+.||++|||+.||+++|+
T Consensus 273 --~Gv~l~El~t~G~~Pf~~~~~-~~~~~~~i~~g~------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~ 343 (353)
T 4ase_A 273 --FGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 343 (353)
T ss_dssp --HHHHHHHHTTTSCCSSTTCCC-SHHHHHHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --hHHHHHHHHhCCCCCCCCCCH-HHHHHHHHHcCC------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 7777788776 6777642211 111111111110 11123345678899999999999999999999999999
Q ss_pred Hhhhh
Q 040925 823 HTRET 827 (833)
Q Consensus 823 ~i~~~ 827 (833)
.+.++
T Consensus 344 ~llq~ 348 (353)
T 4ase_A 344 NLLQA 348 (353)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 98764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=404.24 Aligned_cols=248 Identities=21% Similarity=0.266 Sum_probs=196.0
Q ss_pred cCCccCceeccCcceEEEEEEEC---CCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
++|++.+.||+|+||+||+|++. .+++.||||+++... ......+.+|++++++++|||||++++++.+.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~---- 99 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG---- 99 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT----
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC----
Confidence 57999999999999999999873 468899999997432 223456889999999999999999999976655
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..|+|||||+||+|.+++.+.+ .+++.+++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|
T Consensus 100 -~~~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~D 169 (304)
T 3ubd_A 100 -KLYLILDFLRGGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTD 169 (304)
T ss_dssp -EEEEEECCCTTCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEES
T ss_pred -EEEEEEEcCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecc
Confidence 8999999999999999998754 799999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+|+...... ......+||+.|||||++.+..|+.++|||| .|+++|+++++..|+.....
T Consensus 170 FGla~~~~~~~--------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwS----------lGvilyemltG~~PF~~~~~ 231 (304)
T 3ubd_A 170 FGLSKESIDHE--------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWS----------FGVLMFEMLTGTLPFQGKDR 231 (304)
T ss_dssp SEEEEC-------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHH----------HHHHHHHHHHSSCSSCCSSH
T ss_pred cccceeccCCC--------ccccccccCcccCCHHHhccCCCCCCCcccc----------hHHHHHHHHhCCCCCCCcCH
Confidence 99998654322 1223467999999999999999999999999 89999999999999863221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH-----HHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM-----RDVVA 819 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~ 819 (833)
. ........... ..+..+++.+.+++.+||+.||++|||+ +|+++
T Consensus 232 ~--~~~~~i~~~~~-------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 232 K--ETMTMILKAKL-------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp H--HHHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred H--HHHHHHHcCCC-------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1 11111111111 1123356678999999999999999984 56664
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=433.74 Aligned_cols=445 Identities=20% Similarity=0.183 Sum_probs=293.5
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
+++|||++|+|+++.|.+|.++++|++|+|++|+|+++.|++|..+++|++|+|++|+|+++.+.+|.++++|++|+|++
T Consensus 54 ~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~ 133 (635)
T 4g8a_A 54 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 133 (635)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTT
T ss_pred CCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCC
Confidence 35666666666655555666666666666666666666666666666666666666666655556666666666666666
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceee-CCccccCCCCCcEEEcccCccccccCcCccCCCcCc----eEeccccc
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGS-IPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLL----WLNLEQNN 155 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~----~L~L~~N~ 155 (833)
|+++ .+|...|.++++|++|+|++|.++.. .|..++.+++|++|+|++|+|+++.+..|..+.+++ .++++.|.
T Consensus 134 N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~ 212 (635)
T 4g8a_A 134 TNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 212 (635)
T ss_dssp SCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred CcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence 6665 55655666666666666666666542 355566666666666666666666666655554433 45556665
Q ss_pred CCCCCCCCcccccccCCCCCCCEEEccCCcCcccCCh-hHhh--------------------------------------
Q 040925 156 LGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPH-SIAN-------------------------------------- 196 (833)
Q Consensus 156 l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~-------------------------------------- 196 (833)
++.++...+ ....++.|++++|.....++. .+..
T Consensus 213 l~~i~~~~~-------~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~ 285 (635)
T 4g8a_A 213 MNFIQPGAF-------KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE 285 (635)
T ss_dssp CCEECTTTT-------TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEE
T ss_pred ccccCcccc-------cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhh
Confidence 554433211 111222333333322110000 0000
Q ss_pred ------------------hcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCc-----------------
Q 040925 197 ------------------LSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPD----------------- 241 (833)
Q Consensus 197 ------------------l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----------------- 241 (833)
....+..+.+.+|.+... ..+....+|+.|++.+|.+....+.
T Consensus 286 l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~ 363 (635)
T 4g8a_A 286 FRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGN 363 (635)
T ss_dssp EEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCC
T ss_pred hhhhhhcccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcccchhhhhcccccccCCC
Confidence 001122222333322211 1233334455555555544332221
Q ss_pred --cccCCCCCCEEEcccccCcc--cCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCccccc
Q 040925 242 --AIGELKNLQKLCLFRNFLQG--RIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLS 317 (833)
Q Consensus 242 --~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~ 317 (833)
.+..+++|+.|++++|.+.. ..+..+..+.+|+.|+++.|.+. ..+..+..+++|+.+++++|......+...+.
T Consensus 364 ~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~ 442 (635)
T 4g8a_A 364 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 442 (635)
T ss_dssp BCCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTT
T ss_pred Ccccccccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccc
Confidence 22346677777777777653 24445566777777777777776 34566888999999999998887665554443
Q ss_pred ccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcC-CCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCe
Q 040925 318 ITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQF-SGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKE 396 (833)
Q Consensus 318 ~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 396 (833)
....+..+++++|.+.+..+..+..++.|+.|++++|.+ .+..|..|..+++|++|+|++|+|+++.|..|.++++|++
T Consensus 443 ~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~ 522 (635)
T 4g8a_A 443 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 522 (635)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCE
Confidence 333347899999999988899999999999999999975 4567889999999999999999999999999999999999
Q ss_pred EEccCcccCCCchhhhcCCCCCceEECccCcCccccCCC-Ccc-CCCccccccCCcCCCCCc
Q 040925 397 LNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK-GVF-SNKTKISLQGNMKLCGGI 456 (833)
Q Consensus 397 L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~-~~~-~~~~~l~l~~N~~~c~~~ 456 (833)
|+|++|+|++..|..|..+++|+.|||++|++++.+|.. ..+ .+++.+++++|||.|.+.
T Consensus 523 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 523 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999999999999999999999999999988865 334 678999999999999654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=440.04 Aligned_cols=415 Identities=17% Similarity=0.241 Sum_probs=353.7
Q ss_pred CCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCcccc----------------------------------
Q 040925 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSIC---------------------------------- 68 (833)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~---------------------------------- 68 (833)
.+++.|+|++|.+.+.+|.+|+.+++|++|+|++|.+. ..+..++
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~-~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~ 159 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK-VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS 159 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGG-GTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSC
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccc-cCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHH
Confidence 57999999999999999999999999999999999762 1111111
Q ss_pred -------------------CCCCCcEEECC--CcccccccCchhhcCCCCccEEEccCCcceee----------------
Q 040925 69 -------------------NISSLELIQLA--LNRFSGNLPFDIVVNLPNLKALAIGGNNFFGS---------------- 111 (833)
Q Consensus 69 -------------------~l~~L~~L~L~--~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~---------------- 111 (833)
....++.+.+. .|++++ +|.. |.++++|++|+|++|.+++.
T Consensus 160 ~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~ 237 (636)
T 4eco_A 160 DLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKA-VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237 (636)
T ss_dssp HHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGG-GGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHH
T ss_pred HHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHH-HhcccCCCEEECcCCccccccccccccccccchhcc
Confidence 11122222232 688986 8864 68999999999999999975
Q ss_pred -CCcccc--CCCCCcEEEcccCccccccCcCccCCCcCceEeccccc-CCCCCCCCcccccccCC------CCCCCEEEc
Q 040925 112 -IPYSLS--NASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNN-LGTGTATDLDFVTFLTN------CSSLKALSL 181 (833)
Q Consensus 112 -~~~~~~--~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~l~~------l~~L~~L~L 181 (833)
+|..++ ++++|++|+|++|++.+..|..|.++++|++|+|++|+ ++. ...|..+.+ +++|++|+|
T Consensus 238 ~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~-----~~lp~~~~~L~~~~~l~~L~~L~L 312 (636)
T 4eco_A 238 YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG-----EQLKDDWQALADAPVGEKIQIIYI 312 (636)
T ss_dssp HTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCH-----HHHHHHHHHHHHSGGGGTCCEEEC
T ss_pred cCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCcc-----ccchHHHHhhhccccCCCCCEEEC
Confidence 899998 99999999999999999999999999999999999998 753 012333444 499999999
Q ss_pred cCCcCcccCCh--hHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCC-CCEEEccccc
Q 040925 182 ADNQFGGELPH--SIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKN-LQKLCLFRNF 258 (833)
Q Consensus 182 s~N~l~~~~p~--~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~-L~~L~L~~N~ 258 (833)
++|+++ .+|. .+.++. .++.|++++|++++.+| .|..+++|+.|++++|++. .+|..|..+++ |++|+|++|.
T Consensus 313 ~~n~l~-~ip~~~~l~~l~-~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 388 (636)
T 4eco_A 313 GYNNLK-TFPVETSLQKMK-KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNK 388 (636)
T ss_dssp CSSCCS-SCCCHHHHTTCT-TCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSC
T ss_pred CCCcCC-ccCchhhhccCC-CCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCc
Confidence 999999 8998 888876 48999999999998888 9999999999999999999 78888999999 9999999999
Q ss_pred CcccCCccccCCC--CCCeEEeecccccCCCCCCCC-------CCCccceeecCCceecccCCccccc-ccccceeeecC
Q 040925 259 LQGRIPSGLGNLT--KLANLELSSNSLQGNIPSSLG-------NCQNLMSFTASQNKLTGALPHQLLS-ITTLSLYLDLS 328 (833)
Q Consensus 259 l~~~~~~~~~~l~--~L~~L~L~~N~l~~~~~~~~~-------~l~~L~~L~l~~N~l~~~~p~~~~~-~~~ll~~L~ls 328 (833)
++ .+|..+..++ +|++|+|++|++.+..|..|. .+++|+.|++++|+++ .+|..++. +..+ ++|+|+
T Consensus 389 l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~l~~L-~~L~Ls 465 (636)
T 4eco_A 389 LK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQIS-KFPKELFSTGSPL-SSINLM 465 (636)
T ss_dssp CS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCC-SCCTHHHHTTCCC-SEEECC
T ss_pred Cc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccC-cCCHHHHccCCCC-CEEECC
Confidence 99 7888887765 899999999999999999998 8889999999999999 78887766 5555 899999
Q ss_pred CCccCCCCCcccccCC-------CcCEEeccCCcCCCCCCcccc--CCCCCcEEeecCCccccccCccccCCCCCCeEEc
Q 040925 329 NNLLNGSLPLQVGHLK-------NLVILDISSNQFSGVIPGTLS--TCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNV 399 (833)
Q Consensus 329 ~N~l~~~~~~~~~~l~-------~L~~L~ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 399 (833)
+|.++.+.+..+..+. +|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|
T Consensus 466 ~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~L 543 (636)
T 4eco_A 466 GNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGI 543 (636)
T ss_dssp SSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEEC
T ss_pred CCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEEC
Confidence 9999944444454443 9999999999999 5677776 99999999999999997 7888999999999999
Q ss_pred ------cCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCCCc
Q 040925 400 ------SSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGI 456 (833)
Q Consensus 400 ------~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~~ 456 (833)
++|++.+.+|..+..+++|+.|+|++|+++..+... .+.++.+++++|++.|-..
T Consensus 544 s~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ip~~~--~~~L~~L~Ls~N~l~~~~~ 604 (636)
T 4eco_A 544 RNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI--TPNISVLDIKDNPNISIDL 604 (636)
T ss_dssp CSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBCCSCC--CTTCCEEECCSCTTCEEEC
T ss_pred CCCcccccCcccccChHHHhcCCCCCEEECCCCcCCccCHhH--hCcCCEEECcCCCCccccH
Confidence 568889999999999999999999999995544433 3789999999999988553
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=398.23 Aligned_cols=265 Identities=23% Similarity=0.320 Sum_probs=191.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCC------
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDF------ 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 602 (833)
.++|++.+.||+|+||+||+|+++.+++.||||+++..... ..+.+.+|+++|++++|||||++++++.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35699999999999999999999999999999999754432 34678999999999999999999999865431
Q ss_pred -CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcE
Q 040925 603 -KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681 (833)
Q Consensus 603 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 681 (833)
....+.|+|||||++|+|.+++...... ...++..++.|+.||+.||+|||++ +||||||||+|||++.++.+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~v 157 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVV 157 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcE
Confidence 1233579999999999999999876432 1356777899999999999999999 99999999999999999999
Q ss_pred EEcccccccccCcccccccc----cCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHh
Q 040925 682 HVCDFGLAKFLSDHQLDTAV----KTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTA 757 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~ 757 (833)
||+|||+|+........... .......+.+||+.|||||++.+..|+.++|||| .|+++|++++
T Consensus 158 Kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwS----------lGvilyell~-- 225 (299)
T 4g31_A 158 KVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS----------LGLILFELLY-- 225 (299)
T ss_dssp EECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHH----------HHHHHHHHHS--
T ss_pred EEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHH----------HHHHHHHHcc--
Confidence 99999999877654322111 1112234568999999999999999999999999 7777788763
Q ss_pred CCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 758 LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 758 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
|+..... ............. .....+..+...+++.+||+.||++|||+.|+++.
T Consensus 226 -Pf~~~~~-~~~~~~~~~~~~~------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 226 -PFSTQME-RVRTLTDVRNLKF------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -CCSSHHH-HHHHHHHHHTTCC------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCccH-HHHHHHHHhcCCC------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 4331100 0000111111110 11223344567789999999999999999999873
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=428.69 Aligned_cols=420 Identities=20% Similarity=0.238 Sum_probs=351.4
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|++++|++++..|.+|.++++|++|+|++|++++..|..|+.+++|++|+|++|+|+ .+|.. .+++|++|+|++
T Consensus 23 L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~ 99 (520)
T 2z7x_B 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSF 99 (520)
T ss_dssp CSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCS
T ss_pred ccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccC
Confidence 689999999999888889999999999999999999988999999999999999999999 45655 899999999999
Q ss_pred cccccccC-chhhcCCCCccEEEccCCcceeeCCccccCCCCC--cEEEcccCcc--ccccCcCccC-------------
Q 040925 81 NRFSGNLP-FDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNL--ELLDLSVNQF--KGNVSIDFSS------------- 142 (833)
Q Consensus 81 N~l~~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~i--~~~~~~~~~~------------- 142 (833)
|+++ .++ +..|.++++|++|+|++|.+++ ..|..+++| ++|+|++|++ .+..+..|..
T Consensus 100 N~l~-~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n 175 (520)
T 2z7x_B 100 NAFD-ALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN 175 (520)
T ss_dssp SCCS-SCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSS
T ss_pred Cccc-cccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEeccC
Confidence 9998 433 3677899999999999999975 467888888 9999999999 5555555544
Q ss_pred -------------CCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhh--cccccEEEcc
Q 040925 143 -------------LKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANL--SSTVINFGIG 207 (833)
Q Consensus 143 -------------l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~~l~~L~l~ 207 (833)
+++|+.|++++|.-......-......+..+++|+.|++++|.+++..+..+... ...++.|+++
T Consensus 176 ~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~ 255 (520)
T 2z7x_B 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255 (520)
T ss_dssp SCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEE
T ss_pred cchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEee
Confidence 6778888888875100000000122357889999999999999986555444322 2368999999
Q ss_pred CccccccCChhh-----hcCCCCCeEeccCCcccccCCccccCC---CCCCEEEcccccCcccCCccccCCCCCCeEEee
Q 040925 208 RNQISGTIPPGI-----RNLVNLIGFGAEENQLHGTIPDAIGEL---KNLQKLCLFRNFLQGRIPSGLGNLTKLANLELS 279 (833)
Q Consensus 208 ~n~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 279 (833)
+|++++.+|..+ .++++|+.+++++|.+ ...+..+..+ .+|+.|++++|.+.... .+..+++|++|+|+
T Consensus 256 ~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls 332 (520)
T 2z7x_B 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFS 332 (520)
T ss_dssp EEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECC
T ss_pred cccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeE
Confidence 999999999988 9999999999999999 3333566555 78999999999987532 23688999999999
Q ss_pred cccccCCCCCCCCCCCccceeecCCceecc--cCCcccccccccceeeecCCCccCCCCCc-ccccCCCcCEEeccCCcC
Q 040925 280 SNSLQGNIPSSLGNCQNLMSFTASQNKLTG--ALPHQLLSITTLSLYLDLSNNLLNGSLPL-QVGHLKNLVILDISSNQF 356 (833)
Q Consensus 280 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~~~~~~~ll~~L~ls~N~l~~~~~~-~~~~l~~L~~L~ls~N~l 356 (833)
+|++++..|..+..+++|+.|++++|++++ .+|..+..+..+ ++|++++|.+++.+|. .|..+++|++|++++|++
T Consensus 333 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L-~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l 411 (520)
T 2z7x_B 333 NNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL-QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411 (520)
T ss_dssp SSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTC-CEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCC
T ss_pred CCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCC-CEEECCCCcCCcccccchhccCccCCEEECcCCCC
Confidence 999998899999999999999999999995 556777788887 8999999999984554 588999999999999999
Q ss_pred CCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCC
Q 040925 357 SGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 357 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|++++|++++..+..+..+++|+.|++++|+++|.|+.
T Consensus 412 ~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 486 (520)
T 2z7x_B 412 TDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 486 (520)
T ss_dssp CGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred Ccchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCc
Confidence 877776664 79999999999999 5676677999999999999999965555599999999999999999998874
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=422.63 Aligned_cols=436 Identities=17% Similarity=0.183 Sum_probs=289.8
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
+++++++|+++ .+|..+. ++|++|++++|+|++..|..|+.+++|++|+|++|+|+++.|++|.++++|++|+|++|
T Consensus 34 ~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 58999999999 5777665 79999999999998888899999999999999999999999999999999999999999
Q ss_pred ccccccCchhhcCCCCccEEEccCCcceee-CCccccCCCCCcEEEcccCccccccCcCccCCCcC--ceEecccccC--
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGS-IPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNL--LWLNLEQNNL-- 156 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L--~~L~L~~N~l-- 156 (833)
+++ .+|.. .+++|++|+|++|++++. .|..|+++++|++|+|++|+|+. ..|..+++| ++|+|++|.+
T Consensus 111 ~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 111 RLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp CCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---TTTGGGTTSCEEEEEEEESSCCC
T ss_pred cCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCcccc---CchhhhhhceeeEEEeecccccc
Confidence 998 88876 799999999999999864 46899999999999999999985 356666776 9999999998
Q ss_pred CCCCCCCcccc--------------------cccCCCCCCCEEEccCCcCcc-cC---ChhHhhhcccccEEEccCcccc
Q 040925 157 GTGTATDLDFV--------------------TFLTNCSSLKALSLADNQFGG-EL---PHSIANLSSTVINFGIGRNQIS 212 (833)
Q Consensus 157 ~~~~~~~~~~~--------------------~~l~~l~~L~~L~Ls~N~l~~-~~---p~~~~~l~~~l~~L~l~~n~i~ 212 (833)
+...+..+... ..+.++++|+.|++++|+... .+ +..+..+ ..++.+++.++.++
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l-~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG-PTLLNVTLQHIETT 262 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSC-SSCEEEEEEEEEEC
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhcc-CcceEEEecCCcCc
Confidence 55444332211 123456778888888875210 11 1122222 23445555555444
Q ss_pred ccCChh---hhcCCCCCeEeccCCcccccCCccc-----cCCCCCCEEEcccccCcccCC-ccccC---CCCCCeEEeec
Q 040925 213 GTIPPG---IRNLVNLIGFGAEENQLHGTIPDAI-----GELKNLQKLCLFRNFLQGRIP-SGLGN---LTKLANLELSS 280 (833)
Q Consensus 213 ~~~~~~---~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~---l~~L~~L~L~~ 280 (833)
+..... ....++|++|++++|++.+.+|..+ ..+++|+.++++.|.+ .+| ..+.. ..+|+.|++++
T Consensus 263 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~ 340 (562)
T 3a79_B 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISD 340 (562)
T ss_dssp HHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEES
T ss_pred HHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhhhccCcceEEEccC
Confidence 321111 1123367777777777766666655 5555555555555555 122 22211 14566666666
Q ss_pred ccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCC--CcccccCCCcCEEeccCCcCCC
Q 040925 281 NSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSL--PLQVGHLKNLVILDISSNQFSG 358 (833)
Q Consensus 281 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~--~~~~~~l~~L~~L~ls~N~l~~ 358 (833)
|.+.... ....+++|+.|++++|++++.+|..+..+..+ ++|++++|++++.. |..|.++++|++|++++|++++
T Consensus 341 n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~ 417 (562)
T 3a79_B 341 TPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL-QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNS 417 (562)
T ss_dssp SCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSC-CEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBS
T ss_pred CCccccc--CccCCCCceEEECCCCccccchhhhhcccCCC-CEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCC
Confidence 6654221 12456666666666666665556666555555 56666666666422 3446666666666666666665
Q ss_pred -CCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCC-CC
Q 040925 359 -VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT-KG 436 (833)
Q Consensus 359 -~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~-~~ 436 (833)
.++..|..+++|++|++++|++++..|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++..++. ..
T Consensus 418 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 494 (562)
T 3a79_B 418 HAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFD 494 (562)
T ss_dssp CCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTT
T ss_pred ccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHh
Confidence 3334566666666666666666654444333 56666666666666 3444444666666666666666655544 34
Q ss_pred ccCCCccccccCCcCCCCCc
Q 040925 437 VFSNKTKISLQGNMKLCGGI 456 (833)
Q Consensus 437 ~~~~~~~l~l~~N~~~c~~~ 456 (833)
.++.++.+++++|+|.|..+
T Consensus 495 ~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 495 RLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp TCTTCCCEECCSCCBCCCHH
T ss_pred cCCCCCEEEecCCCcCCCcc
Confidence 55566666666666666544
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=399.27 Aligned_cols=385 Identities=18% Similarity=0.196 Sum_probs=246.1
Q ss_pred EEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCC
Q 040925 27 VIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGN 106 (833)
Q Consensus 27 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N 106 (833)
.++.+++.+ +.+|. +. ++|++|+|++|.|+++.|..|.++++|++|+|++|.+.+.++...|.++++|++|+|++|
T Consensus 14 ~~~c~~~~l-~~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n 89 (455)
T 3v47_A 14 NAICINRGL-HQVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89 (455)
T ss_dssp EEECCSSCC-SSCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC
T ss_pred ccCcCCCCc-ccCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCC
Confidence 445555555 23333 21 455555555555555555555555555555555555544455555555555555555555
Q ss_pred cceeeCCccccCCCCCcEEEcccCcccccc--CcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCC
Q 040925 107 NFFGSIPYSLSNASNLELLDLSVNQFKGNV--SIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADN 184 (833)
Q Consensus 107 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 184 (833)
.+++..|..|+++++|++|+|++|++++.. ...|..+++|++|+|++|.++.+.+. ..+.++++|++|+|++|
T Consensus 90 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~~l~~L~~L~L~~n 164 (455)
T 3v47_A 90 QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA-----SFFLNMRRFHVLDLTFN 164 (455)
T ss_dssp TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCC-----GGGGGCTTCCEEECTTC
T ss_pred ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcc-----cccCCCCcccEEeCCCC
Confidence 555555555555555555555555555422 22355555555555555555543221 12445555666666666
Q ss_pred cCcccCChhHhhhc-ccccEEEccCccccccCChh--------hhcCCCCCeEeccCCcccccCCccccCC---CCCCEE
Q 040925 185 QFGGELPHSIANLS-STVINFGIGRNQISGTIPPG--------IRNLVNLIGFGAEENQLHGTIPDAIGEL---KNLQKL 252 (833)
Q Consensus 185 ~l~~~~p~~~~~l~-~~l~~L~l~~n~i~~~~~~~--------~~~l~~L~~L~L~~N~l~~~~~~~~~~l---~~L~~L 252 (833)
++++..|..+..+. ..++.|++++|.+.+..+.. +..+++|++|++++|++.+..|..|... ++|+.|
T Consensus 165 ~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L 244 (455)
T 3v47_A 165 KVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSL 244 (455)
T ss_dssp CBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEE
T ss_pred cccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeE
Confidence 65555555544432 23455555555555443332 3355677788888888777777666543 677788
Q ss_pred EcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCC--CccceeecCCceecccCCcccccccccceeeecCCC
Q 040925 253 CLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNC--QNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNN 330 (833)
Q Consensus 253 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N 330 (833)
++++|.+.+... ..+.+....+..+..+ ++|+.|++++|++++..|..+..+..+ ++|++++|
T Consensus 245 ~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~Ls~n 309 (455)
T 3v47_A 245 ILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDL-EQLTLAQN 309 (455)
T ss_dssp ECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTC-CEEECTTS
T ss_pred eecccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCC-CEEECCCC
Confidence 887776553211 1111221222222222 456666666666665555555555555 56667777
Q ss_pred ccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchh
Q 040925 331 LLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPE 410 (833)
Q Consensus 331 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 410 (833)
.+++..|..|.++++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|..+++|+.|+|++|++++..+.
T Consensus 310 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 389 (455)
T 3v47_A 310 EINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDG 389 (455)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHh
Confidence 77667777888999999999999999988899999999999999999999988899999999999999999999988888
Q ss_pred hhcCCCCCceEECccCcCccccCCC
Q 040925 411 FLKNLSVLEFLSLSYNHFEGEVPTK 435 (833)
Q Consensus 411 ~l~~l~~L~~L~l~~N~l~~~~~~~ 435 (833)
.+..+++|+.|++++|+++|.+|..
T Consensus 390 ~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 390 IFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp TTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred HhccCCcccEEEccCCCcccCCCcc
Confidence 8899999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=393.76 Aligned_cols=266 Identities=20% Similarity=0.236 Sum_probs=202.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTD-FKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~ 607 (833)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.... +.+.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 579999999999999999999999999999999974432 23467889999999999999999999976542 344568
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+|||||+ |+|.+++...+ .+++.+++.|+.||+.||+|||++ |||||||||+|||++.++.+||+|||
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence 999999996 68999998765 799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
+|+.+...... ........+||+.|||||++.+. .++.++|||| .|+++|++++|..|+......
T Consensus 204 la~~~~~~~~~----~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWS----------lG~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 204 MARGLCTSPAE----HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWS----------VGCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp TCBCC-----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHH----------HHHHHHHHHHTSCSSCCSSHH
T ss_pred eeeecccCccc----cccccccceeChHhcCHHHhcCCCCCCChhheeh----------hHHHHHHHHHCCCCCCCCCHH
Confidence 99876443211 11223457899999999998875 4689999999 788889999998887522111
Q ss_pred ccc-------------ch--------hhhccccchh-hhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPS-------------LL--------MEVMTNNSMI-QEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~-------------~~--------~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+.- .. .......... ........+..++.+.+++.+||..||++|||++|++++
T Consensus 270 ~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 270 HQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 100 00 0000000000 000000111234678899999999999999999999864
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=410.87 Aligned_cols=409 Identities=19% Similarity=0.203 Sum_probs=313.7
Q ss_pred CCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccE
Q 040925 21 NLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKA 100 (833)
Q Consensus 21 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~ 100 (833)
.+...+++++++|.+++ +|..+. ++|++|+|++|+|+++.|.+|.++++|++|+|++|+++ .++++.|.++++|++
T Consensus 29 ~~~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~ 104 (562)
T 3a79_B 29 SNELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEY 104 (562)
T ss_dssp ----CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCC-EECTTTTTTCTTCCE
T ss_pred ccCCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCC-cCCHHHhCCCCCCCE
Confidence 34455899999999965 776665 89999999999999888899999999999999999998 777788999999999
Q ss_pred EEccCCcceeeCCccccCCCCCcEEEcccCcccccc-CcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCC--C
Q 040925 101 LAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNV-SIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSL--K 177 (833)
Q Consensus 101 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L--~ 177 (833)
|+|++|+|+. +|.. .+++|++|+|++|+|++++ +..|.++++|++|+|++|.++... +.++++| +
T Consensus 105 L~Ls~N~l~~-lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~---------~~~l~~L~L~ 172 (562)
T 3a79_B 105 LDVSHNRLQN-ISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD---------LLPVAHLHLS 172 (562)
T ss_dssp EECTTSCCCE-ECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTT---------TGGGTTSCEE
T ss_pred EECCCCcCCc-cCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCc---------hhhhhhceee
Confidence 9999999994 5555 8999999999999999876 478999999999999999997532 3344555 9
Q ss_pred EEEccCCcC--cccCChhHhhhcccccEEEccCccccccCCh-hhhcCCCCCeEeccCCc-----ccccCCccccCCCCC
Q 040925 178 ALSLADNQF--GGELPHSIANLSSTVINFGIGRNQISGTIPP-GIRNLVNLIGFGAEENQ-----LHGTIPDAIGELKNL 249 (833)
Q Consensus 178 ~L~Ls~N~l--~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~-~~~~l~~L~~L~L~~N~-----l~~~~~~~~~~l~~L 249 (833)
+|+|++|++ ++..|..+..+......++++.|.+.+..++ .+..+++|+.|++++|+ +.+ ....|.++++|
T Consensus 173 ~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~-~~~~l~~l~~L 251 (562)
T 3a79_B 173 CILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMT-FLSELTRGPTL 251 (562)
T ss_dssp EEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHH-HHHHHHSCSSC
T ss_pred EEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHH-HHHHHhccCcc
Confidence 999999999 8888988888765555678888888765553 45677788888888774 111 12234445554
Q ss_pred CEEEcccccCcccC----CccccCCCCCCeEEeecccccCCCCCCC-----CCC--------------------------
Q 040925 250 QKLCLFRNFLQGRI----PSGLGNLTKLANLELSSNSLQGNIPSSL-----GNC-------------------------- 294 (833)
Q Consensus 250 ~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l-------------------------- 294 (833)
+.|+|+++.+.+.. +..+ ..++|++|++++|++++.+|..+ ..+
T Consensus 252 ~~L~L~~~~l~~~~~~~~~~~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~ 330 (562)
T 3a79_B 252 LNVTLQHIETTWKCSVKLFQFF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330 (562)
T ss_dssp EEEEEEEEEECHHHHHHHHHHH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHT
T ss_pred eEEEecCCcCcHHHHHHHHHhh-hcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhcc
Confidence 44444444433210 0111 11244444444444444444433 222
Q ss_pred CccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCC--CccccCCCCCcE
Q 040925 295 QNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVI--PGTLSTCVCLEY 372 (833)
Q Consensus 295 ~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~--~~~~~~l~~L~~ 372 (833)
.+|+.|++++|.+.. .+. ...+..+ ++|++++|.+++..|..|+++++|++|++++|++++.. |..|..+++|++
T Consensus 331 ~~L~~L~l~~n~~~~-~~~-~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~ 407 (562)
T 3a79_B 331 MNIKMLSISDTPFIH-MVC-PPSPSSF-TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407 (562)
T ss_dssp CCCSEEEEESSCCCC-CCC-CSSCCCC-CEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCE
T ss_pred CcceEEEccCCCccc-ccC-ccCCCCc-eEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCE
Confidence 357777777777652 220 1344455 88999999999989999999999999999999999754 467999999999
Q ss_pred EeecCCcccc-ccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcC
Q 040925 373 LDISSNSFHG-VIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMK 451 (833)
Q Consensus 373 L~Ls~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~ 451 (833)
|++++|++++ .++..+..+++|+.|++++|++++..|..+. ++|+.|++++|.++..++....+.+++.+++++|..
T Consensus 408 L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l 485 (562)
T 3a79_B 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL 485 (562)
T ss_dssp EECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCC
T ss_pred EECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCC
Confidence 9999999998 5556789999999999999999987776654 789999999999998777777889999999999975
Q ss_pred C
Q 040925 452 L 452 (833)
Q Consensus 452 ~ 452 (833)
.
T Consensus 486 ~ 486 (562)
T 3a79_B 486 K 486 (562)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=410.83 Aligned_cols=425 Identities=21% Similarity=0.215 Sum_probs=342.2
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|+|++|+|+++.|.+|.++++|++|+|++|+|++..+++|..+++|++|+|++|+|+++.+..|+++++|++|+|++
T Consensus 78 L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~ 157 (635)
T 4g8a_A 78 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAH 157 (635)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCS
T ss_pred CCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecccc
Confidence 78999999999988888999999999999999999888888999999999999999999988888999999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCc----EEEcccCccccccCcCccCCCcCceEecccccC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLE----LLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 156 (833)
|.+++...+..+..+++|++|+|++|+|++..+..|..+.+++ .++++.|.++.+.+..+..+ .++.+++.+|..
T Consensus 158 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~-~~~~l~l~~n~~ 236 (635)
T 4g8a_A 158 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFD 236 (635)
T ss_dssp SCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCS
T ss_pred CccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccch-hhhhhhhhcccc
Confidence 9998333356778999999999999999998888887766544 78999999987776655443 344555554422
Q ss_pred C-------------------------------CCCCCCcc---------------------cccc---------------
Q 040925 157 G-------------------------------TGTATDLD---------------------FVTF--------------- 169 (833)
Q Consensus 157 ~-------------------------------~~~~~~~~---------------------~~~~--------------- 169 (833)
. ......+. ....
T Consensus 237 ~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~ 316 (635)
T 4g8a_A 237 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSV 316 (635)
T ss_dssp SHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESC
T ss_pred cccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccc
Confidence 1 00000000 0011
Q ss_pred -------cCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccc--cCC
Q 040925 170 -------LTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHG--TIP 240 (833)
Q Consensus 170 -------l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~--~~~ 240 (833)
+....+|+.|++++|.+....+..+ ..+..+++..|.+... ..+.++++|+.|++++|.+.. ..+
T Consensus 317 ~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l----~~L~~l~l~~n~~~~~--~~~~~l~~L~~L~ls~n~l~~~~~~~ 390 (635)
T 4g8a_A 317 TIERVKDFSYNFGWQHLELVNCKFGQFPTLKL----KSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCS 390 (635)
T ss_dssp EEEECGGGGSCCCCSEEEEESCEESSCCCCBC----TTCCEEEEESCCSCCB--CCCCBCTTCCEEECCSSCCBEEEECC
T ss_pred ccccccccccchhhhhhhcccccccCcCcccc----hhhhhcccccccCCCC--cccccccccccchhhccccccccccc
Confidence 2223345555555555443222211 2244555555555422 234578899999999999864 456
Q ss_pred ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCC-CCCCCCCCccceeecCCceecccCCccccccc
Q 040925 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNI-PSSLGNCQNLMSFTASQNKLTGALPHQLLSIT 319 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 319 (833)
..+..+.+|+.|+++.|.+.. .+..+..+++|+.+++++|+..... +..|.++++++.++++.|.+.+..|..+....
T Consensus 391 ~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~ 469 (635)
T 4g8a_A 391 QSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 469 (635)
T ss_dssp HHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred cchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccch
Confidence 677889999999999999984 5677889999999999998876554 45788999999999999999977777666666
Q ss_pred ccceeeecCCCcc-CCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEE
Q 040925 320 TLSLYLDLSNNLL-NGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELN 398 (833)
Q Consensus 320 ~ll~~L~ls~N~l-~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 398 (833)
.+ +.|++++|.+ .+..|..|..+++|++|+|++|+|+++.|.+|.++++|++|+|++|+|+++.+..|..+++|+.|+
T Consensus 470 ~L-~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~ 548 (635)
T 4g8a_A 470 SL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 548 (635)
T ss_dssp TC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEE
T ss_pred hh-hhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEE
Confidence 66 7899999984 445788999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcccCCCchhhhcCC-CCCceEECccCcCccccCC
Q 040925 399 VSSNNLSGQIPEFLKNL-SVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 399 l~~N~l~~~~p~~l~~l-~~L~~L~l~~N~l~~~~~~ 434 (833)
|++|+|++..|..+..+ ++|+.|+|++|+|.|.|..
T Consensus 549 Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~ 585 (635)
T 4g8a_A 549 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 585 (635)
T ss_dssp CTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence 99999999999999998 6899999999999999975
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=386.51 Aligned_cols=383 Identities=18% Similarity=0.204 Sum_probs=269.7
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCccc-ccCCccccCCCCCcEEECCC
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS-GMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~ 80 (833)
+.++.++++++ .+|. +. ++|++|+|++|++++..|..|+.+++|++|+|++|.+. .+.+..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 35677788887 5665 32 67888888888887777888888888888888888886 34467788888888888888
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCcc--ccCCCCCcEEEcccCccccccCcC-ccCCCcCceEecccccCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYS--LSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLEQNNLG 157 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~~N~l~ 157 (833)
|+++ .+++..|.++++|++|+|++|.+++..|.. |.++++|++|+|++|+|+++.+.. |.++++|++|+|++|.++
T Consensus 89 n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~ 167 (455)
T 3v47_A 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167 (455)
T ss_dssp CTTC-EECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred CccC-ccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence 8887 555566778888888888888887644433 888888888888888888776665 788888888888888887
Q ss_pred CCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHh--------hhcccccEEEccCccccccCChhhhcC---CCCC
Q 040925 158 TGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIA--------NLSSTVINFGIGRNQISGTIPPGIRNL---VNLI 226 (833)
Q Consensus 158 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~--------~l~~~l~~L~l~~n~i~~~~~~~~~~l---~~L~ 226 (833)
......+.. + ...+|+.|++++|.+.+..+..+. .+ ..++.|++++|++++..|..+..+ .+|+
T Consensus 168 ~~~~~~l~~---l-~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~-~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~ 242 (455)
T 3v47_A 168 SICEEDLLN---F-QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN-TSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242 (455)
T ss_dssp CCCTTTSGG---G-TTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTT-CEEEEEECTTSCCCHHHHHHHHHHTTTCCEE
T ss_pred ccChhhhhc---c-ccccccccccccCcccccchhhcccccccccccc-ceeeeEecCCCcccccchhhhhcccccccee
Confidence 765543211 1 125788888888888754433322 11 347788888888888777777665 7888
Q ss_pred eEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccC--CCCCCeEEeecccccCCCCCCCCCCCccceeecCC
Q 040925 227 GFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGN--LTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQ 304 (833)
Q Consensus 227 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 304 (833)
.|++++|.+.+... ..+.+.+..+..+.+ .++|++|++++|++.+..|..|..+++|+.|++++
T Consensus 243 ~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~ 308 (455)
T 3v47_A 243 SLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQ 308 (455)
T ss_dssp EEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTT
T ss_pred eEeecccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCC
Confidence 88888886653211 111122111222221 23455555555555544444555555555555555
Q ss_pred ceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCcccccc
Q 040925 305 NKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI 384 (833)
Q Consensus 305 N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 384 (833)
|++++..|..+..+..+ ++|++++|.+++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++++
T Consensus 309 n~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 387 (455)
T 3v47_A 309 NEINKIDDNAFWGLTHL-LKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVP 387 (455)
T ss_dssp SCCCEECTTTTTTCTTC-CEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CcccccChhHhcCcccC-CEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCC
Confidence 55554444444444444 45666666666566778888999999999999999888999999999999999999999888
Q ss_pred CccccCCCCCCeEEccCcccCCCch
Q 040925 385 PLSLSFLKSIKELNVSSNNLSGQIP 409 (833)
Q Consensus 385 ~~~~~~l~~L~~L~l~~N~l~~~~p 409 (833)
+..|..+++|+.|++++|++++..|
T Consensus 388 ~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 388 DGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred HhHhccCCcccEEEccCCCcccCCC
Confidence 8888999999999999999998766
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=380.57 Aligned_cols=204 Identities=24% Similarity=0.335 Sum_probs=168.3
Q ss_pred HhcCCccCceeccCcceEEEEEEEC---CCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 604 (833)
..++|++.+.||+|+||+||+|+++ .+++.||+|++... ....++.+|+++++.+ +|||||++++++.+.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~--- 93 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKND--- 93 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT---
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECC---
Confidence 4578999999999999999999874 46889999998643 3345788999999998 6999999999976654
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-CcEEE
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHV 683 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL 683 (833)
+.|+||||+++|+|.+++. .+++.+++.++.|++.||+|||++ |||||||||+|||++.+ +.+||
T Consensus 94 --~~~lvmE~~~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl 159 (361)
T 4f9c_A 94 --HVVIAMPYLEHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYAL 159 (361)
T ss_dssp --EEEEEEECCCCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEE
T ss_pred --EEEEEEeCCCcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEE
Confidence 8999999999999999984 588999999999999999999999 99999999999999877 79999
Q ss_pred cccccccccCccccccc--------------------ccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCc
Q 040925 684 CDFGLAKFLSDHQLDTA--------------------VKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDA 742 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~--------------------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~ 742 (833)
+|||+|+...+...... ..........+||+.|||||++.+. .|+.++||||
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWS------- 232 (361)
T 4f9c_A 160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS------- 232 (361)
T ss_dssp CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHH-------
T ss_pred CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhh-------
Confidence 99999986544321100 0011122346799999999998875 4899999999
Q ss_pred cccCCccHHHHHHHhCCCc
Q 040925 743 VFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 743 ~~~~g~~l~~~~~~~~p~~ 761 (833)
.|+++|++++|..|+.
T Consensus 233 ---lG~il~ell~G~~Pf~ 248 (361)
T 4f9c_A 233 ---AGVIFLSLLSGRYPFY 248 (361)
T ss_dssp ---HHHHHHHHHHTCSSSS
T ss_pred ---hHHHHHHHHHCCCCCC
Confidence 8888999999988874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=398.70 Aligned_cols=251 Identities=21% Similarity=0.243 Sum_probs=200.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHH---HHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVA---ECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||+||+|+++.+|+.||||+++... ......+.+ ++.+++.++|||||++++++.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~-- 265 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-- 265 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC--
Confidence 467999999999999999999999999999999996431 222233334 456677789999999999976655
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
..|+|||||+||+|.+++...+ .+++..++.|+.||+.||+|||++ |||||||||+|||++.+|.+||
T Consensus 266 ---~lylVmEy~~GGdL~~~l~~~~------~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL 333 (689)
T 3v5w_A 266 ---KLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 333 (689)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEE
T ss_pred ---EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEe
Confidence 8999999999999999998754 799999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
+|||+|+...... ....+||+.|||||++.+ ..|+.++|||| .|+++|++++|..|+..
T Consensus 334 ~DFGlA~~~~~~~----------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWS----------LGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 334 SDLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFS----------LGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp CCCTTCEECSSCC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHH----------HHHHHHHHHHSSCTTCG
T ss_pred cccceeeecCCCC----------CCCccCCcCccCHHHHhCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCC
Confidence 9999998764422 234679999999999864 57999999999 89999999999999864
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
....+.......+.. .....+..+++.+.+++.+||.+||++|++ ++||.++
T Consensus 394 ~~~~~~~~i~~~i~~------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 394 HKTKDKHEIDRMTLT------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp GGCCCHHHHHHHHHH------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CChHHHHHHHHhhcC------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 332221111111100 011122335667899999999999999998 6777654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=398.96 Aligned_cols=254 Identities=19% Similarity=0.234 Sum_probs=208.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|+++.+|+.||+|+++.......+.+.+|+++|+.++|||||++++++.+.. ..|
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~-----~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS-----EEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEE
Confidence 468999999999999999999999999999999997665555678899999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC--CcEEEcccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD--MVAHVCDFG 687 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~DfG 687 (833)
+|||||+||+|.+++..... .+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 231 iv~E~~~gg~L~~~i~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG 302 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 302 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTS-----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCS
T ss_pred EEEeecCCCcHHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecc
Confidence 99999999999999975432 689999999999999999999999 99999999999999854 899999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+.+..... ....+||+.|||||++.+..|+.++|||| .|+++|++++|..|+.....
T Consensus 303 ~a~~~~~~~~---------~~~~~GT~~y~APEv~~~~~y~~~~DiWS----------lGvilyeml~G~~Pf~~~~~-- 361 (573)
T 3uto_A 303 LTAHLDPKQS---------VKVTTGTAEFAAPEVAEGKPVGYYTDMWS----------VGVLSYILLSGLSPFGGEND-- 361 (573)
T ss_dssp SCEECCTTSE---------EEEECSSGGGCCHHHHTTCCBCHHHHHHH----------HHHHHHHHHHSCCSSCCSSH--
T ss_pred ceeEccCCCc---------eeeeEECccccCHHHhCCCCCCcHHHHHH----------HHHHHHHHHHCCCCCCCcCH--
Confidence 9987654321 22357999999999999999999999999 88899999999999753221
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.............. .......+++.+.+++.+||+.||++|||++|++++
T Consensus 362 ~~~~~~i~~~~~~~---~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 362 DETLRNVKSCDWNM---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp HHHHHHHHTTCCCC---CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCC---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111111111111 111122345678899999999999999999999873
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=383.43 Aligned_cols=349 Identities=22% Similarity=0.212 Sum_probs=229.8
Q ss_pred EEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccc
Q 040925 75 LIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQN 154 (833)
Q Consensus 75 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 154 (833)
.++++++.++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 15 ~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp EEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 3444444444 4443321 34455555555555444445555555555555555555555555555555555555555
Q ss_pred cCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCc
Q 040925 155 NLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQ 234 (833)
Q Consensus 155 ~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~ 234 (833)
+++.++.. .|.++++|++|+|++|++++ ..+..|.++++|+.|++++|+
T Consensus 91 ~l~~~~~~------~~~~l~~L~~L~Ls~n~i~~-------------------------~~~~~~~~l~~L~~L~l~~n~ 139 (477)
T 2id5_A 91 RLKLIPLG------VFTGLSNLTKLDISENKIVI-------------------------LLDYMFQDLYNLKSLEVGDND 139 (477)
T ss_dssp CCCSCCTT------SSTTCTTCCEEECTTSCCCE-------------------------ECTTTTTTCTTCCEEEECCTT
T ss_pred cCCccCcc------cccCCCCCCEEECCCCcccc-------------------------CChhHccccccCCEEECCCCc
Confidence 55444331 23445555555555555542 223334445555555555555
Q ss_pred ccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcc
Q 040925 235 LHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQ 314 (833)
Q Consensus 235 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~ 314 (833)
+.++.+..|.++++|++|+|++|.+++..+..|.++++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+.+|..
T Consensus 140 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~ 219 (477)
T 2id5_A 140 LVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219 (477)
T ss_dssp CCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTT
T ss_pred cceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcc
Confidence 55555555555555555555555555444445555555556666655555555555555566666666655555555555
Q ss_pred cccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCC
Q 040925 315 LLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSI 394 (833)
Q Consensus 315 ~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 394 (833)
.+....+ ++|++++|.++...+..|..+++|+.|+|++|.+++..+..|..+++|++|+|++|+++++.|..|..+++|
T Consensus 220 ~~~~~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 298 (477)
T 2id5_A 220 CLYGLNL-TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYL 298 (477)
T ss_dssp TTTTCCC-SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTC
T ss_pred cccCccc-cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccC
Confidence 5554444 677788888875555678899999999999999998888999999999999999999999999999999999
Q ss_pred CeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCCCcccC
Q 040925 395 KELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDEL 459 (833)
Q Consensus 395 ~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~~~~~ 459 (833)
+.|+|++|++++..+..|..+++|+.|++++|+|.|.|+..+.+.......+.++...|+.|...
T Consensus 299 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p~~~ 363 (477)
T 2id5_A 299 RVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATPEFV 363 (477)
T ss_dssp CEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEESGGG
T ss_pred CEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchHhHHhhhhccccCccCceeCCchHH
Confidence 99999999999888888999999999999999999998865555555567788888899877643
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=375.10 Aligned_cols=387 Identities=24% Similarity=0.292 Sum_probs=270.9
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCC-------------CEEEcCCCcccccCCccc
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNL-------------VSLNVAENKFSGMFPRSI 67 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-------------~~L~L~~n~i~~~~~~~~ 67 (833)
|++|++++|.+ +.+|++|+++++|++|++++|++.+.+|..++.+++| ++|++++|.+++ +|..
T Consensus 13 L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~~- 89 (454)
T 1jl5_A 13 LQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPEL- 89 (454)
T ss_dssp ----------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCSC-
T ss_pred chhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCCC-
Confidence 68899999999 5899999999999999999999999999999998875 999999999985 4442
Q ss_pred cCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCc
Q 040925 68 CNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLL 147 (833)
Q Consensus 68 ~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~ 147 (833)
.++|+.|++++|.++ .+|. .+++|++|++++|++++ +|.. .++|++|++++|++++++ .|.++++|+
T Consensus 90 --~~~L~~L~l~~n~l~-~lp~----~~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~lp--~~~~l~~L~ 156 (454)
T 1jl5_A 90 --PPHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEKLP--ELQNSSFLK 156 (454)
T ss_dssp --CTTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSSCC--CCTTCTTCC
T ss_pred --cCCCCEEEccCCcCC-cccc----ccCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCCCc--ccCCCCCCC
Confidence 478999999999998 5774 34899999999999984 3322 278999999999999865 599999999
Q ss_pred eEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCe
Q 040925 148 WLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIG 227 (833)
Q Consensus 148 ~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~ 227 (833)
+|++++|+++.++. ..++|++|++++|++++ +| .+.++. .++.|++++|++++ +|.. .++|++
T Consensus 157 ~L~l~~N~l~~lp~----------~~~~L~~L~L~~n~l~~-l~-~~~~l~-~L~~L~l~~N~l~~-l~~~---~~~L~~ 219 (454)
T 1jl5_A 157 IIDVDNNSLKKLPD----------LPPSLEFIAAGNNQLEE-LP-ELQNLP-FLTAIYADNNSLKK-LPDL---PLSLES 219 (454)
T ss_dssp EEECCSSCCSCCCC----------CCTTCCEEECCSSCCSS-CC-CCTTCT-TCCEEECCSSCCSS-CCCC---CTTCCE
T ss_pred EEECCCCcCcccCC----------CcccccEEECcCCcCCc-Cc-cccCCC-CCCEEECCCCcCCc-CCCC---cCcccE
Confidence 99999999987553 12589999999999995 66 566654 48899999999986 3432 258999
Q ss_pred EeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCcee
Q 040925 228 FGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKL 307 (833)
Q Consensus 228 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 307 (833)
|++++|++. .+| .|+.+++|++|++++|.+++ +|.. +++|+.|++++|++++ +|.. .++|+.|++++|++
T Consensus 220 L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l 289 (454)
T 1jl5_A 220 IVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIF 289 (454)
T ss_dssp EECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred EECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCcc
Confidence 999999998 556 48999999999999999985 4543 4789999999999985 5543 37899999999999
Q ss_pred cccCCcccccccccceeeecCCCccCCCCCcccccC-CCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCc
Q 040925 308 TGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHL-KNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPL 386 (833)
Q Consensus 308 ~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 386 (833)
++ +|.. ...+++|++++|.+++. + .+ ++|++|++++|++++ +|.. +++|+.|++++|+++++ |.
T Consensus 290 ~~-l~~~----~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~l-p~ 354 (454)
T 1jl5_A 290 SG-LSEL----PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAEV-PE 354 (454)
T ss_dssp SE-ESCC----CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCC-CC
T ss_pred Cc-ccCc----CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccccc-cc
Confidence 84 3321 12337899999999852 2 23 589999999999986 4443 58899999999999954 44
Q ss_pred cccCCCCCCeEEccCcccCC--CchhhhcCC-------------CCCceEECccCcCcc--ccCCCCccCCCccccccCC
Q 040925 387 SLSFLKSIKELNVSSNNLSG--QIPEFLKNL-------------SVLEFLSLSYNHFEG--EVPTKGVFSNKTKISLQGN 449 (833)
Q Consensus 387 ~~~~l~~L~~L~l~~N~l~~--~~p~~l~~l-------------~~L~~L~l~~N~l~~--~~~~~~~~~~~~~l~l~~N 449 (833)
.+++|+.|++++|++++ .+|..+..+ ++|+.||+++|++++ .+| ..+..+.+.+|
T Consensus 355 ---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP-----~sl~~L~~~~~ 426 (454)
T 1jl5_A 355 ---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIP-----ESVEDLRMNSE 426 (454)
T ss_dssp ---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC---------------------------------------------
T ss_pred ---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccch-----hhHhheeCcCc
Confidence 47899999999999998 678888877 789999999999987 333 23455566666
Q ss_pred cCCC
Q 040925 450 MKLC 453 (833)
Q Consensus 450 ~~~c 453 (833)
...|
T Consensus 427 ~~~~ 430 (454)
T 1jl5_A 427 RVVD 430 (454)
T ss_dssp ----
T ss_pred ccCC
Confidence 5443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=367.92 Aligned_cols=349 Identities=28% Similarity=0.395 Sum_probs=268.0
Q ss_pred CCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccE
Q 040925 21 NLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKA 100 (833)
Q Consensus 21 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~ 100 (833)
.+++|+.|++++|.+.. +|. +..+++|++|+|++|.+++..+ |.++++|++|++++|.++ .+++ |.++++|++
T Consensus 44 ~l~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 44 DLDQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP--LANLTNLTG 116 (466)
T ss_dssp HHHTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG--GTTCTTCCE
T ss_pred HhccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccc-cChh--hcCCCCCCE
Confidence 45688899999998854 553 7888999999999999986544 889999999999999987 5554 788999999
Q ss_pred EEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEE
Q 040925 101 LAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180 (833)
Q Consensus 101 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~ 180 (833)
|+|++|.+++..+ |.++++|++|++++|+++++. .+..+++|++|+++ |.+... ..+.++++|++|+
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~--------~~~~~l~~L~~L~ 183 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDL--------KPLANLTTLERLD 183 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCC--------GGGTTCTTCCEEE
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCc--------hhhccCCCCCEEE
Confidence 9999998885543 888999999999999988754 48888999999986 444332 2277888899999
Q ss_pred ccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCc
Q 040925 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQ 260 (833)
Q Consensus 181 Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 260 (833)
+++|++++ + ..+..+++|+.|++++|++.+..| ++.+++|++|++++|.++
T Consensus 184 l~~n~l~~-~--------------------------~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~ 234 (466)
T 1o6v_A 184 ISSNKVSD-I--------------------------SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLK 234 (466)
T ss_dssp CCSSCCCC-C--------------------------GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred CcCCcCCC-C--------------------------hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcc
Confidence 99888762 1 235566677777777777765544 566777777777777776
Q ss_pred ccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCccc
Q 040925 261 GRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV 340 (833)
Q Consensus 261 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~ 340 (833)
+. ..+..+++|+.|++++|++.+..+ +..+++|+.|++++|++++ +|. +..+..+ +.|++++|.+++..+ +
T Consensus 235 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L-~~L~L~~n~l~~~~~--~ 305 (466)
T 1o6v_A 235 DI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTAL-TNLELNENQLEDISP--I 305 (466)
T ss_dssp CC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTC-SEEECCSSCCSCCGG--G
T ss_pred cc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCcc-CeEEcCCCcccCchh--h
Confidence 43 356677777777777777765544 6677777777777777773 333 5555555 677788887775443 7
Q ss_pred ccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCce
Q 040925 341 GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420 (833)
Q Consensus 341 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 420 (833)
..+++|+.|++++|++++..| +..+++|+.|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.
T Consensus 306 ~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 379 (466)
T 1o6v_A 306 SNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQ 379 (466)
T ss_dssp GGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCE
T ss_pred cCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCE
Confidence 788999999999999987665 78899999999999999865 468889999999999999988777 888999999
Q ss_pred EECccCcCccccC
Q 040925 421 LSLSYNHFEGEVP 433 (833)
Q Consensus 421 L~l~~N~l~~~~~ 433 (833)
|++++|++++.+.
T Consensus 380 L~l~~n~~~~~p~ 392 (466)
T 1o6v_A 380 LGLNDQAWTNAPV 392 (466)
T ss_dssp EECCCEEEECCCB
T ss_pred EeccCCcccCCch
Confidence 9999999988543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=359.16 Aligned_cols=272 Identities=24% Similarity=0.337 Sum_probs=215.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++.... ..+
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 83 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK-----RLN 83 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC-----eeE
Confidence 357999999999999999999999999999999986555556678999999999999999999999987655 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 155 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLA 155 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccc
Confidence 99999999999999987432 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccc------cCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 690 KFLSDHQLDTAV------KTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 690 ~~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+........... ..........||+.|+|||++.+..++.++|||| +|+++++++++..|+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 156 RLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFS----------FGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp EECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHTCCSSTTT
T ss_pred eecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHH----------HHHHHHHHhcCCCCCcch
Confidence 876543321110 0011112457999999999999999999999999 888899999888776421
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
......... ..........+..+++.+.+++.+||+.||++|||++|+++.|+.+.+...+
T Consensus 226 ~~~~~~~~~------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 226 LPRTMDFGL------NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp SCBCTTSSB------CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHhh------hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 111110000 0000011112334566789999999999999999999999999999876544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=363.97 Aligned_cols=343 Identities=26% Similarity=0.381 Sum_probs=264.3
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|++++|.++ .+|. +..+++|++|++++|.+++..| |+.+++|++|+|++|.+++..+ |.++++|++|+|++
T Consensus 48 l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~ 121 (466)
T 1o6v_A 48 VTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFN 121 (466)
T ss_dssp CCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred ccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCC
Confidence 689999999999 4664 8899999999999999976554 9999999999999999996555 99999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
|.++ .++. |.++++|++|+|++|.+.+ ++ .+..+++|++|+++ |.+..+. .|..+++|++|++++|.++.++
T Consensus 122 n~l~-~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~~ 193 (466)
T 1o6v_A 122 NQIT-DIDP--LKNLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDIS 193 (466)
T ss_dssp SCCC-CCGG--GTTCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCCG
T ss_pred CCCC-CChH--HcCCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCCh
Confidence 9998 5654 7899999999999999985 33 59999999999997 5566554 3899999999999999997643
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (833)
.+..+++|++|++++|++++..| ++.+++|+.|++++|++.+.
T Consensus 194 --------~l~~l~~L~~L~l~~n~l~~~~~---------------------------~~~l~~L~~L~l~~n~l~~~-- 236 (466)
T 1o6v_A 194 --------VLAKLTNLESLIATNNQISDITP---------------------------LGILTNLDELSLNGNQLKDI-- 236 (466)
T ss_dssp --------GGGGCTTCSEEECCSSCCCCCGG---------------------------GGGCTTCCEEECCSSCCCCC--
T ss_pred --------hhccCCCCCEEEecCCccccccc---------------------------ccccCCCCEEECCCCCcccc--
Confidence 37789999999999999884332 34455566666666666543
Q ss_pred ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccc
Q 040925 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITT 320 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ 320 (833)
..+..+++|++|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++. +. +..+..
T Consensus 237 ~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~ 310 (466)
T 1o6v_A 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI-SP-ISNLKN 310 (466)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC-GG-GGGCTT
T ss_pred hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCc-hh-hcCCCC
Confidence 345566666666666666664433 5666666666666666664433 56666666666666666632 22 444444
Q ss_pred cceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEcc
Q 040925 321 LSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVS 400 (833)
Q Consensus 321 ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~ 400 (833)
+ +.|++++|.+++..| +..+++|++|++++|++++. ..+..+++|+.|++++|++++..| +..+++|+.|+++
T Consensus 311 L-~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~ 383 (466)
T 1o6v_A 311 L-TYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 383 (466)
T ss_dssp C-SEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECC
T ss_pred C-CEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEecc
Confidence 4 567777777775544 67888899999999988865 468888899999999999887766 7888899999999
Q ss_pred CcccCCC
Q 040925 401 SNNLSGQ 407 (833)
Q Consensus 401 ~N~l~~~ 407 (833)
+|++++.
T Consensus 384 ~n~~~~~ 390 (466)
T 1o6v_A 384 DQAWTNA 390 (466)
T ss_dssp CEEEECC
T ss_pred CCcccCC
Confidence 9988863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=353.86 Aligned_cols=252 Identities=21% Similarity=0.273 Sum_probs=208.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+ ..+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-----EEE
Confidence 468999999999999999999999899999999998666666778999999999999999999999977655 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 94 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~ 163 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFC 163 (297)
T ss_dssp EEEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 999999999999999764 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
........ ......||+.|+|||++.+..++.++|||| .|+++++++++..|+......+..
T Consensus 164 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~g~~pf~~~~~~~~~ 225 (297)
T 3fxz_A 164 AQITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS----------LGIMAIEMIEGEPPYLNENPLRAL 225 (297)
T ss_dssp EECCSTTC--------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHH----------HHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred eecCCccc--------ccCCccCCcCccChhhhcCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCHHHHH
Confidence 86654321 122356999999999999999999999999 888999999999887532211111
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. ...... .....+..+++.+.+++.+||+.||++|||++|+++.
T Consensus 226 ~~--~~~~~~----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 226 YL--IATNGT----PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HH--HHHHCS----CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HH--HHhCCC----CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00 000000 0011123456678899999999999999999999864
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=366.92 Aligned_cols=347 Identities=18% Similarity=0.176 Sum_probs=203.2
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcc
Q 040925 3 TLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82 (833)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~ 82 (833)
.++.++++++ .+|..+. ++++.|+|++|+|++..|..|..+++|++|+|++|.|+++.|.+|.++++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 15 AVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 5666677776 5565543 467777777777766666777777777777777777776667777777777777777777
Q ss_pred cccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCC
Q 040925 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTAT 162 (833)
Q Consensus 83 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 162 (833)
++ .+|..+|.++++|++|+|++|.+++..|..|.++++|++|+|++|+++.+.+..|.++++|++|+|++|+++.++.
T Consensus 92 l~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~- 169 (477)
T 2id5_A 92 LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT- 169 (477)
T ss_dssp CC-SCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH-
T ss_pred CC-ccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh-
Confidence 76 6666666677777777777777766666667777777777777777666666666666666666655555543321
Q ss_pred CcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCcc
Q 040925 163 DLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDA 242 (833)
Q Consensus 163 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 242 (833)
..|.++++|+.|++++|.+.++.+..
T Consensus 170 ------------------------------------------------------~~l~~l~~L~~L~l~~n~i~~~~~~~ 195 (477)
T 2id5_A 170 ------------------------------------------------------EALSHLHGLIVLRLRHLNINAIRDYS 195 (477)
T ss_dssp ------------------------------------------------------HHHTTCTTCCEEEEESCCCCEECTTC
T ss_pred ------------------------------------------------------hHhcccCCCcEEeCCCCcCcEeChhh
Confidence 22333444444444444444444445
Q ss_pred ccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccc
Q 040925 243 IGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS 322 (833)
Q Consensus 243 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll 322 (833)
|..+++|++|++++|.+.+.+|..+....+|+.|+|++|+++...+..|..+++|+.|++++|+++
T Consensus 196 ~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-------------- 261 (477)
T 2id5_A 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-------------- 261 (477)
T ss_dssp SCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCC--------------
T ss_pred cccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCC--------------
Confidence 555555555555555554444444444445666666666665433344555555555555444444
Q ss_pred eeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCc
Q 040925 323 LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402 (833)
Q Consensus 323 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 402 (833)
+..+..|..+++|+.|+|++|+++++.|.+|..+++|+.|+|++|+|+++.+..|..+++|+.|+|++|
T Consensus 262 -----------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 262 -----------TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp -----------EECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred -----------ccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 223334445555566666666665555555666666666666666666555555556666666666666
Q ss_pred ccCCCchhhhcCCCCCceEECccCcCccccCC
Q 040925 403 NLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 403 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
++.+..+. ..-...+..+++.++...|..|.
T Consensus 331 ~l~c~c~~-~~~~~~~~~~~~~~~~~~C~~p~ 361 (477)
T 2id5_A 331 PLACDCRL-LWVFRRRWRLNFNRQQPTCATPE 361 (477)
T ss_dssp CEECSGGG-HHHHTTTTSSCCTTCCCBEEESG
T ss_pred CccCccch-HhHHhhhhccccCccCceeCCch
Confidence 66533221 11112233345566666665553
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=356.20 Aligned_cols=283 Identities=32% Similarity=0.537 Sum_probs=223.7
Q ss_pred CCCccchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEee
Q 040925 517 QFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIIT 595 (833)
Q Consensus 517 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~ 595 (833)
....++..++....++|++.+.||+|+||.||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 4567899999999999999999999999999999865 688999999975432 23347899999999999999999999
Q ss_pred EeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee
Q 040925 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL 675 (833)
Q Consensus 596 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll 675 (833)
++.... ..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+.++|+||||||+||++
T Consensus 95 ~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~ 167 (326)
T 3uim_A 95 FCMTPT-----ERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL 167 (326)
T ss_dssp EECCSS-----CCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred EEecCC-----ceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence 976554 789999999999999999876532 1258999999999999999999999877799999999999999
Q ss_pred cCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH
Q 040925 676 DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK 755 (833)
Q Consensus 676 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~ 755 (833)
+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||| .|++++++++
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~ 230 (326)
T 3uim_A 168 DEEFEAVVGDFGLAKLMDYKDT-------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFG----------YGVMLLELIT 230 (326)
T ss_dssp CTTCCEEECCCSSCEECCSSSS-------CEECCCCSCGGGCCHHHHHHSEECHHHHHHH----------HHHHHHHHHH
T ss_pred CCCCCEEeccCccccccCcccc-------cccccccCCcCccCHHHhccCCCCccccchh----------HHHHHHHHHh
Confidence 9999999999999986643221 1122345999999999998888999999999 8888999999
Q ss_pred HhCCCccccccccc--chhhhc----cc----cchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 756 TALPEKVMEIVDPS--LLMEVM----TN----NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 756 ~~~p~~~~~~~~~~--~~~~~~----~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
+..|+......+.. ...+.. .. .............+.++.+.+++.+||+.||++|||++|++++|+..
T Consensus 231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp CCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred CCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 98887522111100 000000 00 00001111223466788999999999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=354.47 Aligned_cols=279 Identities=31% Similarity=0.421 Sum_probs=219.3
Q ss_pred cchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecC
Q 040925 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSST 600 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 600 (833)
++..++...+++|++.+.||+|+||.||+|++. +++.||||++........+.+.+|++++++++||||+++++++...
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 344455567889999999999999999999975 6889999998766666677899999999999999999999997554
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV 680 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 680 (833)
+ ..++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 108 ~-----~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~ 177 (321)
T 2qkw_B 108 N-----EMILIYKYMENGNLKRHLYGSDLP--TMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFV 177 (321)
T ss_dssp T-----CCEEEEECCTTCBTGGGSSSSCCC--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCC
T ss_pred C-----eEEEEEEcCCCCcHHHHHhccCCC--ccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCC
Confidence 3 789999999999999999765422 12589999999999999999999999 9999999999999999999
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
+||+|||+++....... ........||+.|+|||++.+..++.++|||| +|+++++++++..|+
T Consensus 178 ~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ell~g~~p~ 241 (321)
T 2qkw_B 178 PKITDFGISKKGTELDQ------THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYS----------FGVVLFEVLCARSAI 241 (321)
T ss_dssp EEECCCTTCEECSSSSC------CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHH----------HHHHHHHHHHCCTTC
T ss_pred EEEeecccccccccccc------cccccccCCCccccCHHHhcCCCCCcccchHh----------HHHHHHHHHhCCCcc
Confidence 99999999986543211 11122346899999999998889999999999 888899999998876
Q ss_pred cccccccccchh----hhcc----ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 761 KVMEIVDPSLLM----EVMT----NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 761 ~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
......+..... .... ..............+++..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 521111100000 0000 00000111122346678899999999999999999999999999998875
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=355.30 Aligned_cols=274 Identities=22% Similarity=0.328 Sum_probs=207.8
Q ss_pred hcCCccCceeccCcceEEEEEE----ECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGT----LGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|+ ...+++.||||+++.......+.+.+|++++++++||||+++++++...+ .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence 3679999999999999999998 45689999999997655555678999999999999999999999975432 2
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CceEEEEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEcc
Confidence 357899999999999999987542 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++......... .......||+.|+|||++.+..++.++|||| +|+++++++++..|+.....
T Consensus 158 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~~~~~~~~ 222 (295)
T 3ugc_A 158 FGLTKVLPQDKEFF-----KVKEPGESPIFWYAPESLTESKFSVASDVWS----------FGVVLYELFTYIEKSKSPPA 222 (295)
T ss_dssp CCSCC------------------CTTCGGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHHTTCTTCSHHH
T ss_pred CcccccccCCccee-----eeccCCCCccceeCcHHhcCCCCChHHHHHH----------HHHHHHHHHhcccccCCChH
Confidence 99998765432111 1112235788899999999999999999999 78888888888776542210
Q ss_pred ccccchhhhccc--------cchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 766 VDPSLLMEVMTN--------NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 766 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
............ ...........+..+++.+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 223 EFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 000000000000 0000000112233456789999999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=354.41 Aligned_cols=250 Identities=21% Similarity=0.287 Sum_probs=204.6
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
..++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+++++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK----- 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----
Confidence 45689999999999999999999998999999999975422 23467889999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DF 158 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHG------RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADF 158 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECST
T ss_pred EEEEEEECCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeec
Confidence 8999999999999999997654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCC-cccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEAS-MTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|++....... .....+||+.|+|||++.+..++ .++|||| .|+++++++++..|+.....
T Consensus 159 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws----------lG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 159 GFSNEFTVGG---------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWS----------LGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp TCCGGGSSSC---------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHH----------HHHHHHHHHHSSCSSCCSSH
T ss_pred cCceecCCCC---------ccccccCCcceeCcccccCCCcCCchhhhhh----------hHHHHHHHHhCCCCCCCCCH
Confidence 9997654322 12235799999999999888765 7899999 88899999999999763221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ........... ..+...++.+.+++.+||..||++|||++|+++.
T Consensus 220 ~--~~~~~i~~~~~-------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 220 K--ELRERVLRGKY-------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp H--HHHHHHHHCCC-------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred H--HHHHHHHhCCC-------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 11111111111 1112235667899999999999999999999864
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=359.86 Aligned_cols=357 Identities=18% Similarity=0.193 Sum_probs=273.0
Q ss_pred cCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCc
Q 040925 10 YLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPF 89 (833)
Q Consensus 10 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 89 (833)
...+..+..++++++|++|++++|.+++. | .|+.+++|++|+|++|+++++ | ++++++|++|+|++|+++ .+|
T Consensus 29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~-~~~- 101 (457)
T 3bz5_A 29 EMQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLT-NLD- 101 (457)
T ss_dssp TCCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCS-CCC-
T ss_pred CcCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCc-eee-
Confidence 33445566788889999999999999664 5 688899999999999999864 3 889999999999999998 555
Q ss_pred hhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEeccccc-CCCCCCCCccccc
Q 040925 90 DIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNN-LGTGTATDLDFVT 168 (833)
Q Consensus 90 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~ 168 (833)
|.++++|++|+|++|++++. | ++.+++|++|++++|+++++ .+..+++|++|++++|. +..+
T Consensus 102 --~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--------- 164 (457)
T 3bz5_A 102 --VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--------- 164 (457)
T ss_dssp --CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC---------
T ss_pred --cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc---------
Confidence 67899999999999999863 4 88899999999999999876 37888999999999994 4332
Q ss_pred ccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCC
Q 040925 169 FLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKN 248 (833)
Q Consensus 169 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 248 (833)
.+..+++|++|++++|++++ +| +..+ ..++.|++++|++++. .+..+++|+.|++++|++++ +| ++.+++
T Consensus 165 ~~~~l~~L~~L~ls~n~l~~-l~--l~~l-~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~ 234 (457)
T 3bz5_A 165 DVTPQTQLTTLDCSFNKITE-LD--VSQN-KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQ 234 (457)
T ss_dssp CCTTCTTCCEEECCSSCCCC-CC--CTTC-TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTT
T ss_pred ccccCCcCCEEECCCCccce-ec--cccC-CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCC
Confidence 25678899999999999985 55 4444 3478888888888865 37888889999999998887 44 778888
Q ss_pred CCEEEcccccCcccCCccccCCC-------CCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCccccccccc
Q 040925 249 LQKLCLFRNFLQGRIPSGLGNLT-------KLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTL 321 (833)
Q Consensus 249 L~~L~L~~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l 321 (833)
|+.|++++|.+++..+..+.++. +|+.|++++|.+.+.+| ++.+++|+.|++++|...+.+|... ..+
T Consensus 235 L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~---~~L 309 (457)
T 3bz5_A 235 LTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQA---AGI 309 (457)
T ss_dssp CSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTT---CCC
T ss_pred CCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCC---Ccc
Confidence 99999999988876544444333 44455555555444444 4566777777777777665544321 111
Q ss_pred ceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccC
Q 040925 322 SLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401 (833)
Q Consensus 322 l~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 401 (833)
+.|+ +.++++|++|++++|++++. + ++.+++|+.|++++|++++ ++.|..|++++
T Consensus 310 -~~L~-------------l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~ 364 (457)
T 3bz5_A 310 -TELD-------------LSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALN 364 (457)
T ss_dssp -SCCC-------------CTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGG
T ss_pred -eEec-------------hhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccC
Confidence 2222 44557899999999999975 3 8999999999999999986 25677788999
Q ss_pred cccCCCchhhhcCCCCCceEECccCcCccccCCC
Q 040925 402 NNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTK 435 (833)
Q Consensus 402 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~ 435 (833)
|.++|. ..+..|+.+++++|+++|.+|..
T Consensus 365 n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 365 NNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp TSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred CcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 999875 35667888999999999988754
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=359.02 Aligned_cols=375 Identities=25% Similarity=0.317 Sum_probs=275.3
Q ss_pred CccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCC-------------cEEECCCcc
Q 040925 16 PDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSL-------------ELIQLALNR 82 (833)
Q Consensus 16 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L-------------~~L~L~~N~ 82 (833)
|+.+. .++|++|++++|.+ +.+|.+|+.+++|++|++++|++++..|..++++.+| ++|++++|.
T Consensus 5 p~~~~-~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~ 82 (454)
T 1jl5_A 5 PRNVS-NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG 82 (454)
T ss_dssp -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred ccccc-cccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCc
Confidence 55454 58999999999999 8899999999999999999999999999999999875 999999999
Q ss_pred cccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCC
Q 040925 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTAT 162 (833)
Q Consensus 83 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 162 (833)
++ .+|. -.++|++|+|++|.+++ +|.. +++|++|++++|++++++.. .++|++|+|++|+++.++
T Consensus 83 l~-~lp~----~~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~----~~~L~~L~L~~n~l~~lp-- 147 (454)
T 1jl5_A 83 LS-SLPE----LPPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYLGVSNNQLEKLP-- 147 (454)
T ss_dssp CS-CCCS----CCTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEEECCSSCCSSCC--
T ss_pred cc-cCCC----CcCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCC----CCCCCEEECcCCCCCCCc--
Confidence 98 6775 24799999999999996 6654 48899999999999976532 279999999999998754
Q ss_pred CcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCcc
Q 040925 163 DLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDA 242 (833)
Q Consensus 163 ~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 242 (833)
.+.++++|++|++++|++++ +|..+ ..++.|++++|++++ +| .|+++++|+.|++++|++++ +|..
T Consensus 148 ------~~~~l~~L~~L~l~~N~l~~-lp~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~ 213 (454)
T 1jl5_A 148 ------ELQNSSFLKIIDVDNNSLKK-LPDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL 213 (454)
T ss_dssp ------CCTTCTTCCEEECCSSCCSC-CCCCC----TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC
T ss_pred ------ccCCCCCCCEEECCCCcCcc-cCCCc----ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC
Confidence 27899999999999999994 66543 368999999999997 45 69999999999999999996 4443
Q ss_pred ccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccc
Q 040925 243 IGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS 322 (833)
Q Consensus 243 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll 322 (833)
.++|++|++++|.++ .+| .|..+++|++|++++|++++ +|.. +++|+.|++++|+++ .+|... ..+
T Consensus 214 ---~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~-~l~~~~---~~L- 279 (454)
T 1jl5_A 214 ---PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLT-DLPELP---QSL- 279 (454)
T ss_dssp ---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCS-CCCCCC---TTC-
T ss_pred ---cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCccc-ccCccc---CcC-
Confidence 258999999999999 566 49999999999999999985 4543 479999999999999 467543 334
Q ss_pred eeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCC-CCCcEEeecCCccccccCccccCCCCCCeEEccC
Q 040925 323 LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTC-VCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401 (833)
Q Consensus 323 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 401 (833)
++|++++|.+++. |.. .++|+.|++++|+++++ ..+ ++|++|++++|++++ +|.. +++|+.|++++
T Consensus 280 ~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~i-----~~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~ 346 (454)
T 1jl5_A 280 TFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRSL-----CDLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASF 346 (454)
T ss_dssp CEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSEE-----CCCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCS
T ss_pred CEEECcCCccCcc-cCc---CCcCCEEECcCCcCCcc-----cCCcCcCCEEECCCCcccc-cccc---CCcCCEEECCC
Confidence 7899999999863 211 27899999999999853 233 589999999999997 4443 58999999999
Q ss_pred cccCCCchhhhcCCCCCceEECccCcCcc--ccCC-CCcc-------------CCCccccccCCcCC
Q 040925 402 NNLSGQIPEFLKNLSVLEFLSLSYNHFEG--EVPT-KGVF-------------SNKTKISLQGNMKL 452 (833)
Q Consensus 402 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~--~~~~-~~~~-------------~~~~~l~l~~N~~~ 452 (833)
|++++ +|. .+++|++|++++|++++ ..|. .+.+ .+++.+++++|+..
T Consensus 347 N~l~~-lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~ 409 (454)
T 1jl5_A 347 NHLAE-VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409 (454)
T ss_dssp SCCSC-CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------------
T ss_pred Ccccc-ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCC
Confidence 99995 555 47899999999999999 3343 2333 56777778877654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=348.31 Aligned_cols=263 Identities=22% Similarity=0.265 Sum_probs=213.1
Q ss_pred CccchHHHHHHhcC----------CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCC
Q 040925 519 PMVSYAELSKATGE----------FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHR 588 (833)
Q Consensus 519 ~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 588 (833)
+.++.+++..++.. |+..+.||+|+||.||+|++..+|+.||||+++.......+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 56778888887764 77788999999999999999989999999999866666667899999999999999
Q ss_pred ccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCC
Q 040925 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDL 668 (833)
Q Consensus 589 niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dl 668 (833)
||+++++++...+ ..++||||+++|+|.+++... .+++..+..++.|++.||+|||+. +|+||||
T Consensus 103 niv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl 167 (321)
T 2c30_A 103 NVVEMYKSYLVGE-----ELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDI 167 (321)
T ss_dssp TBCCEEEEEEETT-----EEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred CcceEEEEEEECC-----EEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCC
Confidence 9999999987655 899999999999999998753 589999999999999999999999 9999999
Q ss_pred CCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCc
Q 040925 669 KPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGH 748 (833)
Q Consensus 669 kp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~ 748 (833)
||+||+++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||| +|+
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s----------lG~ 229 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKDVP--------KRKSLVGTPYWMAPEVISRSLYATEVDIWS----------LGI 229 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSSSC--------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHH----------HHH
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccCcc--------ccccccCCccccCHhhhcCCCCCchhhHHH----------HHH
Confidence 99999999999999999999986644221 112356999999999999999999999999 888
Q ss_pred cHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 749 SLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 749 ~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++++++++..|+......+ .......... ........+++.+.+++.+||+.||++|||++|+++.
T Consensus 230 il~el~~g~~pf~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 230 MVIEMVDGEPPYFSDSPVQ--AMKRLRDSPP----PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHSSCTTTTSCHHH--HHHHHHHSSC----CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhCCCCCCCCCHHH--HHHHHhcCCC----CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999999988875322111 1000000000 0001112345678899999999999999999999874
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=348.28 Aligned_cols=266 Identities=25% Similarity=0.369 Sum_probs=202.5
Q ss_pred HHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 525 ELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 525 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
++....++|++.+.||+|+||.||+|++ +++.||||++..... ...+.+.+|++++++++||||+++++++....
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 107 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP- 107 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-
Confidence 3334457899999999999999999988 578899999975432 23357889999999999999999999976544
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceeeCCCCCCeeecCCCc
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP--MVHGDLKPSNVLLDHDMV 680 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~ 680 (833)
..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. + |+||||||+||+++.++.
T Consensus 108 ----~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~ 177 (309)
T 3p86_A 108 ----NLSIVTEYLSRGSLYRLLHKSGAR---EQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYT 177 (309)
T ss_dssp ----CCEEEEECCTTCBHHHHHHSTTHH---HHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCC
T ss_pred ----ceEEEEecCCCCcHHHHHhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCc
Confidence 789999999999999999875421 1489999999999999999999999 8 999999999999999999
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
+||+|||+++....... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+
T Consensus 178 ~kL~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~elltg~~Pf 239 (309)
T 3p86_A 178 VKVCDFGLSRLKASTFL--------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYS----------FGVILWELATLQQPW 239 (309)
T ss_dssp EEECCCC-------------------------CCTTSCHHHHTTCCCCTTHHHHH----------HHHHHHHHHHCCCTT
T ss_pred EEECCCCCCcccccccc--------ccccCCCCccccChhhhcCCCCCchhhHHH----------HHHHHHHHHhCCCCC
Confidence 99999999975443211 112356999999999999999999999999 888999999999887
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
...... .......... .....+..+++.+.+++.+||..||++|||++|+++.|+.+.+..
T Consensus 240 ~~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 240 GNLNPA--QVVAAVGFKC-----KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp TTSCHH--HHHHHHHHSC-----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCHH--HHHHHHHhcC-----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 632211 1100000000 001112335567899999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.58 Aligned_cols=253 Identities=20% Similarity=0.240 Sum_probs=205.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc------chhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG------ASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||.||+|++..+|+.||+|+++..... ..+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~-- 88 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT-- 88 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS--
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCC--
Confidence 45799999999999999999999999999999999754322 2467899999999999999999999976554
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC----
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM---- 679 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 679 (833)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+||+++.++
T Consensus 89 ---~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~ 156 (361)
T 2yab_A 89 ---DVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (361)
T ss_dssp ---EEEEEEECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred ---EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCcc
Confidence 8999999999999999997654 689999999999999999999999 999999999999998877
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||| .|+++|+++++..|
T Consensus 157 ~vkl~DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lGvil~~ll~g~~P 217 (361)
T 2yab_A 157 HIKLIDFGLAHEIEDGV---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWS----------IGVITYILLSGASP 217 (361)
T ss_dssp CEEECCCSSCEECCTTC---------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSCCS
T ss_pred CEEEEecCCceEcCCCC---------ccccCCCCccEECchHHcCCCCCccccHHH----------HHHHHHHHHhCCCC
Confidence 79999999998765421 122356999999999999999999999999 88899999999998
Q ss_pred CcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+..... ............... ......+++.+.+++.+||..||++|||++|+++.
T Consensus 218 f~~~~~--~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 218 FLGDTK--QETLANITAVSYDFD---EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp SCCSSH--HHHHHHHHTTCCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCCH--HHHHHHHHhcCCCCC---chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 753211 111111111111000 11122345678899999999999999999999853
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=351.18 Aligned_cols=271 Identities=23% Similarity=0.290 Sum_probs=207.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++. ++.||||+++... .......+|+.++++++||||+++++++.... ......+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CCCceEE
Confidence 468999999999999999999985 7899999996432 23345667999999999999999999987643 1234579
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC-------CCCceeeCCCCCCeeecCCCcEE
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC-------QPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-------~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
+||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ .++|+||||||+||+++.++.+|
T Consensus 99 lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 999999999999999764 5899999999999999999999761 34899999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCC-----CCCCcccccccCCcCCCccccCCccHHHHHHHh
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-----SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTA 757 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~ 757 (833)
|+|||+|+........ .......||+.|+|||++.+ ..++.++|||| +|+++++++++.
T Consensus 172 L~DFg~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws----------lG~il~el~tg~ 235 (322)
T 3soc_A 172 IADFGLALKFEAGKSA------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA----------MGLVLWELASRC 235 (322)
T ss_dssp ECCCTTCEEECTTSCC------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHH----------HHHHHHHHHTTB
T ss_pred EccCCcccccccccCc------cccccCccCccccCHhhcccccccCcCCCccchhHH----------HHHHHHHHHhCC
Confidence 9999999866543211 11223569999999999876 45678899999 888889999988
Q ss_pred CCCccccccc-ccc------------hhh-hccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 758 LPEKVMEIVD-PSL------------LME-VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 758 ~p~~~~~~~~-~~~------------~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
.|+....... ..+ ... ..................+++.+.+++.+||+.||++|||++|+++.|+.
T Consensus 236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 315 (322)
T 3soc_A 236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ 315 (322)
T ss_dssp TTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 8764211000 000 000 00000000111112233456779999999999999999999999999999
Q ss_pred hhhh
Q 040925 824 TRET 827 (833)
Q Consensus 824 i~~~ 827 (833)
+.+.
T Consensus 316 l~~~ 319 (322)
T 3soc_A 316 MQRL 319 (322)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=352.95 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=206.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|++..+ +..||||+++.... ...+.+.+|++++++++||||+++++++....
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 123 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR---- 123 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG----
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC----
Confidence 35799999999999999999999754 44699999975432 33467899999999999999999999975544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 124 -~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 194 (325)
T 3kul_A 124 -LAMIVTEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD 194 (325)
T ss_dssp -CCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred -ccEEEeeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECC
Confidence 78999999999999999976532 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||+++.......... ......+|+.|+|||++.+..++.++|||| +|++++++++ +..|+....
T Consensus 195 fg~a~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ell~~g~~p~~~~~ 259 (325)
T 3kul_A 195 FGLSRVLEDDPDAAY-----TTTGGKIPIRWTAPEAIAFRTFSSASDVWS----------FGVVMWEVLAYGERPYWNMT 259 (325)
T ss_dssp CSSCEECC----CCE-----ECC---CCGGGSCHHHHHHCEECHHHHHHH----------HHHHHHHHHTTSCCTTTTSC
T ss_pred CCcccccccCcccee-----eccCCCCcccccCHhHhcCCCCCcHHHHHH----------HHHHHHHHHcCCCCCcccCC
Confidence 999987654322111 112234788999999999889999999999 7788888887 777764221
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
. .......... . ....+..+++.+.+++.+||..||++|||++||++.|+.+.+...
T Consensus 260 ~--~~~~~~~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 260 N--RDVISSVEEG-Y-----RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp H--HHHHHHHHTT-C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred H--HHHHHHHHcC-C-----CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 1 1111111110 0 011223456778999999999999999999999999999987544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=345.71 Aligned_cols=265 Identities=24% Similarity=0.355 Sum_probs=200.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhh--cCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRN--IRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|++ +++.||||++... ..+.+.+|.+++.. ++||||+++++++.... .....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~ 80 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQ 80 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCce
Confidence 46899999999999999999998 6889999998633 34556677777766 78999999999876542 33456
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHh--------hcCCCCceeeCCCCCCeeecCCC
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH--------HHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH--------~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
.++||||+++|+|.+++... .+++..++.++.|++.||+||| +. +|+||||||+||+++.++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTS
T ss_pred eEEehhhccCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCC
Confidence 89999999999999999643 5899999999999999999999 77 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCC------CCCcccccccCCcCCCccccCCccHHHH
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS------EASMTGDIFTGRRPIDAVFNEGHSLHEF 753 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~~~~~~~~~~~g~~l~~~ 753 (833)
.+||+|||+|+.......... .......||+.|+|||++.+. .++.++|||| +|++++++
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvws----------lG~il~el 216 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLD----VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA----------FGLVLWEV 216 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEE----CCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHH----------HHHHHHHH
T ss_pred CEEEeeCCCeeeccccccccc----ccccccccccceeChhhhcCcCCCCcccCCchhhHHH----------HHHHHHHH
Confidence 999999999976544322111 111234699999999998876 5668999999 78888888
Q ss_pred HHH----------hCCCcccccccccc--hhh-hccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 754 AKT----------ALPEKVMEIVDPSL--LME-VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 754 ~~~----------~~p~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+++ ..|+......+... ... ..................+++.+.+++.+||+.||++|||++|+++.
T Consensus 217 ~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 888 34432111111100 000 00000111111122334577889999999999999999999999999
Q ss_pred HHHh
Q 040925 821 LCHT 824 (833)
Q Consensus 821 L~~i 824 (833)
|+++
T Consensus 297 L~~i 300 (301)
T 3q4u_A 297 LTKI 300 (301)
T ss_dssp HHHH
T ss_pred Hhcc
Confidence 9876
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=348.53 Aligned_cols=250 Identities=23% Similarity=0.270 Sum_probs=205.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||+|+++.. .......+.+|+++++.++||||+++++++...+
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~----- 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----- 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC-----
Confidence 46899999999999999999999999999999999743 2334567889999999999999999999976655
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||+++|+|.+++...+ .+++.+++.++.||+.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DF 149 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeec
Confidence 8999999999999999997654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+|+...... ......+||+.|+|||++.+..++.++|||| .|+++|+++++..|+.....
T Consensus 150 G~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~g~~Pf~~~~~- 210 (337)
T 1o6l_A 150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG----------LGVVMYEMMCGRLPFYNQDH- 210 (337)
T ss_dssp TTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHH----------HHHHHHHHHHSSCSSCCSSH-
T ss_pred cchhhcccCC--------CcccccccChhhCChhhhcCCCCCchhhccc----------chhHHHHHhcCCCCCCCCCH-
Confidence 9998543221 1123457999999999999999999999999 88899999999988753211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
............ ..+..+++.+.+++.+||+.||++|| +++|+++.
T Consensus 211 -~~~~~~i~~~~~-------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 211 -ERLFELILMEEI-------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -HHHHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -HHHHHHHHcCCC-------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 111111111111 11223456788999999999999999 89998765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=345.27 Aligned_cols=262 Identities=21% Similarity=0.339 Sum_probs=207.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.++++++||||+++++++...+ .
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~ 85 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDD-----C 85 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSS-----E
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCC-----e
Confidence 5799999999999999999999999999999998644322 2467899999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 86 ~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 156 (294)
T 4eqm_A 86 YYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFG 156 (294)
T ss_dssp EEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCS
T ss_pred EEEEEeCCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCC
Confidence 999999999999999998654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+++........ ......||+.|+|||++.+..++.++|||| .|+++++++++..|+......+
T Consensus 157 ~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~~ll~g~~pf~~~~~~~ 219 (294)
T 4eqm_A 157 IAKALSETSLT-------QTNHVLGTVQYFSPEQAKGEATDECTDIYS----------IGIVLYEMLVGEPPFNGETAVS 219 (294)
T ss_dssp SSTTC--------------------CCSSCCHHHHHTCCCCTTHHHHH----------HHHHHHHHHHSSCSSCSSCHHH
T ss_pred Ccccccccccc-------ccCccccCccccCHhHhcCCCCCchHhHHH----------HHHHHHHHHhCCCCCCCCChHH
Confidence 99876543211 122356999999999999999999999999 8889999999999876322111
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-CHHHHHHHHHHhhhh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-DMRDVVAKLCHTRET 827 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~i~~~ 827 (833)
. ......... .........++++.+.+++.+||+.||++|| +++++.+.|+.+...
T Consensus 220 ~--~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 220 I--AIKHIQDSV--PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp H--HHHHHSSCC--CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred H--HHHHhhccC--CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 1 111111111 0011112234567889999999999999999 899999999887643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.08 Aligned_cols=247 Identities=21% Similarity=0.280 Sum_probs=198.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|+++.+++.||+|+++... ....+.+.+|..+++++ +||||+++++++...+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~---- 126 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES---- 126 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS----
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC----
Confidence 468999999999999999999999999999999997542 23345688999999887 8999999999976554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++...+ .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 127 -~~~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~D 196 (396)
T 4dc2_A 127 -RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 196 (396)
T ss_dssp -EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred -EEEEEEEcCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEee
Confidence 8999999999999999998654 699999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+|+...... ......+||+.|+|||++.+..++.++|||| .|+++|+++++..|+.....
T Consensus 197 FGla~~~~~~~--------~~~~~~~gt~~Y~aPE~l~~~~~~~~~Diws----------lGvllyell~G~~Pf~~~~~ 258 (396)
T 4dc2_A 197 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWA----------LGVLMFEMMAGRSPFDIVGS 258 (396)
T ss_dssp CTTCBCCCCTT--------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCSSTTTTC
T ss_pred cceeeecccCC--------CccccccCCcccCCchhhcCCCCChHHHHHH----------HHHHHHHHHhCCCCCccccc
Confidence 99998532211 1223467999999999999999999999999 88999999999999853211
Q ss_pred ccc------cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 766 VDP------SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 766 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
.+. ......+.. .....+..++..+.+++.+||+.||++||++
T Consensus 259 ~~~~~~~~~~~~~~~i~~------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 259 SDNPDQNTEDYLFQVILE------KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ------CCHHHHHHHHHH------CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccccchhhHHHHHHHHhc------cccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 110 000110000 0011122345678899999999999999996
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=354.82 Aligned_cols=267 Identities=22% Similarity=0.363 Sum_probs=209.1
Q ss_pred hcCCccCceeccCcceEEEEEEEC-------CCceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLG-------EDEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSST 600 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 600 (833)
.++|++.+.||+|+||.||+|++. .++..||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999874 3567899999975432 2346789999999999 899999999997654
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
+ ..|+||||+++|+|.+++...... .....+++.+++.++.||+.||+|||+. +|+||||||
T Consensus 160 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp 231 (370)
T 2psq_A 160 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231 (370)
T ss_dssp S-----SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCG
T ss_pred C-----CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccch
Confidence 4 789999999999999999875421 0112589999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+||+++.++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||| +|+++
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws----------lG~il 295 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYY------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWS----------FGVLM 295 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTT------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHH----------HHHHH
T ss_pred hhEEECCCCCEEEccccCCcccCcccce------ecccCCCcccceECHhHhcCCCCCcHHHHHH----------HHHHH
Confidence 9999999999999999999866543211 1112245789999999999999999999999 77888
Q ss_pred HHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 751 HEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 751 ~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
|++++ +..|+..... ... ........ ....+..++..+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 296 ~ellt~g~~p~~~~~~--~~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 296 WEIFTLGGSPYPGIPV--EEL-FKLLKEGH-----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHTTSCCSSTTCCG--GGH-HHHHHTTC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCH--HHH-HHHHhcCC-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 88887 7777642211 111 11111110 01122345668899999999999999999999999999987643
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.83 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=202.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|.+.+.||+|+||.||+|++..+++.||||++... .......+.+|+++++.++||||+++++++....
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 82 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT----- 82 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----
Confidence 46899999999999999999999999999999999643 1233467899999999999999999999976655
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+ +|+|.+++.... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~E~~-~g~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DF 152 (336)
T 3h4j_B 83 DIVMVIEYA-GGELFDYIVEKK------RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADF 152 (336)
T ss_dssp EEEEEECCC-CEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCS
T ss_pred EEEEEEECC-CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEe
Confidence 899999999 679999987654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|++........ ....+||+.|+|||++.+..+ +.++|||| .|+++++++++..|+.....
T Consensus 153 G~s~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Diws----------lG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 153 GLSNIMTDGNF---------LKTSCGSPNYAAPEVINGKLYAGPEVDVWS----------CGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp SCTBTTTTSBT---------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHH----------HHHHHHHHHHSSCSSBCSSS
T ss_pred ccceeccCCcc---------cccccCCcCcCCHHHHcCCCCCCCccchhH----------HHHHHHHHHhCCCCCCCccH
Confidence 99986644321 123469999999999988776 68999999 88899999999999763211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+.......... ...+...++.+.+++.+||..||++|||++|+++.
T Consensus 214 --~~~~~~i~~~~-------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 214 --PNLFKKVNSCV-------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp --TTCBCCCCSSC-------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred --HHHHHHHHcCC-------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11111111110 01122345678899999999999999999999764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.53 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=207.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++. +++.||+|+++... ...+.+.+|++++++++||||+++++++.+.. ..+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 81 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PIC 81 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----ceE
Confidence 357999999999999999999997 57789999997443 34567999999999999999999999976544 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 153 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 153 (269)
T ss_dssp EEEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGG
T ss_pred EEEEeCCCCcHHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccc
Confidence 99999999999999976542 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
+......... .....||+.|+|||++.+..++.++|||| .|++++++++ +..|+..... .
T Consensus 154 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~~ll~~g~~p~~~~~~--~ 214 (269)
T 4hcu_A 154 RFVLDDQYTS-------STGTKFPVKWASPEVFSFSRYSSKSDVWS----------FGVLMWEVFSEGKIPYENRSN--S 214 (269)
T ss_dssp GGBCCHHHHS-------TTSTTCCGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTCCH--H
T ss_pred cccccccccc-------ccCcccccccCCHHHhcCCCCCchhhhHH----------HHHHHHHHhcCCCCCCCCCCH--H
Confidence 8765433211 11235788999999999889999999999 7778888887 6777652211 1
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.......... ....+..+++.+.+++.+||+.||++|||++|++++|+++.+.
T Consensus 215 ~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 215 EVVEDISTGF------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHHHTTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCc------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 1111111100 0111122356788999999999999999999999999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=360.66 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=207.7
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++...+ .
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 186 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-----P 186 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS-----S
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC-----C
Confidence 34689999999999999999999998999999999974422 23457889999999999999999999976544 7
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGA-----RLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred cEEEEEcCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence 8999999999999999975432 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~ 766 (833)
+++.......... .....+++.|+|||++.+..++.++|||| +|++++++++ +..|+.....
T Consensus 259 ~s~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws----------lG~il~el~t~g~~p~~~~~~- 321 (377)
T 3cbl_A 259 MSREEADGVYAAS------GGLRQVPVKWTAPEALNYGRYSSESDVWS----------FGILLWETFSLGASPYPNLSN- 321 (377)
T ss_dssp GCEECTTSEEECC------SSCCEEEGGGSCHHHHHHCEEEHHHHHHH----------HHHHHHHHHTTSCCSSTTSCH-
T ss_pred CceecCCCceeec------CCCCCCCcCcCCHhHhccCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCCH-
Confidence 9986543221110 01123678899999999889999999999 7777888876 6666542211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
....+.+.... ....+..+++.+.+++.+||+.||++|||++++++.|+++.+.
T Consensus 322 --~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 322 --QQTREFVEKGG-----RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp --HHHHHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHcCC-----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11111111100 0111233566789999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.87 Aligned_cols=255 Identities=21% Similarity=0.263 Sum_probs=202.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.+++.++||||+++++++.... ..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----eE
Confidence 4689999999999999999999999999999999964432 23467899999999999999999999976654 88
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~ 151 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 151 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeec
Confidence 99999999999999998654 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++......... ......||+.|+|||++.+..+ +.++|||| .|+++++++++..|+.......
T Consensus 152 a~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws----------lG~il~~ll~g~~pf~~~~~~~ 215 (323)
T 3tki_A 152 ATVFRYNNRER------LLNKMCGTLPYVAPELLKRREFHAEPVDVWS----------CGIVLTAMLAGELPWDQPSDSC 215 (323)
T ss_dssp CEECEETTEEC------CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHH----------HHHHHHHHHHSSCSCSSSCTTS
T ss_pred cceeccCCccc------ccCCCccCcCccCcHHhccCCCCCCcccHHH----------HHHHHHHHHhCCCCCCCCchHH
Confidence 98654322111 1223579999999999887775 78899999 8889999999999986332211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... ......... ......++..+.+++.+||..||++|||++|+++.
T Consensus 216 ~~~-~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 216 QEY-SDWKEKKTY-----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp HHH-HHHHTTCTT-----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHH-HHHhccccc-----CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111 111111110 01112345677899999999999999999999764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.85 Aligned_cols=253 Identities=18% Similarity=0.232 Sum_probs=206.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++..+++.||+|.++.. ......+.+|+++++.++||||+++++++.+.+ ..+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 77 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESME-----ELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCC-----EEE
Confidence 46899999999999999999999999999999999743 234567889999999999999999999976655 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC--CCcEEEcccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH--DMVAHVCDFG 687 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~DfG 687 (833)
+||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. ||+||||||+||+++. ++.+||+|||
T Consensus 78 lv~e~~~g~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg 149 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEEeCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECC
Confidence 99999999999999976532 589999999999999999999999 9999999999999987 7899999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+++....... .....||+.|+|||++.+..++.++|||| .|+++++++++..|+.... +
T Consensus 150 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~~ll~g~~pf~~~~--~ 208 (321)
T 1tki_A 150 QARQLKPGDN---------FRLLFTAPEYYAPEVHQHDVVSTATDMWS----------LGTLVYVLLSGINPFLAET--N 208 (321)
T ss_dssp TCEECCTTCE---------EEEEESCGGGSCHHHHTTCEECHHHHHHH----------HHHHHHHHHHSSCTTCCSS--H
T ss_pred CCeECCCCCc---------cccccCChhhcCcHHhcCCCCCchhhHHH----------HHHHHHHHHhCCCCCcCCC--H
Confidence 9987644221 12346999999999999988999999999 8889999999998875322 1
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
............... .....+++..+.+++.+||..||++|||+.|+++.
T Consensus 209 ~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 209 QQIIENIMNAEYTFD---EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHHHHHHHHTCCCCC---HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHcCCCCCC---hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111111111111110 11122346678999999999999999999999885
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=344.87 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=204.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc------chhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG------ASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-- 87 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT-- 87 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC--
Confidence 35699999999999999999999999999999999754321 3467899999999999999999999976554
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC----
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM---- 679 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 679 (833)
..++||||+++|+|.+++.... .+++.+++.++.|++.||.|||+. +|+||||||+||+++.++
T Consensus 88 ---~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 155 (326)
T 2y0a_A 88 ---DVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKP 155 (326)
T ss_dssp ---EEEEEEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSC
T ss_pred ---EEEEEEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCC
Confidence 8999999999999999997654 689999999999999999999999 999999999999999887
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||| .|+++++++++..|
T Consensus 156 ~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~~ll~g~~p 216 (326)
T 2y0a_A 156 RIKIIDFGLAHKIDFGN---------EFKNIFGTPEFVAPEIVNYEPLGLEADMWS----------IGVITYILLSGASP 216 (326)
T ss_dssp CEEECCCTTCEECCTTS---------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSCCS
T ss_pred CEEEEECCCCeECCCCC---------ccccccCCcCcCCceeecCCCCCcHHHHHH----------HHHHHHHHHHCcCC
Confidence 89999999998764321 112346999999999999999999999999 88899999999988
Q ss_pred CcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+...... ............. .......++..+.+++.+||..||++|||++|+++.
T Consensus 217 f~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 217 FLGDTKQ--ETLANVSAVNYEF---EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp SCCSSHH--HHHHHHHHTCCCC---CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCHH--HHHHHHHhcCCCc---CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 7522111 1111111110000 011112345678899999999999999999999874
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.40 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=206.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++. ++..||+|+++... ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 79 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY-----PIY 79 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SEE
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----ceE
Confidence 468999999999999999999887 67789999997543 34567899999999999999999999975544 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~ 151 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGK-----GLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMT 151 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCE
T ss_pred EEEEccCCCcHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccc
Confidence 99999999999999976432 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
.......... .....||+.|+|||++.+..++.++|||| .|++++++++ +..|+......
T Consensus 152 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~~g~~p~~~~~~~-- 212 (268)
T 3sxs_A 152 RYVLDDQYVS-------SVGTKFPVKWSAPEVFHYFKYSSKSDVWA----------FGILMWEVFSLGKMPYDLYTNS-- 212 (268)
T ss_dssp EECCTTCEEE-------CCSCCCCGGGCCHHHHHHSEEETTHHHHH----------HHHHHHHHHTTTCCTTTTSCHH--
T ss_pred eecchhhhhc-------ccCCCcCcccCCHHHHhccCCchhhhhHH----------HHHHHHHHHcCCCCCccccChH--
Confidence 8765433211 12234788999999999888999999999 7788888887 77776522211
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
........... ...+..+++.+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 213 ~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 213 EVVLKVSQGHR------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp HHHHHHHTTCC------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred HHHHHHHcCCC------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 11111111100 011122355788999999999999999999999999998764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=346.45 Aligned_cols=268 Identities=22% Similarity=0.272 Sum_probs=210.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++++++ +||||+++++++.... ..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-----~~~ 81 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGK-----YNA 81 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETT-----EEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCC-----ccE
Confidence 57999999999999999999998899999999986442 345689999999999 8999999999976654 889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc-----EEEc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV-----AHVC 684 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~ 684 (833)
+||||+ +|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 82 lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~ 152 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHII 152 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEEC
T ss_pred EEEEeC-CCCHHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEE
Confidence 999999 8999999986532 689999999999999999999999 9999999999999998887 9999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+|+........... .........||+.|+|||++.+..++.++|||| +|+++++++++..|+....
T Consensus 153 DFg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 153 DFALAKEYIDPETKKHI-PYREHKSLTGTARYMSINTHLGKEQSRRDDLEA----------LGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp CCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHSSCTTTTCC
T ss_pred EcccceeeecCCCCccc-cccccCCcCCCccccChHHHcCCCCCchhHHHH----------HHHHHHHHhcCCCCccccc
Confidence 99999876543221110 111223467999999999999999999999999 8899999999999986432
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
..+.......+....... ........++ .+.+++..||..||.+||++++|.+.|+.+.+.
T Consensus 222 ~~~~~~~~~~i~~~~~~~-~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 222 ADTLKERYQKIGDTKRAT-PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp CSSHHHHHHHHHHHHHHS-CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cccHHHHHHHHHhhhccC-CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 111111111110000000 0000111134 889999999999999999999999999988764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=339.36 Aligned_cols=272 Identities=19% Similarity=0.233 Sum_probs=214.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||.||+|++..+++.||||++... ...+.+.+|+++++++ +|++++++++++.... ..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~ 81 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HN 81 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc-----ee
Confidence 35799999999999999999999889999999998643 2345688999999999 7999999999976554 88
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc-----EEE
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV-----AHV 683 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kL 683 (833)
++||||+ +++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++. +||
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl 152 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYV 152 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEE
T ss_pred EEEEEec-CCCHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEE
Confidence 9999999 8999999986542 589999999999999999999999 9999999999999987775 999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+|||+++........... .........||+.|+|||++.+..++.++|||| +|+++++++++..|+...
T Consensus 153 ~Dfg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 153 VDFGMVKFYRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEA----------LGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp CCCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHSSCTTSSC
T ss_pred EECccccccccccccccc-cccCccCCCCCcccCCchhhcCCCCChHHHHHH----------HHHHHHHHHcCCCCcchh
Confidence 999999876553321111 111233467999999999999999999999999 888999999999998643
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
...+.......+..... ..........+++.+.+++.+||+.||++|||+++|++.|+++.+...
T Consensus 222 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 222 KAATNKQKYERIGEKKQ-STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp CSCCHHHHHHHHHHHHH-HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred hccccHHHHHHHHhhcc-CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 22211111111110000 000111112456789999999999999999999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=356.45 Aligned_cols=255 Identities=19% Similarity=0.214 Sum_probs=204.3
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~----- 83 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEG----- 83 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSS-----
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECC-----
Confidence 45689999999999999999999999999999999975432 23457899999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec---CCCcEEE
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHV 683 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL 683 (833)
..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++ .++.+||
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~------~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL 154 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVARE------YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKL 154 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEE
T ss_pred EEEEEEEeCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEE
Confidence 8999999999999999998764 689999999999999999999999 999999999999998 4678999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+|||+|+....... ......||+.|+|||++.+..++.++|||| .|+++|+++++..|+...
T Consensus 155 ~DFG~a~~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwS----------lGvilyell~G~~Pf~~~ 216 (444)
T 3soa_A 155 ADFGLAIEVEGEQQ--------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWA----------CGVILYILLVGYPPFWDE 216 (444)
T ss_dssp CCCSSCBCCCTTCC--------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCSCCCS
T ss_pred ccCceeEEecCCCc--------eeecccCCcccCCHHHhcCCCCCCccccHH----------HHHHHHHHHhCCCCCCCc
Confidence 99999986654321 122357999999999999999999999999 888999999999887522
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. .............. .......+++.+.+++.+||+.||++|||+.|+++.
T Consensus 217 ~~--~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 217 DQ--HRLYQQIKAGAYDF---PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp SH--HHHHHHHHHTCCCC---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cH--HHHHHHHHhCCCCC---CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11 11111111111100 011112345678899999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=350.05 Aligned_cols=251 Identities=20% Similarity=0.298 Sum_probs=203.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE----- 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence 36799999999999999999999999999999999643 2334567889999999999999999999976655
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DF 159 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV------HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDF 159 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecc
Confidence 8999999999999999998754 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC---CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG---SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
|+|+...... .....+||+.|+|||++.+ ..++.++|||| .|+++|+++++..|+...
T Consensus 160 G~a~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwS----------lG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 160 NIAAMLPRET---------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWS----------LGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp TTCEECCTTC---------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHH----------HHHHHHHHHHSSCSSCCC
T ss_pred ceeeeccCCC---------ceeccCCCccccCCeeeccCCCCCCCccceeec----------hHHHHHHHHhCCCCCCCC
Confidence 9998664321 1234579999999999864 45899999999 888999999999998633
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-HHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-MRDVVA 819 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~ 819 (833)
...+.......... .....+..++..+.+++.+||..||++||+ ++++.+
T Consensus 221 ~~~~~~~~~~~~~~------~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 221 SSTSSKEIVHTFET------TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TTSCHHHHHHHHHH------CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCccHHHHHHHHhh------cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 22211111111100 011112334667899999999999999998 666654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=349.42 Aligned_cols=346 Identities=18% Similarity=0.217 Sum_probs=290.3
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|++++|.+++. | .++.+++|++|++++|++++. | ++.+++|++|+|++|+++++ + |+++++|++|+|++
T Consensus 44 L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~ 115 (457)
T 3bz5_A 44 LTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDT 115 (457)
T ss_dssp CCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCS
T ss_pred CCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCC
Confidence 68999999999964 5 799999999999999999764 4 99999999999999999965 3 99999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
|+++ .+| +..+++|++|+|++|++++. + ++.+++|++|++++|+..+.. .+..+++|++|++++|+++.++
T Consensus 116 N~l~-~l~---~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~l~ 186 (457)
T 3bz5_A 116 NKLT-KLD---VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITELD 186 (457)
T ss_dssp SCCS-CCC---CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCCCC
T ss_pred CcCC-eec---CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccceec
Confidence 9998 565 78999999999999999864 3 889999999999999543222 5889999999999999998753
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (833)
+..+++|+.|++++|++++. + +..+ ..++.|++++|++++ +| +..+++|+.|++++|++++..+
T Consensus 187 ---------l~~l~~L~~L~l~~N~l~~~-~--l~~l-~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~ 250 (457)
T 3bz5_A 187 ---------VSQNKLLNRLNCDTNNITKL-D--LNQN-IQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV 250 (457)
T ss_dssp ---------CTTCTTCCEEECCSSCCSCC-C--CTTC-TTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC
T ss_pred ---------cccCCCCCEEECcCCcCCee-c--cccC-CCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH
Confidence 56889999999999999964 3 5555 458899999999998 45 8899999999999999998776
Q ss_pred ccccCCC-------CCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCc
Q 040925 241 DAIGELK-------NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPH 313 (833)
Q Consensus 241 ~~~~~l~-------~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 313 (833)
..+..+. +|+.|++++|.+.+.+| +..+++|+.|+|++|...+.+|. ..++|+.|++++|.
T Consensus 251 ~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~~~~L~~L~l~~~~------- 318 (457)
T 3bz5_A 251 STLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---QAAGITELDLSQNP------- 318 (457)
T ss_dssp TTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---TTCCCSCCCCTTCT-------
T ss_pred HHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---CCCcceEechhhcc-------
Confidence 6655554 55666666666655554 56789999999999998877774 45678888888772
Q ss_pred ccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCC
Q 040925 314 QLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKS 393 (833)
Q Consensus 314 ~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 393 (833)
.+ ++|++++|++++. .++++++|+.|++++|++++ ++.|..|++++|++.+. ..+..
T Consensus 319 ------~L-~~L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~ 375 (457)
T 3bz5_A 319 ------KL-VYLYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTIT 375 (457)
T ss_dssp ------TC-CEEECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEE
T ss_pred ------cC-CEEECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeee
Confidence 33 7899999999974 38999999999999999985 35677788999999975 35667
Q ss_pred CCeEEccCcccCCCchhhhcC
Q 040925 394 IKELNVSSNNLSGQIPEFLKN 414 (833)
Q Consensus 394 L~~L~l~~N~l~~~~p~~l~~ 414 (833)
|..+++++|+++|.+|..+..
T Consensus 376 l~~l~l~~N~l~g~ip~~~~~ 396 (457)
T 3bz5_A 376 MPKETLTNNSLTIAVSPDLLD 396 (457)
T ss_dssp CCCBCCBTTBEEEECCTTCBC
T ss_pred cCccccccCcEEEEcChhHhc
Confidence 889999999999998876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.77 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=208.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.... ....+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 85 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV 85 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCC---CceEE
Confidence 57999999999999999999999999999999997443 234567889999999999999999999976543 34789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee----cCCCcEEEcc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCD 685 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~D 685 (833)
+||||+++|+|.+++...... ..+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred EEEeCCCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEcc
Confidence 999999999999999875421 1489999999999999999999999 99999999999999 7788899999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccC--------CCCCCcccccccCCcCCCccccCCccHHHHHHHh
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM--------GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTA 757 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~ 757 (833)
||+++....... .....||+.|+|||++. +..++.++|||| +|+++++++++.
T Consensus 160 fg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diws----------lG~il~el~~g~ 220 (319)
T 4euu_A 160 FGAARELEDDEQ---------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS----------IGVTFYHAATGS 220 (319)
T ss_dssp CTTCEECCTTCC---------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHH----------HHHHHHHHHHSS
T ss_pred CCCceecCCCCc---------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHH----------HHHHHHHHHhCC
Confidence 999987654321 12346999999999875 577899999999 788888888888
Q ss_pred CCCccccccc--ccchhhhccccc------------------hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHH
Q 040925 758 LPEKVMEIVD--PSLLMEVMTNNS------------------MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDV 817 (833)
Q Consensus 758 ~p~~~~~~~~--~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 817 (833)
.|+......+ ............ ...+..........+.+.+++.+||+.||++|||++|+
T Consensus 221 ~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~el 300 (319)
T 4euu_A 221 LPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300 (319)
T ss_dssp CSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred CCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHh
Confidence 8865211100 111111100000 00011112346678889999999999999999999999
Q ss_pred HHHHHHh
Q 040925 818 VAKLCHT 824 (833)
Q Consensus 818 l~~L~~i 824 (833)
++.....
T Consensus 301 l~h~~d~ 307 (319)
T 4euu_A 301 FAETSDI 307 (319)
T ss_dssp HHHHHHH
T ss_pred hhccHHH
Confidence 9988754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=346.82 Aligned_cols=247 Identities=22% Similarity=0.279 Sum_probs=198.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|+++.+++.||+|+++.... ...+.+.+|..+++++ +||||+++++++....
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~---- 83 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES---- 83 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC----
Confidence 3579999999999999999999999999999999975422 2345688999999998 8999999999976554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..|+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 84 -~~~lv~e~~~gg~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~D 153 (345)
T 3a8x_A 84 -RLFFVIEYVNGGDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTD 153 (345)
T ss_dssp -EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECC
T ss_pred -EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEe
Confidence 8999999999999999997654 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+|+...... ......+||+.|+|||++.+..++.++|||| .|+++|+++++..|+.....
T Consensus 154 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~g~~pf~~~~~ 215 (345)
T 3a8x_A 154 YGMCKEGLRPG--------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWA----------LGVLMFEMMAGRSPFDIVGS 215 (345)
T ss_dssp GGGCBCSCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCTTTTTTC
T ss_pred ccccccccCCC--------CcccccCCCccccCccccCCCCCChHHhHHH----------HHHHHHHHHhCCCCcCCccc
Confidence 99998533211 1123457999999999999999999999999 88899999999998753211
Q ss_pred cc------ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 766 VD------PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 766 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
.+ .......+... ....+..++..+.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~~~~~~i~~~------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 216 SDNPDQNTEDYLFQVILEK------QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp -------CHHHHHHHHHHC------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ccccccccHHHHHHHHHcC------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 00000000000 001122345678899999999999999996
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=337.38 Aligned_cols=253 Identities=23% Similarity=0.356 Sum_probs=202.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcc-------hhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA-------SRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
++|++.+.||+|+||.||+|++..+++.||+|++....... .+.+.+|++++++++||||+++++++....
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57999999999999999999999999999999996543221 167899999999999999999999974432
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceeeCCCCCCeeecCCCc-
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP--MVHGDLKPSNVLLDHDMV- 680 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~- 680 (833)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. + |+||||||+||+++.++.
T Consensus 97 -----~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~ 163 (287)
T 4f0f_A 97 -----RMVMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDEN 163 (287)
T ss_dssp -----EEEEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTT
T ss_pred -----eEEEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCC
Confidence 699999999999998876542 689999999999999999999999 8 999999999999988776
Q ss_pred ----EEEcccccccccCcccccccccCCCccccccccccccCcccc--CCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 681 ----AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYG--MGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 681 ----~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
+||+|||+++..... .....||+.|+|||++ ....++.++|||| .|+++++++
T Consensus 164 ~~~~~kl~Dfg~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~s----------lG~~l~~l~ 222 (287)
T 4f0f_A 164 APVCAKVADFGLSQQSVHS-----------VSGLLGNFQWMAPETIGAEEESYTEKADTYS----------FAMILYTIL 222 (287)
T ss_dssp CSCCEEECCCTTCBCCSSC-----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHH----------HHHHHHHHH
T ss_pred CceeEEeCCCCcccccccc-----------ccccCCCccccCchhhccCCCCcCchhhHHH----------HHHHHHHHH
Confidence 999999999754332 1234699999999998 4556789999999 888999999
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
++..|+......+............ ....+..+++.+.+++.+||+.||++|||++|+++.|+++
T Consensus 223 ~g~~pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 223 TGEGPFDEYSYGKIKFINMIREEGL-----RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HSSCTTTTCCCCHHHHHHHHHHSCC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cCCCCCccccccHHHHHHHHhccCC-----CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 9998876322211111111111100 1112234567889999999999999999999999999864
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.55 Aligned_cols=280 Identities=28% Similarity=0.414 Sum_probs=218.4
Q ss_pred CCCccchHHHHHHhcCCccC------ceeccCcceEEEEEEECCCceEEEEEEeeccC----CcchhHHHHHHHHHhhcC
Q 040925 517 QFPMVSYAELSKATGEFSSS------NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY----KGASRSFVAECEALRNIR 586 (833)
Q Consensus 517 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~ 586 (833)
....+++.++..++++|... +.||+|+||.||+|++ +++.||||++.... ....+.+.+|+.++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 35678999999999998877 8999999999999987 57889999986432 233567899999999999
Q ss_pred CCccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceee
Q 040925 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHG 666 (833)
Q Consensus 587 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~ 666 (833)
||||+++++++...+ ..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+||
T Consensus 89 h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~ 157 (307)
T 2nru_A 89 HENLVELLGFSSDGD-----DLCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHEN---HHIHR 157 (307)
T ss_dssp CTTBCCEEEEECSSS-----SCEEEEECCTTCBHHHHHHTGGGC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred CCCeEEEEEEEecCC-----ceEEEEEecCCCcHHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhcC---CeecC
Confidence 999999999976544 789999999999999999754321 2689999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccC
Q 040925 667 DLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNE 746 (833)
Q Consensus 667 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~ 746 (833)
||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+ .++.++|||| +
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~s----------l 220 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQT------VMTSRIVGTTAYMAPEALRG-EITPKSDIYS----------F 220 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSSC------EECSSCCSCGGGCCHHHHTT-EECTHHHHHH----------H
T ss_pred CCCHHHEEEcCCCcEEEeeccccccccccccc------ccccccCCCcCcCChHHhcC-CCCccchhHH----------H
Confidence 99999999999999999999999865432211 11123469999999998765 5889999999 8
Q ss_pred CccHHHHHHHhCCCcccccccc--cchhhhccccch----hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 747 GHSLHEFAKTALPEKVMEIVDP--SLLMEVMTNNSM----IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 747 g~~l~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
|+++++++++..|+........ .+.......... ...........++..+.+++.+||+.||++|||++++++.
T Consensus 221 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 221 GVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8899999999888753221110 000000000000 0001112345677889999999999999999999999999
Q ss_pred HHHhhh
Q 040925 821 LCHTRE 826 (833)
Q Consensus 821 L~~i~~ 826 (833)
|+++..
T Consensus 301 L~~l~~ 306 (307)
T 2nru_A 301 LQEMTA 306 (307)
T ss_dssp HHHHC-
T ss_pred HHHHhc
Confidence 998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=355.30 Aligned_cols=278 Identities=20% Similarity=0.297 Sum_probs=214.7
Q ss_pred cchHHHHHHhcCCccCceeccCcceEEEEEE-----ECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceE
Q 040925 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGT-----LGEDEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKI 593 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~ 593 (833)
+....+....++|++.+.||+|+||.||+|+ ...+++.||||+++.... ...+.+.+|+++++++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4556666778899999999999999999998 455779999999975432 2346789999999999 79999999
Q ss_pred eeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCcc------------------------------------------
Q 040925 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV------------------------------------------ 631 (833)
Q Consensus 594 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------ 631 (833)
++++...+ ...++||||+++|+|.+++.......
T Consensus 92 ~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 99986543 35899999999999999998754210
Q ss_pred ------------------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccC
Q 040925 632 ------------------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693 (833)
Q Consensus 632 ------------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 693 (833)
....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 011289999999999999999999999 99999999999999999999999999998664
Q ss_pred cccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccchh
Q 040925 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLM 772 (833)
Q Consensus 694 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~ 772 (833)
..... .......||+.|+|||++.+..++.++|||| +|++++++++ +..|+...... .....
T Consensus 245 ~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ellt~g~~p~~~~~~~-~~~~~ 307 (359)
T 3vhe_A 245 KDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWS----------FGVLLWEIFSLGASPYPGVKID-EEFCR 307 (359)
T ss_dssp SCTTC------EEC--CEECGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHTTTSCCSSTTCCCS-HHHHH
T ss_pred ccccc------hhccccCCCceeEChhhhcCCCCCchhhhhh----------HHHHHHHHHhcCCCCCCccchh-HHHHH
Confidence 32211 1122346899999999999999999999999 7778888887 77776422111 11111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
...... ....+..+++.+.+++.+||+.||++|||++|++++|+++.+..
T Consensus 308 ~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 308 RLKEGT------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHcCC------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 000000 01112234567889999999999999999999999999988653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=350.82 Aligned_cols=252 Identities=22% Similarity=0.262 Sum_probs=200.2
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFK 603 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 603 (833)
...++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|.++++.+ +||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~-- 97 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD-- 97 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS--
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC--
Confidence 3457899999999999999999999999999999999743 223446688999999998 6999999999976655
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||
T Consensus 98 ---~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL 165 (353)
T 3txo_A 98 ---RLFFVMEFVNGGDLMFHIQKSR------RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKL 165 (353)
T ss_dssp ---EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEE
T ss_pred ---EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEE
Confidence 8999999999999999998654 699999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+|||+|+...... ......+||+.|+|||++.+..++.++|||| .|+++|+++++..|+...
T Consensus 166 ~DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 166 ADFGMCKEGICNG--------VTTATFCGTPDYIAPEILQEMLYGPAVDWWA----------MGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp CCCTTCBCSCC-----------------CCGGGCCHHHHHHHHCTTHHHHHH----------HHHHHHHHHHSSCSSCCS
T ss_pred ccccceeecccCC--------ccccccCCCcCeEChhhcCCCCcCCccCCCc----------chHHHHHHHhCCCCCCCC
Confidence 9999998543221 1123457999999999999889999999999 888999999999997632
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH------HHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM------RDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~eil~~ 820 (833)
... ........... ..+...++.+.+++.+||..||++||++ +|++++
T Consensus 228 ~~~--~~~~~i~~~~~-------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 228 NED--DLFEAILNDEV-------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp SHH--HHHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CHH--HHHHHHHcCCC-------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 211 11111111111 1112245668899999999999999998 777653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=345.74 Aligned_cols=266 Identities=24% Similarity=0.313 Sum_probs=200.4
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCC-----
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDF----- 602 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----- 602 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 34679999999999999999999999999999999975433 345789999999999999999999999855431
Q ss_pred -----------------------------------------------CCCceEeEEEEecCCCChhhhhccCCCcccccc
Q 040925 603 -----------------------------------------------KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK 635 (833)
Q Consensus 603 -----------------------------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 635 (833)
......++||||+++|+|.+++...... ..
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~ 160 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---ED 160 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GG
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cc
Confidence 1123489999999999999999876532 24
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCccccccccc----CCCcccccc
Q 040925 636 LSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVK----TPSSSIGLK 711 (833)
Q Consensus 636 l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~----~~~~~~~~~ 711 (833)
.++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++............ .........
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 67778999999999999999999 99999999999999999999999999998775542211100 011223457
Q ss_pred ccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHH
Q 040925 712 GTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEE 791 (833)
Q Consensus 712 gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 791 (833)
||+.|+|||++.+..++.++|||| .|+++++++++..+..... ......... ........
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~~~~~~~~~~~----~~~~~~~~~------~~~~~~~~ 297 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFS----------LGLILFELLYSFSTQMERV----RIITDVRNL------KFPLLFTQ 297 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHH----------HHHHHHHHHSCCCCHHHHH----HHHHHHHTT------CCCHHHHH
T ss_pred CCcCccChHHhcCCCCcchhhHHH----------HHHHHHHHHHcCCChhHHH----HHHHHhhcc------CCCccccc
Confidence 999999999999999999999999 6777777776544422100 000000000 01112234
Q ss_pred HHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 792 CLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 792 ~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..+.+.+++.+||+.||++|||++|+++.
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 55677899999999999999999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=348.37 Aligned_cols=254 Identities=20% Similarity=0.261 Sum_probs=204.9
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
..++|++.+.||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|++++++++||||+++++++.+.+
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~----- 101 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES----- 101 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----
Confidence 45689999999999999999999999999999999975432 23467889999999999999999999976654
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC---CcEEE
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAHV 683 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kL 683 (833)
..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.+ +.+||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl 172 (362)
T 2bdw_A 102 FHYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKL 172 (362)
T ss_dssp EEEEEECCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence 8999999999999999997654 689999999999999999999999 99999999999999865 45999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+|||++....... ......||+.|+|||++.+..++.++|||| .|+++|+++++..|+...
T Consensus 173 ~DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~~ll~g~~Pf~~~ 233 (362)
T 2bdw_A 173 ADFGLAIEVNDSE---------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWA----------CGVILYILLVGYPPFWDE 233 (362)
T ss_dssp CCCTTCBCCTTCC---------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSSCSSCCS
T ss_pred eecCcceEecCCc---------ccccCCCCccccCHHHHccCCCCchhhHHH----------HHHHHHHHHHCCCCCCCC
Confidence 9999998665322 112356999999999999999999999999 888999999999887532
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+. .............. .......+++.+.+++.+||..||++|||+.|+++.
T Consensus 234 ~~--~~~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 234 DQ--HRLYAQIKAGAYDY---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp SH--HHHHHHHHHTCCCC---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CH--HHHHHHHHhCCCCC---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 21 11111111111100 011122346678899999999999999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=349.81 Aligned_cols=254 Identities=19% Similarity=0.236 Sum_probs=205.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|++++++++||||+++++++.... ..+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCC-----EEE
Confidence 468999999999999999999999999999999997654445567899999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC--CCcEEEcccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH--DMVAHVCDFG 687 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~DfG 687 (833)
+||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||
T Consensus 125 lv~E~~~gg~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG 196 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 196 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecc
Confidence 99999999999999976532 589999999999999999999999 9999999999999974 4789999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+....... .....||+.|+|||++.+..++.++|||| .|+++++++++..|+......
T Consensus 197 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lG~il~elltg~~Pf~~~~~~- 256 (387)
T 1kob_A 197 LATKLNPDEI---------VKVTTATAEFAAPEIVDREPVGFYTDMWA----------IGVLGYVLLSGLSPFAGEDDL- 256 (387)
T ss_dssp TCEECCTTSC---------EEEECSSGGGCCHHHHTTCCBCHHHHHHH----------HHHHHHHHHHSCCSSCCSSHH-
T ss_pred cceecCCCcc---------eeeeccCCCccCchhccCCCCCCcccEee----------HhHHHHHHHhCCCCCCCCCHH-
Confidence 9987644221 12246999999999999999999999999 888999999999887532211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
............. .......+++.+.+++.+||..||++|||++|+++.
T Consensus 257 -~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 257 -ETLQNVKRCDWEF---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -HHHHHHHHCCCCC---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHhCCCCC---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 1111111111100 011122346678999999999999999999999874
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=337.36 Aligned_cols=260 Identities=23% Similarity=0.371 Sum_probs=205.4
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
...++|++.+.||+|+||.||+|.+. ++..||+|+++... ...+.+.+|++++++++||||+++++++.... .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~ 93 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----P 93 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----S
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCC-----C
Confidence 34568999999999999999999987 67889999997443 34567899999999999999999999975544 7
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 165 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG 165 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTT
T ss_pred eEEEEeccCCCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccc
Confidence 8999999999999999976432 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~ 766 (833)
+++......... .....||+.|+|||++.+..++.++|||| .|++++++++ +..|+......
T Consensus 166 ~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~~l~~l~t~g~~p~~~~~~~ 228 (283)
T 3gen_A 166 LSRYVLDDEYTS-------SVGSKFPVRWSPPEVLMYSKFSSKSDIWA----------FGVLMWEIYSLGKMPYERFTNS 228 (283)
T ss_dssp GGGGBCCHHHHS-------TTSTTSCGGGCCHHHHHHCCCSHHHHHHH----------HHHHHHHHHTTTCCTTTTSCHH
T ss_pred cccccccccccc-------ccCCccCcccCCHHHhccCCCCchhhHHH----------HHHHHHHHHhCCCCCccccChh
Confidence 998765433211 11234788999999999888999999999 7888888887 77776532211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.......... ....+..+++.+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 229 --~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 229 --ETAEHIAQGL------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --HHHHHHHTTC------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHhccc------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1111111100 0011122356788999999999999999999999999998764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.50 Aligned_cols=262 Identities=26% Similarity=0.425 Sum_probs=196.1
Q ss_pred hcCCccCceeccCcceEEEEEEEC---CCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|++. .++..||||+++.... ...+.+.+|+.++++++||||+++++++....
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---- 119 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK---- 119 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS----
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC----
Confidence 357999999999999999999886 4677899999975432 23467999999999999999999999976544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 120 -~~~lv~e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~D 190 (373)
T 2qol_A 120 -PVMIVTEYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190 (373)
T ss_dssp -SCEEEEECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred -ceEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECc
Confidence 78999999999999999986542 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||+++......... .......+|+.|+|||++.+..++.++|||| +|++++++++ +..|+....
T Consensus 191 fg~a~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~S----------lG~il~ellt~g~~P~~~~~ 255 (373)
T 2qol_A 191 FGLGRVLEDDPEAA-----YTTRGGKIPIRWTSPEAIAYRKFTSASDVWS----------YGIVLWEVMSYGERPYWEMS 255 (373)
T ss_dssp C---------------------------CTTSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTC-CTTTTCC
T ss_pred CccccccccCCccc-----eeccCCCcCCCccChhhhccCCcCchhcHHH----------HHHHHHHHHhCCCCCCCCCC
Confidence 99998765432111 0111224678999999999899999999999 7788888776 777764221
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
. ... ...+.... ....+.+++..+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 256 ~--~~~-~~~i~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 256 N--QDV-IKAVDEGY-----RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp H--HHH-HHHHHTTE-----ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred H--HHH-HHHHHcCC-----CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1 111 11111110 0111223567789999999999999999999999999998754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=344.48 Aligned_cols=281 Identities=24% Similarity=0.337 Sum_probs=204.6
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHH--HhhcCCCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEA--LRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
..++|++.+.||+|+||.||+|++ +++.||||+++.. ....+..|.++ +..++||||+++++++......+..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 356899999999999999999987 6899999999643 23344445444 4558999999999876654455566
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC------CCCceeeCCCCCCeeecCCCc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC------QPPMVHGDLKPSNVLLDHDMV 680 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------~~~ivH~Dlkp~NIll~~~~~ 680 (833)
..++||||+++|+|.+++... ..++..++.++.|++.||+|||+.. .++|+||||||+||+++.++.
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLH-------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred eEEEEEecCCCCcHHHHHhhc-------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 789999999999999999765 4588999999999999999999873 338999999999999999999
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCC-------CCCCcccccccCCcCCCccccCCccHHHH
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-------SEASMTGDIFTGRRPIDAVFNEGHSLHEF 753 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~s~~~~~~~~~~~g~~l~~~ 753 (833)
+||+|||+|+.+...................||+.|+|||++.+ ..++.++|||| +|++++++
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diws----------lG~il~el 228 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYA----------LGLIYWEI 228 (336)
T ss_dssp EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHH----------HHHHHHHH
T ss_pred EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHH----------HHHHHHHH
Confidence 99999999987654332211111222234579999999999887 45778999999 77788888
Q ss_pred HHHhCCCcccccccc---cchhhh------------cc--ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHH
Q 040925 754 AKTALPEKVMEIVDP---SLLMEV------------MT--NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRD 816 (833)
Q Consensus 754 ~~~~~p~~~~~~~~~---~~~~~~------------~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 816 (833)
+++..|+........ ...... .. ......+........+++.+.+++.+||+.||++|||++|
T Consensus 229 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 308 (336)
T 3g2f_A 229 FMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQX 308 (336)
T ss_dssp HTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHH
Confidence 877655432111110 000000 00 0000000111112346778999999999999999999999
Q ss_pred HHHHHHHhhhhhhcC
Q 040925 817 VVAKLCHTRETFLGR 831 (833)
Q Consensus 817 il~~L~~i~~~~~~~ 831 (833)
+++.|+++.+.+.+.
T Consensus 309 ~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 309 AEERMAELMMIWERN 323 (336)
T ss_dssp HHHHHHHHHHCCCC-
T ss_pred HHHHHHHHHHHHHhc
Confidence 999999999887654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=338.64 Aligned_cols=253 Identities=22% Similarity=0.302 Sum_probs=196.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--------------------------cchhHHHHHHHHHh
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--------------------------GASRSFVAECEALR 583 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 583 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999999999999999999964321 12356899999999
Q ss_pred hcCCCccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 040925 584 NIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPM 663 (833)
Q Consensus 584 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 663 (833)
+++||||+++++++.... ....++||||+++|+|.+++... .+++.+++.++.|++.||+|||+. +|
T Consensus 92 ~l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i 158 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPN---EDHLYMVFELVNQGPVMEVPTLK-------PLSEDQARFYFQDLIKGIEYLHYQ---KI 158 (298)
T ss_dssp TCCCTTBCCEEEEEECSS---SSEEEEEEECCTTCBSCCSSCSS-------CCCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hCCCCCCCeEEEEEEcCC---CCEEEEEEecCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---Ce
Confidence 999999999999986532 35789999999999999876532 689999999999999999999999 99
Q ss_pred eeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCC---CCcccccccCCcCC
Q 040925 664 VHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE---ASMTGDIFTGRRPI 740 (833)
Q Consensus 664 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~s~~~~~ 740 (833)
+||||||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||
T Consensus 159 vH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s----- 225 (298)
T 2zv2_A 159 IHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWA----- 225 (298)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHH-----
T ss_pred eccCCCHHHEEECCCCCEEEecCCCccccccccc--------cccCCcCCccccChhhhccCCCCCCCchhhhHh-----
Confidence 9999999999999999999999999986644221 112346999999999987765 478899999
Q ss_pred CccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 741 DAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 741 ~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+|+++++++++..|+...... ........... .......+++.+.+++.+||+.||++|||++|+++.
T Consensus 226 -----lG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 226 -----MGVTLYCFVFGQCPFMDERIM--CLHSKIKSQAL-----EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp -----HHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCC-----CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred -----HHHHHHHHHHCCCCCCCccHH--HHHHHHhcccC-----CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 888899999999887532211 00000000000 001112345678899999999999999999999753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=340.15 Aligned_cols=247 Identities=22% Similarity=0.257 Sum_probs=203.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~----- 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ----- 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC-----
Confidence 467999999999999999999999999999999997432 234567889999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Df 150 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDF 150 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEeCCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeec
Confidence 8999999999999999998754 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++..... ....+||+.|+|||++.+..++.++|||| .|+++++++++..|+......
T Consensus 151 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~g~~pf~~~~~~ 209 (318)
T 1fot_A 151 GFAKYVPDV-----------TYTLCGTPDYIAPEVVSTKPYNKSIDWWS----------FGILIYEMLAGYTPFYDSNTM 209 (318)
T ss_dssp SSCEECSSC-----------BCCCCSCTTTCCHHHHTTCCBCTTHHHHH----------HHHHHHHHHHSSCTTCCSSHH
T ss_pred CcceecCCc-----------cccccCCccccCHhHhcCCCCCcccchhh----------hHHHHHHHHhCCCCCCCCCHH
Confidence 999865432 12356999999999999999999999999 888999999999887532211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
........... ..+..++..+.+++.+||..||++|| +++|+++.
T Consensus 210 --~~~~~i~~~~~-------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 210 --KTYEKILNAEL-------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --HHHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --HHHHHHHhCCC-------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11111111111 01123456788999999999999999 88888754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=358.20 Aligned_cols=265 Identities=19% Similarity=0.229 Sum_probs=208.0
Q ss_pred chHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEee
Q 040925 522 SYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICS 598 (833)
Q Consensus 522 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 598 (833)
...++....++|++.+.||+|+||+||+|++..+++.||+|+++.. .......+.+|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 3445556678999999999999999999999999999999999642 1223345899999999999999999999976
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
+.+ ..|+||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +||||||||+|||++.+
T Consensus 145 ~~~-----~~~lV~Ey~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~ 211 (437)
T 4aw2_A 145 DDN-----NLYLVMDYYVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMN 211 (437)
T ss_dssp CSS-----EEEEEECCCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred eCC-----EEEEEEecCCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCC
Confidence 655 89999999999999999986432 689999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHHH
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHEF 753 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~ 753 (833)
+.+||+|||+|+........ .....+||+.|+|||++. +..++.++|||| .|++++++
T Consensus 212 g~vkL~DFGla~~~~~~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwS----------lGvil~el 274 (437)
T 4aw2_A 212 GHIRLADFGSCLKLMEDGTV-------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS----------LGVCMYEM 274 (437)
T ss_dssp SCEEECCCTTCEECCTTSCE-------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHH----------HHHHHHHH
T ss_pred CCEEEcchhhhhhcccCCCc-------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHH----------HHHHHHHH
Confidence 99999999999765443211 112357999999999986 567899999999 88999999
Q ss_pred HHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCC--CCCHHHHHHH
Q 040925 754 AKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFE--RMDMRDVVAK 820 (833)
Q Consensus 754 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 820 (833)
+++..|+......+ ............. .......+++.+.+++.+|+..+|++ ||+++|+++.
T Consensus 275 ltG~~Pf~~~~~~~--~~~~i~~~~~~~~--~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 275 LYGETPFYAESLVE--TYGKIMNHKERFQ--FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHSSCTTCCSSHHH--HHHHHHTHHHHCC--CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred HhCCCCCCCCChhH--HHHhhhhcccccc--CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 99999976322111 1111110000000 00001124567889999999998888 9999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=347.31 Aligned_cols=257 Identities=20% Similarity=0.257 Sum_probs=203.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-----CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-----KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+++++.++||||+++++++...+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 99 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG--- 99 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC---
Confidence 357999999999999999999999999999999986321 123567999999999999999999999976654
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc---E
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV---A 681 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~ 681 (833)
..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +
T Consensus 100 --~~~lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~v 172 (351)
T 3c0i_A 100 --MLYMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPV 172 (351)
T ss_dssp --EEEEEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCE
T ss_pred --EEEEEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcE
Confidence 899999999999999888653211 11589999999999999999999999 9999999999999986654 9
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
||+|||+++....... ......||+.|+|||++.+..++.++|||| .|+++|+++++..|+.
T Consensus 173 kl~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 173 KLGGFGVAIQLGESGL--------VAGGRVGTPHFMAPEVVKREPYGKPVDVWG----------CGVILFILLSGCLPFY 234 (351)
T ss_dssp EECCCTTCEECCTTSC--------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCSSC
T ss_pred EEecCcceeEecCCCe--------eecCCcCCcCccCHHHHcCCCCCchHhhHH----------HHHHHHHHHHCCCCCC
Confidence 9999999987654321 112356999999999999999999999999 8889999999998875
Q ss_pred ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 762 VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 762 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... ............... ......+++.+.+++.+||..||++|||+.|+++.
T Consensus 235 ~~~---~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 235 GTK---ERLFEGIIKGKYKMN---PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp SSH---HHHHHHHHHTCCCCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcH---HHHHHHHHcCCCCCC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 321 111111111111110 01112345678999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=346.99 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=202.8
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCC
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNI-RHRNLIKIITICSSTDF 602 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 602 (833)
....++|++.+.||+|+||.||+|+++.+++.||+|+++... ....+.+..|.++++.+ +||||+++++++.+.+
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~- 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE- 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC-
Confidence 345678999999999999999999999999999999997532 23456788899999987 8999999999976654
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
..|+||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+|
T Consensus 92 ----~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vk 158 (345)
T 1xjd_A 92 ----NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIK 158 (345)
T ss_dssp ----EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEE
T ss_pred ----EEEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEE
Confidence 8999999999999999998644 689999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
|+|||+|+...... ......+||+.|+|||++.+..++.++|||| .|+++|+++++..|+..
T Consensus 159 L~DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 159 IADFGMCKENMLGD--------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWS----------FGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp ECCCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCSSCC
T ss_pred EeEChhhhhcccCC--------CcccCCCCCcccCChhhhcCCCCCChhhhHH----------HHHHHHHHhcCCCCCCC
Confidence 99999998543211 1123467999999999999999999999999 88899999999988753
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHH-HHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMR-DVVA 819 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~ 819 (833)
... ............ ..+..+++.+.+++.+||..||++||++. |+++
T Consensus 221 ~~~--~~~~~~i~~~~~-------~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 221 QDE--EELFHSIRMDNP-------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp SSH--HHHHHHHHHCCC-------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CCH--HHHHHHHHhCCC-------CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 221 111111111110 11122456788999999999999999997 6643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=348.69 Aligned_cols=275 Identities=18% Similarity=0.251 Sum_probs=208.1
Q ss_pred HhcCCccCceeccCcceEEEEEEECCC-----ceEEEEEEeeccCCcc-----------hhHHHHHHHHHhhcCCCccce
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGED-----EMIVAVKVINLKYKGA-----------SRSFVAECEALRNIRHRNLIK 592 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 592 (833)
..++|++.+.||+|+||.||+|.+..+ ++.||||++....... ......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 345899999999999999999999754 5789999986443111 123445666777788999999
Q ss_pred EeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCC
Q 040925 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSN 672 (833)
Q Consensus 593 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~N 672 (833)
+++++.... .+..+.++||||+ +|+|.+++..... .+++.+++.|+.|++.||+|||+. +|+||||||+|
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N 182 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANAK-----RFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN 182 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence 999987642 2335689999999 8999999987532 699999999999999999999999 99999999999
Q ss_pred eeec--CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 673 VLLD--HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 673 Ill~--~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
|+++ .++.+||+|||+|+.+......... .........||+.|+|||++.+..++.++|||| +|+++
T Consensus 183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~~l 251 (364)
T 3op5_A 183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY-AADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEI----------LGYCM 251 (364)
T ss_dssp EEEESSCTTCEEECCCTTCEESSGGGCCCCS-SCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHH----------HHHHH
T ss_pred EEEecCCCCeEEEEECCcceecccCCccccc-ccCcccccCCCCCccCHHHhCCCCCCchhhHHH----------HHHHH
Confidence 9999 8899999999999877654322111 111223456999999999999999999999999 88999
Q ss_pred HHHHHHhCCCcccccccccchhhhccccchhhhhhhhch------HHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 751 HEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKT------EECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 751 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
++++++..|+.... .++......... . ........ ..+++.+.+++..||..||++||++++|++.|+.+
T Consensus 252 ~el~~g~~Pf~~~~-~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 252 IQWLTGHLPWEDNL-KDPKYVRDSKIR-Y--RENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHHHHSCCTTGGGT-TCHHHHHHHHHH-H--HHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HHHHhCCCCccccc-cCHHHHHHHHHH-h--hhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 99999999976211 111111100000 0 00000001 23367889999999999999999999999999998
Q ss_pred hhhh
Q 040925 825 RETF 828 (833)
Q Consensus 825 ~~~~ 828 (833)
.+..
T Consensus 328 ~~~~ 331 (364)
T 3op5_A 328 LKAI 331 (364)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 8653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=344.68 Aligned_cols=273 Identities=22% Similarity=0.354 Sum_probs=195.5
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCce---EEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEM---IVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
...++|++.+.||+|+||.||+|++..++. .||||+++.. .....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 345689999999999999999999876664 8999999754 23345789999999999999999999999876542
Q ss_pred CC-CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcE
Q 040925 603 KG-TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681 (833)
Q Consensus 603 ~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 681 (833)
.+ ....++||||+++|+|.+++...........+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCE
Confidence 11 112489999999999999997543222222589999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCC
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPE 760 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~ 760 (833)
||+|||+|+......... ......+|+.|+|||++.+..++.++|||| +|++++++++ +..|+
T Consensus 177 kl~Dfg~a~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ell~~g~~p~ 240 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYR------QGCASKLPVKWLALESLADNLYTVHSDVWA----------FGVTMWEIMTRGQTPY 240 (323)
T ss_dssp EECCCCC-----------------------CCGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCTT
T ss_pred EEeecccccccccccccc------ccccccCcccccCchhhcCCCCCCccchhh----------HHHHHHHHHhCCCCCc
Confidence 999999998764432211 111235788999999999999999999999 7888888888 67776
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
..... ........... ....+..+++.+.+++.+||+.||++|||+.++++.|+++.++
T Consensus 241 ~~~~~--~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 241 AGIEN--AEIYNYLIGGN------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp TTCCG--GGHHHHHHTTC------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred cccCh--HHHHHHHhcCC------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 52221 11111111111 0111233556789999999999999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=341.10 Aligned_cols=262 Identities=23% Similarity=0.427 Sum_probs=212.0
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
...++|++.+.||+|+||.||+|.+..++..||+|+++.. ....+.+.+|++++++++||||+++++++.... .
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~ 83 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----P 83 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----S
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----C
Confidence 3457899999999999999999999988999999999743 335578999999999999999999999975544 7
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++...... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg 156 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 156 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTT----TSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred EEEEEEcCCCCcHHHHHHhcccC----CccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCc
Confidence 89999999999999999875432 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~ 766 (833)
++......... ......+|+.|+|||++.+..++.++|||| .|++++++++ +..|+...+.
T Consensus 157 ~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~ll~~g~~p~~~~~~- 218 (288)
T 3kfa_A 157 LSRLMTGDTYT-------AHAGAKFPIKWTAPESLAYNKFSIKSDVWA----------FGVLLWEIATYGMSPYPGIDL- 218 (288)
T ss_dssp GGGTSCSSSSE-------EETTEEECGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCSSTTCCG-
T ss_pred cceeccCCccc-------cccCCccccCcCChhhhccCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCCH-
Confidence 99876543221 112345788999999999889999999999 7888888888 7666642221
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
....+...... ....+..+++.+.+++.+||..||++|||++|+++.|+.+.+.
T Consensus 219 --~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 219 --SQVYELLEKDY-----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp --GGHHHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHhccC-----CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111111110 0111233466789999999999999999999999999988754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=344.85 Aligned_cols=259 Identities=21% Similarity=0.362 Sum_probs=199.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceE----EEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMI----VAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
++|++.+.||+|+||.||+|++..+++. ||+|.++... ....+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 89 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-----
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----
Confidence 5799999999999999999998777665 5788775332 23457899999999999999999999998653
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++..... .+++..++.|+.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~D 160 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred -CeEEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEcc
Confidence 36799999999999999987542 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||+|+......... ......||+.|+|||++.+..++.++|||| +|++++++++ +..|+....
T Consensus 161 fg~a~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ellt~g~~p~~~~~ 224 (327)
T 3poz_A 161 FGLAKLLGAEEKEY------HAEGGKVPIKWMALESILHRIYTHQSDVWS----------YGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp TTHHHHHTTTCC-------------CCCGGGSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTCC
T ss_pred CcceeEccCCcccc------cccCCCccccccChHHhccCCCCchhhhhh----------hHHHHHHHHhcCCCCccCCC
Confidence 99998765432211 112245788999999999999999999999 7888888888 777765322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.. .......... ....+..++..+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 225 ~~---~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 225 AS---EISSILEKGE-----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp GG---GHHHHHHTTC-----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HH---HHHHHHHcCC-----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 11 1111111110 0111233456788999999999999999999999999988753
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=352.37 Aligned_cols=266 Identities=21% Similarity=0.325 Sum_probs=205.2
Q ss_pred hcCCccCceeccCcceEEEEEEE-----CCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||.||+|++ ..+++.||||+++... ......+.+|+.++++++||||+++++++....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-- 147 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-- 147 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC--
Confidence 35799999999999999999994 4567899999996432 233457889999999999999999999976544
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCc-cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC---
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQ-VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM--- 679 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~--- 679 (833)
..++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 148 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 221 (367)
T 3l9p_A 148 ---PRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 221 (367)
T ss_dssp ---SCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred ---CCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCc
Confidence 679999999999999999865421 1122589999999999999999999999 999999999999999555
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhC
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TAL 758 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~ 758 (833)
.+||+|||+|+........ .......||+.|+|||++.+..++.++|||| +|++++++++ +..
T Consensus 222 ~~kL~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws----------lG~il~ellt~g~~ 285 (367)
T 3l9p_A 222 VAKIGDFGMARDIYRAGYY------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS----------FGVLLWEIFSLGYM 285 (367)
T ss_dssp CEEECCCHHHHHHHHHSSC------TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCC
T ss_pred eEEECCCcccccccccccc------ccCCCcCCcccEECHHHhcCCCCCcHHHHHH----------HHHHHHHHHhCCCC
Confidence 5999999999865432211 1122346899999999998889999999999 7778888887 767
Q ss_pred CCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 759 PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 759 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
|+..... ........... ....+..++..+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 286 pf~~~~~--~~~~~~i~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 286 PYPSKSN--QEVLEFVTSGG------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp SSTTCCH--HHHHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCH--HHHHHHHHcCC------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 7652211 11111111110 0111223456788999999999999999999999999998764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=340.86 Aligned_cols=336 Identities=18% Similarity=0.192 Sum_probs=177.2
Q ss_pred CCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEE
Q 040925 22 LSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKAL 101 (833)
Q Consensus 22 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L 101 (833)
+.+++.|++++|.++...+..|..+++|++|+|++|.++++.+..|.++++|++|+|++|+++ .+++..|.++++|++|
T Consensus 44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEE
T ss_pred cCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHHhcCCCCCCEE
Confidence 345555555555554444444455555555555555555444455555555555555555554 4444445555555555
Q ss_pred EccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEc
Q 040925 102 AIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSL 181 (833)
Q Consensus 102 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L 181 (833)
+|++|.++...+..|.++++|++|+|++|+++++.+..|..+++|++|+|++|.++.++ +..+++|+.|++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~---------~~~l~~L~~L~l 193 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---------LSLIPSLFHANV 193 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC---------GGGCTTCSEEEC
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc---------cccccccceeec
Confidence 55555555333333455555555555555555555555555555555555555544321 223344444444
Q ss_pred cCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcc
Q 040925 182 ADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQG 261 (833)
Q Consensus 182 s~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 261 (833)
++|.+ .+ +...++|++|++++|.+..
T Consensus 194 ~~n~l-------------------------------------------------~~-----~~~~~~L~~L~l~~n~l~~ 219 (390)
T 3o6n_A 194 SYNLL-------------------------------------------------ST-----LAIPIAVEELDASHNSINV 219 (390)
T ss_dssp CSSCC-------------------------------------------------SE-----EECCSSCSEEECCSSCCCE
T ss_pred ccccc-------------------------------------------------cc-----cCCCCcceEEECCCCeeee
Confidence 44444 32 1122345555555555553
Q ss_pred cCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccc
Q 040925 262 RIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVG 341 (833)
Q Consensus 262 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~ 341 (833)
. |.. ..++|+.|+|++|++++. ..+..+++|++|++++|++++ ..|..|.
T Consensus 220 ~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~-------------------------~~~~~~~ 269 (390)
T 3o6n_A 220 V-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEK-------------------------IMYHPFV 269 (390)
T ss_dssp E-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCE-------------------------EESGGGT
T ss_pred c-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCC-------------------------cChhHcc
Confidence 2 221 124556666666655532 345555555554444444432 2233444
Q ss_pred cCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceE
Q 040925 342 HLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFL 421 (833)
Q Consensus 342 ~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 421 (833)
.+++|++|+|++|++++ .|..+..+++|++|+|++|++++ .|..+..+++|+.|++++|+++... +..+++|+.|
T Consensus 270 ~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L 344 (390)
T 3o6n_A 270 KMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNL 344 (390)
T ss_dssp TCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEE
T ss_pred ccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCccee-cCccccccCcCCEEECCCCccceeC---chhhccCCEE
Confidence 55555555555555553 23344555666666666666663 3444556666777777777766442 5566777888
Q ss_pred ECccCcCccccCCCCccCCCccccccCCcCCCCCcc
Q 040925 422 SLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGID 457 (833)
Q Consensus 422 ~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~~~ 457 (833)
++++|+|+|.+... .+.......+.+++..|..+.
T Consensus 345 ~l~~N~~~~~~~~~-~~~~~~~~~~~~~~~~c~~~~ 379 (390)
T 3o6n_A 345 TLSHNDWDCNSLRA-LFRNVARPAVDDADQHCKIDY 379 (390)
T ss_dssp ECCSSCEEHHHHHH-HTTTCCTTTBCCCCSCCCTTC
T ss_pred EcCCCCccchhHHH-HHHHHHhhcccccCceecccc
Confidence 88888888765322 234444555677777776543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.29 Aligned_cols=258 Identities=20% Similarity=0.289 Sum_probs=192.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++.... ..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCC-----EE
Confidence 579999999999999999999999999999999975433 23467889999999999999999999976654 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++ ++.+++..... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~ 147 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 999999985 66666654332 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++....... ......||+.|+|||++.+.. ++.++|||| .|+++++++++..|+......+
T Consensus 148 ~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~~l~~~~~p~~~~~~~~ 209 (292)
T 3o0g_A 148 ARAFGIPVR--------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS----------AGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp CEECCSCCS--------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHH----------HHHHHHHHTTTSCCSCCCSSHH
T ss_pred ceecCCccc--------cccCCccccCCcChHHHcCCCCcCchHHHHH----------HHHHHHHHHHcCCCCcCCCCHH
Confidence 986643221 112346899999999987766 899999999 5555555555544432100000
Q ss_pred ccc--------------hh------hhccc-cchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSL--------------LM------EVMTN-NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~--------------~~------~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... .. ..... ...............+..+.+++.+||+.||++|||++|+++.
T Consensus 210 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 00 00000 0000000001112345678899999999999999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=343.59 Aligned_cols=247 Identities=21% Similarity=0.229 Sum_probs=204.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++.+..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~----- 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS----- 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC-----
Confidence 368999999999999999999999999999999996432 234567889999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DF 185 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDF 185 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEcCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccc
Confidence 8999999999999999998654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++..... ....+||+.|+|||++.+..++.++|||| .|+++++++++..|+.....
T Consensus 186 g~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~g~~Pf~~~~~- 243 (350)
T 1rdq_E 186 GFAKRVKGR-----------TWTLCGTPEALAPEIILSKGYNKAVDWWA----------LGVLIYEMAAGYPPFFADQP- 243 (350)
T ss_dssp TTCEECSSC-----------BCCCEECGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCSSCCSSH-
T ss_pred ccceeccCC-----------cccccCCccccCHHHhcCCCCCCcCCEec----------ccHhHhHHhhCCCCCCCCCH-
Confidence 999865432 12356999999999999999999999999 88899999999988753221
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
............ ..+..++..+.+++.+||+.||++||+ ++||++.
T Consensus 244 -~~~~~~i~~~~~-------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 244 -IQIYEKIVSGKV-------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -HHHHHHHHHCCC-------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -HHHHHHHHcCCC-------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 111111111111 112234567889999999999999998 8888754
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=363.77 Aligned_cols=259 Identities=23% Similarity=0.427 Sum_probs=209.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
..+|++.+.||+|+||.||+|++..++..||||+++... ...+.+.+|++++++++||||+++++++.... ..+
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-----~~~ 292 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----PFY 292 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC-----cEE
Confidence 457899999999999999999999889999999997543 34678999999999999999999999986554 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++...... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 365 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLS 365 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTT----TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred EEEEccCCCCHHHHHHhcCcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccc
Confidence 999999999999999865432 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
+......... .....+|+.|+|||++.+..++.++|||| +|++++++++ +..|+.....
T Consensus 366 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS----------lG~~l~el~t~g~~p~~~~~~--- 425 (495)
T 1opk_A 366 RLMTGDTYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWA----------FGVLLWEIATYGMSPYPGIDL--- 425 (495)
T ss_dssp ECCTTCCEEC-------CTTCCCCGGGCCHHHHHHCEECHHHHHHH----------HHHHHHHHHTTSCCSSTTCCG---
T ss_pred eeccCCceee-------cCCCcCCcceeCHhHHhcCCCCcHHhHHh----------HHHHHHHHHhCCCCCCCCCCH---
Confidence 8765432211 11234788999999999889999999999 7788888887 6666642221
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
....+.+.... ....+..+++.+.+++.+||+.||++|||+.+|++.|+.+.+
T Consensus 426 ~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 426 SQVYELLEKDY-----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp GGHHHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred HHHHHHHHcCC-----CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11111111110 011223456788999999999999999999999999998753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=348.61 Aligned_cols=267 Identities=18% Similarity=0.175 Sum_probs=204.6
Q ss_pred HhcCCccCceeccC--cceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 529 ATGEFSSSNMIGQG--SFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 529 ~~~~y~~~~~lg~G--~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
..++|++.+.||+| +||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--- 99 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN--- 99 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC---
Confidence 35689999999999 999999999999999999999975432 23467888999999999999999999987655
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..++||||+++|+|.+++...... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 100 --~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 170 (389)
T 3gni_B 100 --ELWVVTSFMAYGSAKDLICTHFMD----GMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLS 170 (389)
T ss_dssp --EEEEEEECCTTCBHHHHHHHTCTT----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred --EEEEEEEccCCCCHHHHHhhhccc----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence 899999999999999999875322 689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCC--CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
|||.+............ .........||+.|+|||++.+ ..++.++|||| .|+++++++++..|+..
T Consensus 171 dfg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 171 GLRSNLSMISHGQRQRV-VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS----------VGITACELANGHVPFKD 239 (389)
T ss_dssp CGGGCEECEETTEECSC-BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHH----------HHHHHHHHHHSSCTTTT
T ss_pred ccccceeeccccccccc-cccccccccccccccCHHHHhccCCCCCcHhHHHH----------HHHHHHHHHHCCCCCCC
Confidence 99998765432221111 1112223479999999999887 67999999999 78888899988888752
Q ss_pred cccccccchhhhccccc---------------------------------------hhhhhhhhchHHHHHHHHHHhhcc
Q 040925 763 MEIVDPSLLMEVMTNNS---------------------------------------MIQEDKRVKTEECLNAIIRTGVLC 803 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~~~~l~~li~~c 803 (833)
....+. ......... ............+++.+.+++.+|
T Consensus 240 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~ 317 (389)
T 3gni_B 240 MPATQM--LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317 (389)
T ss_dssp CCSTTH--HHHC--------------------------------------------------------CCHHHHHHHHHH
T ss_pred CCHHHH--HHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence 211110 000000000 000000112233556789999999
Q ss_pred CCCCCCCCCCHHHHHHH
Q 040925 804 SMESPFERMDMRDVVAK 820 (833)
Q Consensus 804 l~~dP~~RPt~~eil~~ 820 (833)
|+.||++|||++|+++.
T Consensus 318 L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 318 LQRNPDARPSASTLLNH 334 (389)
T ss_dssp TCSCTTTSCCHHHHTTS
T ss_pred hhcCcccCCCHHHHhcC
Confidence 99999999999999865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=336.34 Aligned_cols=262 Identities=20% Similarity=0.299 Sum_probs=196.9
Q ss_pred HhcCCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
..++|++.+.||+|+||.||+|++..+ +..||+|+++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 87 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence 346899999999999999999998643 56799999864332 234678999999999999999999998632
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (281)
T 1mp8_A 88 -NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 158 (281)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred -CccEEEEecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEEC
Confidence 257899999999999999976532 589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~ 763 (833)
|||+++......... .....+|+.|+|||++.+..++.++|||| +|++++++++ +..|+...
T Consensus 159 Dfg~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 159 DFGLSRYMEDSTYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWM----------FGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp C--------------------------CCGGGCCHHHHHHCCCSHHHHHHH----------HHHHHHHHHTTSCCTTTTC
T ss_pred ccccccccCcccccc-------cccCCCcccccChhhcccCCCCCccCchH----------HHHHHHHHHhcCCCCCCcC
Confidence 999998765432111 11234788999999998889999999999 7778888875 66666422
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
... .......... ....+..+++.+.+++.+||+.||++|||+.|+++.|+++.+...
T Consensus 222 ~~~--~~~~~i~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 279 (281)
T 1mp8_A 222 KNN--DVIGRIENGE------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 279 (281)
T ss_dssp CGG--GHHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CHH--HHHHHHHcCC------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence 111 1111111110 011223456778999999999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=347.68 Aligned_cols=272 Identities=23% Similarity=0.338 Sum_probs=209.5
Q ss_pred HHHhcCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecC
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSST 600 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 600 (833)
....++|++.+.||+|+||.||+|++. .+++.||||+++.... ...+.+.+|++++++++||||+++++++...
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 344678999999999999999999996 3568999999975432 2346789999999999999999999997654
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCcc------------------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQV------------------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPP 662 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ 662 (833)
+ ..++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. +
T Consensus 123 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ 194 (343)
T 1luf_A 123 K-----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 194 (343)
T ss_dssp S-----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred C-----ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4 7899999999999999998643210 013689999999999999999999999 9
Q ss_pred ceeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCc
Q 040925 663 MVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDA 742 (833)
Q Consensus 663 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~ 742 (833)
|+||||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++||||
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s------- 261 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK------ADGNDAIPIRWMPPESIFYNRYTTESDVWA------- 261 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHH-------
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCcccc------ccCCCcccceecChhhhccCCcCcccccHH-------
Confidence 9999999999999999999999999998664432111 112345899999999998889999999999
Q ss_pred cccCCccHHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHH
Q 040925 743 VFNEGHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821 (833)
Q Consensus 743 ~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L 821 (833)
+|++++++++ +..|+..... ............ ...+..++..+.+++.+||..||++|||+.++++.|
T Consensus 262 ---lG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L 330 (343)
T 1luf_A 262 ---YGVVLWEIFSYGLQPYYGMAH--EEVIYYVRDGNI------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330 (343)
T ss_dssp ---HHHHHHHHHTTTCCTTTTSCH--HHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ---HHHHHHHHHhcCCCcCCCCCh--HHHHHHHhCCCc------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 7778888887 7767642211 111111111110 011233566789999999999999999999999999
Q ss_pred HHhhhhhhc
Q 040925 822 CHTRETFLG 830 (833)
Q Consensus 822 ~~i~~~~~~ 830 (833)
+++.+...+
T Consensus 331 ~~~~~~~~~ 339 (343)
T 1luf_A 331 QRMCERAEG 339 (343)
T ss_dssp HHTTC----
T ss_pred HHHHhhhhh
Confidence 999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.56 Aligned_cols=255 Identities=29% Similarity=0.366 Sum_probs=205.4
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
..++|++.+.||+|+||.||+|++. ++.||||+++... ..+.+.+|++++++++||||+++++++.... ...
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~ 262 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK----GGL 262 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT----SCE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC----Cce
Confidence 4567999999999999999999985 7799999997442 4578999999999999999999999975432 368
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++...... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRS----VLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTT----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 9999999999999999865421 478999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~ 767 (833)
++...... ....+|+.|+|||++.+..++.++|||| +|++++++++ +..|+......
T Consensus 336 a~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~sDvws----------lG~~l~el~t~g~~P~~~~~~~- 393 (450)
T 1k9a_A 336 TKEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWS----------FGILLWEIYSFGRVPYPRIPLK- 393 (450)
T ss_dssp CEECC-----------------CCCTTTSCHHHHHSSCCCHHHHHHH----------HHHHHHHHHTTTCCSSTTSCTT-
T ss_pred cccccccc-----------cCCCCCcceeCHHHhcCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCCHH-
Confidence 98543211 1124788999999999999999999999 7788888887 77776532211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
......... . ....+..+++.+.+++.+||..||++|||+.++++.|+.+...
T Consensus 394 -~~~~~i~~~-~-----~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 394 -DVVPRVEKG-Y-----KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp -THHHHHHTT-C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -HHHHHHHcC-C-----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 111111111 0 0112334677899999999999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.88 Aligned_cols=253 Identities=19% Similarity=0.323 Sum_probs=201.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCc-------eEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDE-------MIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
.++|++.+.||+|+||.||+|++..++ ..||+|+++.......+.+.+|++++++++||||+++++++...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~- 85 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD- 85 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-
Confidence 357999999999999999999987665 579999997665566678999999999999999999999976554
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc--
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV-- 680 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-- 680 (833)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 86 ----~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~ 153 (289)
T 4fvq_A 86 ----ENILVQEFVKFGSLDTYLKKNKN-----CINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRK 153 (289)
T ss_dssp ----CCEEEEECCTTCBHHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGG
T ss_pred ----CCEEEEECCCCCCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccc
Confidence 77999999999999999987542 489999999999999999999999 9999999999999998886
Q ss_pred ------EEEcccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHH
Q 040925 681 ------AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEF 753 (833)
Q Consensus 681 ------~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~ 753 (833)
+||+|||++....... ...||+.|+|||++.+ ..++.++|||| +|++++++
T Consensus 154 ~~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~~Diws----------lG~il~el 211 (289)
T 4fvq_A 154 TGNPPFIKLSDPGISITVLPKD------------ILQERIPWVPPECIENPKNLNLATDKWS----------FGTTLWEI 211 (289)
T ss_dssp GTBCCEEEECCCCSCTTTSCHH------------HHHHTTTTSCHHHHHCGGGCCHHHHHHH----------HHHHHHHH
T ss_pred ccccceeeeccCcccccccCcc------------ccCCcCcccCHHHhCCCCCCCchhHHHH----------HHHHHHHH
Confidence 9999999997654322 1348899999999887 67999999999 77788888
Q ss_pred HHHhCCCc-ccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 754 AKTALPEK-VMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 754 ~~~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
+++..++. ..+ ............ ..+...++.+.+++.+||+.||++|||++|+++.|+++...
T Consensus 212 ~~g~~~~~~~~~---~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 212 CSGGDKPLSALD---SQRKLQFYEDRH-------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HTTTCCTTTTSC---HHHHHHHHHTTC-------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred HcCCCCCccccc---hHHHHHHhhccC-------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 88544432 111 111111111000 00111244678999999999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=340.30 Aligned_cols=267 Identities=21% Similarity=0.332 Sum_probs=208.9
Q ss_pred HhcCCccCceeccCcceEEEEEEE-----CCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
..++|.+.+.||+|+||.||+|++ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 99 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG- 99 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC-
Confidence 356899999999999999999988 34568999999975432 23467899999999999999999999976544
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCcc------------------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCce
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQV------------------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMV 664 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~iv 664 (833)
..++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. +|+
T Consensus 100 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iv 172 (314)
T 2ivs_A 100 ----PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLV 172 (314)
T ss_dssp ----SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ----ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCc
Confidence 7899999999999999998754210 112489999999999999999999999 999
Q ss_pred eeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccc
Q 040925 665 HGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVF 744 (833)
Q Consensus 665 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~ 744 (833)
||||||+||+++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++||||
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s--------- 237 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV------KRSQGRIPVKWMAIESLFDHIYTTQSDVWS--------- 237 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE------CSSCCCSCGGGCCHHHHHHCEECHHHHHHH---------
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccce------eccCCCCcccccChhhhcCCCcCchhhHHH---------
Confidence 99999999999999999999999998664432111 111235789999999999888999999999
Q ss_pred cCCccHHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 745 NEGHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 745 ~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
.|++++++++ +..|+..... ......+.... ....+..+++.+.+++.+||+.||++|||+.|+++.|++
T Consensus 238 -lG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~ 308 (314)
T 2ivs_A 238 -FGVLLWEIVTLGGNPYPGIPP---ERLFNLLKTGH-----RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK 308 (314)
T ss_dssp -HHHHHHHHHTTSCCSSTTCCG---GGHHHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -HHHHHHHHHhCCCCCCCCCCH---HHHHHHhhcCC-----cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 7888888888 7777642211 11111111110 011123356678999999999999999999999999999
Q ss_pred hhhh
Q 040925 824 TRET 827 (833)
Q Consensus 824 i~~~ 827 (833)
+.+.
T Consensus 309 ~~~~ 312 (314)
T 2ivs_A 309 MMVK 312 (314)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 8764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=348.00 Aligned_cols=269 Identities=23% Similarity=0.333 Sum_probs=209.7
Q ss_pred hcCCccCceeccCcceEEEEEEECC-------CceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGE-------DEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSST 600 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 600 (833)
.++|.+.+.||+|+||.||+|++.. .+..||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 4689999999999999999999743 346899999975432 2346789999999999 899999999997655
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCcc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQV----------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
+ ..++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. +|+||||||
T Consensus 148 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 219 (382)
T 3tt0_A 148 G-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 219 (382)
T ss_dssp S-----SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCG
T ss_pred C-----ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCc
Confidence 4 7899999999999999998754210 112589999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+||+++.++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||| +|+++
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Diws----------lG~il 283 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWS----------FGVLL 283 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTT------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHH----------HHHHH
T ss_pred ceEEEcCCCcEEEcccCccccccccccc------ccccCCCCCcceeCHHHhcCCCCCchhHHHH----------HHHHH
Confidence 9999999999999999999866543211 1122345789999999999999999999999 77788
Q ss_pred HHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 751 HEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 751 ~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
+++++ +..|+...... .. ...+.... ....+..+++.+.+++.+||+.||++|||++|+++.|+++.....
T Consensus 284 ~ellt~g~~p~~~~~~~--~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 284 WEIFTLGGSPYPGVPVE--EL-FKLLKEGH-----RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHHHTTSCCSSTTCCHH--HH-HHHHHTTC-----CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHHhCCCCCCCCCCHH--HH-HHHHHcCC-----CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 88887 77776422110 11 11111100 011122346678999999999999999999999999999986544
Q ss_pred c
Q 040925 830 G 830 (833)
Q Consensus 830 ~ 830 (833)
.
T Consensus 356 ~ 356 (382)
T 3tt0_A 356 N 356 (382)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.53 Aligned_cols=251 Identities=22% Similarity=0.252 Sum_probs=203.1
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 604 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|.++++.+ +||+|+++++++...+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~--- 94 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD--- 94 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS---
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC---
Confidence 456899999999999999999999989999999999743 223456788999999988 7999999999976554
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 95 --~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~ 163 (353)
T 2i0e_A 95 --RLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIA 163 (353)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEEC
T ss_pred --EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEE
Confidence 8999999999999999998654 689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+|+...... ......+||+.|+|||++.+..++.++|||| .|+++|+++++..|+....
T Consensus 164 DFG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 164 DFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA----------FGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CCTTCBCCCCTT--------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHH----------HHHHHHHHHHSSCSSCCSS
T ss_pred eCCcccccccCC--------cccccccCCccccChhhhcCCCcCCcccccc----------hHHHHHHHHcCCCCCCCCC
Confidence 999998543211 1223457999999999999999999999999 8889999999999875321
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
. ............ ..+...+..+.+++.+||..||++||+ ++|+++.
T Consensus 226 ~--~~~~~~i~~~~~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 226 E--DELFQSIMEHNV-------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp H--HHHHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred H--HHHHHHHHhCCC-------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1 111111111111 112234567889999999999999995 4666553
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=341.64 Aligned_cols=253 Identities=21% Similarity=0.246 Sum_probs=189.7
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++... ..+.+.+|++++++++||||+++++++.... ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT-----EI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS-----EE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC-----eE
Confidence 3467999999999999999999999899999999997432 3466889999999999999999999986654 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CCcEEEcc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVCD 685 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~D 685 (833)
++||||+++|+|.+++.... .+++.+++.++.|++.||.|||+. +|+||||||+||+++. ++.+||+|
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~D 194 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKG------YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIAD 194 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEcc
Confidence 99999999999999998654 689999999999999999999999 9999999999999975 88999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++....... .....||+.|+|||++.+..++.++|||| +|+++++++++..|+.....
T Consensus 195 fg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 195 FGLSKIVEHQVL---------MKTVCGTPGYCAPEILRGCAYGPEVDMWS----------VGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp CC-------------------------CGGGSCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSSCTTCCTTC
T ss_pred CccccccCcccc---------cccccCCCCccCHHHhcCCCCCcccchHH----------HHHHHHHHHhCCCCCCCCcc
Confidence 999986543211 12346999999999999999999999999 88899999999888752211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. .............. ......+++..+.+++.+||..||++|||+.|+++.
T Consensus 256 ~-~~~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 256 D-QFMFRRILNCEYYF---ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp H-HHHHHHHHTTCCCC---CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-HHHHHHHHhCCCcc---CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 10111111111100 011112346678899999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=347.89 Aligned_cols=266 Identities=24% Similarity=0.438 Sum_probs=197.4
Q ss_pred CCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.|++.+.||+|+||.||+|++..+ +..||||.++... ....+.+.+|+.++++++||||+++++++... .+.
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CCC
Confidence 467789999999999999987432 3568999986433 23457899999999999999999999987433 246
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG 237 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFG 237 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEECCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecc
Confidence 7899999999999999976542 578999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~ 766 (833)
+++......... ........+|+.|+|||++.+..++.++|||| +|++++++++ +..|+......
T Consensus 238 ~a~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS----------lG~il~ellt~~~~p~~~~~~~ 303 (373)
T 3c1x_A 238 LARDMYDKEFDS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWS----------FGVLLWELMTRGAPPYPDVNTF 303 (373)
T ss_dssp ------------------------CCGGGSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCSCTTSCSS
T ss_pred cccccccccccc----ccccCCCCCcccccChHHhcCCCCCcHHHHHH----------HHHHHHHHHhCcCCCCCCCCHH
Confidence 998664432111 11122345889999999999999999999999 7888888888 44454322211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhcC
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLGR 831 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~~ 831 (833)
+ .......... ...+..++..+.+++.+||+.||++|||++|+++.|+++...+.+.
T Consensus 304 ~--~~~~~~~~~~------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 304 D--ITVYLLQGRR------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp C--HHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred H--HHHHHHcCCC------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 1 1111111110 1112335667899999999999999999999999999999877654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=332.84 Aligned_cols=251 Identities=24% Similarity=0.361 Sum_probs=192.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC----cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK----GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|++. ++.||||+++.... ...+.+.+|+++++.++||||+++++++...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 79 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP---- 79 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC----
Confidence 468999999999999999999984 78899999864422 23467899999999999999999999976544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC---ceeeCCCCCCeeecC-----
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP---MVHGDLKPSNVLLDH----- 677 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~---ivH~Dlkp~NIll~~----- 677 (833)
..++||||+++++|.+++... .+++..++.++.|++.||+|||+. + |+||||||+||+++.
T Consensus 80 -~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~ 148 (271)
T 3dtc_A 80 -NLCLVMEFARGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENG 148 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSS
T ss_pred -ceEEEEEcCCCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccc
Confidence 789999999999999999643 689999999999999999999999 7 999999999999986
Q ss_pred ---CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 678 ---DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 678 ---~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
++.+||+|||+++....... ....||+.|+|||++.+..++.++|||| .|+++++++
T Consensus 149 ~~~~~~~kl~Dfg~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~~l~ 208 (271)
T 3dtc_A 149 DLSNKILKITDFGLAREWHRTTK----------MSAAGAYAWMAPEVIRASMFSKGSDVWS----------YGVLLWELL 208 (271)
T ss_dssp CCSSCCEEECCCCC-----------------------CCGGGSCHHHHHHCCCSHHHHHHH----------HHHHHHHHH
T ss_pred cccCcceEEccCCcccccccccc----------cCCCCccceeCHHHhccCCCCchhhHHH----------HHHHHHHHH
Confidence 67899999999986544221 1245999999999999889999999999 888999999
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
++..|+....... .......... ....+..+++.+.+++.+||+.||++|||++|++++|+++
T Consensus 209 ~g~~p~~~~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 209 TGEVPFRGIDGLA--VAYGVAMNKL-----ALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HCCCTTTTSCHHH--HHHHHHTSCC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hCCCCCCCCCHHH--HHHhhhcCCC-----CCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 9998875322111 1111111100 0111233456789999999999999999999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=333.38 Aligned_cols=273 Identities=23% Similarity=0.289 Sum_probs=208.4
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
..++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++++.++|++++..++++... ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCce
Confidence 4578999999999999999999998899999999875432 335688999999999988888777776432 3478
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee---cCCCcEEEcc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCD 685 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~D 685 (833)
++||||+ +|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~D 151 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIID 151 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECC
T ss_pred EEEEEcc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEec
Confidence 9999999 8999999985432 689999999999999999999999 99999999999999 7889999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++........... .........||+.|+|||++.+..++.++|||| +|+++++++++..|+.....
T Consensus 152 fg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 152 FGLAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLES----------LGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CTTCEECBCTTTCCBC-CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHSSCTTSSCCC
T ss_pred CccceeccCcccCccC-CCCcccccCCCccccchHHhcCCCCCchhHHHH----------HHHHHHHHhcCCCCCcccch
Confidence 9999876553321111 111223467999999999999999999999999 88899999999999863322
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
.+............. ..........+++.+.+++.+||+.||++|||++++++.|+++.+..
T Consensus 221 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 221 ATKRQKYERISEKKM-STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp SSSSSHHHHHHHHHH-HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhhhcccc-cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 211111111100000 00001111234678999999999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=341.74 Aligned_cols=266 Identities=18% Similarity=0.310 Sum_probs=199.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++..... ....+.+|++++++++||||+++++++.... ....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCCc
Confidence 35899999999999999999999989999999999754322 2357889999999999999999999976543 1223
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 4699999999999999997654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++........ ........||+.|+|||++.+..++.++|||| .|+++++++++..|+......
T Consensus 161 g~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~~ll~g~~pf~~~~~~ 225 (311)
T 3ork_A 161 GIARAIADSGNS-----VTQTAAVIGTAQYLSPEQARGDSVDARSDVYS----------LGCVLYEVLTGEPPFTGDSPV 225 (311)
T ss_dssp SCC-----------------------CCTTCCHHHHHTCCCCHHHHHHH----------HHHHHHHHHHSSCSCCCSSHH
T ss_pred cCcccccccccc-----cccccccCcCcccCCHHHhcCCCCCchHhHHH----------HHHHHHHHHhCCCCCCCCChH
Confidence 999876543211 11122356999999999999999999999999 888999999999887532211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHH-HHHHHhh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVV-AKLCHTR 825 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil-~~L~~i~ 825 (833)
+ ............ .......++..+.+++.+||+.||++||++.+++ ..+..+.
T Consensus 226 ~--~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 226 S--VAYQHVREDPIP---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp H--HHHHHHHCCCCC---HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred H--HHHHHhcCCCCC---cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1 111111111100 0111123466789999999999999999765554 4455543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.73 Aligned_cols=268 Identities=24% Similarity=0.430 Sum_probs=206.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
..+|++.+.||+|+||.||+|++..+ ...||+|.++.... ...+.+.+|+.++++++||||+++++++... .
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~ 99 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----E 99 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----S
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC----C
Confidence 34688999999999999999997533 34689999864332 2346789999999999999999999987433 3
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 171 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVAD 171 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECS
T ss_pred CceEEEEeCCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECc
Confidence 478899999999999999976432 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhC-CCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTAL-PEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~-p~~~~~ 764 (833)
||+++......... ........||+.|+|||++.+..++.++|||| .|+++++++++.. |+....
T Consensus 172 fg~a~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~~~~~~~~~~~ 237 (298)
T 3f66_A 172 FGLARDMYDKEYYS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWS----------FGVLLWELMTRGAPPYPDVN 237 (298)
T ss_dssp CGGGCCCSCGGGCB----C-----CCBCGGGSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCSSTTSC
T ss_pred ccccccccccchhc----cccccCCCCCccccChHHhcCCCCChHHHHHH----------HHHHHHHHHhCCCCCCccCC
Confidence 99998765433211 11223456889999999999889999999999 7788888888444 333221
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhcC
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLGR 831 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~~ 831 (833)
..+ ......... ....+..+++.+.+++.+||+.||++|||++|+++.|+++...+.++
T Consensus 238 ~~~--~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~~ 296 (298)
T 3f66_A 238 TFD--ITVYLLQGR------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296 (298)
T ss_dssp TTT--HHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCCS
T ss_pred HHH--HHHHHhcCC------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 111 111111111 01112234567899999999999999999999999999999887765
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.90 Aligned_cols=252 Identities=21% Similarity=0.274 Sum_probs=193.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.++++++||||+++++++.... ..+
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~~~ 92 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLA 92 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCC-----EEE
Confidence 468999999999999999999999999999999997442 33467889999999999999999999976654 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc--EEEcccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV--AHVCDFG 687 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~DfG 687 (833)
+||||+++|+|.+++...+ .+++..++.++.|++.||+|||+. ||+||||||+||+++.++. +||+|||
T Consensus 93 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg 163 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAG------RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163 (361)
T ss_dssp EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCC
T ss_pred EEEEeCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecC
Confidence 9999999999999997644 689999999999999999999999 9999999999999987765 9999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcc-cccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMT-GDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
+|+...... ......||+.|+|||++.+..++.+ +|||| .|+++++++++..|+......
T Consensus 164 ~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws----------lG~il~ell~g~~Pf~~~~~~ 224 (361)
T 3uc3_A 164 YSKSSVLHS---------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWS----------CGVTLYVMLVGAYPFEDPEEP 224 (361)
T ss_dssp CC------------------------CTTSCHHHHHCSSCCHHHHHHHH----------HHHHHHHHHHSSCSCC----C
T ss_pred ccccccccC---------CCCCCcCCCCcCChhhhcCCCCCCCeeeeeh----------hHHHHHHHHhCCCCCCCCccH
Confidence 997433211 1123469999999999988887665 89999 888999999999987632211
Q ss_pred cc--cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DP--SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. ............. .....+++.+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 225 RDYRKTIQRILSVKYSI-----PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCHHHHHHHHHTTCCCC-----CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHhcCCCCC-----CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 10 0001111111100 0011234678899999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=352.49 Aligned_cols=261 Identities=17% Similarity=0.224 Sum_probs=207.5
Q ss_pred hHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeec
Q 040925 523 YAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSS 599 (833)
Q Consensus 523 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 599 (833)
..++....++|++.+.||+|+||.||+|+++.+++.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 345555678999999999999999999999999999999999642 22334568899999999999999999999766
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
.. ..|+||||+++|+|.+++... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 141 ~~-----~~~lV~E~~~gg~L~~~l~~~-------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g 205 (410)
T 3v8s_A 141 DR-----YLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG 205 (410)
T ss_dssp SS-----EEEEEECCCTTEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTS
T ss_pred CC-----EEEEEEeCCCCCcHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCC
Confidence 54 899999999999999999753 589999999999999999999999 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCC----CCcccccccCCcCCCccccCCccHHHHHH
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE----ASMTGDIFTGRRPIDAVFNEGHSLHEFAK 755 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~s~~~~~~~~~~~g~~l~~~~~ 755 (833)
.+||+|||+|+........ .....+||+.|+|||++.+.. ++.++|||| .|+++|++++
T Consensus 206 ~ikL~DFG~a~~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwS----------lGvilyell~ 268 (410)
T 3v8s_A 206 HLKLADFGTCMKMNKEGMV-------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS----------VGVFLYEMLV 268 (410)
T ss_dssp CEEECCCTTCEECCTTSEE-------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHH----------HHHHHHHHHH
T ss_pred CEEEeccceeEeeccCCcc-------cccCCcCCccccCHHHhhccCCCcCCCCcceEec----------chHHHHHHHh
Confidence 9999999999876543211 122357999999999987665 889999999 8899999999
Q ss_pred HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCC--CCCHHHHHHH
Q 040925 756 TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFE--RMDMRDVVAK 820 (833)
Q Consensus 756 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~eil~~ 820 (833)
+..|+...... ............ ...+....+++.+.+++.+||..+|.+ ||+++||+++
T Consensus 269 G~~Pf~~~~~~--~~~~~i~~~~~~---~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 269 GDTPFYADSLV--GTYSKIMNHKNS---LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp SSCTTCCSSHH--HHHHHHHTHHHH---CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCCCCCCCChh--hHHHHHHhcccc---ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 99997632211 111111110000 000111124567889999999999988 9999999875
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.12 Aligned_cols=258 Identities=24% Similarity=0.299 Sum_probs=196.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|++. +++.||+|+++.... ...+.+.+|++++++++||||+++++++.... .
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~ 93 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER-----C 93 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS-----C
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC-----E
Confidence 468999999999999999999996 689999999974422 23467889999999999999999999976544 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++ +|.+++..... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 164 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFG 164 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEcCCCC-CHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCc
Confidence 9999999985 88888876542 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
+++....... ......||+.|+|||++.+ ..++.++|||| .|+++++++++..|+......
T Consensus 165 ~a~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 165 LARAFGIPVR--------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWS----------IGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp TCEETTSCCC-----------CCCCCCTTCCHHHHTTCCSCCTHHHHHH----------HHHHHHHHHHSSCSCCCSSTT
T ss_pred CceecCCCcc--------cccCCcccCCcCCHHHhcCCCCCCchHHhHH----------HHHHHHHHHhCCCCCCCCChH
Confidence 9986643221 1123468999999999876 56899999999 788888998888776522111
Q ss_pred cccch-hhhcccc------------------c--hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLL-MEVMTNN------------------S--MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~-~~~~~~~------------------~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+.... ....... . ..........+.+++++.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 227 DQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp THHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 10000 0000000 0 00000011112245678899999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=343.57 Aligned_cols=270 Identities=20% Similarity=0.252 Sum_probs=208.3
Q ss_pred cCCccCceeccCcceEEEEEE----ECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGT----LGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
++|++.+.||+|+||.||+|+ ...+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~ 99 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG---RQ 99 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS---SC
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC---Cc
Confidence 579999999999999999999 45689999999997665555677999999999999999999999876432 45
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCG
T ss_pred eEEEEEeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccc
Confidence 78999999999999999986432 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++.......... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+......
T Consensus 172 g~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~ll~g~~p~~~~~~~ 236 (327)
T 3lxl_A 172 GLAKLLPLDKDYYV-----VREPGQSPIFWYAPESLSDNIFSRQSDVWS----------FGVVLYELFTYCDKSCSPSAE 236 (327)
T ss_dssp GGCEECCTTCSEEE-----CSSCCCSCGGGSCHHHHHHCEEEHHHHHHH----------HHHHHHHHHTTTCGGGSHHHH
T ss_pred ccceecccCCccce-----eeccCCccccccCHHHhccCCCChHHhHHH----------HHHHHHHHHhCCCCCccccch
Confidence 99987654322111 112245899999999999888999999999 777888888877765421110
Q ss_pred c---------ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 767 D---------PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 767 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
. ......... ..........+..+++.+.+++.+||+.||++|||++|+++.|+.+....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 237 FLRMMGCERDVPALSRLLE--LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHCC----CCHHHHHHH--HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred hhhhcccccccccHHHHHH--HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 0 000000000 00000011122345678899999999999999999999999999887543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=330.31 Aligned_cols=252 Identities=21% Similarity=0.224 Sum_probs=205.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++..++..||+|++........+.+.+|++++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT-----DIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-----eEE
Confidence 467999999999999999999999999999999998665666788999999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee---cCCCcEEEccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDF 686 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Df 686 (833)
+||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Df 153 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR------VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDF 153 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEeccCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEec
Confidence 9999999999999987654 689999999999999999999999 99999999999999 78899999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|++........ .....||+.|+|||++.+. ++.++|||| .|+++++++++..|+.....
T Consensus 154 g~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~-~~~~~Di~s----------lG~~l~~l~~g~~p~~~~~~- 212 (277)
T 3f3z_A 154 GLAARFKPGKM---------MRTKVGTPYYVSPQVLEGL-YGPECDEWS----------AGVMMYVLLCGYPPFSAPTD- 212 (277)
T ss_dssp TTCEECCTTSC---------BCCCCSCTTTCCHHHHTTC-BCTTHHHHH----------HHHHHHHHHHSSCSSCCSSH-
T ss_pred ccceeccCccc---------hhccCCCCCccChHHhccc-CCchhhehh----------HHHHHHHHHHCCCCCCCCCH-
Confidence 99986644221 1234699999999988764 899999999 88899999999988753221
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.............. .......+++.+.+++.+||+.||++|||+.|+++.
T Consensus 213 -~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 213 -SEVMLKIREGTFTF---PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp -HHHHHHHHHCCCCC---CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -HHHHHHHHhCCCCC---CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111111111100 011111346678999999999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.57 Aligned_cols=268 Identities=23% Similarity=0.355 Sum_probs=203.5
Q ss_pred cCCccCceeccCcceEEEEEE----ECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGT----LGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|++.+.||+|+||.||+|+ ...+++.||||+++... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 97 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG---G 97 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---C
Confidence 458999999999999999999 45689999999997443 234577899999999999999999999987542 3
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 169 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGD 169 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECc
Confidence 468999999999999999965432 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||++.......... .......||+.|+|||++.+..++.++|||| .|+++++++++..|+.....
T Consensus 170 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~ 234 (302)
T 4e5w_A 170 FGLTKAIETDKEYY-----TVKDDRDSPVFWYAPECLMQSKFYIASDVWS----------FGVTLHELLTYCDSDSSPMA 234 (302)
T ss_dssp CTTCEECCTTCCEE-----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHH----------HHHHHHHHHTTTCGGGSHHH
T ss_pred ccccccccCCCcce-----eccCCCCCCccccCCeeecCCCCCcchhHHH----------HHHHHHHHHHccCCCcchhh
Confidence 99998765432211 1112345899999999999989999999999 77777788777665431100
Q ss_pred -----ccc---cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 766 -----VDP---SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 766 -----~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
..+ .......... .........+..+++.+.+++.+||+.||++|||++|+++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 235 LFLKMIGPTHGQMTVTRLVNT-LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHCSCCGGGHHHHHHHH-HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHhhccCCcccccCHHHHHHH-HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 000 0000000000 0000011122345678899999999999999999999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=332.94 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=201.4
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
+.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 82 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT---- 82 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS----
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC----
Confidence 3568999999999999999999999999999999986432 223467899999999999999999999976554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|
T Consensus 83 -~~~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~D 152 (279)
T 3fdn_A 83 -RVYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIAD 152 (279)
T ss_dssp -EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECS
T ss_pred -EEEEEEecCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEe
Confidence 8999999999999999997654 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||++....... .....||+.|+|||++.+..++.++|||| .|+++++++++..|+.....
T Consensus 153 fg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~ 212 (279)
T 3fdn_A 153 FGWSVHAPSSR----------RTDLCGTLDYLPPEMIEGRMHDEKVDLWS----------LGVLCYEFLVGKPPFEANTY 212 (279)
T ss_dssp CCEESCC------------------CCCCTTCCHHHHTTCCCCTTHHHHH----------HHHHHHHHHHSSCTTCCSSH
T ss_pred ccccccCCccc----------ccccCCCCCccCHhHhccCCCCccchhHh----------HHHHHHHHHHCCCCCCCCcH
Confidence 99986543321 12346999999999999999999999999 88899999999888753221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+.. ...... ....+..+++.+.+++.+||+.||++|||++|+++.
T Consensus 213 ~~~~--~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 213 QETY--KRISRV-------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HHHH--HHHHHT-------CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred HHHH--HHHHhC-------CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1100 000000 001122245678899999999999999999999976
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.72 Aligned_cols=274 Identities=22% Similarity=0.366 Sum_probs=210.9
Q ss_pred hcCCccCceeccCcceEEEEEEE----CCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|++ ..+++.||||+++.......+.+.+|++++++++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---C
Confidence 35799999999999999999984 5679999999998665555678999999999999999999999875432 3
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred CceEEEEECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence 467899999999999999987542 589999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc-
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME- 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~- 764 (833)
||+++........... .....+|..|+|||++.+..++.++|||| +|+++++++++..|+....
T Consensus 189 fg~~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~tg~~~~~~~~~ 253 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKV-----KEPGESPIFWYAPESLTESKFSVASDVWS----------FGVVLYELFTYIEKSKSPPA 253 (326)
T ss_dssp CTTCEECCSSCSEEEC-----SSCCSCCGGGCCHHHHHHCEEEHHHHHHH----------HHHHHHHHHHTTCGGGSHHH
T ss_pred Ccchhhcccccccccc-----ccCCCCceeEECchhhcCCCCCchhhHHH----------HHHHHHHHHhcCCCCCCCHH
Confidence 9999876543211111 11235788899999998888999999999 7888888888876654210
Q ss_pred -c---ccc----cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 765 -I---VDP----SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 765 -~---~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
. ... ......... ..........+..++..+.+++.+||..||++|||+.|+++.|+.+.+.+.|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~g 326 (326)
T 2w1i_A 254 EFMRMIGNDKQGQMIVFHLIE-LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326 (326)
T ss_dssp HHHHHHCTTCCTHHHHHHHHH-HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHHhhccccchhhhHHHHHH-HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcC
Confidence 0 000 000000000 0000001112234567899999999999999999999999999999887643
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=357.63 Aligned_cols=261 Identities=22% Similarity=0.397 Sum_probs=208.4
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
....++|++.+.||+|+||.||+|++. ++..||||+++... ...+.+.+|++++++++||||+++++++.. .
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~------~ 255 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------E 255 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC------C
Confidence 344568999999999999999999997 57889999997543 356789999999999999999999999742 2
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DF 328 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF 328 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECST
T ss_pred ccEEEEeecCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeC
Confidence 57899999999999999986432 2588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
|+++......... .....+|+.|+|||++.+..++.++|||| +|++++++++ +..|+.....
T Consensus 329 G~a~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Dvws----------lG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 329 GLARVIEDNEYTA-------REGAKFPIKWTAPEAINFGSFTIKSDVWS----------FGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp TGGGGBCCHHHHT-------TCSSSSCGGGSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCSSTTCCH
T ss_pred CCceEcCCCceec-------cCCCcccccccCHHHhccCCCCcHHHHHh----------HHHHHHHHHhCCCCCCCCCCH
Confidence 9998765432211 11234788999999998889999999999 7888888887 7777642211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.......... . ....+..+++.+.+++.+||..||++|||+++|++.|+.+...
T Consensus 392 --~~~~~~i~~~-~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 392 --PEVIRALERG-Y-----RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp --HHHHHHHHHT-C-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred --HHHHHHHHcC-C-----CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 1111111110 0 0112234567889999999999999999999999999988654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=336.12 Aligned_cols=253 Identities=20% Similarity=0.237 Sum_probs=204.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc------chhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG------ASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 88 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT-- 88 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS--
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC--
Confidence 45799999999999999999999999999999999754322 2467899999999999999999999976554
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC----
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM---- 679 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---- 679 (833)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 89 ---~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~ 156 (321)
T 2a2a_A 89 ---DVVLILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIP 156 (321)
T ss_dssp ---EEEEEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSC
T ss_pred ---EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcC
Confidence 8999999999999999998654 689999999999999999999999 999999999999999888
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
.+||+|||+++....... .....||+.|+|||++.+..++.++|||| .|+++++++++..|
T Consensus 157 ~~kl~Dfg~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p 217 (321)
T 2a2a_A 157 HIKLIDFGLAHEIEDGVE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWS----------IGVITYILLSGASP 217 (321)
T ss_dssp CEEECCCTTCEECCTTCC---------CCCCCSCGGGCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSCCS
T ss_pred CEEEccCccceecCcccc---------ccccCCCCCccCcccccCCCCCCccccHH----------HHHHHHHHHHCCCC
Confidence 799999999986654221 12346999999999999999999999999 88899999999988
Q ss_pred CcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+..... .............. ........+..+.+++.+||..||++|||++|+++.
T Consensus 218 f~~~~~--~~~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 218 FLGDTK--QETLANITSVSYDF---DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp SCCSSH--HHHHHHHHTTCCCC---CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred CCCCCH--HHHHHHHHhccccc---ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 752211 11111111111000 011112345678899999999999999999999874
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=331.42 Aligned_cols=272 Identities=23% Similarity=0.290 Sum_probs=211.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+++++.++|++++..++++... ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~ 81 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNV 81 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCC----CCceE
Confidence 468999999999999999999998899999999986443 345789999999999998877777666432 34789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee---cCCCcEEEccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDF 686 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Df 686 (833)
+||||+ +++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 82 lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Df 152 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 152 (296)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred EEEEec-CCCHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeC
Confidence 999999 8999999975432 689999999999999999999999 99999999999999 48889999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++........... .........||+.|+|||++.+..++.++|||| +|+++++++++..|+......
T Consensus 153 g~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~~~ 221 (296)
T 3uzp_A 153 GLAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLES----------LGYVLMYFNLGSLPWQGLKAA 221 (296)
T ss_dssp TTCEECBCTTTCCBC-CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHSSCTTSSCCCS
T ss_pred CCccccccccccccc-ccccccccccccccCChhhhcCCCCCcchhhHH----------HHHHHHHHHhCCCCCCCcCch
Confidence 999876553321110 011223457999999999999999999999999 888999999999998643222
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
+.......+..... ..........+++.+.+++.+||+.||++|||++++++.|+++.+..
T Consensus 222 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 222 TKRQKYERISEKKM-STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp SSSSHHHHHHHHHH-HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred hhhhhhhhhccccc-CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 21111111111000 00011111335678999999999999999999999999999997654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=336.59 Aligned_cols=265 Identities=22% Similarity=0.282 Sum_probs=197.5
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-----cchhHHHHHHHHHhhcC---CCccceEeeEeecC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-----GASRSFVAECEALRNIR---HRNLIKIITICSST 600 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 600 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 45789999999999999999999998999999999974321 22356788888888875 99999999998766
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV 680 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 680 (833)
........++||||++ |+|.+++...... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP----GLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 5334446899999997 5999999876532 489999999999999999999999 9999999999999999999
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
+||+|||+|+...... ......||+.|+|||++.+..++.++|||| .|+++++++++..|+
T Consensus 159 ~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~~l~~g~~pf 219 (308)
T 3g33_A 159 VKLADFGLARIYSYQM---------ALTPVVVTLWYRAPEVLLQSTYATPVDMWS----------VGCIFAEMFRRKPLF 219 (308)
T ss_dssp EEECSCSCTTTSTTCC---------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHH----------HHHHHHHTTTSSCSC
T ss_pred EEEeeCccccccCCCc---------ccCCccccccccCchHHcCCCCCchHHHHH----------HHHHHHHHHhCCCCC
Confidence 9999999998654322 122356999999999999999999999999 555566666665554
Q ss_pred cccccccc--------------cchhhh--ccccc--hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 761 KVMEIVDP--------------SLLMEV--MTNNS--MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 761 ~~~~~~~~--------------~~~~~~--~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......+. .+.... ..... ..........+++++.+.+++.+||+.||++|||+.|+++.
T Consensus 220 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 220 CGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 31110000 000000 00000 00000011112345678899999999999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=340.96 Aligned_cols=243 Identities=23% Similarity=0.339 Sum_probs=202.4
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--------cchhHHHHHHHHHhhcCCCccceEeeEeecC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--------GASRSFVAECEALRNIRHRNLIKIITICSST 600 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 600 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 45689999999999999999999999999999999975431 1334678899999999999999999997655
Q ss_pred CCCCCceEeEEEEecCCC-ChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC
Q 040925 601 DFKGTDFKAFVFEYMENG-SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~ 679 (833)
+ ..++||||+.+| +|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++
T Consensus 102 ~-----~~~lv~e~~~~g~~l~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 167 (335)
T 3dls_A 102 G-----FFQLVMEKHGSGLDLFAFIDRHP------RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDF 167 (335)
T ss_dssp S-----EEEEEEECCTTSCBHHHHHHTCC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTS
T ss_pred C-----EEEEEEEeCCCCccHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCC
Confidence 4 899999999777 9999998765 689999999999999999999999 999999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhC
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTAL 758 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~ 758 (833)
.+||+|||+++....... .....||+.|+|||++.+..+ +.++|||| +|+++++++++..
T Consensus 168 ~~kL~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Diws----------lG~il~el~~g~~ 228 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGKL---------FYTFCGTIEYCAPEVLMGNPYRGPELEMWS----------LGVTLYTLVFEEN 228 (335)
T ss_dssp CEEECCCTTCEECCTTCC---------BCEECSCGGGCCHHHHTTCCBCSHHHHHHH----------HHHHHHHHHHSSC
T ss_pred cEEEeecccceECCCCCc---------eeccCCCccccChhhhcCCCCCCCcccchh----------HHHHHHHHHhCCC
Confidence 999999999987654321 123569999999999988876 88999999 8889999999999
Q ss_pred CCccccc-ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 759 PEKVMEI-VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 759 p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
|+..... ..... ..+..+++.+.+++.+||..||++|||++|+++.
T Consensus 229 pf~~~~~~~~~~~----------------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 229 PFCELEETVEAAI----------------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SCSSGGGGTTTCC----------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred chhhHHHHHhhcc----------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8763211 11100 0011135578899999999999999999999875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.11 Aligned_cols=279 Identities=22% Similarity=0.366 Sum_probs=203.3
Q ss_pred HHHHHHhcCCccCceeccCcceEEEEEEECC---CceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEee
Q 040925 524 AELSKATGEFSSSNMIGQGSFGYVYKGTLGE---DEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICS 598 (833)
Q Consensus 524 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 598 (833)
.++....++|.+.+.||+|+||.||+|++.. +++.||+|+++.... ...+.+.+|++++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444456789999999999999999998754 566899999975432 23467899999999999999999999987
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
.....+....++||||+++|+|.+++...........+++..++.++.|++.||.|||+. +|+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 665333345799999999999999995433211223689999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-Hh
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TA 757 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~ 757 (833)
+.+||+|||+++......... ......+++.|+|||++.+..++.++|||| +|++++++++ +.
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~~~g~ 247 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYR------QGRIAKMPVKWIAIESLADRVYTSKSDVWA----------FGVTMWEIATRGM 247 (313)
T ss_dssp SCEEECSCSCC----------------------CCGGGSCHHHHHSSCCCHHHHHHH----------HHHHHHHHHTTSC
T ss_pred CcEEEeecCcceecccccccC------cccccCCCccccCchhhcCCCccchhhhHH----------HHHHHHHHHhcCC
Confidence 999999999998664432111 112235788999999999999999999999 7888888888 66
Q ss_pred CCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 758 LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 758 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
.|+..... ........... ....+..+++.+.+++.+||..||++|||++++++.|+.+.+...
T Consensus 248 ~p~~~~~~--~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 248 TPYPGVQN--HEMYDYLLHGH------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp CSSTTCCG--GGHHHHHHTTC------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred CCCccCCH--HHHHHHHHcCC------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 66542211 11111111110 011223456678999999999999999999999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=352.68 Aligned_cols=249 Identities=27% Similarity=0.393 Sum_probs=204.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|.+.+.||+|+||.||+|++..+|+.||||+++... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~----- 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS----- 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----
Confidence 367999999999999999999999999999999996432 223467899999999999999999999976654
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DF 160 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 160 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEec
Confidence 8999999999999999998654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|++........ ....+||+.|+|||++.+..+ +.++|||| .|+++++++++..|+.....
T Consensus 161 G~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS----------lGvil~elltG~~Pf~~~~~ 221 (476)
T 2y94_A 161 GLSNMMSDGEF---------LRTSCGSPNYAAPEVISGRLYAGPEVDIWS----------SGVILYALLCGTLPFDDDHV 221 (476)
T ss_dssp SSCEECCTTCC---------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHH----------HHHHHHHHHHSSCSSCCSSS
T ss_pred cchhhcccccc---------ccccCCCcCeEChhhccCCCCCCCcceehh----------hHHHHHHHhhCCCCCCCCCH
Confidence 99987644221 123469999999999988765 68999999 88899999999988753221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
............ ..+..+++.+.+++.+||..||++|||++|+++.
T Consensus 222 --~~~~~~i~~~~~-------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 222 --PTLFKKICDGIF-------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp --HHHHHHHHTTCC-------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred --HHHHHHHhcCCc-------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 111111111111 1112235578899999999999999999999874
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.44 Aligned_cols=260 Identities=26% Similarity=0.395 Sum_probs=200.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++. ++.||||+++. ....+.+.+|++++++++||||+++++++.+ ..+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~ 75 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVC 75 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcE
Confidence 357999999999999999999985 78899999863 3345789999999999999999999998642 368
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc-EEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV-AHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kL~DfG~ 688 (833)
+||||+++|+|.+++...... ..+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||+
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPL---PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSE---ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred EEEEcCCCCCHHHHHhccCCC---CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 999999999999999865421 24788999999999999999999931129999999999999998886 79999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+....... ....||+.|+|||++.+..++.++|||| +|+++++++++..|+........
T Consensus 153 ~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~~g~~p~~~~~~~~~ 211 (307)
T 2eva_A 153 ACDIQTHM-----------TNNKGSAAWMAPEVFEGSNYSEKCDVFS----------WGIILWEVITRRKPFDEIGGPAF 211 (307)
T ss_dssp -----------------------CCTTSSCHHHHTCCCCCTHHHHHH----------HHHHHHHHHHTCCTTTTTCSSHH
T ss_pred cccccccc-----------ccCCCCCceEChhhhCCCCCCcHHHHHH----------HHHHHHHHHHCCCCchhhCccHH
Confidence 97554321 1235999999999999999999999999 88899999999988753211111
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
.......... .......++..+.+++.+||+.||++|||++|+++.|+.+.+.+.+
T Consensus 212 ~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 212 RIMWAVHNGT------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp HHHHHHHTTC------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred HHHHHHhcCC------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 1110000000 0111233456788999999999999999999999999999876543
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=359.04 Aligned_cols=338 Identities=19% Similarity=0.165 Sum_probs=199.8
Q ss_pred CCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEE
Q 040925 46 LRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELL 125 (833)
Q Consensus 46 l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 125 (833)
+.+++.|++++|.++.+.+..|.++++|+.|+|++|.++ .+++..|..+++|++|+|++|.+++..|..|+++++|++|
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCC-CCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 345566666666665544445555666666666666655 4444555556666666666666655555555666666666
Q ss_pred EcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEE
Q 040925 126 DLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFG 205 (833)
Q Consensus 126 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~ 205 (833)
+|++|+|+.+++..|.++++|++|+|++|.++.+++ ..|.++++|++|+|++|++++. +
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~------~~~~~l~~L~~L~L~~N~l~~~-~-------------- 187 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED------DTFQATTSLQNLQLSSNRLTHV-D-------------- 187 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT------TTTTTCTTCCEEECTTSCCSBC-C--------------
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCCh------hhhhcCCcCcEEECcCCCCCCc-C--------------
Confidence 666666665555555666666666666666554433 2245556666666666655521 0
Q ss_pred ccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccC
Q 040925 206 IGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQG 285 (833)
Q Consensus 206 l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 285 (833)
+..+++|+.|++++|.+.+ +...++|+.|++++|.++...+. + .++|+.|+|++|.+++
T Consensus 188 -------------~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~-~--~~~L~~L~L~~n~l~~ 246 (597)
T 3oja_B 188 -------------LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGP-V--NVELTILKLQHNNLTD 246 (597)
T ss_dssp -------------GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEECS-C--CSCCCEEECCSSCCCC
T ss_pred -------------hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCcccccccc-c--CCCCCEEECCCCCCCC
Confidence 2233445555555555442 22334566666666666533222 1 1456666666666653
Q ss_pred CCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCcccc
Q 040925 286 NIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLS 365 (833)
Q Consensus 286 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 365 (833)
+..+..+++|+.|++++|.++ +..|..|+.+++|+.|+|++|.+++ +|..+.
T Consensus 247 --~~~l~~l~~L~~L~Ls~N~l~-------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~ 298 (597)
T 3oja_B 247 --TAWLLNYPGLVEVDLSYNELE-------------------------KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQ 298 (597)
T ss_dssp --CGGGGGCTTCSEEECCSSCCC-------------------------EEESGGGTTCSSCCEEECTTSCCCE-EECSSS
T ss_pred --ChhhccCCCCCEEECCCCccC-------------------------CCCHHHhcCccCCCEEECCCCCCCC-CCcccc
Confidence 234445555544444444443 3445556666777777777777764 355556
Q ss_pred CCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCcccc
Q 040925 366 TCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKIS 445 (833)
Q Consensus 366 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~ 445 (833)
.+++|+.|+|++|.++ .+|..+..+++|+.|+|++|.+++.. +..+++|+.|++++|+|+|.+... .+.......
T Consensus 299 ~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~~~-~~~~~~~~~ 373 (597)
T 3oja_B 299 PIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRA-LFRNVARPA 373 (597)
T ss_dssp CCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHH-HTTTCCTTT
T ss_pred cCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhHHH-HHHHHhhhc
Confidence 6777777777777777 34556677778888888888887543 566788889999999998876432 244555556
Q ss_pred ccCCcCCCCCcccC
Q 040925 446 LQGNMKLCGGIDEL 459 (833)
Q Consensus 446 l~~N~~~c~~~~~~ 459 (833)
+.++...|+.+...
T Consensus 374 ~~~~~~~C~~~~~~ 387 (597)
T 3oja_B 374 VDDADQHCKIDYQL 387 (597)
T ss_dssp BCCCCCCCCTTCEE
T ss_pred cccccccCCcchhc
Confidence 78888889875543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=342.60 Aligned_cols=259 Identities=22% Similarity=0.341 Sum_probs=202.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceE----EEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMI----VAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
++|++.+.||+|+||.||+|++..+++. ||+|.+.... ....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------ 86 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG------ 86 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB------
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC------
Confidence 4799999999999999999999877765 7778775332 2334678899999999999999999998743
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~D 158 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRG-----ALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVAD 158 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGG-----GSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECS
T ss_pred CccEEEEEeCCCCCHHHHHHHccc-----cCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECC
Confidence 258899999999999999986532 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||+++........ .......||+.|+|||++.+..++.++|||| +|++++++++ +..|+....
T Consensus 159 fg~a~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~el~~~g~~p~~~~~ 222 (325)
T 3kex_A 159 FGVADLLPPDDKQ------LLYSEAKTPIKWMALESIHFGKYTHQSDVWS----------YGVTVWELMTFGAEPYAGLR 222 (325)
T ss_dssp CSGGGGSCCCTTC------CC-----CCTTTSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTSC
T ss_pred CCcccccCccccc------ccccCCCCcccccChHHhccCCCChhhHhHH----------hHHHHHHHHhCCCCCccccC
Confidence 9999876543221 1122346888999999999889999999999 7888888888 777765321
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.. .. ...+.... ....+..++..+.+++.+||..||++|||++|+++.|+.+.+.
T Consensus 223 ~~--~~-~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 223 LA--EV-PDLLEKGE-----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TT--HH-HHHHHTTC-----BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred HH--HH-HHHHHcCC-----CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11 11 11111100 0011122345678999999999999999999999999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.11 Aligned_cols=249 Identities=18% Similarity=0.226 Sum_probs=196.3
Q ss_pred cCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEEEe
Q 040925 535 SSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEY 614 (833)
Q Consensus 535 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 614 (833)
..+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||+++++++...+ ..++||||
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~E~ 167 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKN-----DIVLVMEY 167 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EEEEEEEC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEEEEEeC
Confidence 3578999999999999999899999999998655455678999999999999999999999976654 89999999
Q ss_pred cCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee--cCCCcEEEccccccccc
Q 040925 615 MENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL--DHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 615 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kL~DfG~a~~~ 692 (833)
+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||+++..
T Consensus 168 ~~~~~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~ 239 (373)
T 2x4f_A 168 VDGGELFDRIIDESY-----NLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239 (373)
T ss_dssp CTTCEEHHHHHHTGG-----GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEEC
T ss_pred CCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceec
Confidence 999999998875432 689999999999999999999999 99999999999999 56789999999999876
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchh
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~ 772 (833)
..... .....||+.|+|||++.+..++.++|||| +|+++++++++..|+..... .....
T Consensus 240 ~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~elltg~~pf~~~~~--~~~~~ 298 (373)
T 2x4f_A 240 KPREK---------LKVNFGTPEFLAPEVVNYDFVSFPTDMWS----------VGVIAYMLLSGLSPFLGDND--AETLN 298 (373)
T ss_dssp CTTCB---------CCCCCSSCTTCCHHHHTTCBCCHHHHHHH----------HHHHHHHHHHSSCTTCCSSH--HHHHH
T ss_pred CCccc---------cccccCCCcEeChhhccCCCCCcHHhHHH----------HHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence 54321 12246999999999999999999999999 88899999999988753221 11111
Q ss_pred hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 773 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... ......+++.+.+++.+||..||++|||++|+++.
T Consensus 299 ~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 299 NILACRWDLE---DEEFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHTCCCSC---SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHhccCCCC---hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111000 11122346678999999999999999999999874
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.11 Aligned_cols=264 Identities=22% Similarity=0.288 Sum_probs=186.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||.||+|.+..+++.||+|+++.... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTEN-----KL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT-----EE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECC-----eE
Confidence 4689999999999999999999998999999999975432 33467889999999999999999999976544 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++ |+|.+++...........+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 154 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGL 154 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCcc
Confidence 99999998 59999987643222222589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++....... ......||+.|+|||++.+ ..++.++|||| .|+++++++++..|+......+
T Consensus 155 ~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~~~~~~ 216 (317)
T 2pmi_A 155 ARAFGIPVN--------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWS----------CGCILAEMITGKPLFPGTNDEE 216 (317)
T ss_dssp CEETTSCCC--------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHH----------HHHHHHHHHHSSCSCCCSSHHH
T ss_pred ceecCCCcc--------cCCCCcccccccCchHhhCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCChHH
Confidence 986543211 1123468999999999876 46899999999 7888888888887764211100
Q ss_pred -------------ccchhhhcc---ccchh---------hhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 -------------PSLLMEVMT---NNSMI---------QEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 -------------~~~~~~~~~---~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......... ..... ..........++..+.+++.+||+.||++|||++|+++.
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 217 QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000000000 00000 000000111245678999999999999999999999864
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=336.39 Aligned_cols=308 Identities=19% Similarity=0.201 Sum_probs=249.8
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|++++|.++...+..|..+++|++|++++|++++..+..|..+++|++|+|++|+++++.|..|.++++|++|+|++
T Consensus 47 l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 126 (390)
T 3o6n_A 47 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 126 (390)
T ss_dssp CSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCC
Confidence 58899999999966666789999999999999999988888999999999999999999988899999999999999999
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
|+++ .+|..+|.++++|++|+|++|.+++..|..|.++++|++|++++|+++.+ .+..+++|+.|++++|.++.+
T Consensus 127 n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~~- 201 (390)
T 3o6n_A 127 NDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLSTL- 201 (390)
T ss_dssp SCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSEE-
T ss_pred CccC-cCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccccc-
Confidence 9998 89999999999999999999999988888999999999999999999976 367789999999999998653
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (833)
...++|++|++++|+++. +|. ...++|+.|++++|++++.
T Consensus 202 ----------~~~~~L~~L~l~~n~l~~-~~~---------------------------~~~~~L~~L~l~~n~l~~~-- 241 (390)
T 3o6n_A 202 ----------AIPIAVEELDASHNSINV-VRG---------------------------PVNVELTILKLQHNNLTDT-- 241 (390)
T ss_dssp ----------ECCSSCSEEECCSSCCCE-EEC---------------------------CCCSSCCEEECCSSCCCCC--
T ss_pred ----------CCCCcceEEECCCCeeee-ccc---------------------------cccccccEEECCCCCCccc--
Confidence 344689999999998872 111 1125677777777777743
Q ss_pred ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccc
Q 040925 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITT 320 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ 320 (833)
..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++ +|..+..+++|+.|++++|+++
T Consensus 242 ~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~------------ 308 (390)
T 3o6n_A 242 AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL------------ 308 (390)
T ss_dssp GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC------------
T ss_pred HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce------------
Confidence 467777788888888888777777777777778888888777764 4445556666666555555554
Q ss_pred cceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccc
Q 040925 321 LSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV 383 (833)
Q Consensus 321 ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 383 (833)
.+|..+..+++|+.|++++|++++.. +..+++|+.|++++|+++..
T Consensus 309 --------------~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 309 --------------HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp --------------CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred --------------ecCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCccch
Confidence 33444556777888888888887542 66777888888888888753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=346.64 Aligned_cols=269 Identities=21% Similarity=0.280 Sum_probs=210.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|++++++++||||+++++++.... ....+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~~ 85 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHKV 85 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCeeE
Confidence 57999999999999999999999999999999997432 234567889999999999999999999976543 34679
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee----cCCCcEEEcc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL----DHDMVAHVCD 685 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~D 685 (833)
+||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~D 159 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTD 159 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred EEEecCCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEec
Confidence 999999999999999865421 1389999999999999999999999 99999999999999 7778899999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCC--------CCCCcccccccCCcCCCccccCCccHHHHHHHh
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--------SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTA 757 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~ 757 (833)
||+|+....... .....||+.|+|||++.+ ..++.++|||| +|+++++++++.
T Consensus 160 FG~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwS----------lG~il~el~tg~ 220 (396)
T 4eut_A 160 FGAARELEDDEQ---------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS----------IGVTFYHAATGS 220 (396)
T ss_dssp GGGCEECCCGGG---------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHH----------HHHHHHHHHHSS
T ss_pred CCCceEccCCCc---------cccccCCccccCHHHhhccccccccccCCCcHHHHHH----------HHHHHHHHHHCC
Confidence 999987654321 123469999999998764 56788999999 788888999988
Q ss_pred CCCcccccc--cccchhhhccccch------------------hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHH
Q 040925 758 LPEKVMEIV--DPSLLMEVMTNNSM------------------IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDV 817 (833)
Q Consensus 758 ~p~~~~~~~--~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 817 (833)
.|+...... .............. ..+............+.+++.+||+.||++|||++|+
T Consensus 221 ~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~ 300 (396)
T 4eut_A 221 LPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300 (396)
T ss_dssp CSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred CCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHH
Confidence 886521110 01111111110000 0001112236678889999999999999999999999
Q ss_pred HHHHHHhhhh
Q 040925 818 VAKLCHTRET 827 (833)
Q Consensus 818 l~~L~~i~~~ 827 (833)
++.+..+.+.
T Consensus 301 l~~l~~il~~ 310 (396)
T 4eut_A 301 FAETSDILHR 310 (396)
T ss_dssp HHHHHHHHTC
T ss_pred HHHHHHHhhc
Confidence 9999888653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.11 Aligned_cols=273 Identities=18% Similarity=0.222 Sum_probs=203.1
Q ss_pred cCCccCceeccCcceEEEEEEECC---CceEEEEEEeeccCCc-----------chhHHHHHHHHHhhcCCCccceEeeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGE---DEMIVAVKVINLKYKG-----------ASRSFVAECEALRNIRHRNLIKIITI 596 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~~ 596 (833)
++|++.+.||+|+||.||+|++.. ++..||+|++...... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 7889999998754321 12346778889999999999999999
Q ss_pred eecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 597 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
+... +.+....++||||+ +++|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 117 ~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~ 185 (345)
T 2v62_A 117 GLTE-FKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLG 185 (345)
T ss_dssp EEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccc-cCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEc
Confidence 8763 23456899999999 899999998654 689999999999999999999999 999999999999999
Q ss_pred CCC--cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 677 HDM--VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 677 ~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
.++ .+||+|||+|+.+......... .........||+.|+|||++.+..++.++|||| +|+++++++
T Consensus 186 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ell 254 (345)
T 2v62_A 186 YKNPDQVYLADYGLSYRYCPNGNHKQY-QENPRKGHNGTIEFTSLDAHKGVALSRRSDVEI----------LGYCMLRWL 254 (345)
T ss_dssp SSSTTSEEECCCTTCEESSGGGCCCCC-CCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHH----------HHHHHHHHH
T ss_pred cCCCCcEEEEeCCCceecccccccccc-hhccccccCCCccccCHHHhcCCCCCchhhHHH----------HHHHHHHHH
Confidence 887 9999999999877543221111 111223457999999999999999999999999 888999999
Q ss_pred HHhCCCcccccccccchhhhccccc-hhhhh--hhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNS-MIQED--KRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
++..|+.... .+............ ..... .......+++.+.+++.+||..||++|||+++|++.|+.+..
T Consensus 255 ~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 255 CGKLPWEQNL-KDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HSSCTTGGGT-TCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred hCCCCccccc-cccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 9998874211 11111000000000 00000 000011355689999999999999999999999999987653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=339.49 Aligned_cols=250 Identities=19% Similarity=0.231 Sum_probs=181.5
Q ss_pred CCccC---ceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCce
Q 040925 532 EFSSS---NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 532 ~y~~~---~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 607 (833)
+|++. +.||+|+||.||+|++..+++.||||++... ....+.+|+.+++.+. ||||+++++++.+.. .
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~-----~ 80 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQL-----H 80 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----E
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCC-----E
Confidence 45543 7899999999999999999999999999632 4467889999999997 999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC---cEEEc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM---VAHVC 684 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~ 684 (833)
.++||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~ 151 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKK------HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKII 151 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEEC
T ss_pred EEEEEEccCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEe
Confidence 999999999999999998754 689999999999999999999999 999999999999998766 89999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+++....... ......||+.|+|||++.+..++.++|||| .|+++++++++..|+....
T Consensus 152 Dfg~a~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~Diws----------lG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 152 DFGFARLKPPDNQ--------PLKTPCFTLHYAAPELLNQNGYDESCDLWS----------LGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp CCTTCEECCC------------------------------CCCCHHHHHHH----------HHHHHHHHHHSSCTTC---
T ss_pred ccccceecCCCCC--------cccccCCCcCccCHHHhcCCCCCCccchHH----------HHHHHHHHHhCCCCCCCCc
Confidence 9999986543221 112346899999999999999999999999 8889999999998876322
Q ss_pred ccc-----ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 765 IVD-----PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 765 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
... ............. ........+++.+.+++.+||..||++|||++|+++
T Consensus 214 ~~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 214 RSLTCTSAVEIMKKIKKGDFS---FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp ----CCCHHHHHHHHTTTCCC---CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccccccHHHHHHHHHcCCCC---CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 110 0011111111110 011112335678899999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=328.95 Aligned_cols=258 Identities=25% Similarity=0.379 Sum_probs=206.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++. +++.||+|+++.... ..+.+.+|++++++++||||+++++++...+ ..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 79 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PIC 79 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-----SCE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-----CeE
Confidence 457999999999999999999997 678899999975432 3467999999999999999999999976544 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 80 lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~ 151 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMT 151 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGG
T ss_pred EEEeCCCCCcHHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccc
Confidence 99999999999999976532 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
.......... .....||+.|+|||++.+..++.++|||| .|++++++++ +..|+..... .
T Consensus 152 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~~g~~p~~~~~~--~ 212 (267)
T 3t9t_A 152 RFVLDDQYTS-------STGTKFPVKWASPEVFSFSRYSSKSDVWS----------FGVLMWEVFSEGKIPYENRSN--S 212 (267)
T ss_dssp GGBCCHHHHS-------TTSTTCCGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTCCH--H
T ss_pred cccccccccc-------cccccccccccChhhhcCCCccchhchhh----------hHHHHHHHhccCCCCCCCCCH--H
Confidence 8765432211 11235788999999998888999999999 7778888887 6767642211 1
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
........... ...+..++..+.+++.+||..||++|||++|+++.|+++.+.
T Consensus 213 ~~~~~i~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 213 EVVEDISTGFR------LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp HHHHHHHTTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCCc------CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 11111111100 011122356788999999999999999999999999998764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=343.68 Aligned_cols=256 Identities=19% Similarity=0.242 Sum_probs=195.5
Q ss_pred hcCCccC-ceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSS-NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|.+. +.||+|+||+||+|++..+++.||||+++. ...+.+|++++.++ +||||+++++++... +.+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~-~~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeec-ccCCcE
Confidence 4567776 689999999999999999999999999962 34678899987555 799999999987542 123457
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CCcEEEc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVC 684 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~ 684 (833)
.|+||||+++|+|.+++...... .+++.+++.|+.||+.||.|||+. +|+||||||+||+++. ++.+||+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC-------CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEeCCCCcHHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence 89999999999999999875422 589999999999999999999999 9999999999999997 7899999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+++...... .....+||+.|+|||++.+..++.++|||| +|+++|+++++..|+....
T Consensus 207 DFG~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 207 DFGFAKETTSHN---------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWS----------LGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp CCTTCEECC--------------------CTTCCGGGSCCCCSSSHHHHHH----------HHHHHHHHHHSSCSCCCCT
T ss_pred ecccccccCCCC---------ccccCCCCCCccCHhhcCCCCCCCcccHHH----------HHHHHHHHHhCCCCCCCCc
Confidence 999998654321 112356999999999999999999999999 8889999999999875322
Q ss_pred ccc--ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVD--PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... +............. .......++..+.+++.+||..||++|||++|+++.
T Consensus 268 ~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 268 GLAISPGMKTRIRMGQYEF---PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp TCSSCCSHHHHHHHTCCCC---CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cccccHHHHHHHHcCcccC---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111 11111111111100 011112356678999999999999999999999875
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=334.74 Aligned_cols=262 Identities=21% Similarity=0.245 Sum_probs=198.5
Q ss_pred cCCccC-ceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSS-NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
+.|++. +.||+|+||.||+|++..+++.||||+++.......+.+.+|++++.++ +||||+++++++...+ ..
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~-----~~ 86 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEED-----RF 86 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC-----EE
Confidence 578885 7899999999999999989999999999866555667899999999995 7999999999976654 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc---EEEcc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV---AHVCD 685 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~D 685 (833)
++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~D 157 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIHKRR------HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICD 157 (316)
T ss_dssp EEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECC
T ss_pred EEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEE
Confidence 99999999999999998654 689999999999999999999999 9999999999999998775 99999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCC-----CCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-----SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
||++............ .........||+.|+|||++.+ ..++.++|||| .|+++++++++..|+
T Consensus 158 fg~~~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws----------lG~il~~l~~g~~pf 226 (316)
T 2ac3_A 158 FDLGSGIKLNGDCSPI-STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS----------LGVILYILLSGYPPF 226 (316)
T ss_dssp TTCCC--------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHH----------HHHHHHHHHHSSCSC
T ss_pred ccCccccccCCccccc-cccccccccCCcCccChHHhhcccccccCCCcccccHh----------HHHHHHHHHHCCCCC
Confidence 9999865432211100 1111223469999999999865 55889999999 888999999999887
Q ss_pred cccccccccc-------------hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 761 KVMEIVDPSL-------------LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 761 ~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......+..+ ........... .......++..+.+++.+||..||++|||++|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEF---PDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CCCCCSCSCC----CCHHHHHHHHHHHHHCCCCC---CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cccccccccccccccchhHHHHHHHHHhccCccc---CchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 6332221111 00000000000 000112245678999999999999999999999874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=335.53 Aligned_cols=268 Identities=22% Similarity=0.281 Sum_probs=200.8
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++...+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---- 105 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN---- 105 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT----
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC----
Confidence 3457999999999999999999998899999999997532 223467889999999999999999999987655
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|
T Consensus 106 -~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~D 179 (310)
T 2wqm_A 106 -ELNIVLELADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGD 179 (310)
T ss_dssp -EEEEEEECCCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred -cEEEEEecCCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEe
Confidence 899999999999999999753211 11689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||++........ ......||+.|+|||++.+..++.++|||| +|+++++++++..|+.....
T Consensus 180 fg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s----------lG~il~~l~~g~~p~~~~~~ 241 (310)
T 2wqm_A 180 LGLGRFFSSKTT--------AAHSLVGTPYYMSPERIHENGYNFKSDIWS----------LGCLLYEMAALQSPFYGDKM 241 (310)
T ss_dssp C--------------------------CCSSCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHSSCTTC---C
T ss_pred ccceeeecCCCc--------cccccCCCeeEeChHHhCCCCCCchhhHHH----------HHHHHHHHHhCCCCCcccch
Confidence 999986544221 112346899999999999999999999999 88889999999888652211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
.............. .......++..+.+++.+||..||++|||++++++.|+++.....
T Consensus 242 ~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 242 NLYSLCKKIEQCDY-----PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CHHHHHHHHHTTCS-----CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHHHHHHHhhcccC-----CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11111111111100 001112345678999999999999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=341.60 Aligned_cols=271 Identities=22% Similarity=0.324 Sum_probs=205.9
Q ss_pred HHhcCCccCceeccCcceEEEEEEE-----CCCceEEEEEEeeccC-CcchhHHHHHHHHHhhc-CCCccceEeeEeecC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKY-KGASRSFVAECEALRNI-RHRNLIKIITICSST 600 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 600 (833)
...++|++.+.||+|+||.||+|++ ..+++.||||+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999997 3467889999997442 33457899999999999 899999999997654
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCcc-----------------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQV-----------------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPM 663 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 663 (833)
+ ..++||||+++|+|.+++....... ....+++..++.++.|++.||+|||+. ||
T Consensus 122 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 193 (344)
T 1rjb_A 122 G-----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 193 (344)
T ss_dssp S-----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred C-----ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 4 7899999999999999998754210 012479999999999999999999999 99
Q ss_pred eeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCcc
Q 040925 664 VHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAV 743 (833)
Q Consensus 664 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~ 743 (833)
+||||||+||+++.++.+||+|||++......... .......||+.|+|||++.+..++.++||||
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s-------- 259 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESLFEGIYTIKSDVWS-------- 259 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHH--------
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCccc------eeccCccCccCccCHHHhccCCCChhHhHHH--------
Confidence 99999999999999999999999999866443211 1112345789999999998889999999999
Q ss_pred ccCCccHHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 744 FNEGHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 744 ~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
+|++++++++ +..|+..... +... ........ ....+..+++.+.+++.+||..||++|||+.|+++.|+
T Consensus 260 --lG~il~el~t~g~~p~~~~~~-~~~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 260 --YGILLWEIFSLGVNPYPGIPV-DANF-YKLIQNGF-----KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp --HHHHHHHHTTTSCCSSTTCCC-SHHH-HHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHHHHHHHcCCCCCcccCCc-HHHH-HHHHhcCC-----CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 7777888886 7767642211 1111 11111110 00112234567899999999999999999999999999
Q ss_pred Hhhhhhh
Q 040925 823 HTRETFL 829 (833)
Q Consensus 823 ~i~~~~~ 829 (833)
.+.+...
T Consensus 331 ~~~~~~~ 337 (344)
T 1rjb_A 331 CQLADAE 337 (344)
T ss_dssp HHC----
T ss_pred HHHHHHH
Confidence 9876544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.11 Aligned_cols=248 Identities=26% Similarity=0.312 Sum_probs=192.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHH-HhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEA-LRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|+++.+++.||||+++... ......+.+|..+ ++.++||||+++++++...+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~---- 112 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD---- 112 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS----
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC----
Confidence 457999999999999999999999999999999997543 2233456677776 56789999999999976654
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..|+||||+++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.+|.+||+|
T Consensus 113 -~~~lv~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~D 182 (373)
T 2r5t_A 113 -KLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTD 182 (373)
T ss_dssp -EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECC
T ss_pred -EEEEEEeCCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEee
Confidence 8999999999999999998654 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++...... ......+||+.|+|||++.+..++.++|||| .|+++|+++++..|+.....
T Consensus 183 FG~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 183 FGLCKENIEHN--------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWC----------LGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp CCBCGGGBCCC--------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSSCTTCCSBH
T ss_pred CccccccccCC--------CccccccCCccccCHHHhCCCCCCchhhhHH----------HHHHHHHHHcCCCCCCCCCH
Confidence 99998533211 1223467999999999999999999999999 88899999999988753221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVV 818 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil 818 (833)
............ ..+..++..+.+++.+||+.||++||++.+.+
T Consensus 245 --~~~~~~i~~~~~-------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 245 --AEMYDNILNKPL-------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp --HHHHHHHHHSCC-------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred --HHHHHHHHhccc-------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 111111111111 01123456788999999999999999986433
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.76 Aligned_cols=259 Identities=21% Similarity=0.355 Sum_probs=199.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceE----EEEEEeecc-CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMI----VAVKVINLK-YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
++|++.+.||+|+||.||+|++..+++. ||+|.++.. .....+.+.+|+.++++++||||+++++++...
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----- 89 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 89 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-----
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-----
Confidence 5799999999999999999999877765 467766533 234457899999999999999999999998653
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~D 160 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 160 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred -CceEEEEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEcc
Confidence 37899999999999999987542 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||+++......... ......||+.|+|||++.+..++.++|||| +|++++++++ +..|+....
T Consensus 161 fG~a~~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ell~~g~~p~~~~~ 224 (327)
T 3lzb_A 161 FGLAKLLGAEEKEY------HAEGGKVPIKWMALESILHRIYTHQSDVWS----------YGVTVWELMTFGSKPYDGIP 224 (327)
T ss_dssp TTC----------------------CCCGGGSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTCC
T ss_pred CcceeEccCccccc------cccCCCccccccCHHHHcCCCCChHHHHHH----------HHHHHHHHHHCCCCCCCCCC
Confidence 99998765432211 112235788999999999999999999999 7888888888 777765322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.. .......... ....+..++..+.+++.+||+.||++|||++|+++.|+++.+.
T Consensus 225 ~~---~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 225 AS---EISSILEKGE-----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp GG---GHHHHHHTTC-----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HH---HHHHHHHcCC-----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11 1111111110 0111223456788999999999999999999999999998753
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=334.32 Aligned_cols=275 Identities=24% Similarity=0.332 Sum_probs=203.5
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc--CCCccceEeeEeecCCCCC
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI--RHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~ 604 (833)
....++|++.+.||+|+||.||+|++. ++.||||++... ......+|.+++... +||||+++++++.... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~ 106 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GS 106 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CC
Confidence 344578999999999999999999985 889999998633 234455666666655 8999999999986652 22
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCceeeCCCCCCeeecCCC
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC-----QPPMVHGDLKPSNVLLDHDM 679 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~ 679 (833)
....++||||+++|+|.+++... .+++..++.++.|++.||+|||+.. .++|+||||||+||+++.++
T Consensus 107 ~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 107 WTQLYLITDYHENGSLYDYLKST-------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GCEEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCceEEEEeccCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 24789999999999999999754 5899999999999999999999752 34899999999999999999
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcc------cccccCCcCCCccccCCccHHHH
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMT------GDIFTGRRPIDAVFNEGHSLHEF 753 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~------~Di~s~~~~~~~~~~~g~~l~~~ 753 (833)
.+||+|||+|+.......... .......||+.|+|||++.+..++.+ +|||| +|++++++
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diws----------lG~il~el 245 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVD----IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS----------FGLILWEV 245 (337)
T ss_dssp CEEECCCTTCEECC-------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHH----------HHHHHHHH
T ss_pred CEEEEeCCCceeecccccccc----CCCCCCccCcceeChhhcccccCCccccCccccchHH----------HHHHHHHH
Confidence 999999999976654322111 11123469999999999887766655 89999 78888899
Q ss_pred HHHhCC----------Ccccccccccc--hhhh-ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 754 AKTALP----------EKVMEIVDPSL--LMEV-MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 754 ~~~~~p----------~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+++..+ +......++.. .... ................++++.+.+++.+||+.||++|||+.|+++.
T Consensus 246 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 888443 32111111110 0000 0011111111222344788899999999999999999999999999
Q ss_pred HHHhhhhh
Q 040925 821 LCHTRETF 828 (833)
Q Consensus 821 L~~i~~~~ 828 (833)
|+.+.+..
T Consensus 326 L~~l~~~~ 333 (337)
T 3mdy_A 326 LAKMSESQ 333 (337)
T ss_dssp HHHHHHTT
T ss_pred HHHHHhhc
Confidence 99998764
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=333.98 Aligned_cols=265 Identities=20% Similarity=0.223 Sum_probs=201.2
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
...++|++.+.||+|+||.||+|++..+++.||+|+++..... ..+.+.+|+.++++++||||+++++++...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~--- 107 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG--- 107 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT---
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC---
Confidence 3457899999999999999999999989999999999754222 2367899999999999999999999976654
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 108 --~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~ 176 (309)
T 2h34_A 108 --QLYVDMRLINGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLV 176 (309)
T ss_dssp --EEEEEEECCCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred --eEEEEEEecCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEe
Confidence 8999999999999999998654 689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||++......... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+....
T Consensus 177 Dfg~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 177 DFGIASATTDEKLT-------QLGNTVGTLYYMAPERFSESHATYRADIYA----------LTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp SCCC-----------------------CCGGGCCGGGTCC----CCCHHHH----------HHHHHHHHHHSSCSSCSCH
T ss_pred cCccCccccccccc-------cccccCCCcCccCHHHHcCCCCCchHhHHH----------HHHHHHHHHHCCCCCCCch
Confidence 99999865443211 112346999999999999999999999999 8889999999998876322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-CHHHHHHHHHHhhhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-DMRDVVAKLCHTRETFL 829 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~i~~~~~ 829 (833)
.. ........... ........++..+.+++.+||..||++|| |++++++.|+...+...
T Consensus 240 ~~---~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 240 LS---VMGAHINQAIP---RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp HH---HHHHHHHSCCC---CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred HH---HHHHHhccCCC---CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 11 11111111110 01112234566788999999999999999 99999999998866543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=329.48 Aligned_cols=253 Identities=20% Similarity=0.258 Sum_probs=203.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+.+|++++++++||||+++++++.... .
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-----F 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----E
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCC-----E
Confidence 4689999999999999999999999999999999975432 23467889999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc---EEEc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV---AHVC 684 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~ 684 (833)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~ 150 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLA 150 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEe
Confidence 899999999999999887654 689999999999999999999999 9999999999999986654 9999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||++........ .....||+.|+|||++.+..++.++|||| .|+++++++++..|+....
T Consensus 151 Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~pf~~~~ 211 (284)
T 3kk8_A 151 DFGLAIEVNDSEA---------WHGFAGTPGYLSPEVLKKDPYSKPVDIWA----------CGVILYILLVGYPPFWDED 211 (284)
T ss_dssp CCTTCEECCSSCB---------CCCSCSCGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCSSCCSS
T ss_pred eceeeEEcccCcc---------ccCCCCCcCCcCchhhcCCCCCcccchHH----------HHHHHHHHHHCCCCCCCCc
Confidence 9999976544221 12356999999999999999999999999 8888999999998875322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. ............. .......+++.+.+++.+||+.||++|||++|+++.
T Consensus 212 ~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 212 QH--RLYAQIKAGAYDY---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp HH--HHHHHHHHTCCCC---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hh--HHHHHHHhccccC---CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 11 1111111111000 011112345678899999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=329.59 Aligned_cols=255 Identities=21% Similarity=0.314 Sum_probs=203.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|++. ++.||||+++.... ...+.+.+|+.++++++||||+++++++.... ...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 457999999999999999999984 88899999975432 23467899999999999999999999986542 347
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceeeCCCCCCeeecCCCcEEEcc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP--MVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
.++||||+++|+|.+++...... .+++.+++.++.|++.||+|||+. + |+||||||+||+++.++.++|+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~ 156 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNF----VVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISM 156 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSC----CCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEG
T ss_pred eEeeecccCCCcHHHHHhhcccC----CCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEe
Confidence 89999999999999999875432 589999999999999999999998 8 99999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCc---ccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASM---TGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
||++...... ...||+.|+|||++.+..++. ++|||| +|+++++++++..|+..
T Consensus 157 ~~~~~~~~~~-------------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~s----------lG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 157 ADVKFSFQSP-------------GRMYAPAWVAPEALQKKPEDTNRRSADMWS----------FAVLLWELVTREVPFAD 213 (271)
T ss_dssp GGSCCTTSCT-------------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHH----------HHHHHHHHHHCSCTTTT
T ss_pred ccceeeeccc-------------CccCCccccChhhhccCCCCCCCchhhHHH----------HHHHHHHHHhCCCCccc
Confidence 9987643221 235899999999988765554 799999 88899999999888753
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
....+ .......... ....+..+++.+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 214 ~~~~~--~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 214 LSNME--IGMKVALEGL-----RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp SCHHH--HHHHHHHSCC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cChHH--HHHHHHhcCC-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 22111 1011110100 011123356678999999999999999999999999998865
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=349.03 Aligned_cols=260 Identities=18% Similarity=0.231 Sum_probs=196.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC-CCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDF-KGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.+++.++||||+++++++..... +...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 46899999999999999999999999999999999754 22335678899999999999999999999865432 3345
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||+++ ++.+.+.. .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF 208 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 208 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence 78999999976 57777643 488999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+|+...... .....+||+.|+|||++.+..++.++|||| .|+++++++++..|+...+..
T Consensus 209 G~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lG~il~ell~g~~pF~g~~~~ 269 (464)
T 3ttj_A 209 GLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWS----------VGCIMGEMVRHKILFPGRDYI 269 (464)
T ss_dssp CCC-----CC---------CC----CCCTTCCHHHHTTCCCCTTHHHHH----------HHHHHHHHHHSSCSSCCSSHH
T ss_pred EeeeecCCCc---------ccCCCcccccccCHHHHcCCCCCHHHHHHH----------HHHHHHHHHhCCCCCCCCCHH
Confidence 9998654321 122357999999999999999999999999 788888888888876522211
Q ss_pred cc-------------cchh-------hhcccc-----ch--------hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC
Q 040925 767 DP-------------SLLM-------EVMTNN-----SM--------IQEDKRVKTEECLNAIIRTGVLCSMESPFERMD 813 (833)
Q Consensus 767 ~~-------------~~~~-------~~~~~~-----~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 813 (833)
+. .... ...... .. ..+..........+.+.+++.+||..||++|||
T Consensus 270 ~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t 349 (464)
T 3ttj_A 270 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349 (464)
T ss_dssp HHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC
Confidence 00 0000 000000 00 000001111223667899999999999999999
Q ss_pred HHHHHHH
Q 040925 814 MRDVVAK 820 (833)
Q Consensus 814 ~~eil~~ 820 (833)
++|+++.
T Consensus 350 a~e~L~H 356 (464)
T 3ttj_A 350 VDDALQH 356 (464)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.03 Aligned_cols=270 Identities=21% Similarity=0.234 Sum_probs=204.4
Q ss_pred HHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc-----CCcchhHHHHHHHHHhhcCCCccceEeeEee
Q 040925 524 AELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK-----YKGASRSFVAECEALRNIRHRNLIKIITICS 598 (833)
Q Consensus 524 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 598 (833)
+++....++|++.+.||+|+||.||+|++..+++.||+|+++.. .....+.+.+|++++++++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 34556677899999999999999999999999999999998643 2344578999999999999999999999976
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCc----------------------------------cccccCCHHHHHHH
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ----------------------------------VEVCKLSLIQRVNI 644 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------------------------~~~~~l~~~~~~~i 644 (833)
..+ ..++||||+++|+|.+++...... .....+++..++.+
T Consensus 99 ~~~-----~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 173 (345)
T 3hko_A 99 DEQ-----YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173 (345)
T ss_dssp CSS-----EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred cCC-----eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence 654 899999999999999999631100 00113467888999
Q ss_pred HHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC--cEEEcccccccccCcccccccccCCCccccccccccccCcccc
Q 040925 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM--VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYG 722 (833)
Q Consensus 645 ~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 722 (833)
+.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+++.+....... ........||+.|+|||++
T Consensus 174 ~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~ 246 (345)
T 3hko_A 174 MRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE----YYGMTTKAGTPYFVAPEVL 246 (345)
T ss_dssp HHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------------CCCGGGCCHHHH
T ss_pred HHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccc----cccccccCCCccccCchhh
Confidence 99999999999999 999999999999998776 89999999998654322111 1112235699999999998
Q ss_pred CC--CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHh
Q 040925 723 MG--SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTG 800 (833)
Q Consensus 723 ~~--~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 800 (833)
.+ ..++.++|||| +|+++++++++..|+...... ............. .......+++.+.+++
T Consensus 247 ~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~li 311 (345)
T 3hko_A 247 NTTNESYGPKCDAWS----------AGVLLHLLLMGAVPFPGVNDA--DTISQVLNKKLCF---ENPNYNVLSPLARDLL 311 (345)
T ss_dssp TCSSSCCCTHHHHHH----------HHHHHHHHHHSSCSSCCSSHH--HHHHHHHHCCCCT---TSGGGGGSCHHHHHHH
T ss_pred ccCCCCCCcHHHHHH----------HHHHHHHHHHCCCCCCCCChH--HHHHHHHhccccc---CCcccccCCHHHHHHH
Confidence 65 67899999999 888999999999987532211 1111111111100 1111223456788999
Q ss_pred hccCCCCCCCCCCHHHHHHH
Q 040925 801 VLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 801 ~~cl~~dP~~RPt~~eil~~ 820 (833)
.+||+.||++|||+.|+++.
T Consensus 312 ~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 312 SNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHSCSCTTTSCCHHHHHHS
T ss_pred HHHcCCChhHCCCHHHHhcC
Confidence 99999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=344.82 Aligned_cols=209 Identities=26% Similarity=0.342 Sum_probs=179.0
Q ss_pred CCccchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-----CCccce
Q 040925 518 FPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-----HRNLIK 592 (833)
Q Consensus 518 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 592 (833)
...+++.+.....++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+..|+++++.++ ||||++
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 34556666666678999999999999999999999989999999999632 233466788999999996 999999
Q ss_pred EeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCC
Q 040925 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSN 672 (833)
Q Consensus 593 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~N 672 (833)
+++++...+ ..++||||+ +++|.+++...... .+++.+++.++.|++.||+|||+. +|+||||||+|
T Consensus 101 ~~~~~~~~~-----~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~N 167 (360)
T 3llt_A 101 YHGKFMYYD-----HMCLIFEPL-GPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPEN 167 (360)
T ss_dssp EEEEEEETT-----EEEEEECCC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred ccceeeECC-----eeEEEEcCC-CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCccc
Confidence 999987655 899999999 88999999876532 589999999999999999999999 99999999999
Q ss_pred eeecC-------------------------CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCC
Q 040925 673 VLLDH-------------------------DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA 727 (833)
Q Consensus 673 Ill~~-------------------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 727 (833)
|+++. ++.+||+|||+|+...... ....||+.|+|||++.+..+
T Consensus 168 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~ 236 (360)
T 3llt_A 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----------GSIINTRQYRAPEVILNLGW 236 (360)
T ss_dssp EEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----------CSCCSCGGGCCHHHHTTCCC
T ss_pred EEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----------cCccCcccccCcHHHcCCCC
Confidence 99975 7899999999998643321 13469999999999999999
Q ss_pred CcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 728 SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 728 ~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
+.++|||| .|+++++++++..|+.
T Consensus 237 ~~~~Diws----------lG~il~ell~g~~pf~ 260 (360)
T 3llt_A 237 DVSSDMWS----------FGCVLAELYTGSLLFR 260 (360)
T ss_dssp CTTHHHHH----------HHHHHHHHHHSSCSCC
T ss_pred CCccchHH----------HHHHHHHHHHCCCCCC
Confidence 99999999 7888888888888865
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=354.99 Aligned_cols=250 Identities=23% Similarity=0.254 Sum_probs=195.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++.. .......+.+|+++++.++||||+++++++...+
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD----- 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT-----
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC-----
Confidence 46799999999999999999999999999999999743 2334456788999999999999999999987655
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ . ||+||||||+||+++.++.+||+|
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~D 292 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRER------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITD 292 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECC
T ss_pred EEEEEEeeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEcc
Confidence 8999999999999999997654 68999999999999999999998 8 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+|+....... .....+||+.|+|||++.+..++.++|||| +|+++++++++..|+.....
T Consensus 293 FG~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 293 FGLCKEGIKDGA--------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWG----------LGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp CCCCCTTCC-------------CCSSSCGGGCCHHHHHTSCCCTHHHHHH----------HHHHHHHHHHSSCSSCCSSH
T ss_pred CCCceeccCCCc--------ccccccCCccccCHhhcCCCCCCCccchhh----------hHHHHHHHhhCCCCCCCCCH
Confidence 999985433211 122357999999999999999999999999 88899999999998753221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
. ........... ..+..+++.+.+++.+||+.||++|| |++|+++.
T Consensus 355 ~--~~~~~i~~~~~-------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 355 E--KLFELILMEEI-------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp H--HHHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred H--HHHHHHHhCCC-------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1 11111111111 11223456788999999999999999 99999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=330.88 Aligned_cols=267 Identities=23% Similarity=0.372 Sum_probs=208.1
Q ss_pred CCccCceeccCcceEEEEEEECCCc---eEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDE---MIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.|.+.+.||+|+||.||+|++..++ ..||+|.++.... ...+.+.+|+.++++++||||+++++++...+ ..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----GL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----SC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----CC
Confidence 4666799999999999999975443 4799999864332 23467899999999999999999999985443 34
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+.+|+|.+++..... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg 169 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQR-----NPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFG 169 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTT
T ss_pred cEEEEecccCCCHHHHHhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCC
Confidence 5899999999999999987432 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+++......... ........||+.|+|||.+.+..++.++|||| +|+++++++++..|+.... +
T Consensus 170 ~~~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~~~~~~~--~ 233 (298)
T 3pls_A 170 LARDILDREYYS----VQQHRHARLPVKWTALESLQTYRFTTKSDVWS----------FGVLLWELLTRGAPPYRHI--D 233 (298)
T ss_dssp SSCTTTTGGGGC----SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHTSCCTTTTS--C
T ss_pred CcccccCCcccc----cccCcCCCCCccccChhhhccCCCChhhchhh----------HHHHHHHHhhCCCCCCccC--C
Confidence 998765433211 11223356899999999999999999999999 7888899988655543111 1
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhcC
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLGR 831 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~~ 831 (833)
+........... ....+..+++.+.+++.+||+.||++|||++++++.|+++.+.+.+.
T Consensus 234 ~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 234 PFDLTHFLAQGR-----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp GGGHHHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred HHHHHHHhhcCC-----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 111111111110 01112234567899999999999999999999999999999887654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=336.71 Aligned_cols=250 Identities=20% Similarity=0.237 Sum_probs=193.0
Q ss_pred hcCCccCceeccCcceEEEEEEEC---CCceEEEEEEeeccC----CcchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKY----KGASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
.++|++.+.||+|+||.||+|++. .+++.||+|+++... ......+.+|++++++++||||+++++++...+
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~- 94 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG- 94 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS-
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC-
Confidence 468999999999999999999984 589999999997542 223456788999999999999999999976654
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
..|+||||+++|+|.+++.... .+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+|
T Consensus 95 ----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~k 161 (327)
T 3a62_A 95 ----KLYLILEYLSGGELFMQLEREG------IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVK 161 (327)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEE
T ss_pred ----EEEEEEeCCCCCcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEE
Confidence 8999999999999999997654 689999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
|+|||+++....... ......||+.|+|||++.+..++.++|||| .|+++++++++..|+..
T Consensus 162 l~Dfg~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 162 LTDFGLCKESIHDGT--------VTHTFCGTIEYMAPEILMRSGHNRAVDWWS----------LGALMYDMLTGAPPFTG 223 (327)
T ss_dssp ECCCSCC------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHH----------HHHHHHHHHHSSCSCCC
T ss_pred EEeCCcccccccCCc--------cccccCCCcCccCHhhCcCCCCCCcccchh----------HHHHHHHHHHCCCCCCC
Confidence 999999975433211 122356999999999999999999999999 88899999999988753
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
.... ........... ..+..+++.+.+++.+||..||++|| +++|+++.
T Consensus 224 ~~~~--~~~~~i~~~~~-------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 224 ENRK--KTIDKILKCKL-------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp SSHH--HHHHHHHHTCC-------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred CCHH--HHHHHHHhCCC-------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 2211 11111111111 11123456788999999999999999 77788764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=327.99 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=184.0
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 84 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN---- 84 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS----
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC----
Confidence 3468999999999999999999998899999999996432 223467899999999999999999999976554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 85 -~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~d 155 (278)
T 3cok_A 85 -YVYLVLEMCHNGEMNRYLKNRVK-----PFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIAD 155 (278)
T ss_dssp -EEEEEEECCTTEEHHHHHHTCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECC
T ss_pred -eEEEEEecCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEe
Confidence 89999999999999999986532 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||++........ ......||+.|+|||++.+..++.++|||| .|+++++++++..|+.....
T Consensus 156 fg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 156 FGLATQLKMPHE--------KHYTLCGTPNYISPEIATRSAHGLESDVWS----------LGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp CTTCEECC------------------------------------CTHHHH----------HHHHHHHHHHSSCSSCCCSC
T ss_pred ecceeeccCCCC--------cceeccCCCCcCCcchhcCCCCCchhhHHH----------HHHHHHHHHhCCCCCCChhH
Confidence 999986543221 112246999999999999988999999999 88899999999988763221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+ .......... ..+..++..+.+++.+||+.||++|||++|+++.
T Consensus 218 ~~--~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 218 KN--TLNKVVLADY-------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp C-------CCSSCC-------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HH--HHHHHhhccc-------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 11 0000010100 0112245678899999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.66 Aligned_cols=264 Identities=19% Similarity=0.205 Sum_probs=206.2
Q ss_pred chHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEee
Q 040925 522 SYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICS 598 (833)
Q Consensus 522 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 598 (833)
...+.....++|++.+.||+|+||.||+|+++.+++.||||+++... ....+.+.+|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34555566789999999999999999999999999999999996431 223456889999999999999999999976
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
+.+ ..|+||||+++|+|.+++...+. .+++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 132 ~~~-----~~~lVmE~~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~ 198 (412)
T 2vd5_A 132 DEN-----YLYLVMEYYVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRC 198 (412)
T ss_dssp CSS-----EEEEEECCCCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred eCC-----EEEEEEcCCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCC
Confidence 654 89999999999999999976432 689999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccC-------CCCCCcccccccCCcCCCccccCCccHH
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-------GSEASMTGDIFTGRRPIDAVFNEGHSLH 751 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~s~~~~~~~~~~~g~~l~ 751 (833)
+.+||+|||+|+........ .....+||+.|+|||++. +..++.++|||| .|+++|
T Consensus 199 g~vkL~DFGla~~~~~~~~~-------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwS----------lGvily 261 (412)
T 2vd5_A 199 GHIRLADFGSCLKLRADGTV-------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWA----------LGVFAY 261 (412)
T ss_dssp SCEEECCCTTCEECCTTSCE-------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHH----------HHHHHH
T ss_pred CCEEEeechhheeccCCCcc-------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhH----------HhHHHH
Confidence 99999999999876443211 112357999999999987 457899999999 889999
Q ss_pred HHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCC---CCHHHHHHH
Q 040925 752 EFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFER---MDMRDVVAK 820 (833)
Q Consensus 752 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~eil~~ 820 (833)
+++++..|+...... ............. ........+++.+.+++.+||. +|++| |+++|++++
T Consensus 262 elltG~~Pf~~~~~~--~~~~~i~~~~~~~--~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 262 EMFYGQTPFYADSTA--ETYGKIVHYKEHL--SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHHSSCTTCCSSHH--HHHHHHHTHHHHC--CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHHhCCCCCCCCCHH--HHHHHHHhcccCc--CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 999999987532211 1111111100000 0000112356778999999999 99998 589998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.37 Aligned_cols=260 Identities=20% Similarity=0.347 Sum_probs=202.9
Q ss_pred HhcCCccCceeccCcceEEEEEEECC---CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGE---DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
..++|++.+.||+|+||.||+|++.. ++..||+|.++.... ...+.+.+|++++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence 34689999999999999999998643 455799999975422 3456789999999999999999999996433
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 86 --~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~ 155 (281)
T 3cc6_A 86 --PTWIIMELYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLG 155 (281)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEEC
T ss_pred --CCEEEEecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeC
Confidence 45899999999999999976432 589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~ 763 (833)
|||++.......... .....+|+.|+|||++.+..++.++|||| +|++++++++ +..|+...
T Consensus 156 Dfg~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 156 DFGLSRYIEDEDYYK-------ASVTRLPIKWMSPESINFRRFTTASDVWM----------FAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp CCCGGGCC----------------CCCCCGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTTCCTTTTS
T ss_pred ccCCCcccccccccc-------cccCCCCcceeCchhhccCCCCchhccHH----------HHHHHHHHHhCCCCCcccC
Confidence 999998765432111 12235789999999998888999999999 7888888887 77776522
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
...+ ......... ....+..+++.+.+++.+||..||++|||+.|+++.|+.+.+.
T Consensus 219 ~~~~--~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 219 ENKD--VIGVLEKGD------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp CGGG--HHHHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ChHH--HHHHHhcCC------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 2111 111110000 0111223456789999999999999999999999999998764
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=336.61 Aligned_cols=269 Identities=21% Similarity=0.357 Sum_probs=210.1
Q ss_pred HhcCCccCceeccCcceEEEEEEE-----CCCceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSSTD 601 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 601 (833)
..++|++.+.||+|+||.||+|++ ..+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346899999999999999999985 45788999999975433 2346789999999999 8999999999976554
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCc------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCC
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQ------------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLK 669 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlk 669 (833)
..++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||+. +|+|||||
T Consensus 101 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlk 172 (313)
T 1t46_A 101 -----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (313)
T ss_dssp -----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred -----CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCc
Confidence 789999999999999999865421 0112489999999999999999999999 99999999
Q ss_pred CCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCcc
Q 040925 670 PSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHS 749 (833)
Q Consensus 670 p~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~ 749 (833)
|+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||| +|++
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~i 236 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYV------VKGNARLPVKWMAPESIFNCVYTFESDVWS----------YGIF 236 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSE------ECSSSEECGGGCCHHHHHHCCCCHHHHHHH----------HHHH
T ss_pred cceEEEcCCCCEEEccccccccccccccce------eccCCCCcceeeChHHhcCCCCChHHHHHH----------HHHH
Confidence 999999999999999999998765432111 112245788999999998889999999999 7888
Q ss_pred HHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 750 LHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 750 l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
++++++ +..|+...... ... ........ ....+..++..+.+++.+||..||++|||++|+++.|+++.+..
T Consensus 237 l~ellt~g~~p~~~~~~~-~~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVD-SKF-YKMIKEGF-----RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHTTTCCSSTTCCSS-HHH-HHHHHHTC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCCCCCCcccch-hHH-HHHhccCC-----CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 888887 77776532211 111 11110000 01112234567899999999999999999999999999987653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.36 Aligned_cols=245 Identities=22% Similarity=0.218 Sum_probs=191.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.++||+|+||+||+|++..+++.||||++...... .......|+..+.++ +||||+++++++.... .
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~-----~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG-----I 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC-----E
Confidence 5799999999999999999999999999999998644322 233455666666666 8999999999986655 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+ +|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG 202 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFG 202 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCT
T ss_pred EEEEEecc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccce
Confidence 99999999 6799998876542 599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++........ .....||+.|+|||++.+ .++.++|||| +|+++++++++..++...+..+
T Consensus 203 ~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~-~~~~~~Diws----------lG~il~el~~g~~~~~~~~~~~ 262 (311)
T 3p1a_A 203 LLVELGTAGA---------GEVQEGDPRYMAPELLQG-SYGTAADVFS----------LGLTILEVACNMELPHGGEGWQ 262 (311)
T ss_dssp TCEECC---------------CCCCCGGGCCGGGGGT-CCSTHHHHHH----------HHHHHHHHHHTCCCCSSHHHHH
T ss_pred eeeecccCCC---------CcccCCCccccCHhHhcC-CCCchhhHHH----------HHHHHHHHHhCCCCCCCccHHH
Confidence 9986644321 122459999999999876 7999999999 8888899988855443211110
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
....... .......+++.+.+++.+||+.||++|||++|+++
T Consensus 263 -----~~~~~~~-----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 263 -----QLRQGYL-----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -----HHTTTCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----HHhccCC-----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0000000 01112234667899999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=331.77 Aligned_cols=258 Identities=19% Similarity=0.316 Sum_probs=202.4
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC------
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDF------ 602 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 602 (833)
..++|++.+.||+|+||.||+|++..+++.||+|+++... +.+.+|++++++++||||+++++++....+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457999999999999999999999899999999997432 467889999999999999999998754211
Q ss_pred -----CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC
Q 040925 603 -----KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH 677 (833)
Q Consensus 603 -----~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 677 (833)
......++||||+++|+|.+++...... .+++..++.++.|++.||.|||+. +|+||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE----KLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVD 157 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcC
Confidence 1234689999999999999999764322 689999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHh
Q 040925 678 DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTA 757 (833)
Q Consensus 678 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~ 757 (833)
++.+||+|||++........ .....||+.|+|||++.+..++.++|||| +|+++++++++.
T Consensus 158 ~~~~kl~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~~~ 218 (284)
T 2a19_B 158 TKQVKIGDFGLVTSLKNDGK---------RTRSKGTLRYMSPEQISSQDYGKEVDLYA----------LGLILAELLHVC 218 (284)
T ss_dssp TTEEEECCCTTCEESSCCSC---------CCCCCSCCTTSCHHHHHCSCCCTHHHHHH----------HHHHHHHHHSCC
T ss_pred CCCEEECcchhheecccccc---------ccccCCcccccChhhhccCCCcchhhhHH----------HHHHHHHHHhcC
Confidence 99999999999987654321 12245999999999999999999999999 566666666655
Q ss_pred CCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 758 LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 758 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
.|+..... ........ .....++..+.+++.+||..||++|||+.|+++.+..+.....
T Consensus 219 ~~~~~~~~----~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 219 DTAFETSK----FFTDLRDG---------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp SSHHHHHH----HHHHHHTT---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred CcchhHHH----HHHHhhcc---------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 44321110 00000000 0111234567899999999999999999999999998876543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=350.35 Aligned_cols=205 Identities=23% Similarity=0.370 Sum_probs=157.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++.....+.....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 689999999999999999999999999999999964322 234678999999999999999999999876655566689
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
|+||||+. |+|.+++.... .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 133 ~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEECCCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccc-cchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence 99999985 69999997654 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccc-------------------cCCCccccccccccccCcccc-CCCCCCcccccccCCcCCCccccCCc
Q 040925 689 AKFLSDHQLDTAV-------------------KTPSSSIGLKGTVGYVAPEYG-MGSEASMTGDIFTGRRPIDAVFNEGH 748 (833)
Q Consensus 689 a~~~~~~~~~~~~-------------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~s~~~~~~~~~~~g~ 748 (833)
|+........... .........+||+.|+|||++ .+..++.++|||| .|+
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwS----------lG~ 272 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWS----------IGC 272 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHH----------HHH
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHH----------HHH
Confidence 9876532211000 000123456799999999975 5667999999999 566
Q ss_pred cHHHHHH
Q 040925 749 SLHEFAK 755 (833)
Q Consensus 749 ~l~~~~~ 755 (833)
+++++++
T Consensus 273 il~ellt 279 (458)
T 3rp9_A 273 IFAELLN 279 (458)
T ss_dssp HHHHHHT
T ss_pred HHHHHHH
Confidence 6666665
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.51 Aligned_cols=262 Identities=24% Similarity=0.423 Sum_probs=207.4
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
..++|++.+.||+|+||.||+|.+. ++..||||+++... ...+.+.+|++++++++||||+++++++... ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~ 82 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PI 82 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SC
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcCC------Cc
Confidence 4468999999999999999999986 67789999997443 3457899999999999999999999987432 47
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 155 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGL 155 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcc
Confidence 899999999999999976431 2589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~ 767 (833)
+.......... .....+|+.|+|||++.+..++.++|||| +|++++++++ +..|+.....
T Consensus 156 ~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~el~~~g~~p~~~~~~-- 216 (279)
T 1qpc_A 156 ARLIEDNEYTA-------REGAKFPIKWTAPEAINYGTFTIKSDVWS----------FGILLTEIVTHGRIPYPGMTN-- 216 (279)
T ss_dssp CEECSSSCEEC-------CTTCCCCTTTSCHHHHHHCEECHHHHHHH----------HHHHHHHHHTTTCCSSTTCCH--
T ss_pred cccccCccccc-------ccCCCCccCccChhhhccCCCCchhhhHH----------HHHHHHHHHhCCCCCCcccCH--
Confidence 98765432211 11235788999999998888999999999 7888888887 7777642111
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
........... ....+..+++.+.+++.+||..||++|||++++++.|+++.....+
T Consensus 217 ~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 217 PEVIQNLERGY------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp HHHHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred HHHHHHHhccc------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 11111111100 0111223456789999999999999999999999999999876544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=333.91 Aligned_cols=259 Identities=21% Similarity=0.307 Sum_probs=196.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++.... .
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR-----R 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC-----e
Confidence 36899999999999999999999989999999998644322 2456889999999999999999999976654 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 147 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQR------GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFG 147 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEeCCCchHHHHHhhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCC
Confidence 999999999999999887654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
++........ ......||+.|+|||++.+ ..++.++|||| .|+++++++++..|+......
T Consensus 148 ~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~~ 209 (311)
T 4agu_A 148 FARLLTGPSD--------YYDDEVATRWYRSPELLVGDTQYGPPVDVWA----------IGCVFAELLSGVPLWPGKSDV 209 (311)
T ss_dssp TCEECC--------------------GGGCCHHHHHTCSCCCTHHHHHH----------HHHHHHHHHHSSCSCCCSSHH
T ss_pred CchhccCccc--------ccCCCcCCccccChHHHhcCCCCCcchhhHH----------HHHHHHHHHhCCCCCCCCCHH
Confidence 9987653221 1123468999999999876 66899999999 788888999988876522211
Q ss_pred cccchh-hhcc-----------------ccchhh----hhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLM-EVMT-----------------NNSMIQ----EDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~-~~~~-----------------~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+..... .... ...... .........++..+.+++.+||+.||++|||++|+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 210 DQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 110000 0000 000000 00001112345678899999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=337.52 Aligned_cols=272 Identities=23% Similarity=0.336 Sum_probs=207.9
Q ss_pred CC-ccCceeccCcceEEEEEEE----CCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 532 EF-SSSNMIGQGSFGYVYKGTL----GEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 532 ~y-~~~~~lg~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
+| ++.+.||+|+||.||+|.+ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++...+ .
T Consensus 31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 107 (318)
T 3lxp_A 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG---A 107 (318)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT---T
T ss_pred HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC---C
Confidence 45 9999999999999988765 34789999999975432 23467899999999999999999999987542 3
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
...++||||+++|+|.+++... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~D 177 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-------SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGD 177 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred ceEEEEEecccCCcHHHHHhhC-------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECC
Confidence 4789999999999999999764 489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++......... .......||+.|+|||++.+..++.++|||| .|+++++++++..|+.....
T Consensus 178 fg~a~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~ll~g~~p~~~~~~ 242 (318)
T 3lxp_A 178 FGLAKAVPEGHEYY-----RVREDGDSPVFWYAPECLKEYKFYYASDVWS----------FGVTLYELLTHCDSSQSPPT 242 (318)
T ss_dssp GGGCEECCTTCSEE-----EC---CCCCGGGCCHHHHHHCEEEHHHHHHH----------HHHHHHHHHTTTCGGGSHHH
T ss_pred cccccccccccccc-----ccccCCCCCceeeChHHhcCCCCCcHHHHHH----------HHHHHHHHHhCCCcccccch
Confidence 99998765432111 1112345889999999999989999999999 77888888888777652211
Q ss_pred ccccch------hhhc-cccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhcC
Q 040925 766 VDPSLL------MEVM-TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLGR 831 (833)
Q Consensus 766 ~~~~~~------~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~~ 831 (833)
...... .... .............+..++..+.+++.+||+.||++|||++|+++.|+.+.+.+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 243 KFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred hhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 000000 0000 00000000011122345678999999999999999999999999999999887653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=340.06 Aligned_cols=253 Identities=23% Similarity=0.264 Sum_probs=199.8
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCce
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 607 (833)
..++|++.+.||+|+||.||+|+++.+++.||||+++.... ...+|++++.++ +||||+++++++.+.. .
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~-----~ 90 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGK-----Y 90 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSS-----E
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCC-----E
Confidence 35679999999999999999999999999999999974432 345788999888 7999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC----CcEEE
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD----MVAHV 683 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kL 683 (833)
.|+||||+++|+|.+++.... .+++.++..++.||+.||+|||+. ||+||||||+||++.++ +.+||
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl 161 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK------FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRI 161 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEE
T ss_pred EEEEEeCCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEE
Confidence 999999999999999998654 689999999999999999999999 99999999999998543 35999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+|||+++....... .....+||+.|+|||++.+..++.++|||| .|+++|+++++..|+...
T Consensus 162 ~Dfg~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 162 CDFGFAKQLRAENG--------LLMTPCYTANFVAPEVLERQGYDAACDIWS----------LGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CCCTTCEECBCTTC--------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHH----------HHHHHHHHHHSSCSSCSS
T ss_pred EECCCcccCcCCCC--------ceeccCCCccccCHHHhcCCCCCCccCeee----------HhHHHHHHhcCCCCCCCC
Confidence 99999986543221 122356999999999998888999999999 888999999999887632
Q ss_pred cccccc-chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPS-LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
...+.. +........... .......+++.+.+++.+||..||++|||+.|+++.
T Consensus 224 ~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 224 PDDTPEEILARIGSGKFSL---SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TTSCHHHHHHHHHHCCCCC---CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CcCCHHHHHHHHccCCccc---CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 211111 111111111100 001112345678899999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=330.17 Aligned_cols=257 Identities=22% Similarity=0.298 Sum_probs=194.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||.||+|++ .+++.||+|+++.... ...+.+.+|++++++++||||+++++++...+ ..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCC-----eE
Confidence 5799999999999999999999 4789999999965432 23467889999999999999999999976554 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++ +|.+++..... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 146 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (288)
T ss_dssp EEEEECCSE-EHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred EEEEEecCC-CHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECcc
Confidence 999999985 99999876532 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
++....... ......||+.|+|||++.+. .++.++|||| .|+++++++++..|+......+
T Consensus 147 ~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~~l~~g~~pf~~~~~~~ 208 (288)
T 1ob3_A 147 ARAFGIPVR--------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS----------VGCIFAEMVNGTPLFPGVSEAD 208 (288)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHH----------HHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccCcccc--------ccccccccccccCchheeCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCHHH
Confidence 986543211 11234689999999998764 5899999999 7888888888887764221100
Q ss_pred ccch-hh------------hc---ccc--c--hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLL-ME------------VM---TNN--S--MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~-~~------------~~---~~~--~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.... .. .. ... . .............++.+.+++.+||+.||++|||++|+++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000 00 00 000 0 00000001112345678899999999999999999999763
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=354.84 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=205.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+|+.||+|+++.. .......+.+|++++++++||||+++++++.+.+
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 257 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD----- 257 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCC-----
Confidence 46799999999999999999999999999999999643 2234466889999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||++||+|.+++...... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~----~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DF 330 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQA----GFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDL 330 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEec
Confidence 899999999999999999875422 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc-
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI- 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~- 765 (833)
|+|+....... ....+||+.|+|||++.+..++.++|||| .|+++|+++++..|+.....
T Consensus 331 Gla~~~~~~~~---------~~~~~GT~~Y~APEvl~~~~~~~~~DiwS----------LGvilyeLltG~~PF~~~~~~ 391 (576)
T 2acx_A 331 GLAVHVPEGQT---------IKGRVGTVGYMAPEVVKNERYTFSPDWWA----------LGCLLYEMIAGQSPFQQRKKK 391 (576)
T ss_dssp TTCEECCTTCC---------EECCCSCGGGCCHHHHTTCEESSHHHHHH----------HHHHHHHHHHSSCSSSCSSSC
T ss_pred ccceecccCcc---------ccccCCCccccCHHHHcCCCCCccchHHH----------HHHHHHHHHhCCCCCcccccc
Confidence 99987643221 12347999999999999999999999999 88999999999999863221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
.........+.. .....+..++..+.+++.+||..||++|| +++|++++
T Consensus 392 ~~~~~i~~~i~~------~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 392 IKREEVERLVKE------VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCHHHHHHHHHH------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred hhHHHHHHHhhc------ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 111111111100 00111233466789999999999999999 78888764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=347.95 Aligned_cols=210 Identities=24% Similarity=0.369 Sum_probs=168.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++....+.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 3589999999999999999999999999999999975422 23467899999999999999999999987665444467
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||++ |+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCC
Confidence 999999996 59999998654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccc--------------cCCCccccccccccccCcccc-CCCCCCcccccccCCcCCCccccCCccHHH
Q 040925 688 LAKFLSDHQLDTAV--------------KTPSSSIGLKGTVGYVAPEYG-MGSEASMTGDIFTGRRPIDAVFNEGHSLHE 752 (833)
Q Consensus 688 ~a~~~~~~~~~~~~--------------~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~ 752 (833)
+|+........... .........+||+.|+|||++ .+..++.++|||| .|+++++
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwS----------lG~il~e 244 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS----------TGCIFAE 244 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHH----------HHHHHHH
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccch----------HHHHHHH
Confidence 99876543211000 000123456899999999985 5667999999999 6667777
Q ss_pred HHHHhCC
Q 040925 753 FAKTALP 759 (833)
Q Consensus 753 ~~~~~~p 759 (833)
++++..|
T Consensus 245 ll~g~~p 251 (432)
T 3n9x_A 245 LLNMLQS 251 (432)
T ss_dssp HHTTCTT
T ss_pred HHhcccc
Confidence 7764433
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.96 Aligned_cols=255 Identities=23% Similarity=0.263 Sum_probs=194.3
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--------CcchhHHHHHHHHHhhcCCCccceEeeEeec
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--------KGASRSFVAECEALRNIRHRNLIKIITICSS 599 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 599 (833)
...++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999999999999999996432 1122458899999999999999999998643
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD- 678 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~- 678 (833)
. ..++||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 212 ~------~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~ 276 (419)
T 3i6u_A 212 E------DYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQE 276 (419)
T ss_dssp S------EEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSS
T ss_pred C------ceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCC
Confidence 2 5789999999999999988654 689999999999999999999999 99999999999999754
Q ss_pred --CcEEEcccccccccCcccccccccCCCccccccccccccCccccCC---CCCCcccccccCCcCCCccccCCccHHHH
Q 040925 679 --MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG---SEASMTGDIFTGRRPIDAVFNEGHSLHEF 753 (833)
Q Consensus 679 --~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~~~~~~~~~~~g~~l~~~ 753 (833)
+.+||+|||+|+....... .....||+.|+|||++.+ ..++.++|||| .|++++++
T Consensus 277 ~~~~~kl~DFG~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diws----------lG~il~~l 337 (419)
T 3i6u_A 277 EDCLIKITDFGHSKILGETSL---------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS----------LGVILFIC 337 (419)
T ss_dssp SSCCEEECCSSTTTSCC--------------------CTTCCTTTTC----CTTHHHHHHHH----------HHHHHHHH
T ss_pred CcceEEEeecccceecCCCcc---------ccccCCCCCccCceeeecCCCCCCCchhhhHh----------HHHHHHHH
Confidence 4599999999987654321 123569999999999753 56889999999 88899999
Q ss_pred HHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 754 AKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 754 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+++..|+...... ............... ......+++.+.+++.+||+.||++|||++|+++.
T Consensus 338 ltg~~pf~~~~~~-~~~~~~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 338 LSGYPPFSEHRTQ-VSLKDQITSGKYNFI---PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHSSCSSCCCSSS-CCHHHHHHTTCCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCCCCcch-HHHHHHHhcCCCCCC---chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 9999987532111 111111111111000 11112346678999999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=331.67 Aligned_cols=252 Identities=22% Similarity=0.244 Sum_probs=201.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|.+.+.||+|+||.||+|++..+++.||+|+++.......+.+.+|++++++++||||+++++++.... ..+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT-----HYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS-----EEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC-----EEE
Confidence 457999999999999999999999899999999998654445567899999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee---cCCCcEEEccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDF 686 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Df 686 (833)
+||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||++ +.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Df 153 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG------VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDF 153 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSC
T ss_pred EEEEcCCCccHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccC
Confidence 9999999999999987654 689999999999999999999999 99999999999999 78889999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++...... .....||+.|+|||++.+..++.++|||| .|+++++++++..|+.....
T Consensus 154 g~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~~- 212 (304)
T 2jam_A 154 GLSKMEQNGI----------MSTACGTPGYVAPEVLAQKPYSKAVDCWS----------IGVITYILLCGYPPFYEETE- 212 (304)
T ss_dssp STTCCCCCBT----------THHHHSCCCBCCTTTBSSCSCCHHHHHHH----------HHHHHHHHHHSSCTTTTSCH-
T ss_pred CcceecCCCc----------cccccCCCCccChHHhccCCCCchhhHHH----------HHHHHHHHHHCCCCCCCCCH-
Confidence 9997543321 12245999999999999999999999999 78889999999888752211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.............. .......+++.+.+++.+||..||++|||++|+++.
T Consensus 213 -~~~~~~i~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 213 -SKLFEKIKEGYYEF---ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -HHHHHHHHHCCCCC---CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHcCCCCC---CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111111110000 011122345678999999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=335.12 Aligned_cols=279 Identities=18% Similarity=0.196 Sum_probs=210.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++..+++.||||++........+.+.+|++++++++||||+++++++.... ......+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeE
Confidence 468999999999999999999998899999999997655556678999999999999999999999986321 2234789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEeCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 999999999999999763211 12689999999999999999999999 9999999999999999999999999998
Q ss_pred cccCcccccccc-cCCCccccccccccccCccccCCCC---CCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 690 KFLSDHQLDTAV-KTPSSSIGLKGTVGYVAPEYGMGSE---ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 690 ~~~~~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
............ ..........||+.|+|||++.+.. ++.++|||| +|+++++++++..|+.....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s----------lG~il~el~~g~~p~~~~~~ 251 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWS----------LGCVLYAMMFGEGPYDMVFQ 251 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHH----------HHHHHHHHHHSSCTTHHHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHH----------HHHHHHHHHhCCCChhhhhc
Confidence 765432110000 0000011245799999999987654 688999999 78889999999888752211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
......... .... .......++..+.+++.+||+.||++|||++|+++.|+.+.....+
T Consensus 252 ~~~~~~~~~-~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 252 KGDSVALAV-QNQL-----SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp TTSCHHHHH-HCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred ccchhhHHh-hccC-----CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 111111111 1110 0111123456789999999999999999999999999998765443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=324.25 Aligned_cols=256 Identities=21% Similarity=0.255 Sum_probs=204.9
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.+++.++||||+++++++.... .
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 79 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----I 79 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----E
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC-----E
Confidence 3568999999999999999999999899999999997443 234577899999999999999999999976654 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 150 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFG 150 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEEecCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCC
Confidence 899999999999999997654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
.+.......... ......||+.|+|||++.+..+ +.++|||| .|+++++++++..|+......
T Consensus 151 ~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~~ 214 (276)
T 2yex_A 151 LATVFRYNNRER------LLNKMCGTLPYVAPELLKRREFHAEPVDVWS----------CGIVLTAMLAGELPWDQPSDS 214 (276)
T ss_dssp TCEECEETTEEC------CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHH----------HHHHHHHHHHSSCCCSCSCTT
T ss_pred CccccCCCcchh------cccCCccccCccChHHHhcCCCCCCcchHHH----------HHHHHHHHHhCCCCCCCCchH
Confidence 998654322111 1123569999999999887765 78899999 888999999999887633211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.... ........ .......++..+.+++.+||+.||++|||++|+++.
T Consensus 215 ~~~~-~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 215 CQEY-SDWKEKKT-----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp SHHH-HHHHTTCT-----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHH-HHhhhccc-----ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 1111 11111100 001112345678899999999999999999999863
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=337.37 Aligned_cols=268 Identities=21% Similarity=0.342 Sum_probs=206.5
Q ss_pred hcCCccCceeccCcceEEEEEEEC-------CCceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLG-------EDEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSST 600 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 600 (833)
.++|++.+.||+|+||.||+|++. .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 468999999999999999999985 3577899999975432 2346789999999999 899999999997654
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCcc----------ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQV----------EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
+ ..++||||+++|+|.+++....... ....+++.+++.++.|++.||+|||+. +|+||||||
T Consensus 114 ~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp 185 (334)
T 2pvf_A 114 G-----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185 (334)
T ss_dssp S-----CCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred C-----ceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCcc
Confidence 4 7899999999999999998754210 112489999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+||+++.++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||| +|+++
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il 249 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYK------KTTNGRLPVKWMAPEALFDRVYTHQSDVWS----------FGVLM 249 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEE------CCSCCCCCGGGCCHHHHHHCEECHHHHHHH----------HHHHH
T ss_pred ceEEEcCCCCEEEcccccccccccccccc------ccCCCCcccceeChHHhcCCCcChHHHHHH----------HHHHH
Confidence 99999999999999999998665432111 111235789999999998888999999999 77788
Q ss_pred HHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 751 HEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 751 ~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
+++++ +..|+..... ........... ....+..++..+.+++.+||..||++|||++|+++.|+++.....
T Consensus 250 ~ellt~g~~p~~~~~~--~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 250 WEIFTLGGSPYPGIPV--EELFKLLKEGH------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHHHTTSCCSSTTCCH--HHHHHHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHhCCCCCcCcCCH--HHHHHHHhcCC------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 88887 7666642211 01100000000 011122345678999999999999999999999999999976543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=333.59 Aligned_cols=274 Identities=24% Similarity=0.318 Sum_probs=208.3
Q ss_pred HHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhh--cCCCccceEeeEeecCCC
Q 040925 525 ELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRN--IRHRNLIKIITICSSTDF 602 (833)
Q Consensus 525 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~ 602 (833)
.-....++|++.+.||+|+||.||+|++ +++.||||+++.. ..+.+.+|.+++.. ++||||+++++++....
T Consensus 36 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~- 109 (342)
T 1b6c_B 36 VQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN- 109 (342)
T ss_dssp HHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-
T ss_pred ecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-
Confidence 3344567899999999999999999998 5889999999632 34677889999888 68999999999986553
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHh--------hcCCCCceeeCCCCCCee
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH--------HHCQPPMVHGDLKPSNVL 674 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH--------~~~~~~ivH~Dlkp~NIl 674 (833)
......++||||+++|+|.+++... .+++.+++.++.|++.||+||| +. +|+||||||+||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNIL 179 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEE
T ss_pred CccceeEEEEeecCCCcHHHHHhcc-------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEE
Confidence 1223689999999999999999753 5899999999999999999999 77 9999999999999
Q ss_pred ecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCC------CCCcccccccCCcCCCccccCCc
Q 040925 675 LDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS------EASMTGDIFTGRRPIDAVFNEGH 748 (833)
Q Consensus 675 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~~~~~~~~~~~g~ 748 (833)
++.++.+||+|||+++.......... .......||+.|+|||++.+. .++.++|||| +|+
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~s----------lG~ 245 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTID----IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA----------MGL 245 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEE----ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHH----------HHH
T ss_pred ECCCCCEEEEECCCceeccccccccc----cccccCCcCcccCCHhhhcccccccccccCCcccHHH----------HHH
Confidence 99999999999999976544321110 011234699999999998765 3447899999 788
Q ss_pred cHHHHHHH----------hCCCcccccccc---cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHH
Q 040925 749 SLHEFAKT----------ALPEKVMEIVDP---SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMR 815 (833)
Q Consensus 749 ~l~~~~~~----------~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 815 (833)
++++++++ ..|+......++ .+...............+....++++.+.+++.+||+.||++|||++
T Consensus 246 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 325 (342)
T 1b6c_B 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325 (342)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence 88888887 445432111111 11111111111111112223446788899999999999999999999
Q ss_pred HHHHHHHHhhhhh
Q 040925 816 DVVAKLCHTRETF 828 (833)
Q Consensus 816 eil~~L~~i~~~~ 828 (833)
||++.|+.+.+..
T Consensus 326 ~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 326 RIKKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHh
Confidence 9999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=353.60 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=202.1
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
...++|++.+.||+|+||.||+|++.. +..||||+++... ...+.+.+|++++++++||||+++++++.. ..
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~ 252 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EP 252 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------Cc
Confidence 345679999999999999999999974 5679999997543 345689999999999999999999999754 25
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred eEEEehhhcCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCc
Confidence 7899999999999999975321 1589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~ 766 (833)
+++........ ......+|+.|+|||++.+..++.++|||| +|++++++++ +..|+.....
T Consensus 326 ~a~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~sDvws----------lG~~l~el~t~g~~P~~~~~~- 387 (452)
T 1fmk_A 326 LARLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWS----------FGILLTELTTKGRVPYPGMVN- 387 (452)
T ss_dssp TTC---------------------CCGGGSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTTCCSSTTCCH-
T ss_pred cceecCCCcee-------cccCCcccccccCHhHHhcCCCCccccHHh----------HHHHHHHHHhCCCCCCCCCCH-
Confidence 99876543211 112235788999999998889999999999 7888888888 7777642211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
........... ....+..+++.+.+++.+||+.||++|||++++++.|+.+...
T Consensus 388 -~~~~~~i~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 388 -REVLDQVERGY------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -HHHHHHHHTTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -HHHHHHHHcCC------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 11111111110 0112234567889999999999999999999999999988654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=329.10 Aligned_cols=261 Identities=28% Similarity=0.413 Sum_probs=194.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|++.. .||+|+++.... ...+.+.+|++++++++||||+++++++.. ..
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~ 93 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 93 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC------Cc
Confidence 4689999999999999999998753 499999975433 234678999999999999999999997533 25
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASET-----KFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred cEEEEEecCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccce
Confidence 7899999999999999975542 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
+++........ .......||+.|+|||++. +..++.++|||| .|+++++++++..|+....
T Consensus 166 ~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s----------lG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 166 LATEKSRWSGS------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYA----------FGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp ------------------------CCCTTCCHHHHC----CCSCHHHHHHH----------HHHHHHHHHHSSCTTSSCC
T ss_pred ecccccccccc------ccccccCCCccccCchhhcccCCCCCCcccchHH----------HHHHHHHHHHCCCCccccc
Confidence 99765432111 1122356999999999886 667889999999 8889999999998875322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
.. ............ .+........+++.+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 230 ~~--~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 230 NR--DQIIEMVGRGSL-SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CH--HHHHHHHHHTSC-CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred hH--HHHHHHhccccc-CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 11 111111111000 000111123456789999999999999999999999999998864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=330.45 Aligned_cols=263 Identities=22% Similarity=0.292 Sum_probs=205.3
Q ss_pred HhcCCccCc-eeccCcceEEEEEEE--CCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 529 ATGEFSSSN-MIGQGSFGYVYKGTL--GEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 529 ~~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
..++|.+.+ .||+|+||.||+|.+ ..+++.||||+++.... ...+.+.+|++++++++||||+++++++..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 89 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA---- 89 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES----
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC----
Confidence 346788888 999999999999954 56688999999975432 235679999999999999999999999732
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 90 --~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl 158 (291)
T 1xbb_A 90 --ESWMLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKI 158 (291)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred --CCcEEEEEeCCCCCHHHHHHhCc------CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEE
Confidence 25789999999999999998754 689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKV 762 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~ 762 (833)
+|||++........... ......||+.|+|||++.+..++.++|||| +|++++++++ +..|+..
T Consensus 159 ~Dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 159 SDFGLSKALRADENYYK-----AQTHGKWPVKWYAPECINYYKFSSKSDVWS----------FGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp CCCTTCEECCTTCSEEE-----C----CCCGGGCCHHHHHHCEEEHHHHHHH----------HHHHHHHHHTTTCCSSTT
T ss_pred ccCCcceeeccCCCccc-----ccccCCCCceeeChHHhccCCCChhhhHHH----------HHHHHHHHHhcCCCCCCC
Confidence 99999987654322111 111234788999999998888999999999 7888888888 7777653
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
.... .. ........ ....+..+++.+.+++.+||+.||++|||+.++++.|+++.....
T Consensus 224 ~~~~--~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 224 MKGS--EV-TAMLEKGE-----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp CCHH--HH-HHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCHH--HH-HHHHHcCC-----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 2211 11 11111000 011123456778999999999999999999999999999986544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=345.01 Aligned_cols=269 Identities=21% Similarity=0.301 Sum_probs=191.8
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKG 604 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 604 (833)
...++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++++. ||||+++++++...+
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~--- 82 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN--- 82 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT---
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC---
Confidence 34578999999999999999999999999999999986432 233467889999999997 999999999986533
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
....|+||||++ |+|.+++... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 83 ~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~ 151 (388)
T 3oz6_A 83 DRDVYLVFDYME-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVA 151 (388)
T ss_dssp SSCEEEEEECCS-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEEC
T ss_pred CCEEEEEecccC-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEec
Confidence 346899999997 5999999763 589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCccccccc-------------ccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccH
Q 040925 685 DFGLAKFLSDHQLDTA-------------VKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~-------------~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
|||+|+.......... ..........+||+.|+|||++.+ ..++.++|||| .|+++
T Consensus 152 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS----------lG~il 221 (388)
T 3oz6_A 152 DFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWS----------LGCIL 221 (388)
T ss_dssp CCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHH----------HHHHH
T ss_pred CCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHH----------HHHHH
Confidence 9999986543111000 001112334689999999999876 67899999999 78888
Q ss_pred HHHHHHhCCCcccccccccch-hhhcc-----------ccchh-------------hhhhh-------------hchHHH
Q 040925 751 HEFAKTALPEKVMEIVDPSLL-MEVMT-----------NNSMI-------------QEDKR-------------VKTEEC 792 (833)
Q Consensus 751 ~~~~~~~~p~~~~~~~~~~~~-~~~~~-----------~~~~~-------------~~~~~-------------~~~~~~ 792 (833)
++++++..|+......+.-.. ..... ..... ..... .....+
T Consensus 222 ~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (388)
T 3oz6_A 222 GEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301 (388)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC
Confidence 888888877642211100000 00000 00000 00000 000123
Q ss_pred HHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 793 LNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 793 ~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++.+.+++.+||..||++|||++|+++.
T Consensus 302 ~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 302 NEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 5678899999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=325.93 Aligned_cols=257 Identities=21% Similarity=0.243 Sum_probs=203.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC------cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK------GASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|+.++++++||||+++++++....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 81 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKT--- 81 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCC---
Confidence 579999999999999999999998999999999975422 13567899999999999999999999976554
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC----c
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM----V 680 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~ 680 (833)
..++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .
T Consensus 82 --~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~ 150 (283)
T 3bhy_A 82 --DVVLILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPR 150 (283)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCC
T ss_pred --eEEEEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCc
Confidence 8999999999999999997643 689999999999999999999999 999999999999998877 8
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
+||+|||++........ .....||+.|+|||++.+..++.++|||| +|+++++++++..|+
T Consensus 151 ~kl~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 151 IKLIDFGIAHKIEAGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWS----------IGVITYILLSGASPF 211 (283)
T ss_dssp EEECCCTTCEECC-----------------CCCGGGCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSSCTT
T ss_pred eEEEecccceeccCCCc---------ccccCCCcCccCcceecCCCCCcchhhhh----------HHHHHHHHHHCCCCC
Confidence 99999999986644221 12346999999999999999999999999 888899999998887
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH--HHHhh
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK--LCHTR 825 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~--L~~i~ 825 (833)
...... ............. .......++..+.+++.+||..||++|||+.|+++. ++.+.
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 212 LGETKQ--ETLTNISAVNYDF---DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CCSSHH--HHHHHHHTTCCCC---CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CCcchH--HHHHHhHhcccCC---cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 532211 1111111110000 011112345678899999999999999999999984 44443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=328.41 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=206.9
Q ss_pred cCCccCc-eeccCcceEEEEEEEC--CCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSN-MIGQGSFGYVYKGTLG--EDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
++|.+.+ .||+|+||.||+|++. .++..||||+++.... ...+.+.+|++++++++||||+++++++.. +
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~ 82 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E 82 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC------C
Confidence 5677776 9999999999999864 4688899999975432 345678999999999999999999999732 2
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 83 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred CcEEEEEeCCCCCHHHHHHhCCc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence 58999999999999999975432 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
|+++.......... ......||+.|+|||++.+..++.++|||| +|++++++++ +..|+.....
T Consensus 155 g~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 155 GLSKALGADDSYYT-----ARSAGKWPLKWYAPECINFRKFSSRSDVWS----------YGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp TTCEECTTCSCEEC-----CCCSSCCCGGGCCHHHHHHCEECHHHHHHH----------HHHHHHHHHTTSCCTTTTCCT
T ss_pred cceeeeccCcceee-----ccccccccccccCHHHhccCCCCchhhHHH----------HHHHHHHHHcCCCCCcccCCH
Confidence 99987654321111 112234789999999998888999999999 7888888887 7777653221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
........... ....+..+++.+.+++.+||..||++|||+.|+++.|+++..+...
T Consensus 220 --~~~~~~i~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 220 --PEVMAFIEQGK------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp --HHHHHHHHTTC------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred --HHHHHHHhcCC------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 11111111110 0111234567889999999999999999999999999999876543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-38 Score=327.63 Aligned_cols=253 Identities=23% Similarity=0.284 Sum_probs=195.8
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.... ..+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-----~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH-----NMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----EEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC-----eEE
Confidence 57999999999999999999999999999999997543 334578999999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee---cCCCcEEEccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCDF 686 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Df 686 (833)
+||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||+||
T Consensus 97 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Df 171 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDF 171 (285)
T ss_dssp EEECCCSCCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred EEEEeCCCCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEee
Confidence 999999999999998653211 12689999999999999999999999 99999999999999 45678999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|++........ .....||+.|+|||++. ..++.++|||| .|+++++++++..|+......
T Consensus 172 g~a~~~~~~~~---------~~~~~~t~~y~aPE~~~-~~~~~~~Di~s----------lG~il~~ll~g~~pf~~~~~~ 231 (285)
T 3is5_A 172 GLAELFKSDEH---------STNAAGTALYMAPEVFK-RDVTFKCDIWS----------AGVVMYFLLTGCLPFTGTSLE 231 (285)
T ss_dssp CCCCC-------------------CTTGGGCCHHHHT-TCCCHHHHHHH----------HHHHHHHHHHSSCSSCCSSHH
T ss_pred ecceecCCccc---------CcCcccccCcCChHHhc-cCCCcccCeeh----------HHHHHHHHHhCCCCCCCCCHH
Confidence 99986544221 12346999999999875 46899999999 888999999999887532211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
+.. .......... .......++.+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~--~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 232 EVQ--QKATYKEPNY----AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHH--HHHHHCCCCC----CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHH--hhhccCCccc----ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 100 0000000000 0001113457789999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=341.29 Aligned_cols=271 Identities=13% Similarity=0.129 Sum_probs=205.9
Q ss_pred cCCccCceeccCcceEEEEEEECC--------CceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccce----------
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGE--------DEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK---------- 592 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 592 (833)
++|++.+.||+|+||.||+|++.. .++.||||+++.. +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 689999999999999999999986 3889999998633 46889999999999999998
Q ss_pred -----EeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeC
Q 040925 593 -----IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGD 667 (833)
Q Consensus 593 -----~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~D 667 (833)
+++++... ....++||||+ +|+|.+++...... .+++.+++.++.|++.||+|||+. +|+|||
T Consensus 117 ~~i~~~~~~~~~~----~~~~~lv~e~~-~~~L~~~l~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~D 184 (352)
T 2jii_A 117 LAIPTCMGFGVHQ----DKYRFLVLPSL-GRSLQSALDVSPKH----VLSERSVLQVACRLLDALEFLHEN---EYVHGN 184 (352)
T ss_dssp CSCCCCCEEEEET----TTEEEEEEECC-CEEHHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSC
T ss_pred cCccchhhccccC----CcEEEEEecCC-CcCHHHHHHhCCcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCC
Confidence 45555431 35889999999 89999999875321 799999999999999999999999 999999
Q ss_pred CCCCCeeecCCC--cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCcccc
Q 040925 668 LKPSNVLLDHDM--VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFN 745 (833)
Q Consensus 668 lkp~NIll~~~~--~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~ 745 (833)
|||+||+++.++ .+||+|||+++........... .........||+.|+|||++.+..++.++||||
T Consensus 185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s---------- 253 (352)
T 2jii_A 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY-VEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQS---------- 253 (352)
T ss_dssp CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCC-CTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHH----------
T ss_pred CCHHHEEEcCCCCceEEEecCcceeeccCCCccccc-cccccccccCCccccCHHHHccCCCCchhhHHH----------
Confidence 999999999998 9999999999877654321111 111223457999999999999999999999999
Q ss_pred CCccHHHHHHHhCCCcccccccccchhhhc--cccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 746 EGHSLHEFAKTALPEKVMEIVDPSLLMEVM--TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 746 ~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
+|+++++++++..|+............... ................+++.+.+++.+||..||++|||++++++.|++
T Consensus 254 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 254 LGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp HHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 888999999998887633211111100000 000000000000001235678999999999999999999999999999
Q ss_pred hhhhhh
Q 040925 824 TRETFL 829 (833)
Q Consensus 824 i~~~~~ 829 (833)
+.+...
T Consensus 334 ~~~~~~ 339 (352)
T 2jii_A 334 LLQDLR 339 (352)
T ss_dssp HHHHTT
T ss_pred HHHhcC
Confidence 987643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=336.87 Aligned_cols=279 Identities=20% Similarity=0.300 Sum_probs=214.4
Q ss_pred cchHHHHHHhcCCccCceeccCcceEEEEEEE-----CCCceEEEEEEeeccCCc-chhHHHHHHHHHhhc-CCCccceE
Q 040925 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKG-ASRSFVAECEALRNI-RHRNLIKI 593 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~~ 593 (833)
+....+....++|++.+.||+|+||.||+|++ ..+++.||||+++..... ..+.+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455556678999999999999999999985 356789999999754332 345789999999999 69999999
Q ss_pred eeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccc----------cccCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 040925 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVE----------VCKLSLIQRVNIAIDVASAMEYLHHHCQPPM 663 (833)
Q Consensus 594 ~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----------~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 663 (833)
++++...+ ...++||||+++|+|.+++........ ...+++..++.++.|++.||.|||+. +|
T Consensus 97 ~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i 169 (316)
T 2xir_A 97 LGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KC 169 (316)
T ss_dssp EEEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred EEEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 99975433 458999999999999999987643100 11278999999999999999999999 99
Q ss_pred eeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCcc
Q 040925 664 VHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAV 743 (833)
Q Consensus 664 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~ 743 (833)
+||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||
T Consensus 170 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s-------- 235 (316)
T 2xir_A 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY------VRKGDARLPLKWMAPETIFDRVYTIQSDVWS-------- 235 (316)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHH--------
T ss_pred ccccCccceEEECCCCCEEECCCccccccccCccc------eeccCCCcceeecCchhhccccccchhHHHH--------
Confidence 99999999999999999999999999866432211 1112345889999999999889999999999
Q ss_pred ccCCccHHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHH
Q 040925 744 FNEGHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLC 822 (833)
Q Consensus 744 ~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~ 822 (833)
+|++++++++ +..|+..... +............ ...+..+++.+.+++.+||+.||++|||+.|+++.|+
T Consensus 236 --lG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 306 (316)
T 2xir_A 236 --FGVLLWEIFSLGASPYPGVKI-DEEFCRRLKEGTR------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 306 (316)
T ss_dssp --HHHHHHHHHTTSCCSSTTCCC-SHHHHHHHHHTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred --HHHHHHHHHhCCCCCCcccch-hHHHHHHhccCcc------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 7888888887 7777642221 1111111110000 0111224567889999999999999999999999999
Q ss_pred Hhhhhhh
Q 040925 823 HTRETFL 829 (833)
Q Consensus 823 ~i~~~~~ 829 (833)
.+.+...
T Consensus 307 ~~~~~~~ 313 (316)
T 2xir_A 307 NLLQANA 313 (316)
T ss_dssp HHHHHHC
T ss_pred HHHhhhc
Confidence 9987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=326.98 Aligned_cols=248 Identities=19% Similarity=0.302 Sum_probs=203.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK----- 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC-----
Confidence 467999999999999999999999999999999996431 223467899999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Df 158 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADF 158 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecc
Confidence 8999999999999999998654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|++....... .....||+.|+|||++.+..++.++|||| .|+++++++++..|+......
T Consensus 159 g~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~~~ 218 (284)
T 2vgo_A 159 GWSVHAPSLR----------RRTMCGTLDYLPPEMIEGKTHDEKVDLWC----------AGVLCYEFLVGMPPFDSPSHT 218 (284)
T ss_dssp TTCEECSSSC----------BCCCCSCGGGCCHHHHTTCCBCTTHHHHH----------HHHHHHHHHHSSCTTCCSSHH
T ss_pred cccccCcccc----------cccccCCCCcCCHHHhccCCCCcccchhh----------HHHHHHHHHHCCCCCCCCCHh
Confidence 9987554321 12346999999999999999999999999 888999999998887532211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+ .......... ..+..++..+.+++.+||..||++|||++|+++.
T Consensus 219 ~--~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 219 E--THRRIVNVDL-------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp H--HHHHHHTTCC-------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred H--HHHHHhcccc-------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1 1111111110 1112345678899999999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=337.48 Aligned_cols=247 Identities=24% Similarity=0.323 Sum_probs=198.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
+.|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++...+ .
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-----e
Confidence 4589999999999999999999889999999999754322 2357889999999999999999999986654 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||++ |++.+++..... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 199 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 199 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEecCC-CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeecc
Confidence 999999997 688888864332 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
+++..... ....||+.|+|||++. +..++.++|||| +|+++++++++..|+....
T Consensus 200 ~a~~~~~~------------~~~~gt~~y~aPE~~~~~~~~~~~~~~Diws----------lG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 200 SASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWS----------LGITCIELAERKPPLFNMN 257 (348)
T ss_dssp TCBSSSSB------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHH----------HHHHHHHHHHSSCTTTTSC
T ss_pred CceecCCC------------CcccCCcceeCHhhhccccCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCC
Confidence 99765432 1246999999999874 567899999999 8889999999988865322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..+ .......... .......+++.+.+++.+||+.||++|||++++++.
T Consensus 258 ~~~--~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 258 AMS--ALYHIAQNES-----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HHH--HHHHHHHSCC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred hHH--HHHHHHhcCC-----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 1111111110 011112345678899999999999999999999864
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-38 Score=335.10 Aligned_cols=262 Identities=26% Similarity=0.411 Sum_probs=198.9
Q ss_pred cCCccCceeccCcceEEEEEEECCC----ceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGED----EMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|++.+.||+|+||.||+|++..+ +..||||+++.... .....+.+|++++++++||||+++++++....
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---- 119 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK---- 119 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC----
Confidence 4688889999999999999988644 35699999975432 23457889999999999999999999975544
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|+|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 120 -~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D 190 (333)
T 1mqb_A 120 -PMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 190 (333)
T ss_dssp -SEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred -CcEEEEeCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECC
Confidence 78999999999999999976432 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||+++......... .......+|+.|+|||++.+..++.++|||| +|++++++++ +..|+....
T Consensus 191 fg~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 191 FGLSRVLEDDPEAT-----YTTSGGKIPIRWTAPEAISYRKFTSASDVWS----------FGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTCC
T ss_pred CCcchhhccccccc-----cccCCCCccccccCchhcccCCCCchhhhHH----------HHHHHHHHHcCCCCCcccCC
Confidence 99998765432111 1111234788999999999889999999999 7778888887 777764221
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
. ........... ....+..++..+.+++.+||+.||++|||+.|+++.|+++.+..
T Consensus 256 ~--~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 256 N--HEVMKAINDGF------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp H--HHHHHHHHTTC------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred H--HHHHHHHHCCC------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1 11111111110 01112234667899999999999999999999999999987653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=336.52 Aligned_cols=264 Identities=22% Similarity=0.292 Sum_probs=191.5
Q ss_pred hHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecC
Q 040925 523 YAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSST 600 (833)
Q Consensus 523 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 600 (833)
........++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++...
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 26 AAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp ------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred cCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 33445567799999999999999999999999999999999975432 2245678999999999999999999997665
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec----
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD---- 676 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~---- 676 (833)
. ..++||||++ |+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++
T Consensus 106 ~-----~~~lv~e~~~-~~L~~~~~~~~------~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~ 170 (329)
T 3gbz_A 106 H-----RLHLIFEYAE-NDLKKYMDKNP------DVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA 170 (329)
T ss_dssp T-----EEEEEEECCS-EEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred C-----EEEEEEecCC-CCHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence 5 8999999998 59999998765 689999999999999999999999 999999999999994
Q ss_pred -CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHH
Q 040925 677 -HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 677 -~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
.++.+||+|||+++....... ......||+.|+|||++.+. .++.++|||| .|+++++++
T Consensus 171 ~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~ell 232 (329)
T 3gbz_A 171 SETPVLKIGDFGLARAFGIPIR--------QFTHEIITLWYRPPEILLGSRHYSTSVDIWS----------IACIWAEML 232 (329)
T ss_dssp --CCEEEECCTTHHHHHC-------------------CCTTCCHHHHTTCCCCCTHHHHHH----------HHHHHHHHH
T ss_pred CccceEEECcCCCccccCCccc--------ccCCCcCCccccCHHHhcCCCCCCcHHHHHH----------HHHHHHHHH
Confidence 555699999999986543211 11234689999999998874 4899999999 777888888
Q ss_pred HHhCCCcccccccccchh-hh------------c-----ccc---chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC
Q 040925 755 KTALPEKVMEIVDPSLLM-EV------------M-----TNN---SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD 813 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~-~~------------~-----~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 813 (833)
++..|+......+..... .. . ... .............+++.+.+++.+||+.||++|||
T Consensus 233 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 312 (329)
T 3gbz_A 233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312 (329)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence 888776422111000000 00 0 000 00000001111124567889999999999999999
Q ss_pred HHHHHH
Q 040925 814 MRDVVA 819 (833)
Q Consensus 814 ~~eil~ 819 (833)
++|+++
T Consensus 313 ~~e~l~ 318 (329)
T 3gbz_A 313 AKNALE 318 (329)
T ss_dssp HHHHHT
T ss_pred HHHHhC
Confidence 999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.60 Aligned_cols=274 Identities=22% Similarity=0.338 Sum_probs=211.8
Q ss_pred cchHHHHHHhcCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEe
Q 040925 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKII 594 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~ 594 (833)
+..+++....++|++.+.||+|+||.||+|++. .+++.||||.+..... .....+.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 344555666789999999999999999999876 3578899999974432 2345688999999999999999999
Q ss_pred eEeecCCCCCCceEeEEEEecCCCChhhhhccCCCc----cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ----VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 595 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
+++.... ..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +|+||||||
T Consensus 95 ~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp 166 (322)
T 1p4o_A 95 GVVSQGQ-----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAA 166 (322)
T ss_dssp EEECSSS-----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSG
T ss_pred EEEccCC-----ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCcc
Confidence 9975544 789999999999999999764211 0012568999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||| .|+++
T Consensus 167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il 230 (322)
T 1p4o_A 167 RNCMVAEDFTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWS----------FGVVL 230 (322)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEE------GGGSSEECGGGCCHHHHHHCCCCHHHHHHH----------HHHHH
T ss_pred ceEEEcCCCeEEECcCccccccccccccc------cccCCCCCCCccChhhhccCCCCchhhHHH----------HHHHH
Confidence 99999999999999999998664432211 111235789999999998889999999999 78888
Q ss_pred HHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 751 HEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 751 ~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
+++++ +..|+..... ............ ...+..++..+.+++.+||..||++|||+.|+++.|+++.+
T Consensus 231 ~el~~~g~~p~~~~~~--~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 231 WEIATLAEQPYQGLSN--EQVLRFVMEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHTSCCTTTTSCH--HHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHhcCCCccccCCH--HHHHHHHHcCCc------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 88888 6666642211 111111111110 01123346678999999999999999999999999988754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=325.84 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=199.4
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+.+|+.++++++||||+++++++.... .+....+
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~ 105 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIV 105 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceEE
Confidence 4788889999999999999999999999999997542 233467899999999999999999999876542 3345789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceeeCCCCCCeeec-CCCcEEEccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP--MVHGDLKPSNVLLD-HDMVAHVCDF 686 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~Df 686 (833)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||+. + |+||||||+||+++ .++.+||+||
T Consensus 106 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred EEEEecCCCCHHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 9999999999999997644 689999999999999999999999 8 99999999999997 7899999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|++....... .....||+.|+|||++.+ .++.++|||| .|+++++++++..|+......
T Consensus 177 g~~~~~~~~~----------~~~~~~t~~y~aPE~~~~-~~~~~~Di~s----------lG~~l~~l~~g~~pf~~~~~~ 235 (290)
T 1t4h_A 177 GLATLKRASF----------AKAVIGTPEFMAPEMYEE-KYDESVDVYA----------FGMCMLEMATSEYPYSECQNA 235 (290)
T ss_dssp TGGGGCCTTS----------BEESCSSCCCCCGGGGGT-CCCTHHHHHH----------HHHHHHHHHHSSCTTTTCSSH
T ss_pred CCcccccccc----------cccccCCcCcCCHHHHhc-cCCCcchHHH----------HHHHHHHHHhCCCCCCCcCcH
Confidence 9997543321 123469999999998764 5899999999 888999999998887532111
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ........... ........++.+.+++.+||..||++|||++|+++.
T Consensus 236 ~--~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 236 A--QIYRRVTSGVK----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp H--HHHHHHTTTCC----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H--HHHHHHhccCC----ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 11111111100 011112234568899999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=338.26 Aligned_cols=275 Identities=19% Similarity=0.262 Sum_probs=209.7
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEECCCce-----EEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEee
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGEDEM-----IVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICS 598 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 598 (833)
+....++|++.+.||+|+||.||+|.+..+++ .||+|.++.... ...+.+.+|+++++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 44456789999999999999999999876554 799999975432 2346789999999999 8999999999976
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCc--------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ--------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
..+ ..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +|+||||||
T Consensus 121 ~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 192 (333)
T 2i1m_A 121 HGG-----PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192 (333)
T ss_dssp SSS-----SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred cCC-----ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCccc
Confidence 554 789999999999999999754210 0012579999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++|||| +|+++
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il 256 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYI------VKGNARLPVKWMAPESIFDCVYTVQSDVWS----------YGILL 256 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSE------ECSSCEECGGGSCHHHHHHCCCCHHHHHHH----------HHHHH
T ss_pred ceEEECCCCeEEECcccccccccccccee------ecCCCCCCccccCHHHhccCCCChHHHHHH----------HHHHH
Confidence 99999999999999999998654432111 112245788999999998889999999999 67777
Q ss_pred HHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 751 HEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 751 ~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
+++++ +..|+..... ............ ....+..+++.+.+++.+||+.||++|||++|+++.|+++.+...
T Consensus 257 ~el~t~g~~p~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 257 WEIFSLGLNPYPGILV--NSKFYKLVKDGY-----QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp HHHTTTSCCSSTTCCS--SHHHHHHHHHTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCcccch--hHHHHHHHhcCC-----CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence 77776 6556542111 111011111000 001112235678899999999999999999999999999987665
Q ss_pred cC
Q 040925 830 GR 831 (833)
Q Consensus 830 ~~ 831 (833)
..
T Consensus 330 ~~ 331 (333)
T 2i1m_A 330 RE 331 (333)
T ss_dssp HH
T ss_pred cc
Confidence 44
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=329.06 Aligned_cols=250 Identities=18% Similarity=0.252 Sum_probs=204.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~----- 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----- 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCC-----
Confidence 467999999999999999999999999999999987542 223467889999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 159 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 159 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEec
Confidence 8999999999999999987643 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|++........ ......||+.|+|||++.+..++.++|||| .|+++++++++..|+......
T Consensus 160 g~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~p~~~~~~~ 221 (294)
T 2rku_A 160 GLATKVEYDGE--------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWS----------IGCIMYTLLVGKPPFETSCLK 221 (294)
T ss_dssp TTCEECCSTTC--------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHH----------HHHHHHHHHHSSCTTCCSSHH
T ss_pred cCceecccCcc--------ccccccCCCCcCCcchhccCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCHH
Confidence 99986543221 112346999999999999988999999999 888899999998887532211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+ .......... ..+..++..+.+++.+||+.||++|||++|+++.
T Consensus 222 ~--~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 222 E--TYLRIKKNEY-------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp H--HHHHHHTTCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred H--HHHHHhhccC-------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1 1011111110 1112345678899999999999999999999875
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=328.21 Aligned_cols=255 Identities=29% Similarity=0.366 Sum_probs=197.9
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
..++|++.+.||+|+||.||+|++. ++.||||+++.. ...+.+.+|++++++++||||+++++++... .+..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~ 90 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGL 90 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CC
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCce
Confidence 3568999999999999999999884 889999999643 3457789999999999999999999987433 2468
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EEEEecCCCCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccc
Confidence 999999999999999976431 1488999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~ 767 (833)
+........ ...+|+.|+|||++.+..++.++|||| +|++++++++ +..|+......
T Consensus 164 ~~~~~~~~~-----------~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~t~g~~p~~~~~~~- 221 (278)
T 1byg_A 164 TKEASSTQD-----------TGKLPVKWTAPEALREKKFSTKSDVWS----------FGILLWEIYSFGRVPYPRIPLK- 221 (278)
T ss_dssp -----------------------CCTTTSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCSCTTSCGG-
T ss_pred ccccccccc-----------CCCccccccCHHHhCCCCCCchhcHHH----------HHHHHHHHHhCCCCCCCCCCHH-
Confidence 975543211 124789999999998889999999999 7788888887 77776522211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
..... +.... ....+..+++.+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 222 -~~~~~-~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 222 -DVVPR-VEKGY-----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -GHHHH-HTTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHH-HhcCC-----CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 11111 11100 0111233567789999999999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=349.16 Aligned_cols=253 Identities=25% Similarity=0.291 Sum_probs=202.3
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
..++|++.+.||+|+||.||+|++..+++.||||++... .......+.+|++++++++||||+++++++....
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 94 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS----- 94 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC-----
Confidence 346799999999999999999999999999999999643 2334567899999999999999999999976654
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec---CCCcEEE
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHV 683 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL 683 (833)
..++||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++ .++.+||
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 165 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKI 165 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEE
Confidence 8999999999999999987654 689999999999999999999999 999999999999995 4568999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+|||+|+....... .....||+.|+|||++.+ .++.++|||| .|+++|+++++..|+...
T Consensus 166 ~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~-~~~~~~Diws----------lG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 166 IDFGLSTCFQQNTK---------MKDRIGTAYYIAPEVLRG-TYDEKCDVWS----------AGVILYILLSGTPPFYGK 225 (486)
T ss_dssp CSCSCTTTBCCC-------------CCTTGGGGCCGGGGGS-CCCHHHHHHH----------HHHHHHHHHHSSCSSCCS
T ss_pred EECCcCeECCCCCc---------cCCCcCCCCCCCHHHhCC-CCCchhhHHH----------HHHHHHHHHhCCCCCCCC
Confidence 99999986544221 123469999999999876 5999999999 888999999999987532
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. .............. .......+++.+.+++.+||..||++|||+.|+++.
T Consensus 226 ~~--~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 226 NE--YDILKRVETGKYAF---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SH--HHHHHHHHHTCCCS---CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CH--HHHHHHHHhCCCCC---CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 21 11111111111100 011122345678899999999999999999999875
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=349.83 Aligned_cols=255 Identities=23% Similarity=0.314 Sum_probs=204.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|.+.+.||+|+||.||+|++..+++.||+|+++... ....+.+.+|++++++++||||+++++++....
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~----- 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT----- 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS-----
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC-----
Confidence 367999999999999999999999999999999996432 233467889999999999999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||++||+|.+++...... ...+++..++.++.||+.||.|||+. +|+||||||+||+++.+|.+||+||
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DF 333 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDL 333 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEEeccCCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeec
Confidence 899999999999999999765421 12689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc-
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI- 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~- 765 (833)
|+++....... .....+||+.|+|||++.+..++.++|||| .|+++|+++++..|+.....
T Consensus 334 Gla~~~~~~~~--------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwS----------lGvilyelltG~~PF~~~~~~ 395 (543)
T 3c4z_A 334 GLAVELKAGQT--------KTKGYAGTPGFMAPELLLGEEYDFSVDYFA----------LGVTLYEMIAARGPFRARGEK 395 (543)
T ss_dssp TTCEECCTTCC--------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCSSCCTTCC
T ss_pred ceeeeccCCCc--------ccccccCCccccChhhhcCCCCChHHhcCc----------chHHHHHHHhCCCCCCCCccc
Confidence 99987644221 122357999999999999999999999999 88999999999999863211
Q ss_pred ccc-cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH-----HHHHH
Q 040925 766 VDP-SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM-----RDVVA 819 (833)
Q Consensus 766 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~ 819 (833)
... .+........ ...+..++..+.+++.+||..||++||++ ++|++
T Consensus 396 ~~~~~~~~~i~~~~-------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 396 VENKELKQRVLEQA-------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCHHHHHHHHHHCC-------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred hhHHHHHHHHhhcc-------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 111 1111111111 11123356678899999999999999975 66654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=334.75 Aligned_cols=260 Identities=14% Similarity=0.116 Sum_probs=202.5
Q ss_pred HHhcCCccCceeccCcceEEEEEE-----ECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC---CCccceEeeEeec
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGT-----LGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR---HRNLIKIITICSS 599 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~ 599 (833)
...++|.+.+.||+|+||.||+|+ ...+++.||||+++.. ....+..|++++++++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345689999999999999999994 5668899999999643 4567788888888886 9999999999866
Q ss_pred CCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC--
Q 040925 600 TDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-- 677 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-- 677 (833)
.+ ..++||||+++|+|.+++...... ....+++..++.|+.|++.||+|||+. +||||||||+|||++.
T Consensus 139 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~ 209 (365)
T 3e7e_A 139 QN-----GSVLVGELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGF 209 (365)
T ss_dssp SS-----CEEEEECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGG
T ss_pred CC-----CcEEEEeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccc
Confidence 55 789999999999999999753211 012699999999999999999999999 9999999999999998
Q ss_pred ---------CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCc
Q 040925 678 ---------DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGH 748 (833)
Q Consensus 678 ---------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~ 748 (833)
++.+||+|||+|+.+..... .......+||+.|||||++.+..++.++|||| +|+
T Consensus 210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~ 273 (365)
T 3e7e_A 210 LEQDDEDDLSAGLALIDLGQSIDMKLFPK------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFG----------VAA 273 (365)
T ss_dssp TCC------CTTEEECCCTTCEEGGGSCT------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHH----------HHH
T ss_pred cCccccccccCCEEEeeCchhhhhhccCC------CceeeeecCCCCCCChHHhcCCCCCccccHHH----------HHH
Confidence 89999999999976542211 11123357999999999999999999999999 899
Q ss_pred cHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCC-CCHHHHHHHHHHhhhh
Q 040925 749 SLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFER-MDMRDVVAKLCHTRET 827 (833)
Q Consensus 749 ~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~eil~~L~~i~~~ 827 (833)
++++++++..|+.......... .... .+.. ..+.+.+++..|++.+|.+| |+++++.+.|+.+.+.
T Consensus 274 il~elltg~~pf~~~~~~~~~~-~~~~---------~~~~---~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 274 TVYCMLFGTYMKVKNEGGECKP-EGLF---------RRLP---HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp HHHHHHHSSCCCEEEETTEEEE-CSCC---------TTCS---SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCccccCCCCceee-chhc---------cccC---cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 9999999999875322111110 0000 0001 14456788889999999999 5788888888887665
Q ss_pred h
Q 040925 828 F 828 (833)
Q Consensus 828 ~ 828 (833)
.
T Consensus 341 ~ 341 (365)
T 3e7e_A 341 H 341 (365)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=332.64 Aligned_cols=263 Identities=16% Similarity=0.189 Sum_probs=204.9
Q ss_pred chHHHHHHhcCCccC-ceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcC-CCccceEeeEe
Q 040925 522 SYAELSKATGEFSSS-NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIR-HRNLIKIITIC 597 (833)
Q Consensus 522 ~~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 597 (833)
.+.......++|.+. +.||+|+||.||+|++..+++.||+|+++.... .....+.+|+.++++++ ||||+++++++
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 344445566678887 899999999999999999999999999975432 23567899999999995 79999999997
Q ss_pred ecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC
Q 040925 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH 677 (833)
Q Consensus 598 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 677 (833)
.... ..++||||+++|+|.+++...... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.
T Consensus 99 ~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~ 166 (327)
T 3lm5_A 99 ENTS-----EIILILEYAAGGEIFSLCLPELAE----MVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSS 166 (327)
T ss_dssp ECSS-----EEEEEEECCTTEEGGGGGSSCC-C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESC
T ss_pred EeCC-----eEEEEEEecCCCcHHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEec
Confidence 6554 899999999999999998754322 689999999999999999999999 9999999999999988
Q ss_pred ---CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 678 ---DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 678 ---~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
++.+||+|||+++....... .....||+.|+|||++.+..++.++|||| .|+++++++
T Consensus 167 ~~~~~~~kL~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~~ll 227 (327)
T 3lm5_A 167 IYPLGDIKIVDFGMSRKIGHACE---------LREIMGTPEYLAPEILNYDPITTATDMWN----------IGIIAYMLL 227 (327)
T ss_dssp BTTBCCEEECCGGGCEEC------------------CCCGGGCCHHHHTTCCCCTHHHHHH----------HHHHHHHHH
T ss_pred CCCCCcEEEeeCccccccCCccc---------cccccCCcCccCCeeecCCCCCchhhHHH----------HHHHHHHHH
Confidence 78999999999987644221 12346999999999999999999999999 888999999
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++..|+......+... ....... .........+++.+.+++.+||+.||++|||++|+++.
T Consensus 228 ~g~~pf~~~~~~~~~~--~i~~~~~---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 228 THTSPFVGEDNQETYL--NISQVNV---DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HSSCSSCCSSHHHHHH--HHHHTCC---CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred hCCCCCCCCCchHHHH--HHHhccc---ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 9998875322111100 0000000 00111122346678899999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=335.24 Aligned_cols=250 Identities=18% Similarity=0.252 Sum_probs=204.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----- 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDND----- 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-----
Confidence 467999999999999999999999999999999997542 223467889999999999999999999976654
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Df 185 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDF 185 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecCCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeec
Confidence 8999999999999999987643 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+++....... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+......
T Consensus 186 g~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~~~ 247 (335)
T 2owb_A 186 GLATKVEYDGE--------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWS----------IGCIMYTLLVGKPPFETSCLK 247 (335)
T ss_dssp TTCEECCSTTC--------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHH----------HHHHHHHHHHSSCTTCCSSHH
T ss_pred cCceecccCcc--------cccccCCCccccCHHHhccCCCCchhhHHH----------HHHHHHHHHHCcCCCCCCCHH
Confidence 99986643221 112346999999999999989999999999 888899999998887532211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+ .......... ..+..++..+.+++.+||+.||++|||++|+++.
T Consensus 248 ~--~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 248 E--TYLRIKKNEY-------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp H--HHHHHHHTCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred H--HHHHHhcCCC-------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 1011111100 1112345568899999999999999999999874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=348.31 Aligned_cols=312 Identities=22% Similarity=0.210 Sum_probs=246.4
Q ss_pred CCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccE
Q 040925 21 NLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKA 100 (833)
Q Consensus 21 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~ 100 (833)
.+.+++.|++++|.++...+..|..+++|++|+|++|.|+++.|..|.++++|++|+|++|.++ .+|+..|.++++|++
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~ 127 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV 127 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCC-CCCHHHHcCCCCCCE
Confidence 4578899999999998777777899999999999999999888889999999999999999998 788888899999999
Q ss_pred EEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEE
Q 040925 101 LAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180 (833)
Q Consensus 101 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~ 180 (833)
|+|++|.|++..+..|+++++|++|+|++|+|+++.+..|.++++|++|+|++|.++.++ +..+++|+.|+
T Consensus 128 L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---------~~~l~~L~~L~ 198 (597)
T 3oja_B 128 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---------LSLIPSLFHAN 198 (597)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---------GGGCTTCSEEE
T ss_pred EEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---------hhhhhhhhhhh
Confidence 999999999777777899999999999999999999999999999999999999997753 34678899999
Q ss_pred ccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCc
Q 040925 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQ 260 (833)
Q Consensus 181 Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 260 (833)
+++|.+++. ....+|+.|++++|.+....+.. .++|+.|+|++|.++
T Consensus 199 l~~n~l~~l------------------------------~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~ 245 (597)
T 3oja_B 199 VSYNLLSTL------------------------------AIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLT 245 (597)
T ss_dssp CCSSCCSEE------------------------------ECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCC
T ss_pred cccCccccc------------------------------cCCchhheeeccCCccccccccc---CCCCCEEECCCCCCC
Confidence 999988731 11234566666666665433322 246666777777666
Q ss_pred ccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCccc
Q 040925 261 GRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV 340 (833)
Q Consensus 261 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~ 340 (833)
+ +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|+++ .+|..+..++.+ +.|+|++|.++ .+|..+
T Consensus 246 ~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L-~~L~Ls~N~l~-~i~~~~ 320 (597)
T 3oja_B 246 D--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTL-KVLDLSHNHLL-HVERNQ 320 (597)
T ss_dssp C--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC-EEECSSSCCTTC-CEEECCSSCCC-CCGGGH
T ss_pred C--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC-CCCcccccCCCC-cEEECCCCCCC-ccCccc
Confidence 4 355666667777777777776666666777777777777777776 355555555555 67777777777 567778
Q ss_pred ccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccc
Q 040925 341 GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV 383 (833)
Q Consensus 341 ~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 383 (833)
..+++|+.|+|++|.+++.. +..+++|+.|+|++|.+.+.
T Consensus 321 ~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 321 PQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp HHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHH
T ss_pred ccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCCh
Confidence 88999999999999998653 67788999999999999854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=339.36 Aligned_cols=256 Identities=23% Similarity=0.367 Sum_probs=201.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|++++++++||||+++++++...+ ..+
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 107 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EIS 107 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETT-----EEE
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECC-----EEE
Confidence 579999999999999999999999999999999975532 23467899999999999999999999987654 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||++
T Consensus 108 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 179 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS 179 (360)
T ss_dssp EEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEECCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCC
Confidence 9999999999999998654 6899999999999999999999832 8999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
....... .....||+.|+|||++.+..++.++|||| +|+++++++++..|+......+-.
T Consensus 180 ~~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~~~~~~ 239 (360)
T 3eqc_A 180 GQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWS----------MGLSLVEMAVGRYPIPPPDAKELE 239 (360)
T ss_dssp HHHHHHC--------------CCCCTTCCHHHHTTCCCSHHHHHHH----------HHHHHHHHHHTSCCSSCCCHHHHH
T ss_pred ccccccc----------ccCCCCCCCeECHHHHcCCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCHHHHH
Confidence 7553321 11246999999999999999999999999 788889999998887522111000
Q ss_pred chhh------------------------------------hccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC
Q 040925 770 LLME------------------------------------VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD 813 (833)
Q Consensus 770 ~~~~------------------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 813 (833)
.... .... .............++..+.+++.+||+.||++|||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 318 (360)
T 3eqc_A 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY-IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 318 (360)
T ss_dssp HHHC------------------------------CCCHHHHHHH-HHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCC
T ss_pred HHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhH-HhccCCCCCCcccccHHHHHHHHHHhhcChhhCCC
Confidence 0000 0000 00000000111124567899999999999999999
Q ss_pred HHHHHHH
Q 040925 814 MRDVVAK 820 (833)
Q Consensus 814 ~~eil~~ 820 (833)
++|+++.
T Consensus 319 ~~ell~h 325 (360)
T 3eqc_A 319 LKQLMVH 325 (360)
T ss_dssp HHHHHTS
T ss_pred HHHHhhC
Confidence 9999875
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=333.64 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=204.0
Q ss_pred HHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--------chhHHHHHHHHHhhc-CCCccceEe
Q 040925 524 AELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--------ASRSFVAECEALRNI-RHRNLIKII 594 (833)
Q Consensus 524 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~~~ 594 (833)
.......++|++.+.||+|+||.||+|++..+|+.||||+++..... ..+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 34445567899999999999999999999889999999999754321 135678999999999 799999999
Q ss_pred eEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCee
Q 040925 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVL 674 (833)
Q Consensus 595 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIl 674 (833)
+++.... ..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. ||+||||||+||+
T Consensus 167 ~~~~~~~-----~~~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl 232 (365)
T 2y7j_A 167 DSYESSS-----FMFLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENIL 232 (365)
T ss_dssp EEEEBSS-----EEEEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred EEEeeCC-----EEEEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 9976554 8999999999999999997643 689999999999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCC------CCCCcccccccCCcCCCccccCCc
Q 040925 675 LDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG------SEASMTGDIFTGRRPIDAVFNEGH 748 (833)
Q Consensus 675 l~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Di~s~~~~~~~~~~~g~ 748 (833)
++.++.+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||| +|+
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~s----------lG~ 293 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPGEK---------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA----------CGV 293 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTTCC---------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHH----------HHH
T ss_pred ECCCCCEEEEecCcccccCCCcc---------cccCCCCCCccChhhccccccccCcCCCchhhHHh----------HHH
Confidence 99999999999999986654221 123569999999998753 35889999999 888
Q ss_pred cHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 749 SLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 749 ~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
++++++++..|+...... .............. ......++..+.+++.+||..||++|||++|+++
T Consensus 294 il~ell~g~~pf~~~~~~--~~~~~i~~~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 294 ILFTLLAGSPPFWHRRQI--LMLRMIMEGQYQFS---SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHHHSSCSSCCSSHH--HHHHHHHHTCCCCC---HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCCCCCCCCCHH--HHHHHHHhCCCCCC---CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999999887532111 11111111110000 0111223567889999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=334.42 Aligned_cols=258 Identities=20% Similarity=0.283 Sum_probs=192.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|+||.||+|++..+++.||||+++..... ....+.+|++++++++||||+++++++.... ..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEK-----SLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSS-----CEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCC-----EEE
Confidence 5799999999999999999999999999999999744322 2235567999999999999999999976554 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++ |+|.+++..... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 77 lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 147 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLA 147 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEE
T ss_pred EEecccc-cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCccc
Confidence 9999997 599999886542 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+....... ......||+.|+|||++.+ ..++.++|||| .|+++++++++..|+......+.
T Consensus 148 ~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~~l~~g~~pf~~~~~~~~ 209 (324)
T 3mtl_A 148 RAKSIPTK--------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWG----------VGCIFYEMATGRPLFPGSTVEEQ 209 (324)
T ss_dssp ECC--------------------CGGGCCHHHHTTCCCCCTHHHHHH----------HHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCcc--------ccccccCcccccChhhhcCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCHHHH
Confidence 86543221 1123468999999999876 56899999999 78888888888877652211100
Q ss_pred -------------cchhhhcccc--------chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 -------------SLLMEVMTNN--------SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 -------------~~~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... .............+++.+.+++.+||+.||++|||++|+++.
T Consensus 210 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 210 LHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 000000001112345678899999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.66 Aligned_cols=262 Identities=26% Similarity=0.389 Sum_probs=203.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEE--EEEEeecc-CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIV--AVKVINLK-YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 606 (833)
++|++.+.||+|+||.||+|++..++..+ |+|.++.. .....+.+.+|+++++++ +||||+++++++...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~----- 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----- 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC-----
Confidence 57999999999999999999998788755 99998743 233456789999999999 8999999999986654
Q ss_pred eEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
..++||||+++|+|.+++...... .....+++.+++.++.|++.||+|||+. ||+||||||+||+++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 176 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 176 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEc
Confidence 899999999999999999865410 0112689999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-
Q 040925 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK- 755 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~- 755 (833)
.++.+||+|||+++....... .....+|+.|+|||++.+..++.++|||| .|++++++++
T Consensus 177 ~~~~~kL~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ellt~ 237 (327)
T 1fvr_A 177 ENYVAKIADFGLSRGQEVYVK---------KTMGRLPVRWMAIESLNYSVYTTNSDVWS----------YGVLLWEIVSL 237 (327)
T ss_dssp GGGCEEECCTTCEESSCEECC---------C----CCTTTCCHHHHHHCEECHHHHHHH----------HHHHHHHHHTT
T ss_pred CCCeEEEcccCcCcccccccc---------ccCCCCCccccChhhhccccCCchhcchH----------HHHHHHHHHcC
Confidence 999999999999974432111 11234788999999998888999999999 7788888887
Q ss_pred HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 756 TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 756 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
+..|+...... ... ..+.... ....+..+++.+.+++.+||..||++|||++|+++.|..+.+.
T Consensus 238 g~~pf~~~~~~--~~~-~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 238 GGTPYCGMTCA--ELY-EKLPQGY-----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp SCCTTTTCCHH--HHH-HHGGGTC-----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCcHH--HHH-HHhhcCC-----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 77776422111 010 1111000 0011223456789999999999999999999999999998764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.23 Aligned_cols=266 Identities=21% Similarity=0.243 Sum_probs=204.9
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
..++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|++++++++||||+++++++..........
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 34689999999999999999999999999999999974332 23467889999999999999999999987765555567
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||++ |+|.+++... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEcccC-cCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence 899999997 5999998753 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
+++......... .......||+.|+|||++.+ ..++.++|||| .|+++++++++..|+......
T Consensus 174 ~a~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws----------lG~il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 174 LARVADPDHDHT-----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS----------VGCILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp TCEECCGGGCBC-----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHH----------HHHHHHHHHHSSCSSCCSSGG
T ss_pred ceEecCCCCCcc-----ccccccccccCCCCCHHhcCCCCCCcchhHHH----------HHHHHHHHHHCCCCCCCCChH
Confidence 998765432211 11233579999999998654 45899999999 888899999998887532211
Q ss_pred cccchh-hhccccc---------------------hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLM-EVMTNNS---------------------MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~-~~~~~~~---------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+..... ....... ............++..+.+++.+||+.||++|||++|+++.
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 239 DQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp GHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 110000 0000000 00000000112245678899999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=356.95 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=201.9
Q ss_pred CCccCc-eeccCcceEEEEEEEC--CCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 532 EFSSSN-MIGQGSFGYVYKGTLG--EDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 532 ~y~~~~-~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++.+.+ .||+|+||.||+|.+. .++..||||+++... ....+.+.+|++++++++|||||++++++... .
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~------~ 409 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------A 409 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS------S
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC------C
Confidence 444445 7999999999999875 356789999997543 23457899999999999999999999998542 5
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++|+|.+++..... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFG 481 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFG 481 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCS
T ss_pred eEEEEEeCCCCcHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeecc
Confidence 8999999999999999976432 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~ 766 (833)
+|+.......... ......+|+.|+|||++.+..++.++|||| +|++++++++ +..|+.....
T Consensus 482 la~~~~~~~~~~~-----~~~~~~~~~~y~APE~~~~~~~~~~sDvwS----------lGv~l~ellt~G~~Pf~~~~~- 545 (613)
T 2ozo_A 482 LSKALGADDSYYT-----ARSAGKWPLKWYAPECINFRKFSSRSDVWS----------YGVTMWEALSYGQKPYKKMKG- 545 (613)
T ss_dssp TTTTCC-------------------CCTTSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTCCS-
T ss_pred CcccccCCCceee-----eccCCCCccceeCHhhhcCCCCCcHHHHHH----------HHHHHHHHHHCCCCCCCCCCH-
Confidence 9987654321110 111224678999999999889999999999 7888888887 7777653221
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
........... ....+..+++.+.+++.+||..||++|||+++|++.|+.+..+..
T Consensus 546 -~~~~~~i~~~~------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 546 -PEVMAFIEQGK------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp -HHHHHHHHTTC------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred -HHHHHHHHcCC------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 11111111110 011223467789999999999999999999999999999876543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=327.05 Aligned_cols=249 Identities=25% Similarity=0.346 Sum_probs=203.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
+.|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+.++++++||||+++++++.... ..+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 96 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDT-----KLW 96 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-----eEE
Confidence 46999999999999999999999899999999997543 334578999999999999999999999986654 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++... .+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 97 lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~ 166 (303)
T 3a7i_A 97 IIMEYLGGGSALDLLEPG-------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVA 166 (303)
T ss_dssp EEEECCTTEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccc
Confidence 999999999999999753 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
........ ......||+.|+|||++.+..++.++|||| +|+++++++++..|+.......
T Consensus 167 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~~~-- 226 (303)
T 3a7i_A 167 GQLTDTQI--------KRNTFVGTPFWMAPEVIKQSAYDSKADIWS----------LGITAIELARGEPPHSELHPMK-- 226 (303)
T ss_dssp EECBTTBC--------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCTTTTSCHHH--
T ss_pred eecCcccc--------ccCccCCCcCccCHHHHhcCCCCchhhhHH----------HHHHHHHHccCCCCCCCcCHHH--
Confidence 87654321 112346999999999999999999999999 8888999999988875321110
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......... .......++..+.+++.+||..||++|||++|+++.
T Consensus 227 ~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 227 VLFLIPKNN------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp HHHHHHHSC------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred HHHHhhcCC------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000 001112345678899999999999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=348.67 Aligned_cols=252 Identities=21% Similarity=0.277 Sum_probs=198.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|++..++..||+|+++... ......+.+|+.+++.++||||+++++++.... .
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-----~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKR-----N 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC-----E
Confidence 457999999999999999999999999999999997542 334567899999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CCcEEEc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVC 684 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~ 684 (833)
.++|||||++|+|.+++.... .+++..++.++.|++.||+|||+. ||+||||||+||+++. ++.+||+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~ 181 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRM------KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIV 181 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEE
Confidence 999999999999999887654 689999999999999999999999 9999999999999976 4569999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+|+...... ......||+.|+|||++. ..++.++|||| .|+++|+++++..|+....
T Consensus 182 DfG~a~~~~~~~---------~~~~~~gt~~y~aPE~l~-~~~~~~~Diws----------lG~il~~ll~g~~pf~~~~ 241 (494)
T 3lij_A 182 DFGLSAVFENQK---------KMKERLGTAYYIAPEVLR-KKYDEKCDVWS----------IGVILFILLAGYPPFGGQT 241 (494)
T ss_dssp CCTTCEECBTTB---------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHH----------HHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCeECCCCc---------cccccCCCcCeeCHHHHc-ccCCCchhHHH----------HHHHHHHHHhCCCCCCCCC
Confidence 999998664422 122356999999999876 46999999999 8889999999999875322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ............... ......+++.+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~--~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 242 D--QEILRKVEKGKYTFD---SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp H--HHHHHHHHHTCCCCC---SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred H--HHHHHHHHhCCCCCC---chhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 1 111111111111100 11112345678899999999999999999999865
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-37 Score=342.10 Aligned_cols=270 Identities=21% Similarity=0.277 Sum_probs=207.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCC-CccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRH-RNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+|+++++.++| ++|..+..++... ...
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~-----~~~ 78 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEG-----DYN 78 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEET-----TEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeC-----CEE
Confidence 368999999999999999999999899999999986443 33568899999999987 4555555554433 478
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee---cCCCcEEEcc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHVCD 685 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~D 685 (833)
++||||+ +++|.+++..... .+++.+++.|+.||+.||+|||+. +||||||||+|||+ +.++.+||+|
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~D 149 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIID 149 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECC
T ss_pred EEEEECC-CCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEe
Confidence 9999999 8999999985432 689999999999999999999999 99999999999999 5889999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+++.+......... .........||+.|+|||++.+..++.++|||| +|+++|+++++..|+.....
T Consensus 150 FGla~~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwS----------lGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 150 FGLAKKYRDTSTHQHI-PYRENKNLTGTARYASVNTHLGIEQSRRDDLES----------LGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CTTCEECBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHSSCTTSSCCC
T ss_pred CCcceeccCCcccccc-ccccccccCCCccccCHHHhcCCCCChHHHHHH----------HHHHHHHHHhCCCCCccccc
Confidence 9999876543321110 111223467999999999999999999999999 88899999999999863222
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.+.......+..... ..........++.++.+++..||..||++||++++|++.|+.+...
T Consensus 219 ~~~~~~~~~i~~~~~-~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 219 GTKKQKYEKISEKKV-ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp SSHHHHHHHHHHHHH-HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHhhccc-cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111100000 0001111233467899999999999999999999999999998653
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=321.30 Aligned_cols=307 Identities=24% Similarity=0.354 Sum_probs=215.5
Q ss_pred CCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCC
Q 040925 43 LGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNL 122 (833)
Q Consensus 43 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 122 (833)
+..+++|++|++++|.++. +| .|..+++|++|++++|+++ .++. |.++++|++|+|++|.++. + ..|.++++|
T Consensus 40 ~~~l~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~-~~~~--~~~l~~L~~L~L~~n~i~~-~-~~~~~l~~L 112 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQIT-DISP--LSNLVKLTNLYIGTNKITD-I-SALQNLTNL 112 (347)
T ss_dssp HHHHTTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTC
T ss_pred chhcccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccc-cchh--hhcCCcCCEEEccCCcccC-c-hHHcCCCcC
Confidence 4567788888888888874 33 3777888888888888887 5554 6777888888888887764 2 357777888
Q ss_pred cEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhccccc
Q 040925 123 ELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVI 202 (833)
Q Consensus 123 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~ 202 (833)
++|+|++|+++++++ +..+++|++|++++|..... +..+..+++|++|++++|++.+
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~-------~~~~~~l~~L~~L~l~~~~~~~-------------- 169 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSD-------LSPLSNMTGLNYLTVTESKVKD-------------- 169 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCC-------CGGGTTCTTCCEEECCSSCCCC--------------
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCccc-------ccchhhCCCCcEEEecCCCcCC--------------
Confidence 888888887776554 67777777777777743321 1225666777777777776651
Q ss_pred EEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeeccc
Q 040925 203 NFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNS 282 (833)
Q Consensus 203 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 282 (833)
.+. +..+++|+.|++++|++.+..+ +..+++|+.|++++|.+++..+ +..+++|++|++++|+
T Consensus 170 ------------~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~ 232 (347)
T 4fmz_A 170 ------------VTP-IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK 232 (347)
T ss_dssp ------------CGG-GGGCTTCSEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred ------------chh-hccCCCCCEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCc
Confidence 111 5566677777777777764433 6666777777777777764433 6666777777777777
Q ss_pred ccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCc
Q 040925 283 LQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPG 362 (833)
Q Consensus 283 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~ 362 (833)
+++..+ +..+++|++|++++|.++ +. ..+..+++|++|++++|.+++. .
T Consensus 233 l~~~~~--~~~l~~L~~L~l~~n~l~-------------------------~~--~~~~~l~~L~~L~l~~n~l~~~--~ 281 (347)
T 4fmz_A 233 ITDLSP--LANLSQLTWLEIGTNQIS-------------------------DI--NAVKDLTKLKMLNVGSNQISDI--S 281 (347)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCC-------------------------CC--GGGTTCTTCCEEECCSSCCCCC--G
T ss_pred cCCCcc--hhcCCCCCEEECCCCccC-------------------------CC--hhHhcCCCcCEEEccCCccCCC--h
Confidence 664333 556666655555555544 22 3466788888999999988865 4
Q ss_pred cccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCc
Q 040925 363 TLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE 429 (833)
Q Consensus 363 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~ 429 (833)
.+..+++|+.|++++|++++..+..+..+++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 282 ~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp GGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 58888899999999999888888888888999999999999987666 788889999999998876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=321.94 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=195.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++... ....+.+.+|+++++.++||||+++++++...+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT----- 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC-----
Confidence 468999999999999999999999899999999996432 233467899999999999999999999976654
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~df 155 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHG------RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADF 155 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCC
T ss_pred eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeec
Confidence 8999999999999999997654 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|++........ .....||+.|+|||++.+..+ +.++|||| .|+++++++++..|+.....
T Consensus 156 g~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~~l~~l~~g~~p~~~~~~ 216 (276)
T 2h6d_A 156 GLSNMMSDGEF---------LRTSCGSPNYAAPEVISGRLYAGPEVDIWS----------CGVILYALLCGTLPFDDEHV 216 (276)
T ss_dssp CGGGCCCC----------------------CCTGGGTTSCCCHHHHHHHH----------HHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccCCCcc---------eecccCCccccCHHHHcCCCCCCccchHHH----------HHHHHHHHHhCCCCCCCCcH
Confidence 99986644221 112458999999999888765 68999999 88889999999888753211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
........... ...+..++..+.+++.+||+.||++|||++|+++.
T Consensus 217 --~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 217 --PTLFKKIRGGV-------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp --HHHHHHHHHCC-------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHhhcCc-------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01111100000 01112245678899999999999999999999885
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=350.72 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=204.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~----- 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG----- 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC-----
Confidence 457999999999999999999999999999999996442 334577999999999999999999999976654
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee---cCCCcEEE
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL---DHDMVAHV 683 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kL 683 (833)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||++ +.++.+||
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl 170 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRK------RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRI 170 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS------CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEE
Confidence 8999999999999999998654 689999999999999999999999 99999999999999 56789999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+|||+|+...... ......||+.|+|||++.+ .++.++|||| .|+++|+++++..|+...
T Consensus 171 ~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~Diws----------lG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 171 IDFGLSTHFEASK---------KMKDKIGTAYYIAPEVLHG-TYDEKCDVWS----------TGVILYILLSGCPPFNGA 230 (484)
T ss_dssp CCTTHHHHBCCCC---------SHHHHTTGGGTCCHHHHHT-CCCTHHHHHH----------HHHHHHHHHHSSCSSCCS
T ss_pred EeeeeeEEccccc---------ccccCCCCccccCceeecC-CCCCcceeHH----------HHHHHHHHHHCCCCCCCC
Confidence 9999998654322 1223469999999999876 6999999999 888999999999987632
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... ............. .......+++.+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~--~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 231 NEY--DILKKVEKGKYTF---ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp SHH--HHHHHHHHCCCCC---CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CHH--HHHHHHHcCCCCC---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 211 1111111111100 011123356678899999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=333.14 Aligned_cols=259 Identities=19% Similarity=0.266 Sum_probs=194.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTD-FKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 606 (833)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+.+|++++++++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 3679999999999999999999999999999999964322 23467889999999999999999999986543 12224
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||+ +++|.+++... .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df 172 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 172 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence 579999999 78999999763 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|+++..... .....||+.|+|||++.+ ..++.++|||| .|+++++++++..|+...+.
T Consensus 173 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 173 GLARQADSE-----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWS----------VGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp TTCEECCSS-----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHH----------HHHHHHHHHHSSCSSCCSSH
T ss_pred ecccccccc-----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHH----------HHHHHHHHHhCCCCCCCCCH
Confidence 999865432 123468999999999877 67999999999 77888888888887652221
Q ss_pred cccc-------------ch--------hhhccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPS-------------LL--------MEVMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~-------------~~--------~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+.- .. ...+.... .............++.+.+++.+||..||++|||++|+++.
T Consensus 232 ~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 232 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 1100 00 00000000 00000001112345678899999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=358.82 Aligned_cols=254 Identities=23% Similarity=0.299 Sum_probs=199.1
Q ss_pred ceeccCcceEEEEEEE--CCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTL--GEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
+.||+|+||.||+|.+ ..+++.||||+++.... ...+.+.+|++++++++|||||++++++... ..++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~------~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS------SEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC------CEEEEE
Confidence 4799999999999955 45678999999975432 2357899999999999999999999997532 478999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++.+++.|+.||+.||+|||+. +|+||||||+||+++.++.+||+|||+|+.+
T Consensus 449 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred EccCCCCHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 9999999999997654 689999999999999999999999 9999999999999999999999999999876
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccch
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLL 771 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~ 771 (833)
....... .......||+.|+|||++.+..++.++|||| +|++++++++ +..|+...... ..
T Consensus 520 ~~~~~~~-----~~~~~~~~t~~y~APE~~~~~~~~~~sDvwS----------lGv~l~ellt~G~~Pf~~~~~~--~~- 581 (635)
T 4fl3_A 520 RADENYY-----KAQTHGKWPVKWYAPECINYYKFSSKSDVWS----------FGVLMWEAFSYGQKPYRGMKGS--EV- 581 (635)
T ss_dssp TC------------------CGGGSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTTCCSSTTCCHH--HH-
T ss_pred ccCcccc-----ccccCCCCceeeeChhhhcCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCCHH--HH-
Confidence 5432111 1112234788999999999989999999999 7888889887 88887532211 11
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
...+.... ....+..+++.+.+++.+||+.||++|||+++|++.|+.+..++
T Consensus 582 ~~~i~~~~-----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 582 TAMLEKGE-----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCC-----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 11111100 01122345678999999999999999999999999999987654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=343.30 Aligned_cols=258 Identities=14% Similarity=0.112 Sum_probs=192.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHH---HHhhcCCCccceEe-------eE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECE---ALRNIRHRNLIKII-------TI 596 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~~~-------~~ 596 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|+. ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46799999999999999999999889999999999743 2334577899994 55555899999998 44
Q ss_pred eecCCC-------CCCc-----eEeEEEEecCCCChhhhhccCCCcc-ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 040925 597 CSSTDF-------KGTD-----FKAFVFEYMENGSLKDWLHQSDDQV-EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPM 663 (833)
Q Consensus 597 ~~~~~~-------~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 663 (833)
+...+. .+.+ ..++||||+ +|+|.+++....... ....+++..++.|+.||+.||+|||+. +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 433310 0111 278999999 579999998643110 011344588889999999999999999 99
Q ss_pred eeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCC-----------CCCcccc
Q 040925 664 VHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-----------EASMTGD 732 (833)
Q Consensus 664 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~D 732 (833)
+||||||+||+++.++.+||+|||+|+..... .....| +.|+|||++.+. .++.++|
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 295 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFD 295 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTCE-----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCCc-----------ccCCCC-cCccChhhhcccccccccccccccCChhhh
Confidence 99999999999999999999999999854321 123457 999999999887 8999999
Q ss_pred cccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC
Q 040925 733 IFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM 812 (833)
Q Consensus 733 i~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 812 (833)
||| +|+++++++++..|+......+. ....... ...+++.+.+++.+||..||++||
T Consensus 296 vwS----------lG~il~elltg~~Pf~~~~~~~~--~~~~~~~-----------~~~~~~~~~~li~~~L~~dp~~Rp 352 (377)
T 3byv_A 296 AWA----------LGLVIYWIWCADLPITKDAALGG--SEWIFRS-----------CKNIPQPVRALLEGFLRYPKEDRL 352 (377)
T ss_dssp HHH----------HHHHHHHHHHSSCCC------CC--SGGGGSS-----------CCCCCHHHHHHHHHHTCSSGGGCC
T ss_pred HHH----------HHHHHHHHHHCCCCCcccccccc--hhhhhhh-----------ccCCCHHHHHHHHHHcCCCchhCC
Confidence 999 88899999999988753221111 0000000 012356788999999999999999
Q ss_pred CHHHHHHH--HHHhhh
Q 040925 813 DMRDVVAK--LCHTRE 826 (833)
Q Consensus 813 t~~eil~~--L~~i~~ 826 (833)
|+.|+++. +.++.+
T Consensus 353 t~~e~l~hp~f~~~~~ 368 (377)
T 3byv_A 353 LPLQAMETPEYEQLRT 368 (377)
T ss_dssp CHHHHHTSHHHHHHHH
T ss_pred CHHHHhhChHHHHHHH
Confidence 99999863 444443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=329.24 Aligned_cols=253 Identities=20% Similarity=0.293 Sum_probs=198.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~~ 92 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-----KLW 92 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------CEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-----eEE
Confidence 468999999999999999999999899999999997666666788999999999999999999999986654 789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+|||++
T Consensus 93 lv~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 164 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVS 164 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHH
T ss_pred EEEEeCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCC
Confidence 99999999999999875332 689999999999999999999999 9999999999999999999999999988
Q ss_pred cccCcccccccccCCCccccccccccccCcccc-----CCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYG-----MGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
........ ......||+.|+|||++ .+..++.++|||| +|+++++++++..|+....
T Consensus 165 ~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 165 AKNLKTLQ--------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS----------LGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp HHHHHHHH--------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHH----------HHHHHHHHHHSSCTTTTSC
T ss_pred cccccccc--------ccccccCChhhcCCeeeccccCCCCCCchhhhHHH----------HHHHHHHHhcCCCCCccCC
Confidence 64322111 11124699999999987 4677899999999 8888999999988875322
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
..+ .......... .....+..++..+.+++.+||..||++|||++|+++
T Consensus 227 ~~~--~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 227 PMR--VLLKIAKSDP----PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHH--HHHHHHHSCC----CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHH--HHHHHhccCC----cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111 1111111100 001112334567889999999999999999999976
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=332.47 Aligned_cols=259 Identities=20% Similarity=0.303 Sum_probs=197.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|++++++++||||+++++++.... .
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKK-----R 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----E
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCC-----E
Confidence 45799999999999999999999999999999998654332 2356789999999999999999999986654 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++++|.++..... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 99 ~~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg 169 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELFPN------GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFG 169 (331)
T ss_dssp EEEEEECCSEEHHHHHHHSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCcchHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCC
Confidence 999999999999988876544 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
+++....... ......||+.|+|||++.+. .++.++|||| .|+++++++++..|+......
T Consensus 170 ~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~~~ 231 (331)
T 4aaa_A 170 FARTLAAPGE--------VYDDEVATRWYRAPELLVGDVKYGKAVDVWA----------IGCLVTEMFMGEPLFPGDSDI 231 (331)
T ss_dssp TC--------------------CCCCCTTCCHHHHTTCTTCCTHHHHHH----------HHHHHHHHHHSSCSCCCSSHH
T ss_pred CceeecCCcc--------ccCCCcCCccccCcccccCCCCcchHHHHHH----------HHHHHHHHHhCCCCCCCCCcH
Confidence 9986544221 11234699999999998775 6899999999 788888998888776522211
Q ss_pred cccchh-hhcc---------------------ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLM-EVMT---------------------NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~-~~~~---------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+..... .... .............+.+++.+.+++.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 232 DQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 100000 0000 00000000011112346778999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=332.63 Aligned_cols=271 Identities=19% Similarity=0.219 Sum_probs=193.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCC---CCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTD---FKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~---~~~~ 605 (833)
..+|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.+++++. ||||+++++++.... ....
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 458999999999999999999999999999999997655555678899999999996 999999999985322 1334
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceeeCCCCCCeeecCCCcEEE
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP--MVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kL 683 (833)
...++||||++ |+|.+++...... ..+++.+++.++.|++.||+|||+. + |+||||||+||+++.++.+||
T Consensus 107 ~~~~lv~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 107 AEFLLLTELCK-GQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp EEEEEEEECCS-EEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEB
T ss_pred ceEEEEEEecC-CCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEE
Confidence 56899999996 6999988752211 1689999999999999999999999 8 999999999999999999999
Q ss_pred cccccccccCccccccccc----CCCccccccccccccCcccc---CCCCCCcccccccCCcCCCccccCCccHHHHHHH
Q 040925 684 CDFGLAKFLSDHQLDTAVK----TPSSSIGLKGTVGYVAPEYG---MGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
+|||+++............ .........||+.|+|||++ .+..++.++|||| +|+++++++++
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~s----------lG~il~el~~g 249 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA----------LGCILYLLCFR 249 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHH----------HHHHHHHHHHS
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHH----------HHHHHHHHHhC
Confidence 9999998765432211000 00111234699999999998 5677899999999 88889999999
Q ss_pred hCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 757 ALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
..|+...... ... ....... .....+..+.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 250 ~~p~~~~~~~--~~~----~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 250 QHPFEDGAKL--RIV----NGKYSIP-----PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp SCCC------------------CCCC-----TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCCCcchhHH--Hhh----cCcccCC-----cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 9887522211 110 0000000 01112345778999999999999999999999999987653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=333.74 Aligned_cols=262 Identities=23% Similarity=0.304 Sum_probs=192.1
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-----cchhHHHHHHHHHhhcCCCccceEeeEeecCC
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-----GASRSFVAECEALRNIRHRNLIKIITICSSTD 601 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 601 (833)
....++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|++++++++||||+++++++....
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 3445789999999999999999999998999999999974322 12357889999999999999999999975544
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcE
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 681 (833)
..++||||+++ +|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 86 -----~~~lv~e~~~~-~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 151 (346)
T 1ua2_A 86 -----NISLVFDFMET-DLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVL 151 (346)
T ss_dssp -----CCEEEEECCSE-EHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCE
T ss_pred -----ceEEEEEcCCC-CHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCE
Confidence 78999999985 89998876542 588999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
||+|||+++....... ......||+.|+|||++.+. .++.++|||| .|+++++++++..|+
T Consensus 152 kl~Dfg~a~~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~ell~g~~~~ 213 (346)
T 1ua2_A 152 KLADFGLAKSFGSPNR--------AYTHQVVTRWYRAPELLFGARMYGVGVDMWA----------VGCILAELLLRVPFL 213 (346)
T ss_dssp EECCCGGGSTTTSCCC--------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH----------HHHHHHHHHHSSCSS
T ss_pred EEEecccceeccCCcc--------cCCcccccccccCchHhhCCCCCCchhhhHh----------HHHHHHHHHHCCCCC
Confidence 9999999987643221 12234699999999998764 4899999999 777788888876665
Q ss_pred cccccccc--cch-----------h------hhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 761 KVMEIVDP--SLL-----------M------EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 761 ~~~~~~~~--~~~-----------~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......+. ... . +..................++..+.+++.+||..||++|||++|+++.
T Consensus 214 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 214 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 42111000 000 0 000000000000001112345678999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=347.60 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=200.7
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-------------cchhHHHHHHHHHhhcCCCccceEee
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-------------GASRSFVAECEALRNIRHRNLIKIIT 595 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~ 595 (833)
..++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|++++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35689999999999999999999999999999999974321 23467899999999999999999999
Q ss_pred EeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee
Q 040925 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL 675 (833)
Q Consensus 596 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll 675 (833)
++.... ..++|||||++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~~~-----~~~lv~e~~~gg~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~ 179 (504)
T 3q5i_A 114 VFEDKK-----YFYLVTEFYEGGELFEQIINRH------KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILL 179 (504)
T ss_dssp EEECSS-----EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred EEEcCC-----EEEEEEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEE
Confidence 976554 8999999999999999997654 689999999999999999999999 99999999999999
Q ss_pred cCCC---cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHH
Q 040925 676 DHDM---VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHE 752 (833)
Q Consensus 676 ~~~~---~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~ 752 (833)
+.++ .+||+|||+|+...... ......||+.|+|||++.+ .++.++|||| .|+++|+
T Consensus 180 ~~~~~~~~~kl~Dfg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~Diws----------lG~il~~ 239 (504)
T 3q5i_A 180 ENKNSLLNIKIVDFGLSSFFSKDY---------KLRDRLGTAYYIAPEVLKK-KYNEKCDVWS----------CGVIMYI 239 (504)
T ss_dssp SSTTCCSSEEECCCTTCEECCTTS---------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHH----------HHHHHHH
T ss_pred ecCCCCccEEEEECCCCEEcCCCC---------ccccccCCcCCCCHHHhcc-CCCchHHHHH----------HHHHHHH
Confidence 8776 69999999998765432 1223469999999999774 6999999999 8889999
Q ss_pred HHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 753 FAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 753 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++++..|+..... ............... ......+++.+.+++.+||..||++|||++|+++.
T Consensus 240 ll~g~~pf~~~~~--~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 240 LLCGYPPFGGQND--QDIIKKVEKGKYYFD---FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHSSCSSCCSSH--HHHHHHHHHCCCCCC---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhCCCCCCCCCH--HHHHHHHHcCCCCCC---ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 9999988763221 111111111111000 01112345678999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=323.61 Aligned_cols=254 Identities=22% Similarity=0.293 Sum_probs=198.2
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
+|.....||+|+||.||+|++..+++.||||.++.......+.+.+|+.+++.++||||+++++++...+ ..++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv 97 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENG-----FIKIF 97 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC-----cEEEE
Confidence 4555669999999999999999899999999998665556678999999999999999999999986654 88999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-CCcEEEccccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-DMVAHVCDFGLAK 690 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfG~a~ 690 (833)
|||+++++|.+++...... ..+++..++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||++.
T Consensus 98 ~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~ 171 (295)
T 2clq_A 98 MEQVPGGSLSALLRSKWGP---LKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSK 171 (295)
T ss_dssp EECCSEEEHHHHHHHTTCC---CTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCE
T ss_pred EEeCCCCCHHHHHHhhccC---CCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeeccccc
Confidence 9999999999999865321 1467889999999999999999999 9999999999999987 8999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCC--CCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE--ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
....... ......||+.|+|||++.+.. ++.++|||| +|+++++++++..|+........
T Consensus 172 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~~~~~ 233 (295)
T 2clq_A 172 RLAGINP--------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWS----------LGCTIIEMATGKPPFYELGEPQA 233 (295)
T ss_dssp ESCC-------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHH----------HHHHHHHHHHTSCTTGGGSSHHH
T ss_pred ccCCCCC--------cccccCCCccccChhhhcCCCCCCCcHHHHHH----------HHHHHHHHHHCCCCccCCCchhH
Confidence 6543211 112346999999999987643 789999999 88899999999888753211111
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......... .....+..++..+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 234 AMFKVGMFK------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp HHHHHHHHC------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred HHHhhcccc------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110000000 0001123346678899999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=327.66 Aligned_cols=260 Identities=20% Similarity=0.261 Sum_probs=203.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|++..+++.||+|+++.... ...+.+.+|++++++++||||+++++++.... ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG---GTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC---Cce
Confidence 4689999999999999999999999999999999975432 23467899999999999999999999875322 347
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC-----ceeeCCCCCCeeecCCCcEE
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP-----MVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~k 682 (833)
.++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+|
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~k 156 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVK 156 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEE
T ss_pred EEEEEeCCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEE
Confidence 89999999999999999764311 12489999999999999999999999 8 99999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
|+|||+++....... ......||+.|+|||++.+..++.++|||| +|+++++++++..|+..
T Consensus 157 l~dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 157 LGDFGLARILNHDTS--------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWS----------LGCLLYELCALMPPFTA 218 (279)
T ss_dssp ECCCCHHHHC---CH--------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHH----------HHHHHHHHHHSSCSSCC
T ss_pred EecCchheeeccccc--------cccccCCCccccChHHhccCCCCchhhHHH----------HHHHHHHHHHCCCCCcc
Confidence 999999986543211 111245899999999999889999999999 88899999999888753
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
... ............ ...+..++..+.+++.+||+.||++|||++|+++.+..
T Consensus 219 ~~~--~~~~~~i~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 219 FSQ--KELAGKIREGKF------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp SSH--HHHHHHHHHTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cCH--HHHHHHHhhccc------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 221 111111111100 01122346678999999999999999999999986543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=331.51 Aligned_cols=268 Identities=22% Similarity=0.312 Sum_probs=198.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCC---CC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDF---KG 604 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 604 (833)
.++|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|++++++++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4689999999999999999999998999999999864432 234578899999999999999999999876431 11
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
.+..++||||+++ ++.+.+..... .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~ 166 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 166 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEc
Confidence 3478999999975 88887766532 689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
|||+|+.+...... .........||+.|+|||++.+ ..++.++|||| .|+++++++++..|+...
T Consensus 167 Dfg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws----------lG~il~ell~g~~pf~~~ 232 (351)
T 3mi9_A 167 DFGLARAFSLAKNS----QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG----------AGCIMAEMWTRSPIMQGN 232 (351)
T ss_dssp CCTTCEECCCCSSS----SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHH----------HHHHHHHHHHSSCSCCCS
T ss_pred cchhcccccccccc----cccccCCcccccCccCchhhcCCCCCCcHhHHHH----------HHHHHHHHHhCCCCCCCC
Confidence 99999876532211 1122234578999999998876 45899999999 777788888887775421
Q ss_pred ccc-------------cccchhhhcc----ccch-hhhh-----hhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIV-------------DPSLLMEVMT----NNSM-IQED-----KRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~-------------~~~~~~~~~~----~~~~-~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... .+........ .... .... .........+.+.+++.+||+.||++|||++|+++.
T Consensus 233 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 233 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 100 0000000000 0000 0000 000001113568899999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=355.73 Aligned_cols=261 Identities=27% Similarity=0.408 Sum_probs=206.2
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
....++|++.+.||+|+||.||+|++.. +..||||+++... ...+.+.+|+++|++++||||+++++++.. .
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~ 334 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 334 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee------c
Confidence 3445679999999999999999999974 5679999997543 345689999999999999999999999754 2
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++|+|.+++..... ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF 407 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 407 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCT
T ss_pred cceEeeehhcCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccc
Confidence 57899999999999999975321 1589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
|+++......... .....+|..|+|||++.+..++.++|||| +|++++++++ +..|+.....
T Consensus 408 G~a~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS----------lGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 408 GLARLIEDNEYTA-------RQGAKFPIKWTAPEAALYGRFTIKSDVWS----------FGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp TSTTTCCCHHHHT-------TCSTTSCGGGSCHHHHHHCCCCHHHHHHH----------HHHHHHHHTTTTCCSSTTCCH
T ss_pred ccceecCCCceec-------ccCCcCcccccCHHHhccCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCCH
Confidence 9998765432211 11234788999999998889999999999 7777778777 6666542111
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.......... . ....+..++..+.++|.+||+.||++|||+++|++.|+.+...
T Consensus 471 --~~~~~~i~~~-~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 471 --REVLDQVERG-Y-----RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp --HHHHHHHHTT-C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred --HHHHHHHHcC-C-----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 1111111110 0 0111234567789999999999999999999999999988654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=325.49 Aligned_cols=249 Identities=20% Similarity=0.232 Sum_probs=195.2
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 605 (833)
..++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+..+.++ +||||+++++++...+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~---- 84 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD---- 84 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT----
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC----
Confidence 3568999999999999999999999899999999997542 23456788999999999 8999999999986655
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-------
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD------- 678 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~------- 678 (833)
..++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||+. +|+||||||+||+++.+
T Consensus 85 -~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~ 158 (289)
T 1x8b_A 85 -HMLIQNEYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAAS 158 (289)
T ss_dssp -EEEEEEECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC---------
T ss_pred -eEEEEEEecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccc
Confidence 899999999999999999864211 12689999999999999999999999 99999999999999844
Q ss_pred ------------CcEEEcccccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCcccc
Q 040925 679 ------------MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFN 745 (833)
Q Consensus 679 ------------~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~ 745 (833)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||
T Consensus 159 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------------~~~gt~~y~aPE~~~~~~~~~~~~Di~s---------- 216 (289)
T 1x8b_A 159 EEGDEDDWASNKVMFKIGDLGHVTRISSPQ------------VEEGDSRFLANEVLQENYTHLPKADIFA---------- 216 (289)
T ss_dssp -----------CCCEEECCCTTCEETTCSC------------CCCCCGGGCCHHHHTTCCTTHHHHHHHH----------
T ss_pred cccccccccCCceEEEEcccccccccCCcc------------ccCCCccccChhHhcCCCCCCchhhHHH----------
Confidence 479999999998664422 13499999999998776 5678999999
Q ss_pred CCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 746 EGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 746 ~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+|++++++.++..++...+.. ........ ...+..+++.+.+++.+||+.||++|||++|+++.
T Consensus 217 lG~il~~l~~~~~~~~~~~~~-----~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 217 LALTVVCAAGAEPLPRNGDQW-----HEIRQGRL------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp HHHHHHHHTTCCCCCSSSHHH-----HHHHTTCC------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred HHHHHHHHhcCCCCCcchhHH-----HHHHcCCC------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 667777777666543321110 01111100 01112345678899999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.18 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=191.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCC--CccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRH--RNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|.+. +++.||||+++..... ..+.+.+|++++++++| |||+++++++....
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~---- 82 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ---- 82 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS----
T ss_pred cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC----
Confidence 357999999999999999999985 6889999999754322 34678999999999986 99999999976655
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++|||| .+|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++ ++.+||+|
T Consensus 83 -~~~lv~e~-~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~D 150 (343)
T 3dbq_A 83 -YIYMVMEC-GNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLID 150 (343)
T ss_dssp -EEEEEECC-CSEEHHHHHHHSC------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECC
T ss_pred -EEEEEEeC-CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEee
Confidence 89999995 5789999998754 689999999999999999999999 999999999999997 67899999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCC-----------CCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-----------SEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
||+++........ .......||+.|+|||++.+ ..++.++|||| +|+++++++
T Consensus 151 FG~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Diws----------lG~il~ell 214 (343)
T 3dbq_A 151 FGIANQMQPDTTS------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS----------LGCILYYMT 214 (343)
T ss_dssp CSSSCCC------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHH----------HHHHHHHHH
T ss_pred cccccccCccccc------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHH----------HHHHHHHHH
Confidence 9999876543211 11223569999999998754 67899999999 888999999
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++..|+....... ........... ....+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 215 ~g~~pf~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 215 YGKTPFQQIINQI-SKLHAIIDPNH-----EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HSSCTTTTCCSHH-HHHHHHHCTTS-----CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCcchhhhhHH-HHHHHHhcCCc-----ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 9998875211000 00000000000 000111224567899999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=325.57 Aligned_cols=253 Identities=23% Similarity=0.306 Sum_probs=198.8
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
..++|++.+.||+|+||.||+|.+..+++.||+|.+... ...+.+.+|+.++++++||||+++++++.... ..
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNT-----DL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCC-----EE
Confidence 456899999999999999999999989999999999753 34567899999999999999999999986654 88
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||+++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 171 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNK-----TLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGV 171 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEeecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeeccc
Confidence 999999999999999974321 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+........ ......||+.|+|||++.+..++.++|||| +|+++++++++..|+........
T Consensus 172 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~~~~~~ 233 (314)
T 3com_A 172 AGQLTDTMA--------KRNTVIGTPFWMAPEVIQEIGYNCVADIWS----------LGITAIEMAEGKPPYADIHPMRA 233 (314)
T ss_dssp CEECBTTBS--------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHH----------HHHHHHHHHHSSCTTTTSCHHHH
T ss_pred chhhhhhcc--------ccCccCCCCCccChhhcCCCCCCccccHHH----------HHHHHHHHHhCCCCCCCCChHHH
Confidence 976544221 112346999999999999989999999999 88889999999888753221111
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. ....... .....+..++..+.+++.+||..||++|||+.++++.
T Consensus 234 ~~--~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 234 IF--MIPTNPP----PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HH--HHHHSCC----CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HH--HHhcCCC----cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 0000000 0001122345678899999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.53 Aligned_cols=261 Identities=10% Similarity=-0.043 Sum_probs=183.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhc--CCCccceEe-------eEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNI--RHRNLIKII-------TIC 597 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~-------~~~ 597 (833)
..+|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 3459999999999999999999999999999999986543 2345677886555555 699988855 333
Q ss_pred ecCCCC------------CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHH------HHHHHHHHHHHHHHhhcC
Q 040925 598 SSTDFK------------GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQR------VNIAIDVASAMEYLHHHC 659 (833)
Q Consensus 598 ~~~~~~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~qi~~gL~~LH~~~ 659 (833)
...... .....|+||||++ |+|.+++..... .+++..+ ..++.|++.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQSK- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHHC-
Confidence 222100 0145899999998 899999986432 3444555 67789999999999999
Q ss_pred CCCceeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCC--CCCCcccccccCC
Q 040925 660 QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFTGR 737 (833)
Q Consensus 660 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~~ 737 (833)
+|+||||||+||+++.++.+||+|||+|+....... ...||+.|+|||++.+ ..++.++||||
T Consensus 214 --~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~-----------~~~~t~~y~aPE~~~~~~~~~~~~~DiwS-- 278 (371)
T 3q60_A 214 --GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP-----------ASSVPVTYAPREFLNASTATFTHALNAWQ-- 278 (371)
T ss_dssp --TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEEE-----------GGGSCGGGCCHHHHTCSEEECCHHHHHHH--
T ss_pred --CCccCcCCHHHEEECCCCCEEEEecceeeecCCCcc-----------CccCCcCCcChhhccCCCCCcCccccHHH--
Confidence 999999999999999999999999999986643221 2347799999999987 77999999999
Q ss_pred cCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHH
Q 040925 738 RPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDV 817 (833)
Q Consensus 738 ~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 817 (833)
+|+++++++++..|+...............................+++.+.+++.+||+.||++|||+.|+
T Consensus 279 --------lG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 279 --------LGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350 (371)
T ss_dssp --------HHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred --------HHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 888999999999987633211111000000000000000001112346678999999999999999999999
Q ss_pred HHH
Q 040925 818 VAK 820 (833)
Q Consensus 818 l~~ 820 (833)
++.
T Consensus 351 l~h 353 (371)
T 3q60_A 351 MET 353 (371)
T ss_dssp TTS
T ss_pred hcC
Confidence 763
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.62 Aligned_cols=266 Identities=21% Similarity=0.318 Sum_probs=200.0
Q ss_pred hcCCccCceeccCcceEEEEEE-----ECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGT-----LGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||.||+|+ ...+++.||||++.... ......+.+|+.++++++||||+++++++....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-- 106 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-- 106 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC--
Confidence 4689999999999999999999 44578899999996432 234467899999999999999999999976544
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCcc-ccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CC
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQV-EVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DM 679 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~ 679 (833)
..++||||+++|+|.+++....... ....+++.+++.++.|++.||.|||+. +|+||||||+||+++. +.
T Consensus 107 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 107 ---PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp ---SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred ---CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence 6799999999999999998754221 112589999999999999999999999 9999999999999984 44
Q ss_pred cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhC
Q 040925 680 VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TAL 758 (833)
Q Consensus 680 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~ 758 (833)
.+||+|||+++........ .......||+.|+|||++.+..++.++|||| +|++++++++ +..
T Consensus 181 ~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~ellt~g~~ 244 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRASYY------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWS----------FGVLLWEIFSLGYM 244 (327)
T ss_dssp CEEECCCHHHHHHHC------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCC
T ss_pred eEEECcccccccccccccc------ccCCCcCCCcceeCHhHhcCCCCCchhhHHH----------HHHHHHHHHcCCCC
Confidence 6999999999755332211 1112345899999999998889999999999 7778888886 666
Q ss_pred CCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 759 PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 759 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
|+..... ............ ......++..+.+++.+||+.||++|||+.|+++.++.+...
T Consensus 245 p~~~~~~--~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 245 PYPSKSN--QEVLEFVTSGGR------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp SSTTCCH--HHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCcCH--HHHHHHHhcCCC------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 6542211 111111111100 011223456788999999999999999999999999988653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.26 Aligned_cols=268 Identities=22% Similarity=0.319 Sum_probs=202.2
Q ss_pred ccchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEee
Q 040925 520 MVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICS 598 (833)
Q Consensus 520 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 598 (833)
.++..++....++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3455555667789999999999999999999999899999999997443 3457889999999999 7999999999987
Q ss_pred cCCCC-CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC
Q 040925 599 STDFK-GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH 677 (833)
Q Consensus 599 ~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 677 (833)
..... .....++||||+++|+|.+++...... .+++..++.++.|++.||+|||+. ||+||||||+||+++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~ 164 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTE 164 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECT
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcC
Confidence 64311 135789999999999999999865322 689999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccccccCcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHH
Q 040925 678 DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHE 752 (833)
Q Consensus 678 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~ 752 (833)
++.+||+|||++........ ......||+.|+|||++. +..++.++|||| +|+++++
T Consensus 165 ~~~~kl~Dfg~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s----------lG~il~~ 226 (326)
T 2x7f_A 165 NAEVKLVDFGVSAQLDRTVG--------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS----------LGITAIE 226 (326)
T ss_dssp TCCEEECCCTTTC---------------------CCGGGCCHHHHC--------CCTTHHHHH----------HHHHHHH
T ss_pred CCCEEEeeCcCceecCcCcc--------ccccccCCccccChhhhccccccCcCCCccchHHH----------HHHHHHH
Confidence 99999999999986543211 112346999999999986 567899999999 8888999
Q ss_pred HHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 753 FAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 753 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++++..|+........ ........ ........++..+.+++.+||..||++|||++|+++.
T Consensus 227 l~~g~~p~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 227 MAEGAPPLCDMHPMRA--LFLIPRNP-----APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHSSCTTTTSCHHHH--HHHHHHSC-----CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhCCCCCCCCcHHHH--HHHhhcCc-----cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 9999888752221110 00000000 0011112245678899999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=325.16 Aligned_cols=253 Identities=19% Similarity=0.223 Sum_probs=197.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|+||.||+|++..+++.||||+++. ...+.+.+|++++++++ ||||+++++++.... ....+
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~---~~~~~ 109 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA 109 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCCEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCC---CCceE
Confidence 679999999999999999999999999999999963 34577899999999997 999999999986532 34789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-cEEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~ 688 (833)
+||||+++++|.+++. .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 110 lv~e~~~~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~ 177 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 177 (330)
T ss_dssp EEEECCCCCCHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEeccCchhHHHHHH---------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCC
Confidence 9999999999999885 478899999999999999999999 999999999999999777 899999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
|+....... .....||+.|+|||++.+ ..++.++|||| .|+++++++++..|+.......
T Consensus 178 a~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Diws----------lG~il~~ll~g~~p~~~~~~~~ 238 (330)
T 3nsz_A 178 AEFYHPGQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWS----------LGCMLASMIFRKEPFFHGHDNY 238 (330)
T ss_dssp CEECCTTCC---------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHH----------HHHHHHHHHHTCSSSSCCSSHH
T ss_pred ceEcCCCCc---------cccccccccccChhhhcCCCcCCchhhHHH----------HHHHHHHHHhCCCCcccCCchH
Confidence 986544221 123468999999999877 67899999999 7888888888888863111000
Q ss_pred ccc-----------hhhhccc-cc-----------------hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHH
Q 040925 768 PSL-----------LMEVMTN-NS-----------------MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVV 818 (833)
Q Consensus 768 ~~~-----------~~~~~~~-~~-----------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil 818 (833)
..+ ..+.... .. ............+++.+.+++.+||+.||++|||++|++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l 318 (330)
T 3nsz_A 239 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 318 (330)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 000 0000000 00 000000011112467789999999999999999999998
Q ss_pred HH
Q 040925 819 AK 820 (833)
Q Consensus 819 ~~ 820 (833)
+.
T Consensus 319 ~h 320 (330)
T 3nsz_A 319 EH 320 (330)
T ss_dssp TS
T ss_pred cC
Confidence 74
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=329.78 Aligned_cols=260 Identities=18% Similarity=0.234 Sum_probs=193.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTD-FKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 606 (833)
.++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.... .....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999999999999999999975422 23467889999999999999999999986543 22334
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 171 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 171 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEcCCC-CHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEe
Confidence 78999999974 88888853 588999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+|+...... ......||+.|+|||++.+..++.++|||| .|+++++++++..|+......
T Consensus 172 g~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~~~~~ 232 (371)
T 2xrw_A 172 GLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWS----------VGCIMGEMIKGGVLFPGTDHI 232 (371)
T ss_dssp CC-------------------------CTTCCHHHHTTCCCCTTHHHHH----------HHHHHHHHHHSSCSSCCSSHH
T ss_pred eccccccccc---------ccCCceecCCccCHHHhcCCCCCchHhHHH----------HHHHHHHHHhCCCCCCCCCHH
Confidence 9998654321 112346999999999999999999999999 788888888888876522111
Q ss_pred cc-------------cchhh-------hccccc-------------hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC
Q 040925 767 DP-------------SLLME-------VMTNNS-------------MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD 813 (833)
Q Consensus 767 ~~-------------~~~~~-------~~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 813 (833)
+. ..... ...... ...+.........+..+.+++.+||..||++|||
T Consensus 233 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t 312 (371)
T 2xrw_A 233 DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 312 (371)
T ss_dssp HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC
Confidence 00 00000 000000 0000011112334678999999999999999999
Q ss_pred HHHHHHH
Q 040925 814 MRDVVAK 820 (833)
Q Consensus 814 ~~eil~~ 820 (833)
++|+++.
T Consensus 313 ~~e~l~h 319 (371)
T 2xrw_A 313 VDEALQH 319 (371)
T ss_dssp HHHHHHS
T ss_pred HHHHhCC
Confidence 9999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=322.50 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=202.0
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---------cchhHHHHHHHHHhhcC-CCccceEeeEee
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---------GASRSFVAECEALRNIR-HRNLIKIITICS 598 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 598 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35689999999999999999999999999999999975431 12356789999999996 999999999976
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD 678 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~ 678 (833)
... ..++||||+++|+|.+++.... .+++..++.++.|++.||.|||+. +|+||||||+||+++.+
T Consensus 95 ~~~-----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~ 160 (298)
T 1phk_A 95 TNT-----FFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDD 160 (298)
T ss_dssp CSS-----EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTT
T ss_pred cCC-----eEEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCC
Confidence 554 8999999999999999998643 689999999999999999999999 99999999999999999
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccC------CCCCCcccccccCCcCCCccccCCccHHH
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM------GSEASMTGDIFTGRRPIDAVFNEGHSLHE 752 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~s~~~~~~~~~~~g~~l~~ 752 (833)
+.+||+|||++....... ......||+.|+|||++. ...++.++|||| .|+++++
T Consensus 161 ~~~kl~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~s----------lG~~l~~ 221 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGE---------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS----------TGVIMYT 221 (298)
T ss_dssp CCEEECCCTTCEECCTTC---------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHH----------HHHHHHH
T ss_pred CcEEEecccchhhcCCCc---------ccccccCCccccCHHHhccccccccccCCcccccHh----------HHHHHHH
Confidence 999999999998654322 112346999999999874 456889999999 8889999
Q ss_pred HHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 753 FAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 753 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
++++..|+...... ............. .......++..+.+++.+||+.||++|||++|+++
T Consensus 222 l~~g~~p~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 222 LLAGSPPFWHRKQM--LMLRMIMSGNYQF---GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHSSCSSCCSSHH--HHHHHHHHTCCCC---CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCcCccHH--HHHHHHhcCCccc---CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 99998887532211 1111111111100 01112235667899999999999999999999986
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.50 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=191.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcC--CCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIR--HRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~ 606 (833)
.+|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++ ||||+++++++...+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~----- 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ----- 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred CceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-----
Confidence 46999999999999999999987 489999999975432 23467899999999996 599999999976655
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||| +.+|+|.+++.... .+++.+++.++.||+.||.|||+. +|+||||||+||+++ ++.+||+||
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DF 198 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDF 198 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCC
T ss_pred EEEEEEe-cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEec
Confidence 7999999 55789999998754 688999999999999999999999 999999999999995 689999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC-----------CCCCcccccccCCcCCCccccCCccHHHHHH
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-----------SEASMTGDIFTGRRPIDAVFNEGHSLHEFAK 755 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~ 755 (833)
|+++.+...... ......+||+.|+|||++.+ ..++.++|||| +|++++++++
T Consensus 199 G~a~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwS----------lGvil~ell~ 262 (390)
T 2zmd_A 199 GIANQMQPDTTS------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS----------LGCILYYMTY 262 (390)
T ss_dssp SSSCCC---------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHH----------HHHHHHHHHH
T ss_pred CccccccCCCcc------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHH----------HHHHHHHHHH
Confidence 999876543211 11223569999999998765 46899999999 8889999999
Q ss_pred HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 756 TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 756 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+..|+...... ............. ...+...+..+.+++.+||..||++|||+.|+++.
T Consensus 263 G~~Pf~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 263 GKTPFQQIINQ-ISKLHAIIDPNHE-----IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp SSCTTTTCCCH-HHHHHHHHCTTSC-----CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCcchhhhHH-HHHHHHHhCcccc-----CCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 99887521100 0000111110000 00011124568899999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=356.70 Aligned_cols=251 Identities=22% Similarity=0.251 Sum_probs=204.0
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFK 603 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 603 (833)
...++|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+..|.+++..+ +||+|+++++++.+.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--- 414 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--- 414 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS---
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC---
Confidence 3457899999999999999999999999999999999743 233456788999999988 699999999996544
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
...|+||||+++|+|.+++...+ .+++.+++.|+.||+.||+|||+. +||||||||+|||++.++.+||
T Consensus 415 --~~~~lV~E~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL 483 (674)
T 3pfq_A 415 --DRLYFVMEYVNGGDLMYHIQQVG------RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKI 483 (674)
T ss_dssp --SEEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEE
T ss_pred --CEEEEEEeCcCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEE
Confidence 48999999999999999998654 689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+|||+|+...... ......+||+.|+|||++.+..++.++|||| +|+++|+++++..|+...
T Consensus 484 ~DFGla~~~~~~~--------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwS----------lGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 484 ADFGMCKENIWDG--------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWA----------FGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp CCCTTCEECCCTT--------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHH----------HHHHHHHHHHSSCSSCCS
T ss_pred eecceeeccccCC--------cccccccCCCcccCHhhhcCCCCCccceEec----------hHHHHHHHHcCCCCCCCC
Confidence 9999998543221 1223467999999999999999999999999 889999999999998632
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH-----HHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM-----RDVVA 819 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~eil~ 819 (833)
+. ............ ..+...++.+.+++.+||+.||++||++ +||++
T Consensus 546 ~~--~~~~~~i~~~~~-------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 546 DE--DELFQSIMEHNV-------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SH--HHHHHHHHSSCC-------CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CH--HHHHHHHHhCCC-------CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 21 111111111111 1122346678999999999999999997 66654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.22 Aligned_cols=253 Identities=24% Similarity=0.255 Sum_probs=196.4
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--------CcchhHHHHHHHHHhhcCCCccceEeeEeecC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--------KGASRSFVAECEALRNIRHRNLIKIITICSST 600 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 600 (833)
..++|++.+.||+|+||.||+|++..+++.||||++.... ......+.+|++++++++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467999999999999999999999999999999986432 11234688999999999999999999997543
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV 680 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 680 (833)
..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 88 ------~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~ 152 (322)
T 2ycf_A 88 ------DYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEE 152 (322)
T ss_dssp ------SEEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSS
T ss_pred ------ceEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCC
Confidence 3799999999999999997654 689999999999999999999999 9999999999999987654
Q ss_pred ---EEEcccccccccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 681 ---AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 681 ---~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
+||+|||+++....... .....||+.|+|||++. ...++.++|||| +|+++++++
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s----------lG~il~~l~ 213 (322)
T 2ycf_A 153 DCLIKITDFGHSKILGETSL---------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS----------LGVILFICL 213 (322)
T ss_dssp SCCEEECCCTTCEECCCCHH---------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHH----------HHHHHHHHH
T ss_pred CCeEEEccCccceecccccc---------cccccCCcCccCchhhccCCCCCCCchhhHHH----------HHHHHHHHH
Confidence 99999999987644221 11246899999999863 567899999999 888999999
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
++..|+....... .............. ......++..+.+++.+||..||++|||++|+++
T Consensus 214 ~g~~pf~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 214 SGYPPFSEHRTQV-SLKDQITSGKYNFI---PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HSSCSSCSTTCSS-CHHHHHHHTCCCCC---HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCCCCCcccchHH-HHHHHHHhCccccC---chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9998875322110 11111111110000 0111234667899999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.35 Aligned_cols=197 Identities=24% Similarity=0.316 Sum_probs=168.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc------CCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI------RHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~~ 603 (833)
..+|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|+++++.+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~-- 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN-- 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT--
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC--
Confidence 35799999999999999999999999999999999643 22345678899988887 5779999999976654
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc--E
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV--A 681 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~ 681 (833)
..++||||++ |+|.+++...... .+++..++.++.||+.||+|||+. +|+||||||+||+++.++. +
T Consensus 173 ---~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~v 241 (429)
T 3kvw_A 173 ---HICMTFELLS-MNLYELIKKNKFQ----GFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGI 241 (429)
T ss_dssp ---EEEEEECCCC-CBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCE
T ss_pred ---eEEEEEeccC-CCHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcce
Confidence 8999999996 6999999876532 589999999999999999999999 9999999999999999987 9
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
||+|||+|+..... .....||+.|+|||++.+..++.++|||| +|+++++++++..|+.
T Consensus 242 kL~DFG~a~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lG~il~elltG~~pf~ 300 (429)
T 3kvw_A 242 KVIDFGSSCYEHQR-----------VYTYIQSRFYRAPEVILGARYGMPIDMWS----------LGCILAELLTGYPLLP 300 (429)
T ss_dssp EECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHHTBCCCTHHHHHH----------HHHHHHHHHHSSCSSC
T ss_pred EEeecccceecCCc-----------ccccCCCCCccChHHHhCCCCCchHHHHh----------HHHHHHHHHhCCCCCC
Confidence 99999999754332 12346999999999999999999999999 7778888888877654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=334.86 Aligned_cols=263 Identities=21% Similarity=0.249 Sum_probs=194.9
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC----
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDF---- 602 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 602 (833)
....++|++.+.||+|+||.||+|++..+++.||||++.... ....+|+++++.++||||+++++++.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 345678999999999999999999999999999999986432 223479999999999999999999855431
Q ss_pred -----------------------------CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHH
Q 040925 603 -----------------------------KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653 (833)
Q Consensus 603 -----------------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~ 653 (833)
.+..+.++||||++ |+|.+.+...... ...+++..++.++.|++.||+
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--GRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHH
Confidence 23446889999998 5888777642111 116899999999999999999
Q ss_pred HHhhcCCCCceeeCCCCCCeeec-CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCC-CCCccc
Q 040925 654 YLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTG 731 (833)
Q Consensus 654 ~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~ 731 (833)
|||+. ||+||||||+||+++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++
T Consensus 156 ~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~ 223 (383)
T 3eb0_A 156 FIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---------SVAYICSRFYRAPELMLGATEYTPSI 223 (383)
T ss_dssp HHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---------CCCCCCCSSCCCHHHHTTCSSCCTHH
T ss_pred HHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---------CcCcccCCCccCHHHhcCCCCCCcch
Confidence 99999 999999999999997 688999999999986543221 1234689999999998775 489999
Q ss_pred ccccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhcc----------------------ccchhhhhhhhch
Q 040925 732 DIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMT----------------------NNSMIQEDKRVKT 789 (833)
Q Consensus 732 Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~ 789 (833)
|||| .|+++++++++..|+......+. ....+. ............+
T Consensus 224 Diws----------lG~il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (383)
T 3eb0_A 224 DLWS----------IGCVFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291 (383)
T ss_dssp HHHH----------HHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred hhhh----------HHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence 9999 78888888888887753221110 000000 0000000011122
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 790 EECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 790 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..++..+.+++.+||+.||++|||+.|+++.
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2345678999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=333.54 Aligned_cols=253 Identities=20% Similarity=0.273 Sum_probs=199.8
Q ss_pred hcCCccCceeccCcceEEEEEEEC---CCceEEEEEEeeccC----CcchhHHHHHHHHHhhc-CCCccceEeeEeecCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLG---EDEMIVAVKVINLKY----KGASRSFVAECEALRNI-RHRNLIKIITICSSTD 601 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 601 (833)
.++|++.+.||+|+||.||+|++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468999999999999999999984 478999999986432 22345678899999999 6999999999976654
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcE
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 681 (833)
..++||||+++|+|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 133 -----~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 198 (355)
T 1vzo_A 133 -----KLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV 198 (355)
T ss_dssp -----EEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred -----eEEEEeecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcE
Confidence 8999999999999999998654 689999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCC--CCCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||| +|+++++++++..|
T Consensus 199 kl~DfG~a~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~~Dvws----------lG~il~ell~g~~p 261 (355)
T 1vzo_A 199 VLTDFGLSKEFVADETE-------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS----------LGVLMYELLTGASP 261 (355)
T ss_dssp EESCSSEEEECCGGGGG-------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHH----------HHHHHHHHHHSSCT
T ss_pred EEeeCCCCeecccCCCC-------cccCcccCcCccChhhhcCCCCCCCchhhHHH----------HHHHHHHHHHCCCC
Confidence 99999999865432211 1223569999999999885 34789999999 88899999999988
Q ss_pred Ccccccccc--cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 760 EKVMEIVDP--SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 760 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
+........ .+....... ....+.+++..+.+++.+||..||++|| |++|+++.
T Consensus 262 f~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 262 FTVDGEKNSQAEISRRILKS-------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp TSCTTSCCCHHHHHHHHHHC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CccCCccchHHHHHHHHhcc-------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 753221111 010010000 1112233456788999999999999999 99999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=330.99 Aligned_cols=270 Identities=22% Similarity=0.263 Sum_probs=202.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|++++++++||||+++++++....+......
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4689999999999999999999998999999999964322 234578899999999999999999999877655566789
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++||||++ |+|.+++... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||+
T Consensus 90 ~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGL 158 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccC-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccc
Confidence 99999997 5999998753 589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccc--cCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 689 AKFLSDHQLDTAV--KTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 689 a~~~~~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
++........... ..........||+.|+|||++.+ ..++.++|||| .|+++++++++..|+.....
T Consensus 159 a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~~ 228 (353)
T 2b9h_A 159 ARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWS----------CGCILAELFLRRPIFPGRDY 228 (353)
T ss_dssp CEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHH----------HHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHH----------HHHHHHHHHhCCCCCCCCCc
Confidence 9876543221110 01111234579999999998654 67899999999 78888888888887652221
Q ss_pred ccccc----------------------hhhhccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSL----------------------LMEVMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~----------------------~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+... ..+...... ............+++.+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000 000000000 00000011112356778899999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=329.04 Aligned_cols=270 Identities=18% Similarity=0.199 Sum_probs=200.0
Q ss_pred chHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-----------chhHHHHHHHHHhhcCCCcc
Q 040925 522 SYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-----------ASRSFVAECEALRNIRHRNL 590 (833)
Q Consensus 522 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni 590 (833)
...++....++|++.+.||+|+||.||+|.+. +++.||||++...... ..+.+.+|++++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 45678888899999999999999999999987 5899999998643221 12678999999999999999
Q ss_pred ceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 591 v~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
+++++++...+.......++||||++ |+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 162 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI-----VISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHP 162 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCCh
Confidence 99999986654344557899999998 589888876532 689999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCcc
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHS 749 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~ 749 (833)
+||+++.++.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||| .|++
T Consensus 163 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~i 223 (362)
T 3pg1_A 163 GNILLADNNDITICDFNLAREDTADAN---------KTHYVTHRWYRAPELVMQFKGFTKLVDMWS----------AGCV 223 (362)
T ss_dssp GGEEECTTCCEEECCTTC------------------------CGGGCCHHHHTTCTTCCTHHHHHH----------HHHH
T ss_pred HHEEEcCCCCEEEEecCcccccccccc---------cceecccceecCcHHhcCCCCCCcHhHHHh----------HHHH
Confidence 999999999999999999975433221 123468999999998876 67899999999 7888
Q ss_pred HHHHHHHhCCCcccccccccc-h--------------------hhhccccch--hhhhhhhchHHHHHHHHHHhhccCCC
Q 040925 750 LHEFAKTALPEKVMEIVDPSL-L--------------------MEVMTNNSM--IQEDKRVKTEECLNAIIRTGVLCSME 806 (833)
Q Consensus 750 l~~~~~~~~p~~~~~~~~~~~-~--------------------~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~ 806 (833)
+++++++..|+......+... . .+....... ............++.+.+++.+||+.
T Consensus 224 l~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 303 (362)
T 3pg1_A 224 MAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303 (362)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcC
Confidence 888888888765221100000 0 000000000 00000111123356788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 040925 807 SPFERMDMRDVVAK 820 (833)
Q Consensus 807 dP~~RPt~~eil~~ 820 (833)
||++|||++|+++.
T Consensus 304 dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 304 NPQRRISTEQALRH 317 (362)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHHcC
Confidence 99999999999875
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.37 Aligned_cols=256 Identities=21% Similarity=0.353 Sum_probs=199.4
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC----CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY----KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
..++|++.+.||+|+||.||+|.+..+++.||+|+++... ....+.+.+|++++++++||||+++++++... .
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 79 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---E 79 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC----
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---C
Confidence 3578999999999999999999999999999999996432 23456799999999999999999999997532 2
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
....++||||++++ +.+++...... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~ 151 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPEK----RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKIS 151 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTTC----SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred CCeEEEEehhccCC-HHHHHHhCccc----ccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEee
Confidence 34789999999875 87877764432 689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCC--CCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE--ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
|||++......... .......||+.|+|||++.+.. ++.++|||| .|+++++++++..|+..
T Consensus 152 dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 152 ALGVAEALHPFAAD------DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWS----------AGVTLYNITTGLYPFEG 215 (305)
T ss_dssp CCTTCEECCTTCSS------CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHH----------HHHHHHHHHHSSCSCCC
T ss_pred ccccccccCccccc------cccccCCCCCCCcChhhccCcccCCcchhhHHH----------HHHHHHHHHhCCCCCCC
Confidence 99999866432211 1112346999999999987644 478999999 88899999999988753
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.... .......... ...+..++..+.+++.+||..||++|||++|+++.
T Consensus 216 ~~~~--~~~~~i~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 216 DNIY--KLFENIGKGS-------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp SSHH--HHHHHHHHCC-------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred chHH--HHHHHHhcCC-------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2211 1111110110 01122345678899999999999999999999875
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=314.66 Aligned_cols=308 Identities=24% Similarity=0.378 Sum_probs=231.0
Q ss_pred cccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCC
Q 040925 18 FVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPN 97 (833)
Q Consensus 18 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~ 97 (833)
.+..+++|++|++++|.+.. +|. +..+++|++|+|++|+++++.+ |.++++|++|+|++|.++ .+| .|.++++
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~-~~~-~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~-~~~--~~~~l~~ 111 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVAS-IQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS--ALQNLTN 111 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG--GGTTCTT
T ss_pred cchhcccccEEEEeCCcccc-chh-hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCccc-Cch--HHcCCCc
Confidence 45678899999999999954 443 8889999999999999985444 999999999999999998 555 4789999
Q ss_pred ccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCC
Q 040925 98 LKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLK 177 (833)
Q Consensus 98 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~ 177 (833)
|++|+|++|.+++..+ +..+++|++|++++|...... ..+..+++|++|++++|.+..++. +..+++|+
T Consensus 112 L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--------~~~l~~L~ 180 (347)
T 4fmz_A 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--------IANLTDLY 180 (347)
T ss_dssp CSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--------GGGCTTCS
T ss_pred CCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--------hccCCCCC
Confidence 9999999999985433 889999999999999655333 348899999999999999876442 67889999
Q ss_pred EEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccc
Q 040925 178 ALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRN 257 (833)
Q Consensus 178 ~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 257 (833)
+|++++|++++ ++ . +..+++|+.|++++|++.+..+ +..+++|++|++++|
T Consensus 181 ~L~l~~n~l~~-~~-------------------------~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n 231 (347)
T 4fmz_A 181 SLSLNYNQIED-IS-------------------------P-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNN 231 (347)
T ss_dssp EEECTTSCCCC-CG-------------------------G-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSS
T ss_pred EEEccCCcccc-cc-------------------------c-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCC
Confidence 99999998872 11 1 4556666667777766664433 666667777777777
Q ss_pred cCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCC
Q 040925 258 FLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLP 337 (833)
Q Consensus 258 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~ 337 (833)
.+++..+ +..+++|++|++++|++++. ..+..+++|+.|++++|++++ +| .+..+..+ +.|++++|.+++..+
T Consensus 232 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L-~~L~L~~n~l~~~~~ 304 (347)
T 4fmz_A 232 KITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISD-IS-VLNNLSQL-NSLFLNNNQLGNEDM 304 (347)
T ss_dssp CCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTC-SEEECCSSCCCGGGH
T ss_pred ccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCC-Ch-hhcCCCCC-CEEECcCCcCCCcCh
Confidence 7764332 66667777777777776643 346666777777777777763 32 34455555 677777777777777
Q ss_pred cccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccc
Q 040925 338 LQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH 381 (833)
Q Consensus 338 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 381 (833)
..|..+++|++|++++|++++..| +..+++|++|++++|.|+
T Consensus 305 ~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 305 EVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 778888999999999999987666 888899999999999876
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=332.78 Aligned_cols=259 Identities=19% Similarity=0.260 Sum_probs=182.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTD-FKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 606 (833)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|++++++++||||+++++++.... .....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3689999999999999999999999999999999964422 23467889999999999999999999986542 22234
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||+ +++|.+++... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+||+||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF 176 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF 176 (367)
T ss_dssp CCEEEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred eEEEEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence 679999999 67999998753 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|+++..... .....||+.|+|||++.+ ..++.++|||| .|+++++++++..|+...+.
T Consensus 177 G~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 177 GLARHTADE-----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWS----------VGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp -------------------------CCCTTCCHHHHTTCCSCCTTHHHHH----------HHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccc-----------CCCcCcCcCccChHHHcCCcCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCH
Confidence 999865432 123469999999999877 67899999999 78888888888887652221
Q ss_pred cccc-------------ch--------hhhccccchh-hhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPS-------------LL--------MEVMTNNSMI-QEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~-------------~~--------~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+.- .. .......... ...........++.+.+++.+||..||++|||++|+++.
T Consensus 236 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 236 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 1100 00 0000000000 000000011235678899999999999999999999874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.83 Aligned_cols=265 Identities=25% Similarity=0.325 Sum_probs=195.1
Q ss_pred hcCCccCceeccCcceEEEEEEECC-C--ceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGE-D--EMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||.||+|++.. + +..||||+++... ....+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 93 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 93 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC---
Confidence 3579999999999999999998642 2 3469999987542 23456789999999999999999999997543
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||
T Consensus 94 ---~~~~v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl 162 (291)
T 1u46_A 94 ---PMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKI 162 (291)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred ---CceeeEecccCCCHHHHHHhccC-----CcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEE
Confidence 37899999999999999976431 689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKV 762 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~ 762 (833)
+|||++........... ......+|+.|+|||++.+..++.++|||| +|++++++++ +..|+..
T Consensus 163 ~Dfg~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 163 GDFGLMRALPQNDDHYV-----MQEHRKVPFAWCAPESLKTRTFSHASDTWM----------FGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp CCCTTCEECCC-CCEEE-----C-----CCGGGCCHHHHHHCEEEHHHHHHH----------HHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccccccchh-----hhccCCCCceeeCchhhcCCCCCchhhHHH----------HHHHHHHHHhCCCCCccc
Confidence 99999987654321111 112245788999999998888999999999 7888888888 7777652
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
... ............ .......++..+.+++.+||..||++|||+.++++.|+++......
T Consensus 228 ~~~--~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 288 (291)
T 1u46_A 228 LNG--SQILHKIDKEGE-----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMR 288 (291)
T ss_dssp CCH--HHHHHHHHTSCC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred CCH--HHHHHHHHccCC-----CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchh
Confidence 211 111111111100 0111233567789999999999999999999999999998765443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=327.82 Aligned_cols=270 Identities=22% Similarity=0.284 Sum_probs=183.7
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
...++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++||||+++++++...+
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 86 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD----- 86 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-----
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-----
Confidence 44578999999999999999999998889999999986442 234567889999999999999999999986655
Q ss_pred eEeEEEEecCCCChhhhhccCCCc--cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQ--VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence 789999999999999998742100 0012589999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
|||++.......... .........||+.|+|||++.+ ..++.++|||| +|+++++++++..|+...
T Consensus 164 dfg~~~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~ 230 (303)
T 2vwi_A 164 DFGVSAFLATGGDIT---RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWS----------FGITAIELATGAAPYHKY 230 (303)
T ss_dssp CCHHHHHCC------------------CCCTTCCHHHHHHHHCCCTHHHHHH----------HHHHHHHHHHSSCTTTTS
T ss_pred eccchheeccCCCcc---chhhhcccCCCccccCHHHhccccCCCchhhHHH----------HHHHHHHHHhCCCCCccC
Confidence 999997654322110 0111223569999999998865 56899999999 888899999998887532
Q ss_pred ccccccchhhhccccchhh---hhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQ---EDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
...+. ............ .........++..+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 231 PPMKV--LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CGGGH--HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred chhhH--HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 21111 000000000000 00001112245678899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=321.49 Aligned_cols=256 Identities=22% Similarity=0.270 Sum_probs=185.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-c-hhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-A-SRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|++..+++.||+|+++..... . .+.+.++...++.++||||+++++++...+ .
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-----~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-----D 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----S
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-----C
Confidence 46899999999999999999999999999999999754222 2 233445555678889999999999986554 7
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||++ |+|.+++...... ...+++..++.++.|++.||+|||++. ||+||||||+||+++.++.+||+|||
T Consensus 81 ~~lv~e~~~-~~l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 81 VWICMELMD-TSLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred EEEEEehhc-cchHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecC
Confidence 899999997 5888877642111 116899999999999999999999853 89999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCcccc----CCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYG----MGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+++....... .....||+.|+|||++ .+..++.++|||| .|+++++++++..|+...
T Consensus 156 ~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~p~~~~ 216 (290)
T 3fme_A 156 ISGYLVDDVA---------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWS----------LGITMIELAILRFPYDSW 216 (290)
T ss_dssp -----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHH----------HHHHHHHHHHTSCSSCCC
T ss_pred Cccccccccc---------ccccCCCccccChhhcChhhcCcCCCcHHHHHH----------HHHHHHHHHHCCCCcccc
Confidence 9986644321 1123599999999995 5667899999999 888999999999887532
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....... ........ .......+++.+.+++.+||+.||++|||++|+++.
T Consensus 217 ~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 217 GTPFQQL-KQVVEEPS-----PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp SCHHHHH-HHHHHSCC-----CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CchHHHH-HHHhccCC-----CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1111111 11111110 111122345678999999999999999999999873
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=327.65 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=198.9
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcc---h--------------hHHHHHHHHHhhcCCCccce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGA---S--------------RSFVAECEALRNIRHRNLIK 592 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~--------------~~~~~E~~~l~~l~h~niv~ 592 (833)
.++|++.+.||+|+||.||+|++ +++.||||++....... . +.+.+|++++++++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 89999999997432111 1 78999999999999999999
Q ss_pred EeeEeecCCCCCCceEeEEEEecCCCChhhh------hccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCcee
Q 040925 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDW------LHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVH 665 (833)
Q Consensus 593 ~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH 665 (833)
+++++...+ ..++||||+++|+|.++ +..... ..+++..++.++.|++.||+|||+ . ||+|
T Consensus 108 ~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H 175 (348)
T 2pml_X 108 CEGIITNYD-----EVYIIYEYMENDSILKFDEYFFVLDKNYT----CFIPIQVIKCIIKSVLNSFSYIHNEK---NICH 175 (348)
T ss_dssp CSEEEESSS-----EEEEEEECCTTCBSSEESSSEESSCSSSC----CCCCHHHHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred EEEEEeeCC-----eEEEEEeccCCCcHHHHHHHhhhhhhccc----cCCCHHHHHHHHHHHHHHHHHHhccC---CEee
Confidence 999986654 89999999999999999 554222 278999999999999999999999 8 9999
Q ss_pred eCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCC-CCCc-ccccccCCcCCCcc
Q 040925 666 GDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASM-TGDIFTGRRPIDAV 743 (833)
Q Consensus 666 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Di~s~~~~~~~~ 743 (833)
|||||+||+++.++.+||+|||.+....... .....||+.|+|||++.+. .++. ++||||
T Consensus 176 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s-------- 237 (348)
T 2pml_X 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDKK----------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWS-------- 237 (348)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTCEECBTTE----------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHH--------
T ss_pred cCCChHhEEEcCCCcEEEecccccccccccc----------ccCCCCCcCccCchhhcCCCCCCcchhhHHH--------
Confidence 9999999999999999999999998654431 1224699999999999887 6666 999999
Q ss_pred ccCCccHHHHHHHhCCCcccccccccchhhhccccchhhh------------hhhhchHHHHHHHHHHhhccCCCCCCCC
Q 040925 744 FNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQE------------DKRVKTEECLNAIIRTGVLCSMESPFER 811 (833)
Q Consensus 744 ~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~R 811 (833)
.|+++++++++..|+...... ................ ........++..+.+++.+||+.||++|
T Consensus 238 --lG~il~~l~~g~~pf~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 314 (348)
T 2pml_X 238 --LGICLYVMFYNVVPFSLKISL-VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAER 314 (348)
T ss_dssp --HHHHHHHHHHSSCSSCCSSCS-HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGS
T ss_pred --HHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhC
Confidence 788889999988887532210 0111111111000000 0000113356778999999999999999
Q ss_pred CCHHHHHHH
Q 040925 812 MDMRDVVAK 820 (833)
Q Consensus 812 Pt~~eil~~ 820 (833)
||++|+++.
T Consensus 315 ps~~e~l~h 323 (348)
T 2pml_X 315 ITSEDALKH 323 (348)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=322.62 Aligned_cols=262 Identities=19% Similarity=0.263 Sum_probs=194.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCC---------
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTD--------- 601 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------- 601 (833)
++|++.+.||+|+||.||+|++..+++.||+|++........+.+.+|++++++++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 58999999999999999999999899999999997665555678899999999999999999999875432
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec-CCCc
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD-HDMV 680 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~ 680 (833)
.......++||||++ |+|.+++... .+++..++.++.|++.||+|||+. ||+||||||+||+++ +++.
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 123457899999998 5999999753 589999999999999999999999 999999999999997 5679
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
+||+|||+++........ ........||+.|+|||++.+ ..++.++|||| +|+++++++++..|
T Consensus 160 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~el~~g~~p 224 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSH-----KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA----------AGCIFAEMLTGKTL 224 (320)
T ss_dssp EEECCCTTCBCC-------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHH----------HHHHHHHHHHSSCS
T ss_pred EEEccCccccccCCCccc-----ccccccccccccccCcHHhcCcccCCchhhhHh----------HHHHHHHHHhCCCC
Confidence 999999999876432211 111223458999999998765 67899999999 78888899998888
Q ss_pred Ccccccccccchhhhccccch-----------------------hhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHH
Q 040925 760 EKVMEIVDPSLLMEVMTNNSM-----------------------IQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRD 816 (833)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 816 (833)
+......+ ........... ...........++..+.+++.+||+.||++|||++|
T Consensus 225 f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 302 (320)
T 2i6l_A 225 FAGAHELE--QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEE 302 (320)
T ss_dssp SCCSSHHH--HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCCCHHH--HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHH
Confidence 75222110 00000000000 000000111234677899999999999999999999
Q ss_pred HHHH
Q 040925 817 VVAK 820 (833)
Q Consensus 817 il~~ 820 (833)
+++.
T Consensus 303 ll~h 306 (320)
T 2i6l_A 303 ALSH 306 (320)
T ss_dssp HHTS
T ss_pred HhCC
Confidence 9874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=331.93 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=199.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC--------CCccceEeeEeecCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR--------HRNLIKIITICSSTD 601 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~ 601 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|++++++++ ||||+++++++....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999999999999999999633 234567889999999995 788999999876321
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC--
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-- 679 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-- 679 (833)
......++||||+ +|++.+++...... .+++..++.++.||+.||+|||+++ ||+||||||+|||++.++
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIKSNYQ----GLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHH
T ss_pred -CCCceEEEEEecc-CccHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchh
Confidence 1234789999999 56777776654322 6899999999999999999999964 899999999999999775
Q ss_pred -----------------------------------------------cEEEcccccccccCcccccccccCCCccccccc
Q 040925 680 -----------------------------------------------VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712 (833)
Q Consensus 680 -----------------------------------------------~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~g 712 (833)
.+||+|||+|+...... ....|
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----------~~~~g 255 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----------TEDIQ 255 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----------CSCCS
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----------ccCCC
Confidence 79999999998654321 12469
Q ss_pred cccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc----ch---hhh-----------
Q 040925 713 TVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS----LL---MEV----------- 774 (833)
Q Consensus 713 t~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~----~~---~~~----------- 774 (833)
|+.|+|||++.+..++.++|||| +|+++++++++..|+......+.. .. ...
T Consensus 256 t~~y~aPE~~~~~~~~~~~Diws----------lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 325 (397)
T 1wak_A 256 TRQYRSLEVLIGSGYNTPADIWS----------TACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVA 325 (397)
T ss_dssp CGGGCCHHHHHTSCCCTHHHHHH----------HHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHH
T ss_pred CCcccCChhhcCCCCCcHHHHHH----------HHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhc
Confidence 99999999999999999999999 888899999998887522111000 00 000
Q ss_pred -------cccc--------------chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 775 -------MTNN--------------SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 775 -------~~~~--------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.... ............+.+..+.+++.+||+.||++|||++|+++.
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 326 GKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0000 000000011245677889999999999999999999999863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=319.80 Aligned_cols=265 Identities=21% Similarity=0.311 Sum_probs=201.2
Q ss_pred HhcCCccCceeccCcceEEEEEEEC-CCceEEEEEEeeccCC--cchhHHHHHHHHHhhc---CCCccceEeeEeecCCC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLG-EDEMIVAVKVINLKYK--GASRSFVAECEALRNI---RHRNLIKIITICSSTDF 602 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~ 602 (833)
..++|++.+.||+|+||.||+|++. .+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++.....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999974432 2335677888888877 79999999999864332
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
......++||||++ |+|.+++...... .+++..++.++.|++.||+|||+. ||+||||||+||+++.++.+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~k 160 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIK 160 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEE
Confidence 34457899999998 6999999875432 589999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
|+|||+++....... .....||+.|+|||++.+..++.++|||| +|+++++++++..|+..
T Consensus 161 l~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 161 LADFGLARIYSFQMA---------LTSVVVTLWYRAPEVLLQSSYATPVDLWS----------VGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp ECSCCSCCCCCGGGG---------GCCCCCCCTTCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSSCSCCC
T ss_pred EecCcccccccCCCC---------ccccccccceeCHHHHhcCCCCcchhHHH----------HHHHHHHHHcCCCCCCC
Confidence 999999986653221 12346899999999999999999999999 77888888888877652
Q ss_pred cccccc--------------cchhhhcccc----chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 763 MEIVDP--------------SLLMEVMTNN----SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 763 ~~~~~~--------------~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....+. .+........ ............+++..+.+++.+||..||++|||+.|+++.
T Consensus 222 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 222 SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp SSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 211000 0000000000 000000011122346678899999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=318.53 Aligned_cols=266 Identities=21% Similarity=0.255 Sum_probs=191.8
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCC-------
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTD------- 601 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 601 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|+.++++++||||+++++++....
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356799999999999999999999989999999999643 234567899999999999999999999876531
Q ss_pred -CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc
Q 040925 602 -FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV 680 (833)
Q Consensus 602 -~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 680 (833)
.......++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENL-----NQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCG-----GGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcccc-----ccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 1234578999999999999999986432 578899999999999999999999 9999999999999999999
Q ss_pred EEEcccccccccCccccccc------ccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHH
Q 040925 681 AHVCDFGLAKFLSDHQLDTA------VKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEF 753 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~ 753 (833)
+||+|||++........... ...........||+.|+|||++.+. .++.++|||| .|++++++
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~~l 224 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS----------LGIIFFEM 224 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHH----------HHHHHHHH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHH----------HHHHHHHH
Confidence 99999999986643211000 0001122345699999999998764 6899999999 66666776
Q ss_pred HHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 754 AKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 754 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++ |+..... .............. .........+..+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~---p~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 225 IY---PFSTGME-RVNILKKLRSVSIE---FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HS---CCSSHHH-HHHHHHHHHSTTCC---CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Hh---ccCCchh-HHHHHHhccccccc---cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 65 2211000 00000000000000 0011122345668899999999999999999999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=325.28 Aligned_cols=258 Identities=18% Similarity=0.221 Sum_probs=195.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCCCccceEeeEeecCCCC-CCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRHRNLIKIITICSSTDFK-GTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~~~ 606 (833)
.++|.+.+.||+|+||.||+|.+..+++.||||+++..... ..+.+.+|+.++++++||||+++++++...+.. ...
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 35899999999999999999999999999999999754322 246788999999999999999999998665411 112
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++||||++ |+|.+++.. .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df 188 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF 188 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred eEEEEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence 3499999997 589888743 589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|+++..... .....||+.|+|||++.+ ..++.++|||| .|+++++++++..|+.....
T Consensus 189 g~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~il~el~~g~~pf~~~~~ 247 (371)
T 4exu_A 189 GLARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWS----------VGCIMAEMLTGKTLFKGKDY 247 (371)
T ss_dssp TCC-------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHH----------HHHHHHHHHHSSCSCCCSSH
T ss_pred CcccccccC-----------cCCcccCccccCHHHhcCCCCCCcHHhHHH----------HHHHHHHHHhCCCCCCCCCh
Confidence 999865432 123468999999999877 67999999999 78888999998888753221
Q ss_pred ccccchh---------------------hhccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLM---------------------EVMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~---------------------~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+..... ....... ............+++.+.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 248 LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 1100000 0000000 00000000112345678999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-36 Score=314.72 Aligned_cols=254 Identities=24% Similarity=0.286 Sum_probs=201.4
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
...++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+.+|++++++++||||+++++++....
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 94 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSS---- 94 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS----
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCC----
Confidence 34568999999999999999999999899999999996442 234567899999999999999999999976554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC---CcEE
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD---MVAH 682 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~k 682 (833)
..++||||+++++|.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.+ +.+|
T Consensus 95 -~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~k 164 (287)
T 2wei_A 95 -SFYIVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIK 164 (287)
T ss_dssp -EEEEEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred -eEEEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEE
Confidence 8999999999999999887644 689999999999999999999999 99999999999999754 4799
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
|+|||++........ .....||+.|+|||++.+ .++.++|||| +|+++++++++..|+..
T Consensus 165 L~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~-~~~~~~Di~s----------lG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 165 IIDFGLSTCFQQNTK---------MKDRIGTAYYIAPEVLRG-TYDEKCDVWS----------AGVILYILLSGTPPFYG 224 (287)
T ss_dssp ECSTTGGGTBCCCSS---------CSCHHHHHTTCCHHHHTT-CCCTHHHHHH----------HHHHHHHHHHSSCSSCC
T ss_pred EeccCcceeecCCCc---------cccccCcccccChHHhcC-CCCCchhhHh----------HHHHHHHHHhCCCCCCC
Confidence 999999986543211 122458999999998876 4899999999 88889999999888753
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.... ............. .......+++.+.+++.+||..||++|||++|+++.
T Consensus 225 ~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 225 KNEY--DILKRVETGKYAF---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp SSHH--HHHHHHHHCCCCC---CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCHH--HHHHHHHcCCCCC---CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 2211 1111111111100 011112345678899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=322.63 Aligned_cols=256 Identities=19% Similarity=0.257 Sum_probs=197.5
Q ss_pred hcCCccCceeccCcceEEEEEEE-CCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCC------ccceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTL-GEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHR------NLIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~~ 602 (833)
.++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+++++.++|+ +++++++++...+
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~- 90 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG- 90 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT-
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC-
Confidence 35899999999999999999998 557899999999633 23456788999999999765 4999999976554
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-----
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH----- 677 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~----- 677 (833)
..++||||+ +++|.+++...... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.
T Consensus 91 ----~~~lv~e~~-~~~l~~~l~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 91 ----HICIVFELL-GLSTYDFIKENGFL----PFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp ----EEEEEEECC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred ----cEEEEEcCC-CCCHHHHHHhcCCC----CCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence 899999999 78999999876432 688999999999999999999999 9999999999999987
Q ss_pred --------------CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCcc
Q 040925 678 --------------DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAV 743 (833)
Q Consensus 678 --------------~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~ 743 (833)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~~~~~~~Di~s-------- 219 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----------HSTLVSTRHYRAPEVILALGWSQPCDVWS-------- 219 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETTSC-----------CCSSCSCGGGCCHHHHTTSCCCTHHHHHH--------
T ss_pred ccCCccccccccccCCCceEeeCcccccCccc-----------cccccCCccccChHHhhCCCCCcchhhHH--------
Confidence 668999999999764332 11346999999999999999999999999
Q ss_pred ccCCccHHHHHHHhCCCcccccccccchhhhccccc-----------------------------------hhhhhhhhc
Q 040925 744 FNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNS-----------------------------------MIQEDKRVK 788 (833)
Q Consensus 744 ~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~ 788 (833)
+|+++++++++..|+......+............ .........
T Consensus 220 --lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (339)
T 1z57_A 220 --IGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLS 297 (339)
T ss_dssp --HHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSC
T ss_pred --HHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhccc
Confidence 7788888888877765221110000000000000 000000111
Q ss_pred hHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 789 TEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 789 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
...+++.+.+++.+||+.||++|||++|+++.
T Consensus 298 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 298 QDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp CSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred chhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 23456789999999999999999999999864
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=306.37 Aligned_cols=291 Identities=18% Similarity=0.258 Sum_probs=147.8
Q ss_pred CCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEc
Q 040925 24 DLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI 103 (833)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 103 (833)
+++.++++++.++ .+|..+. ++|++|+|++|+|+++.+..|.++++|++|+|++|+++ .+++..|.++++|++|+|
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCC-eeCHHHhcCCCCCCEEEC
Confidence 4444444444442 2333332 34444444444444444444444444444444444444 333334444444444444
Q ss_pred cCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccC
Q 040925 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLAD 183 (833)
Q Consensus 104 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 183 (833)
++|.++ .+|..+. ++|++|++++|+++++.+..|.++++|++|+|++|.++.... .+..+.++++|++|++++
T Consensus 108 s~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~~~l~~L~~L~l~~ 180 (330)
T 1xku_A 108 SKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI----ENGAFQGMKKLSYIRIAD 180 (330)
T ss_dssp CSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGB----CTTGGGGCTTCCEEECCS
T ss_pred CCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCc----ChhhccCCCCcCEEECCC
Confidence 444444 2232221 344455555554444444444444555555555444432111 012234444555555555
Q ss_pred CcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccC
Q 040925 184 NQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRI 263 (833)
Q Consensus 184 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 263 (833)
|+++ .+|..+. ..++.|++++|++++..+..|.++++|+.|++++|++++..+..|..+++|++|+|++|.++ .+
T Consensus 181 n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l 255 (330)
T 1xku_A 181 TNIT-TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 255 (330)
T ss_dssp SCCC-SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred Cccc-cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cC
Confidence 5544 3333322 33455555555555555666666666777777777766666666666667777777777666 45
Q ss_pred CccccCCCCCCeEEeecccccCCCCCCCCCC------CccceeecCCceecc--cCCcccccccccceeeecCCCc
Q 040925 264 PSGLGNLTKLANLELSSNSLQGNIPSSLGNC------QNLMSFTASQNKLTG--ALPHQLLSITTLSLYLDLSNNL 331 (833)
Q Consensus 264 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~l~~N~l~~--~~p~~~~~~~~ll~~L~ls~N~ 331 (833)
|..+..+++|++|+|++|+|++..+..|+.. ++|+.|++++|.+.. ..|..+..+..+ +.++|++|+
T Consensus 256 p~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l-~~l~L~~N~ 330 (330)
T 1xku_A 256 PGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR-AAVQLGNYK 330 (330)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCG-GGEEC----
T ss_pred ChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccce-eEEEecccC
Confidence 6666666677777777777766555555432 556666777776642 233444444444 556666663
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=322.72 Aligned_cols=255 Identities=21% Similarity=0.246 Sum_probs=175.8
Q ss_pred hcCCccCc-eeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHH-HHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSN-MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|.+.+ .||+|+||.||+|++..+++.||||++... ....+|+. .++.++||||+++++++.... .+...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCce
Confidence 46899865 699999999999999999999999999632 22233333 456668999999999976532 22346
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CCcEEEc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVC 684 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~ 684 (833)
.++||||+++|+|.+++...... .+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~----~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQ----AFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeccCCCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence 89999999999999999876432 689999999999999999999999 9999999999999976 4569999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+++....... ....||+.|+|||++.+..++.++|||| +|+++++++++..|+....
T Consensus 174 Dfg~~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~~ 233 (336)
T 3fhr_A 174 DFGFAKETTQNAL----------QTPCYTPYYVAPEVLGPEKYDKSCDMWS----------LGVIMYILLCGFPPFYSNT 233 (336)
T ss_dssp CCTTCEEC--------------------------------CHHHHHHHHHH----------HHHHHHHHHHSSCCC----
T ss_pred ccccceecccccc----------ccCCCCcCccChhhhCCCCCCchhhHHH----------HHHHHHHHHHCCCCCCCcc
Confidence 9999986543221 1245899999999998889999999999 8888999999988875222
Q ss_pred cc--cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IV--DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.. .............. ........+++.+.+++.+||..||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 234 GQAISPGMKRRIRLGQYG---FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----------------C---CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred chhhhhhHHHhhhccccc---cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 11 11111110000000 0111112346678899999999999999999999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=350.45 Aligned_cols=263 Identities=20% Similarity=0.302 Sum_probs=203.9
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEECC---CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCC
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGE---DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTD 601 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 601 (833)
.....++|++.+.||+|+||.||+|++.. .+..||+|+++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-- 462 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-- 462 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec--
Confidence 33445789999999999999999999854 356799999864332 234678999999999999999999999743
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcE
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 681 (833)
+..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 463 ----~~~~lv~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~v 530 (656)
T 2j0j_A 463 ----NPVWIIMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCV 530 (656)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEE
T ss_pred ----CceEEEEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCE
Confidence 257899999999999999986532 589999999999999999999999 99999999999999999999
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCC
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPE 760 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~ 760 (833)
||+|||+++......... .....||+.|+|||++.+..++.++|||| +|++++++++ +..|+
T Consensus 531 kL~DFG~a~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwS----------lG~il~ellt~g~~Pf 593 (656)
T 2j0j_A 531 KLGDFGLSRYMEDSTYYK-------ASKGKLPIKWMAPESINFRRFTSASDVWM----------FGVCMWEILMHGVKPF 593 (656)
T ss_dssp EECCCCCCCSCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCTT
T ss_pred EEEecCCCeecCCCccee-------ccCCCCCcceeCHHHhcCCCCCchhhHHH----------HHHHHHHHHHcCCCCC
Confidence 999999998765432211 11234788999999998889999999999 7778888875 66665
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
...... .......... ....+..+++.+.+++.+||..||++|||+.|+++.|+.+.+.
T Consensus 594 ~~~~~~--~~~~~i~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 594 QGVKNN--DVIGRIENGE------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TTCCHH--HHHHHHHHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHH--HHHHHHHcCC------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 422111 1111111100 0112234567889999999999999999999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=324.84 Aligned_cols=270 Identities=20% Similarity=0.217 Sum_probs=190.3
Q ss_pred hHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC
Q 040925 523 YAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDF 602 (833)
Q Consensus 523 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 602 (833)
........++|++.+.||+|+||.||+|++..+++.||||++... ........+|++.++.++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 355667789999999999999999999999989999999998643 2334567788888999999999999999865432
Q ss_pred --CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHh--hcCCCCceeeCCCCCCeeecC-
Q 040925 603 --KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH--HHCQPPMVHGDLKPSNVLLDH- 677 (833)
Q Consensus 603 --~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH--~~~~~~ivH~Dlkp~NIll~~- 677 (833)
......++||||+++ ++.+.+...... ...+++..++.++.|++.||.||| +. +|+||||||+||+++.
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRR--QVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCC
Confidence 123347899999986 655544321100 116889999999999999999999 88 9999999999999996
Q ss_pred CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccCCccHHHHHHH
Q 040925 678 DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 678 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
++.+||+|||+++....... .....||+.|+|||++.+.. ++.++|||| +|+++++++++
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~ell~g 228 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP---------NVAYICSRYYRAPELIFGNQHYTTAVDIWS----------VGCIFAEMMLG 228 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC---------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHH----------HHHHHHHHHHS
T ss_pred CCcEEEeeCCCceecCCCCC---------cccccCCcceeCHHHHcCCCCCCcHHHHHH----------HHHHHHHHHhC
Confidence 89999999999987654321 12346899999999986654 899999999 78888899988
Q ss_pred hCCCcccccccccchhhhcc-------------------------ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCC
Q 040925 757 ALPEKVMEIVDPSLLMEVMT-------------------------NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFER 811 (833)
Q Consensus 757 ~~p~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 811 (833)
..|+......+ ....... ...............+++.+.+++.+||+.||++|
T Consensus 229 ~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 306 (360)
T 3e3p_A 229 EPIFRGDNSAG--QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306 (360)
T ss_dssp SCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGS
T ss_pred CCCcCCCChHH--HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCcccc
Confidence 88865221100 0000000 00000000000111246688999999999999999
Q ss_pred CCHHHHHHH
Q 040925 812 MDMRDVVAK 820 (833)
Q Consensus 812 Pt~~eil~~ 820 (833)
||+.|+++.
T Consensus 307 pt~~e~l~h 315 (360)
T 3e3p_A 307 MKPYEALCH 315 (360)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhcC
Confidence 999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.95 Aligned_cols=243 Identities=19% Similarity=0.273 Sum_probs=198.7
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc------chhHHHHHHHHHhhcC--CCccceEeeEeecC
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG------ASRSFVAECEALRNIR--HRNLIKIITICSST 600 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~ 600 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|+.++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 456899999999999999999999999999999999754321 2356778999999996 59999999997665
Q ss_pred CCCCCceEeEEEEecCC-CChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec-CC
Q 040925 601 DFKGTDFKAFVFEYMEN-GSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD-HD 678 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~ 678 (833)
+ ..++||||+.+ ++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+++ .+
T Consensus 121 ~-----~~~lv~e~~~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 121 D-----SFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNR 186 (320)
T ss_dssp S-----EEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTT
T ss_pred C-----cEEEEEEcCCCCccHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCC
Confidence 4 89999999976 89999998644 689999999999999999999999 999999999999999 78
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHh
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTA 757 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~ 757 (833)
+.+||+|||+++....... ....||+.|+|||++.+..+ +.++|||| +|+++++++++.
T Consensus 187 ~~~kL~Dfg~~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~el~~g~ 246 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTVY----------TDFDGTRVYSPPEWIRYHRYHGRSAAVWS----------LGILLYDMVCGD 246 (320)
T ss_dssp TEEEECCCTTCEECCSSCB----------CCCCSCGGGSCHHHHHHSCBCHHHHHHHH----------HHHHHHHHHHSS
T ss_pred CCEEEeeCccccccccccc----------cCCCCCccCCChHHhccCCCCCccchHHh----------HHHHHHHHHHCC
Confidence 9999999999987654221 12459999999999877665 68889999 888999999999
Q ss_pred CCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 758 LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 758 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.|+........ ... .....+++.+.+++.+||..||++|||++|+++.
T Consensus 247 ~pf~~~~~~~~--------~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 247 IPFEHDEEIIR--------GQV-------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp CSCCSHHHHHH--------CCC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCChhhhhc--------ccc-------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 88753221100 000 0111235678899999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=333.07 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=192.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC-CCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDF-KGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 609 (833)
.+|++.+.||+|+||.||+|++..+++.||||++.... +...+|++++++++||||+++++++..... .+..+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46999999999999999999999899999999986432 233579999999999999999998765321 2233577
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-CcEEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~ 688 (833)
+||||+++ ++.+++...... ...+++..++.++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred eehhcccc-cHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 99999985 777666532110 12689999999999999999999999 99999999999999965 5789999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
|+....... .....||+.|+|||++.+. .++.++|||| +|+++++++++..|+......+
T Consensus 204 a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS----------lG~il~ell~G~~pf~~~~~~~ 264 (420)
T 1j1b_A 204 AKQLVRGEP---------NVSYICSRYYRAPELIFGATDYTSSIDVWS----------AGCVLAELLLGQPIFPGDSGVD 264 (420)
T ss_dssp CEECCTTCC---------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHH----------HHHHHHHHHHSSCSSCCSSHHH
T ss_pred hhhcccCCC---------ceeeeeCCCcCCHHHHcCCCCCCchhhhHH----------HHHHHHHHHhCCCCCCCCCHHH
Confidence 986543211 1235689999999998765 7999999999 7888889998888775222111
Q ss_pred ccchhhhcc-----------------ccchhh-----hhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMT-----------------NNSMIQ-----EDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~-----------------~~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ....+. ...... +.........+..+.+++.+||..||++|||+.|+++.
T Consensus 265 ~--l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 265 Q--LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp H--HHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred H--HHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 000000 000000 00001112335678999999999999999999999864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.05 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=224.5
Q ss_pred ccEEEccCccccc--cCChhhhcCCCCCeEeccC-CcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEE
Q 040925 201 VINFGIGRNQISG--TIPPGIRNLVNLIGFGAEE-NQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLE 277 (833)
Q Consensus 201 l~~L~l~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 277 (833)
++.|++++|.+++ .+|..|.++++|++|++++ |.+.+.+|..|+.+++|++|+|++|.+++.+|..|.++++|++|+
T Consensus 52 l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~ 131 (313)
T 1ogq_A 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEe
Confidence 4455555555555 6677788888888888884 888888888888888899999999988888888888888999999
Q ss_pred eecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCC
Q 040925 278 LSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFS 357 (833)
Q Consensus 278 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~ 357 (833)
|++|++++.+|..|..+++|++|++++|++++.+|..+..+...+++|++++|.+++..|..|..++ |++|++++|.++
T Consensus 132 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~ 210 (313)
T 1ogq_A 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEE
T ss_pred CCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCccc
Confidence 9999888888888888889999999999988888888888874448899999999888899999887 999999999999
Q ss_pred CCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCc
Q 040925 358 GVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGV 437 (833)
Q Consensus 358 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 437 (833)
+..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|++++.+|..+.
T Consensus 211 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~ 289 (313)
T 1ogq_A 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT
T ss_pred CcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCcc
Confidence 99999999999999999999999976665 88899999999999999999999999999999999999999999998888
Q ss_pred cCCCccccccCCcCCCCCccc
Q 040925 438 FSNKTKISLQGNMKLCGGIDE 458 (833)
Q Consensus 438 ~~~~~~l~l~~N~~~c~~~~~ 458 (833)
+.+++.+++.+|+++||.+..
T Consensus 290 l~~L~~l~l~~N~~lc~~p~~ 310 (313)
T 1ogq_A 290 LQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp GGGSCGGGTCSSSEEESTTSS
T ss_pred ccccChHHhcCCCCccCCCCC
Confidence 999999999999999997553
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=328.76 Aligned_cols=260 Identities=21% Similarity=0.261 Sum_probs=190.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC-CCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDF-KGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 609 (833)
.+|++.+.||+|+||.||+|++..+++ ||+|++..... ...+|+++++.++||||+++++++..... .+....+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 479999999999999999999986665 88888753322 23469999999999999999999865442 2344578
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec-CCCcEEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfG~ 688 (833)
+||||+++ ++.+.+..... ....+++..++.++.|++.||+|||+. ||+||||||+||+++ .++.+||+|||+
T Consensus 115 lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeeccCc-cHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 99999986 44443332110 011689999999999999999999999 999999999999999 799999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
|+....... .....||+.|+|||++.+. .++.++|||| .|+++++++++..|+......+
T Consensus 189 a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS----------lG~il~ell~g~~pf~~~~~~~ 249 (394)
T 4e7w_A 189 AKILIAGEP---------NVSYICSRYYRAPELIFGATNYTTNIDIWS----------TGCVMAELMQGQPLFPGESGID 249 (394)
T ss_dssp CEECCTTCC---------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHH----------HHHHHHHHHHSSCSSCCSSHHH
T ss_pred cccccCCCC---------CcccccCcCccCHHHHcCCCCCCcHHHHHH----------HHHHHHHHHhCCCCCCCCCHHH
Confidence 986643221 1235689999999998765 5899999999 7888889999888875322111
Q ss_pred ccch-h----------------hhccccc---hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLL-M----------------EVMTNNS---MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~-~----------------~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.-.. . ....... ...+.........++.+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 250 QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 0 0000000 00000011112245678999999999999999999999875
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=308.15 Aligned_cols=291 Identities=20% Similarity=0.263 Sum_probs=233.8
Q ss_pred CCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEE
Q 040925 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALA 102 (833)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~ 102 (833)
.+++.++++++.++ .+|..+. ++|++|+|++|.++++.|.+|.++++|++|+|++|+++ .+++..|.++++|++|+
T Consensus 33 c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 33 CHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLY 108 (332)
T ss_dssp EETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECGGGSTTCTTCCEEE
T ss_pred ccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccC-ccCHhHhhCcCCCCEEE
Confidence 36888888888884 5666554 68888999999888777888888899999999988887 66667778888899999
Q ss_pred ccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEcc
Q 040925 103 IGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLA 182 (833)
Q Consensus 103 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls 182 (833)
|++|.++ .+|..+. ++|++|++++|+|+.+++..|.++++|++|++++|.++..... +..+..+ +|++|+++
T Consensus 109 L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~----~~~~~~l-~L~~L~l~ 180 (332)
T 2ft3_A 109 ISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFE----PGAFDGL-KLNYLRIS 180 (332)
T ss_dssp CCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSC----TTSSCSC-CCSCCBCC
T ss_pred CCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCC----cccccCC-ccCEEECc
Confidence 9998887 4454443 7888999999998888888888889999999998888642211 2335566 88889999
Q ss_pred CCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCccc
Q 040925 183 DNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGR 262 (833)
Q Consensus 183 ~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 262 (833)
+|+++ .+|..+. ..++.|++++|.+++..+..|.++++|+.|++++|++.+..+..|..+++|++|+|++|.++ .
T Consensus 181 ~n~l~-~l~~~~~---~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~ 255 (332)
T 2ft3_A 181 EAKLT-GIPKDLP---ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-R 255 (332)
T ss_dssp SSBCS-SCCSSSC---SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-B
T ss_pred CCCCC-ccCcccc---CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-e
Confidence 99888 4666544 46888899999999888889999999999999999999888888999999999999999998 6
Q ss_pred CCccccCCCCCCeEEeecccccCCCCCCCCCC------CccceeecCCceec--ccCCcccccccccceeeecCCCc
Q 040925 263 IPSGLGNLTKLANLELSSNSLQGNIPSSLGNC------QNLMSFTASQNKLT--GALPHQLLSITTLSLYLDLSNNL 331 (833)
Q Consensus 263 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~l~~N~l~--~~~p~~~~~~~~ll~~L~ls~N~ 331 (833)
+|..+..+++|++|+|++|+|++..+..|... ++|+.|++++|.+. +..|..+..+..+ +.+++++|+
T Consensus 256 lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L-~~l~l~~n~ 331 (332)
T 2ft3_A 256 VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDR-LAIQFGNYK 331 (332)
T ss_dssp CCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCS-TTEEC----
T ss_pred cChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchh-hhhhccccc
Confidence 78889999999999999999998877777654 67899999999987 4556666666666 678998885
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=323.39 Aligned_cols=268 Identities=22% Similarity=0.281 Sum_probs=199.2
Q ss_pred HHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCC
Q 040925 524 AELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTD 601 (833)
Q Consensus 524 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 601 (833)
.+.....++|++.+.||+|+||.||+|++.. .||+|+++... ....+.+.+|+.++++++||||+++++++....
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 3334446789999999999999999999864 39999987542 233466888999999999999999999987654
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcE
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVA 681 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 681 (833)
..++||||+++++|.+++..... .+++.+++.++.|++.||+|||+. +|+||||||+||+++ ++.+
T Consensus 103 -----~~~iv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~ 168 (319)
T 2y4i_B 103 -----HLAIITSLCKGRTLYSVVRDAKI-----VLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKV 168 (319)
T ss_dssp -----CEEEECBCCCSEEHHHHTTSSCC-----CCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CC
T ss_pred -----ceEEEeecccCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCE
Confidence 78999999999999999986542 589999999999999999999999 999999999999998 6899
Q ss_pred EEcccccccccCcccccccccCCCccccccccccccCccccCC---------CCCCcccccccCCcCCCccccCCccHHH
Q 040925 682 HVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG---------SEASMTGDIFTGRRPIDAVFNEGHSLHE 752 (833)
Q Consensus 682 kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Di~s~~~~~~~~~~~g~~l~~ 752 (833)
||+|||+++......... .........||+.|+|||++.+ ..++.++|||| +|+++++
T Consensus 169 ~l~Dfg~~~~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~s----------lG~il~e 235 (319)
T 2y4i_B 169 VITDFGLFSISGVLQAGR---REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFA----------LGTIWYE 235 (319)
T ss_dssp EECCCSCCC-------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHH----------HHHHHHH
T ss_pred EEeecCCccccccccccc---cccccccCCCcccccChHHhhhccccccccccCCCchhhHHH----------HHHHHHH
Confidence 999999987653321111 1112223469999999998764 45788999999 8888999
Q ss_pred HHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 753 FAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 753 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
++++..|+...... ........... .......++..+.+++.+||..||++|||++++++.|+.+.+..
T Consensus 236 l~~g~~p~~~~~~~--~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 236 LHAREWPFKTQPAE--AIIWQMGTGMK-----PNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHSSCSSSSCCHH--HHHHHHHTTCC-----CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHhCCCCCCCCCHH--HHHHHhccCCC-----CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 99998887532211 11111100000 00011123456889999999999999999999999999987653
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=320.84 Aligned_cols=246 Identities=20% Similarity=0.284 Sum_probs=192.3
Q ss_pred HHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC------cchhHHHHHHHHHhhc----CCCccceEee
Q 040925 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK------GASRSFVAECEALRNI----RHRNLIKIIT 595 (833)
Q Consensus 526 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~~ 595 (833)
.....++|++.+.||+|+||.||+|++..+++.||||+++.... .....+.+|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34456789999999999999999999998999999999965432 1234567899999999 8999999999
Q ss_pred EeecCCCCCCceEeEEEEe-cCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCee
Q 040925 596 ICSSTDFKGTDFKAFVFEY-MENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVL 674 (833)
Q Consensus 596 ~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIl 674 (833)
++...+ ..++|||| +++++|.+++.... .+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 106 ~~~~~~-----~~~~v~e~~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil 171 (312)
T 2iwi_A 106 WFETQE-----GFMLVLERPLPAQDLFDYITEKG------PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENIL 171 (312)
T ss_dssp EC----------CEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEE
T ss_pred EEecCC-----eEEEEEEecCCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEE
Confidence 965543 78999999 78999999998654 689999999999999999999999 9999999999999
Q ss_pred ec-CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHH
Q 040925 675 LD-HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHE 752 (833)
Q Consensus 675 l~-~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~ 752 (833)
++ .++.+||+|||+++....... ....||+.|+|||++.+..+ +.++|||| .|+++++
T Consensus 172 ~~~~~~~~kl~dfg~~~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~~ 231 (312)
T 2iwi_A 172 IDLRRGCAKLIDFGSGALLHDEPY----------TDFDGTRVYSPPEWISRHQYHALPATVWS----------LGILLYD 231 (312)
T ss_dssp EETTTTEEEECCCSSCEECCSSCB----------CCCCSCTTTSCHHHHHHSCBCHHHHHHHH----------HHHHHHH
T ss_pred EeCCCCeEEEEEcchhhhcccCcc----------cccCCcccccCceeeecCCCCCccchHHH----------HHHHHHH
Confidence 99 889999999999987654321 23459999999998877665 45899999 8889999
Q ss_pred HHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 753 FAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 753 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++++..|+........ ... .....++..+.+++.+||+.||++|||++|+++.
T Consensus 232 l~~g~~pf~~~~~~~~--------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 232 MVCGDIPFERDQEILE--------AEL-------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHHSSCSCCSHHHHHH--------TCC-------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HHHCCCCCCChHHHhh--------hcc-------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999988753221100 000 0112245678899999999999999999999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=324.58 Aligned_cols=202 Identities=24% Similarity=0.306 Sum_probs=168.2
Q ss_pred HHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CC-----ccceEeeEeecC
Q 040925 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HR-----NLIKIITICSST 600 (833)
Q Consensus 527 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~~~~ 600 (833)
....++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+..|+++++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 34467899999999999999999999999999999999632 223466788999998885 55 499999987665
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec--CC
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD--HD 678 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~--~~ 678 (833)
+ ..++||||++ |+|.+++...... .+++..++.++.|++.||.|||++ ..||+||||||+||+++ .+
T Consensus 129 ~-----~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~ 197 (382)
T 2vx3_A 129 N-----HLCLVFEMLS-YNLYDLLRNTNFR----GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKR 197 (382)
T ss_dssp T-----EEEEEEECCC-CBHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTS
T ss_pred C-----ceEEEEecCC-CCHHHHHhhcCcC----CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCC
Confidence 4 8999999996 5999999876432 589999999999999999999952 22999999999999995 47
Q ss_pred CcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhC
Q 040925 679 MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTAL 758 (833)
Q Consensus 679 ~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~ 758 (833)
+.+||+|||+|+..... .....||+.|+|||++.+..++.++|||| +|+++++++++..
T Consensus 198 ~~~kL~DFG~a~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~DiwS----------lG~il~elltg~~ 256 (382)
T 2vx3_A 198 SAIKIVDFGSSCQLGQR-----------IYQYIQSRFYRSPEVLLGMPYDLAIDMWS----------LGCILVEMHTGEP 256 (382)
T ss_dssp CCEEECCCTTCEETTCC-----------CCSSCSCGGGCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSSC
T ss_pred CcEEEEeccCceecccc-----------cccccCCccccChHHHcCCCCCcHHHHHH----------HHHHHHHHHhCCC
Confidence 78999999999866432 11346999999999999999999999999 7778888888877
Q ss_pred CCc
Q 040925 759 PEK 761 (833)
Q Consensus 759 p~~ 761 (833)
|+.
T Consensus 257 pf~ 259 (382)
T 2vx3_A 257 LFS 259 (382)
T ss_dssp SSC
T ss_pred CCC
Confidence 765
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=320.19 Aligned_cols=257 Identities=19% Similarity=0.234 Sum_probs=194.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCCCccceEeeEeecCCC-CCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRHRNLIKIITICSSTDF-KGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 607 (833)
++|.+.+.||+|+||.||+|++..+|+.||||++...... ..+.+.+|+.++++++||||+++++++..... .....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5799999999999999999999999999999999654322 24678899999999999999999999865431 11124
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||++ |+|.+++.. .+++.+++.++.|++.||+|||+. ||+||||||+||+++.++.+||+|||
T Consensus 104 ~~lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred EEEEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence 599999997 599888753 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
+++..... .....||+.|+|||++.+ ..++.++|||| .|+++++++++..|+......
T Consensus 172 ~~~~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~s----------lG~il~el~~g~~pf~~~~~~ 230 (353)
T 3coi_A 172 LARHADAE-----------MTGYVVTRWYRAPEVILSWMHYNQTVDIWS----------VGCIMAEMLTGKTLFKGKDYL 230 (353)
T ss_dssp CTTC-------------------CCSBCCSCHHHHSCCSCCCTTHHHHH----------HHHHHHHHHHSSCSSBSSCHH
T ss_pred cccCCCCC-----------ccccccCcCcCCHHHHhCcCCCCchhhHHH----------HHHHHHHHHhCCCCCCCCCHH
Confidence 99865432 112468999999999877 67899999999 788888999888887532211
Q ss_pred ccc-------------chh--------hhccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPS-------------LLM--------EVMTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~-------------~~~--------~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+.- +.. ....... ............++..+.+++.+||..||++|||++|+++.
T Consensus 231 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 231 DQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 100 000 0000000 00000001112346778999999999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.89 Aligned_cols=261 Identities=18% Similarity=0.268 Sum_probs=199.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-----------CCccceEeeEee
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-----------HRNLIKIITICS 598 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~ 598 (833)
.++|++.+.||+|+||.||+|++..+++.||||+++.. ....+.+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35899999999999999999999989999999999632 223467889999999886 899999999976
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec--
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD-- 676 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~-- 676 (833)
... ......++||||+ +++|.+++...... .+++..++.++.||+.||+|||+++ ||+||||||+||+++
T Consensus 97 ~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~ 168 (373)
T 1q8y_A 97 HKG-PNGVHVVMVFEVL-GENLLALIKKYEHR----GIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIV 168 (373)
T ss_dssp EEE-TTEEEEEEEECCC-CEEHHHHHHHTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEE
T ss_pred ccC-CCCceEEEEEecC-CCCHHHHHHHhhcc----CCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEecc
Confidence 542 2234789999999 78999999875432 5899999999999999999999953 899999999999994
Q ss_pred ----CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHH
Q 040925 677 ----HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHE 752 (833)
Q Consensus 677 ----~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~ 752 (833)
..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||| +|+++++
T Consensus 169 ~~~~~~~~~kl~Dfg~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~Di~s----------lG~il~e 227 (373)
T 1q8y_A 169 DSPENLIQIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWS----------TACLIFE 227 (373)
T ss_dssp ETTTTEEEEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHH----------HHHHHHH
T ss_pred CCCcCcceEEEcccccccccCCCC-----------CCCCCCccccCcHHHhCCCCCchHhHHH----------HHHHHHH
Confidence 44589999999998654321 1236899999999999999999999999 7888889
Q ss_pred HHHHhCCCcccccccc----cchhhhcc---c----------------------------c----chhhhhhhhchHHHH
Q 040925 753 FAKTALPEKVMEIVDP----SLLMEVMT---N----------------------------N----SMIQEDKRVKTEECL 793 (833)
Q Consensus 753 ~~~~~~p~~~~~~~~~----~~~~~~~~---~----------------------------~----~~~~~~~~~~~~~~~ 793 (833)
++++..|+........ ........ . . ..........+..++
T Consensus 228 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (373)
T 1q8y_A 228 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307 (373)
T ss_dssp HHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHH
T ss_pred HHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchH
Confidence 9988888752211000 00000000 0 0 000000112235678
Q ss_pred HHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 794 NAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 794 ~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+.+.+++.+||+.||++|||++|+++.
T Consensus 308 ~~~~~li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 308 KEISDFLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHHHHHHHhccCccccCCHHHHhhC
Confidence 899999999999999999999999874
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.20 Aligned_cols=288 Identities=21% Similarity=0.212 Sum_probs=155.2
Q ss_pred CCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEec
Q 040925 72 SLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNL 151 (833)
Q Consensus 72 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 151 (833)
+|+.+++++|.++ .+|..++ ++|++|+|++|.+++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 4555555555554 5554332 45555666666655555555666666666666666666555555555666666666
Q ss_pred ccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEecc
Q 040925 152 EQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAE 231 (833)
Q Consensus 152 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 231 (833)
++|.++.++.. +. ++|++|++++|+++ +..+..|.++++|+.|+++
T Consensus 110 ~~n~l~~l~~~-------~~--~~L~~L~l~~n~i~-------------------------~~~~~~~~~l~~L~~L~l~ 155 (332)
T 2ft3_A 110 SKNHLVEIPPN-------LP--SSLVELRIHDNRIR-------------------------KVPKGVFSGLRNMNCIEMG 155 (332)
T ss_dssp CSSCCCSCCSS-------CC--TTCCEEECCSSCCC-------------------------CCCSGGGSSCSSCCEEECC
T ss_pred CCCcCCccCcc-------cc--ccCCEEECCCCccC-------------------------ccCHhHhCCCccCCEEECC
Confidence 65555544331 11 44555555555544 1223344555555556666
Q ss_pred CCccc--ccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecc
Q 040925 232 ENQLH--GTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTG 309 (833)
Q Consensus 232 ~N~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 309 (833)
+|.++ +..+..|..+ +|++|++++|.+++ +|..+. ++|++|+|++|++++..+..|..+++|+.|++++|++++
T Consensus 156 ~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~ 231 (332)
T 2ft3_A 156 GNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRM 231 (332)
T ss_dssp SCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCC
T ss_pred CCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCc
Confidence 55553 2455555555 66666666666663 343333 566666666666665555666666666655555555542
Q ss_pred cCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCcccc
Q 040925 310 ALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLS 389 (833)
Q Consensus 310 ~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 389 (833)
..+..|..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..|.
T Consensus 232 -------------------------~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~ 285 (332)
T 2ft3_A 232 -------------------------IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285 (332)
T ss_dssp -------------------------CCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSS
T ss_pred -------------------------CChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHcc
Confidence 33334444555555555555554 3344455555555555555555544444443
Q ss_pred C------CCCCCeEEccCcccC--CCchhhhcCCCCCceEECccCc
Q 040925 390 F------LKSIKELNVSSNNLS--GQIPEFLKNLSVLEFLSLSYNH 427 (833)
Q Consensus 390 ~------l~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~L~l~~N~ 427 (833)
. ...|+.|++++|++. +..|..|..++.|+.+++++|.
T Consensus 286 ~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 2 245566666666665 4556666666666666666653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.25 Aligned_cols=256 Identities=19% Similarity=0.250 Sum_probs=195.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCc-eEEEEEEeeccCCcchhHHHHHHHHHhhcCCCc------cceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDE-MIVAVKVINLKYKGASRSFVAECEALRNIRHRN------LIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~~ 602 (833)
.++|++.+.||+|+||.||+|.+..++ +.||+|+++.. ....+.+.+|++++++++|++ ++.+++++....
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~- 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG- 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC-
Confidence 368999999999999999999997666 79999999632 234567889999999997665 889988876554
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee-------
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL------- 675 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll------- 675 (833)
..++||||+ ++++.+++...... .+++.+++.++.|++.||+|||+. +|+||||||+||++
T Consensus 96 ----~~~lv~e~~-~~~l~~~l~~~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 96 ----HMCIAFELL-GKNTFEFLKENNFQ----PYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp ----EEEEEEECC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEE
T ss_pred ----eEEEEEecc-CCChHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccc
Confidence 899999999 56787777665422 689999999999999999999999 99999999999999
Q ss_pred ------------cCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCcc
Q 040925 676 ------------DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAV 743 (833)
Q Consensus 676 ------------~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~ 743 (833)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++||||
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~Di~s-------- 224 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----------TTIVATRHYRPPEVILELGWAQPCDVWS-------- 224 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----------CSSCSCGGGCCHHHHTTCCCCTHHHHHH--------
T ss_pred cccccccccccccCCCcEEEeecCccccccccc-----------cCCcCCCcccCCeeeecCCCCCccchHH--------
Confidence 567899999999997643321 2346999999999999999999999999
Q ss_pred ccCCccHHHHHHHhCCCcccccccccchhhhccccc-----------------------------------hhhhhhhhc
Q 040925 744 FNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNS-----------------------------------MIQEDKRVK 788 (833)
Q Consensus 744 ~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~ 788 (833)
.|+++++++++..|+......+............ .........
T Consensus 225 --lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (355)
T 2eu9_A 225 --IGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQ 302 (355)
T ss_dssp --HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSC
T ss_pred --HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccc
Confidence 7888888888888875322110000000000000 000000011
Q ss_pred hHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 789 TEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 789 ~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....+..+.+++.+||..||++|||++|+++.
T Consensus 303 ~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 303 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp CSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 22345688999999999999999999999864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.20 Aligned_cols=260 Identities=20% Similarity=0.263 Sum_probs=177.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC-cchhHHHHHHH-HHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-GASRSFVAECE-ALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||.||+|.+..+++.||||+++.... .....+..|+. +++.++||||+++++++...+ .
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~-----~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG-----D 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS-----E
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC-----c
Confidence 3689999999999999999999998999999999975432 22345556666 677789999999999986654 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+++ +|.+++...... ....+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSV-LDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHT-TCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred eEEEEeecCC-ChHHHHHHHHhh-hcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCC
Confidence 8999999985 888887631100 0116899999999999999999999853 89999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCcccc----CCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYG----MGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+++....... .....||+.|+|||++ .+..++.++|||| +|+++++++++..|+...
T Consensus 172 ~~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 172 ISGQLVDSIA---------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWS----------LGITLYELATGRFPYPKW 232 (327)
T ss_dssp SSCC---------------------------------------CCSHHHHHH----------HHHHHHHHHHSCCCSSCC
T ss_pred Cceecccccc---------cccCCCCccccCceeeccccCcCCCCchhhHHH----------HHHHHHHHHHCCCCCCCc
Confidence 9986644221 1123599999999998 4667899999999 888999999998887532
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....... ......... .........+++.+.+++.+||..||++|||++|+++.
T Consensus 233 ~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 233 NSVFDQL-TQVVKGDPP--QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp --------CCCCCSCCC--CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred chHHHHH-HHHhcCCCC--CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 2111111 111111000 00000112245678999999999999999999999764
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=302.11 Aligned_cols=291 Identities=20% Similarity=0.222 Sum_probs=161.0
Q ss_pred CCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEc
Q 040925 48 NLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDL 127 (833)
Q Consensus 48 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 127 (833)
++++++++++.++ .+|..+. ++|+.|+|++|+++ .++...|.++++|++|+|++|.+++..|..|.++++|++|+|
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 107 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCC-EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEEC
Confidence 5666666666665 3444443 45666666666665 455555556666666666666665555555666666666666
Q ss_pred ccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEcc
Q 040925 128 SVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIG 207 (833)
Q Consensus 128 ~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~ 207 (833)
++|+|+.++...+ ++|++|++++|.++.++. ..+.++++|++|++++|+++.
T Consensus 108 s~n~l~~l~~~~~---~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n~l~~------------------- 159 (330)
T 1xku_A 108 SKNQLKELPEKMP---KTLQELRVHENEITKVRK------SVFNGLNQMIVVELGTNPLKS------------------- 159 (330)
T ss_dssp CSSCCSBCCSSCC---TTCCEEECCSSCCCBBCH------HHHTTCTTCCEEECCSSCCCG-------------------
T ss_pred CCCcCCccChhhc---ccccEEECCCCcccccCH------hHhcCCccccEEECCCCcCCc-------------------
Confidence 6666554443322 445555555555543321 224444555555555554431
Q ss_pred CccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCC
Q 040925 208 RNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNI 287 (833)
Q Consensus 208 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 287 (833)
.+..+..|.++++|+.|++++|+++. +|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..
T Consensus 160 ----~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~ 232 (330)
T 1xku_A 160 ----SGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 232 (330)
T ss_dssp ----GGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred ----cCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeC
Confidence 01334455555555555555555553 222222 45555555555555555555555555555555555555444
Q ss_pred CCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCC
Q 040925 288 PSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTC 367 (833)
Q Consensus 288 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l 367 (833)
+..|..+++|+.|++++| .++ .+|..+..+++|++|++++|+|+++.+..|...
T Consensus 233 ~~~~~~l~~L~~L~L~~N-------------------------~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~ 286 (330)
T 1xku_A 233 NGSLANTPHLRELHLNNN-------------------------KLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 286 (330)
T ss_dssp TTTGGGSTTCCEEECCSS-------------------------CCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCS
T ss_pred hhhccCCCCCCEEECCCC-------------------------cCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCc
Confidence 445555555554444444 444 445556666777777777777776666666433
Q ss_pred ------CCCcEEeecCCcccc--ccCccccCCCCCCeEEccCcc
Q 040925 368 ------VCLEYLDISSNSFHG--VIPLSLSFLKSIKELNVSSNN 403 (833)
Q Consensus 368 ------~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~l~~N~ 403 (833)
..|+.|++++|.+.. +.|..|..+..++.++|++|+
T Consensus 287 ~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp SCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred ccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 567777777777653 556677777777788877774
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.17 Aligned_cols=207 Identities=24% Similarity=0.317 Sum_probs=154.2
Q ss_pred cCCcc-CceeccCcceEEEEEEEC--CCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSS-SNMIGQGSFGYVYKGTLG--EDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~-~~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
+.|++ .++||+|+||.||+|++. .+++.||||+++.. .....+.+|++++++++||||+++++++.... ...
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~---~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHA---DRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETT---TTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCC---CCe
Confidence 34666 458999999999999976 46889999999633 33457889999999999999999999985422 457
Q ss_pred EeEEEEecCCCChhhhhccCCCc---cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeee----cCCCc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQ---VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLL----DHDMV 680 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll----~~~~~ 680 (833)
.++||||++ |+|.+++...... .....+++..++.++.||+.||+|||+. +|+||||||+||++ +.++.
T Consensus 95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 170 (405)
T 3rgf_A 95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR 170 (405)
T ss_dssp EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence 999999997 5888888643211 1112489999999999999999999999 99999999999999 67789
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
+||+|||+|+........ ........||+.|+|||++.+. .++.++|||| .|+++++++++..|
T Consensus 171 ~kl~Dfg~a~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS----------lG~il~ell~g~~p 235 (405)
T 3rgf_A 171 VKIADMGFARLFNSPLKP-----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWA----------IGCIFAELLTSEPI 235 (405)
T ss_dssp EEECCTTCCC---------------------CCCTTCCHHHHTTCCSCCHHHHHHH----------HHHHHHHHHHSSCT
T ss_pred EEEEECCCceecCCCCcc-----cccCCCceecCcccCchhhcCCCcccchhhhHH----------HHHHHHHHHhCCCC
Confidence 999999999876542211 1122345799999999998874 5899999999 78888888888887
Q ss_pred Cc
Q 040925 760 EK 761 (833)
Q Consensus 760 ~~ 761 (833)
+.
T Consensus 236 f~ 237 (405)
T 3rgf_A 236 FH 237 (405)
T ss_dssp TC
T ss_pred CC
Confidence 74
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-36 Score=317.12 Aligned_cols=261 Identities=21% Similarity=0.301 Sum_probs=194.4
Q ss_pred cchHHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcC--CCccceEeeE
Q 040925 521 VSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIR--HRNLIKIITI 596 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~~~~~ 596 (833)
+.+..+....++|++.+.||+|+||.||+|.+. +++.||||++..... ...+.+.+|++++++++ ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 334444455678999999999999999999986 588999999975432 23467899999999997 5999999999
Q ss_pred eecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 597 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
+.... ..++||| +.+++|.+++.... .+++.+++.++.|++.||.|||+. +|+||||||+||+++
T Consensus 97 ~~~~~-----~~~lv~e-~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~ 161 (313)
T 3cek_A 97 EITDQ-----YIYMVME-CGNIDLNSWLKKKK------SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV 161 (313)
T ss_dssp EECSS-----EEEEEEC-CCSEEHHHHHHHCS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE
T ss_pred eecCC-----EEEEEEe-cCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE
Confidence 76655 8999999 55789999998754 689999999999999999999999 999999999999996
Q ss_pred CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCC-----------CCCCcccccccCCcCCCcccc
Q 040925 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-----------SEASMTGDIFTGRRPIDAVFN 745 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~s~~~~~~~~~~ 745 (833)
++.+||+|||+++........ .......||+.|+|||++.+ ..++.++||||
T Consensus 162 -~~~~kL~Dfg~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~s---------- 224 (313)
T 3cek_A 162 -DGMLKLIDFGIANQMQPDTTS------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWS---------- 224 (313)
T ss_dssp -TTEEEECCCSSSCC--------------------CCGGGCCHHHHTTCC----------CCCHHHHHHH----------
T ss_pred -CCeEEEeeccccccccCcccc------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHH----------
Confidence 489999999999876543211 11123469999999999865 46888999999
Q ss_pred CCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 746 EGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 746 ~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+|+++++++++..|+.......... ........ ....+...+..+.+++.+||+.||++|||++|+++.
T Consensus 225 lG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 225 LGCILYYMTYGKTPFQQIINQISKL-HAIIDPNH-----EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHHHHHHHSSCTTTTCCSHHHHH-HHHHCTTS-----CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHhCCCchhhHHHHHHHH-HHHHhccc-----ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 8888999999998875211000000 00000000 000111124568899999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=335.94 Aligned_cols=272 Identities=22% Similarity=0.292 Sum_probs=200.2
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTD-FKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 606 (833)
..++|++.+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|++++++++||||+++++++.... +....
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 3478999999999999999999999899999999987542 233467899999999999999999999875522 22355
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc---EEE
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV---AHV 683 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kL 683 (833)
..++||||+++|+|.+++...... ..+++..++.++.|++.||+|||+. ||+||||||+||+++.++. +||
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred eEEEEEEeCCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence 789999999999999999875422 2588999999999999999999999 9999999999999997764 999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+|||++........ .....||+.|+|||++.+..++.++|||| .|+++++++++..|+...
T Consensus 166 ~DFG~a~~~~~~~~---------~~~~~gt~~Y~APE~l~~~~~s~ksDIwS----------LGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 166 IDLGYAKELDQGEL---------CTEFVGTLQYLAPELLEQKKYTVTVDYWS----------FGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CSCCCCCBTTSCCC---------CCCCCSCCTTCSSCSSCCSCCSTTHHHHH----------HHHHHHHHHSSCSSCCSS
T ss_pred cccccccccccccc---------cccccCCcccCChHHhccCCCCchhHHHH----------HHHHHHHHHHCCCCCCcc
Confidence 99999987654321 12356999999999999999999999999 788888888888876421
Q ss_pred cc-------c----ccc-chhhhccccc---hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHH-----HHHHHH
Q 040925 764 EI-------V----DPS-LLMEVMTNNS---MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDV-----VAKLCH 823 (833)
Q Consensus 764 ~~-------~----~~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei-----l~~L~~ 823 (833)
.. . ... ...+...... ...+........+++.+.+++.+||.+||++|||++|+ .+.+..
T Consensus 227 ~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 227 WQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred cchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 00 0 000 0000000000 00011112233467789999999999999999999884 444544
Q ss_pred hh
Q 040925 824 TR 825 (833)
Q Consensus 824 i~ 825 (833)
+.
T Consensus 307 iL 308 (676)
T 3qa8_A 307 IL 308 (676)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=326.69 Aligned_cols=257 Identities=21% Similarity=0.207 Sum_probs=182.3
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceEeE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
.|.+.+.||+|+||+||.+... +|+.||||++... ..+.+.+|+++++++ +||||+++++++.... ..++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~-----~~~l 86 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDR-----FLYI 86 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSS-----EEEE
T ss_pred eeeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC-----eEEE
Confidence 3555688999999999876544 7899999998643 345678999999987 8999999999976554 8999
Q ss_pred EEEecCCCChhhhhccCCCcccc-ccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-----------
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEV-CKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD----------- 678 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~----------- 678 (833)
||||++ |+|.+++......... ...++..++.++.||+.||+|||+. +|+||||||+||+++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence 999996 6999999876432111 0123445678999999999999999 99999999999999754
Q ss_pred --CcEEEcccccccccCcccccccccCCCccccccccccccCccccCC-------CCCCcccccccCCcCCCccccCCcc
Q 040925 679 --MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-------SEASMTGDIFTGRRPIDAVFNEGHS 749 (833)
Q Consensus 679 --~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~s~~~~~~~~~~~g~~ 749 (833)
+.+||+|||+|+......... ........||+.|+|||++.+ ..++.++|||| +|++
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS----------lG~i 228 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSF----RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS----------MGCV 228 (434)
T ss_dssp CSCEEEECCCTTCEECCC------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH----------HHHH
T ss_pred CceEEEEcccccceecCCCCccc----eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh----------HHHH
Confidence 489999999998765432111 011223569999999999865 66899999999 7888
Q ss_pred HHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 750 LHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 750 l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
++++++ +..|+.......... .................++..+.+++.+||+.||++|||+.|+++
T Consensus 229 l~ellt~g~~Pf~~~~~~~~~i----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 229 FYYILSKGKHPFGDKYSRESNI----IRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHTTSCCTTCSTTTHHHHH----HHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhCCCCCCCCchhhHHHH----hcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 888887 777764221111111 111111111112223456788999999999999999999999986
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=349.37 Aligned_cols=389 Identities=16% Similarity=0.129 Sum_probs=238.9
Q ss_pred CCCCEEEccCCcccccCCcc-CCCCCCCCEEEcCCCcccc----cCCccccCCCCCcEEECCCcccccccCchhhcCCC-
Q 040925 23 SDLEVIRIMGNSLGGKIPTT-LGLLRNLVSLNVAENKFSG----MFPRSICNISSLELIQLALNRFSGNLPFDIVVNLP- 96 (833)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~-~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~- 96 (833)
++|++|+|++|+++...... +..+++|++|+|++|+++. .++..+..+++|++|+|++|++++..+..++..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 46778888888886544333 6778888888888888874 34667778888888888888887444455556666
Q ss_pred ---CccEEEccCCccee----eCCccccCCCCCcEEEcccCccccccCcCc-----cCCCcCceEecccccCCCCCCCCc
Q 040925 97 ---NLKALAIGGNNFFG----SIPYSLSNASNLELLDLSVNQFKGNVSIDF-----SSLKNLLWLNLEQNNLGTGTATDL 164 (833)
Q Consensus 97 ---~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~ 164 (833)
+|++|+|++|.++. .++..|..+++|++|+|++|+|+......+ ...++|++|+|++|+++.....
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~-- 160 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCE-- 160 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHH--
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHH--
Confidence 68899999998873 457788888999999999998875444333 2356788888888887653321
Q ss_pred ccccccCCCCCCCEEEccCCcCcccCChhHhhh----cccccEEEccCcccccc----CChhhhcCCCCCeEeccCCccc
Q 040925 165 DFVTFLTNCSSLKALSLADNQFGGELPHSIANL----SSTVINFGIGRNQISGT----IPPGIRNLVNLIGFGAEENQLH 236 (833)
Q Consensus 165 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l----~~~l~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~ 236 (833)
.++..+..+++|++|+|++|+++...+..+... ...++.|++++|.++.. ++..+..+++|++|++++|++.
T Consensus 161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 240 (461)
T 1z7x_W 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240 (461)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence 234456677888888888888875544444332 11344455555544432 2334444444555555544444
Q ss_pred ccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCC----CCCCCCCCCccceeecCCceecccCC
Q 040925 237 GTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN----IPSSLGNCQNLMSFTASQNKLTGALP 312 (833)
Q Consensus 237 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p 312 (833)
+.....+. +..+..+++|++|+|++|+++.. ++..+..+++|++|++++|.+++..+
T Consensus 241 ~~~~~~l~-------------------~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 301 (461)
T 1z7x_W 241 DVGMAELC-------------------PGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA 301 (461)
T ss_dssp HHHHHHHH-------------------HHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH
T ss_pred hHHHHHHH-------------------HHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHH
Confidence 32110000 11122344455555555544422 23334444555555555555442222
Q ss_pred cccccc----cccceeeecCCCccCCC----CCcccccCCCcCEEeccCCcCCCCCCccccC-----CCCCcEEeecCCc
Q 040925 313 HQLLSI----TTLSLYLDLSNNLLNGS----LPLQVGHLKNLVILDISSNQFSGVIPGTLST-----CVCLEYLDISSNS 379 (833)
Q Consensus 313 ~~~~~~----~~ll~~L~ls~N~l~~~----~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~ 379 (833)
..+... ...+++|++++|.+++. ++..+..+++|++|++++|.+++..+..+.. +++|++|+|++|+
T Consensus 302 ~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~ 381 (461)
T 1z7x_W 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCD 381 (461)
T ss_dssp HHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSC
T ss_pred HHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCC
Confidence 222211 11225566666665543 3455667788888888888887654444443 6688888888888
Q ss_pred ccc----ccCccccCCCCCCeEEccCcccCCCchhhhc-----CCCCCceEECccCcCcccc
Q 040925 380 FHG----VIPLSLSFLKSIKELNVSSNNLSGQIPEFLK-----NLSVLEFLSLSYNHFEGEV 432 (833)
Q Consensus 380 l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~-----~l~~L~~L~l~~N~l~~~~ 432 (833)
+++ .++..+..+++|++|++++|++++.....+. ....|+.|++.+|.+....
T Consensus 382 i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~~~~ 443 (461)
T 1z7x_W 382 VSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEM 443 (461)
T ss_dssp CCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHH
T ss_pred CChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccCHHH
Confidence 875 5667777788888888888888754222222 2345777777777766543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=311.57 Aligned_cols=254 Identities=19% Similarity=0.273 Sum_probs=178.9
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-c-hhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-A-SRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
..++|++.+.||+|+||.||+|++..+++.||||+++..... . .+.+.++..+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~----- 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT----- 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-----
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC-----
Confidence 356899999999999999999999989999999999754322 1 233445555778889999999999986654
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+ ++.+..+...... .+++..++.++.|++.||.|||+ . ||+||||||+||+++.++.+||+|
T Consensus 98 ~~~lv~e~~-~~~~~~l~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~d 168 (318)
T 2dyl_A 98 DVFIAMELM-GTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCD 168 (318)
T ss_dssp EEEEEECCC-SEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECC
T ss_pred cEEEEEecc-CCcHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEE
Confidence 899999999 4566655543221 68999999999999999999998 6 899999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
||++........ .....||+.|+|||++. +..++.++|||| +|+++++++++..|+
T Consensus 169 fg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s----------lG~il~~l~~g~~pf 229 (318)
T 2dyl_A 169 FGISGRLVDDKA---------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWS----------LGISLVELATGQFPY 229 (318)
T ss_dssp CTTC-----------------------CCTTCCHHHHC--------CCTHHHHHH----------HHHHHHHHHHSSCTT
T ss_pred CCCchhccCCcc---------ccccCCCccccChhhcccccccccCCccccchhh----------HHHHHHHHHhCCCCC
Confidence 999976544221 11245999999999984 556889999999 888899999998887
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
..... +.............. ......++..+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 230 KNCKT-DFEVLTKVLQEEPPL----LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp TTCCS-HHHHHHHHHHSCCCC----CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCc-cHHHHHHHhccCCCC----CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 53111 111111111111000 00111245678899999999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-35 Score=312.52 Aligned_cols=246 Identities=17% Similarity=0.190 Sum_probs=179.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--------cchhHHHHHHHHHhhcC---------CCccce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--------GASRSFVAECEALRNIR---------HRNLIK 592 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~ 592 (833)
.++|++.+.||+|+||+||+|++ +++.||||+++.... ...+.+.+|++++++++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46799999999999999999998 679999999975432 22367899999999986 666666
Q ss_pred EeeEeecC-------------------------CCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHH
Q 040925 593 IITICSST-------------------------DFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAID 647 (833)
Q Consensus 593 ~~~~~~~~-------------------------~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~q 647 (833)
+.+++... ++.+....|+||||+++|++.+.+.+. .+++.+++.++.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~-------~~~~~~~~~i~~q 169 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-------LSSLATAKSILHQ 169 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT-------CCCHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc-------CCCHHHHHHHHHH
Confidence 66654211 011245899999999999777666432 5899999999999
Q ss_pred HHHHHHHHh-hcCCCCceeeCCCCCCeeecCCC--------------------cEEEcccccccccCcccccccccCCCc
Q 040925 648 VASAMEYLH-HHCQPPMVHGDLKPSNVLLDHDM--------------------VAHVCDFGLAKFLSDHQLDTAVKTPSS 706 (833)
Q Consensus 648 i~~gL~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kL~DfG~a~~~~~~~~~~~~~~~~~ 706 (833)
|+.||+||| +. +|+||||||+|||++.++ .+||+|||+|+.....
T Consensus 170 i~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----------- 235 (336)
T 2vuw_A 170 LTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----------- 235 (336)
T ss_dssp HHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-----------
T ss_pred HHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-----------
Confidence 999999999 89 999999999999999887 8999999999865432
Q ss_pred cccccccccccCccccCCCCCCcccccccC-CcCCCccccCCccHHHHHH-HhCCCcccccccccchhhhccccchhhhh
Q 040925 707 SIGLKGTVGYVAPEYGMGSEASMTGDIFTG-RRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQED 784 (833)
Q Consensus 707 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~-~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 784 (833)
...||+.|||||++.+.. +.++||||. +.+..++|.....+..... ...... . ..........
T Consensus 236 --~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~--------~----~~~~~~~~~~ 300 (336)
T 2vuw_A 236 --IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDK--------M----LKQMTFKTKC 300 (336)
T ss_dssp --EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHH--------H----HHTCCCSSCC
T ss_pred --cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHh--------h----hhhhccCccc
Confidence 136999999999998776 899999993 4445555554444332110 000000 0 0000000001
Q ss_pred hhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHH
Q 040925 785 KRVKTEECLNAIIRTGVLCSMESPFERMDMRDVV 818 (833)
Q Consensus 785 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil 818 (833)
.......+++.+.+++.+||++| |++|++
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 11234567888999999999977 899887
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=320.68 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=180.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
..+|.+.+.||+|+||+||.... .+++.||||++... ....+.+|+++++++ +||||+++++++.... ..
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~-----~~ 93 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQ-----FQ 93 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETT-----EE
T ss_pred cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCC-----EE
Confidence 34689999999999999664433 37889999999643 234467899999999 7999999999976554 88
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-----CCcEEE
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-----DMVAHV 683 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL 683 (833)
|+||||++ |+|.+++..... ..++..++.++.||+.||+|||+. +|+||||||+||+++. ...+||
T Consensus 94 ~lv~E~~~-g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL 164 (432)
T 3p23_A 94 YIAIELCA-ATLQEYVEQKDF-----AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMI 164 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSSC-----CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEE
T ss_pred EEEEECCC-CCHHHHHHhcCC-----CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEE
Confidence 99999996 599999987643 345556788999999999999999 9999999999999953 236889
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccC---CCCCCcccccccCCcCCCccccCCccHHHHHH-HhCC
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM---GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALP 759 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p 759 (833)
+|||+|+........ ........||+.|+|||++. +..++.++|||| .|++++++++ +..|
T Consensus 165 ~DFG~a~~~~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwS----------lG~il~ellt~g~~p 229 (432)
T 3p23_A 165 SDFGLCKKLAVGRHS-----FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFS----------AGCVFYYVISEGSHP 229 (432)
T ss_dssp CCTTEEECC-----------------CCSCTTSCCGGGTSCC---CCCTHHHHHH----------HHHHHHHHHTTSCBT
T ss_pred ecccceeeccCCCcc-----eeeccccCCCcCccChhhhhcccccCCCcHHHHHH----------HHHHHHHHHcCCCCC
Confidence 999999876543211 11223457999999999987 456788999999 7778888888 6666
Q ss_pred CcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
+.......... .... ..... ..........+.+++.+||+.||++|||++|+++
T Consensus 230 f~~~~~~~~~~---~~~~-~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 230 FGKSLQRQANI---LLGA-CSLDC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TBSTTTHHHHH---HTTC-CCCTT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhHHHHHH---Hhcc-CCccc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 54211100000 0000 00000 0011223556789999999999999999999984
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-34 Score=298.55 Aligned_cols=233 Identities=12% Similarity=0.040 Sum_probs=184.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||.||+|++..+++.||||+++..... ..+.+.+|+.++++++||||+++++++...+ .
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~-----~ 105 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRA-----G 105 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT-----E
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECC-----c
Confidence 5799999999999999999999989999999999755332 2367899999999999999999999976654 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+||||+++++|.+++... ....++.+++.|++.||+|||+. ||+||||||+||+++.++.+||+++|
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~ 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC
T ss_pred EEEEEEecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc
Confidence 99999999999999999542 35557889999999999999999 99999999999999999999997443
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
|++| ++.++|||| +|+++|+++++..|+......+
T Consensus 175 ----------------------------~~~~-------~~~~~Di~s----------lG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 175 ----------------------------TMPD-------ANPQDDIRG----------IGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp ----------------------------CCTT-------CCHHHHHHH----------HHHHHHHHHHSEECSCCCSBCC
T ss_pred ----------------------------ccCC-------CCchhHHHH----------HHHHHHHHHHCCCCCCcCCcch
Confidence 3333 688999999 8899999999999986332211
Q ss_pred cc-chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhh
Q 040925 768 PS-LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETF 828 (833)
Q Consensus 768 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~ 828 (833)
.- .......... ........++++.+.+++.+||+.||++| |+.|+++.|+.+....
T Consensus 210 ~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 210 GLAPAERDTAGQP---IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp CSEECCBCTTSCB---CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hhHHHHHHhccCC---CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 10 0000001110 01111123456778999999999999999 9999999999987543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=336.65 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=193.0
Q ss_pred cCCccCceeccCcceEEEEEEECC-CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGE-DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|++++++++||||+++++++...+..+....
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 689999999999999999999975 689999999864322 334578899999999999999999999877653333347
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
|+||||+++++|.+++.. .+++.+++.|+.||+.||.|||+. |||||||||+||+++.+ .+||+|||+
T Consensus 160 ~lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 999999999999987754 589999999999999999999999 99999999999999875 899999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
++..... ....||+.|+|||++.+. ++.++|||| +|++++++.++..|+.... .+
T Consensus 228 a~~~~~~------------~~~~gt~~y~aPE~~~~~-~~~~sDi~s----------lG~~l~~l~~g~~~~~~~~-~~- 282 (681)
T 2pzi_A 228 VSRINSF------------GYLYGTPGFQAPEIVRTG-PTVATDIYT----------VGRTLAALTLDLPTRNGRY-VD- 282 (681)
T ss_dssp CEETTCC------------SCCCCCTTTSCTTHHHHC-SCHHHHHHH----------HHHHHHHHHSCCCEETTEE-CS-
T ss_pred chhcccC------------CccCCCccccCHHHHcCC-CCCceehhh----------hHHHHHHHHhCCCCCcccc-cc-
Confidence 9865432 124699999999988765 488999999 7788888887765543111 00
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-HHHHHHHHHHhhh
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-MRDVVAKLCHTRE 826 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~eil~~L~~i~~ 826 (833)
.. . ........++.+.+++.+||+.||++||+ ++++...+..+.+
T Consensus 283 ~~-----~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 283 GL-----P--------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp SC-----C--------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred cc-----c--------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 00 0 00111234567889999999999999995 6677777776654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=300.53 Aligned_cols=255 Identities=30% Similarity=0.471 Sum_probs=221.0
Q ss_pred CCCCEEEccCCcCcc--cCChhHhhhcccccEEEccC-ccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCC
Q 040925 174 SSLKALSLADNQFGG--ELPHSIANLSSTVINFGIGR-NQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQ 250 (833)
Q Consensus 174 ~~L~~L~Ls~N~l~~--~~p~~~~~l~~~l~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 250 (833)
.+++.|+|++|++++ .+|..+.++. .++.|++++ |.+.+.+|..|.++++|++|+|++|++++.+|..|..+++|+
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 128 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred ceEEEEECCCCCccCCcccChhHhCCC-CCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence 356666666666666 6666666654 366677773 777777888888899999999999999888899999999999
Q ss_pred EEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCC-ccceeecCCceecccCCcccccccccceeeecCC
Q 040925 251 KLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQ-NLMSFTASQNKLTGALPHQLLSITTLSLYLDLSN 329 (833)
Q Consensus 251 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~ 329 (833)
+|+|++|.+++.+|..|..+++|++|+|++|++++.+|..+..++ +|+.|++++|++++.+|..+..+. +++|++++
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~--L~~L~Ls~ 206 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN--LAFVDLSR 206 (313)
T ss_dssp EEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC--CSEEECCS
T ss_pred EEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc--ccEEECcC
Confidence 999999999988899999999999999999999888888898888 899999999999988888888776 48899999
Q ss_pred CccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCch
Q 040925 330 NLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIP 409 (833)
Q Consensus 330 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 409 (833)
|.+++..|..|..+++|+.|+|++|.+++.+|. +..+++|++|+|++|++++..|..+..+++|+.|+|++|++++.+|
T Consensus 207 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip 285 (313)
T 1ogq_A 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp SEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred CcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCC
Confidence 999988999999999999999999999976665 8899999999999999999999999999999999999999999888
Q ss_pred hhhcCCCCCceEECccCcCccccC
Q 040925 410 EFLKNLSVLEFLSLSYNHFEGEVP 433 (833)
Q Consensus 410 ~~l~~l~~L~~L~l~~N~l~~~~~ 433 (833)
.. ..+++|+.+++++|+.-|..|
T Consensus 286 ~~-~~l~~L~~l~l~~N~~lc~~p 308 (313)
T 1ogq_A 286 QG-GNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp CS-TTGGGSCGGGTCSSSEEESTT
T ss_pred CC-ccccccChHHhcCCCCccCCC
Confidence 76 889999999999999655444
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=334.96 Aligned_cols=376 Identities=16% Similarity=0.110 Sum_probs=245.6
Q ss_pred CcEEECCCcccccccCchhhcCCCCccEEEccCCccee----eCCccccCCCCCcEEEcccCccccccCcCc-cCCC---
Q 040925 73 LELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFG----SIPYSLSNASNLELLDLSVNQFKGNVSIDF-SSLK--- 144 (833)
Q Consensus 73 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~-~~l~--- 144 (833)
|+.|+|++|++++.....+|..+++|++|+|++|.++. .++..+..+++|++|+|++|+|.......+ ..++
T Consensus 5 l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~ 84 (461)
T 1z7x_W 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS 84 (461)
T ss_dssp EEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTT
T ss_pred ceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCC
Confidence 34444444444322222224444444555555444432 123344444555555555555543222221 2233
Q ss_pred -cCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhh----cccccEEEccCcccccc----C
Q 040925 145 -NLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANL----SSTVINFGIGRNQISGT----I 215 (833)
Q Consensus 145 -~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l----~~~l~~L~l~~n~i~~~----~ 215 (833)
+|++|+|++|.++..... .++..+..+++|++|+|++|+++...+..+... ...++.|++++|++++. +
T Consensus 85 ~~L~~L~L~~n~i~~~~~~--~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 85 CKIQKLSLQNCCLTGAGCG--VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp CCCCEEECTTSCCBGGGHH--HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CceeEEEccCCCCCHHHHH--HHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 455555555554321110 123345555566666666666554444444332 12355666666666543 3
Q ss_pred ChhhhcCCCCCeEeccCCcccccCCcccc-----CCCCCCEEEcccccCccc----CCccccCCCCCCeEEeecccccCC
Q 040925 216 PPGIRNLVNLIGFGAEENQLHGTIPDAIG-----ELKNLQKLCLFRNFLQGR----IPSGLGNLTKLANLELSSNSLQGN 286 (833)
Q Consensus 216 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~ 286 (833)
+..+..+++|++|++++|.+....+..+. ..++|++|+|++|.+++. ++..+..+++|++|+|++|+++..
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 55677789999999999999876555554 367999999999999864 466778899999999999998753
Q ss_pred C-----CCCCCCCCccceeecCCceeccc----CCcccccccccceeeecCCCccCCCCCccccc-----CCCcCEEecc
Q 040925 287 I-----PSSLGNCQNLMSFTASQNKLTGA----LPHQLLSITTLSLYLDLSNNLLNGSLPLQVGH-----LKNLVILDIS 352 (833)
Q Consensus 287 ~-----~~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~-----l~~L~~L~ls 352 (833)
. +..+..+++|+.|++++|++++. ++..+.....+ ++|++++|.+++..+..+.. .++|++|+++
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L-~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~ 321 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL-KELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 321 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTC-CEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCc-ceEECCCCCCchHHHHHHHHHhccCCccceeeEcC
Confidence 2 33444689999999999999843 56666667777 78999999987544444433 3799999999
Q ss_pred CCcCCCC----CCccccCCCCCcEEeecCCccccccCccccC-----CCCCCeEEccCcccCC----CchhhhcCCCCCc
Q 040925 353 SNQFSGV----IPGTLSTCVCLEYLDISSNSFHGVIPLSLSF-----LKSIKELNVSSNNLSG----QIPEFLKNLSVLE 419 (833)
Q Consensus 353 ~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~----~~p~~l~~l~~L~ 419 (833)
+|.+++. .+..+..+++|++|+|++|++++..+..+.. .++|+.|++++|.+++ .+|..+..+++|+
T Consensus 322 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~ 401 (461)
T 1z7x_W 322 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401 (461)
T ss_dssp TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred CCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCcc
Confidence 9999865 4566788899999999999998765554442 6799999999999986 7888999999999
Q ss_pred eEECccCcCccccCCC------CccCCCccccccCCcC
Q 040925 420 FLSLSYNHFEGEVPTK------GVFSNKTKISLQGNMK 451 (833)
Q Consensus 420 ~L~l~~N~l~~~~~~~------~~~~~~~~l~l~~N~~ 451 (833)
.|++++|+++...... .....++.+.+.++.+
T Consensus 402 ~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~ 439 (461)
T 1z7x_W 402 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 439 (461)
T ss_dssp EEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred EEECCCCCCCHHHHHHHHHHhccCCcchhheeeccccc
Confidence 9999999998642100 1123456666665544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-34 Score=312.59 Aligned_cols=252 Identities=15% Similarity=0.107 Sum_probs=183.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC---cchhHHHHHHHHHhhcCC-CccceEe---------eE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRH-RNLIKII---------TI 596 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~~---------~~ 596 (833)
...|...+.||+|+||.||+|++..+++.||||+++.... ...+.+.+|+.+++.++| ++...+. +.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457888999999999999999999999999999874322 235789999999999977 3221111 11
Q ss_pred eec------------CCCCCCceEeEEEEecCCCChhhhhccCCC-ccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCc
Q 040925 597 CSS------------TDFKGTDFKAFVFEYMENGSLKDWLHQSDD-QVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPM 663 (833)
Q Consensus 597 ~~~------------~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~i 663 (833)
+.. .........+++|+++ +++|.+++..... ......+++..++.++.|++.||+|||+. +|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 111 0000012467778776 5799999852110 00012578899999999999999999999 99
Q ss_pred eeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCcccc----------CCCCCCccccc
Q 040925 664 VHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYG----------MGSEASMTGDI 733 (833)
Q Consensus 664 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Di 733 (833)
+||||||+|||++.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++||
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv 300 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT 300 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----------cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence 99999999999999999999999999865443 122457 999999998 66678999999
Q ss_pred ccCCcCCCccccCCccHHHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC
Q 040925 734 FTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD 813 (833)
Q Consensus 734 ~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 813 (833)
|| +|+++++++++..|+....... ........ ...+++.+.+++.+||+.||++|||
T Consensus 301 wS----------lGvil~elltg~~Pf~~~~~~~--~~~~~~~~-----------~~~~~~~~~~li~~~l~~dP~~Rpt 357 (413)
T 3dzo_A 301 WT----------LGLAIYWIWCADLPNTDDAALG--GSEWIFRS-----------CKNIPQPVRALLEGFLRYPKEDRLL 357 (413)
T ss_dssp HH----------HHHHHHHHHHSSCCCCTTGGGS--CSGGGGSS-----------CCCCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HH----------HHHHHHHHHHCCCCCCCcchhh--hHHHHHhh-----------cccCCHHHHHHHHHHccCChhhCcC
Confidence 99 8889999999999876332111 10111110 0123467899999999999999999
Q ss_pred HHHHHHH
Q 040925 814 MRDVVAK 820 (833)
Q Consensus 814 ~~eil~~ 820 (833)
+.|+++.
T Consensus 358 ~~~~l~~ 364 (413)
T 3dzo_A 358 PLQAMET 364 (413)
T ss_dssp HHHHTTS
T ss_pred HHHHHhC
Confidence 8887543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-33 Score=293.15 Aligned_cols=235 Identities=18% Similarity=0.261 Sum_probs=182.2
Q ss_pred hcCCccC-ceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHH-hhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSS-NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEAL-RNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~-~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|.+. +.||+|+||.||+|.+..+++.||+|+++. ...+.+|++++ +..+||||+++++++... ..+...
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~-~~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhh-cCCCce
Confidence 4578887 789999999999999999999999999962 35678899988 555899999999997652 123457
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CCcEEEc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVC 684 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~ 684 (833)
.++||||+++|+|.+++...... .+++.+++.++.|++.||+|||+. +|+||||||+||+++. ++.+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred EEEEEeecCCCcHHHHHHhccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 89999999999999999875432 689999999999999999999999 9999999999999998 7899999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||++.... +..++.++|||| .|+++++++++..|+....
T Consensus 163 Dfg~a~~~~------------------------------~~~~~~~~Diws----------lG~il~el~tg~~pf~~~~ 202 (299)
T 3m2w_A 163 DFGFAKETT------------------------------GEKYDKSCDMWS----------LGVIMYILLCGYPPFYSNH 202 (299)
T ss_dssp CCTTCEECT------------------------------TCGGGGHHHHHH----------HHHHHHHHHHSSCSCCC--
T ss_pred ccccccccc------------------------------cccCCchhhHHH----------HHHHHHHHHHCCCCCCCCc
Confidence 999986432 134678999999 8889999999998875322
Q ss_pred ccc--ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVD--PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... ............. ........+++.+.+++.+||+.||++|||++|+++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 203 GLAISPGMKTRIRMGQYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -----CCSCCSSCTTCCS---SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhHHHHHHHhhcccc---CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 1111111001000 0111112356778999999999999999999999874
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-30 Score=290.79 Aligned_cols=248 Identities=20% Similarity=0.232 Sum_probs=200.2
Q ss_pred CCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEc
Q 040925 24 DLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI 103 (833)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 103 (833)
....++.+++.+ +.+|..+. ++|++|+|++|+|+++.|..|.++++|+.|+|++|+++ .++...|.++++|++|+|
T Consensus 55 ~~~~v~c~~~~l-~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L 130 (452)
T 3zyi_A 55 QFSKVVCTRRGL-SEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLEL 130 (452)
T ss_dssp SSCEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEEC
T ss_pred CCcEEEECCCCc-CccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-CcChhhccCcccCCEEEC
Confidence 456788888888 45665554 67888888888888777888888888888888888887 677777888888888888
Q ss_pred cCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEeccc-ccCCCCCCCCcccccccCCCCCCCEEEcc
Q 040925 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQ-NNLGTGTATDLDFVTFLTNCSSLKALSLA 182 (833)
Q Consensus 104 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls 182 (833)
++|+|+...+..|.++++|++|+|++|+|+.+++..|..+++|++|+|++ |.+..++. ..|.++++|++|+|+
T Consensus 131 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~------~~~~~l~~L~~L~L~ 204 (452)
T 3zyi_A 131 FDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISE------GAFEGLFNLKYLNLG 204 (452)
T ss_dssp CSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT------TTTTTCTTCCEEECT
T ss_pred CCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccCh------hhccCCCCCCEEECC
Confidence 88888877777788888888888888888888888888888888888887 45554443 236778888888888
Q ss_pred CCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCccc
Q 040925 183 DNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGR 262 (833)
Q Consensus 183 ~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 262 (833)
+|++++ +| .+..+++|+.|+|++|++.++.|..|.++++|++|+|++|.+++.
T Consensus 205 ~n~l~~-~~--------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 257 (452)
T 3zyi_A 205 MCNIKD-MP--------------------------NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257 (452)
T ss_dssp TSCCSS-CC--------------------------CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE
T ss_pred CCcccc-cc--------------------------cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE
Confidence 888762 11 256677888888888888888888888889999999999999888
Q ss_pred CCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceec
Q 040925 263 IPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT 308 (833)
Q Consensus 263 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 308 (833)
.+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|.+.
T Consensus 258 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred CHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 8888888899999999999998777888888899999999999887
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=289.63 Aligned_cols=249 Identities=22% Similarity=0.263 Sum_probs=206.4
Q ss_pred CCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEE
Q 040925 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALA 102 (833)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~ 102 (833)
.....++.+++.+ +.+|..+. ++++.|+|++|+|+++.+..|.++++|++|+|++|.++ .++...|.++++|++|+
T Consensus 43 ~~~~~v~c~~~~l-~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~~L~~L~ 118 (440)
T 3zyj_A 43 NQFSKVICVRKNL-REVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLE 118 (440)
T ss_dssp TTSCEEECCSCCC-SSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC-EECGGGGTTCSSCCEEE
T ss_pred CCCCEEEeCCCCc-CcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC-ccChhhccCCccCCEEE
Confidence 3567888888888 45666555 68888888888888888888888888888888888887 77778888888888888
Q ss_pred ccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEeccc-ccCCCCCCCCcccccccCCCCCCCEEEc
Q 040925 103 IGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQ-NNLGTGTATDLDFVTFLTNCSSLKALSL 181 (833)
Q Consensus 103 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~l~~l~~L~~L~L 181 (833)
|++|+|+.+.+..|..+++|++|+|++|+|+.+++..|..+++|++|+|++ |.+..++. ..|.++++|++|+|
T Consensus 119 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~------~~~~~l~~L~~L~L 192 (440)
T 3zyj_A 119 LFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISE------GAFEGLSNLRYLNL 192 (440)
T ss_dssp CCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECT------TTTTTCSSCCEEEC
T ss_pred CCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCc------chhhcccccCeecC
Confidence 888888877777888888889999998888888888888888899998888 45544443 34678888999998
Q ss_pred cCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcc
Q 040925 182 ADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQG 261 (833)
Q Consensus 182 s~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 261 (833)
++|+++ .+| .+..+++|+.|+|++|+++++.|..|.++++|++|+|++|.|++
T Consensus 193 ~~n~l~-~~~--------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~ 245 (440)
T 3zyj_A 193 AMCNLR-EIP--------------------------NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245 (440)
T ss_dssp TTSCCS-SCC--------------------------CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred CCCcCc-ccc--------------------------ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE
Confidence 888887 222 25677888888888888888888888899999999999999988
Q ss_pred cCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceec
Q 040925 262 RIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT 308 (833)
Q Consensus 262 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 308 (833)
+.+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 246 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 246 IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp ECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred EChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 88888889999999999999998888888888999999999999886
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=285.54 Aligned_cols=276 Identities=18% Similarity=0.164 Sum_probs=186.4
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcc
Q 040925 3 TLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82 (833)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~ 82 (833)
..+++++.++ .+|..+. ++|++|++++|++++..+..|..+++|++|+|++|+++++.|.+|.++++|++|+|++|+
T Consensus 35 ~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (353)
T 2z80_A 35 ICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111 (353)
T ss_dssp EEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCc
Confidence 4577788888 5666555 378888888888877666678888888888888888887777788888888888888888
Q ss_pred cccccCchhhcCCCCccEEEccCCcceeeCC-ccccCCCCCcEEEcccC-ccccccCcCccCCCcCceEecccccCCCCC
Q 040925 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIP-YSLSNASNLELLDLSVN-QFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 83 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
++ .+|...|.++++|++|+|++|+++...+ ..|.++++|++|++++| .+..+.+..|.++++|++|++++|.++...
T Consensus 112 l~-~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 190 (353)
T 2z80_A 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190 (353)
T ss_dssp CS-SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred CC-cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccC
Confidence 87 7777777888888888888888875444 46788888888888888 577777777888888888888888876543
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (833)
+ ..+.++++|++|++++|+++ .+|..+......++.|++++|.+++..+..+..
T Consensus 191 ~------~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~------------------- 244 (353)
T 2z80_A 191 P------KSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELST------------------- 244 (353)
T ss_dssp T------TTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTTCCCC-----------------------
T ss_pred H------HHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCcccccccccccc-------------------
Confidence 3 34667778888888888776 444444433334455555555554433322211
Q ss_pred ccccCCCCCCEEEcccccCcc----cCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceeccc
Q 040925 241 DAIGELKNLQKLCLFRNFLQG----RIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGA 310 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 310 (833)
......++.++|++|.+++ .+|..+..+++|++|+|++|+++...+..|..+++|+.|++++|.+.+.
T Consensus 245 --~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 245 --GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp ----CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred --ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 1123455566666655553 2445566666666666666666643333456666666666666666643
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-31 Score=285.02 Aligned_cols=282 Identities=20% Similarity=0.208 Sum_probs=168.2
Q ss_pred CCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCce
Q 040925 69 NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLW 148 (833)
Q Consensus 69 ~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~ 148 (833)
.++.....++++|.++ .+|..++ ++|++|+|++|.+++..+..|.++++|++|+|++|+|+++.+..|.++++|++
T Consensus 29 ~C~~~~~c~~~~~~l~-~iP~~~~---~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 104 (353)
T 2z80_A 29 SCDRNGICKGSSGSLN-SIPSGLT---EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH 104 (353)
T ss_dssp EECTTSEEECCSTTCS-SCCTTCC---TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred CCCCCeEeeCCCCCcc-ccccccc---ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence 3444455666666666 6665443 36666777777666655556667777777777777776666666666666666
Q ss_pred EecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeE
Q 040925 149 LNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGF 228 (833)
Q Consensus 149 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L 228 (833)
|+|++|+++.++. ..+.++++|++|+|++|+
T Consensus 105 L~Ls~n~l~~~~~------~~~~~l~~L~~L~L~~n~------------------------------------------- 135 (353)
T 2z80_A 105 LDLSYNYLSNLSS------SWFKPLSSLTFLNLLGNP------------------------------------------- 135 (353)
T ss_dssp EECCSSCCSSCCH------HHHTTCTTCSEEECTTCC-------------------------------------------
T ss_pred EECCCCcCCcCCH------hHhCCCccCCEEECCCCC-------------------------------------------
Confidence 6555555543221 113344444444444444
Q ss_pred eccCCcccccCC-ccccCCCCCCEEEcccc-cCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCce
Q 040925 229 GAEENQLHGTIP-DAIGELKNLQKLCLFRN-FLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNK 306 (833)
Q Consensus 229 ~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 306 (833)
++++.+ ..|..+++|++|++++| .+.+..+..|.++++|++|++++|++++..|..|..+++|++|++++|+
T Consensus 136 ------l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~ 209 (353)
T 2z80_A 136 ------YKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ 209 (353)
T ss_dssp ------CSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSC
T ss_pred ------CcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCc
Confidence 443322 34556666666666666 3555555566666666666666666666666666666666666666665
Q ss_pred ecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccc---cCCCCCcEEeecCCcccc-
Q 040925 307 LTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTL---STCVCLEYLDISSNSFHG- 382 (833)
Q Consensus 307 l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~---~~l~~L~~L~Ls~N~l~~- 382 (833)
++ .+|..+. ..+++|+.|++++|.+++..+..+ .....++.++|++|.+++
T Consensus 210 l~-~~~~~~~------------------------~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 210 HI-LLLEIFV------------------------DVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp ST-THHHHHH------------------------HHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred cc-cchhhhh------------------------hhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence 54 3332222 223444444444444443333222 224456666666666654
Q ss_pred ---ccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCC
Q 040925 383 ---VIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 383 ---~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
.+|..+..+++|+.|++++|+++...+..|..+++|++|++++|+++|.+|.
T Consensus 265 ~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 265 SLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp HHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred chhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 3466778888888888888888855544568888888899999988888873
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=286.78 Aligned_cols=246 Identities=22% Similarity=0.269 Sum_probs=181.6
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
++++.+++.++ .+|..+. ++++.|+|++|+|++..+..|..+++|++|+|++|+|+++.+.+|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 35667777777 5666555 47777777777777777777777777777777777777777777777777777777777
Q ss_pred ccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEccc-CccccccCcCccCCCcCceEecccccCCCCC
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSV-NQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
+++ .+|...|..+++|++|+|++|.|+.+.+..|.++++|++|+|++ |.+..+.+..|.++++|++|+|++|+++.++
T Consensus 123 ~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 201 (440)
T 3zyj_A 123 RLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP 201 (440)
T ss_dssp CCS-SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC
T ss_pred cCC-eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc
Confidence 777 67777777777777777777777776677777777777777777 5566666667777777777777777776554
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (833)
. +..+++|++|+|++|++++ ..|..|.++++|+.|+|++|+++++.+
T Consensus 202 ~--------~~~l~~L~~L~Ls~N~l~~-------------------------~~~~~~~~l~~L~~L~L~~n~l~~~~~ 248 (440)
T 3zyj_A 202 N--------LTPLIKLDELDLSGNHLSA-------------------------IRPGSFQGLMHLQKLWMIQSQIQVIER 248 (440)
T ss_dssp C--------CTTCSSCCEEECTTSCCCE-------------------------ECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred c--------cCCCcccCEEECCCCccCc-------------------------cChhhhccCccCCEEECCCCceeEECh
Confidence 2 5666777777777776652 345566677777777777777777777
Q ss_pred ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeeccccc
Q 040925 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ 284 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 284 (833)
.+|.++++|++|+|++|.|++..+..|..+++|+.|+|++|.+.
T Consensus 249 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 292 (440)
T 3zyj_A 249 NAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292 (440)
T ss_dssp TSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred hhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence 77777777777777777777766677777777777777777765
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.5e-30 Score=286.92 Aligned_cols=246 Identities=22% Similarity=0.242 Sum_probs=180.2
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
+.++.++++++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 35667777777 5666554 47777777777777777777777777777777777777777777777777777777777
Q ss_pred ccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEccc-CccccccCcCccCCCcCceEecccccCCCCC
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSV-NQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
+++ .+|...|.++++|++|+|++|.|+.+.+..|.++++|++|+|++ |.+..+++..|.++++|++|+|++|+++.++
T Consensus 134 ~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 212 (452)
T 3zyi_A 134 WLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP 212 (452)
T ss_dssp CCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC
T ss_pred cCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc
Confidence 776 67777777777777777777777766666777777777777777 5666666667777777777777777776543
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (833)
. +..+++|++|+|++|++++ ..|..|.++++|+.|+|++|++.++.+
T Consensus 213 ~--------~~~l~~L~~L~Ls~N~l~~-------------------------~~~~~~~~l~~L~~L~L~~n~l~~~~~ 259 (452)
T 3zyi_A 213 N--------LTPLVGLEELEMSGNHFPE-------------------------IRPGSFHGLSSLKKLWVMNSQVSLIER 259 (452)
T ss_dssp C--------CTTCTTCCEEECTTSCCSE-------------------------ECGGGGTTCTTCCEEECTTSCCCEECT
T ss_pred c--------ccccccccEEECcCCcCcc-------------------------cCcccccCccCCCEEEeCCCcCceECH
Confidence 2 5566777777777776652 345556667777777777777777777
Q ss_pred ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeeccccc
Q 040925 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ 284 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 284 (833)
..|.++++|++|+|++|.|++..+..|..+++|+.|+|++|.+.
T Consensus 260 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred HHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence 77777777777777777777666667777777777777777765
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=279.47 Aligned_cols=277 Identities=21% Similarity=0.251 Sum_probs=179.9
Q ss_pred ceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCC
Q 040925 147 LWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLI 226 (833)
Q Consensus 147 ~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~ 226 (833)
+.++++++.++.++.. + .++|++|+|++|+++ .+| +..|.++++|+
T Consensus 10 ~~l~c~~~~l~~ip~~-------~--~~~l~~L~L~~n~l~-~i~------------------------~~~~~~l~~L~ 55 (306)
T 2z66_A 10 TEIRCNSKGLTSVPTG-------I--PSSATRLELESNKLQ-SLP------------------------HGVFDKLTQLT 55 (306)
T ss_dssp TEEECCSSCCSSCCSC-------C--CTTCCEEECCSSCCC-CCC------------------------TTTTTTCTTCS
T ss_pred CEEEcCCCCcccCCCC-------C--CCCCCEEECCCCccC-ccC------------------------HhHhhccccCC
Confidence 4567777777665542 1 145666666666666 333 33345555555
Q ss_pred eEeccCCccccc--CCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCC-CCCCCCCccceeecC
Q 040925 227 GFGAEENQLHGT--IPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIP-SSLGNCQNLMSFTAS 303 (833)
Q Consensus 227 ~L~L~~N~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~ 303 (833)
+|+|++|++... .+..+.++++|++|+|++|.++ .+|..+.++++|++|++++|++++..+ ..+..+++|+.|+++
T Consensus 56 ~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~ 134 (306)
T 2z66_A 56 KLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 134 (306)
T ss_dssp EEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECT
T ss_pred EEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECC
Confidence 555555555422 1344445555555555555555 244445555555555555555554433 345555555555555
Q ss_pred CceecccCCcccccccccceeeecCCCccCC-CCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCcccc
Q 040925 304 QNKLTGALPHQLLSITTLSLYLDLSNNLLNG-SLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHG 382 (833)
Q Consensus 304 ~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~-~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 382 (833)
+|.+++..|..+..+..+ ++|++++|.+++ ..|..|..+++|++|++++|.+++..|..|..+++|++|+|++|++++
T Consensus 135 ~n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 213 (306)
T 2z66_A 135 HTHTRVAFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 213 (306)
T ss_dssp TSCCEECSTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCcCCccchhhcccCcCC-CEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence 555554444444444444 556666666554 456777888888888888888888878888888888888888888887
Q ss_pred ccCccccCCCCCCeEEccCcccCCCchhhhcCCC-CCceEECccCcCccccCCC---CccCCCccccccCCcCCCCCccc
Q 040925 383 VIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLS-VLEFLSLSYNHFEGEVPTK---GVFSNKTKISLQGNMKLCGGIDE 458 (833)
Q Consensus 383 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~-~L~~L~l~~N~l~~~~~~~---~~~~~~~~l~l~~N~~~c~~~~~ 458 (833)
..+..+..+++|+.|++++|++++..|..+..++ +|+.|++++|+|+|.++.. ..+.....+....+...|..|..
T Consensus 214 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~ 293 (306)
T 2z66_A 214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 293 (306)
T ss_dssp CCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred cChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence 7777888888889999999988888888888884 8889999999998877642 11233344555667777876654
Q ss_pred C
Q 040925 459 L 459 (833)
Q Consensus 459 ~ 459 (833)
.
T Consensus 294 ~ 294 (306)
T 2z66_A 294 K 294 (306)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=273.31 Aligned_cols=249 Identities=22% Similarity=0.253 Sum_probs=143.1
Q ss_pred CEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccC--chhhcCCCCccEEEc
Q 040925 26 EVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLP--FDIVVNLPNLKALAI 103 (833)
Q Consensus 26 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~~l~~L~~L~L 103 (833)
+.++.+++.+ +.+|..+. ++|++|+|++|+++.+.+..|.++++|++|+|++|+++ .+. ...+.++++|++|+|
T Consensus 10 ~~l~c~~~~l-~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~~~~~~L~~L~L 85 (306)
T 2z66_A 10 TEIRCNSKGL-TSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFGTTSLKYLDL 85 (306)
T ss_dssp TEEECCSSCC-SSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-EEEEEEHHHHSCSCCCEEEC
T ss_pred CEEEcCCCCc-ccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccC-cccCcccccccccccCEEEC
Confidence 3455555555 33343332 45555666666655444444555666666666666554 221 122335566666666
Q ss_pred cCCcceeeCCccccCCCCCcEEEcccCccccccC-cCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEcc
Q 040925 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVS-IDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLA 182 (833)
Q Consensus 104 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls 182 (833)
++|.++ .+|..|.++++|++|+|++|+++++.+ ..|..+++|++|++++|.++.... ..+.++++|++|+|+
T Consensus 86 s~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~ 158 (306)
T 2z66_A 86 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN------GIFNGLSSLEVLKMA 158 (306)
T ss_dssp CSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECST------TTTTTCTTCCEEECT
T ss_pred CCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccch------hhcccCcCCCEEECC
Confidence 666665 344445666666666666666665554 456666666666666666554332 235556666666666
Q ss_pred CCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCccc
Q 040925 183 DNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGR 262 (833)
Q Consensus 183 ~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 262 (833)
+|++++. ..|..|..+++|++|++++|++++..|..|..+++|++|+|++|.+++.
T Consensus 159 ~n~l~~~------------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (306)
T 2z66_A 159 GNSFQEN------------------------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 214 (306)
T ss_dssp TCEEGGG------------------------EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred CCccccc------------------------cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence 6666520 2334455556666666666666665566666666666666666666655
Q ss_pred CCccccCCCCCCeEEeecccccCCCCCCCCCCC-ccceeecCCceecc
Q 040925 263 IPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQ-NLMSFTASQNKLTG 309 (833)
Q Consensus 263 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~ 309 (833)
.+..|..+++|++|+|++|++++..|..+..++ +|+.|++++|.+++
T Consensus 215 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 215 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp CSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred ChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 555566666666666666666666666666663 66666666666653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.2e-30 Score=268.03 Aligned_cols=253 Identities=21% Similarity=0.218 Sum_probs=126.2
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcc
Q 040925 3 TLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82 (833)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~ 82 (833)
++++++++++ .+|..+ .++|++|++++|++++..+..|..+++|++|+|++|.++++.|.+|.++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 91 (285)
T 1ozn_A 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (285)
T ss_dssp EEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCC
Confidence 4555555555 344333 2355555555555555444555555555555555555555545555555555555555554
Q ss_pred -cccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCC
Q 040925 83 -FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTA 161 (833)
Q Consensus 83 -l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 161 (833)
+. .+++..|..+++|++|+|++|.+++..|..|.++++|++|+|++|+++.+++..|..
T Consensus 92 ~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------------------- 151 (285)
T 1ozn_A 92 QLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD------------------- 151 (285)
T ss_dssp TCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTT-------------------
T ss_pred Ccc-ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhcc-------------------
Confidence 43 444444455555555555555555444444555555555555555555444444444
Q ss_pred CCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCc
Q 040925 162 TDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPD 241 (833)
Q Consensus 162 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 241 (833)
+++|++|+|++|++++ ..+..|.++++|+.|++++|++.+..|.
T Consensus 152 -----------l~~L~~L~l~~n~l~~-------------------------~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 195 (285)
T 1ozn_A 152 -----------LGNLTHLFLHGNRISS-------------------------VPERAFRGLHSLDRLLLHQNRVAHVHPH 195 (285)
T ss_dssp -----------CTTCCEEECCSSCCCE-------------------------ECTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred -----------CCCccEEECCCCcccc-------------------------cCHHHhcCccccCEEECCCCcccccCHh
Confidence 4455555555554441 1222344444555555555555555555
Q ss_pred cccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCccc
Q 040925 242 AIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQL 315 (833)
Q Consensus 242 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~ 315 (833)
.|..+++|++|+|++|.+++..+..|..+++|+.|+|++|.+....+. ..-...++.+..+.+.+....|..+
T Consensus 196 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~-~~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGG
T ss_pred HccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCc-HHHHHHHHhcccccCccccCCchHh
Confidence 555555555555555555544444455555555555555555422211 0111234444445555554455443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-30 Score=267.65 Aligned_cols=254 Identities=24% Similarity=0.213 Sum_probs=172.0
Q ss_pred CEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEccc
Q 040925 177 KALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFR 256 (833)
Q Consensus 177 ~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 256 (833)
+.++++++.++ .+|..+ ...++.|++++|.+++..+..|.++++|++|++++|+++++.|..|.++++|++|+|++
T Consensus 14 ~~~~c~~~~l~-~ip~~~---~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI---PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp CEEECCSSCCS-SCCTTC---CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred eEEEcCcCCcc-cCCcCC---CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 56777777776 445432 23344555555555544444455555555555555555544444555555555555555
Q ss_pred cc-CcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCC
Q 040925 257 NF-LQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGS 335 (833)
Q Consensus 257 N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~ 335 (833)
|. ++...|..|..+++|++|+|++|++++..|..|.++++| ++|++++|.+++.
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-------------------------~~L~l~~n~l~~~ 144 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL-------------------------QYLYLQDNALQAL 144 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTC-------------------------CEEECCSSCCCCC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCC-------------------------CEEECCCCccccc
Confidence 54 443334444455555555555555544444444444444 4555666666655
Q ss_pred CCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCC
Q 040925 336 LPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNL 415 (833)
Q Consensus 336 ~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 415 (833)
.+..|+.+++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|..+++|+.|++++|++++..+..+..+
T Consensus 145 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 224 (285)
T 1ozn_A 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPL 224 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTC
T ss_pred CHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccC
Confidence 56678889999999999999998878889999999999999999998888899999999999999999998888889999
Q ss_pred CCCceEECccCcCccccCCCCccCCCccccccCCcCCCCCcccC
Q 040925 416 SVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDEL 459 (833)
Q Consensus 416 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~~~~~ 459 (833)
++|+.|++++|++.|.++..+.+..+..+....+...|..|...
T Consensus 225 ~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~~~~~~~~c~~p~~l 268 (285)
T 1ozn_A 225 RALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268 (285)
T ss_dssp TTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred cccCEEeccCCCccCCCCcHHHHHHHHhcccccCccccCCchHh
Confidence 99999999999999988765444445555667777888776654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=292.90 Aligned_cols=242 Identities=20% Similarity=0.155 Sum_probs=162.7
Q ss_pred cccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEee
Q 040925 200 TVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELS 279 (833)
Q Consensus 200 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 279 (833)
.++.|++++|.|++..|..|.++++|++|+|++|.+++..| |..+++|++|+|++|.|++..+ .++|++|+|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEECc
Confidence 45556666666666666677777777777777777776554 7777777777777777774322 2677777777
Q ss_pred cccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccc-cCCCcCEEeccCCcCCC
Q 040925 280 SNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVG-HLKNLVILDISSNQFSG 358 (833)
Q Consensus 280 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~-~l~~L~~L~ls~N~l~~ 358 (833)
+|.|++..+.. +++|+.|++++|.+++..|..+..+..+ ++|+|++|.+++..|..|. .+++|+.|+|++|.|++
T Consensus 108 ~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~ 183 (487)
T 3oja_A 108 NNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD 183 (487)
T ss_dssp SSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSE-EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE
T ss_pred CCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCC-CEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccc
Confidence 77777655443 4667777777777776666666666666 6777777777766666665 67778888888887775
Q ss_pred CCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccC--CCC
Q 040925 359 VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVP--TKG 436 (833)
Q Consensus 359 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~--~~~ 436 (833)
..+ +..+++|+.|+|++|+|++++| .+..+++|+.|+|++|.+++ +|..+..+++|+.|++++|++.|..+ ..+
T Consensus 184 ~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~ 259 (487)
T 3oja_A 184 VKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (487)
T ss_dssp EEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHT
T ss_pred ccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHH
Confidence 532 3347777888888887776544 47777778888888887774 56667777777788888887774322 123
Q ss_pred ccCCCcccccc-------CCcCCCCCc
Q 040925 437 VFSNKTKISLQ-------GNMKLCGGI 456 (833)
Q Consensus 437 ~~~~~~~l~l~-------~N~~~c~~~ 456 (833)
.+..+..+.+. +|++.|..+
T Consensus 260 ~l~~L~~l~~~~~~~~~~~~~~~c~~~ 286 (487)
T 3oja_A 260 KNQRVQTVAKQTVKKLTGQNEEECTVP 286 (487)
T ss_dssp TCHHHHHHHHHHHHHHTSSSSCCCSST
T ss_pred hCCCCcEEeccccccccCCCcccccCC
Confidence 34444444443 566666553
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=279.23 Aligned_cols=84 Identities=29% Similarity=0.310 Sum_probs=51.4
Q ss_pred eeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcc
Q 040925 324 YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNN 403 (833)
Q Consensus 324 ~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 403 (833)
+|++++|.|++ +| ..+++|+.|+|++|.|+.+ |. .+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+
T Consensus 225 ~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~l-p~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~ 295 (622)
T 3g06_A 225 ELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSL-PM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295 (622)
T ss_dssp EEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCC
T ss_pred EEEccCCccCc-CC---CCCCcCcEEECCCCCCCcC-Cc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCC
Confidence 44444444442 23 2346677777777777643 33 4566777777777777 445667777777777777777
Q ss_pred cCCCchhhhcCCC
Q 040925 404 LSGQIPEFLKNLS 416 (833)
Q Consensus 404 l~~~~p~~l~~l~ 416 (833)
+++..|..+..++
T Consensus 296 l~~~~~~~l~~L~ 308 (622)
T 3g06_A 296 LSERTLQALREIT 308 (622)
T ss_dssp CCHHHHHHHHHHH
T ss_pred CCCcCHHHHHhcc
Confidence 7766666665544
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=277.77 Aligned_cols=256 Identities=18% Similarity=0.203 Sum_probs=155.1
Q ss_pred EEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCccc
Q 040925 4 LAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRF 83 (833)
Q Consensus 4 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l 83 (833)
++++++.+...++..+..+++|++|+|++|++++..|..|+.+++|++|+|++|++++..+ |.++++|++|+|++|++
T Consensus 15 ~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l 92 (317)
T 3o53_A 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92 (317)
T ss_dssp ESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEE
T ss_pred eeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcc
Confidence 3444555554444445555566666666666655555566666666666666666654333 66666666666666666
Q ss_pred ccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCC
Q 040925 84 SGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATD 163 (833)
Q Consensus 84 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 163 (833)
+ .++ ..++|++|++++|++++..+.. +++|++|+|++|+++++.+..|..+++|++|+|++|.++.+...
T Consensus 93 ~-~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~- 162 (317)
T 3o53_A 93 Q-ELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA- 162 (317)
T ss_dssp E-EEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGG-
T ss_pred c-ccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHH-
Confidence 5 333 2256666666666665544433 34566666666666666555666666666666666665543221
Q ss_pred cccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccc
Q 040925 164 LDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAI 243 (833)
Q Consensus 164 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 243 (833)
..+..+++|++|+|++|+++ +. .....+++|++|+|++|+++++.+ .|
T Consensus 163 ----~~~~~l~~L~~L~L~~N~l~-------------------------~~--~~~~~l~~L~~L~Ls~N~l~~l~~-~~ 210 (317)
T 3o53_A 163 ----ELAASSDTLEHLNLQYNFIY-------------------------DV--KGQVVFAKLKTLDLSSNKLAFMGP-EF 210 (317)
T ss_dssp ----GGGGGTTTCCEEECTTSCCC-------------------------EE--ECCCCCTTCCEEECCSSCCCEECG-GG
T ss_pred ----HHhhccCcCCEEECCCCcCc-------------------------cc--ccccccccCCEEECCCCcCCcchh-hh
Confidence 11234555666666666554 22 112236677777777777775444 37
Q ss_pred cCCCCCCEEEcccccCcccCCccccCCCCCCeEEeeccccc-CCCCCCCCCCCccceeecCC
Q 040925 244 GELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ-GNIPSSLGNCQNLMSFTASQ 304 (833)
Q Consensus 244 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~ 304 (833)
..+++|++|+|++|.|+ .+|..+..+++|+.|+|++|++. +..|..+..+++|+.|++++
T Consensus 211 ~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~ 271 (317)
T 3o53_A 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271 (317)
T ss_dssp GGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHH
T ss_pred cccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCC
Confidence 77777777777777777 35666777777777777777776 56666777777777777763
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-28 Score=278.14 Aligned_cols=261 Identities=25% Similarity=0.283 Sum_probs=146.8
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
+++|++++|.++ .+|..+. ++|++|++++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|++
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECS
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcC
Confidence 356777777777 5666554 57777777777774 3444 45677777777777763 443 566777777777
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
|+++ .+|. .+++|+.|+|++|+|+. +|.. +++|++|+|++|+|++++. .+++|+.|++++|.|+.++
T Consensus 111 N~l~-~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~l~~----~~~~L~~L~L~~N~l~~l~ 177 (622)
T 3g06_A 111 NPLT-HLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLASLPA----LPSELCKLWAYNNQLTSLP 177 (622)
T ss_dssp CCCC-CCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCC
T ss_pred CcCC-CCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCCcCC----ccCCCCEEECCCCCCCCCc
Confidence 7776 5554 45667777777777764 4433 3667777777777765542 2456777777777776544
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCC
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 240 (833)
..+++|+.|+|++|+++ .+|.. ...++.|++++|.++.+ |. .+++|+.|++++|+|++ +|
T Consensus 178 ----------~~~~~L~~L~Ls~N~l~-~l~~~----~~~L~~L~L~~N~l~~l-~~---~~~~L~~L~Ls~N~L~~-lp 237 (622)
T 3g06_A 178 ----------MLPSGLQELSVSDNQLA-SLPTL----PSELYKLWAYNNRLTSL-PA---LPSGLKELIVSGNRLTS-LP 237 (622)
T ss_dssp ----------CCCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSSC-CC---CCTTCCEEECCSSCCSC-CC
T ss_pred ----------ccCCCCcEEECCCCCCC-CCCCc----cchhhEEECcCCccccc-CC---CCCCCCEEEccCCccCc-CC
Confidence 13466777777777766 23322 13344555555555422 21 12445555555555543 22
Q ss_pred ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCc
Q 040925 241 DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPH 313 (833)
Q Consensus 241 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 313 (833)
..+++|++|+|++|.|+. +|. .+++|+.|+|++|+|+ .+|..|.++++|+.|++++|.+++..|.
T Consensus 238 ---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 238 ---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp ---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred ---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 233445555555555542 222 3344555555555554 3344455555555555555554443333
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-31 Score=310.57 Aligned_cols=407 Identities=13% Similarity=0.107 Sum_probs=269.9
Q ss_pred CCccccCCCCCCEEEccCCcc---cccCCccCC------------CCCCCCEEEcCCCcccccCCccccCC--CCCcEEE
Q 040925 15 LPDFVGNLSDLEVIRIMGNSL---GGKIPTTLG------------LLRNLVSLNVAENKFSGMFPRSICNI--SSLELIQ 77 (833)
Q Consensus 15 ~~~~~~~l~~L~~L~l~~n~l---~~~~~~~~~------------~l~~L~~L~L~~n~i~~~~~~~~~~l--~~L~~L~ 77 (833)
.+..+..+++|+.|+++++.. .+.+|..++ .+++|++|+|++|.+++..+..+... .+|++|+
T Consensus 65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~ 144 (592)
T 3ogk_B 65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK 144 (592)
T ss_dssp HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence 344566777888888877543 133444444 67888888888888876666666653 3488888
Q ss_pred CCCcc-cccccCchhhcCCCCccEEEccCCcceee----CCccccCCCCCcEEEcccCccccccC----cCccCCCcCce
Q 040925 78 LALNR-FSGNLPFDIVVNLPNLKALAIGGNNFFGS----IPYSLSNASNLELLDLSVNQFKGNVS----IDFSSLKNLLW 148 (833)
Q Consensus 78 L~~N~-l~~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~ 148 (833)
|++|. ++..--..+..++++|++|+|++|.+++. ++..+..+++|++|+|++|.++++.. ..+..+++|++
T Consensus 145 L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~ 224 (592)
T 3ogk_B 145 LDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVS 224 (592)
T ss_dssp EESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCE
T ss_pred CcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcE
Confidence 88876 22111122345778888888888887654 23345667888888888888874333 23456788888
Q ss_pred EecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCc---ccCChhHhhhcccccEEEccCccccccCChhhhcCCCC
Q 040925 149 LNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFG---GELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNL 225 (833)
Q Consensus 149 L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~---~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L 225 (833)
|+|++|.+.. .+..+.++++|++|+++++... ...+..+..+ ..++.+++.++.. ...|..+..+++|
T Consensus 225 L~L~~~~~~~-------l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~-~~L~~L~l~~~~~-~~l~~~~~~~~~L 295 (592)
T 3ogk_B 225 VKVGDFEILE-------LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFP-RKLCRLGLSYMGP-NEMPILFPFAAQI 295 (592)
T ss_dssp EECSSCBGGG-------GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCC-TTCCEEEETTCCT-TTGGGGGGGGGGC
T ss_pred EeccCccHHH-------HHHHHhhhhHHHhhcccccccccchHHHHHHhhcc-ccccccCccccch-hHHHHHHhhcCCC
Confidence 8888887754 2345677788888888754332 1222233333 3466777776533 3566777788888
Q ss_pred CeEeccCCcccccCC-ccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeec-----------ccccCC-CCCCCC
Q 040925 226 IGFGAEENQLHGTIP-DAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSS-----------NSLQGN-IPSSLG 292 (833)
Q Consensus 226 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-----------N~l~~~-~~~~~~ 292 (833)
++|+|++|.+++... ..+..+++|++|+|+++...+.++..+..+++|++|+|++ |.++.. .+..+.
T Consensus 296 ~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~ 375 (592)
T 3ogk_B 296 RKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQ 375 (592)
T ss_dssp CEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHH
T ss_pred cEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHh
Confidence 888888888765433 3467888888888883332222333445678888888883 555533 222244
Q ss_pred CCCccceeecCCceecccCCccccc-ccccceeeecC----CCccCCC-----CCcccccCCCcCEEeccCCc--CCCCC
Q 040925 293 NCQNLMSFTASQNKLTGALPHQLLS-ITTLSLYLDLS----NNLLNGS-----LPLQVGHLKNLVILDISSNQ--FSGVI 360 (833)
Q Consensus 293 ~l~~L~~L~l~~N~l~~~~p~~~~~-~~~ll~~L~ls----~N~l~~~-----~~~~~~~l~~L~~L~ls~N~--l~~~~ 360 (833)
.+++|+.|+++.|.+++..+..+.. ++.+ +.|+++ .|.+++. ++..+.++++|+.|++++|. +++..
T Consensus 376 ~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L-~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 376 GCQELEYMAVYVSDITNESLESIGTYLKNL-CDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HCTTCSEEEEEESCCCHHHHHHHHHHCCSC-CEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hCccCeEEEeecCCccHHHHHHHHhhCCCC-cEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 5788888888888887666655555 4444 778885 6777753 22336678899999997533 55444
Q ss_pred Ccccc-CCCCCcEEeecCCccccc-cCccccCCCCCCeEEccCcccCCC-chhhhcCCCCCceEECccCcCccc
Q 040925 361 PGTLS-TCVCLEYLDISSNSFHGV-IPLSLSFLKSIKELNVSSNNLSGQ-IPEFLKNLSVLEFLSLSYNHFEGE 431 (833)
Q Consensus 361 ~~~~~-~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L~l~~N~l~~~ 431 (833)
+..+. .+++|++|+|++|++++. .+..+..+++|+.|++++|.+++. ++..+..+++|+.|++++|+++..
T Consensus 455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 44443 478899999999988753 344557788999999999998654 344556788999999999987754
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-28 Score=260.06 Aligned_cols=212 Identities=20% Similarity=0.294 Sum_probs=166.6
Q ss_pred cCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCC
Q 040925 214 TIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGN 293 (833)
Q Consensus 214 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 293 (833)
.+|..+..+++|++|+|++|++. .+|..|+.+++|++|+|++|.++ .+|..|.++++|++|+|++|++.+.+|..+..
T Consensus 95 ~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~ 172 (328)
T 4fcg_A 95 QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAS 172 (328)
T ss_dssp SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEE
T ss_pred hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhh
Confidence 44555556666777777777776 56666677777777777777776 55666777777777777776666666665543
Q ss_pred ---------CCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccc
Q 040925 294 ---------CQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTL 364 (833)
Q Consensus 294 ---------l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~ 364 (833)
+++|+.|++++|+++ .+|..+..+..+ ++|++++|.+++ +|..+..+++|++|+|++|.+.+..|..|
T Consensus 173 ~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L-~~L~L~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~ 249 (328)
T 4fcg_A 173 TDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL-KSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIF 249 (328)
T ss_dssp EC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTC-CEEEEESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCT
T ss_pred ccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCC-CEEEccCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHh
Confidence 777777777777777 677777777666 678888888874 55678889999999999999988899999
Q ss_pred cCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCcc
Q 040925 365 STCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEG 430 (833)
Q Consensus 365 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 430 (833)
..+++|++|+|++|++.+..|..+..+++|+.|+|++|++.+.+|..+.++++|+.+++..|.+..
T Consensus 250 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 250 GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp TCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred cCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence 999999999999999888889889999999999999999999999999999999999998877654
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=271.72 Aligned_cols=249 Identities=21% Similarity=0.199 Sum_probs=194.1
Q ss_pred cCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCcccc-ccCChhhh-------cCCCCCeEeccCCcccccCCc
Q 040925 170 LTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQIS-GTIPPGIR-------NLVNLIGFGAEENQLHGTIPD 241 (833)
Q Consensus 170 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~-~~~~~~~~-------~l~~L~~L~L~~N~l~~~~~~ 241 (833)
+++.++|++|++++|.+ .+|..+... ++.|++++|++. ...|..+. ++++|++|+|++|++++..|.
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~---L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI---IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH---HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH---HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 34455666667777776 566665554 556677777773 34555554 788999999999999888887
Q ss_pred cc--cCCCCCCEEEcccccCcccCCccccCC-----CCCCeEEeecccccCCCCCCCCCCCccceeecCCceeccc--CC
Q 040925 242 AI--GELKNLQKLCLFRNFLQGRIPSGLGNL-----TKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGA--LP 312 (833)
Q Consensus 242 ~~--~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~p 312 (833)
.+ ..+++|++|+|++|.+++. |..+..+ ++|++|+|++|++.+..|..|+.+++|++|++++|++.+. +|
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 76 8899999999999999876 7777776 8999999999999988888899999999999999987654 23
Q ss_pred ccc--ccccccceeeecCCCccCCC---CCcccccCCCcCEEeccCCcCCCCCC-ccccCCCCCcEEeecCCccccccCc
Q 040925 313 HQL--LSITTLSLYLDLSNNLLNGS---LPLQVGHLKNLVILDISSNQFSGVIP-GTLSTCVCLEYLDISSNSFHGVIPL 386 (833)
Q Consensus 313 ~~~--~~~~~ll~~L~ls~N~l~~~---~~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~ 386 (833)
..+ ..+..+ ++|++++|.+++. ....+.++++|++|+|++|++++..| ..+..+++|++|+|++|+|+ .+|.
T Consensus 193 ~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~ 270 (312)
T 1wwl_A 193 SALCPLKFPTL-QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK 270 (312)
T ss_dssp HHSCTTSCTTC-CEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCS
T ss_pred HHHHhccCCCC-CEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhh
Confidence 333 455555 7899999988732 22345678999999999999988765 56777899999999999998 4555
Q ss_pred cccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCcc
Q 040925 387 SLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEG 430 (833)
Q Consensus 387 ~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 430 (833)
.+. ++|+.|+|++|+|++. |. +..+++|++|++++|+|++
T Consensus 271 ~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 271 GLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp SCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 555 8899999999999876 55 8899999999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=288.99 Aligned_cols=193 Identities=13% Similarity=-0.013 Sum_probs=134.3
Q ss_pred eeccCcceEEEEEEECCCceEEEEEEeeccCC----------cchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCc
Q 040925 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK----------GASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 538 ~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 606 (833)
..+.|+.|.+..++....|+.||||++..... ...+++.+|+++|+++ .|+||+++++++.+..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~----- 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ----- 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS-----
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC-----
Confidence 45667777777766666788899999964321 1235699999999999 6999999999976554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..||||||++||+|.++|...+ +++.. +|+.||+.||+|+|++ |||||||||+|||++++|.+||+||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~------~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DF 383 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGE------EIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDF 383 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTC------CCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCC
T ss_pred EEEEEEecCCCCcHHHHHHhCC------CCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeec
Confidence 8999999999999999998765 56554 4889999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHH
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
|+|+....... .....+||+.|||||++.+ .+..++|+|+.++..++++..+..+......
T Consensus 384 GlAr~~~~~~~--------~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~~~~l~~ 444 (569)
T 4azs_A 384 GSIVTTPQDCS--------WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNWLYAVWQ 444 (569)
T ss_dssp TTEESCC---C--------CSHHHHHHHHHHHHHHC------------------CCCCTTHHHHHHHHHT
T ss_pred ccCeeCCCCCc--------cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchhHHHhhc
Confidence 99987654321 2234679999999999876 4677899999998888887766555554443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=273.92 Aligned_cols=264 Identities=20% Similarity=0.160 Sum_probs=141.1
Q ss_pred EEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccc
Q 040925 75 LIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQN 154 (833)
Q Consensus 75 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N 154 (833)
.++++.+.+. ..+..++..+++|++|+|++|.+++..|..|.++++|++|+|++|+++++.+ |..+++|++|+|++|
T Consensus 14 i~~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 14 IEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EESCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred Eeeccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 3344445554 3444445555555555555555554444555555555555555555554433 555555555555555
Q ss_pred cCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCc
Q 040925 155 NLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQ 234 (833)
Q Consensus 155 ~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~ 234 (833)
.++.++ ..++|++|++++|++++..+. .+++|+.|++++|+
T Consensus 91 ~l~~l~-----------~~~~L~~L~l~~n~l~~~~~~----------------------------~~~~L~~L~l~~N~ 131 (317)
T 3o53_A 91 YVQELL-----------VGPSIETLHAANNNISRVSCS----------------------------RGQGKKNIYLANNK 131 (317)
T ss_dssp EEEEEE-----------ECTTCCEEECCSSCCSEEEEC----------------------------CCSSCEEEECCSSC
T ss_pred cccccc-----------CCCCcCEEECCCCccCCcCcc----------------------------ccCCCCEEECCCCC
Confidence 543211 224566666666655521111 12345555555555
Q ss_pred ccccCCccccCCCCCCEEEcccccCcccCCcccc-CCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCc
Q 040925 235 LHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLG-NLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPH 313 (833)
Q Consensus 235 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 313 (833)
+++..+..|..+++|++|+|++|.+++..+..+. .+++|++|+|++|+|++. +. ...+++|++|++++|+++
T Consensus 132 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~----- 204 (317)
T 3o53_A 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLA----- 204 (317)
T ss_dssp CCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCC-----
T ss_pred CCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCC-----
Confidence 5555555555555666666666666554444442 455566666666655533 11 122444444444444443
Q ss_pred ccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccc-cccCccccCCC
Q 040925 314 QLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH-GVIPLSLSFLK 392 (833)
Q Consensus 314 ~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~ 392 (833)
+ +|..|..+++|++|+|++|++++ +|..+..+++|+.|++++|++. +..+..+..++
T Consensus 205 --------------------~-l~~~~~~l~~L~~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~ 262 (317)
T 3o53_A 205 --------------------F-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262 (317)
T ss_dssp --------------------E-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCH
T ss_pred --------------------c-chhhhcccCcccEEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccc
Confidence 2 22235556667777777777763 4555666777777777777776 55566667777
Q ss_pred CCCeEEcc-CcccCCCch
Q 040925 393 SIKELNVS-SNNLSGQIP 409 (833)
Q Consensus 393 ~L~~L~l~-~N~l~~~~p 409 (833)
+|+.|+++ .+.+++..|
T Consensus 263 ~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 263 RVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp HHHHHHHHHHHHHHSSSS
T ss_pred cceEEECCCchhccCCch
Confidence 77777776 334554443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-30 Score=302.44 Aligned_cols=418 Identities=15% Similarity=0.096 Sum_probs=306.5
Q ss_pred CcEEEcCCCcC---cccCCcccc------------CCCCCCEEEccCCcccccCCccCCCC--CCCCEEEcCCCc-ccc-
Q 040925 1 LQTLAVNDNYL---TGQLPDFVG------------NLSDLEVIRIMGNSLGGKIPTTLGLL--RNLVSLNVAENK-FSG- 61 (833)
Q Consensus 1 L~~L~l~~n~l---~~~~~~~~~------------~l~~L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~n~-i~~- 61 (833)
|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..+... .+|++|+|++|. ++.
T Consensus 75 L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~ 154 (592)
T 3ogk_B 75 LRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTD 154 (592)
T ss_dssp CSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHH
T ss_pred CeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHH
Confidence 57888877543 134444444 78999999999999987777777663 459999999997 321
Q ss_pred cCCccccCCCCCcEEECCCcccccccC---chhhcCCCCccEEEccCCcce----eeCCccccCCCCCcEEEcccCcccc
Q 040925 62 MFPRSICNISSLELIQLALNRFSGNLP---FDIVVNLPNLKALAIGGNNFF----GSIPYSLSNASNLELLDLSVNQFKG 134 (833)
Q Consensus 62 ~~~~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~N~i~~ 134 (833)
.++..+.++++|++|+|++|.+++.-. ...+..+++|++|+|++|.++ ...+..+.++++|++|+|++|.+.+
T Consensus 155 ~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~ 234 (592)
T 3ogk_B 155 GLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE 234 (592)
T ss_dssp HHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG
T ss_pred HHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH
Confidence 122334588999999999999874311 134568999999999999997 3445556789999999999999997
Q ss_pred ccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCcccccc
Q 040925 135 NVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGT 214 (833)
Q Consensus 135 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~ 214 (833)
++ ..+..+++|++|+++.+...... ......+..+++|+.|+++++... .+|..+..++ .++.|++++|.+++.
T Consensus 235 l~-~~~~~~~~L~~L~l~~~~~~~~~---~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~-~L~~L~Ls~~~l~~~ 308 (592)
T 3ogk_B 235 LV-GFFKAAANLEEFCGGSLNEDIGM---PEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAA-QIRKLDLLYALLETE 308 (592)
T ss_dssp GH-HHHHHCTTCCEEEECBCCCCTTC---TTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGG-GCCEEEETTCCCCHH
T ss_pred HH-HHHhhhhHHHhhcccccccccch---HHHHHHhhccccccccCccccchh-HHHHHHhhcC-CCcEEecCCCcCCHH
Confidence 55 67899999999999864332111 122345778899999999997544 6666665554 589999999998755
Q ss_pred CC-hhhhcCCCCCeEeccCCcccc-cCCccccCCCCCCEEEcc-----------cccCcccCC-ccccCCCCCCeEEeec
Q 040925 215 IP-PGIRNLVNLIGFGAEENQLHG-TIPDAIGELKNLQKLCLF-----------RNFLQGRIP-SGLGNLTKLANLELSS 280 (833)
Q Consensus 215 ~~-~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~-----------~N~l~~~~~-~~~~~l~~L~~L~L~~ 280 (833)
.. ..+..+++|+.|+++ |.+.. .++..+..+++|++|+|+ .|.+++... ..+..+++|++|+++.
T Consensus 309 ~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~ 387 (592)
T 3ogk_B 309 DHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYV 387 (592)
T ss_dssp HHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEE
T ss_pred HHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeec
Confidence 44 446899999999999 44443 344455778999999999 366664322 2244689999999999
Q ss_pred ccccCCCCCCCCC-CCccceeecC----Cceeccc-----CCcccccccccceeeecCCCc--cCCCCCcccc-cCCCcC
Q 040925 281 NSLQGNIPSSLGN-CQNLMSFTAS----QNKLTGA-----LPHQLLSITTLSLYLDLSNNL--LNGSLPLQVG-HLKNLV 347 (833)
Q Consensus 281 N~l~~~~~~~~~~-l~~L~~L~l~----~N~l~~~-----~p~~~~~~~~ll~~L~ls~N~--l~~~~~~~~~-~l~~L~ 347 (833)
|++++..+..+.. +++|+.|+++ .|.+++. ++..+..+..+ ++|++++|. +++..+..+. .+++|+
T Consensus 388 ~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L-~~L~L~~~~~~l~~~~~~~~~~~~~~L~ 466 (592)
T 3ogk_B 388 SDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKL-RRFAFYLRQGGLTDLGLSYIGQYSPNVR 466 (592)
T ss_dssp SCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTC-CEEEEECCGGGCCHHHHHHHHHSCTTCC
T ss_pred CCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCC-CEEEEecCCCCccHHHHHHHHHhCccce
Confidence 9998766666665 8899999996 7788742 33335556666 789997544 5544444443 489999
Q ss_pred EEeccCCcCCC-CCCccccCCCCCcEEeecCCccccc-cCccccCCCCCCeEEccCcccCCCchhhh-cCCCCCceEECc
Q 040925 348 ILDISSNQFSG-VIPGTLSTCVCLEYLDISSNSFHGV-IPLSLSFLKSIKELNVSSNNLSGQIPEFL-KNLSVLEFLSLS 424 (833)
Q Consensus 348 ~L~ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~L~l~ 424 (833)
.|++++|++++ ..+..+.++++|++|+|++|.+++. .+..+..+++|+.|+|++|+++..-...+ ..++.+....+.
T Consensus 467 ~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~ 546 (592)
T 3ogk_B 467 WMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIP 546 (592)
T ss_dssp EEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEEC
T ss_pred EeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEec
Confidence 99999999986 3345568899999999999998754 34445678999999999999987544333 356666665555
Q ss_pred cC
Q 040925 425 YN 426 (833)
Q Consensus 425 ~N 426 (833)
.+
T Consensus 547 ~~ 548 (592)
T 3ogk_B 547 SR 548 (592)
T ss_dssp CC
T ss_pred Cc
Confidence 44
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-30 Score=273.47 Aligned_cols=248 Identities=21% Similarity=0.241 Sum_probs=113.0
Q ss_pred CCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccc-cccCchhh------cCCCCccEEEccCCcceeeCCccc
Q 040925 44 GLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFS-GNLPFDIV------VNLPNLKALAIGGNNFFGSIPYSL 116 (833)
Q Consensus 44 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~------~~l~~L~~L~L~~N~l~~~~~~~~ 116 (833)
+..++|++|++++|.+ ..|..+... |+.|+|++|+++ ..+|...+ .++++|++|+|++|++++..|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 3444555555555555 334433332 555555555553 12332221 135555555555555554455443
Q ss_pred --cCCCCCcEEEcccCccccccCcCccCC-----CcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCccc
Q 040925 117 --SNASNLELLDLSVNQFKGNVSIDFSSL-----KNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGE 189 (833)
Q Consensus 117 --~~l~~L~~L~L~~N~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 189 (833)
..+++|++|+|++|+|+++ +..|..+ ++|++|+|++|+++.++.. .+.++++|++|+|++|++.+.
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~ 188 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCE------QVRVFPALSTLDLSDNPELGE 188 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTT------TCCCCSSCCEEECCSCTTCHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHH------HhccCCCCCEEECCCCCcCcc
Confidence 5555555555555555554 4444444 5555555555555544332 244555555555555554422
Q ss_pred C--ChhH--hhhcccccEEEccCcccc---ccCChhhhcCCCCCeEeccCCcccccCC-ccccCCCCCCEEEcccccCcc
Q 040925 190 L--PHSI--ANLSSTVINFGIGRNQIS---GTIPPGIRNLVNLIGFGAEENQLHGTIP-DAIGELKNLQKLCLFRNFLQG 261 (833)
Q Consensus 190 ~--p~~~--~~l~~~l~~L~l~~n~i~---~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~ 261 (833)
+ |..+ ..+ ..++.|++++|+|+ ......+.++++|+.|++++|++++..| ..+..+++|++|+|++|.|+
T Consensus 189 ~~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~- 266 (312)
T 1wwl_A 189 RGLISALCPLKF-PTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK- 266 (312)
T ss_dssp HHHHHHSCTTSC-TTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-
T ss_pred hHHHHHHHhccC-CCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-
Confidence 1 1111 000 01111111122111 0111223344555555555555554443 33444555555555555555
Q ss_pred cCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceec
Q 040925 262 RIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT 308 (833)
Q Consensus 262 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 308 (833)
.+|..+. ++|++|+|++|+|++. |. +..+++|+.|++++|+++
T Consensus 267 ~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~ 309 (312)
T 1wwl_A 267 QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL 309 (312)
T ss_dssp SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence 3444433 4555555555555533 33 555555555555555444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=255.20 Aligned_cols=185 Identities=22% Similarity=0.243 Sum_probs=123.9
Q ss_pred hhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCcccc---------CCCCCCeEEeecccccCCCC
Q 040925 218 GIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLG---------NLTKLANLELSSNSLQGNIP 288 (833)
Q Consensus 218 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---------~l~~L~~L~L~~N~l~~~~~ 288 (833)
.|+++++|++|+|++|+++ .+|..|..+++|++|+|++|.+.+.+|..+. ++++|++|+|++|+++ .+|
T Consensus 122 ~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp 199 (328)
T 4fcg_A 122 TMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLP 199 (328)
T ss_dssp CGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCC
T ss_pred HHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cch
Confidence 3334444444444444444 3344444444444444444444444444333 3666666666666666 555
Q ss_pred CCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCC
Q 040925 289 SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCV 368 (833)
Q Consensus 289 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~ 368 (833)
..+..+++|+.|++++|+++ .+|..+..+..+ ++|++++|.+.+.+|..|+.+++|++|+|++|.+.+..|..|..++
T Consensus 200 ~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L-~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~ 277 (328)
T 4fcg_A 200 ASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL-EELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLT 277 (328)
T ss_dssp GGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTC-CEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCT
T ss_pred HhhcCCCCCCEEEccCCCCC-cCchhhccCCCC-CEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCC
Confidence 55666666666666666666 455555555555 5677777777777788888888888999988888888888888888
Q ss_pred CCcEEeecCCccccccCccccCCCCCCeEEccCcccCC
Q 040925 369 CLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG 406 (833)
Q Consensus 369 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 406 (833)
+|++|+|++|++.+.+|..+..+++|+.+++..|.+..
T Consensus 278 ~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~ 315 (328)
T 4fcg_A 278 QLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQ 315 (328)
T ss_dssp TCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC
T ss_pred CCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHH
Confidence 89999999888888888888888889888888777653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-28 Score=271.45 Aligned_cols=244 Identities=18% Similarity=0.215 Sum_probs=189.0
Q ss_pred CCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEc
Q 040925 175 SLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCL 254 (833)
Q Consensus 175 ~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 254 (833)
+|++|+|++|.+++..|..+..++ .++.|++++|.+++..| |..+++|++|+|++|.++++.+ .++|++|+|
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~L~L 106 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFT-KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCT-TCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCEEEC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCC-CCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCEEEC
Confidence 344444444444433333333332 24444444444444443 7788899999999999986543 378999999
Q ss_pred ccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccc-cccccceeeecCCCccC
Q 040925 255 FRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLL-SITTLSLYLDLSNNLLN 333 (833)
Q Consensus 255 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~-~~~~ll~~L~ls~N~l~ 333 (833)
++|.|++..+. .+++|+.|+|++|++++..|..|..+++|+.|++++|.+++..|..+. .+..+ ++|+|++|.++
T Consensus 107 ~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L-~~L~Ls~N~l~ 182 (487)
T 3oja_A 107 ANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL-EHLNLQYNFIY 182 (487)
T ss_dssp CSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTC-CEEECTTSCCC
T ss_pred cCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcc-cEEecCCCccc
Confidence 99999876554 357899999999999988888999999999999999999987787776 45555 88999999998
Q ss_pred CCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccC-CCchhhh
Q 040925 334 GSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLS-GQIPEFL 412 (833)
Q Consensus 334 ~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p~~l 412 (833)
+.. .+..+++|+.|+|++|.|++++|. |..+++|+.|+|++|+|++ +|..+..+++|+.|++++|.++ +.+|..+
T Consensus 183 ~~~--~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~ 258 (487)
T 3oja_A 183 DVK--GQVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF 258 (487)
T ss_dssp EEE--CCCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHH
T ss_pred ccc--ccccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHH
Confidence 653 344699999999999999976555 9999999999999999996 5667999999999999999998 6778889
Q ss_pred cCCCCCceEECc-------cCcCccccCC
Q 040925 413 KNLSVLEFLSLS-------YNHFEGEVPT 434 (833)
Q Consensus 413 ~~l~~L~~L~l~-------~N~l~~~~~~ 434 (833)
..++.|+.++++ .|++.|.++.
T Consensus 259 ~~l~~L~~l~~~~~~~~~~~~~~~c~~~~ 287 (487)
T 3oja_A 259 SKNQRVQTVAKQTVKKLTGQNEEECTVPT 287 (487)
T ss_dssp TTCHHHHHHHHHHHHHHTSSSSCCCSSTT
T ss_pred HhCCCCcEEeccccccccCCCcccccCCc
Confidence 999999999987 6666665553
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=240.91 Aligned_cols=228 Identities=21% Similarity=0.251 Sum_probs=157.2
Q ss_pred EEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccc
Q 040925 178 ALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRN 257 (833)
Q Consensus 178 ~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 257 (833)
..+.++..++ .+|..+ +..++.|++++|++++..+..|.++++|++|++++|++.++.+..|..+++|++|+|++|
T Consensus 11 ~~~c~~~~l~-~ip~~l---~~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNL---PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp EEECTTSCCS-SCCSSS---CTTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTC
T ss_pred eEEecCCCcc-ccCCCC---CCCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCC
Confidence 4566666665 455433 234555666666665555555555555666666655555555555555555555555555
Q ss_pred cCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCC-C
Q 040925 258 FLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGS-L 336 (833)
Q Consensus 258 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~-~ 336 (833)
.+++..+..|.++++|++|++++|++.+..+..+..+++|++ |++++|.+++. +
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-------------------------L~l~~n~l~~~~l 141 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE-------------------------LNVAHNLIQSFKL 141 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCE-------------------------EECCSSCCCCCCC
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCE-------------------------EECcCCccceecC
Confidence 555555555555555555555555555444444555555554 55555555432 4
Q ss_pred CcccccCCCcCEEeccCCcCCCCCCccccCCCCCc----EEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhh
Q 040925 337 PLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLE----YLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFL 412 (833)
Q Consensus 337 ~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l 412 (833)
|..|.++++|++|++++|++++..+..|..+.+|+ .|++++|++++..+..+.. .+|+.|++++|++++..+..+
T Consensus 142 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~ 220 (276)
T 2z62_A 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIF 220 (276)
T ss_dssp CGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTT
T ss_pred chhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHh
Confidence 77888899999999999999988888888877777 8999999999777766654 489999999999998888888
Q ss_pred cCCCCCceEECccCcCccccCCC
Q 040925 413 KNLSVLEFLSLSYNHFEGEVPTK 435 (833)
Q Consensus 413 ~~l~~L~~L~l~~N~l~~~~~~~ 435 (833)
..+++|+.|++++|+|+|.++..
T Consensus 221 ~~l~~L~~L~l~~N~~~c~c~~l 243 (276)
T 2z62_A 221 DRLTSLQKIWLHTNPWDCSCPRI 243 (276)
T ss_dssp TTCCSCCEEECCSSCBCCCTTTT
T ss_pred cccccccEEEccCCcccccCCch
Confidence 99999999999999999998854
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-26 Score=239.10 Aligned_cols=227 Identities=20% Similarity=0.208 Sum_probs=166.8
Q ss_pred EEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCC
Q 040925 27 VIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGN 106 (833)
Q Consensus 27 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N 106 (833)
.++..+..+ ..+|..+. ++|++|+|++|+++++.+..|.++++|++|+|++|+++ .++...|.++++|++|+|++|
T Consensus 11 ~~~c~~~~l-~~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n 86 (276)
T 2z62_A 11 TYQCMELNF-YKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86 (276)
T ss_dssp EEECTTSCC-SSCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTC
T ss_pred eEEecCCCc-cccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCC
Confidence 455566666 44555554 56788888888887776677888888888888888887 677777778888888888888
Q ss_pred cceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcC
Q 040925 107 NFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186 (833)
Q Consensus 107 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 186 (833)
.+++..+..|.++++|++|++++|+++++.+..|..+++|++|+|++|.++.+. .+..+.++++|++|+|++|++
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~-----l~~~~~~l~~L~~L~Ls~N~l 161 (276)
T 2z62_A 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK-----LPEYFSNLTNLEHLDLSSNKI 161 (276)
T ss_dssp CCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC-----CCGGGGGCTTCCEEECCSSCC
T ss_pred ccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceec-----CchhhccCCCCCEEECCCCCC
Confidence 888777778888888888888888888877777888888888888888886543 234577888999999999988
Q ss_pred cccCChhHhhhcccccEEEccCccccccCChhhhcCCCCC-eEeccCCcccccCCccccCCCCCCEEEcccccCcccCCc
Q 040925 187 GGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLI-GFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPS 265 (833)
Q Consensus 187 ~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 265 (833)
++..+..+..+. .++.|. .|++++|++.++.+..|.. .+|++|+|++|.+++..+.
T Consensus 162 ~~~~~~~~~~l~----------------------~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~ 218 (276)
T 2z62_A 162 QSIYCTDLRVLH----------------------QMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDG 218 (276)
T ss_dssp CEECGGGGHHHH----------------------TCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTT
T ss_pred CcCCHHHhhhhh----------------------hccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHh
Confidence 854444333322 122222 6777788877666665554 3788888888888876666
Q ss_pred cccCCCCCCeEEeecccccC
Q 040925 266 GLGNLTKLANLELSSNSLQG 285 (833)
Q Consensus 266 ~~~~l~~L~~L~L~~N~l~~ 285 (833)
.|..+++|+.|+|++|++..
T Consensus 219 ~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 219 IFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp TTTTCCSCCEEECCSSCBCC
T ss_pred HhcccccccEEEccCCcccc
Confidence 77888888888888888874
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-29 Score=288.32 Aligned_cols=412 Identities=15% Similarity=0.130 Sum_probs=239.2
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCccc---ccCCcc------------CCCCCCCCEEEcCCCcccccCCccc
Q 040925 3 TLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLG---GKIPTT------------LGLLRNLVSLNVAENKFSGMFPRSI 67 (833)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---~~~~~~------------~~~l~~L~~L~L~~n~i~~~~~~~~ 67 (833)
.++++++.-. ..+..+..+++|+.|+++++.-. ...|.. +..+++|++|+|++|.+++..+..+
T Consensus 47 ~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l 125 (594)
T 2p1m_B 47 KVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELI 125 (594)
T ss_dssp EEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHH
T ss_pred EEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHH
Confidence 4455544333 22345677888999999987632 112221 2457788999999988887666667
Q ss_pred c-CCCCCcEEECCCc-ccccccCchhhcCCCCccEEEccCCcceeeCCcccc----CCCCCcEEEcccCccccccCcCc-
Q 040925 68 C-NISSLELIQLALN-RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLS----NASNLELLDLSVNQFKGNVSIDF- 140 (833)
Q Consensus 68 ~-~l~~L~~L~L~~N-~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~L~~N~i~~~~~~~~- 140 (833)
. .+++|+.|+|++| .+++.....++.++++|++|+|++|.+++..+..+. .+++|++|+|++|. ..+....+
T Consensus 126 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~ 204 (594)
T 2p1m_B 126 AKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALE 204 (594)
T ss_dssp HHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHH
T ss_pred HHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHH
Confidence 5 6888999999888 554222334556788899999988887755444333 56688888888886 22322233
Q ss_pred ---cCCCcCceEeccccc-CCCCCCCCcccccccCCCCCCCEEEccCCc-------CcccCChhHhhhcccccEE-EccC
Q 040925 141 ---SSLKNLLWLNLEQNN-LGTGTATDLDFVTFLTNCSSLKALSLADNQ-------FGGELPHSIANLSSTVINF-GIGR 208 (833)
Q Consensus 141 ---~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-------l~~~~p~~~~~l~~~l~~L-~l~~ 208 (833)
..+++|++|+|++|. ++ .++..+.++++|++|+++.+. +. .++..+.++. .++.+ .+.+
T Consensus 205 ~l~~~~~~L~~L~L~~~~~~~-------~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~-~l~~~l~~~~-~L~~Ls~~~~ 275 (594)
T 2p1m_B 205 RLVTRCPNLKSLKLNRAVPLE-------KLATLLQRAPQLEELGTGGYTAEVRPDVYS-GLSVALSGCK-ELRCLSGFWD 275 (594)
T ss_dssp HHHHHCTTCCEEECCTTSCHH-------HHHHHHHHCTTCSEEECSBCCCCCCHHHHH-HHHHHHHTCT-TCCEEECCBT
T ss_pred HHHHhCCCCcEEecCCCCcHH-------HHHHHHhcCCcceEcccccccCccchhhHH-HHHHHHhcCC-CcccccCCcc
Confidence 345888888888872 21 134556677888888855543 33 2333444433 24444 2322
Q ss_pred ccccccCChhhhcCCCCCeEeccCCcccccCC-ccccCCCCCCEEEcccccCccc-CCccccCCCCCCeEEeec------
Q 040925 209 NQISGTIPPGIRNLVNLIGFGAEENQLHGTIP-DAIGELKNLQKLCLFRNFLQGR-IPSGLGNLTKLANLELSS------ 280 (833)
Q Consensus 209 n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~------ 280 (833)
... ..++..+..+++|+.|++++|.+.+... ..+..+++|++|++++| +... ++.....+++|++|+|++
T Consensus 276 ~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~ 353 (594)
T 2p1m_B 276 AVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVM 353 (594)
T ss_dssp CCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCS
T ss_pred cch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCccccc
Confidence 221 2344444566777777777777654322 23456777777777776 3321 111222467777777733
Q ss_pred ---ccccCCCCCCCC-CCCccceeecCCceecccCCccccc-ccccceeeecC--C----CccCCCCC-----cccccCC
Q 040925 281 ---NSLQGNIPSSLG-NCQNLMSFTASQNKLTGALPHQLLS-ITTLSLYLDLS--N----NLLNGSLP-----LQVGHLK 344 (833)
Q Consensus 281 ---N~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p~~~~~-~~~ll~~L~ls--~----N~l~~~~~-----~~~~~l~ 344 (833)
+.+++.....+. ++++|+.|.++.|.+++..+..+.. ++.+ +.|+++ + |.++.... ..+..++
T Consensus 354 ~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L-~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~ 432 (594)
T 2p1m_B 354 EPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNM-TRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCK 432 (594)
T ss_dssp SCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTC-CEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCT
T ss_pred ccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCc-ceeEeecccCCCcccccCCchhhHHHHHHhhCC
Confidence 334322222222 3567777777667666444444432 3333 566666 3 44442111 1245566
Q ss_pred CcCEEeccCCcCCCCCCccccC-CCCCcEEeecCCccccccCccc-cCCCCCCeEEccCcccCCCchh-hhcCCCCCceE
Q 040925 345 NLVILDISSNQFSGVIPGTLST-CVCLEYLDISSNSFHGVIPLSL-SFLKSIKELNVSSNNLSGQIPE-FLKNLSVLEFL 421 (833)
Q Consensus 345 ~L~~L~ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~l~~N~l~~~~p~-~l~~l~~L~~L 421 (833)
+|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++.....+ ..+++|+.|+|++|.+++.... ....+++|+.|
T Consensus 433 ~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L 511 (594)
T 2p1m_B 433 DLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSL 511 (594)
T ss_dssp TCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEE
T ss_pred CccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEE
Confidence 777777765 554443344443 6667777777777654433333 4567777777777777543332 33446677777
Q ss_pred ECccCcCc
Q 040925 422 SLSYNHFE 429 (833)
Q Consensus 422 ~l~~N~l~ 429 (833)
++++|+++
T Consensus 512 ~l~~~~~~ 519 (594)
T 2p1m_B 512 WMSSCSVS 519 (594)
T ss_dssp EEESSCCB
T ss_pred eeeCCCCC
Confidence 77777664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-25 Score=230.09 Aligned_cols=156 Identities=26% Similarity=0.332 Sum_probs=130.0
Q ss_pred CCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEE
Q 040925 22 LSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKAL 101 (833)
Q Consensus 22 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L 101 (833)
....+.+++++++++ .+|..+. ++|++|+|++|+++++.+.+|.++++|++|+|++|+++ .+|..+|.++++|++|
T Consensus 15 ~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L 90 (270)
T 2o6q_A 15 NNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETL 90 (270)
T ss_dssp ETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEE
T ss_pred CCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEE
Confidence 346788999999995 5676555 68999999999999877788999999999999999998 8888888999999999
Q ss_pred EccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEc
Q 040925 102 AIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSL 181 (833)
Q Consensus 102 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~L 181 (833)
+|++|.++...+..|.++++|++|+|++|+++.+++..|..+++|++|+|++|.++.++.. .|..+++|++|+|
T Consensus 91 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~------~~~~l~~L~~L~L 164 (270)
T 2o6q_A 91 WVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKG------VFDKLTSLKELRL 164 (270)
T ss_dssp ECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT------TTTTCTTCCEEEC
T ss_pred ECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHh------HccCCcccceeEe
Confidence 9999999877778889999999999999999999888899999999999999888765542 2456666666666
Q ss_pred cCCcCc
Q 040925 182 ADNQFG 187 (833)
Q Consensus 182 s~N~l~ 187 (833)
++|+++
T Consensus 165 ~~n~l~ 170 (270)
T 2o6q_A 165 YNNQLK 170 (270)
T ss_dssp CSSCCS
T ss_pred cCCcCc
Confidence 666655
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-25 Score=231.17 Aligned_cols=206 Identities=23% Similarity=0.253 Sum_probs=139.8
Q ss_pred CCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCC
Q 040925 225 LIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQ 304 (833)
Q Consensus 225 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 304 (833)
.+.+++++|+++. +|..+. ++|++|+|++|.|+++.+..|.++++|++|+|++|+++...+..|.++++|++|++++
T Consensus 18 ~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~ 94 (270)
T 2o6q_A 18 KNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTD 94 (270)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCS
T ss_pred CCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCC
Confidence 3445555555542 232222 3455555555555544444555555555555555555544444445555555555555
Q ss_pred ceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCcccccc
Q 040925 305 NKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI 384 (833)
Q Consensus 305 N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 384 (833)
|++++..+..+..+..+ ++|++++|.+++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|+++++.
T Consensus 95 n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 95 NKLQALPIGVFDQLVNL-AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SCCCCCCTTTTTTCSSC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CcCCcCCHhHcccccCC-CEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 55552222223333333 55666666666666777888899999999999998887788899999999999999999888
Q ss_pred CccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCC
Q 040925 385 PLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 385 ~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|+|.|.++.
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 223 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNG 223 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCcc
Confidence 87888999999999999999987777888899999999999999988764
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=234.25 Aligned_cols=207 Identities=23% Similarity=0.246 Sum_probs=151.9
Q ss_pred hhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccc
Q 040925 219 IRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLM 298 (833)
Q Consensus 219 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 298 (833)
+.++++++++++++|+++.+ |..+. ++++.|+|++|.|++..+..|.++++|++|+|++|+|++..+. ..+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~~i-p~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCSSC-CSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCCcC-CCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 55667777888888877743 33332 5777888888888777777777888888888888887754332 6677777
Q ss_pred eeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCC
Q 040925 299 SFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSN 378 (833)
Q Consensus 299 ~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 378 (833)
.|++++|+++ .+|..+..+..+ ++|++++|++++..+..|.++++|++|+|++|++++.++..|..+++|+.|+|++|
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L-~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTC-CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred EEECCCCcCC-cCchhhccCCCC-CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 7777777777 666666666665 66777777777666677777888888888888887777777778888888888888
Q ss_pred ccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccC
Q 040925 379 SFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVP 433 (833)
Q Consensus 379 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 433 (833)
+|+++++..|..+++|+.|+|++|+++ .+|..+..+..|+.|+|++|+|.|.|.
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c~ 212 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcCc
Confidence 888766667777888888888888887 456666666777888888887777663
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-25 Score=233.31 Aligned_cols=207 Identities=25% Similarity=0.232 Sum_probs=187.4
Q ss_pred cccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCccccccccc
Q 040925 242 AIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTL 321 (833)
Q Consensus 242 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~l 321 (833)
.++.+++++++++++|.++ .+|..+. ++++.|+|++|++++..+..|.++++|+.|++++|.+++ ++.. ..+..+
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcC
Confidence 4778899999999999999 4666554 689999999999998889999999999999999999994 4443 555665
Q ss_pred ceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccC
Q 040925 322 SLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401 (833)
Q Consensus 322 l~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 401 (833)
++|++++|.++ .+|..+..+++|++|+|++|+|++..+..|.++++|++|+|++|+|+++++..|..+++|+.|+|++
T Consensus 80 -~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 157 (290)
T 1p9a_G 80 -GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (290)
T ss_dssp -CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred -CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence 89999999999 6788899999999999999999988889999999999999999999998888899999999999999
Q ss_pred cccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCCC
Q 040925 402 NNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGG 455 (833)
Q Consensus 402 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~ 455 (833)
|+|++..+..|..+++|+.|+|++|+++..++.......++.+.+.+|||.|..
T Consensus 158 N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 158 NNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 999988888889999999999999999988877777778999999999999954
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-28 Score=284.78 Aligned_cols=424 Identities=16% Similarity=0.141 Sum_probs=286.4
Q ss_pred CcEEEcCCCcCcc---cCCc------------cccCCCCCCEEEccCCcccccCCccCC-CCCCCCEEEcCCC-ccccc-
Q 040925 1 LQTLAVNDNYLTG---QLPD------------FVGNLSDLEVIRIMGNSLGGKIPTTLG-LLRNLVSLNVAEN-KFSGM- 62 (833)
Q Consensus 1 L~~L~l~~n~l~~---~~~~------------~~~~l~~L~~L~l~~n~l~~~~~~~~~-~l~~L~~L~L~~n-~i~~~- 62 (833)
|++|+++++.-.. ..|. .+..+++|++|+|++|.+++..+..+. .+++|++|+|++| .++..
T Consensus 68 L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~ 147 (594)
T 2p1m_B 68 VRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDG 147 (594)
T ss_dssp CCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHH
T ss_pred ceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHH
Confidence 6788888876321 2222 245688999999999999877777775 6899999999999 56533
Q ss_pred CCccccCCCCCcEEECCCcccccccCc---hhhcCCCCccEEEccCCc--cee-eCCccccCCCCCcEEEcccC-ccccc
Q 040925 63 FPRSICNISSLELIQLALNRFSGNLPF---DIVVNLPNLKALAIGGNN--FFG-SIPYSLSNASNLELLDLSVN-QFKGN 135 (833)
Q Consensus 63 ~~~~~~~l~~L~~L~L~~N~l~~~~~~---~~~~~l~~L~~L~L~~N~--l~~-~~~~~~~~l~~L~~L~L~~N-~i~~~ 135 (833)
++..+.++++|++|+|++|.+++..+. .+...+++|++|+|++|. +.. ..+..+..+++|++|+|++| .+.+
T Consensus 148 l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~- 226 (594)
T 2p1m_B 148 LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK- 226 (594)
T ss_dssp HHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-
T ss_pred HHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-
Confidence 344455899999999999998732221 223467799999999997 221 11222345699999999998 5554
Q ss_pred cCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEE-EccCCcCcccCChhHhhhcccccEEEccCcccccc
Q 040925 136 VSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL-SLADNQFGGELPHSIANLSSTVINFGIGRNQISGT 214 (833)
Q Consensus 136 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~ 214 (833)
.+..+..+++|++|+++.+........--..+..+.++++|+.| .+.+.... .+|..+..+ ..++.|++++|.++..
T Consensus 227 l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~-~l~~~~~~~-~~L~~L~L~~~~l~~~ 304 (594)
T 2p1m_B 227 LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPA-YLPAVYSVC-SRLTTLNLSYATVQSY 304 (594)
T ss_dssp HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGG-GGGGGHHHH-TTCCEEECTTCCCCHH
T ss_pred HHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchh-hHHHHHHhh-CCCCEEEccCCCCCHH
Confidence 45567788999999976553210000000122356788888888 45444332 444444433 4588899998887644
Q ss_pred CCh-hhhcCCCCCeEeccCCccccc-CCccccCCCCCCEEEccc---------ccCcccCCcccc-CCCCCCeEEeeccc
Q 040925 215 IPP-GIRNLVNLIGFGAEENQLHGT-IPDAIGELKNLQKLCLFR---------NFLQGRIPSGLG-NLTKLANLELSSNS 282 (833)
Q Consensus 215 ~~~-~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~---------N~l~~~~~~~~~-~l~~L~~L~L~~N~ 282 (833)
... .+..+++|+.|++++| +... .+.....+++|++|+|++ +.+++.....+. ++++|+.|+++.|+
T Consensus 305 ~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~ 383 (594)
T 2p1m_B 305 DLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQ 383 (594)
T ss_dssp HHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESC
T ss_pred HHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCC
Confidence 333 3568899999999988 4432 222334588999998843 455533222333 47899999998888
Q ss_pred ccCCCCCCCC-CCCccceeecC--C----ceecc-----cCCcccccccccceeeecCCCccCCCCCccccc-CCCcCEE
Q 040925 283 LQGNIPSSLG-NCQNLMSFTAS--Q----NKLTG-----ALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGH-LKNLVIL 349 (833)
Q Consensus 283 l~~~~~~~~~-~l~~L~~L~l~--~----N~l~~-----~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~-l~~L~~L 349 (833)
+++.....+. .+++|+.|+++ + |.+++ .++..+..+..+ +.|++++ .+++..+..+.. +++|+.|
T Consensus 384 l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L-~~L~L~~-~l~~~~~~~l~~~~~~L~~L 461 (594)
T 2p1m_B 384 MTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDL-RRLSLSG-LLTDKVFEYIGTYAKKMEML 461 (594)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTC-CEEECCS-SCCHHHHHHHHHHCTTCCEE
T ss_pred cCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCc-cEEeecC-cccHHHHHHHHHhchhccEe
Confidence 8765555554 57899999998 4 55551 111223344555 7899977 666544455554 8999999
Q ss_pred eccCCcCCCCCCccc-cCCCCCcEEeecCCccccccCc-cccCCCCCCeEEccCcccCCCchhhh-cCCCCCceEECccC
Q 040925 350 DISSNQFSGVIPGTL-STCVCLEYLDISSNSFHGVIPL-SLSFLKSIKELNVSSNNLSGQIPEFL-KNLSVLEFLSLSYN 426 (833)
Q Consensus 350 ~ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~L~l~~N 426 (833)
+|++|.+++..+..+ .++++|++|+|++|.+++.... ....+++|+.|++++|+++......+ ..++.|+...+..+
T Consensus 462 ~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~ 541 (594)
T 2p1m_B 462 SVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDER 541 (594)
T ss_dssp EEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSS
T ss_pred eccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCC
Confidence 999999976555555 6799999999999999754433 34568999999999999965444445 56788877777766
Q ss_pred cCcc
Q 040925 427 HFEG 430 (833)
Q Consensus 427 ~l~~ 430 (833)
.-..
T Consensus 542 ~~~~ 545 (594)
T 2p1m_B 542 GAPD 545 (594)
T ss_dssp SCGG
T ss_pred Cccc
Confidence 5443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=224.69 Aligned_cols=223 Identities=21% Similarity=0.245 Sum_probs=184.6
Q ss_pred EcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccc
Q 040925 5 AVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFS 84 (833)
Q Consensus 5 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 84 (833)
++..+.++.. ..+..+++|+.|++++|.++. + ..++.+++|++|+|++|++++. ..+.++++|++|+|++|.++
T Consensus 25 ~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~ 98 (272)
T 3rfs_A 25 NLKKKSVTDA--VTQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQ 98 (272)
T ss_dssp HHTCSCTTSE--ECHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCC
T ss_pred HhcCcccccc--cccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccC
Confidence 3455555532 346778899999999999953 3 3588999999999999999853 48999999999999999998
Q ss_pred cccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCc
Q 040925 85 GNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDL 164 (833)
Q Consensus 85 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 164 (833)
.++...|.++++|++|+|++|++++..+..|.++++|++|+|++|+++++++..|..+++|++|+|++|+++.++..
T Consensus 99 -~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-- 175 (272)
T 3rfs_A 99 -SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEG-- 175 (272)
T ss_dssp -CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT--
T ss_pred -ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHH--
Confidence 78888889999999999999999988888899999999999999999999988899999999999999999876653
Q ss_pred ccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCcccc
Q 040925 165 DFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIG 244 (833)
Q Consensus 165 ~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 244 (833)
.+.++++|++|+|++|++++ ..+..|..+++|+.|++++|.+.+
T Consensus 176 ----~~~~l~~L~~L~L~~N~l~~-------------------------~~~~~~~~l~~L~~L~l~~N~~~~------- 219 (272)
T 3rfs_A 176 ----VFDKLTQLKDLRLYQNQLKS-------------------------VPDGVFDRLTSLQYIWLHDNPWDC------- 219 (272)
T ss_dssp ----TTTTCTTCCEEECCSSCCSC-------------------------CCTTTTTTCTTCCEEECCSSCBCC-------
T ss_pred ----HhcCCccCCEEECCCCcCCc-------------------------cCHHHHhCCcCCCEEEccCCCccc-------
Confidence 36788999999999998873 334456777888888888887764
Q ss_pred CCCCCCEEEcccccCcccCCccccCCCC
Q 040925 245 ELKNLQKLCLFRNFLQGRIPSGLGNLTK 272 (833)
Q Consensus 245 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 272 (833)
.+++|+.|+++.|.+++.+|..++.+..
T Consensus 220 ~~~~l~~l~~~~n~~~g~ip~~~~~~~~ 247 (272)
T 3rfs_A 220 TCPGIRYLSEWINKHSGVVRNSAGSVAP 247 (272)
T ss_dssp CTTTTHHHHHHHHHTGGGBBCTTSCBCG
T ss_pred cCcHHHHHHHHHHhCCCcccCcccccCC
Confidence 3557888888888888888887776543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-26 Score=246.09 Aligned_cols=262 Identities=17% Similarity=0.233 Sum_probs=165.0
Q ss_pred EEccCCcccccCCccCCCCCCCCEEEcCCCcccccCC----ccccCCC-CCcEEECCCcccccccCchhhcCC-----CC
Q 040925 28 IRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFP----RSICNIS-SLELIQLALNRFSGNLPFDIVVNL-----PN 97 (833)
Q Consensus 28 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~~l-----~~ 97 (833)
++++.|.+++.+|..+...++|++|+|++|.|++..+ ..|.+++ +|++|+|++|+++ ......|..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~-~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG-FKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGG-GSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCC-HHHHHHHHHHHhccCCC
Confidence 5677777777777766666667777777777776655 6677777 7777777777776 4333344443 67
Q ss_pred ccEEEccCCcceeeCCcc----ccCC-CCCcEEEcccCccccccCcCccC-----CCcCceEecccccCCCCCCCCcccc
Q 040925 98 LKALAIGGNNFFGSIPYS----LSNA-SNLELLDLSVNQFKGNVSIDFSS-----LKNLLWLNLEQNNLGTGTATDLDFV 167 (833)
Q Consensus 98 L~~L~L~~N~l~~~~~~~----~~~l-~~L~~L~L~~N~i~~~~~~~~~~-----l~~L~~L~L~~N~l~~~~~~~~~~~ 167 (833)
|++|+|++|.+++..+.. +..+ ++|++|+|++|+|+......|.. .++|++|+|++|.++..... .+.
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~--~l~ 159 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD--ELI 159 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHH--HHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHH--HHH
Confidence 777777777776544443 3333 66777777777776555544322 14566666666665532221 122
Q ss_pred cccCCCC-CCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcC-CCCCeEeccCCccccc----CCc
Q 040925 168 TFLTNCS-SLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNL-VNLIGFGAEENQLHGT----IPD 241 (833)
Q Consensus 168 ~~l~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l-~~L~~L~L~~N~l~~~----~~~ 241 (833)
..+..++ +|++|+|++|++++..+..+.. .+..+ ++|++|+|++|++++. ++.
T Consensus 160 ~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~---------------------~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~ 218 (362)
T 3goz_A 160 QILAAIPANVNSLNLRGNNLASKNCAELAK---------------------FLASIPASVTSLDLSANLLGLKSYAELAY 218 (362)
T ss_dssp HHHHTSCTTCCEEECTTSCGGGSCHHHHHH---------------------HHHTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred HHHhcCCccccEeeecCCCCchhhHHHHHH---------------------HHHhCCCCCCEEECCCCCCChhHHHHHHH
Confidence 2233333 5555555555555433333322 23334 4788888888888753 344
Q ss_pred cccC-CCCCCEEEcccccCcccCC----ccccCCCCCCeEEeecccccCC-------CCCCCCCCCccceeecCCceecc
Q 040925 242 AIGE-LKNLQKLCLFRNFLQGRIP----SGLGNLTKLANLELSSNSLQGN-------IPSSLGNCQNLMSFTASQNKLTG 309 (833)
Q Consensus 242 ~~~~-l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~-------~~~~~~~l~~L~~L~l~~N~l~~ 309 (833)
.+.. .++|++|+|++|.|++..+ ..+..+++|++|+|++|.+... ++..+..+++|+.|++++|++.+
T Consensus 219 ~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~ 298 (362)
T 3goz_A 219 IFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHP 298 (362)
T ss_dssp HHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCG
T ss_pred HHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCC
Confidence 5554 3589999999998886544 3456778899999999985533 33467788888888898888875
Q ss_pred cCCc
Q 040925 310 ALPH 313 (833)
Q Consensus 310 ~~p~ 313 (833)
..+.
T Consensus 299 ~~~~ 302 (362)
T 3goz_A 299 SHSI 302 (362)
T ss_dssp GGCH
T ss_pred cchH
Confidence 5443
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=228.93 Aligned_cols=181 Identities=27% Similarity=0.258 Sum_probs=97.8
Q ss_pred hcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccce
Q 040925 220 RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMS 299 (833)
Q Consensus 220 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 299 (833)
..+++|++|++++|++.+. ..+..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|..+++|+.
T Consensus 60 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 137 (272)
T 3rfs_A 60 QYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY 137 (272)
T ss_dssp GGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred ccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCE
Confidence 3344444444444444431 24445555555555555555444444555555555555555555444444455555444
Q ss_pred eecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCc
Q 040925 300 FTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNS 379 (833)
Q Consensus 300 L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 379 (833)
|++++|+++ +..+..|..+++|+.|++++|++++..+..|..+++|++|++++|+
T Consensus 138 L~L~~n~l~-------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 192 (272)
T 3rfs_A 138 LNLAHNQLQ-------------------------SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQ 192 (272)
T ss_dssp EECCSSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCccC-------------------------ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCc
Confidence 444444333 2333344555666666666666665555556666666666666666
Q ss_pred cccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCC
Q 040925 380 FHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 380 l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
+++..+..+..+++|+.|++++|.+.+. ++.|+.|++..|.++|.+|.
T Consensus 193 l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~ 240 (272)
T 3rfs_A 193 LKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRN 240 (272)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBC
T ss_pred CCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccC
Confidence 6655555566666666666666666543 33466666666666666654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-26 Score=245.81 Aligned_cols=260 Identities=18% Similarity=0.213 Sum_probs=192.4
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCC----ccCCCCC-CCCEEEcCCCcccccCCccccCC-----CC
Q 040925 3 TLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIP----TTLGLLR-NLVSLNVAENKFSGMFPRSICNI-----SS 72 (833)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l-----~~ 72 (833)
.+.+++|.+++.+|..+...++|++|+|++|.+++..+ ..|..++ +|++|+|++|+|++..+..|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 36899999999999988888889999999999987777 7888998 99999999999998888888876 99
Q ss_pred CcEEECCCcccccccCchh----hcCC-CCccEEEccCCcceeeCCcccc----C-CCCCcEEEcccCccccccCcC---
Q 040925 73 LELIQLALNRFSGNLPFDI----VVNL-PNLKALAIGGNNFFGSIPYSLS----N-ASNLELLDLSVNQFKGNVSID--- 139 (833)
Q Consensus 73 L~~L~L~~N~l~~~~~~~~----~~~l-~~L~~L~L~~N~l~~~~~~~~~----~-l~~L~~L~L~~N~i~~~~~~~--- 139 (833)
|++|+|++|+++ ..+... +..+ ++|++|+|++|.+++..+..+. . .++|++|+|++|+|+......
T Consensus 82 L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~ 160 (362)
T 3goz_A 82 VTSLNLSGNFLS-YKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQ 160 (362)
T ss_dssp CCEEECCSSCGG-GSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHH
T ss_pred ccEEECcCCcCC-hHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHH
Confidence 999999999998 444442 4445 8999999999999876665443 3 369999999999999654433
Q ss_pred -ccCCC-cCceEecccccCCCCCCCCcccccccCCC-CCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCC
Q 040925 140 -FSSLK-NLLWLNLEQNNLGTGTATDLDFVTFLTNC-SSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIP 216 (833)
Q Consensus 140 -~~~l~-~L~~L~L~~N~l~~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~ 216 (833)
+..++ +|++|+|++|+++..... .+...+..+ ++|++|+|++|+++......+ +
T Consensus 161 ~l~~~~~~L~~L~Ls~n~l~~~~~~--~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l---------------------~ 217 (362)
T 3goz_A 161 ILAAIPANVNSLNLRGNNLASKNCA--ELAKFLASIPASVTSLDLSANLLGLKSYAEL---------------------A 217 (362)
T ss_dssp HHHTSCTTCCEEECTTSCGGGSCHH--HHHHHHHTSCTTCCEEECTTSCGGGSCHHHH---------------------H
T ss_pred HHhcCCccccEeeecCCCCchhhHH--HHHHHHHhCCCCCCEEECCCCCCChhHHHHH---------------------H
Confidence 34555 999999999999765442 223445666 599999999999985322211 2
Q ss_pred hhhhc-CCCCCeEeccCCcccccCC----ccccCCCCCCEEEcccccCcccC-------CccccCCCCCCeEEeeccccc
Q 040925 217 PGIRN-LVNLIGFGAEENQLHGTIP----DAIGELKNLQKLCLFRNFLQGRI-------PSGLGNLTKLANLELSSNSLQ 284 (833)
Q Consensus 217 ~~~~~-l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~~~-------~~~~~~l~~L~~L~L~~N~l~ 284 (833)
..+.. .++|++|+|++|++++..+ ..+..+++|++|+|++|.+.++. +..+..+++|+.|||++|++.
T Consensus 218 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~ 297 (362)
T 3goz_A 218 YIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297 (362)
T ss_dssp HHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred HHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence 23333 2356666666666655433 33455677777777777744322 235566777777777777776
Q ss_pred CC
Q 040925 285 GN 286 (833)
Q Consensus 285 ~~ 286 (833)
..
T Consensus 298 ~~ 299 (362)
T 3goz_A 298 PS 299 (362)
T ss_dssp GG
T ss_pred Cc
Confidence 44
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-24 Score=234.81 Aligned_cols=240 Identities=21% Similarity=0.220 Sum_probs=161.2
Q ss_pred CEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccE-EEcc
Q 040925 26 EVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKA-LAIG 104 (833)
Q Consensus 26 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~-L~L~ 104 (833)
++++.+++++ +.+|..+ .+++++|+|++|+|+.+.+++|.++++|++|+|++|++.+.+|.++|.++++|++ +.++
T Consensus 12 ~~v~C~~~~L-t~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKV-TEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTC-CSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCC-CccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 5678888888 4566655 3678888888888887767788888888888888888865788888888888765 6667
Q ss_pred CCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEeccc-ccCCCCCCCCcccccccCCC-CCCCEEEcc
Q 040925 105 GNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQ-NNLGTGTATDLDFVTFLTNC-SSLKALSLA 182 (833)
Q Consensus 105 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~~~~l~~l-~~L~~L~Ls 182 (833)
+|+|+.+.|..|.++++|++|++++|+|+.+++..+....++..|++.+ |++..++... |..+ ..++.|+|+
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~------f~~~~~~l~~L~L~ 162 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS------FVGLSFESVILWLN 162 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTS------STTSBSSCEEEECC
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccc------hhhcchhhhhhccc
Confidence 7888888888888888888888888888888877777777788887754 5666554432 3333 246666666
Q ss_pred CCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEecc-CCcccccCCccccCCCCCCEEEcccccCcc
Q 040925 183 DNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAE-ENQLHGTIPDAIGELKNLQKLCLFRNFLQG 261 (833)
Q Consensus 183 ~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 261 (833)
+|+|+ .+|. ..| ...+|+.|++. +|.++.+.+++|.++++|++|+|++|+|+.
T Consensus 163 ~N~i~-~i~~------------------------~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~ 216 (350)
T 4ay9_X 163 KNGIQ-EIHN------------------------SAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216 (350)
T ss_dssp SSCCC-EECT------------------------TSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC
T ss_pred ccccc-CCCh------------------------hhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCc
Confidence 66665 2222 222 23456666665 355555555666777777777777777765
Q ss_pred cCCccccCCCCCCeEEeecc-cccCCCCCCCCCCCccceeecCCc
Q 040925 262 RIPSGLGNLTKLANLELSSN-SLQGNIPSSLGNCQNLMSFTASQN 305 (833)
Q Consensus 262 ~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~l~~N 305 (833)
+.+..|. +|+.|.+.++ .++ .+| .+.++++|+.++++++
T Consensus 217 lp~~~~~---~L~~L~~l~~~~l~-~lP-~l~~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 217 LPSYGLE---NLKKLRARSTYNLK-KLP-TLEKLVALMEASLTYP 256 (350)
T ss_dssp CCSSSCT---TCCEEECTTCTTCC-CCC-CTTTCCSCCEEECSCH
T ss_pred cChhhhc---cchHhhhccCCCcC-cCC-CchhCcChhhCcCCCC
Confidence 4444443 3444443333 233 444 3666667776666543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=254.63 Aligned_cols=176 Identities=18% Similarity=0.154 Sum_probs=129.3
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--------chhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--------ASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
+...+.||+|+||.||+|.. .++.+|+|+....... ..+.+.+|++++++++||||+++..++...+
T Consensus 338 ~~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~--- 412 (540)
T 3en9_A 338 KIPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD--- 412 (540)
T ss_dssp ----------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT---
T ss_pred CCCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC---
Confidence 34567999999999999955 5778899986533211 1245799999999999999995555544333
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..|+||||+++|+|.+++.. +..++.|++.||+|||++ +|+||||||+||+++. .+||+
T Consensus 413 --~~~lVmE~~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~ 471 (540)
T 3en9_A 413 --NKRIMMSYINGKLAKDVIED--------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYII 471 (540)
T ss_dssp --TTEEEEECCCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEEC
T ss_pred --ccEEEEECCCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEE
Confidence 56999999999999999874 457899999999999999 9999999999999998 99999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCC--CCCCccccccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG--SEASMTGDIFT 735 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~s 735 (833)
|||+|+........... .........||+.|||||++.+ ..|+..+|+|+
T Consensus 472 DFGla~~~~~~~~~~~~-~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws 523 (540)
T 3en9_A 472 DFGLGKISNLDEDKAVD-LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWE 523 (540)
T ss_dssp CCTTCEECCCHHHHHHH-HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHH
T ss_pred ECccCEECCCccccccc-hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHH
Confidence 99999977553211100 0001124679999999999876 56888889887
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=219.14 Aligned_cols=196 Identities=16% Similarity=0.183 Sum_probs=112.7
Q ss_pred CCCEEEcCCCcccccCCccccCCCCCcEEECCCcc-cccccCchhhcCCCCccEEEccC-CcceeeCCccccCCCCCcEE
Q 040925 48 NLVSLNVAENKFSGMFPRSICNISSLELIQLALNR-FSGNLPFDIVVNLPNLKALAIGG-NNFFGSIPYSLSNASNLELL 125 (833)
Q Consensus 48 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L 125 (833)
+|++|+|++|+|+++.+..|.++++|++|++++|+ ++ .++...|.++++|++|+|++ |.++.+.+..|.++++|++|
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 56666666666665555566666666666666665 54 55555566666666666665 66665555566666666666
Q ss_pred EcccCccccccCcCccCCCcCc---eEecccc-cCCCCCCCCcccccccCCCCCCC-EEEccCCcCcccCChhHhhhccc
Q 040925 126 DLSVNQFKGNVSIDFSSLKNLL---WLNLEQN-NLGTGTATDLDFVTFLTNCSSLK-ALSLADNQFGGELPHSIANLSST 200 (833)
Q Consensus 126 ~L~~N~i~~~~~~~~~~l~~L~---~L~L~~N-~l~~~~~~~~~~~~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~~ 200 (833)
+|++|++++++. |..+++|+ +|++++| .++.++.. .|.++++|+ +|++++|+++ .+|..
T Consensus 111 ~l~~n~l~~lp~--~~~l~~L~~L~~L~l~~N~~l~~i~~~------~~~~l~~L~~~L~l~~n~l~-~i~~~------- 174 (239)
T 2xwt_C 111 GIFNTGLKMFPD--LTKVYSTDIFFILEITDNPYMTSIPVN------AFQGLCNETLTLKLYNNGFT-SVQGY------- 174 (239)
T ss_dssp EEEEECCCSCCC--CTTCCBCCSEEEEEEESCTTCCEECTT------TTTTTBSSEEEEECCSCCCC-EECTT-------
T ss_pred eCCCCCCccccc--cccccccccccEEECCCCcchhhcCcc------cccchhcceeEEEcCCCCCc-ccCHh-------
Confidence 666666665433 55555555 6666666 55544432 244556666 6666666655 33322
Q ss_pred ccEEEccCccccccCChhhhcCCCCCeEeccCCc-ccccCCccccCC-CCCCEEEcccccCcccCCccccCCCCCCeEEe
Q 040925 201 VINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQ-LHGTIPDAIGEL-KNLQKLCLFRNFLQGRIPSGLGNLTKLANLEL 278 (833)
Q Consensus 201 l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 278 (833)
.|.. ++|+.|++++|+ ++++.+..|.++ ++|++|+|++|.|+++ |.. .+++|+.|++
T Consensus 175 -----------------~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l 233 (239)
T 2xwt_C 175 -----------------AFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIA 233 (239)
T ss_dssp -----------------TTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEEC
T ss_pred -----------------hcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeec
Confidence 2222 455555666663 555555566666 6666666666666643 322 4456666666
Q ss_pred ecc
Q 040925 279 SSN 281 (833)
Q Consensus 279 ~~N 281 (833)
+++
T Consensus 234 ~~~ 236 (239)
T 2xwt_C 234 RNT 236 (239)
T ss_dssp TTC
T ss_pred cCc
Confidence 554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.2e-23 Score=213.53 Aligned_cols=178 Identities=23% Similarity=0.310 Sum_probs=164.0
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
++++++++.++ .+|..+. ++++.|+|++|++++..+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|
T Consensus 17 ~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 93 (251)
T 3m19_A 17 KEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN 93 (251)
T ss_dssp TEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred eEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCC
Confidence 67999999999 6787766 59999999999999999999999999999999999999988999999999999999999
Q ss_pred ccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCC
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTA 161 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 161 (833)
+++ .+|...|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|+++++..|..+++|++|+|++|+++.++.
T Consensus 94 ~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 94 QLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred ccc-ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 998 8888999999999999999999998888889999999999999999999999899999999999999999987765
Q ss_pred CCcccccccCCCCCCCEEEccCCcCccc
Q 040925 162 TDLDFVTFLTNCSSLKALSLADNQFGGE 189 (833)
Q Consensus 162 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 189 (833)
. .+..+++|++|+|++|++.+.
T Consensus 173 ~------~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 173 G------AFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp T------TTTTCTTCCEEECCSCCBCTT
T ss_pred H------HHhCCCCCCEEEeeCCceeCC
Confidence 3 477899999999999999854
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=216.57 Aligned_cols=207 Identities=16% Similarity=0.204 Sum_probs=173.5
Q ss_pred cCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCc-ccccCCccccCCCCCcEEECCC-ccccccc
Q 040925 10 YLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENK-FSGMFPRSICNISSLELIQLAL-NRFSGNL 87 (833)
Q Consensus 10 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~-i~~~~~~~~~~l~~L~~L~L~~-N~l~~~~ 87 (833)
.++ .+|. +.. +|++|++++|++++..+..|..+++|++|+|++|+ ++++.+.+|.++++|++|+|++ |+++ .+
T Consensus 22 ~l~-~ip~-~~~--~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~-~i 96 (239)
T 2xwt_C 22 DIQ-RIPS-LPP--STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLT-YI 96 (239)
T ss_dssp SCS-SCCC-CCT--TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCC-EE
T ss_pred Ccc-ccCC-CCC--cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCee-Ec
Confidence 366 5676 544 89999999999988888899999999999999997 9888888999999999999998 9998 88
Q ss_pred CchhhcCCCCccEEEccCCcceeeCCccccCCCCCc---EEEcccC-ccccccCcCccCCCcCc-eEecccccCCCCCCC
Q 040925 88 PFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLE---LLDLSVN-QFKGNVSIDFSSLKNLL-WLNLEQNNLGTGTAT 162 (833)
Q Consensus 88 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~---~L~L~~N-~i~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~ 162 (833)
|...|.++++|++|+|++|.+++ +|. |..+++|+ +|++++| +++.+++..|.++++|+ +|+|++|.++.++..
T Consensus 97 ~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~ 174 (239)
T 2xwt_C 97 DPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGY 174 (239)
T ss_dssp CTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTT
T ss_pred CHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHh
Confidence 88899999999999999999985 665 88899998 9999999 99999999999999999 999999999877653
Q ss_pred CcccccccCCCCCCCEEEccCCc-CcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCC
Q 040925 163 DLDFVTFLTNCSSLKALSLADNQ-FGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEEN 233 (833)
Q Consensus 163 ~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N 233 (833)
. +.. ++|++|+|++|+ ++...+..+..+...++.|++++|++++..+. .+++|+.|+++++
T Consensus 175 ~------~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 175 A------FNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELIARNT 236 (239)
T ss_dssp T------TTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEECTTC
T ss_pred h------cCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceeeccCc
Confidence 2 334 789999999995 98555556666525688999999999854443 4556666666654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=229.52 Aligned_cols=240 Identities=17% Similarity=0.173 Sum_probs=194.9
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCccccc-CCccccCCCCCcE-EECC
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGM-FPRSICNISSLEL-IQLA 79 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~-L~L~ 79 (833)
++++.++++|+ .+|..+. +++++|+|++|+|+.+.+++|.++++|++|+|++|++.+. .+.+|.++++|.. +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 57889999999 7887763 6899999999999887788999999999999999998654 4568999999875 6777
Q ss_pred CcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEccc-CccccccCcCccCCC-cCceEecccccCC
Q 040925 80 LNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSV-NQFKGNVSIDFSSLK-NLLWLNLEQNNLG 157 (833)
Q Consensus 80 ~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~i~~~~~~~~~~l~-~L~~L~L~~N~l~ 157 (833)
.|+|+ .+++++|.++++|++|++++|+|+...+..+....++..|++.+ |+|..++...|..+. .|+.|+|++|+|+
T Consensus 89 ~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 89998 89999999999999999999999988888888888999999965 689999999999886 6899999999998
Q ss_pred CCCCCCcccccccCCCCCCCEEEccC-CcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCccc
Q 040925 158 TGTATDLDFVTFLTNCSSLKALSLAD-NQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLH 236 (833)
Q Consensus 158 ~~~~~~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~ 236 (833)
.++... ...++|++|++++ |+++ .+.++.|.++++|+.|+|++|+|+
T Consensus 168 ~i~~~~-------f~~~~L~~l~l~~~n~l~-------------------------~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 168 EIHNSA-------FNGTQLDELNLSDNNNLE-------------------------ELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp EECTTS-------STTEEEEEEECTTCTTCC-------------------------CCCTTTTTTEECCSEEECTTSCCC
T ss_pred CCChhh-------ccccchhHHhhccCCccc-------------------------CCCHHHhccCcccchhhcCCCCcC
Confidence 876643 2445677887764 4444 244467888899999999999999
Q ss_pred ccCCccccCCCCCCEEEcccc-cCcccCCccccCCCCCCeEEeeccc
Q 040925 237 GTIPDAIGELKNLQKLCLFRN-FLQGRIPSGLGNLTKLANLELSSNS 282 (833)
Q Consensus 237 ~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N~ 282 (833)
.+.+..|.+ |+.|.+.++ .++ .+| .+..+++|+.++++++.
T Consensus 216 ~lp~~~~~~---L~~L~~l~~~~l~-~lP-~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 216 SLPSYGLEN---LKKLRARSTYNLK-KLP-TLEKLVALMEASLTYPS 257 (350)
T ss_dssp CCCSSSCTT---CCEEECTTCTTCC-CCC-CTTTCCSCCEEECSCHH
T ss_pred ccChhhhcc---chHhhhccCCCcC-cCC-CchhCcChhhCcCCCCc
Confidence 776666554 455554443 344 556 47889999999998764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=2.8e-23 Score=219.34 Aligned_cols=193 Identities=22% Similarity=0.348 Sum_probs=101.5
Q ss_pred CCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCc
Q 040925 44 GLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLE 123 (833)
Q Consensus 44 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 123 (833)
..+++|++|++++|.++. +| .+..+++|+.|+|++|.++ .++. +..+++|++|+|++|.+++. + .|..+++|+
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~-~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~ 110 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQIT-DLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK 110 (308)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCC-CChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence 345556666666666553 23 4555566666666666655 3433 45555666666666655532 2 455556666
Q ss_pred EEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccE
Q 040925 124 LLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVIN 203 (833)
Q Consensus 124 ~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~ 203 (833)
+|+|++|+|+++++ |..+++|++|+|++|.++.++. +..+++|++|+|++|++++
T Consensus 111 ~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--------l~~l~~L~~L~l~~n~l~~--------------- 165 (308)
T 1h6u_A 111 TLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--------LAGLTNLQYLSIGNAQVSD--------------- 165 (308)
T ss_dssp EEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--------GGGCTTCCEEECCSSCCCC---------------
T ss_pred EEECCCCCCCCchh--hcCCCCCCEEECCCCccCcCcc--------ccCCCCccEEEccCCcCCC---------------
Confidence 66666666554432 5555555555555555543321 3445555555555555441
Q ss_pred EEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccc
Q 040925 204 FGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSL 283 (833)
Q Consensus 204 L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 283 (833)
.+. +..+++|+.|++++|++++..+ +..+++|++|+|++|.+++.. .+..+++|+.|+|++|++
T Consensus 166 -----------~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 166 -----------LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTI 229 (308)
T ss_dssp -----------CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEE
T ss_pred -----------Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCee
Confidence 111 4444555555555555553332 555555555555555555432 255555555555555555
Q ss_pred c
Q 040925 284 Q 284 (833)
Q Consensus 284 ~ 284 (833)
+
T Consensus 230 ~ 230 (308)
T 1h6u_A 230 T 230 (308)
T ss_dssp E
T ss_pred e
Confidence 4
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=7.2e-26 Score=248.14 Aligned_cols=250 Identities=17% Similarity=0.239 Sum_probs=129.8
Q ss_pred cCCccCCCCCCCCEEEcCCCcccccCC----ccccCCCCCcEEECCCc---ccccccCchh------hcCCCCccEEEcc
Q 040925 38 KIPTTLGLLRNLVSLNVAENKFSGMFP----RSICNISSLELIQLALN---RFSGNLPFDI------VVNLPNLKALAIG 104 (833)
Q Consensus 38 ~~~~~~~~l~~L~~L~L~~n~i~~~~~----~~~~~l~~L~~L~L~~N---~l~~~~~~~~------~~~l~~L~~L~L~ 104 (833)
.++..+..+++|++|+|++|.|+...+ ..|..+++|++|+|++| ++++.+|..+ |..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 344445555666666666666654422 23555666666666654 2333333332 3456666666666
Q ss_pred CCccee----eCCccccCCCCCcEEEcccCccccccCcCccC----C---------CcCceEecccccCCCCCCCCcccc
Q 040925 105 GNNFFG----SIPYSLSNASNLELLDLSVNQFKGNVSIDFSS----L---------KNLLWLNLEQNNLGTGTATDLDFV 167 (833)
Q Consensus 105 ~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~----l---------~~L~~L~L~~N~l~~~~~~~~~~~ 167 (833)
+|.++. .+|..+..+++|++|+|++|.|+......+.. + ++|++|+|++|+++..... .+.
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~--~l~ 180 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK--EWA 180 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHH--HHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHH--HHH
Confidence 666654 34555666666666666666665443333332 2 5555555555555421110 011
Q ss_pred cccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCccc----ccCCccc
Q 040925 168 TFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLH----GTIPDAI 243 (833)
Q Consensus 168 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~----~~~~~~~ 243 (833)
..+..+++|++|+|++|+++.. .+. ...+..+..+++|+.|+|++|.++ ..+|..+
T Consensus 181 ~~l~~~~~L~~L~L~~n~l~~~---g~~-----------------~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l 240 (386)
T 2ca6_A 181 KTFQSHRLLHTVKMVQNGIRPE---GIE-----------------HLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 240 (386)
T ss_dssp HHHHHCTTCCEEECCSSCCCHH---HHH-----------------HHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHG
T ss_pred HHHHhCCCcCEEECcCCCCCHh---HHH-----------------HHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHH
Confidence 2344455555555555555410 000 012224555566666666666664 3455556
Q ss_pred cCCCCCCEEEcccccCccc----CCcccc--CCCCCCeEEeecccccC----CCCCCC-CCCCccceeecCCceecc
Q 040925 244 GELKNLQKLCLFRNFLQGR----IPSGLG--NLTKLANLELSSNSLQG----NIPSSL-GNCQNLMSFTASQNKLTG 309 (833)
Q Consensus 244 ~~l~~L~~L~L~~N~l~~~----~~~~~~--~l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~l~~N~l~~ 309 (833)
..+++|++|+|++|.|++. ++..+. .+++|++|+|++|+++. .+|..+ .++++|+.|++++|++++
T Consensus 241 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 241 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp GGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred ccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 6666666666666666543 334442 25666666666666654 244444 345666666666666553
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.90 E-value=4.2e-23 Score=217.97 Aligned_cols=209 Identities=23% Similarity=0.388 Sum_probs=173.9
Q ss_pred cCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCccccc
Q 040925 6 VNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSG 85 (833)
Q Consensus 6 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 85 (833)
+..+.++.. ..+..+++|+.|++++|.++. +| .+..+++|++|+|++|++++..+ |.++++|++|+|++|+++
T Consensus 26 l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~- 98 (308)
T 1h6u_A 26 AGKSNVTDT--VTQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK- 98 (308)
T ss_dssp TTCSSTTSE--ECHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-
T ss_pred hCCCCcCce--ecHHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCC-
Confidence 344444432 235568899999999999954 45 68999999999999999996544 999999999999999998
Q ss_pred ccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcc
Q 040925 86 NLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165 (833)
Q Consensus 86 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 165 (833)
.++ .+..+++|++|+|++|.+++. + .|..+++|++|+|++|+++++.+ +..+++|++|+|++|.++.++.
T Consensus 99 ~~~--~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~---- 168 (308)
T 1h6u_A 99 NVS--AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP---- 168 (308)
T ss_dssp CCG--GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG----
T ss_pred Cch--hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh----
Confidence 555 478999999999999999864 3 39999999999999999998765 8999999999999999976432
Q ss_pred cccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccC
Q 040925 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGE 245 (833)
Q Consensus 166 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (833)
+.++++|+.|+|++|++++ ++. +..+++|+.|++++|++.+.. .+..
T Consensus 169 ----l~~l~~L~~L~l~~n~l~~--------------------------~~~-l~~l~~L~~L~L~~N~l~~~~--~l~~ 215 (308)
T 1h6u_A 169 ----LANLSKLTTLKADDNKISD--------------------------ISP-LASLPNLIEVHLKNNQISDVS--PLAN 215 (308)
T ss_dssp ----GTTCTTCCEEECCSSCCCC--------------------------CGG-GGGCTTCCEEECTTSCCCBCG--GGTT
T ss_pred ----hcCCCCCCEEECCCCccCc--------------------------Chh-hcCCCCCCEEEccCCccCccc--cccC
Confidence 7789999999999999872 111 677889999999999998665 3889
Q ss_pred CCCCCEEEcccccCcccCCc
Q 040925 246 LKNLQKLCLFRNFLQGRIPS 265 (833)
Q Consensus 246 l~~L~~L~L~~N~l~~~~~~ 265 (833)
+++|+.|+|++|.+++ .|.
T Consensus 216 l~~L~~L~l~~N~i~~-~~~ 234 (308)
T 1h6u_A 216 TSNLFIVTLTNQTITN-QPV 234 (308)
T ss_dssp CTTCCEEEEEEEEEEC-CCE
T ss_pred CCCCCEEEccCCeeec-CCe
Confidence 9999999999999984 443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.3e-23 Score=220.65 Aligned_cols=229 Identities=17% Similarity=0.194 Sum_probs=127.2
Q ss_pred CCCEEEccCCcCcccCChhHhhh--cccccEEEccCccccccCChhh--hcCCCCCeEeccCCcccccCC----ccccCC
Q 040925 175 SLKALSLADNQFGGELPHSIANL--SSTVINFGIGRNQISGTIPPGI--RNLVNLIGFGAEENQLHGTIP----DAIGEL 246 (833)
Q Consensus 175 ~L~~L~Ls~N~l~~~~p~~~~~l--~~~l~~L~l~~n~i~~~~~~~~--~~l~~L~~L~L~~N~l~~~~~----~~~~~l 246 (833)
.++.|.+.++.++...-..+... ...+++|++++|.+.+..|..+ ..+++|++|+|++|++.+..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 46666666666542111111110 0124455555555555555555 556666666666666654333 233455
Q ss_pred CCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCC---C-CCCCCCCCccceeecCCceecccCCcccccccccc
Q 040925 247 KNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN---I-PSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS 322 (833)
Q Consensus 247 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~---~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll 322 (833)
++|++|+|++|.+.+..+..|.++++|++|+|++|++.+. . +..+..+++|++|++++|+++ .+|...
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~------- 216 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVC------- 216 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHH-------
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHH-------
Confidence 6666666666666655555666666666666666665421 1 122345555555555555554 222110
Q ss_pred eeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCC---CCCcEEeecCCccccccCccccCCCCCCeEEc
Q 040925 323 LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTC---VCLEYLDISSNSFHGVIPLSLSFLKSIKELNV 399 (833)
Q Consensus 323 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 399 (833)
+..++.+++|++|+|++|++++..|..+..+ ++|++|+|++|+|+. +|..+. ++|+.|+|
T Consensus 217 --------------~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~L 279 (310)
T 4glp_A 217 --------------AALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDL 279 (310)
T ss_dssp --------------HHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEEC
T ss_pred --------------HHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEEC
Confidence 0024556677777777777776656555555 577777777777773 344443 67777777
Q ss_pred cCcccCCCchhhhcCCCCCceEECccCcCcc
Q 040925 400 SSNNLSGQIPEFLKNLSVLEFLSLSYNHFEG 430 (833)
Q Consensus 400 ~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~ 430 (833)
++|+|++. |. +..+++|+.|++++|+|+.
T Consensus 280 s~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 280 SSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 77777754 32 5667777777777777763
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=222.84 Aligned_cols=227 Identities=18% Similarity=0.179 Sum_probs=173.5
Q ss_pred CcEEEcCCCcCcccC-Cc--cccCCCCCCEEEccCCcccccCCccC--CCCCCCCEEEcCCCcccccCC----ccccCCC
Q 040925 1 LQTLAVNDNYLTGQL-PD--FVGNLSDLEVIRIMGNSLGGKIPTTL--GLLRNLVSLNVAENKFSGMFP----RSICNIS 71 (833)
Q Consensus 1 L~~L~l~~n~l~~~~-~~--~~~~l~~L~~L~l~~n~l~~~~~~~~--~~l~~L~~L~L~~n~i~~~~~----~~~~~l~ 71 (833)
++.|.+.++.++... .. .+..+++|++|++++|++++..|..+ ..+++|++|+|++|++++..+ ..+..++
T Consensus 66 l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~ 145 (310)
T 4glp_A 66 VRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKP 145 (310)
T ss_dssp CCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCS
T ss_pred eeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhcc
Confidence 356777777765211 11 12334679999999999998999988 899999999999999987555 5567899
Q ss_pred CCcEEECCCcccccccCchhhcCCCCccEEEccCCccee---eC-CccccCCCCCcEEEcccCccccccCc---CccCCC
Q 040925 72 SLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFG---SI-PYSLSNASNLELLDLSVNQFKGNVSI---DFSSLK 144 (833)
Q Consensus 72 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~---~~-~~~~~~l~~L~~L~L~~N~i~~~~~~---~~~~l~ 144 (833)
+|++|+|++|+++ .++...|.++++|++|+|++|++.+ .. +..+..+++|++|+|++|+|+.++.. .+..++
T Consensus 146 ~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l~ 224 (310)
T 4glp_A 146 GLKVLSIAQAHSP-AFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAGV 224 (310)
T ss_dssp CCCEEEEECCSSC-CCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHTC
T ss_pred CCCEEEeeCCCcc-hhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcCC
Confidence 9999999999997 7787888999999999999999764 22 33457899999999999999855443 367889
Q ss_pred cCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCC
Q 040925 145 NLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVN 224 (833)
Q Consensus 145 ~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~ 224 (833)
+|++|+|++|+++...+..+ ..+..+++|++|+|++|+++ .+|.. +. ++
T Consensus 225 ~L~~L~Ls~N~l~~~~p~~~---~~~~~~~~L~~L~Ls~N~l~-~lp~~-------------------------~~--~~ 273 (310)
T 4glp_A 225 QPHSLDLSHNSLRATVNPSA---PRCMWSSALNSLNLSFAGLE-QVPKG-------------------------LP--AK 273 (310)
T ss_dssp CCSSEECTTSCCCCCCCSCC---SSCCCCTTCCCEECCSSCCC-SCCSC-------------------------CC--SC
T ss_pred CCCEEECCCCCCCccchhhH---HhccCcCcCCEEECCCCCCC-chhhh-------------------------hc--CC
Confidence 99999999999987633221 12333479999999999998 44432 21 57
Q ss_pred CCeEeccCCcccccCCccccCCCCCCEEEcccccCcc
Q 040925 225 LIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQG 261 (833)
Q Consensus 225 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 261 (833)
|+.|+|++|+++++ |. +..+++|++|+|++|.|+.
T Consensus 274 L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 274 LRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred CCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 78888888888754 33 6777888888888888863
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=9.1e-23 Score=208.91 Aligned_cols=181 Identities=22% Similarity=0.245 Sum_probs=131.5
Q ss_pred CCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeec
Q 040925 223 VNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTA 302 (833)
Q Consensus 223 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 302 (833)
.+.++++++++.++. +|..+. ++|+.|+|++|.+++..+..|.++++|++|+|++|+|++..+..|..+++|+.|++
T Consensus 14 ~~~~~l~~~~~~l~~-~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 14 EGKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGGTEEECTTCCCSS-CCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCeEEecCCCCccc-cCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 346678888888874 444443 57788888888888777777888888888888888887777777777777776666
Q ss_pred CCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCcccc
Q 040925 303 SQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHG 382 (833)
Q Consensus 303 ~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 382 (833)
++|+++ +..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++
T Consensus 91 ~~n~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 145 (251)
T 3m19_A 91 ANNQLA-------------------------SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQS 145 (251)
T ss_dssp TTSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCccc-------------------------ccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCc
Confidence 666655 3444556667777777777777776666667777777777777777776
Q ss_pred ccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccc
Q 040925 383 VIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGE 431 (833)
Q Consensus 383 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~ 431 (833)
+.+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|+|+|.
T Consensus 146 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 146 IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 6666677777777777777777776666777777777777777777776
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=9.9e-24 Score=218.91 Aligned_cols=153 Identities=18% Similarity=0.153 Sum_probs=120.8
Q ss_pred HHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC------------------cchhHHHHHHHHHhhc
Q 040925 524 AELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK------------------GASRSFVAECEALRNI 585 (833)
Q Consensus 524 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 585 (833)
..+......|++.+.||+|+||.||+|.+ .+|+.||||+++.... .....+.+|+++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34444455677789999999999999999 6899999999964321 1235688999999999
Q ss_pred CCCccceEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 040925 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVH 665 (833)
Q Consensus 586 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH 665 (833)
+| +++.+++.. +..++||||++||+|.+ +... ....++.|++.||.|||+. ||+|
T Consensus 162 ~~---~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~~------------~~~~i~~qi~~~l~~lH~~---giiH 216 (282)
T 1zar_A 162 QG---LAVPKVYAW------EGNAVLMELIDAKELYR-VRVE------------NPDEVLDMILEEVAKFYHR---GIVH 216 (282)
T ss_dssp TT---SSSCCEEEE------ETTEEEEECCCCEEGGG-CCCS------------CHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cC---CCcCeEEec------cceEEEEEecCCCcHHH-cchh------------hHHHHHHHHHHHHHHHHHC---CCEe
Confidence 94 555554322 24689999999999998 4321 2346999999999999999 9999
Q ss_pred eCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCC
Q 040925 666 GDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG 724 (833)
Q Consensus 666 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 724 (833)
|||||+||+++ ++.+||+|||+|+ .+..|+|||++.+
T Consensus 217 rDlkp~NILl~-~~~vkl~DFG~a~---------------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 217 GDLSQYNVLVS-EEGIWIIDFPQSV---------------------EVGEEGWREILER 253 (282)
T ss_dssp SCCSTTSEEEE-TTEEEECCCTTCE---------------------ETTSTTHHHHHHH
T ss_pred CCCCHHHEEEE-CCcEEEEECCCCe---------------------ECCCCCHHHHHHH
Confidence 99999999999 9999999999997 3455789997643
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=8.3e-24 Score=227.24 Aligned_cols=225 Identities=19% Similarity=0.236 Sum_probs=109.9
Q ss_pred CCEEEccCCcccccCCccCCCC--CCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEE
Q 040925 25 LEVIRIMGNSLGGKIPTTLGLL--RNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALA 102 (833)
Q Consensus 25 L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~ 102 (833)
++.|++++|.+. +..+..+ ++++.|++++|.+++..+. +.++++|+.|+|++|.+++......+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 555666666553 3444444 5566666666666544333 445566666666666554321223345555666666
Q ss_pred ccCCcceeeCCccccCCCCCcEEEcccC-ccccc-cCcCccCCCcCceEecccc-cCCCCCCCCcccccccCCCC-CCCE
Q 040925 103 IGGNNFFGSIPYSLSNASNLELLDLSVN-QFKGN-VSIDFSSLKNLLWLNLEQN-NLGTGTATDLDFVTFLTNCS-SLKA 178 (833)
Q Consensus 103 L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~l~~l~-~L~~ 178 (833)
|++|.+++..+..|+.+++|++|+|++| .+++. .+..+.++++|++|+|++| .++.. ..+..+..++ +|++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~-----~~~~~~~~l~~~L~~ 199 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEK-----HVQVAVAHVSETITQ 199 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHH-----HHHHHHHHSCTTCCE
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChH-----HHHHHHHhcccCCCE
Confidence 6666555555555555555555555555 34431 2223444455555555555 44320 0122233444 4444
Q ss_pred EEccCCcCcccCChhHhhhcccccEEEccCcccc-ccCChhhhcCCCCCeEeccCCc-ccccCCccccCCCCCCEEEccc
Q 040925 179 LSLADNQFGGELPHSIANLSSTVINFGIGRNQIS-GTIPPGIRNLVNLIGFGAEENQ-LHGTIPDAIGELKNLQKLCLFR 256 (833)
Q Consensus 179 L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~ 256 (833)
|+|++|.+ .++ +.++..+..+++|+.|++++|. +++..+..+..+++|++|+|++
T Consensus 200 L~l~~~~~-----------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~ 256 (336)
T 2ast_B 200 LNLSGYRK-----------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 256 (336)
T ss_dssp EECCSCGG-----------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred EEeCCCcc-----------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCC
Confidence 44444421 111 1223344455555566665555 4444455555555566666655
Q ss_pred cc-CcccCCccccCCCCCCeEEeecc
Q 040925 257 NF-LQGRIPSGLGNLTKLANLELSSN 281 (833)
Q Consensus 257 N~-l~~~~~~~~~~l~~L~~L~L~~N 281 (833)
|. +.......+.++++|+.|++++|
T Consensus 257 ~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 257 CYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 53 21111113445555555555555
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=201.85 Aligned_cols=181 Identities=22% Similarity=0.268 Sum_probs=140.5
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
+.+++++++++ .+|..+ .++|++|++++|++++..+..|+.+++|++|+|++|+++++.+..|.++++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 46777888887 456544 347888888888887777777888888888888888888776777788888888888888
Q ss_pred ccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCC
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTA 161 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 161 (833)
+++ .+|...|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|+++++..|..+++|++|+|++|.+.
T Consensus 87 ~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~---- 161 (208)
T 2o6s_A 87 QLQ-SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD---- 161 (208)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC----
T ss_pred cCC-ccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee----
Confidence 887 777777788888888888888888766767888888888888888888777777888888888888888653
Q ss_pred CCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcc
Q 040925 162 TDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSS 199 (833)
Q Consensus 162 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 199 (833)
..+++|++|+++.|++++.+|..++.+..
T Consensus 162 ---------~~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 162 ---------CTCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ---------CCTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ---------cCCCCHHHHHHHHHhCCceeeccCccccC
Confidence 35567777888888887777776665543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1e-23 Score=226.53 Aligned_cols=254 Identities=20% Similarity=0.266 Sum_probs=200.0
Q ss_pred CcEEEcCCCcCcccCCccccCC--CCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCccccc-CCccccCCCCCcEEE
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNL--SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGM-FPRSICNISSLELIQ 77 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~-~~~~~~~l~~L~~L~ 77 (833)
+++|++++|.+. |..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. .|..+.++++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 468999999887 5677777 8999999999999776665 66799999999999999865 888899999999999
Q ss_pred CCCcccccccCchhhcCCCCccEEEccCC-ccee-eCCccccCCCCCcEEEcccC-ccccc-cCcCccCCC-cCceEecc
Q 040925 78 LALNRFSGNLPFDIVVNLPNLKALAIGGN-NFFG-SIPYSLSNASNLELLDLSVN-QFKGN-VSIDFSSLK-NLLWLNLE 152 (833)
Q Consensus 78 L~~N~l~~~~~~~~~~~l~~L~~L~L~~N-~l~~-~~~~~~~~l~~L~~L~L~~N-~i~~~-~~~~~~~l~-~L~~L~L~ 152 (833)
|++|.+++..+ ..+..+++|++|+|++| .+++ ..+..+.++++|++|+|++| .+++. .+..+..++ +|++|+|+
T Consensus 125 L~~~~l~~~~~-~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~ 203 (336)
T 2ast_B 125 LEGLRLSDPIV-NTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLS 203 (336)
T ss_dssp CTTCBCCHHHH-HHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECC
T ss_pred CcCcccCHHHH-HHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeC
Confidence 99999985544 45678999999999999 6775 26677889999999999999 99864 355688899 99999999
Q ss_pred ccc--CCCCCCCCcccccccCCCCCCCEEEccCCc-CcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEe
Q 040925 153 QNN--LGTGTATDLDFVTFLTNCSSLKALSLADNQ-FGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFG 229 (833)
Q Consensus 153 ~N~--l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~ 229 (833)
+|. ++. ...+..+.++++|++|+|++|. +++ ..+..+..+++|+.|+
T Consensus 204 ~~~~~~~~-----~~l~~~~~~~~~L~~L~l~~~~~l~~-------------------------~~~~~l~~l~~L~~L~ 253 (336)
T 2ast_B 204 GYRKNLQK-----SDLSTLVRRCPNLVHLDLSDSVMLKN-------------------------DCFQEFFQLNYLQHLS 253 (336)
T ss_dssp SCGGGSCH-----HHHHHHHHHCTTCSEEECTTCTTCCG-------------------------GGGGGGGGCTTCCEEE
T ss_pred CCcccCCH-----HHHHHHHhhCCCCCEEeCCCCCcCCH-------------------------HHHHHHhCCCCCCEee
Confidence 994 432 1234556788999999999998 553 2334566778888888
Q ss_pred ccCCc-ccccCCccccCCCCCCEEEcccccCcccCCccccCC-CCCCeEEeecccccCCCCCCCCC
Q 040925 230 AEENQ-LHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNL-TKLANLELSSNSLQGNIPSSLGN 293 (833)
Q Consensus 230 L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~~~~~~~~~ 293 (833)
+++|. +.......+..+++|++|++++| ++. ..+..+ ..|+.|++++|++++..|..++.
T Consensus 254 l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 254 LSRCYDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCCCCCHHHHHHHhcCCCCCEEeccCc-cCH---HHHHHHHhhCcceEEecccCccccCCcccc
Confidence 88885 33222236788899999999988 432 334444 34777778999998888877665
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-24 Score=238.28 Aligned_cols=243 Identities=20% Similarity=0.238 Sum_probs=148.3
Q ss_pred cccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCC---cccccCCccc-
Q 040925 168 TFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEEN---QLHGTIPDAI- 243 (833)
Q Consensus 168 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N---~l~~~~~~~~- 243 (833)
..+..+++|++|+|++|+++...+..++ ..|..+++|+.|+|++| ++.+.+|..+
T Consensus 26 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~---------------------~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~ 84 (386)
T 2ca6_A 26 AVLLEDDSVKEIVLSGNTIGTEAARWLS---------------------ENIASKKDLEIAEFSDIFTGRVKDEIPEALR 84 (386)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHH---------------------HTTTTCTTCCEEECCSCCTTSCGGGSHHHHH
T ss_pred HHHhcCCCccEEECCCCCCCHHHHHHHH---------------------HHHHhCCCccEEeCcccccCccccchhHHHH
Confidence 4456677777777777777644333322 22445556666666664 2333334333
Q ss_pred ------cCCCCCCEEEcccccCcc----cCCccccCCCCCCeEEeecccccCCCCCCCC----CC---------Ccccee
Q 040925 244 ------GELKNLQKLCLFRNFLQG----RIPSGLGNLTKLANLELSSNSLQGNIPSSLG----NC---------QNLMSF 300 (833)
Q Consensus 244 ------~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l---------~~L~~L 300 (833)
..+++|++|+|++|.+++ .++..+..+++|++|+|++|.++...+..+. .+ ++|++|
T Consensus 85 ~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L 164 (386)
T 2ca6_A 85 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSI 164 (386)
T ss_dssp HHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEE
T ss_pred HHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEE
Confidence 556666666666666664 2455556666666666666666533222222 22 566666
Q ss_pred ecCCceec-ccCC---cccccccccceeeecCCCccCC-----CCCcccccCCCcCEEeccCCcCC----CCCCccccCC
Q 040925 301 TASQNKLT-GALP---HQLLSITTLSLYLDLSNNLLNG-----SLPLQVGHLKNLVILDISSNQFS----GVIPGTLSTC 367 (833)
Q Consensus 301 ~l~~N~l~-~~~p---~~~~~~~~ll~~L~ls~N~l~~-----~~~~~~~~l~~L~~L~ls~N~l~----~~~~~~~~~l 367 (833)
++++|+++ +.+| ..+.....+ ++|++++|.++. ..+..+..+++|+.|+|++|.++ ..+|..+..+
T Consensus 165 ~L~~n~l~~~~~~~l~~~l~~~~~L-~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~ 243 (386)
T 2ca6_A 165 ICGRNRLENGSMKEWAKTFQSHRLL-HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 243 (386)
T ss_dssp ECCSSCCTGGGHHHHHHHHHHCTTC-CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGC
T ss_pred ECCCCCCCcHHHHHHHHHHHhCCCc-CEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccC
Confidence 66666665 2233 233334444 566666666651 23336677778888888888874 4556677777
Q ss_pred CCCcEEeecCCccccc----cCcccc--CCCCCCeEEccCcccCC----Cchhhh-cCCCCCceEECccCcCcccc
Q 040925 368 VCLEYLDISSNSFHGV----IPLSLS--FLKSIKELNVSSNNLSG----QIPEFL-KNLSVLEFLSLSYNHFEGEV 432 (833)
Q Consensus 368 ~~L~~L~Ls~N~l~~~----~~~~~~--~l~~L~~L~l~~N~l~~----~~p~~l-~~l~~L~~L~l~~N~l~~~~ 432 (833)
++|++|+|++|++++. ++..+. .+++|+.|+|++|.+++ .+|..+ .++++|+.|++++|++++..
T Consensus 244 ~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 244 PNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp TTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred CCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 8888888888887754 344553 37778888888888876 366666 56778888888888777543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-21 Score=193.50 Aligned_cols=153 Identities=21% Similarity=0.240 Sum_probs=122.5
Q ss_pred CCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEcc
Q 040925 25 LEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIG 104 (833)
Q Consensus 25 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~ 104 (833)
-+.++.+++.++ .+|..+ .++|++|+|++|+++++.+..|.++++|++|+|++|+++ .+|...|..+++|++|+|+
T Consensus 9 ~~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls 84 (208)
T 2o6s_A 9 GTTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLS 84 (208)
T ss_dssp TTEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCCcCEEECC
Confidence 357888888884 455444 358899999999998777777888999999999999887 7788888888889999999
Q ss_pred CCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCC
Q 040925 105 GNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADN 184 (833)
Q Consensus 105 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 184 (833)
+|++++..+..|.++++|++|+|++|+|+++++..|..+++|++|+|++|+++.++.. .+..+++|++|+|++|
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~------~~~~l~~L~~L~l~~N 158 (208)
T 2o6s_A 85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG------VFDRLTSLQYIWLHDN 158 (208)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT------TTTTCTTCCEEECCSC
T ss_pred CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH------HhccCCCccEEEecCC
Confidence 8888877777788888888888888888888887788888888888888888765542 3566777788887777
Q ss_pred cCc
Q 040925 185 QFG 187 (833)
Q Consensus 185 ~l~ 187 (833)
.+.
T Consensus 159 ~~~ 161 (208)
T 2o6s_A 159 PWD 161 (208)
T ss_dssp CBC
T ss_pred Cee
Confidence 765
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.86 E-value=3.2e-21 Score=192.66 Aligned_cols=152 Identities=22% Similarity=0.299 Sum_probs=103.1
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
+.+++++++++ .+|..+. ++|+.|++++|+|++..+..|..+++|++|+|++|+|+++.|.+|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 35667777777 4555544 46777777777776666666777777777777777777666777777777777777777
Q ss_pred ccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCC
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLG 157 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 157 (833)
+|+ .+|..+|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+.
T Consensus 91 ~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 776 666666666777777777777776666666666777777777777776666666666666666666666553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.2e-21 Score=208.60 Aligned_cols=180 Identities=18% Similarity=0.209 Sum_probs=89.9
Q ss_pred CEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCcccc-CCCCCcEEECCCcccccccCchhhcCCCCccEEEcc
Q 040925 26 EVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSIC-NISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIG 104 (833)
Q Consensus 26 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~ 104 (833)
+++++++|.++ .+|..+. .+++.|+|++|+|+++.+..|. ++++|+.|+|++|+|+ .++...|.++++|++|+|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC-ccChhhccCCCCCCEEECC
Confidence 34555555552 3343332 2355555555555544444454 5555555555555554 4444455555555555555
Q ss_pred CCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCC
Q 040925 105 GNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADN 184 (833)
Q Consensus 105 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 184 (833)
+|+|+.+.+..|.++++|++|+|++|+|+.+.+..|.++++|++|+|++|+|+.++...+ ..+..+++|+.|+|++|
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~---~~~~~l~~L~~L~L~~N 173 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELI---KDGNKLPKLMLLDLSSN 173 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGT---C----CTTCCEEECCSS
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHh---cCcccCCcCCEEECCCC
Confidence 555554444455555555555555555555555555555555555555555554443210 01134555666666666
Q ss_pred cCcccCChhHhhhccc-ccEEEccCcccc
Q 040925 185 QFGGELPHSIANLSST-VINFGIGRNQIS 212 (833)
Q Consensus 185 ~l~~~~p~~~~~l~~~-l~~L~l~~n~i~ 212 (833)
+|+...+..+..+... +..|++++|.+.
T Consensus 174 ~l~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 174 KLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CCCccCHHHhhhccHhhcceEEecCCCcc
Confidence 6653333344444332 344566666554
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=8.3e-21 Score=214.81 Aligned_cols=195 Identities=26% Similarity=0.305 Sum_probs=153.2
Q ss_pred CCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEc
Q 040925 24 DLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI 103 (833)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 103 (833)
+|+.|++++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|+ .+|. |.+ +|++|+|
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~-~ip~--l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLS-TLPE--LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCS-CCCC--CCT--TCCEEEC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCC-Ccch--hhc--CCCEEEC
Confidence 89999999999966 666553 78999999999999 566 55789999999999998 5887 444 9999999
Q ss_pred cCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccC
Q 040925 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLAD 183 (833)
Q Consensus 104 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 183 (833)
++|.|++ +|. .+++|++|+|++|+|++++. .+++|++|+|++|.|+.++. |. ++|++|+|++
T Consensus 128 s~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~lp~--------l~--~~L~~L~Ls~ 189 (571)
T 3cvr_A 128 DNNQLTM-LPE---LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTFLPE--------LP--ESLEALDVST 189 (571)
T ss_dssp CSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC--------CC--TTCCEEECCS
T ss_pred CCCcCCC-CCC---cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCCcch--------hh--CCCCEEECcC
Confidence 9999986 555 58999999999999998665 57899999999999987553 22 8999999999
Q ss_pred CcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccC
Q 040925 184 NQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRI 263 (833)
Q Consensus 184 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 263 (833)
|+|+ .+|. +.. .+ +.....|+.|+|++|+|+ .+|..+..+++|+.|+|++|.|++.+
T Consensus 190 N~L~-~lp~-~~~---~L-----------------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~ 246 (571)
T 3cvr_A 190 NLLE-SLPA-VPV---RN-----------------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRI 246 (571)
T ss_dssp SCCS-SCCC-CC----------------------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHH
T ss_pred CCCC-chhh-HHH---hh-----------------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcC
Confidence 9998 5554 221 11 122234588888888888 46666666889999999999998888
Q ss_pred CccccCCC
Q 040925 264 PSGLGNLT 271 (833)
Q Consensus 264 ~~~~~~l~ 271 (833)
|..|..++
T Consensus 247 p~~l~~l~ 254 (571)
T 3cvr_A 247 RESLSQQT 254 (571)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHhh
Confidence 87776543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=213.95 Aligned_cols=189 Identities=22% Similarity=0.314 Sum_probs=100.8
Q ss_pred CCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEec
Q 040925 72 SLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNL 151 (833)
Q Consensus 72 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L 151 (833)
+|+.|+|++|.|+ .+|..++ ++|++|+|++|.|+ .+| ..+++|++|+|++|+|++++. |.+ +|++|+|
T Consensus 60 ~L~~L~Ls~n~L~-~lp~~l~---~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~ip~--l~~--~L~~L~L 127 (571)
T 3cvr_A 60 QFSELQLNRLNLS-SLPDNLP---PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLSTLPE--LPA--SLKHLDV 127 (571)
T ss_dssp TCSEEECCSSCCS-CCCSCCC---TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSCCCC--CCT--TCCEEEC
T ss_pred CccEEEeCCCCCC-ccCHhHc---CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCCcch--hhc--CCCEEEC
Confidence 4455555555544 3444332 34555555555554 233 224455555555555554333 332 4555555
Q ss_pred ccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEecc
Q 040925 152 EQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAE 231 (833)
Q Consensus 152 ~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~ 231 (833)
++|+|+.++. .+++|+.|+|++|+|++ + |. .+++|+.|+|+
T Consensus 128 s~N~l~~lp~----------~l~~L~~L~Ls~N~l~~-l-------------------------p~---~l~~L~~L~Ls 168 (571)
T 3cvr_A 128 DNNQLTMLPE----------LPALLEYINADNNQLTM-L-------------------------PE---LPTSLEVLSVR 168 (571)
T ss_dssp CSSCCSCCCC----------CCTTCCEEECCSSCCSC-C-------------------------CC---CCTTCCEEECC
T ss_pred CCCcCCCCCC----------cCccccEEeCCCCccCc-C-------------------------CC---cCCCcCEEECC
Confidence 5555443221 23455555555555541 1 21 23456666666
Q ss_pred CCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCC-------CeEEeecccccCCCCCCCCCCCccceeecCC
Q 040925 232 ENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKL-------ANLELSSNSLQGNIPSSLGNCQNLMSFTASQ 304 (833)
Q Consensus 232 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-------~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 304 (833)
+|+|++ +|. |. ++|+.|+|++|.|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++
T Consensus 169 ~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~ 239 (571)
T 3cvr_A 169 NNQLTF-LPE-LP--ESLEALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILED 239 (571)
T ss_dssp SSCCSC-CCC-CC--TTCCEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCS
T ss_pred CCCCCC-cch-hh--CCCCEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeC
Confidence 666664 333 44 66777777777776 3444 443 55 77777777777 4566666677777777777
Q ss_pred ceecccCCcccccccc
Q 040925 305 NKLTGALPHQLLSITT 320 (833)
Q Consensus 305 N~l~~~~p~~~~~~~~ 320 (833)
|++++.+|..+..+..
T Consensus 240 N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 240 NPLSSRIRESLSQQTA 255 (571)
T ss_dssp SSCCHHHHHHHHHHHH
T ss_pred CcCCCcCHHHHHHhhc
Confidence 7777666766655443
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-20 Score=187.44 Aligned_cols=150 Identities=23% Similarity=0.267 Sum_probs=71.2
Q ss_pred EEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCC-ccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 3 TLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIP-TTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 3 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
++++++|.++ .+|..+.. .+++|+|++|+|++..| ..|..+++|++|+|++|+|+++.+.+|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~~--~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCCT--TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCCC--CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4455555555 24443322 33455555555544422 23445555555555555555444444555555555555555
Q ss_pred ccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccC
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 156 (833)
+++ .++...|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+
T Consensus 92 ~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 92 RLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp CCC-CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred ccC-ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence 554 44444444455555555555555444444444445555555555554444444444444444444444433
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.84 E-value=5.5e-21 Score=218.89 Aligned_cols=64 Identities=30% Similarity=0.429 Sum_probs=37.6
Q ss_pred hhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCC
Q 040925 219 IRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN 286 (833)
Q Consensus 219 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 286 (833)
|..+++|+.|+|++|++.+..| |..+++|+.|+|++|.|++. ..|..+++|+.|+|++|++.+.
T Consensus 149 l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 149 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred hcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 4455555555555555554444 55666666666666666643 3456666666666666666543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=196.30 Aligned_cols=64 Identities=30% Similarity=0.404 Sum_probs=40.0
Q ss_pred hhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccC
Q 040925 218 GIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQG 285 (833)
Q Consensus 218 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 285 (833)
.+..+++|+.|++++|++++..+ +..+++|++|+|++|.|++. + .+..+++|+.|++++|++..
T Consensus 151 ~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 151 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred hhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 34555566666666666665443 66666777777777776643 2 36666777777777776664
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=5.7e-21 Score=190.82 Aligned_cols=158 Identities=20% Similarity=0.144 Sum_probs=122.9
Q ss_pred CEEEcccccCcccCCccccCCCCCCeEEeecccccCCCC-CCCCCCCccceeecCCceecccCCcccccccccceeeecC
Q 040925 250 QKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIP-SSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLS 328 (833)
Q Consensus 250 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls 328 (833)
+.+++++|.++. +|..+. ..+++|+|++|+|++..+ ..|..+++|+.|++++|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i--------------------- 69 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI--------------------- 69 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCC---------------------
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcC---------------------
Confidence 467777777763 455443 345677777777765533 3455666665555555544
Q ss_pred CCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCc
Q 040925 329 NNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI 408 (833)
Q Consensus 329 ~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 408 (833)
+++.+..|.++++|++|+|++|+++++.+..|.++++|++|+|++|+|+++.|..|..+++|+.|+|++|+|++..
T Consensus 70 ----~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 145 (220)
T 2v70_A 70 ----TDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVA 145 (220)
T ss_dssp ----CEECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBC
T ss_pred ----CEECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEEC
Confidence 4455667888899999999999998888888999999999999999999888888999999999999999999888
Q ss_pred hhhhcCCCCCceEECccCcCccccCCC
Q 040925 409 PEFLKNLSVLEFLSLSYNHFEGEVPTK 435 (833)
Q Consensus 409 p~~l~~l~~L~~L~l~~N~l~~~~~~~ 435 (833)
|..|..+++|+.|++++|+|+|.++..
T Consensus 146 ~~~~~~l~~L~~L~L~~N~l~c~c~l~ 172 (220)
T 2v70_A 146 PGAFDTLHSLSTLNLLANPFNCNCYLA 172 (220)
T ss_dssp TTTTTTCTTCCEEECCSCCEECSGGGH
T ss_pred HHHhcCCCCCCEEEecCcCCcCCCchH
Confidence 899999999999999999999888743
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.9e-21 Score=190.72 Aligned_cols=157 Identities=17% Similarity=0.208 Sum_probs=125.6
Q ss_pred CEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCC
Q 040925 250 QKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSN 329 (833)
Q Consensus 250 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~ 329 (833)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|+++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~--------------------- 69 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS--------------------- 69 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCC---------------------
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCC---------------------
Confidence 57888888887 4565554 67888888888888777777777777776666666655
Q ss_pred CccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCch
Q 040925 330 NLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIP 409 (833)
Q Consensus 330 N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p 409 (833)
+..|..|.++++|++|+|++|+|+.+++..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|+|++..+
T Consensus 70 ----~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 145 (220)
T 2v9t_B 70 ----ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAK 145 (220)
T ss_dssp ----EECTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred ----CcCHHHhhCCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECH
Confidence 3456677788888888888888887777778888888888888888888888888888888888888888888877
Q ss_pred hhhcCCCCCceEECccCcCccccCC
Q 040925 410 EFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 410 ~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
..|..+++|+.|+|++|+|.|.+..
T Consensus 146 ~~~~~l~~L~~L~L~~N~~~c~c~l 170 (220)
T 2v9t_B 146 GTFSPLRAIQTMHLAQNPFICDCHL 170 (220)
T ss_dssp TTTTTCTTCCEEECCSSCEECSGGG
T ss_pred HHHhCCCCCCEEEeCCCCcCCCCcc
Confidence 7888888899999999998887764
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=1e-20 Score=204.57 Aligned_cols=181 Identities=23% Similarity=0.149 Sum_probs=139.7
Q ss_pred CeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCcccc-CCCCCCeEEeecccccCCCCCCCCCCCccceeecCC
Q 040925 226 IGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLG-NLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQ 304 (833)
Q Consensus 226 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 304 (833)
+.+++++|+++. +|..+. ..++.|+|++|.|+++.+..|. ++++|++|+|++|+|++..+..|.++++|+.|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 567888888774 444433 3577888888888877777776 778888888888888776667777777777666666
Q ss_pred ceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCcccccc
Q 040925 305 NKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI 384 (833)
Q Consensus 305 N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 384 (833)
|+|+ ...+..|.++++|++|+|++|+|+++.|..|.++++|+.|+|++|+|+++.
T Consensus 98 N~l~-------------------------~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~ 152 (361)
T 2xot_A 98 NHLH-------------------------TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFP 152 (361)
T ss_dssp SCCC-------------------------EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCC
T ss_pred CcCC-------------------------cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeC
Confidence 6655 344556778888999999999998888888999999999999999998766
Q ss_pred Cccc---cCCCCCCeEEccCcccCCCchhhhcCCCCC--ceEECccCcCccccCC
Q 040925 385 PLSL---SFLKSIKELNVSSNNLSGQIPEFLKNLSVL--EFLSLSYNHFEGEVPT 434 (833)
Q Consensus 385 ~~~~---~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L--~~L~l~~N~l~~~~~~ 434 (833)
+..| ..+++|+.|+|++|+|++..+..+..++.+ +.|+|++|+|.|.|..
T Consensus 153 ~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 6666 568899999999999998877888888874 8899999999987753
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.9e-20 Score=185.40 Aligned_cols=155 Identities=20% Similarity=0.236 Sum_probs=94.3
Q ss_pred CCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEcc
Q 040925 25 LEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIG 104 (833)
Q Consensus 25 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~ 104 (833)
-+.++.+++.+ +.+|..+. ++|++|+|++|+|+++.|..|.++++|+.|+|++|+|+ .+|..+|.++++|++|+|+
T Consensus 21 ~~~v~c~~~~l-~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 21 GTTVDCRSKRH-ASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp TTEEECTTSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred CCEeEccCCCc-CccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEECC
Confidence 44566666666 34444333 56666666666666655666666666666666666665 5666666666666666666
Q ss_pred CCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCC
Q 040925 105 GNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADN 184 (833)
Q Consensus 105 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 184 (833)
+|+|+++.+..|..+++|++|+|++|+|+.+ +..+..+++|++|+|++|+|+.++. ..|..+++|+.|+|++|
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~L~L~~N~l~~~~~------~~~~~l~~L~~L~l~~N 169 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLTEL-PRGIERLTHLTHLALDQNQLKSIPH------GAFDRLSSLTHAYLFGN 169 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCSC-CTTGGGCTTCSEEECCSSCCCCCCT------TTTTTCTTCCEEECTTS
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccccc-CcccccCCCCCEEECCCCcCCccCH------HHHhCCCCCCEEEeeCC
Confidence 6666655555566666666666666666643 3445666666666666666665543 22556666777777777
Q ss_pred cCcccC
Q 040925 185 QFGGEL 190 (833)
Q Consensus 185 ~l~~~~ 190 (833)
.+.+..
T Consensus 170 ~~~c~c 175 (229)
T 3e6j_A 170 PWDCEC 175 (229)
T ss_dssp CBCTTB
T ss_pred CccCCc
Confidence 766443
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.83 E-value=9.5e-21 Score=202.26 Aligned_cols=266 Identities=14% Similarity=0.126 Sum_probs=143.9
Q ss_pred CCCCCEEEccCCcccccCCccCCC-CCCCCEEEcCCCccc--ccCCccccCCCCCcEEECCCcccccccCchhhcC----
Q 040925 22 LSDLEVIRIMGNSLGGKIPTTLGL-LRNLVSLNVAENKFS--GMFPRSICNISSLELIQLALNRFSGNLPFDIVVN---- 94 (833)
Q Consensus 22 l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~L~~n~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~---- 94 (833)
+.+++.|.++++ +....-..+.. +++|++|||++|+|. ...+..+. .+..+.+..| .+|..+|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~~---~~~~~~~~~~----~I~~~aF~~~~~~ 95 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTYP---NGKFYIYMAN----FVPAYAFSNVVNG 95 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSSG---GGCCEEECTT----EECTTTTEEEETT
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccccc---cccccccccc----ccCHHHhcccccc
Confidence 567888888865 22222222333 778888888888887 33333332 2455555555 456777888
Q ss_pred ----CCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEeccccc----CCCCCCCCccc
Q 040925 95 ----LPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNN----LGTGTATDLDF 166 (833)
Q Consensus 95 ----l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~----l~~~~~~~~~~ 166 (833)
+++|+.|+|.+ .++.+.+.+|.++++|+.|+|++|.+..+.+.+|.+..++..+.+..+. ...+...
T Consensus 96 ~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~---- 170 (329)
T 3sb4_A 96 VTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHF---- 170 (329)
T ss_dssp EEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTS----
T ss_pred cccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccc----
Confidence 88888888888 7777777788888888888888888888888888887777777665522 1222211
Q ss_pred ccccCCCCCCC-EEEccCCcCcccCChhHhhh---cccccEEEccCccccccCChhh-hcCCCCCeEeccCCcccccCCc
Q 040925 167 VTFLTNCSSLK-ALSLADNQFGGELPHSIANL---SSTVINFGIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPD 241 (833)
Q Consensus 167 ~~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~~l---~~~l~~L~l~~n~i~~~~~~~~-~~l~~L~~L~L~~N~l~~~~~~ 241 (833)
.|.++.+|+ .+.+.... .++..+... ...+..+.+.++-.. .....+ ..+++|+.|+|++|+++.+.+.
T Consensus 171 --~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~ 244 (329)
T 3sb4_A 171 --AFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDF 244 (329)
T ss_dssp --CEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTT
T ss_pred --ccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHh
Confidence 133444555 33333221 222222211 112222333222111 111111 1244555555555555544445
Q ss_pred cccCCCCCCEEEcccccCcccCCccccCCCCCC-eEEeecccccCCCCCCCCCCCccceeecCCceec
Q 040925 242 AIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLA-NLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLT 308 (833)
Q Consensus 242 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 308 (833)
+|.++.+|++|+|.+| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.+++++|.++
T Consensus 245 aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~ 310 (329)
T 3sb4_A 245 TFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT 310 (329)
T ss_dssp TTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC
T ss_pred hhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC
Confidence 5555555555555554 4444444555555555 555554 444444455555555555555555554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=7.1e-20 Score=191.41 Aligned_cols=173 Identities=23% Similarity=0.291 Sum_probs=119.9
Q ss_pred ccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCc
Q 040925 19 VGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL 98 (833)
Q Consensus 19 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L 98 (833)
+..+++|+.|++++|.+... + .+..+++|++|+|++|++++..+ +.++++|+.|+|++|+++ .+|. +..+++|
T Consensus 42 ~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~-~~~~--l~~l~~L 114 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS--LKDLKKL 114 (291)
T ss_dssp HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CGGG--GTTCTTC
T ss_pred hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC-CChh--hccCCCC
Confidence 44567777777777777443 3 37777777777777777775444 777777777777777776 4443 6677777
Q ss_pred cEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCE
Q 040925 99 KALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKA 178 (833)
Q Consensus 99 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~ 178 (833)
++|+|++|++++. ..+..+++|++|+|++|+|+++ ..|..+++|++|+|++|.++.++. +..+++|++
T Consensus 115 ~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--------l~~l~~L~~ 182 (291)
T 1h6t_A 115 KSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--------LAGLTKLQN 182 (291)
T ss_dssp CEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--------GTTCTTCCE
T ss_pred CEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--------hcCCCccCE
Confidence 7777777777643 4577777777777777777765 467777777777777777765432 567777777
Q ss_pred EEccCCcCcccCChhHhhhcccccEEEccCccccc
Q 040925 179 LSLADNQFGGELPHSIANLSSTVINFGIGRNQISG 213 (833)
Q Consensus 179 L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~ 213 (833)
|+|++|++++ +|. +..+. .++.|++++|.++.
T Consensus 183 L~L~~N~i~~-l~~-l~~l~-~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 183 LYLSKNHISD-LRA-LAGLK-NLDVLELFSQECLN 214 (291)
T ss_dssp EECCSSCCCB-CGG-GTTCT-TCSEEEEEEEEEEC
T ss_pred EECCCCcCCC-Chh-hccCC-CCCEEECcCCcccC
Confidence 7777777773 443 44443 46777777777764
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=207.81 Aligned_cols=189 Identities=23% Similarity=0.297 Sum_probs=142.1
Q ss_pred CcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecc
Q 040925 73 LELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLE 152 (833)
Q Consensus 73 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 152 (833)
+..+.++.+.+.+.++ +..+++|+.|+|++|.|.. ++ .|..+++|++|+|++|+|+++++ |..+++|+.|+|+
T Consensus 23 l~~l~l~~~~i~~~~~---~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls 95 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT---QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLD 95 (605)
T ss_dssp HHHHHTTCSCTTSEEC---HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECC
T ss_pred HHHHhccCCCcccccc---hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECc
Confidence 3444555555542222 3456667777777777653 23 46777777777777777776655 7777777777777
Q ss_pred cccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccC
Q 040925 153 QNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEE 232 (833)
Q Consensus 153 ~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~ 232 (833)
+|.|+.++ .+..+++|+.|+|++|++.+ .+.+..+++|+.|+|++
T Consensus 96 ~N~l~~l~--------~l~~l~~L~~L~Ls~N~l~~---------------------------l~~l~~l~~L~~L~Ls~ 140 (605)
T 1m9s_A 96 ENKIKDLS--------SLKDLKKLKSLSLEHNGISD---------------------------INGLVHLPQLESLYLGN 140 (605)
T ss_dssp SSCCCCCT--------TSTTCTTCCEEECTTSCCCC---------------------------CGGGGGCTTCSEEECCS
T ss_pred CCCCCCCh--------hhccCCCCCEEEecCCCCCC---------------------------CccccCCCccCEEECCC
Confidence 77776533 26677888888888888762 12467788899999999
Q ss_pred CcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecc
Q 040925 233 NQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTG 309 (833)
Q Consensus 233 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 309 (833)
|++.++ ..|..+++|+.|+|++|.|++..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+
T Consensus 141 N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 141 NKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp SCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred CccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 999865 678999999999999999997655 89999999999999999864 368999999999999999983
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-18 Score=188.55 Aligned_cols=259 Identities=10% Similarity=0.097 Sum_probs=150.4
Q ss_pred CcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCch
Q 040925 11 LTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFD 90 (833)
Q Consensus 11 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 90 (833)
++.+...+|.++ +|+.+.+.++ ++.+...+|... +|+.+.|.+ .++.+.+.+|.++++|+.++|+.|+++ .++..
T Consensus 124 i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~ 198 (401)
T 4fdw_A 124 VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPAS 198 (401)
T ss_dssp CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTT
T ss_pred cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-Eechh
Confidence 333444455553 4555555544 545555555552 455555554 444455555555555555555555555 55555
Q ss_pred hhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCccccccc
Q 040925 91 IVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFL 170 (833)
Q Consensus 91 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l 170 (833)
+|. ..+|+.+.|..+ ++.+...+|.++++|+.++|..| ++.+...+|.+ .+|+.+.| .|.++.++.. .|
T Consensus 199 aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~------aF 267 (401)
T 4fdw_A 199 TFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASR------AF 267 (401)
T ss_dssp TTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTT------TT
T ss_pred hEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChh------Hh
Confidence 554 355555555533 44455555555555555555543 44455555555 55555555 3334444332 24
Q ss_pred CCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCC
Q 040925 171 TNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQ 250 (833)
Q Consensus 171 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 250 (833)
.++++|+.+++.+|.+. .+.+..+.+.+|.++++|+.+.|. +.+..+...+|.++.+|+
T Consensus 268 ~~c~~L~~l~l~~~~~~--------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~ 326 (401)
T 4fdw_A 268 YYCPELAEVTTYGSTFN--------------------DDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVT 326 (401)
T ss_dssp TTCTTCCEEEEESSCCC--------------------CCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCC
T ss_pred hCCCCCCEEEeCCcccc--------------------CCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCcc
Confidence 45555555555555443 111123556677777778887777 446667777777777788
Q ss_pred EEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCC-ccceeecCCceec
Q 040925 251 KLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQ-NLMSFTASQNKLT 308 (833)
Q Consensus 251 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~ 308 (833)
.++|..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.+.
T Consensus 327 ~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 327 QLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp EEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred EEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 8877554 665667777777 788888877777766667777774 6667776666544
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.81 E-value=5.4e-20 Score=188.57 Aligned_cols=137 Identities=19% Similarity=0.169 Sum_probs=107.2
Q ss_pred CccCceeccCcceEEEEEEECCCceE--EEEEEeeccCCcc------------------------hhHHHHHHHHHhhcC
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMI--VAVKVINLKYKGA------------------------SRSFVAECEALRNIR 586 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 586 (833)
|++.+.||+|+||.||+|.+..+|+. ||||+++...... ...+.+|+++++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999667888 9999975431110 125789999999998
Q ss_pred CCcc--ceEeeEeecCCCCCCceEeEEEEecCC-C----ChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHh-hc
Q 040925 587 HRNL--IKIITICSSTDFKGTDFKAFVFEYMEN-G----SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH-HH 658 (833)
Q Consensus 587 h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH-~~ 658 (833)
|+++ +.++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~~~ 190 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQEA 190 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHHHC
Confidence 8764 444432 145899999942 4 66665432 234567789999999999999 88
Q ss_pred CCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 659 ~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+||||||+|||++. .++|+|||+|...
T Consensus 191 ---givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 191 ---ELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred ---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 9999999999999988 9999999999754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=5.4e-19 Score=177.72 Aligned_cols=152 Identities=20% Similarity=0.276 Sum_probs=142.2
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
+++++++++++ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|+.+.+..|.++++|+.|+|++|
T Consensus 22 ~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N 98 (229)
T 3e6j_A 22 TTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN 98 (229)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCC
Confidence 57899999999 6777665 79999999999999998999999999999999999999877888999999999999999
Q ss_pred ccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCC
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGT 158 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 158 (833)
+|+ .+|..+|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+.+++..|..+++|+.|+|++|.+..
T Consensus 99 ~l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 99 QLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred cCC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 998 889899999999999999999998 678899999999999999999999999999999999999999999865
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-20 Score=191.53 Aligned_cols=61 Identities=26% Similarity=0.315 Sum_probs=28.8
Q ss_pred hcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeeccccc
Q 040925 220 RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ 284 (833)
Q Consensus 220 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 284 (833)
..+++|+.|++++|+++++ + .+..+++|++|+|++|.|++. ..+..+++|+.|++++|++.
T Consensus 125 ~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 125 IHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp TTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEE
T ss_pred cCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCccc
Confidence 3344444444444444432 1 344445555555555555433 34445555555555555554
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.79 E-value=6.1e-20 Score=188.74 Aligned_cols=101 Identities=24% Similarity=0.258 Sum_probs=43.5
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEE
Q 040925 47 RNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLD 126 (833)
Q Consensus 47 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 126 (833)
.+++.+++++|.++++. .+..+++|+.|++++|.++ .+| .+..+++|++|+|++|+|++..+ |.++++|++|+
T Consensus 19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 33444444444444221 3444444444444444444 333 23344444444444444443222 44444444444
Q ss_pred cccCccccccCcCccCCCcCceEecccccCC
Q 040925 127 LSVNQFKGNVSIDFSSLKNLLWLNLEQNNLG 157 (833)
Q Consensus 127 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 157 (833)
|++|+|++++.... ++|++|+|++|+++
T Consensus 92 L~~N~l~~l~~~~~---~~L~~L~L~~N~l~ 119 (263)
T 1xeu_A 92 VNRNRLKNLNGIPS---ACLSRLFLDNNELR 119 (263)
T ss_dssp CCSSCCSCCTTCCC---SSCCEEECCSSCCS
T ss_pred CCCCccCCcCcccc---CcccEEEccCCccC
Confidence 44444443332111 44444444444443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.4e-22 Score=225.98 Aligned_cols=203 Identities=19% Similarity=0.164 Sum_probs=125.0
Q ss_pred CCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcc-------------cccccCchhhcCCCCccEEE-ccCCcce
Q 040925 44 GLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR-------------FSGNLPFDIVVNLPNLKALA-IGGNNFF 109 (833)
Q Consensus 44 ~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~~l~~L~~L~-L~~N~l~ 109 (833)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +. ..++..+..+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~-~~~~~~l~~l~~L~~L~~l~~n~~~ 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL-LYEKETLQYFSTLKAVDPMRAAYLD 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTG-GGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccc-cCCHHHHHHHHhcccCcchhhcccc
Confidence 45677777788888776 667777777788877776664 33 23344556677777776 5555432
Q ss_pred eeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCccc
Q 040925 110 GSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGE 189 (833)
Q Consensus 110 ~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~ 189 (833)
+|+.+.+++|.|+.+++. .|+.|+|++|.|+.++ . +.++++|+.|+|++|+|+ .
T Consensus 424 -----------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~lp-------~-~~~l~~L~~L~Ls~N~l~-~ 477 (567)
T 1dce_A 424 -----------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTVLC-------H-LEQLLLVTHLDLSHNRLR-A 477 (567)
T ss_dssp -----------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSSCC-------C-GGGGTTCCEEECCSSCCC-C
T ss_pred -----------hhhhhhhhcccccccCcc------CceEEEecCCCCCCCc-------C-ccccccCcEeecCccccc-c
Confidence 344455566666554432 3677777777776543 1 556677777777777776 2
Q ss_pred CChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccC-Ccccc
Q 040925 190 LPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRI-PSGLG 268 (833)
Q Consensus 190 ~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~~ 268 (833)
+|..|+++++|+.|+|++|+|++ +| .|+.+++|++|+|++|.|++.. |..|.
T Consensus 478 -------------------------lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~ 530 (567)
T 1dce_A 478 -------------------------LPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLV 530 (567)
T ss_dssp -------------------------CCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGG
T ss_pred -------------------------cchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHh
Confidence 33445555566666666666664 34 5666666666666666666554 66666
Q ss_pred CCCCCCeEEeecccccCCCCCC---CCCCCccceee
Q 040925 269 NLTKLANLELSSNSLQGNIPSS---LGNCQNLMSFT 301 (833)
Q Consensus 269 ~l~~L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~ 301 (833)
.+++|+.|+|++|++++.+|.. +..+++|+.|+
T Consensus 531 ~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 531 SCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp GCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred cCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 6666666666666666444321 12355666554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=2.6e-19 Score=174.69 Aligned_cols=158 Identities=23% Similarity=0.308 Sum_probs=112.3
Q ss_pred ceeecCCceecccCCcccccccccceeeecCCCccCCCCCc-ccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeec
Q 040925 298 MSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPL-QVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDIS 376 (833)
Q Consensus 298 ~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~-~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls 376 (833)
+.+++++|+++ .+|..+.. .+ +.|++++|.+++..+. .|..+++|++|+|++|+|++..|.+|.++++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l-~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HT-TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TC-SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC--CC-CEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 34555555554 44443332 22 5677777777655553 47788888888888888888888888888888888888
Q ss_pred CCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCCCc
Q 040925 377 SNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGI 456 (833)
Q Consensus 377 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~~ 456 (833)
+|+|++..+..|..+++|+.|+|++|+|++..|..+..+++|+.|+|++|+|+|.++..+....+....+.++...|+.|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~~~l~~~~~~~~~~~C~~P 166 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHHHHHHHcCCCCCCCCCCCC
Confidence 88888888877888888888888888888888888888888888888888888877643322222333455666677766
Q ss_pred ccC
Q 040925 457 DEL 459 (833)
Q Consensus 457 ~~~ 459 (833)
...
T Consensus 167 ~~l 169 (192)
T 1w8a_A 167 SKV 169 (192)
T ss_dssp TTT
T ss_pred hHH
Confidence 543
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-19 Score=190.67 Aligned_cols=285 Identities=12% Similarity=0.046 Sum_probs=216.9
Q ss_pred CcEEEcCCCcCcccCCccccC-CCCCCEEEccCCccc--ccCCccCCCCCCCCEEEcCCCcccccCCccccC--------
Q 040925 1 LQTLAVNDNYLTGQLPDFVGN-LSDLEVIRIMGNSLG--GKIPTTLGLLRNLVSLNVAENKFSGMFPRSICN-------- 69 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~--~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~-------- 69 (833)
|++|.++++ +....-..+.. +++|++|||++|+|. ...+..+ +.+..+.+..|. +.+.+|.+
T Consensus 27 l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~---I~~~aF~~~~~~~~~g 99 (329)
T 3sb4_A 27 ITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANF---VPAYAFSNVVNGVTKG 99 (329)
T ss_dssp CSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTE---ECTTTTEEEETTEEEE
T ss_pred eeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccccc---cccccccccccc---cCHHHhcccccccccc
Confidence 456777653 22111123334 789999999999996 3333333 336677777774 45678888
Q ss_pred CCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccC----ccccccCcCccCCCc
Q 040925 70 ISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVN----QFKGNVSIDFSSLKN 145 (833)
Q Consensus 70 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N----~i~~~~~~~~~~l~~ 145 (833)
+++|+.|+|+. .++ .|+..+|.++++|+.|+|++|.+..+.+.+|.++.++..+.+..+ ....+...+|.+..+
T Consensus 100 ~~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~ 177 (329)
T 3sb4_A 100 KQTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEP 177 (329)
T ss_dssp CTTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCC
T ss_pred cCCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccc
Confidence 99999999999 887 899999999999999999999999899999999988888888774 334566777888888
Q ss_pred Cc-eEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCC
Q 040925 146 LL-WLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVN 224 (833)
Q Consensus 146 L~-~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~ 224 (833)
|+ .+.+.... .++. .....-....++..+.+.++-.. .-...+......++.+++.+|+++.+.+.+|.++.+
T Consensus 178 L~~~i~~~~~~--~l~~---~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~ 251 (329)
T 3sb4_A 178 LETTIQVGAMG--KLED---EIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKY 251 (329)
T ss_dssp CEEEEEECTTC--CHHH---HHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTT
T ss_pred cceeEEecCCC--cHHH---HHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCC
Confidence 87 55554321 1110 00011123556777777766332 233334444556888999999999888999999999
Q ss_pred CCeEeccCCcccccCCccccCCCCCC-EEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeec
Q 040925 225 LIGFGAEENQLHGTIPDAIGELKNLQ-KLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTA 302 (833)
Q Consensus 225 L~~L~L~~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 302 (833)
|+.|+|.+| +..+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.|++++|+++.+.+.+|.++++|+.++.
T Consensus 252 L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 252 LLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp CCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 999999998 8888999999999999 999998 788788899999999999999999999888899999999999874
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.7e-18 Score=169.82 Aligned_cols=155 Identities=16% Similarity=0.200 Sum_probs=127.7
Q ss_pred cccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCC
Q 040925 18 FVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPN 97 (833)
Q Consensus 18 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~ 97 (833)
....+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+..+.++++|++|++++|++++..+ ..|..+++
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~-~~l~~l~~ 113 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKI-PNLSGLTS 113 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGS-CCCTTCTT
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccC-hhhcCCCC
Confidence 3467788999999999995 455 6888999999999999876 33478999999999999999984344 44678999
Q ss_pred ccEEEccCCcceeeCCccccCCCCCcEEEcccCc-cccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCC
Q 040925 98 LKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQ-FKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSL 176 (833)
Q Consensus 98 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L 176 (833)
|++|+|++|.+++..|..|..+++|++|+|++|+ ++.++ .+..+++|++|++++|.++.++ .+..+++|
T Consensus 114 L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~--~l~~l~~L~~L~l~~n~i~~~~--------~l~~l~~L 183 (197)
T 4ezg_A 114 LTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM--PLKTLPELKSLNIQFDGVHDYR--------GIEDFPKL 183 (197)
T ss_dssp CCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG--GGGGCSSCCEEECTTBCCCCCT--------TGGGCSSC
T ss_pred CCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH--hhcCCCCCCEEECCCCCCcChH--------HhccCCCC
Confidence 9999999999987778889999999999999998 87664 6889999999999999997654 26788999
Q ss_pred CEEEccCCcCc
Q 040925 177 KALSLADNQFG 187 (833)
Q Consensus 177 ~~L~Ls~N~l~ 187 (833)
++|++++|++.
T Consensus 184 ~~L~l~~N~i~ 194 (197)
T 4ezg_A 184 NQLYAFSQTIG 194 (197)
T ss_dssp CEEEECBC---
T ss_pred CEEEeeCcccC
Confidence 99999999886
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-19 Score=212.71 Aligned_cols=227 Identities=20% Similarity=0.154 Sum_probs=121.7
Q ss_pred CCCCEEEccCCcccccCCccCCCCCCCCE-----EEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCC
Q 040925 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVS-----LNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPN 97 (833)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~-----L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~ 97 (833)
+.++.|+|.+|.+.. .+..+....+|.. ++++.|++. ..|+.|..+++|+.|+|++|++. .+|..+| ++++
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-~l~~ 248 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIF-KYDF 248 (727)
T ss_dssp ---------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGG-GCCS
T ss_pred CccceEEeeCCCCCc-chhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhc-CCCC
Confidence 567888998888855 4444333333333 334445555 67899999999999999999998 8998887 8999
Q ss_pred ccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCC
Q 040925 98 LKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLK 177 (833)
Q Consensus 98 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~ 177 (833)
|++|+|++|.|+ .+|..|.++++|++|+|++|+|+.+ +..|.+|++|++|+|++|.|+.++. .|.++++|+
T Consensus 249 L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~l-p~~~~~l~~L~~L~L~~N~l~~lp~-------~~~~l~~L~ 319 (727)
T 4b8c_D 249 LTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLTSL-PAELGSCFQLKYFYFFDNMVTTLPW-------EFGNLCNLQ 319 (727)
T ss_dssp CSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCSSC-CSSGGGGTTCSEEECCSSCCCCCCS-------STTSCTTCC
T ss_pred CCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCCcc-ChhhcCCCCCCEEECCCCCCCccCh-------hhhcCCCcc
Confidence 999999999998 7889999999999999999999955 7789999999999999999987654 378999999
Q ss_pred EEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccc
Q 040925 178 ALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRN 257 (833)
Q Consensus 178 ~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 257 (833)
+|+|++|+|++.+|..+..+......+++++|.+++.+|.. |..|+++.|... -. ..+
T Consensus 320 ~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n~~~---~~-------------~~~ 377 (727)
T 4b8c_D 320 FLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTDGEP---QR-------------EYD 377 (727)
T ss_dssp CEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------------------------------
T ss_pred EEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeeccccc---cc-------------ccC
Confidence 99999999999999888776544444566666666555543 233344443100 00 011
Q ss_pred cCcccCCccccCCCCCCeEEeeccccc
Q 040925 258 FLQGRIPSGLGNLTKLANLELSSNSLQ 284 (833)
Q Consensus 258 ~l~~~~~~~~~~l~~L~~L~L~~N~l~ 284 (833)
.+.+..+..+..+..++...+++|-+.
T Consensus 378 ~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 378 SLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp ------------------------CCC
T ss_pred Cccccccchhhcccccceeeeeccccc
Confidence 333333444555666666777777664
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-17 Score=180.28 Aligned_cols=241 Identities=11% Similarity=0.080 Sum_probs=135.8
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEE
Q 040925 47 RNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLD 126 (833)
Q Consensus 47 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 126 (833)
..++.+.+.+ .++.+...+|.++ +|+.+.+..| ++ .|+..+|.+ .+|+.+.|.. .++.+.+.+|.++++|+.++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 4444444443 2333444555543 4555555443 43 445555544 2455555543 34444445555555555555
Q ss_pred cccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEc
Q 040925 127 LSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGI 206 (833)
Q Consensus 127 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l 206 (833)
|++|+++.++..+|. .++|+.+.|.. +++.+... .|.++++|+.+++.+| ++.....+|.+ ..++.+.+
T Consensus 187 l~~n~l~~I~~~aF~-~~~L~~l~lp~-~l~~I~~~------aF~~~~~L~~l~l~~~-l~~I~~~aF~~--~~L~~i~l 255 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-YAGIEEVLLPV-TLKEIGSQ------AFLKTSQLKTIEIPEN-VSTIGQEAFRE--SGITTVKL 255 (401)
T ss_dssp CTTSCCSEECTTTTT-TCCCSEEECCT-TCCEECTT------TTTTCTTCCCEECCTT-CCEECTTTTTT--CCCSEEEE
T ss_pred cCCCcceEechhhEe-ecccCEEEeCC-chheehhh------HhhCCCCCCEEecCCC-ccCcccccccc--CCccEEEe
Confidence 555555555555554 24555555542 24443332 2445555555555443 33122222222 23444444
Q ss_pred cCccccccCChhhhcCCCCCeEeccCCccc-----ccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecc
Q 040925 207 GRNQISGTIPPGIRNLVNLIGFGAEENQLH-----GTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSN 281 (833)
Q Consensus 207 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 281 (833)
.+.++.+...+|.++++|+.+.+.+|.+. .+.+.+|.++++|+.++|. +.++.+...+|.++++|+.++|..|
T Consensus 256 -p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~ 333 (401)
T 4fdw_A 256 -PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN 333 (401)
T ss_dssp -ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT
T ss_pred -CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc
Confidence 23344466777888888888888777665 5667778888888888887 4476677777888888888888554
Q ss_pred cccCCCCCCCCCCCccceeecCCceec
Q 040925 282 SLQGNIPSSLGNCQNLMSFTASQNKLT 308 (833)
Q Consensus 282 ~l~~~~~~~~~~l~~L~~L~l~~N~l~ 308 (833)
++.+.+.+|.++ +|+.+++++|.+.
T Consensus 334 -l~~I~~~aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 334 -VTQINFSAFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp -CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred -ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence 665667778877 7877777777665
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=8e-19 Score=172.20 Aligned_cols=155 Identities=17% Similarity=0.204 Sum_probs=115.1
Q ss_pred CCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCC
Q 040925 43 LGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNL 122 (833)
Q Consensus 43 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 122 (833)
...+++|++|++++|.|+ .+| .+..+++|++|++++|.++ .++ .+..+++|++|+|++|.+++..+..|+.+++|
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~~--~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NYN--PISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CCG--GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cch--hhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 366778888888888887 445 5888888888888888775 443 46778888888888888877677788888888
Q ss_pred cEEEcccCccccccCcCccCCCcCceEeccccc-CCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccc
Q 040925 123 ELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNN-LGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTV 201 (833)
Q Consensus 123 ~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l 201 (833)
++|+|++|++++..+..|..+++|++|+|++|. ++.++ .+.++++|++|++++|++++ ++ .+..++ .+
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~--------~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~-~L 183 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM--------PLKTLPELKSLNIQFDGVHD-YR-GIEDFP-KL 183 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG--------GGGGCSSCCEEECTTBCCCC-CT-TGGGCS-SC
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH--------hhcCCCCCCEEECCCCCCcC-hH-HhccCC-CC
Confidence 888888888887667778888888888888887 65542 36678888888888888874 44 555554 47
Q ss_pred cEEEccCccccc
Q 040925 202 INFGIGRNQISG 213 (833)
Q Consensus 202 ~~L~l~~n~i~~ 213 (833)
+.|++++|+|.+
T Consensus 184 ~~L~l~~N~i~~ 195 (197)
T 4ezg_A 184 NQLYAFSQTIGG 195 (197)
T ss_dssp CEEEECBC----
T ss_pred CEEEeeCcccCC
Confidence 888888888753
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=4.7e-21 Score=218.21 Aligned_cols=193 Identities=20% Similarity=0.205 Sum_probs=147.9
Q ss_pred hcCCCCCeEeccCCcccccCCccccCCCCCCEEEccccc-------------CcccCCccccCCCCCCeEE-eecccccC
Q 040925 220 RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNF-------------LQGRIPSGLGNLTKLANLE-LSSNSLQG 285 (833)
Q Consensus 220 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-------------l~~~~~~~~~~l~~L~~L~-L~~N~l~~ 285 (833)
..+++|+.|+|++|++. .+|+.++.+++|++|++++|. +.+..|..+.++++|+.|+ ++.|.+
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~-- 422 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYL-- 422 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHH--
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhccc--
Confidence 45667777777777776 567777777777777776654 3344555555566666665 555543
Q ss_pred CCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCcccc
Q 040925 286 NIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLS 365 (833)
Q Consensus 286 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~ 365 (833)
.+|..+.+++|.++ .+|.. . ++.|+|++|.|++ +|. |+.+++|+.|+|++|.|+ .+|..|+
T Consensus 423 ---------~~L~~l~l~~n~i~-~l~~~-----~-L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~ 483 (567)
T 1dce_A 423 ---------DDLRSKFLLENSVL-KMEYA-----D-VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALA 483 (567)
T ss_dssp ---------HHHHHHHHHHHHHH-HHHHT-----T-CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGG
T ss_pred ---------chhhhhhhhccccc-ccCcc-----C-ceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhh
Confidence 24555556666665 22221 2 3789999999995 565 999999999999999998 6788999
Q ss_pred CCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCc-hhhhcCCCCCceEECccCcCccccCCCC
Q 040925 366 TCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQI-PEFLKNLSVLEFLSLSYNHFEGEVPTKG 436 (833)
Q Consensus 366 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p~~l~~l~~L~~L~l~~N~l~~~~~~~~ 436 (833)
.+++|+.|+|++|+|++ +| .+..+++|+.|+|++|+|++.. |..+..+++|+.|+|++|++++.+|...
T Consensus 484 ~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~ 553 (567)
T 1dce_A 484 ALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQE 553 (567)
T ss_dssp GCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTT
T ss_pred cCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHH
Confidence 99999999999999997 45 8999999999999999999877 9999999999999999999999887653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.76 E-value=4e-17 Score=178.71 Aligned_cols=335 Identities=12% Similarity=0.085 Sum_probs=183.9
Q ss_pred ccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCc
Q 040925 35 LGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPY 114 (833)
Q Consensus 35 l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 114 (833)
++.+...+|..+.+|+.+.|.++ ++.+...+|.++++|+.+++..+ ++ .++..+|.++.+|+.+.+..+ +..+...
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~ 134 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVE 134 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTT
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecce
Confidence 44555566666666666666533 55566666666666666666543 44 566666666666666655544 3335555
Q ss_pred cccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhH
Q 040925 115 SLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSI 194 (833)
Q Consensus 115 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~ 194 (833)
+|.+...++.... +.+..+...+|.+.++|+.+.+.++ +..+.. ..|.++++|+.+++..| ++
T Consensus 135 aF~~~~~~~~~~~--~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~------~~F~~c~~L~~i~l~~~-~~------- 197 (394)
T 4fs7_A 135 AFKGCDFKEITIP--EGVTVIGDEAFATCESLEYVSLPDS-METLHN------GLFSGCGKLKSIKLPRN-LK------- 197 (394)
T ss_dssp TTTTCCCSEEECC--TTCCEECTTTTTTCTTCCEEECCTT-CCEECT------TTTTTCTTCCBCCCCTT-CC-------
T ss_pred eeecccccccccC--ccccccchhhhcccCCCcEEecCCc-cceecc------ccccCCCCceEEEcCCC-ce-------
Confidence 6665543333222 2223355556666666666666543 233332 23555666666655444 22
Q ss_pred hhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCC
Q 040925 195 ANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLA 274 (833)
Q Consensus 195 ~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 274 (833)
.+...+|.++..|+.+.+..+... + .+.+....+|+.+.+..+ ++.+...+|.++..|+
T Consensus 198 ------------------~I~~~~F~~~~~L~~i~~~~~~~~-i-~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~ 256 (394)
T 4fs7_A 198 ------------------IIRDYCFAECILLENMEFPNSLYY-L-GDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLE 256 (394)
T ss_dssp ------------------EECTTTTTTCTTCCBCCCCTTCCE-E-CTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCC
T ss_pred ------------------EeCchhhccccccceeecCCCceE-e-ehhhcccCCCceEEECCC-ceecccccccccccce
Confidence 123344555555555555444332 1 222223345555555433 2224445555666666
Q ss_pred eEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCC
Q 040925 275 NLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSN 354 (833)
Q Consensus 275 ~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N 354 (833)
.+.+..+... +...+|..+..++.+....+.+. ...+.....+ ..+.+.++ ++.+...+|.++.+|+.+++..+
T Consensus 257 ~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L-~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~ 330 (394)
T 4fs7_A 257 SISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSL-TEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL 330 (394)
T ss_dssp EEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTC-CEEEECTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred eEEcCCCcce-eeccccccccccceeccCceeec---cccccccccc-cccccccc-cceechhhhcCCCCCCEEEeCCc
Confidence 6666555433 44555556666655555444322 1112222222 34444433 33355667777778888877644
Q ss_pred cCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceE
Q 040925 355 QFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFL 421 (833)
Q Consensus 355 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 421 (833)
++.+...+|.+|.+|+.+.+..| ++.+...+|.++++|+.+++.++ ++ .....|.++++|+.+
T Consensus 331 -v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 331 -VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp -CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred -ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 66566777888888888888766 66666777888888888877654 33 234566666666653
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.8e-19 Score=208.19 Aligned_cols=178 Identities=22% Similarity=0.224 Sum_probs=105.9
Q ss_pred ccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCC
Q 040925 169 FLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKN 248 (833)
Q Consensus 169 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 248 (833)
.+..+++|+.|+|++|++. .+|..+.++++|++|+|++|+|+ .+|..|+.+++
T Consensus 219 ~~~~l~~L~~L~Ls~n~l~--------------------------~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~ 271 (727)
T 4b8c_D 219 SKYDDQLWHALDLSNLQIF--------------------------NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSN 271 (727)
T ss_dssp ---CCCCCCEEECTTSCCS--------------------------CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTT
T ss_pred hhccCCCCcEEECCCCCCC--------------------------CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCC
Confidence 3556666677777766665 33334446677888888888888 67777888888
Q ss_pred CCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecC
Q 040925 249 LQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLS 328 (833)
Q Consensus 249 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls 328 (833)
|++|+|++|.|+ .+|..|.++++|++|+|++|.|+ .+|..|..+++|+.|+|++|+|++.+|..+.........++|+
T Consensus 272 L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~ 349 (727)
T 4b8c_D 272 LRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLR 349 (727)
T ss_dssp CCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhc
Confidence 888888888888 56888888888888888888887 6677788888888888888888877777765554433457788
Q ss_pred CCccCCCCCcccccCCCcCEEeccCC--------cCCCCCCccccCCCCCcEEeecCCccc
Q 040925 329 NNLLNGSLPLQVGHLKNLVILDISSN--------QFSGVIPGTLSTCVCLEYLDISSNSFH 381 (833)
Q Consensus 329 ~N~l~~~~~~~~~~l~~L~~L~ls~N--------~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 381 (833)
+|.+++.+|. .|+.|+++.| .+.+..+..+..+..+....+++|-+.
T Consensus 350 ~N~l~~~~p~------~l~~l~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~ 404 (727)
T 4b8c_D 350 DNRPEIPLPH------ERRFIEINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC 404 (727)
T ss_dssp HCCCCCCCCC------C-----------------------------------------CCC
T ss_pred cCcccCcCcc------ccceeEeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence 8888877664 4555666666 222233333344444444455555443
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.74 E-value=1.6e-17 Score=162.05 Aligned_cols=128 Identities=20% Similarity=0.274 Sum_probs=60.7
Q ss_pred CEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCc-cccCCCCCcEEECCCcccccccCchhhcCCCCccEEEcc
Q 040925 26 EVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPR-SICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIG 104 (833)
Q Consensus 26 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~ 104 (833)
++|++++|.+ +.+|..+.. +|++|+|++|+|+++.+. .|.++++|++|+|++|+|+ .+++..|.++++|++|+|+
T Consensus 11 ~~l~~s~~~l-~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGL-KEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCC-SSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCc-CcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCC-CcCHhHcCCcccCCEEECC
Confidence 3444444444 233333322 444444444444433332 2444444555555555444 3333444445555555555
Q ss_pred CCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCC
Q 040925 105 GNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLG 157 (833)
Q Consensus 105 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~ 157 (833)
+|+|++..+..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.++
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 139 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc
Confidence 55555444444555555555555555555555555555555555555555543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=3.5e-18 Score=166.56 Aligned_cols=157 Identities=22% Similarity=0.272 Sum_probs=120.6
Q ss_pred ceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecC
Q 040925 298 MSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISS 377 (833)
Q Consensus 298 ~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 377 (833)
+.+++++|.++ .+|..+.. . ++.|++++|.|+ .+|..|.++++|+.|+|++|.|+++.+.+|.++++|++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~~--~-l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIPR--D-VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCCT--T-CCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCCC--C-CCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 34555555555 45544331 2 367888888887 5678899999999999999999988889999999999999999
Q ss_pred CccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCCCcc
Q 040925 378 NSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGID 457 (833)
Q Consensus 378 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~~~ 457 (833)
|+|+++.+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|+|.|.+...+...-+.......+...|..|.
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~l~~l~~~~~~~~~~~~~~~C~~P~ 167 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCNMQWLSDWVKSEYKEPGIARCAGPG 167 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGGGHHHHHHHHHSSCCCSCCBEEESG
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCcCHHHHHHHHhccCCCCCcCcCCch
Confidence 99999888899999999999999999998878889999999999999999999886432111111112233445677766
Q ss_pred cC
Q 040925 458 EL 459 (833)
Q Consensus 458 ~~ 459 (833)
..
T Consensus 168 ~l 169 (193)
T 2wfh_A 168 EM 169 (193)
T ss_dssp GG
T ss_pred HH
Confidence 54
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.4e-16 Score=174.42 Aligned_cols=319 Identities=13% Similarity=0.035 Sum_probs=243.5
Q ss_pred cccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccC
Q 040925 58 KFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVS 137 (833)
Q Consensus 58 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~ 137 (833)
.++.+...+|.++++|+.+.|.. .++ .|+..+|.++++|+.++|..+ ++.+...+|.++.+|+.+.+..+ +..+..
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~ 133 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGV 133 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecc
Confidence 46677888899999999999974 476 788888999999999999765 66677788888888888877654 666788
Q ss_pred cCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCCh
Q 040925 138 IDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPP 217 (833)
Q Consensus 138 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~ 217 (833)
.+|.+...+....... +..+.. ..|.++++|+.+.+.++-.. +...
T Consensus 134 ~aF~~~~~~~~~~~~~--~~~i~~------~aF~~c~~L~~i~l~~~~~~--------------------------I~~~ 179 (394)
T 4fs7_A 134 EAFKGCDFKEITIPEG--VTVIGD------EAFATCESLEYVSLPDSMET--------------------------LHNG 179 (394)
T ss_dssp TTTTTCCCSEEECCTT--CCEECT------TTTTTCTTCCEEECCTTCCE--------------------------ECTT
T ss_pred eeeecccccccccCcc--ccccch------hhhcccCCCcEEecCCccce--------------------------eccc
Confidence 8888776544443332 222222 34677888888877654322 5567
Q ss_pred hhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCcc
Q 040925 218 GIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNL 297 (833)
Q Consensus 218 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 297 (833)
+|.++.+|+.+.+..| +..+...+|.+...|+.+.+..+... +.+.+....+|+.+.+..+ ++.+...+|.++.+|
T Consensus 180 ~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l 255 (394)
T 4fs7_A 180 LFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDL 255 (394)
T ss_dssp TTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSC
T ss_pred cccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccc
Confidence 8899999999999887 66678889999999999998877654 3444555688999999765 344667789999999
Q ss_pred ceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecC
Q 040925 298 MSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISS 377 (833)
Q Consensus 298 ~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 377 (833)
+.+.+..+... .....+.....+ ..+....+.+ ....|..+.+|+.+.+..+ ++.+...+|.+|.+|+.++|.+
T Consensus 256 ~~~~~~~~~~~-i~~~~F~~~~~l-~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~ 329 (394)
T 4fs7_A 256 ESISIQNNKLR-IGGSLFYNCSGL-KKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPY 329 (394)
T ss_dssp CEEEECCTTCE-ECSCTTTTCTTC-CEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCT
T ss_pred eeEEcCCCcce-eecccccccccc-ceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCC
Confidence 99999887654 333344444444 5566665543 3457889999999999875 7768889999999999999975
Q ss_pred CccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccC
Q 040925 378 NSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYN 426 (833)
Q Consensus 378 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N 426 (833)
+ ++.+...+|.++++|+.+++..| ++.+...+|.++++|+.+++..|
T Consensus 330 ~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 330 L-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp T-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred c-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 5 77788899999999999999877 77777889999999999998754
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.3e-17 Score=158.94 Aligned_cols=140 Identities=19% Similarity=0.166 Sum_probs=120.9
Q ss_pred cCCCCCCEEEccCCccc-ccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCc
Q 040925 20 GNLSDLEVIRIMGNSLG-GKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL 98 (833)
Q Consensus 20 ~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L 98 (833)
...++|+.|++++|+++ +.+|..|..+++|++|+|++|.|++. ..|..+++|++|+|++|+++ ...+..+..+++|
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L 97 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIF-GGLDMLAEKLPNL 97 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCC-SCCCHHHHHCTTC
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCc-hHHHHHHhhCCCC
Confidence 34478999999999996 57888899999999999999999865 88999999999999999998 4345667789999
Q ss_pred cEEEccCCcceeeCC-ccccCCCCCcEEEcccCccccccC---cCccCCCcCceEecccccCCCCCCC
Q 040925 99 KALAIGGNNFFGSIP-YSLSNASNLELLDLSVNQFKGNVS---IDFSSLKNLLWLNLEQNNLGTGTAT 162 (833)
Q Consensus 99 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~N~l~~~~~~ 162 (833)
++|+|++|.|++..+ ..|..+++|++|+|++|+++++++ ..|..+++|++|++++|.+..++..
T Consensus 98 ~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 165 (168)
T 2ell_A 98 THLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPDS 165 (168)
T ss_dssp CEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCSS
T ss_pred CEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcccc
Confidence 999999999986432 789999999999999999998776 5889999999999999999876653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=5e-17 Score=158.33 Aligned_cols=128 Identities=27% Similarity=0.369 Sum_probs=99.2
Q ss_pred CEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccC
Q 040925 26 EVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGG 105 (833)
Q Consensus 26 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~ 105 (833)
+++++++|.++ .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|+ .++...|.++++|++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCC-EeCHhHccCCCCCCEEECCC
Confidence 56777777774 4555443 57888888888887 56677888888888888888887 67777778888888888888
Q ss_pred CcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCC
Q 040925 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGT 158 (833)
Q Consensus 106 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 158 (833)
|+|+++.|..|.++++|++|+|++|+|+.+++..|..+++|++|+|++|.+..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 88887777778888888888888888887777778888888888888887754
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=2.9e-17 Score=156.60 Aligned_cols=141 Identities=22% Similarity=0.221 Sum_probs=112.7
Q ss_pred CCCCCEEEcCCCccc-ccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcE
Q 040925 46 LRNLVSLNVAENKFS-GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLEL 124 (833)
Q Consensus 46 l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 124 (833)
.++|++|+|++|.++ +.+|..|..+++|+.|+|++|.++ .+ ..|..+++|++|+|++|++++.+|..+..+++|++
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 99 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTH 99 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-CC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-Ch--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCE
Confidence 478889999999987 567888888899999999999887 44 56778889999999999988767887888889999
Q ss_pred EEcccCccccccC-cCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChh
Q 040925 125 LDLSVNQFKGNVS-IDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHS 193 (833)
Q Consensus 125 L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~ 193 (833)
|+|++|+|++++. ..|..+++|++|+|++|.++..+.. ....+..+++|++|++++|.+. .+|++
T Consensus 100 L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~---~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 100 LNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDY---RESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp EECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTH---HHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred EeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHH---HHHHHHhCccCcEecCCCCChh-hcccc
Confidence 9999999887654 6788888999999999988765430 0124778889999999999887 55543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.68 E-value=2.7e-16 Score=151.22 Aligned_cols=130 Identities=22% Similarity=0.237 Sum_probs=81.3
Q ss_pred CCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEcc
Q 040925 25 LEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIG 104 (833)
Q Consensus 25 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~ 104 (833)
.+.+++++|+++ .+|..+. ++|++|+|++|+++++.+..|.++++|++|+|++|+++ .+|...|.++++|++|+|+
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcce-EeChhHccCCCccCEEECC
Confidence 355666666663 3343332 46666666666666555555666666666666666665 5565666666666666666
Q ss_pred CCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCC
Q 040925 105 GNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGT 158 (833)
Q Consensus 105 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 158 (833)
+|.|++..+..|.++++|++|+|++|+|+++++..|..+++|++|+|++|.+..
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 666665555556666666666666666666666666666667777777666643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=2.5e-17 Score=174.25 Aligned_cols=138 Identities=14% Similarity=0.184 Sum_probs=101.0
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--------------chhH--------HHHHHHHHhhcCCCc
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--------------ASRS--------FVAECEALRNIRHRN 589 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--------------~~~~--------~~~E~~~l~~l~h~n 589 (833)
=|++...||.|++|.||+|.+. +|+.||||+++..... .... ..+|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3899999999999999999986 7999999998632100 0011 234666666665443
Q ss_pred cc--eEeeEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeC
Q 040925 590 LI--KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGD 667 (833)
Q Consensus 590 iv--~~~~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~D 667 (833)
+. ..+++ ...++||||++|++|.++... .....++.|++.||.|||+. ||||||
T Consensus 175 v~vp~p~~~---------~~~~LVME~i~G~~L~~l~~~------------~~~~~l~~qll~~l~~lH~~---gIVHrD 230 (397)
T 4gyi_A 175 FPVPEPIAQ---------SRHTIVMSLVDALPMRQVSSV------------PDPASLYADLIALILRLAKH---GLIHGD 230 (397)
T ss_dssp CSCCCEEEE---------ETTEEEEECCSCEEGGGCCCC------------SCHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCCCeeeec---------cCceEEEEecCCccHhhhccc------------HHHHHHHHHHHHHHHHHHHC---CCcCCC
Confidence 32 22221 123799999999888765432 12356789999999999999 999999
Q ss_pred CCCCCeeecCCC----------cEEEcccccccccCc
Q 040925 668 LKPSNVLLDHDM----------VAHVCDFGLAKFLSD 694 (833)
Q Consensus 668 lkp~NIll~~~~----------~~kL~DfG~a~~~~~ 694 (833)
|||.|||+++++ .+.|+||+-+.....
T Consensus 231 LKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 231 FNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp CSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CCHHHEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence 999999998776 389999998875443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=7.2e-17 Score=150.45 Aligned_cols=130 Identities=22% Similarity=0.255 Sum_probs=112.5
Q ss_pred CCCCCCEEEccCCccc-ccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCcc
Q 040925 21 NLSDLEVIRIMGNSLG-GKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLK 99 (833)
Q Consensus 21 ~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~ 99 (833)
..++|+.|++++|.++ +.+|..++.+++|++|+|++|.+++. ..|.++++|++|+|++|++++.+ +..+..+++|+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~-~~~~~~l~~L~ 91 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGL-EVLAEKCPNLT 91 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCT-HHHHHHCTTCC
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchH-HHHhhhCCCCC
Confidence 3468999999999997 58888899999999999999999865 78999999999999999998434 45667899999
Q ss_pred EEEccCCcceee-CCccccCCCCCcEEEcccCccccccC---cCccCCCcCceEeccc
Q 040925 100 ALAIGGNNFFGS-IPYSLSNASNLELLDLSVNQFKGNVS---IDFSSLKNLLWLNLEQ 153 (833)
Q Consensus 100 ~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~i~~~~~---~~~~~l~~L~~L~L~~ 153 (833)
+|+|++|.+++. .+..+..+++|++|++++|+++++++ ..|..+++|++|++++
T Consensus 92 ~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 999999999864 34789999999999999999998877 6789999999999864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=4.2e-16 Score=149.92 Aligned_cols=132 Identities=20% Similarity=0.259 Sum_probs=81.3
Q ss_pred CCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcc
Q 040925 49 LVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLS 128 (833)
Q Consensus 49 L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 128 (833)
.+.+++++|+++ .+|..+. ++|+.|++++|+++ .+|...|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 355666666666 3343332 46666666666665 5565666666666666666666665555556666666666666
Q ss_pred cCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccC
Q 040925 129 VNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGEL 190 (833)
Q Consensus 129 ~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 190 (833)
+|+|+++++..|..+++|++|+|++|.++.++.. .+..+++|++|+|++|.+.+..
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~------~~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDG------IFDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT------TTTTCTTCCEEECCSSCBCCCH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHH------HhcCCcccCEEEecCCCeeccC
Confidence 6666666666666666666666666666654432 2455666666666666666443
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.67 E-value=8.8e-17 Score=149.85 Aligned_cols=132 Identities=19% Similarity=0.173 Sum_probs=94.2
Q ss_pred CCCCCEEEcCCCccc-ccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcE
Q 040925 46 LRNLVSLNVAENKFS-GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLEL 124 (833)
Q Consensus 46 l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 124 (833)
.++|++|++++|.++ +..|..+..+++|+.|++++|.++ .+ ..|..+++|++|+|++|.+++.+|..+..+++|++
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~-~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCC-CC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCC-Cc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 366778888888877 566777777888888888888776 44 45677778888888888887666777777778888
Q ss_pred EEcccCcccccc-CcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccC
Q 040925 125 LDLSVNQFKGNV-SIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLAD 183 (833)
Q Consensus 125 L~L~~N~i~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 183 (833)
|++++|+|++++ +..|..+++|++|++++|.++..+.. ....+..+++|++|++++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~---~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDY---RENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTH---HHHHHHHCTTCCEETTBC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHH---HHHHHHHCCCcccccCCC
Confidence 888888877653 35677778888888888877654420 012356677788877763
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.64 E-value=2.3e-16 Score=151.45 Aligned_cols=134 Identities=15% Similarity=0.208 Sum_probs=89.5
Q ss_pred ccccCCCCCCEEEccCCcccccCCccCCCC-CCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCC
Q 040925 17 DFVGNLSDLEVIRIMGNSLGGKIPTTLGLL-RNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNL 95 (833)
Q Consensus 17 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l 95 (833)
..+.++.+|+.|++++|+++. +|. +..+ ++|++|+|++|.|+++ ..|.++++|++|+|++|+|+ .+|+.+|..+
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l 87 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQAL 87 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHC
T ss_pred HhcCCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCccc-ccCcchhhcC
Confidence 346667778888888888853 344 4443 3788888888887754 56777777777777777776 6666666777
Q ss_pred CCccEEEccCCcceeeCCc--cccCCCCCcEEEcccCccccccCc---CccCCCcCceEecccccC
Q 040925 96 PNLKALAIGGNNFFGSIPY--SLSNASNLELLDLSVNQFKGNVSI---DFSSLKNLLWLNLEQNNL 156 (833)
Q Consensus 96 ~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~i~~~~~~---~~~~l~~L~~L~L~~N~l 156 (833)
++|++|+|++|.|+ .+|. .+..+++|++|+|++|.++.++.. .+..+++|++|++++|.+
T Consensus 88 ~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 88 PDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp TTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCH
Confidence 77777777777775 3443 667777777777777777654332 355555555555555544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.62 E-value=3.1e-14 Score=155.66 Aligned_cols=130 Identities=12% Similarity=0.087 Sum_probs=62.5
Q ss_pred ccccCCC-CCCEEEccCCcccccCCccCCCCCCCCEEEcCCCc---ccccCCccccCCCCCcEEECCCcccccccCchhh
Q 040925 17 DFVGNLS-DLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENK---FSGMFPRSICNISSLELIQLALNRFSGNLPFDIV 92 (833)
Q Consensus 17 ~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~---i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 92 (833)
.+|.++. .|+.+.+..+ ++.+...+|.++.+|+.+.+.+|. ++.+...+|.++.+|+.+.+..+ ++ .++..+|
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~-~I~~~aF 133 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VT-EIDSEAF 133 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CS-EECTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cc-eehhhhh
Confidence 3444442 3555555432 444555555555555555555442 44444555555555555544432 33 4445555
Q ss_pred cCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecc
Q 040925 93 VNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLE 152 (833)
Q Consensus 93 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~ 152 (833)
.+..+|+.+.+..+ +..+....|..+.+|+.+.+..+ ++.+...+|.. .+|+.+.+.
T Consensus 134 ~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip 190 (394)
T 4gt6_A 134 HHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIP 190 (394)
T ss_dssp TTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEEC
T ss_pred hhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEEC
Confidence 55555555555433 22244445555555555555433 33444445543 345555444
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.60 E-value=6.9e-14 Score=152.94 Aligned_cols=322 Identities=11% Similarity=0.096 Sum_probs=176.0
Q ss_pred ccccCCccCCCCC-CCCEEEcCCCcccccCCccccCCCCCcEEECCCcc---cccccCchhhcCCCCccEEEccCCccee
Q 040925 35 LGGKIPTTLGLLR-NLVSLNVAENKFSGMFPRSICNISSLELIQLALNR---FSGNLPFDIVVNLPNLKALAIGGNNFFG 110 (833)
Q Consensus 35 l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~---l~~~~~~~~~~~l~~L~~L~L~~N~l~~ 110 (833)
++.+...+|..+. .|+.+.+-++ ++.+...+|.++++|+.+.++.|. ++ .|+..+|.+..+|+.+.+..+ ++.
T Consensus 51 Vt~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~aF~~c~~L~~i~~~~~-~~~ 127 (394)
T 4gt6_A 51 VSKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQAFMFCSELTDIPILDS-VTE 127 (394)
T ss_dssp EEEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTTTTTTCTTCCBCGGGTT-CSE
T ss_pred eeEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeee-EechhhchhcccceeeccCCc-cce
Confidence 4455566777663 5777777654 666777778888888888777664 55 677777777777777777655 444
Q ss_pred eCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccC
Q 040925 111 SIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGEL 190 (833)
Q Consensus 111 ~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 190 (833)
+...+|.++.+|+.+.+..+ +..+....|....+|+.+.+..+ ++.+...+ |. ..+|+.+.+..+-..
T Consensus 128 I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~a------F~-~~~l~~i~ip~~~~~--- 195 (394)
T 4gt6_A 128 IDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERA------FT-GTALTQIHIPAKVTR--- 195 (394)
T ss_dssp ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTT------TT-TCCCSEEEECTTCCE---
T ss_pred ehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEecccc------cc-ccceeEEEECCcccc---
Confidence 66677777777777777643 45577777777777777777644 44444332 22 245666655443222
Q ss_pred ChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCcccc-------------CCCCCCEEEcccc
Q 040925 191 PHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIG-------------ELKNLQKLCLFRN 257 (833)
Q Consensus 191 p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-------------~l~~L~~L~L~~N 257 (833)
+...+|.++.++.......+.........+. ....+..+.+. +
T Consensus 196 -----------------------i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~ 251 (394)
T 4gt6_A 196 -----------------------IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-N 251 (394)
T ss_dssp -----------------------ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-T
T ss_pred -----------------------cccchhhhccccceecccccccccccceeecccccccccccccccccccceEEcC-C
Confidence 3344555555555555554443321111111 11223333332 1
Q ss_pred cCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCC
Q 040925 258 FLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLP 337 (833)
Q Consensus 258 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~ 337 (833)
.++.+...+|.++..|+.+.+.++... +...+|.++++|+.+.+. +.++.+..
T Consensus 252 ~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~--------------------------~~i~~I~~ 304 (394)
T 4gt6_A 252 GVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS--------------------------SRITELPE 304 (394)
T ss_dssp TEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC--------------------------TTCCEECT
T ss_pred cceEcccceeeecccccEEecccccce-ecCcccccccccccccCC--------------------------CcccccCc
Confidence 222233444555555555555443322 334445555555444432 12222344
Q ss_pred cccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCC
Q 040925 338 LQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSV 417 (833)
Q Consensus 338 ~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~ 417 (833)
.+|.++.+|+.+++..+ ++.+...+|.+|.+|+.+.|..+ ++.+...+|.++++|+.+++.+|... -..+.....
T Consensus 305 ~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~ 379 (394)
T 4gt6_A 305 SVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSG 379 (394)
T ss_dssp TTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCC
T ss_pred eeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCC
Confidence 55666667777776643 55455666777777777777543 55555666777777777777666543 134555566
Q ss_pred CceEECccCc
Q 040925 418 LEFLSLSYNH 427 (833)
Q Consensus 418 L~~L~l~~N~ 427 (833)
|+.+.+..|.
T Consensus 380 L~~i~i~~~~ 389 (394)
T 4gt6_A 380 LQNLPVAPGS 389 (394)
T ss_dssp C---------
T ss_pred CCEEEeCCCC
Confidence 6666655443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=1.3e-15 Score=146.30 Aligned_cols=130 Identities=18% Similarity=0.195 Sum_probs=112.9
Q ss_pred CcEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 1 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
|++|++++|+++. +|......++|+.|++++|+|++. ..|+.+++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus 21 L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 97 (176)
T 1a9n_A 21 DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97 (176)
T ss_dssp CEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCS
T ss_pred ceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCC
Confidence 6899999999994 565444445999999999999765 6899999999999999999977667779999999999999
Q ss_pred cccccccCc-hhhcCCCCccEEEccCCcceeeCCc----cccCCCCCcEEEcccCccccc
Q 040925 81 NRFSGNLPF-DIVVNLPNLKALAIGGNNFFGSIPY----SLSNASNLELLDLSVNQFKGN 135 (833)
Q Consensus 81 N~l~~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~----~~~~l~~L~~L~L~~N~i~~~ 135 (833)
|+++ .+|. ..+..+++|++|+|++|.++ ..|. .+..+++|++||+++|.+...
T Consensus 98 N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~~ 155 (176)
T 1a9n_A 98 NSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKER 155 (176)
T ss_dssp CCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred CcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence 9997 7775 56789999999999999998 4565 499999999999999998743
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.56 E-value=9.3e-15 Score=139.06 Aligned_cols=109 Identities=21% Similarity=0.273 Sum_probs=89.7
Q ss_pred eeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCc
Q 040925 323 LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402 (833)
Q Consensus 323 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 402 (833)
+.+++++|.++ .+|..+ .++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++.+..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccC--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 45778888877 455544 378888888888888888888888888888888888888877777888888888888888
Q ss_pred ccCCCchhhhcCCCCCceEECccCcCccccCC
Q 040925 403 NLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 403 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
+|++..+..|..+++|+.|+|++|+|+|.++.
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~ 120 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSD 120 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGG
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchh
Confidence 88877777788888899999999988888763
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=2.4e-17 Score=161.71 Aligned_cols=161 Identities=19% Similarity=0.204 Sum_probs=102.6
Q ss_pred ccCCCCCCEEEccCCcccccCCc------cCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhh
Q 040925 19 VGNLSDLEVIRIMGNSLGGKIPT------TLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIV 92 (833)
Q Consensus 19 ~~~l~~L~~L~l~~n~l~~~~~~------~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 92 (833)
+.....++.++++++.+.+..|. .|+.+++|++|+|++|++++ +| .|.++++|++|+|++|+++ .+|. .+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~-~~ 89 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIEN-LD 89 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSS-HH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccc-hh
Confidence 34445566666666666665555 67777777777777777774 45 6777777777777777776 5664 44
Q ss_pred cCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccC-cCccCCCcCceEecccccCCCCCCCC----cccc
Q 040925 93 VNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVS-IDFSSLKNLLWLNLEQNNLGTGTATD----LDFV 167 (833)
Q Consensus 93 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~~ 167 (833)
..+++|++|+|++|++++ +| .+..+++|++|+|++|+|+.++. ..+..+++|++|++++|.++...+.. ....
T Consensus 90 ~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~ 167 (198)
T 1ds9_A 90 AVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI 167 (198)
T ss_dssp HHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHH
T ss_pred hcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHH
Confidence 556777777777777764 33 46677777777777777776544 45667777777777777764421110 0001
Q ss_pred cccCCCCCCCEEEccCCcCc
Q 040925 168 TFLTNCSSLKALSLADNQFG 187 (833)
Q Consensus 168 ~~l~~l~~L~~L~Ls~N~l~ 187 (833)
..+..+++|+.|| +|.++
T Consensus 168 ~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 168 EVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHHHCSSCSEEC--CGGGT
T ss_pred HHHHhCCCcEEEC--CcccC
Confidence 2256677777776 66655
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.54 E-value=2.4e-14 Score=136.20 Aligned_cols=108 Identities=19% Similarity=0.266 Sum_probs=90.0
Q ss_pred CCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEc
Q 040925 24 DLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI 103 (833)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 103 (833)
..+.|++++|+++ .+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|..+|.++++|++|+|
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L 85 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSL 85 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCCCCCEEEC
Confidence 4578888888884 4666553 78888899999888888888888899999999999888 788888888999999999
Q ss_pred cCCcceeeCCccccCCCCCcEEEcccCccccc
Q 040925 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKGN 135 (833)
Q Consensus 104 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 135 (833)
++|+|+++.+..|.++++|++|+|++|.+...
T Consensus 86 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 86 NDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 99999877777788999999999999988743
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.9e-14 Score=137.29 Aligned_cols=109 Identities=22% Similarity=0.282 Sum_probs=90.3
Q ss_pred eeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCc
Q 040925 323 LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402 (833)
Q Consensus 323 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 402 (833)
..+++++|.++ .+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+++++..|..+++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45788888887 5565553 78888999999988888888888889999999999988877777888889999999999
Q ss_pred ccCCCchhhhcCCCCCceEECccCcCccccCC
Q 040925 403 NLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 403 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
+|++..+..|..+++|+.|+|++|+|.+.++.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~ 123 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRD 123 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGG
T ss_pred ccceeCHHHhccccCCCEEEeCCCCccccccc
Confidence 99877777788889999999999998887763
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.53 E-value=3.9e-14 Score=135.16 Aligned_cols=107 Identities=15% Similarity=0.247 Sum_probs=92.7
Q ss_pred CCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEcc
Q 040925 25 LEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIG 104 (833)
Q Consensus 25 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~ 104 (833)
-+.+++++|++ +.+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|..+|.++++|++|+|+
T Consensus 14 ~~~l~~~~n~l-~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~ 89 (174)
T 2r9u_A 14 QTLVNCQNIRL-ASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLN 89 (174)
T ss_dssp SSEEECCSSCC-SSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECC
T ss_pred CcEEEeCCCCC-CccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEECC
Confidence 47889999999 56676664 88999999999999888889999999999999999998 7888888899999999999
Q ss_pred CCcceeeCCccccCCCCCcEEEcccCccccc
Q 040925 105 GNNFFGSIPYSLSNASNLELLDLSVNQFKGN 135 (833)
Q Consensus 105 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~ 135 (833)
+|+|+++.+..|..+++|++|+|++|.+...
T Consensus 90 ~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~ 120 (174)
T 2r9u_A 90 DNHLKSIPRGAFDNLKSLTHIYLYNNPWDCE 120 (174)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred CCccceeCHHHhccccCCCEEEeCCCCcccc
Confidence 9999877777799999999999999998743
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.2e-16 Score=156.64 Aligned_cols=135 Identities=25% Similarity=0.316 Sum_probs=70.3
Q ss_pred hhcCCCCCeEeccCCcccccCCc------cccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCC
Q 040925 219 IRNLVNLIGFGAEENQLHGTIPD------AIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLG 292 (833)
Q Consensus 219 ~~~l~~L~~L~L~~N~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 292 (833)
+.....++.++++.+.+.+..|. .|..+++|++|+|++|.+++ +| .+.++++|++|+|++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 45555666666666666655554 55555666666666666554 33 5555555555555555555 3333333
Q ss_pred CCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCC-ccccCCCCCc
Q 040925 293 NCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIP-GTLSTCVCLE 371 (833)
Q Consensus 293 ~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~-~~~~~l~~L~ 371 (833)
.+++|+.|++++|+++ + +| .+..+++|++|++++|++++..+ ..+..+++|+
T Consensus 91 ~~~~L~~L~L~~N~l~-------------------------~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~ 143 (198)
T 1ds9_A 91 VADTLEELWISYNQIA-------------------------S-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLE 143 (198)
T ss_dssp HHHHCSEEEEEEEECC-------------------------C-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCS
T ss_pred cCCcCCEEECcCCcCC-------------------------c-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCC
Confidence 3444444444444333 2 12 34445555566666665553322 3455555555
Q ss_pred EEeecCCccccc
Q 040925 372 YLDISSNSFHGV 383 (833)
Q Consensus 372 ~L~Ls~N~l~~~ 383 (833)
+|++++|.+++.
T Consensus 144 ~L~l~~N~l~~~ 155 (198)
T 1ds9_A 144 DLLLAGNPLYND 155 (198)
T ss_dssp EEEECSCHHHHH
T ss_pred EEEecCCccccc
Confidence 555555555544
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.42 E-value=1.8e-13 Score=147.06 Aligned_cols=131 Identities=22% Similarity=0.189 Sum_probs=105.8
Q ss_pred eeecCCC-ccCCCCCcccccCCCcCEEeccC-CcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccC
Q 040925 324 YLDLSNN-LLNGSLPLQVGHLKNLVILDISS-NQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSS 401 (833)
Q Consensus 324 ~L~ls~N-~l~~~~~~~~~~l~~L~~L~ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~ 401 (833)
.++++++ +|+ .+|. +..+++|+.|+|++ |.|+++++..|.++++|+.|+|++|+|++++|..|..+++|+.|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4678887 788 4666 88899999999996 999988888999999999999999999999898999999999999999
Q ss_pred cccCCCchhhhcCCCCCceEECccCcCccccCCCC--ccCCCccccccCCcCCCCCcc
Q 040925 402 NNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKG--VFSNKTKISLQGNMKLCGGID 457 (833)
Q Consensus 402 N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~--~~~~~~~l~l~~N~~~c~~~~ 457 (833)
|+|++.++..+..++ |+.|+|++|+|.|.|...+ .|.......+..+...|..+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~ 146 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG 146 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence 999987777777776 9999999999999886431 122223334555677787665
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.42 E-value=4.5e-15 Score=159.84 Aligned_cols=144 Identities=19% Similarity=0.153 Sum_probs=66.8
Q ss_pred CCccEEEccCCcceeeCCccc-cCCCCCcEEEcccCccccccCcCc-----cCCCcCceEecccccCCCCCCCCcccccc
Q 040925 96 PNLKALAIGGNNFFGSIPYSL-SNASNLELLDLSVNQFKGNVSIDF-----SSLKNLLWLNLEQNNLGTGTATDLDFVTF 169 (833)
Q Consensus 96 ~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~i~~~~~~~~-----~~l~~L~~L~L~~N~l~~~~~~~~~~~~~ 169 (833)
++|++|+|++|.|+......+ ..+++|++|+|++|+|+......+ ...++|++|+|++|.|+..... .+...
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~--~l~~~ 178 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVA--VLMEG 178 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHH--HHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHH--HHHHH
Confidence 344444444444432211111 123345555555555543333322 1234555555555555432111 12233
Q ss_pred cCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCccccc----CCccccC
Q 040925 170 LTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGT----IPDAIGE 245 (833)
Q Consensus 170 l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~ 245 (833)
+..+++|++|+|++|+|+...... +...+...++|+.|+|++|.|+.. ++.++..
T Consensus 179 L~~~~~L~~L~Ls~N~l~~~g~~~---------------------L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~ 237 (372)
T 3un9_A 179 LAGNTSVTHLSLLHTGLGDEGLEL---------------------LAAQLDRNRQLQELNVAYNGAGDTAALALARAARE 237 (372)
T ss_dssp HHTCSSCCEEECTTSSCHHHHHHH---------------------HHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHH
T ss_pred HhcCCCcCEEeCCCCCCCcHHHHH---------------------HHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHh
Confidence 445666667777777665322111 122334445566666666665532 2233344
Q ss_pred CCCCCEEEcccccCccc
Q 040925 246 LKNLQKLCLFRNFLQGR 262 (833)
Q Consensus 246 l~~L~~L~L~~N~l~~~ 262 (833)
.++|++|+|++|.|++.
T Consensus 238 ~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 238 HPSLELLHLYFNELSSE 254 (372)
T ss_dssp CSSCCEEECTTSSCCHH
T ss_pred CCCCCEEeccCCCCCHH
Confidence 56666666666666643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.42 E-value=2.2e-11 Score=132.41 Aligned_cols=167 Identities=12% Similarity=0.122 Sum_probs=104.5
Q ss_pred hhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccc
Q 040925 219 IRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLM 298 (833)
Q Consensus 219 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 298 (833)
+.....+..+.+..+.-. +...+|....+|+.+.+..+ +..+...+|.++..|+.+.+..+ ++.+...+|.++.+|+
T Consensus 190 ~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~ 266 (379)
T 4h09_A 190 YPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALK 266 (379)
T ss_dssp CCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCC
T ss_pred ccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhc
Confidence 444445555555444332 55566777777887777654 44466677777788888888765 5556667777777777
Q ss_pred eeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCC
Q 040925 299 SFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSN 378 (833)
Q Consensus 299 ~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 378 (833)
.+.+..+ ++ .+...+|.++.+|+.+.+.++.++.+...+|.+|.+|+.+.|..+
T Consensus 267 ~i~l~~~-i~-------------------------~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 267 TLNFYAK-VK-------------------------TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp EEEECCC-CS-------------------------EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred ccccccc-ce-------------------------eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 6665332 21 123345666677777777777676666677777777777777544
Q ss_pred ccccccCccccCCCCCCeEEccCcccCCCchhhhcCCC
Q 040925 379 SFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLS 416 (833)
Q Consensus 379 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~ 416 (833)
++.+...+|.++++|+.+.+..+ ++.+-..+|.+..
T Consensus 321 -l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 321 -LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp -CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTSS
T ss_pred -ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCCC
Confidence 55566667777777777776544 5545555665553
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=99.41 E-value=1.7e-11 Score=133.21 Aligned_cols=147 Identities=13% Similarity=0.088 Sum_probs=72.6
Q ss_pred CChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCC
Q 040925 215 IPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNC 294 (833)
Q Consensus 215 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 294 (833)
....+....+|+.+.+..+ +..+...+|.+..+|+.+.+..+ ++.+...+|.++.+|+.+.+..+ +..+...+|.++
T Consensus 209 ~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c 285 (379)
T 4h09_A 209 TAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGC 285 (379)
T ss_dssp CTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTC
T ss_pred eecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccc
Confidence 3444555555555555443 33344455555555555555444 33344455555555555555433 333444455555
Q ss_pred CccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEe
Q 040925 295 QNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLD 374 (833)
Q Consensus 295 ~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~ 374 (833)
++|+.+.+.++.++ .+...+|.++.+|+.++|..+ ++.+...+|.+|.+|+.+.
T Consensus 286 ~~L~~i~l~~~~i~-------------------------~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ 339 (379)
T 4h09_A 286 SNLTKVVMDNSAIE-------------------------TLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTIS 339 (379)
T ss_dssp TTCCEEEECCTTCC-------------------------EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCC
T ss_pred cccccccccccccc-------------------------eehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEE
Confidence 55554444333322 123344555555555555433 4444455555555555555
Q ss_pred ecCCccccccCccccCC
Q 040925 375 ISSNSFHGVIPLSLSFL 391 (833)
Q Consensus 375 Ls~N~l~~~~~~~~~~l 391 (833)
+..+ ++.+...+|.+.
T Consensus 340 ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 340 YPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CCTT-CCEECTTTTTTS
T ss_pred ECCc-cCEEchhHhhCC
Confidence 5433 444444555444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.1e-14 Score=156.97 Aligned_cols=173 Identities=16% Similarity=0.145 Sum_probs=79.8
Q ss_pred CCCCEEEcCCCcccccCCccccCC-----CCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccc-----
Q 040925 47 RNLVSLNVAENKFSGMFPRSICNI-----SSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL----- 116 (833)
Q Consensus 47 ~~L~~L~L~~n~i~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~----- 116 (833)
++|++|+|++|.|+......|..+ ++|+.|+|++|.+++.-...++..+++|++|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 345555555555553333332222 4555555555555422222233334455555555555543322222
Q ss_pred cCCCCCcEEEcccCccccccCcC----ccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCCh
Q 040925 117 SNASNLELLDLSVNQFKGNVSID----FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPH 192 (833)
Q Consensus 117 ~~l~~L~~L~L~~N~i~~~~~~~----~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~ 192 (833)
...++|++|+|++|.|+...... +...++|++|+|++|.|+..... .+...+...++|++|+|++|.|+.....
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~--~L~~~L~~~~~L~~L~Ls~N~i~~~g~~ 229 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLE--LLAAQLDRNRQLQELNVAYNGAGDTAAL 229 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHH--HHHHHGGGCSCCCEEECCSSCCCHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHH--HHHHHHhcCCCcCeEECCCCCCCHHHHH
Confidence 23455556666666554322222 24455556666666555432111 1123344455566666666666543322
Q ss_pred hHhhh---cccccEEEccCccccccCChhhhc
Q 040925 193 SIANL---SSTVINFGIGRNQISGTIPPGIRN 221 (833)
Q Consensus 193 ~~~~l---~~~l~~L~l~~n~i~~~~~~~~~~ 221 (833)
.+... ...++.|+|++|.|+......+..
T Consensus 230 ~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~ 261 (372)
T 3un9_A 230 ALARAAREHPSLELLHLYFNELSSEGRQVLRD 261 (372)
T ss_dssp HHHHHHHHCSSCCEEECTTSSCCHHHHHHHHH
T ss_pred HHHHHHHhCCCCCEEeccCCCCCHHHHHHHHH
Confidence 22221 123556666666665444444443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.7e-12 Score=139.36 Aligned_cols=105 Identities=18% Similarity=0.162 Sum_probs=83.0
Q ss_pred CEEEccCC-cccccCCccCCCCCCCCEEEcCC-CcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEc
Q 040925 26 EVIRIMGN-SLGGKIPTTLGLLRNLVSLNVAE-NKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI 103 (833)
Q Consensus 26 ~~L~l~~n-~l~~~~~~~~~~l~~L~~L~L~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 103 (833)
..++++++ +|+ .+|. |..+++|++|+|++ |+|+++.+.+|.++++|+.|+|++|+|+ .+++.+|.++++|++|+|
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGGGSCSCCCEEEC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccc-eeCHHHhcCCcCCCEEeC
Confidence 34677777 774 4666 88888888888885 8888777788888888888888888887 677778888888888888
Q ss_pred cCCcceeeCCccccCCCCCcEEEcccCcccc
Q 040925 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKG 134 (833)
Q Consensus 104 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~ 134 (833)
++|+|+++.+..|..++ |++|+|.+|++..
T Consensus 88 ~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 88888876666676666 8888888888874
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.33 E-value=7.3e-12 Score=128.65 Aligned_cols=148 Identities=17% Similarity=0.173 Sum_probs=115.3
Q ss_pred HHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCC
Q 040925 525 ELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFK 603 (833)
Q Consensus 525 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 603 (833)
.+....++|++....+.|+.+.||++... +..+++|+...........+.+|+++++.+. +..+.++++++...+
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~-- 83 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG-- 83 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT--
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCC--
Confidence 34556678999999999999999999764 6789999986533233457899999999995 677889998875543
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC------------------------
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC------------------------ 659 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------------------------ 659 (833)
..|+||||++|.++.+.... ......++.+++++++.||+..
T Consensus 84 ---~~~lv~e~i~G~~l~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (263)
T 3tm0_A 84 ---WSNLLMSEADGVLCSEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNND 149 (263)
T ss_dssp ---EEEEEEECCSSEEHHHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTT
T ss_pred ---ceEEEEEecCCeehhhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcc
Confidence 78999999999999876321 1123467889999999999810
Q ss_pred --------------------------------CCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 660 --------------------------------QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 660 --------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
.+.++|+|++|.||+++++..+.|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 150 LADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876566799999875
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.13 E-value=1.1e-10 Score=119.74 Aligned_cols=139 Identities=14% Similarity=0.099 Sum_probs=100.2
Q ss_pred HhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCc--cceEeeEeecCCCCCCc
Q 040925 529 ATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRN--LIKIITICSSTDFKGTD 606 (833)
Q Consensus 529 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~ 606 (833)
...+|.+....+.|..+.||++... +|..+++|+.... ....+.+|+++++.+.+.+ +.+++++.... +
T Consensus 18 ~~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-----~ 88 (264)
T 1nd4_A 18 RLFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-----G 88 (264)
T ss_dssp TTTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-----S
T ss_pred hcCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-----C
Confidence 3445665444446667999999764 6778999997533 3356889999999996544 55688875443 3
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC---------------------------
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC--------------------------- 659 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--------------------------- 659 (833)
..++||||++|.++. ... .+ ...++.++++.++.||+..
T Consensus 89 ~~~~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (264)
T 1nd4_A 89 RDWLLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVD 154 (264)
T ss_dssp CEEEEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCC
T ss_pred CCEEEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCcc
Confidence 689999999998884 211 11 1256778888888888751
Q ss_pred ----------------------------CCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 660 ----------------------------QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 660 ----------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
.+.++|+|++|.||++++++.+.|+|||.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 155 QDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.03 E-value=6.8e-10 Score=119.52 Aligned_cols=145 Identities=14% Similarity=0.206 Sum_probs=107.4
Q ss_pred cCceeccCcceEEEEEEECCCceEEEEEEee--ccCC-cchhHHHHHHHHHhhcC--CCccceEeeEeecCCCCCCceEe
Q 040925 535 SSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN--LKYK-GASRSFVAECEALRNIR--HRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 535 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
..+.++.|.++.||++... +..+++|+.. .... .....+.+|+++++.+. +..+.++++++.+... .+..+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~ 117 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAF 117 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeE
Confidence 4578899999999999875 4578888875 3221 22457889999999997 4568889888765431 23578
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC------------------------------
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC------------------------------ 659 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~------------------------------ 659 (833)
+||||++|.++.+.... .++..+...++.++++.|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~~~--------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQSLP--------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS 189 (359)
T ss_dssp EEEECCCCBCCCCTTCT--------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred EEEEecCCeecCCCccc--------cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence 99999998777542211 4678888999999999999999731
Q ss_pred -------------------------CCCceeeCCCCCCeeecCCCc--EEEcccccccc
Q 040925 660 -------------------------QPPMVHGDLKPSNVLLDHDMV--AHVCDFGLAKF 691 (833)
Q Consensus 660 -------------------------~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~ 691 (833)
.+.++|+|++|.||+++.++. +.|+||+.+..
T Consensus 190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.95 E-value=8.7e-10 Score=117.42 Aligned_cols=164 Identities=21% Similarity=0.259 Sum_probs=95.7
Q ss_pred hhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCcc--CCCcCceEeccc--ccCC-CCCCCCc
Q 040925 90 DIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFS--SLKNLLWLNLEQ--NNLG-TGTATDL 164 (833)
Q Consensus 90 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~--~l~~L~~L~L~~--N~l~-~~~~~~~ 164 (833)
.++..+|+|+.|+|++|.-. ..+. +. +++|++|+|..|.+.......+. .+++|+.|+|+. |... .....++
T Consensus 166 ~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 166 PVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 44567788888888777311 1222 33 77888888888877643333333 678888888753 2211 1001111
Q ss_pred cccccc--CCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccC---
Q 040925 165 DFVTFL--TNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI--- 239 (833)
Q Consensus 165 ~~~~~l--~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~--- 239 (833)
...+ ..+++|++|+|++|.++...+..++.. ..+++|+.|+|+.|.+.+..
T Consensus 243 --~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a----------------------~~~~~L~~LdLs~n~L~d~G~~~ 298 (362)
T 2ra8_A 243 --RPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES----------------------DILPQLETMDISAGVLTDEGARL 298 (362)
T ss_dssp --GGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHC----------------------SSGGGCSEEECCSSCCBHHHHHH
T ss_pred --HHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhC----------------------ccCCCCCEEECCCCCCChHHHHH
Confidence 1112 247899999999998875443333321 13567777777777776532
Q ss_pred -CccccCCCCCCEEEcccccCcccCCccccC-CCCCCeEEeeccc
Q 040925 240 -PDAIGELKNLQKLCLFRNFLQGRIPSGLGN-LTKLANLELSSNS 282 (833)
Q Consensus 240 -~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~ 282 (833)
+..+..+++|+.|+|++|.|+...-..+.. + ...+++++++
T Consensus 299 L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 299 LLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 223345677888888888776443333332 2 3557777776
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.91 E-value=8e-10 Score=117.68 Aligned_cols=186 Identities=17% Similarity=0.151 Sum_probs=107.1
Q ss_pred hhhcCCCCCeEeccCCccc---------ccCCccccCCCCCCEEEccccc-CcccCCccccCCCCCCeEEeecccccCCC
Q 040925 218 GIRNLVNLIGFGAEENQLH---------GTIPDAIGELKNLQKLCLFRNF-LQGRIPSGLGNLTKLANLELSSNSLQGNI 287 (833)
Q Consensus 218 ~~~~l~~L~~L~L~~N~l~---------~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 287 (833)
+...+++|+.|.+..+... +.+...+..+++|+.|+|++|. +. ++. +. +++|+.|+|..|.+....
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~--l~~-~~-~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLS--IGK-KP-RPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCB--CCS-CB-CTTCSEEEEECSBCCHHH
T ss_pred hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCce--ecc-cc-CCCCcEEEEecCCCChHH
Confidence 3455667777777654321 1233455677788888887773 22 222 33 677888888777765332
Q ss_pred CCCCC--CCCccceeecCCc--eecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCcc
Q 040925 288 PSSLG--NCQNLMSFTASQN--KLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGT 363 (833)
Q Consensus 288 ~~~~~--~l~~L~~L~l~~N--~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~ 363 (833)
...+. .+++|+.|+|+.+ ...+. ..+..+..+ +. -..+++|+.|+|++|.+.+..+..
T Consensus 210 l~~l~~~~lp~L~~L~L~~~~~~~~~~--~~~~~l~~~--------------l~--~~~~p~Lr~L~L~~~~i~~~~~~~ 271 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLYVGVEDYGFD--GDMNVFRPL--------------FS--KDRFPNLKWLGIVDAEEQNVVVEM 271 (362)
T ss_dssp HHHHHHSBCTTCCEEEEECBCGGGTCC--SCGGGTGGG--------------SC--TTTCTTCCEEEEESCTTHHHHHHH
T ss_pred HHHHHHccCCCCcEEEEeccccccccc--hhHHHHHHH--------------Hh--cCCCCCcCEEeCCCCCCchHHHHH
Confidence 22332 5677777776421 11100 000000000 00 024678888888888886433223
Q ss_pred cc---CCCCCcEEeecCCcccccc----CccccCCCCCCeEEccCcccCCCchhhhcC-CCCCceEECccCc
Q 040925 364 LS---TCVCLEYLDISSNSFHGVI----PLSLSFLKSIKELNVSSNNLSGQIPEFLKN-LSVLEFLSLSYNH 427 (833)
Q Consensus 364 ~~---~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~-l~~L~~L~l~~N~ 427 (833)
+. .+++|+.|+|+.|.|.+.. +..+..+++|+.|+|++|.|+...-..+.. + ...+++++|+
T Consensus 272 la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 272 FLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred HHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 32 4678888888888887632 333456788888888888887544444443 2 3457777776
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.59 E-value=8.1e-08 Score=100.53 Aligned_cols=139 Identities=19% Similarity=0.259 Sum_probs=100.4
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCc--cceEeeEeecCCCCCCceEeEEE
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRN--LIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
++.++.|....||++. ..+++|+.... .....+.+|+++++.+. +.. +.+++++..... .....|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~--~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE--TYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS--SCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC--CCCcceEEE
Confidence 4678999999999874 34889986422 23567899999999884 322 445555432221 112458899
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC--------------------------------- 659 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--------------------------------- 659 (833)
|+++|.++.+.... .++..++..++.++++.++.||+..
T Consensus 96 ~~i~G~~l~~~~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG 167 (304)
T ss_dssp ECCCCEECCHHHHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred cccCCeECCccccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence 99999888654321 4677788888999999999999621
Q ss_pred ----------------------CCCceeeCCCCCCeeecC--CCcEEEcccccccc
Q 040925 660 ----------------------QPPMVHGDLKPSNVLLDH--DMVAHVCDFGLAKF 691 (833)
Q Consensus 660 ----------------------~~~ivH~Dlkp~NIll~~--~~~~kL~DfG~a~~ 691 (833)
.+.++|+|++|.||++++ ...+.++||+.+..
T Consensus 168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 145899999999999998 45688999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=6.4e-07 Score=91.96 Aligned_cols=144 Identities=15% Similarity=0.082 Sum_probs=103.4
Q ss_pred HHhcCCccCceeccCcce-EEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCC
Q 040925 528 KATGEFSSSNMIGQGSFG-YVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 605 (833)
.....|+. +.+..|..+ .||+......+..+++|+-.. .....+.+|.+.|+.+. +--|.++++++.+.+
T Consensus 22 ~~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~---- 93 (272)
T 4gkh_A 22 ADLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPD---- 93 (272)
T ss_dssp HHHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETT----
T ss_pred ccccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECC----
Confidence 33444543 345556655 699988876778899998653 24567889999999885 334778888876554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC--------------------------
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC-------------------------- 659 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-------------------------- 659 (833)
..++|||+++|.++.+..... ......++.+++..|+-||+..
T Consensus 94 -~~~lvme~l~G~~~~~~~~~~----------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (272)
T 4gkh_A 94 -DAWLLTTAIPGKTAFQVLEEY----------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLV 162 (272)
T ss_dssp -EEEEEEECCCSEEHHHHHHHC----------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCC
T ss_pred -eEEEEEEeeCCccccccccCC----------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhh
Confidence 789999999998887765432 1223456677777777787531
Q ss_pred -----------------------------CCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 660 -----------------------------QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 660 -----------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
.+.++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 163 DASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp CGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237999999999999987777899999886
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.48 E-value=2.7e-08 Score=100.17 Aligned_cols=106 Identities=21% Similarity=0.289 Sum_probs=60.3
Q ss_pred ccCCCCCCE--EEccCCcccccCCcc----CCCCCCCCEEEcCCCccccc--CCccccCCCCCcEEECCCcccccccCch
Q 040925 19 VGNLSDLEV--IRIMGNSLGGKIPTT----LGLLRNLVSLNVAENKFSGM--FPRSICNISSLELIQLALNRFSGNLPFD 90 (833)
Q Consensus 19 ~~~l~~L~~--L~l~~n~l~~~~~~~----~~~l~~L~~L~L~~n~i~~~--~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 90 (833)
|...+.|.. ++++.|+. ...+.. ...+++|++|+|++|+|+++ +|..+..+++|+.|+|++|+|++.-..+
T Consensus 137 l~~dp~L~~~~l~l~~N~~-~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~~~l~ 215 (267)
T 3rw6_A 137 LRSDPDLVAQNIDVVLNRR-SCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELD 215 (267)
T ss_dssp GGGCHHHHHTTCCCCTTSH-HHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSGGGGG
T ss_pred cCCCcchhhcCccccCCHH-HHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCchhhh
Confidence 333344444 55566643 222222 24466777777777777752 3455667777777777777776321222
Q ss_pred hhcCCCCccEEEccCCcceeeCCc-------cccCCCCCcEEE
Q 040925 91 IVVNLPNLKALAIGGNNFFGSIPY-------SLSNASNLELLD 126 (833)
Q Consensus 91 ~~~~l~~L~~L~L~~N~l~~~~~~-------~~~~l~~L~~L~ 126 (833)
.+..+ +|++|+|++|.+++..|. .+..+++|+.||
T Consensus 216 ~l~~l-~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 216 KIKGL-KLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp GGTTS-CCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred hcccC-CcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 23333 777777777777654442 356677777765
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.46 E-value=2.5e-08 Score=95.70 Aligned_cols=68 Identities=19% Similarity=0.283 Sum_probs=35.1
Q ss_pred CCCCCcEEEcccCcccccc----CcCccCCCcCceEec--ccccCCCCCCCCcccccccCCCCCCCEEEccCCcCc
Q 040925 118 NASNLELLDLSVNQFKGNV----SIDFSSLKNLLWLNL--EQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFG 187 (833)
Q Consensus 118 ~l~~L~~L~L~~N~i~~~~----~~~~~~l~~L~~L~L--~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 187 (833)
..++|++|+|++|.|.... ...+...+.|++|+| ++|.|+.... ..+...+...++|++|+|++|.+.
T Consensus 91 ~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~--~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 91 VNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVE--MEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHH--HHHHHHHHHCSSCCEEECCCSSHH
T ss_pred hCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHH--HHHHHHHHhCCCcCEEeccCCCCC
Confidence 3344555555555554321 223334445555555 5555543211 112334556677888888888875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=7.7e-07 Score=92.93 Aligned_cols=136 Identities=18% Similarity=0.190 Sum_probs=94.2
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCC---ccceEeeEeecCCCCCCceEeEEE
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHR---NLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
.+.++.|....||++ +..+++|+-+ .......+.+|.++++.+.+. .|.+++.++... .+..++||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~----~g~~~~v~ 92 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRS----DGNPFVGY 92 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECT----TSCEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccC----CCceEEEE
Confidence 456888999999998 3457888853 222346789999999999642 366777765421 24578999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH---------------------------------- 658 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~---------------------------------- 658 (833)
||++|.++.+.... .++..+...++.++++.|+.||+.
T Consensus 93 e~i~G~~l~~~~~~--------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l 164 (306)
T 3tdw_A 93 RKVQGQILGEDGMA--------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLL 164 (306)
T ss_dssp ECCCSEECHHHHHT--------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGS
T ss_pred eccCCeECchhhhh--------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccccc
Confidence 99999888763221 234445555555566665555543
Q ss_pred -----------------------CCCCceeeCCCCCCeeecC---CCc-EEEccccccc
Q 040925 659 -----------------------CQPPMVHGDLKPSNVLLDH---DMV-AHVCDFGLAK 690 (833)
Q Consensus 659 -----------------------~~~~ivH~Dlkp~NIll~~---~~~-~kL~DfG~a~ 690 (833)
..+.++|+|++|.||+++. ++. +.|+||+.+.
T Consensus 165 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 165 DESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp CHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred chhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1235699999999999987 455 5899999876
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.44 E-value=3.6e-08 Score=94.55 Aligned_cols=18 Identities=22% Similarity=0.283 Sum_probs=9.4
Q ss_pred ccCCCCCcEEEcccC-ccc
Q 040925 116 LSNASNLELLDLSVN-QFK 133 (833)
Q Consensus 116 ~~~l~~L~~L~L~~N-~i~ 133 (833)
+...++|++|+|++| .|.
T Consensus 32 l~~~~~L~~L~L~~n~~i~ 50 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIP 50 (185)
T ss_dssp HTTCTTCCEEECTTCTTCC
T ss_pred HhcCCCCCEEEecCCCCCC
Confidence 444455555555555 544
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.38 E-value=6.8e-08 Score=97.23 Aligned_cols=80 Identities=20% Similarity=0.323 Sum_probs=55.1
Q ss_pred ccCCCcCEEeccCCcCCCC--CCccccCCCCCcEEeecCCccccccCccccCCC--CCCeEEccCcccCCCch-------
Q 040925 341 GHLKNLVILDISSNQFSGV--IPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLK--SIKELNVSSNNLSGQIP------- 409 (833)
Q Consensus 341 ~~l~~L~~L~ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~p------- 409 (833)
.++++|+.|+|++|+|+++ +|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+..|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 4567788888888888763 345666788888888888888765 2233333 78888888888876444
Q ss_pred hhhcCCCCCceEE
Q 040925 410 EFLKNLSVLEFLS 422 (833)
Q Consensus 410 ~~l~~l~~L~~L~ 422 (833)
..+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 3466777777765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=5.1e-06 Score=88.98 Aligned_cols=85 Identities=13% Similarity=0.065 Sum_probs=58.2
Q ss_pred Ccee-ccCcceEEEEEEEC---C---CceEEEEEEeeccC---CcchhHHHHHHHHHhhcC-C--CccceEeeEeecCCC
Q 040925 536 SNMI-GQGSFGYVYKGTLG---E---DEMIVAVKVINLKY---KGASRSFVAECEALRNIR-H--RNLIKIITICSSTDF 602 (833)
Q Consensus 536 ~~~l-g~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~ 602 (833)
.+.| +.|....+|++... + ++..+++|+..... ......+.+|+++++.+. + -.+.++++++.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4667 88989999998763 1 16678899865332 112356889999999884 3 357788887644321
Q ss_pred CCCceEeEEEEecCCCChhh
Q 040925 603 KGTDFKAFVFEYMENGSLKD 622 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~ 622 (833)
.+..++||||++|.++.+
T Consensus 105 --~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 --LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp --TSSCEEEEECCCCBCCCB
T ss_pred --cCCceEEEEecCCCChhh
Confidence 134679999999877654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.1e-05 Score=87.78 Aligned_cols=76 Identities=18% Similarity=0.129 Sum_probs=50.2
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCC-------cchhHHHHHHHHHhhcCC--C-ccceEeeEeecCCCCCC
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-------GASRSFVAECEALRNIRH--R-NLIKIITICSSTDFKGT 605 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~ 605 (833)
.+.+|.|..+.||+++...+++.|+||....... ...+++..|.++++.+.. | .+.+++.+. .+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~---- 108 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE---- 108 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT----
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC----
Confidence 4689999999999997655677899998653211 223567889999988842 3 345666542 11
Q ss_pred ceEeEEEEecCCC
Q 040925 606 DFKAFVFEYMENG 618 (833)
Q Consensus 606 ~~~~lv~e~~~~g 618 (833)
..++||||+++.
T Consensus 109 -~~~lvmE~l~g~ 120 (397)
T 2olc_A 109 -MAVTVMEDLSHL 120 (397)
T ss_dssp -TTEEEECCCTTS
T ss_pred -ccEEEEEeCCCc
Confidence 347999999763
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.94 E-value=2.9e-06 Score=78.94 Aligned_cols=83 Identities=13% Similarity=0.077 Sum_probs=44.4
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCcEEECCCcc-cccccCchhhcCC----CCccEEEccCCc-ceeeCCccccCCC
Q 040925 47 RNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR-FSGNLPFDIVVNL----PNLKALAIGGNN-FFGSIPYSLSNAS 120 (833)
Q Consensus 47 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~ 120 (833)
.+|++|||++|.|+...-..+.++++|+.|+|++|. |++ -.-..+..+ ++|++|+|++|. |++.--..+..++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD-~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~ 139 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIED-GCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR 139 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCH-HHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCH-HHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence 457777777777765555566666667777666664 441 111112222 245555555553 4433333344555
Q ss_pred CCcEEEcccC
Q 040925 121 NLELLDLSVN 130 (833)
Q Consensus 121 ~L~~L~L~~N 130 (833)
+|++|+|+++
T Consensus 140 ~L~~L~L~~c 149 (176)
T 3e4g_A 140 NLKYLFLSDL 149 (176)
T ss_dssp TCCEEEEESC
T ss_pred CCCEEECCCC
Confidence 5555555555
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.87 E-value=5.7e-06 Score=76.95 Aligned_cols=84 Identities=17% Similarity=0.120 Sum_probs=55.8
Q ss_pred CCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCc-cccccCccccCC----CCCCeEEccCcc-cCCCchhhhcCCCC
Q 040925 344 KNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNS-FHGVIPLSLSFL----KSIKELNVSSNN-LSGQIPEFLKNLSV 417 (833)
Q Consensus 344 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~l~~N~-l~~~~p~~l~~l~~ 417 (833)
.+|+.||++++.|+...-..+.++++|+.|+|++|. |++.--..+..+ ++|+.|+|++|. +|..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 467777777777766555566777777888887774 654333334443 367788887764 66554556667777
Q ss_pred CceEECccCc
Q 040925 418 LEFLSLSYNH 427 (833)
Q Consensus 418 L~~L~l~~N~ 427 (833)
|+.|++++++
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888777654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00014 Score=75.27 Aligned_cols=75 Identities=16% Similarity=0.145 Sum_probs=58.3
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC---CCccceEeeEeecCCCCCCceEeEEE
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR---HRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
.+.|+.|....+|++.. ++..+++|+.... ....+..|.+.|+.+. ...+.++++++... +..++||
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-----g~~~lvm 110 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-----GHSFLLL 110 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-----SEEEEEE
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-----CceEEEE
Confidence 46789999999999986 4667889987532 3567889999999984 36688888886543 3789999
Q ss_pred EecCCCCh
Q 040925 613 EYMENGSL 620 (833)
Q Consensus 613 e~~~~gsL 620 (833)
||+++..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00021 Score=75.71 Aligned_cols=148 Identities=16% Similarity=0.130 Sum_probs=80.6
Q ss_pred ceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCC--CccceEeeEeecCC-CCCCceEeEEEE
Q 040925 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRH--RNLIKIITICSSTD-FKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~-~~~~~~~~lv~e 613 (833)
+.|+.|..+.||++... ++ .+++|+... ....+..|.++++.+.. -.+.+++....... ....+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~-~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD-SG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET-TE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC-CC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666778899999874 34 489999864 22445566777766631 12344443110000 011346789999
Q ss_pred ecCCCChhh--------------hhccCCC----ccc----cccCCHHH-------------------------------
Q 040925 614 YMENGSLKD--------------WLHQSDD----QVE----VCKLSLIQ------------------------------- 640 (833)
Q Consensus 614 ~~~~gsL~~--------------~l~~~~~----~~~----~~~l~~~~------------------------------- 640 (833)
|++|.++.. .++.... ... ...-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 999865420 0111000 000 00011211
Q ss_pred HHHHHHHHHHHHHHHhh----------cCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 641 RVNIAIDVASAMEYLHH----------HCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 641 ~~~i~~qi~~gL~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
...+..++..++.+|+. ...+.++|+|++|.||+++.++.+.++||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234456667763 123489999999999999888899999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00024 Score=73.18 Aligned_cols=78 Identities=15% Similarity=0.143 Sum_probs=57.7
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-C--CccceEeeEeecCCCCCCceE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-H--RNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~~~~ 608 (833)
+...++.+|.|..+.||+++.. +|+.|++|+-..........+..|++.|+.+. . --+.+++++. ..
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~ 85 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DR 85 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TT
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cc
Confidence 3455678999999999999986 78899999876444444567889999999884 2 2356666542 23
Q ss_pred eEEEEecCCCC
Q 040925 609 AFVFEYMENGS 619 (833)
Q Consensus 609 ~lv~e~~~~gs 619 (833)
++||||++++.
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 68999998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00027 Score=77.19 Aligned_cols=30 Identities=27% Similarity=0.566 Sum_probs=27.0
Q ss_pred CCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 661 PPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 661 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
+.++|+|++|.||+++.++ ++++||+.+..
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 4899999999999998776 99999998874
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00045 Score=71.64 Aligned_cols=74 Identities=9% Similarity=0.122 Sum_probs=46.5
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCcc-ceEeeEeecCCCCCCceEeEE
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNL-IKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv 611 (833)
+.-.+.|+.|....+|++ ..+++|+...... ......+|+.+++.+....+ .+++++..+ .-+++
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~-------~~~~v 85 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDPA-------TGVMV 85 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT-------TCCEE
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEECC-------CCEEE
Confidence 333688999999999999 3488998764322 12234678888888752222 466655321 23689
Q ss_pred EEec-CCCCh
Q 040925 612 FEYM-ENGSL 620 (833)
Q Consensus 612 ~e~~-~~gsL 620 (833)
+||+ +|.++
T Consensus 86 ~e~i~~g~~l 95 (301)
T 3dxq_A 86 TRYIAGAQTM 95 (301)
T ss_dssp EECCTTCEEC
T ss_pred EeecCCCccC
Confidence 9999 65444
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00063 Score=71.29 Aligned_cols=168 Identities=12% Similarity=0.098 Sum_probs=91.3
Q ss_pred ccchHHHHHHhcCCcc-----CceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCc--cce
Q 040925 520 MVSYAELSKATGEFSS-----SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRN--LIK 592 (833)
Q Consensus 520 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 592 (833)
.++.+++......|.+ .+.|+.|....+|++... ++ .+++|+.... .....+..|.++++.+.... +.+
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 4566777777777765 245677888999999875 33 5889988642 23346677888888884222 334
Q ss_pred EeeEeecCC-CCCCceEeEEEEecCCCChhhh--------------hccC----CCcc-c-cccCCHHHHHH--------
Q 040925 593 IITICSSTD-FKGTDFKAFVFEYMENGSLKDW--------------LHQS----DDQV-E-VCKLSLIQRVN-------- 643 (833)
Q Consensus 593 ~~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~--------------l~~~----~~~~-~-~~~l~~~~~~~-------- 643 (833)
++....... ....+..+++|+|++|..+... ++.. .... . .....|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 432210000 0012357899999998653210 1110 0000 0 00001111000
Q ss_pred ----HHHHHHHHHHHHhhc----CCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 644 ----IAIDVASAMEYLHHH----CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 644 ----i~~qi~~gL~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
+...+.+.+++++.. ...+++|+|+.|.||+++.+..+.++||+.+..
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 134799999999999998876668999998763
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00018 Score=63.84 Aligned_cols=61 Identities=21% Similarity=0.343 Sum_probs=45.0
Q ss_pred EEeecCCccc-cccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCC
Q 040925 372 YLDISSNSFH-GVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPT 434 (833)
Q Consensus 372 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~ 434 (833)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+.+.+..|..+++|+.|+|++|+|.|.+..
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC~l 73 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDCRL 73 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSGGG
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccCcc
Confidence 5677777776 12333322 4688888888888877778888888899999999999887764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.36 E-value=4.8e-05 Score=72.13 Aligned_cols=16 Identities=25% Similarity=0.457 Sum_probs=7.5
Q ss_pred CCCCCCEEEccCCcCc
Q 040925 172 NCSSLKALSLADNQFG 187 (833)
Q Consensus 172 ~l~~L~~L~Ls~N~l~ 187 (833)
.-+.|+.|+|++|+|.
T Consensus 68 ~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 68 NSKHIEKFSLANTAIS 83 (197)
T ss_dssp TCSCCCEEECTTSCCB
T ss_pred hCCCcCEEEccCCCCC
Confidence 3344444444444444
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.30 E-value=6.6e-05 Score=71.22 Aligned_cols=67 Identities=15% Similarity=0.141 Sum_probs=30.2
Q ss_pred ccCCCCCcEEEcccCccccccCcCcc----CCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCC
Q 040925 116 LSNASNLELLDLSVNQFKGNVSIDFS----SLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADN 184 (833)
Q Consensus 116 ~~~l~~L~~L~L~~N~i~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N 184 (833)
+..-+.|+.|+|++|+|.......+. .-+.|++|+|++|.|+.... ..+...+..-+.|++|+|++|
T Consensus 66 L~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga--~ala~aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL--ARLLRSTLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH--HHHHHHTTTTCCCSEEECCCC
T ss_pred HhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH--HHHHHHHhhCCceeEEECCCC
Confidence 34445555555555555433322222 23445555555555542211 122233444455666666544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0013 Score=72.03 Aligned_cols=75 Identities=16% Similarity=0.103 Sum_probs=49.4
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCcc-ceEeeEeecCCCCCCceEeEEEEe
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNL-IKIITICSSTDFKGTDFKAFVFEY 614 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 614 (833)
.+.|+.|-...+|++...+.+..|++|+....... .-...+|..+++.+...++ .++++++ .+ ..||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~-------G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN-------GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT-------EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC-------eEEEEe
Confidence 46788888999999998644578899987533221 1223689999999964444 5677664 11 259999
Q ss_pred cCCCCh
Q 040925 615 MENGSL 620 (833)
Q Consensus 615 ~~~gsL 620 (833)
++|.++
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0011 Score=69.81 Aligned_cols=144 Identities=11% Similarity=0.040 Sum_probs=74.0
Q ss_pred ceeccCcceE-EEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-C-CccceEeeEeecCCCCCCceEeEEEE
Q 040925 537 NMIGQGSFGY-VYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-H-RNLIKIITICSSTDFKGTDFKAFVFE 613 (833)
Q Consensus 537 ~~lg~G~~g~-Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~~~~~~~~~~~~~~~~~~lv~e 613 (833)
+.|+.|.... +|+.... ++..+++|...... ...+..|+++++.+. + -.+.+++.+... .+ +++||
T Consensus 24 ~~l~gg~s~~~~~r~~~~-~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~-----~g--~ll~e 92 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSP-TGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHA-----RG--LLLIE 92 (333)
T ss_dssp CC--------CCEEEECT-TCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETT-----TT--EEEEC
T ss_pred eECCCCCCCceEEEEEcC-CCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCC-----CC--EEEEe
Confidence 4566565554 6777642 35667777654321 134566888888774 2 235667665321 12 68999
Q ss_pred ecCCCChhhhhccCCCc--------------------cccccCCHHHHH-------H-------------HHHHHHHHHH
Q 040925 614 YMENGSLKDWLHQSDDQ--------------------VEVCKLSLIQRV-------N-------------IAIDVASAME 653 (833)
Q Consensus 614 ~~~~gsL~~~l~~~~~~--------------------~~~~~l~~~~~~-------~-------------i~~qi~~gL~ 653 (833)
++.+.++.+.+...... .....++..... . ....+...+.
T Consensus 93 ~l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~ 172 (333)
T 3csv_A 93 DLGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFA 172 (333)
T ss_dssp CCCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHH
T ss_pred eCCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHH
Confidence 99776666544322100 000011111000 0 0001112222
Q ss_pred HHh---hcCCCCceeeCCCCCCeeecCC----CcEEEcccccccc
Q 040925 654 YLH---HHCQPPMVHGDLKPSNVLLDHD----MVAHVCDFGLAKF 691 (833)
Q Consensus 654 ~LH---~~~~~~ivH~Dlkp~NIll~~~----~~~kL~DfG~a~~ 691 (833)
.+. ....+.++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 173 ~l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 173 QILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 221 1123479999999999999875 6899999998863
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0031 Score=66.15 Aligned_cols=99 Identities=12% Similarity=0.071 Sum_probs=59.5
Q ss_pred CCccchHHHHHHhcCCcc-----CceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCC--cc
Q 040925 518 FPMVSYAELSKATGEFSS-----SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHR--NL 590 (833)
Q Consensus 518 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni 590 (833)
+..++.+.+......|.+ .+.++ |....||++... +|+.+++|...... .....+..|.++++.+... .+
T Consensus 8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~v 84 (328)
T 1zyl_A 8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPV 84 (328)
T ss_dssp CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSB
T ss_pred CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCee
Confidence 344555666655555533 24566 778899998764 46678999986331 2345677899988888522 24
Q ss_pred ceEeeEeecCC-CCCCceEeEEEEecCCCCh
Q 040925 591 IKIITICSSTD-FKGTDFKAFVFEYMENGSL 620 (833)
Q Consensus 591 v~~~~~~~~~~-~~~~~~~~lv~e~~~~gsL 620 (833)
++++.. .... ....+..++||||++|.++
T Consensus 85 p~~~~~-~g~~~~~~~g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 85 AAPVAF-NGQTLLNHQGFYFAVFPSVGGRQF 114 (328)
T ss_dssp CCCCCB-TTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeec-CCcEEEEECCEEEEEEEecCCCCC
Confidence 444443 1100 0113466889999987543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0013 Score=71.77 Aligned_cols=74 Identities=20% Similarity=0.167 Sum_probs=50.5
Q ss_pred CceeccCcceEEEEEEECC-------CceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCce
Q 040925 536 SNMIGQGSFGYVYKGTLGE-------DEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 607 (833)
.+.|+.|....||++.... .+..|++|+.... .....+..|..+++.+. +.-..++++.+. +
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~------ 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G------ 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C------
Confidence 3578888899999998753 2568899988421 12255668999999885 333466776531 1
Q ss_pred EeEEEEecCCCCh
Q 040925 608 KAFVFEYMENGSL 620 (833)
Q Consensus 608 ~~lv~e~~~~gsL 620 (833)
.+||||++|.++
T Consensus 148 -g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 -GRLEEYIPSRPL 159 (429)
T ss_dssp -EEEECCCCEEEC
T ss_pred -CEEEEEeCCccc
Confidence 389999986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0013 Score=70.03 Aligned_cols=146 Identities=14% Similarity=0.160 Sum_probs=84.9
Q ss_pred CceeccCcceEEEEEEECC-------CceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCce
Q 040925 536 SNMIGQGSFGYVYKGTLGE-------DEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 607 (833)
++.+..|....+|++.... +++.|++|+.... ......+.+|.++++.+. +.-..++++++. +
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~------ 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E------ 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T------
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C------
Confidence 3567778888999998752 3568999986332 223456779999999884 333466776642 1
Q ss_pred EeEEEEecCCCChhhh-h----------------ccCCCccccccC-CHHHHHHHHHHHHH-------------------
Q 040925 608 KAFVFEYMENGSLKDW-L----------------HQSDDQVEVCKL-SLIQRVNIAIDVAS------------------- 650 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~-l----------------~~~~~~~~~~~l-~~~~~~~i~~qi~~------------------- 650 (833)
.+||||++|.++..- + +........... -+.++.++..++..
T Consensus 126 -g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 204 (379)
T 3feg_A 126 -GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKD 204 (379)
T ss_dssp -EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHH
T ss_pred -ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHH
Confidence 289999998655321 0 011000000011 24555555544422
Q ss_pred HHHHHhh----c-CCCCceeeCCCCCCeeecCC----CcEEEcccccccc
Q 040925 651 AMEYLHH----H-CQPPMVHGDLKPSNVLLDHD----MVAHVCDFGLAKF 691 (833)
Q Consensus 651 gL~~LH~----~-~~~~ivH~Dlkp~NIll~~~----~~~kL~DfG~a~~ 691 (833)
.+..|.+ . ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 205 ~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 205 EMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2333321 1 12368999999999999876 7899999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.001 Score=58.91 Aligned_cols=55 Identities=16% Similarity=0.296 Sum_probs=24.7
Q ss_pred EEEccCCccc-ccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCccc
Q 040925 27 VIRIMGNSLG-GKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRF 83 (833)
Q Consensus 27 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l 83 (833)
.++.+++.++ ..+|..+. ++|++|+|++|+|+.+.++.|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555552 13443222 2444555555555444444444444444444444443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0029 Score=67.62 Aligned_cols=75 Identities=12% Similarity=0.167 Sum_probs=45.7
Q ss_pred CceeccCcceEEEEEEECCC--------ceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCc-cceEeeEeecCCCCCCc
Q 040925 536 SNMIGQGSFGYVYKGTLGED--------EMIVAVKVINLKYKGASRSFVAECEALRNIRHRN-LIKIITICSSTDFKGTD 606 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~ 606 (833)
.+.++.|....+|++...+. +..|++|+...... .......|.++++.+...+ +.++++.. .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~------ 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N------ 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T------
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C------
Confidence 35677888889999987531 26788998753321 1223468899998885333 45666542 1
Q ss_pred eEeEEEEecCCCCh
Q 040925 607 FKAFVFEYMENGSL 620 (833)
Q Consensus 607 ~~~lv~e~~~~gsL 620 (833)
-++||||++|.++
T Consensus 109 -~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 -GGRIEEWLYGDPL 121 (369)
T ss_dssp -TEEEEECCCSEEC
T ss_pred -CcEEEEEecCCcC
Confidence 2589999987543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.55 E-value=0.0092 Score=62.74 Aligned_cols=31 Identities=19% Similarity=0.352 Sum_probs=27.6
Q ss_pred CCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 661 PPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 661 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
..++|+|+.|.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987763
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.84 E-value=0.017 Score=62.18 Aligned_cols=145 Identities=11% Similarity=0.112 Sum_probs=86.0
Q ss_pred CceeccCcceEEEEEEECCC-------ceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCce
Q 040925 536 SNMIGQGSFGYVYKGTLGED-------EMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 607 (833)
++.+..|-...+|++..... ++.|++|+...... ..-...+|.++++.+. +.-..++++.+ .
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~------- 144 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P------- 144 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T-------
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C-------
Confidence 35677788889999987521 57799998754322 2224568999998885 33345666542 1
Q ss_pred EeEEEEecCCCChhhh-hc----------------cCCC-----cc--ccccCCHHHHHHHHHHH---------------
Q 040925 608 KAFVFEYMENGSLKDW-LH----------------QSDD-----QV--EVCKLSLIQRVNIAIDV--------------- 648 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~-l~----------------~~~~-----~~--~~~~l~~~~~~~i~~qi--------------- 648 (833)
-+.||||++|.++..- +. .... .. ...+..+.++.++..++
T Consensus 145 ~~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~ 224 (424)
T 3mes_A 145 EGRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKEL 224 (424)
T ss_dssp TEEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHH
T ss_pred CCEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhcccc
Confidence 2689999998654210 00 0000 00 00011244444444332
Q ss_pred ----HHHHHHHhhc---------------------CCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 649 ----ASAMEYLHHH---------------------CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 649 ----~~gL~~LH~~---------------------~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
...+.+|.+. ....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 225 ~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 225 YSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2223333211 1236899999999999 7888999999998864
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=94.75 E-value=0.059 Score=51.20 Aligned_cols=104 Identities=15% Similarity=0.094 Sum_probs=62.5
Q ss_pred ChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccccCccccc
Q 040925 619 SLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLD 698 (833)
Q Consensus 619 sL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 698 (833)
||.+++...+. ++++.++|.++.|.+.+|.-+-.+. .-..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~~-----PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ-----PINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred cHHHHHHHcCC-----CcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc--------
Confidence 78999987653 7999999999999999988772210 111223457899999999988764 2111
Q ss_pred ccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCc
Q 040925 699 TAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761 (833)
Q Consensus 699 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~ 761 (833)
.....+.|||... ...+.+.=|+| .|+++|..+.-.++..
T Consensus 98 ------------~~~~~~~~pe~~~-~~~te~~~Iys----------LG~tLY~ALDygL~e~ 137 (229)
T 2yle_A 98 ------------AGEPPPVAGKLGY-SQCMETEVIES----------LGIIIYKALDYGLKEN 137 (229)
T ss_dssp ---------------------CCSS-SSSCHHHHHHH----------HHHHHHHHHTTTCCTT
T ss_pred ------------ccccCCCChhhcc-ccchHHHHHHH----------HHHHHHHHhhcCCCcc
Confidence 0223466888753 23344555555 7777777655555544
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.46 E-value=0.094 Score=56.37 Aligned_cols=29 Identities=24% Similarity=0.479 Sum_probs=24.8
Q ss_pred ceeeCCCCCCeee------cCCCcEEEcccccccc
Q 040925 663 MVHGDLKPSNVLL------DHDMVAHVCDFGLAKF 691 (833)
Q Consensus 663 ivH~Dlkp~NIll------~~~~~~kL~DfG~a~~ 691 (833)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4456899999998864
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.01 E-value=2 Score=40.68 Aligned_cols=51 Identities=12% Similarity=0.165 Sum_probs=44.2
Q ss_pred cCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 635 KLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 635 ~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
..+...+++++.+|+.-..++++. +|--+.|+||+++.++.+++.-.|+..
T Consensus 77 ~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~f~~~~~p~i~~RGik~ 127 (215)
T 4ann_A 77 SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELFFTRDGLPIAKTRGLQN 127 (215)
T ss_dssp GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEEECTTSCEEESCCEETT
T ss_pred hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEEEcCCCCEEEEEccCcc
Confidence 578899999999999988766655 888999999999999999998887654
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.62 E-value=3.2 Score=39.51 Aligned_cols=51 Identities=18% Similarity=0.307 Sum_probs=42.8
Q ss_pred cCCHHHHHHHHHHHHHHHH-HHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 635 KLSLIQRVNIAIDVASAME-YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 635 ~l~~~~~~~i~~qi~~gL~-~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
..+...+++++.+++.-.. +++++ +|--+.|+||+++.++.+++.-.|+-.
T Consensus 81 ~~~~~eKlrll~nl~~L~~~~~~~r-----~tf~l~P~NL~f~~~~~p~i~hRGi~~ 132 (219)
T 4ano_A 81 KTTLLSRIRAAIHLVSKVKHHSARR-----LIFIVCPENLMFNRALEPFFLHVGVKE 132 (219)
T ss_dssp TSCHHHHHHHHHHHHHHHSSCCSSS-----EECCCCGGGEEECTTCCEEESCCEETT
T ss_pred hcCHHHHHHHHHHHHHHHHHhhhCc-----eeEEEeCceEEEeCCCcEEEEEcCCcc
Confidence 5788899999999888776 56544 888999999999999999998877643
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.48 E-value=0.16 Score=55.51 Aligned_cols=63 Identities=13% Similarity=0.034 Sum_probs=18.7
Q ss_pred ccCceeccCcceEEEEEEECCCceEEEE------EEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeec
Q 040925 534 SSSNMIGQGSFGYVYKGTLGEDEMIVAV------KVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSS 599 (833)
Q Consensus 534 ~~~~~lg~G~~g~Vy~~~~~~~~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 599 (833)
.+.+.+| ||.||+|.+.....+||| |..+... .+....+.+|..+++..+|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3456676 999999999765568888 7665322 2233568889999999999999999887543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 833 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-41 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-41 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-39 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 8e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-35 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-34 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-33 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-32 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-31 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-31 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-30 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-30 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-27 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-26 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-25 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-25 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-13 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-24 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-23 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-11 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-12 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-19 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-09 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1zyla1 | 325 | d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: | 0.004 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 8e-51
Identities = 72/306 (23%), Positives = 118/306 (38%), Gaps = 61/306 (19%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHR 588
G+ + IG GSFG VYKG D VAVK++N+ ++F E LR RH
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
N++ + ++ A V ++ E SL LH + K +I+ ++IA
Sbjct: 65 NILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIE-----TKFEMIKLIDIARQT 113
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
A M+YLH ++H DLK +N+ L D+ + DFGLA S +
Sbjct: 114 AQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ----- 165
Query: 709 GLKGTVGYVAPEYGMGSEA---SMTGDIF----------TGRRPIDAVFNEGHSLHEFAK 755
L G++ ++APE + S D++ TG+ P + N + +
Sbjct: 166 -LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
Query: 756 TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMR 815
L + ++ C A+ R C + ER
Sbjct: 225 GYLSPDLSKVRS-----------------------NCPKAMKRLMAECLKKKRDERPLFP 261
Query: 816 DVVAKL 821
++A +
Sbjct: 262 QILASI 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 3e-49
Identities = 73/313 (23%), Positives = 136/313 (43%), Gaps = 46/313 (14%)
Query: 522 SYAELSKATGEFSSS---------NMIGQGSFGYVYKGTL---GEDEMIVAVKVINLKY- 568
++ + ++A EF+ +IG G FG V G L G+ E+ VA+K + Y
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 569 KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD 628
+ R F++E + H N+I + + + + + E+MENGSL +L Q
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-----MIITEFMENGSLDSFLRQ-- 120
Query: 629 DQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688
+ ++IQ V + +A+ M+YL VH DL N+L++ ++V V DFGL
Sbjct: 121 ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGH 748
++FL D DT+ T +S++G K + + APE + + D+++ + V + G
Sbjct: 175 SRFLED---DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 749 SLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESP 808
+ + V+ ++ + +C +A+ + + C +
Sbjct: 232 RPYWDMT---NQDVINAIEQDYRLP--------------PPMDCPSALHQLMLDCWQKDR 274
Query: 809 FERMDMRDVVAKL 821
R +V L
Sbjct: 275 NHRPKFGQIVNTL 287
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 5e-47
Identities = 62/309 (20%), Positives = 116/309 (37%), Gaps = 37/309 (11%)
Query: 526 LSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS-FVAECEALRN 584
+ +F + +G G+ G V+K + +++A K+I+L+ K A R+ + E + L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 585 IRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI 644
++ S + E+M+ GSL L ++ ++ +
Sbjct: 61 CNSPYIVGFYGAFYSDGEI-----SICMEHMDGGSLDQVLKKAG------RIPEQILGKV 109
Query: 645 AIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
+I V + YL ++H D+KPSN+L++ +CDFG++ L D ++ V
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--- 164
Query: 705 SSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHEFA 754
GT Y++PE G+ S+ DI+ GR PI + L
Sbjct: 165 -------GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP--PDAKELELMF 215
Query: 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814
+ E ++ + + E L+ I+ F +
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL-EF 274
Query: 815 RDVVAKLCH 823
+D V K
Sbjct: 275 QDFVNKCLI 283
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-45
Identities = 64/301 (21%), Positives = 112/301 (37%), Gaps = 37/301 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG+G FG V++G VAVK+ + + + S AE +RH N++ I +
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+ T V +Y E+GSL D+L++ +++ + +A+ AS + +LH
Sbjct: 68 KDNGTWTQL-WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHME 119
Query: 659 C-----QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
+P + H DLK N+L+ + + D GLA + GT
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH----RVGT 175
Query: 714 VGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLME 773
Y+APE S + F ++ G E A+ + E
Sbjct: 176 KRYMAPEVLDDSINMKHFESF----KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 774 VMTNNSMIQEDKRVKTE-------------ECLNAIIRTGVLCSMESPFERMDMRDVVAK 820
V ++ S+ + K V + E L + + C + R+ +
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291
Query: 821 L 821
L
Sbjct: 292 L 292
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-45
Identities = 61/284 (21%), Positives = 116/284 (40%), Gaps = 41/284 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G FG V+ G VAVK + + + +F+AE ++ ++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYY-NGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+ EYMENGSL D+L KL++ + +++A +A M ++
Sbjct: 79 QEPI------YIITEYMENGSLVDFLKTPSGI----KLTINKLLDMAAQIAEGMAFIEER 128
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
+H DL+ +N+L+ + + DFGLA+ + D++ G K + + A
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA-------REGAKFPIKWTA 178
Query: 719 PEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNN 778
PE ++ D+++ G L E P M
Sbjct: 179 PEAINYGTFTIKSDVWSF----------GILLTEIVTHGRI--------PYPGMTNPEVI 220
Query: 779 SMIQEDKR-VKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
++ R V+ + C + + LC E P +R + + L
Sbjct: 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-45
Identities = 59/270 (21%), Positives = 103/270 (38%), Gaps = 35/270 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITI 596
IG+GSF VYKG E + VA + + K + F E E L+ ++H N+++
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
ST KG V E M +G+LK +L + + + + + +++LH
Sbjct: 77 WESTV-KGKKCIVLVTELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLH 129
Query: 657 HHCQPPMVHGDLKPSNVLL-DHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
PP++H DLK N+ + + D GLA + GT
Sbjct: 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI----------GTPE 178
Query: 716 YVAPEYGMG--SEAS-------MTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766
++APE E+ ++ T P N P ++
Sbjct: 179 FMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 767 DPSLLMEVMTNNSMIQED--KRVKTEECLN 794
P + E++ I+++ +R ++ LN
Sbjct: 239 IPE-VKEII--EGCIRQNKDERYSIKDLLN 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-43
Identities = 56/288 (19%), Positives = 106/288 (36%), Gaps = 39/288 (13%)
Query: 539 IGQGSFGYVYKGTL--GEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIIT 595
+G G+FG V +G + ++ VA+KV+ K + + E + + + + ++++I
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+C + V E G L +L ++ + + V+ M+YL
Sbjct: 77 VCQAEAL------MLVMEMAGGGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYL 125
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
VH DL NVLL + A + DFGL+K L ++ K +
Sbjct: 126 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-----SYYTARSAGKWPLK 177
Query: 716 YVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVM 775
+ APE + S D+++ + + G ++ K +VM ++ ME
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIEQGKRMEC- 233
Query: 776 TNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823
EC + C + +R D V ++
Sbjct: 234 -------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 6e-43
Identities = 70/295 (23%), Positives = 123/295 (41%), Gaps = 40/295 (13%)
Query: 532 EFSSSNMIGQGSFGYVYKGTL----GEDEMIVAVKVINLKYKGASR-SFVAECEALRNIR 586
+ +IG G FG VYKG L G+ E+ VA+K + Y R F+ E +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H N+I++ + S + EYMENG+L +L + D + S++Q V +
Sbjct: 68 HHNIIRLEGVISKYKPM-----MIITEYMENGALDKFLREKD-----GEFSVLQLVGMLR 117
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
+A+ M + VH DL N+L++ ++V V DFGL++ L D T +
Sbjct: 118 GIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-----YT 169
Query: 707 SIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766
+ G K + + APE + + D+++ + V G + +VM+ +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVMKAI 226
Query: 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
+ + +C +AI + + C + R D+V+ L
Sbjct: 227 NDGFRLP--------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 7e-43
Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 39/290 (13%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+GQG FG V+ GT VA+K + +F+ E + ++ +RH L+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 75
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
++ + S V EYM GSL D+L + Q V++A +AS
Sbjct: 76 QLYAVVSEEPI------YIVTEYMSKGSLLDFLKGETGKYLRLP----QLVDMAAQIASG 125
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
M Y+ VH DL+ +N+L+ ++V V DFGLA+ + D++ ++ G K
Sbjct: 126 MAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-------TARQGAK 175
Query: 712 GTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771
+ + APE + ++ D+++ + + +G + +V++ V+
Sbjct: 176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLDQVERGYR 232
Query: 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
M EC ++ C + P ER + A L
Sbjct: 233 MPC--------------PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-42
Identities = 62/286 (21%), Positives = 101/286 (35%), Gaps = 39/286 (13%)
Query: 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRN 584
S+A ++ IG GS+G K D I+ K ++ + + V+E LR
Sbjct: 1 SRAE-DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59
Query: 585 IRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNI 644
++H N+++ + V EY E G L + + + + L + +
Sbjct: 60 LKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQ--YLDEEFVLRV 114
Query: 645 AIDVASAMEYLHHH--CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVK 702
+ A++ H ++H DLKP+NV LD + DFGLA+ L+
Sbjct: 115 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT------ 168
Query: 703 TPSSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHE 752
S + GT Y++PE + DI+ P S E
Sbjct: 169 --SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-----AFSQKE 221
Query: 753 FAKTALPEKVMEIVD--PSLLMEVMTNNSMIQED--KRVKTEECLN 794
A K I L E++ M+ R EE L
Sbjct: 222 LAGKIREGKFRRIPYRYSDELNEII--TRMLNLKDYHRPSVEEILE 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-42
Identities = 66/300 (22%), Positives = 122/300 (40%), Gaps = 39/300 (13%)
Query: 536 SNMIGQGSFGYVYKGTLGED---EMIVAVKVIN-LKYKGASRSFVAECEALRNIRHRNLI 591
+ +IG+G FG VY GTL ++ ++ AVK +N + G F+ E +++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
++ IC ++ V YM++G L++++ E ++ + + VA
Sbjct: 92 SLLGICLRSEGS----PLVVLPYMKHGDLRNFIRN-----ETHNPTVKDLIGFGLQVAKG 142
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
M VH DL N +LD V DFGLA+ + D + D + + G K
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD----SVHNKTGAK 195
Query: 712 GTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771
V ++A E + + D V++ G L E P P
Sbjct: 196 LPVKWMALESLQTQKFTTKSD----------VWSFGVLLWELMTRGAP--------PYPD 237
Query: 772 MEVMTNNSMIQEDKR-VKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830
+ + + +R ++ E C + + + C R ++V+++ TF+G
Sbjct: 238 VNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (386), Expect = 5e-42
Identities = 63/308 (20%), Positives = 127/308 (41%), Gaps = 39/308 (12%)
Query: 514 MEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASR 573
M+ P +Y + + + + +G G +G VY+G + + VAVK + +
Sbjct: 2 MDPSSP--NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVE 58
Query: 574 SFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEV 633
F+ E ++ I+H NL++++ +C+ + E+M G+L D+L + + Q
Sbjct: 59 EFLKEAAVMKEIKHPNLVQLLGVCTREPPFY-----IITEFMTYGNLLDYLRECNRQ--- 110
Query: 634 CKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
++S + + +A ++SAMEYL +H DL N L+ + + V DFGL++ ++
Sbjct: 111 -EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166
Query: 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEF 753
G K + + APE ++ S+ D++ + + G S +
Sbjct: 167 GDTYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 754 AKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD 813
+V E+++ ME + E C + C +P +R
Sbjct: 220 ID---LSQVYELLEKDYRME--------------RPEGCPEKVYELMRACWQWNPSDRPS 262
Query: 814 MRDVVAKL 821
++
Sbjct: 263 FAEIHQAF 270
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 9e-42
Identities = 59/291 (20%), Positives = 103/291 (35%), Gaps = 41/291 (14%)
Query: 537 NMIGQGSFGYVYKGTL--GEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIK 592
+G G+FG V KG + VAVK++ + +AE ++ + + +++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+I IC + + V E E G L +L Q+ + + + V+ M
Sbjct: 73 MIGICEAESW------MLVMEMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGM 120
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
+YL VH DL NVLL A + DFGL+K L + + K
Sbjct: 121 KYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHGKW 172
Query: 713 TVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772
V + APE + S D+++ + F+ G + K +V +++ M
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVTAMLEKGERM 229
Query: 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823
E + + C R V +L +
Sbjct: 230 GCPAGCP----------REMYDLMNL----CWTYDVENRPGFAAVELRLRN 266
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-41
Identities = 74/288 (25%), Positives = 109/288 (37%), Gaps = 45/288 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG+G FG V G VAVK I K +++F+AE + +RH NL++++ +
Sbjct: 15 IGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
V EYM GSL D+L V L + ++DV AMEYL +
Sbjct: 71 EEK----GGLYIVTEYMAKGSLVDYLRSRGRSV----LGGDCLLKFSLDVCEAMEYLEGN 122
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
VH DL NVL+ D VA V DFGL K S S+ K V + A
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----------STQDTGKLPVKWTA 168
Query: 719 PEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNN 778
PE + S D V++ G L E P + +
Sbjct: 169 PEALREKKFSTKSD----------VWSFGILLWEIYSFGRV--------PYPRIPLKDVV 210
Query: 779 SMIQEDKRVK-TEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825
+++ ++ + C A+ C R + +L H +
Sbjct: 211 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 7e-41
Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 39/290 (13%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
E + IG G FG V+ G ++ VA+K I + + F+ E E + + H L+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
++ +C VFE+ME+G L D+L + + + + +DV
Sbjct: 64 QLYGVCLEQAPI-----CLVFEFMEHGCLSDYLRT-----QRGLFAAETLLGMCLDVCEG 113
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+ + + ++H DL N L+ + V V DFG+ +F+ D Q +SS G K
Sbjct: 114 ---MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-------TSSTGTK 163
Query: 712 GTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771
V + +PE S S D+++ + VF+EG +E +V+E +
Sbjct: 164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFR 220
Query: 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
+ R+ + + C E P +R ++ +L
Sbjct: 221 L----------YKPRLASTHVYQIMNH----CWKERPEDRPAFSRLLRQL 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 7e-41
Identities = 64/291 (21%), Positives = 110/291 (37%), Gaps = 41/291 (14%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLI 591
+ + +G G FG V G + VA+K+I + + F+ E + + N+ H L+
Sbjct: 5 DLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
++ +C+ + EYM NG L ++L + + Q + + DV A
Sbjct: 63 QLYGVCTKQRPI-----FIITEYMANGCLLNYLREMR-----HRFQTQQLLEMCKDVCEA 112
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
MEYL +H DL N L++ V V DFGL++++ D + +SS+G K
Sbjct: 113 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-------TSSVGSK 162
Query: 712 GTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771
V + PE M S+ S DI+ G + E P
Sbjct: 163 FPVRWSPPEVLMYSKFSSKSDIWAF----------GVLMWEIYSLGKM--------PYER 204
Query: 772 MEVMTNNSMIQEDKR-VKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
I + R + + C E ER + +++ +
Sbjct: 205 FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-40
Identities = 57/308 (18%), Positives = 115/308 (37%), Gaps = 54/308 (17%)
Query: 538 MIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASR-SFVAECEALRNI-RHRNL 590
++G G+FG V T + VAVK++ K + R + ++E + + + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQS-----------------DDQVEV 633
+ ++ C+ + +FEY G L ++L +++ ++
Sbjct: 104 VNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 634 CKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
L+ + A VA ME+L VH DL NVL+ H V +CDFGLA+ +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 694 DHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEF 753
+ V ++APE ++ D+++ + +F+ G + +
Sbjct: 216 SDSNYVVRGNA------RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP--Y 267
Query: 754 AKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD 813
+ +++ M+ + EE + C +R
Sbjct: 268 PGIPVDANFYKLIQNGFKMDQPFYAT----------EEIYIIMQS----CWAFDSRKRPS 313
Query: 814 MRDVVAKL 821
++ + L
Sbjct: 314 FPNLTSFL 321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-40
Identities = 51/278 (18%), Positives = 99/278 (35%), Gaps = 37/278 (13%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRN 589
++ +G+G++G V E VAVK++++K + E + + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
++K + + + EY G L D + + +
Sbjct: 65 VVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPD------IGMPEPDAQRFFHQLM 113
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
+ + YLH + H D+KP N+LLD + DFGLA + + +
Sbjct: 114 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK------ 164
Query: 710 LKGTVGYVAPEYGMGSE-ASMTGDIF----------TGRRPIDAVFNEGHSLHEFAKTAL 758
+ GT+ YVAPE E + D++ G P D + ++ +
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224
Query: 759 PEKVMEIVDPSLLMEVMTNNSMIQED--KRVKTEECLN 794
+ +D + L + ++ E+ R+ +
Sbjct: 225 YLNPWKKIDSAPLALLH---KILVENPSARITIPDIKK 259
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 9e-40
Identities = 54/279 (19%), Positives = 104/279 (37%), Gaps = 47/279 (16%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN---LKYKGASRSFVAECEALRNIRHR 588
+F +G+G FG VY + + I+A+KV+ L+ G E E ++RH
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
N++++ + EY G++ L + K + ++
Sbjct: 67 NILRLYGYFHDATRV-----YLILEYAPLGTVYRELQKLS------KFDEQRTATYITEL 115
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
A+A+ Y H ++H D+KP N+LL + DFG + + T
Sbjct: 116 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC------- 165
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDAV-FNEGHSLHEFAKTA 757
GT+ Y+ PE G D++ G+ P +A + E + +
Sbjct: 166 ---GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT 222
Query: 758 LPEKVMEIVDPSLLMEVMTNNSMIQED--KRVKTEECLN 794
P+ V +++ + +++ + +R E L
Sbjct: 223 FPDFV-----TEGARDLI--SRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 53/273 (19%), Positives = 100/273 (36%), Gaps = 41/273 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G+FG VYK E ++ A KVI+ K + ++ E + L + H N++K++
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+ + E+ G++ + + + L+ Q + A+ YLH +
Sbjct: 80 Y-----ENNLWILIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN 129
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVA 718
++H DLK N+L D + DFG++ + GT ++A
Sbjct: 130 ---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--------QRRDSFIGTPYWMA 178
Query: 719 PEYGMGSEASMTG-----DIF----------TGRRPIDAVFNEGHSLHEFAKTALPEKVM 763
PE M + D++ P N L + AK+ P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE-LNPMRVLLKIAKSEPPTLAQ 237
Query: 764 EIVDPSLLMEVMTNNSMIQED--KRVKTEECLN 794
S + + ++++ R T + L
Sbjct: 238 PSRWSSNFKDFL--KKCLEKNVDARWTTSQLLQ 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 1e-39
Identities = 63/325 (19%), Positives = 106/325 (32%), Gaps = 57/325 (17%)
Query: 522 SYAELSKATGEFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKY-KGASRSF 575
L IG+G+FG V++ E +VAVK++ + F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 576 VAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVC- 634
E + + N++K++ +C+ +FEYM G L ++L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSL 118
Query: 635 -----------------KLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH 677
LS +++ IA VA+ M YL VH DL N L+
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGE 175
Query: 678 DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGR 737
+MV + DFGL++ + A + ++ PE + + D
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGND------AIPIRWMPPESIFYNRYTTESD----- 224
Query: 738 RPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKT-EECLNAI 796
V+ G L E L P M +++ + E C +
Sbjct: 225 -----VWAYGVVLWEIFSYGLQ--------PYYGMAHEEVIYYVRDGNILACPENCPLEL 271
Query: 797 IRTGVLCSMESPFERMDMRDVVAKL 821
LC + P +R + L
Sbjct: 272 YNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (368), Expect = 2e-39
Identities = 60/289 (20%), Positives = 102/289 (35%), Gaps = 43/289 (14%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK---GASRSFVAECEALRNIRHRN 589
FS IG GSFG VY + +VA+K ++ K + + E L+ +RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVA 649
I+ V EY + L ++ +
Sbjct: 77 TIQYRGCYLREHTA-----WLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGAL 125
Query: 650 SAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIG 709
+ YLH H M+H D+K N+LL + + DFG A ++ +
Sbjct: 126 QGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------------ANS 170
Query: 710 LKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769
GT ++APE + M + G+ V++ G + E A+ P + + S
Sbjct: 171 FVGTPYWMAPEVILA----MDEGQYDGKV---DVWSLGITCIELAERKPP--LFNMNAMS 221
Query: 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVV 818
L + N S + +E N + C + P +R ++
Sbjct: 222 ALYHIAQNESPALQSGHW-SEYFRNFVDS----CLQKIPQDRPTSEVLL 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-39
Identities = 64/319 (20%), Positives = 120/319 (37%), Gaps = 57/319 (17%)
Query: 518 FPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRS 574
+P++ + + ++IG+G+FG V K + +D + + + +K K R
Sbjct: 4 YPVLDW-------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 575 FVAECEALRNI-RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSD----- 628
F E E L + H N+I ++ C + + EY +G+L D+L +S
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 111
Query: 629 -----DQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683
LS Q ++ A DVA M + Q +H DL N+L+ + VA +
Sbjct: 112 PAFAIANSTASTLSSQQLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKI 168
Query: 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAV 743
DFGL++ + T + V ++A E S + D+++ + +
Sbjct: 169 ADFGLSRGQEVYVKKTMG---------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 744 FNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKT-EECLNAIIRTGVL 802
+ G + P M + + R++ C + +
Sbjct: 220 VSLGGT------------------PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQ 261
Query: 803 CSMESPFERMDMRDVVAKL 821
C E P+ER ++ L
Sbjct: 262 CWREKPYERPSFAQILVSL 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-38
Identities = 57/302 (18%), Positives = 108/302 (35%), Gaps = 49/302 (16%)
Query: 539 IGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASR-SFVAECEALRNI-RHRNLI 591
+G G+FG V + T + M VAVK++ R + ++E + L + H N++
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQV------------EVCKLSLI 639
++ C+ + EY G L ++L + D + L L
Sbjct: 91 NLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT 699
++ + VA M +L +H DL N+LL H + +CDFGLA+ + +
Sbjct: 146 DLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDS--- 199
Query: 700 AVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759
+ V ++APE + D+++ + +F+ G S +
Sbjct: 200 ---NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV--D 254
Query: 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819
K +++ M E + C P +R + +V
Sbjct: 255 SKFYKMIKEGFRML--------------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
Query: 820 KL 821
+
Sbjct: 301 LI 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 4e-38
Identities = 65/297 (21%), Positives = 112/297 (37%), Gaps = 41/297 (13%)
Query: 510 DTSPMEKQFPMVSYAELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK 569
D +EK +VS + K +++ IGQG+ G VY VA++ +NL+ +
Sbjct: 2 DEEILEKLRSIVSVGDPKK---KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ 58
Query: 570 GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDD 629
+ E +R ++ N++ + D V EY+ GSL D + +
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE--- 110
Query: 630 QVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689
+ Q + + A+E+LH + ++H D+K N+LL D + DFG
Sbjct: 111 ----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 163
Query: 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRP 739
++ Q S + GT ++APE DI+ G P
Sbjct: 164 AQITPEQ--------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
Query: 740 IDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQED--KRVKTEECLN 794
N +L+ A PE ++ + + N + D KR +E L
Sbjct: 216 YLN-ENPLRALYLIATNGTPELQNPEKLSAIFRDFL--NRCLDMDVEKRGSAKELLQ 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 5e-38
Identities = 63/289 (21%), Positives = 98/289 (33%), Gaps = 41/289 (14%)
Query: 539 IGQGSFGYVYKGTL---GEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIK 592
+G GSFG V +G + VAVK + A F+ E A+ ++ HRNLI+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + + K V E GSL D L + L A+ VA M
Sbjct: 76 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGM 124
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
YL +H DL N+LL + + DFGL + L + ++ K
Sbjct: 125 GYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-----HRKV 176
Query: 713 TVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLM 772
+ APE S D + + +F G + + + +I +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKIDKEGERL 234
Query: 773 EVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
+ E+C I V C P +R + L
Sbjct: 235 P--------------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-37
Identities = 55/295 (18%), Positives = 116/295 (39%), Gaps = 42/295 (14%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGED----EMIVAVKVINL-KYKGASRSFVAECEALRNIR 586
EF ++G G+FG VYKG + ++ VA+K + A++ + E + ++
Sbjct: 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
+ ++ +++ IC ++ + + + M G L D++ + D + +N +
Sbjct: 70 NPHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNI-----GSQYLLNWCV 118
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
+A M YL +VH DL NVL+ + DFGLAK L +
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE------KEYH 169
Query: 707 SIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766
+ G K + ++A E + + V++ G ++ E K + +
Sbjct: 170 AEGGKVPIKWMALESILHRIYT----------HQSDVWSYGVTVWELM--TFGSKPYDGI 217
Query: 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
S + ++ + + T + +++ C M R R+++ +
Sbjct: 218 PASEISSILEKGERLPQPPIC-TIDVYMIMVK----CWMIDADSRPKFRELIIEF 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 58/301 (19%), Positives = 111/301 (36%), Gaps = 43/301 (14%)
Query: 532 EFSSSNMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKYKGASR-SFVAECEALRNI 585
+ + S +GQGSFG VY+G E E VA+K +N R F+ E ++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVE----VCKLSLIQR 641
++++++ + S + E M G LK +L + + SL +
Sbjct: 81 NCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 642 VNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAV 701
+ +A ++A M YL+ + VH DL N ++ D + DFG+ + + +
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 702 KTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEK 761
V +++PE + V++ G L E A A
Sbjct: 193 GKG------LLPVRWMSPESLKDGVFT----------TYSDVWSFGVVLWEIATLAEQ-- 234
Query: 762 VMEIVDPSLLMEVMTNNSMIQEDKRV-KTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820
P + + E + K + C + + +C +P R ++++
Sbjct: 235 ------PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
Query: 821 L 821
+
Sbjct: 289 I 289
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 140 bits (355), Expect = 4e-37
Identities = 49/272 (18%), Positives = 92/272 (33%), Gaps = 42/272 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G+FG V++ T A K + ++ + E + + +RH L+ +
Sbjct: 34 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+ ++E+M G L + + + K+S + V V + ++H +
Sbjct: 94 D-----DNEMVMIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
VH DLKP N++ + DFGL L Q S GT +
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---------SVKVTTGTAEF 191
Query: 717 VAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHEFAKT--ALPEKVME 764
APE G D++ +G P N+ +L + +
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWNMDDSAFS 250
Query: 765 IVDPSLLMEVMTNNSMIQED--KRVKTEECLN 794
+ + ++ D R+ + L
Sbjct: 251 GISEDGKDFIR---KLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 49/221 (22%), Positives = 82/221 (37%), Gaps = 33/221 (14%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHR 588
+F ++G+GSF V A+K++ ++ + E + + + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
+K+ + F Y +NG L ++ + ++
Sbjct: 69 FFVKLYFTFQDDEKL-----YFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEI 117
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
SA+EYLH ++H DLKP N+LL+ DM + DFG AK LS +
Sbjct: 118 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS----- 169
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRP 739
GT YV+PE A + D++ G P
Sbjct: 170 -FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 8e-36
Identities = 53/288 (18%), Positives = 105/288 (36%), Gaps = 42/288 (14%)
Query: 538 MIGQGSFGYVYKGTL---GEDEMIVAVKVINLKYKGASRS-FVAECEALRNIRHRNLIKI 593
IG+G FG V++G + VA+K + R F+ E +R H +++K+
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 594 ITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
I + + + + E G L+ +L L L + A +++A+
Sbjct: 74 IGVITE------NPVWIIMELCTLGELRSFLQV-----RKYSLDLASLILYAYQLSTALA 122
Query: 654 YLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
YL VH D+ NVL+ + + DFGL++++ D T + K
Sbjct: 123 YLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-------TYYKASKGKLP 172
Query: 714 VGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLME 773
+ ++APE + D++ G + E + + V + ++
Sbjct: 173 IKWMAPESINFRRFTSASDVWMF----------GVCMWEILMHGVK--PFQGVKNNDVIG 220
Query: 774 VMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKL 821
+ N + + + + C P R ++ A+L
Sbjct: 221 RIENGERLPMPPNC-PPTLYSLMTK----CWAYDPSRRPRFTELKAQL 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 136 bits (343), Expect = 1e-35
Identities = 51/271 (18%), Positives = 94/271 (34%), Gaps = 40/271 (14%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G+FG V++ + K IN Y + E + + H LI +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
+ E++ G L D + D K+S + +N ++++H H
Sbjct: 97 D-----KYEMVLILEFLSGGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHEH 146
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
+VH D+KP N++ + + V DFGLA L+ ++ T +
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---------VKVTTATAEF 194
Query: 717 VAPEYGMGSEASMTGDIF----------TGRRPIDAVFN-EGHSLHEFAKTALPEKVMEI 765
APE D++ +G P + E + E
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 766 VDPSLLMEVMTNNSMIQED--KRVKTEECLN 794
V P + +++Q++ KR+ + L
Sbjct: 255 VSPEAKDFIK---NLLQKEPRKRLTVHDALE 282
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 132 bits (332), Expect = 7e-35
Identities = 50/288 (17%), Positives = 105/288 (36%), Gaps = 33/288 (11%)
Query: 527 SKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALR 583
S + + ++G G V+ VAVKV+ F E +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 584 NIRHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVN 643
+ H ++ + + G V EY++ +L+D +H ++ + +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIE 115
Query: 644 IAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKT 703
+ D A+ + H + ++H D+KP+N+++ V DFG+A+ ++D +
Sbjct: 116 VIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG-----NS 167
Query: 704 PSSSIGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHEF 753
+ + + GT Y++PE G D++ TG P +
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV 227
Query: 754 AKTALPEKVMEIVDPSLLMEVMTNNSMIQED--KRVKT-EECLNAIIR 798
+ +P + L V+ + ++ R +T E ++R
Sbjct: 228 REDPIPPSARHEGLSADLDAVV--LKALAKNPENRYQTAAEMRADLVR 273
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-34
Identities = 62/302 (20%), Positives = 112/302 (37%), Gaps = 50/302 (16%)
Query: 539 IGQGSFGYVYKGTL-------GEDEMIVAVKVINLKY-KGASRSFVAECEALRNI-RHRN 589
+G+G+FG V VAVK++ + ++E E ++ I +H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 590 LIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQ----------SDDQVEVCKLSLI 639
+I ++ C+ + EY G+L+++L + +LS
Sbjct: 81 IINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT 699
V+ A VA MEYL +H DL NVL+ D V + DFGLA+ +
Sbjct: 136 DLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID--- 189
Query: 700 AVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759
+ + V ++APE + D+++ + +F G S +
Sbjct: 190 ---YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---V 243
Query: 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819
E++ +++ M+ K C N + C P +R + +V
Sbjct: 244 EELFKLLKEGHRMD--------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
Query: 820 KL 821
L
Sbjct: 290 DL 291
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 2e-33
Identities = 53/301 (17%), Positives = 105/301 (34%), Gaps = 44/301 (14%)
Query: 537 NMIGQGSFGYVYKGTL-----GEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNL 590
+G+G+FG V + VAVK++ R+ ++E + L +I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCK----------LSLIQ 640
+ + + + E+ + G+L +L ++ K L+L
Sbjct: 79 VVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 641 RVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTA 700
+ + VA ME+L +H DL N+LL V +CDFGLA+ +
Sbjct: 136 LICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP---- 188
Query: 701 VKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760
+ + ++APE ++ D+++ + +F+ G + + E
Sbjct: 189 --DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDE 244
Query: 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820
+ + M + E ++ C P +R ++V
Sbjct: 245 EFCRRLKEGTRMRAPDYTT----------PEMYQTMLD----CWHGEPSQRPTFSELVEH 290
Query: 821 L 821
L
Sbjct: 291 L 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 4e-33
Identities = 60/291 (20%), Positives = 103/291 (35%), Gaps = 34/291 (11%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITIC 597
IG GSFG +Y GT VA+K+ +K K E + + ++ I I C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+ D+ V E + + S K SL + +A + S +EY+H
Sbjct: 72 GAEG----DYNVMVMELLGPSLEDLFNFCSR------KFSLKTVLLLADQMISRIEYIHS 121
Query: 658 HCQPPMVHGDLKPSNVL---LDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTV 714
+H D+KP N L + ++ DFGLAK D + + + L GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK-NLTGTA 177
Query: 715 GYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLLMEV 774
Y + +G E S D+ + G+ L F +LP + ++ E
Sbjct: 178 RYASINTHLGIEQSRRDDLESL----------GYVLMYFNLGSLPWQGLKAATKRQKYER 227
Query: 775 MTNNSMIQEDKRVKTE--ECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823
++ M + + + C ++ D + +
Sbjct: 228 ISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 126 bits (317), Expect = 8e-33
Identities = 58/291 (19%), Positives = 108/291 (37%), Gaps = 42/291 (14%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---------KGASRSFVAECEALRNIR- 586
++G+G V + AVK+I++ + + + E + LR +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
H N+I++ + F VF+ M+ G L D+L + LS + I
Sbjct: 69 HPNIIQLKDTYETNTFF-----FLVFDLMKKGELFDYLTEKV------TLSEKETRKIMR 117
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSS 706
+ + LH +VH DLKP N+LLD DM + DFG + L + V
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV----- 169
Query: 707 SIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766
GT Y+APE S + +D +++ G ++ + P + +
Sbjct: 170 ----CGTPSYLAPEIIECSMNDNHPGY---GKEVD-MWSTGVIMYTLLAGSPPFWHRKQM 221
Query: 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDV 817
+L +M+ N + + + ++ + P +R +
Sbjct: 222 L--MLRMIMSGNYQFGSPEWDDYSDTVKDLVSR---FLVVQPQKRYTAEEA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-32
Identities = 53/272 (19%), Positives = 90/272 (33%), Gaps = 37/272 (13%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIIT 595
+++G G+F V + +VA+K I K +G S E L I+H N++ +
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
I S + + + G L D + + + + V A++YL
Sbjct: 75 IYESGGHL-----YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYL 123
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
H LD D + DFGL+K + + GT G
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA---------CGTPG 174
Query: 716 YVAPEYGMGSEASMTGDIF----------TGRRPIDAVFN-EGHSLHEFAKTALPEKVME 764
YVAPE S D + G P + + A+ +
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 234
Query: 765 IVDPSLLMEVMTNNSMIQED--KRVKTEECLN 794
+ S + ++++D KR E+ L
Sbjct: 235 DISDSAKDFIR---HLMEKDPEKRFTCEQALQ 263
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-32
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 12/166 (7%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIK 592
++ + +IG GSFG VY+ L + +VA+K + R E + +R + H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVR 77
Query: 593 IITIC-SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ SS + K + V +Y+ + H S + L +I + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ---TLPVIYVKLYMYQLFRS 134
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAKFLSDHQ 696
+ Y+H + H D+KP N+LLD D V +CDFG AK L +
Sbjct: 135 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 124 bits (313), Expect = 2e-31
Identities = 39/179 (21%), Positives = 71/179 (39%), Gaps = 20/179 (11%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY------KGASRSFVAECEALRNI 585
+FS +IG+G FG VY + + A+K ++ K + + + +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 586 RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
++ + + D +F+ + M G L L Q E A
Sbjct: 65 DCPFIVCMSYAFHTPDKL-----SFILDLMNGGDLHYHLSQHGVFSE------ADMRFYA 113
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTP 704
++ +E++H+ +V+ DLKP+N+LLD + D GLA S + +V T
Sbjct: 114 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 169
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 3e-31
Identities = 46/197 (23%), Positives = 82/197 (41%), Gaps = 17/197 (8%)
Query: 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVIN-LKYKGASRSFVAECEALRNIRHR 588
+++ + IG+G++G V +++ VA+K I+ +++ + + E + L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
N+I I I + + ++ ++ L L LS +
Sbjct: 67 NIIGINDIIRAPTIE-QMKDVYLVTHLMGADLYKLLKTQ-------HLSNDHICYFLYQI 118
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
++Y+H ++H DLKPSN+LL+ +CDFGLA+ T T
Sbjct: 119 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE---- 171
Query: 709 GLKGTVGYVAPEYGMGS 725
T Y APE + S
Sbjct: 172 -YVATRWYRAPEIMLNS 187
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (308), Expect = 3e-31
Identities = 47/271 (17%), Positives = 99/271 (36%), Gaps = 41/271 (15%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G+G FG V++ + K + +K E L RHRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESFE 71
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
S + +FE++ + + ++ S +L+ + V+ V A+++LH H
Sbjct: 72 S-----MEELVMIFEFISGLDIFERINTSA-----FELNEREIVSYVHQVCEALQFLHSH 121
Query: 659 CQPPMVHGDLKPSNVLLDHDMVAHV--CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
+ H D++P N++ + + +FG A+ L + Y
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL---------FTAPEY 169
Query: 717 VAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEG-HSLHEFAKTALPEKVMEI 765
APE S D++ +G P A N+ A+ E+ +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 766 VDPSLLMEVMTNNSMIQED--KRVKTEECLN 794
+ + + + + ++ ++ R+ E L
Sbjct: 230 ISIEAM-DFV--DRLLVKERKSRMTASEALQ 257
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 8e-31
Identities = 50/275 (18%), Positives = 99/275 (36%), Gaps = 40/275 (14%)
Query: 538 MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEAL-RNIRHRNLIKIITI 596
++G G G V + + A+K++ E E R + ++++I+ +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
+ G V E ++ G L + DQ + + I + A++YLH
Sbjct: 74 Y-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLH 128
Query: 657 HHCQPPMVHGDLKPSNVLLDH---DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
+ H D+KP N+L + + + DFG AK + H S T
Sbjct: 129 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---------SLTTPCYT 176
Query: 714 VGYVAPEYGMGSEASMTGDIF----------TGRRPIDAVFNEGHSLHEFAKTALPEKVM 763
YVAPE + + D++ G P + S + + +
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236
Query: 764 EIVDPSLLMEVMTN--NSMIQED--KRVKTEECLN 794
+ S + E + ++++ + +R+ E +N
Sbjct: 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (303), Expect = 1e-30
Identities = 48/222 (21%), Positives = 81/222 (36%), Gaps = 36/222 (16%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEAL-RNIRH 587
+F M+G+GSFG V+ + A+K + + E L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 588 RNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAID 647
L + + + FV EY+ G L + K L + A +
Sbjct: 63 PFLTHMFCTFQTKENL-----FFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAE 111
Query: 648 VASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSS 707
+ +++LH +V+ DLK N+LLD D + DFG+ K + +
Sbjct: 112 IILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--------AKT 160
Query: 708 IGLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRP 739
GT Y+APE +G + + + D + G+ P
Sbjct: 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 202
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (302), Expect = 1e-30
Identities = 45/214 (21%), Positives = 72/214 (33%), Gaps = 38/214 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIIT 595
+G GSFG V+ + A+KV+ + E L + H +I++
Sbjct: 12 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 71
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ +Y+E G L L +S V L
Sbjct: 72 TFQDAQQI-----FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV---------CLAL 117
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
+ +++ DLKP N+LLD + + DFG AK++ D L GT
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----------LCGTPD 166
Query: 716 YVAPEYGMGSEASMTGDIF----------TGRRP 739
Y+APE + + D + G P
Sbjct: 167 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 63/316 (19%), Positives = 120/316 (37%), Gaps = 42/316 (13%)
Query: 526 LSKATGEFSSSNMIGQGSFGYVYKGT-LGEDEMIVAVKVINLKY--KGASRSFVAECEAL 582
L +A ++ IG+G++G V+K L VA+K + ++ +G S + E L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 583 RNI---RHRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLI 639
R++ H N++++ +C+ + VFE+++ + +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTE 116
Query: 640 QRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDT 699
++ + +++LH H +VH DLKP N+L+ + DFGLA+ S T
Sbjct: 117 TIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 173
Query: 700 AVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDI----------FTGRRPIDAVFNEGHS 749
+V T+ Y APE + S + D+ F + +
Sbjct: 174 SV---------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL 224
Query: 750 LHEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKT--EECLNAIIRTGVLCSMES 807
LP + D +L + + S +K V E + +++ C +
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK----CLTFN 280
Query: 808 PFERMDMRDVVAKLCH 823
P +R+ L H
Sbjct: 281 PAKRISAYSA---LSH 293
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 9e-30
Identities = 46/228 (20%), Positives = 96/228 (42%), Gaps = 29/228 (12%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHR 588
++ IGQG+FG V+K + VA+K + ++ +G + + E + L+ ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 589 NLIKIITICSSTDFKGTDFKA---FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIA 645
N++ +I IC + K VF++ E+ + + K +L + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV------LVKFTLSEIKRVM 123
Query: 646 IDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPS 705
+ + L++ + ++H D+K +NVL+ D V + DFGLA+ S + + +
Sbjct: 124 QMLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 706 SSIGLKGTVGYVAPEYGMG-----------SEASMTGDIFTGRRPIDA 742
T+ Y PE +G + +++T +
Sbjct: 181 ----RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 1e-28
Identities = 53/204 (25%), Positives = 85/204 (41%), Gaps = 28/204 (13%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK-----GASRSFVAECEALRNIRHRNLI 591
+ +G+G F VYK IVA+K I L ++ G +R+ + E + L+ + H N+I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
++ + VF++ME S L+ +
Sbjct: 64 GLLDAFGHKSNI-----SLVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQG 112
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+EYLH H ++H DLKP+N+LLD + V + DFGLAK +
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--------PNRAYTHQV 161
Query: 712 GTVGYVAPEYGMGSEA-SMTGDIF 734
T Y APE G+ + D++
Sbjct: 162 VTRWYRAPELLFGARMYGVGVDMW 185
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 113 bits (284), Expect = 2e-28
Identities = 39/201 (19%), Positives = 71/201 (35%), Gaps = 21/201 (10%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
IG+GSFG +++GT + VA+K + + E + + I +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH 658
V + + K S+ A + + ++ +H
Sbjct: 71 QEG----LHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 659 CQPPMVHGDLKPSNVLLD-----HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGT 713
+V+ D+KP N L+ + + +V DFG+ KF D + L GT
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK-NLSGT 176
Query: 714 VGYVAPEYGMGSEASMTGDIF 734
Y++ +G E S D+
Sbjct: 177 ARYMSINTHLGREQSRRDDLE 197
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 113 bits (284), Expect = 5e-28
Identities = 55/307 (17%), Positives = 109/307 (35%), Gaps = 52/307 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITIC 597
+G+G + V++ + V VK++ K + E + L N+R N+I + I
Sbjct: 43 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 99
Query: 598 SSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH 657
+ A VFE++ N K L+ ++ A++Y H
Sbjct: 100 KDPV---SRTPALVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHS 147
Query: 658 HCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
++H D+KP NV++DH+ + D+GLA+F Q + +
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR---------VASRYF 195
Query: 717 VAPEYGMGSEA-SMTGDIF----------TGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765
PE + + + D++ + P + L AK E + +
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255
Query: 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGV-------LCSM--ESPFERMDMRD 816
+D + N ++ R + E +++ + V L + R+ R+
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315
Query: 817 VVAKLCH 823
+ H
Sbjct: 316 A---MEH 319
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 9e-28
Identities = 42/206 (20%), Positives = 75/206 (36%), Gaps = 33/206 (16%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS------FVAECEALRNIRHRNLIK 592
+G G F V K + A K I + +SR E L+ I+H N+I
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 593 IITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAM 652
+ + + + E + G L D+L + + E ++++ +
Sbjct: 78 LHEVYEN-----KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI---------L 123
Query: 653 EYLHHHCQPPMVHGDLKPSNVLLDHDMVA----HVCDFGLAKFLSDHQLDTAVKTPSSSI 708
+++ + H DLKP N++L V + DFGLA + +
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI------- 176
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDIF 734
GT +VAPE + D++
Sbjct: 177 --FGTPEFVAPEIVNYEPLGLEADMW 200
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-27
Identities = 49/221 (22%), Positives = 79/221 (35%), Gaps = 35/221 (15%)
Query: 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHR 588
+F ++G+G+FG V A+K++ + K V E L+N RH
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 589 NLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDV 648
L + + D FV EY G L L + + + ++
Sbjct: 66 FLTALKYAFQTHDRL-----CFVMEYANGGELFFHLSRE------RVFTEERARFYGAEI 114
Query: 649 ASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSI 708
SA L + +V+ D+K N++LD D + DFGL K ++
Sbjct: 115 VSA---LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------ATMK 163
Query: 709 GLKGTVGYVAPEYGMGSEASMTGDIF----------TGRRP 739
GT Y+APE ++ D + GR P
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 5e-27
Identities = 44/209 (21%), Positives = 83/209 (39%), Gaps = 29/209 (13%)
Query: 525 ELSKATGEFSSS----NMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAE 578
E++K E + +G G++G V G VA+K + + + ++ E
Sbjct: 8 EVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE 67
Query: 579 CEALRNIRHRNLIKIITICSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLS 637
L+++RH N+I ++ + + + + V +M K H+ KL
Sbjct: 68 LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE--------KLG 119
Query: 638 LIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQL 697
+ + + + Y+H ++H DLKP N+ ++ D + DFGLA+ D ++
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEM 175
Query: 698 DTAVKTPSSSIGLKGTVGYVAPEYGMGSE 726
V T Y APE +
Sbjct: 176 TGYVVTR----------WYRAPEVILNWM 194
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-26
Identities = 47/286 (16%), Positives = 83/286 (29%), Gaps = 57/286 (19%)
Query: 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRS------FVAECEALRN 584
++ ++G G FG VY G D + VA+K + E L+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 585 IR--HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRV 642
+ +I+++ D + E E E L
Sbjct: 64 VSSGFSGVIRLLDWFER-----PDSFVLILERPEPVQDLFDFIT-----ERGALQEELAR 113
Query: 643 NIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MVAHVCDFGLAKFLSDHQLDTAV 701
+ V A+ + H+ ++H D+K N+L+D + + DFG L D
Sbjct: 114 SFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD 170
Query: 702 KTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIF----------TGRRPIDAVFNEGHSL 750
GT Y PE+ + ++ G P F +
Sbjct: 171 ----------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----FEHDEEI 216
Query: 751 HEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQED--KRVKTEECLN 794
+ ++V S ++ + R EE N
Sbjct: 217 IR-GQVFFRQRV-----SSECQHLI--RWCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 4e-26
Identities = 52/294 (17%), Positives = 104/294 (35%), Gaps = 29/294 (9%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITI 596
IG+G++G V+K E IVA+K + L +G S + E L+ ++H+N++++ +
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
S VFE+ + K + + D + + + + H
Sbjct: 70 LHSDKKLT-----LVFEFCDQDLKKYFDSCNGDLDP------EIVKSFLFQLLKGLGFCH 118
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSD------HQLDTAVKTPSSSIGL 710
++H DLKP N+L++ + + +FGLA+ ++ T P +
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 711 KGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770
+ G + ++ RP+ + L + + +
Sbjct: 176 AKLYSTSIDMWSAG---CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232
Query: 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVL-CSMESPFERMDMRDVVAKLCH 823
L + V LNA R + +P +R+ + L H
Sbjct: 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA---LQH 283
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 7e-26
Identities = 40/199 (20%), Positives = 79/199 (39%), Gaps = 24/199 (12%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITI 596
IG G+ G V + VA+K ++ + + ++ E ++ + H+N+I ++ +
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 597 CSSTDFKGTDFKAF-VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
+ + V E M+ + + D + + + + +++L
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE---------RMSYLLYQMLCGIKHL 135
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
H ++H DLKPSN+++ D + DFGLA+ + T T
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---------VVTRY 183
Query: 716 YVAPEYGMGSEASMTGDIF 734
Y APE +G DI+
Sbjct: 184 YRAPEVILGMGYKENVDIW 202
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 106 bits (266), Expect = 1e-25
Identities = 47/217 (21%), Positives = 73/217 (33%), Gaps = 38/217 (17%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIIT 595
+G GSFG V E A+K+++ + + E L+ + L+K+
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 596 ICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYL 655
V EY+ G + L + + S A + EYL
Sbjct: 109 SFKDNSNLY-----MVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYL 157
Query: 656 HHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVG 715
H +++ DLKP N+L+D V DFG AK + L GT
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----------LCGTPE 203
Query: 716 YVAPEYGMGSEASMTGDIF----------TGRRPIDA 742
+APE + + D + G P A
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (261), Expect = 2e-25
Identities = 49/220 (22%), Positives = 86/220 (39%), Gaps = 34/220 (15%)
Query: 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNL 590
F IG+G++G VYK +VA+K I L +G + + E L+ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 591 IKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVAS 650
+K++ + + + VFE++ L + D + + L + +
Sbjct: 64 VKLLDVIHTENKL-----YLVFEFLHQ-----DLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 651 AMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGL 710
+ + H H ++H DLKP N+L++ + + DFGLA+ +
Sbjct: 114 GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--------RTYTHE 162
Query: 711 KGTVGYVAPE-YGMGSEASMTGDIF----------TGRRP 739
T+ Y APE S DI+ T R
Sbjct: 163 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 107 bits (266), Expect = 2e-25
Identities = 73/388 (18%), Positives = 138/388 (35%), Gaps = 32/388 (8%)
Query: 46 LRNLVSLNVAENKFSGMFPRS-ICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIG 104
L + + + + ++ + +++L+ +L + G V L NL +
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG------VEYLNNLTQINFS 74
Query: 105 GNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDL 164
N P L N + L + ++ NQ + + L L Q
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 165 DFVTFLTNCSSLKALSLADNQFGGELPHSIAN------LSSTVINFGIGRNQISGTIPPG 218
+ + +++ +S + L++ + + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 219 IRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLEL 278
+ L NL A NQ+ P I NL +L L N L+ L +LT L +L+L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 279 SSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPL 338
++N + P L L N+++ P L+ T + ++
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS----- 301
Query: 339 QVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELN 398
+ +LKNL L + N S + P +S+ L+ L ++N SL+ L +I L+
Sbjct: 302 PISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLS 357
Query: 399 VSSNNLSGQIPEFLKNLSVLEFLSLSYN 426
N +S P L NL+ + L L+
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.5 bits (231), Expect = 7e-21
Identities = 79/399 (19%), Positives = 142/399 (35%), Gaps = 42/399 (10%)
Query: 4 LAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMF 63
+ +T + +L + ++ + K + L NL +N + N+ + +
Sbjct: 27 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTDIT 82
Query: 64 PRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLE 123
P + N++ L I + N+ + P + N + N +
Sbjct: 83 P--LKNLTKLVDILMNNNQIADITPLANLTN-------------------LTGLTLFNNQ 121
Query: 124 LLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLAD 183
+ D+ + N++ S + ++ + + VT L ++L L D
Sbjct: 122 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLD 181
Query: 184 NQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAI 243
S+ + + + NQIS P GI NL NQL +
Sbjct: 182 ISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTL 237
Query: 244 GELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTAS 303
L NL L L N + P L LTKL L+L +N + P L L + +
Sbjct: 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELN 293
Query: 304 QNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGT 363
+N+L P L T YL L N ++ P+ L L L ++N+ S +
Sbjct: 294 ENQLEDISPISNLKNLT---YLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSS 346
Query: 364 LSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402
L+ + +L N + P L+ L I +L ++
Sbjct: 347 LANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.7 bits (177), Expect = 4e-14
Identities = 84/410 (20%), Positives = 142/410 (34%), Gaps = 60/410 (14%)
Query: 78 LALNRFSGNLPFDIVVNLPNLK---ALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKG 134
L + + P + + L +G N ++ S ++ + L K
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIK- 57
Query: 135 NVSID-FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHS 193
SID L NL +N N L +T L N + L + + +NQ P +
Sbjct: 58 --SIDGVEYLNNLTQINFSNNQLTD--------ITPLKNLTKLVDILMNNNQIADITPLA 107
Query: 194 IANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLC 253
G+ T ++NL NL N + +
Sbjct: 108 NLTN-----LTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFG 162
Query: 254 LFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPH 313
L NLT L L++SSN + + NL S A+ N+++ P
Sbjct: 163 NQVTD-----LKPLANLTTLERLDISSNKVSDISVLA--KLTNLESLIATNNQISDITPL 215
Query: 314 QLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYL 373
+L+ L L+ N L + L NL LD+++NQ S + P LS L L
Sbjct: 216 GILTNLD---ELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268
Query: 374 DISSNSFHGVIPLS--------------------LSFLKSIKELNVSSNNLSGQIPEFLK 413
+ +N + PL+ +S LK++ L + NN+S P +
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VS 326
Query: 414 NLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDELHLPS 463
+L+ L+ L + N V + +N +S N ++ +L
Sbjct: 327 SLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHN-QISDLTPLANLTR 374
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.0 bits (170), Expect = 3e-13
Identities = 41/184 (22%), Positives = 73/184 (39%), Gaps = 21/184 (11%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L L++N N L + +L++L + + N + P L L L L + N+ S
Sbjct: 221 LDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 276
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ P ++ L + + + NL NL L + NN P +S+ +
Sbjct: 277 NISP-----LAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLT 329
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L+ L + N+ S ++L N+ WL+ N + +T L N + + L
Sbjct: 330 KLQRLFFANNKVSDVSS--LANLTNINWLSAGHNQISD--------LTPLANLTRITQLG 379
Query: 181 LADN 184
L D
Sbjct: 380 LNDQ 383
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 1e-24
Identities = 36/203 (17%), Positives = 81/203 (39%), Gaps = 12/203 (5%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGAS--RSFVAECEALRNIRHRNLIKIITI 596
+G G++G V + + VAVK ++ ++ + E L++++H N+I ++ +
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLH 656
+ ++ ++ L + + KL+ + + ++Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIH 138
Query: 657 HHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGY 716
++H DLKPSN+ ++ D + DFGLA+ D + + +
Sbjct: 139 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 717 VAPEYGMGSEASMTGDIFTGRRP 739
+ S + ++ TGR
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 102 bits (254), Expect = 2e-24
Identities = 58/306 (18%), Positives = 110/306 (35%), Gaps = 51/306 (16%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKII 594
IG+G++G VYK E A+K I L+ +G + + E L+ ++H N++K+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEY 654
+ T + + + LK L + L + + + + + + Y
Sbjct: 67 DVIH------TKKRLVLVFEHLDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAY 115
Query: 655 LHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL--SDHQLDTAVKTPSSSIGLKG 712
H ++H DLKP N+L++ + + DFGLA+ + + T
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-------- 164
Query: 713 TVGYVAPEYGMGSEA-SMTGDIF----------TGRRPIDAVFNEGH--SLHEFAKTALP 759
Y AP+ MGS+ S T DI+ G V + T
Sbjct: 165 --WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVK--TEECLNAIIRTGVLCSMESPFERMDMRDV 817
+ + + T + + +K E ++ + + P +R+ +
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK----MLKLDPNQRITAKQA 278
Query: 818 VAKLCH 823
L H
Sbjct: 279 ---LEH 281
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (242), Expect = 5e-23
Identities = 46/257 (17%), Positives = 84/257 (32%), Gaps = 5/257 (1%)
Query: 174 SSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEEN 233
++ + + L N+ S + I + + ++
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 234 QLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGN 293
QL P L L L L R LQ P L L L L N+LQ + +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 294 CQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISS 353
NL N+++ + +L L N + P L L+ L + +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 354 NQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLK 413
N S + L+ L+YL ++ N + +++ SS+ + +P+ L
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLA 269
Query: 414 NLSVLEFLSLSYNHFEG 430
+ L+ N +G
Sbjct: 270 GRDLKR---LAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 2e-12
Identities = 33/171 (19%), Positives = 55/171 (32%), Gaps = 2/171 (1%)
Query: 263 IPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS 322
+P G+ ++ + L N + +S C+NL N L + L
Sbjct: 26 VPVGIPAASQ--RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 323 LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHG 382
N L P L L L + + PG L+YL + N+
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 383 VIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVP 433
+ + L ++ L + N +S + L L+ L L N P
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 3e-12
Identities = 51/263 (19%), Positives = 86/263 (32%), Gaps = 11/263 (4%)
Query: 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82
+ + I + GN + + RNL L + N + + + ++ LE + L+ N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSS 142
++ L L L + P + L+ L L N + F
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 143 LKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVI 202
L NL L L N + + SL L L N+ PH+ +L +
Sbjct: 152 LGNLTHLFLHGNRISS------VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205
Query: 203 NFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGR 262
+ + N +S + L L +N A LQK + +
Sbjct: 206 LY-LFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCS 263
Query: 263 IPSGLGNLTKLANLELSSNSLQG 285
+P L L++N LQG
Sbjct: 264 LPQRLAGRDL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 3e-12
Identities = 40/217 (18%), Positives = 63/217 (29%), Gaps = 3/217 (1%)
Query: 238 TIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNL 297
+P I Q++ L N + + L L L SN L ++ L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 298 MSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFS 357
S N ++ L L L P L L L + N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 358 GVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSV 417
+ T L +L + N V + L S+ L + N ++ P ++L
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 418 LEFLSLSYNHFEG-EVPTKGVFSNKTKISLQGNMKLC 453
L L L N+ + L N +C
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (138), Expect = 1e-09
Identities = 44/247 (17%), Positives = 81/247 (32%), Gaps = 34/247 (13%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNS-------------------------L 35
Q + ++ N ++ +L ++ + N L
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 36 GGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNL 95
P T L L +L++ + P +++L+ + L N LP D +L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDL 152
Query: 96 PNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNN 155
NL L + GN + +L+ L L N+ F L L+ L L NN
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 156 LGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTI 215
L L +L+ L L DN + + L + + F +++ ++
Sbjct: 213 LSA------LPTEALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSL 264
Query: 216 PPGIRNL 222
P +
Sbjct: 265 PQRLAGR 271
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 99.0 bits (245), Expect = 8e-23
Identities = 42/220 (19%), Positives = 78/220 (35%), Gaps = 25/220 (11%)
Query: 539 IGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICS 598
+G G F V+ + VA+K++ K + + E + L+ + + K ++ +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 599 STDFK-----GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAME 653
+ K V M L + L + E + LI I+ + ++
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 654 YLHHHCQPPMVHGDLKPSNVLLD-HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKG 712
Y+H C ++H D+KP NVL++ D ++ +A A
Sbjct: 140 YMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADL------GNACWYDEHYTNSIQ 191
Query: 713 TVGYVAPEYGMGSEASMTGDI----------FTGRRPIDA 742
T Y +PE +G+ DI TG +
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 8e-22
Identities = 44/220 (20%), Positives = 82/220 (37%), Gaps = 39/220 (17%)
Query: 539 IGQGSFGYVYKG---TLGEDEMIVAVKVINLKY----KGASRSFVAECEALRNIRHRNLI 591
+G G++G V+ + + + A+KV+ + E + L +IR +
Sbjct: 32 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 91
Query: 592 KIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASA 651
+ T+ + +Y+ G L L Q + E + I V
Sbjct: 92 VTLHYAFQTE----TKLHLILDYINGGELFTHLSQRERFTEHE---------VQIYVGEI 138
Query: 652 MEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLK 711
+ L H + +++ D+K N+LLD + + DFGL+K + + A
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC------- 191
Query: 712 GTVGYVAPEYGMGSEASMTG--DIF----------TGRRP 739
GT+ Y+AP+ G ++ D + TG P
Sbjct: 192 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 92.9 bits (229), Expect = 4e-21
Identities = 68/267 (25%), Positives = 109/267 (40%), Gaps = 9/267 (3%)
Query: 201 VINFGIGRNQISG--TIPPGIRNLVNLIGFG-AEENQLHGTIPDAIGELKNLQKLCLFRN 257
V N + + IP + NL L N L G IP AI +L L L +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 258 FLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLS 317
+ G IP L + L L+ S N+L G +P S+ + NL+ T N+++GA+P S
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 318 ITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISS 377
+ L + +S N L G +P +L + S L +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 378 NSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGV 437
+ + K++ L++ +N + G +P+ L L L L++S+N+ GE+P G
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 438 FSNKTKISLQGNMKLCGGIDELHLPSC 464
+ N LCG LP+C
Sbjct: 290 LQRFDVSAYANNKCLCGS----PLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 62.1 bits (149), Expect = 8e-11
Identities = 56/296 (18%), Positives = 96/296 (32%), Gaps = 37/296 (12%)
Query: 1 LQTLAVNDNYLTG--QLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENK 58
+ L ++ L +P + NL L + I G N
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGI-----------------------NN 88
Query: 59 FSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSN 118
G P +I ++ L + + SG D + + L L N G++P S+S+
Sbjct: 89 LVGPIPPAIAKLTQLHYLYITHTNVSGA-IPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 119 ASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKA 178
NL + N+ G + + S L N TG L +
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRN 207
Query: 179 LSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGT 238
+ D + + + ++ + +L N N+++GT
Sbjct: 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRN--------NRIYGT 259
Query: 239 IPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNC 294
+P + +LK L L + N L G IP GNL + ++N P L C
Sbjct: 260 LPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP--LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.4 bits (103), Expect = 4e-05
Identities = 36/141 (25%), Positives = 57/141 (40%), Gaps = 2/141 (1%)
Query: 265 SGLGNLTKLANLELSSNSLQGN--IPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS 322
++ NL+LS +L IPSSL N L ++ T
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 323 LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHG 382
YL +++ ++G++P + +K LV LD S N SG +P ++S+ L + N G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 383 VIPLSLSFLKSIKELNVSSNN 403
IP S + S N
Sbjct: 164 AIPDSYGSFSKLFTSMTISRN 184
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.8 bits (216), Expect = 2e-19
Identities = 46/236 (19%), Positives = 92/236 (38%), Gaps = 6/236 (2%)
Query: 195 ANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCL 254
+L + N+I+ +NL NL N++ P A L L++L L
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL 86
Query: 255 FRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQ 314
+N L+ L +L E ++ ++ + L + + K +G
Sbjct: 87 SKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGA 145
Query: 315 LLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLD 374
+ LS +++ + + G +L L + N+ + V +L L L
Sbjct: 146 FQGMKKLSYI-RIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 375 ISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEG 430
+S NS V SL+ ++EL++++N L ++P L + ++ + L N+
Sbjct: 202 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 256
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.4 bits (215), Expect = 3e-19
Identities = 48/237 (20%), Positives = 79/237 (33%), Gaps = 9/237 (3%)
Query: 214 TIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTK 272
+P + + L + N++ LKNL L L N + P L K
Sbjct: 24 KVPKDLPPDTALLD---LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 273 LANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLL 332
L L LS N L+ Q L K+ ++ + L + + L +
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN--PLKS 138
Query: 333 NGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLK 392
+G +K L + I+ + + G + L L + N V SL L
Sbjct: 139 SGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS---LTELHLDGNKITKVDAASLKGLN 195
Query: 393 SIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGN 449
++ +L +S N++S L N L L L+ N + L N
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 252
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.5 bits (210), Expect = 1e-18
Identities = 63/326 (19%), Positives = 106/326 (32%), Gaps = 40/326 (12%)
Query: 68 CNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDL 127
C++ ++ L L + +LP P+ L + N N NL L L
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLP-------PDTALLDLQNNKITEIKDGDFKNLKNLHTLIL 62
Query: 128 SVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFG 187
N+ F+ L L L L +N L + L + + + F
Sbjct: 63 INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQEL-RVHENEITKVRKSVFN 121
Query: 188 GELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELK 247
G + L + + SG + + L + + TIP +
Sbjct: 122 GLNQMIVVELGTN-------PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PP 171
Query: 248 NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKL 307
+L +L L N + + L L LA L LS NS+ SL N +L + NKL
Sbjct: 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231
Query: 308 TGALPHQLLSITTLSLYLDLSNNLLNG------SLPLQVGHLKNLVILDISSNQFSGVIP 361
P L + + L NN ++ P + + + SN
Sbjct: 232 VKV-PGGLADHKYIQ-VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP------ 283
Query: 362 GTLSTCVCLEYLDISSNSFHGVIPLS 387
++Y +I ++F V +
Sbjct: 284 --------VQYWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 85.1 bits (209), Expect = 1e-18
Identities = 52/262 (19%), Positives = 92/262 (35%), Gaps = 13/262 (4%)
Query: 174 SSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEEN 233
L L +N+ NL + + + N+IS P LV L +N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKN-LHTLILINNKISKISPGAFAPLVKLERLYLSKN 89
Query: 234 QLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGN 293
QL L+ L+ ++ + +GL + + L + G +
Sbjct: 90 QLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQG 148
Query: 294 CQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISS 353
+ L + +T S+T L L N + + L NL L +S
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLT----ELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 354 NQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSG------Q 407
N S V G+L+ L L +++N +P L+ K I+ + + +NN+S
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263
Query: 408 IPEFLKNLSVLEFLSLSYNHFE 429
P + + +SL N +
Sbjct: 264 PPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.1 bits (178), Expect = 1e-14
Identities = 56/284 (19%), Positives = 100/284 (35%), Gaps = 20/284 (7%)
Query: 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNR 82
D ++ + N + L+NL +L + NK S + P + + LE + L+ N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 83 FSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSS 142
LP + L L+ S+ L+ +EL + G + F
Sbjct: 91 LK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-LKSSGIENGAFQG 148
Query: 143 LKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVI 202
+K L ++ + N+ T SL L L N+ S+ L + +
Sbjct: 149 MKKLSYIRIADTNITT---------IPQGLPPSLTELHLDGNKITKVDAASLKGL-NNLA 198
Query: 203 NFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQG- 261
G+ N IS + N +L N+L +P + + K +Q + L N +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257
Query: 262 -----RIPSGLGNLTKLANLELSSNSLQ-GNIPSSLGNCQNLMS 299
P + + L SN +Q I S C + +
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 67.4 bits (163), Expect = 1e-12
Identities = 43/286 (15%), Positives = 94/286 (32%), Gaps = 21/286 (7%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L + +N +T NL +L + ++ N + P L L L +++N+
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 61 GMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNAS 120
+ + + L + + + + ++ + N + L G +
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGL--NQMIVVELGTNPLKSSGIENGAFQGMK 150
Query: 121 NLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L + ++ +I +L L+L+ N + A L ++L L
Sbjct: 151 KLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLK------GLNNLAKLG 201
Query: 181 LADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIP 240
L+ N S+AN + + N +P G+ + + N +
Sbjct: 202 LSFNSISAVDNGSLAN--TPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGS 259
Query: 241 DA------IGELKNLQKLCLFRNFLQGR--IPSGLGNLTKLANLEL 278
+ + + + LF N +Q PS + A ++L
Sbjct: 260 NDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 5e-19
Identities = 25/167 (14%), Positives = 51/167 (30%), Gaps = 29/167 (17%)
Query: 537 NMIGQGSFGYVYKGTLGEDEMIVAVKVINL----------KYKGASRSFVAECEALRNIR 586
++G+G V+ + VK + K F
Sbjct: 6 KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 587 HRNLIKIITICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAI 646
R L K+ + + + A + E ++ L ++ D+ +
Sbjct: 65 FRALQKLQGLAVPKVY-AWEGNAVLMELIDAKELYRVRVENPDE-------------VLD 110
Query: 647 DVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLS 693
+ + +H +VHGDL NVL+ + + DF + +
Sbjct: 111 MILEEVAKFYHRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 41/270 (15%), Positives = 83/270 (30%), Gaps = 8/270 (2%)
Query: 32 GNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDI 91
G +L + L L + +++ + ++ + L+ + + I
Sbjct: 9 GKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSP-FRVQHMDLSNSVIEVSTLHGI 66
Query: 92 VVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLS--VNQFKGNVSIDFSSLKNLLWL 149
+ L+ L++ G I +L+ SNL L+LS + + SS L L
Sbjct: 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126
Query: 150 NLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRN 209
NL T + + L N +L + + V
Sbjct: 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV 186
Query: 210 QISGTIPPGIRNLVNLIGFGAEE-NQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLG 268
+ L L + +GE+ L+ L +F G +
Sbjct: 187 MLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE 246
Query: 269 NLTKLANLELSSNSLQGNIPSSLGNCQNLM 298
L +L+++ + ++GN +N
Sbjct: 247 ALP---HLQINCSHFTTIARPTIGNKKNQE 273
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 4e-06
Identities = 41/280 (14%), Positives = 83/280 (29%), Gaps = 24/280 (8%)
Query: 147 LW--LNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINF 204
LW L+L NL L + A + L + ++
Sbjct: 1 LWQTLDLTGKNLHPDVTGRLLSQ-------GVIAFRCPRSFMDQPLAEHFSPFRVQHMD- 52
Query: 205 GIGRNQISGTIPPGI-RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFR--NFLQG 261
+ + I + GI L E +L I + + + NL +L L F +
Sbjct: 53 -LSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF 111
Query: 262 RIPSGLGNLTKLANL------ELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQL 315
+ + L + ++L L + + +Q + L +N L +
Sbjct: 112 ALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLV 171
Query: 316 LSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISS-NQFSGVIPGTLSTCVCLEYLD 374
L + +L + L L L +S L L+ L
Sbjct: 172 RRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 231
Query: 375 ISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKN 414
+ G + L +++ L ++ ++ + + N
Sbjct: 232 VFGIVPDGTLQL---LKEALPHLQINCSHFTTIARPTIGN 268
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.3 bits (134), Expect = 3e-09
Identities = 33/193 (17%), Positives = 49/193 (25%), Gaps = 17/193 (8%)
Query: 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLG-------- 157
++P L + +L LS N L LNL++ L
Sbjct: 19 KRNLTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTL 76
Query: 158 ------TGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQI 211
+ L + L + LP + + N++
Sbjct: 77 PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136
Query: 212 SGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLT 271
P + L N L + L+NL L L N L IP G
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSH 195
Query: 272 KLANLELSSNSLQ 284
L L N
Sbjct: 196 LLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (126), Expect = 3e-08
Identities = 46/191 (24%), Positives = 71/191 (37%), Gaps = 6/191 (3%)
Query: 263 IPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS 322
+P L T L LS N L ++L L + +LT L
Sbjct: 25 LPPDLPKDTT--ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLP----V 78
Query: 323 LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHG 382
L ++ SLPL L L +LD+S N+ + + G L L+ L + N
Sbjct: 79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138
Query: 383 VIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKT 442
+ P L+ +++L++++NNL+ L L L+ L L N
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLP 198
Query: 443 KISLQGNMKLC 453
L GN LC
Sbjct: 199 FAFLHGNPWLC 209
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 13/59 (22%), Positives = 21/59 (35%), Gaps = 3/59 (5%)
Query: 323 LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFH 381
L ++ L +LP + K+ IL +S N TL L L++
Sbjct: 13 LEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 12/67 (17%), Positives = 20/67 (29%), Gaps = 8/67 (11%)
Query: 367 CVC-----LEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFL 421
C ++ + +P L K L++S N L L + L L
Sbjct: 4 CEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 422 SLSYNHF 428
+L
Sbjct: 61 NLDRAEL 67
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.5 bits (88), Expect = 0.002
Identities = 31/178 (17%), Positives = 55/178 (30%), Gaps = 25/178 (14%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L +++N L + + L + + G L L +L+++ N+
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTKLQVDGTLPVLGTLDLSHNQLQ 90
Query: 61 GMFP------------RSICNISSLELIQLALNR----------FSGNLPFDIVVNLPNL 98
+ S ++SL L L LP ++ P L
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 99 KALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156
+ L++ NN L+ NL+ L L N + F L + L N
Sbjct: 151 EKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 55.4 bits (132), Expect = 5e-09
Identities = 42/217 (19%), Positives = 73/217 (33%), Gaps = 21/217 (9%)
Query: 221 NLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSS 280
L N I A ++ + T+ A +L + L F + G+ L L LEL
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 281 NSLQGNIPSS------LGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNG 334
N + P S ++ L+ T ++ L+
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 335 SLPLQVGHLKNLVILDI-------SSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLS 387
L L + + N+ L S L+ L L N + PL+
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLA 192
Query: 388 LSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLS 424
L ++ E+++ +N +S P L N S L ++L+
Sbjct: 193 --SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 3e-06
Identities = 42/238 (17%), Positives = 78/238 (32%), Gaps = 27/238 (11%)
Query: 118 NASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLK 177
+N + + V+ + L + L+ + T ++ V +L N L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-----TTIEGVQYLNN---LI 66
Query: 178 ALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHG 237
L L DNQ P + + G +S ++L +
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 238 TIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNL 297
+ + +L ++ LS + Q + + L N L
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQ-----------YLSIGNAQVSDLTPLANLSKL 175
Query: 298 MSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQ 355
+ A NK++ P L S+ L + L NN ++ PL + NL I+ + +NQ
Sbjct: 176 TTLKADDNKISDISP--LASLPNLI-EVHLKNNQISDVSPL--ANTSNLFIVTL-TNQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 8e-06
Identities = 32/218 (14%), Positives = 64/218 (29%), Gaps = 17/218 (7%)
Query: 94 NLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLE 152
L N +A G +N ++ + ++ + L +I+ L NL+ L L+
Sbjct: 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT---TIEGVQYLNNLIGLELK 71
Query: 153 QNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQIS 212
N + S +++ + + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 213 GTIPPGIRNLVNLIGFGAEENQLHG-------TIPDAIGELKNLQKLCLFRNFLQGRIPS 265
+ + + N+ N + + + L L L N + P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 266 GLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTAS 303
L +L L + L +N + P L N NL T +
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 15/67 (22%), Positives = 22/67 (32%), Gaps = 4/67 (5%)
Query: 86 NLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKN 145
+ NL L L N P L++ NL + L NQ ++ N
Sbjct: 163 VSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSN 218
Query: 146 LLWLNLE 152
L + L
Sbjct: 219 LFIVTLT 225
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.0 bits (124), Expect = 1e-08
Identities = 28/109 (25%), Positives = 48/109 (44%), Gaps = 6/109 (5%)
Query: 324 YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV 383
L L++ L ++ + L + LD+S N+ + P L+ CLE L S N+ V
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58
Query: 384 IPLSLSFLKSIKELNVSSNNL-SGQIPEFLKNLSVLEFLSLSYNHFEGE 431
++ L ++EL + +N L + L + L L+L N E
Sbjct: 59 DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.2 bits (114), Expect = 2e-07
Identities = 27/111 (24%), Positives = 40/111 (36%), Gaps = 7/111 (6%)
Query: 250 QKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTG 309
+ L L L + L L + +L+LS N L+ P+ L + L AS N L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALEN 57
Query: 310 ALPHQLLSITTLSLYLDLSNNLLNG-SLPLQVGHLKNLVILDISSNQFSGV 359
L L L NN L + + LV+L++ N
Sbjct: 58 VDGVANLPRLQ---ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 7e-08
Identities = 13/78 (16%), Positives = 28/78 (35%), Gaps = 3/78 (3%)
Query: 121 NLELLDLSVNQFKGN-VSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKAL 179
+++ LD+ + + L+ + L+ L D+ + L +L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI--SSALRVNPALAEL 60
Query: 180 SLADNQFGGELPHSIANL 197
+L N+ G H +
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 9e-07
Identities = 16/82 (19%), Positives = 30/82 (36%), Gaps = 9/82 (10%)
Query: 361 PGTLSTCVCLEYLDISSNSFHGV----IPLSLSFLKSIKELNVSSNNLSGQIPEFL---- 412
G L L ++ + +L S++EL++S+N L L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 413 -KNLSVLEFLSLSYNHFEGEVP 433
+ +LE L L ++ E+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 2e-06
Identities = 12/67 (17%), Positives = 21/67 (31%), Gaps = 5/67 (7%)
Query: 370 LEYLDISSNSF-HGVIPLSLSFLKSIKELNVSSNNLSGQ----IPEFLKNLSVLEFLSLS 424
++ LDI L L+ + + + L+ I L+ L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 425 YNHFEGE 431
N
Sbjct: 64 SNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 16/94 (17%), Positives = 29/94 (30%), Gaps = 10/94 (10%)
Query: 345 NLVILDISSNQFSGV-IPGTLSTCVCLEYLDISSNSFHGV----IPLSLSFLKSIKELNV 399
++ LDI + S L + + + I +L ++ ELN+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 400 SSNNLSGQIPEFL-----KNLSVLEFLSLSYNHF 428
SN L + ++ LSL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 17/86 (19%), Positives = 29/86 (33%), Gaps = 5/86 (5%)
Query: 116 LSNASNLELLDLSVNQFKGNVSIDFSS----LKNLLWLNLEQNNLGTGTATDLDFVTFLT 171
S L +L L+ + ++ +L L+L N LG L +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL-VESVRQ 423
Query: 172 NCSSLKALSLADNQFGGELPHSIANL 197
L+ L L D + E+ + L
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 6e-06
Identities = 13/94 (13%), Positives = 28/94 (29%), Gaps = 6/94 (6%)
Query: 320 TLSL-YLDLS-NNLLNGSLPLQVGHLKNLVILDISSNQFSGV----IPGTLSTCVCLEYL 373
+L + LD+ L + + L+ ++ + + I L L L
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 374 DISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQ 407
++ SN V + + +L
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 7e-06
Identities = 16/81 (19%), Positives = 30/81 (37%), Gaps = 9/81 (11%)
Query: 344 KNLVILDISSNQFSGV----IPGTLSTCVCLEYLDISSNSFHGVIPLSLS-----FLKSI 394
L +L ++ S + TL L LD+S+N L L +
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 395 KELNVSSNNLSGQIPEFLKNL 415
++L + S ++ + L+ L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 15/87 (17%), Positives = 28/87 (32%), Gaps = 6/87 (6%)
Query: 140 FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGE----LPHSIA 195
L L L ++ + + L L SL+ L L++N G L S+
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSL--AATLLANHSLRELDLSNNCLGDAGILQLVESVR 422
Query: 196 NLSSTVINFGIGRNQISGTIPPGIRNL 222
+ + S + ++ L
Sbjct: 423 QPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 7e-05
Identities = 9/89 (10%), Positives = 26/89 (29%), Gaps = 4/89 (4%)
Query: 72 SLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNF----FGSIPYSLSNASNLELLDL 127
++ + + S +++ L + + + I +L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 128 SVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156
N+ +++ +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 19/88 (21%), Positives = 31/88 (35%), Gaps = 10/88 (11%)
Query: 324 YLDLSNNLLNG----SLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVC-----LEYLD 374
L L++ ++ SL + +L LD+S+N L V LE L
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 375 ISSNSFHGVIPLSL-SFLKSIKELNVSS 401
+ + + L + K L V S
Sbjct: 433 LYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 13/95 (13%), Positives = 32/95 (33%), Gaps = 9/95 (9%)
Query: 296 NLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNG----SLPLQVGHLKNLVILDI 351
++ S +L+ A +LL + + L + L + + L L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 352 SSNQFSGVIPGTL-----STCVCLEYLDISSNSFH 381
SN+ V + + ++ L + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 13/91 (14%), Positives = 31/91 (34%), Gaps = 5/91 (5%)
Query: 1 LQTLAVNDNYLT-GQLPDFVGNLSDLEVIRIMGNSLGGK----IPTTLGLLRNLVSLNVA 55
+Q+L + L+ + + + L +V+R+ L I + L + L LN+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 56 ENKFSGMFPRSICNISSLELIQLALNRFSGN 86
N+ + + ++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 6e-04
Identities = 14/93 (15%), Positives = 32/93 (34%), Gaps = 12/93 (12%)
Query: 269 NLTKLANLELSSNSLQGN----IPSSLGNCQNLMSFTASQNKLTG----ALPHQLLSITT 320
+ L L L+ + + + ++L +L S N L L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 321 LSLYLDLSNNLLNGSLPLQVGHLK----NLVIL 349
L L L + + + ++ L+ +L ++
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 19/90 (21%), Positives = 24/90 (26%), Gaps = 20/90 (22%)
Query: 239 IPDAIGELKNLQKLCLFRNFLQGR----IPSGLGNLTKLANLELSSNSLQGNIPSSLGNC 294
+ + L+ Q + L L I S L LA L L SN L +
Sbjct: 19 WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQ- 77
Query: 295 QNLMSFTASQNKLTGALPHQLLSITTLSLY 324
L I LSL
Sbjct: 78 ---------------GLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 18/95 (18%), Positives = 29/95 (30%), Gaps = 6/95 (6%)
Query: 97 NLKALAIGGNNF-FGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSS----LKNLLWLNL 151
++++L I L +++ L D SS L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 152 EQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186
N LG + T ++ LSL +
Sbjct: 63 RSNELGDVGVHCV-LQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 17/96 (17%), Positives = 27/96 (28%), Gaps = 11/96 (11%)
Query: 94 NLPNLKALAIGGNNF----FGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSS-----LK 144
L+ L + + S+ +L +L LDLS N +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 145 NLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180
L L L L + SL+ +S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQ--ALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 14/93 (15%), Positives = 31/93 (33%), Gaps = 12/93 (12%)
Query: 21 NLSDLEVIRIMGNSLGGK----IPTTLGLLRNLVSLNVAENKFSGMFPRSIC-----NIS 71
S L V+ + + + TL +L L+++ N +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 72 SLELIQLALNRFSGNLPF---DIVVNLPNLKAL 101
LE + L +S + + + P+L+ +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 7e-08
Identities = 19/94 (20%), Positives = 38/94 (40%), Gaps = 9/94 (9%)
Query: 327 LSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPL 386
N + + +L L++S+N+ +P LE L S N +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHL-AEVP- 320
Query: 387 SLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEF 420
+++K+L+V N L + P+ +++ L
Sbjct: 321 --ELPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 20/94 (21%), Positives = 33/94 (35%), Gaps = 10/94 (10%)
Query: 253 CLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALP 312
+ N I S L L +S+N L +P+ + L AS N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP 320
Query: 313 HQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNL 346
++ L + N L P +++L
Sbjct: 321 ELPQNLK----QLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 9e-05
Identities = 18/76 (23%), Positives = 27/76 (35%), Gaps = 8/76 (10%)
Query: 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDF 140
S N + P+L+ L + N +P LE L S N +
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPR---LERLIASFNHLA---EVP- 320
Query: 141 SSLKNLLWLNLEQNNL 156
+NL L++E N L
Sbjct: 321 ELPQNLKQLHVEYNPL 336
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.9 bits (99), Expect = 1e-04
Identities = 20/88 (22%), Positives = 38/88 (43%), Gaps = 10/88 (11%)
Query: 163 DLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNL 222
+ + SL+ L++++N+ ELP L + +F N ++ +P +NL
Sbjct: 273 SNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLIASF----NHLA-EVPELPQNL 326
Query: 223 VNLIGFGAEENQLHGTIPDAIGELKNLQ 250
L E N L PD +++L+
Sbjct: 327 KQLH---VEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 42.5 bits (98), Expect = 2e-04
Identities = 19/89 (21%), Positives = 31/89 (34%), Gaps = 9/89 (10%)
Query: 209 NQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLG 268
N S I +L N+L +P L++L N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQ 324
Query: 269 NLTKLANLELSSNSLQGNIPSSLGNCQNL 297
NL + L + N L+ P + ++L
Sbjct: 325 NLKQ---LHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.7 bits (96), Expect = 2e-04
Identities = 18/90 (20%), Positives = 33/90 (36%), Gaps = 10/90 (11%)
Query: 57 NKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSL 116
N S SLE + ++ N+ ++ P L+ L N+ +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-----ELPALPPRLERLIASFNHL-AEVPELP 323
Query: 117 SNASNLELLDLSVNQFKGNVSIDFSSLKNL 146
N L+ L + N + I S+++L
Sbjct: 324 QN---LKQLHVEYNPLREFPDI-PESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 16/99 (16%), Positives = 29/99 (29%), Gaps = 16/99 (16%)
Query: 127 LSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186
+N + +L LN+ N L + L+ L + N
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKL----------IELPALPPRLERLIASFNHL 316
Query: 187 GGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNL 225
E+P NL + N + P ++ +L
Sbjct: 317 -AEVPELPQNLKQ----LHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 23/83 (27%), Positives = 35/83 (42%), Gaps = 7/83 (8%)
Query: 367 CVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYN 426
L N+ I S++ELNVS+N L ++P LE L S+N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFN 314
Query: 427 HFEGEVPTKGVFSNKTKISLQGN 449
H EVP + N ++ ++ N
Sbjct: 315 HLA-EVP--ELPQNLKQLHVEYN 334
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.002
Identities = 21/75 (28%), Positives = 32/75 (42%), Gaps = 9/75 (12%)
Query: 1 LQTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFS 60
L+ L V++N L +LP L L N L ++P L +NL L+V N
Sbjct: 286 LEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP---ELPQNLKQLHVEYNPLR 337
Query: 61 GMFPRSICNISSLEL 75
FP ++ L +
Sbjct: 338 E-FPDIPESVEDLRM 351
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.3 bits (108), Expect = 3e-06
Identities = 17/104 (16%), Positives = 34/104 (32%), Gaps = 5/104 (4%)
Query: 253 CLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALP 312
L N ++ L +L L L N + +P S + +L S + N
Sbjct: 84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143
Query: 313 HQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQF 356
+ L+ P ++++ I D+ ++F
Sbjct: 144 LAWFA--EWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEF 182
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.9 bits (86), Expect = 0.002
Identities = 24/106 (22%), Positives = 46/106 (43%), Gaps = 5/106 (4%)
Query: 28 IRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNL 87
+++ N + L L +LN+ +N+ S + P S +++SL + LA N F+ N
Sbjct: 83 LQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142
Query: 88 PFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFK 133
K+L G P + + +++ DL ++FK
Sbjct: 143 HLAWFAEWLRKKSLN--GGAARCGAPSKVRD---VQIKDLPHSEFK 183
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 3e-06
Identities = 38/204 (18%), Positives = 71/204 (34%), Gaps = 17/204 (8%)
Query: 221 NLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSS 280
I ++ + + EL ++ ++ + ++ G+ L + L L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77
Query: 281 NSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV 340
N L P L N +NL +NK+ + L + +NG + L
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135
Query: 341 GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVS 400
L I+ S L+ L + N ++P L+ L ++ L +S
Sbjct: 136 LESLYLGNNKITDITVL-------SRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186
Query: 401 SNNLSGQIPEFLKNLSVLEFLSLS 424
N++S L L L+ L L
Sbjct: 187 KNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 39/207 (18%), Positives = 66/207 (31%), Gaps = 22/207 (10%)
Query: 74 ELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFK 133
E I+ L + S L ++ + ++ + N+ L L+ N+
Sbjct: 25 ETIKDNLKKKSVTDAVTQN-ELNSIDQIIANNSDI--KSVQGIQYLPNVTKLFLNGNKLT 81
Query: 134 GNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHS 193
++LKNL WL L++N + ++ +
Sbjct: 82 DI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLE-------------HNGISD 126
Query: 194 IANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLC 253
I L + T + L L E+NQ+ +P + L LQ L
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184
Query: 254 LFRNFLQGRIPSGLGNLTKLANLELSS 280
L +N + L L L LEL S
Sbjct: 185 LSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.3 bits (100), Expect = 9e-05
Identities = 40/327 (12%), Positives = 87/327 (26%), Gaps = 21/327 (6%)
Query: 114 YSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNC 173
+S+ S L+L ++ K + ++ + L N +GT A L + +
Sbjct: 3 FSIEGKS-LKLDAITTEDEKSVFA-VLLEDDSVKEIVLSGNTIGTEAARWL--SENIASK 58
Query: 174 SSLKALSLADNQ---FGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGA 230
L+ +D E+P ++ L ++ +
Sbjct: 59 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAF-GPTAQEPLIDFL 117
Query: 231 EENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSS 290
++ + L + R + + N L ++ N L+
Sbjct: 118 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE 177
Query: 291 LGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILD 350
+ + + + + L + N
Sbjct: 178 WAKTFQSHRLLHTVKMVQNGIRPEGIEHLL-------LEGLAYCQELKVLDLQDNTFTHL 230
Query: 351 ISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVI-PLSLSFLKSIKELNVSSNNLSGQIP 409
SS + + L +S+ V+ S ++ L + N +
Sbjct: 231 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 290
Query: 410 EFL-----KNLSVLEFLSLSYNHFEGE 431
L + + L FL L+ N F E
Sbjct: 291 RTLKTVIDEKMPDLLFLELNGNRFSEE 317
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 7e-04
Identities = 41/312 (13%), Positives = 96/312 (30%), Gaps = 26/312 (8%)
Query: 72 SLELIQLALNRFSGNLPFDIV---VNLPNLKALAIGGNNF----FGSIPYSLSNASNLEL 124
S+E L L+ + + + ++K + + GN + ++++ +LE+
Sbjct: 4 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63
Query: 125 LDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGT-----GTATDLDFVTFLTNCSSLKAL 179
+ S +L+ LL L+ L T + S L
Sbjct: 64 AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
Query: 180 SLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239
G P + A ++ + + + + I N + G+ +
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183
Query: 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMS 299
+ + + + ++ + GL +L L+L N+ S+L
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243
Query: 300 FTASQ----NKLTGALPHQLLSITTLS-----LYLDLSNNLLNGSLPLQV-----GHLKN 345
L+ ++ + L L N + + + +
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303
Query: 346 LVILDISSNQFS 357
L+ L+++ N+FS
Sbjct: 304 LLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 0.001
Identities = 51/325 (15%), Positives = 99/325 (30%), Gaps = 25/325 (7%)
Query: 97 NLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGN----VSIDFSSLKNLLWLNLE 152
+LK AI + S+ L +++ + LS N +S + +S K+L
Sbjct: 9 SLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 153 QNNLGTGTATDLDFVTFLT----NCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGR 208
G + + L C L + L+DN FG + + S
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 209 NQISGTIPPGIRNLVNLIGFGAEENQLHG-TIPDAIGELKNLQKLCLFRNFLQGRIPSGL 267
+G P + + A + +I +N + + + + L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 268 GNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTG---ALPHQLLSITTLSLY 324
+ K+ + ++ + L CQ L N T + L
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 325 LDLSNNLLNG------SLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVC-----LEYL 373
L L++ LL+ L L + N+ TL T + L +L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 374 DISSNSFHGVIPLSLSFLKSIKELN 398
+++ N F + ++ +
Sbjct: 308 ELNGNRF-SEEDDVVDEIREVFSTR 331
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 34/326 (10%), Positives = 91/326 (27%), Gaps = 28/326 (8%)
Query: 1 LQTLAVNDNYLTGQ----LPDFVGNLSDLEVIRIMGNSLGGK----IPTTLGLLRNLVSL 52
++ ++ + +T + + + ++ I + GN++G + + + ++L
Sbjct: 5 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 53 NVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSI 112
++ + + L L + D + L +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 113 PYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTN 172
L N + + ++++ + ++ + ++ +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 173 CSSLKALSLADNQFGGELP--------HSIANLSSTVINFGIGRNQISGTIPPGIRNLVN 224
L + + N E L + + S + +++ N
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 225 LIGFGAEENQLHGTIPDAIGE------LKNLQKLCLFRNFLQGRIPSGL-----GNLTKL 273
L G + L A+ + LQ L L N ++ L + L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 274 ANLELSSNSLQGNIPSSLGNCQNLMS 299
LEL+ N + + + S
Sbjct: 305 LFLELNGNRF-SEEDDVVDEIREVFS 329
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.004
Identities = 14/71 (19%), Positives = 19/71 (26%), Gaps = 2/71 (2%)
Query: 138 IDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANL 197
L L L+ N + L V L L L N+F E + +
Sbjct: 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVID-EKMPDLLFLELNGNRF-SEEDDVVDEI 324
Query: 198 SSTVINFGIGR 208
G G
Sbjct: 325 REVFSTRGRGE 335
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.6 bits (94), Expect = 2e-04
Identities = 26/144 (18%), Positives = 39/144 (27%), Gaps = 11/144 (7%)
Query: 239 IPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLM 298
+ + + + + L L R L L S+ + N L+
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELL 68
Query: 299 SFTASQNKLTGALPHQLLSITTLSL-YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFS 357
S S N+L + +L L+LS N L L L L + N S
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 358 GVIPGT-------LSTCVCLEYLD 374
L LD
Sbjct: 129 DTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 6e-04
Identities = 25/146 (17%), Positives = 49/146 (33%), Gaps = 9/146 (6%)
Query: 38 KIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLE-LIQLALNRFSGNLPFDIVVNLP 96
++ + + + RS ++ + + L I N+P
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL-----RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIP 65
Query: 97 NLKALAIGGNNF--FGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQN 154
L +L + N + + A NL++L+LS N+ K +D L L L+ N
Sbjct: 66 ELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGN 125
Query: 155 NLGTGTATDLDFVTF-LTNCSSLKAL 179
+L +++ L L
Sbjct: 126 SLSDTFRDQSTYISAIRERFPKLLRL 151
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 41/201 (20%), Positives = 75/201 (37%), Gaps = 17/201 (8%)
Query: 221 NLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSS 280
L + + + T+ +L + L R ++ G+ L L + S+
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSN 71
Query: 281 NSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQV 340
N L P + +Q L + + L+ + +
Sbjct: 72 NQLTDITPLKNLTKLVDILMNNNQIADITPLANL-------TNLTGLTLFNNQITDIDPL 124
Query: 341 GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVS 400
+L NL L++SSN S + + L+ L+ SSN + P L+ L +++ L++S
Sbjct: 125 KNLTNLNRLELSSNTISDISALS--GLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 401 SNNLSGQIPEFLKNLSVLEFL 421
SN +S L L+ LE L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 6e-04
Identities = 8/39 (20%), Positives = 11/39 (28%)
Query: 341 GHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNS 379
VILDIS + + L L +
Sbjct: 198 HGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 6e-04
Identities = 9/58 (15%), Positives = 16/58 (27%)
Query: 367 CVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLS 424
E +N+ + L++S + L+NL L S
Sbjct: 176 TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.002
Identities = 15/86 (17%), Positives = 27/86 (31%), Gaps = 3/86 (3%)
Query: 324 YLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGV 383
L L+ N + + + +N + LDIS H +
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216
Query: 384 IPLSLSFLKSIKELNVSSNNLSGQIP 409
L LK ++ + NL ++P
Sbjct: 217 PSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 21/103 (20%), Positives = 38/103 (36%), Gaps = 5/103 (4%)
Query: 327 LSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPL 386
L+ L+ + Q + LD+ + VI +T + +D S N +
Sbjct: 3 LTAELIEQAA--QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG- 58
Query: 387 SLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFE 429
L+ +K L V++N + + L L L L+ N
Sbjct: 59 -FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Score = 37.9 bits (87), Expect = 0.004
Identities = 12/87 (13%), Positives = 25/87 (28%), Gaps = 7/87 (8%)
Query: 608 KAFVFEYMENGSLKDWLHQSDDQVEVCK-LSLIQRVNIAIDVASAMEYLHHHCQPP---- 662
+ +F + L ++L + E + + + + H +
Sbjct: 134 RKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193
Query: 663 MVHGDLKPSNVLLDHDMVAHVCDFGLA 689
+HGD N+L D A
Sbjct: 194 RLHGDCHAGNILWRDGP--MFVDLDDA 218
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 37.7 bits (86), Expect = 0.004
Identities = 13/87 (14%), Positives = 28/87 (32%), Gaps = 3/87 (3%)
Query: 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHH---CQPP 662
D + + L + + ++ + + D ++L +
Sbjct: 125 DISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELV 184
Query: 663 MVHGDLKPSNVLLDHDMVAHVCDFGLA 689
HGDL SN+ + V+ D G +
Sbjct: 185 FSHGDLGDSNIFVKDGKVSGFIDLGRS 211
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 833 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.87 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.84 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.84 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.83 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.81 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.79 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.64 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.62 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.6 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.59 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.59 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.54 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.53 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.52 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.47 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.44 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.44 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.44 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.64 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.61 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.91 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.72 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.18 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.16 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.13 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.71 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.68 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-49 Score=402.85 Aligned_cols=254 Identities=21% Similarity=0.258 Sum_probs=203.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||+||+|+++.+++.||||+++... ....+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~-----~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-----IQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETT-----EE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc-----ee
Confidence 357999999999999999999999999999999997543 233467899999999999999999999977655 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
|+|||||++|+|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~ 149 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGL 149 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEeccCCCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchh
Confidence 99999999999999997654 699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
|+........ ......+||+.|||||++.+..+ +.++|||| .|+++|++++|..|+.......
T Consensus 150 a~~~~~~~~~------~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwS----------lGvilyeml~G~~pf~~~~~~~ 213 (271)
T d1nvra_ 150 ATVFRYNNRE------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWS----------CGIVLTAMLAGELPWDQPSDSC 213 (271)
T ss_dssp CEECEETTEE------CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHH----------HHHHHHHHHHSSCSCSSSSTTS
T ss_pred heeeccCCcc------ccccceeeCcCccCHhHhcCCCCCCCceeeeH----------hHHHHHHHHhCCCCCCCCChHH
Confidence 9876543221 11234679999999999988876 57899999 8999999999999986332111
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.... ....... .......+++.+.+++.+||+.||++|||++|+++
T Consensus 214 ~~~~-~~~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 214 QEYS-DWKEKKT-----YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHH-HHHTTCT-----TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHH-HHhcCCC-----CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 1111111 01112234567789999999999999999999965
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=403.67 Aligned_cols=251 Identities=22% Similarity=0.272 Sum_probs=208.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+ ..|+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-----ELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-----EEEE
Confidence 47999999999999999999999999999999998666556678999999999999999999999977655 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
|||||++|+|.+++... .+++.+++.++.||+.||+|||++ |||||||||+|||++.++.+||+|||+|+
T Consensus 95 vmEy~~gg~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp EEECCTTCBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecCCCcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhhe
Confidence 99999999999988653 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
.+..... .....+||+.|||||++.+..++.++|||| .|+++|++++|..|+......+.
T Consensus 165 ~~~~~~~--------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS----------lGvilyemltG~~Pf~~~~~~~~-- 224 (293)
T d1yhwa1 165 QITPEQS--------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWS----------LGIMAIEMIEGEPPYLNENPLRA-- 224 (293)
T ss_dssp ECCSTTC--------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHH----------HHHHHHHHHHSSCTTTTSCHHHH--
T ss_pred eeccccc--------cccccccCCCccChhhhcCCCCCchhceeh----------HhHHHHHHhhCCCCCCCCCHHHH--
Confidence 7654321 122357999999999999999999999999 88999999999999753221111
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
......... .....+..+++.+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 225 LYLIATNGT----PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp HHHHHHHCS----CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred HHHHHhCCC----CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111111100 0011223456778999999999999999999999763
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=405.85 Aligned_cols=264 Identities=27% Similarity=0.399 Sum_probs=205.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||+||+|+++. .||||+++... ....+.+.+|++++++++|||||++++++... .
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~------~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP------Q 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSS------S
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEecc------E
Confidence 4689999999999999999998752 49999997442 33457899999999999999999999987432 4
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++|||||++|+|.+++..... .+++.++..|+.||++||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFG 149 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFG 149 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCC
T ss_pred EEEEEecCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEcccc
Confidence 7899999999999999976542 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC---CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG---SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
+|+........ .......||+.|||||++.+ ..|+.++|||| +|+++||++++..|+....
T Consensus 150 la~~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS----------~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 150 LATVKSRWSGS------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYA----------FGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp CSCC------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHH----------HHHHHHHHHHSSCTTTTCC
T ss_pred ceeeccccCCc------ccccccccCcccCCHHHHhcccCCCCCchhhhhh----------hHHHHHHHHHCCCCCCCCC
Confidence 99876543211 12234579999999999864 34899999999 8999999999999875321
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
.. ........... ..+.......++++.+.+++.+||+.||++|||++||++.|+.+.++..
T Consensus 214 ~~--~~~~~~~~~~~-~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 214 NR--DQIIFMVGRGY-LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CH--HHHHHHHHHTS-CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred hH--HHHHHHHhcCC-CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11 11111111111 0111112234467789999999999999999999999999999988754
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=398.37 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=206.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||+||+|+++.+++.||+|++... .....+.+.+|++++++++|||||++++++.+.+ .
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT-----R 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS-----E
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC-----E
Confidence 5799999999999999999999999999999998643 2334567899999999999999999999976655 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+|||||++|+|.+++.... .+++.+++.++.||+.||+|||++ +||||||||+|||++.++.+||+|||
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG 151 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFG 151 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred EEEEEeecCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccc
Confidence 999999999999999998654 699999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+...... .....||+.|||||++.+..++.++|||| .|+++|++++|..|+......
T Consensus 152 ~a~~~~~~~----------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwS----------lGvilyell~G~~Pf~~~~~~- 210 (263)
T d2j4za1 152 WSVHAPSSR----------RTTLCGTLDYLPPEMIEGRMHDEKVDLWS----------LGVLCYEFLVGKPPFEANTYQ- 210 (263)
T ss_dssp SCSCCCCCC----------CEETTEEGGGCCHHHHTTCCCCTTHHHHH----------HHHHHHHHHHSSCTTCCSSHH-
T ss_pred eeeecCCCc----------ccccCCCCcccCHHHHcCCCCCchhhhhh----------HhHHHHHHhcCCCCCCCCCHH-
Confidence 998654422 12356999999999999999999999999 899999999999997532211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
........... ..++.+++.+.+++.+||+.||++|||++|+++.
T Consensus 211 -~~~~~i~~~~~-------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 211 -ETYKRISRVEF-------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -HHHHHHHTTCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHHHHHHcCCC-------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11111111111 1122356678899999999999999999999863
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-49 Score=407.38 Aligned_cols=262 Identities=23% Similarity=0.412 Sum_probs=212.1
Q ss_pred HHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
...++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|++++++++|||||++++++.+.+ .
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~ 87 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-----P 87 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----S
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCC-----e
Confidence 3456899999999999999999999989999999999744 334578999999999999999999999986554 7
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++|||||++|+|.+++...... .+++..++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~----~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG 160 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQ----EVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFG 160 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTT----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred eEEEeecccCcchHHHhhhcccc----chHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEcccc
Confidence 89999999999999999765432 789999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+......... ..+..||+.|||||++.+..++.++|||| +|+++|+++++..|+.... +
T Consensus 161 ~a~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS----------~Gv~l~ell~~~~p~~~~~--~ 221 (287)
T d1opja_ 161 LSRLMTGDTYTA-------HAGAKFPIKWTAPESLAYNKFSIKSDVWA----------FGVLLWEIATYGMSPYPGI--D 221 (287)
T ss_dssp CTTTCCSSSSEE-------ETTEEECGGGCCHHHHHHCCCSHHHHHHH----------HHHHHHHHHTTSCCSSTTC--C
T ss_pred ceeecCCCCcee-------eccccccccccChHHHcCCCCCchhhhhh----------HHHHHHHHHhCCCCCCCcc--h
Confidence 998765432211 12345899999999999999999999999 7888888888666543111 1
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
.....+.+.... ....+..+++.+.+++.+||+.||++|||++||++.|+.+.+
T Consensus 222 ~~~~~~~i~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 222 LSQVYELLEKDY-----RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp HHHHHHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred HHHHHHHHhcCC-----CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111111111111 011223456788999999999999999999999999988754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=397.72 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=198.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
++|++.+.||+|+||+||+|++. +++.||||+++.. ....+++.+|++++++++|||||+++|+|...+ ..++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-----~~~l 77 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-----PICL 77 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-----SCEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCC-----ceEE
Confidence 47899999999999999999997 6778999999753 344578999999999999999999999986654 7899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++|+|.+++..... .+++..++.|+.|++.||+|||+. +|+||||||+||++++++.+||+|||+|+
T Consensus 78 v~E~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~ 149 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 149 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---
T ss_pred EEEecCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchhe
Confidence 9999999999999876542 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSL 770 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~ 770 (833)
......... .....||+.|||||++.+..++.++|||| +|+++||++++..|+.... .....
T Consensus 150 ~~~~~~~~~-------~~~~~gt~~y~aPE~l~~~~~~~k~DVwS----------~Gvil~el~t~~~~~~~~~-~~~~~ 211 (263)
T d1sm2a_ 150 FVLDDQYTS-------STGTKFPVKWASPEVFSFSRYSSKSDVWS----------FGVLMWEVFSEGKIPYENR-SNSEV 211 (263)
T ss_dssp ----------------------CTTSCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHTTSCCTTCSC-CHHHH
T ss_pred eccCCCcee-------ecceecCcccCChHHhcCCCCCchhhhcc----------hHHHHHHHHHCCCCCCCCC-CHHHH
Confidence 765432211 12346999999999999999999999999 7777888877544332111 01111
Q ss_pred hhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 771 LMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 771 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
........ ....+..+++.+.+++.+||+.||++|||++||+++|+++.++
T Consensus 212 ~~~i~~~~------~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 212 VEDISTGF------RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHHHTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcC------CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 11111110 1112233466789999999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=398.48 Aligned_cols=253 Identities=20% Similarity=0.312 Sum_probs=207.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
+.|++.+.||+|+||+||+|++..+++.||||+++.......+.+.+|++++++++|||||++++++.+.+ ..++
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-----NLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETT-----EEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-----eEEE
Confidence 46899999999999999999999999999999998766666788999999999999999999999987655 8999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
|||||++|+|.+++..... .+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 vmEy~~~g~L~~~~~~~~~-----~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~ 158 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELER-----PLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSA 158 (288)
T ss_dssp EEECCTTEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhh
Confidence 9999999999999865432 699999999999999999999999 99999999999999999999999999997
Q ss_pred ccCcccccccccCCCccccccccccccCccccC-----CCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM-----GSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
....... ......||+.|||||++. +..|+.++|||| .|+++|+++++..|+.....
T Consensus 159 ~~~~~~~--------~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwS----------lGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 159 KNTRTIQ--------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS----------LGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp ECHHHHH--------HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHH----------HHHHHHHHHHSSCTTTTSCG
T ss_pred ccCCCcc--------cccccccccccCCHHHHhhcccCCCCCChhhhHHH----------HHHHHHHHhhCCCCCCCCCH
Confidence 6543221 112356999999999873 456899999999 88999999999999763221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
. ........... .....+..+++.+.+++.+||+.||++|||++|+++.
T Consensus 221 ~--~~~~~i~~~~~----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 221 M--RVLLKIAKSEP----PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp G--GHHHHHHHSCC----CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred H--HHHHHHHcCCC----CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 11111111111 0111223456778999999999999999999999763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=399.10 Aligned_cols=258 Identities=21% Similarity=0.266 Sum_probs=195.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.. ....
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~---~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT---NTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCC---CCEE
Confidence 579999999999999999999999999999999975432 23467899999999999999999999875432 3468
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC--CCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC--QPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
|+|||||++|+|.+++...... ...+++..++.++.|++.||+|||++. ..+||||||||+|||++.++.+||+||
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEecCCCCcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 9999999999999998753211 126999999999999999999999971 113999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+|+....... ......||+.|||||++.+..++.++|||| +|+++|+++++..|+......
T Consensus 159 G~a~~~~~~~~--------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwS----------lGvilyel~tg~~Pf~~~~~~ 220 (269)
T d2java1 159 GLARILNHDTS--------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWS----------LGCLLYELCALMPPFTAFSQK 220 (269)
T ss_dssp HHHHHC-------------------CCCSCCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHSSCSCCCSSHH
T ss_pred cceeecccCCC--------ccccCCCCcccCCHHHHcCCCCChHHHHHh----------hCHHHHHHhhCCCCCCCCCHH
Confidence 99987654321 122357999999999999999999999999 899999999999987532211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
........... ...+..+++++.+++.+||+.||++|||++|+++
T Consensus 221 --~~~~~i~~~~~------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 221 --ELAGKIREGKF------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp --HHHHHHHHTCC------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHHHcCCC------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111111111 1112335667899999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.1e-48 Score=401.67 Aligned_cols=263 Identities=26% Similarity=0.412 Sum_probs=196.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCce---EEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEM---IVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
++|++.+.||+|+||+||+|+++.+++ .||||.+..... ...+.+.+|++++++++|||||+++|++...+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~----- 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST----- 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-----
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-----
Confidence 457778999999999999999976554 689998864432 34467999999999999999999999986554
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..++|||||++|+|.+++..... .+++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 172 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDF 172 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCc
Confidence 78999999999999998886542 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
|+|+......... ......+..||+.|||||++.+..++.++|||| +|+++||+++ +..|+.....
T Consensus 173 Gla~~~~~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS----------~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 173 GLSRFLEDDTSDP---TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWS----------YGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp --------------------------CGGGSCHHHHHSCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTCCH
T ss_pred ccceEccCCCCcc---eeeecccccCCccccCHHHHhcCCCCccccccc----------chHHHHHHHhCCCCCCCCCCH
Confidence 9998765533211 111222346899999999999999999999999 7788888886 6777642211
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
........... ....+.++++.+.+++.+||+.||++|||++||++.|+++.++
T Consensus 240 --~~~~~~i~~~~------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 240 --QDVINAIEQDY------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --HHHHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --HHHHHHHHcCC------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11111111111 1112334667889999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=393.40 Aligned_cols=258 Identities=23% Similarity=0.409 Sum_probs=206.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||+||+|+++ +++.||||+++.. ....+.+.+|++++++++|||||+++|++... ..+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~------~~~ 83 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE------PIY 83 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeeccC------CeE
Confidence 457999999999999999999987 6788999999744 33457899999999999999999999987433 468
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++..... .++++.+++.|+.||++||+|||+. +|+||||||+||++++++.+||+|||+|
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla 156 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA 156 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccce
Confidence 99999999999998875432 2689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
+........ ......||+.|||||++.+..++.++|||| +|+++||++++..|+.... ....
T Consensus 157 ~~~~~~~~~-------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS----------~Gvvl~ellt~~~~~~~~~-~~~~ 218 (272)
T d1qpca_ 157 RLIEDNEYT-------AREGAKFPIKWTAPEAINYGTFTIKSDVWS----------FGILLTEIVTHGRIPYPGM-TNPE 218 (272)
T ss_dssp EECSSSCEE-------CCTTCCCCTTTSCHHHHHHCEECHHHHHHH----------HHHHHHHHHTTTCCSSTTC-CHHH
T ss_pred EEccCCccc-------cccccCCcccccChHHHhCCCCCchhhhhh----------hHHHHHHHHhCCCCCCCCC-CHHH
Confidence 877543221 112346999999999999889999999999 7888888888655433111 0111
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
......... ....++.+++.+.+++.+||+.||++|||++||++.|+.+..
T Consensus 219 ~~~~i~~~~------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 219 VIQNLERGY------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcC------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 111111111 111223456778999999999999999999999999988754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=389.18 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=198.7
Q ss_pred ccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 534 SSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 534 ~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
+..+.||+|+||+||+|++..+++.||+|++.... ....+.+.+|++++++++|||||++++++.... .+....|+|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEE
Confidence 56678999999999999999999999999997543 223467899999999999999999999986532 334578999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCC--ceeeCCCCCCeeec-CCCcEEEccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPP--MVHGDLKPSNVLLD-HDMVAHVCDFGL 688 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~DfG~ 688 (833)
|||+++|+|.+++.... .+++.+++.++.||+.||+|||++ + |+||||||+|||++ +++.+||+|||+
T Consensus 91 mE~~~~g~L~~~l~~~~------~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK------VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp EECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EeCCCCCcHHHHHhccc------cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 99999999999998654 689999999999999999999998 6 99999999999996 578999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
|+..... .....+||+.|||||++.+ .++.++|||| .|+++|+++++..|+.... +.
T Consensus 162 a~~~~~~----------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwS----------lGvilyel~~g~~Pf~~~~--~~ 218 (270)
T d1t4ha_ 162 ATLKRAS----------FAKAVIGTPEFMAPEMYEE-KYDESVDVYA----------FGMCMLEMATSEYPYSECQ--NA 218 (270)
T ss_dssp GGGCCTT----------SBEESCSSCCCCCGGGGGT-CCCTHHHHHH----------HHHHHHHHHHSSCTTTTCS--SH
T ss_pred ceeccCC----------ccCCcccCccccCHHHhCC-CCCCcCchhh----------HHHHHHHHHHCCCCCCCcc--cH
Confidence 9754332 1224579999999998875 5999999999 8899999999999975221 11
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
......+..... .......+++++.+++.+||++||++|||++|+++
T Consensus 219 ~~~~~~i~~~~~----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 219 AQIYRRVTSGVK----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHHHHTTTCC----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHcCCC----CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111111111110 01112223556889999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=403.57 Aligned_cols=257 Identities=23% Similarity=0.371 Sum_probs=203.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.++|++.+.||+|+||+||+|++..+|+.||+|+++... ....+.+.+|+.++++++|||||++++++.+.+ ..
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 79 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EI 79 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSS-----EE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EE
Confidence 468999999999999999999999999999999997543 333567899999999999999999999987655 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
|+||||+++|+|.+++.+.+ .+++..++.++.|++.||.|||+ . ||+||||||+|||++.++.+||+|||
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~------~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFG 150 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFG 150 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCC
T ss_pred EEEEEcCCCCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCC
Confidence 99999999999999998654 68999999999999999999997 5 89999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+...... ....+||+.|||||++.+..|+.++|||| .|++++++++|..|+...+...
T Consensus 151 la~~~~~~~----------~~~~~GT~~Y~APEvl~~~~y~~~~DiWS----------lGvil~ell~G~~Pf~~~~~~~ 210 (322)
T d1s9ja_ 151 VSGQLIDSM----------ANSFVGTRSYMSPERLQGTHYSVQSDIWS----------MGLSLVEMAVGRYPIPPPDAKE 210 (322)
T ss_dssp CCHHHHHHT----------C---CCSSCCCCHHHHHCSCCCTTHHHHH----------HHHHHHHHHHSSCCSSCCCTTH
T ss_pred CccccCCCc----------cccccCCccccCchHHcCCCCCcHHHHHH----------HHHHHHHHHHCCCCCCCCCHHH
Confidence 998654322 12357999999999999999999999999 8888999999988875221110
Q ss_pred ccchhhh-ccc----------------------cc------------hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC
Q 040925 768 PSLLMEV-MTN----------------------NS------------MIQEDKRVKTEECLNAIIRTGVLCSMESPFERM 812 (833)
Q Consensus 768 ~~~~~~~-~~~----------------------~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 812 (833)
....... ... .. .............+.++.+++.+||..||++||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ 290 (322)
T d1s9ja_ 211 LELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 290 (322)
T ss_dssp HHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCc
Confidence 0000000 000 00 000000000011245788999999999999999
Q ss_pred CHHHHHHH
Q 040925 813 DMRDVVAK 820 (833)
Q Consensus 813 t~~eil~~ 820 (833)
|++|+++.
T Consensus 291 ta~e~L~H 298 (322)
T d1s9ja_ 291 DLKQLMVH 298 (322)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhhC
Confidence 99999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-47 Score=391.87 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=208.1
Q ss_pred cCCccCce-eccCcceEEEEEEECC--CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNM-IGQGSFGYVYKGTLGE--DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~-lg~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.... ...+++.+|++++++++|||||+++|++...
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE------ 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC------
Confidence 45777774 9999999999998753 456899999975432 3356899999999999999999999997543
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+|||||++|+|.+++...+. .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DF 153 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKRE-----EIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 153 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred eEEEEEEeCCCCcHHHHhhcccc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccc
Confidence 47899999999999999865432 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~ 765 (833)
|+|+.+........ ......||+.|||||++.+..++.++|||| +|+++||+++ |..|+....
T Consensus 154 Gla~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS----------~Gv~l~E~lt~G~~Pf~~~~- 217 (285)
T d1u59a_ 154 GLSKALGADDSYYT-----ARSAGKWPLKWYAPECINFRKFSSRSDVWS----------YGVTMWEALSYGQKPYKKMK- 217 (285)
T ss_dssp TTCEECTTCSCEEC-----CCCSSCCCGGGCCHHHHHHCEECHHHHHHH----------HHHHHHHHHTTSCCTTTTCC-
T ss_pred hhhhcccccccccc-----cccccccCccccChHHHhCCCCCccchhhc----------chHHHHHHHhCCCCCCCCCC-
Confidence 99987754332111 122346899999999999999999999999 7888888876 677765322
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhc
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLG 830 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~ 830 (833)
............. ...++.+++.+.+++.+||+.||++|||+.+|++.|+.+..+...
T Consensus 218 -~~~~~~~i~~~~~------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 218 -GPEVMAFIEQGKR------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp -THHHHHHHHTTCC------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -HHHHHHHHHcCCC------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 1222111111111 112344677889999999999999999999999999988765443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=395.74 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=204.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|++++++++|||||++++++.+.+ .
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~-----~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE-----K 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS-----E
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC-----E
Confidence 5799999999999999999999999999999999643 2334567999999999999999999999976554 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+|||||++|+|.+++...+ .+++..++.++.|++.||+|||+. +||||||||+||++++++.+||+|||
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG 153 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFG 153 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEccCCCCHHHhhhccC------CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccc
Confidence 999999999999999988655 799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+.+...... ......+||+.|||||++.+..++.++|||| .|+++|++++|..|+......
T Consensus 154 ~a~~~~~~~~~------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwS----------lGvilyell~g~~Pf~~~~~~- 216 (288)
T d1uu3a_ 154 TAKVLSPESKQ------ARANSFVGTAQYVSPELLTEKSACKSSDLWA----------LGCIIYQLVAGLPPFRAGNEY- 216 (288)
T ss_dssp TCEECC----------------CCCCGGGCCHHHHHTCCCCHHHHHHH----------HHHHHHHHHHSSCSSCCSSHH-
T ss_pred cceecccCCcc------cccccccCCccccCceeeccCCCCcccceeh----------hhHHHHHHhhCCCCCCCcCHH-
Confidence 99876543211 1222357999999999999999999999999 899999999999998632211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
........... ..++.+++.+.+++.+||+.||++|||++|+++.
T Consensus 217 -~~~~~i~~~~~-------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 217 -LIFQKIIKLEY-------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -HHHHHHHTTCC-------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -HHHHHHHcCCC-------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 11111111111 1122345678899999999999999999997543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=382.97 Aligned_cols=254 Identities=24% Similarity=0.387 Sum_probs=207.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
++|++.+.||+|+||+||+|+++ +++.||||+++... ...+++.+|+.++++++||||++++|+|.+.+ ..++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-----~~~i 76 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-----PIFI 76 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-----SEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-----ceEE
Confidence 58999999999999999999996 78899999998543 34578999999999999999999999986554 7999
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
||||+++|++.+++..... .+++..+++++.|+++||+|||+. ||+||||||+||+++.++.+||+|||+|+
T Consensus 77 v~Ey~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~ 148 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSR 148 (258)
T ss_dssp EEECCTTEEHHHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCC
T ss_pred EEEccCCCcHHHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhhe
Confidence 9999999999999776542 689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccccccccc
Q 040925 691 FLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPS 769 (833)
Q Consensus 691 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~ 769 (833)
........ ......||+.|+|||++.+..++.++|||| +|+++|++.+ +..|+.... ...
T Consensus 149 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS----------~G~~l~el~t~g~~Pf~~~~--~~~ 209 (258)
T d1k2pa_ 149 YVLDDEYT-------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWA----------FGVLMWEIYSLGKMPYERFT--NSE 209 (258)
T ss_dssp BCSSSSCC-------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTSC--HHH
T ss_pred eccCCCce-------eecccCCCCCcCCcHHhcCCCCCcceeecc----------cchhhHhHHhcCCCCCCCCC--HHH
Confidence 76543221 122356999999999999999999999999 7888888886 577765222 111
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
.......... ...+..+++.+.+++.+||+.||++|||++||++.|..|
T Consensus 210 ~~~~i~~~~~------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 210 TAEHIAQGLR------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp HHHHHHTTCC------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HHHHHHhCCC------CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 1111111111 112233456789999999999999999999999998643
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-47 Score=394.88 Aligned_cols=253 Identities=22% Similarity=0.262 Sum_probs=191.6
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.+.|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-----HL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSS-----EE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EE
Confidence 356999999999999999999999999999999997543 223456889999999999999999999976554 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec---CCCcEEEcc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD---HDMVAHVCD 685 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~D 685 (833)
|+|||||+||+|.+++...+ .+++.++..++.||+.||+|||+. +|+||||||+||++. +++.+||+|
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred EEEEeccCCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEec
Confidence 99999999999999998654 799999999999999999999999 999999999999994 578999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+|+....... ....+||+.|||||++.+..|+.++|||| .|+++|++++|..|+.....
T Consensus 154 FG~a~~~~~~~~---------~~~~~GT~~y~APE~~~~~~~~~~~DiwS----------lGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 154 FGLSKMEDPGSV---------LSTACGTPGYVAPEVLAQKPYSKAVDCWS----------IGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp C---------------------------CTTSCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSSCSCCCSSH
T ss_pred cceeEEccCCCe---------eeeeeeCccccCcHHHcCCCCCcHHHhhh----------hhHHHHHHHhCCCCCCCCCH
Confidence 999986544321 22357999999999999999999999999 88999999999999753221
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.............. ......++++.+.+++.+||++||++|||++|+++.
T Consensus 215 --~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 215 --AKLFEQILKAEYEF---DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --HHHHHHHHTTCCCC---CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --HHHHHHHhccCCCC---CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11111111111111 111223456678999999999999999999999874
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=386.92 Aligned_cols=253 Identities=23% Similarity=0.289 Sum_probs=199.1
Q ss_pred ceeccCcceEEEEEEEC--CCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEEE
Q 040925 537 NMIGQGSFGYVYKGTLG--EDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFVF 612 (833)
Q Consensus 537 ~~lg~G~~g~Vy~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 612 (833)
++||+|+||+||+|.++ .+++.||||+++... ....+.+.+|++++++++|||||+++|+|... ..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence 47999999999999864 356889999996432 22346799999999999999999999998543 468999
Q ss_pred EecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccccccc
Q 040925 613 EYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFL 692 (833)
Q Consensus 613 e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 692 (833)
||+++|+|.+++.... .+++.+++.|+.||+.||+|||+. +||||||||+||+++.++.+||+|||+|+..
T Consensus 87 E~~~~g~L~~~l~~~~------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~ 157 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 157 (277)
T ss_dssp ECCTTEEHHHHHHHCT------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EcCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhc
Confidence 9999999999998754 699999999999999999999999 9999999999999999999999999999876
Q ss_pred CcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccccch
Q 040925 693 SDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDPSLL 771 (833)
Q Consensus 693 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~~~~ 771 (833)
........ ......||+.|||||++.+..++.++|||| +|+++||+++ +..|+..... ....
T Consensus 158 ~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDiwS----------~Gv~l~ellt~g~~Pf~~~~~--~~~~ 220 (277)
T d1xbba_ 158 RADENYYK-----AQTHGKWPVKWYAPECINYYKFSSKSDVWS----------FGVLMWEAFSYGQKPYRGMKG--SEVT 220 (277)
T ss_dssp CTTCSEEE-----C----CCCGGGCCHHHHHHCEEEHHHHHHH----------HHHHHHHHHTTTCCSSTTCCH--HHHH
T ss_pred cccccccc-----cccccCCCceecCchhhcCCCCCchhhhcc----------chhhhhHHhhCCCCCCCCCCH--HHHH
Confidence 54322111 112346999999999999999999999999 7888888876 6777653221 1111
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
....... ....+..+++.+.+++.+||+.||++|||+++|.+.|+....+
T Consensus 221 ~~i~~~~------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 221 AMLEKGE------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp HHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCC------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1111111 1112334567889999999999999999999999998887543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.4e-46 Score=397.56 Aligned_cols=254 Identities=19% Similarity=0.234 Sum_probs=208.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|++..+|+.||||++........+.+.+|++++++++|||||++++++.+.+ ..|
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~ 99 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN-----EMV 99 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT-----EEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence 468999999999999999999999999999999997665555678899999999999999999999976654 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC--CCcEEEcccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH--DMVAHVCDFG 687 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~DfG 687 (833)
+|||||+||+|.+++..... .+++.+++.|+.||+.||+|||++ |||||||||+|||++. ++.+||+|||
T Consensus 100 ivmE~~~gg~L~~~l~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG 171 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHN-----KMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFG 171 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTS-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecc
Confidence 99999999999999965432 699999999999999999999999 9999999999999964 5789999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+.+..... .....||+.|||||++.+..++.++|||| .|+++|++++|..|+.....
T Consensus 172 ~a~~~~~~~~---------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwS----------lGvilyell~G~~Pf~~~~~-- 230 (350)
T d1koaa2 172 LTAHLDPKQS---------VKVTTGTAEFAAPEVAEGKPVGYYTDMWS----------VGVLSYILLSGLSPFGGEND-- 230 (350)
T ss_dssp TCEECCTTSC---------EEEECSCTTTCCHHHHHTCCBCHHHHHHH----------HHHHHHHHHHSSCSSCCSSH--
T ss_pred hheecccccc---------cceecCcccccCHHHHcCCCCChhHhhhh----------hhHHHHHHHhCCCCCCCCCH--
Confidence 9987654322 22357999999999999999999999999 89999999999999753211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.............. .......+++.+.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 231 DETLRNVKSCDWNM---DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp HHHHHHHHHTCCCS---CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHhCCCCC---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11111111111111 111122345678899999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=388.63 Aligned_cols=262 Identities=26% Similarity=0.404 Sum_probs=198.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCc----eEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDE----MIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
..|++.+.||+|+||+||+|+++.++ ..||||+++.... .....+.+|++++++++|||||+++|++.+.+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~---- 82 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK---- 82 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS----
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC----
Confidence 46888999999999999999986544 5799999975433 23457899999999999999999999986554
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..++||||+++|++.+++..... .+++.++..++.|++.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 83 -~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~D 153 (283)
T d1mqba_ 83 -PMMIITEYMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSD 153 (283)
T ss_dssp -SEEEEEECCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECC
T ss_pred -ceEEEEEecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcc
Confidence 78999999999999998876542 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
||+|+......... .......||+.|||||++.+..++.++|||| +|+++||++++..|+....
T Consensus 154 FGla~~~~~~~~~~-----~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S----------~Gvil~el~t~~~~~~~~~- 217 (283)
T d1mqba_ 154 FGLSRVLEDDPEAT-----YTTSGGKIPIRWTAPEAISYRKFTSASDVWS----------FGIVMWEVMTYGERPYWEL- 217 (283)
T ss_dssp CCC----------------------CCCGGGSCHHHHHSCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTC-
T ss_pred cchhhcccCCCccc-----eEeccCCCCccccCHHHHccCCCCCcccccc----------cHHHHHHHHhCCCCccccC-
Confidence 99998765432111 1122346899999999999999999999999 7777777777554433111
Q ss_pred ccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 766 VDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
........ +.... ....+.+++..+.+++.+||+.||++||||.||++.|+++.+.
T Consensus 218 ~~~~~~~~-i~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 218 SNHEVMKA-INDGF-----RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CHHHHHHH-HHTTC-----CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CHHHHHHH-HhccC-----CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 01111111 11111 1112334567889999999999999999999999999988764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.3e-46 Score=390.96 Aligned_cols=246 Identities=23% Similarity=0.297 Sum_probs=200.7
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
..|+..+.||+|+||+||+|++..+++.||||+++..... ..+.+.+|++++++++|||||++++++.+.+ .
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~ 89 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH-----T 89 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----E
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC-----E
Confidence 3599999999999999999999999999999999754332 2356889999999999999999999987655 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+|||||++|++..++.... ++++.+++.++.||+.||.|||++ |||||||||+|||++.++.+||+|||
T Consensus 90 ~~iv~E~~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 90 AWLVMEYCLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp EEEEEECCSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred EEEEEEecCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecc
Confidence 999999999999987776544 799999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCC---CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG---SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
+|+..... ....||+.|||||++.+ ..|+.++|||| +|+++|+++++..|+....
T Consensus 161 ~a~~~~~~------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwS----------lGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 161 SASIMAPA------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWS----------LGITCIELAERKPPLFNMN 218 (309)
T ss_dssp TCBSSSSB------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHH----------HHHHHHHHHHSSCTTTTSC
T ss_pred cccccCCC------------CccccCccccCHHHHhccCCCCcCchhhhhh----------HHHHHHHHHHCCCCCCCCC
Confidence 99865432 12469999999999864 45899999999 8889999999998875221
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
.. ........... .......+++.+.+++.+||+.||++|||++|+++
T Consensus 219 ~~--~~~~~i~~~~~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 219 AM--SALYHIAQNES-----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HH--HHHHHHHHSCC-----CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HH--HHHHHHHhCCC-----CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 11111111111 01112234567899999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-46 Score=395.95 Aligned_cols=254 Identities=19% Similarity=0.237 Sum_probs=208.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||+||+|++..+|+.||||+++.......+.+.+|++++++++|||||++++++.+.+ ..|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY-----EMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS-----EEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-----EEE
Confidence 357999999999999999999999999999999998655455667889999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec--CCCcEEEcccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD--HDMVAHVCDFG 687 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DfG 687 (833)
+|||||+||+|.+++..... ++++.+++.|+.||+.||+|||+. |||||||||+|||++ .++.+||+|||
T Consensus 103 ivmE~~~gg~L~~~~~~~~~-----~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFG 174 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDY-----KMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFG 174 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTC-----CBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCT
T ss_pred EEEEcCCCChHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecc
Confidence 99999999999998876542 699999999999999999999999 999999999999998 57899999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+.+..... .....||+.|||||++.+..++.++|||| .|+++|++++|..|+......
T Consensus 175 la~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lGvilyelltG~~Pf~~~~~~- 234 (352)
T d1koba_ 175 LATKLNPDEI---------VKVTTATAEFAAPEIVDREPVGFYTDMWA----------IGVLGYVLLSGLSPFAGEDDL- 234 (352)
T ss_dssp TCEECCTTSC---------EEEECSSGGGCCHHHHTTCCBCHHHHHHH----------HHHHHHHHHHSCCSSCCSSHH-
T ss_pred cceecCCCCc---------eeeccCcccccCHHHHcCCCCCCccchHH----------HHHHHHHHHhCCCCCCCCCHH-
Confidence 9987654321 22346999999999999999999999999 899999999999997532211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
............. .......+++.+.+++.+||+.||++|||++|+++.
T Consensus 235 -~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 235 -ETLQNVKRCDWEF---DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp -HHHHHHHHCCCCC---CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHhCCCCC---CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111100 111123356678999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=384.77 Aligned_cols=252 Identities=21% Similarity=0.241 Sum_probs=205.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC------cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK------GASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
++|++.+.||+|+||+||+|+++.+|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--- 86 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT--- 86 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS---
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC---
Confidence 579999999999999999999999999999999964321 23467899999999999999999999976655
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC----c
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM----V 680 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~----~ 680 (833)
..|+|||||++|+|.+++...+ .+++.+++.++.|++.||+|||+. +|+||||||+||+++.++ .
T Consensus 87 --~~~iv~E~~~gg~L~~~i~~~~------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~ 155 (293)
T d1jksa_ 87 --DVILILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPR 155 (293)
T ss_dssp --EEEEEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCC
T ss_pred --EEEEEEEcCCCccccchhcccc------ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccc
Confidence 8999999999999999998654 699999999999999999999999 999999999999998876 5
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
+|++|||+|+....... .....||+.|||||++.+..++.++|||| .|+++|+++++..|+
T Consensus 156 vkl~DfG~a~~~~~~~~---------~~~~~~t~~y~APE~~~~~~~~~~~DiwS----------lGvilyell~g~~Pf 216 (293)
T d1jksa_ 156 IKIIDFGLAHKIDFGNE---------FKNIFGTPEFVAPEIVNYEPLGLEADMWS----------IGVITYILLSGASPF 216 (293)
T ss_dssp EEECCCTTCEECTTSCB---------CSCCCCCGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCSS
T ss_pred eEecchhhhhhcCCCcc---------ccccCCCCcccCHHHHcCCCCCCcccchh----------hhHHHHHHHcCCCCC
Confidence 99999999987654321 22356999999999999999999999999 889999999999997
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
...... ............. .......+++.+.+++.+||+.||++|||++|+++.
T Consensus 217 ~~~~~~--~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 217 LGDTKQ--ETLANVSAVNYEF---EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCSSHH--HHHHHHHTTCCCC---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCHH--HHHHHHHhcCCCC---CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 632211 1111111111100 111122345678899999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=387.44 Aligned_cols=250 Identities=23% Similarity=0.262 Sum_probs=207.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD----- 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS-----
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc-----
Confidence 46799999999999999999999999999999999743 2334577899999999999999999999976655
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+|||||++|+|.+++...+ .+++..++.++.|++.||+|||++ |||||||||+|||++.+|.+||+||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DF 149 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRER------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDF 149 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ccccceeccCCCchhhhhhccc------CCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeec
Confidence 8999999999999999998765 789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+|+...... ......+||+.|||||++.+..|+.++|||| .|+++|++++|..|+...+..
T Consensus 150 G~a~~~~~~~--------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwS----------lGvilyeml~G~~pf~~~~~~ 211 (337)
T d1o6la_ 150 GLCKEGISDG--------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG----------LGVVMYEMMCGRLPFYNQDHE 211 (337)
T ss_dssp TTCBCSCCTT--------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHH----------HHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccccccCC--------cccccceeCHHHhhhhhccCCCCChhhcccc----------hhhHHHHHHHCCCCCCCcCHH
Confidence 9998654322 1223467999999999999999999999999 899999999999887633211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
........... ..+..+++.+.+++.+||++||++||+ ++|++++
T Consensus 212 --~~~~~i~~~~~-------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 212 --RLFELILMEEI-------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --HHHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --HHHHHHhcCCC-------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 11111111111 112334567889999999999999995 7888763
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-46 Score=391.51 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=202.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCc-----eEEEEEEeecc-CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDE-----MIVAVKVINLK-YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 602 (833)
.++|++.+.||+|+||+||+|++..++ ..||||.+... .......+.+|+.+++++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~- 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG- 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC-
Confidence 367999999999999999999986543 47999998644 233456789999999998 8999999999976654
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCc-----------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCcee
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQ-----------------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVH 665 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH 665 (833)
..++|||||++|+|.+++...... .....+++..++.|+.||+.||+|||++ +|||
T Consensus 115 ----~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiH 187 (325)
T d1rjba_ 115 ----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVH 187 (325)
T ss_dssp ----SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred ----eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 789999999999999999765421 0112589999999999999999999999 9999
Q ss_pred eCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCcccc
Q 040925 666 GDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFN 745 (833)
Q Consensus 666 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~ 745 (833)
|||||+||+++.++.+||+|||+|+........ .......||+.|||||++.+..++.++||||
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS---------- 251 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNY------VVRGNARLPVKWMAPESLFEGIYTIKSDVWS---------- 251 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTS------EEETTEEECGGGCCHHHHHHCCCCHHHHHHH----------
T ss_pred ccCchhccccccCCeEEEeeccccccccCCCce------eeeccccCCCccCChHHHcCCCCCcceeccc----------
Confidence 999999999999999999999999866543211 1122356899999999999999999999999
Q ss_pred CCccHHHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHH
Q 040925 746 EGHSLHEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCH 823 (833)
Q Consensus 746 ~g~~l~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~ 823 (833)
+|+++||+++ +..|+..... .......+.... ....+..+++.+.+++.+||+.||++|||++||+++|..
T Consensus 252 ~Gvil~emlt~g~~Pf~~~~~--~~~~~~~~~~~~-----~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 252 YGILLWEIFSLGVNPYPGIPV--DANFYKLIQNGF-----KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHTTTSCCSSTTCCC--SHHHHHHHHTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hhHHHHHHHhCCCCCCCCCCH--HHHHHHHHhcCC-----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 7788888876 6777642111 111111111111 011223456788999999999999999999999999853
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-46 Score=383.35 Aligned_cols=259 Identities=26% Similarity=0.408 Sum_probs=201.1
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||+||+|+++. ++.||||+++.. ....+.+.+|+.++++++|||||+++|++.+. ..+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~------~~~ 87 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE------PIY 87 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS------SCE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEecC------CeE
Confidence 4679999999999999999999974 467999999744 33457899999999999999999999997432 468
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|..++...... .+++.+++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|
T Consensus 88 lv~Ey~~~g~l~~~~~~~~~~----~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla 160 (285)
T d1fmka3 88 IVTEYMSKGSLLDFLKGETGK----YLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLA 160 (285)
T ss_dssp EEECCCTTCBHHHHHSHHHHT----TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred EEEEecCCCchhhhhhhcccc----cchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchh
Confidence 999999999999998764322 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPS 769 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~ 769 (833)
+........ ......||+.|+|||++.+..++.++|||| +|+++|+++++..|+..... +..
T Consensus 161 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S----------~Giil~el~t~~~p~~~~~~-~~~ 222 (285)
T d1fmka3 161 RLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRFTIKSDVWS----------FGILLTELTTKGRVPYPGMV-NRE 222 (285)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTTCCSSTTCC-HHH
T ss_pred hhccCCCce-------eeccccccccccChHHHhCCCCCcHHhhhc----------chHHHHHHHhCCCCCCCCCC-HHH
Confidence 876543221 112346999999999999999999999999 78888888876555432111 111
Q ss_pred chhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 770 LLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
......... ....+..+++++.+++.+||+.||++|||+++|++.|+.....
T Consensus 223 ~~~~i~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 223 VLDQVERGY------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp HHHHHHTTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHhcC------CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 111111111 1112334567889999999999999999999999998876543
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-45 Score=378.24 Aligned_cols=266 Identities=18% Similarity=0.305 Sum_probs=206.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
.++|++.+.||+|+||+||+|++..+++.||||+++..... ..+.+.+|++++++++|||||++++++...+ ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 35799999999999999999999999999999999754322 2457899999999999999999999987653 2334
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||++||+|.+++...+ .+++.+++.++.||+.||+|||+. ||+||||||+||+++.++.++++||
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCC
T ss_pred eEEEEEECCCCCEehhhhcccC------CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehh
Confidence 6899999999999999987654 699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|.+........ ........+||+.|||||++.+..++.++|||| .|+++|++++|..|+......
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwS----------lGvilyelltG~~Pf~~~~~~ 220 (277)
T d1o6ya_ 156 GIARAIADSGN-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS----------LGCVLYEVLTGEPPFTGDSPV 220 (277)
T ss_dssp TTCEECC---------------------TTCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHSSCSCCCSSHH
T ss_pred hhhhhhccccc-----cccccccccCcccccCHHHHcCCCCCcceeccc----------chHHHHHHHhCCCCCCCcCHH
Confidence 99876543321 112233467999999999999999999999999 899999999999997632211
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-CHHHHHHHHHHhh
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-DMRDVVAKLCHTR 825 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~eil~~L~~i~ 825 (833)
............. .....+++++.+.+++.+||++||++|| |++++++.|.++.
T Consensus 221 --~~~~~~~~~~~~~---~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 221 --SVAYQHVREDPIP---PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp --HHHHHHHHCCCCC---GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --HHHHHHHhcCCCC---CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111111111110 1111233567889999999999999999 8999999988775
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.1e-45 Score=382.41 Aligned_cols=246 Identities=22% Similarity=0.257 Sum_probs=205.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++.+.||+|+||+||+|+++.+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+ .
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-----Q 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS-----E
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC-----e
Confidence 5799999999999999999999999999999999643 2334567899999999999999999999976655 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+|||||+||++.+++.... .+++..++.++.||+.||+|||++ +||||||||+|||++.+|.+||+|||
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG 149 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFG 149 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCS
T ss_pred eeeEeeecCCccccccccccc------cccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCc
Confidence 999999999999999998765 688999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+...... ...+||+.|||||++.+..|+.++|||| .|+++|++++|..|+......
T Consensus 150 ~a~~~~~~~-----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwS----------lGvilyemltG~~Pf~~~~~~- 207 (316)
T d1fota_ 150 FAKYVPDVT-----------YTLCGTPDYIAPEVVSTKPYNKSIDWWS----------FGILIYEMLAGYTPFYDSNTM- 207 (316)
T ss_dssp SCEECSSCB-----------CCCCSCTTTCCHHHHTTCCBCTTHHHHH----------HHHHHHHHHHSSCTTCCSSHH-
T ss_pred cceEecccc-----------ccccCcccccCHHHHcCCCCCchhhccc----------cchhHHHHHhCCCCCCCcCHH-
Confidence 998764421 2357999999999999999999999999 899999999999998632211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
........... ..+..+++.+.+++.+||.+||++|| |++|++++
T Consensus 208 -~~~~~i~~~~~-------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 208 -KTYEKILNAEL-------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp -HHHHHHHHCCC-------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred -HHHHHHHcCCC-------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11111111111 11223456788999999999999996 89999764
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=374.90 Aligned_cols=254 Identities=29% Similarity=0.368 Sum_probs=197.8
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||.||+|+++ |+.||||+++. ....+.+.+|++++++++||||++++|+|.+. .+..+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~ 77 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY 77 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEE
Confidence 357889999999999999999984 77899999964 33457899999999999999999999998543 23679
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||+++|+|.+++..... ..+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++|||++
T Consensus 78 lv~ey~~~g~L~~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s 150 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLT 150 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred EEEeccCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccc
Confidence 99999999999999976432 1589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~~~~~ 768 (833)
+...... ....+|+.|+|||++.+..++.++|||| +|+++||+++ +..|+......
T Consensus 151 ~~~~~~~-----------~~~~~~~~y~aPE~l~~~~~t~~sDIwS----------fG~il~el~t~~~~p~~~~~~~-- 207 (262)
T d1byga_ 151 KEASSTQ-----------DTGKLPVKWTAPEALREKKFSTKSDVWS----------FGILLWEIYSFGRVPYPRIPLK-- 207 (262)
T ss_dssp ----------------------CCTTTSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCSCTTSCGG--
T ss_pred eecCCCC-----------ccccccccCCChHHHhCCCCChHHHHHh----------HHHHHHHHHHCCCCCCCCCCHH--
Confidence 8654321 1235899999999999999999999999 7888888887 46555422211
Q ss_pred cchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 769 SLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 769 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
..... +.... ....+..+++.+.+++.+||..||++|||+.|++++|++++.+
T Consensus 208 ~~~~~-i~~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 208 DVVPR-VEKGY-----KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp GHHHH-HTTTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH-HHcCC-----CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 11111 11111 1112234567789999999999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=378.02 Aligned_cols=261 Identities=20% Similarity=0.298 Sum_probs=198.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.++|++.+.||+|+||.||+|++..+ +..||||.++..... ..+.+.+|++++++++|||||+++|++.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 35799999999999999999998644 457899998644332 34679999999999999999999999743
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
+..++||||+++|++.+++..... .+++.+++.++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~D 151 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGD 151 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC
T ss_pred CeEEEEEEeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEcc
Confidence 257999999999999998775542 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||+|+........ ......||+.|+|||++.+..++.++|||| +|+++|++++ +..|+....
T Consensus 152 fG~a~~~~~~~~~-------~~~~~~gt~~y~apE~l~~~~~~~~~DiwS----------lGvil~e~lt~g~~P~~~~~ 214 (273)
T d1mp8a_ 152 FGLSRYMEDSTYY-------KASKGKLPIKWMAPESINFRRFTSASDVWM----------FGVCMWEILMHGVKPFQGVK 214 (273)
T ss_dssp --------------------------CCGGGCCHHHHHHCCCSHHHHHHH----------HHHHHHHHHTTSCCTTTTCC
T ss_pred chhheeccCCcce-------eccceecCcccchhhHhccCCCCCcccccc----------chHHHHHHHhcCCCCCCCCC
Confidence 9999876543221 122346899999999999999999999999 7888888876 566654222
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFL 829 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~ 829 (833)
. ............ ...++.+++.+.+++.+||+.||++|||++||++.|+++.+...
T Consensus 215 ~--~~~~~~i~~~~~------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~k 271 (273)
T d1mp8a_ 215 N--NDVIGRIENGER------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271 (273)
T ss_dssp G--GGHHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred H--HHHHHHHHcCCC------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence 1 111111111111 11233466789999999999999999999999999999987644
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-45 Score=383.81 Aligned_cols=274 Identities=20% Similarity=0.316 Sum_probs=201.0
Q ss_pred HHHHHHhcCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeE
Q 040925 524 AELSKATGEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITI 596 (833)
Q Consensus 524 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 596 (833)
+.++...++|++.+.||+|+||.||+|++.. +++.||||+++.... ...+.+.+|..++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 3333444689999999999999999999753 457899999974432 3346788888888887 68999999998
Q ss_pred eecCCCCCCceEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceee
Q 040925 597 CSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHG 666 (833)
Q Consensus 597 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~ 666 (833)
+... ....++|||||++|+|.+++...... .....+++.+++.++.||+.||+|||++ +||||
T Consensus 86 ~~~~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr 158 (299)
T d1ywna1 86 CTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 158 (299)
T ss_dssp ECST----TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred eccC----CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCC
Confidence 7543 34689999999999999999765321 0122589999999999999999999999 99999
Q ss_pred CCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccC
Q 040925 667 DLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNE 746 (833)
Q Consensus 667 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~ 746 (833)
||||+|||+++++.+||+|||+|+....... ........||+.|||||++.+..++.++|||| +
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS----------~ 222 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKDPD------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWS----------F 222 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSCTT------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHH----------H
T ss_pred cCCccceeECCCCcEEEccCcchhhcccccc------ccccCceeeCccccchhHhhcCCCCcccceee----------h
Confidence 9999999999999999999999986544321 11223457999999999999999999999999 7
Q ss_pred CccHHHHHHHhC-CCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhh
Q 040925 747 GHSLHEFAKTAL-PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTR 825 (833)
Q Consensus 747 g~~l~~~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~ 825 (833)
|+++|+++++.. |+.... .+..+. ....... ....++.+++.+.+++.+||+.||++|||++||+++|+++.
T Consensus 223 Gvil~ellt~~~~p~~~~~-~~~~~~-~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 223 GVLLWEIFSLGASPYPGVK-IDEEFC-RRLKEGT-----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHTTSCCSSTTCC-CSHHHH-HHHHHTC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCC-HHHHHH-HHHhcCC-----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 888888887644 443211 111111 1111100 01112335667899999999999999999999999999987
Q ss_pred hh
Q 040925 826 ET 827 (833)
Q Consensus 826 ~~ 827 (833)
++
T Consensus 296 q~ 297 (299)
T d1ywna1 296 QA 297 (299)
T ss_dssp HH
T ss_pred hC
Confidence 64
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-45 Score=383.96 Aligned_cols=259 Identities=21% Similarity=0.367 Sum_probs=201.2
Q ss_pred cCCccCceeccCcceEEEEEEECCCce----EEEEEEeecc-CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEM----IVAVKVINLK-YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGT 605 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 605 (833)
.+|++.+.||+|+||+||+|++..+|+ +||+|+++.. .....+.+.+|++++++++|||||+++|+|.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 469999999999999999999987765 6888888643 334467899999999999999999999998654
Q ss_pred ceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcc
Q 040925 606 DFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCD 685 (833)
Q Consensus 606 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D 685 (833)
..+++|||+.+|+|.+++..... .+++..+++|+.||+.||+|||++ +||||||||+||+++.++.+||+|
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred -CeeEEEEeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeec
Confidence 36789999999999998876543 689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCcccc
Q 040925 686 FGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVME 764 (833)
Q Consensus 686 fG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~~ 764 (833)
||+|+........ .......||+.|||||++.+..++.++|||| +|+++||+++ +..|+....
T Consensus 155 FGla~~~~~~~~~------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS----------~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 155 FGLAKLLGAEEKE------YHAEGGKVPIKWMALESILHRIYTHQSDVWS----------YGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp CSHHHHTTTTCC--------------CCTTTSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCTTTTSC
T ss_pred cccceeccccccc------ccccccccCccccChHHHhcCCCChhhhhhh----------HHHHHHHHHHCCCCCCCCCC
Confidence 9999876543221 1122346899999999999999999999999 7778888877 566654221
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
. ..+ ...+.... ....++.+++.+.+++.+||+.||++|||+.||++.+..+...
T Consensus 219 ~--~~~-~~~i~~~~-----~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 219 A--SEI-SSILEKGE-----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp G--GGH-HHHHHHTC-----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred H--HHH-HHHHHcCC-----CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 1 111 11111110 1112234567789999999999999999999999999888643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-45 Score=385.14 Aligned_cols=270 Identities=23% Similarity=0.344 Sum_probs=210.4
Q ss_pred HHHHHhcCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCCc-chhHHHHHHHHHhhcCCCccceEeeEee
Q 040925 525 ELSKATGEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYKG-ASRSFVAECEALRNIRHRNLIKIITICS 598 (833)
Q Consensus 525 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~ 598 (833)
+++...++|++.+.||+|+||+||+|+++ .+++.||||+++..... ..+++.+|++++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999975 35689999999754332 3467999999999999999999999986
Q ss_pred cCCCCCCceEeEEEEecCCCChhhhhccCCCc------------------cccccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 040925 599 STDFKGTDFKAFVFEYMENGSLKDWLHQSDDQ------------------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQ 660 (833)
Q Consensus 599 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~ 660 (833)
... ..++||||+++|+|.+++...... .....+++..++.|+.|++.||+|||+.
T Consensus 87 ~~~-----~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-- 159 (301)
T d1lufa_ 87 VGK-----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 159 (301)
T ss_dssp SSS-----SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred cCC-----ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC--
Confidence 554 789999999999999999754321 1122589999999999999999999999
Q ss_pred CCceeeCCCCCCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCC
Q 040925 661 PPMVHGDLKPSNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPI 740 (833)
Q Consensus 661 ~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~ 740 (833)
+||||||||+||+++.++.+||+|||+|+......... ......||+.|||||++.+..++.++||||
T Consensus 160 -~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS----- 227 (301)
T d1lufa_ 160 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK------ADGNDAIPIRWMPPESIFYNRYTTESDVWA----- 227 (301)
T ss_dssp -TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----------CCBCGGGCCHHHHHHCCCCHHHHHHH-----
T ss_pred -CeEeeEEcccceEECCCCcEEEccchhheeccCCcccc------ccCCCCcCcCcCCHHHHccCCCChhhhhcc-----
Confidence 99999999999999999999999999998665433211 122356899999999999999999999999
Q ss_pred CccccCCccHHHHHHHhCC-CcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 741 DAVFNEGHSLHEFAKTALP-EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 741 ~~~~~~g~~l~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
+|+++||++++..| +.... +.+.......... ...++.+++.+.+++.+||+.||++||||.||++
T Consensus 228 -----~Gvvl~ell~~~~~p~~~~~--~~e~~~~v~~~~~------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 228 -----YGVVLWEIFSYGLQPYYGMA--HEEVIYYVRDGNI------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp -----HHHHHHHHHTTTCCTTTTSC--HHHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----chhhHHHHHccCCCCCCCCC--HHHHHHHHHcCCC------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 78888888877543 33111 1111111111111 1123345677899999999999999999999999
Q ss_pred HHHHhhh
Q 040925 820 KLCHTRE 826 (833)
Q Consensus 820 ~L~~i~~ 826 (833)
.|+++.+
T Consensus 295 ~L~~i~~ 301 (301)
T d1lufa_ 295 ILQRMCE 301 (301)
T ss_dssp HHHHTTC
T ss_pred HHHHhcC
Confidence 9999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=376.11 Aligned_cols=270 Identities=24% Similarity=0.308 Sum_probs=202.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHH--HHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFV--AECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
.+|...+.||+|+||.||+|++ +|+.||||+++.. ..+.+. .|+..+.+++|||||+++++|...+ ......
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEE
Confidence 4678889999999999999997 5889999999643 223333 4555556789999999999997654 233468
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCceeeCCCCCCeeecCCCcEEE
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC-----QPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
|+|||||++|+|.+++++. .+++.++++++.|++.||+|+|+.. .++||||||||+|||++.++.+||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred EEEEecccCCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence 9999999999999999864 5899999999999999999999731 239999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCC------CCCcccccccCCcCCCccccCCccHHHHHHHh
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS------EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTA 757 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~ 757 (833)
+|||+++......... ........||+.|||||++.+. .++.++|||| +|+++||++++.
T Consensus 150 ~DFGl~~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S----------~Gvvl~el~tg~ 215 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTI----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA----------MGLVFWEIARRC 215 (303)
T ss_dssp CCCTTCEEEETTTTEE----CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHH----------HHHHHHHHHHTB
T ss_pred EecCccccccCCCcce----eccccceecccCcCChhhccccccccCCCcCcchhhhh----------hHHHHHHHhhCC
Confidence 9999998765432211 1122346799999999997764 3678999999 888999999987
Q ss_pred CCCcccccccccc------------hhhh-ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 758 LPEKVMEIVDPSL------------LMEV-MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 758 ~p~~~~~~~~~~~------------~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
.|+.......... .... ................+.+..+.+++.+||+.||++|||+.||++.|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 216 SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp CBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 7654221111000 0000 00111111122333455677899999999999999999999999999998
Q ss_pred hhh
Q 040925 825 RET 827 (833)
Q Consensus 825 ~~~ 827 (833)
.+.
T Consensus 296 ~~~ 298 (303)
T d1vjya_ 296 SQQ 298 (303)
T ss_dssp HHH
T ss_pred HHh
Confidence 764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=377.45 Aligned_cols=264 Identities=24% Similarity=0.441 Sum_probs=207.7
Q ss_pred CceeccCcceEEEEEEECCCc---eEEEEEEeecc-CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeEE
Q 040925 536 SNMIGQGSFGYVYKGTLGEDE---MIVAVKVINLK-YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAFV 611 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 611 (833)
.++||+|+||+||+|++..++ ..||||+++.. .....+++.+|++++++++||||++++|++...+ +..++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~----~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSE----GSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETT----TEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecC----CceEEE
Confidence 468999999999999986543 46999999643 3334578999999999999999999999985432 478999
Q ss_pred EEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccccc
Q 040925 612 FEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAKF 691 (833)
Q Consensus 612 ~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 691 (833)
||||++|+|.+++..... ..++..+++++.|++.||.|+|+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 108 ~E~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EECCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhh
Confidence 999999999999886543 577889999999999999999999 999999999999999999999999999987
Q ss_pred cCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccccch
Q 040925 692 LSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDPSLL 771 (833)
Q Consensus 692 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~~~~ 771 (833)
........ ........||+.|+|||++.+..++.++|||| +|++++|++++..|+.... ......
T Consensus 180 ~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S----------fGivl~El~t~~~p~~~~~-~~~~~~ 244 (311)
T d1r0pa_ 180 MYDKEFDS----VHNKTGAKLPVKWMALESLQTQKFTTKSDVWS----------FGVLLWELMTRGAPPYPDV-NTFDIT 244 (311)
T ss_dssp TTTTTCCC----TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHH----------HHHHHHHHHTTSCCSCC-------CH
T ss_pred cccccccc----ceecccccccccccChHHHhcCCCCChhHhhh----------hHHHHHHHHHCCCCCCCCC-CHHHHH
Confidence 65533211 11223457999999999999999999999999 8888889888776654211 111222
Q ss_pred hhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhhhhcCC
Q 040925 772 MEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRETFLGRR 832 (833)
Q Consensus 772 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~~~~~~ 832 (833)
......... ..++.+++.+.+++.+||+.||++|||+.||+++|+++.+++.+++
T Consensus 245 ~~i~~g~~~------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~~ 299 (311)
T d1r0pa_ 245 VYLLQGRRL------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH 299 (311)
T ss_dssp HHHHTTCCC------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred HHHHcCCCC------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhhh
Confidence 222211111 1123356778999999999999999999999999999998877653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=381.10 Aligned_cols=256 Identities=18% Similarity=0.230 Sum_probs=202.2
Q ss_pred hcCCccCc-eeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSN-MIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~-~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|.+.. .||+|+||+||+|++..+++.||||+++. ...+.+|++++.++ +|||||++++++.+. ......
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~-~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENL-YAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEE-ETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeec-ccCCCE
Confidence 46898875 59999999999999999999999999962 35678899997765 799999999987653 123457
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CCcEEEc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVC 684 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~ 684 (833)
.|+|||||+||+|.+++...+.. .+++.+++.|+.||+.||+|||+. ||+||||||+||+++. ++.+||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~----~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQ----AFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCC----CEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEECCCCCcHHHHHHhcCCC----CcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 89999999999999999865432 699999999999999999999999 9999999999999985 5679999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+|+....... .....||+.|||||++.+..|+.++|||| .|+++|++++|..|+....
T Consensus 157 DFG~a~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~y~~~~DiwS----------lGvily~lltg~~Pf~~~~ 217 (335)
T d2ozaa1 157 DFGFAKETTSHNS---------LTTPCYTPYYVAPEVLGPEKYDKSCDMWS----------LGVIMYILLCGYPPFYSNH 217 (335)
T ss_dssp CCTTCEECCCCCC---------CCCCSCCCSSCCCCCCCGGGGSHHHHHHH----------HHHHHHHHTTSSCSCEETT
T ss_pred ccceeeeccCCCc---------cccccCCcccCCcHHHcCCCCCHHHHHHh----------hchhHHHHhhCCCCCCCCC
Confidence 9999986654321 22356999999999999999999999999 8889999999999975322
Q ss_pred ccc--ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 765 IVD--PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 765 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... ..+.......... .+......+++++.+++.+||+.||++|||++|+++.
T Consensus 218 ~~~~~~~~~~~i~~~~~~---~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 218 GLAISPGMKTRIRMGQYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CC--------CCCSCSSS---CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHHHhcCCCC---CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 1111111111110 1112234566789999999999999999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-44 Score=370.83 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=204.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc---------chhHHHHHHHHHhhcC-CCccceEeeEeecC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG---------ASRSFVAECEALRNIR-HRNLIKIITICSST 600 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 600 (833)
++|++.+.||+|+||+||+|++..+++.||||+++..... ..+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5899999999999999999999999999999999754321 1246889999999997 99999999997665
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCc
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMV 680 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 680 (833)
+ ..|+|||||++|+|.+++...+ .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.
T Consensus 83 ~-----~~~ivmE~~~~g~L~~~l~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ 148 (277)
T d1phka_ 83 T-----FFFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMN 148 (277)
T ss_dssp S-----EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCC
T ss_pred c-----ceEEEEEcCCCchHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCC
Confidence 5 8999999999999999998654 799999999999999999999999 9999999999999999999
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccC------CCCCCcccccccCCcCCCccccCCccHHHHH
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGM------GSEASMTGDIFTGRRPIDAVFNEGHSLHEFA 754 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~ 754 (833)
+||+|||+|+....... .....||+.|+|||++. ...++.++|||| .|+++|+++
T Consensus 149 ~kl~DFG~a~~~~~~~~---------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diws----------lGvilyeml 209 (277)
T d1phka_ 149 IKLTDFGFSCQLDPGEK---------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS----------TGVIMYTLL 209 (277)
T ss_dssp EEECCCTTCEECCTTCC---------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHH----------HHHHHHHHH
T ss_pred eEEccchheeEccCCCc---------eeeeeccCCCCCHHHhhccccccCCCCCchheEcc----------cchhhhhhc
Confidence 99999999987654321 12356999999999875 345788999999 899999999
Q ss_pred HHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 755 KTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 755 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++..|+...... ............. .......+++++.+++.+||++||++|||++||++.
T Consensus 210 ~g~~Pf~~~~~~--~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 210 AGSPPFWHRKQM--LMLRMIMSGNYQF---GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HSSCSSCCSSHH--HHHHHHHHTCCCC---CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred cCCCCCCCCCHH--HHHHHHHhCCCCC---CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 999998633211 1111111111111 111223456778999999999999999999998653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.8e-44 Score=385.73 Aligned_cols=251 Identities=21% Similarity=0.244 Sum_probs=199.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC---CcchhHHHH---HHHHHhhcCCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY---KGASRSFVA---ECEALRNIRHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+ |+++++.++|||||++++++...+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~-- 80 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-- 80 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS--
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC--
Confidence 368999999999999999999999999999999986331 122233444 466777778999999999976654
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
..|+|||||++|+|.+++.... .+++.+++.++.||+.||+|||++ +||||||||+|||++.+|.+||
T Consensus 81 ---~~~ivmE~~~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl 148 (364)
T d1omwa3 81 ---KLSFILDLMNGGDLHYHLSQHG------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRI 148 (364)
T ss_dssp ---EEEEEECCCCSCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEE
T ss_pred ---EEEEEEEecCCCcHHHHHHhcc------cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEE
Confidence 8999999999999999998654 689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKV 762 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~ 762 (833)
+|||+|+...... .....||+.|||||++.+ ..|+.++|||| .|+++|++++|..|+..
T Consensus 149 ~DFGla~~~~~~~----------~~~~~GT~~y~APE~~~~~~~~~~~~DiwS----------lGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 149 SDLGLACDFSKKK----------PHASVGTHGYMAPEVLQKGVAYDSSADWFS----------LGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CCCTTCEECSSSC----------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHH----------HHHHHHHHHHSSCSSCS
T ss_pred eeeceeeecCCCc----------ccccccccccchhHHhhcCCCCCcccchhH----------HHHHHHHHHhCCCCCCC
Confidence 9999998665432 123469999999999864 56899999999 89999999999999864
Q ss_pred cccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCC-----HHHHHHH
Q 040925 763 MEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMD-----MRDVVAK 820 (833)
Q Consensus 763 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~eil~~ 820 (833)
....+........... ....+..+++.+.+++.+||+.||++||| ++|++++
T Consensus 209 ~~~~~~~~~~~~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 209 HKTKDKHEIDRMTLTM------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SCSSCHHHHHHHSSSC------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CCHHHHHHHHHhcccC------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 3322221111111110 01112234667899999999999999999 6888753
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-44 Score=383.08 Aligned_cols=246 Identities=21% Similarity=0.237 Sum_probs=205.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
++|++++.||+|+||.||+|+++.+|+.||||+++.. .....+.+.+|++++++++|||||++++++.... .
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-----N 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----E
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc-----c
Confidence 5799999999999999999999999999999999643 2234567899999999999999999999976655 8
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.++||||+.+|+|.+++...+ .+++.+++.++.||+.||.|||++ +||||||||+|||++.++.+||+|||
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG 186 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFG 186 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred cccccccccccchhhhHhhcC------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeece
Confidence 999999999999999998654 689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+.+.... ....||+.|||||++.+..++.++|||| .|+++|++++|..|+......
T Consensus 187 ~a~~~~~~~-----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwS----------lGvilyemltG~~Pf~~~~~~- 244 (350)
T d1rdqe_ 187 FAKRVKGRT-----------WTLCGTPEALAPEIILSKGYNKAVDWWA----------LGVLIYEMAAGYPPFFADQPI- 244 (350)
T ss_dssp TCEECSSCB-----------CCCEECGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCSSCCSSHH-
T ss_pred eeeeccccc-----------ccccCccccCCHHHHcCCCCCccccccc----------hhHHHHHHHhCCCCCCCcCHH-
Confidence 998764321 2356999999999999999999999999 899999999999998632211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~~ 820 (833)
........... ..+..+++.+.+++.+||+.||++|+ |++|++++
T Consensus 245 -~~~~~i~~~~~-------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 245 -QIYEKIVSGKV-------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -HHHHHHHHCCC-------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -HHHHHHhcCCC-------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 11111111111 11233566788999999999999994 89999763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=376.77 Aligned_cols=253 Identities=18% Similarity=0.218 Sum_probs=205.3
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.++|++.+.||+|+||+||+|++..+++.||||+++... .....+.+|+++|++++|||||++++++.+.+ ..|
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~-----~~~ 77 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESME-----ELV 77 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETT-----EEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECC-----EEE
Confidence 468999999999999999999999999999999997543 23456889999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC--CcEEEcccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD--MVAHVCDFG 687 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~DfG 687 (833)
+|||||+||+|.+++...+. .+++.+++.|+.||+.||+|||+. ||+||||||+|||++.+ +.+||+|||
T Consensus 78 lvmE~~~gg~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG 149 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFG 149 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCT
T ss_pred EEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccc
Confidence 99999999999999986542 589999999999999999999999 99999999999999854 489999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+++....... .....||+.|+|||...+..++.++|||| .|+++|++++|..|+......
T Consensus 150 ~~~~~~~~~~---------~~~~~~t~~y~ape~~~~~~~~~~~DiWS----------lGvily~ll~G~~Pf~~~~~~- 209 (321)
T d1tkia_ 150 QARQLKPGDN---------FRLLFTAPEYYAPEVHQHDVVSTATDMWS----------LGTLVYVLLSGINPFLAETNQ- 209 (321)
T ss_dssp TCEECCTTCE---------EEEEESCGGGSCHHHHTTCEECHHHHHHH----------HHHHHHHHHHSSCTTCCSSHH-
T ss_pred hhhccccCCc---------ccccccccccccchhccCCCCCchhhccc----------HHHHHHHHHhCCCCCCCCCHH-
Confidence 9986543221 12346899999999999999999999999 889999999999997632211
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
............. ......++++.+.+++.+||..||++|||++|++++
T Consensus 210 -~~~~~i~~~~~~~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 210 -QIIENIMNAEYTF---DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp -HHHHHHHHTCCCC---CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -HHHHHHHhCCCCC---ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111111 111112345678899999999999999999999874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=372.46 Aligned_cols=258 Identities=25% Similarity=0.330 Sum_probs=194.2
Q ss_pred cCCccCceeccCcceEEEEEEECCC---ceEEEEEEeeccC---CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGED---EMIVAVKVINLKY---KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKG 604 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 604 (833)
++|++.+.||+|+||+||+|++... ...||||+++... ....+.+.+|++++++++|||||+++|++.+.
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---- 83 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP---- 83 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec----
Confidence 5799999999999999999987432 3578999986442 23346799999999999999999999998543
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
..++||||+++|++.+++..... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+
T Consensus 84 --~~~lv~e~~~~~~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~ 153 (273)
T d1u46a_ 84 --PMKMVTELAPLGSLLDRLRKHQG-----HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIG 153 (273)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHGG-----GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEEC
T ss_pred --chheeeeeecCcchhhhhhcccC-----CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeec
Confidence 46899999999999998876432 699999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHH-HhCCCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAK-TALPEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~-~~~p~~~~ 763 (833)
|||+++......... .......||+.|+|||++.+..++.++|||| +|+++||+++ |..|+...
T Consensus 154 DfGl~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S----------~Gvil~emlt~G~~Pf~~~ 218 (273)
T d1u46a_ 154 DFGLMRALPQNDDHY-----VMQEHRKVPFAWCAPESLKTRTFSHASDTWM----------FGVTLWEMFTYGQEPWIGL 218 (273)
T ss_dssp CCTTCEECCC-CCEE-----EC-----CCGGGCCHHHHHHCEEEHHHHHHH----------HHHHHHHHHTTSCCTTTTC
T ss_pred cchhhhhcccCCCcc-----eecCccccCcccCCHHHHhCCCCCcchhhhh----------hHHHHHHHHhCCCCCCCCc
Confidence 999999765433211 1122346889999999999999999999999 7788888886 67776422
Q ss_pred ccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHh
Q 040925 764 EIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHT 824 (833)
Q Consensus 764 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i 824 (833)
.. ............ ....++.+++.+.+++.+||+.||++|||++||.+.|++.
T Consensus 219 ~~--~~~~~~i~~~~~-----~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 219 NG--SQILHKIDKEGE-----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CH--HHHHHHHHTSCC-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CH--HHHHHHHHhCCC-----CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11 111111111111 0112234567789999999999999999999999998875
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-44 Score=377.04 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=202.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeecc---CCcchhHHHHHHHHHh-hcCCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK---YKGASRSFVAECEALR-NIRHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 606 (833)
++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+..|..++. .++|||||++++++.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~----- 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE----- 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS-----
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC-----
Confidence 5799999999999999999999999999999999743 2334456777777765 689999999999976655
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
..|+||||+++|+|.+++.... .+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DF 147 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADF 147 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCC
T ss_pred ceeEEEeecCCCcHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceecccc
Confidence 8999999999999999998655 689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
|+|+....... ......||+.|+|||++.+..++.++|||| .|+++|++++|..|+.....
T Consensus 148 G~a~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lGvilyemltG~~PF~~~~~- 208 (320)
T d1xjda_ 148 GMCKENMLGDA--------KTNTFCGTPDYIAPEILLGQKYNHSVDWWS----------FGVLLYEMLIGQSPFHGQDE- 208 (320)
T ss_dssp TTCBCCCCTTC--------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHH----------HHHHHHHHHHSSCSSCCSSH-
T ss_pred chhhhcccccc--------cccccCCCCCcCCHHHHcCCCCCchhhhhh----------hhHHHHHHHhCCCCCCCCCH-
Confidence 99986543221 122357999999999999999999999999 89999999999999863221
Q ss_pred cccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHH-HHHH
Q 040925 767 DPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMR-DVVA 819 (833)
Q Consensus 767 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-eil~ 819 (833)
............ ..+..+++.+.+++.+||..||++|||+. |+++
T Consensus 209 -~~~~~~i~~~~~-------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 209 -EELFHSIRMDNP-------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -HHHHHHHHHCCC-------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -HHHHHHHHcCCC-------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 111111111111 11223456789999999999999999995 6754
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=375.69 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=203.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCce--EEEEEEeecc-CCcchhHHHHHHHHHhhc-CCCccceEeeEeecCCCCCCc
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEM--IVAVKVINLK-YKGASRSFVAECEALRNI-RHRNLIKIITICSSTDFKGTD 606 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 606 (833)
++|++.+.||+|+||+||+|+++.++. .||||+++.. .....+.+.+|+++++++ +|||||+++|+|...+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~----- 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG----- 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT-----
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC-----
Confidence 578999999999999999999987776 4677887533 333456899999999999 7999999999987655
Q ss_pred eEeEEEEecCCCChhhhhccCCC----------ccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeec
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDD----------QVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLD 676 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~ 676 (833)
..++||||+++|+|.+++..... ......+++.++++++.||+.||.|+|+. +|+||||||+|||++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVG 161 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEc
Confidence 89999999999999999976521 01123689999999999999999999999 999999999999999
Q ss_pred CCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHH
Q 040925 677 HDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKT 756 (833)
Q Consensus 677 ~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~ 756 (833)
.++.+||+|||+|+....... .....||+.|+|||.+.+..++.++|||| +|+++++++++
T Consensus 162 ~~~~~kl~DfG~a~~~~~~~~---------~~~~~gt~~y~aPE~l~~~~~~~~sDvwS----------fGvil~ell~~ 222 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQEVYVK---------KTMGRLPVRWMAIESLNYSVYTTNSDVWS----------YGVLLWEIVSL 222 (309)
T ss_dssp GGGCEEECCTTCEESSCEECC---------C----CCTTTCCHHHHHHCEECHHHHHHH----------HHHHHHHHHTT
T ss_pred CCCceEEcccccccccccccc---------ccceecCCcccchHHhccCCCCccceeeh----------hHHHHHHHHhc
Confidence 999999999999986544221 11245899999999999999999999999 78888888886
Q ss_pred hC-CCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 757 AL-PEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 757 ~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.. |+.... ...+......... ...+..+++.+.+++.+||+.||++||||+||++.|+++.+.
T Consensus 223 ~~~p~~~~~--~~~~~~~i~~~~~------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 223 GGTPYCGMT--CAELYEKLPQGYR------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp SCCTTTTCC--HHHHHHHGGGTCC------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCC--HHHHHHHHHhcCC------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 54 443211 1111111111110 111233567889999999999999999999999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=371.06 Aligned_cols=254 Identities=24% Similarity=0.268 Sum_probs=191.2
Q ss_pred cCceeccCcceEEEEEEECCCceEEEEEEeeccCCc-----chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 535 SSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG-----ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 535 ~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
..+.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.++++++|||||++++++...+ ..|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-----~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-----NIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-----CCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-----cee
Confidence 457899999999999999999999999999644221 2357899999999999999999999976554 899
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
+||||++++++..+..... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+|
T Consensus 77 ivmE~~~~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a 147 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 147 (299)
T ss_dssp EEEECCSEEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ehhhhhcchHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccc
Confidence 9999999887777665443 689999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+....... .....+||+.|||||++.+. .++.++|||| .|+++++++++..|+......+.
T Consensus 148 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS----------lGvil~el~~g~~pf~~~~~~~~ 209 (299)
T d1ua2a_ 148 KSFGSPNR--------AYTHQVVTRWYRAPELLFGARMYGVGVDMWA----------VGCILAELLLRVPFLPGDSDLDQ 209 (299)
T ss_dssp STTTSCCC--------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHH----------HHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cccCCCcc--------cccceecChhhccHHHHccCCCCChhhhhhh----------cchHHHHHHhCcCCCCCCCHHHH
Confidence 86654321 12235799999999988654 5799999999 78888888888877642211110
Q ss_pred c-------------chhhh------ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 S-------------LLMEV------MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~-------------~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
- ..... ..................++.+.+++.+||+.||++|||++|++++
T Consensus 210 l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 210 LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0 00000 0000000000000111235678899999999999999999999863
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=370.89 Aligned_cols=268 Identities=21% Similarity=0.342 Sum_probs=208.8
Q ss_pred hcCCccCceeccCcceEEEEEEEC-----CCceEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLG-----EDEMIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSSTDF 602 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 602 (833)
.++|++.+.||+|+||.||+|++. .+++.||||+++.... .....+.+|+.+++++ +|||||+++|+|....
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~- 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG- 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC-
Confidence 468999999999999999999863 4678999999975433 2345789999999999 6999999999986654
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCc------------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQ------------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
..++|||||++|+|.+++...... .....+++..+..++.||+.||+|||++ +||||||||
T Consensus 101 ----~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp 173 (311)
T d1t46a_ 101 ----PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAA 173 (311)
T ss_dssp ----SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred ----EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccc
Confidence 789999999999999999765421 1122589999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+||+++.++.+|++|||.++........ .......||+.|+|||++.+..++.++|||| +|+++
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS----------~G~~l 237 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNY------VVKGNARLPVKWMAPESIFNCVYTFESDVWS----------YGIFL 237 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTS------EECSSSEECGGGCCHHHHHHCCCCHHHHHHH----------HHHHH
T ss_pred ccccccccCcccccccchheeccCCCcc------eEeeecccChHHcCHHHhcCCCCCCcccccc----------hHHHH
Confidence 9999999999999999999876543221 1122357999999999999999999999999 78888
Q ss_pred HHHHHHhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 751 HEFAKTALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 751 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
++++++..|+......+..+ ...+.... ....++.+++.+.+++.+||+.||++||||+||+++|+++..+
T Consensus 238 ~ellt~g~p~~~~~~~~~~~-~~~i~~~~-----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 238 WELFSLGSSPYPGMPVDSKF-YKMIKEGF-----RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHTTTCCSSTTCCSSHHH-HHHHHHTC-----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHH-HHHHhcCC-----CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 88887544433221111111 11111111 1112233567789999999999999999999999999886543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-44 Score=367.48 Aligned_cols=241 Identities=19% Similarity=0.275 Sum_probs=196.6
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc------chhHHHHHHHHHhhcC--CCccceEeeEeecCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG------ASRSFVAECEALRNIR--HRNLIKIITICSSTDF 602 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~ 602 (833)
++|++.+.||+|+||+||+|++..+++.||||+++..... ...++.+|+.++++++ |||||++++++.+.+
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~- 82 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD- 82 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS-
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC-
Confidence 5799999999999999999999999999999999743211 2245778999999996 899999999976655
Q ss_pred CCCceEeEEEEecCC-CChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCC-Cc
Q 040925 603 KGTDFKAFVFEYMEN-GSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHD-MV 680 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~-~~ 680 (833)
..++||||+.+ +++.+++.... .+++.+++.++.|++.||+|||+. +|+||||||+||+++.+ +.
T Consensus 83 ----~~~lv~e~~~~~~~l~~~~~~~~------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 83 ----SFVLILERPEPVQDLFDFITERG------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp ----EEEEEEECCSSEEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred ----eEEEEEEeccCcchHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCe
Confidence 89999999975 67888887654 799999999999999999999999 99999999999999854 79
Q ss_pred EEEcccccccccCcccccccccCCCccccccccccccCccccCCCCC-CcccccccCCcCCCccccCCccHHHHHHHhCC
Q 040925 681 AHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEA-SMTGDIFTGRRPIDAVFNEGHSLHEFAKTALP 759 (833)
Q Consensus 681 ~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p 759 (833)
+||+|||+|+...... .....||+.|||||++.+..+ +.++|||| .|+++|+++++..|
T Consensus 150 vkl~DFG~a~~~~~~~----------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwS----------lGvilyell~g~~P 209 (273)
T d1xwsa_ 150 LKLIDFGSGALLKDTV----------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWS----------LGILLYDMVCGDIP 209 (273)
T ss_dssp EEECCCTTCEECCSSC----------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHH----------HHHHHHHHHHSSCS
T ss_pred EEECccccceeccccc----------ccccccCCCcCCHHHHcCCCCCCccccccc----------ceeeehhHhhCCCC
Confidence 9999999998654322 123569999999999887765 57789999 88999999999999
Q ss_pred CcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 760 EKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 760 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+...+.+. .... .....+++++.+++.+||+.||++|||++|+++.
T Consensus 210 f~~~~~i~--------~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 210 FEHDEEII--------RGQV-------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCSHHHHH--------HCCC-------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCchHHh--------hccc-------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 86322110 0000 0111235678899999999999999999999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=368.75 Aligned_cols=265 Identities=23% Similarity=0.349 Sum_probs=202.7
Q ss_pred hcCCccCceeccCcceEEEEEEECCCc-------eEEEEEEeeccCC-cchhHHHHHHHHHhhc-CCCccceEeeEeecC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDE-------MIVAVKVINLKYK-GASRSFVAECEALRNI-RHRNLIKIITICSST 600 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 600 (833)
.++|++.+.||+|+||.||+|+...++ ..||||+++.... ....++.+|...+.++ +|||||+++++|.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 358999999999999999999875443 5799999975543 2346788999999998 799999999998655
Q ss_pred CCCCCceEeEEEEecCCCChhhhhccCCCc----------cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCC
Q 040925 601 DFKGTDFKAFVFEYMENGSLKDWLHQSDDQ----------VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKP 670 (833)
Q Consensus 601 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp 670 (833)
+ ..++||||+++|+|.+++...... .....+++.+++.++.||+.||+|||+. +||||||||
T Consensus 92 ~-----~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 92 G-----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp S-----SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred C-----eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecc
Confidence 4 789999999999999999765421 1123689999999999999999999999 999999999
Q ss_pred CCeeecCCCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccH
Q 040925 671 SNVLLDHDMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSL 750 (833)
Q Consensus 671 ~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l 750 (833)
+|||++.++.+||+|||+++........ .......||+.|+|||++.+..|+.++|||| +|+++
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~------~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS----------~Gvvl 227 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYY------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWS----------FGVLL 227 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTT------CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHH----------HHHHH
T ss_pred cceeecCCCCeEeccchhhccccccccc------cccccCCCChhhhhhhHhcCCCCCchhhhHH----------hHHHH
Confidence 9999999999999999999876553321 1223456999999999999999999999999 77778
Q ss_pred HHHHH-HhCCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 751 HEFAK-TALPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 751 ~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
|++++ +..|+..... ... ...+.... ....+..+++.+.+++.+||+.||++|||+.||++.|+++..
T Consensus 228 ~ell~~g~~p~~~~~~--~~~-~~~i~~~~-----~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 228 WEIFTLGGSPYPGVPV--EEL-FKLLKEGH-----RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHTTSCCSSTTCCH--HHH-HHHHHTTC-----CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCH--HHH-HHHHHcCC-----CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 88876 4555542111 111 11111111 011122346678999999999999999999999999998854
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=366.26 Aligned_cols=259 Identities=22% Similarity=0.311 Sum_probs=196.1
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||+||+|++..+++.||||+++.... ...+.+.+|++++++++|||||++++++.+.+ ..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~-----~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN-----KL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETT-----EE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccccc-----ce
Confidence 589999999999999999999999999999999964432 23568899999999999999999999987655 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
|+||||+.+ ++.+++...... .+++.+++.++.|++.||+|||+. +||||||||+|||++.++.+||+|||+
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~~----~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred eEEEeecCC-chhhhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCc
Confidence 999999975 555555433222 699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
|+...... .......||+.|+|||++.... ++.++|||| .|+++|++++|..|+......+
T Consensus 149 a~~~~~~~--------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwS----------lGvily~m~~G~~Pf~~~~~~~ 210 (298)
T d1gz8a_ 149 ARAFGVPV--------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWS----------LGCIFAEMVTRRALFPGDSEID 210 (298)
T ss_dssp HHHHCCCS--------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHH----------HHHHHHHHHHSSCSCCCSSHHH
T ss_pred ceeccCCc--------ccceeecccceeeehhhhccccCCCccccccc----------cchhhhHHhhCCCCCCCCCHHH
Confidence 98654322 1222356999999999877665 578999999 7888999999988875221100
Q ss_pred -------------ccchhhhccc---cchh----hhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 -------------PSLLMEVMTN---NSMI----QEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 -------------~~~~~~~~~~---~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.......... .... ...........++.+.+++.+||+.||++|||++|+++.
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 211 QLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0000000000 0000 000000111234678899999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-42 Score=364.84 Aligned_cols=264 Identities=20% Similarity=0.287 Sum_probs=199.5
Q ss_pred hcCCccCceeccCcceEEEEEEECCC-ceEEEEEEeeccC--CcchhHHHHHHHHHhhc---CCCccceEeeEeecCCCC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGED-EMIVAVKVINLKY--KGASRSFVAECEALRNI---RHRNLIKIITICSSTDFK 603 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~ 603 (833)
.++|++.+.||+|+||+||+|++..+ ++.||||+++... ......+.+|+.+++.+ +||||+++++++.....+
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999999654 7789999997542 22345677888888777 799999999998765545
Q ss_pred CCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEE
Q 040925 604 GTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHV 683 (833)
Q Consensus 604 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL 683 (833)
.....+++|||+++|++......... .+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP-----GVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT-----CSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCceEEEEEEeccCCchhhhhhccCC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeee
Confidence 55688999999988766544443321 689999999999999999999999 9999999999999999999999
Q ss_pred cccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 684 CDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 684 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
+|||+++....... .....||+.|||||++.+..|+.++|||| .|+++|+++++..|+...
T Consensus 158 ~dfg~~~~~~~~~~---------~~~~~gT~~Y~APE~~~~~~y~~~~DiwS----------lG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 158 ADFGLARIYSFQMA---------LTSVVVTLWYRAPEVLLQSSYATPVDLWS----------VGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CSCCSCCCCCGGGG---------GCCCCCCCTTCCHHHHTTCCCCTHHHHHH----------HHHHHHHHHHSSCSCCCS
T ss_pred cchhhhhhhccccc---------CCCcccChhhcCcchhcCCCCChhehhhc----------hHHHHHHHHHCCCCCCCC
Confidence 99999986544321 22356999999999999999999999999 788888999888887522
Q ss_pred ccccc--------------cchhhh----ccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVDP--------------SLLMEV----MTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~~--------------~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
...+. .+.... ..................++.+.+++.+||++||++|||++|+++.
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 219 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11100 000000 0000000000111122345678899999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-43 Score=369.54 Aligned_cols=268 Identities=22% Similarity=0.350 Sum_probs=208.8
Q ss_pred HHhcCCccCceeccCcceEEEEEEECC-----CceEEEEEEeeccCC-cchhHHHHHHHHHhhcCCCccceEeeEeecCC
Q 040925 528 KATGEFSSSNMIGQGSFGYVYKGTLGE-----DEMIVAVKVINLKYK-GASRSFVAECEALRNIRHRNLIKIITICSSTD 601 (833)
Q Consensus 528 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 601 (833)
...++|++.+.||+|+||+||+|++.. +++.||||+++.... .....+.+|+.++++++|||||+++|++...+
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 334689999999999999999998852 357899999974432 23356899999999999999999999986554
Q ss_pred CCCCceEeEEEEecCCCChhhhhccCCCc----cccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC
Q 040925 602 FKGTDFKAFVFEYMENGSLKDWLHQSDDQ----VEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH 677 (833)
Q Consensus 602 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~ 677 (833)
..++||||+++|+|.+++...... .....+++..+.+++.|+++||.|||+. +|+||||||+|||+++
T Consensus 97 -----~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 97 -----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 168 (308)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECT
T ss_pred -----ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecC
Confidence 789999999999999998754321 1112478999999999999999999999 9999999999999999
Q ss_pred CCcEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHh
Q 040925 678 DMVAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTA 757 (833)
Q Consensus 678 ~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~ 757 (833)
++++||+|||+|+......... ......||+.|+|||.+.+..++.++|||| +|++++|++++.
T Consensus 169 ~~~~Kl~DFGla~~~~~~~~~~------~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S----------~G~il~El~t~~ 232 (308)
T d1p4oa_ 169 DFTVKIGDFGMTRDIYETDYYR------KGGKGLLPVRWMSPESLKDGVFTTYSDVWS----------FGVVLWEIATLA 232 (308)
T ss_dssp TCCEEECCTTCCCGGGGGGCEE------GGGSSEECGGGCCHHHHHHCCCCHHHHHHH----------HHHHHHHHHHTS
T ss_pred CceEEEeecccceeccCCccee------eccceecccccCCHHHHccCCCCccccccc----------HHHHHHHHHhCC
Confidence 9999999999998765433211 122346899999999999999999999999 788888888875
Q ss_pred -CCCcccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 758 -LPEKVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 758 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
.|+.... ............. ...+..+++.+.+++.+||+.||++|||++||+++|++..+.
T Consensus 233 ~~p~~~~~--~~~~~~~i~~~~~------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 233 EQPYQGLS--NEQVLRFVMEGGL------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp CCTTTTSC--HHHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCCCCCCC--HHHHHHHHHhCCC------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 4443111 1111111111111 112234567899999999999999999999999999887654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.4e-41 Score=353.55 Aligned_cols=269 Identities=19% Similarity=0.238 Sum_probs=211.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCC-CccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRH-RNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+|++.++.++| +|++.+++++.... ..+
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~-----~~~ 77 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL-----HNV 77 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT-----EEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCC-----ccE
Confidence 58999999999999999999999999999999986432 34567889999999975 89999999976554 889
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC-----CCcEEEc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH-----DMVAHVC 684 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~ 684 (833)
+||||+ +|+|.+++..... .+++.++..++.|++.||+|||+. ||+||||||+||+++. ++.+||+
T Consensus 78 ~vme~~-~~~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp EEEECC-CCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred EEEEec-CCCHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEc
Confidence 999999 6899999876542 689999999999999999999999 9999999999999974 5789999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVME 764 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~ 764 (833)
|||+|+........... .........||+.|||||++.+..++.++|||| +|+++++++++..|+....
T Consensus 149 DFG~a~~~~~~~~~~~~-~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwS----------lG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHI-PYREKKNLSGTARYMSINTHLGREQSRRDDLEA----------LGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp CCTTCEESBCTTTCCBC-CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH----------HHHHHHHHHHSSCTTSSCC
T ss_pred ccceeEEcccCccccce-eecccCceEEchhhcCHHHhcCCCCChHHHHHH----------hhHHHHHHHhCCCcCCCcc
Confidence 99999876543322111 122334568999999999999999999999999 8999999999999986333
Q ss_pred cccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhhh
Q 040925 765 IVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRET 827 (833)
Q Consensus 765 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~~ 827 (833)
..........+....... ..+.....+++++.+++..|+..+|++||+++.+.+.++++.+.
T Consensus 218 ~~~~~~~~~~i~~~~~~~-~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~ 279 (293)
T d1csna_ 218 AATNKQKYERIGEKKQST-PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279 (293)
T ss_dssp SCCHHHHHHHHHHHHHHS-CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHhccCCC-ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence 222211111111110000 11111233567899999999999999999999999998887654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5e-42 Score=356.90 Aligned_cols=256 Identities=21% Similarity=0.253 Sum_probs=194.5
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC--CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY--KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||+||+|+++ +++.||||+++... ....+.+.+|+.++++++|||||++++++...+ ..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-----~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-----RL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-----CE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-----ce
Confidence 58999999999999999999997 78999999996542 233578999999999999999999999976655 89
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
+++|||+.++.+..+....+ .+++..++.++.||+.||+|||+. +||||||||+|||++.++.+|++|||.
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~ 146 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGL 146 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTH
T ss_pred eEEEEeehhhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEeccccc
Confidence 99999998877766665543 799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
|.....+.. ......|++.|+|||.+.+. .++.++|||| .|++++++++|..|+......+
T Consensus 147 a~~~~~~~~--------~~~~~~~~~~y~~pE~~~~~~~~~~~~Diws----------lGv~l~el~~G~~pf~~~~~~~ 208 (286)
T d1ob3a_ 147 ARAFGIPVR--------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWS----------VGCIFAEMVNGTPLFPGVSEAD 208 (286)
T ss_dssp HHHHCC-----------------CCCTTCCHHHHTTCCSCCTHHHHHH----------HHHHHHHHHHSSCSCCCSSHHH
T ss_pred ceecccCcc--------ccceecccchhhhHHHHhCCCCCCcceeehh----------cCcHHHHHHHCCCCCCCCCHHH
Confidence 987654321 12234689999999998754 4689999999 7888888888888864211100
Q ss_pred c-------------cchhhhcc-------ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHH
Q 040925 768 P-------------SLLMEVMT-------NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVA 819 (833)
Q Consensus 768 ~-------------~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~ 819 (833)
. ........ ................++.+.+++.+||+.||++|||++|+++
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000000 0000000001112234567889999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-41 Score=356.52 Aligned_cols=269 Identities=23% Similarity=0.293 Sum_probs=202.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEeE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKAF 610 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 610 (833)
++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+..|+++++.++|++++..++.+... ....++
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~i 80 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVM 80 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEE
Confidence 47999999999999999999999999999999987543 335688999999999877766655554322 247899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecC---CCcEEEcccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDH---DMVAHVCDFG 687 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfG 687 (833)
||||+. |++.+.+..... .+++..+..++.|++.||+|||++ +||||||||+||+++. +..+||+|||
T Consensus 81 vme~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG 151 (299)
T d1ckia_ 81 VMELLG-PSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151 (299)
T ss_dssp EEECCC-CBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCS
T ss_pred EEEEcC-CchhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccC
Confidence 999995 577776655432 689999999999999999999999 9999999999999864 4579999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+|+.+......... .........||+.|||||++.+..++.++|||| +|+++++++++..|+......+
T Consensus 152 ~a~~~~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 152 LAKKYRDARTHQHI-PYRENKNLTGTARYASINTHLGIEQSRRDDLES----------LGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp SCEECBCTTTCCBC-CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHH----------HHHHHHHHHHSSCTTCCCC---
T ss_pred cceeccccccccce-eccccCCcCCCccccCHHHHhCCCCCChhhEEe----------cCHHHHHHHhCCCcccccchHH
Confidence 99977554322111 112233567999999999999999999999999 8999999999999986433222
Q ss_pred ccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHHHHHhhh
Q 040925 768 PSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAKLCHTRE 826 (833)
Q Consensus 768 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~~i~~ 826 (833)
............. ....+.....+++++.+++..||+.||++||+++++.+.|+.+..
T Consensus 221 ~~~~~~~~~~~~~-~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 221 KRQKYERISEKKM-STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp ----HHHHHHHHH-HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHhhcccC-CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 2211111100000 001111223456789999999999999999999999988887753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-41 Score=358.29 Aligned_cols=264 Identities=20% Similarity=0.219 Sum_probs=198.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccC-CcchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKY-KGASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
.+|++++.||+|+||+||+|++..+|+.||||+++... ....+.+.+|+++|++++||||+++++++....+......+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 47999999999999999999999999999999997443 23346788999999999999999999998776655555555
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGLA 689 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 689 (833)
++ +|+.+|+|.+++... .+++..++.++.|++.||+|||++ |||||||||+|||++.++.+||+|||+|
T Consensus 88 l~-~~~~~g~L~~~l~~~-------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 88 LV-THLMGADLYKLLKTQ-------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EE-EECCCEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EE-EeecCCchhhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCce
Confidence 55 456689999999754 589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+........ .......+||+.|+|||++.. ..++.++|||| .|+++++++++..|+......+.
T Consensus 157 ~~~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwS----------lG~il~eml~g~~pf~~~~~~~~ 221 (345)
T d1pmea_ 157 RVADPDHDH-----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWS----------VGCILAEMLSNRPIFPGKHYLDQ 221 (345)
T ss_dssp EECCGGGCB-----CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHH----------HHHHHHHHHHSSCSCCCSSHHHH
T ss_pred eeccCCCcc-----ceeeccccccceechHHHhhcCCCCCchhhhhc----------cCceehHHhhCCCCCCCCCHHHH
Confidence 876554321 122234679999999999754 45789999999 88889999999888753221111
Q ss_pred cchhhhc-c---------------------ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 SLLMEVM-T---------------------NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~~~~~~~-~---------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
....... . ..................++.+++.+||+.||++|||++|+++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 222 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 0 00000000000111234568899999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=352.87 Aligned_cols=268 Identities=21% Similarity=0.284 Sum_probs=195.2
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeecc--CCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC---CC
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK--YKGASRSFVAECEALRNIRHRNLIKIITICSSTDF---KG 604 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 604 (833)
.++|++++.||+|+||+||+|++..+|+.||||++... .....+.+.+|+.+|++++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999999999999999998644 23345678999999999999999999999865431 22
Q ss_pred CceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEc
Q 040925 605 TDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVC 684 (833)
Q Consensus 605 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 684 (833)
....|+||||++++.+..+..... .+++..++.++.|++.||.|||+. ||+||||||+||+++.++.+||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~------~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~ 159 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV------KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLA 159 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEEeccCCCccchhhhccc------ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEee
Confidence 346899999998876665544433 689999999999999999999999 99999999999999999999999
Q ss_pred ccccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccc
Q 040925 685 DFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVM 763 (833)
Q Consensus 685 DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~ 763 (833)
|||+|+......... .......+||+.|+|||++.+. .++.++|||| .|+++++++++..|+...
T Consensus 160 dfg~~~~~~~~~~~~----~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwS----------lGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 160 DFGLARAFSLAKNSQ----PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG----------AGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp CCTTCEECCC---------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHH----------HHHHHHHHHHSSCSCCCS
T ss_pred ecceeeecccccccc----cccccceecCHHHhhHHHHcCCCCCCcHHHccc----------CCceeeeHhhCCCCCCCC
Confidence 999998765433211 1222345799999999998765 6899999999 788888888888776421
Q ss_pred cccc-------------ccchhhh--------cccc--chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 764 EIVD-------------PSLLMEV--------MTNN--SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 764 ~~~~-------------~~~~~~~--------~~~~--~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
...+ +...... .... ...............+.+.+++.+||++||++|||++|++++
T Consensus 226 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 226 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 1000 0000000 0000 000000001111223467789999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=358.21 Aligned_cols=260 Identities=23% Similarity=0.301 Sum_probs=192.0
Q ss_pred CCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCccceEeeEeecCCC-CCCceEeE
Q 040925 532 EFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNLIKIITICSSTDF-KGTDFKAF 610 (833)
Q Consensus 532 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l 610 (833)
+|+..++||+|+||+||+|++..+|+.||||+++.... ...+|++++++++||||+++++++..... .+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 68899999999999999999999999999999974432 23479999999999999999999865432 33456899
Q ss_pred EEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-cEEEcccccc
Q 040925 611 VFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCDFGLA 689 (833)
Q Consensus 611 v~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a 689 (833)
|||||++|.+..+..... ....+++.+++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus 97 v~Ey~~~~~~~~l~~~~~---~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSR---AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEECCSEEHHHHHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEeccCCccHHHHHhhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 999998654333322111 012699999999999999999999999 999999999999999875 8999999999
Q ss_pred cccCcccccccccCCCccccccccccccCccccCC-CCCCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccccc
Q 040925 690 KFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMG-SEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVDP 768 (833)
Q Consensus 690 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~~ 768 (833)
+....... .....||+.|+|||.+.+ ..++.++|||| .|+++++++++..|+......+.
T Consensus 171 ~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwS----------lG~il~el~~g~~pf~~~~~~~~ 231 (350)
T d1q5ka_ 171 KQLVRGEP---------NVSYICSRYYRAPELIFGATDYTSSIDVWS----------AGCVLAELLLGQPIFPGDSGVDQ 231 (350)
T ss_dssp EECCTTSC---------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHH----------HHHHHHHHHHTSCSSCCSSHHHH
T ss_pred hhccCCcc---------cccccccccccChHHhhcccCCCcceeecc----------cceEEEehhhCCCCCCCCCHHHH
Confidence 87644321 223569999999998765 56899999999 78888888888887652221110
Q ss_pred cc-------------hhhhc----c---ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 769 SL-------------LMEVM----T---NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 769 ~~-------------~~~~~----~---~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
-. ..... . ......+..+......++.+.+++.+||.+||++|||++|+++.
T Consensus 232 l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000 0 00000000111122345678899999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.8e-40 Score=352.38 Aligned_cols=252 Identities=19% Similarity=0.226 Sum_probs=192.9
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCceEe
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDFKA 609 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 609 (833)
++|++.+.||+|+||+||+|++..+++.||||+++. ...+++.+|+++|++++ ||||+++++++.... ....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~---~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPV---SRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTT---TCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecC---CCcee
Confidence 589999999999999999999999999999999963 34567899999999996 999999999976432 34789
Q ss_pred EEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCC-cEEEccccc
Q 040925 610 FVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDM-VAHVCDFGL 688 (833)
Q Consensus 610 lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~ 688 (833)
+|||||++|+|.++.+ .+++.+++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+
T Consensus 109 ~v~e~~~~~~L~~~~~---------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~ 176 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ---------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGL 176 (328)
T ss_dssp EEEECCCSCBGGGTTT---------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGG
T ss_pred EEEeecCCCcHHHHhc---------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeeccccc
Confidence 9999999999987643 589999999999999999999999 999999999999998655 699999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc-c
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI-V 766 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~-~ 766 (833)
|+....... .....||+.|+|||.+.+.. ++.++|||| .|++++++.++..|+..... .
T Consensus 177 a~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~Diws----------lG~~l~e~~~g~~pf~~~~~~~ 237 (328)
T d3bqca1 177 AEFYHPGQE---------YNVRVASRYFKGPELLVDYQMYDYSLDMWS----------LGCMLASMIFRKEPFFHGHDNY 237 (328)
T ss_dssp CEECCTTCC---------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHH----------HHHHHHHHHHTCSSSSCCSSHH
T ss_pred ceeccCCCc---------ccccccCccccCcccccCCCCCCcccchhh----------hhhhhHHhccCCCCCCCCchhH
Confidence 986654321 22356999999999977654 799999999 67777777777776542110 0
Q ss_pred cc----------------------cchh---hhccc---cchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHH
Q 040925 767 DP----------------------SLLM---EVMTN---NSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVV 818 (833)
Q Consensus 767 ~~----------------------~~~~---~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil 818 (833)
+. .... ..... ..............+++++.+++.+||++||++|||++|++
T Consensus 238 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00 0000 00000 00000000111223456788999999999999999999998
Q ss_pred H
Q 040925 819 A 819 (833)
Q Consensus 819 ~ 819 (833)
+
T Consensus 318 ~ 318 (328)
T d3bqca1 318 E 318 (328)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=355.65 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=194.0
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCC-CCCCc
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTD-FKGTD 606 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~ 606 (833)
.++|++++.||+|+||+||+|++..+|+.||||+++.... ...+.+.+|+++|++++|||||++++++...+ .....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 3589999999999999999999999999999999975422 23467889999999999999999999987654 22344
Q ss_pred eEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccc
Q 040925 607 FKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDF 686 (833)
Q Consensus 607 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 686 (833)
+.|+||||+ +++|..+++.. .+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+|++||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Df 165 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 165 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred eEEEEEecc-cccHHHHHHhc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccc
Confidence 679999999 56888877643 699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCcccccccccCCCccccccccccccCccccCCC-CCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccc
Q 040925 687 GLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS-EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEI 765 (833)
Q Consensus 687 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~ 765 (833)
|+|+...... ....||+.|+|||++.+. .++.++|||| .|+++++++++..|+...+.
T Consensus 166 g~a~~~~~~~-----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwS----------lGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 166 GLARQADSEM-----------TGYVVTRWYRAPEVILNWMRYTQTVDIWS----------VGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp TTCEECCSSC-----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHH----------HHHHHHHHHHSSCSSCCSSH
T ss_pred cceeccCCcc-----------ccccccccccCHHHHcCCCCCCccchhhc----------chHHHHHHHHCcCCCCCCCh
Confidence 9998654321 235699999999998764 5789999999 78889999999888753221
Q ss_pred ccccchh------------hhcccc----------chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 766 VDPSLLM------------EVMTNN----------SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 766 ~~~~~~~------------~~~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
.+.-... ...... ...............+.+.+++.+||..||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1100000 000000 000000001112234567899999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=345.53 Aligned_cols=258 Identities=20% Similarity=0.266 Sum_probs=196.3
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCceE
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDFK 608 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 608 (833)
++|++.+.||+|+||+||+|++..+++.||||+++.... .....+.+|+.++++++||||+++++++.... ..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ce
Confidence 589999999999999999999999999999999975432 33578899999999999999999999987665 88
Q ss_pred eEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEccccc
Q 040925 609 AFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFGL 688 (833)
Q Consensus 609 ~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 688 (833)
++|||++.++++..++...+ .+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~ 147 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGL 147 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEeeecccccccccccccc------ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecch
Confidence 99999999999988887654 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 689 AKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 689 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
|+....... ......+++.|+|||++.+.. ++.++|||| .|+++++++++..|+......+
T Consensus 148 a~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwS----------lG~il~ell~g~~p~~~~~~~~ 209 (292)
T d1unla_ 148 ARAFGIPVR--------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWS----------AGCIFAELANAGRPLFPGNDVD 209 (292)
T ss_dssp CEECCSCCS--------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHH----------HHHHHHHHTTTSCCSCCCSSHH
T ss_pred hhcccCCCc--------cceeeccccchhhhhHhccCCCCCchhhccc----------cchHHHHHhhCCCCCCCCCCHH
Confidence 987654322 112235789999999887665 689999999 5555666665555532100000
Q ss_pred ccc--------------------hhhhcc-ccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 768 PSL--------------------LMEVMT-NNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 768 ~~~--------------------~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
... ..+... .................+.+.+++.+||++||.+||||+|+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000000 00000000111122334567899999999999999999999763
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-40 Score=350.93 Aligned_cols=259 Identities=18% Similarity=0.243 Sum_probs=191.4
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCC--cchhHHHHHHHHHhhcCCCccceEeeEeecCCC-CCCce
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYK--GASRSFVAECEALRNIRHRNLIKIITICSSTDF-KGTDF 607 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 607 (833)
++|++.+.||+|+||+||+|++..+|+.||||+++.... ...+++.+|+.++++++|||||++++++...+. +....
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 579999999999999999999999999999999975432 234578899999999999999999999865432 34568
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.|+|||||.++ +.+.+.. .+++.+++.++.|++.||+|||+. ||+||||||+|||++.++.+|++|||
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~--------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred eEEEEeccchH-HHHhhhc--------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence 99999999765 4444432 589999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHHHHHHHhCCCccccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIVD 767 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~~ 767 (833)
+++...... ......||+.|+|||++.+..++.++|||| .|+++++++++..|+...+..+
T Consensus 165 ~~~~~~~~~---------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwS----------lG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 165 LARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWS----------VGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp C------------------------CCTTCCHHHHTTCCCCTTHHHHH----------HHHHHHHHHHSSCSSCCSSHHH
T ss_pred hhhcccccc---------ccccccccccccChhhhcCCCCCCCccccc----------ccchHHHHhhCCCCCCCCCHHH
Confidence 988654422 222356999999999999999999999999 7778888888887764211000
Q ss_pred c-------------cch-------hhhcccc-------------chhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCH
Q 040925 768 P-------------SLL-------MEVMTNN-------------SMIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDM 814 (833)
Q Consensus 768 ~-------------~~~-------~~~~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 814 (833)
. ... ....... ..............++.+.+++.+||..||++||||
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta 305 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH
Confidence 0 000 0000000 000011112234467788999999999999999999
Q ss_pred HHHHHH
Q 040925 815 RDVVAK 820 (833)
Q Consensus 815 ~eil~~ 820 (833)
+|+++.
T Consensus 306 ~elL~H 311 (355)
T d2b1pa1 306 DDALQH 311 (355)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999865
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-40 Score=349.05 Aligned_cols=253 Identities=20% Similarity=0.274 Sum_probs=200.4
Q ss_pred cCCccCceeccCcceEEEEEEE---CCCceEEEEEEeeccC----CcchhHHHHHHHHHhhcCC-CccceEeeEeecCCC
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTL---GEDEMIVAVKVINLKY----KGASRSFVAECEALRNIRH-RNLIKIITICSSTDF 602 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~---~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 602 (833)
++|++.+.||+|+||+||+|++ +.+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~- 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET- 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT-
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC-
Confidence 5799999999999999999987 4468999999986432 2334678899999999976 89999999976655
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEE
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAH 682 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 682 (833)
..++||||+.+|+|.+++...+ .+++..++.++.|++.||+|+|+. +||||||||+||+++.++.+|
T Consensus 103 ----~~~~v~e~~~~~~L~~~i~~~~------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vk 169 (322)
T d1vzoa_ 103 ----KLHLILDYINGGELFTHLSQRE------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVV 169 (322)
T ss_dssp ----EEEEEECCCCSCBHHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred ----ceeeeeecccccHHHHHHHhcc------cccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEE
Confidence 8999999999999999998765 678899999999999999999999 999999999999999999999
Q ss_pred EcccccccccCcccccccccCCCccccccccccccCccccCCC--CCCcccccccCCcCCCccccCCccHHHHHHHhCCC
Q 040925 683 VCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGS--EASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPE 760 (833)
Q Consensus 683 L~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~ 760 (833)
|+|||+|+.+....... .....||+.|+|||.+.+. .++.++|||| .|+++|++++|..|+
T Consensus 170 L~DFG~a~~~~~~~~~~-------~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWS----------lG~iLyelltG~~PF 232 (322)
T d1vzoa_ 170 LTDFGLSKEFVADETER-------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWS----------LGVLMYELLTGASPF 232 (322)
T ss_dssp ESCSSEEEECCGGGGGG-------GCGGGSCCTTCCHHHHTTCC---CTHHHHHH----------HHHHHHHHHHSSCTT
T ss_pred Eeeccchhhhccccccc-------ccccccccccchhHHhhcCCcCCCchhhhHH----------HHHHHHHHHhCCCCC
Confidence 99999998765433221 2235699999999998764 4678999999 899999999999998
Q ss_pred cccccccccchhhhccccchhhhhhhhchHHHHHHHHHHhhccCCCCCCCCC-----CHHHHHH
Q 040925 761 KVMEIVDPSLLMEVMTNNSMIQEDKRVKTEECLNAIIRTGVLCSMESPFERM-----DMRDVVA 819 (833)
Q Consensus 761 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~eil~ 819 (833)
......+... ....... ......+..+++.+.+++.+||++||++|| |++|+++
T Consensus 233 ~~~~~~~~~~--~i~~~~~---~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 233 TVDGEKNSQA--EISRRIL---KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCTTSCCCHH--HHHHHHH---HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCHHHHHH--HHHHhcc---cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 6332222111 1111000 000111234567889999999999999999 4788876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=347.46 Aligned_cols=260 Identities=18% Similarity=0.249 Sum_probs=195.4
Q ss_pred hcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc--chhHHHHHHHHHhhcCCCccceEeeEeecCCCCCCce
Q 040925 530 TGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG--ASRSFVAECEALRNIRHRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 530 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 607 (833)
.++|++.+.||+|+||+||+|++..+|+.||||+++..... ..+.+.+|++++++++|||||++++++..........
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45899999999999999999999999999999999754332 3457889999999999999999999986554333344
Q ss_pred EeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCeeecCCCcEEEcccc
Q 040925 608 KAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVLLDHDMVAHVCDFG 687 (833)
Q Consensus 608 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG 687 (833)
.+++|+|+.+|+|.+++... ++++.+++.++.||+.||+|||++ ||+||||||+||+++.++.+|++|||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred eEEEEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence 56677888899999999653 599999999999999999999999 99999999999999999999999999
Q ss_pred cccccCcccccccccCCCccccccccccccCccccCCCC-CCcccccccCCcCCCccccCCccHHHHHHHhCCCcccccc
Q 040925 688 LAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSE-ASMTGDIFTGRRPIDAVFNEGHSLHEFAKTALPEKVMEIV 766 (833)
Q Consensus 688 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s~~~~~~~~~~~g~~l~~~~~~~~p~~~~~~~ 766 (833)
.|....... ....||+.|+|||+..+.. ++.++|||| .|+++++++++..|+...+..
T Consensus 167 ~a~~~~~~~-----------~~~~g~~~y~apE~~~~~~~~~~~~DiwS----------lGv~l~~ll~g~~pF~~~~~~ 225 (348)
T d2gfsa1 167 LARHTDDEM-----------TGYVATRWYRAPEIMLNWMHYNQTVDIWS----------VGCIMAELLTGRTLFPGTDHI 225 (348)
T ss_dssp ---CCTGGG-----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHH----------HHHHHHHHHHSSCSCCCSSHH
T ss_pred hhcccCccc-----------ccccccccccCchhhcCCccCCcccchhh----------hhHHHHHHHhCCCCCCCCCHH
Confidence 997654321 2346999999999876654 688999999 788889999998886422111
Q ss_pred cccchh-hh--------------------ccccc-hhhhhhhhchHHHHHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 767 DPSLLM-EV--------------------MTNNS-MIQEDKRVKTEECLNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 767 ~~~~~~-~~--------------------~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
+..... .. ..... .............++.+.+++.+||..||++|||++|++++
T Consensus 226 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000 00 00000 00000000011234567899999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.6e-35 Score=316.62 Aligned_cols=258 Identities=18% Similarity=0.216 Sum_probs=187.0
Q ss_pred cCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-----------CCccceEeeEeec
Q 040925 531 GEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-----------HRNLIKIITICSS 599 (833)
Q Consensus 531 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 599 (833)
++|++.+.||+|+||+||+|++..+|+.||||+++.. ....+.+.+|+.++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999999999999999999743 223467788999988875 5789999988754
Q ss_pred CCCCCCceEeEEEEecCCCCh-hhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhh-cCCCCceeeCCCCCCeeecC
Q 040925 600 TDFKGTDFKAFVFEYMENGSL-KDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHH-HCQPPMVHGDLKPSNVLLDH 677 (833)
Q Consensus 600 ~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~-~~~~~ivH~Dlkp~NIll~~ 677 (833)
.. ....+++|+++..+.. ......... ..+++..++.++.|++.||+|||+ . ||+||||||+|||++.
T Consensus 92 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 92 KG---PNGVHVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEI 161 (362)
T ss_dssp EE---TTEEEEEEEECCCCEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEE
T ss_pred cc---ccceeeeeeecccccccccccccccc----cCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeec
Confidence 32 3456677777655443 222222221 268999999999999999999998 6 9999999999999986
Q ss_pred CC------cEEEcccccccccCcccccccccCCCccccccccccccCccccCCCCCCcccccccCCcCCCccccCCccHH
Q 040925 678 DM------VAHVCDFGLAKFLSDHQLDTAVKTPSSSIGLKGTVGYVAPEYGMGSEASMTGDIFTGRRPIDAVFNEGHSLH 751 (833)
Q Consensus 678 ~~------~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s~~~~~~~~~~~g~~l~ 751 (833)
++ .+|++|||.|....... ...+||+.|+|||++.+..++.++|||| .|++++
T Consensus 162 ~~~~~~~~~~kl~dfg~s~~~~~~~-----------~~~~gt~~y~aPE~~~~~~~~~~~DiwS----------lG~il~ 220 (362)
T d1q8ya_ 162 VDSPENLIQIKIADLGNACWYDEHY-----------TNSIQTREYRSPEVLLGAPWGCGADIWS----------TACLIF 220 (362)
T ss_dssp EETTTTEEEEEECCCTTCEETTBCC-----------CSCCSCGGGCCHHHHHTCCCCTHHHHHH----------HHHHHH
T ss_pred cCcccccceeeEeeccccccccccc-----------ccccccccccChhhccccCCCccccccc----------hHHHHH
Confidence 65 49999999997543321 2346999999999999999999999999 777778
Q ss_pred HHHHHhCCCcccccccc-------------------cchh------hhc---------cc----c-chhhhhhhhchHHH
Q 040925 752 EFAKTALPEKVMEIVDP-------------------SLLM------EVM---------TN----N-SMIQEDKRVKTEEC 792 (833)
Q Consensus 752 ~~~~~~~p~~~~~~~~~-------------------~~~~------~~~---------~~----~-~~~~~~~~~~~~~~ 792 (833)
+++++..|+...+.... .... ... .. . ..............
T Consensus 221 el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (362)
T d1q8ya_ 221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300 (362)
T ss_dssp HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHH
T ss_pred HHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCccc
Confidence 88887777542211000 0000 000 00 0 00000111223567
Q ss_pred HHHHHHHhhccCCCCCCCCCCHHHHHHH
Q 040925 793 LNAIIRTGVLCSMESPFERMDMRDVVAK 820 (833)
Q Consensus 793 ~~~l~~li~~cl~~dP~~RPt~~eil~~ 820 (833)
++.+.+++.+|+++||.+|||++|++++
T Consensus 301 ~~~~~dll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 301 AKEISDFLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 7889999999999999999999999864
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=2.2e-30 Score=281.68 Aligned_cols=342 Identities=26% Similarity=0.336 Sum_probs=209.1
Q ss_pred CCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcE
Q 040925 45 LLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLEL 124 (833)
Q Consensus 45 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 124 (833)
.+.+|++|++++|.|+.+ +.+..+++|++|+|++|+|+ .+|+ |.++++|++|+|++|++.+.. .++++++|+.
T Consensus 42 ~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~-~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~ 114 (384)
T d2omza2 42 DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLT-DITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTG 114 (384)
T ss_dssp HHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCE
T ss_pred HhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCC-CCcc--ccCCccccccccccccccccc--cccccccccc
Confidence 344555555555555432 23455555555555555554 3332 445555555555555554322 2455555555
Q ss_pred EEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEE
Q 040925 125 LDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINF 204 (833)
Q Consensus 125 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L 204 (833)
|++++|.++++.. ......+..+....|.+....... ................+. .+... ......
T Consensus 115 L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~------~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~ 180 (384)
T d2omza2 115 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALS------GLTSLQQLSFGNQVTDLK-----PLANL-TTLERL 180 (384)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGT------TCTTCSEEEEEESCCCCG-----GGTTC-TTCCEE
T ss_pred ccccccccccccc--cccccccccccccccccccccccc------ccccccccccccccchhh-----hhccc-cccccc
Confidence 5555555554332 223344445555555443322210 001111111111111111 11111 112222
Q ss_pred EccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeeccccc
Q 040925 205 GIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ 284 (833)
Q Consensus 205 ~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 284 (833)
....|.. .....+..+++++.+++++|.+++..| +...++|++|++++|.+++. +.+..+++|+.|++++|+++
T Consensus 181 ~~~~~~~--~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~ 254 (384)
T d2omza2 181 DISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS 254 (384)
T ss_dssp ECCSSCC--CCCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred ccccccc--ccccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccC
Confidence 2333332 334566777888888888888886544 45567888888888888742 46778888888888888887
Q ss_pred CCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccc
Q 040925 285 GNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTL 364 (833)
Q Consensus 285 ~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~ 364 (833)
+..+ +..+++|+.|++++|++++ ++. +.....+ ..+++++|.+++ ...+..+++++.|++++|+++++. .+
T Consensus 255 ~~~~--~~~~~~L~~L~l~~~~l~~-~~~-~~~~~~l-~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l 325 (384)
T d2omza2 255 NLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTAL-TNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PV 325 (384)
T ss_dssp CCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTC-SEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GG
T ss_pred CCCc--ccccccCCEeeccCcccCC-CCc-ccccccc-cccccccccccc--ccccchhcccCeEECCCCCCCCCc--cc
Confidence 5443 7778888888888888873 332 4444444 678888888874 335778889999999999998653 38
Q ss_pred cCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccC
Q 040925 365 STCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYN 426 (833)
Q Consensus 365 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N 426 (833)
..+++|++|++++|+|+++ + .+..+++|++|++++|++++..| +.++++|+.|+|++|
T Consensus 326 ~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 326 SSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp GGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 8889999999999998853 3 58888999999999999987655 888899999999887
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.97 E-value=5.5e-32 Score=285.19 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=229.6
Q ss_pred cEEEccCccccc--cCChhhhcCCCCCeEeccC-CcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEe
Q 040925 202 INFGIGRNQISG--TIPPGIRNLVNLIGFGAEE-NQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLEL 278 (833)
Q Consensus 202 ~~L~l~~n~i~~--~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 278 (833)
+.|+|++|.+.+ .+|+.++++++|++|+|++ |++.+.+|..|+++++|++|+|++|.+.+..+..+..+.+|+.+++
T Consensus 53 ~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l 132 (313)
T d1ogqa_ 53 NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132 (313)
T ss_dssp EEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEEC
T ss_pred EEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhccccc
Confidence 344444444443 4678899999999999986 8999899999999999999999999999989999999999999999
Q ss_pred ecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCC
Q 040925 279 SSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSG 358 (833)
Q Consensus 279 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~ 358 (833)
++|++.+.+|..+.++++|+.+++++|.+.+.+|..+..+..+.+.+++++|++++..|..+..+..+ .+++++|.+.+
T Consensus 133 ~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~ 211 (313)
T d1ogqa_ 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEG 211 (313)
T ss_dssp CSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEE
T ss_pred ccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccc
Confidence 99999999999999999999999999999999999999998888899999999999999888887655 79999999999
Q ss_pred CCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCcc
Q 040925 359 VIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVF 438 (833)
Q Consensus 359 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 438 (833)
.+|..+..+++|+.|++++|.+.+.++ .+..+++|+.|+|++|++++.+|..|.++++|++|||++|+|+|.+|..+.+
T Consensus 212 ~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L 290 (313)
T d1ogqa_ 212 DASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290 (313)
T ss_dssp CCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTG
T ss_pred ccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccC
Confidence 999999999999999999999997654 6888999999999999999999999999999999999999999999988889
Q ss_pred CCCccccccCCcCCCCCcc
Q 040925 439 SNKTKISLQGNMKLCGGID 457 (833)
Q Consensus 439 ~~~~~l~l~~N~~~c~~~~ 457 (833)
..+..+++.||+.+||.|.
T Consensus 291 ~~L~~l~l~~N~~l~g~pl 309 (313)
T d1ogqa_ 291 QRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp GGSCGGGTCSSSEEESTTS
T ss_pred CCCCHHHhCCCccccCCCC
Confidence 9999999999999999754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=2.5e-29 Score=273.32 Aligned_cols=356 Identities=24% Similarity=0.328 Sum_probs=272.0
Q ss_pred cCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCccccc
Q 040925 6 VNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSG 85 (833)
Q Consensus 6 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 85 (833)
++.+.+++.+. ...+.+|++|++++|.|+. + +.++.+++|++|+|++|+|+++. .|+++++|++|++++|+++
T Consensus 29 l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~- 101 (384)
T d2omza2 29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIA- 101 (384)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-
T ss_pred hCCCCCCCccC--HHHhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccc-
Confidence 45556665443 3567789999999999964 3 45889999999999999999653 3999999999999999998
Q ss_pred ccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcc
Q 040925 86 NLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165 (833)
Q Consensus 86 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 165 (833)
.+++ +.++++|+.|++++|.+++..+ ......+..+....|.+..+....................+
T Consensus 102 ~i~~--l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--------- 168 (384)
T d2omza2 102 DITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL--------- 168 (384)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC---------
T ss_pred cccc--cccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchh---------
Confidence 5553 6899999999999999975443 45567889999999998866655544444444433333322
Q ss_pred cccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccC
Q 040925 166 FVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGE 245 (833)
Q Consensus 166 ~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 245 (833)
..+...+.........|... .+.....+. .+..+++++|.+++..| +...++|+.|++++|+++.. +.+..
T Consensus 169 --~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~-~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~ 239 (384)
T d2omza2 169 --KPLANLTTLERLDISSNKVS--DISVLAKLT-NLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLAS 239 (384)
T ss_dssp --GGGTTCTTCCEEECCSSCCC--CCGGGGGCT-TCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGG
T ss_pred --hhhccccccccccccccccc--ccccccccc-ccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhc
Confidence 22444555666666666554 233333333 36677788887776544 56678899999999998853 46788
Q ss_pred CCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceee
Q 040925 246 LKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYL 325 (833)
Q Consensus 246 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L 325 (833)
+++|+.|++++|.+++.. .+..+++|++|++++|++++.. .+..++.++.+.+++|++++ + ..+.....+ +.|
T Consensus 240 l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l-~~L 312 (384)
T d2omza2 240 LTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED-I-SPISNLKNL-TYL 312 (384)
T ss_dssp CTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTC-SEE
T ss_pred ccccchhccccCccCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccc-c-cccchhccc-CeE
Confidence 899999999999998643 3778899999999999998553 37788899999999999873 3 335555666 789
Q ss_pred ecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcc
Q 040925 326 DLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNN 403 (833)
Q Consensus 326 ~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~ 403 (833)
++++|++++.. .+..+++|++|++++|+|+++ + .|.++++|++|++++|+|+++.| +.++++|+.|+|++|.
T Consensus 313 ~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 313 TLYFNNISDIS--PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp ECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred ECCCCCCCCCc--ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence 99999999653 388999999999999999853 3 69999999999999999998765 8999999999999984
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=7.7e-30 Score=268.61 Aligned_cols=251 Identities=31% Similarity=0.485 Sum_probs=206.7
Q ss_pred CCCEEEccCCcCcc--cCChhHhhhcccccEEEccC-ccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCE
Q 040925 175 SLKALSLADNQFGG--ELPHSIANLSSTVINFGIGR-NQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQK 251 (833)
Q Consensus 175 ~L~~L~Ls~N~l~~--~~p~~~~~l~~~l~~L~l~~-n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 251 (833)
+++.|+|++|.+++ .+|..+++++. |++|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~-L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPY-LNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTT-CSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEECCCCCCCCCCCCChHHhcCcc-ccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 35555555555554 35555555543 55566654 5666677778888888888899988888888888888888999
Q ss_pred EEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCcc-ceeecCCceecccCCcccccccccceeeecCCC
Q 040925 252 LCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNL-MSFTASQNKLTGALPHQLLSITTLSLYLDLSNN 330 (833)
Q Consensus 252 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N 330 (833)
+++++|.+.+.+|..|.+++.|+.+++++|.+.+.+|..+..+.++ +.+++++|++++..|..+..+... .+++++|
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~--~l~l~~~ 207 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA--FVDLSRN 207 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS--EEECCSS
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc--ccccccc
Confidence 9999988888888888888999999999998888888888888775 788889999988777777665543 5899999
Q ss_pred ccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchh
Q 040925 331 LLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPE 410 (833)
Q Consensus 331 ~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~ 410 (833)
...+..|..+..+++|+.|++++|.+++.+| .+..+++|+.|+|++|++++.+|..|..+++|+.|+|++|+|+|.+|.
T Consensus 208 ~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~ 286 (313)
T d1ogqa_ 208 MLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp EEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC
Confidence 9998999999999999999999999986654 688899999999999999999999999999999999999999998884
Q ss_pred hhcCCCCCceEECccCcCcc
Q 040925 411 FLKNLSVLEFLSLSYNHFEG 430 (833)
Q Consensus 411 ~l~~l~~L~~L~l~~N~l~~ 430 (833)
+.++++|+.+++++|+..|
T Consensus 287 -~~~L~~L~~l~l~~N~~l~ 305 (313)
T d1ogqa_ 287 -GGNLQRFDVSAYANNKCLC 305 (313)
T ss_dssp -STTGGGSCGGGTCSSSEEE
T ss_pred -cccCCCCCHHHhCCCcccc
Confidence 6789999999999998544
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=9e-28 Score=251.71 Aligned_cols=265 Identities=20% Similarity=0.282 Sum_probs=168.6
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
++++.++++++ .+|..+. +++++|+|++|+|+...+.+|..+++|++|++++|.+..+.|.+|.++++|++|++++|
T Consensus 13 ~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 13 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 45666666666 4555543 45666666666665555556666666666666666666656666666666666666666
Q ss_pred ccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccc--cccCcCccCCCcCceEecccccCCCC
Q 040925 82 RFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFK--GNVSIDFSSLKNLLWLNLEQNNLGTG 159 (833)
Q Consensus 82 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~--~~~~~~~~~l~~L~~L~L~~N~l~~~ 159 (833)
+++ .+|... ...++.|++++|.+....+..+.....+..++...|... ......|..+++|+++++++|.+..+
T Consensus 90 ~l~-~l~~~~---~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l 165 (305)
T d1xkua_ 90 QLK-ELPEKM---PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 165 (305)
T ss_dssp CCS-BCCSSC---CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred ccC-cCccch---hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcccc
Confidence 665 555433 245566666666666555555555566666666665433 22233455555566666665555443
Q ss_pred CCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccC
Q 040925 160 TATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTI 239 (833)
Q Consensus 160 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 239 (833)
+.. ..++|+.|++++|. +....+..|.+++.++.|++++|.+.++.
T Consensus 166 ~~~---------~~~~L~~L~l~~n~-------------------------~~~~~~~~~~~~~~l~~L~~s~n~l~~~~ 211 (305)
T d1xkua_ 166 PQG---------LPPSLTELHLDGNK-------------------------ITKVDAASLKGLNNLAKLGLSFNSISAVD 211 (305)
T ss_dssp CSS---------CCTTCSEEECTTSC-------------------------CCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred Ccc---------cCCccCEEECCCCc-------------------------CCCCChhHhhccccccccccccccccccc
Confidence 321 12445555555554 44556667777777888888888888777
Q ss_pred CccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCC------CCCCccceeecCCceec
Q 040925 240 PDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSL------GNCQNLMSFTASQNKLT 308 (833)
Q Consensus 240 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~l~~N~l~ 308 (833)
+.+|.++++|++|+|++|.|+ .+|.+|.++++|++|+|++|+|+.+....| ..+.+|+.|++++|.+.
T Consensus 212 ~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 212 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 778888888888888888887 456778888888888888888875544333 34667888888888775
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=6.4e-28 Score=252.86 Aligned_cols=290 Identities=20% Similarity=0.252 Sum_probs=218.6
Q ss_pred CCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEc
Q 040925 24 DLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI 103 (833)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 103 (833)
.++.++-++++++ .+|..+. +++++|+|++|+|+.+.+.+|.++++|++|++++|+++ .+++..|.++++|++|+|
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~-~i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccc-ccchhhhhCCCccCEecc
Confidence 6788999999994 5676664 68999999999999777778999999999999999998 788888999999999999
Q ss_pred cCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccC
Q 040925 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLAD 183 (833)
Q Consensus 104 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 183 (833)
++|+|+. +|..+ ...++.|++++|.+..+....|.....+..++...|....... ....+..+++|+.+++++
T Consensus 87 ~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~----~~~~~~~l~~L~~l~l~~ 159 (305)
T d1xkua_ 87 SKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI----ENGAFQGMKKLSYIRIAD 159 (305)
T ss_dssp CSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGB----CTTGGGGCTTCCEEECCS
T ss_pred cCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCC----CccccccccccCcccccc
Confidence 9999984 45443 3578999999999998888888888888888888876644322 224466777888888888
Q ss_pred CcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccC
Q 040925 184 NQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRI 263 (833)
Q Consensus 184 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 263 (833)
|+++ .+ |.. .+++|+.|++++|.+....+..|.+++.++.|++++|.+++..
T Consensus 160 n~l~-~l-------------------------~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~ 211 (305)
T d1xkua_ 160 TNIT-TI-------------------------PQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211 (305)
T ss_dssp SCCC-SC-------------------------CSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEEC
T ss_pred CCcc-cc-------------------------Ccc--cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccc
Confidence 8776 12 211 1456788888888888788888888888888888888888777
Q ss_pred CccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccC
Q 040925 264 PSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHL 343 (833)
Q Consensus 264 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l 343 (833)
+..|.++++|++|+|++|+|+ .+|.+|..+++|+.|+|++|+|+ .++...+. .+..+..+
T Consensus 212 ~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~-~i~~~~f~------------------~~~~~~~~ 271 (305)
T d1xkua_ 212 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFC------------------PPGYNTKK 271 (305)
T ss_dssp TTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCC-CCCTTSSS------------------CSSCCTTS
T ss_pred cccccccccceeeeccccccc-ccccccccccCCCEEECCCCccC-ccChhhcc------------------Ccchhccc
Confidence 778888888888888888887 45677888888888888888777 44432211 12233456
Q ss_pred CCcCEEeccCCcCC--CCCCccccCCCCCcE
Q 040925 344 KNLVILDISSNQFS--GVIPGTLSTCVCLEY 372 (833)
Q Consensus 344 ~~L~~L~ls~N~l~--~~~~~~~~~l~~L~~ 372 (833)
.+|+.|+|++|+++ .+.|.+|.-+.....
T Consensus 272 ~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~ 302 (305)
T d1xkua_ 272 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 302 (305)
T ss_dssp CCCSEEECCSSSSCGGGSCGGGGTTCCCGGG
T ss_pred CCCCEEECCCCcCccCcCCHhHhcccccCcc
Confidence 67788888888765 356666665544433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=9.2e-27 Score=241.00 Aligned_cols=223 Identities=20% Similarity=0.214 Sum_probs=153.7
Q ss_pred EEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEc-cC
Q 040925 27 VIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI-GG 105 (833)
Q Consensus 27 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L-~~ 105 (833)
.++.+++.+ +.+|..+. +++++|+|++|+|+++.+.+|.++++|++|++++|++. .++...+.++..++.+.. ..
T Consensus 15 ~v~c~~~~L-~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~-~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 15 TTSCPQQGL-QAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp EEECCSSCC-SSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCC-CccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccc-ccccccccccccccccccccc
Confidence 456666666 34555443 56777777777777666667777777777777777776 666677777777777765 35
Q ss_pred CcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCc
Q 040925 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQ 185 (833)
Q Consensus 106 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 185 (833)
|.++...+..|+++++|++|++++|.+..+....+...++|+.+++++|+|+.++.. .|..+++|+.|++++|+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~------~f~~~~~L~~L~l~~N~ 164 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD------TFRDLGNLTHLFLHGNR 164 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT------TTTTCTTCCEEECCSSC
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChh------HhccccchhhcccccCc
Confidence 566666677788888888888888888777777777777788888887777765543 24556666666666666
Q ss_pred CcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCc
Q 040925 186 FGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPS 265 (833)
Q Consensus 186 l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 265 (833)
++. +.+..|.++++|+.+++++|+++++.|+.|.++++|++|++++|.+.+..+.
T Consensus 165 l~~-------------------------l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~ 219 (284)
T d1ozna_ 165 ISS-------------------------VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219 (284)
T ss_dssp CCE-------------------------ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHH
T ss_pred ccc-------------------------cchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccc
Confidence 652 3445566666666666666666666666777777777777777777666666
Q ss_pred cccCCCCCCeEEeeccccc
Q 040925 266 GLGNLTKLANLELSSNSLQ 284 (833)
Q Consensus 266 ~~~~l~~L~~L~L~~N~l~ 284 (833)
.|.++++|++|+|++|.+.
T Consensus 220 ~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 220 ALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp HHTTCTTCCEEECCSSCEE
T ss_pred ccccccccCEEEecCCCCC
Confidence 6666777777777777665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.3e-27 Score=242.26 Aligned_cols=235 Identities=22% Similarity=0.218 Sum_probs=163.8
Q ss_pred CCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEee-cccccCCCCCCCCCCCccceeec
Q 040925 224 NLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELS-SNSLQGNIPSSLGNCQNLMSFTA 302 (833)
Q Consensus 224 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~l 302 (833)
++++|+|++|+|+++.+.+|.++++|++|++++|.+..+.+..+.++..++.++.. .|.++...+..|.++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 34555555555554444555555555555555555555555555555555555443 34444444555555555555555
Q ss_pred CCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCcccc
Q 040925 303 SQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHG 382 (833)
Q Consensus 303 ~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 382 (833)
++|.+....+..+.....+ +.+++++|.++++.+..|..+++|+.|++++|+++++.+.+|.++++|+++++++|++++
T Consensus 113 ~~n~~~~~~~~~~~~~~~L-~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAAL-QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCcccccccccccchhccc-chhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccc
Confidence 5555552223333333333 566777777776667778888999999999999998889999999999999999999999
Q ss_pred ccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCCCcccC
Q 040925 383 VIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGGIDEL 459 (833)
Q Consensus 383 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~~~~~ 459 (833)
+.|..|..+++|+.|++++|++++..+..|..+++|++|++++|+|.|.|+..+....++......+...|..|...
T Consensus 192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~~~~~~~C~~p~~l 268 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL 268 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCSEECCCBEEESGGG
T ss_pred cChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcCCCCceEeCCchHH
Confidence 88999999999999999999999999999999999999999999999988754333334455555566677655543
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=1.2e-24 Score=222.38 Aligned_cols=181 Identities=25% Similarity=0.229 Sum_probs=120.7
Q ss_pred CCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeec
Q 040925 248 NLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDL 327 (833)
Q Consensus 248 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~l 327 (833)
+|++|+|++|.|+++.+.+|.++++|++|+|++|+|+.. | .++.+++|+.|++++|+++ ..+..+..+..+ ++|++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L-~~L~l 107 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPAL-TVLDV 107 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTC-CEEEC
T ss_pred CCCEEECcCCcCCCcCHHHhhcccccccccccccccccc-c-ccccccccccccccccccc-cccccccccccc-ccccc
Confidence 344444444444443334444444455555544444422 1 2334444555555554444 233334444443 45556
Q ss_pred CCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCC
Q 040925 328 SNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQ 407 (833)
Q Consensus 328 s~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 407 (833)
++|.+....+..+..+.++++|++++|.++.+.+..+..+++|+.|++++|+|+++.+..|..+++|+.|+|++|+|+ .
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~ 186 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-C
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-c
Confidence 666665566667778888888888888888888888888888888888888888888888888888888888888888 5
Q ss_pred chhhhcCCCCCceEECccCcCccccC
Q 040925 408 IPEFLKNLSVLEFLSLSYNHFEGEVP 433 (833)
Q Consensus 408 ~p~~l~~l~~L~~L~l~~N~l~~~~~ 433 (833)
+|+.+..+++|+.|+|++|+|.|.|.
T Consensus 187 lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 187 IPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred cChhHCCCCCCCEEEecCCCCCCCcc
Confidence 67777788888888888888888764
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.3e-24 Score=220.18 Aligned_cols=206 Identities=25% Similarity=0.226 Sum_probs=184.9
Q ss_pred ccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccc
Q 040925 243 IGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLS 322 (833)
Q Consensus 243 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll 322 (833)
+.....+.+.+.+++.|+ .+|..+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+|. +..+..+
T Consensus 6 ~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L- 79 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVL- 79 (266)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTC-
T ss_pred EcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccc-
Confidence 345667888999999999 4677665 68999999999999887889999999999999999998 5654 3456666
Q ss_pred eeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCc
Q 040925 323 LYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402 (833)
Q Consensus 323 ~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 402 (833)
+.|+|++|+++ ..+..+.++++|+.|++++|.+.+..+..+..+.++++|++++|.++.+.+..+..++.|+.|++++|
T Consensus 80 ~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N 158 (266)
T d1p9ag_ 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (266)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred ccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccc
Confidence 89999999998 56778999999999999999999999999999999999999999999888899999999999999999
Q ss_pred ccCCCchhhhcCCCCCceEECccCcCccccCCCCccCCCccccccCCcCCCCC
Q 040925 403 NLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKGVFSNKTKISLQGNMKLCGG 455 (833)
Q Consensus 403 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~l~l~~N~~~c~~ 455 (833)
++++..+..|..+++|++|||++|.|+..++.......++.++++||||.|..
T Consensus 159 ~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 159 NLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred cccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCc
Confidence 99999999999999999999999999987777777888999999999999964
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.89 E-value=4.8e-21 Score=204.43 Aligned_cols=313 Identities=25% Similarity=0.313 Sum_probs=178.0
Q ss_pred CCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEc
Q 040925 24 DLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAI 103 (833)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L 103 (833)
++++|+|++|.|+ .+|+. .++|++|+|++|+|+ .+|+. +.+|+.|++++|+++ .++. -.+.|++|+|
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~----lp~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD----LPPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS----CCTTCCEEEC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccc---hhhhhhhhhhhcccc-hhhh----hccccccccc
Confidence 5778888888884 45643 467888888888887 45654 346778888888876 5542 1245888888
Q ss_pred cCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccC
Q 040925 104 GGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLAD 183 (833)
Q Consensus 104 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~ 183 (833)
++|.+. .+|. ++.+++|++|++++|.+..... ....+..+.+..+..... ..+..++.++.|++++
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~~--------~~l~~l~~l~~L~l~~ 171 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEEL--------PELQNLPFLTAIYADN 171 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSC--------CCCTTCTTCCEEECCS
T ss_pred cccccc-cccc-hhhhccceeecccccccccccc----ccccccchhhcccccccc--------ccccccccceeccccc
Confidence 888877 3443 5677888888888887764432 245566676666655432 2255677777888877
Q ss_pred CcCcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccC
Q 040925 184 NQFGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRI 263 (833)
Q Consensus 184 N~l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 263 (833)
|.+. ..+... ...+.+...++.+. ..+ .+..++.|+.+++++|.... .
T Consensus 172 n~~~-~~~~~~----------------------------~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~ 219 (353)
T d1jl5a_ 172 NSLK-KLPDLP----------------------------LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-L 219 (353)
T ss_dssp SCCS-SCCCCC----------------------------TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-C
T ss_pred cccc-cccccc----------------------------cccccccccccccc-ccc-cccccccccccccccccccc-c
Confidence 7765 222110 11223333333333 222 24455666666666666552 2
Q ss_pred CccccCCCCCCeEEeecccccCCCCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccC
Q 040925 264 PSGLGNLTKLANLELSSNSLQGNIPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHL 343 (833)
Q Consensus 264 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l 343 (833)
+. ...++..+.+.+|++.. .+.. ..++...++..|.+.+ ++ .+.......++..|.+.+. ...+
T Consensus 220 ~~---~~~~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~-l~----~l~~~~~~~~~~~~~~~~~----~~~~ 283 (353)
T d1jl5a_ 220 PD---LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSG-LS----ELPPNLYYLNASSNEIRSL----CDLP 283 (353)
T ss_dssp CS---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSE-ES----CCCTTCCEEECCSSCCSEE----CCCC
T ss_pred cc---ccccccccccccccccc-cccc---cccccccccccccccc-cc----cccchhcccccccCccccc----cccC
Confidence 22 23456666666666552 2222 2233444444443331 11 1111123455566655522 2335
Q ss_pred CCcCEEeccCCcCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEEC
Q 040925 344 KNLVILDISSNQFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSL 423 (833)
Q Consensus 344 ~~L~~L~ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l 423 (833)
++|++|+|++|+|+. +|. .+++|+.|+|++|+|+. +|. .+++|+.|++++|+|+ .+|... .+|+.|.+
T Consensus 284 ~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~~-l~~---~~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~ 351 (353)
T d1jl5a_ 284 PSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLAE-VPE---LPQNLKQLHVEYNPLR-EFPDIP---ESVEDLRM 351 (353)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-SCCCCC---TTCCEEEC
T ss_pred CCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCCc-ccc---ccCCCCEEECcCCcCC-CCCccc---cccCeeEC
Confidence 678888888888773 343 35677777888887774 332 2456777777777776 444432 23455544
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=1.2e-23 Score=203.03 Aligned_cols=135 Identities=19% Similarity=0.205 Sum_probs=106.3
Q ss_pred CccCceeccCcceEEEEEEECCCceEEEEEEeeccCCc------------------chhHHHHHHHHHhhcCCCccceEe
Q 040925 533 FSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKG------------------ASRSFVAECEALRNIRHRNLIKII 594 (833)
Q Consensus 533 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~~~ 594 (833)
+.+.++||+|+||+||+|++. +|+.||||+++..... ......+|...+.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 456789999999999999986 7899999987632110 012345788899999999999988
Q ss_pred eEeecCCCCCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcCCCCceeeCCCCCCee
Q 040925 595 TICSSTDFKGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHCQPPMVHGDLKPSNVL 674 (833)
Q Consensus 595 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~~~~ivH~Dlkp~NIl 674 (833)
++. ..+++|||++++.+.+ ++...+..++.|+++|++|||+. ||+||||||+|||
T Consensus 81 ~~~---------~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NIL 135 (191)
T d1zara2 81 AWE---------GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVL 135 (191)
T ss_dssp EEE---------TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred Eec---------CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhhee
Confidence 652 2379999998754432 34445678999999999999999 9999999999999
Q ss_pred ecCCCcEEEcccccccccCc
Q 040925 675 LDHDMVAHVCDFGLAKFLSD 694 (833)
Q Consensus 675 l~~~~~~kL~DfG~a~~~~~ 694 (833)
++++ .++|+|||.|+....
T Consensus 136 v~~~-~~~liDFG~a~~~~~ 154 (191)
T d1zara2 136 VSEE-GIWIIDFPQSVEVGE 154 (191)
T ss_dssp EETT-EEEECCCTTCEETTS
T ss_pred eeCC-CEEEEECCCcccCCC
Confidence 9865 589999999976543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.87 E-value=2.2e-20 Score=199.22 Aligned_cols=304 Identities=26% Similarity=0.324 Sum_probs=207.0
Q ss_pred CCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEE
Q 040925 47 RNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLD 126 (833)
Q Consensus 47 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 126 (833)
.+|++|||++|.++ .+|+. .++|++|+|++|+|+ .+|. .+.+|+.|++++|+++. ++.. .+.|++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~----~~~~L~~L~l~~n~l~~-l~~l---p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPE----LPQSLKSLLVDNNNLKA-LSDL---PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCC----CCTTCCEEECCSSCCSC-CCSC---CTTCCEEE
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-cccc----chhhhhhhhhhhcccch-hhhh---cccccccc
Confidence 36888888888887 46643 467888888888887 7774 24678888888888763 3321 24578888
Q ss_pred cccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEc
Q 040925 127 LSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGI 206 (833)
Q Consensus 127 L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l 206 (833)
+++|.|+.++. +..+++|++|++++|.+...+. ....+..|.+.++...
T Consensus 105 L~~n~l~~lp~--~~~l~~L~~L~l~~~~~~~~~~----------~~~~l~~l~~~~~~~~------------------- 153 (353)
T d1jl5a_ 105 VSNNQLEKLPE--LQNSSFLKIIDVDNNSLKKLPD----------LPPSLEFIAAGNNQLE------------------- 153 (353)
T ss_dssp CCSSCCSSCCC--CTTCTTCCEEECCSSCCSCCCC----------CCTTCCEEECCSSCCS-------------------
T ss_pred ccccccccccc--hhhhccceeecccccccccccc----------ccccccchhhcccccc-------------------
Confidence 88888776543 5667777777777777654332 2344555555555443
Q ss_pred cCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCC
Q 040925 207 GRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGN 286 (833)
Q Consensus 207 ~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 286 (833)
....+..++.++.|++++|.+.... . .....+.+...++.+. ..+ .+..++.|+.+++++|... .
T Consensus 154 --------~~~~l~~l~~l~~L~l~~n~~~~~~-~---~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~ 218 (353)
T d1jl5a_ 154 --------ELPELQNLPFLTAIYADNNSLKKLP-D---LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-T 218 (353)
T ss_dssp --------SCCCCTTCTTCCEEECCSSCCSSCC-C---CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-S
T ss_pred --------ccccccccccceecccccccccccc-c---cccccccccccccccc-ccc-ccccccccccccccccccc-c
Confidence 2345667888999999999887432 2 2234667888877776 333 4678999999999999887 3
Q ss_pred CCCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCCCCccccC
Q 040925 287 IPSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGVIPGTLST 366 (833)
Q Consensus 287 ~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~~~~~~~ 366 (833)
.+. ...++..+.+.+|.+. ..+.....+ ...++..+.+.+... -.......++..|.+.+. ...
T Consensus 219 ~~~---~~~~l~~~~~~~~~~~-~~~~~~~~l----~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~----~~~ 282 (353)
T d1jl5a_ 219 LPD---LPPSLEALNVRDNYLT-DLPELPQSL----TFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSL----CDL 282 (353)
T ss_dssp CCS---CCTTCCEEECCSSCCS-CCCCCCTTC----CEEECCSSCCSEESC----CCTTCCEEECCSSCCSEE----CCC
T ss_pred ccc---cccccccccccccccc-ccccccccc----ccccccccccccccc----ccchhcccccccCccccc----ccc
Confidence 443 3456778888888887 333332221 345565555542111 124556778888888643 345
Q ss_pred CCCCcEEeecCCccccccCccccCCCCCCeEEccCcccCCCchhhhcCCCCCceEECccCcCccccC
Q 040925 367 CVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSNNLSGQIPEFLKNLSVLEFLSLSYNHFEGEVP 433 (833)
Q Consensus 367 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~ 433 (833)
+++|++|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|.. +++|+.|++++|+++..+.
T Consensus 283 ~~~L~~L~Ls~N~l~~-lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~lp~ 341 (353)
T d1jl5a_ 283 PPSLEELNVSNNKLIE-LPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREFPD 341 (353)
T ss_dssp CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSCCC
T ss_pred CCCCCEEECCCCccCc-ccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCCCCc
Confidence 6899999999999995 453 3678999999999998 45543 4679999999999997554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=5.9e-21 Score=192.00 Aligned_cols=130 Identities=25% Similarity=0.318 Sum_probs=84.1
Q ss_pred CEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEcc-
Q 040925 26 EVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIG- 104 (833)
Q Consensus 26 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~- 104 (833)
+.++.+++.++ .+|+.+. +++++|+|++|+|+.+.+.+|.++++|++|+|++|.+.+.++...|.+++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 56777777774 5555443 4677788888777766666777777777777777777655666777777777777664
Q ss_pred CCcceeeCCccccCCCCCcEEEcccCccccccCcC-ccCCCcCceEecccccCCC
Q 040925 105 GNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSID-FSSLKNLLWLNLEQNNLGT 158 (833)
Q Consensus 105 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~-~~~l~~L~~L~L~~N~l~~ 158 (833)
.|.+....+..|.++++|++|++++|++....... +..+..|..+...++.+..
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~ 142 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 142 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCE
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccccccccccccccc
Confidence 35666666667777777777777777776443322 2334444444444444443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=5.8e-21 Score=192.04 Aligned_cols=222 Identities=14% Similarity=0.088 Sum_probs=124.4
Q ss_pred CEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceee-CCccccCCCCCcEEEcc
Q 040925 50 VSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGS-IPYSLSNASNLELLDLS 128 (833)
Q Consensus 50 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~ 128 (833)
++++.+++.++ .+|..+. +++++|+|++|+|+ .+|..+|.++++|++|+|++|.+... .+.+|.+++++++|.+.
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 45555555555 3443332 34555666666555 55555555556666666665555432 23445555555555554
Q ss_pred c-CccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEcc
Q 040925 129 V-NQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIG 207 (833)
Q Consensus 129 ~-N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~ 207 (833)
. |++..+.+..|.++++|++|++++|.+...+.. ..+..+..+..+..+++++....+..+..+...+..++++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~-----~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~ 161 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV-----HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 161 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCC-----TTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred ccccccccccccccccccccccccchhhhcccccc-----cccccccccccccccccccccccccccccccccceeeecc
Confidence 2 455555555555556666666665555443221 1233344444555555555544444444444455556666
Q ss_pred CccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeec
Q 040925 208 RNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSS 280 (833)
Q Consensus 208 ~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 280 (833)
+|+++.+.+..|.....++.+++++|+++.+.++.|.++++|++|+|++|+|+.+.+..|.++++|+.+++.+
T Consensus 162 ~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 162 KNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp SSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred cccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 6666554444444333233445667777766666778888888888888888866566677777777766644
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=3.2e-23 Score=230.20 Aligned_cols=384 Identities=16% Similarity=0.149 Sum_probs=201.4
Q ss_pred CCCEEEccCCcccccC-CccCCCCCCCCEEEcCCCcccc----cCCccccCCCCCcEEECCCcccccc----cCchhhcC
Q 040925 24 DLEVIRIMGNSLGGKI-PTTLGLLRNLVSLNVAENKFSG----MFPRSICNISSLELIQLALNRFSGN----LPFDIVVN 94 (833)
Q Consensus 24 ~L~~L~l~~n~l~~~~-~~~~~~l~~L~~L~L~~n~i~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~~ 94 (833)
+|+.||+++|++++.. ...+..++++++|+|++|.|+. .+...+..+++|++|+|++|+|++. +.......
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 4677777777775432 3345556777777777777763 2344566777788888887777521 11111112
Q ss_pred CCCccEEEccCCcceee----CCccccCCCCCcEEEcccCccccccCcCcc-----CCCcCceEecccccCCCCCCCCcc
Q 040925 95 LPNLKALAIGGNNFFGS----IPYSLSNASNLELLDLSVNQFKGNVSIDFS-----SLKNLLWLNLEQNNLGTGTATDLD 165 (833)
Q Consensus 95 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-----~l~~L~~L~L~~N~l~~~~~~~~~ 165 (833)
..+|++|+|++|++++. ++..+..+++|++|+|++|+|.......+. .......+......+..... ..
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~--~~ 160 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC--EP 160 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH--HH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhh--cc
Confidence 34688888888877632 345677788888888888887643322221 11223333333333321110 11
Q ss_pred cccccCCCCCCCEEEccCCcCcccC----ChhHhhhcccccEEEccCcccccc----CChhhhcCCCCCeEeccCCcccc
Q 040925 166 FVTFLTNCSSLKALSLADNQFGGEL----PHSIANLSSTVINFGIGRNQISGT----IPPGIRNLVNLIGFGAEENQLHG 237 (833)
Q Consensus 166 ~~~~l~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~~l~~L~l~~n~i~~~----~~~~~~~l~~L~~L~L~~N~l~~ 237 (833)
....+.....++.++++++.+.... ...+.........+++..+.+... ....+...+.++.+++.+|++..
T Consensus 161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~ 240 (460)
T d1z7xw1 161 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 240 (460)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccc
Confidence 1223445677888888888765221 111222223445566666655421 11234455667777777776542
Q ss_pred -----cCCccccCCCCCCEEEcccccCcccC----CccccCCCCCCeEEeecccccCCCCCC-----CCCCCccceeecC
Q 040925 238 -----TIPDAIGELKNLQKLCLFRNFLQGRI----PSGLGNLTKLANLELSSNSLQGNIPSS-----LGNCQNLMSFTAS 303 (833)
Q Consensus 238 -----~~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~-----~~~l~~L~~L~l~ 303 (833)
..+..+.....|+.|++++|.+.... ...+...+.++.+++++|.+....... ......|+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~ 320 (460)
T d1z7xw1 241 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK 320 (460)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred cccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccc
Confidence 22333444566777777777665321 122344566777777777664221111 1122345555555
Q ss_pred CceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCcCCCC----CCccc-cCCCCCcEEeecCC
Q 040925 304 QNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQFSGV----IPGTL-STCVCLEYLDISSN 378 (833)
Q Consensus 304 ~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~l~~~----~~~~~-~~l~~L~~L~Ls~N 378 (833)
+|.++......+ ...+...++|++|+|++|+|++. ++..+ ...+.|++|+|++|
T Consensus 321 ~~~l~~~~~~~l---------------------~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n 379 (460)
T d1z7xw1 321 SCSFTAACCSHF---------------------SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 379 (460)
T ss_dssp TSCCBGGGHHHH---------------------HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred ccchhhhhhhhc---------------------ccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCC
Confidence 555442111111 11223345666666666666432 11222 23455666677766
Q ss_pred ccccc----cCccccCCCCCCeEEccCcccCCCchhh----hc-CCCCCceEECccCcCcc
Q 040925 379 SFHGV----IPLSLSFLKSIKELNVSSNNLSGQIPEF----LK-NLSVLEFLSLSYNHFEG 430 (833)
Q Consensus 379 ~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~p~~----l~-~l~~L~~L~l~~N~l~~ 430 (833)
+|++. +...+..+++|++|+|++|+|+...... +. +...|+.|++.+|.+..
T Consensus 380 ~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 380 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp CCCHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred CCChHHHHHHHHHHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 66532 2333455566777777777665432222 22 23356777777776664
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.81 E-value=2.5e-20 Score=179.50 Aligned_cols=172 Identities=21% Similarity=0.317 Sum_probs=117.1
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccc-cCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCC
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGG-KIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLAL 80 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 80 (833)
+++++++++++ .+|..+. +++++|+|++|+|+. ..+..|..+++|+.|+|++|+++.+.+..|.++++|++|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 46777788887 5666553 577788888888854 4466677778888888888888777777777788888888888
Q ss_pred cccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCC
Q 040925 81 NRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGT 160 (833)
Q Consensus 81 N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 160 (833)
|+|+ .+|+++|.++++|++|+|++|+|+.+.+.+|..+++|++|+|++|.+.......+ -...++.+.+..|.+....
T Consensus 88 N~l~-~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 88 NKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp CCCC-EECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHHHHCCSGGGCBBCS
T ss_pred cccc-ccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHH-HhhhhhhhcccCCCeEeCC
Confidence 8877 7777777777888888888888777777777777778888887777764322111 1223455556666554322
Q ss_pred CCCcccccccCCCCCCCEEEccCCcCc
Q 040925 161 ATDLDFVTFLTNCSSLKALSLADNQFG 187 (833)
Q Consensus 161 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~ 187 (833)
+ ..+..++.++|+.|+++
T Consensus 166 p---------~~l~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 166 P---------SKVRDVQIKDLPHSEFK 183 (192)
T ss_dssp S---------TTTTTSBGGGSCTTTCC
T ss_pred C---------hhhcCCEeeecCHhhCc
Confidence 1 23444555666666665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=2.2e-19 Score=178.16 Aligned_cols=205 Identities=20% Similarity=0.284 Sum_probs=142.5
Q ss_pred CEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccC
Q 040925 26 EVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGG 105 (833)
Q Consensus 26 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~ 105 (833)
..++++.+++++.. .+..+.+|+.|++.+|.|+++ ..+..+++|++|++++|+++ .+++ |.++++|++|++++
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~-~~~~--l~~l~~l~~l~~~~ 94 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQIT-DLAP--LKNLTKITELELSG 94 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCC-CCGG--GTTCCSCCEEECCS
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceee-cccc--cccccccccccccc
Confidence 34566666665433 345667778888888887743 34777888888888888776 3332 67778888888888
Q ss_pred CcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCc
Q 040925 106 NNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQ 185 (833)
Q Consensus 106 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~ 185 (833)
|.++. + ..|.++++|+.|++++|.+.++. .+...+.+..+.++.+.+.... .+.+.++|++|++++|+
T Consensus 95 n~~~~-i-~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--------~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 95 NPLKN-V-SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--------PLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp CCCSC-C-GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--------GGGGCTTCCEEECCSSC
T ss_pred ccccc-c-ccccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--------hhccccccccccccccc
Confidence 87763 2 34777888888888888776443 4666777888888777765422 25567778888888877
Q ss_pred CcccCChhHhhhcccccEEEccCccccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCc
Q 040925 186 FGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPS 265 (833)
Q Consensus 186 l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 265 (833)
+.. ...+.++++|+.|+|++|+++++. .|+++++|++|+|++|+|+++.
T Consensus 163 ~~~---------------------------~~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i~-- 211 (227)
T d1h6ua2 163 VSD---------------------------LTPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDVS-- 211 (227)
T ss_dssp CCC---------------------------CGGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBCG--
T ss_pred ccc---------------------------chhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCCc--
Confidence 651 123566777888888888877532 3778888888888888888543
Q ss_pred cccCCCCCCeEEeec
Q 040925 266 GLGNLTKLANLELSS 280 (833)
Q Consensus 266 ~~~~l~~L~~L~L~~ 280 (833)
.+.++++|+.|++++
T Consensus 212 ~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 212 PLANTSNLFIVTLTN 226 (227)
T ss_dssp GGTTCTTCCEEEEEE
T ss_pred ccccCCCCCEEEeeC
Confidence 377888888888874
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.81 E-value=1.1e-19 Score=180.41 Aligned_cols=203 Identities=22% Similarity=0.265 Sum_probs=124.0
Q ss_pred EEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccC
Q 040925 51 SLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVN 130 (833)
Q Consensus 51 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 130 (833)
.++++.+++++. ..+..+.+|+.|++++|.|+ .++. +..+++|++|+|++|.+++..| |.++++|++|++++|
T Consensus 23 ~~~l~~~~~~d~--~~~~~l~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 23 KIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHTTCSSTTSE--ECHHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHhCCCCcCCc--CCHHHcCCcCEEECCCCCCC-cchh--HhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 344555555532 23445555666666666555 3431 4455555555555555553322 555555555555555
Q ss_pred ccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhhhcccccEEEccCcc
Q 040925 131 QFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIANLSSTVINFGIGRNQ 210 (833)
Q Consensus 131 ~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~~l~~L~l~~n~ 210 (833)
.++.+. .|.++++|+.++++++....+. .+...+.++.++++++.+.
T Consensus 96 ~~~~i~--~l~~l~~L~~l~l~~~~~~~~~--------~~~~~~~~~~l~~~~~~~~----------------------- 142 (227)
T d1h6ua2 96 PLKNVS--AIAGLQSIKTLDLTSTQITDVT--------PLAGLSNLQVLYLDLNQIT----------------------- 142 (227)
T ss_dssp CCSCCG--GGTTCTTCCEEECTTSCCCCCG--------GGTTCTTCCEEECCSSCCC-----------------------
T ss_pred cccccc--cccccccccccccccccccccc--------hhccccchhhhhchhhhhc-----------------------
Confidence 555332 3445555555555555443321 1334444555554444443
Q ss_pred ccccCChhhhcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeecccccCCCCCC
Q 040925 211 ISGTIPPGIRNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQGNIPSS 290 (833)
Q Consensus 211 i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 290 (833)
. ...+.++++|+.|++++|.+... ..|+++++|++|+|++|+++++ ..|+++++|++|+|++|+|++..|
T Consensus 143 --~--~~~~~~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l--~~l~~l~~L~~L~Ls~N~lt~i~~-- 212 (227)
T d1h6ua2 143 --N--ISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP-- 212 (227)
T ss_dssp --C--CGGGGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECTTSCCCBCGG--
T ss_pred --h--hhhhccccccccccccccccccc--hhhcccccceecccCCCccCCC--hhhcCCCCCCEEECcCCcCCCCcc--
Confidence 2 23466778889999999988743 3478889999999999988854 347888899999999999885543
Q ss_pred CCCCCccceeecC
Q 040925 291 LGNCQNLMSFTAS 303 (833)
Q Consensus 291 ~~~l~~L~~L~l~ 303 (833)
++++++|+.|+++
T Consensus 213 l~~l~~L~~L~ls 225 (227)
T d1h6ua2 213 LANTSNLFIVTLT 225 (227)
T ss_dssp GTTCTTCCEEEEE
T ss_pred cccCCCCCEEEee
Confidence 7888888888876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=7.1e-22 Score=219.15 Aligned_cols=378 Identities=16% Similarity=0.095 Sum_probs=221.3
Q ss_pred CCcEEECCCcccccccCchhhcCCCCccEEEccCCccee----eCCccccCCCCCcEEEcccCccccccC----cCcc-C
Q 040925 72 SLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFG----SIPYSLSNASNLELLDLSVNQFKGNVS----IDFS-S 142 (833)
Q Consensus 72 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~i~~~~~----~~~~-~ 142 (833)
+|+.||+++|++++.-=..++..++++++|+|++|.|+. .+...+..+++|++|||++|+|+.... ..+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 345555555555421112334455666666666666552 223345566666666666666643211 1111 2
Q ss_pred CCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCChhHhh----hcccccEEEccCccccccC---
Q 040925 143 LKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELPHSIAN----LSSTVINFGIGRNQISGTI--- 215 (833)
Q Consensus 143 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~----l~~~l~~L~l~~n~i~~~~--- 215 (833)
..+|++|+|++|.++..... .+...+..+++|++|+|++|++.......+.. ..............+....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~--~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 160 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCG--VLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP 160 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHH--HHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred CCCCCEEECCCCCccccccc--cccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcc
Confidence 24577777777766542211 12344566777777777777776433333322 1112233333333332111
Q ss_pred -ChhhhcCCCCCeEeccCCcccccC----Cccc-cCCCCCCEEEcccccCccc----CCccccCCCCCCeEEeecccccC
Q 040925 216 -PPGIRNLVNLIGFGAEENQLHGTI----PDAI-GELKNLQKLCLFRNFLQGR----IPSGLGNLTKLANLELSSNSLQG 285 (833)
Q Consensus 216 -~~~~~~l~~L~~L~L~~N~l~~~~----~~~~-~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~ 285 (833)
...+.....++.++++++.+.... ...+ ........+++..+.+... ....+.....++.+++++|++..
T Consensus 161 ~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~ 240 (460)
T d1z7xw1 161 LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD 240 (460)
T ss_dssp HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccc
Confidence 123455677888888887765321 1111 2234567788888776532 11233456788889988887642
Q ss_pred -----CCCCCCCCCCccceeecCCceecccC----CcccccccccceeeecCCCccCCCCCcc-----cccCCCcCEEec
Q 040925 286 -----NIPSSLGNCQNLMSFTASQNKLTGAL----PHQLLSITTLSLYLDLSNNLLNGSLPLQ-----VGHLKNLVILDI 351 (833)
Q Consensus 286 -----~~~~~~~~l~~L~~L~l~~N~l~~~~----p~~~~~~~~ll~~L~ls~N~l~~~~~~~-----~~~l~~L~~L~l 351 (833)
..+..+.....++.+++++|.+.... ...+.....+ ..+++++|.++...... ......|+.+++
T Consensus 241 ~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l-~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l 319 (460)
T d1z7xw1 241 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESL-KELSLAGNELGDEGARLLCETLLEPGCQLESLWV 319 (460)
T ss_dssp HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTC-CEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred cccchhhcccccccccccccccccccccccccccccccccccccc-cccccccccccccccchhhccccccccccccccc
Confidence 22334455678888999988876321 2223333444 67889998876322211 123468999999
Q ss_pred cCCcCCCCCCc----cccCCCCCcEEeecCCccccc----cCccc-cCCCCCCeEEccCcccCCC----chhhhcCCCCC
Q 040925 352 SSNQFSGVIPG----TLSTCVCLEYLDISSNSFHGV----IPLSL-SFLKSIKELNVSSNNLSGQ----IPEFLKNLSVL 418 (833)
Q Consensus 352 s~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~----~~~~~-~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L 418 (833)
++|.++..... .+..+++|++|+|++|++++. +...+ ...+.|+.|+|++|+|+.. +++.+..+++|
T Consensus 320 ~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L 399 (460)
T d1z7xw1 320 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 399 (460)
T ss_dssp TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCC
T ss_pred cccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCC
Confidence 99999754333 345667899999999999753 22233 3467899999999999853 45567788999
Q ss_pred ceEECccCcCccccCC-----C-CccCCCccccccCCcCC
Q 040925 419 EFLSLSYNHFEGEVPT-----K-GVFSNKTKISLQGNMKL 452 (833)
Q Consensus 419 ~~L~l~~N~l~~~~~~-----~-~~~~~~~~l~l~~N~~~ 452 (833)
++|||++|+++..-.. . .....++.+.+.+|.+.
T Consensus 400 ~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~ 439 (460)
T d1z7xw1 400 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 439 (460)
T ss_dssp CEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred CEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence 9999999999752110 0 12235778888888764
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.79 E-value=2.4e-19 Score=172.57 Aligned_cols=127 Identities=19% Similarity=0.244 Sum_probs=71.8
Q ss_pred CEEEccCCcccccCCccCCCCCCCCEEEcCCCcccc-cCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEcc
Q 040925 26 EVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSG-MFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIG 104 (833)
Q Consensus 26 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~ 104 (833)
++++.++++++ .+|..+. +++++|+|++|+|++ +.+..|.++++|+.|+|++|.+. .++.+.|..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~-~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccc-cccccccccccccceeeec
Confidence 45666666663 3444432 456666666666653 33455555666666666666655 4555555555566666666
Q ss_pred CCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccC
Q 040925 105 GNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNL 156 (833)
Q Consensus 105 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l 156 (833)
+|+|+.+.|.+|.++++|++|+|++|+|+.+++++|.++++|++|+|++|.+
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~ 138 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCB
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccc
Confidence 6665555555555556666666666665555555555555555555555544
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=6.7e-19 Score=171.94 Aligned_cols=56 Identities=30% Similarity=0.448 Sum_probs=28.9
Q ss_pred hcCCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEee
Q 040925 220 RNLVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELS 279 (833)
Q Consensus 220 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 279 (833)
..+++|+.+++++|+++++. .|+++++|++|+|++|.|++ ++ .|.++++|++|+|+
T Consensus 153 ~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 153 SRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp GGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cccccccccccccccccccc--cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 34445555555555554322 25555555666666555553 22 35555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.4e-18 Score=169.51 Aligned_cols=165 Identities=23% Similarity=0.295 Sum_probs=101.2
Q ss_pred CCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccE
Q 040925 21 NLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKA 100 (833)
Q Consensus 21 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~ 100 (833)
.+..|+.|++++|.++.. + .+..+++|++|+|++|+|+++. .++++++|++|++++|+++ .+| .+.++++|+.
T Consensus 44 ~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~--~l~~l~~L~~ 116 (210)
T d1h6ta2 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS--SLKDLKKLKS 116 (210)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG--GGTTCTTCCE
T ss_pred HhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc--cccccccccc
Confidence 355666777777776432 2 2666677777777777776432 3566677777777777766 454 2556677777
Q ss_pred EEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEE
Q 040925 101 LAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180 (833)
Q Consensus 101 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~ 180 (833)
|++++|.+.. ...+..+++|+.+++++|.+++. ..+..+++|+++++++|+++.++ .+.++++|++|+
T Consensus 117 L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~--------~l~~l~~L~~L~ 184 (210)
T d1h6ta2 117 LSLEHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIV--------PLAGLTKLQNLY 184 (210)
T ss_dssp EECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--------GGTTCTTCCEEE
T ss_pred cccccccccc--ccccccccccccccccccccccc--ccccccccccccccccccccccc--------cccCCCCCCEEE
Confidence 7777776642 23466667777777777766643 24556667777777777665432 155667777777
Q ss_pred ccCCcCcccCChhHhhhcccccEEEcc
Q 040925 181 LADNQFGGELPHSIANLSSTVINFGIG 207 (833)
Q Consensus 181 Ls~N~l~~~~p~~~~~l~~~l~~L~l~ 207 (833)
|++|+++ .+| .+..+. .|+.|+++
T Consensus 185 Ls~N~i~-~l~-~l~~l~-~L~~L~Ls 208 (210)
T d1h6ta2 185 LSKNHIS-DLR-ALAGLK-NLDVLELF 208 (210)
T ss_dssp CCSSCCC-BCG-GGTTCT-TCSEEEEE
T ss_pred CCCCCCC-CCh-hhcCCC-CCCEEEcc
Confidence 7777766 344 355443 36666654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=2.6e-18 Score=166.21 Aligned_cols=161 Identities=24% Similarity=0.344 Sum_probs=113.2
Q ss_pred cCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCccccc
Q 040925 6 VNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSG 85 (833)
Q Consensus 6 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~ 85 (833)
++.+.+++..+ ...+.+++.|++++|.|+. ++ .+..+++|++|+|++|++++..| |+++++|++|++++|.+.
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~- 97 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA- 97 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-
T ss_pred hCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-
Confidence 44555554332 2456777888888888854 32 47777888888888888875433 778888888888888776
Q ss_pred ccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcc
Q 040925 86 NLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD 165 (833)
Q Consensus 86 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 165 (833)
.++. +.++++|+.|++++|.+... ..+..+++|+.|++++|++..++ .+..+++|++|++++|+++.++
T Consensus 98 ~~~~--l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~~--~l~~~~~L~~L~l~~n~l~~l~----- 166 (199)
T d2omxa2 98 DITP--LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLNFSSNQVTDLK----- 166 (199)
T ss_dssp CCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCG-----
T ss_pred cccc--cccccccccccccccccccc--cccchhhhhHHhhhhhhhhcccc--cccccccccccccccccccCCc-----
Confidence 5543 66778888888888877632 34677788888888888877543 4777788888888888776543
Q ss_pred cccccCCCCCCCEEEccCCcCc
Q 040925 166 FVTFLTNCSSLKALSLADNQFG 187 (833)
Q Consensus 166 ~~~~l~~l~~L~~L~Ls~N~l~ 187 (833)
.+.++++|++|++++|+++
T Consensus 167 ---~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 167 ---PLANLTTLERLDISSNKVS 185 (199)
T ss_dssp ---GGTTCTTCCEEECCSSCCC
T ss_pred ---cccCCCCCCEEECCCCCCC
Confidence 2667778888888888776
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=2.4e-18 Score=166.42 Aligned_cols=59 Identities=32% Similarity=0.410 Sum_probs=25.0
Q ss_pred CCCCCeEeccCCcccccCCccccCCCCCCEEEcccccCcccCCccccCCCCCCeEEeeccccc
Q 040925 222 LVNLIGFGAEENQLHGTIPDAIGELKNLQKLCLFRNFLQGRIPSGLGNLTKLANLELSSNSLQ 284 (833)
Q Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 284 (833)
+++|+.|++++|++... +.+..+++|++|++++|.+++. ..|.++++|++|++++|+|+
T Consensus 127 l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~~l--~~l~~l~~L~~L~ls~N~i~ 185 (199)
T d2omxa2 127 LTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDL--KPLANLTTLERLDISSNKVS 185 (199)
T ss_dssp CTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCC
T ss_pred hhhhHHhhhhhhhhccc--ccccccccccccccccccccCC--ccccCCCCCCEEECCCCCCC
Confidence 33444444444444321 1244444444444444444432 12444444444444444444
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.64 E-value=1.2e-16 Score=147.93 Aligned_cols=112 Identities=15% Similarity=0.175 Sum_probs=60.5
Q ss_pred ccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCc
Q 040925 19 VGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNL 98 (833)
Q Consensus 19 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L 98 (833)
|.+...+++|+|++|+|+. ++..+..+++|++|+|++|+|+.+ +.|..+++|++|++++|+++ .+|..+|..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L 89 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDL 89 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhccccccc-CCCcccccccccc
Confidence 4455556666666666633 344455556666666666666533 23555556666666666655 4555555555555
Q ss_pred cEEEccCCcceeeCC-ccccCCCCCcEEEcccCcccc
Q 040925 99 KALAIGGNNFFGSIP-YSLSNASNLELLDLSVNQFKG 134 (833)
Q Consensus 99 ~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~i~~ 134 (833)
++|+|++|+|+.... ..+..+++|++|++++|.++.
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~ 126 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTN 126 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGG
T ss_pred ccceeccccccccccccccccccccchhhcCCCcccc
Confidence 555555555543211 234555555555555555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.1e-16 Score=146.18 Aligned_cols=131 Identities=16% Similarity=0.091 Sum_probs=90.7
Q ss_pred CCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCC
Q 040925 43 LGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNL 122 (833)
Q Consensus 43 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 122 (833)
|.+..+|++|+|++|+|+. ++..+..+++|+.|+|++|+|+ .++. |..+++|++|+|++|+++.+.+..+..+++|
T Consensus 14 ~~n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~~--~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLDG--FPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EECTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EECC--CCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred ccCcCcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccCC--cccCcchhhhhcccccccCCCcccccccccc
Confidence 5666778888888888874 4666677788888888888877 5542 5677778888888888776666666777778
Q ss_pred cEEEcccCccccccC-cCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEE
Q 040925 123 ELLDLSVNQFKGNVS-IDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALS 180 (833)
Q Consensus 123 ~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~ 180 (833)
++|+|++|+|+.+.. ..+..+++|++|++++|.++..+.. -...+..+++|++||
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~---r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY---RLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTH---HHHHHHHCTTCSEET
T ss_pred ccceeccccccccccccccccccccchhhcCCCccccccch---HHHHHHHCCCcCeeC
Confidence 888888887776544 4567777777777777777554320 012355667777765
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.60 E-value=1.6e-15 Score=133.15 Aligned_cols=102 Identities=25% Similarity=0.356 Sum_probs=55.8
Q ss_pred cEEEcCCCcCcccCCccccCCCCCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCc
Q 040925 2 QTLAVNDNYLTGQLPDFVGNLSDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALN 81 (833)
Q Consensus 2 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N 81 (833)
|+|+|++|+++ .++ .+..+++|++|++++|+|+ .+|+.|+.+++|++|++++|+|++ +| .|.++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 45666666666 333 2566666666666666663 345556666666666666666653 22 3555556666666665
Q ss_pred ccccccCc-hhhcCCCCccEEEccCCcce
Q 040925 82 RFSGNLPF-DIVVNLPNLKALAIGGNNFF 109 (833)
Q Consensus 82 ~l~~~~~~-~~~~~l~~L~~L~L~~N~l~ 109 (833)
+|+ .+|. ..+..+++|++|+|++|.++
T Consensus 76 ~i~-~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCC-SSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccC-CCCCchhhcCCCCCCEEECCCCcCC
Confidence 555 3332 33444555555555555544
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.59 E-value=1.4e-15 Score=133.55 Aligned_cols=101 Identities=26% Similarity=0.374 Sum_probs=55.6
Q ss_pred EEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCC
Q 040925 27 VIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGN 106 (833)
Q Consensus 27 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N 106 (833)
+|+|++|+|+ .++ .++.+++|++|+|++|+|+ .+|..|+.+++|+.|++++|.|+ .+|. |..+++|++|++++|
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELLLCNN 75 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCSS
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccCc--cccccccCeEECCCC
Confidence 4566666663 233 2566666666666666665 34555666666666666666665 4432 455555555555555
Q ss_pred cceeeCC-ccccCCCCCcEEEcccCccc
Q 040925 107 NFFGSIP-YSLSNASNLELLDLSVNQFK 133 (833)
Q Consensus 107 ~l~~~~~-~~~~~l~~L~~L~L~~N~i~ 133 (833)
+|+.... ..+..+++|++|++++|+|+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 5553321 34555555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=4.9e-16 Score=158.90 Aligned_cols=183 Identities=20% Similarity=0.180 Sum_probs=91.2
Q ss_pred CCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcEEEcccC-ccccccCc-CccCCCcCc
Q 040925 70 ISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLELLDLSVN-QFKGNVSI-DFSSLKNLL 147 (833)
Q Consensus 70 l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~i~~~~~~-~~~~l~~L~ 147 (833)
..+|++|||+++.+++.....++..+++|++|+|++|.+++..+..++.+++|++|+|+++ .++...-. .+.++++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 3455555555555543323344555666666666666655555555566666666666663 34321111 123455566
Q ss_pred eEecccc-cCCCCCCCCccccccc-CCCCCCCEEEccCCc--CcccCChhHhhhcccccEEEccCccccccCChhhhcCC
Q 040925 148 WLNLEQN-NLGTGTATDLDFVTFL-TNCSSLKALSLADNQ--FGGELPHSIANLSSTVINFGIGRNQISGTIPPGIRNLV 223 (833)
Q Consensus 148 ~L~L~~N-~l~~~~~~~~~~~~~l-~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~~l~~L~l~~n~i~~~~~~~~~~l~ 223 (833)
+|+++++ .++.. .....+ ...++|+.|+++++. ++.. .+...+.+++
T Consensus 125 ~L~ls~c~~~~~~-----~~~~~~~~~~~~L~~L~l~~~~~~i~~~------------------------~l~~l~~~~~ 175 (284)
T d2astb2 125 ELNLSWCFDFTEK-----HVQVAVAHVSETITQLNLSGYRKNLQKS------------------------DLSTLVRRCP 175 (284)
T ss_dssp EEECCCCTTCCHH-----HHHHHHHHSCTTCCEEECCSCGGGSCHH------------------------HHHHHHHHCT
T ss_pred ccccccccccccc-----cchhhhcccccccchhhhcccccccccc------------------------cccccccccc
Confidence 6666553 22210 000111 123456666666542 2211 0111224455
Q ss_pred CCCeEeccCC-cccccCCccccCCCCCCEEEcccc-cCcccCCccccCCCCCCeEEeecc
Q 040925 224 NLIGFGAEEN-QLHGTIPDAIGELKNLQKLCLFRN-FLQGRIPSGLGNLTKLANLELSSN 281 (833)
Q Consensus 224 ~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N 281 (833)
+|++|++++| .+++.....+..+++|++|+|++| .|++.....++++++|+.|+++++
T Consensus 176 ~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 6666666654 345445555666666666666663 455444445556666666666665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.54 E-value=4.6e-15 Score=151.54 Aligned_cols=224 Identities=16% Similarity=0.162 Sum_probs=131.9
Q ss_pred CEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceee-CCccccCCCCCcEEEcc
Q 040925 50 VSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGS-IPYSLSNASNLELLDLS 128 (833)
Q Consensus 50 ~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~ 128 (833)
+.|||+++.+.......+.. ..+..+.++...+. ..... .....+|++|+|++|.++.. +...+..+++|++|+|+
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~-~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMD-QPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEEC-SCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccc-cchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence 36777777664221111111 23455666655553 21112 22455677777777766532 33446667777777777
Q ss_pred cCccccccCcCccCCCcCceEecccc-cCCCCCCCCcccccccCCCCCCCEEEccCC-cCcccCChhHhhhcccccEEEc
Q 040925 129 VNQFKGNVSIDFSSLKNLLWLNLEQN-NLGTGTATDLDFVTFLTNCSSLKALSLADN-QFGGELPHSIANLSSTVINFGI 206 (833)
Q Consensus 129 ~N~i~~~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~~l~~L~l 206 (833)
+|+++......+..+++|++|+|+++ .++.. .....+.++++|++|+++++ .++..
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~-----~l~~l~~~~~~L~~L~ls~c~~~~~~----------------- 137 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF-----ALQTLLSSCSRLDELNLSWCFDFTEK----------------- 137 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH-----HHHHHHHHCTTCCEEECCCCTTCCHH-----------------
T ss_pred ccCCCcHHHHHHhcCCCCcCcccccccccccc-----ccchhhHHHHhccccccccccccccc-----------------
Confidence 77766555556666777777777763 34321 11122345667777777764 23210
Q ss_pred cCccccccCChhhhc-CCCCCeEeccCC--ccccc-CCccccCCCCCCEEEcccc-cCcccCCccccCCCCCCeEEeecc
Q 040925 207 GRNQISGTIPPGIRN-LVNLIGFGAEEN--QLHGT-IPDAIGELKNLQKLCLFRN-FLQGRIPSGLGNLTKLANLELSSN 281 (833)
Q Consensus 207 ~~n~i~~~~~~~~~~-l~~L~~L~L~~N--~l~~~-~~~~~~~l~~L~~L~L~~N-~l~~~~~~~~~~l~~L~~L~L~~N 281 (833)
.....+.. .++|+.|+++++ .++.. +...+..+++|++|+|++| .+++.....+..+++|++|+|++|
T Consensus 138 -------~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C 210 (284)
T d2astb2 138 -------HVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 210 (284)
T ss_dssp -------HHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred -------cchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCC
Confidence 01111222 356788888764 33322 2233456788999999885 467666677888888999999884
Q ss_pred -cccCCCCCCCCCCCccceeecCCc
Q 040925 282 -SLQGNIPSSLGNCQNLMSFTASQN 305 (833)
Q Consensus 282 -~l~~~~~~~~~~l~~L~~L~l~~N 305 (833)
.++......++.+++|+.|+++++
T Consensus 211 ~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 211 YDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCChHHHHHHhcCCCCCEEeeeCC
Confidence 676555566777888888888776
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.53 E-value=2.5e-16 Score=166.61 Aligned_cols=90 Identities=17% Similarity=0.245 Sum_probs=47.1
Q ss_pred hhcCCCCCeEeccCCccccc----CCccccCCCCCCEEEcccccCcccCCcc----cc--CCCCCCeEEeecccccCC--
Q 040925 219 IRNLVNLIGFGAEENQLHGT----IPDAIGELKNLQKLCLFRNFLQGRIPSG----LG--NLTKLANLELSSNSLQGN-- 286 (833)
Q Consensus 219 ~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~----~~--~l~~L~~L~L~~N~l~~~-- 286 (833)
+..+++|+.|+|++|.++.. +...+...++|++|+|++|.|++..... +. ....|++|++++|+|+..
T Consensus 211 l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~ 290 (344)
T d2ca6a1 211 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 290 (344)
T ss_dssp GGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHH
T ss_pred hcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHH
Confidence 44556666666666665432 2334455666666666666665432222 21 234566666666666522
Q ss_pred --CCCCCC-CCCccceeecCCceec
Q 040925 287 --IPSSLG-NCQNLMSFTASQNKLT 308 (833)
Q Consensus 287 --~~~~~~-~l~~L~~L~l~~N~l~ 308 (833)
+...+. ++++|+.|++++|++.
T Consensus 291 ~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 291 RTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp HHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred HHHHHHHHccCCCCCEEECCCCcCC
Confidence 112221 3455666666666664
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.52 E-value=5.9e-16 Score=163.68 Aligned_cols=251 Identities=17% Similarity=0.194 Sum_probs=140.1
Q ss_pred ccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCccc---CChhHhhhcccccEEEccCccccccCC
Q 040925 140 FSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGE---LPHSIANLSSTVINFGIGRNQISGTIP 216 (833)
Q Consensus 140 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~~l~~L~l~~n~i~~~~~ 216 (833)
+...+.|+.|+|++|.+...... .+...+...++|+.|+++++..... .|..+. .+.
T Consensus 27 L~~~~~l~~L~Ls~n~i~~~~~~--~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~------------------~l~ 86 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGNTIGTEAAR--WLSENIASKKDLEIAEFSDIFTGRVKDEIPEALR------------------LLL 86 (344)
T ss_dssp HHHCSCCCEEECTTSEECHHHHH--HHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHH------------------HHH
T ss_pred HhhCCCCCEEECcCCcCCHHHHH--HHHHHHHhCCCCCEEECCCCcccccccccchHHH------------------HHH
Confidence 44566777777777766432111 1223456667777777776654311 111111 112
Q ss_pred hhhhcCCCCCeEeccCCccccc----CCccccCCCCCCEEEcccccCcccCCccc-------------cCCCCCCeEEee
Q 040925 217 PGIRNLVNLIGFGAEENQLHGT----IPDAIGELKNLQKLCLFRNFLQGRIPSGL-------------GNLTKLANLELS 279 (833)
Q Consensus 217 ~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~~-------------~~l~~L~~L~L~ 279 (833)
..+...++|+.|+|++|.+... +...+...++|++|++++|.+.......+ ...+.|+.|+++
T Consensus 87 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~ 166 (344)
T d2ca6a1 87 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 166 (344)
T ss_dssp HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECC
T ss_pred HHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecc
Confidence 3445566777777777776643 23334456777777777776642111111 234456666666
Q ss_pred cccccCCC----CCCCCCCCccceeecCCceecccCCcccccccccceeeecCCCccCCCCCcccccCCCcCEEeccCCc
Q 040925 280 SNSLQGNI----PSSLGNCQNLMSFTASQNKLTGALPHQLLSITTLSLYLDLSNNLLNGSLPLQVGHLKNLVILDISSNQ 355 (833)
Q Consensus 280 ~N~l~~~~----~~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ll~~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N~ 355 (833)
+|++.... ...+...+.|+.|++++|+++.. .+. ..+...+..+++|+.|+|++|.
T Consensus 167 ~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~---g~~-----------------~~l~~~l~~~~~L~~L~Ls~N~ 226 (344)
T d2ca6a1 167 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE---GIE-----------------HLLLEGLAYCQELKVLDLQDNT 226 (344)
T ss_dssp SSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHH---HHH-----------------HHHHTTGGGCTTCCEEECCSSC
T ss_pred cccccccccccccchhhhhhhhccccccccccccc---ccc-----------------cchhhhhcchhhhccccccccc
Confidence 66554211 11222334444444444444310 000 0122345667888888888888
Q ss_pred CCCC----CCccccCCCCCcEEeecCCccccccCc----ccc--CCCCCCeEEccCcccCCC----chhhhc-CCCCCce
Q 040925 356 FSGV----IPGTLSTCVCLEYLDISSNSFHGVIPL----SLS--FLKSIKELNVSSNNLSGQ----IPEFLK-NLSVLEF 420 (833)
Q Consensus 356 l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~~~----~~~--~l~~L~~L~l~~N~l~~~----~p~~l~-~l~~L~~ 420 (833)
++.. +...+..+++|++|+|++|.|++.... .+. ..+.|++|++++|+|+.. +...+. +++.|++
T Consensus 227 i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~ 306 (344)
T d2ca6a1 227 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 306 (344)
T ss_dssp CHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCE
T ss_pred ccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCE
Confidence 7532 334567788888888888888754222 222 235788888888888642 233343 5678888
Q ss_pred EECccCcCcc
Q 040925 421 LSLSYNHFEG 430 (833)
Q Consensus 421 L~l~~N~l~~ 430 (833)
|+|++|.+..
T Consensus 307 L~l~~N~~~~ 316 (344)
T d2ca6a1 307 LELNGNRFSE 316 (344)
T ss_dssp EECTTSBSCT
T ss_pred EECCCCcCCC
Confidence 8888888864
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=4.4e-14 Score=129.39 Aligned_cols=134 Identities=19% Similarity=0.133 Sum_probs=105.9
Q ss_pred eeecCCCccCCCCCcccccCCCcCEEeccCC-cCCCCCCccccCCCCCcEEeecCCccccccCccccCCCCCCeEEccCc
Q 040925 324 YLDLSNNLLNGSLPLQVGHLKNLVILDISSN-QFSGVIPGTLSTCVCLEYLDISSNSFHGVIPLSLSFLKSIKELNVSSN 402 (833)
Q Consensus 324 ~L~ls~N~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 402 (833)
.++.+++.+. ..|..+..+++|++|++++| .|+.+.+++|.++++|+.|+|++|+|+.+.+.+|..+++|+.|+|++|
T Consensus 12 ~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N 90 (156)
T d2ifga3 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (156)
T ss_dssp CEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred eEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCC
Confidence 4677777777 56777888999999999866 598888899999999999999999999998999999999999999999
Q ss_pred ccCCCchhhhcCCCCCceEECccCcCccccCCCC--ccCCCccccccCCcCCCCCcccC
Q 040925 403 NLSGQIPEFLKNLSVLEFLSLSYNHFEGEVPTKG--VFSNKTKISLQGNMKLCGGIDEL 459 (833)
Q Consensus 403 ~l~~~~p~~l~~l~~L~~L~l~~N~l~~~~~~~~--~~~~~~~l~l~~N~~~c~~~~~~ 459 (833)
+|+...+..+..+ .|+.|+|++|+|.|.+...+ .|.......+..+...|.++...
T Consensus 91 ~l~~l~~~~~~~~-~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l 148 (156)
T d2ifga3 91 ALESLSWKTVQGL-SLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPL 148 (156)
T ss_dssp CCSCCCSTTTCSC-CCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCS
T ss_pred CCcccChhhhccc-cccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHH
Confidence 9997666667655 69999999999998775321 12222333444566677766543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.44 E-value=6.3e-16 Score=148.28 Aligned_cols=155 Identities=19% Similarity=0.217 Sum_probs=109.3
Q ss_pred CCCEEEccCC--cccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEE
Q 040925 24 DLEVIRIMGN--SLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKAL 101 (833)
Q Consensus 24 ~L~~L~l~~n--~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L 101 (833)
.++.+++.++ .+ ..+|.+|..+++|++|+|++|+|+.+ + .|.++++|+.|+|++|+|+ .+|. .+..+++|++|
T Consensus 24 ~~~~~~l~~~~~~i-~~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~-~~~~~~~L~~L 98 (198)
T d1m9la_ 24 EAEKVELHGMIPPI-EKMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIEN-LDAVADTLEEL 98 (198)
T ss_dssp TCSCEECCBCCTTC-CCCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSS-HHHHHHHCCEE
T ss_pred ccceeeeecccCch-hhhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-cccc-ccccccccccc
Confidence 4555666654 34 44566788888888888888888843 3 5888888888888888887 6663 44456678888
Q ss_pred EccCCcceeeCCccccCCCCCcEEEcccCccccccC-cCccCCCcCceEecccccCCCCCCCCcccc----cccCCCCCC
Q 040925 102 AIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVS-IDFSSLKNLLWLNLEQNNLGTGTATDLDFV----TFLTNCSSL 176 (833)
Q Consensus 102 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~----~~l~~l~~L 176 (833)
++++|+|+.+ ..+..+++|++|+|++|+|+.+.. ..|..+++|++|+|++|.+........... ..+..+|+|
T Consensus 99 ~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L 176 (198)
T d1m9la_ 99 WISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176 (198)
T ss_dssp ECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSC
T ss_pred cccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCc
Confidence 8888888743 347778888888888888887654 467888888888888887765433221111 125678899
Q ss_pred CEEEccCCcCc
Q 040925 177 KALSLADNQFG 187 (833)
Q Consensus 177 ~~L~Ls~N~l~ 187 (833)
+.|| +..++
T Consensus 177 ~~LD--~~~I~ 185 (198)
T d1m9la_ 177 KKLD--GMPVD 185 (198)
T ss_dssp CEES--SGGGT
T ss_pred CEeC--CccCC
Confidence 9886 44443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=5.8e-14 Score=128.58 Aligned_cols=108 Identities=16% Similarity=0.103 Sum_probs=81.3
Q ss_pred CCCCEEEccCCcccccCCccCCCCCCCCEEEcCCC-cccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEE
Q 040925 23 SDLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAEN-KFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKAL 101 (833)
Q Consensus 23 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L 101 (833)
...+.++.+++.+ ...|..+..+++|++|+|++| .|+.+.+.+|.++++|+.|+|++|+|+ .+++++|.++++|++|
T Consensus 8 ~~~~~l~c~~~~~-~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 8 HGSSGLRCTRDGA-LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRL 85 (156)
T ss_dssp SSSSCEECCSSCC-CTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGGGSCSCCCEE
T ss_pred CCCCeEEecCCCC-ccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccC-Ccccccccccccccce
Confidence 3456677777777 446667777888888888655 477777777888888888888888887 7777888888888888
Q ss_pred EccCCcceeeCCccccCCCCCcEEEcccCccc
Q 040925 102 AIGGNNFFGSIPYSLSNASNLELLDLSVNQFK 133 (833)
Q Consensus 102 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~ 133 (833)
+|++|+|+.+.+..|..+ +|++|+|++|.+.
T Consensus 86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred eccCCCCcccChhhhccc-cccccccCCCccc
Confidence 888888875555556554 6888888888774
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.44 E-value=4.9e-16 Score=149.07 Aligned_cols=133 Identities=20% Similarity=0.211 Sum_probs=92.9
Q ss_pred CCCCEEEcCCC--cccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeCCccccCCCCCcE
Q 040925 47 RNLVSLNVAEN--KFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSIPYSLSNASNLEL 124 (833)
Q Consensus 47 ~~L~~L~L~~n--~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 124 (833)
..++.++++++ .+. .++.+|..+++|++|+|++|+|+ .++. +.++++|++|+|++|.|+ .+|..+..+++|++
T Consensus 23 ~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~-~i~~--l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~ 97 (198)
T d1m9la_ 23 TEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS--LSGMENLRILSLGRNLIK-KIENLDAVADTLEE 97 (198)
T ss_dssp TTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEES-CCCC--HHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCE
T ss_pred cccceeeeecccCchh-hhhhHHhcccccceeECcccCCC-Cccc--ccCCccccChhhcccccc-cccccccccccccc
Confidence 34555666554 243 45667888888888888888887 5652 667888888888888887 44555555667888
Q ss_pred EEcccCccccccCcCccCCCcCceEecccccCCCCCCCCcccccccCCCCCCCEEEccCCcCcccCC
Q 040925 125 LDLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQFGGELP 191 (833)
Q Consensus 125 L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~p 191 (833)
|++++|+|+.+. .+..+++|++|+|++|+|+.++ ....+..+++|++|+|++|++....+
T Consensus 98 L~l~~N~i~~l~--~~~~l~~L~~L~L~~N~i~~~~-----~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 98 LWISYNQIASLS--GIEKLVNLRVLYMSNNKITNWG-----EIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp EECSEEECCCHH--HHHHHHHSSEEEESEEECCCHH-----HHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred cccccccccccc--cccccccccccccccchhcccc-----ccccccCCCccceeecCCCccccCcc
Confidence 888888887653 4777888888888888876532 12346778888888888887764443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.64 E-value=4.2e-10 Score=103.21 Aligned_cols=121 Identities=25% Similarity=0.197 Sum_probs=82.5
Q ss_pred CCCEEEccCCcccccCCccCCCCCCCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccC--chhhcCCCCccEE
Q 040925 24 DLEVIRIMGNSLGGKIPTTLGLLRNLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLP--FDIVVNLPNLKAL 101 (833)
Q Consensus 24 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~~~~l~~L~~L 101 (833)
..+.|++++++. .+ .+..+..+..|++.+|.+. .++..+.++++|++|+|++|+|+ .++ ...+..+++|+.|
T Consensus 23 ~~~~Ldls~l~~---~~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 23 SQQALDLKGLRS---DP-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSCCBCCCCCSS---CT-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCC
T ss_pred hhCeeecccCCC---Cc-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCcccc-CCchhHHHHhhCCccccc
Confidence 445566666543 22 3455555666666666554 45666677888888888888887 554 2456778888889
Q ss_pred EccCCcceeeCCccccCCCCCcEEEcccCccccccCc-------CccCCCcCceEe
Q 040925 102 AIGGNNFFGSIPYSLSNASNLELLDLSVNQFKGNVSI-------DFSSLKNLLWLN 150 (833)
Q Consensus 102 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~-------~~~~l~~L~~L~ 150 (833)
+|++|.|+...+-.+.+..+|++|+|++|.+...... .+..+++|+.||
T Consensus 97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 9999888865554455556788899999988754432 256788888875
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=5.6e-10 Score=102.30 Aligned_cols=131 Identities=18% Similarity=0.163 Sum_probs=95.2
Q ss_pred CCCEEEcCCCcccccCCccccCCCCCcEEECCCcccccccCchhhcCCCCccEEEccCCcceeeC--CccccCCCCCcEE
Q 040925 48 NLVSLNVAENKFSGMFPRSICNISSLELIQLALNRFSGNLPFDIVVNLPNLKALAIGGNNFFGSI--PYSLSNASNLELL 125 (833)
Q Consensus 48 ~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L 125 (833)
..+.|++++++.. ..+..+..+..++...|... . ...++..+++|++|+|++|+|+... +..+..+++|+.|
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~-l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-T-LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-H-HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-h-hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccc
Confidence 4667888776643 23555566666666666553 3 3467778999999999999998653 3557889999999
Q ss_pred EcccCccccccCcCccCCCcCceEecccccCCCCCCCCcc-cccccCCCCCCCEEEccCCcC
Q 040925 126 DLSVNQFKGNVSIDFSSLKNLLWLNLEQNNLGTGTATDLD-FVTFLTNCSSLKALSLADNQF 186 (833)
Q Consensus 126 ~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~~~~l~~l~~L~~L~Ls~N~l 186 (833)
+|++|+|+.+....+....+|+.|+|++|.+......... ....+..+|+|+.|| ++++
T Consensus 97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET--TEEC
T ss_pred ccccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC--cCCC
Confidence 9999999988876676777899999999999764432211 113366789999986 5544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=1.6e-07 Score=93.46 Aligned_cols=149 Identities=17% Similarity=0.193 Sum_probs=105.5
Q ss_pred HHHHHHhcCCccCceeccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCC
Q 040925 524 AELSKATGEFSSSNMIGQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDF 602 (833)
Q Consensus 524 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 602 (833)
.++......|+.++..+.++.+.||++.. ++..+++|+...........+.+|...++.+. +--+.++++++...+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~- 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG- 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT-
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC-
Confidence 46667778888777766566679999864 45667889886554445556888999988874 433567777654443
Q ss_pred CCCceEeEEEEecCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC-----------------------
Q 040925 603 KGTDFKAFVFEYMENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC----------------------- 659 (833)
Q Consensus 603 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~----------------------- 659 (833)
..++||++++|.++.+...... ....++.++++.++.||+..
T Consensus 84 ----~~~lv~~~l~G~~~~~~~~~~~-----------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (263)
T d1j7la_ 84 ----WSNLLMSEADGVLCSEEYEDEQ-----------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNN 148 (263)
T ss_dssp ----EEEEEEECCSSEEHHHHTTTCS-----------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHT
T ss_pred ----ceEEEEEecccccccccccccc-----------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHH
Confidence 7899999999988866543211 12335566677777777531
Q ss_pred ---------------------------------CCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 660 ---------------------------------QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 660 ---------------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
.+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 149 DLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237999999999999887667799999886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.03 E-value=3.8e-06 Score=82.68 Aligned_cols=130 Identities=15% Similarity=0.118 Sum_probs=85.5
Q ss_pred eeccCcc-eEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCC--CccceEeeEeecCCCCCCceEeEEEEe
Q 040925 538 MIGQGSF-GYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRH--RNLIKIITICSSTDFKGTDFKAFVFEY 614 (833)
Q Consensus 538 ~lg~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~ 614 (833)
.+..|.. +.||++... ++..+++|..... ....+..|.+.++.+.. -.+.++++++.+.+ ..++||+|
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~-----~~~~v~~~ 87 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAG-----RDWLLLGE 87 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSS-----CEEEEEEC
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeeccccc-----ceEEEEEe
Confidence 4455554 689999875 5667888986533 33467889998888743 33567777655443 68899999
Q ss_pred cCCCChhhhhccCCCccccccCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 040925 615 MENGSLKDWLHQSDDQVEVCKLSLIQRVNIAIDVASAMEYLHHHC----------------------------------- 659 (833)
Q Consensus 615 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~gL~~LH~~~----------------------------------- 659 (833)
++|.++.+.. ... ...+.++++.++-||+..
T Consensus 88 i~G~~~~~~~-----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (255)
T d1nd4a_ 88 VPGQDLLSSH-----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 153 (255)
T ss_dssp CSSEETTTSC-----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred eecccccccc-----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchh
Confidence 9986654321 111 112234444444454321
Q ss_pred --------------------CCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 660 --------------------QPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 660 --------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
.+.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 154 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1247999999999999987777899999875
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.91 E-value=1.5e-05 Score=83.51 Aligned_cols=77 Identities=17% Similarity=0.154 Sum_probs=50.8
Q ss_pred CceeccCcceEEEEEEECCCceEEEEEEeecc-------CCcchhHHHHHHHHHhhcC-C--CccceEeeEeecCCCCCC
Q 040925 536 SNMIGQGSFGYVYKGTLGEDEMIVAVKVINLK-------YKGASRSFVAECEALRNIR-H--RNLIKIITICSSTDFKGT 605 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~~~~ 605 (833)
.+.||.|....||+++...+++.|+||.-... .....++...|.+.++.+. + ..+.+++++..+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~------ 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE------ 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC------
Confidence 45789999999999998777888999975321 1123355677999888773 2 456677765322
Q ss_pred ceEeEEEEecCCCC
Q 040925 606 DFKAFVFEYMENGS 619 (833)
Q Consensus 606 ~~~~lv~e~~~~gs 619 (833)
..++|||++++..
T Consensus 105 -~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 -MAVTVMEDLSHLK 117 (392)
T ss_dssp -TTEEEECCCTTSE
T ss_pred -CCEEEEeccCCcc
Confidence 3478999997644
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.72 E-value=4e-06 Score=76.30 Aligned_cols=89 Identities=15% Similarity=0.182 Sum_probs=43.7
Q ss_pred ccCCCCCcEEECCCcccccccC---chhhcCCCCccEEEccCCcceee----CCccccCCCCCcEEEcccCccccccC--
Q 040925 67 ICNISSLELIQLALNRFSGNLP---FDIVVNLPNLKALAIGGNNFFGS----IPYSLSNASNLELLDLSVNQFKGNVS-- 137 (833)
Q Consensus 67 ~~~l~~L~~L~L~~N~l~~~~~---~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~i~~~~~-- 137 (833)
+...++|+.|+|++|.+.+.-. .+++...+.|++|+|++|.|+.. +-.++...+.|++|+|++|++..+..
T Consensus 40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~ 119 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQV 119 (167)
T ss_dssp HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHH
T ss_pred HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHH
Confidence 4444455555555555431100 11233345556666666655421 12235555667777777766554321
Q ss_pred -----cCccCCCcCceEeccccc
Q 040925 138 -----IDFSSLKNLLWLNLEQNN 155 (833)
Q Consensus 138 -----~~~~~l~~L~~L~L~~N~ 155 (833)
..+..-+.|+.|+++.+.
T Consensus 120 ~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 120 EMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHHHhCCCccEeeCcCCC
Confidence 223345667777766553
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.66 E-value=7e-06 Score=74.62 Aligned_cols=18 Identities=17% Similarity=0.301 Sum_probs=8.4
Q ss_pred ccCCCCCcEEEcccCccc
Q 040925 116 LSNASNLELLDLSVNQFK 133 (833)
Q Consensus 116 ~~~l~~L~~L~L~~N~i~ 133 (833)
+...++|++|+|++|.+.
T Consensus 40 L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 40 ACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp HTTCSCCCEEECTTSCCB
T ss_pred HhhCCccceeeccccccc
Confidence 334444555555555443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.18 E-value=0.00023 Score=72.20 Aligned_cols=72 Identities=14% Similarity=0.085 Sum_probs=45.8
Q ss_pred eEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCcc--ceEeeEeecCCCCCCceEeEEEEecCCC
Q 040925 545 GYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNL--IKIITICSSTDFKGTDFKAFVFEYMENG 618 (833)
Q Consensus 545 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~g 618 (833)
-.||+++.. +|+.|++|+.+... ...+++..|.+.+..+....+ +..........+...+..+.++++++|.
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 589999885 78889999987542 245668889999988852222 2222111111122345678899999864
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.16 E-value=1.8e-05 Score=71.91 Aligned_cols=19 Identities=16% Similarity=0.204 Sum_probs=10.9
Q ss_pred ccCCCCCCCEEEccCCcCc
Q 040925 169 FLTNCSSLKALSLADNQFG 187 (833)
Q Consensus 169 ~l~~l~~L~~L~Ls~N~l~ 187 (833)
.+...++|++|+|++|.++
T Consensus 41 al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 41 ALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HHTTCCSCCEEECTTSCCC
T ss_pred HHhcCCccCeeeccCCccc
Confidence 3445556666666666554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.13 E-value=5.1e-05 Score=68.69 Aligned_cols=69 Identities=19% Similarity=0.276 Sum_probs=32.0
Q ss_pred ccCCCCCcEEEcccCccccccC----cCccCCCcCceEec--ccccCCCCCCCCcccccccCCCCCCCEEEccCCcC
Q 040925 116 LSNASNLELLDLSVNQFKGNVS----IDFSSLKNLLWLNL--EQNNLGTGTATDLDFVTFLTNCSSLKALSLADNQF 186 (833)
Q Consensus 116 ~~~l~~L~~L~L~~N~i~~~~~----~~~~~l~~L~~L~L--~~N~l~~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l 186 (833)
+...+.++.|++++|.+..... ..+...++|+.++| ++|.+... ....+...+...++|+.|+++.+..
T Consensus 70 l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~--~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 70 LKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNN--VEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHH--HHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHH--HHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 3344555555555555542211 23344455554333 23333221 1112334455666777777766654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.71 E-value=0.0022 Score=66.65 Aligned_cols=74 Identities=20% Similarity=0.173 Sum_probs=50.7
Q ss_pred CceeccCcceEEEEEEECC-------CceEEEEEEeeccCCcchhHHHHHHHHHhhcC-CCccceEeeEeecCCCCCCce
Q 040925 536 SNMIGQGSFGYVYKGTLGE-------DEMIVAVKVINLKYKGASRSFVAECEALRNIR-HRNLIKIITICSSTDFKGTDF 607 (833)
Q Consensus 536 ~~~lg~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 607 (833)
++.|+.|-.-.+|++.... ..+.|++++.. .. .......+|..+++.+. +.-..++++++. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~------ 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G------ 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C------
Confidence 3678888889999998753 24567777764 22 23345678999999885 544567877742 1
Q ss_pred EeEEEEecCCCCh
Q 040925 608 KAFVFEYMENGSL 620 (833)
Q Consensus 608 ~~lv~e~~~~gsL 620 (833)
.+||||++|.++
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 579999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.68 E-value=0.0021 Score=64.51 Aligned_cols=166 Identities=10% Similarity=0.014 Sum_probs=85.8
Q ss_pred cchHHHHHHhcCCccCcee-----ccCcceEEEEEEECCCceEEEEEEeeccCCcchhHHHHHHHHHhhcCCCcc--ceE
Q 040925 521 VSYAELSKATGEFSSSNMI-----GQGSFGYVYKGTLGEDEMIVAVKVINLKYKGASRSFVAECEALRNIRHRNL--IKI 593 (833)
Q Consensus 521 ~~~~~~~~~~~~y~~~~~l-----g~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~ 593 (833)
++.+++.....+|.+.+.. ..|---+.|+++.. +| .+++|++... ...+.+..|++++..+...++ ...
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~p 78 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLP 78 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCC--CCHHHHHHHHHHHHhhhhcccccccc
Confidence 4677888888889775443 45666788999875 34 4899998643 234566778888888743222 111
Q ss_pred eeEeecCC-CCCCceEeEEEEecCCCChhhhhcc------------------CCCccc-----------------cccCC
Q 040925 594 ITICSSTD-FKGTDFKAFVFEYMENGSLKDWLHQ------------------SDDQVE-----------------VCKLS 637 (833)
Q Consensus 594 ~~~~~~~~-~~~~~~~~lv~e~~~~gsL~~~l~~------------------~~~~~~-----------------~~~l~ 637 (833)
........ ..-......++.+..+......-.. ...... .....
T Consensus 79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 158 (316)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence 11100000 0012345566777665332110000 000000 00000
Q ss_pred HHHHHHHHHHHHHHHHHHhhc-CCCCceeeCCCCCCeeecCCCcEEEccccccc
Q 040925 638 LIQRVNIAIDVASAMEYLHHH-CQPPMVHGDLKPSNVLLDHDMVAHVCDFGLAK 690 (833)
Q Consensus 638 ~~~~~~i~~qi~~gL~~LH~~-~~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 690 (833)
.......+......+.-.+.. ...|+||+|+.++||+++.+...-++||+.|.
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 111112222222222322221 23489999999999999988877899999886
|